<SEC-DOCUMENT>0000920148-20-000058.txt : 20201029
<SEC-HEADER>0000920148-20-000058.hdr.sgml : 20201029
<ACCEPTANCE-DATETIME>20201029095401
ACCESSION NUMBER:		0000920148-20-000058
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		78
CONFORMED PERIOD OF REPORT:	20200930
FILED AS OF DATE:		20201029
DATE AS OF CHANGE:		20201029

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LABORATORY CORP OF AMERICA HOLDINGS
		CENTRAL INDEX KEY:			0000920148
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				133757370
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11353
		FILM NUMBER:		201270848

	BUSINESS ADDRESS:	
		STREET 1:		358 S MAIN ST
		CITY:			BURLINGTON
		STATE:			NC
		ZIP:			27215
		BUSINESS PHONE:		3362291127

	MAIL ADDRESS:	
		STREET 1:		358 S MAIN ST
		CITY:			BURLINGTON
		STATE:			NC
		ZIP:			27215

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NATIONAL HEALTH LABORATORIES HOLDINGS INC
		DATE OF NAME CHANGE:	19940314
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>lh-20200930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:fc8a7d57-4cce-43ce-b480-996ae8b97c72,g:096b564a-e6b9-41cc-ab37-c90f57b146f8,d:417074d9a2c24c34bcac25f32d2ec0c1--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:lh="http://www.labcorp.com/20200930" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>lh-20200930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMy9mcmFnOjEwN2ZkOTQ2ZjgwYjQyMjg4M2M5YTJjMTZhOWNmYTI4L3RhYmxlOmEwYmEwNmU3NzEzMTQwNTViOGZmOGY5OTA0OGU2YzhkL3RhYmxlcmFuZ2U6YTBiYTA2ZTc3MTMxNDA1NWI4ZmY4Zjk5MDQ4ZTZjOGRfMi0xLTEtMS0w_59c5087c-eff0-4120-afef-735f23faddd0">26.6</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMy9mcmFnOjEwN2ZkOTQ2ZjgwYjQyMjg4M2M5YTJjMTZhOWNmYTI4L3RhYmxlOmEwYmEwNmU3NzEzMTQwNTViOGZmOGY5OTA0OGU2YzhkL3RhYmxlcmFuZ2U6YTBiYTA2ZTc3MTMxNDA1NWI4ZmY4Zjk5MDQ4ZTZjOGRfMi0zLTEtMS0w_c021f123-4ec4-41e5-92c2-6d39d9216f5d">19.0</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMy9mcmFnOjEwN2ZkOTQ2ZjgwYjQyMjg4M2M5YTJjMTZhOWNmYTI4L3RhYmxlOmEwYmEwNmU3NzEzMTQwNTViOGZmOGY5OTA0OGU2YzhkL3RhYmxlcmFuZ2U6YTBiYTA2ZTc3MTMxNDA1NWI4ZmY4Zjk5MDQ4ZTZjOGRfNS0xLTEtMS0w_0c06064b-9f24-4c4d-8614-7577dbccc8e8">97.4</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMy9mcmFnOjEwN2ZkOTQ2ZjgwYjQyMjg4M2M5YTJjMTZhOWNmYTI4L3RhYmxlOmEwYmEwNmU3NzEzMTQwNTViOGZmOGY5OTA0OGU2YzhkL3RhYmxlcmFuZ2U6YTBiYTA2ZTc3MTMxNDA1NWI4ZmY4Zjk5MDQ4ZTZjOGRfNS0zLTEtMS0w_854495a5-cd14-4bd4-a5c3-03e48bfaf61f">97.2</ix:nonFraction><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMjQvZnJhZzo1ODVhMjgzNzI3MzU0ZGMzOTAxOTZkNDJjMjg0ZTA0MS90YWJsZTo1YzU4YTQ0ZWQ2YTU0ODkzYTQ2MjY5NDM4NGQwZGUwMS90YWJsZXJhbmdlOjVjNThhNDRlZDZhNTQ4OTNhNDYyNjk0Mzg0ZDBkZTAxXzQtMS0xLTEtMA_1799b277-aad9-49b1-9874-9ee8f0c1d96d">0000920148</ix:nonNumeric><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMjQvZnJhZzo1ODVhMjgzNzI3MzU0ZGMzOTAxOTZkNDJjMjg0ZTA0MS90YWJsZTo1YzU4YTQ0ZWQ2YTU0ODkzYTQ2MjY5NDM4NGQwZGUwMS90YWJsZXJhbmdlOjVjNThhNDRlZDZhNTQ4OTNhNDYyNjk0Mzg0ZDBkZTAxXzUtMS0xLTEtMA_43877e13-58eb-4423-9741-90cb59df6019">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMjQvZnJhZzo1ODVhMjgzNzI3MzU0ZGMzOTAxOTZkNDJjMjg0ZTA0MS90YWJsZTo1YzU4YTQ0ZWQ2YTU0ODkzYTQ2MjY5NDM4NGQwZGUwMS90YWJsZXJhbmdlOjVjNThhNDRlZDZhNTQ4OTNhNDYyNjk0Mzg0ZDBkZTAxXzktMS0xLTEtMA_b9a2ad55-849c-45e0-a164-c7d36f341ad5">2020</ix:nonNumeric><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMjQvZnJhZzo1ODVhMjgzNzI3MzU0ZGMzOTAxOTZkNDJjMjg0ZTA0MS90YWJsZTo1YzU4YTQ0ZWQ2YTU0ODkzYTQ2MjY5NDM4NGQwZGUwMS90YWJsZXJhbmdlOjVjNThhNDRlZDZhNTQ4OTNhNDYyNjk0Mzg0ZDBkZTAxXzEwLTEtMS0xLTA_01b5fe14-28bb-4dee-9ed8-0698564348a9">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMjQvZnJhZzo1ODVhMjgzNzI3MzU0ZGMzOTAxOTZkNDJjMjg0ZTA0MS90YWJsZTo1YzU4YTQ0ZWQ2YTU0ODkzYTQ2MjY5NDM4NGQwZGUwMS90YWJsZXJhbmdlOjVjNThhNDRlZDZhNTQ4OTNhNDYyNjk0Mzg0ZDBkZTAxXzExLTEtMS0xLTA_e94037f3-8791-4e11-8a56-6add6577584b">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="lh-20200930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i3cbe3c928a064308830aa690527b4879_I20201028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3142bfab671e4d37943fa55426510724_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i7ed61e2c58d04a4f96f4455f58dc8906_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibaa1c40cdb9547b6aa52d2c4edcc8188_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i102884c59d1543caa2ca620678208c40_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79d400b1fb3b429b8cf4d8afe9e3f8b2_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibedc8534cf6f4afb870b205b0eee4330_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ac49907696d40399215ce933a047245_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d1cc0f890c444fc8065f85eaf2c3eb2_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9805616bfc147a685777006a4f3a977_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fd2acd8725944849260da540e21b13e_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6aecc811560c4997ad0a94f7656fb5f2_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3aa1360071d489f9642129871989937_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedd14e246c1d49da9ac324e7575d5643_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dd1e22b6a154e39814fd636f0fab4ce_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i749c4690686f45c3b2850fcbb9a0d1df_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9b90f619f8b4a7083d154d69233d90f_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4aa40f4beab4847b0614e40e1cd143c_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib974ad7e470d46998daf31767f2af398_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bdc2fd7db454059a73ac63fbcf696e8_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic342c0d96ffa4ec4ba03f2801ad1e983_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib09142dcedba4260954ddf2d9692acb6_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83d083f1fa054115979e180a0197c0c3_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f0351d0ac5340749dcbd3417ca3b6cf_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75641ae84a834af19a49dbc2f325caa0_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fed346eafa54192b0996a2c5e59af06_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia796b50fb78c4d8ea1305d6cb87f4c80_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5fd99aa026e4d049d9880148cd3673f_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41dc70e79a434c8584c71c9871c4d297_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3830d635761e46d59cb5beb48e8e5c06_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4332a0967964a7e951d06b4f757007e_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbf3e729d39d476fbac2a1d7b95feece_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cc52edd079c41dba66111baf03d7d8d_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f2b2ef9fa394b91a5ebeb5644627072_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92acbc0b60c64d71979b7d2ca0a3d393_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8dc748344574f268131764ada7e2c98_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i330e9e0c1f764aa28705cf6255807ed9_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e93e2032f774e388fbc09993a955665_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i219dadfad6ec4f15ab02c46b30294757_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i121e54f584574754a997b2e8da14cb33_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf92e2a580e040a495fdd34dbb61b1e3_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52114c8d18b9499a9e0444fcbab899ab_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ebf6d35695d43bebd0e1036cfd88d00_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6295bf6566e4265bac5d6f0714100b1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i995498342f4d4bbeb12d006cd72d61b1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id047e5b85b904a12801017a2fd441c52_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4d943c067664cd3bb4ef38017cfc703_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb05081604c34e979bb4fd456055049e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8a89f8ac83b437aa6f0f277429e7b04_I20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d1419fac15d45ba8998356ea892ab07_I20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic71057ddd9b94ee9bbf0a3919bd94bd4_I20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0b1ac80eac24afe88d4fb1b2e16aefd_I20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia31964c5cf72480688ceb520816d7665_I20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib51bcbbe3b3b40dabc2fef3fab8b97b2_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0abf8234cd2f4de5ad2609359991f8d3_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id31a66599db3453db1095d8dd3713397_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2584e4e56f14caaa4332a71ef56576f_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25486ee4361d42f18c47644aa116250b_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia962c16050fa4b28adc73e0d729703c5_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d6506b821ec4b6a89acd1558aaf0f20_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f1b50d6e33142a797ba59094a4d6109_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ecd2df0683345df840720ba03e366f6_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4033d4ed5ac4e2a90cf122db9d649b7_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i906c32823da3454c88cf7e570cb8bde4_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50a2dfaccda94b87acda43c31ec50e7a_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e645a01cc63416894fda41c9b202e41_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iceabf34577cf4df1ae006d401b431793_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5513a927c4444339f73687e0a972d90_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f4911a3cd4244faa921cef6beedbda0_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70e36036ee974a9383e7b832ec83f7bf_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i612a5521f96f4a1db5dcc91dda46a2e8_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a0d6c3c99214086849193c76b863382_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6421b026529d4cb8a7d4ed4b2b200529_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35550650089c49acaebcaf52a144d1f7_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad6fff0892aa4905843f6f15944bd070_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie055d220bf39404a910b28a899727919_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8272c3d15f864e709f533b5532e0c9c8_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbbfb6e65e55467184de04732ad5dbca_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafb98936914b4c85ad9a3c7728022c47_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84ab37a796dd4ad595c43567718e60ab_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba6759ae8a5847a883ff4cd2ca1523c4_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec50023dc3d34301836e4d6d2ab126fe_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b9f3b204a7e4d5bb84fdca35b0388af_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02dd23ef8e2c4ff6ad5ce9aa02fd57a1_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i003fb35d67544342982c7134cef34000_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb420f938cb849e7b63729c500bdb2ef_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42f654e418554a0aba5b6a17b3942bae_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i1982102278bd444d897b0ac03dedfda5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4674d28875524974925c86ea26137e4b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60bf6e0de9384f37926fac0c0db06385_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if366c14694954f6f84a2c0fe5708324e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e46390b74524a39961dc3a71697bb7f_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">lh:EquityMethodIncomeLossNetDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf06093237eb40b7b4693f9bb03c1107_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47c2cf5a89a849cd94e6efd1d321b938_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia74b9c93ead74b108c97cc4640c2fe07_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9626ef1cd2547cfa89fd9b389064cc6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c47ed00c06b4961a64f099959fe759f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6ce3c437b1e4049899878b45e0fb6e0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib50b6d8435904455951c7565779b7341_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2a6785d04ea48f7a2a1542a0d7d001d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3daf06395da4489ea42ddd3f54707d86_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14aa48993fda4a6f8eaad4578904f2df_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic259290288f44d458eac49b83b8ad944_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16c280dd720347169ee01886277f5b70_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e98179fa8e44ec4aa8b9eb0699e9a4f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6f7b06ec61042f192b8d0c0ecb380fa_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie27a2846b55f44e3bb10629c8b4a6d09_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07d524d7631c4f689e36c4a9e9f86e2c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14a4aff636b04769856789d12e03a871_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea9e025d0f644fa485e22a580d3f4cd7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e22f6a7e0374793b9cefc9bcd3585b5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90ac3c1fb02144f099e252661fe37fe8_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad4735e1e849483bad4da486a568d55c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea9b5f420b964fd5aace6048e7b0921e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5ea73c3e164417cbd60d881836d1e1d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie17f2d3381d644e6bbd5e83aaa53ffe4_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b07ec7181b24fe79db83b2887a77770_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62b5c18a94ba4af9a2783e2211f603d6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ca0e774190547d58bf6ce7ab795efb9_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i085d47025332478a925481cbd318fc65_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5238791a93ca4316b581e997a3d384e3_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee6febeb28ab42fbbe765be16edd24cb_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43148fef08f94203b85d962c5ae8fb07_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03c7187cc2214dcd9fbe27e11b92de30_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia185a66890a2414584681a11add7d192_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a65613c19cd422597c0eebb88c2b3d0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9722f55060174cccbd82ef9b8610b196_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibaa23ac123cf4574b439cc76d55df4f2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd62d7344fa0462a991ba65da1c7ffb7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2c41f77470b457d9ed4965bab8f7ee3_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38839c3f1f934895b768a54821da0a2c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa2e5eb5177045ea88f2c41735e55445_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f6b988e5cc14246b5d95a62c430643d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61068721174646479a719d0d82691d66_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i599da8b7d2d14e4791521d86ea88a36f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fc62abb869f43369975ea7f0bf80db0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d47fd2ebbac412db1f27e585bf53e3f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id53db043a8034950b09968edb83a0607_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i204f3a1eb6b44643b050bf8f2540765d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6f1cdadc4de42b38c3a6a8dddb06604_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6323cfeff41f4159acf7a53bb092c3c6_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9dfb8b56aede469ea13f92e3015dc958_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01dfc480ee174b02ac0b09584e2317ce_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cfe9d5cd85d46b3897e697a5fdd49c7_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7baa4f0065bd47a59ee4fe85f7b5755d_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25a211144dd8470d8b356d8b001c8501_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2281dda8aa1a4d30af776c18df61d1c8_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8052a0e56c404ff5a4113a6c4c023c88_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49463c9f0be949a4b668835f86737567_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic45f90b4ea0f41e9a9f8d1a4f466f54f_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic549b3c324ba47f38e5480ce02fd0558_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie917065bc7e643ca9770aad73add4250_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9414919f80cf49ebb2777851ee4fed37_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9474df2c9ec4f0588048ef29d346752_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3462aa035a72495e9fc1ecf11fbd2049_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i154bbdad5d524723b675883f9c7065a6_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ccb82ced1094bd59e3d613df27e2c24_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie700d5333095493db55774137661401e_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05e2445018784b01a0f279f4ffeb2d49_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c1e1e6af87a4db689abaf6a994ffc67_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i450bf78169c642e09eeb275ebfaeea7c_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifecb6bbb2d3c42288aa163006edb1553_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38357c17172f498586667865e1980e9b_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fc1f599be994436af4c261f3c7f98c1_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cfaa96b273d45b1a241e9f02c7a7c7b_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia021b225de1b429189702e36fc573e16_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i333fbc87a53747a7b8553fad99660865_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i359c7aa0655644ea80c898242ddcf80d_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43a981ae8185490d984dcb30bc0eee10_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i460eab215fae419a8cf81c41cdb90279_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3eef33bbb5e342da8dee7597bfe3f461_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04baf8b50a6c40d5a4d98d6de87046e4_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd95aab1b5024137b07364cf3867cbf8_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ee2ea6e83ea4fc29a6b36fe34613f52_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42d9fc1bf025408c9fe447f1b3cafa5d_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id01bbc615be14b70965d98cee7de2b26_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6502f4abf6b47edaf675df7d9727ce5_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2eab7066fb3e411da4d882666bb1218e_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0ce21fe8c654b7c8a7360072ceba887_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9482ee714bc546369167c573a2564714_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdb48a87cc234ca697c8b0c54bd62d31_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i389ae4c4c9f24473a15143884e9da492_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1df72b2b1d6d4c6fb88d7a315c3cc960_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26560d40f7624e208364bac468677a3a_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26e2079e9fa2414b8068d97842ea4ddb_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i631604fdcc4444ffaad24e9b13db902f_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d30dccc4d364639b665ffbe677c7647_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b8a3952cfa54d32b76aeb203dd87494_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05d10f6fbfbb494fb6fce435672dcf23_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieff9b96c85334e939753b0c4e6ef2d63_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77f9248d57974574bc9adc8bcfcdc8e1_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i280e8f364ec54f6bacf36535657ece2f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e0eec8d36874fcb811be9de7dfc1394_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0174357050ce426eb9072c176613559e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5b5a7fb19a640759ff41fd96d890a0a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91c6a68811984e989e0f9bec6fbe7865_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7960720916204ded977638cc08e62b56_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i693603475db345f8b0944c13afcdbc10_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc807183e1564343bd31c0159b51bcbb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69a59eef10334badbbe7740a6961bf20_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f8c193f87c34f2db43b82541239c4db_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26a632e3297b4c43bc30ad60a11821cb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f7285237d6143a88b08d4f6094f9950_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37d8778b4638498d984b5ef4a80387ac_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedc4cdb92e6d4a918e4cae457e5095e4_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c4af8fb06a3468b842884b2d7f5e43f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7ee075779ba482ba14540bf413c99c6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2c8d81029dc4f4ea85b448efa38bad7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10f238e753b94349a34e63521a517705_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88f53878399541aab3dbf15a0f35c2ff_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d952d8add4a423c841dcb828a6395d4_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ec27280b43d41cfb61cf079469c0a60_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i067fa16ca9d545099aaef7dfae0ba189_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ad7fc029ac844a49ffa1b856f5d56f6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5af8a070f9bc46658055f2e8175a8ce3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie14bb7a57ad64858b6c10be22525e07e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ba4b7d86f204b6a9d7d562281386f61_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibeebbb5e419f4d849feadf2a965eda69_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa5d6637f88c446481fad357f1d45753_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae17d5d53f964b1198bb9bec44994813_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia07d85355268435f99e328b11dc3a41b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if615f680db594c4abf7dda191e8cb043_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa1fd9f69a7b43eea8506545464daab0_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i652bd6addb2f48ccb11829f65d6bbfda_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7fdd15f57ab4e47b5ba9a975330c61c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee20f2c502354597935b92371dbe0d94_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0e7e0d5ac1844e9950e43fe31ea5e07_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i339500f8642943c2b6c982af6cf9dfea_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5a9b3edded440719a65fa42688ad89f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0729ff016c534ca29e10e62194985ae7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f2f788044f24469ada3249aca7b98b1_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0ca0a967b334598808b418e2700013f_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bcbb30927c34620bf18c72d093bec3b_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib55a432be0f249e2afa7e0e1d560e1fe_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56ef410ac516442db21e732867090a7d_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd34f489e3cf4bc68520fb4156dc30d5_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i860cb23b9d0b4f0f94851daff5988983_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad868dce52b44ad790b6864d29035e06_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86cabdaea3ff4402b13c640c489942dd_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e295a8c616e4444bfb546859426b1d7_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6da967c8920c43edb991c0528d2ad964_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i765da38bd1524d5ea57eb2c302a51993_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13839e115ef34c2e9cdbfd5996444ec4_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbaa79c605ea46b49097dafde16b4c63_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03a302c67b6a4bb7a2a2e19bbbc2a9ab_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38329f0d027145598d9b90d0a83b4b3d_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24a86d409aee4a37b73db1b51534770c_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23169375ab504448a8b52398bc5131ea_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9aeaac1d1f984a51bcb01399ecd48b56_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8c943708ddb4c9a824d53b38aca3911_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if12ca51a38a34b098329f98278e9316d_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65ba32b3197b47a89d8e18f5ce7bf26f_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib44011bd3f5846bebee1bd4b98050562_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ba36fdfcf704ad6ba7b509e8b7da78f_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27fed185eaf64f0c9df3d3de7b9cdfcf_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbafa9f2fce94b9b8a2c5abf17d6940a_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3d222c52e0c4a28b8e6198bd6eb1ce8_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d602e784d274adcb804041ffb3aa3d2_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6646c81346544c4d99e9fa1d0e57c80c_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia75364130e1648e78fa02c61892d115d_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15b5a11fc3bb4619b499f9c929493fa1_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6959b7c2c57d4c76bebc490ae176fcfd_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8eeb5ffe9464ea18f019180489ed088_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54d000cbf2214f02a540a13d16a2e6fa_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf29f2ab93f848ea80feac95f899a8e9_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b5a3389083844e18566cd906171e56b_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3dc0765c3e2434885f5a3a11ecac3d6_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i272813f6653f43e188e55ba3267529a8_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc3a82b251f447e2bb647e6978c13daa_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i851a94e1b5a84e1aadc1d6c2a58c7df0_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia658bdb62dae4582bd04be509941c2b5_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8425684776dc4bd99f6c93fbcbaeed28_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a6729fa89514d4e80eba6b05b6bdddc_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf7ad2e2b01e4065b8a00585446b245c_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia718fc35144f49d886e94436e951426b_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ba397b83c7c4a58bcf44d9eead0473a_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0269009dcd1e4b8e8b5484651bfc3b7f_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78561ec2276d4506995dfccf9bff7d1c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i603496ec6a9840f2a7691f78b350638a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d3f91adb0694c9f8cda5c55c146646b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5f5b39b26164231afef597275eaa72d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib21823aba6f14b7abd5b9938f0373824_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33a372065d96498db0755abec1a36919_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">lh:UnbilledContractsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc7ed4faa9454198b02470d9bf8c948d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e065a3d3a9a44bd9969178157790cfd_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:EnvigoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc042ac91d2148ea90e2852e684aa7d1_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f8f9d7520ef4499b316c87363b01437_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc1b3052e0d1420fae79ce70434a92f8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29bbac08d4cd42b590e8d38341b247a4_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8ba5b5579de49a1834d28dc2798cee3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83cd8f691c1a4a83bc738d2b7ddb6e5f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id22f921dc2c74abe80fcd674d286c147_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b54967480df4194966a376ec02d6eb4_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7b895159e664819875373401fc83cfe_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if96ac9c12a5b46ffa647f1720c503604_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id93dacc653da4b5f9dccaf725dcbc769_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32a9df56eb784dc7a4b220f78de9bd76_D20190603-20190603"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:EnvigoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-03</xbrli:startDate><xbrli:endDate>2019-06-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb6fe2a304194224befa49dcb5ed37d4_I20190603"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9cc69f41c9c44488b638ef3aaccdb61_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:EnvigoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae23e3cdb39a44b8968341916d4a2dee_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:EnvigoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05c3bfa9f9624b64841e19fc622f33fa_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:EnvigoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08f70824033d48f0ad6009880d1268f6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34ea8623f99d450ba0c680719bfe3105_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43d39dfc46f64e9ca238eb8a039fa85f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5bcb822134b4295bec55008826197e5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i616e955ba8fd4b48be31816f59836100_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dfebc2c21b9448d96ac217371534543_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb6c26b91b524c4abbfa955d1ddc4457_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fb8d4ae4a074deead96aadd66375f97_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cd3b488f83048afa58403e54590e370_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b26803c2ed7463f9f6e7e437606b796_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5fa039b6da0439ba94ea7516654e077_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id303bba4b3024ee9bc49c49292c283c3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84f2eb55fbc34238bd4e45bb4e88d0d3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied5787aeaaf147b3ac9ba7c20d2c10ca_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i074bfbf2d5a14f098b9866224c866c60_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0aec6588c61a425bbfbaa20d82e54da0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd1aeab8e4f84964b6228ddbf6f745c4_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e01eb55dbc7406c97793a4ef9f2d6fc_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb47c57b65f949f7a7c4c95751563b2f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9227de05b374430bb6014f0912ee355f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07693b8e43fa40fd96c729928953fdf2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i667ca8a683be43908b933939e90db6ab_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">lh:PatentsLicensesAndTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i350c55aa64654b5eaec00a68eb64ffcc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">lh:PatentsLicensesAndTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4b591e887b949ce852974492383726e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i565f137a551b40788c8efe1cd6a5249a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bf99eb3ad5c4326ad848c0c5cbd06d0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i370b422d371e47b595a9edeb8e53d595_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab6b50825a0346fda5c7a57c46854607_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:UseRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabe5e13fb7d54f829c7b91d468ea08cd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:UseRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if63915653cb94496b21de8a1a2fa6d6c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2794dd6e7b2744c099a93cd25ba76ec6_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab77a3a920bd45ec8c8a0ce85071ae92_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16b4dd493f294c068810b89a1566d767_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c8777e25b1f43d891ec105edf96653f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3dd7ebb2472d4c31906ef3769da45911_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ccdf4f5309844119bbb0e0786d0933d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Seniornotesdue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i167711db2a824eb5abbd3592c79dac6a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Seniornotesdue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i657d0be39de346838d90040f8d8f348e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Seniornotesdue2024MemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bd3af0136af40129f6e820d13a1ae7c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Seniornotesdue2024MemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7afb899941084ecea85f2f14bfb617e3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Seniornotesdue2025MemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8a898daea154e4e8f10db94ed74cfa4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Seniornotesdue2025MemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f958adbe35f4caab3789a03b8cec98f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Seniornotesdue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i717fbdf29e6443d699ab792d8711e563_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Seniornotesdue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33c11262f4464ffea951db61842a0276_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Seniornotesdue2045Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1da5761b40b5492f8293785134f8ab79_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Seniornotesdue2045Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib861cf324bf4423f8474deaaa80a20a6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:A2019TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i391abd34dc914608a327d3e643899d6b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorNotesDue2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8826a53a9f514573b843bca48b3cf833_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">lh:A2019TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb68008a843e40baab3187013ce2c0a2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">lh:A2019TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0187e44c0d748c594cf9f1d3948e793_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">lh:A2019TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68588eebfb8e4548bfe358f5a18f2c3f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9247fa03b7041468d61fb949531d7c4_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="rate"><xbrli:measure>utr:Rate</xbrli:measure></xbrli:unit><xbrli:context id="i053c189109464dc2b30dcc1a0729589f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">lh:TermLoanandRevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3ee871e124f4fbc9fc99ccaf3849f33_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">lh:TermLoanandRevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i772995039ebd4eb5b458fda1865f139f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">lh:A2019TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4dacd586a4f14b008d9dddcced9904a0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ecb5a349ee9456dbdca2fe6adf8c4b3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d95d9565fa048cabbe7fe142c315893_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e01cc0ff9ce44ef99f7acd5a862967e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:CovanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib199336a2dd2420097e56516adfbc4d1_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:CovanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia13373a9d55d49f19ffcc37b5bd497f3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:CovanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3eb0e387c6aa4d82ac76ca334fbc0143_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:CovanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc93dd882afa412083acfde2ba592eee_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2cd501dd8ab4346aa80fd4754cc040c_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb40acae056445528eb8911537232df5_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icddc15843aad45e5aededcb204169bef_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if69fa5cada7744eeb0c7092963608d33_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionAndOtherPostretirementPlansCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e0edd28826044888669adf1110662a2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionAndOtherPostretirementPlansCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5229937ecb2d46eaa667d49484539b53_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab089143fc42417c81a2d2bfabbd8654_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacfbc074fcc44dfb86499f5096b2b493_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ded3a94ce0f45598710ac45a034a923_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0f0ae542d5a48d89e69a0ec76905efe_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7abc6c3f0ace4f678cb9c9f7caec9b6b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30fd4fe5553348999dc8935c8ef8e7ab_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">lh:SeniorNotesDue2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe0d3f0eae0e4636b83723ad38c201f0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">lh:SeniorNotesDue2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i157730e7ca9e4995bdae523b7501fc18_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Crosscurrencyswapmaturing2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e6ac05e86da4a5e81f44c16ffdf25ee_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Crosscurrencyswapmaturing2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b2d1e688ceb488f882b2976928f2162_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9709977fa99a4330a25d6ae199b8dcef_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorLongTermNotesDue2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedf8eaddfda44623be579df701c1a1fe_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65cf17ee050f4482a7c6583428aea61b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorLongTermNotesDue2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c7e9ea78df3464f91a5468557f3b4a3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd87dafe403e465ea18e34466c3c7939_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d5061e0be7847e68312a7cca228cf95_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefe19a4e91fb49b3a68616c5ff46e9e5_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ec6f971894c47229132bd1159446ec6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7a8e6e061ca4fad8a9d6109d3fb30b9_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ccde3dbf4f348e184653bd3cde3ece9_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id37ee09894034b178815f25b8d74e8e8_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3997aafec9e6480ba5de1fc7fc5ae356_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57fefb8fd43c402695470e30d3a2fee3_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i060a850910964d4baaae2bbf8a6f8fa8_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3059b6353b34be0bc21870bf9a54a49_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5cb7f86911741a9b2e604fc4fb6237e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7613840514f4435bb5f3e61d09adf8b5_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bc43a85b31c461e9c8951056efb762f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b2b623128cd4e32a331207c59b1041a_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i417074d9a2c24c34bcac25f32d2ec0c1_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C.&#160;&#160;20549</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjg1_119280b8-d079-4c50-bc42-5afa831ad18a">10-Q</ix:nonNumeric> </span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjg2_a2323689-df2f-45c2-863e-a2175afa1315">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the quarterly period ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8zODQ4MjkwNjk5ODAz_07e8d103-8ded-4d25-91e8-1d5d897a80f1">September 30, 2020</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OR</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjg3_b64a2b03-e973-4959-9bab-c16f41cf0063">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from ______ to&#160;&#160;______</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commission file number&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjgw_5f4b8b3d-1e4f-4706-9173-7d8b32fec66d">1-11353</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjgx_9205ad08-ff96-4828-8d81-0f1aaeb93dc1">LABORATORY CORPORATION OF AMERICA HOLDINGS</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.535%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGFibGU6NzFmYzFmODFjMDEzNDY1MTgyNTkzZmU1MTdiNTFkYTMvdGFibGVyYW5nZTo3MWZjMWY4MWMwMTM0NjUxODI1OTNmZTUxN2I1MWRhM18wLTAtMS0xLTA_8fbdb34b-e8bd-4f0c-b76f-fbfe3d71484c">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGFibGU6NzFmYzFmODFjMDEzNDY1MTgyNTkzZmU1MTdiNTFkYTMvdGFibGVyYW5nZTo3MWZjMWY4MWMwMTM0NjUxODI1OTNmZTUxN2I1MWRhM18wLTItMS0xLTA_2dd04aa5-a4a0-4609-9f35-87e8cfc79799">13-3757370</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:23.680%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.680%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.607%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGFibGU6ODhkNWI2M2VjMGIyNDk0MDk2MzUzMTYxZDY5ZDYzYWYvdGFibGVyYW5nZTo4OGQ1YjYzZWMwYjI0OTQwOTYzNTMxNjFkNjlkNjNhZl8wLTAtMS0xLTA_d2dfe4f5-76ab-42cf-a305-c6ad4355562e">358 South Main Street</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGFibGU6ODhkNWI2M2VjMGIyNDk0MDk2MzUzMTYxZDY5ZDYzYWYvdGFibGVyYW5nZTo4OGQ1YjYzZWMwYjI0OTQwOTYzNTMxNjFkNjlkNjNhZl8xLTAtMS0xLTA_9448d893-9f81-41b2-9d1b-508a0c2ff2c9">Burlington,</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGFibGU6ODhkNWI2M2VjMGIyNDk0MDk2MzUzMTYxZDY5ZDYzYWYvdGFibGVyYW5nZTo4OGQ1YjYzZWMwYjI0OTQwOTYzNTMxNjFkNjlkNjNhZl8xLTEtMS0xLTA_88e254de-0def-4d77-ad02-6892cfb09b9f">North Carolina</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGFibGU6ODhkNWI2M2VjMGIyNDk0MDk2MzUzMTYxZDY5ZDYzYWYvdGFibGVyYW5nZTo4OGQ1YjYzZWMwYjI0OTQwOTYzNTMxNjFkNjlkNjNhZl8xLTMtMS0xLTA_23c9ea1b-7ba6-4099-befa-b57fde61e192">27215</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant's telephone number, including area code) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjgy_c63bebcf-cb08-4fe7-88f5-4bc799ad1439">336</ix:nonNumeric>-<ix:nonNumeric contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjky_ca139a43-5d01-40f2-a3cc-c0151e52378b">229-1127</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Exchange Act.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Title of Each Class&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trading Symbol&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Name of exchange on which registered</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjgz_f94942b1-b15c-4dce-95df-d5e28b3f16c1">Common Stock, $0.10 par value</ix:nonNumeric>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjg0_2a6e0788-015c-4c94-9984-12ab85329ee7">LH</ix:nonNumeric>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjg5_3fffcfb4-626c-4728-bca2-96b1c7771d19">New York Stock Exchange</ix:nonNumeric>  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjkw_c8b2aab9-da0b-418a-97e3-e9abf4621a44">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (paragraph 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjkx_8d3cf5ea-0f8c-4a57-ab98-9d3e425d519a">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221;, and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:44.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.152%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.154%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGFibGU6NzcxYThjYTgwOWUwNGY3MWE1ZDQ4ZjI1ZjVhZjM1YmYvdGFibGVyYW5nZTo3NzFhOGNhODA5ZTA0ZjcxYTVkNDhmMjVmNWFmMzViZl8wLTAtMS0xLTA_45f37070-7fcb-49fc-8252-6c134489e265">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGFibGU6NzcxYThjYTgwOWUwNGY3MWE1ZDQ4ZjI1ZjVhZjM1YmYvdGFibGVyYW5nZTo3NzFhOGNhODA5ZTA0ZjcxYTVkNDhmMjVmNWFmMzViZl8xLTMtMS0xLTA_d5e4de5a-f015-4ca8-8a6a-e15a3a8633c9">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGFibGU6NzcxYThjYTgwOWUwNGY3MWE1ZDQ4ZjI1ZjVhZjM1YmYvdGFibGVyYW5nZTo3NzFhOGNhODA5ZTA0ZjcxYTVkNDhmMjVmNWFmMzViZl8yLTMtMS0xLTA_baeb0e00-01c1-45f0-a029-272d8ac5e40a">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjg4_6f415ca7-b5b6-4d5d-b9c7-a2385aff822f">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares outstanding of the issuer's common stock is <ix:nonFraction unitRef="shares" contextRef="i3cbe3c928a064308830aa690527b4879_I20201028" decimals="-5" name="dei:EntityCommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjU0_c82d187a-bd87-41ae-a187-611f3e49f865">97.4</ix:nonFraction> million shares as of October&#160;28, 2020.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i417074d9a2c24c34bcac25f32d2ec0c1_4"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I. FINANCIAL INFORMATION</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.302%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.299%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_7">Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_10">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_10">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020 and December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_16">Condensed Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three and nine months ended September 30, 2020 and 2019</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_19">Condensed Consolidated Statements of Comprehensive Earnings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three and nine months ended September 30, 2020 and 2019</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_22">Condensed Consolidated Statements of Changes in Shareholders&#8217; Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_22">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three and nine months ended September 30, 2020 and 2019</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_25">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_25">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine months ended September 30, 2020 and 2019</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_28">Notes to Unaudited Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_28">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_85">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_85">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_97">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_97">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_100">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_100">39</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II. OTHER INFORMATION</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.302%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.299%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_106">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_106">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_109">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_109">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_112">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_112">42</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_115">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_115">42</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_115">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_115">42</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i417074d9a2c24c34bcac25f32d2ec0c1_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I&#160;&#8211;&#160;FINANCIAL INFORMATION</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements (unaudited)</span></div><div><span><br/></span></div><div id="i417074d9a2c24c34bcac25f32d2ec0c1_10"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMy0xLTEtMS0w_f01c3d48-8251-44a5-bec1-6b94d1e5c200">667.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMy0zLTEtMS0w_466cfca6-2b79-4385-9acd-335ae707aaa5">337.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance for doubtful accounts of $26.6 and $19.0 as of September 30, 2020, and December 31, 2019, respectively</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNC0xLTEtMS0w_f3a6c856-4d73-479a-9c03-56421925e6e3">2,095.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNC0zLTEtMS0w_f254bcc8-8ad2-4073-9453-2afbbf56053b">1,543.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:UnbilledContractsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNS0xLTEtMS0w_7dbd2a43-a44d-4104-bff4-1b920fc9e26d">603.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:UnbilledContractsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNS0zLTEtMS0w_e7c8a7e6-53ac-4343-b0df-a578bc3f34bd">481.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNi0xLTEtMS0w_dfc16e75-57e3-491f-9a5c-9321b432eda0">392.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNi0zLTEtMS0w_d8f381f1-9f2c-4757-8234-e26f38479d3d">244.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNy0xLTEtMS0w_9f7f3717-afc6-4c7f-811d-e3fafe3f2798">327.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNy0zLTEtMS0w_d5c5aa4d-26ec-434c-95d9-468e941006c6">373.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfOS0xLTEtMS0w_828476be-da79-4842-929c-05be7b95924f">4,085.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfOS0zLTEtMS0w_416a2abb-12da-4e42-a114-c34d83ed3330">2,981.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTAtMS0xLTEtMA_de027f9a-6e54-4e27-bac6-e148af88a255">2,608.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTAtMy0xLTEtMA_1536a53e-26d6-4a99-a46e-7820f70dc9d8">2,636.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTEtMS0xLTEtMA_9631cead-1003-401e-8c3b-3e7cbaad01e3">7,613.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTEtMy0xLTEtMA_e4391530-dd76-46c6-892e-c80b7eddf028">7,865.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTItMS0xLTEtMA_29a667fa-05c7-40a1-b274-c763cbd84284">3,920.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTItMy0xLTEtMA_d11649f9-72fd-45f8-a6c2-48034d65445c">4,034.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joint venture partnerships and equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTMtMS0xLTEtMA_1ce9e408-b0ce-4faf-a817-47f42959727d">70.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTMtMy0xLTEtMA_b34c2ac2-14ea-4e61-ae12-274dfcbe7270">84.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:DeferredIncomeTaxesAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTQtMS0xLTEtMA_0aac29e8-8158-4af6-b680-80b28775963d">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:DeferredIncomeTaxesAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTQtMy0xLTEtMA_06aff0ac-86ed-42b8-9d89-5d32a5c51122">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTUtMS0xLTEtMA_56e460af-1bae-4c40-a892-1885076a0be3">437.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTUtMy0xLTEtMA_6fbd1209-a748-4f9c-87ab-af2c5abe1c07">435.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTctMS0xLTEtMA_503104ff-9c12-48f6-a457-63ba4a83bdc1">18,739.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTctMy0xLTEtMA_8c3fa0ee-588d-4a76-9370-25e7c6cf6230">18,046.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjEtMS0xLTEtMA_fe79898d-81d9-4822-9b78-a394e30162c8">639.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjEtMy0xLTEtMA_862074aa-4238-441a-bde4-ec0a450c53cb">632.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjItMS0xLTEtMA_bdd9239d-4352-4998-9d14-470a609db88b">1,297.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjItMy0xLTEtMA_5d9e1271-ad1e-406a-bde2-2ae7021f004d">942.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjMtMS0xLTEtMA_fb6d2424-5511-4c77-b22e-fc1b20013fb8">494.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjMtMy0xLTEtMA_02a160f3-bdd9-404a-ac7c-f6da8e128d68">451.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjQtMS0xLTEtMA_e6577228-2bd5-4b5c-b1ac-f8e644521168">193.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjQtMy0xLTEtMA_28787d82-2f9b-4f6f-9ccb-895c882c2378">206.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjUtMS0xLTEtMA_23695424-af28-4bfd-9b18-f6eaff36184b">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjUtMy0xLTEtMA_935ab810-7fb2-4b2a-a8da-7e2b8d85cd9f">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings and current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjYtMS0xLTEtMA_0ad26e3a-2246-456e-84f6-3430e8d9cf55">376.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjYtMy0xLTEtMA_fb336c9f-f7b4-4ed3-a947-99b830a1ecbd">415.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjgtMS0xLTEtMA_e20b6646-8045-405c-a152-381343e41819">3,009.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjgtMy0xLTEtMA_d0fd9142-d4be-46d4-bdaa-8a16e9bd4009">2,655.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, less current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjktMS0xLTEtMA_f08dcd63-b5a4-4254-820b-a34257e7f3bd">5,417.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjktMy0xLTEtMA_55b3078a-a5f1-4274-9b2b-5c12879350f1">5,789.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzAtMS0xLTEtMA_04afe47c-cd99-4a24-910c-6b6ac6a0f0a1">602.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzAtMy0xLTEtMA_63d8d107-cde1-472c-b411-dd885115d783">596.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzEtMS0xLTEtMA_49ed732c-8878-4e46-a742-0fa7fc3c9c34">86.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzEtMy0xLTEtMA_86087fda-71b1-49f5-8b3f-82cc2ad5bbdd">91.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes and other tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="lh:DeferredIncomeTaxesAndOtherTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzItMS0xLTEtMA_ee501355-938b-48e1-abd5-d386f724a88d">891.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="lh:DeferredIncomeTaxesAndOtherTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzItMy0xLTEtMA_e2016c98-f8d5-4fc2-8186-e56b77a3b2c0">942.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzMtMS0xLTEtMA_00126927-5792-452d-a114-28890ff3986a">473.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzMtMy0xLTEtMA_25016e87-aca4-419e-a980-47f0246fdd64">383.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzUtMS0xLTEtMA_ce1637fc-efc8-4666-ae6c-bda4436596ca">10,480.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzUtMy0xLTEtMA_06b7b1d4-f90e-472b-a2f8-cb1952b41ec3">10,459.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingent liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="lh:NoncontrollingInterestMezzanineEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzctMS0xLTEtMA_83e6218b-5ec8-4c65-992d-c28bef1b54cf">19.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="lh:NoncontrollingInterestMezzanineEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzctMy0xLTEtMA_0bdf12bf-a282-478e-a63a-564116b0f503">20.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, 97.4 and 97.2 shares outstanding at September 30, 2020, and December 31, 2019, respectively</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzktMS0xLTEtMA_764b1a63-dca5-4689-8a19-af088dda5397">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzktMy0xLTEtMA_b53481cd-1f44-4b61-adb4-25ab5a53629c">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNDAtMS0xLTEtMA_b2251445-4723-4c5e-89e4-776d089d161e">80.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNDAtMy0xLTEtMA_1018bd17-d6e8-41f9-b126-7a17e25ddd41">26.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNDEtMS0xLTEtMA_429d7838-80a3-4439-b0ee-5a5f3e0c5722">8,464.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNDEtMy0xLTEtMA_2d0a25a2-a917-4587-b4e9-08fcae4966f2">7,903.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNDMtMS0xLTEtMA_b39256b6-3f1d-47f2-a271-eb8cf9335c06">314.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNDMtMy0xLTEtMA_59c7b82c-c2c5-4732-b501-87da96ffe8bd">372.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNDQtMS0xLTEtMA_94e472bc-880f-4af7-a243-401c27631598">8,239.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNDQtMy0xLTEtMA_a734135d-8473-43c2-b999-97da2daf6740">7,567.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNDUtMS0xLTEtMA_6045b635-bc0c-4aae-857a-6d9864b83584">18,739.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNDUtMy0xLTEtMA_67b42e9c-31d7-49c3-8ac6-f2d316e2a647">18,046.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i417074d9a2c24c34bcac25f32d2ec0c1_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">co  LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.409%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMi0xLTEtMS0w_3d6b62ab-5fbd-4d7d-98ff-e2d6037623b3">3,896.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMi0zLTEtMS0w_c3eba47f-e8d7-4f2e-851b-947c4024ef77">2,928.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMi01LTEtMS0w_94240c3a-dac7-44ff-8391-3beecd4fa3e8">9,488.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMi03LTEtMS0w_19e2dc00-1729-4197-9e49-124c7f6c1366">8,601.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMy0xLTEtMS0w_703ec647-ac36-4491-9231-8b8f02ab2507">2,336.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMy0zLTEtMS0w_38b60cf5-4e09-4671-b7a6-910a344e090d">2,111.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMy01LTEtMS0w_8f9b3055-8345-4918-b1b9-6c71be0ac23c">6,440.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMy03LTEtMS0w_ccb3879f-7b1e-4c4d-b1d9-7e35041b76c3">6,169.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfNS0xLTEtMS0w_404b612a-8a32-47a0-a2b4-da08b05f2645">1,559.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfNS0zLTEtMS0w_0b4c7628-e7df-4c5d-beb9-a0a25ea75564">817.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfNS01LTEtMS0w_fdb6e107-fad1-4ac4-99d2-a6ee900a3c20">3,047.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfNS03LTEtMS0w_d9b78f09-06f6-4589-b1eb-85ff3515a748">2,431.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="INF" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfNi0xLTEtMS0w_cc44aeff-11e5-4f88-b448-2035dc305b19">419.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfNi0zLTEtMS0w_19c872a5-4695-45c2-a216-184c4703873a">401.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfNi01LTEtMS0w_29aec792-abd8-4471-bba5-279356b9add1">1,211.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfNi03LTEtMS0w_d7b0f676-9dd0-457c-87de-b9964d57d1ea">1,210.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="INF" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfNy0xLTEtMS0w_76269eb2-c088-4970-8755-91de3feb2d1c">62.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfNy0zLTEtMS0w_f92fc852-8956-4494-a1c3-7f6bfd27a6a2">61.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfNy01LTEtMS0w_1f6b3d12-7cbd-4a85-8b0e-0c873a55b196">184.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfNy03LTEtMS0w_82833094-4b69-4412-bce6-1cb8b1d684b4">179.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other asset impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="INF" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfOC0xLTEtMS0w_a9af0adb-a7ca-4feb-a7f0-42661de9acaf">23.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfOC0zLTEtMS0w_0d90958a-b10a-4bdf-a063-040fcf9a6fbc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfOC01LTEtMS0w_6f8f9841-9be6-44ae-abc2-a4d365f5f6df">460.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetImpairmentCharges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfOC03LTEtMS0w_8b2c098e-c5f6-4ede-870e-5fd2d9c2138f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="INF" name="lh:NetRestructuringAndOtherSpecialCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfOS0xLTEtMS0w_5066a572-f483-49e3-97aa-7d54da3030d2">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="lh:NetRestructuringAndOtherSpecialCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfOS0zLTEtMS0w_be50d2b8-79da-428f-92ec-e16c01a57d04">14.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" name="lh:NetRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfOS01LTEtMS0w_06232df5-c987-4874-b531-2ef3cb24bfdb">38.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3142bfab671e4d37943fa55426510724_D20190101-20191231" decimals="INF" name="lh:NetRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfOS03LTEtMS0w_f89f8dc3-2bd9-4319-a632-7b77a4f985a3">48.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTAtMS0xLTEtMA_fa26ae48-4d7d-4cd0-a4a7-e509a46f7fe0">1,047.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTAtMy0xLTEtMA_dfcd8c3b-c23a-47df-b1ba-e926042deaa8">339.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTAtNS0xLTEtMA_fce1ca46-47e2-4621-b297-2fbf51f84f25">1,152.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTAtNy0xLTEtMA_6bb137d9-0949-4b0c-b739-2a29dbed6163">993.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="INF" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTItMS0xLTEtMA_30277764-7921-4a14-869f-b8df639a0056">51.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTItMy0xLTEtMA_4e80af1e-2489-4c86-b954-aa18b3681b68">60.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTItNS0xLTEtMA_094f3a28-4fba-44cd-9262-22850df9ed2a">159.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTItNy0xLTEtMA_04c52afc-2a51-4a86-8e21-42ef529952ce">176.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method income (loss), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="INF" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTMtMS0xLTEtMA_a2e66619-abdf-492d-a8ec-aef9ccbae14b">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTMtMy0xLTEtMA_84e545ab-70bd-4496-bbe2-0a9bb4865a68">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTMtNS0xLTEtMA_939bfe9c-9aef-41c5-92cf-ed9dc1398c1c">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTMtNy0xLTEtMA_81357270-015e-4b61-b290-a92427098147">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="INF" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTQtMS0xLTEtMA_23a78b21-6296-4a9c-b5cb-430acaeecf73">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTQtMy0xLTEtMA_18781e95-d20e-4f4f-be16-e36ea0544440">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTQtNS0xLTEtMA_53a4d606-09ea-4d7f-9f00-4e30b2b690fe">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTQtNy0xLTEtMA_a92f19be-d5c5-4154-9853-0797dd199f37">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="INF" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTUtMS0xLTEtMA_cd4b7449-c2a4-4ba6-b5d9-d77b75e8acca">54.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTUtMy0xLTEtMA_f48b6f6c-9c96-4b3e-a358-bc930daf8dba">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTUtNS0xLTEtMA_5a38575b-1771-47f4-ad5d-92e8ad95dbec">22.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTUtNy0xLTEtMA_588e8cd1-716a-4961-aa1e-ca328c32d4da">18.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-3" name="lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTYtMS0xLTEtMA_cb227687-5dfe-48b7-88bf-b5b6de118d19">947.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTYtMy0xLTEtMA_feceb4cb-e229-4ec7-b26e-71678123ab20">287.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" name="lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTYtNS0xLTEtMA_172c7167-f7a8-450d-b4a6-ae938e15e496">976.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" name="lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTYtNy0xLTEtMA_34dbc3bd-90f4-433f-95f6-34d6b34dc1fb">812.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTctMS0xLTEtMA_342c49d1-0c57-4f1f-8e7d-be7b1b446483">243.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTctMy0xLTEtMA_6a878fe1-105f-4f93-aea4-d43350dc320e">66.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTctNS0xLTEtMA_7fbf428d-cafc-4169-94a3-56c722db3177">358.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTctNy0xLTEtMA_8908efe3-f96f-4320-8e7d-e20388aa52e0">214.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-3" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTgtMS0xLTEtMA_3319bcda-da84-4270-b86f-d5f9a7add30c">703.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTgtMy0xLTEtMA_685978d2-4c95-496c-86bb-4c6c283472a1">221.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTgtNS0xLTEtMA_0dc5943b-bdb9-4ec8-bc29-8b696ab3616e">618.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTgtNy0xLTEtMA_af1de74f-335b-474a-a234-c16ffa061bba">597.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net earnings attributable to the noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="INF" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTktMS0xLTEtMA_d636050a-1827-41ef-ba43-10ea107f9343">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTktMy0xLTEtMA_6ce7191a-25fd-4e6e-9307-58983bf62b84">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTktNS0xLTEtMA_e822d39f-06c0-4e05-9604-d12cff3f6875">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTktNy0xLTEtMA_9123a072-bb46-4f2f-9b80-b405c95d6689">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Laboratory Corporation of America Holdings</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMjAtMS0xLTEtMA_600d58df-8667-43bf-9945-12bb2b314bcc">703.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMjAtMy0xLTEtMA_49117119-626c-4a46-a4fa-b583c9d237d5">220.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMjAtNS0xLTEtMA_571379b7-299d-4420-af54-acf26ca79392">617.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMjAtNy0xLTEtMA_73fe8b05-a6ff-4b85-840b-dd6b03d99de5">596.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="INF" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMjItMS0xLTEtMA_cb2f01e6-0af8-406a-b721-fec31af221d4">7.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMjItMy0xLTEtMA_f4249bcc-1505-4ca2-8a3a-3edb906b4481">2.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMjItNS0xLTEtMA_2588bbfa-8c68-4325-98e2-5bd62b67ee1f">6.35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMjItNy0xLTEtMA_d295d5ff-3df9-4195-9a4a-6e29f879db97">6.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="INF" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMjMtMS0xLTEtMA_a9c2f699-821d-4441-b55e-a8e78ff7f84c">7.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMjMtMy0xLTEtMA_aae399e8-8a5d-4c69-9b8f-c77b01c9a87b">2.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMjMtNS0xLTEtMA_56b87990-e333-456c-a126-acea499858f4">6.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMjMtNy0xLTEtMA_77cb1670-b3f5-4df1-babd-ea94dee9f20e">6.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i417074d9a2c24c34bcac25f32d2ec0c1_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:58.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.434%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMy0xLTEtMS0w_6afcda43-1c7c-4761-8547-2d02d4232525">703.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMy0zLTEtMS0w_685978d2-4c95-496c-86bb-4c6c283472a1">221.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMy01LTEtMS0w_1b0ca367-9db5-4032-a541-af5f8ee2ba4e">618.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMy03LTEtMS0w_af1de74f-335b-474a-a234-c16ffa061bba">597.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfNC0xLTEtMS0w_2c8c7508-78b6-4545-8586-812dc00c1ac3">132.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfNC0zLTEtMS0w_85ea54ce-e02a-4a03-b272-365c0ce17487">92.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfNC01LTEtMS0w_661e336d-d70f-4f37-8123-43e5df1d3a19">52.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfNC03LTEtMS0w_b998e58a-7d0d-489a-9e43-e549934094b2">45.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net benefit plan adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfNS0xLTEtMS0w_3ad2e75e-3483-464e-b96f-070cccf18c95">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfNS0zLTEtMS0w_7c978efc-d23c-42c4-8dce-c8990a2ac9d1">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfNS01LTEtMS0w_8ba87153-4067-4c95-819c-fe90e0782cb3">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfNS03LTEtMS0w_140b655e-dd47-49c4-9af0-d7246d9fdbc8">8.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss) before tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfNy0xLTEtMS0w_f562ceef-4bbe-449e-a99e-785372e96f16">135.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfNy0zLTEtMS0w_0f763971-f546-4485-aca6-77314f001cab">89.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfNy01LTEtMS0w_48706be7-033b-44ae-a7c9-58a30fc20800">59.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfNy03LTEtMS0w_b3e25680-8dfa-4cc7-9aa8-0d44b26e69e4">36.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit for income tax related to items of comprehensive earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfOC0xLTEtMS0w_b0b95bf6-e7c1-4c07-8cff-46bd4586b504">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfOC0zLTEtMS0w_f3aeb297-2753-46e8-8823-e65a1d136590">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfOC01LTEtMS0w_edb3af19-eb83-45bb-8fcf-7611c95ed8b4">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfOC03LTEtMS0w_c0c7b733-c3f1-40b8-a1b2-d99aa4067f6f">2.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss), net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfOS0xLTEtMS0w_f6d325a1-b2b5-407b-80ce-800a355c2290">134.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfOS0zLTEtMS0w_77678110-3b8e-4c0c-8c76-b4f2a53d4103">90.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfOS01LTEtMS0w_c5e1cf2b-9dcc-4c71-8003-186766424147">57.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfOS03LTEtMS0w_ce03bec2-dcac-4df7-977c-e5e82cb9ed94">39.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMTAtMS0xLTEtMA_701d6cbd-236b-4bbe-930c-908e0d6a7b9e">838.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMTAtMy0xLTEtMA_7589a320-725d-44ff-8071-7e6c078f3a83">130.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMTAtNS0xLTEtMA_cf42d5e1-fc3f-4765-a642-994a1b04eae0">676.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMTAtNy0xLTEtMA_f40ba535-5971-4f25-96a5-721c99e37229">558.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net earnings attributable to the noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="INF" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMTEtMS0xLTEtMA_d636050a-1827-41ef-ba43-10ea107f9343">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMTEtMy0xLTEtMA_6ce7191a-25fd-4e6e-9307-58983bf62b84">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMTEtNS0xLTEtMA_e822d39f-06c0-4e05-9604-d12cff3f6875">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMTEtNy0xLTEtMA_9123a072-bb46-4f2f-9b80-b405c95d6689">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive earnings attributable to Laboratory Corporation of America Holdings</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMTItMS0xLTEtMA_524622f6-73ae-4c22-9c69-a3f43232b30e">837.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMTItMy0xLTEtMA_4abc2217-98dc-446c-a1fc-f1f05e09b0d8">130.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMTItNS0xLTEtMA_8aafb777-7163-41f8-a741-4e27180c03ca">675.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMTItNy0xLTEtMA_a6550c60-025c-46aa-8ce2-0e9786036d2a">557.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i417074d9a2c24c34bcac25f32d2ec0c1_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SHAREHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:46.330%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.507%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.535%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.303%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Treasury<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Earnings (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total<br/>Shareholders&#8217;<br/>Equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE AT DECEMBER 31, 2018</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed61e2c58d04a4f96f4455f58dc8906_I20181231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMS0xLTEtMS0w_db11a56a-02d5-433f-9f73-727d83086c9a">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaa1c40cdb9547b6aa52d2c4edcc8188_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMS0zLTEtMS0w_a19e6419-734f-4e0e-adff-afe1c52e6345">1,451.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i102884c59d1543caa2ca620678208c40_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMS01LTEtMS0w_cc0f154b-3da3-42df-8116-f03ed2fe426a">7,079.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79d400b1fb3b429b8cf4d8afe9e3f8b2_I20181231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMS03LTEtMS0w_67aaf3b4-e961-4d6e-af22-a72d509cefc7">1,108.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibedc8534cf6f4afb870b205b0eee4330_I20181231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMS05LTEtMS0w_bc19dfda-acaa-42a1-b8e5-28f290d53a25">463.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac49907696d40399215ce933a047245_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMS0xMS0xLTEtMA_f4b316b2-8696-416a-85f9-c8015595ccf4">6,971.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings attributable to Laboratory Corporation of America Holdings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d1cc0f890c444fc8065f85eaf2c3eb2_D20190101-20190331" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMi0xLTEtMS0w_4c5d3cf9-0a8a-4e79-9f1f-a9347d247da3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9805616bfc147a685777006a4f3a977_D20190101-20190331" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMi0zLTEtMS0w_c5e73e5c-371a-453e-9f0c-c896f835d28d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fd2acd8725944849260da540e21b13e_D20190101-20190331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMi01LTEtMS0w_76bba64b-c792-4065-a976-0e7d19cf1993">185.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aecc811560c4997ad0a94f7656fb5f2_D20190101-20190331" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMi03LTEtMS0w_d7b4e85f-a31f-4669-b3ad-53244939916f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3aa1360071d489f9642129871989937_D20190101-20190331" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMi05LTEtMS0w_c5d36dde-50a9-4c0b-b042-6f4db14e4a8d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedd14e246c1d49da9ac324e7575d5643_D20190101-20190331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMi0xMS0xLTEtMA_b672d8a1-b56c-49cb-b4c0-97d703d5895d">185.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive earnings, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d1cc0f890c444fc8065f85eaf2c3eb2_D20190101-20190331" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMy0xLTEtMS0w_a76529f2-d09c-45ec-9b1e-ba9f4e4f18d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9805616bfc147a685777006a4f3a977_D20190101-20190331" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMy0zLTEtMS0w_430b3c47-53ee-49c4-b1ac-5c5f3aa69b1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fd2acd8725944849260da540e21b13e_D20190101-20190331" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMy01LTEtMS0w_37442adc-890e-4256-a0bb-877776504063">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aecc811560c4997ad0a94f7656fb5f2_D20190101-20190331" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMy03LTEtMS0w_f85d60e8-ce0b-4022-ba81-5c3cd34808e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3aa1360071d489f9642129871989937_D20190101-20190331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMy05LTEtMS0w_010b8f27-15e2-476e-8994-cf3269bef9c6">23.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedd14e246c1d49da9ac324e7575d5643_D20190101-20190331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMy0xMS0xLTEtMA_c9941c5b-4134-48d8-850b-563c6f1f4ddc">23.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d1cc0f890c444fc8065f85eaf2c3eb2_D20190101-20190331" decimals="-5" format="ixt:zerodash" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNS0xLTEtMS0w_ad278cd8-002c-40eb-891e-a4f24fce5e29">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9805616bfc147a685777006a4f3a977_D20190101-20190331" decimals="-5" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNS0zLTEtMS0w_e6630a68-9d9f-4055-8462-b8205bb5dcc1">24.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fd2acd8725944849260da540e21b13e_D20190101-20190331" decimals="-5" format="ixt:zerodash" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNS01LTEtMS0w_fb19e5c6-2089-4565-a90d-22d5e4fa007a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aecc811560c4997ad0a94f7656fb5f2_D20190101-20190331" decimals="-5" format="ixt:zerodash" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNS03LTEtMS0w_8ae4713f-c4cc-46b7-b7be-ac6776fa43dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3aa1360071d489f9642129871989937_D20190101-20190331" decimals="-5" format="ixt:zerodash" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNS05LTEtMS0w_e2e79771-2ffb-4acd-b384-69a40fa3f02d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedd14e246c1d49da9ac324e7575d5643_D20190101-20190331" decimals="-5" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNS0xMS0xLTEtMA_a063a816-0ae8-4da7-84e7-3845c5d6f655">24.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net share settlement tax payments from issuance of stock to employees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d1cc0f890c444fc8065f85eaf2c3eb2_D20190101-20190331" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNi0xLTEtMS0w_1c9f20ba-8197-4d9b-89f9-6c18e3c5adb8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9805616bfc147a685777006a4f3a977_D20190101-20190331" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNi0zLTEtMS0w_6823a719-9d35-43f6-b421-b1faae57f45a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fd2acd8725944849260da540e21b13e_D20190101-20190331" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNi01LTEtMS0w_8b943f02-e403-43db-819f-49a8f1befe4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aecc811560c4997ad0a94f7656fb5f2_D20190101-20190331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNi03LTEtMS0w_ab8cab94-5c4e-45f7-a951-6c0743471185">19.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3aa1360071d489f9642129871989937_D20190101-20190331" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNi05LTEtMS0w_e8ae97c5-480c-4d6c-a41f-375a2f7ec0cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iedd14e246c1d49da9ac324e7575d5643_D20190101-20190331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNi0xMS0xLTEtMA_c3c65c46-9cd3-434a-8b2e-b5e6d8982058">19.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d1cc0f890c444fc8065f85eaf2c3eb2_D20190101-20190331" decimals="-5" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfOC0xLTEtMS0w_231e2ce3-df47-4795-a291-cd11991a9b87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9805616bfc147a685777006a4f3a977_D20190101-20190331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfOC0zLTEtMS0w_50e4c268-836c-464a-a8b4-96da685cd37a">25.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fd2acd8725944849260da540e21b13e_D20190101-20190331" decimals="-5" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfOC01LTEtMS0w_9b647870-75fc-4900-92b7-3ecd919cf584">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aecc811560c4997ad0a94f7656fb5f2_D20190101-20190331" decimals="-5" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfOC03LTEtMS0w_a2629559-ec96-4fe9-bd53-edc0c150936e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3aa1360071d489f9642129871989937_D20190101-20190331" decimals="-5" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfOC05LTEtMS0w_0be60dd0-1d2f-4255-837d-998b89892430">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedd14e246c1d49da9ac324e7575d5643_D20190101-20190331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfOC0xMS0xLTEtMA_5fc282cf-f0eb-48c0-87e9-818811b4e9d9">25.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d1cc0f890c444fc8065f85eaf2c3eb2_D20190101-20190331" decimals="-5" sign="-" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTAtMS0xLTEtMA_cd5db882-926e-41ce-ba57-cf395dbd9c7b">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9805616bfc147a685777006a4f3a977_D20190101-20190331" decimals="-5" sign="-" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTAtMy0xLTEtMA_fb5ae560-f4de-4062-9853-6abf8e9b5095">100.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fd2acd8725944849260da540e21b13e_D20190101-20190331" decimals="-5" format="ixt:zerodash" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTAtNS0xLTEtMA_dfa94c08-ba86-457f-bc4d-909905796873">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aecc811560c4997ad0a94f7656fb5f2_D20190101-20190331" decimals="-5" format="ixt:zerodash" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTAtNy0xLTEtMA_00ce493c-49f5-461f-99e5-ca1d72f5e525">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3aa1360071d489f9642129871989937_D20190101-20190331" decimals="-5" format="ixt:zerodash" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTAtOS0xLTEtMA_f52dc22c-17f4-4f0b-921c-08cd811a6e24">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iedd14e246c1d49da9ac324e7575d5643_D20190101-20190331" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTAtMTEtMS0xLTA_a32f5008-9ed7-48ac-b3b1-edfae5952d50">100.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE AT MARCH 31, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd1e22b6a154e39814fd636f0fab4ce_I20190331" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTEtMS0xLTEtMA_8f170166-5248-441f-932a-2165ff96baa5">11.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i749c4690686f45c3b2850fcbb9a0d1df_I20190331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTEtMy0xLTEtMA_357577fe-647f-482d-80cf-9f36afc91a65">1,401.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9b90f619f8b4a7083d154d69233d90f_I20190331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTEtNS0xLTEtMA_3eb72f56-e827-4b34-bccb-ca3033757076">7,265.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4aa40f4beab4847b0614e40e1cd143c_I20190331" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTEtNy0xLTEtMA_a59be3c3-0ce6-436f-840b-997b3f2f9059">1,127.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib974ad7e470d46998daf31767f2af398_I20190331" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTEtOS0xLTEtMA_e11788b1-2e8f-4878-ac89-3974a44ad6da">439.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bdc2fd7db454059a73ac63fbcf696e8_I20190331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTEtMTEtMS0xLTA_ebea2820-2332-452a-8c2e-2937355f0b14">7,111.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings attributable to Laboratory Corporation of America Holdings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic342c0d96ffa4ec4ba03f2801ad1e983_D20190401-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTItMS0xLTEtMA_8253688c-c8b7-469d-b216-b009ef34df6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib09142dcedba4260954ddf2d9692acb6_D20190401-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTItMy0xLTEtMA_dd10f822-0939-4848-a548-b67035e58978">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83d083f1fa054115979e180a0197c0c3_D20190401-20190630" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTItNS0xLTEtMA_5dbe1905-a4a2-40ff-8be6-40c5eeffd28c">190.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f0351d0ac5340749dcbd3417ca3b6cf_D20190401-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTItNy0xLTEtMA_f494e579-8355-425b-a1f7-290f735a4d70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75641ae84a834af19a49dbc2f325caa0_D20190401-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTItOS0xLTEtMA_6ea03b79-dce1-42d4-93a0-1665469c3b8f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fed346eafa54192b0996a2c5e59af06_D20190401-20190630" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTItMTEtMS0xLTA_b92d84aa-2135-47cf-bd02-cbaa03ccd537">190.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive earnings, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic342c0d96ffa4ec4ba03f2801ad1e983_D20190401-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTMtMS0xLTEtMA_d65d7875-b1a0-49f4-9960-f5911842692d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib09142dcedba4260954ddf2d9692acb6_D20190401-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTMtMy0xLTEtMA_707d377d-56cd-4ad2-8fd0-2c17249de7e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83d083f1fa054115979e180a0197c0c3_D20190401-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTMtNS0xLTEtMA_8fe7ec09-836b-4ab3-993a-4c3b2ebab378">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f0351d0ac5340749dcbd3417ca3b6cf_D20190401-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTMtNy0xLTEtMA_889de378-b1f1-422d-b115-d897ff7055d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75641ae84a834af19a49dbc2f325caa0_D20190401-20190630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTMtOS0xLTEtMA_2f4d609a-3f7a-4de4-939b-1b40e635ce52">27.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fed346eafa54192b0996a2c5e59af06_D20190401-20190630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTMtMTEtMS0xLTA_7933a56b-53c4-4b70-853d-79b1f7c30921">27.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic342c0d96ffa4ec4ba03f2801ad1e983_D20190401-20190630" decimals="-5" format="ixt:zerodash" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTQtMS0xLTEtMA_8c48e178-e12d-48f1-a0d8-51320a3b2696">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib09142dcedba4260954ddf2d9692acb6_D20190401-20190630" decimals="-5" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTQtMy0xLTEtMA_31f0812e-5a1b-49fc-ae03-5134e5e92428">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83d083f1fa054115979e180a0197c0c3_D20190401-20190630" decimals="-5" format="ixt:zerodash" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTQtNS0xLTEtMA_eb2918e6-1c2a-4f1f-ad63-eca3b0989c51">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f0351d0ac5340749dcbd3417ca3b6cf_D20190401-20190630" decimals="-5" format="ixt:zerodash" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTQtNy0xLTEtMA_2462e541-b465-46f8-9106-bf8b4293729c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75641ae84a834af19a49dbc2f325caa0_D20190401-20190630" decimals="-5" format="ixt:zerodash" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTQtOS0xLTEtMA_f1cc2c0c-5b53-4241-b1f4-4061600a6f51">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fed346eafa54192b0996a2c5e59af06_D20190401-20190630" decimals="-5" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTQtMTEtMS0xLTA_982f52a0-21d9-420a-b05d-996e6648abf0">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net share settlement tax payments from issuance of stock to employees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic342c0d96ffa4ec4ba03f2801ad1e983_D20190401-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTUtMS0xLTEtMA_634f9b22-cf3e-4f3c-87d3-f412c9a0a33b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib09142dcedba4260954ddf2d9692acb6_D20190401-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTUtMy0xLTEtMA_f301ec13-9f8e-4b7a-9e4a-c14809d40a9a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83d083f1fa054115979e180a0197c0c3_D20190401-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTUtNS0xLTEtMA_b8b0e205-f2f0-4361-befa-c8caaab7d942">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f0351d0ac5340749dcbd3417ca3b6cf_D20190401-20190630" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTUtNy0xLTEtMA_c5d73689-3252-4606-8bdc-9940da0cbd2b">20.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75641ae84a834af19a49dbc2f325caa0_D20190401-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTUtOS0xLTEtMA_6c6d7150-8fd5-40b8-be69-d0cd6fd553eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1fed346eafa54192b0996a2c5e59af06_D20190401-20190630" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTUtMTEtMS0xLTA_3ca4f99b-5930-45b5-bff1-85b3347f5f2f">20.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic342c0d96ffa4ec4ba03f2801ad1e983_D20190401-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTctMS0xLTEtMA_91855339-0e43-4d40-887b-f516c4951474">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib09142dcedba4260954ddf2d9692acb6_D20190401-20190630" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTctMy0xLTEtMA_0ee028e5-7409-4092-b012-197f5b60a499">26.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83d083f1fa054115979e180a0197c0c3_D20190401-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTctNS0xLTEtMA_303ebfdd-d280-4ca0-8ceb-a146e1fb81c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f0351d0ac5340749dcbd3417ca3b6cf_D20190401-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTctNy0xLTEtMA_f0079269-28bc-4ee4-a90b-d9077ae7c061">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75641ae84a834af19a49dbc2f325caa0_D20190401-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTctOS0xLTEtMA_bc6aefbe-5439-4bbd-bedc-25d0ae4e75e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fed346eafa54192b0996a2c5e59af06_D20190401-20190630" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTctMTEtMS0xLTA_aa7b0f84-a602-4d2f-9a46-b73863bce75e">26.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retirement of treasury stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic342c0d96ffa4ec4ba03f2801ad1e983_D20190401-20190630" decimals="-5" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTgtMS0xLTEtMA_855c9cee-14fb-4d6e-a585-584497903885">2.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib09142dcedba4260954ddf2d9692acb6_D20190401-20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTgtMy0xLTEtMA_dd1e5150-d79c-4314-840d-d42e8f5779b0">1,145.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83d083f1fa054115979e180a0197c0c3_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTgtNS0xLTEtMA_944d89e3-f7c0-4f4f-af99-15a3ba6ecb5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f0351d0ac5340749dcbd3417ca3b6cf_D20190401-20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTgtNy0xLTEtMA_a3e7d646-d968-498e-907d-a5ba0fc4fd78">1,148.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75641ae84a834af19a49dbc2f325caa0_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTgtOS0xLTEtMA_f2edd53b-100e-438f-b61b-8257ba4a57a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fed346eafa54192b0996a2c5e59af06_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTgtMTEtMS0xLTA_3b18aae7-f212-409b-a731-685272a2c7dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic342c0d96ffa4ec4ba03f2801ad1e983_D20190401-20190630" decimals="-5" sign="-" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTktMS0xLTEtMA_b2467373-e54f-4e5d-97a1-0f9a7516a3c1">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib09142dcedba4260954ddf2d9692acb6_D20190401-20190630" decimals="-5" sign="-" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTktMy0xLTEtMA_e54e92c7-aa21-4e7c-9ea4-e41fa9be7cc6">199.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83d083f1fa054115979e180a0197c0c3_D20190401-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTktNS0xLTEtMA_78e6f382-b883-41fe-b637-21d4ab7327dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f0351d0ac5340749dcbd3417ca3b6cf_D20190401-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTktNy0xLTEtMA_c5d73f02-40df-4bb5-a5f1-026cb33bf1e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75641ae84a834af19a49dbc2f325caa0_D20190401-20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTktOS0xLTEtMA_9496b2af-70eb-45f5-9ee4-be4aa409acf6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1fed346eafa54192b0996a2c5e59af06_D20190401-20190630" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTktMTEtMS0xLTA_729cdc3c-57e8-4dd8-8a57-aeac04c5d9ae">199.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE AT JUNE 30, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia796b50fb78c4d8ea1305d6cb87f4c80_I20190630" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjAtMS0xLTEtMA_400199d4-6af5-4d5a-8149-7f9e83a2b135">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5fd99aa026e4d049d9880148cd3673f_I20190630" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjAtMy0xLTEtMA_cc9776af-a995-4266-95ad-a2751235463d">91.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41dc70e79a434c8584c71c9871c4d297_I20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjAtNS0xLTEtMA_ba18cbf1-d18e-4c74-948c-583f0af48aab">7,455.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3830d635761e46d59cb5beb48e8e5c06_I20190630" decimals="-5" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjAtNy0xLTEtMA_f81a4e80-96dd-4708-8144-a6ae5294322d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4332a0967964a7e951d06b4f757007e_I20190630" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjAtOS0xLTEtMA_8eb6685c-69af-4089-bf81-a075209118ce">411.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbf3e729d39d476fbac2a1d7b95feece_I20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjAtMTEtMS0xLTA_2bdbdf63-babd-47ff-acab-65dcce590e1a">7,144.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings attributable to Laboratory Corporation of America Holdings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cc52edd079c41dba66111baf03d7d8d_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjEtMS0xLTEtMA_5e8128a3-1f14-487b-8966-feba3714c704">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f2b2ef9fa394b91a5ebeb5644627072_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjEtMy0xLTEtMA_83b0f68d-d418-4e1d-b74c-6e200934d656">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjEtNS0xLTEtMA_49117119-626c-4a46-a4fa-b583c9d237d5">220.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92acbc0b60c64d71979b7d2ca0a3d393_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjEtNy0xLTEtMA_78a97c66-d10f-4d8f-af38-91d9f8af2061">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8dc748344574f268131764ada7e2c98_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjEtOS0xLTEtMA_57c2670b-9837-4763-a7e6-b687c123b284">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjEtMTEtMS0xLTA_1543efcf-1023-4a20-b37e-045e4be0b565">220.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cc52edd079c41dba66111baf03d7d8d_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjItMS0xLTEtMA_75122e38-7e5e-45e8-89b7-08adce026c1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f2b2ef9fa394b91a5ebeb5644627072_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjItMy0xLTEtMA_d4991585-9f72-46be-9fc6-32e28273c4df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i330e9e0c1f764aa28705cf6255807ed9_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjItNS0xLTEtMA_18854ba3-36ff-45a5-8b1c-66616b0db268">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92acbc0b60c64d71979b7d2ca0a3d393_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjItNy0xLTEtMA_187f64e3-61db-41f0-9263-7ef764824a66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjItOS0xLTEtMA_77678110-3b8e-4c0c-8c76-b4f2a53d4103">90.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjItMTEtMS0xLTA_44034b64-5003-43c1-b683-66e41b99b7dc">90.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cc52edd079c41dba66111baf03d7d8d_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjMtMS0xLTEtMA_32720044-b76a-412c-8592-82e42cf6e064">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f2b2ef9fa394b91a5ebeb5644627072_D20190701-20190930" decimals="-5" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjMtMy0xLTEtMA_66e6f43a-eb69-487e-bdda-1b143d2b036b">25.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i330e9e0c1f764aa28705cf6255807ed9_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjMtNS0xLTEtMA_64d6c040-fdf1-4a81-9447-47b69f72fd4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92acbc0b60c64d71979b7d2ca0a3d393_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjMtNy0xLTEtMA_388f3664-263e-4412-b0c6-05e689c44c52">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8dc748344574f268131764ada7e2c98_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjMtOS0xLTEtMA_ac2f6f2e-fc7c-4ae9-9274-c9f5cc67a0a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="-5" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjMtMTEtMS0xLTA_01eda7ad-873f-4f8b-a3d4-c83a72094b6b">25.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net share settlement tax payments from issuance of stock to employees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cc52edd079c41dba66111baf03d7d8d_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjQtMS0xLTEtMA_cc10649b-680a-4d56-93fc-f9ddb8394d9a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f2b2ef9fa394b91a5ebeb5644627072_D20190701-20190930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjQtMy0xLTEtMA_552eb95a-6e8c-4b0d-bf53-8e677044dc65">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i330e9e0c1f764aa28705cf6255807ed9_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjQtNS0xLTEtMA_6981ac63-cadc-4ec3-84cb-47fe8e8018b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92acbc0b60c64d71979b7d2ca0a3d393_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjQtNy0xLTEtMA_5c2911c1-b7ab-4073-bb24-24fbc770e944">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8dc748344574f268131764ada7e2c98_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjQtOS0xLTEtMA_312a45c5-18a5-4a16-abbd-f3fd6e28b428">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjQtMTEtMS0xLTA_c23bbd4f-3e78-447f-bf79-9a5fb45fba18">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cc52edd079c41dba66111baf03d7d8d_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjYtMS0xLTEtMA_f70ee729-a961-4029-9a9a-e14aaa347413">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f2b2ef9fa394b91a5ebeb5644627072_D20190701-20190930" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjYtMy0xLTEtMA_49329bc7-20b9-47eb-a489-13a0538788a4">31.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i330e9e0c1f764aa28705cf6255807ed9_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjYtNS0xLTEtMA_82ed2a21-b7ae-424e-902d-5bac00c1ea13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92acbc0b60c64d71979b7d2ca0a3d393_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjYtNy0xLTEtMA_164232ec-50ca-4b22-9899-6ff1560fbe45">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8dc748344574f268131764ada7e2c98_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjYtOS0xLTEtMA_14252234-a3ce-450d-937a-c3389828b22c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjYtMTEtMS0xLTA_3cee55cd-9720-4ae6-a0bc-d8cef5b81dab">31.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6cc52edd079c41dba66111baf03d7d8d_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjctMS0xLTEtMA_520a7b80-5c11-4c88-8fc7-53cb3358b9b0">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f2b2ef9fa394b91a5ebeb5644627072_D20190701-20190930" decimals="-5" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjctMy0xLTEtMA_8790cb7c-2678-4062-ae26-9f3b024159e9">99.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i330e9e0c1f764aa28705cf6255807ed9_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjctNS0xLTEtMA_950248ed-94d6-45c5-9068-19563ffb77e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92acbc0b60c64d71979b7d2ca0a3d393_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjctNy0xLTEtMA_f60a5c66-0dbb-48a6-a56b-47102788aba5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8dc748344574f268131764ada7e2c98_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjctOS0xLTEtMA_789e62a8-8b57-445f-9265-461c89dd0f41">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjctMTEtMS0xLTA_ee905bc0-fca7-4c95-9586-dc7aaaa9af67">100.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE AT SEPTEMBER 30, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e93e2032f774e388fbc09993a955665_I20190930" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjgtMS0xLTEtMA_2ac11d79-3155-446c-ab70-99e3bc1dd57b">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i219dadfad6ec4f15ab02c46b30294757_I20190930" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjgtMy0xLTEtMA_d9fa696c-6ca6-4e96-9440-7621fcd24599">47.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i121e54f584574754a997b2e8da14cb33_I20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjgtNS0xLTEtMA_27c2d5df-6109-478f-b902-6a291ff38d9e">7,676.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf92e2a580e040a495fdd34dbb61b1e3_I20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjgtNy0xLTEtMA_e1598476-894f-4fe7-9967-10872227f317">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52114c8d18b9499a9e0444fcbab899ab_I20190930" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjgtOS0xLTEtMA_ed0411d5-470d-4e66-99c9-b2245c9a98b8">502.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ebf6d35695d43bebd0e1036cfd88d00_I20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjgtMTEtMS0xLTA_c2410271-2f32-4543-90ac-46c8560cd666">7,231.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE AT DECEMBER 31, 2019</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6295bf6566e4265bac5d6f0714100b1_I20191231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzAtMS0xLTEtMA_0084f948-02a8-4e63-b8b1-aaaac30b499e">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i995498342f4d4bbeb12d006cd72d61b1_I20191231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzAtMy0xLTEtMA_5973641b-548f-4dda-a839-fde306b94751">26.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id047e5b85b904a12801017a2fd441c52_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzAtNS0xLTEtMA_123d8f41-5b3f-4e07-b930-d0d34904dfda">7,903.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4d943c067664cd3bb4ef38017cfc703_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzAtNy0xLTEtMA_be5102e7-0bf7-4a25-afb4-058d7047fbbf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb05081604c34e979bb4fd456055049e_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzAtOS0xLTEtMA_7c00c236-2eff-4af5-b9be-acc981248f4b">372.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzAtMTEtMS0xLTA_418d69e1-9078-4f9f-96ca-7f1f7de34257">7,567.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adoption of credit loss accounting standard</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8a89f8ac83b437aa6f0f277429e7b04_I20200101" decimals="-6" format="ixt:zerodash" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzEtMS0xLTEtMA_eb7c523d-d3ab-4f76-b3fa-2981aeaea689">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d1419fac15d45ba8998356ea892ab07_I20200101" decimals="-6" format="ixt:zerodash" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzEtMy0xLTEtMA_d5a96bf6-66bc-4ba3-bf8a-d5dcafaa5f79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic71057ddd9b94ee9bbf0a3919bd94bd4_I20200101" decimals="-6" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzEtNS0xLTEtMA_849ac6b3-611c-4416-9251-6d1fc700ac63">7.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b1ac80eac24afe88d4fb1b2e16aefd_I20200101" decimals="-6" format="ixt:zerodash" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzEtNy0xLTEtMA_8b873dac-8501-4b2c-af96-7f44aa5d0041">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31964c5cf72480688ceb520816d7665_I20200101" decimals="-6" format="ixt:zerodash" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzEtOS0xLTEtMA_c14e47aa-e80e-4f97-af7d-7d5ebb1aa531">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic71057ddd9b94ee9bbf0a3919bd94bd4_I20200101" decimals="-6" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzEtMTEtMS0xLTA_dcbef723-bd24-4f1c-864b-3946ab738014">7.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings (loss) attributable to Laboratory Corporation of America Holdings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib51bcbbe3b3b40dabc2fef3fab8b97b2_D20200101-20200331" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzItMS0xLTEtMA_c2d0809c-a53b-4b79-a11c-4b6d97dd78c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0abf8234cd2f4de5ad2609359991f8d3_D20200101-20200331" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzItMy0xLTEtMA_6283c357-1695-452c-88dc-28ac83a6832b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id31a66599db3453db1095d8dd3713397_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzItNS0xLTEtMA_7d729707-4f67-494f-a7d1-d077a30cedbb">317.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2584e4e56f14caaa4332a71ef56576f_D20200101-20200331" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzItNy0xLTEtMA_0a2c596f-2047-4d8a-ad84-ca13136c878b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25486ee4361d42f18c47644aa116250b_D20200101-20200331" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzItOS0xLTEtMA_73acd66d-f5e6-4a6f-a97d-6c59c8a75579">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia962c16050fa4b28adc73e0d729703c5_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzItMTEtMS0xLTA_ff7ec535-34cd-4c78-a2e6-96c3a6aa0e57">317.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss), net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib51bcbbe3b3b40dabc2fef3fab8b97b2_D20200101-20200331" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzMtMS0xLTEtMA_c114866f-086c-4737-9fed-cd991cf5fb08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0abf8234cd2f4de5ad2609359991f8d3_D20200101-20200331" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzMtMy0xLTEtMA_7ab2edfa-e205-41aa-be91-9048f97cf520">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id31a66599db3453db1095d8dd3713397_D20200101-20200331" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzMtNS0xLTEtMA_c6481cf5-2b15-4ad8-96a1-bafc26fdc6f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2584e4e56f14caaa4332a71ef56576f_D20200101-20200331" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzMtNy0xLTEtMA_91be7005-b7b5-4200-b5c5-b23eb01fe6a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25486ee4361d42f18c47644aa116250b_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzMtOS0xLTEtMA_442fcbd3-f696-48ec-8f2d-e7343b9bb9ea">145.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia962c16050fa4b28adc73e0d729703c5_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzMtMTEtMS0xLTA_234120ff-0c5f-4818-903c-6b760cd1a72a">145.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib51bcbbe3b3b40dabc2fef3fab8b97b2_D20200101-20200331" decimals="-5" format="ixt:zerodash" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzQtMS0xLTEtMA_a82a74cd-b59a-4f73-9d96-dacc434f06de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0abf8234cd2f4de5ad2609359991f8d3_D20200101-20200331" decimals="-5" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzQtMy0xLTEtMA_c4c7c388-48ba-4ea4-8cd3-033221ff35ad">26.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id31a66599db3453db1095d8dd3713397_D20200101-20200331" decimals="-5" format="ixt:zerodash" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzQtNS0xLTEtMA_0fd4b610-cef7-4370-b1df-75be113f724e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2584e4e56f14caaa4332a71ef56576f_D20200101-20200331" decimals="-5" format="ixt:zerodash" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzQtNy0xLTEtMA_972a23dd-a135-4c9d-8f53-85f81445eaf7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25486ee4361d42f18c47644aa116250b_D20200101-20200331" decimals="-5" format="ixt:zerodash" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzQtOS0xLTEtMA_eee1d5ea-71bd-4445-a8fb-c9a8739d07fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia962c16050fa4b28adc73e0d729703c5_D20200101-20200331" decimals="-5" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzQtMTEtMS0xLTA_66c2fd44-e4b0-4b9f-968e-01a4496c8698">26.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net share settlement tax payments from issuance of stock to employees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib51bcbbe3b3b40dabc2fef3fab8b97b2_D20200101-20200331" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzUtMS0xLTEtMA_b2177d79-1030-4884-9498-1a2b8fe8cbdf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0abf8234cd2f4de5ad2609359991f8d3_D20200101-20200331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzUtMy0xLTEtMA_38f2bdac-9b61-4c5e-b7ec-186090ad723d">22.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id31a66599db3453db1095d8dd3713397_D20200101-20200331" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzUtNS0xLTEtMA_de67b401-8f8b-44d6-b3c1-6a82987a99b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2584e4e56f14caaa4332a71ef56576f_D20200101-20200331" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzUtNy0xLTEtMA_71aee384-07e4-4367-9fbe-46c7d867a74f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25486ee4361d42f18c47644aa116250b_D20200101-20200331" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzUtOS0xLTEtMA_ccb094e6-44c8-4dfd-89b7-6a54aa617068">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia962c16050fa4b28adc73e0d729703c5_D20200101-20200331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzUtMTEtMS0xLTA_8ca6b328-4e35-4b40-8a94-34f392b310fb">22.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib51bcbbe3b3b40dabc2fef3fab8b97b2_D20200101-20200331" decimals="-5" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzctMS0xLTEtMA_036e7fc0-2920-4bee-a8ae-3f0ad5936d28">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0abf8234cd2f4de5ad2609359991f8d3_D20200101-20200331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzctMy0xLTEtMA_498a9cc6-b777-4dd2-a912-a4b7abfb5a71">17.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id31a66599db3453db1095d8dd3713397_D20200101-20200331" decimals="-5" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzctNS0xLTEtMA_15f3a92e-38f0-4745-8d00-fb16185fca2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2584e4e56f14caaa4332a71ef56576f_D20200101-20200331" decimals="-5" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzctNy0xLTEtMA_0b94d24e-c10b-4b5a-a8a3-b17af2eb22a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25486ee4361d42f18c47644aa116250b_D20200101-20200331" decimals="-5" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzctOS0xLTEtMA_459a7e57-5c0c-4c29-aa47-a2008830389f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia962c16050fa4b28adc73e0d729703c5_D20200101-20200331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzctMTEtMS0xLTA_d64ac46c-5b73-4c2e-8c61-4a6f5cc81a17">17.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib51bcbbe3b3b40dabc2fef3fab8b97b2_D20200101-20200331" decimals="-5" format="ixt:zerodash" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzktMS0xLTEtMA_447fd76a-ce93-4e3a-b6d4-4b19f1339d47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0abf8234cd2f4de5ad2609359991f8d3_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzktMy0xLTEtMA_a4d40d63-12f2-42ea-855f-e8d587815762">49.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id31a66599db3453db1095d8dd3713397_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzktNS0xLTEtMA_09bd678c-abf7-4dba-a64e-985292063ef7">50.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2584e4e56f14caaa4332a71ef56576f_D20200101-20200331" decimals="-5" format="ixt:zerodash" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzktNy0xLTEtMA_078c08eb-3cbb-4b3d-9474-92a9ec5ff4ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25486ee4361d42f18c47644aa116250b_D20200101-20200331" decimals="-5" format="ixt:zerodash" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzktOS0xLTEtMA_9636e789-1d57-4196-bbdc-b1e7799bff90">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia962c16050fa4b28adc73e0d729703c5_D20200101-20200331" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzktMTEtMS0xLTA_27b304d8-a773-404b-8bde-cbf867114135">100.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE AT MARCH 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d6506b821ec4b6a89acd1558aaf0f20_I20200331" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDAtMS0xLTEtMA_26c3b8d4-7498-4ddf-8c53-3d9ef736e4bf">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f1b50d6e33142a797ba59094a4d6109_I20200331" decimals="-5" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDAtMy0xLTEtMA_9f729795-2710-4940-b5b3-dd4a017aee90">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ecd2df0683345df840720ba03e366f6_I20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDAtNS0xLTEtMA_771e8569-69c2-48be-a257-9813793c328a">7,529.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4033d4ed5ac4e2a90cf122db9d649b7_I20200331" decimals="-5" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDAtNy0xLTEtMA_3dd7511a-804f-4a07-bceb-47fdb7857420">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i906c32823da3454c88cf7e570cb8bde4_I20200331" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDAtOS0xLTEtMA_117c7523-2996-4d9f-93d8-96b1c258e5d9">517.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50a2dfaccda94b87acda43c31ec50e7a_I20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDAtMTEtMS0xLTA_4901928a-0506-417b-be09-84bb477a5e87">7,020.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings attributable to Laboratory Corporation of America Holdings</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e645a01cc63416894fda41c9b202e41_D20200401-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDEtMS0xLTEtMA_afd342d0-ffec-4990-b589-6c6e44baae87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iceabf34577cf4df1ae006d401b431793_D20200401-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDEtMy0xLTEtMA_b2c43694-59f4-4413-8f7b-846980509ac6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5513a927c4444339f73687e0a972d90_D20200401-20200630" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDEtNS0xLTEtMA_c97c4eb5-3b36-421a-b578-cce733e25f09">231.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f4911a3cd4244faa921cef6beedbda0_D20200401-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDEtNy0xLTEtMA_e51c404c-4d7d-4247-ac18-c7b6f67e1f28">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70e36036ee974a9383e7b832ec83f7bf_D20200401-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDEtOS0xLTEtMA_08861c7d-1d0f-444e-9024-b0ef2f4c1b35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i612a5521f96f4a1db5dcc91dda46a2e8_D20200401-20200630" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDEtMTEtMS0xLTA_ebb75ad3-b119-43a5-b353-df732d0f48bd">231.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive earnings, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e645a01cc63416894fda41c9b202e41_D20200401-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDItMS0xLTEtMA_8cf30ec1-bfbe-49ea-9c0c-4ee8469eb464">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iceabf34577cf4df1ae006d401b431793_D20200401-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDItMy0xLTEtMA_c9d09daf-106f-4a07-9344-5fe28d8802bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5513a927c4444339f73687e0a972d90_D20200401-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDItNS0xLTEtMA_01ea1c4f-4a43-445e-b112-707a86e59309">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f4911a3cd4244faa921cef6beedbda0_D20200401-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDItNy0xLTEtMA_f359ba04-b9fb-48df-b94e-3501a8839668">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70e36036ee974a9383e7b832ec83f7bf_D20200401-20200630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDItOS0xLTEtMA_3c228e40-4c6d-427e-aef8-02503d8bb683">68.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i612a5521f96f4a1db5dcc91dda46a2e8_D20200401-20200630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDItMTEtMS0xLTA_582abfcc-da3f-41cf-b8bd-c3827b6c3813">68.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e645a01cc63416894fda41c9b202e41_D20200401-20200630" decimals="-5" format="ixt:zerodash" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDMtMS0xLTEtMA_ad204abe-6813-4b99-89f3-35c0d1e24878">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iceabf34577cf4df1ae006d401b431793_D20200401-20200630" decimals="-5" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDMtMy0xLTEtMA_57b7e0ea-de41-4cc5-bb45-c8492453bfe2">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5513a927c4444339f73687e0a972d90_D20200401-20200630" decimals="-5" format="ixt:zerodash" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDMtNS0xLTEtMA_a52a216e-1695-4937-9a61-3c2b1db8bd5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f4911a3cd4244faa921cef6beedbda0_D20200401-20200630" decimals="-5" format="ixt:zerodash" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDMtNy0xLTEtMA_6d89683d-9dd2-47ba-8793-650faa2794e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70e36036ee974a9383e7b832ec83f7bf_D20200401-20200630" decimals="-5" format="ixt:zerodash" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDMtOS0xLTEtMA_bf4880cf-0635-46c4-8baf-b73349eb9ccc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i612a5521f96f4a1db5dcc91dda46a2e8_D20200401-20200630" decimals="-5" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDMtMTEtMS0xLTA_18331624-a7d1-4e24-ab69-a4117dedb39c">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net share settlement tax payments from issuance of stock to employees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e645a01cc63416894fda41c9b202e41_D20200401-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDQtMS0xLTEtMA_14d40d09-38d4-48e3-9ff4-ef5f0615cb67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iceabf34577cf4df1ae006d401b431793_D20200401-20200630" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDQtMy0xLTEtMA_88c770f3-e69e-4f98-999f-ebd6e6e59996">9.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5513a927c4444339f73687e0a972d90_D20200401-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDQtNS0xLTEtMA_fd08b2eb-de22-434a-b9d3-54fafc92fb5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f4911a3cd4244faa921cef6beedbda0_D20200401-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDQtNy0xLTEtMA_90e83f5e-44f7-4eac-8d96-c4af5c73a2e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70e36036ee974a9383e7b832ec83f7bf_D20200401-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDQtOS0xLTEtMA_f98cbee3-3f71-4402-8c97-dc95570a051d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i612a5521f96f4a1db5dcc91dda46a2e8_D20200401-20200630" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDQtMTEtMS0xLTA_291c7fbb-f321-475b-ac48-9c8425fd47eb">9.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e645a01cc63416894fda41c9b202e41_D20200401-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDYtMS0xLTEtMA_19a57c65-fe6d-41bb-b9cc-ee6c078a9161">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iceabf34577cf4df1ae006d401b431793_D20200401-20200630" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDYtMy0xLTEtMA_2495e6f8-f0ff-4cc3-b650-f9dec29b0d0b">39.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5513a927c4444339f73687e0a972d90_D20200401-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDYtNS0xLTEtMA_f5eebbc9-74e3-4abd-a5c5-45bc735a1674">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f4911a3cd4244faa921cef6beedbda0_D20200401-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDYtNy0xLTEtMA_a94be5b6-ea26-4989-8dd4-7a3668e51bcc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70e36036ee974a9383e7b832ec83f7bf_D20200401-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDYtOS0xLTEtMA_ef740e12-6a6c-41e1-b953-16c576e249bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i612a5521f96f4a1db5dcc91dda46a2e8_D20200401-20200630" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDYtMTEtMS0xLTA_c1756827-1c4d-4a42-953f-7f9cf48c07b8">39.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE AT JUNE 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a0d6c3c99214086849193c76b863382_I20200630" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDktMS0xLTEtMA_756531b2-72cc-405d-a0d6-2cf6446d332a">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6421b026529d4cb8a7d4ed4b2b200529_I20200630" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDktMy0xLTEtMA_9cf32bab-9a11-422e-b709-762e47d7d27c">32.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35550650089c49acaebcaf52a144d1f7_I20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDktNS0xLTEtMA_2c60fb95-44ad-4e56-bee0-9d57a64b4c07">7,760.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad6fff0892aa4905843f6f15944bd070_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDktNy0xLTEtMA_8f99dcb9-5e74-441f-a4ca-796019c08044">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie055d220bf39404a910b28a899727919_I20200630" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDktOS0xLTEtMA_61bd8e77-5c4b-4d37-bc6a-8f361b4d7c93">449.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8272c3d15f864e709f533b5532e0c9c8_I20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDktMTEtMS0xLTA_afa29eb5-e61e-4d7c-8221-5870565cc16e">7,352.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings attributable to Laboratory Corporation of America Holdings</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbbfb6e65e55467184de04732ad5dbca_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTAtMS0xLTEtMA_c7e9d035-49f4-478b-aab5-7d41a6e1e48f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafb98936914b4c85ad9a3c7728022c47_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTAtMy0xLTEtMA_c52d7b19-417d-4fc3-b73f-c4ef9d84ef51">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84ab37a796dd4ad595c43567718e60ab_D20200701-20200930" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTAtNS0xLTEtMA_7d67d65d-71b5-45ae-95db-c6f04e00d8d9">703.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba6759ae8a5847a883ff4cd2ca1523c4_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTAtNy0xLTEtMA_461131ee-2512-416b-87f2-e2eb7d3edece">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec50023dc3d34301836e4d6d2ab126fe_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTAtOS0xLTEtMA_6a50aa8c-a82b-4ef1-b85b-2331cf5c6bc8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTAtMTEtMS0xLTA_8e28f457-f6c6-4019-9de5-686dfca31642">703.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive earnings, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbbfb6e65e55467184de04732ad5dbca_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTEtMS0xLTEtMA_2dc98809-f5a5-45fe-a8d0-d6be5f2f0aa9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafb98936914b4c85ad9a3c7728022c47_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTEtMy0xLTEtMA_51b5dda4-3df8-4131-94c1-0acee4aeacee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84ab37a796dd4ad595c43567718e60ab_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTEtNS0xLTEtMA_886ae8f7-5d8e-4ce4-9496-dc8b41055b1d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba6759ae8a5847a883ff4cd2ca1523c4_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTEtNy0xLTEtMA_4857a68b-b15a-4af4-b5fb-3defc4f237a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec50023dc3d34301836e4d6d2ab126fe_D20200701-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTEtOS0xLTEtMA_bf455847-aeda-4ee7-af9c-0ca8beaf33da">134.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTEtMTEtMS0xLTA_9bdbd481-d4a2-4fca-9b6c-c21b456e77fe">134.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbbfb6e65e55467184de04732ad5dbca_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTItMS0xLTEtMA_a9786519-8d80-42c9-9ef7-a5594b3680ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafb98936914b4c85ad9a3c7728022c47_D20200701-20200930" decimals="-5" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTItMy0xLTEtMA_55aa8095-24a6-4fef-8a41-7a8e84e1b0f8">21.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84ab37a796dd4ad595c43567718e60ab_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTItNS0xLTEtMA_f4f8b7b8-8ca9-4b28-8552-2ff2a73dc09e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba6759ae8a5847a883ff4cd2ca1523c4_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTItNy0xLTEtMA_444ddd39-aa66-4926-8644-c200fffcc3a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec50023dc3d34301836e4d6d2ab126fe_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTItOS0xLTEtMA_c386c04a-09e1-4b26-8e81-de03f61b64d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTItMTEtMS0xLTA_2a663805-1f1f-4079-8362-67ffc09c91a8">21.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net share settlement tax payments from issuance of stock to employees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbbfb6e65e55467184de04732ad5dbca_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTMtMS0xLTEtMA_dc71eabf-9f74-47ce-84b6-7a6bf78c33ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafb98936914b4c85ad9a3c7728022c47_D20200701-20200930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTMtMy0xLTEtMA_84659ed7-124a-4952-8837-3f2d8b5035b3">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84ab37a796dd4ad595c43567718e60ab_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTMtNS0xLTEtMA_6fe4ac65-337f-43c1-950c-b97c179b4bdd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba6759ae8a5847a883ff4cd2ca1523c4_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTMtNy0xLTEtMA_22e3cb03-cffa-4779-b892-3bd2a909f3de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec50023dc3d34301836e4d6d2ab126fe_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTMtOS0xLTEtMA_cb027aa8-5db6-41aa-8f89-7e4564a61af1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTMtMTEtMS0xLTA_c4bf3390-a56b-492c-8876-fd7f2f271725">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbbfb6e65e55467184de04732ad5dbca_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTUtMS0xLTEtMA_9524f1fc-f00f-46d3-88cc-0ec6844404f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafb98936914b4c85ad9a3c7728022c47_D20200701-20200930" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTUtMy0xLTEtMA_eb07f81f-64f4-4af2-9179-f9ac075ff8da">27.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84ab37a796dd4ad595c43567718e60ab_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTUtNS0xLTEtMA_4da95aa7-161a-48ea-ac9a-543a0dc067ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba6759ae8a5847a883ff4cd2ca1523c4_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTUtNy0xLTEtMA_dee6ff1b-6206-4481-b47c-798f6af2806a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec50023dc3d34301836e4d6d2ab126fe_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTUtOS0xLTEtMA_e0286977-4a00-44a7-83b0-7d73346165cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTUtMTEtMS0xLTA_6d6681f0-1fec-46fb-8b04-0d85f2dbea6a">27.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE AT SEPTEMBER 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b9f3b204a7e4d5bb84fdca35b0388af_I20200930" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTctMS0xLTEtMA_53090608-4506-4b2f-a51b-0c2c58fdad20">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02dd23ef8e2c4ff6ad5ce9aa02fd57a1_I20200930" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTctMy0xLTEtMA_01839383-0fe0-4d93-95bd-6ffe7f88cb88">80.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i003fb35d67544342982c7134cef34000_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTctNS0xLTEtMA_4921f4e4-0b2a-4039-bc71-5b8d8ec1235a">8,464.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb420f938cb849e7b63729c500bdb2ef_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTctNy0xLTEtMA_56f9d62e-08ed-42da-b597-4ca766f16bf6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f654e418554a0aba5b6a17b3942bae_I20200930" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTctOS0xLTEtMA_6c89eefa-70b0-4ca3-b887-46ede530c8ae">314.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTctMTEtMS0xLTA_7950eafa-b060-495f-9171-ec3070575ca4">8,239.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i417074d9a2c24c34bcac25f32d2ec0c1_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.778%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH FLOWS FROM OPERATING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMy0xLTEtMS0w_1b0ca367-9db5-4032-a541-af5f8ee2ba4e">618.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMy0zLTEtMS0w_af1de74f-335b-474a-a234-c16ffa061bba">597.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNS0xLTEtMS0w_90e3dc3d-91c1-49a2-8f56-5ca885fefefb">440.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNS0zLTEtMS0w_3246a2e6-0862-49af-9dcf-d1a661e4051d">421.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNi0xLTEtMS0w_66c0c5fd-7c7e-4b5e-be27-75ed811522f6">84.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNi0zLTEtMS0w_18349aa8-56b5-4edc-a71d-f947743d2cfb">83.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="lh:DepreciationAndAmortizationOfLeasedAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTEtMS0xLTEtMA_446f4f4d-9203-4ea4-b86e-e2bd66dfe171">150.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="lh:DepreciationAndAmortizationOfLeasedAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTEtMy0xLTEtMA_6e26bc4d-3c85-4414-9d50-d7e9a4991010">144.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTMtMS0xLTEtMA_d7c0a191-6bcf-49d0-82e1-30bece710993">460.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTMtMy0xLTEtMA_fc6d7f74-1a02-42e4-bba7-59deff7e14d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTQtMS0xLTEtMA_abe04a66-a14c-490a-974a-840e5939e079">48.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTQtMy0xLTEtMA_8209b68f-8e06-4f3e-a67e-487b264b1acd">23.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTUtMS0xLTEtMA_d4f38b0b-2c39-4e10-9dcd-9c14af5b2ba0">55.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTUtMy0xLTEtMA_bb87f509-7a0c-4dcb-9062-e0b52ceb671e">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in assets and liabilities (net of effects of acquisitions and divestitures):</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 24.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTctMS0xLTEtMA_d5806e9f-a01e-4c62-bbcf-a44d709c73ef">546.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTctMy0xLTEtMA_65c95e49-aee3-43fe-b2c1-cd0eef61b23b">144.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 24.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in unbilled services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="lh:IncreaseDecreaseinUnbilledContractReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTgtMS0xLTEtMA_d4f6c4b4-d01f-4b46-809d-6a826e180945">117.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="lh:IncreaseDecreaseinUnbilledContractReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTgtMy0xLTEtMA_c1d57e1f-141e-4864-9d4d-49b1d0b1b491">59.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 24.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in supplies inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTktMS0xLTEtMA_09ba3c90-3e8c-4648-b909-e3b61a0368e8">147.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTktMy0xLTEtMA_5ff92097-d6b3-4a80-bdff-af010b321fe8">14.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 24.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjAtMS0xLTEtMA_79bbfe4b-db80-44d6-a33b-5811f0e8d87a">26.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjAtMy0xLTEtMA_edd319e5-d905-4a23-97ae-38b1f77d7a26">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 24.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) increase in accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjEtMS0xLTEtMA_37a1568f-4d15-4919-b422-1497b16b441e">17.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjEtMy0xLTEtMA_7070a55f-be08-41cf-a9f5-a80626205d07">28.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 24.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) increase in unearned revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjItMS0xLTEtMA_ad7d37c6-aa85-49fe-a2ed-b2c2273deaed">44.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjItMy0xLTEtMA_9bbba2b1-024e-4c25-9e14-2e0fefecb1c4">1.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 24.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) increase in accrued expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjQtMS0xLTEtMA_44c87b4d-51de-440b-b485-64056b89ddcc">323.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjQtMy0xLTEtMA_16db3f42-deb9-4099-98cc-c85dce29d0cb">165.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjUtMS0xLTEtMA_612a6203-0456-4c0d-8a2a-ab2c1b89c842">1,360.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjUtMy0xLTEtMA_1aa7e761-5b1f-4d4a-9e6e-df4cfa3dc285">874.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH FLOWS FROM INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjctMS0xLTEtMA_4fe6a417-f034-424b-a23e-f826f509dfab">282.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjctMy0xLTEtMA_0ee79b88-1325-4150-ae65-2f648f57c2d0">272.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjgtMS0xLTEtMA_addcb19b-d166-4dec-b82c-b9fadaec3eb7">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjgtMy0xLTEtMA_18b601fe-71c8-409a-914c-5d2494a28c40">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale or distribution of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjktMS0xLTEtMA_c61561af-5645-44a9-83ee-eaa4727a6abd">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjktMy0xLTEtMA_a31cd6c1-dc0a-4ebb-8df2-92ab6f746268">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exit from swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:ProceedsFromHedgeInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzItMS0xLTEtNTQ5Mg_68593234-4186-4bda-8a83-f8f9279028a8">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromHedgeInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzItMy0xLTEtNTQ5Ng_812494e9-0533-4eff-912c-d4cf411ab772">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in equity affiliates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzItMS0xLTEtMA_e361182d-d0de-4afc-bf27-8d4721a416eb">29.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzItMy0xLTEtMA_1f544b3c-94e4-4129-a402-70ff75774094">21.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of businesses, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzMtMS0xLTEtMA_a26b98f8-19ea-4625-b5e5-3f539a1cb4e6">208.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzMtMy0xLTEtMA_7582427a-27a8-45f5-91ca-544c86b777ff">852.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzQtMS0xLTEtMA_721c4f72-8e78-4d92-82df-2cd480f67a14">515.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzQtMy0xLTEtMA_b554a4f1-6149-49c2-bf95-bd541d1bb245">1,131.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH FLOWS FROM FINANCING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from term loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzctMS0xLTEtMA_b737f81d-44ec-40e8-b588-7f3bf414c658">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzctMy0xLTEtMA_cdb47114-3a11-4654-8065-d99fc896008b">850.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on term loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:RepaymentsOfOtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzgtMS0xLTEtMA_8ffda8d6-dce8-446d-99f1-2c3677a221b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:RepaymentsOfOtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzgtMy0xLTEtMA_550ba6b5-0a74-488a-821a-7e4b6c408fbf">250.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from revolving credit facilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:ProceedsFromLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzktMS0xLTEtMA_90637fbe-3109-4229-beb4-4c3663e7c98f">151.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:ProceedsFromLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzktMy0xLTEtMA_5d5be32e-499d-4036-ba68-67e67d325a4d">473.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on revolving credit facilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNDAtMS0xLTEtMA_eb90a932-3dbc-4f67-95b8-f4a6915e6c52">151.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNDAtMy0xLTEtMA_b478565f-eebf-4845-aacb-33ef64930b9b">473.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:RepaymentsOfSeniorDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNDMtMS0xLTEtMA_9c3b05fb-c49f-4da4-a462-4153c9afef79">412.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RepaymentsOfSeniorDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNDMtMy0xLTEtMA_5f5332a4-0629-42ce-8a82-dc2ffee0b3c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net share settlement tax payments from issuance of stock to employees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTEtMS0xLTEtMA_f6f311fd-89c2-4a23-be69-1400a06940cb">32.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTEtMy0xLTEtMA_c16bf478-67b6-443a-a6e3-043b6e90a179">40.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net proceeds from issuance of stock to employees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="lh:NetProceedsFromIssuanceOfStockToEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTItMS0xLTEtMA_53bb76cd-595a-4753-9ca9-b316a6146b2e">50.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="lh:NetProceedsFromIssuanceOfStockToEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTItMy0xLTEtMA_f4ce5af6-ddd2-4e5d-bf63-fa2fbd56627d">59.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTMtMS0xLTEtMA_01a54d39-e81c-48b1-8596-c193476c4fec">100.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTMtMy0xLTEtMA_d5d7a2c9-618a-48ef-9068-ed9fa2c4fe01">400.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="lh:OtherFinancingCashFlows" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTQtMS0xLTEtMA_fdd36af5-e4f9-4ed6-be2a-d67e906f1fa3">22.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="lh:OtherFinancingCashFlows" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTQtMy0xLTEtMA_0dcf3283-a452-4cb5-afd3-4b5ee152f02a">21.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used for) financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTUtMS0xLTEtMA_e0746aef-1752-4bdf-a3c3-d782e5463908">516.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTUtMy0xLTEtMA_1cef2205-e930-43a5-ad33-0648d661e9db">196.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTYtMS0xLTEtMA_8773c214-d646-4de2-9373-a50577a687bc">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTYtMy0xLTEtMA_e9f82b28-d1de-4ed5-a152-d618cfed7326">6.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTctMS0xLTEtMA_6aa4edae-fb18-4957-8e71-22258824f788">329.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTctMy0xLTEtMA_83c3f756-4969-4db6-b3f5-d86797f9742f">65.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTgtMS0xLTEtMA_74a5649e-4b8f-4ab6-bbf6-ec76ec318966">337.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac49907696d40399215ce933a047245_I20181231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTgtMy0xLTEtMA_a3320ee5-d19a-40a4-b292-fa6037296903">426.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNjAtMS0xLTEtMA_eac8ae4f-d982-4e46-b79c-d3f623318469">667.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ebf6d35695d43bebd0e1036cfd88d00_I20190930" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNjAtMy0xLTEtMA_8a26a42d-8638-4852-8203-00bb61934b9a">361.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i417074d9a2c24c34bcac25f32d2ec0c1_28"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><div><span><br/></span></div><div id="i417074d9a2c24c34bcac25f32d2ec0c1_31"></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMTE2NDc_4eb7c897-5327-4b4a-bdad-5da4fc27a4b7" continuedAt="idbdcd32b35a04738a6475c9e62b0e946" escape="true"><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMTE2NTQ_de855777-e752-4a52-9dd9-d6ad69d09765" continuedAt="i34af81084c4c430b8f4bc3abc2fdd903" escape="true">BASIS OF FINANCIAL STATEMENT PRESENTATION</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="idbdcd32b35a04738a6475c9e62b0e946" continuedAt="i416e1fbb008d420aa5387cedb6eefdd5"><ix:continuation id="i34af81084c4c430b8f4bc3abc2fdd903"><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory Corporation of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Holdings together with its subsidiaries (the Company) is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. The Company&#8217;s mission is to improve health and improve lives by delivering world-class diagnostic solutions, bringing innovative medicines to patients faster and using technology to provide better care. The Company serves a broad range of customers, including managed care organizations (MCOs), biopharmaceutical and medical device companies, governmental agencies, physicians and other health care providers (e.g., physician assistants and nurse practitioners, generally referred to herein as physicians), hospitals and health systems, employers, patients and consumers, contract research organizations (CROs), and independent clinical laboratories. </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports its business in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). For further financial information about these segments, see Note 15 Business Segment Information to the Condensed Consolidated Financial Statements. During the three months ended September&#160;30, 2020, LCD and CDD contributed approximately <ix:nonFraction unitRef="number" contextRef="i1982102278bd444d897b0ac03dedfda5_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMTI4NQ_793d0583-2bfe-43a6-a2a5-8f06a37d3703">68</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i4674d28875524974925c86ea26137e4b_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMTI5Mg_d48ab2bb-678f-4ee4-b16d-b91460797a63">32</ix:nonFraction>% respectively, of revenues to the Company. During the nine months ended September&#160;30, 2020, LCD and CDD contributed approximately <ix:nonFraction unitRef="number" contextRef="i60bf6e0de9384f37926fac0c0db06385_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMTQwNg_9b7c5d22-55f4-46de-a681-d719aca4ceb4">63</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="if366c14694954f6f84a2c0fe5708324e_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMTQxMw_5ec8586b-c972-414a-a860-918aba28a618">37</ix:nonFraction>%, respectively, of revenues to the Company.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries for which it exercises control. Long-term investments in affiliated companies in which the Company exercises significant influence, but which it does not control, are accounted for using the equity method. Investments in which the Company does not exercise significant influence (generally, when the Company has an investment of less than <ix:nonFraction unitRef="number" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="3" name="lh:CostMethodInvestmentsMaximumOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMTkxOA_8785174e-de1a-466b-a950-cfe8a001bb4a">20.0</ix:nonFraction>% and no representation on the investee's board of directors) are accounted for at fair value or at cost minus impairment adjusted for observable price changes in orderly transactions for an identical or similar investment of the same issuer for those investments that do not have readily determinable fair values. All significant inter-company transactions and accounts have been eliminated. The Company does not have any significant variable interest entities or special purpose entities whose financial results are not included in the condensed consolidated financial statements.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of the Company's operating foreign subsidiaries are measured using the local currency as the functional currency.&#160;Assets and liabilities are translated at exchange rates as of the balance sheet date.&#160;Revenues and expenses are translated at average monthly exchange rates prevailing during the period.&#160;Resulting translation adjustments are included in &#8220;Accumulated other comprehensive income.&#8221;</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements of the Company are unaudited. In the opinion of management, all adjustments necessary for a fair statement of results of operations, cash flows, and financial position have been made. Except as otherwise disclosed, all such adjustments are of a normal recurring nature. Interim results are not necessarily indicative of results for a full year. The year-end condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by generally accepted accounting principles.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements and notes are presented in accordance with the rules and regulations of the United States (U.S.) Securities and Exchange Commission (SEC) and do not contain certain information included in the Company&#8217;s 2019 Annual Report on Form 10-K (Annual Report). Therefore, these interim statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company&#8217;s Annual Report.</span></div></ix:continuation><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="lh:RecentlyAdoptedAccountingGuidancePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMTE2NjI_65b0f3a8-36f6-4fb2-b8b6-5e751d8b3836" continuedAt="i19daf5f4915a4e248715344aa38754b5" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Guidance </span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued a new accounting standard intended to provide financial statement users with more decision-useful information about expected credit losses and other commitments to extend credit held by the reporting entity. The standard replaces the incurred loss impairment methodology in current generally accepted accounting principles</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(GAAP) with one that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The Company recorded an opening retained earnings adjustment of $<ix:nonFraction unitRef="usd" contextRef="ic71057ddd9b94ee9bbf0a3919bd94bd4_I20200101" decimals="-6" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfNDYwNQ_849ac6b3-611c-4416-9251-6d1fc700ac63">7.0</ix:nonFraction> with the adoption of this standard on January 1, 2020. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued a new accounting standard to reduce, modify, and add to the disclosure requirements on fair value measurements. The Company adopted this standard effective January 1, 2020. The adoption of this standard did not have a material impact on the consolidated financial statements.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued a new accounting standard to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><ix:continuation id="i416e1fbb008d420aa5387cedb6eefdd5" continuedAt="i77c14a00d6604290a87a2da52c61fa7d"><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i19daf5f4915a4e248715344aa38754b5">to develop or obtain internal-use software. The Company adopted this standard effective January 1, 2020. The adoption of this standard did not have a material impact on the consolidated financial statements.</ix:continuation></span></div><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMTE2NDk_4ddebbd8-81cf-4b50-b155-231ef7a96bd7" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Pronouncements</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued a new accounting standard to reduce, modify, and add to the disclosure requirements on defined benefit pension and other postretirement plans. The standard is effective on January 1, 2021, with early adoption permitted. The adoption of this standard is not expected to have a material impact on the consolidated financial statements.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued a new accounting standard to simplify accounting for income taxes and remove, modify, and add to the disclosure requirements of income taxes. The standard is effective January 1, 2021, with early adoption permitted. The adoption of this standard is not expected to have a material impact on the consolidated financial statements.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued a new accounting standard to clarify the interaction of the accounting for equity securities and investments accounted for under the equity method of accounting and the accounting for certain forward contracts and purchased options. The standard is effective January 1, 2021. The adoption of this standard is not expected to have a material impact on the consolidated financial statements.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued a new accounting standard to provide optional expedients and exceptions if certain conditions are met for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform. The expedients and exceptions in the standard are effective between March 12, 2020, and December 31, 2022. The Company did not elect to apply any of the expedients or exceptions for the period ended September 30, 2020, and is currently evaluating the impact this new standard will have on the consolidated financial statements. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued a new accounting standard to address issues identified as a result of the complexity associated with applying generally accepted accounting principles for convertible instruments and contracts in an entity's own equity. The standard is effective January 1, 2022, with early adoption permitted. The Company is evaluating the impact this new standard will have on the consolidated financial statements.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="lh:NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMTE2NjM_4f21b5f2-a984-4435-a654-f30efc181f82" escape="true"><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Novel Coronavirus (COVID-19) Financial Statement Impact</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, COVID-19 was declared a pandemic. COVID-19 has had and continues to have an extensive impact on the global health and economic environments. During the nine months ended September 30, 2020, the Company recorded goodwill and other asset impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" name="lh:COVID19PandemicGoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMzI5ODUzNDg5NjEyMQ_14c3b9a0-f9bb-41ca-8440-468cd2ac1a10">437.4</ix:nonFraction>, as a result of the negative financial impact of COVID-19 during the first quarter of 2020. See Note 6 Goodwill and Intangible Assets for a discussion of goodwill and intangible asset impairment and Note 2 Revenues for a discussion of credit losses and additional price concessions. The Company also impaired certain of the Company's investments by a total of $<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" name="us-gaap:ImpairmentOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMjE5OTAyMzI2ODExNg_a04712c2-4e31-4fe8-9e05-e6f3ef9a831c">25.4</ix:nonFraction> during the nine months ended September 30, 2020, due to the impact of COVID-19; $<ix:nonFraction unitRef="usd" contextRef="i6e46390b74524a39961dc3a71697bb7f_D20200101-20200331" decimals="-5" name="us-gaap:ImpairmentOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMTY0OTI2NzQ1NDM5MA_b23ee77f-3db6-4b0f-98e9-7585cf7c8dea">7.1</ix:nonFraction> was included in Equity method earnings (loss), net during the three months ended March 31, 2020, and $<ix:nonFraction unitRef="usd" contextRef="idf06093237eb40b7b4693f9bb03c1107_D20200101-20200331" decimals="-5" name="us-gaap:ImpairmentOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMTY0OTI2NzQ1NDQyMQ_d94b35d6-0889-4382-8ec6-a2149c834b53">13.1</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i47c2cf5a89a849cd94e6efd1d321b938_D20200401-20200630" decimals="-5" name="us-gaap:ImpairmentOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMzI5ODUzNDkwMDY4Mg_14a95e1a-f54e-4959-b900-b46d86a30490">5.2</ix:nonFraction> were included in Other, net during the three months ended March 31, 2020, and June 30, 2020, respectively.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In April 2020, the Company received cash payments of approximately $<ix:nonFraction unitRef="usd" contextRef="ia74b9c93ead74b108c97cc4640c2fe07_D20200401-20200430" decimals="-5" name="lh:CashPaymentReceivedAppropriatedbyU.S.CongressCovid19" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfOTM2OA_f9efb503-2004-40a6-aed9-35b6c5de0bc4">55.9</ix:nonFraction> from the Public Health and Social Services Emergency Fund for provider relief that was appropriated by Congress to the Department of Health and Human Services (HHS) in the Coronavirus Aid, Relief, and Economic Security Act (CARES Act Provider Relief Funds). Upon receiving and satisfying the terms and conditions associated with the distributed funds, the Company accounted for the transaction by applying the guidance in ASC 450-30 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Gain Contingencies, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">recorded these funds in Other, net non-operating income in the Consolidated Statement of Operations as of June 30, 2020. In August 2020, the Company received an additional $<ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" name="lh:CashPaymentReceivedAppropriatedbyU.S.CongressCovid19" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMzI5ODUzNDkwMTkzOQ_97ac6864-9c92-4478-ad6d-20987d25a14b">76.2</ix:nonFraction> in CARES Act Provider Relief Funds. As the Company's Diagnostic business demonstrated recovery and demand for COVID-19 testing increased, the Company determined that the negative financial impact of COVID-19 which the CARES Act Provider Relief Funds were designed to address no longer applied to the Company. As a result, the Company derecognized the income associated with the $<ix:nonFraction unitRef="usd" contextRef="ia74b9c93ead74b108c97cc4640c2fe07_D20200401-20200430" decimals="-5" name="lh:CashPaymentReceivedAppropriatedbyU.S.CongressCovid19" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMzI5ODUzNDg5OTU4NQ_f9efb503-2004-40a6-aed9-35b6c5de0bc4">55.9</ix:nonFraction> received during the second quarter as a change in estimate and did not recognize any income related to the cash payment of $<ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" name="lh:CashPaymentReceivedAppropriatedbyU.S.CongressCovid19" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMzI5ODUzNDg5OTY4NA_97ac6864-9c92-4478-ad6d-20987d25a14b">76.2</ix:nonFraction> received in the third quarter. The Company plans to return the CARES Act Provider Relief Funds to the government in the fourth quarter of 2020 and has recorded a liability of $<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="lh:CARESActFundsAccruedLiabilitiesAndOtherLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMzI5ODUzNDg5OTAwNw_5dc9ce2f-f4c9-4cbb-8cba-62bd61a75e65">132.1</ix:nonFraction> in Accrued expenses and other as of September 30, 2020.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMTE2NTA_d0af313c-e007-4d5b-b4cd-d3762e2d8eae" continuedAt="i41bd3e76af754591ae2c45c3197bdb2e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which the COVID-19 pandemic has and will impact the Company&#8217;s business and financial results depend on numerous evolving factors including, but not limited to: the magnitude and duration of the COVID-19 pandemic, the impact to worldwide macroeconomic conditions including interest rates, employment rates and health insurance coverage, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of September&#160;30, 2020, and through the date of this </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i77c14a00d6604290a87a2da52c61fa7d"><ix:continuation id="i41bd3e76af754591ae2c45c3197bdb2e">report. The accounting matters assessed included, but were not limited to, the Company&#8217;s implicit price concessions and credit losses, equity investments, notes receivable and the carrying value of goodwill and other long-lived assets. The Company&#8217;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in additional material impacts to the Company&#8217;s consolidated financial statements in future reporting periods.</ix:continuation></ix:continuation></span></div><div id="i417074d9a2c24c34bcac25f32d2ec0c1_34"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfNDY5Ng_20e694b4-19f0-4105-a077-01fa155cfb3a" continuedAt="i788ac2783b994790ae7d35aab636ee93" escape="true">REVENUES</ix:nonNumeric></span></div><ix:continuation id="i788ac2783b994790ae7d35aab636ee93" continuedAt="i22f7a82d818c4564830bbb9f635b4699"><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfNDcwNg_5acddf82-f761-4af0-b8e4-3944c3b9d26a" continuedAt="ic968f8759bd7402d8a06788fed28a767" escape="true"><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues by segment payers/customer groups for the three and nine months ended September&#160;30, 2020, and 2019, were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:23.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Canada</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United Kingdom</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Switzerland</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payer/Customer</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">LCD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Clients</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id9626ef1cd2547cfa89fd9b389064cc6_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNC0xLTEtMS0w_47f13909-693b-4639-acde-95e0c0d378dc">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7c47ed00c06b4961a64f099959fe759f_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNC0zLTEtMS0w_35762719-6db8-4fed-a39f-b17f81a91ad6">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic6ce3c437b1e4049899878b45e0fb6e0_D20200701-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNC01LTEtMS0w_f60b6b95-7f61-4c76-b743-05c897dfedf8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib50b6d8435904455951c7565779b7341_D20200701-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNC03LTEtMS0w_ac7797b0-85ec-49f4-b81a-149af4cc8ea1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2a6785d04ea48f7a2a1542a0d7d001d_D20200701-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNC05LTEtMS0w_a1235110-d431-4be5-b08d-14afde44ee04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3daf06395da4489ea42ddd3f54707d86_D20200701-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNC0xMS0xLTEtMA_5a637180-464b-42aa-aa68-35c0e3991e64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i14aa48993fda4a6f8eaad4578904f2df_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNC0xMy0xLTEtMA_2aae7d3b-9331-4cd2-9a4e-9ee175953d20">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Patients</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic259290288f44d458eac49b83b8ad944_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNS0xLTEtMS0w_4fcaacc5-1154-4700-bf09-1743d07dc10a">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i16c280dd720347169ee01886277f5b70_D20200701-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNS0zLTEtMS0w_8e5ab853-da08-4730-ab1d-4a244a4c470d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5e98179fa8e44ec4aa8b9eb0699e9a4f_D20200701-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNS01LTEtMS0w_03dab321-4f28-4b8d-8a7f-8e357063400a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id6f7b06ec61042f192b8d0c0ecb380fa_D20200701-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNS03LTEtMS0w_909aff79-f47e-4f77-ab22-63f4b4966074">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie27a2846b55f44e3bb10629c8b4a6d09_D20200701-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNS05LTEtMS0w_cafcaed6-c5ff-499e-aa9a-bce28f59fa5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3daf06395da4489ea42ddd3f54707d86_D20200701-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNS0xMS0xLTEtMA_e57915f2-0908-440a-8ed4-5733852b9015">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i07d524d7631c4f689e36c4a9e9f86e2c_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNS0xMy0xLTEtMA_165cc204-767d-4aa7-9140-8191b5a3b390">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Medicare and Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i14a4aff636b04769856789d12e03a871_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNi0xLTEtMS0w_d45f0c78-ccfb-4b78-998f-4fff93c13088">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iea9e025d0f644fa485e22a580d3f4cd7_D20200701-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNi0zLTEtMS0w_9030912f-c164-4949-8b76-22dcc59ebd80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4e22f6a7e0374793b9cefc9bcd3585b5_D20200701-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNi01LTEtMS0w_9fb7fd20-e32b-46d6-b36c-6c812281e029">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i90ac3c1fb02144f099e252661fe37fe8_D20200701-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNi03LTEtMS0w_dbc033e4-5182-49fb-8ccc-6140689750c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iad4735e1e849483bad4da486a568d55c_D20200701-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNi05LTEtMS0w_b9b05dd9-94e1-4058-8b00-024f970182dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iea9b5f420b964fd5aace6048e7b0921e_D20200701-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNi0xMS0xLTEtMA_638b77a1-8717-4c6e-b5ba-49b29b33f8c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic5ea73c3e164417cbd60d881836d1e1d_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNi0xMy0xLTEtMA_636963e2-fb1c-4b3a-8489-96e784d206c4">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Third-party</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie17f2d3381d644e6bbd5e83aaa53ffe4_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNy0xLTEtMS0w_7f032044-5744-494b-8d2f-0f071c964e21">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0b07ec7181b24fe79db83b2887a77770_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNy0zLTEtMS0w_f959605a-a4e9-4489-8127-cd51070a0270">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i62b5c18a94ba4af9a2783e2211f603d6_D20200701-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNy01LTEtMS0w_90edf8cc-940c-4370-ae98-c695e900fc56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ca0e774190547d58bf6ce7ab795efb9_D20200701-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNy03LTEtMS0w_a126662a-efda-4bb1-a9c6-99d17196f077">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i085d47025332478a925481cbd318fc65_D20200701-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNy05LTEtMS0w_b833d114-41d0-49cc-acad-e07d469bbd89">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5238791a93ca4316b581e997a3d384e3_D20200701-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNy0xMS0xLTEtMA_0e75a38e-4995-48d6-a948-3847c303d65e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iee6febeb28ab42fbbe765be16edd24cb_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNy0xMy0xLTEtMA_a80db2c0-edce-4dd2-bc37-d1096bc0bdf6">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Total LCD revenues by payer</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i43148fef08f94203b85d962c5ae8fb07_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfOC0xLTEtMS0w_6bb29341-9ff6-4cc4-9f00-a23e9f664aac">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i03c7187cc2214dcd9fbe27e11b92de30_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfOC0zLTEtMS0w_c942160c-0456-4aea-b63d-4827af13e2ae">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia185a66890a2414584681a11add7d192_D20200701-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfOC01LTEtMS0w_b33da9be-2281-4f87-976e-ffed0a731e37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2a65613c19cd422597c0eebb88c2b3d0_D20200701-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfOC03LTEtMS0w_0dbdadfd-974a-4e89-a20d-ba480b8a0d45">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9722f55060174cccbd82ef9b8610b196_D20200701-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfOC05LTEtMS0w_9722a486-7bee-40eb-a2b1-bf6e7cb47c2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3daf06395da4489ea42ddd3f54707d86_D20200701-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfOC0xMS0xLTEtMA_30154423-1dbc-454b-ac29-c59c51a93260">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1982102278bd444d897b0ac03dedfda5_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfOC0xMy0xLTEtMA_96bf0859-0c4d-4504-b2af-082d514e213f">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">CDD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Biopharmaceutical and medical device companies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibaa23ac123cf4574b439cc76d55df4f2_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTEtMS0xLTEtMA_e4594d47-17ed-490a-9a41-0b2d0532d037">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icd62d7344fa0462a991ba65da1c7ffb7_D20200701-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTEtMy0xLTEtMA_09ccc768-f4c2-4245-88a0-c8805b0eb072">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic2c41f77470b457d9ed4965bab8f7ee3_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTEtNS0xLTEtMA_34c8e357-1be2-4155-a22a-7a561d79f58a">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i38839c3f1f934895b768a54821da0a2c_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTEtNy0xLTEtMA_e48d3103-c70a-45b9-956a-e90b0db614f6">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifa2e5eb5177045ea88f2c41735e55445_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTEtOS0xLTEtMA_0a3a1d97-1f1d-4f22-bee3-8a0e2c87ade8">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3f6b988e5cc14246b5d95a62c430643d_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTEtMTEtMS0xLTA_d35a5d52-fb23-450f-b196-65ed1d5b2242">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i61068721174646479a719d0d82691d66_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTEtMTMtMS0xLTA_009a8279-3ddc-45e8-8e72-3de8aa9aaf15">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i599da8b7d2d14e4791521d86ea88a36f_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTMtMS0xLTEtMA_98190bc4-b2a3-4ab0-9cf3-1e831c8b0ff7">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5fc62abb869f43369975ea7f0bf80db0_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTMtMy0xLTEtMA_d52494d1-8417-41ee-9a7c-d3b8ac3ce963">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6d47fd2ebbac412db1f27e585bf53e3f_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTMtNS0xLTEtMA_d02f51a0-af34-497b-b1a5-7d84dbe4baf6">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id53db043a8034950b09968edb83a0607_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTMtNy0xLTEtMA_c6dc1e3d-5ba1-4b59-b2c5-8d00c3f09985">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i204f3a1eb6b44643b050bf8f2540765d_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTMtOS0xLTEtMA_735a3237-66c7-4020-ad31-f92c0b926784">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id6f1cdadc4de42b38c3a6a8dddb06604_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTMtMTEtMS0xLTA_8d363820-0c6a-46a9-b85d-a31eaa24ab24">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTMtMTMtMS0xLTA_6f81534a-2004-4dca-8461-b8b872cc5746">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:24.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.875%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Canada</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United Kingdom</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Switzerland</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payer/Customer</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">LCD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Clients</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6323cfeff41f4159acf7a53bb092c3c6_D20190701-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNC0xLTEtMS0w_ab45877c-c524-4a2b-b5cc-62e67220137c">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9dfb8b56aede469ea13f92e3015dc958_D20190701-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNC0zLTEtMS0w_218ce0eb-8b78-48a5-a1ef-9589cf67a520">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i01dfc480ee174b02ac0b09584e2317ce_D20190701-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNC01LTEtMS0w_7f3c7846-eed6-4da9-b052-0914ec573cbb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2cfe9d5cd85d46b3897e697a5fdd49c7_D20190701-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNC03LTEtMS0w_bd6ed90b-79cb-4fec-961c-8d9d662eadd1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7baa4f0065bd47a59ee4fe85f7b5755d_D20190701-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNC05LTEtMS0w_3183d684-c108-4eb8-bea0-3c67f4c8bace">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i25a211144dd8470d8b356d8b001c8501_D20190701-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNC0xMS0xLTEtMA_c5642164-f6d0-4aee-8f39-67e50f14d17f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2281dda8aa1a4d30af776c18df61d1c8_D20190701-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNC0xMy0xLTEtMA_cb6489ee-4545-49e2-aba6-7f5cc4dd2452">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Patients</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8052a0e56c404ff5a4113a6c4c023c88_D20190701-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNS0xLTEtMS0w_177fa725-ef4d-420c-8f06-34e2ac765ad5">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i49463c9f0be949a4b668835f86737567_D20190701-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNS0zLTEtMS0w_eb46d11c-97af-4e0d-b18a-ed3e748d4351">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic45f90b4ea0f41e9a9f8d1a4f466f54f_D20190701-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNS01LTEtMS0w_ee566951-760d-44ed-aa24-9cea97946e15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic549b3c324ba47f38e5480ce02fd0558_D20190701-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNS03LTEtMS0w_c24d840d-e2a1-4088-bf5d-38d181dec59c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie917065bc7e643ca9770aad73add4250_D20190701-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNS05LTEtMS0w_0d80f099-e935-423b-b023-c065b8287d32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i25a211144dd8470d8b356d8b001c8501_D20190701-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNS0xMS0xLTEtMA_569b857e-df0b-454e-a6e1-1850b7d621e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9414919f80cf49ebb2777851ee4fed37_D20190701-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNS0xMy0xLTEtMA_1ab0c003-8e6f-4bcd-a0d7-53657c0e6f0c">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Medicare and Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie9474df2c9ec4f0588048ef29d346752_D20190701-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNi0xLTEtMS0w_8c6814b5-55e7-4f87-aaab-7113abcb52f8">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3462aa035a72495e9fc1ecf11fbd2049_D20190701-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNi0zLTEtMS0w_913b310c-1125-44c0-9e16-14dbc5878e5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i154bbdad5d524723b675883f9c7065a6_D20190701-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNi01LTEtMS0w_ac964be5-904e-42dc-a3b5-ec0a2c53d4a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5ccb82ced1094bd59e3d613df27e2c24_D20190701-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNi03LTEtMS0w_0f0c4cf3-cef3-43be-b311-e835141b97db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie700d5333095493db55774137661401e_D20190701-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNi05LTEtMS0w_a4a972b4-ce95-4a22-a6aa-943d3c3f17ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i05e2445018784b01a0f279f4ffeb2d49_D20190701-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNi0xMS0xLTEtMA_ebcb1686-bdd9-4e4c-a461-36daf6341391">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9c1e1e6af87a4db689abaf6a994ffc67_D20190701-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNi0xMy0xLTEtMA_f01e7338-adaf-4311-9f42-d443ca074416">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Third-party</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i450bf78169c642e09eeb275ebfaeea7c_D20190701-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNy0xLTEtMS0w_36a369bd-a4ca-457c-b0b1-baea82aabd2d">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifecb6bbb2d3c42288aa163006edb1553_D20190701-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNy0zLTEtMS0w_96e66783-59fc-41d6-a4b3-54a809d59e3e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i38357c17172f498586667865e1980e9b_D20190701-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNy01LTEtMS0w_0f431658-bec0-4802-affd-639a53a4b69a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5fc1f599be994436af4c261f3c7f98c1_D20190701-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNy03LTEtMS0w_8e75c39f-2727-4d1d-b092-7e971488c15d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8cfaa96b273d45b1a241e9f02c7a7c7b_D20190701-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNy05LTEtMS0w_6de9f8ac-052d-4772-9899-274931c314e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia021b225de1b429189702e36fc573e16_D20190701-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNy0xMS0xLTEtMA_1a891cb9-cb05-4fb9-a496-5c33eb228e92">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i333fbc87a53747a7b8553fad99660865_D20190701-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNy0xMy0xLTEtMA_269bcafd-7dcc-4373-aa92-a93daabd0cfe">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Total LCD revenues by payer</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i359c7aa0655644ea80c898242ddcf80d_D20190701-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfOC0xLTEtMS0w_77fa047c-3603-4852-80c5-0d5ab0e3ddb4">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i43a981ae8185490d984dcb30bc0eee10_D20190701-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfOC0zLTEtMS0w_365b365c-49b8-4d9e-8dd8-ba030d54db92">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i460eab215fae419a8cf81c41cdb90279_D20190701-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfOC01LTEtMS0w_888effc5-c2af-48da-bba8-3da45b759634">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3eef33bbb5e342da8dee7597bfe3f461_D20190701-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfOC03LTEtMS0w_294e5384-1227-4c48-8a1e-286d9fe36af9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i04baf8b50a6c40d5a4d98d6de87046e4_D20190701-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfOC05LTEtMS0w_4b65afe2-20f2-4335-8217-bde8fda11e7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i25a211144dd8470d8b356d8b001c8501_D20190701-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfOC0xMS0xLTEtMA_9ac81d93-ddb5-44b4-b40c-91425896ffe7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idd95aab1b5024137b07364cf3867cbf8_D20190701-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfOC0xMy0xLTEtMA_69695bcd-a474-41ae-8c25-a95fcab59ed2">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">CDD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Biopharmaceutical and medical device companies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ee2ea6e83ea4fc29a6b36fe34613f52_D20190701-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTEtMS0xLTEtMA_d53869c2-f4c2-432e-9a75-d54a57c278d7">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i42d9fc1bf025408c9fe447f1b3cafa5d_D20190701-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTEtMy0xLTEtMA_2afcb233-7dfe-4759-8e3b-ba762763c3c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id01bbc615be14b70965d98cee7de2b26_D20190701-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTEtNS0xLTEtMA_fee7c913-5a52-4b90-9f2c-4822ce4d6677">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id6502f4abf6b47edaf675df7d9727ce5_D20190701-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTEtNy0xLTEtMA_54a4183a-7cee-48a6-b34e-a03f58e43250">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2eab7066fb3e411da4d882666bb1218e_D20190701-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTEtOS0xLTEtMA_476182ae-e61d-4dc8-9944-1952a3029105">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie0ce21fe8c654b7c8a7360072ceba887_D20190701-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTEtMTEtMS0xLTA_6c6a9c72-ccc9-4af2-b93e-d950bda06f64">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9482ee714bc546369167c573a2564714_D20190701-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTEtMTMtMS0xLTA_4fc38445-1ec8-4585-910d-76a65e845174">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifdb48a87cc234ca697c8b0c54bd62d31_D20190701-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTMtMS0xLTEtMA_6ea04552-f2d9-4c88-96c1-33a7f8c61a7b">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i389ae4c4c9f24473a15143884e9da492_D20190701-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTMtMy0xLTEtMA_644b8a20-3b1f-40f3-bc6b-e7619c59bed6">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1df72b2b1d6d4c6fb88d7a315c3cc960_D20190701-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTMtNS0xLTEtMA_68939ea0-7e2e-4409-bc01-9377557d558c">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i26560d40f7624e208364bac468677a3a_D20190701-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTMtNy0xLTEtMA_202d5eae-f59c-4293-bfe7-928f0ce8ceff">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i26e2079e9fa2414b8068d97842ea4ddb_D20190701-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTMtOS0xLTEtMA_0701281d-7854-4824-8b3e-0077a08eb98a">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i631604fdcc4444ffaad24e9b13db902f_D20190701-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTMtMTEtMS0xLTA_b6a04f44-9dc0-4e9a-b3a9-4e942ac24ad4">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTMtMTMtMS0xLTA_30a993a3-4356-4f4e-a603-f3aa75ea8044">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><ix:continuation id="i22f7a82d818c4564830bbb9f635b4699" continuedAt="i951acd827066419ab51a4b6682dbe1e7"><ix:continuation id="ic968f8759bd7402d8a06788fed28a767"><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:24.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.875%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Canada</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United Kingdom</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Switzerland</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payer/Customer</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">LCD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Clients</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8d30dccc4d364639b665ffbe677c7647_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNC0xLTEtMS0w_682ce1fa-996d-4794-b04f-4e55fcf91771">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9b8a3952cfa54d32b76aeb203dd87494_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNC0zLTEtMS0w_fb55464e-1a43-4f8c-9acf-3588f62c514a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i05d10f6fbfbb494fb6fce435672dcf23_D20200101-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNC01LTEtMS0w_27073a54-3fce-4cca-b055-9cf3b059420f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieff9b96c85334e939753b0c4e6ef2d63_D20200101-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNC03LTEtMS0w_73000a05-fe64-4f3d-88d5-60cb54b82ed1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i77f9248d57974574bc9adc8bcfcdc8e1_D20200101-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNC05LTEtMS0w_3b20ea54-91e2-486b-8c15-31a922547dc5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i280e8f364ec54f6bacf36535657ece2f_D20200101-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNC0xMS0xLTEtMA_a76f1cca-7929-4e67-9fc4-520a80969e42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0e0eec8d36874fcb811be9de7dfc1394_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNC0xMy0xLTEtMA_1526ebbe-f114-49dc-86f5-4cacd8cff9a4">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Patients</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0174357050ce426eb9072c176613559e_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNS0xLTEtMS0w_cd586fb6-06c3-4c50-a69c-fa3bb4fb0ab2">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id5b5a7fb19a640759ff41fd96d890a0a_D20200101-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNS0zLTEtMS0w_4491011b-785d-4c9c-a7af-a32c585b13ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i91c6a68811984e989e0f9bec6fbe7865_D20200101-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNS01LTEtMS0w_40bc9ab9-d5bf-4d44-aeec-655fdb38f3fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7960720916204ded977638cc08e62b56_D20200101-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNS03LTEtMS0w_eb7da495-3eb0-4aa9-b959-c27a37dc478f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i693603475db345f8b0944c13afcdbc10_D20200101-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNS05LTEtMS0w_e22a70f3-0886-43ed-959d-dc3b1f59d9b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i280e8f364ec54f6bacf36535657ece2f_D20200101-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNS0xMS0xLTEtMA_5555dd4a-ce87-422f-8cfb-a3045a654caf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibc807183e1564343bd31c0159b51bcbb_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNS0xMy0xLTEtMA_610f0292-80ee-4198-9737-a0fb91bec27b">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Medicare and Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i69a59eef10334badbbe7740a6961bf20_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNi0xLTEtMS0w_b09e4aa9-d911-4670-b3cd-cf3e372f60e1">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5f8c193f87c34f2db43b82541239c4db_D20200101-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNi0zLTEtMS0w_0f736b48-1f9a-451e-845c-278c3c79856c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i26a632e3297b4c43bc30ad60a11821cb_D20200101-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNi01LTEtMS0w_888f16e1-e391-47cf-ac62-ff24bb401fab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9f7285237d6143a88b08d4f6094f9950_D20200101-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNi03LTEtMS0w_66747bbe-d5e8-4847-90ea-c54e3658bf80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37d8778b4638498d984b5ef4a80387ac_D20200101-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNi05LTEtMS0w_594f1ef0-e113-4c05-b20b-7d3b8ab0a508">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iedc4cdb92e6d4a918e4cae457e5095e4_D20200101-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNi0xMS0xLTEtMA_6ef9ddf0-c49c-4622-bfea-c7564304a407">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6c4af8fb06a3468b842884b2d7f5e43f_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNi0xMy0xLTEtMA_91b6b18a-d745-4977-9845-4f56903f83f7">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Third-party</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id7ee075779ba482ba14540bf413c99c6_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNy0xLTEtMS0w_59619fa1-27ab-4eb7-b797-63838b03d1c4">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if2c8d81029dc4f4ea85b448efa38bad7_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNy0zLTEtMS0w_036ab22a-e866-413d-8a8d-8187c3e960cd">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i10f238e753b94349a34e63521a517705_D20200101-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNy01LTEtMS0w_3be27469-39b0-49de-82e5-1a2f9ef67a35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i88f53878399541aab3dbf15a0f35c2ff_D20200101-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNy03LTEtMS0w_9e201b6f-c066-42f5-9cef-d3addc9442ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1d952d8add4a423c841dcb828a6395d4_D20200101-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNy05LTEtMS0w_86de6d9b-06ed-4d7a-a888-f07e2104e9c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6ec27280b43d41cfb61cf079469c0a60_D20200101-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNy0xMS0xLTEtMA_5140958a-9ef9-4827-bebb-7872d204d865">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i067fa16ca9d545099aaef7dfae0ba189_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNy0xMy0xLTEtMA_410bc7c6-3f50-49de-af13-967702c444fd">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Total LCD revenues by payer</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9ad7fc029ac844a49ffa1b856f5d56f6_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfOC0xLTEtMS0w_8f094869-026a-4f5d-970f-fcb6d1e824c2">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5af8a070f9bc46658055f2e8175a8ce3_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfOC0zLTEtMS0w_a9e5fa9d-e6c2-4a37-8852-66295b1518a5">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie14bb7a57ad64858b6c10be22525e07e_D20200101-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfOC01LTEtMS0w_c7962d3f-47a6-4603-aebc-8c65f72fcda8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1ba4b7d86f204b6a9d7d562281386f61_D20200101-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfOC03LTEtMS0w_da29b1e8-1491-461d-9db0-afb15aabd896">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibeebbb5e419f4d849feadf2a965eda69_D20200101-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfOC05LTEtMS0w_45b133a6-5807-4d08-a950-b49f87c41d7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i280e8f364ec54f6bacf36535657ece2f_D20200101-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfOC0xMS0xLTEtMA_44fbf84c-6a8d-48fa-ae8b-eb1a4cda298c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i60bf6e0de9384f37926fac0c0db06385_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfOC0xMy0xLTEtMA_98789c13-c315-4885-b109-a9e1d22062f6">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">CDD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Biopharmaceutical and medical device companies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaa5d6637f88c446481fad357f1d45753_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTEtMS0xLTEtMA_7b34c7bb-374b-4542-94a1-9c3436b3ee7e">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iae17d5d53f964b1198bb9bec44994813_D20200101-20200930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTEtMy0xLTEtMA_b661c224-33eb-451d-940d-e5b8d6c20370">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia07d85355268435f99e328b11dc3a41b_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTEtNS0xLTEtMA_f5e47ed5-cd16-4717-aa4a-25c19bd5ce63">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if615f680db594c4abf7dda191e8cb043_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTEtNy0xLTEtMA_9e90e1d1-7a5a-433d-b588-2bd56f594304">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaa1fd9f69a7b43eea8506545464daab0_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTEtOS0xLTEtMA_0271e808-8a89-48de-bfdc-0eadc714cdab">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i652bd6addb2f48ccb11829f65d6bbfda_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTEtMTEtMS0xLTA_e36253eb-3cba-4995-9f0b-9377164ca2ae">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id7fdd15f57ab4e47b5ba9a975330c61c_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTEtMTMtMS0xLTA_30da8f0d-66da-42bc-97af-8b3bace2ae31">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iee20f2c502354597935b92371dbe0d94_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTMtMS0xLTEtMA_0840b592-11b5-4482-a244-9b684e13bfd5">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie0e7e0d5ac1844e9950e43fe31ea5e07_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTMtMy0xLTEtMA_9bb2d42f-8e8d-4f3d-95f7-4417cda506e4">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i339500f8642943c2b6c982af6cf9dfea_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTMtNS0xLTEtMA_00ba5dfc-214b-4be9-a178-92975a71841b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id5a9b3edded440719a65fa42688ad89f_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTMtNy0xLTEtMA_b1145059-44ae-4fc6-ae47-da55bebb1344">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0729ff016c534ca29e10e62194985ae7_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTMtOS0xLTEtMA_24e9af31-fb54-4613-bd88-41836a42465f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0f2f788044f24469ada3249aca7b98b1_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTMtMTEtMS0xLTA_5c35904d-ea97-46f3-b354-1508f697b1a3">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTMtMTMtMS0xLTA_99dd70fc-367b-4544-ac5f-a08a03c9e5eb">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:24.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.859%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Canada</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United Kingdom</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Switzerland</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payer/Customer</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">LCD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Clients</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id0ca0a967b334598808b418e2700013f_D20190101-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNC0xLTEtMS0w_cb047963-4d7a-4982-b2a4-49e796e79698">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7bcbb30927c34620bf18c72d093bec3b_D20190101-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNC0zLTEtMS0w_afff637c-02a3-4246-b75d-cade9ca96bdb">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib55a432be0f249e2afa7e0e1d560e1fe_D20190101-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNC01LTEtMS0w_4ca4a7a8-2ddf-4ae2-9b00-c22749bc8265">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i56ef410ac516442db21e732867090a7d_D20190101-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNC03LTEtMS0w_ed8d2518-7a2d-41b5-b7c7-9d4a6337f77f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icd34f489e3cf4bc68520fb4156dc30d5_D20190101-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNC05LTEtMS0w_28589c2a-5d3f-4e3c-84f8-64c3622b47b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i860cb23b9d0b4f0f94851daff5988983_D20190101-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNC0xMS0xLTEtMA_fba57d1b-b0c5-4ead-abf5-aeb3f4c50bfe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iad868dce52b44ad790b6864d29035e06_D20190101-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNC0xMy0xLTEtMA_14427614-7807-473b-8075-76fad3173621">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Patients</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i86cabdaea3ff4402b13c640c489942dd_D20190101-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNS0xLTEtMS0w_92f07c82-485c-4154-8089-eac2d32e4535">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6e295a8c616e4444bfb546859426b1d7_D20190101-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNS0zLTEtMS0w_c49c67ad-622e-4bc5-98d1-55568ff25036">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6da967c8920c43edb991c0528d2ad964_D20190101-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNS01LTEtMS0w_86709516-6d50-4a4d-b106-64c600e10964">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i765da38bd1524d5ea57eb2c302a51993_D20190101-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNS03LTEtMS0w_4f57e3ae-1868-4f1c-83f3-00df63643a62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i13839e115ef34c2e9cdbfd5996444ec4_D20190101-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNS05LTEtMS0w_d5bdf69f-7ccb-45b1-849f-63005dbe15bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i860cb23b9d0b4f0f94851daff5988983_D20190101-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNS0xMS0xLTEtMA_060c9e8d-5b79-4c71-9538-8a761268b850">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idbaa79c605ea46b49097dafde16b4c63_D20190101-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNS0xMy0xLTEtMA_48836f04-3f16-4c33-a910-acc0485734f9">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Medicare and Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i03a302c67b6a4bb7a2a2e19bbbc2a9ab_D20190101-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNi0xLTEtMS0w_d9c9ca49-e44a-4ec2-a36d-78d4d1b840c7">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i38329f0d027145598d9b90d0a83b4b3d_D20190101-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNi0zLTEtMS0w_76355661-309e-4fda-a655-cf16b2634650">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i24a86d409aee4a37b73db1b51534770c_D20190101-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNi01LTEtMS0w_624585df-2891-4f53-95d1-f23f53b06878">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i23169375ab504448a8b52398bc5131ea_D20190101-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNi03LTEtMS0w_6dfff7fb-704a-4ab9-be11-bdb130181a43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9aeaac1d1f984a51bcb01399ecd48b56_D20190101-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNi05LTEtMS0w_7de042a2-326e-4ef0-b182-bfea3c5f69f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie8c943708ddb4c9a824d53b38aca3911_D20190101-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNi0xMS0xLTEtMA_1e302391-78c4-47a0-8810-7158d58787bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if12ca51a38a34b098329f98278e9316d_D20190101-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNi0xMy0xLTEtMA_39205c47-4f63-45f0-b8df-1582437412fb">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Third-party</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i65ba32b3197b47a89d8e18f5ce7bf26f_D20190101-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNy0xLTEtMS0w_7c6d7bec-5450-4ad8-9a47-a1f3ed6fbd8d">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib44011bd3f5846bebee1bd4b98050562_D20190101-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNy0zLTEtMS0w_e5a3df88-20a6-4c8a-90f1-b52b9f772e66">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1ba36fdfcf704ad6ba7b509e8b7da78f_D20190101-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNy01LTEtMS0w_f3e337ba-8053-4105-95ed-a7852149c267">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i27fed185eaf64f0c9df3d3de7b9cdfcf_D20190101-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNy03LTEtMS0w_bccdc0ab-e843-45f1-8004-a7dd6bd9c87c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idbafa9f2fce94b9b8a2c5abf17d6940a_D20190101-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNy05LTEtMS0w_6729945d-9974-4bca-b1ad-674231168395">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie3d222c52e0c4a28b8e6198bd6eb1ce8_D20190101-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNy0xMS0xLTEtMA_5340ae6e-5ee2-485b-b913-192c8abac808">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3d602e784d274adcb804041ffb3aa3d2_D20190101-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNy0xMy0xLTEtMA_b7bdff48-a2f2-4386-b563-3946fe94d0d8">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Total LCD revenues by payer</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6646c81346544c4d99e9fa1d0e57c80c_D20190101-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfOC0xLTEtMS0w_63a41009-8ab9-4a54-ae14-b45a092af9c8">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia75364130e1648e78fa02c61892d115d_D20190101-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfOC0zLTEtMS0w_47f00588-4547-46cb-a0e1-86892e62136f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i15b5a11fc3bb4619b499f9c929493fa1_D20190101-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfOC01LTEtMS0w_28236543-765f-4ac6-8751-bbac4acf61cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6959b7c2c57d4c76bebc490ae176fcfd_D20190101-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfOC03LTEtMS0w_9d037f70-8b6c-4e77-8695-2341fb55594d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8eeb5ffe9464ea18f019180489ed088_D20190101-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfOC05LTEtMS0w_6d5df48f-efb7-49a0-bd41-3ae1932aaf40">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i860cb23b9d0b4f0f94851daff5988983_D20190101-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfOC0xMS0xLTEtMA_6d54b5f9-b402-4f77-8396-f1bc29574f65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i54d000cbf2214f02a540a13d16a2e6fa_D20190101-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfOC0xMy0xLTEtMA_a74fb2c8-ce8c-42b3-9674-39763761ae13">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">CDD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Biopharmaceutical and medical device companies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaf29f2ab93f848ea80feac95f899a8e9_D20190101-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTEtMS0xLTEtMA_6d4c8ebb-56f9-4588-811f-de40583e3f3f">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6b5a3389083844e18566cd906171e56b_D20190101-20190930" decimals="2" format="ixt:zerodash" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTEtMy0xLTEtMA_fb905e13-587b-42ba-ba1c-3d738073c5ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic3dc0765c3e2434885f5a3a11ecac3d6_D20190101-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTEtNS0xLTEtMA_f5574f63-a37c-451b-bc34-843a99a963f4">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i272813f6653f43e188e55ba3267529a8_D20190101-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTEtNy0xLTEtMA_974fa715-f3a2-4246-8a9f-5fda5fce8bd4">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibc3a82b251f447e2bb647e6978c13daa_D20190101-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTEtOS0xLTEtMA_fcc208db-c025-43ad-abb2-7ffa795948b5">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i851a94e1b5a84e1aadc1d6c2a58c7df0_D20190101-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTEtMTEtMS0xLTA_80ed816e-6a40-4e69-beec-8464f272c723">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia658bdb62dae4582bd04be509941c2b5_D20190101-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTEtMTMtMS0xLTA_ff0b0894-5098-484d-b21b-c3c510d5ff08">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8425684776dc4bd99f6c93fbcbaeed28_D20190101-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTMtMS0xLTEtMA_1946a2c3-1d77-4966-b2eb-7bc2ff601b4b">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8a6729fa89514d4e80eba6b05b6bdddc_D20190101-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTMtMy0xLTEtMA_565f735e-711d-4b4a-b80e-a87b36d0a703">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idf7ad2e2b01e4065b8a00585446b245c_D20190101-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTMtNS0xLTEtMA_9d6685ee-2942-4613-8079-311ef7a5a206">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia718fc35144f49d886e94436e951426b_D20190101-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTMtNy0xLTEtMA_99779516-26f7-4a28-9f30-6bafa0b7b70b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5ba397b83c7c4a58bcf44d9eead0473a_D20190101-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTMtOS0xLTEtMA_9118c6c0-fc8d-449a-a139-5f6cf7982104">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0269009dcd1e4b8e8b5484651bfc3b7f_D20190101-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTMtMTEtMS0xLTA_decd5db4-2a7d-4569-adda-bb53b3745e21">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTMtMTMtMS0xLTA_3eb2f333-5146-42b7-ae76-a326e3f94a29">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation><div style="margin-bottom:3pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract costs</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CDD incurs sales commissions in the process of obtaining contracts with customers, which are recoverable through the service fees in the contract. Sales commissions that are payable upon contract award are recognized as assets and amortized over the expected contract term, along with related payroll tax expense. The amortization of commission expense is based on the weighted average contract duration for all commissionable awards in the respective business in which the commission expense is paid, which approximates the period over which goods and services are transferred to the customer. The amortization period of sales commissions ranges from approximately <ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" format="ixt-sec:duryear" name="lh:SalesCommissionAmortizationPeriodMinimum" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfODE0_d28b2658-2ff5-497a-a59d-76bfa14b2599">1</ix:nonNumeric> to <ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" format="ixt-sec:duryear" name="lh:SalesCommissionAmortizationPeriodMaximum" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfODIw_b01c3486-ca38-4d55-92b7-55a38beb85e8">5</ix:nonNumeric> years, depending on the business. For businesses that enter into primarily short-term contracts, the Company applies the practical expedient, which allows costs to obtain a contract to be expensed when incurred if the amortization period of the assets that would otherwise have been recognized is one year or less. Amortization of assets from sales commissions is included in selling, general, and administrative expense.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CDD incurs costs to fulfill contracts with customers, which are recoverable through the service fees in the contract. Contract fulfillment costs include software implementation costs and setup costs for certain market access solutions. These costs are recognized as assets and amortized over the expected term of the contract to which the implementation relates, which is the period over which services are expected to be provided to the customer. This period typically ranges from <ix:nonNumeric contextRef="i78561ec2276d4506995dfccf9bff7d1c_I20200930" format="ixt-sec:duryear" name="us-gaap:CapitalizedContractCostAmortizationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMTcyNw_739652cc-8688-4791-9fce-e6ff34174743">2</ix:nonNumeric> to <ix:nonNumeric contextRef="i603496ec6a9840f2a7691f78b350638a_I20200930" format="ixt-sec:duryear" name="us-gaap:CapitalizedContractCostAmortizationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMTczMw_bc6a91a4-669f-49a9-aa97-5faef006d6fd">5</ix:nonNumeric> years. Amortization of deferred contract fulfillment costs is included in cost of goods sold.</span></div><div style="margin-bottom:12pt;margin-top:5pt"><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:CapitalizedContractCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfNDcwNw_0dd5ccd2-1b43-47e8-91e0-6b542d13d4d8" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:60.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.136%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.110%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales commission assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:AccruedSalesCommissionCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjJkZTUxOTRhMjc5MDQwMjliOTRjNjE3ZGE3OTcyZmY2L3RhYmxlcmFuZ2U6MmRlNTE5NGEyNzkwNDAyOWI5NGM2MTdkYTc5NzJmZjZfMS0xLTEtMS0w_99d0e16f-3e0b-493f-84cf-6b9ebde226cd">32.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:AccruedSalesCommissionCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjJkZTUxOTRhMjc5MDQwMjliOTRjNjE3ZGE3OTcyZmY2L3RhYmxlcmFuZ2U6MmRlNTE5NGEyNzkwNDAyOWI5NGM2MTdkYTc5NzJmZjZfMS0zLTEtMS0w_c9de9fdf-3d3a-46bb-8f8a-6b9994f2abea">28.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract fulfillment costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:CapitalizedContractCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjJkZTUxOTRhMjc5MDQwMjliOTRjNjE3ZGE3OTcyZmY2L3RhYmxlcmFuZ2U6MmRlNTE5NGEyNzkwNDAyOWI5NGM2MTdkYTc5NzJmZjZfMi0xLTEtMS0w_059d47a2-de59-4411-8fb2-d0a8934667d0">12.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:CapitalizedContractCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjJkZTUxOTRhMjc5MDQwMjliOTRjNjE3ZGE3OTcyZmY2L3RhYmxlcmFuZ2U6MmRlNTE5NGEyNzkwNDAyOWI5NGM2MTdkYTc5NzJmZjZfMi0zLTEtMS0w_3e9e74f9-639a-4a67-aab7-fe56cb9a4788">14.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:AmountOfDeferredCostsRelatedToLongTermContracts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjJkZTUxOTRhMjc5MDQwMjliOTRjNjE3ZGE3OTcyZmY2L3RhYmxlcmFuZ2U6MmRlNTE5NGEyNzkwNDAyOWI5NGM2MTdkYTc5NzJmZjZfMy0xLTEtMS0w_6cafff7b-6896-4248-8f77-0b7422ed045c">45.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:AmountOfDeferredCostsRelatedToLongTermContracts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjJkZTUxOTRhMjc5MDQwMjliOTRjNjE3ZGE3OTcyZmY2L3RhYmxlcmFuZ2U6MmRlNTE5NGEyNzkwNDAyOWI5NGM2MTdkYTc5NzJmZjZfMy0zLTEtMS0w_11843984-4f68-4ab8-8e41-5cb7bc140657">43.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization related to sales commission assets and associated payroll taxes for the three months ended September&#160;30, 2020, and 2019, was $<ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" name="us-gaap:AmortizationOfDeferredSalesCommissions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMTk1Mg_309fbcb4-93ba-4163-beaf-fbd388d42c9e">6.0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="-5" name="us-gaap:AmortizationOfDeferredSalesCommissions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMTk1OQ_167cce14-972d-4945-901f-0f127ad7e93b">5.8</ix:nonFraction>, respectively, and for the nine months ended September&#160;30, 2020, and 2019, was $<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:AmortizationOfDeferredSalesCommissions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMjAyOA_01bf8ab8-157d-4032-a104-3495b8e3d348">16.8</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:AmortizationOfDeferredSalesCommissions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMjAzNQ_3c70e159-fa44-4777-be18-561c0d5f6404">15.3</ix:nonFraction>, respectively. Amortization related to deferred contract fulfillment costs for the three months ended September&#160;30, 2020, </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><ix:continuation id="i951acd827066419ab51a4b6682dbe1e7"><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and 2019, was $<ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMjE1Ng_60a28a8a-dcd7-4918-a8ce-739629e674cd">2.3</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMjE2Mw_b43af797-c68b-406e-964e-5a60646a18af">2.3</ix:nonFraction>, respectively, and was $<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMjE4OQ_53f3624f-55c7-406a-bb35-e20263307343">7.6</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMjE5Ng_b51abb55-c683-488a-b2ec-8e829b72ab3f">6.1</ix:nonFraction>, respectively, for the nine months ended September&#160;30, 2020, and 2019.</span></div><div style="margin-bottom:3pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receivables, Unbilled Services and Unearned Revenue</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Unbilled services are comprised primarily of unbilled receivables, but also include contract assets. A contract asset is recorded when a right to payment has been earned for work performed, but billing and payment for that work is determined by certain contractual milestones, whereas unbilled receivables are billable upon the passage of time. While CDD attempts to negotiate terms that provide for billing and payment of services prior or in close proximity to the provision of services, this is not always possible and there are fluctuations in the level of unbilled services and unearned revenue from period to period. The following table provides information about receivables, unbilled services, and unearned revenue (contract liabilities) from contracts with customers for CDD.</span></div><div style="margin-bottom:8pt;margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfNDY5NA_3e45c5a9-17c1-4835-a47e-75614d18d430" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, which are included in accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d3f91adb0694c9f8cda5c55c146646b_I20200930" decimals="-5" name="us-gaap:UnbilledContractsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmQwZGUwZjQ4ZmM4MTQzZjQ5NmEzZjNmMGNjYThjOGViL3RhYmxlcmFuZ2U6ZDBkZTBmNDhmYzgxNDNmNDk2YTNmM2YwY2NhOGM4ZWJfMS0xLTEtMS0w_dc4835ba-e080-43b8-94a6-17e30d25bc5b">834.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f5b39b26164231afef597275eaa72d_I20191231" decimals="-5" name="us-gaap:UnbilledContractsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmQwZGUwZjQ4ZmM4MTQzZjQ5NmEzZjNmMGNjYThjOGViL3RhYmxlcmFuZ2U6ZDBkZTBmNDhmYzgxNDNmNDk2YTNmM2YwY2NhOGM4ZWJfMS0zLTEtMS0w_860f1f4d-2195-4d4d-8cef-15d56423d00e">771.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:ContractWithCustomerAssetGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmQwZGUwZjQ4ZmM4MTQzZjQ5NmEzZjNmMGNjYThjOGViL3RhYmxlcmFuZ2U6ZDBkZTBmNDhmYzgxNDNmNDk2YTNmM2YwY2NhOGM4ZWJfMi0xLTEtMS0w_73627dc0-a577-436e-8114-99962f248f86">609.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:ContractWithCustomerAssetGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmQwZGUwZjQ4ZmM4MTQzZjQ5NmEzZjNmMGNjYThjOGViL3RhYmxlcmFuZ2U6ZDBkZTBmNDhmYzgxNDNmNDk2YTNmM2YwY2NhOGM4ZWJfMi0zLTEtMS0w_5810eee8-b25d-4ff0-85d6-e25e27e7144d">483.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmQwZGUwZjQ4ZmM4MTQzZjQ5NmEzZjNmMGNjYThjOGViL3RhYmxlcmFuZ2U6ZDBkZTBmNDhmYzgxNDNmNDk2YTNmM2YwY2NhOGM4ZWJfMy0xLTEtMS0w_9a99d4c8-ee58-4a3a-bc79-0bf166199d09">492.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmQwZGUwZjQ4ZmM4MTQzZjQ5NmEzZjNmMGNjYThjOGViL3RhYmxlcmFuZ2U6ZDBkZTBmNDhmYzgxNDNmNDk2YTNmM2YwY2NhOGM4ZWJfMy0zLTEtMS0w_a3924dab-7e8b-4787-9cf3-8e1c4a94bc43">449.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized during the period, that were included in the unearned revenue balance at the beginning of the period for the nine months ended September&#160;30, 2020, and September&#160;30, 2019, were $<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:DeferredRevenueRevenueRecognized1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMzI2MQ_ef472f9a-948d-4d59-b85c-c2102d8771cf">237.2</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:DeferredRevenueRevenueRecognized1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMzI2OA_ada9c589-e6a3-4b01-8b41-030ad96feb52">232.8</ix:nonFraction>, respectively. </span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Loss Rollforward</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the adoption of the current expected credit loss standard in 2020, the Company estimates future expected losses on accounts receivable, unbilled services and notes receivable over the remaining collection period of the instrument. <ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfNDY5NQ_d27702d2-703d-4dde-8623-ece10ce249ac" continuedAt="iff0de94e824a4fcca923d4da403e138e" escape="true">The rollforward for the allowance for credit losses for the nine months ended September 30, 2020, is as follows:</ix:nonNumeric></span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><ix:continuation id="iff0de94e824a4fcca923d4da403e138e"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:52.938%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.153%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accounts Receivable</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unbilled Services</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Note and Other Receivables</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfMi0xLTEtMS0w_c021f123-4ec4-41e5-92c2-6d39d9216f5d">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="lh:UnbilledServicesAllowanceforCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfMi0zLTEtMS0w_81cbb13a-d0a6-4110-b50f-d85ccffd68a2">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" format="ixt:zerodash" name="lh:NoteReceivableAllowanceforCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfMi01LTEtMS0w_0f5590eb-edb3-4d35-b579-6c0b30ef41e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="lh:AllowanceforCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfMi03LTEtMS0w_15ef2fc3-7c91-4f73-bd5d-4d0287dd1e71">21.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current expected credit losses opening balance impact on retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib21823aba6f14b7abd5b9938f0373824_D20200101-20200930" decimals="-5" name="lh:CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfMy0xLTEtMS0w_f9e67e02-22c9-40be-8673-ca213ed55005">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a372065d96498db0755abec1a36919_D20200101-20200930" decimals="-5" name="lh:CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfMy0zLTEtMS0w_8bd66e55-febc-4999-9283-4d5dfe5055ef">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc7ed4faa9454198b02470d9bf8c948d_D20200101-20200930" decimals="-5" name="lh:CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfMy01LTEtMS0w_9c3791ff-ab3a-44d5-b84c-6ddf20b18d0d">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="lh:CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfMy03LTEtMS0w_171c1ca7-a709-4893-ac43-a22401c36887">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus, credit loss expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfNC0xLTEtMS0w_3155d2ff-3a8a-4bb8-b1b9-fa46396bdecf">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="lh:UnbilledServicesCreditLossExpenseReversal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfNC0zLTEtMS0w_b0481424-e6e2-49f7-ae65-4a18c0ba09a1">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="lh:NoteReceivableCreditLossExpenseReversal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfNC01LTEtMS0w_c57b16e5-de51-4cd9-b1bd-0fbc2d98f02d">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="lh:CreditLossExpenseReversal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfNC03LTEtMS0w_3a16dd94-35f4-4dae-b7c2-84cc5aa54e68">14.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less, write offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib21823aba6f14b7abd5b9938f0373824_D20200101-20200930" decimals="-5" name="lh:AllowanceforCreditLossWriteOff" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfNS0xLTEtMS0w_9e8e483d-1127-43e6-ba94-0f4411a746c0">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a372065d96498db0755abec1a36919_D20200101-20200930" decimals="-5" name="lh:AllowanceforCreditLossWriteOff" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfNS0zLTEtMS0w_b9779ced-203e-43e1-b345-5fbe83414dba">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc7ed4faa9454198b02470d9bf8c948d_D20200101-20200930" decimals="-5" format="ixt:zerodash" name="lh:AllowanceforCreditLossWriteOff" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfNS01LTEtMS0w_fd8760a9-5235-4622-920b-822bf37b416a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="lh:AllowanceforCreditLossWriteOff" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfNS03LTEtMS0w_fc3c353b-43cc-4707-937a-23fda88eb8fb">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending allowance for credit losses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfNi0xLTEtMS0w_59c5087c-eff0-4120-afef-735f23faddd0">26.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="lh:UnbilledServicesAllowanceforCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfNi0zLTEtMS0w_0373b807-1d66-453d-8182-e65dd2945799">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="lh:NoteReceivableAllowanceforCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfNi01LTEtMS0w_7678c777-5058-47b4-a248-da18c83213e6">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="lh:AllowanceforCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfNi03LTEtMS0w_0d666683-d85f-47e9-bfa9-d04d6d736659">38.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes and other receivables includes the $<ix:nonFraction unitRef="usd" contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630" decimals="-5" name="us-gaap:NotesReceivableFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMzI5ODUzNDg4ODkxNg_4bfcfd76-d0c2-4bc2-9b6c-edcbd67ad95d">110.0</ix:nonFraction> due 2022 from the Envigo transaction which is recorded in Other assets, net. During the three months ended September 30, 2020, the Company recorded an impairment for a note receivable related to an LCD investment of $<ix:nonFraction unitRef="usd" contextRef="i1982102278bd444d897b0ac03dedfda5_D20200701-20200930" decimals="-5" name="lh:Impairmentoffloatingratenotereceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMzI5ODUzNDg4ODMxMQ_2369b258-26af-4b76-961c-4e596779695c">0.7</ix:nonFraction>.</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Obligations Under Long-Term Contracts</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term contracts at the Company consist primarily of fully managed clinical studies within CDD. The amount of existing performance obligations under such long-term contracts unsatisfied as of September&#160;30, 2020, was $<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfNDE4MQ_286df2d7-e393-40b7-9cca-a974a87db320">4,795.0</ix:nonFraction>. The Company expects to recognize approximately <ix:nonFraction unitRef="number" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="2" name="lh:Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfNDIzMg_74940cfc-b67d-4c86-b4b6-7fd5cddc521f">32</ix:nonFraction>% of the remaining performance obligations as of September&#160;30, 2020, as revenue over the next 12 months, and the balance thereafter. The Company's long-term contracts generally range from <ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" format="ixt-sec:duryear" name="lh:LongTermContractsDurationMinimum" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfNDQwNQ_d8d079d2-59ce-4a46-ab7e-adac672a1c4d">1</ix:nonNumeric> to <ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" format="ixt-sec:duryear" name="lh:LongTermContractsDurationMaximum" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfNDQxMQ_688968d5-7619-465f-9b48-ce4ec734ad03">8</ix:nonNumeric> years.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within CDD, revenues of $<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfNDQ0NQ_8b18f170-9cda-47b8-bb7e-e19b17e67e4a">44.8</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfNDQ1Mg_afe61afc-6d90-417e-bbc4-fec272c82ae5">67.7</ix:nonFraction> were recognized during the nine months ended September&#160;30, 2020, and 2019, respectively, from performance obligations that were satisfied in previous periods. This revenue comes from adjustments related to changes in scope and estimates in full service clinical studies.</span></div></ix:continuation><div id="i417074d9a2c24c34bcac25f32d2ec0c1_37"></div><div style="margin-bottom:7pt;margin-top:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMzE5Nw_7fb9be15-399b-42f1-8607-5d742029cb14" continuedAt="i6b4f469ab844496384d6e5a51ad1eda4" escape="true">BUSINESS ACQUISITIONS AND DISPOSITIONS </ix:nonNumeric></span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6b4f469ab844496384d6e5a51ad1eda4" continuedAt="i3a2eeb05c73c4b3bb984b756528ca732">During the nine months ended September 30, 2020, the Company acquired various business and related assets for approximately $<ix:nonFraction unitRef="usd" contextRef="ifc042ac91d2148ea90e2852e684aa7d1_D20200101-20200930" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMTA5OTUxMTYzMzA5NA_7c5c841c-ddd5-4a04-89d6-7f7fc482d28e">208.8</ix:nonFraction> in cash (including contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMTA5OTUxMTYzMzE0NQ_46aacc47-3856-4993-99cc-3b8cc75684fc">6.0</ix:nonFraction> and net of cash acquired), $<ix:nonFraction unitRef="usd" contextRef="i2f8f9d7520ef4499b316c87363b01437_D20200101-20200930" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfNDk0NzgwMjMzODA0MA_29d3ce24-c60c-4231-b59a-bc068cc00f21">113.4</ix:nonFraction> within LCD and $<ix:nonFraction unitRef="usd" contextRef="ifc1b3052e0d1420fae79ce70434a92f8_D20200101-20200930" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfNDk0NzgwMjMzODA2Mw_092e44c1-0896-4413-b16c-156c01dbbcd6">95.4</ix:nonFraction> within CDD. The purchase consideration for all acquisitions in the nine months ended September 30, 2020, has been allocated under the acquisition method of accounting to the estimated fair market value of the net assets acquired, including approximately $<ix:nonFraction unitRef="usd" contextRef="ifc042ac91d2148ea90e2852e684aa7d1_D20200101-20200930" decimals="-5" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMTA5OTUxMTYzMzMzMA_0a77bcb2-6d56-4fa4-bf20-2c890d7996eb">88.5</ix:nonFraction> in identifiable intangible assets and a residual amount of non-tax deductible goodwill of approximately $<ix:nonFraction unitRef="usd" contextRef="ifc042ac91d2148ea90e2852e684aa7d1_D20200101-20200930" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMTA5OTUxMTYzMzQzOA_1fc54fd5-64bd-4bb4-84f8-9abc11b369fc">128.9</ix:nonFraction>. The amortization periods for intangible assets acquired from these businesses range from <ix:nonNumeric contextRef="i29bbac08d4cd42b590e8d38341b247a4_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMTA5OTUxMTYzNjc3MA_64166a6e-2960-4d0f-bfd5-0431d26f3c7e">5</ix:nonNumeric> to <ix:nonNumeric contextRef="ie8ba5b5579de49a1834d28dc2798cee3_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMTA5OTUxMTYzNjc3Nw_08426bb4-ca2e-44ec-9902-7fd233e2992f">15</ix:nonNumeric> years for customer relationships and non-compete agreements. These acquisitions were made primarily to extend the Company's geographic reach in important market areas, enhance the Company's scientific differentiation and to expand the breadth and scope of the </ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><ix:continuation id="i3a2eeb05c73c4b3bb984b756528ca732" continuedAt="i20b4a76a474c480db180e32e597ae739"><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company's CRO services. The excess of the fair value of the consideration conveyed over the fair value of the net assets acquired was recorded as goodwill. The goodwill reflects the Company's expectations to utilize the acquired businesses' workforce and established relationships and the benefits of being able to leverage operational efficiencies with favorable growth opportunities in these markets.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These acquisitions contributed $<ix:nonFraction unitRef="usd" contextRef="i83cd8f691c1a4a83bc738d2b7ddb6e5f_D20200701-20200930" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMTA5OTUxMTYzOTczNg_a5ac9fce-b654-4abc-9a22-f28d825c2747">13.1</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ifc042ac91d2148ea90e2852e684aa7d1_D20200101-20200930" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMzI5ODUzNDg5Nzc2Ng_44e548eb-7b51-4bc6-a844-1cc9113a3a69">13.8</ix:nonFraction> of revenue during the three and nine months ended September 30, 2020, respectively. The acquisitions contributed $<ix:nonFraction unitRef="usd" contextRef="i83cd8f691c1a4a83bc738d2b7ddb6e5f_D20200701-20200930" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMTA5OTUxMTYzOTc0NA_6faa1356-9a96-406c-9c8b-eb58fb898986">3.5</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ifc042ac91d2148ea90e2852e684aa7d1_D20200101-20200930" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMTA5OTUxMTYzOTc0OA_3096e43d-a033-4e73-9501-b82b7ea98a8b">3.6</ix:nonFraction> of operating income, during the three and nine months ended September 30, 2020, respectively.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2019, the Company acquired various businesses and related assets for approximately $<ix:nonFraction unitRef="usd" contextRef="id22f921dc2c74abe80fcd674d286c147_D20190101-20190930" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMTkyOQ_2d3a4bd7-8c91-4cf5-9382-35b28d82edf5">852.9</ix:nonFraction> in cash (net of cash acquired), $<ix:nonFraction unitRef="usd" contextRef="i9b54967480df4194966a376ec02d6eb4_D20190101-20190930" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfNDk0NzgwMjMzODA4Mg_1921ab86-ec6f-46a5-9c38-1bd37ee610ab">647.4</ix:nonFraction> within CDD and $<ix:nonFraction unitRef="usd" contextRef="ic7b895159e664819875373401fc83cfe_D20190101-20190930" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfNDk0NzgwMjMzODEwMQ_e7229d74-2478-4b38-a328-344fc8ba021d">205.5</ix:nonFraction> within LCD. The purchase consideration for all acquisitions in the nine months ended September 30, 2019, has been allocated to the estimated fair market value of the net assets acquired, including approximately $<ix:nonFraction unitRef="usd" contextRef="id22f921dc2c74abe80fcd674d286c147_D20190101-20190930" decimals="-5" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMjE1Nw_9324fabb-2359-4084-8dc1-f7e7566d99de">324.1</ix:nonFraction> in identifiable intangible assets and a residual amount of non-tax deductible goodwill for approximately $<ix:nonFraction unitRef="usd" contextRef="id22f921dc2c74abe80fcd674d286c147_D20190101-20190930" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMjI2NQ_4f89256e-40e9-4e9d-8efe-e565dd3ff62e">512.3</ix:nonFraction>. The amortization periods for intangible assets acquired from these businesses range from <ix:nonNumeric contextRef="if96ac9c12a5b46ffa647f1720c503604_D20190101-20190930" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMjM1OA_f0150748-158f-481e-ad42-5802a89ed17b">11</ix:nonNumeric> to <ix:nonNumeric contextRef="id93dacc653da4b5f9dccaf725dcbc769_D20190101-20190930" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMjM2NA_d9210c3f-f42f-42ea-a96d-f1bad7877925">15</ix:nonNumeric> years for customer relationships. These acquisitions were made primarily to extend the Company's geographic reach in important market areas, enhance the Company's scientific differentiation and to expand the breadth and scope of the Company's CRO services. The excess of the fair value of the consideration conveyed over the fair value of the net assets acquired was recorded as goodwill. The goodwill reflects the Company's expectations to utilize the acquired businesses' workforce and established relationships and the benefits of being able to leverage operational efficiencies with favorable growth opportunities in these markets.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;3, 2019, CDD acquired Envigo's nonclinical contract research services business, expanding CDD's global nonclinical drug development capabilities with additional locations and resources. Additionally, the Company divested the Covance Research Products business (CRP), which was a part of CDD, to Envigo. As part of this sale, CDD entered into a multi-year, renewable supply agreement with Envigo. The Company paid cash consideration of $<ix:nonFraction unitRef="usd" contextRef="i32a9df56eb784dc7a4b220f78de9bd76_D20190603-20190603" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMzI5ODUzNDg5Njk0Nw_89c54f18-82a1-4317-8dd8-a9f5f9de3617">601.0</ix:nonFraction> (which is included in the nine month acquisition numbers above), received a floating rate secured note of $<ix:nonFraction unitRef="usd" contextRef="ieb6fe2a304194224befa49dcb5ed37d4_I20190603" decimals="-5" name="us-gaap:NotesReceivableFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMzI5ODUzNDg5Njk5Mw_bd4ba44f-d457-42c6-a61c-ec577e94317f">110.0</ix:nonFraction>, and recorded a loss on the sale of CRP of $<ix:nonFraction unitRef="usd" contextRef="i3142bfab671e4d37943fa55426510724_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:GainLossOnDispositionOfAssets1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMzI5ODUzNDg5NzA0MA_f82cbc43-341c-4b6e-98b3-a7f9be94f5cb">12.2</ix:nonFraction>. The Company funded the transaction through a new term loan facility.</span></div><ix:nonNumeric contextRef="i612a5521f96f4a1db5dcc91dda46a2e8_D20200401-20200630" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMTA5OTUxMTY0MjE5Nw_ec718758-b11e-496a-8cea-3039b9efe08c" escape="true"><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final valuation of acquired assets and assumed liabilities in the transaction as of June 3, 2019, include the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:81.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.371%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consideration Transferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a9df56eb784dc7a4b220f78de9bd76_D20190603-20190603" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMS01LTEtMS05MTY0_89c54f18-82a1-4317-8dd8-a9f5f9de3617">601.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of CRP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb6fe2a304194224befa49dcb5ed37d4_I20190603" decimals="-5" name="us-gaap:NotesReceivableFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMi01LTEtMS05MTY0_bd4ba44f-d457-42c6-a61c-ec577e94317f">110.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb6fe2a304194224befa49dcb5ed37d4_I20190603" decimals="-5" name="lh:Totalacquisitionconsiderationcashstocknotesetc." scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMy0yLTEtMS05MzI2_c9e52ea7-e801-4902-ab73-606befd6857c">711.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Final <br/>June 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Assets Acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfNy02LTEtMS05MTU1_bb3970b4-3543-4d64-94e2-b7442f8a147f">11.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfOC02LTEtMS05MTU1_a36a1e11-752a-4ca0-845f-957dec7f2dc1">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfOS02LTEtMS05MTU1_31d80ad9-113c-49e7-8c43-3e47a1e2858c">25.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMTAtNi0xLTEtOTE1NQ_c86f5460-aa58-4ea5-885e-0ec8e0c2ec61">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMTEtNi0xLTEtOTE1NQ_a4ab6a59-03bb-4470-9113-76ed49d03326">10.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMTItNi0xLTEtOTE1NQ_e702f33d-9182-41b7-b396-881586f73742">128.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMTMtNi0xLTEtOTE1NQ_f2414e44-22b3-40cb-86f5-ce091798f28c">25.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMTQtNi0xLTEtOTE1NQ_49816b1e-e03c-48d1-87cd-e16382b77aaa">376.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9cc69f41c9c44488b638ef3aaccdb61_I20200630" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMTUtNi0xLTEtOTE1NQ_e78f2a62-e6be-45e3-91a9-cf9b247d55f6">140.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name and trademarks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae23e3cdb39a44b8968341916d4a2dee_I20200630" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMTYtNi0xLTEtOTE1NQ_49dfe84b-6592-41bf-a963-c7897d3020ae">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMTctNi0xLTEtOTE1NQ_0427e072-5468-491e-88f0-eeb162e2ad89">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMTgtNi0xLTEtOTE1NQ_bf64a532-92ac-458e-83bf-3721a2b8fb06">745.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMTktNi0xLTEtOTE1NQ_57533d1e-ac0a-49f6-8305-009e7f98679e">15.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMjAtNi0xLTEtOTE1NQ_32456fe5-028e-4bde-8977-b5b8bf6a450f">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMjEtNi0xLTEtOTE1NQ_a1ad8173-c3ce-46ef-b846-3a93f4e92484">49.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMjQtNi0xLTEtOTE1NQ_088e784c-408f-4f45-9fc5-e4273a479dad">69.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMjUtNi0xLTEtOTE1NQ_53af557a-7c07-4342-91a7-6eb9e0abf8bf">144.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Envigo assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMjYtNi0xLTEtOTE1NQ_52e665c3-536e-4716-9888-f0d548a82d92">601.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating rate secured note receivable due 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630" decimals="-5" name="us-gaap:NotesReceivableFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMjctMi0xLTEtOTE5Mw_4bfcfd76-d0c2-4bc2-9b6c-edcbd67ad95d">110.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8272c3d15f864e709f533b5532e0c9c8_I20200630" decimals="-5" name="lh:Totalacquisitionconsiderationcashstocknotesetc." scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMjgtMi0xLTEtOTMyOA_75bf26e8-af29-43e8-a49e-ed801c3060e3">711.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><ix:continuation id="i20b4a76a474c480db180e32e597ae739"><div style="margin-bottom:7pt;margin-top:11pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final purchase consideration for Envigo has been allocated to the estimated fair market value of the net assets acquired, including approximately $<ix:nonFraction unitRef="usd" contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMzI5ODUzNDg5NzM5Mw_160a0d99-8e12-4465-a002-1d1630c138ce">141.4</ix:nonFraction> in identifiable intangible assets and a residual amount of non-tax-deductible goodwill of approximately $<ix:nonFraction unitRef="usd" contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMzI5ODUzNDg5NzUwMQ_f0e49062-694b-47ae-bc40-e480277d8ef7">376.6</ix:nonFraction>. The amortization period for intangible assets acquired is <ix:nonNumeric contextRef="i05c3bfa9f9624b64841e19fc622f33fa_D20200401-20200630" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMzI5ODUzNDg5NzU2NA_d27a2b78-49d7-48b5-8f17-bfbca3b53af5">11</ix:nonNumeric> years for customer relationships. </span></div><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMzIwMg_ec0a4714-c452-4cdc-a256-212359f4b6be" escape="true"><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Information </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Had the Company's total 2019 and 2020 acquisitions been completed as of January 1, 2018, or January 1, 2019, respectively, the Company's pro forma results would have been as follows:</span><span style="color:#0094ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmQwZDFiZmY5ODBiNTRhYjFhOTZhNWVkNjEyOGY3ZDYzL3RhYmxlcmFuZ2U6ZDBkMWJmZjk4MGI1NGFiMWE5NmE1ZWQ2MTI4ZjdkNjNfMi0xLTEtMS0w_58f1990d-641f-447d-bd6b-afa96b6e05bf">3,899.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmQwZDFiZmY5ODBiNTRhYjFhOTZhNWVkNjEyOGY3ZDYzL3RhYmxlcmFuZ2U6ZDBkMWJmZjk4MGI1NGFiMWE5NmE1ZWQ2MTI4ZjdkNjNfMi0yLTEtMS0w_2fe60acf-8051-4f33-bac5-44e92af46bf3">2,969.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmQwZDFiZmY5ODBiNTRhYjFhOTZhNWVkNjEyOGY3ZDYzL3RhYmxlcmFuZ2U6ZDBkMWJmZjk4MGI1NGFiMWE5NmE1ZWQ2MTI4ZjdkNjNfMi00LTEtMS0w_65d68f35-5e9b-4b06-8642-d828375086a5">9,524.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmQwZDFiZmY5ODBiNTRhYjFhOTZhNWVkNjEyOGY3ZDYzL3RhYmxlcmFuZ2U6ZDBkMWJmZjk4MGI1NGFiMWE5NmE1ZWQ2MTI4ZjdkNjNfMi01LTEtMS0w_2ab334a8-41e4-4f2e-baf2-e822465f3dda">8,827.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Laboratory Corporation of America Holdings</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmQwZDFiZmY5ODBiNTRhYjFhOTZhNWVkNjEyOGY3ZDYzL3RhYmxlcmFuZ2U6ZDBkMWJmZjk4MGI1NGFiMWE5NmE1ZWQ2MTI4ZjdkNjNfMy0xLTEtMS0w_a78c6a84-ae77-448a-a6b0-353460abfa2a">744.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmQwZDFiZmY5ODBiNTRhYjFhOTZhNWVkNjEyOGY3ZDYzL3RhYmxlcmFuZ2U6ZDBkMWJmZjk4MGI1NGFiMWE5NmE1ZWQ2MTI4ZjdkNjNfMy0yLTEtMS0w_7c6127b5-1b09-4153-a764-99930c2d9f1d">224.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmQwZDFiZmY5ODBiNTRhYjFhOTZhNWVkNjEyOGY3ZDYzL3RhYmxlcmFuZ2U6ZDBkMWJmZjk4MGI1NGFiMWE5NmE1ZWQ2MTI4ZjdkNjNfMy00LTEtMS0w_5dba48da-952c-4a82-bbda-16454a770e9b">666.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmQwZDFiZmY5ODBiNTRhYjFhOTZhNWVkNjEyOGY3ZDYzL3RhYmxlcmFuZ2U6ZDBkMWJmZjk4MGI1NGFiMWE5NmE1ZWQ2MTI4ZjdkNjNfMy01LTEtMS0w_260726a1-9e06-47a7-bb91-9111a52edacc">612.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i417074d9a2c24c34bcac25f32d2ec0c1_40"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RleHRyZWdpb246OTU4OGQyMzhkODkyNDljZjlkNWVhNjIyNzQxN2ViYWRfMTQ1OA_9ffebff2-d816-4613-9540-2ad06cc025b9" continuedAt="idf981b11506a4b28ad43a9cd8e8e22c1" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><ix:continuation id="idf981b11506a4b28ad43a9cd8e8e22c1"><div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing net earnings attributable to Laboratory Corporation of America Holdings by the weighted average number of common shares outstanding. Diluted earnings per share is computed by dividing net earnings including the impact of dilutive adjustments by the weighted average number of common shares outstanding plus potentially dilutive shares, as if they had been issued at the earlier of the date of issuance or the beginning of the period presented. Potentially dilutive common shares result primarily from the Company&#8217;s outstanding stock options, restricted stock awards, restricted stock units, and performance share awards.</span></div><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RleHRyZWdpb246OTU4OGQyMzhkODkyNDljZjlkNWVhNjIyNzQxN2ViYWRfMTQ1MA_52036e64-7efb-4bf2-80d0-1e36d0fcde4e" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents a reconciliation of basic earnings per share to diluted earnings per share:</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Per Share Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Per Share Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earning</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Per Share Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Per Share Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="INF" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNC0xLTEtMS0w_1cae89d9-0ad6-40ca-bcb0-f4ccc412e49d">703.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNC0zLTEtMS0w_98b73f09-9203-44fa-8108-10ab9cb5c167">97.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="INF" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNC01LTEtMS0w_cb2f01e6-0af8-406a-b721-fec31af221d4">7.22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNC03LTEtMS0w_49117119-626c-4a46-a4fa-b583c9d237d5">220.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNC05LTEtMS0w_1d571c7b-4b70-4546-bf8e-3d56b7358d32">97.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNC0xMS0xLTEtMA_f4249bcc-1505-4ca2-8a3a-3edb906b4481">2.26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNC0xMy0xLTEtMA_5070a3f8-7f46-436f-a590-f64284d6c9b4">617.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNC0xNS0xLTEtMA_1778eb66-9e01-470d-9240-903bd065ae6f">97.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNC0xNy0xLTEtMA_2588bbfa-8c68-4325-98e2-5bd62b67ee1f">6.35</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNC0xOS0xLTEtMA_73fe8b05-a6ff-4b85-840b-dd6b03d99de5">596.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNC0yMS0xLTEtMA_a6a309b9-75fd-4587-9abd-c31d8ba60250">98.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNC0yMy0xLTEtMA_d295d5ff-3df9-4195-9a4a-6e29f879db97">6.08</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dilutive effect of employee&#160;stock options and awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNS0zLTEtMS0w_25a69057-75b6-44ca-9374-08eed84231e4">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNS05LTEtMS0w_ea01927e-74ea-448d-8be4-113165e7259b">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNS0xNS0xLTEtMA_f5193758-239b-480e-9341-1c8753340d23">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNS0yMS0xLTEtMA_2266c5d7-a877-41db-a6ed-aaa08c9fc758">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings including impact of dilutive adjustments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfOC0xLTEtMS0w_dd9d3f0d-7ae7-40bf-b8c6-aa906a5e6c67">703.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfOC0zLTEtMS0w_546d277f-9439-46a3-9f32-fc26752061fd">98.1</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="INF" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfOC01LTEtMS0w_a9c2f699-821d-4441-b55e-a8e78ff7f84c">7.17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfOC03LTEtMS0w_acdf1eb8-4519-4d22-9c21-be382bbbb3a6">220.7</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfOC05LTEtMS0w_acba1609-6ac8-4859-b163-d09b5e3f1595">98.3</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfOC0xMS0xLTEtMA_aae399e8-8a5d-4c69-9b8f-c77b01c9a87b">2.25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfOC0xMy0xLTEtMA_29648cb8-6681-47de-95ed-e290fd23396a">617.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfOC0xNS0xLTEtMA_f2355de2-ac67-4f02-92f7-53becccdcd92">97.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfOC0xNy0xLTEtMA_56b87990-e333-456c-a126-acea499858f4">6.31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfOC0xOS0xLTEtMA_54e47da4-1eac-492c-9000-81bfec2dd128">596.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfOC0yMS0xLTEtMA_93582092-e77d-4b78-9026-0cecc5c45888">98.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfOC0yMy0xLTEtMA_77cb1670-b3f5-4df1-babd-ea94dee9f20e">6.04</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per share represent the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. These potential shares include dilutive stock options and unissued restricted stock awards. <ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RleHRyZWdpb246OTU4OGQyMzhkODkyNDljZjlkNWVhNjIyNzQxN2ViYWRfMTQyOA_c2dbd1ac-086e-4313-9da5-d97fea27b5c7" continuedAt="i6e8c1c278fb74052ab57617c45188fc5" escape="true">The following table summarizes the potential common shares not included in the computation of diluted earnings per share because their impact would have been antidilutive:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i6e8c1c278fb74052ab57617c45188fc5"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.087%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock options and awards</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjIxMzllM2M0NGRkNjRlOWI5NzJiYjc3Yzg5NzdhMzUwL3RhYmxlcmFuZ2U6MjEzOWUzYzQ0ZGQ2NGU5Yjk3MmJiNzdjODk3N2EzNTBfMi0xLTEtMS0w_c10562bf-e491-4afb-b4ca-3b6efe5090b3">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjIxMzllM2M0NGRkNjRlOWI5NzJiYjc3Yzg5NzdhMzUwL3RhYmxlcmFuZ2U6MjEzOWUzYzQ0ZGQ2NGU5Yjk3MmJiNzdjODk3N2EzNTBfMi0zLTEtMS0w_50cdd7fe-0c2c-4033-b287-6424a41f1a7e">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjIxMzllM2M0NGRkNjRlOWI5NzJiYjc3Yzg5NzdhMzUwL3RhYmxlcmFuZ2U6MjEzOWUzYzQ0ZGQ2NGU5Yjk3MmJiNzdjODk3N2EzNTBfMi01LTEtMS0w_ec4265f2-5cb2-4979-9944-5afeebdf8f52">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjIxMzllM2M0NGRkNjRlOWI5NzJiYjc3Yzg5NzdhMzUwL3RhYmxlcmFuZ2U6MjEzOWUzYzQ0ZGQ2NGU5Yjk3MmJiNzdjODk3N2EzNTBfMi03LTEtMS0w_d9046031-6d1c-4d61-9fb0-2bc61d186077">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div id="i417074d9a2c24c34bcac25f32d2ec0c1_43"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfMTExNg_afe54f1e-6781-4b02-ad4b-b281550159c2" continuedAt="iafbeae63772b487380c5cbb95fe654c7" escape="true">RESTRUCTURING AND OTHER CHARGES</ix:nonNumeric></span></div><ix:continuation id="iafbeae63772b487380c5cbb95fe654c7" continuedAt="i440564f5a93341e5801e8fd058bad1ff"><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2020, the Company recorded net restructuring and other charges of $<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" name="lh:NetRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfMTA5OTUxMTYyOTAwNA_06232df5-c987-4874-b531-2ef3cb24bfdb">38.9</ix:nonFraction>: $<ix:nonFraction unitRef="usd" contextRef="i60bf6e0de9384f37926fac0c0db06385_D20200101-20200930" decimals="INF" name="lh:NetRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfMTA5OTUxMTYyOTAxMQ_a404ccf5-ea15-4696-a6e8-a59c0581e555">13.4</ix:nonFraction> within LCD and $<ix:nonFraction unitRef="usd" contextRef="if366c14694954f6f84a2c0fe5708324e_D20200101-20200930" decimals="INF" name="lh:NetRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfMTA5OTUxMTYyOTAxOQ_a185c597-2e17-4470-9d73-e2e953a13f4a">25.5</ix:nonFraction> within CDD. The charges were comprised of $<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfMTg3_ef0e0f78-79e8-4449-a623-00b7b409b853">12.8</ix:nonFraction> related to severance and other personnel costs, $<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:OtherAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfMjM4_25ba2618-7295-423a-85f9-1a059ff771c2">11.0</ix:nonFraction> for a CDD leased lab facility and equipment impairments, and $<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfMjk1_bfba342c-1c5d-42aa-8f06-4854b2c673a8">24.0</ix:nonFraction> in facility closures, impairment of operating lease right-of use assets and general integration activities. The charges were offset by the reversal of previously established liability of $<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" name="lh:EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfNDg1_daba2453-2e38-42e6-8f43-189174478d9f">1.1</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="lh:Unusedfacilityrestructuringreserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfNDky_3cf76135-46b8-4a29-8e8e-bfbdbf13bb03">7.8</ix:nonFraction> in unused severance costs and facility-related costs, respectively. </span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2019, the Company recorded net restructuring and other charges of $<ix:nonFraction unitRef="usd" contextRef="i3142bfab671e4d37943fa55426510724_D20190101-20191231" decimals="INF" name="lh:NetRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfMTA5OTUxMTYyODk4Mw_f89f8dc3-2bd9-4319-a632-7b77a4f985a3">48.4</ix:nonFraction>: $<ix:nonFraction unitRef="usd" contextRef="i08f70824033d48f0ad6009880d1268f6_D20190101-20191231" decimals="INF" name="lh:NetRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfMTA5OTUxMTYyODk5MA_f748a733-d5e2-47ae-a826-d00751bc51fb">22.8</ix:nonFraction> within LCD and $<ix:nonFraction unitRef="usd" contextRef="i34ea8623f99d450ba0c680719bfe3105_D20190101-20191231" decimals="INF" name="lh:NetRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfMTA5OTUxMTYyODk5Nw_aa7a7a4c-f420-4966-a2fe-175d967e5435">25.6</ix:nonFraction> within CDD. The charges were comprised of $<ix:nonFraction unitRef="usd" contextRef="i3142bfab671e4d37943fa55426510724_D20190101-20191231" decimals="-5" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfNzA5_d7ab1ba8-2611-4ad7-87c5-04d734694fd7">26.2</ix:nonFraction> related to severance and other personnel costs and $<ix:nonFraction unitRef="usd" contextRef="i3142bfab671e4d37943fa55426510724_D20190101-20191231" decimals="-5" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfNzYz_ec0ccf34-4504-4a4f-8f11-0a60591c7fdc">22.0</ix:nonFraction> in costs associated with facility closures, impairment of operating lease right-of-use assets and general integration initiatives. The charges were increased by the adjustment of previously established reserves of $<ix:nonFraction unitRef="usd" contextRef="i3142bfab671e4d37943fa55426510724_D20190101-20191231" decimals="-5" name="lh:EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfOTgw_c80fe76f-20b7-43c1-a3ef-e953d459b406">0.4</ix:nonFraction> in severance reserves and decreased by a reversal of $<ix:nonFraction unitRef="usd" contextRef="i3142bfab671e4d37943fa55426510724_D20190101-20191231" decimals="-5" name="lh:Unusedfacilityrestructuringreserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfMTY0OTI2NzQ0MjgzNA_57526324-1743-425a-9050-31c8697e4e36">0.2</ix:nonFraction> in unused facility reserves. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><ix:continuation id="i440564f5a93341e5801e8fd058bad1ff"><ix:nonNumeric contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfMTEyNw_aebfe503-db9e-4c28-963a-d8463a5aa351" escape="true"><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents the Company&#8217;s restructuring reserve activities for the period indicated:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:40.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.692%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.775%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.692%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.775%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.747%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LCD</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CDD</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and Other Employee Costs</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and Other Employee Costs</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43d39dfc46f64e9ca238eb8a039fa85f_I20191231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfMi0xLTEtMS0w_5e0dc059-4a43-4665-9d93-b857c6722891">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5bcb822134b4295bec55008826197e5_I20191231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfMi0zLTEtMS0w_7795f3c0-291b-4166-a0ef-3bb5e5db5536">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i616e955ba8fd4b48be31816f59836100_I20191231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfMi01LTEtMS0w_553aab91-e1c0-4dad-8b0f-c54cc8be48c4">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dfebc2c21b9448d96ac217371534543_I20191231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfMi03LTEtMS0w_fea6a51e-bba1-41c4-b2bd-65240e75bd57">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfMi05LTEtMS0w_e849feba-6b12-456c-a733-6f087cb5d2da">13.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6c26b91b524c4abbfa955d1ddc4457_D20200101-20200930" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfNC0xLTEtMS0w_02ee4bcb-558b-4e9f-b0a6-2b93a647d50b">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb8d4ae4a074deead96aadd66375f97_D20200101-20200930" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfNC0zLTEtMS0w_92395ca7-ce14-4fcf-aef2-388f7356f6af">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cd3b488f83048afa58403e54590e370_D20200101-20200930" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfNC01LTEtMS0w_ed80a376-b9d0-4a9f-b438-6503d1679f24">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b26803c2ed7463f9f6e7e437606b796_D20200101-20200930" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfNC03LTEtMS0w_f6d232a4-c5b8-45b4-aa72-088debfd4fde">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfNC05LTEtMS0w_8e4569be-9020-4a9d-81dc-fd10a2ce6180">24.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of lab facility and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6c26b91b524c4abbfa955d1ddc4457_D20200101-20200930" decimals="-5" format="ixt:zerodash" name="lh:RestructuringImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfNi0xLTEtMS0w_d5d5d16e-104d-4434-bec6-c8876ce3dc01">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb8d4ae4a074deead96aadd66375f97_D20200101-20200930" decimals="-5" name="lh:RestructuringImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfNi0zLTEtMS0w_4efcd719-c356-4e35-9d13-fdb5ef5967c3">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cd3b488f83048afa58403e54590e370_D20200101-20200930" decimals="-5" format="ixt:zerodash" name="lh:RestructuringImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfNi01LTEtMS0w_2bd0bc0d-03cc-4527-82f8-164057524042">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b26803c2ed7463f9f6e7e437606b796_D20200101-20200930" decimals="-5" name="lh:RestructuringImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfNi03LTEtMS0w_009a4ada-4617-468a-b60c-fb9e48ccc4b5">17.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="lh:RestructuringImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfNi05LTEtMS0w_efa7c61f-5231-4387-b801-aa4dbdddaa28">23.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6c26b91b524c4abbfa955d1ddc4457_D20200101-20200930" decimals="-5" name="lh:RestructuringReserveSettledWithCashAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfOC0xLTEtMS0w_b19b2a17-dc11-4fe2-844b-28839638b52b">4.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fb8d4ae4a074deead96aadd66375f97_D20200101-20200930" decimals="-5" name="lh:RestructuringReserveSettledWithCashAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfOC0zLTEtMS0w_452d25f6-c7e6-4b81-9f31-b31a329c7a2b">12.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6cd3b488f83048afa58403e54590e370_D20200101-20200930" decimals="-5" name="lh:RestructuringReserveSettledWithCashAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfOC01LTEtMS0w_406b2512-eb75-4001-a719-cd76825a2867">10.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b26803c2ed7463f9f6e7e437606b796_D20200101-20200930" decimals="-5" name="lh:RestructuringReserveSettledWithCashAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfOC03LTEtMS0w_2a1a5f47-17bb-4fa0-9d1a-ef75e7b3edf0">23.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="lh:RestructuringReserveSettledWithCashAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfOC05LTEtMS0w_80fbc23e-17d6-4e55-b67a-28507080b08b">50.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5fa039b6da0439ba94ea7516654e077_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfOS0xLTEtMS0w_4da95a93-c9c1-4aa8-99b9-fb96e8e63dbd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id303bba4b3024ee9bc49c49292c283c3_I20200930" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfOS0zLTEtMS0w_328fea7c-f3be-4c39-9e0e-508e863d0b0d">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f2eb55fbc34238bd4e45bb4e88d0d3_I20200930" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfOS01LTEtMS0w_eebd3c2b-4b1a-47ed-b1bb-4c2dfafb8994">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied5787aeaaf147b3ac9ba7c20d2c10ca_I20200930" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfOS03LTEtMS0w_52699624-0b75-4bd5-af80-6b3d2df3bc58">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfOS05LTEtMS0w_f4b5d3be-d6e5-4bd6-8d92-505f21181cd2">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:RestructuringReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfMTAtOS0xLTEtMA_76fe8f00-2bae-4856-8f34-56277e297823">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:RestructuringReserveNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfMTEtOS0xLTEtMA_e56670fe-fcd4-41f7-838f-e8471fe095c5">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfMTItOS0xLTEtMA_60d9540b-f3ca-4e8a-8734-636fe162dff1">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i417074d9a2c24c34bcac25f32d2ec0c1_46"></div><div style="margin-bottom:6pt;margin-top:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfNTI5NA_f6fb66b2-fe2b-4a1a-97c5-5dc5c51f35cc" continuedAt="i71a9ed4e9d6f427c895db310892bce41" escape="true">GOODWILL AND INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="i71a9ed4e9d6f427c895db310892bce41" continuedAt="i1b5b4b5ff0564bc5af72353593541f9b"><ix:nonNumeric contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfNTI3OQ_84b7baf7-c0fd-483b-baf8-d58d1a880f31" escape="true"><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the nine months ended September&#160;30, 2020, are as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LCD</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CDD</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i074bfbf2d5a14f098b9866224c866c60_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfMy0xLTEtMS0w_a08a6ea6-8309-43d9-ba6f-a5865c6621e5">3,721.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f5b39b26164231afef597275eaa72d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfMy01LTEtMS0w_99f53de5-b0db-48e1-be61-846829cab5cc">4,143.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfMy05LTEtMS0w_94c5ce94-3449-45ad-9a1c-fa7f016ef468">7,865.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60bf6e0de9384f37926fac0c0db06385_D20200101-20200930" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfNC0xLTEtMS0w_54ed2684-1886-44d2-9b14-57afd457b5ca">66.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if366c14694954f6f84a2c0fe5708324e_D20200101-20200930" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfNC01LTEtMS0w_ce57644f-9f1a-4e83-96a5-3bce38af1bb8">73.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfNC05LTEtMS0w_ef50981a-dc8f-49bb-b27f-0d565ed9d01f">139.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60bf6e0de9384f37926fac0c0db06385_D20200101-20200930" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfNy0xLTEtMS0w_52a04635-91cc-44ae-9f79-a3defbc3dd1b">3.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if366c14694954f6f84a2c0fe5708324e_D20200101-20200930" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfNy01LTEtMS0w_05e49bc6-be10-4f44-b6ba-c3d8c04c4576">418.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfNy05LTEtMS0w_29c3ff84-143a-4f5a-8b0c-d0b2bbb8c5fc">422.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency impact and other adjustments to goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60bf6e0de9384f37926fac0c0db06385_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfOC0xLTEtMS0w_d8e98dae-89e4-4317-af21-34e07f9483a5">2.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if366c14694954f6f84a2c0fe5708324e_D20200101-20200930" decimals="-5" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfOC01LTEtMS0w_1c258d45-d523-4438-be31-15c6a9f40a4b">34.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfOC05LTEtMS0w_a5a5fd20-4a6b-4da5-b65b-c116a696e765">32.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aec6588c61a425bbfbaa20d82e54da0_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfOS0xLTEtMS0w_944bfddf-6349-4e75-8b6e-7b40636e29a6">3,781.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d3f91adb0694c9f8cda5c55c146646b_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfOS01LTEtMS0w_33a65b9c-1da6-4b7b-861f-45fc1931353c">3,832.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfOS05LTEtMS0w_ba7ad626-034c-45d6-988c-659f37cfdb75">7,613.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:7pt;margin-top:11pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses goodwill and indefinite-lived intangibles for impairment at least annually or whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Based upon the revised forecasted revenues and operating income following the declaration of the COVID-19 global pandemic, management concluded there was a triggering event and updated its annual 2019 goodwill impairment testing as of March 31, 2020, for its CDD reporting units and its LCD reporting units. Based on the quantitative impairment assessment, the Company concluded that the fair value was less than carrying value for two of its reporting units, including one where the 2019 fair value exceeded carrying value by approximately <ix:nonFraction unitRef="number" contextRef="icd1aeab8e4f84964b6228ddbf6f745c4_I20200331" decimals="2" name="lh:PercentageFairValueofGoodwillExceededCarryingValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMzI5ODUzNDg5MTYzMg_5ec85eed-85a9-4dbc-aee9-9f9df6ceb480">10.0</ix:nonFraction>%, and recorded a goodwill impairment of $<ix:nonFraction unitRef="usd" contextRef="if366c14694954f6f84a2c0fe5708324e_D20200101-20200930" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMTA5OTUxMTYzMzEyNw_1c137812-e48e-4075-a395-bbc6fd321238">418.7</ix:nonFraction> for the CDD segment and $<ix:nonFraction unitRef="usd" contextRef="i60bf6e0de9384f37926fac0c0db06385_D20200101-20200930" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMTA5OTUxMTYzMzEyMg_5870a483-d9dc-4de5-9fa3-3ed95fd3c1b6">3.7</ix:nonFraction> for LCD segment. </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilized a combination of income and market approaches to determine the fair value of the CDD reporting units. Based upon the results of the quantitative assessments, the Company concluded that the fair value was less than its carrying value for one of the CDD reporting units. A non-cash charge of $<ix:nonFraction unitRef="usd" contextRef="if366c14694954f6f84a2c0fe5708324e_D20200101-20200930" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMTI5NA_63de6383-8571-4069-841c-a5889099e41b">418.7</ix:nonFraction> was recognized and included in goodwill and other asset impairments on the Consolidated Statement of Operations to reduce the carrying amount of goodwill for the CDD reporting unit to fair value. Following the impairment charge, the carrying value of goodwill for this reporting unit is $<ix:nonFraction unitRef="usd" contextRef="icd1aeab8e4f84964b6228ddbf6f745c4_I20200331" decimals="-5" format="ixt:numdotdecimal" name="lh:ValueofReportingUnitsGoodwillFollowingImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMTU4NA_ddb62483-1d68-4a0a-a521-b0b16639f052">1,627.5</ix:nonFraction> as of September 30, 2020. The other CDD reporting unit evaluated indicated a fair value that exceeded carrying value by less than <ix:nonFraction unitRef="number" contextRef="icd1aeab8e4f84964b6228ddbf6f745c4_I20200331" decimals="2" name="lh:PercentageFairValueofGoodwillExceededCarryingValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMTY5Mg_5ec85eed-85a9-4dbc-aee9-9f9df6ceb480">10.0</ix:nonFraction>%. Management notes that a +<ix:nonFraction unitRef="number" contextRef="icd1aeab8e4f84964b6228ddbf6f745c4_I20200331" decimals="2" name="lh:PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMTcyMA_d501179a-5fb8-489c-aaef-1f744ad8eb3f">1.0</ix:nonFraction>% change in the discount rate in the March 31, 2020 analysis would reduce the headroom to approximately <ix:nonFraction unitRef="number" contextRef="icd1aeab8e4f84964b6228ddbf6f745c4_I20200331" decimals="2" name="lh:PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMTgyNg_e3219d3f-1401-41c3-9e7a-e2c6ac5ed0c7">2.0</ix:nonFraction>%. Goodwill for this reporting unit as of September 30, 2020 is $<ix:nonFraction unitRef="usd" contextRef="i3d3f91adb0694c9f8cda5c55c146646b_I20200930" decimals="-5" name="lh:ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMTg3NQ_a915a8f0-34e3-4b96-8a47-097c2eea6e64">646.2</ix:nonFraction>. </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilized the income approach to determine </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the fair value of the LCD reporting units. Based upon the results of the quantitative assessments, the Company concluded the fair value of one of the reporting units was less than its carrying value. A non-cash charge of $<ix:nonFraction unitRef="usd" contextRef="i60bf6e0de9384f37926fac0c0db06385_D20200101-20200930" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMjE1NQ_4fe380d4-3a62-4084-a764-73a867440e69">3.7</ix:nonFraction> was recognized and included in goodwill and other asset impairments on the Consolidated Statement of Operations to reduce the carrying amount of goodwill for this LCD reporting unit to zero. The other LCD reporting unit evaluated indicated a fair value that exceeded carrying value by less than <ix:nonFraction unitRef="number" contextRef="i4e01eb55dbc7406c97793a4ef9f2d6fc_I20200331" decimals="3" name="lh:PercentageFairValueofGoodwillExceededCarryingValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMjQ1Mw_3f039dee-3b8d-4313-a78f-7293c94de5d3">10.0</ix:nonFraction>%. Management notes that a +<ix:nonFraction unitRef="number" contextRef="i4e01eb55dbc7406c97793a4ef9f2d6fc_I20200331" decimals="2" name="lh:PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMjQ4MQ_7d52ebcd-4499-496c-a9df-2247310094e9">1.0</ix:nonFraction>% change in the discount rate in the March 31, 2020 analysis would cause the fair value to be less than carrying value and would result in an impairment of approximately $<ix:nonFraction unitRef="usd" contextRef="i4e01eb55dbc7406c97793a4ef9f2d6fc_I20200331" decimals="1" name="lh:ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMjY1Mw_4365c65a-611a-47c5-9738-527bda207852">40.0</ix:nonFraction>. Goodwill and indefinite-lived intangibles of Canadian licenses for this reporting unit as of September 30, 2020, were $<ix:nonFraction unitRef="usd" contextRef="i0aec6588c61a425bbfbaa20d82e54da0_I20200930" decimals="1" name="lh:ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMjc1OA_744aa93e-8246-4860-a74b-a7f91c4a88f3">86.0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="icb47c57b65f949f7a7c4c95751563b2f_I20200930" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMjc2NQ_fe066692-1275-45f5-9ac3-b32eb109cf48">468.4</ix:nonFraction>, respectively.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company believes that the current assumptions and estimates used in its goodwill analysis are reasonable, supportable, and appropriate, continued efforts to maintain or improve the performance of these businesses could be impacted by unfavorable or unforeseen changes which could impact the existing assumptions used in the impairment analysis. Various factors could reasonably be expected to unfavorably impact existing assumptions: primarily delays in new customer bookings and the related delay in revenue from new customers, increases in customer termination activity or increases in operating costs. In addition, given the ongoing and rapidly changing nature of the COVID-19 pandemic, there is significant uncertainty </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><ix:continuation id="i1b5b4b5ff0564bc5af72353593541f9b" continuedAt="i5a626d0d935640748cfda00ee6409203"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">regarding the duration and severity of the pandemic as well as any future government restrictions, which may unfavorably impact existing assumptions. Accordingly, there can be no assurance that the estimates and assumptions made for the purposes of the goodwill impairment analysis will prove to be accurate predictions of future performance.&#160;</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will continue to monitor the financial performance of and assumptions for its reporting units. Management's impairment analysis utilizes significant judgments and assumptions related to the market comparable method analysis, such as selected market multiples, and those related to cash flow projections, such as revenue and terminal growth rates, projected operating margin, and the discount rate. A significant increase in the discount rate, decrease in the revenue and terminal growth rates, decreased operating margin, or substantial reductions in end markets and volume assumptions, could have a negative impact on the estimated fair value of the reporting units. A future impairment charge for goodwill or intangible assets could have a material effect on the Company's consolidated financial position and results of operations. </span></div><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfNTI4Mw_8be4946a-9e09-4095-9e25-c2e7dc9d577b" escape="true"><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of identifiable intangible assets are as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:25.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.048%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9227de05b374430bb6014f0912ee355f_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfMi0xLTEtMS0w_4d52e21d-b413-4834-b79f-1eb5c4834ecc">4,530.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9227de05b374430bb6014f0912ee355f_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfMi0zLTEtMS0w_f3eb9017-a024-4382-a162-c56d98786503">1,473.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9227de05b374430bb6014f0912ee355f_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfMi01LTEtMS0w_1b40768c-a13d-479b-99b5-0a4e8faac757">3,057.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693b8e43fa40fd96c729928953fdf2_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfMi03LTEtMS0w_094768a5-f3ac-412c-b84e-95aac48e8aed">4,441.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07693b8e43fa40fd96c729928953fdf2_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfMi05LTEtMS0w_3ec23f5b-0f1a-4c46-a8fe-545db1f57ada">1,329.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07693b8e43fa40fd96c729928953fdf2_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfMi0xMS0xLTEtMA_5c083513-fe23-429e-99a6-1c993428b4fb">3,112.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents, licenses and technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i667ca8a683be43908b933939e90db6ab_I20200930" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfMy0xLTEtMS0w_769a7589-0b99-433a-a7c7-dd474d7c1fcd">427.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i667ca8a683be43908b933939e90db6ab_I20200930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfMy0zLTEtMS0w_02e202e4-b5e8-400b-9b4f-edd511bb5075">245.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i667ca8a683be43908b933939e90db6ab_I20200930" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfMy01LTEtMS0w_641d205d-9b35-4b5e-8537-ffb97f7690cb">182.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i350c55aa64654b5eaec00a68eb64ffcc_I20191231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfMy03LTEtMS0w_aaa7c1d2-b05c-4c87-a8f5-4aecb88886c9">453.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i350c55aa64654b5eaec00a68eb64ffcc_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfMy05LTEtMS0w_6d0949d2-5cc9-4cc8-82ef-644ddc774b0d">235.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i350c55aa64654b5eaec00a68eb64ffcc_I20191231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfMy0xMS0xLTEtMA_dde893ac-a310-43b5-adfe-f4e00d18eb79">217.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4b591e887b949ce852974492383726e_I20200930" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNC0xLTEtMS0w_fb49e429-1772-4715-b048-bfce7ad348f5">105.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4b591e887b949ce852974492383726e_I20200930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNC0zLTEtMS0w_d861adce-3bd5-452f-9d93-afec6eaded20">67.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4b591e887b949ce852974492383726e_I20200930" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNC01LTEtMS0w_2f7782ce-27fd-47f3-b443-5c6fdecece6d">37.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i565f137a551b40788c8efe1cd6a5249a_I20191231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNC03LTEtMS0w_d6bf6dd5-1b1a-4b51-a288-70868abbc072">90.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i565f137a551b40788c8efe1cd6a5249a_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNC05LTEtMS0w_ccc16b55-830e-4d62-96c2-85de96bbd1a9">60.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i565f137a551b40788c8efe1cd6a5249a_I20191231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNC0xMS0xLTEtMA_942bdeef-ac01-4377-af0c-bc8d4a84c6e9">30.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bf99eb3ad5c4326ad848c0c5cbd06d0_I20200930" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNS0xLTEtMS0w_e30d0c7e-0365-45e9-ab95-62e1defc559c">410.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bf99eb3ad5c4326ad848c0c5cbd06d0_I20200930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNS0zLTEtMS0w_e1918d0b-e8db-4e29-a856-2e755811cd0d">240.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bf99eb3ad5c4326ad848c0c5cbd06d0_I20200930" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNS01LTEtMS0w_c8017bc7-7c87-464b-ac5d-3d06aa6cff7f">170.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i370b422d371e47b595a9edeb8e53d595_I20191231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNS03LTEtMS0w_6ecd17b6-8ed0-48b9-a757-cbd3fdd0ff8f">408.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i370b422d371e47b595a9edeb8e53d595_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNS05LTEtMS0w_4bdae146-ce8a-4fdb-867a-6cc9c5019334">219.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i370b422d371e47b595a9edeb8e53d595_I20191231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNS0xMS0xLTEtMA_0ea235a8-118c-4f06-a1b4-673c4fe2e410">188.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land use right</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6b50825a0346fda5c7a57c46854607_I20200930" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNi0xLTEtMS0w_60e289c1-a547-46ae-9c13-a24495fda47c">10.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6b50825a0346fda5c7a57c46854607_I20200930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNi0zLTEtMS0w_34a4323f-2e7b-497b-97d0-5ac9b396f92a">6.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6b50825a0346fda5c7a57c46854607_I20200930" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNi01LTEtMS0w_513dae14-9d23-4154-b355-de56d2560e29">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabe5e13fb7d54f829c7b91d468ea08cd_I20191231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNi03LTEtMS0w_9c68f231-c430-486e-b774-829bffadba04">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iabe5e13fb7d54f829c7b91d468ea08cd_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNi05LTEtMS0w_525d817a-8139-42bc-a37d-ea90e053aa4e">5.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabe5e13fb7d54f829c7b91d468ea08cd_I20191231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNi0xMS0xLTEtMA_75012a15-2ff4-426b-87f7-5dffa2b6f70a">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canadian licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb47c57b65f949f7a7c4c95751563b2f_I20200930" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNy0xLTEtMS0w_fe066692-1275-45f5-9ac3-b32eb109cf48">468.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb47c57b65f949f7a7c4c95751563b2f_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNy0zLTEtMS0w_0aeab3d5-a33d-404c-b556-1e3a93ee6f63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb47c57b65f949f7a7c4c95751563b2f_I20200930" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNy01LTEtMS0w_ba5b3c6a-e7d8-46af-a877-afce22c17d9d">468.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if63915653cb94496b21de8a1a2fa6d6c_I20191231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNy03LTEtMS0w_85f2e8b5-9357-4304-ad94-0b9849385b53">480.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if63915653cb94496b21de8a1a2fa6d6c_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNy05LTEtMS0w_9ffd2f12-0a6e-413a-8e19-455e5aefe4de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if63915653cb94496b21de8a1a2fa6d6c_I20191231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNy0xMS0xLTEtMA_a9a4fede-57d0-40d9-9407-e34fc1463e20">480.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfOC0xLTEtMS0w_04787892-dcee-465d-a3ec-88a731d7d683">5,953.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfOC0zLTEtMS0w_51363a21-1322-4d0d-9b62-1cbbf93d5d48">2,032.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfOC01LTEtMS0w_3208d361-f107-4893-97ad-c23886e460c3">3,920.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfOC03LTEtMS0w_1d781626-5e86-461a-b214-c15f008e7375">5,885.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfOC05LTEtMS0w_86ffa965-2495-4455-9d13-a03080180c4d">1,851.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfOC0xMS0xLTEtMA_cc3df9f6-6148-47c5-b490-1bbc7961ef3b">4,034.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded non-cash charges of $<ix:nonFraction unitRef="usd" contextRef="i60bf6e0de9384f37926fac0c0db06385_D20200101-20200930" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMzI5ODUzNDg5MTQwMw_1ee03319-6955-4baa-925f-ac0b0b0b4a8b">30.5</ix:nonFraction> for the impairment of identifiable intangible assets during the nine months ended September 30, 2020, within CDD. During the three months ended March 31, 2020, a $<ix:nonFraction unitRef="usd" contextRef="i2794dd6e7b2744c099a93cd25ba76ec6_D20200101-20200331" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMTA5OTUxMTYzMzQ4OA_c60fa013-4fc1-4580-8f28-2c13e0e2b2f7">2.7</ix:nonFraction> impairment charge was recorded for a tradename. During the three months ended September 30, 2020, additional impairment charges of $<ix:nonFraction unitRef="usd" contextRef="iab77a3a920bd45ec8c8a0ce85071ae92_D20200701-20200930" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMTA5OTUxMTYzMzQ5NA_417dba07-ab35-4c51-8f57-f13c0a756d4f">10.1</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i16b4dd493f294c068810b89a1566d767_D20200701-20200930" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMzI5ODUzNDg5MDY0OA_f7fb7541-a54a-4d44-8ad9-c4d9ff5b3d4b">17.7</ix:nonFraction> for customer relationships and technology intangible assets, respectively were recorded due to the loss of a contract from a prior acquisition. </span></div></ix:continuation><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5a626d0d935640748cfda00ee6409203">Amortization of intangible assets for the three months ended September&#160;30, 2020, and 2019, was $<ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfNDk2NQ_de75e5a8-e408-4435-b8b3-56e2cdfa7f26">62.2</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfNDk3Mg_a14a10c7-4be6-4e34-a09e-d6ec14dec981">61.7</ix:nonFraction>, respectively and for the nine months ended September 30, 2020, and 2019 was $<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfNTAzMg_2822b8fb-d933-4c30-8e04-0abeef33bbb1">184.6</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfNTAzOQ_1e143fa1-dd3d-4a4a-a8e6-d7731f42567c">179.0</ix:nonFraction>, respectively. Amortization expense for the net carrying amount of intangible assets is estimated to be $<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfNTE0Ng_ba07713e-2840-4647-b1cf-5e9e1ad3d8f8">60.0</ix:nonFraction> for the remainder of fiscal 2020, $<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfNTE4Mg_c999cc65-21fd-4c57-83f5-f3cfa565ad10">238.5</ix:nonFraction> in fiscal 2021, $<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfNTE5OQ_0fb31793-2cb4-43a0-8c23-e549051fc2c7">232.6</ix:nonFraction> in fiscal 2022, $<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfNTIxNg_85fd56e5-729a-427d-8f08-dff322c72ddb">229.5</ix:nonFraction> in fiscal 2023, $<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfNTIzMw_44ea1f42-9acc-4b78-a5ab-0bfe31db928c">224.6</ix:nonFraction> in fiscal 2024, and $<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfNTI1NA_5a324a33-3c40-41b8-a4a0-43b4a9c0e22b">2,380.2</ix:nonFraction> thereafter.</ix:continuation> </span></div><div id="i417074d9a2c24c34bcac25f32d2ec0c1_49"></div><div style="margin-top:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;<ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNDg1Mg_387fea9b-a103-42c8-9328-3b577c73ca4e" continuedAt="i440cdde3ae3d45228187da46637d1562" escape="true">DEBT </ix:nonNumeric></span></div><ix:continuation id="i440cdde3ae3d45228187da46637d1562" continuedAt="ifc3f06e063c84ae9bb7f2cb98e13c40d"><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:ScheduleOfShortTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNDg2Mw_a1a69783-b4bd-4fed-be8c-7df6ed90ca3b" escape="true"><div style="margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term borrowings and the current portion of long-term debt at September&#160;30, 2020, and December&#160;31, 2019, consisted of the following:</span></div><div style="margin-bottom:11pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625% senior notes due 2020</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" format="ixt:zerodash" name="lh:A4.625Seniornotesdue2020" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjA3MmM0NDFiYjk4YzRmNzRiZTg1Y2VmNzcyZTRiN2ZiL3RhYmxlcmFuZ2U6MDcyYzQ0MWJiOThjNGY3NGJlODVjZWY3NzJlNGI3ZmJfMi0xLTEtMS0w_f6bbc7f3-8392-4a43-88f3-305327713c25">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="lh:A4.625Seniornotesdue2020" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjA3MmM0NDFiYjk4YzRmNzRiZTg1Y2VmNzcyZTRiN2ZiL3RhYmxlcmFuZ2U6MDcyYzQ0MWJiOThjNGY3NGJlODVjZWY3NzJlNGI3ZmJfMi0zLTEtMS0w_59e4d68e-1207-4263-9bb9-a1a6804e7de7">413.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Term Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-6" name="lh:A2019TermLoan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjA3MmM0NDFiYjk4YzRmNzRiZTg1Y2VmNzcyZTRiN2ZiL3RhYmxlcmFuZ2U6MDcyYzQ0MWJiOThjNGY3NGJlODVjZWY3NzJlNGI3ZmJfMy0xLTEtMS0w_6fd128fa-a087-4432-ac9d-fc23e3af2fa2">375.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-6" format="ixt:zerodash" name="lh:A2019TermLoan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjA3MmM0NDFiYjk4YzRmNzRiZTg1Y2VmNzcyZTRiN2ZiL3RhYmxlcmFuZ2U6MDcyYzQ0MWJiOThjNGY3NGJlODVjZWY3NzJlNGI3ZmJfMy0zLTEtMS0w_32c665cc-d74d-4c52-9773-04a2c7451382">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="lh:Shorttermdebtissuancecosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjA3MmM0NDFiYjk4YzRmNzRiZTg1Y2VmNzcyZTRiN2ZiL3RhYmxlcmFuZ2U6MDcyYzQ0MWJiOThjNGY3NGJlODVjZWY3NzJlNGI3ZmJfNC0xLTEtMS0w_a2b81453-5576-4e60-88e1-378e35175847">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="lh:Shorttermdebtissuancecosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjA3MmM0NDFiYjk4YzRmNzRiZTg1Y2VmNzcyZTRiN2ZiL3RhYmxlcmFuZ2U6MDcyYzQ0MWJiOThjNGY3NGJlODVjZWY3NzJlNGI3ZmJfNC0zLTEtMS0w_cfb7136d-51cc-40df-ac83-07588e5c1dbd">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of note payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:NotesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjA3MmM0NDFiYjk4YzRmNzRiZTg1Y2VmNzcyZTRiN2ZiL3RhYmxlcmFuZ2U6MDcyYzQ0MWJiOThjNGY3NGJlODVjZWY3NzJlNGI3ZmJfNS0xLTEtMS0w_5e0a0f41-37a9-48ac-99f7-520d9a22622b">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:NotesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjA3MmM0NDFiYjk4YzRmNzRiZTg1Y2VmNzcyZTRiN2ZiL3RhYmxlcmFuZ2U6MDcyYzQ0MWJiOThjNGY3NGJlODVjZWY3NzJlNGI3ZmJfNS0zLTEtMS0w_d4293a68-66d9-4324-9af1-0a1d0154ccfe">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term borrowings and current portion of long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjA3MmM0NDFiYjk4YzRmNzRiZTg1Y2VmNzcyZTRiN2ZiL3RhYmxlcmFuZ2U6MDcyYzQ0MWJiOThjNGY3NGJlODVjZWY3NzJlNGI3ZmJfNi0xLTEtMS0w_c43c9418-2a02-477d-8f70-682e38e45ede">376.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjA3MmM0NDFiYjk4YzRmNzRiZTg1Y2VmNzcyZTRiN2ZiL3RhYmxlcmFuZ2U6MDcyYzQ0MWJiOThjNGY3NGJlODVjZWY3NzJlNGI3ZmJfNi0zLTEtMS0w_c9cb44c9-5e2b-4b6c-b2db-3db53b9882de">415.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify;text-indent:15.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:15.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:15.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:15.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:15.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:15.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:15.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:15.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:15.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:15.75pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><div style="text-align:justify;text-indent:15.75pt"><span><br/></span></div><ix:continuation id="ifc3f06e063c84ae9bb7f2cb98e13c40d" continuedAt="iae4410fc30a14136a6e91f45ec5464fe"><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNDg4OA_1efd2ee8-b7f9-4f2d-a8cb-9b2aafc15fa6" escape="true"><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt at September&#160;30, 2020, and December&#160;31, 2019, consisted of the following:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.20% senior notes due 2022</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8777e25b1f43d891ec105edf96653f_I20200930" decimals="-5" name="us-gaap:SeniorLongTermNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfNC0xLTEtMS0w_5e14614e-a3ba-4173-a937-419761409a4a">500.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd7ebb2472d4c31906ef3769da45911_I20191231" decimals="-5" name="us-gaap:SeniorLongTermNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfNC0zLTEtMS0w_899a5266-33cc-4409-8534-52310788cb61">500.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75% senior notes due 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8777e25b1f43d891ec105edf96653f_I20200930" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfNS0xLTEtMS0w_e8d7b55f-ccb8-4ba4-b142-d89c836c572d">500.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd7ebb2472d4c31906ef3769da45911_I20191231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfNS0zLTEtMS0w_afdf91a0-0141-4003-8651-a38b5faf686b">500.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00% senior notes due 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ccdf4f5309844119bbb0e0786d0933d_I20200930" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfNi0xLTEtMS0w_d7a33730-33b0-49aa-85cc-2cb47ab4d9b8">300.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i167711db2a824eb5abbd3592c79dac6a_I20191231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfNi0zLTEtMS0w_f790a995-ce62-45db-8525-552bd49dcd5c">300.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25% senior notes due 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i657d0be39de346838d90040f8d8f348e_I20200930" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfNy0xLTEtMS0w_05378721-df19-4fe5-8ab5-db7fcde3350d">600.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bd3af0136af40129f6e820d13a1ae7c_I20191231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfNy0zLTEtMS0w_8ad884fd-4172-4a21-8110-bcc18c4cf684">600.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30% senior notes due 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="lh:A2.30seniornotesdue2024" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfOC0xLTEtMS04MzQy_55104a20-ba92-4130-bb86-35d44f2c9059">400.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="lh:A2.30seniornotesdue2024" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfOC0zLTEtMS04MzQy_d5bd5d7d-0b75-419e-90a3-6cd0dae87c0d">400.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.60% senior notes due 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7afb899941084ecea85f2f14bfb617e3_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfOC0xLTEtMS0w_891c6d4d-dfa7-42c9-85e9-cdfdb3836aac">1,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8a898daea154e4e8f10db94ed74cfa4_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfOC0zLTEtMS0w_997d8ce9-f8a3-424d-ac0a-1983b333d52f">1,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.60% senior notes due 2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f958adbe35f4caab3789a03b8cec98f_I20200930" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfOS0xLTEtMS0w_b04167d0-4410-4993-a35f-4feda3470c6c">600.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i717fbdf29e6443d699ab792d8711e563_I20191231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfOS0zLTEtMS0w_b8e14ed5-1c1b-4c7d-8268-4a1e2a130415">600.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.95% senior notes due 2029</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="lh:A2.95seniornotesdue2029" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfMTItMS0xLTEtMA_dbd46711-8a4c-4af6-a553-ecf6a09c239e">650.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="lh:A2.95seniornotesdue2029" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfMTItMy0xLTEtMA_e9c977d0-8cd9-4446-88d5-9dead4c9895b">650.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.70% senior notes due 2045</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33c11262f4464ffea951db61842a0276_I20200930" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfMTQtMS0xLTEtODMzNw_4e3baf0c-d350-41f5-818a-bf70db4b0554">900.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1da5761b40b5492f8293785134f8ab79_I20191231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfMTQtMy0xLTEtODMzNw_bbd52885-b282-414b-ab7e-26f90ca2c46f">900.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Term Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib861cf324bf4423f8474deaaa80a20a6_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfMTQtMS0xLTEtMA_1e793651-8446-4afa-a8ee-cda98106dca6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfMTQtMy0xLTEtMA_30dbb0d5-7ff3-4ba8-9c9e-95c2d75f7cb3">375.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="lh:Longtermdebtissuancecosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfMTYtMS0xLTEtMA_73263d2e-bc08-48fb-82e2-f709c0494b65">38.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="lh:Longtermdebtissuancecosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfMTYtMy0xLTEtMA_c2030e0d-6a1d-4951-86b3-6f5a121a2129">42.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfMTgtMS0xLTEtMA_eb4b5ce4-9ff8-4505-a10d-a570c812257d">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfMTgtMy0xLTEtMA_421cebaf-0ee9-4977-bdef-c5a1a7467810">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfMTktMS0xLTEtMA_5d24a008-5803-47f3-a5e2-014a20551ecb">5,417.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfMTktMy0xLTEtMA_6d101c50-1a99-4373-9bbb-16b009a320e3">5,789.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Senior Notes</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 17, 2020, the Company redeemed the remaining $<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="lh:BalanceOfSeniorNotesMatureDuringQ42020" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMTA5OTUxMTYzMjgxMQ_f691c758-e732-44ae-a4a5-876eecbbeae8">412.2</ix:nonFraction> of its <ix:nonFraction unitRef="number" contextRef="i391abd34dc914608a327d3e643899d6b_I20200930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMTA5OTUxMTYzMjgyMQ_8c2e5805-ae45-4207-a91a-2b692be7c6a2">4.625</ix:nonFraction>% Senior Notes due November 15, 2020, using available cash on hand. The Company exited the remaining fixed-to-variable interest rate swap arrangement in August 2020, in connection with this redemption and recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="INF" name="lh:GainInterestRateSwapArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMzI5ODUzNDg4OTc0NQ_e2792842-7455-4bc0-952c-2f3f391de1c9">1.6</ix:nonFraction> on the extinguishment. The gain was included in Other, net on the Condensed Consolidated Statement of Operations.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Facilities</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 3, 2019, the Company entered into a new $<ix:nonFraction unitRef="usd" contextRef="ieb6fe2a304194224befa49dcb5ed37d4_I20190603" decimals="-5" name="lh:A2019TermLoan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMjYy_c49c5dd5-58b3-4176-ba14-fa7524db8e0c">850.0</ix:nonFraction> 2019 term loan facility that matures on June 3, 2021. The 2019 term loan facility accrues interest at a per annum rate equal to,</span><span style="color:#1f497d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">at the Company's election, either a LIBOR rate plus a margin ranging from <ix:nonNumeric contextRef="i8826a53a9f514573b843bca48b3cf833_D20200701-20200930" name="us-gaap:LineOfCreditFacilityInterestRateDescription" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNDY4_08fd4892-0d88-4c9c-9fe5-68a8dc03c03e">0.55% to 1.175%</ix:nonNumeric>, or a base rate determined according to a prime rate or federal funds rate plus a margin ranging from <ix:nonNumeric contextRef="ieb68008a843e40baab3187013ce2c0a2_D20200701-20200930" name="us-gaap:LineOfCreditFacilityInterestRateDescription" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNTcz_69bbcbe5-99d1-448f-912c-fdae68d18edd">0.0% to 0.175%</ix:nonNumeric>. The 2019 term loan balance at September&#160;30, 2020, and December&#160;31, 2019, was $<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-6" name="lh:A2019TermLoan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNjIy_6fd128fa-a087-4432-ac9d-fc23e3af2fa2">375.0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNjI5_30dbb0d5-7ff3-4ba8-9c9e-95c2d75f7cb3">375.0</ix:nonFraction>, respectively. As of September&#160;30, 2020, the effective interest rate on the 2019 term loan was <ix:nonFraction unitRef="number" contextRef="ic0187e44c0d748c594cf9f1d3948e793_I20200930" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNzEx_0f7d92df-12be-43c0-8e47-d23e4b979b52">0.95</ix:nonFraction>%.</span></div><div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains a senior revolving credit facility consisting of a five-year facility in the principal amount of up to $<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfODQ1_4b8db779-9d3c-4c59-9751-8b52e4e7afdc">1,000.0</ix:nonFraction>, with the option of increasing the facility by up to an additional $<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="lh:CreditFacilityOptiontoIncrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfOTE1_c8cb0dd1-f076-486d-91c8-50d5a1abd297">350.0</ix:nonFraction>, subject to the agreement of one or more new or existing lenders to provide such additional amounts and certain other customary conditions. The revolving credit facility also provides for a subfacility of up to $<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="lh:CreditFacilityMaximumSwingLineBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMTEyOQ_44a4846d-aa49-494e-9c40-5c719355ae93">100.0</ix:nonFraction> for swing line borrowings and a subfacility of up to $<ix:nonFraction unitRef="usd" contextRef="i68588eebfb8e4548bfe358f5a18f2c3f_I20200930" decimals="-5" name="lh:CreditFacilityMaximumLettersofCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMTE4NQ_a2f1dfcf-1e09-42f3-979d-290634c741e5">150.0</ix:nonFraction> for issuances of letters of credit. The Company is required to pay a facility fee on the aggregate commitments under the revolving credit facility, at a per annum rate ranging from <ix:nonNumeric contextRef="if9247fa03b7041468d61fb949531d7c4_D20200701-20200930" name="us-gaap:LineOfCreditFacilityInterestRateDescription" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMTM2OQ_0b2c61df-3853-4090-8ffa-2d47b85f5ee4">0.00% to 0.25%</ix:nonNumeric>. The revolving credit facility is permitted to be used for general corporate purposes, including working capital, capital expenditures, funding of share repurchases and certain other payments, acquisitions and other investments. There were no balances outstanding on the Company's current revolving credit facility at September&#160;30, 2020, and December&#160;31, 2019. As of September&#160;30, 2020, the effective interest rate on the revolving credit facility was <ix:nonFraction unitRef="rate" contextRef="i68588eebfb8e4548bfe358f5a18f2c3f_I20200930" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMTc3Nw_7434d7ae-1b00-4a77-9ff9-d23e6819f6dc">1.12</ix:nonFraction>%. The credit facility expires on September 15, 2022. </span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the term loan facility and the revolving credit facility, the Company is subject to negative covenants limiting subsidiary indebtedness and certain other covenants typical for investment grade-rated borrowers, and the Company is required to maintain certain leverage ratios. In May 2020, the Company entered into amendments to its term loan facility and its revolving credit facility, in each case to, among other things, increase the maximum leverage ratio covenant to <ix:nonFraction unitRef="number" contextRef="i053c189109464dc2b30dcc1a0729589f_I20200930" decimals="1" name="lh:DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMjMwOQ_9475774f-131a-4c56-b7b8-93fefde6f793">5.0</ix:nonFraction>x debt to last twelve months EBITDA for each of the three periods ended June 30, September 30, and December 31, 2020, and <ix:nonFraction unitRef="number" contextRef="ic3ee871e124f4fbc9fc99ccaf3849f33_I20200930" decimals="1" name="lh:DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMjQyOQ_03bcde31-1935-4e88-ab7b-9c435afa0afa">4.5</ix:nonFraction>x for period ended March 31, 2021. From and including the period ending June 30, 2021, the maximum leverage ratio reverts back to <ix:nonFraction unitRef="number" contextRef="ic3ee871e124f4fbc9fc99ccaf3849f33_I20200930" decimals="2" name="lh:DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMjQ5MA_7ef3047c-cdaf-4751-b410-a7a44d598d90">4.0</ix:nonFraction>x. The Company was in compliance with all covenants in the term loan facility and the revolving credit facility at September&#160;30, 2020, and expects that it will remain in compliance with its existing debt covenants for the next twelve months.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's availability of $<ix:nonFraction unitRef="usd" contextRef="i68588eebfb8e4548bfe358f5a18f2c3f_I20200930" decimals="-5" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMjc0Nw_b014dc2e-7b0c-4da3-946b-b8fea3ef7642">997.0</ix:nonFraction> at September&#160;30, 2020, under its revolving credit facility reflects a reduction equivalent to the amount of the Company's outstanding letters of credit.</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At September 30, 2020, the Company had $<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMzE1MQ_f01c3d48-8251-44a5-bec1-6b94d1e5c200">667.2</ix:nonFraction> of cash and cash equivalents and $<ix:nonFraction unitRef="usd" contextRef="i68588eebfb8e4548bfe358f5a18f2c3f_I20200930" decimals="-5" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMzE2Ng_b014dc2e-7b0c-4da3-946b-b8fea3ef7642">997.0</ix:nonFraction> of available borrowings under its revolving credit facility, which does not mature until 2022, and the Company was in compliance with all of its debt covenants. In May 2020, in order to obtain increased financial covenant flexibility, the Company and its lenders entered into amendments </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><ix:continuation id="iae4410fc30a14136a6e91f45ec5464fe"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">to the term loan facility and the revolving credit facility to increase the maximum leverage ratio to <ix:nonFraction unitRef="number" contextRef="i053c189109464dc2b30dcc1a0729589f_I20200930" decimals="1" name="lh:DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMzU1OA_9475774f-131a-4c56-b7b8-93fefde6f793">5.0</ix:nonFraction>x debt to last twelve months EBITDA for the three month periods ending June 30, September 30 and December 31, 2020, and <ix:nonFraction unitRef="number" contextRef="ic3ee871e124f4fbc9fc99ccaf3849f33_I20200930" decimals="1" name="lh:DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMzY3OQ_03bcde31-1935-4e88-ab7b-9c435afa0afa">4.5</ix:nonFraction>x for the period ended March 31, 2021. From and including the period ending June 30, 2021, the maximum leverage ratio reverts back to <ix:nonFraction unitRef="number" contextRef="ic3ee871e124f4fbc9fc99ccaf3849f33_I20200930" decimals="2" name="lh:DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNDk0NzgwMjMzMjE2Ng_7ef3047c-cdaf-4751-b410-a7a44d598d90">4.0</ix:nonFraction>x. The amendments also provide that during any period in which the Company's leverage ratio exceeds <ix:nonFraction unitRef="number" contextRef="ic3ee871e124f4fbc9fc99ccaf3849f33_I20200930" decimals="1" name="lh:DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMzgxNw_03bcde31-1935-4e88-ab7b-9c435afa0afa">4.5</ix:nonFraction>x debt to last twelve months EBITDA (i) the Company will be prohibited from consummating share repurchases, subject to limited exceptions, (ii) borrowings under the revolving credit facility will accrue interest at a per annum rate equal to, at the Company's election, either a LIBOR rate plus a margin of <ix:nonFraction unitRef="rate" contextRef="i68588eebfb8e4548bfe358f5a18f2c3f_I20200930" decimals="4" name="lh:RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNDEyNQ_de869942-8a48-461e-a4d4-450e8759a3b7">1.25</ix:nonFraction>% or a base rate plus a margin of <ix:nonFraction unitRef="rate" contextRef="i68588eebfb8e4548bfe358f5a18f2c3f_I20200930" decimals="4" name="lh:RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNDE2MA_73a56cd3-a5d8-453a-acf3-f9b1afa32a31">0.25</ix:nonFraction>%, (iii) the facility fee that the Company is required to pay on the aggregate commitments under the revolving credit facility will be <ix:nonFraction unitRef="rate" contextRef="i68588eebfb8e4548bfe358f5a18f2c3f_I20200930" decimals="4" name="lh:RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNDI5Ng_abb45510-bb6f-4847-b16e-d18adce93ed2">0.25</ix:nonFraction>% per annum, and (iv) borrowings under the term loan facility will accrue interest at a per annum rate equal to, at the Company's election, either a LIBOR rate plus a margin of <ix:nonFraction unitRef="rate" contextRef="i772995039ebd4eb5b458fda1865f139f_I20200930" decimals="5" name="lh:TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNDQ3NA_feb251a4-c79f-40c7-8ceb-1e7c3ff50e04">1.175</ix:nonFraction>% or a base rate plus a margin of <ix:nonFraction unitRef="rate" contextRef="i772995039ebd4eb5b458fda1865f139f_I20200930" decimals="5" name="lh:TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNDUwOQ_787f108f-9206-429f-abfe-c255ad8e1c43">0.175</ix:nonFraction>%.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is closely monitoring the impact of the COVID-19 pandemic on all aspects of its business and the effects such impacts are having and will have on the Company's liquidity. The significance of the impact on the Company&#8217;s business is not yet certain and depends on numerous evolving factors that the Company may not be able to accurately predict.</span></div></ix:continuation><div id="i417074d9a2c24c34bcac25f32d2ec0c1_55"></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.      <ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RleHRyZWdpb246YjU4MzY2NTBiZjM2NGQ4ZTk3NDRlMDkyZTI1N2Q2NGRfMTM3Ng_2e0c6fb4-bbbb-465b-a7ce-07860c751986" continuedAt="i2c3aa6fdf2c74df79a2280382cbe95d2" escape="true">PREFERRED STOCK AND COMMON SHAREHOLDERS&#8217; EQUITY</ix:nonNumeric></span></div><ix:continuation id="i2c3aa6fdf2c74df79a2280382cbe95d2"><div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to issue up to <ix:nonFraction unitRef="shares" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RleHRyZWdpb246YjU4MzY2NTBiZjM2NGQ4ZTk3NDRlMDkyZTI1N2Q2NGRfMTAy_4081969c-b47b-4737-a75c-1b6761826904">265.0</ix:nonFraction> shares of common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RleHRyZWdpb246YjU4MzY2NTBiZjM2NGQ4ZTk3NDRlMDkyZTI1N2Q2NGRfMTM5_c2e83488-22ac-4115-ba8c-d59bb7e0b11e">0.10</ix:nonFraction> per share. The Company is authorized to issue up to <ix:nonFraction unitRef="shares" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RleHRyZWdpb246YjU4MzY2NTBiZjM2NGQ4ZTk3NDRlMDkyZTI1N2Q2NGRfMTk0_0afdb8bb-6e49-4ceb-b5dc-e1beecc393be">30.0</ix:nonFraction> shares of preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="2" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RleHRyZWdpb246YjU4MzY2NTBiZjM2NGQ4ZTk3NDRlMDkyZTI1N2Q2NGRfMjM0_80bf0689-0e1a-49f9-b426-1470ffd43dee">0.10</ix:nonFraction> per share. There were <ix:nonFraction unitRef="shares" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RleHRyZWdpb246YjU4MzY2NTBiZjM2NGQ4ZTk3NDRlMDkyZTI1N2Q2NGRfMjU5_c0247d63-9b55-4774-a51d-cc4a03ec1c8b">no</ix:nonFraction> preferred shares outstanding as of September&#160;30, 2020, and December&#160;31, 2019. </span></div><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="lh:ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RleHRyZWdpb246YjU4MzY2NTBiZjM2NGQ4ZTk3NDRlMDkyZTI1N2Q2NGRfMTM3OQ_ea1436f1-146f-4c20-9dfb-4cac9b936253" escape="true"><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in common shares issued are summarized below:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.166%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.634%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued and Outstanding</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4dacd586a4f14b008d9dddcced9904a0_I20191231" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOjhmNjM3ZjkzNjdkNDQ3YzNiNGY5YjdlNjIwNmI1MjYwL3RhYmxlcmFuZ2U6OGY2MzdmOTM2N2Q0NDdjM2I0ZjliN2U2MjA2YjUyNjBfMS0xLTEtMS0w_5bde1f26-e21e-48ee-a6e4-4523ed301f0f">97.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7ecb5a349ee9456dbdca2fe6adf8c4b3_D20200101-20200930" decimals="-5" name="lh:CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOjhmNjM3ZjkzNjdkNDQ3YzNiNGY5YjdlNjIwNmI1MjYwL3RhYmxlcmFuZ2U6OGY2MzdmOTM2N2Q0NDdjM2I0ZjliN2U2MjA2YjUyNjBfMi0xLTEtMS0w_4fb64227-625d-46e6-af58-918f8de8853a">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7ecb5a349ee9456dbdca2fe6adf8c4b3_D20200101-20200930" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOjhmNjM3ZjkzNjdkNDQ3YzNiNGY5YjdlNjIwNmI1MjYwL3RhYmxlcmFuZ2U6OGY2MzdmOTM2N2Q0NDdjM2I0ZjliN2U2MjA2YjUyNjBfNS0xLTEtMS0w_83ce5611-5d18-455b-a9a8-3e22bf04e68d">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares at September 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1d95d9565fa048cabbe7fe142c315893_I20200930" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOjhmNjM3ZjkzNjdkNDQ3YzNiNGY5YjdlNjIwNmI1MjYwL3RhYmxlcmFuZ2U6OGY2MzdmOTM2N2Q0NDdjM2I0ZjliN2U2MjA2YjUyNjBfNy0xLTEtMS0w_971b4221-ef2c-4bb4-995b-e56804758ddb">97.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:15pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div style="margin-bottom:7.1pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the end of 2019, the Company had outstanding authorization from the board of directors to purchase $<ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="lh:CommonStockRepurchaseAuthorizationOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RleHRyZWdpb246YjU4MzY2NTBiZjM2NGQ4ZTk3NDRlMDkyZTI1N2Q2NGRfNDk2_6ff8272b-0217-4bf0-9e8d-0cd10cf359e7">900.0</ix:nonFraction> of Company common stock. During three months ended March 31, 2020, the Company purchased&#160;<ix:nonFraction unitRef="shares" contextRef="ia962c16050fa4b28adc73e0d729703c5_D20200101-20200331" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RleHRyZWdpb246YjU4MzY2NTBiZjM2NGQ4ZTk3NDRlMDkyZTI1N2Q2NGRfNTcy_1f5564aa-92dd-46bb-88a7-ef1bc3e7471a">0.6</ix:nonFraction>&#160;shares of its common stock. When the Company repurchases shares, the amount paid to repurchase the shares in excess of the par or stated value is allocated to additional paid-in-capital unless subject to limitation or the balance in additional paid-in-capital is exhausted. Remaining amounts are recognized as a reduction in retained earnings. As of September&#160;30, 2020, the Company had outstanding authorization from the board of directors to purchase up to $<ix:nonFraction unitRef="shares" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-7" name="us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RleHRyZWdpb246YjU4MzY2NTBiZjM2NGQ4ZTk3NDRlMDkyZTI1N2Q2NGRfMTAxNw_cdb8048f-b37b-4e79-ba4e-8539cbeed4e8">800.0</ix:nonFraction> of the Company's common stock. The repurchase authorization has no expiration date. The Company reinstated its share repurchase program in October 2020 following the temporary suspension of stock repurchases beginning in March 2020 as a result of the anticipated impact of the COVID-19 pandemic.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Earnings </span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RleHRyZWdpb246YjU4MzY2NTBiZjM2NGQ4ZTk3NDRlMDkyZTI1N2Q2NGRfMTM4OQ_5a58e983-a116-4ec2-abc0-9ef0f5711a7a" continuedAt="i6f883921d1674be89ef42b653185d9da" escape="true">The components of accumulated other comprehensive earnings (loss) are as follows:</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:5pt"><ix:continuation id="i6f883921d1674be89ef42b653185d9da"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.885%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.334%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.120%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Benefit Plan Adjustments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Earnings (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOmFkYjg5ODBiOTE5ZTRkMTM4YWViMTU5MzNlMmM5NzIwL3RhYmxlcmFuZ2U6YWRiODk4MGI5MTllNGQxMzhhZWIxNTkzM2UyYzk3MjBfMS0xLTEtMS0w_df745509-a408-4521-94cb-aba46d004899">285.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOmFkYjg5ODBiOTE5ZTRkMTM4YWViMTU5MzNlMmM5NzIwL3RhYmxlcmFuZ2U6YWRiODk4MGI5MTllNGQxMzhhZWIxNTkzM2UyYzk3MjBfMS0zLTEtMS0w_0f122fa3-1ed3-44f4-988b-e004b1a66ca7">87.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOmFkYjg5ODBiOTE5ZTRkMTM4YWViMTU5MzNlMmM5NzIwL3RhYmxlcmFuZ2U6YWRiODk4MGI5MTllNGQxMzhhZWIxNTkzM2UyYzk3MjBfMS03LTEtMS0w_bd1ff757-d805-4560-abdf-65fff5411719">372.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year adjustments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOmFkYjg5ODBiOTE5ZTRkMTM4YWViMTU5MzNlMmM5NzIwL3RhYmxlcmFuZ2U6YWRiODk4MGI5MTllNGQxMzhhZWIxNTkzM2UyYzk3MjBfMi0xLTEtMS0w_6da58af7-088e-4242-9fb9-63895223452b">52.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOmFkYjg5ODBiOTE5ZTRkMTM4YWViMTU5MzNlMmM5NzIwL3RhYmxlcmFuZ2U6YWRiODk4MGI5MTllNGQxMzhhZWIxNTkzM2UyYzk3MjBfMi0zLTEtMS0w_c7ea36c1-a0a3-4d44-bd06-327bce27b1ff">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOmFkYjg5ODBiOTE5ZTRkMTM4YWViMTU5MzNlMmM5NzIwL3RhYmxlcmFuZ2U6YWRiODk4MGI5MTllNGQxMzhhZWIxNTkzM2UyYzk3MjBfMi03LTEtMS0w_12dd1cb8-5d14-49a1-aa78-3cdfb6f3813d">59.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Tax effect of adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOmFkYjg5ODBiOTE5ZTRkMTM4YWViMTU5MzNlMmM5NzIwL3RhYmxlcmFuZ2U6YWRiODk4MGI5MTllNGQxMzhhZWIxNTkzM2UyYzk3MjBfNC0xLTEtMS0w_4b563add-5960-40ca-a005-12ecbe8c8e71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOmFkYjg5ODBiOTE5ZTRkMTM4YWViMTU5MzNlMmM5NzIwL3RhYmxlcmFuZ2U6YWRiODk4MGI5MTllNGQxMzhhZWIxNTkzM2UyYzk3MjBfNC0zLTEtMS0w_998e5fe3-26a2-4c6b-ad48-bd1911ad042b">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOmFkYjg5ODBiOTE5ZTRkMTM4YWViMTU5MzNlMmM5NzIwL3RhYmxlcmFuZ2U6YWRiODk4MGI5MTllNGQxMzhhZWIxNTkzM2UyYzk3MjBfNC03LTEtMS0w_d9f08af4-28e9-49c6-ba1d-2267aea06748">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOmFkYjg5ODBiOTE5ZTRkMTM4YWViMTU5MzNlMmM5NzIwL3RhYmxlcmFuZ2U6YWRiODk4MGI5MTllNGQxMzhhZWIxNTkzM2UyYzk3MjBfNS0xLTEtMS0w_f231448f-88dc-4802-9fe9-650bfe3434f2">233.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOmFkYjg5ODBiOTE5ZTRkMTM4YWViMTU5MzNlMmM5NzIwL3RhYmxlcmFuZ2U6YWRiODk4MGI5MTllNGQxMzhhZWIxNTkzM2UyYzk3MjBfNS0zLTEtMS0w_e9ce9324-2923-479b-8375-0fdef97173d4">81.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOmFkYjg5ODBiOTE5ZTRkMTM4YWViMTU5MzNlMmM5NzIwL3RhYmxlcmFuZ2U6YWRiODk4MGI5MTllNGQxMzhhZWIxNTkzM2UyYzk3MjBfNS03LTEtMS0w_e0a065d0-7c78-4bf2-8c30-f95c316e2b96">314.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div id="i417074d9a2c24c34bcac25f32d2ec0c1_58"></div><div style="margin-top:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81OC9mcmFnOjUxMDVlYjhlODc0NDRmMTFiOTZkMGNhNzE1ZTYzMjE0L3RleHRyZWdpb246NTEwNWViOGU4NzQ0NGYxMWI5NmQwY2E3MTVlNjMyMTRfMTY0Nw_7171d93a-c81e-4eb1-b31a-bf8486783aab" continuedAt="i583494417e464f3bb00ff7490bb1e07d" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="i583494417e464f3bb00ff7490bb1e07d" continuedAt="ia50a60eb45a44454adc738996a25d2c3"><div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not recognize a tax benefit unless it concludes that it is more likely than not that the benefit will be sustained on audit by the taxing authority based solely on the technical merits of the associated tax position. If the recognition threshold is met, the Company recognizes a tax benefit measured at the largest amount of the tax benefit that it believes is greater than <ix:nonFraction unitRef="number" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="2" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81OC9mcmFnOjUxMDVlYjhlODc0NDRmMTFiOTZkMGNhNzE1ZTYzMjE0L3RleHRyZWdpb246NTEwNWViOGU4NzQ0NGYxMWI5NmQwY2E3MTVlNjMyMTRfNDEz_a69f7ed7-79c4-42f9-821e-e4c16bc19bae">50</ix:nonFraction>% likely to be realized.</span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross unrecognized income tax benefits were $<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81OC9mcmFnOjUxMDVlYjhlODc0NDRmMTFiOTZkMGNhNzE1ZTYzMjE0L3RleHRyZWdpb246NTEwNWViOGU4NzQ0NGYxMWI5NmQwY2E3MTVlNjMyMTRfNDg3_117a93d0-f70c-4c37-98d9-be6eb8374b70">41.3</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81OC9mcmFnOjUxMDVlYjhlODc0NDRmMTFiOTZkMGNhNzE1ZTYzMjE0L3RleHRyZWdpb246NTEwNWViOGU4NzQ0NGYxMWI5NmQwY2E3MTVlNjMyMTRfNDk0_9e7a4afc-0886-4822-a07c-931c72032b68">31.7</ix:nonFraction> at September&#160;30, 2020, and December&#160;31, 2019, respectively. It is anticipated that the amount of the unrecognized income tax benefits will change within the next 12 months; </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><ix:continuation id="ia50a60eb45a44454adc738996a25d2c3"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">however, these changes are not expected to have a significant impact on the results of operations, cash flows or the financial position of the Company.</span></div><div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, and December&#160;31, 2019, $<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81OC9mcmFnOjUxMDVlYjhlODc0NDRmMTFiOTZkMGNhNzE1ZTYzMjE0L3RleHRyZWdpb246NTEwNWViOGU4NzQ0NGYxMWI5NmQwY2E3MTVlNjMyMTRfODA3_47dec33e-7db0-4e1a-af17-52ca48e3cd65">41.3</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81OC9mcmFnOjUxMDVlYjhlODc0NDRmMTFiOTZkMGNhNzE1ZTYzMjE0L3RleHRyZWdpb246NTEwNWViOGU4NzQ0NGYxMWI5NmQwY2E3MTVlNjMyMTRfODE0_122d4c86-4ea5-4a56-905b-af8aec1f7b1e">31.7</ix:nonFraction>, respectively, are the approximate amounts of gross unrecognized income tax benefits that, if recognized, would favorably affect the effective income tax rate in future periods. </span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes interest and penalties related to unrecognized income tax benefits in income tax expense. Accrued interest and penalties related to uncertain tax positions totaled $<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81OC9mcmFnOjUxMDVlYjhlODc0NDRmMTFiOTZkMGNhNzE1ZTYzMjE0L3RleHRyZWdpb246NTEwNWViOGU4NzQ0NGYxMWI5NmQwY2E3MTVlNjMyMTRfMTE4Mw_2a8cc678-1576-4552-9b29-120f3b8e761d">9.0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81OC9mcmFnOjUxMDVlYjhlODc0NDRmMTFiOTZkMGNhNzE1ZTYzMjE0L3RleHRyZWdpb246NTEwNWViOGU4NzQ0NGYxMWI5NmQwY2E3MTVlNjMyMTRfMTE5MA_8374e54a-2d12-44ae-b4ad-3d1eb10b4027">5.5</ix:nonFraction> as of September&#160;30, 2020, and December&#160;31, 2019, respectively. </span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company has substantially concluded all U.S. federal income tax matters for years through 2016. Substantially all material state and local and foreign income tax matters have been concluded through 2015 and 2011, respectively.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has various state and foreign income tax examinations ongoing throughout the year. The Company believes adequate provisions have been recorded related to all open tax years.</span></div></ix:continuation><div id="i417074d9a2c24c34bcac25f32d2ec0c1_61"></div><div style="margin-top:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82MS9mcmFnOmQwYzNiZGUwZTIyMTQ4ZGQ4MzZkNTQ2NWYzMDFjZDViL3RleHRyZWdpb246ZDBjM2JkZTBlMjIxNDhkZDgzNmQ1NDY1ZjMwMWNkNWJfMjQyMjM_236b218a-e99d-4a2b-9f69-edc8eab1bcc1" continuedAt="i3971899c3ff74820915312b404b63a77" escape="true">COMMITMENTS AND CONTINGENCIES </ix:nonNumeric></span></div><ix:continuation id="i3971899c3ff74820915312b404b63a77" continuedAt="i303289f1d79448e8a43814b11acfa60c"><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved from time to time in various claims and legal actions, including arbitrations, class actions, and other litigation (including those described in more detail below), arising in the ordinary course of business. Some of these actions involve claims that are substantial in amount. These matters include, but are not limited to, intellectual property disputes; commercial and contract disputes; professional liability claims; employee-related matters; and inquiries, including subpoenas and other civil investigative demands, from governmental agencies, Medicare or Medicaid payers and MCOs reviewing billing practices or requesting comment on allegations of billing irregularities that are brought to their attention through billing audits or third parties. The Company receives civil investigative demands or other inquiries from various governmental bodies in the ordinary course of its business. Such inquiries can relate to the Company or other parties, including physicians and other health care providers. The Company works cooperatively to respond to appropriate requests for information.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also is named from time to time in suits brought under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provisions of the False Claims Act and comparable state laws. These suits typically allege that the Company has made false statements and/or certifications in connection with claims for payment from U.S. federal or state healthcare programs. The suits may remain under seal (hence, unknown to the Company) for some time while the government decides whether to intervene on behalf of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> plaintiff. Such claims are an inevitable part of doing business in the healthcare field today.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that it is in compliance in all material respects with all statutes, regulations, and other requirements applicable to its commercial laboratory operations and drug development support services. The healthcare diagnostics and drug development industries are, however, subject to extensive regulation, and the courts have not interpreted many of the applicable statutes and regulations. Therefore, the applicable statutes and regulations could be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that would adversely affect the Company. Potential sanctions for violation of these statutes and regulations include significant civil and criminal penalties, fines, the loss of various licenses, certificates and authorizations, additional liabilities from third-party claims, and/or exclusion from participation in government programs.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the current claims and legal actions against the Company are in preliminary stages, and many of these cases seek an indeterminate amount of damages. The Company records an aggregate legal reserve, which is determined using calculations based on historical loss rates and assessment of trends experienced in settlements and defense costs. In accordance with FASB Accounting Standards Codification Topic 450 &#8220;Contingencies,&#8221; the Company establishes reserves for judicial, regulatory, and arbitration matters outside the aggregate legal reserve if and when those matters present loss contingencies that are both probable and estimable and would exceed the aggregate legal reserve. When loss contingencies are not both probable and estimable, the Company does not establish separate reserves.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is unable to estimate a range of reasonably probable loss for the proceedings described in more detail below in which damages either have not been specified or, in the Company's judgment, are unsupported and/or exaggerated and (i) the proceedings are in early stages; (ii) there is uncertainty as to the outcome of pending appeals or motions; (iii) there are significant factual issues to be resolved; and/or (iv) there are novel legal issues to be presented. For these proceedings, however, the Company does not believe, based on currently available information, that the outcomes will have a material adverse effect on the Company's financial condition, though the outcomes could be material to the Company's operating results for any particular period, depending, in part, upon the operating results for such period. </span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously reported, the Company responded to an October 2007 subpoena from the U.S. Department of Health &amp; Human Services Office of Inspector General's regional office in New York. On August 17, 2011, the U.S. District Court for the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><ix:continuation id="i303289f1d79448e8a43814b11acfa60c" continuedAt="i32f4c90f05f7440f8fede44da1e30a89"><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Southern District of New York unsealed a False Claims Act lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States of America ex rel. NPT Associates v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which alleges that the Company offered UnitedHealthcare kickbacks in the form of discounts in return for Medicare business. The Plaintiff's Third Amended Complaint further alleges that the Company's billing practices violated the False Claims Acts of 14 states and the District of Columbia. The lawsuit seeks actual and treble damages and civil penalties for each alleged false claim, as well as recovery of costs, attorney's fees, and legal expenses. Neither the U.S. government nor any state government has intervened in the lawsuit. The Company's Motion to Dismiss was granted in October 2014 and Plaintiff was granted the right to replead. On January 11, 2016, Plaintiff filed a motion requesting leave to file an amended complaint under seal and to vacate the briefing schedule for the Company's Motion to Dismiss, while the government reviews the amended complaint. The Court granted the motion and vacated the briefing dates. Plaintiff then filed the Amended Complaint under seal. The Company will vigorously defend the lawsuit.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company has received various other subpoenas since 2007 related to Medicaid billing. In October 2009, the Company received a subpoena from the State of Michigan Department of Attorney General seeking documents related to its billing to Michigan Medicaid. The Company cooperated with this request. In October 2013, the Company received a Civil Investigative Demand from the State of Texas Office of the Attorney General requesting documents related to its billing to Texas Medicaid. The Company cooperated with this request. On October 5, 2018, the Company received a second Civil Investigative Demand from the State of Texas Office of the Attorney General requesting documents related to its billing to Texas Medicaid. The Company is cooperating with this request.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 31, 2015, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patty Davis v. Laboratory Corporation of America, et al.,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> filed in the Circuit Court of the Thirteenth Judicial Circuit for Hillsborough County, Florida. The complaint alleges that the Company violated the Florida Consumer Collection Practices Act by billing patients who were collecting benefits under the Workers' Compensation Statutes. The lawsuit seeks injunctive relief and actual and statutory damages, as well as recovery of attorney's fees and legal expenses. In April 2017, the Circuit Court granted the Company&#8217;s Motion for Judgment on the Pleadings. The Plaintiff appealed the Circuit Court&#8217;s ruling to the Florida Second District Court of Appeal. On October 16, 2019, the Court of Appeal reversed the Circuit Court&#8217;s dismissal, but certified a controlling issue of Florida law to the Florida Supreme Court. On February 17, 2020, the Florida Supreme Court accepted jurisdiction of the lawsuit. The Court has scheduled oral arguments for December 9, 2020. The Company will vigorously defend the lawsuit.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2014, the Company received a Civil Investigative Demand issued pursuant to the U.S. False Claims Act from the U.S. Attorney's Office for South Carolina, which requested information regarding alleged remuneration and services provided by the Company to physicians who also received draw and processing/handling fees from competitor laboratories Health Diagnostic Laboratory, Inc. (HDL) and Singulex, Inc. (Singulex). The Company cooperated with the request. On April 4, 2018, the U.S. District Court for the District of South Carolina, Beaufort Division, unsealed a False Claims Act lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States of America ex rel. Scarlett Lutz, et al. v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which alleges that the Company's financial relationships with referring physicians violate federal and state anti-kickback statutes. The Plaintiffs' Fourth Amended Complaint further alleges that the Company conspired with HDL and Singulex in violation of the Federal False Claims Act and the California and Illinois insurance fraud prevention acts by facilitating HDL's and Singulex's offers of illegal inducements to physicians and the referral of patients to HDL and Singulex for laboratory testing. The lawsuit seeks actual and treble damages and civil penalties for each alleged false claim, as well as recovery of costs, attorney's fees, and legal expenses. Neither the U.S. government nor any state government has intervened in the lawsuit. The Company filed a Motion to Dismiss seeking the dismissal of the claims asserted under the California and Illinois insurance fraud prevention statutes, the conspiracy claim, the reverse False Claims Act claim, and all claims based on the theory that the Company performed medically unnecessary testing. On January 16, 2019, the Court entered an order granting in part and denying in part the Motion to Dismiss. The Court dismissed the Plaintiffs' claims based on the theory that the Company performed medically unnecessary testing, the claims asserted under the California and Illinois insurance fraud prevention statutes, and the reverse False Claims Act claim. The Court denied the Motion to Dismiss as to the conspiracy claim. The Company will vigorously defend the lawsuit.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Company's acquisition of Sequenom, Inc. (Sequenom) between August 15, 2016 and August 24, 2016, six putative class-action lawsuits were filed on behalf of purported Sequenom stockholders (captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Malkoff v. Sequenom, Inc., et al., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No. 16-cv-02054- JAH-BLM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Gupta v. Sequenom, Inc., et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., No. 16-cv-02084-JAH-KSC,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Fruchter v. Sequenom, Inc., et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., No. 16-cv-02101- WQH-KSC, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asiatrade Development Ltd. v. Sequenom, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 16-cv-02113-AJB-JMA, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nunes v. Sequenom, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 16-cv-02128-AJB-MDD, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cusumano v. Sequenom, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 16-cv-02134-LAB-JMA) in the U.S. District Court for the Southern District of California challenging the acquisition transaction. The complaints asserted claims against Sequenom and members of its board of directors (the Individual Defendants). The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nunes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">action also named the Company and Savoy Acquisition Corp. (Savoy), a wholly owned subsidiary of the Company, as defendants. The complaints alleged that the defendants violated Sections 14(e), 14(d)(4) and 20 of the Securities Exchange Act of 1934 by failing to </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><ix:continuation id="i32f4c90f05f7440f8fede44da1e30a89" continuedAt="i3620f2c1e57540f692ec231d0436e73a"><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">disclose certain allegedly material information. In addition, the complaints in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Malkoff </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">action, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asiatrade </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">action, and the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cusumano </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">action alleged that the Individual Defendants breached their fiduciary duties to Sequenom shareholders. The actions sought, among other things, injunctive relief enjoining the merger. On August 30, 2016, the parties entered into a Memorandum of Understanding (MOU) in each of the above-referenced actions. On September 6, 2016, the Court entered an order consolidating for all pre-trial purposes the six individual actions described above under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re Sequenom, Inc. Shareholder Litig.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Lead Case No. 16-cv-02054-JAH-BLM, and designating the complaint from the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Malkoff </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">action as the operative complaint for the consolidated action. On November 11, 2016, two competing motions were filed by two separate stockholders (James Reilly and Shikha Gupta) seeking appointment as lead plaintiff under the terms of the Private Securities Litigation Reform Act of 1995. On June 7, 2017, the Court entered an order declaring Mr. Reilly as the lead plaintiff and approving Mr. Reilly's selection of lead counsel. The parties agree that the MOU has been terminated. The Plaintiffs filed a Consolidated Amended Class Action Complaint on July 24, 2017, and the Defendants filed a Motion to Dismiss, which remains pending. On March 13, 2019, the Court stayed the action in its entirety pending the U.S. Supreme Court's anticipated decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Emulex Corp. v. Varjabedian</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On April 23, 2019, however, the U.S. Supreme Court dismissed the writ of certiorari in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Emulex </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as improvidently granted. The Company will vigorously defend the lawsuit.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2017, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Victoria Bouffard, et al. v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the U.S. District Court for the Middle District of North Carolina. The complaint alleges that the Company's patient list prices unlawfully exceed the rates negotiated for the same services with private and public health insurers in violation of various state consumer protection laws. The lawsuit also alleges breach of implied contract or quasi-contract, unjust enrichment, and fraud. The lawsuit seeks statutory, exemplary, and punitive damages, injunctive relief, and recovery of attorney's fees and costs. In May 2017, the Company filed a Motion to Dismiss Plaintiffs' Complaint and Strike Class Allegations; the Motion to Dismiss was granted in March 2018 without prejudice. On October 10, 2017, a second putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sheryl Anderson, et al. v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was filed in the U.S. District Court for the Middle District of North Carolina. The complaint contained similar allegations and sought similar relief to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bouffard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint, and added additional counts regarding state consumer protection laws. On August 10, 2018, the Plaintiffs filed an Amended Complaint, which consolidated the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bouffard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anderson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> actions. On September 10, 2018, the Company filed a Motion to Dismiss Plaintiffs' Amended Complaint and Strike Class Allegations. On August 16, 2019, the Court entered an order granting in part and denying in part the Motion to Dismiss the Amended Complaint, and denying the Motion to Strike the Class Allegations. The Company will vigorously defend the lawsuit.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2019, Covance Research Products was served with a Grand Jury Subpoena issued by the Department of Justice (DOJ) in Miami, Florida requiring the production of documents related to the importation into the United States of live non-human primate shipments originating from or transiting through China, Cambodia, and/or Vietnam from April 1, 2014 through March 28, 2019. The Company is cooperating with the DOJ.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 14, 2019, Retrieval-Masters Creditors Bureau, Inc. d/b/a American Medical Collection Agency (AMCA), an external collection agency, notified the Company about a security incident AMCA experienced that may have involved certain personal information about some of the Company&#8217;s patients (the AMCA Incident). The Company referred patient balances to AMCA only when direct collection efforts were unsuccessful. The Company&#8217;s systems were not impacted by the AMCA Incident. Upon learning of the AMCA Incident, the Company promptly stopped sending new collection requests to AMCA and stopped AMCA from continuing to work on any pending collection requests from the Company. AMCA informed the Company that it appeared that an unauthorized user had access to AMCA&#8217;s system between August 1, 2018, and March 30, 2019, and that AMCA could not rule out the possibility that personal information on AMCA&#8217;s system was at risk during that time period. Information on AMCA&#8217;s affected system from the Company may have included name, address, and balance information for the patient and person responsible for payment, along with the patient&#8217;s phone number, date of birth, referring physician, and date of service. The Company was later informed by AMCA that health insurance information may have been included for some individuals, and because some insurance carriers utilize the Social Security Number as a subscriber identification number, the Social Security Number for </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">some </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">individuals may also have been affected. No ordered tests, laboratory test results, or diagnostic information from the Company were in the AMCA affected system. The Company notified individuals for whom it had a valid mailing address. For the individuals whose Social Security Number was affected, the notice included an offer to enroll in credit monitoring and identity protection services that will be provided free of charge for 24 months.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Twenty-three putative class action lawsuits were filed against the Company related to the AMCA Incident in various U.S. District Courts. Numerous similar lawsuits have been filed against other health care providers who used AMCA. These lawsuits have been consolidated into a multidistrict litigation in the District of New Jersey. On November 15, 2019, the Plaintiffs filed a Consolidated Class Action Complaint in the U.S. District Court of New Jersey. On January 22, 2020, the Company filed Motions to Dismiss all claims. The consolidated Complaint generally alleges that the Company did not adequately protect its </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><ix:continuation id="i3620f2c1e57540f692ec231d0436e73a" continuedAt="i3fea4c2088e149148fa6d152cc026173"><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">patients&#8217; data and failed to timely notify those patients of the AMCA Incident. The Complaint asserts various causes of action, including but not limited to negligence, breach of implied contract, unjust enrichment, and the violation of state data protection statutes. The Complaint seeks damages on behalf of a class of all affected Company customers. The Company will vigorously defend the multi-district litigation. </span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was served with a shareholder derivative lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Raymond Eugenio, Derivatively on Behalf of Nominal Defendant, Laboratory Corporation of America Holdings v. Lance Berberian, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the Court of Chancery of the State of Delaware on April 23, 2020.&#160;The complaint asserts derivative claims on the Company&#8217;s behalf against the Company&#8217;s board of directors and certain executive officers.&#160;The complaint generally alleges that the defendants failed to ensure that the Company utilized proper cybersecurity safeguards and failed to implement a sufficient response to data security incidents, including the AMCA Incident.&#160;The complaint asserts derivative claims for breach of fiduciary duty and seeks relief including damages, certain disclosures, and certain changes to the Company&#8217;s internal governance practices. On June 2, 2020, the Company filed a Motion to Stay the lawsuit due to its overlap with the multi-district litigation referenced above. On July 2, 2020, the Company filed a Motion to Dismiss. On July 14, 2020, the Court entered an order staying the lawsuit pending the resolution of the multi-district litigation. The lawsuit will be vigorously defended.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain governmental entities have requested information from the Company related to the AMCA Incident. The Company received a request for information from the Office for Civil Rights (OCR) of the Department of Health and Human Services.&#160;On April 28, 2020, OCR notified the Company of the closure of its inquiry. The Company has also received requests from a multi-state group of state Attorneys General and is cooperating with these requests for information.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three putative class action lawsuits related to California wage and hour laws have been served on the Company. On September 21, 2018, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Alma Haro v. Laboratory Corporation of America, et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., filed in the Superior Court of California, County of Los Angeles. On June 10, 2019, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ignacio v. Laboratory Corporation of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in Superior Court of California, County of Los Angeles. On July 1, 2019, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jan v. Laboratory Corporation of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the Superior Court of California, County of Sacramento. All three lawsuits were subsequently removed to the U.S. District Court for the Central District of California, and then consolidated for all pre-trial proceedings. In the lawsuits, the Plaintiffs allege that employees were not properly paid overtime compensation, minimum wages, meal and rest break premiums, did not receive compliant wage statements, and were not properly paid wages upon termination of employment. The Plaintiffs assert these actions violate various California Labor Code provisions and constitute an unfair competition practice under California law. The lawsuits seek monetary damages, civil penalties, and recovery of attorney's fees and costs. On July 22, 2020, the Court issued an order granting preliminary approval of a settlement resolving all three lawsuits. If the settlement does not receive final approval, the Company will vigorously defend the lawsuits. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 30, 2019, the Company was served with a class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mitchell v. Covance, Inc. et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the U.S. District Court for the Eastern District of Pennsylvania. Plaintiff alleges that certain individuals employed by Covance Inc. and Chiltern International Inc. were misclassified as exempt employees under the Fair Labor Standards Act and the Pennsylvania Minimum Wage Act and were thereby not properly paid overtime compensation. The lawsuit seeks monetary damages, liquidated damages, and recovery of attorneys&#8217; fees and costs. On February 3, 2020, the Court denied without prejudice the Plaintiff's motion to conditionally certify a putative class action. On July 20, 2020, Plaintiff executed a settlement agreement resolving the lawsuit.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2020, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Luke Davis and Julian Vargas, et al. v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the U.S. District Court for the Central District of California. The lawsuit alleges that visually impaired patients are unable to use the Company's touchscreen kiosks at Company patient service centers in violation of the Americans with Disabilities Act and similar California statutes. The lawsuit seeks statutory damages, injunctive relief, and attorney's fees and costs. On March 20, 2020, the Company filed a Motion to Dismiss Plaintiffs' Complaint and to Strike Class Allegations. In August 2020, the Plaintiffs filed an Amended Complaint. The Company will vigorously defend the lawsuit.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 14, 2020, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jose Bermejo v. Laboratory Corporation of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> filed in the Superior Court of California, County of Los Angeles Central District, alleging that certain non-exempt California-based employees were not properly compensated for driving time or properly paid wages upon termination of employment. The Plaintiff asserts these actions violate various California Labor Code provisions and Section 17200 of the Business and Professional Code. The lawsuit seeks monetary damages, civil penalties, and recovery of attorney&#8217;s fees and costs. On June 15, 2020, the lawsuit was removed to the U.S. District Court for the Central District of California. On June 16, 2020, the Company was served with a Private Attorney General Act lawsuit by the same plaintiff in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jose Bermejo v. Laboratory </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><ix:continuation id="i3fea4c2088e149148fa6d152cc026173"><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporation of America, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">filed in the Superior Court of California, County of Los Angeles Central District, alleging that certain Company practices violated California Labor Code penalty provisions related to unpaid and minimum wages, unpaid overtime, unpaid mean and rest break premiums, untimely payment of wages following separation of employment, failure to maintain accurate pay records, and non-reimbursement of business expenses. The second lawsuit seeks to recover civil penalties and recovery of attorney's fees and costs. The Company will vigorously defend both lawsuits.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 14, 2020, the Company was served with a Subpoena Duces Tecum issued by the State of Colorado Office of the Attorney General requiring the production of documents related to urine drug testing in all states. The Company is cooperating with this request.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 2, 2020, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Peterson v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the U.S. District Court for the Northern District of New York, alleging claims for a failure to properly pay service representatives compensation for all hours worked and overtime under the Fair Labor Standards Act, as well as notice and recordkeeping claims under the New York Labor Code. The lawsuit seeks monetary damages, liquidated damages, equitable and injunctive relief, and recovery of attorney's fees and costs. The Company will vigorously defend the lawsuit.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 5, 2020, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Williams v. LabCorp Employer Services, Inc. et al, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">filed in the Superior Court of California, County of Los Angeles, alleging that certain non-exempt California-based employees were not properly compensated for work and overtime hours, not properly paid meal and rest break premiums, not reimbursed for certain business-related expenses, not properly paid for driving or wait times, and received inaccurate wage statements. The Plaintiff also asserts claims for unfair competition under Section 17200 of the Business and Professional Code. The lawsuit seeks monetary damages, liquidated damages, civil penalties, and recovery of attorney's fees and costs. The Company will vigorously defend the lawsuit. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Company's present insurance programs, coverage is obtained for catastrophic exposure as well as those risks required to be insured by law or contract. The Company is responsible for the uninsured portion of losses related primarily to general, professional and vehicle liability, certain medical costs and workers' compensation. The self-insured retentions are on a per-occurrence basis without any aggregate annual limit. Provisions for losses expected under these programs are recorded based upon the Company's estimates of the aggregated liability of claims incurred.</span></div></ix:continuation><div id="i417074d9a2c24c34bcac25f32d2ec0c1_64"></div><div style="margin-top:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfNDQ4Nw_ac953705-b230-4e42-9a96-39a9af874fb1" continuedAt="i8259cc11be74499ead2d33a80c3d36d7" escape="true">PENSION AND POSTRETIREMENT PLANS</ix:nonNumeric></span></div><ix:continuation id="i8259cc11be74499ead2d33a80c3d36d7" continuedAt="ic5c5ab69fca24cd6b79fd9eddc8bc181"><div style="margin-bottom:3pt;margin-top:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retirement Plans</span></div><div style="margin-bottom:7.1pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All employees eligible for the LCD defined-contribution retirement plan (LCD 401(k) Plan) receive a minimum <ix:nonFraction unitRef="number" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="2" name="lh:NonElectiveContribution" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfMTY4_832a7ac2-55dc-4b1b-b71e-32dde53157d3">3</ix:nonFraction>% non-elective contribution (NEC) concurrent with each payroll period. Employees are not required to make a contribution to the LCD 401(k) Plan to receive the NEC. The NEC is non-forfeitable and vests immediately. The LCD 401(k) Plan also permits discretionary contributions by the Company of <ix:nonFraction unitRef="number" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="2" name="lh:DiscretionaryContributionPercentageMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfNDYy_c80af34a-afe8-412d-9f0a-414d432155d3">1</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="2" name="lh:DiscretionaryContributionPercentageMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfNDY4_b873c01a-038e-4ef7-99f8-e686ac5d2d9e">3</ix:nonFraction>% of pay for eligible employees based on service. The Company incurred expense of $<ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" name="lh:DefinedContributionPlanTotalExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfNTUx_b8de94bc-6c9a-444c-a24e-00f938fd4aef">14.0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="-5" name="lh:DefinedContributionPlanTotalExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfNTU4_506a23e6-4185-48d5-a67e-3efa8e7bcb72">16.7</ix:nonFraction> for the LCD 401(k) Plan during the three months ended September&#160;30, 2020, and 2019, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="lh:DefinedContributionPlanTotalExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfNjQz_f03ad28e-4bc4-4975-ae02-9941a9c3c2ed">41.4</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="lh:DefinedContributionPlanTotalExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfNjUw_8aa6725e-d1d4-465a-aa09-cbc837bdc6f7">48.9</ix:nonFraction> during the nine months ended September&#160;30, 2020, and 2019, respectively.</span></div><div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the CDD U.S. employees are eligible to participate in the CDD 401(k) Plan, which is available on a voluntary basis and features a maximum <ix:nonFraction unitRef="number" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="3" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfODUy_70346423-9593-4389-a140-7a114006397d">4.5</ix:nonFraction>% Company match, based upon a percentage of the employee&#8217;s contributions. The Company incurred expense of $<ix:nonFraction unitRef="usd" contextRef="i1e01cc0ff9ce44ef99f7acd5a862967e_D20200701-20200930" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfOTU5_32e61a85-30ff-45b3-8747-d3698206f54e">21.0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ib199336a2dd2420097e56516adfbc4d1_D20190701-20190930" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfOTY2_95483a97-13f5-424e-9430-1886c088cbcb">18.2</ix:nonFraction> for the Covance 401(k) plan during the three months ended September&#160;30, 2020, and 2019, respectively, and $<ix:nonFraction unitRef="usd" contextRef="ia13373a9d55d49f19ffcc37b5bd497f3_D20200101-20200930" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfMTA1OA_2ea2ee7d-cbac-4075-a5e9-3dd657e50d0e">64.8</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i3eb0e387c6aa4d82ac76ca334fbc0143_D20190101-20190930" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfMTA2NQ_2234f820-4319-4cd2-8697-5abab51a9bbd">56.0</ix:nonFraction> during the nine months ended September&#160;30, 2020, and 2019, respectively.</span></div><div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains several other small 401(k) plans associated with companies acquired over the last several years. </span></div><div style="margin-bottom:3pt;margin-top:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pension Plans</span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a defined-benefit retirement plan (Company Plan) and a nonqualified supplemental retirement plan (PEP). Both plans have been closed to new participants since December 31, 2009. Employees participating in the Company Plan and PEP no longer earn service-based credits, but continue to earn investment credits.</span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company Plan covers substantially all LCD employees employed prior to December 31, 2009. The benefits to be paid under the Company Plan are based on years of credited service through December 31, 2009, interest credits and average compensation. The Company's policy is to fund the Company Plan with at least the minimum amount required by applicable regulations.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><ix:continuation id="ic5c5ab69fca24cd6b79fd9eddc8bc181"><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PEP covers a portion of the Company's senior management group. Prior to 2010, the PEP provided for the payment of the difference, if any, between the amount of any maximum limitation on annual benefit payments under the Employee Retirement Income Security Act of 1974 and the annual benefit that would be payable under the Company Plan but for such limitation. Effective January 1, 2010, employees participating in the PEP no longer earn service-based credits. The PEP is an unfunded plan.</span></div><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfNDUwOQ_3d2123bf-6ed6-4f5f-b86a-29747e25ed96" escape="true"><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect on operations for the Company Plan and the PEP is summarized as follows:</span></div><div style="margin-bottom:11pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost for administrative expenses</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc93dd882afa412083acfde2ba592eee_D20200701-20200930" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfMi0xLTEtMS0w_99c9b3c5-f1b7-4f78-b48c-01dd3c1e8ce9">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2cd501dd8ab4346aa80fd4754cc040c_D20190701-20190930" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfMi0zLTEtMS0w_acf28e08-211d-4e7d-9102-3e1f960b4b15">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb40acae056445528eb8911537232df5_D20200101-20200930" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfMi01LTEtMS0w_7c1e96de-1c8d-46b8-bd4f-90977e8dfd58">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icddc15843aad45e5aededcb204169bef_D20190101-20190930" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfMi03LTEtMS0w_dd71aa25-d7e1-4f7b-9c24-6a612240512c">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on benefit obligation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc93dd882afa412083acfde2ba592eee_D20200701-20200930" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfMy0xLTEtMS0w_a027629c-f1e0-4e39-a0a9-7af913b2f732">2.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2cd501dd8ab4346aa80fd4754cc040c_D20190701-20190930" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfMy0zLTEtMS0w_a0064227-9023-4353-a5ec-3e265f9b6d0b">3.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb40acae056445528eb8911537232df5_D20200101-20200930" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfMy01LTEtMS0w_bf82a3da-c3f6-41dd-8d74-f8a4e05754a0">8.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icddc15843aad45e5aededcb204169bef_D20190101-20190930" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfMy03LTEtMS0w_72995dbf-2435-444a-8a62-6565b0da5097">10.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc93dd882afa412083acfde2ba592eee_D20200701-20200930" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfNC0xLTEtMS0w_e39e9287-0e13-4830-8b80-4ee97d097a42">3.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2cd501dd8ab4346aa80fd4754cc040c_D20190701-20190930" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfNC0zLTEtMS0w_f492976c-14cc-4c03-94eb-29a906b40111">3.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb40acae056445528eb8911537232df5_D20200101-20200930" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfNC01LTEtMS0w_34dd4aa1-e1cf-4c94-b859-dd4684fbe98f">11.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icddc15843aad45e5aededcb204169bef_D20190101-20190930" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfNC03LTEtMS0w_d0242721-dc69-485b-abb1-d76af575cd48">11.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amortization and deferral</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc93dd882afa412083acfde2ba592eee_D20200701-20200930" decimals="-5" name="lh:NetDefinedBenefitPlanAmortizationAndDeferral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfNS0xLTEtMS0w_869970bd-4f9e-451e-bd8c-b99a1f41fff5">2.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2cd501dd8ab4346aa80fd4754cc040c_D20190701-20190930" decimals="-5" name="lh:NetDefinedBenefitPlanAmortizationAndDeferral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfNS0zLTEtMS0w_17100af8-f4b5-419b-9f80-81e21719736d">3.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb40acae056445528eb8911537232df5_D20200101-20200930" decimals="-5" name="lh:NetDefinedBenefitPlanAmortizationAndDeferral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfNS01LTEtMS0w_5353bc3f-b14c-4c3f-8c16-0675fac9ae60">7.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icddc15843aad45e5aededcb204169bef_D20190101-20190930" decimals="-5" name="lh:NetDefinedBenefitPlanAmortizationAndDeferral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfNS03LTEtMS0w_a1c5722f-7138-4a23-8a65-118acc23e3c2">8.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit plan costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc93dd882afa412083acfde2ba592eee_D20200701-20200930" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfNi0xLTEtMS0w_a6682e09-cf80-4ff2-b92e-f7e341d196bd">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2cd501dd8ab4346aa80fd4754cc040c_D20190701-20190930" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfNi0zLTEtMS0w_65ee376a-8449-4133-a1ad-774ebfb4b737">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb40acae056445528eb8911537232df5_D20200101-20200930" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfNi01LTEtMS0w_cda67b34-d7cb-4e89-bf18-6e66a97527fd">8.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icddc15843aad45e5aededcb204169bef_D20190101-20190930" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfNi03LTEtMS0w_fd99092f-bdd2-440f-a9aa-ef7e1d66f707">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The service cost component of net periodic pension cost and net periodic post-retirement benefit cost is included in operating expenses with other employee compensation costs. The other components of net benefit cost, including amortization or prior service cost/credit and settlement and curtailment effects are included in other, net non-operating expenses. During the nine months ended September&#160;30, 2020, the Company made no contributions to the Company Plan. The related net pension obligation for the Company Plan and PEP was $<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfMzAzMA_2672d6b8-202c-4a83-8ae4-956fb467b2ed">92.6</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfMzAzNw_6cc704fa-8d1e-41ad-bd2f-4919b0f0e640">93.4</ix:nonFraction> as of September&#160;30, 2020, and December&#160;31, 2019, respectively.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Covance acquisition, the Company sponsors two defined benefit pension plans for the benefit of its employees at two U.K. subsidiaries (U.K. Plans) and one defined benefit pension plan for the benefit of its employees at a German subsidiary (German Plan), all of which are legacy plans of previously acquired companies. The U.K. Plans were closed to future accrual as of December 31, 2019. Benefit amounts for all three plans are based upon years of service and compensation; however, the U.K. Plans were based on service and compensation through December 31, 2019. The German Plan is unfunded while the U.K. Plans are funded. The Company&#8217;s funding policy has been to contribute annually a fixed percentage of the eligible employee's salary, and additional amounts, at least equal to the local statutory funding requirements.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Envigo acquisition, the Company assumed a defined benefit pension plan for the benefit of Envigo's U.K. employees (the Envigo Plan), which is a legacy plan of a company previously acquired by Envigo. The Envigo Plan is a funded plan that is closed to future accrual. The Company&#8217;s funding policy has been to contribute amounts at least equal to the local statutory funding requirements.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The related net pension obligation for these plans inclusive of the U.K. Plans, German Plan, and the Envigo Plan, was&#160;$<ix:nonFraction unitRef="usd" contextRef="if69fa5cada7744eeb0c7092963608d33_I20200930" decimals="-5" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfNDQzOQ_772e63fa-1847-4ac2-bf89-294b19c5e65c">85.4</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i9e0edd28826044888669adf1110662a2_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfNDQ0Ng_068ab0f3-387e-4968-bcc1-9e5dd57591ef">99.1</ix:nonFraction>&#160;as of September&#160;30, 2020, and December&#160;31, 2019, respectively.</span></div></ix:continuation><div id="i417074d9a2c24c34bcac25f32d2ec0c1_67"></div><div style="margin-top:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RleHRyZWdpb246ZjNhZDBiYWZkZjViNDI2MmI4ZTY1NDU2MmMxMDUwZThfMjY3NQ_8b53c4f8-5c5a-48c6-b81f-4c46d3385a28" continuedAt="ie9fec945bbb949c695247e256421d712" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><ix:continuation id="ie9fec945bbb949c695247e256421d712" continuedAt="i2c10c76db7b14a838bfbb5599b5bdb02"><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RleHRyZWdpb246ZjNhZDBiYWZkZjViNDI2MmI4ZTY1NDU2MmMxMDUwZThfMjY2Mw_7db3e3dd-6868-4cf8-897e-c400ac34252a" continuedAt="ifceed102c3044709b3a11903894091c2" escape="true"><div style="margin-bottom:6pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s population of financial assets and liabilities subject to fair value measurements as of September&#160;30, 2020, and December&#160;31, 2019, is as follows:</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:37.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.665%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.101%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Measurements as of</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value<br/>as of</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Using Fair Value Hierarchy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest put</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfNC0zLTEtMS0w_303afa02-2005-47e4-b6f9-db67eac3a448">15.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5229937ecb2d46eaa667d49484539b53_I20200930" decimals="-5" format="ixt:zerodash" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfNC01LTEtMS0w_83219034-ef07-4c89-8335-af4276d9c0be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab089143fc42417c81a2d2bfabbd8654_I20200930" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfNC03LTEtMS0w_b383cda8-9dac-4e59-9db5-f484f2f5cd1f">15.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacfbc074fcc44dfb86499f5096b2b493_I20200930" decimals="-5" format="ixt:zerodash" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfNC05LTEtMS0w_35b94413-6bcd-436e-a9e2-b753d88c768f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfNS0zLTEtMS0w_90a581ff-5b37-43e0-b51a-6e2f70632d26">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5229937ecb2d46eaa667d49484539b53_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfNS01LTEtMS0w_7b672e2c-1716-4ec5-a00c-37da049eb7d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab089143fc42417c81a2d2bfabbd8654_I20200930" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfNS03LTEtMS0w_fc8b5a55-a3d5-4211-b618-00ab6b488d10">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacfbc074fcc44dfb86499f5096b2b493_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfNS05LTEtMS0w_93986c89-63c8-4cc8-9e3c-c9942fa2ba90">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfOS0zLTEtMS0w_5fee85f8-e0d7-4fcc-be4e-5307cb466391">82.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5229937ecb2d46eaa667d49484539b53_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfOS01LTEtMS0w_ebf1a97b-028e-49eb-8e62-2bbaa531bccc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab089143fc42417c81a2d2bfabbd8654_I20200930" decimals="-5" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfOS03LTEtMS0w_3e43966a-28f3-4b18-a7a0-33a7630652bf">82.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacfbc074fcc44dfb86499f5096b2b493_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfOS05LTEtMS0w_e55e8bdf-61bd-4b78-80cc-edaa2f2a3440">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfMTAtMy0xLTEtMA_73b18bba-357a-443a-a2d1-837955a02982">81.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5229937ecb2d46eaa667d49484539b53_I20200930" decimals="-5" format="ixt:zerodash" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfMTAtNS0xLTEtMA_95de986d-d0ae-4865-aa7b-57fd69e5cf30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab089143fc42417c81a2d2bfabbd8654_I20200930" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfMTAtNy0xLTEtMA_be006461-9c86-4dac-aa37-8f7c07587f7f">81.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacfbc074fcc44dfb86499f5096b2b493_I20200930" decimals="-5" format="ixt:zerodash" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfMTAtOS0xLTEtMA_ff11ff45-bfcb-4b0e-9649-53514b9f7f9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfMTEtMy0xLTEtMA_e13de405-8fcf-4917-a599-1d95be146d46">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5229937ecb2d46eaa667d49484539b53_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfMTEtNS0xLTEtMA_0bb0ce9a-bf9a-41ed-b5f1-9d88e16fdab5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab089143fc42417c81a2d2bfabbd8654_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfMTEtNy0xLTEtMA_51167198-d878-4071-9732-a5748ebbc74d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacfbc074fcc44dfb86499f5096b2b493_I20200930" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfMTEtOS0xLTEtMA_10ac9ecd-a44f-4d3d-8e1b-fa0982c4d566">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><ix:continuation id="i2c10c76db7b14a838bfbb5599b5bdb02" continuedAt="ib71730af20de43f59f690fcd73296656"><div style="margin-bottom:8pt;margin-top:5pt"><ix:continuation id="ifceed102c3044709b3a11903894091c2"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:36.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.194%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.138%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Measurements as of</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value<br/>as of</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Using Fair Value Hierarchy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest put</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNC0zLTEtMS0w_05bb5ecc-f571-4bb9-8210-ee65e7bf56a8">15.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ded3a94ce0f45598710ac45a034a923_I20191231" decimals="-5" format="ixt:zerodash" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNC01LTEtMS0w_a09c7cec-c413-494c-936a-14baedb1ab07">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0f0ae542d5a48d89e69a0ec76905efe_I20191231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNC03LTEtMS0w_2363c244-bb5f-4bdd-9d24-8fe1ae20e562">15.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7abc6c3f0ace4f678cb9c9f7caec9b6b_I20191231" decimals="-5" format="ixt:zerodash" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNC05LTEtMS0w_7d71cf51-c0df-4a97-941a-e46806702abe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNS0zLTEtMS0w_51b0907e-5eb0-449c-9bbe-d0bc577bf5de">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ded3a94ce0f45598710ac45a034a923_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNS01LTEtMS0w_1e70b3d1-5a2e-489e-804b-dce09c1becdd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0f0ae542d5a48d89e69a0ec76905efe_I20191231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNS03LTEtMS0w_f04b68df-e2c4-4395-be43-ca56b2d071b1">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7abc6c3f0ace4f678cb9c9f7caec9b6b_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNS05LTEtMS0w_d62d9ff5-e44d-458c-acfe-20b77851dec1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:FairValueHedgesAtFairValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNi0zLTEtMS0w_16fe9b34-ef41-4c5b-9ecd-fcf3606ab891">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ded3a94ce0f45598710ac45a034a923_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueHedgesAtFairValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNi01LTEtMS0w_bd44f0c8-f449-48d2-8110-347858101df2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0f0ae542d5a48d89e69a0ec76905efe_I20191231" decimals="-5" name="us-gaap:FairValueHedgesAtFairValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNi03LTEtMS0w_4fa4c269-da84-4862-97cb-2e0bdcb247b9">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7abc6c3f0ace4f678cb9c9f7caec9b6b_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueHedgesAtFairValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNi05LTEtMS0w_6730d6cb-5ffb-46d8-a87a-eab6ee9bfcc0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNy0zLTEtMS0w_7a9b9438-108d-4237-a9df-baaeda9a0423">80.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ded3a94ce0f45598710ac45a034a923_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNy01LTEtMS0w_981f2fe9-76a6-4c3f-b2f2-cf1795234f34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0f0ae542d5a48d89e69a0ec76905efe_I20191231" decimals="-5" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNy03LTEtMS0w_64606877-85f7-4eb9-9491-448ff7d568d1">80.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7abc6c3f0ace4f678cb9c9f7caec9b6b_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNy05LTEtMS0w_0a019c2a-0e0b-4471-ae71-6573dbb1c965">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfOC0zLTEtMS0w_d3897df8-dbb0-4534-bce1-ceefd6ce1e97">76.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ded3a94ce0f45598710ac45a034a923_I20191231" decimals="-5" format="ixt:zerodash" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfOC01LTEtMS0w_6a711298-0b92-4920-85d3-77dd061bcdfc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0f0ae542d5a48d89e69a0ec76905efe_I20191231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfOC03LTEtMS0w_ff05c068-c301-442b-9cd8-26d40bda30a7">76.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7abc6c3f0ace4f678cb9c9f7caec9b6b_I20191231" decimals="-5" format="ixt:zerodash" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfOC05LTEtMS0w_8d09cf74-ce24-4e01-843b-391852eab9d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfOS0zLTEtMS0w_e27ed8fc-326c-4568-ad0f-6f129a2e0314">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ded3a94ce0f45598710ac45a034a923_I20191231" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfOS01LTEtMS0w_4cfefb91-e6d5-4e48-a142-c6ef5cfe602f">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0f0ae542d5a48d89e69a0ec76905efe_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfOS03LTEtMS0w_31078709-48c9-493f-9956-ca741ccede6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7abc6c3f0ace4f678cb9c9f7caec9b6b_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfOS05LTEtMS0w_e93b22f6-7790-41e2-9456-931d1eae0aa8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfMTAtMy0xLTEtMA_3fdd225b-32b3-47d1-b631-b3996ede44f1">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ded3a94ce0f45598710ac45a034a923_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfMTAtNS0xLTEtMA_1da959ad-1962-4b85-b8bc-9ab51ab624aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0f0ae542d5a48d89e69a0ec76905efe_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfMTAtNy0xLTEtMA_72322132-4c44-41e6-84b4-d05954d69c01">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7abc6c3f0ace4f678cb9c9f7caec9b6b_I20191231" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfMTAtOS0xLTEtMA_77cd1deb-7957-4207-b38d-28688b865a65">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:8pt;margin-top:5pt"><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RleHRyZWdpb246ZjNhZDBiYWZkZjViNDI2MmI4ZTY1NDU2MmMxMDUwZThfMjY2MQ_447b1478-509f-49ff-906f-7416533c24f7" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Measurement of Level 3 Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7abc6c3f0ace4f678cb9c9f7caec9b6b_I20191231" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjA5N2RmOTE2MmE0YzQyNzZhMDJkMTM2NzAyNWNmMjMzL3RhYmxlcmFuZ2U6MDk3ZGY5MTYyYTRjNDI3NmEwMmQxMzY3MDI1Y2YyMzNfMy0yLTEtMS0w_4ca09870-8642-4de5-9d55-8ce2e9d80c85">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="lh:Lh_BusinessCombinationContingentConsiderationArrangementsPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjA5N2RmOTE2MmE0YzQyNzZhMDJkMTM2NzAyNWNmMjMzL3RhYmxlcmFuZ2U6MDk3ZGY5MTYyYTRjNDI3NmEwMmQxMzY3MDI1Y2YyMzNfNC0yLTEtMS0w_ea8548d4-9927-468b-a1ab-3b18d2527210">4.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="lh:Contingentconsiderationadjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjA5N2RmOTE2MmE0YzQyNzZhMDJkMTM2NzAyNWNmMjMzL3RhYmxlcmFuZ2U6MDk3ZGY5MTYyYTRjNDI3NmEwMmQxMzY3MDI1Y2YyMzNfNS0yLTEtMS0w_c0cc2405-4994-41ca-b533-22beda699824">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjA5N2RmOTE2MmE0YzQyNzZhMDJkMTM2NzAyNWNmMjMzL3RhYmxlcmFuZ2U6MDk3ZGY5MTYyYTRjNDI3NmEwMmQxMzY3MDI1Y2YyMzNfNi0yLTEtMS0w_730beb06-5e26-4df6-93ed-6806ae477ffa">6.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacfbc074fcc44dfb86499f5096b2b493_I20200930" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjA5N2RmOTE2MmE0YzQyNzZhMDJkMTM2NzAyNWNmMjMzL3RhYmxlcmFuZ2U6MDk3ZGY5MTYyYTRjNDI3NmEwMmQxMzY3MDI1Y2YyMzNfNy0yLTEtMS0w_0a78593a-d886-4f8d-86d4-4f42fba8eb30">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a noncontrolling interest put related to its Ontario subsidiary that has been classified as mezzanine equity in the Company&#8217;s condensed consolidated balance sheets. The noncontrolling interest put is valued at its contractually determined value, which approximates fair value.  </span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers certain employees the opportunity to participate in an employee-funded deferred compensation plan (DCP). A participant's deferrals are allocated by the participant to one or more of <ix:nonFraction unitRef="number" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="0" name="lh:NumberofMeasurementFundsAvailableForParticipantElection" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RleHRyZWdpb246ZjNhZDBiYWZkZjViNDI2MmI4ZTY1NDU2MmMxMDUwZThfNjY3_5be9b8fd-537a-4567-9d18-608835882ae2">16</ix:nonFraction> measurement funds, which are indexed to externally managed funds. From time to time, to offset the cost of the growth in the participant's investment accounts, the Company purchases life insurance policies, with the Company named as beneficiary of the policies. Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments, which are typically invested in a similar manner to the participants' allocations. Changes in the fair value of the DCP obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units. The cash surrender value and the DCP obligations are classified within Level 2 because their inputs are derived principally from observable market data by correlation to the hypothetical investments.  </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent acquisition consideration liabilities are measured at fair value using Level 3 valuations. These contingent consideration liabilities were recorded at fair value on the acquisition date and are remeasured quarterly based on the then assessed fair value and adjusted if necessary. The increases or decreases in the fair value of contingent consideration payable can result from changes in anticipated revenue levels and changes in assumed discount periods and rates. As the fair value measure is based on significant inputs that are not observable in the market, they are categorized as Level 3.</span></div></ix:continuation><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib71730af20de43f59f690fcd73296656">The carrying amounts of cash and cash equivalents, accounts receivable, income taxes receivable, and accounts payable are considered to be representative of their respective fair values due to their short-term nature. The fair market value of the Senior Notes, based on market pricing, was approximately $<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" format="ixt:numdotdecimal" name="lh:SeniorNotesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RleHRyZWdpb246ZjNhZDBiYWZkZjViNDI2MmI4ZTY1NDU2MmMxMDUwZThfMjQ0Mg_713cee0b-c3db-4395-a85f-9141f2ac6c84">6,107.9</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" format="ixt:numdotdecimal" name="lh:SeniorNotesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RleHRyZWdpb246ZjNhZDBiYWZkZjViNDI2MmI4ZTY1NDU2MmMxMDUwZThfMjQ0OQ_ba2ebf1e-3427-4430-9df1-01c80129b0f9">6,140.6</ix:nonFraction> as of September&#160;30, 2020, and December&#160;31, 2019, respectively. The Company's note and debt instruments are classified as Level 2 instruments, as the fair market values of these instruments are determined using other observable inputs.</ix:continuation> </span></div><div id="i417074d9a2c24c34bcac25f32d2ec0c1_70"></div><div style="margin-top:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RleHRyZWdpb246ZTFmM2MyZTk4OTVlNDM1MWFiZWQzNDRkNWFkNzhmNjFfMzM2Mg_5cd73284-d1bc-41db-b155-b493fe304a1d" continuedAt="ic09c9c228f3c425290ed0f3897b10988" escape="true">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</ix:nonNumeric></span></div><ix:continuation id="ic09c9c228f3c425290ed0f3897b10988" continuedAt="icd13a5888daf489faf4159d7e1962326"><div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company addresses its exposure to market risks, principally the market risk associated with changes in interest rates and foreign currency exchange rates, through a controlled program of risk management that includes, from time to time, the use of derivative financial instruments.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company does not hold or issue derivative financial instruments for trading purposes. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not believe that its exposure to market risk is material to the Company&#8217;s financial position or results of operations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Swap</span></div><div style="margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On August 17, 2020, the Company redeemed its remaining $<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" name="lh:BalanceOfSeniorNotesMatureDuringQ42020" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RleHRyZWdpb246ZTFmM2MyZTk4OTVlNDM1MWFiZWQzNDRkNWFkNzhmNjFfMzI5ODUzNDg4OTc5Mg_f691c758-e732-44ae-a4a5-876eecbbeae8">412.2</ix:nonFraction> <ix:nonFraction unitRef="number" contextRef="i391abd34dc914608a327d3e643899d6b_I20200930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RleHRyZWdpb246ZTFmM2MyZTk4OTVlNDM1MWFiZWQzNDRkNWFkNzhmNjFfMzI5ODUzNDg4OTc5Ng_8c2e5805-ae45-4207-a91a-2b692be7c6a2">4.625</ix:nonFraction>% Senior Notes due November 15, 2020, using available cash on hand. The Company exited the remaining fixed-to-variable interest rate swap arrangement in August 2020, in connection with the redemption of the <ix:nonFraction unitRef="number" contextRef="i391abd34dc914608a327d3e643899d6b_I20200930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RleHRyZWdpb246ZTFmM2MyZTk4OTVlNDM1MWFiZWQzNDRkNWFkNzhmNjFfMzI5ODUzNDg5MDE0NA_8c2e5805-ae45-4207-a91a-2b692be7c6a2">4.625</ix:nonFraction>% Senior Notes due 2020. </span></div></ix:continuation><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RleHRyZWdpb246ZTFmM2MyZTk4OTVlNDM1MWFiZWQzNDRkNWFkNzhmNjFfMzM1Mg_83b0551b-7eaf-405d-a014-bc69cf836673" continuedAt="i37038471d7664362a5c3bc60fd221d01" escape="true"></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><ix:continuation id="icd13a5888daf489faf4159d7e1962326"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><ix:continuation id="i37038471d7664362a5c3bc60fd221d01"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:26.465%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.641%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.646%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount of hedged liabilities as of</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Liabilities as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance Sheet Line Item in which Hedged Items are Included</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion, long term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30fd4fe5553348999dc8935c8ef8e7ab_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:ShorttermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjkzZThlZTRiNDkyZTQ5MmQ4NTNmYzdkN2M2MDU2NjRiL3RhYmxlcmFuZ2U6OTNlOGVlNGI0OTJlNDkyZDg1M2ZjN2Q3YzYwNTY2NGJfMy0yLTEtMS0w_e7391242-7b98-4468-a050-169f26082661">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe0d3f0eae0e4636b83723ad38c201f0_I20191231" decimals="-5" name="us-gaap:ShorttermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjkzZThlZTRiNDkyZTQ5MmQ4NTNmYzdkN2M2MDU2NjRiL3RhYmxlcmFuZ2U6OTNlOGVlNGI0OTJlNDkyZDg1M2ZjN2Q3YzYwNTY2NGJfMy00LTEtMS0w_fbd8392b-eee7-4b80-91d4-330a097dd09e">301.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueHedgeLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjkzZThlZTRiNDkyZTQ5MmQ4NTNmYzdkN2M2MDU2NjRiL3RhYmxlcmFuZ2U6OTNlOGVlNGI0OTJlNDkyZDg1M2ZjN2Q3YzYwNTY2NGJfMy02LTEtMS0w_cc391a21-e15a-48dd-acd6-41a0dfe1861d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231" decimals="-5" name="us-gaap:FairValueHedgeLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjkzZThlZTRiNDkyZTQ5MmQ4NTNmYzdkN2M2MDU2NjRiL3RhYmxlcmFuZ2U6OTNlOGVlNGI0OTJlNDkyZDg1M2ZjN2Q3YzYwNTY2NGJfMy04LTEtMS0w_8936972d-a924-4f9a-91ff-d24c5f3dc1c3">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cross Currency Swap</span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2018, the Company entered into six U.S. Dollar to Swiss Franc cross-currency swap agreements with an aggregate notional value of $<ix:nonFraction unitRef="usd" contextRef="i9f958adbe35f4caab3789a03b8cec98f_I20200930" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RleHRyZWdpb246ZTFmM2MyZTk4OTVlNDM1MWFiZWQzNDRkNWFkNzhmNjFfMTg2MA_9574127d-05fa-4fcc-8cd6-e1279c7718c2">600.0</ix:nonFraction> and which are accounted for as a hedge against the impact of foreign exchange movements on its net investment in a Swiss subsidiary. Of the notional value, $<ix:nonFraction unitRef="usd" contextRef="i157730e7ca9e4995bdae523b7501fc18_I20200930" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RleHRyZWdpb246ZTFmM2MyZTk4OTVlNDM1MWFiZWQzNDRkNWFkNzhmNjFfMjAxOQ_4ed2ae79-b784-418b-9320-a5272992ca44">300.0</ix:nonFraction> matures in 2022 and $<ix:nonFraction unitRef="usd" contextRef="i7e6ac05e86da4a5e81f44c16ffdf25ee_I20200930" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RleHRyZWdpb246ZTFmM2MyZTk4OTVlNDM1MWFiZWQzNDRkNWFkNzhmNjFfMjA0Mg_26f9eda6-6ab2-4f4b-a901-ab8b8f1b2246">300.0</ix:nonFraction> matures in 2025. These cross currency swaps maturing in 2022 and 2025 are included in other long-term assets as of September&#160;30, 2020. Changes in the fair value of the cross-currency swaps are recorded as a component of the foreign currency translation adjustment in accumulated other comprehensive income in the Condensed Consolidated Balance Sheet until the hedged item is recognized in earnings. The cumulative amount of the fair value hedging adjustment included in the current value of the cross currency swaps was $(<ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RleHRyZWdpb246ZTFmM2MyZTk4OTVlNDM1MWFiZWQzNDRkNWFkNzhmNjFfMjU0OA_485572b7-6a2a-43d7-9285-a796f6126c30">23.1</ix:nonFraction>) and $(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RleHRyZWdpb246ZTFmM2MyZTk4OTVlNDM1MWFiZWQzNDRkNWFkNzhmNjFfMjU1NQ_6fcaf344-8068-4c64-a053-487eff95dd44">12.0</ix:nonFraction>) for the three and nine months ended September&#160;30, 2020, respectively, and was recognized as currency translation within the Condensed Consolidated Statement of Comprehensive Earnings. There were no amounts reclassified from the Condensed Consolidated Statement of Comprehensive Earnings to the Condensed Consolidated Statement of Operations during the three months or nine months ended September&#160;30, 2020.</span></div><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RleHRyZWdpb246ZTFmM2MyZTk4OTVlNDM1MWFiZWQzNDRkNWFkNzhmNjFfMzM1OA_6a1a173d-6aec-4e40-8913-be5d2718e156" escape="true"><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of derivatives on a gross basis and the balance sheet classification of those instruments:</span></div><div style="margin-bottom:12.1pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:17.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.530%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.084%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.378%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.084%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.383%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value of Derivative</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value of Derivative</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance Sheet Caption</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liability</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liability</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Dollar Notional</span></td></tr><tr><td colspan="30" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Derivatives Designated as Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b2d1e688ceb488f882b2976928f2162_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueHedgeAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOmUwYTU5ZTJhYzQyNTRkYzRhOGRlNjIyMjA0OGU5ZjI1L3RhYmxlcmFuZ2U6ZTBhNTllMmFjNDI1NGRjNGE4ZGU2MjIyMDQ4ZTlmMjVfNS0zLTEtMS0w_9f7c6d62-74fe-486e-b292-79519d1f2034">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b2d1e688ceb488f882b2976928f2162_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueHedgeLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOmUwYTU5ZTJhYzQyNTRkYzRhOGRlNjIyMjA0OGU5ZjI1L3RhYmxlcmFuZ2U6ZTBhNTllMmFjNDI1NGRjNGE4ZGU2MjIyMDQ4ZTlmMjVfNS01LTEtMS0w_d18a6d39-a05a-48f4-a1e5-37b0d2ee2cdb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9709977fa99a4330a25d6ae199b8dcef_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOmUwYTU5ZTJhYzQyNTRkYzRhOGRlNjIyMjA0OGU5ZjI1L3RhYmxlcmFuZ2U6ZTBhNTllMmFjNDI1NGRjNGE4ZGU2MjIyMDQ4ZTlmMjVfNS03LTEtMS0w_2a65bc8d-67b7-48ce-9ff1-fbfc1e090666">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedf8eaddfda44623be579df701c1a1fe_I20191231" decimals="-5" name="us-gaap:FairValueHedgeAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOmUwYTU5ZTJhYzQyNTRkYzRhOGRlNjIyMjA0OGU5ZjI1L3RhYmxlcmFuZ2U6ZTBhNTllMmFjNDI1NGRjNGE4ZGU2MjIyMDQ4ZTlmMjVfNS05LTEtMS0w_5d577a91-42e0-4c36-9d89-01dcd1fafeb5">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedf8eaddfda44623be579df701c1a1fe_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueHedgeLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOmUwYTU5ZTJhYzQyNTRkYzRhOGRlNjIyMjA0OGU5ZjI1L3RhYmxlcmFuZ2U6ZTBhNTllMmFjNDI1NGRjNGE4ZGU2MjIyMDQ4ZTlmMjVfNS0xMS0xLTEtMA_3d1e5c3b-c893-4bac-8106-38b440107277">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65cf17ee050f4482a7c6583428aea61b_I20191231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOmUwYTU5ZTJhYzQyNTRkYzRhOGRlNjIyMjA0OGU5ZjI1L3RhYmxlcmFuZ2U6ZTBhNTllMmFjNDI1NGRjNGE4ZGU2MjIyMDQ4ZTlmMjVfNS0xMy0xLTEtMA_7a4973ac-2cf8-4309-b82e-0e23fcd757fa">300.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net or Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c7e9ea78df3464f91a5468557f3b4a3_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueHedgeAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOmUwYTU5ZTJhYzQyNTRkYzRhOGRlNjIyMjA0OGU5ZjI1L3RhYmxlcmFuZ2U6ZTBhNTllMmFjNDI1NGRjNGE4ZGU2MjIyMDQ4ZTlmMjVfNi0zLTEtMS0w_1095bb59-6d45-4760-ba58-879186123a49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c7e9ea78df3464f91a5468557f3b4a3_I20200930" decimals="-5" name="us-gaap:FairValueHedgeLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOmUwYTU5ZTJhYzQyNTRkYzRhOGRlNjIyMjA0OGU5ZjI1L3RhYmxlcmFuZ2U6ZTBhNTllMmFjNDI1NGRjNGE4ZGU2MjIyMDQ4ZTlmMjVfNi01LTEtMS0w_10429038-e54d-4fd6-bfca-3afc9da10ab4">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f958adbe35f4caab3789a03b8cec98f_I20200930" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOmUwYTU5ZTJhYzQyNTRkYzRhOGRlNjIyMjA0OGU5ZjI1L3RhYmxlcmFuZ2U6ZTBhNTllMmFjNDI1NGRjNGE4ZGU2MjIyMDQ4ZTlmMjVfNi03LTEtMS0w_9c3e1ba2-b2b9-46b7-bc2b-dcc27ba0df6d">600.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd87dafe403e465ea18e34466c3c7939_I20191231" decimals="-5" name="us-gaap:FairValueHedgeAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOmUwYTU5ZTJhYzQyNTRkYzRhOGRlNjIyMjA0OGU5ZjI1L3RhYmxlcmFuZ2U6ZTBhNTllMmFjNDI1NGRjNGE4ZGU2MjIyMDQ4ZTlmMjVfNi05LTEtMS0w_017c10e4-132b-4a34-82cf-67992f54e435">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd87dafe403e465ea18e34466c3c7939_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueHedgeLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOmUwYTU5ZTJhYzQyNTRkYzRhOGRlNjIyMjA0OGU5ZjI1L3RhYmxlcmFuZ2U6ZTBhNTllMmFjNDI1NGRjNGE4ZGU2MjIyMDQ4ZTlmMjVfNi0xMS0xLTEtMA_3dd382ee-66ee-4dbe-91be-9f6793cfa25d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i717fbdf29e6443d699ab792d8711e563_I20191231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOmUwYTU5ZTJhYzQyNTRkYzRhOGRlNjIyMjA0OGU5ZjI1L3RhYmxlcmFuZ2U6ZTBhNTllMmFjNDI1NGRjNGE4ZGU2MjIyMDQ4ZTlmMjVfNi0xMy0xLTEtMA_659287c4-db39-4fb8-b41b-e41cecc15796">600.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RleHRyZWdpb246ZTFmM2MyZTk4OTVlNDM1MWFiZWQzNDRkNWFkNzhmNjFfMzM1OQ_c2a81a95-97e4-4caa-899b-ce5080a62dbf" escape="true"><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides information regarding the location and amount of pretax (gains) losses of derivatives designated in fair value hedging:</span></div><div style="margin-bottom:12.1pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:19.371%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.589%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of pre-tax gain/(loss) included in other comprehensive income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified to the <br/>Statement of Operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of pre-tax gain/(loss) included in other comprehensive income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified to the <br/>Statement of Operations</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d5061e0be7847e68312a7cca228cf95_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfMy0yLTEtMS0w_7024274b-c10e-402d-b0ec-fff8fc3a61ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefe19a4e91fb49b3a68616c5ff46e9e5_D20190701-20190930" decimals="-5" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfMy00LTEtMS0w_6a8ec044-418d-44f2-ac5f-e3caef479e74">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d5061e0be7847e68312a7cca228cf95_D20200701-20200930" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfMy02LTEtMS0w_d6a3327b-86bb-4290-9be1-2584d7e308ae">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefe19a4e91fb49b3a68616c5ff46e9e5_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfMy04LTEtMS0w_d2770087-0fd3-4e65-ac86-a26653740c50">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ec6f971894c47229132bd1159446ec6_D20200101-20200930" decimals="-5" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfMy0xMC0xLTEtMA_eaf431f0-5479-487a-a03e-8e94993ff8ed">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7a8e6e061ca4fad8a9d6109d3fb30b9_D20190101-20190930" decimals="-5" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfMy0xMi0xLTEtMA_f0a576a7-bd76-4208-bcf5-6f9af053df18">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ec6f971894c47229132bd1159446ec6_D20200101-20200930" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfMy0xNC0xLTEtMA_87e50f2b-7455-441e-8be8-15931d5a9abe">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7a8e6e061ca4fad8a9d6109d3fb30b9_D20190101-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfMy0xNi0xLTEtMA_be5f0203-b28d-4726-b801-99dc41cfaf31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ccde3dbf4f348e184653bd3cde3ece9_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfNC0yLTEtMS0w_94a53c85-2599-4cb6-beae-6e2747992f7e">23.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id37ee09894034b178815f25b8d74e8e8_D20190701-20190930" decimals="-5" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfNC00LTEtMS0w_d25864ff-67c3-41ea-ad47-0e5919a2315d">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ccde3dbf4f348e184653bd3cde3ece9_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfNC02LTEtMS0w_2309dcb2-b259-4590-8767-2f7099e8e06c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id37ee09894034b178815f25b8d74e8e8_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfNC04LTEtMS0w_86c60135-4b37-4694-b9d4-579f513afd7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3997aafec9e6480ba5de1fc7fc5ae356_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfNC0xMC0xLTEtMA_39039bd4-8c5c-4267-9ac9-ee2d4e242dd5">12.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57fefb8fd43c402695470e30d3a2fee3_D20190101-20190930" decimals="-5" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfNC0xMi0xLTEtMA_1b667a06-7493-4acf-b604-fd17ee19adb8">22.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3997aafec9e6480ba5de1fc7fc5ae356_D20200101-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfNC0xNC0xLTEtMA_cb620fa1-f3ff-428d-ba07-842312d09d47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57fefb8fd43c402695470e30d3a2fee3_D20190101-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfNC0xNi0xLTEtMA_bca31a2e-f561-4781-be5d-a691f9e94d4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="INF" name="lh:GainInterestRateSwapArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RleHRyZWdpb246ZTFmM2MyZTk4OTVlNDM1MWFiZWQzNDRkNWFkNzhmNjFfMTY0OTI2NzQ0OTQ0Ng_e2792842-7455-4bc0-952c-2f3f391de1c9">1.6</ix:nonFraction> on the extinguishment of the interest rate swap arrangement, which was included in Other, net on the Condensed Consolidated Statement of Operations. No additional gains or losses from derivative instruments have been recognized into income for the three and nine months ended September&#160;30, 2020, and 2019.</span></div></ix:continuation><div id="i417074d9a2c24c34bcac25f32d2ec0c1_76"></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83Ni9mcmFnOmFkNzBmOWRhNjkwZTQ3NjM4MTFmMTllYjhlMzdmNDRlL3RleHRyZWdpb246YWQ3MGY5ZGE2OTBlNDc2MzgxMWYxOWViOGUzN2Y0NGVfNjE_d88651c0-cde6-4c9c-8b0c-591794c5bd14" continuedAt="i4ff652ad92d44b078462a7749fa9f287" escape="true">SUPPLEMENTAL CASH FLOW INFORMATION</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i4ff652ad92d44b078462a7749fa9f287"><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83Ni9mcmFnOmFkNzBmOWRhNjkwZTQ3NjM4MTFmMTllYjhlMzdmNDRlL3RleHRyZWdpb246YWQ3MGY5ZGE2OTBlNDc2MzgxMWYxOWViOGUzN2Y0NGVfNTE_e30ee9e1-4a74-49ed-b89c-54d2100f8b01" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental schedule of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during period for:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 24.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="lh:InterestPaidInCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83Ni9mcmFnOmFkNzBmOWRhNjkwZTQ3NjM4MTFmMTllYjhlMzdmNDRlL3RhYmxlOjg4MDE1NWVjZDViOTQwMGQ5ODhmNDc0YWJjYzYzMzI1L3RhYmxlcmFuZ2U6ODgwMTU1ZWNkNWI5NDAwZDk4OGY0NzRhYmNjNjMzMjVfNC0xLTEtMS0w_2ba91862-49bc-4a81-bc3c-26ae550049d1">195.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="lh:InterestPaidInCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83Ni9mcmFnOmFkNzBmOWRhNjkwZTQ3NjM4MTFmMTllYjhlMzdmNDRlL3RhYmxlOjg4MDE1NWVjZDViOTQwMGQ5ODhmNDc0YWJjYzYzMzI1L3RhYmxlcmFuZ2U6ODgwMTU1ZWNkNWI5NDAwZDk4OGY0NzRhYmNjNjMzMjVfNC0zLTEtMS0w_269cdb23-ea92-4666-bb7f-78aaeac7a5b9">216.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 24.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes, net of refunds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83Ni9mcmFnOmFkNzBmOWRhNjkwZTQ3NjM4MTFmMTllYjhlMzdmNDRlL3RhYmxlOjg4MDE1NWVjZDViOTQwMGQ5ODhmNDc0YWJjYzYzMzI1L3RhYmxlcmFuZ2U6ODgwMTU1ZWNkNWI5NDAwZDk4OGY0NzRhYmNjNjMzMjVfNS0xLTEtMS0w_c85a7b5a-3561-4b33-b3a3-3bcbe6fd42e0">217.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83Ni9mcmFnOmFkNzBmOWRhNjkwZTQ3NjM4MTFmMTllYjhlMzdmNDRlL3RhYmxlOjg4MDE1NWVjZDViOTQwMGQ5ODhmNDc0YWJjYzYzMzI1L3RhYmxlcmFuZ2U6ODgwMTU1ZWNkNWI5NDAwZDk4OGY0NzRhYmNjNjMzMjVfNS0zLTEtMS0w_9e2055af-18d5-470a-9f4b-c8e25a14a958">181.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosure of non-cash financing and investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion of zero-coupon convertible debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" format="ixt:zerodash" name="lh:ConversionOfZeroCouponConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83Ni9mcmFnOmFkNzBmOWRhNjkwZTQ3NjM4MTFmMTllYjhlMzdmNDRlL3RhYmxlOjg4MDE1NWVjZDViOTQwMGQ5ODhmNDc0YWJjYzYzMzI1L3RhYmxlcmFuZ2U6ODgwMTU1ZWNkNWI5NDAwZDk4OGY0NzRhYmNjNjMzMjVfOC0xLTEtMS0w_a90a2cff-718e-410b-92d9-ca24a4cad6e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="lh:ConversionOfZeroCouponConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83Ni9mcmFnOmFkNzBmOWRhNjkwZTQ3NjM4MTFmMTllYjhlMzdmNDRlL3RhYmxlOjg4MDE1NWVjZDViOTQwMGQ5ODhmNDc0YWJjYzYzMzI1L3RhYmxlcmFuZ2U6ODgwMTU1ZWNkNWI5NDAwZDk4OGY0NzRhYmNjNjMzMjVfOC0zLTEtMS0w_4522dde5-0a7b-47c9-a60b-bd6bc4376256">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in accrued property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="lh:DecreaseinCapitalExpendituresIncurredbutnotyetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83Ni9mcmFnOmFkNzBmOWRhNjkwZTQ3NjM4MTFmMTllYjhlMzdmNDRlL3RhYmxlOjg4MDE1NWVjZDViOTQwMGQ5ODhmNDc0YWJjYzYzMzI1L3RhYmxlcmFuZ2U6ODgwMTU1ZWNkNWI5NDAwZDk4OGY0NzRhYmNjNjMzMjVfMTAtMS0xLTEtMA_6ab1e9d8-6c16-4f7b-bfae-a161ebbcf7ae">24.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83Ni9mcmFnOmFkNzBmOWRhNjkwZTQ3NjM4MTFmMTllYjhlMzdmNDRlL3RhYmxlOjg4MDE1NWVjZDViOTQwMGQ5ODhmNDc0YWJjYzYzMzI1L3RhYmxlcmFuZ2U6ODgwMTU1ZWNkNWI5NDAwZDk4OGY0NzRhYmNjNjMzMjVfMTAtMy0xLTEtMA_d2bd6ff6-f93e-4504-b7c3-08beb9fd2e2f">15.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating rate secured note receivable due 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:NotesReceivableFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83Ni9mcmFnOmFkNzBmOWRhNjkwZTQ3NjM4MTFmMTllYjhlMzdmNDRlL3RhYmxlOjg4MDE1NWVjZDViOTQwMGQ5ODhmNDc0YWJjYzYzMzI1L3RhYmxlcmFuZ2U6ODgwMTU1ZWNkNWI5NDAwZDk4OGY0NzRhYmNjNjMzMjVfMTEtMS0xLTEtMA_a9581278-c90a-4fb1-a475-977395b51809">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ebf6d35695d43bebd0e1036cfd88d00_I20190930" decimals="-6" name="us-gaap:NotesReceivableFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83Ni9mcmFnOmFkNzBmOWRhNjkwZTQ3NjM4MTFmMTllYjhlMzdmNDRlL3RhYmxlOjg4MDE1NWVjZDViOTQwMGQ5ODhmNDc0YWJjYzYzMzI1L3RhYmxlcmFuZ2U6ODgwMTU1ZWNkNWI5NDAwZDk4OGY0NzRhYmNjNjMzMjVfMTEtMy0xLTEtMA_56bbe2b7-3f22-49b9-9ef6-ad04b2138d7e">110.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div id="i417074d9a2c24c34bcac25f32d2ec0c1_79"></div><div style="margin-top:15pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RleHRyZWdpb246N2U5YmM0NWM1YzkwNDFlOTk1MTM2MDVjZTljZjdlYjhfMTAxMA_3363d55e-e939-4d91-9aa6-235838c20529" continuedAt="ice084b938e3c4f08ade5fbb2a7e986f2" escape="true">BUSINESS SEGMENT INFORMATION</ix:nonNumeric></span></div><ix:continuation id="ice084b938e3c4f08ade5fbb2a7e986f2"><div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of segment information for the three and nine months ended September&#160;30, 2020, and 2019. The management approach has been used to present the following segment information. This approach is based upon the way the management of the Company organizes segments within an enterprise for making operating decisions and assessing performance. Financial information is reported on the basis that it is used internally by the chief operating decision maker (CODM) for evaluating segment performance and deciding how to allocate resources to segments. The Company&#8217;s chief executive officer has been identified as the CODM. </span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment asset information is not presented because it is not used by the CODM at the segment level. Operating earnings of each segment represents revenues less directly identifiable expenses to arrive at operating income for the segment. General management and administrative corporate expenses are included in general corporate expenses below. </span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><ix:nonNumeric contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RleHRyZWdpb246N2U5YmM0NWM1YzkwNDFlOTk1MTM2MDVjZTljZjdlYjhfMTAwNg_953caf9f-6222-4ed1-bd43-f6eef3be6207" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.407%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues:</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LCD</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1982102278bd444d897b0ac03dedfda5_D20200701-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNC0xLTEtMS0w_a16cdbd3-4298-4219-a45e-a79e55dd8c21">2,704.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd95aab1b5024137b07364cf3867cbf8_D20190701-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNC0zLTEtMS0w_c44f38c0-9045-402a-a3e8-4671dd2c232c">1,759.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60bf6e0de9384f37926fac0c0db06385_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNC01LTEtMS0w_b88f466b-3c6c-406e-a0c0-f28c0529442b">6,098.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54d000cbf2214f02a540a13d16a2e6fa_D20190101-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNC03LTEtMS0w_f0b35468-21b2-4a6f-92de-4dd3a2f30f98">5,242.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CDD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4674d28875524974925c86ea26137e4b_D20200701-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNS0xLTEtMS0w_be158454-afcf-4d08-985b-57a6b5ec84ba">1,241.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i060a850910964d4baaae2bbf8a6f8fa8_D20190701-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNS0zLTEtMS0w_923a9a55-1c98-4777-afbd-fb07318867b3">1,175.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if366c14694954f6f84a2c0fe5708324e_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNS01LTEtMS0w_02620113-37ed-452a-a51d-703bae2af216">3,479.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3059b6353b34be0bc21870bf9a54a49_D20190101-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNS03LTEtMS0w_706a0978-b09d-4c34-8707-53f6a92a74a6">3,376.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intercompany eliminations and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="INF" name="lh:Intercompanyrevenueelimination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNi0xLTEtMS0w_8a282604-a3e2-4705-b08f-2d1d3d3588f6">50.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="lh:Intercompanyrevenueelimination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNi0zLTEtMS0w_5371455d-da0d-451d-962d-daf458f5674b">6.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" name="lh:Intercompanyrevenueelimination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNi01LTEtMS0w_cfdd7f57-7fff-45a7-a5ff-9513cb129105">90.0</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" name="lh:Intercompanyrevenueelimination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNi03LTEtMS0w_619b62b8-9318-4be9-8eaf-446f9c360735">17.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNy0xLTEtMS0w_3d6b62ab-5fbd-4d7d-98ff-e2d6037623b3">3,896.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNy0zLTEtMS0w_c3eba47f-e8d7-4f2e-851b-947c4024ef77">2,928.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNy01LTEtMS0w_e2929ded-8376-47f2-a77e-bcd4ec4efbf9">9,488.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNy03LTEtMS0w_19e2dc00-1729-4197-9e49-124c7f6c1366">8,601.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating earnings (loss):</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LCD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1982102278bd444d897b0ac03dedfda5_D20200701-20200930" decimals="INF" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTAtMS0xLTEtMA_463f87a0-82b0-404a-9fe7-959a542ce6b3">964.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd95aab1b5024137b07364cf3867cbf8_D20190701-20190930" decimals="INF" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTAtMy0xLTEtMA_2c3d240e-c167-487d-9e7f-77b5d0a9fdb1">262.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60bf6e0de9384f37926fac0c0db06385_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTAtNS0xLTEtMA_c121c245-381c-4ba7-9588-034c54a0a39e">1,451.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54d000cbf2214f02a540a13d16a2e6fa_D20190101-20190930" decimals="INF" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTAtNy0xLTEtMA_f67ca67e-dd73-4694-8a13-31cbfbccac6c">843.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CDD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4674d28875524974925c86ea26137e4b_D20200701-20200930" decimals="INF" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTEtMS0xLTEtMA_c2663f32-5a65-4955-9d04-b14b85de7e2b">142.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i060a850910964d4baaae2bbf8a6f8fa8_D20190701-20190930" decimals="INF" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTEtMy0xLTEtMA_80928e3c-5140-4270-a288-ae66fadbe6f0">123.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if366c14694954f6f84a2c0fe5708324e_D20200101-20200930" decimals="INF" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTEtNS0xLTEtMA_daf7a216-022a-47ee-960b-8ac8f346a9c6">131.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3059b6353b34be0bc21870bf9a54a49_D20190101-20190930" decimals="INF" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTEtNy0xLTEtMA_d2a5caa8-83ce-4c3c-b1b5-afbb0b12736e">277.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5cb7f86911741a9b2e604fc4fb6237e_D20200701-20200930" decimals="INF" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTItMS0xLTEtMA_2bd6aa5c-e014-4965-9163-64f72be493bd">59.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7613840514f4435bb5f3e61d09adf8b5_D20190701-20190930" decimals="INF" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTItMy0xLTEtMA_f7117842-8c42-416f-a577-dcc4ec1e1302">46.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bc43a85b31c461e9c8951056efb762f_D20200101-20200930" decimals="INF" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTItNS0xLTEtMA_3237c4c9-a7a8-4442-80ef-e9d78093e75f">168.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b2b623128cd4e32a331207c59b1041a_D20190101-20190930" decimals="INF" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTItNy0xLTEtMA_4765c152-7c63-49dd-830a-41c9ed172a6a">126.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTMtMS0xLTEtMA_ded7f873-6cdc-4fca-a885-e3c0be484f35">1,047.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTMtMy0xLTEtMA_dfcd8c3b-c23a-47df-b1ba-e926042deaa8">339.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTMtNS0xLTEtMA_7a4c81ca-fa1f-4128-ab9b-506b61a24c03">1,152.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTMtNy0xLTEtMA_6bb137d9-0949-4b0c-b739-2a29dbed6163">993.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating expenses, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="INF" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTQtMS0xLTEtMA_fa440425-86b4-4b67-b96c-13e48eb2ad0f">100.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTQtMy0xLTEtMA_db083abd-a41b-4ced-bf1c-fcaff89db1e5">52.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTQtNS0xLTEtMA_6a009c98-d226-4db4-b340-90074916fa0c">175.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTQtNy0xLTEtMA_61e5965c-e562-4c15-afa5-e6bef4b48aa2">181.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" name="lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTUtMS0xLTEtMA_71bb94ab-e54d-4eae-b271-11d3a1290d11">947.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTUtMy0xLTEtMA_feceb4cb-e229-4ec7-b26e-71678123ab20">287.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" name="lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTUtNS0xLTEtMA_1d3cc2e6-083e-4f3e-a5d3-5f1b154ce917">976.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" name="lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTUtNy0xLTEtMA_34dbc3bd-90f4-433f-95f6-34d6b34dc1fb">812.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTYtMS0xLTEtMA_342c49d1-0c57-4f1f-8e7d-be7b1b446483">243.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTYtMy0xLTEtMA_6a878fe1-105f-4f93-aea4-d43350dc320e">66.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTYtNS0xLTEtMA_7fbf428d-cafc-4169-94a3-56c722db3177">358.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTYtNy0xLTEtMA_8908efe3-f96f-4320-8e7d-e20388aa52e0">214.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="INF" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTctMS0xLTEtMA_81f1f1b6-f1b6-4b66-b2bf-bc1967cb81ff">703.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTctMy0xLTEtMA_685978d2-4c95-496c-86bb-4c6c283472a1">221.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTctNS0xLTEtMA_1b0ca367-9db5-4032-a541-af5f8ee2ba4e">618.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTctNy0xLTEtMA_af1de74f-335b-474a-a234-c16ffa061bba">597.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net earnings attributable to the noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="INF" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTgtMS0xLTEtMA_d636050a-1827-41ef-ba43-10ea107f9343">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTgtMy0xLTEtMA_6ce7191a-25fd-4e6e-9307-58983bf62b84">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTgtNS0xLTEtMA_e822d39f-06c0-4e05-9604-d12cff3f6875">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTgtNy0xLTEtMA_9123a072-bb46-4f2f-9b80-b405c95d6689">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings attributable to Laboratory Corporation of America Holdings</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTktMS0xLTEtMA_3630dd92-4512-4cf7-b7fb-b2510e933b7c">703.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930" decimals="INF" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTktMy0xLTEtMA_49117119-626c-4a46-a4fa-b583c9d237d5">220.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="INF" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTktNS0xLTEtMA_5070a3f8-7f46-436f-a590-f64284d6c9b4">617.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="INF" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTktNy0xLTEtMA_73fe8b05-a6ff-4b85-840b-dd6b03d99de5">596.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i417074d9a2c24c34bcac25f32d2ec0c1_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORWARD-LOOKING STATEMENTS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory Corporation of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Holdings together with its subsidiaries (the Company) has made in this report, and from time to time may otherwise make in its public filings, press releases and discussions by Company management, forward-looking statements concerning the Company&#8217;s operations, performance and financial condition, as well as its strategic objectives.&#160;Some of these forward-looking statements relate to future events and expectations and can be identified by the use of forward-looking words such as &#8220;believes&#8221;, &#8220;expects&#8221;, &#8220;may&#8221;, &#8220;will&#8221;, &#8220;should&#8221;, &#8220;seeks&#8221;, &#8220;approximately&#8221;, &#8220;intends&#8221;, &#8220;plans&#8221;, &#8220;estimates&#8221;, or &#8220;anticipates&#8221; or the negative of those words or other comparable terminology. Such forward-looking statements speak only as of the time they are made and are subject to various risks and uncertainties. The Company claims the protection afforded by the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from those currently anticipated due to a number of factors in addition to those discussed elsewhere herein, including in the "Risk Factors" section of the Annual Report on Form 10-K, and in the Company&#8217;s other public filings, press releases, and discussions with Company management, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.    &#160;&#160;&#160;&#160;changes in government and third-party payer regulations, reimbursement, or coverage policies or other future reforms in the healthcare system (or in the interpretation of current regulations), new insurance or payment systems, including state, regional or private insurance cooperatives (e.g., health insurance exchanges) affecting governmental and third-party coverage or reimbursement for commercial laboratory testing, including the impact of the U.S. Protecting Access to Medicare Act of 2014 (PAMA);</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;significant monetary damages, fines, penalties, assessments, refunds, repayments, damage to the Company&#8217;s reputation, unanticipated compliance expenditures, and/or exclusion or debarment from or ineligibility to participate in government programs, among other adverse consequences, arising from enforcement of anti-fraud and abuse laws and other laws applicable to the Company in jurisdictions in which the Company conducts business;    </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.    &#160;&#160;&#160;&#160;significant fines, penalties, costs, unanticipated compliance expenditures and/or damage to the Company&#8217;s reputation arising from the failure to comply with applicable privacy and security laws and regulations, including the U.S. Health Insurance Portability and Accountability Act of 1996, the U.S. Health Information Technology for Economic and Clinical Health Act, the European Union's General Data Protection Regulation and similar laws and regulations in jurisdictions in which the Company conducts business; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;loss or suspension of a license or imposition of a fine or penalties under, or future changes in, or interpretations of applicable licensing laws or regulations regarding the operation of clinical laboratories and the delivery of clinical laboratory test results, including, but not limited to, the U.S. Clinical Laboratory Improvement Act of 1967 and the U.S. Clinical Laboratory Improvement Amendments of 1988 and similar laws and regulations in jurisdictions in which the Company conducts business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.    &#160;&#160;&#160;&#160;penalties or loss of license arising from the failure to comply with applicable occupational and workplace safety laws and regulations, including the U.S. Occupational Safety and Health Administration requirements and the U.S. Needlestick Safety and Prevention Act and similar laws and regulations in jurisdictions in which the Company conducts business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;fines, unanticipated compliance expenditures, suspension of manufacturing, enforcement actions, damage to the Company&#8217;s reputation, injunctions, or criminal prosecution arising from failure to maintain compliance with current good manufacturing practice regulations and similar requirements of various regulatory agencies in jurisdictions in which the Company conducts business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;sanctions or other remedies, including fines, unanticipated compliance expenditures, enforcement actions, injunctions or criminal prosecution arising from failure to comply with the Animal Welfare Act or applicable national, state and local laws and regulations in jurisdictions in which the Company conducts business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;changes in testing guidelines or recommendations by government agencies, medical specialty societies and other authoritative bodies affecting the utilization of laboratory tests;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;changes in applicable government regulations or policies affecting the approval, availability of, and the selling and marketing of diagnostic tests, drug development, or the conduct of drug development and medical device and diagnostic studies and trials, including regulations and policies of the U.S. Food and Drug Administration, the U.S. Department of Agriculture, the Medicine and Healthcare products Regulatory Agency in the United Kingdom (U.K.), the National Medical Products Administration in China, the Pharmaceutical and Medical Devices Agency in Japan, the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">European Medicines Agency and similar regulations and policies of agencies in other jurisdictions in which the Company conducts business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;changes in government regulations or reimbursement pertaining to the biopharmaceutical and medical device and diagnostic industries, changes in reimbursement of biopharmaceutical products or reduced spending on research and development by biopharmaceutical customers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.&#160;&#160;&#160;&#160;liabilities that result from the failure to comply with corporate governance requirements;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.  &#160;&#160;&#160;&#160;increased competition, including price competition, potential reduction in rates in response to price transparency and consumerism, competitive bidding and/or changes or reductions to fee schedules and competition from companies that do not comply with existing laws or regulations or otherwise disregard compliance standards in the industry;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.    &#160;&#160;&#160;&#160;changes in payer mix or payment structure, including insurance carrier participation in health insurance exchanges, an increase in capitated reimbursement mechanisms, the impact of a shift to consumer-driven health plans or plans carrying an increased level of member cost-sharing, and adverse changes in payer reimbursement or payer coverage policies (implemented directly or through a third-party utilization management organization) related to specific diagnostic tests, categories of testing or testing methodologies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.      failure to retain or attract managed care organization (MCO) business as a result of changes in business models, including new risk-based or network approaches, out-sourced laboratory network management or utilization management companies, or other changes in strategy or business models by MCOs;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.    &#160;&#160;&#160;&#160;failure to obtain and retain new customers, an unfavorable change in the mix of testing services ordered, or a reduction in tests ordered, specimens submitted or services requested by existing customers, and delays in payment from customers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.    &#160;&#160;&#160;&#160;difficulty in maintaining relationships with customers or retaining key employees as a result of uncertainty surrounding the integration of acquisitions and the resulting negative effects on the business of the Company;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.&#160;&#160;&#160;&#160;consolidation and convergence of MCOs, biopharmaceutical companies, health systems, large physician organizations and other customers, potentially causing material shifts in insourcing, utilization, pricing and reimbursement, including full and partial risk-based models;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.&#160;&#160;&#160;&#160;failure to effectively develop and deploy new systems, system modifications or enhancements required in response to evolving market and business needs;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.&#160;&#160;&#160;&#160;customers choosing to insource services that are or could be purchased from the Company;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.  &#160;&#160;&#160;&#160;failure to identify, successfully close, and effectively integrate and/or manage acquisitions of new businesses;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.&#160;&#160;&#160;&#160;inability to achieve the expected benefits and synergies of newly-acquired businesses, including due to items not discovered in the due-diligence process, and the impact on the Company's cash position, levels of indebtedness and stock price;  </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.&#160;&#160;&#160;&#160;termination, loss, delay, reduction in scope or increased costs of contracts, including large contracts and multiple contracts;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.&#160;&#160;&#160;&#160;liability arising from errors or omissions in the performance of testing services, contract research services, or other contractual arrangements;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.&#160;&#160;&#160;&#160;changes or disruption in the provision or transportation of services or supplies provided by third parties; or their termination for failure to follow the Company's performance standards and requirements;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25. &#160;&#160;&#160;&#160;damage or disruption to the Company's facilities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.  &#160;&#160;&#160;&#160;damage to the Company's reputation, loss of business, or other harm from acts of animal rights activists or potential harm and/or liability arising from animal research activities;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.&#160;&#160;&#160;&#160;adverse results in litigation matters;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28. &#160;&#160;&#160;&#160;inability to attract and retain experienced and qualified personnel or the loss of significant personnel as a result of illness or otherwise;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.&#160;&#160;&#160;&#160;failure to develop or acquire licenses for new or improved technologies, such as point-of-care testing, mobile health technologies, and digital pathology, or potential use of new technologies by customers and/or consumers to perform their own tests;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.&#160;&#160;&#160;&#160;substantial costs arising from the inability to commercialize newly licensed tests or technologies or to obtain appropriate coverage or reimbursement for such tests;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.&#160;&#160;&#160;&#160;failure to obtain, maintain and enforce intellectual property rights for protection of the Company's products and services and defend against challenges to those rights;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.&#160;&#160;&#160;&#160;scope, validity and enforceability of patents and other proprietary rights held by third parties that may impact the Company's ability to develop, perform, or market the Company's products or services or operate its business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33.&#160;&#160;&#160;&#160;business interruption, receivable impairment, delays in cash collection impacting days sales outstanding, supply chain disruptions, increases in operating costs, or other impacts on the business due to natural disasters, including adverse weather, fires and earthquakes, political crises, including terrorism and war, public health crises and disease epidemics and pandemics, and other events outside of the Company's control;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34.&#160;&#160;&#160;&#160;discontinuation or recalls of existing testing products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35.&#160;&#160;&#160;&#160;a failure in the Company's information technology systems, including with respect to testing turnaround time and billing processes, or the failure of the Company or its third-party suppliers and vendors to maintain the security of business information or systems or to protect against cybersecurity attacks such as denial of service attacks, malware, ransomware and computer viruses, or delays or failures in the development and implementation of the Company&#8217;s automation platforms, any of which could result in a negative effect on the Company&#8217;s performance of services, a loss of business or increased costs, damages to the Company&#8217;s reputation, significant litigation exposure, an inability to meet required financial reporting deadlines, or the failure to meet future regulatory or customer information technology, data security and connectivity requirements;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36.&#160;&#160;&#160;&#160;business interruption, increased costs, and other adverse effects on the Company's operations due to the unionization of employees, union strikes, work stoppages, general labor unrest or failure to comply with labor or employment laws;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37.    &#160;&#160;&#160;&#160;failure to maintain the Company's days sales outstanding levels, cash collections (in light of increasing levels of patient responsibility), profitability and/or reimbursement arising from unfavorable changes in third-party payer policies, payment delays introduced by third party utilization management organizations and increasing levels of patient payment responsibility;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38.&#160;&#160;&#160;&#160;impact on the Company's revenues, cash collections and the availability of credit for general liquidity or other financing needs arising from a significant deterioration in the economy or financial markets or in the Company's credit ratings by Standard &amp; Poor's and/or Moody's;    &#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39.&#160;&#160;&#160;&#160;failure to maintain the expected capital structure for the Company, including failure to maintain the Company's investment grade rating, or leverage ratio covenants under its term loan facility and revolving credit facility;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40.&#160;&#160;&#160;&#160;changes in reimbursement by foreign governments and foreign currency fluctuations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41. &#160;&#160;&#160;&#160;inability to obtain certain billing information from physicians, resulting in increased costs and complexity, a temporary disruption in receipts and ongoing reductions in reimbursements and revenues; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42.&#160;&#160;&#160;&#160;expenses and risks associated with international operations, including, but not limited to, compliance with the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act, other applicable anti-corruption laws and regulations, trade sanction laws and regulations, and economic, political, legal and other operational risks associated with foreign jurisdictions; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43.&#160;&#160;&#160;&#160;failure to achieve expected efficiencies and savings in connection with the Company's business process improvement initiatives;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44.&#160;&#160;&#160;&#160;changes in tax laws and regulations or changes in their interpretation, including the U.S. Tax Cuts and Jobs Act (TCJA);</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45.&#160;&#160;&#160;&#160;global economic conditions and government and regulatory changes, including, but not limited to the U.K.'s exit from the European Union; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46. &#160;&#160;&#160;&#160;effects, duration, and severity of the ongoing COVID-19 pandemic, including the impact on operations, personnel, liquidity, and collections, and the actions the Company, or governments, have taken or may take in response, and damage to the Company's reputation or loss of business resulting from the perception of the Company's response to the COVID-19 pandemic, including the availability and accuracy and timeliness of delivery of any tests that the Company develops, collaborates on or provides for the detection of COVID-19.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     &#160;&#160;&#160;&#160;     Except as may be required by applicable law, the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Given these uncertainties, one should not put undue reliance on any forward-looking statements.</span></div><div id="i417074d9a2c24c34bcac25f32d2ec0c1_88"></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">GENERAL (dollars in millions, except per share data)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues for the nine months ended September 30, 2020, were $9,488.7, an increase of 10.3% from $8,601.4 during the nine months ended September&#160;30, 2019. The increase in revenues was due to organic growth of 8.3%, acquisitions of 2.1%, and favorable foreign currency translation 0.1%, partially offset by the disposition of a business of 0.2%. The 8.3% increase in organic revenue includes the 16.4% contribution from COVID-19 Testing, partially offset by the 8.1% reduction in the Company's organic Base Business due to the pandemic. Base Business includes the Company's business operations except for PCR and antibody COVID-19 testing (COVID-19 Testing). The decline in the organic Base Business includes the negative impact of PAMA of 0.6%.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, COVID-19 was declared a pandemic. COVID-19 has had and continues to have an extensive impact on the global health and economic environments. Given the continued unpredictability of the COVID-19 pandemic and the corresponding government restrictions and customer behavior, there are a wide-range of feasible financial results for 2020. Throughout the year, the Company's COVID-19 Testing has helped to offset the pressure experienced in the Base Business. To date, the Company has performed more than 18 million PCR and 3.0 million antibody COVID-19 tests and has a current capacity of 210,000 PCR and 300,000 antibody tests per day. The Company continues to increase capacity across multiple platforms for its COVID-19 Testing subject to the availability of equipment and testing supplies and key personnel. </span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2020, the Company recorded goodwill and other asset impairment charges of $437.4, as a result of the negative financial impact of COVID-19 during the first quarter of 2020. See Note 6 Goodwill and Intangible Assets for a discussion of goodwill and intangible asset impairment and Note 2 Revenues for a discussion of credit losses and additional price concessions. The Company also impaired certain of the Company's investments by a total of $25.4 during the nine months ended September 30, 2020, due to the impact of COVID-19; $7.1 was included in Equity method earnings (loss), net during the three months ended March 31, 2020, and $13.1 and $5.2 were included in Other, net during the three months ended March 31, 2020, and June 30, 2020, respectively.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In April 2020, the Company received cash payments of approximately $55.9 from the Public Health and Social Services Emergency Fund for provider relief that was appropriated by Congress to the Department of Health and Human Services (HHS) in the Coronavirus Aid, Relief, and Economic Security Act (CARES Act Provider Relief Funds). Upon receiving and satisfying the terms and conditions associated with the distributed funds, the Company accounted for the transaction by applying the guidance in ASC 450-30 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Gain Contingencies, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">recorded these funds in Other, net non-operating income in the Consolidated Statement of Operations as of June 30, 2020. In August 2020, the Company received an additional $76.2 in CARES Act Provider Relief Funds. As the Company's Diagnostic business demonstrated recovery and demand for COVID-19 testing increased, the Company determined that the negative financial impact of COVID-19 which the CARES Act Provider Relief Funds were designed to address no longer applied to the Company. As a result, the Company derecognized the income associated with the $55.9 received during the second quarter as a change in estimate and did not recognize any income related to the cash payment of $76.2 received in the third quarter. The Company plans to return the CARES Act Provider Relief Funds to the government in the fourth quarter of 2020 and has recorded a liability of $132.1 in Accrued expenses and other as of September 30, 2020.</span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">There remains significant uncertainty regarding the duration and severity of the pandemic and its impact on the Company&#8217;s business, results of operations and financial position for the balance of 2020 and beyond. For more information regarding the risks associated with COVID-19 and its impact on the Company&#8217;s business, see Risk Factors in Part II - Item 1A. </span></div><div style="text-align:justify;text-indent:15.75pt"><span><br/></span></div><div id="i417074d9a2c24c34bcac25f32d2ec0c1_91"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">RESULTS OF OPERATIONS (dollars in millions)</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three months ended September&#160;30, 2020, compared with three months ended September&#160;30, 2019 </span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Revenues </span></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:53.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.565%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LCD</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,704.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,759.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CDD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,175.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intercompany eliminations and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,896.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,928.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in revenues for the three months ended September&#160;30, 2020, as compared with the corresponding period in 2019 was 33.0%.&#160;The increase in revenue was due to organic growth of 31.5%, acquisitions of 1.0%, and favorable foreign currency translation of 0.5%. The 31.5% increase in organic revenue includes the 32.6% contribution from COVID-19 Testing, partially offset by the 1.1% reduction in the Company's organic Base Business due to the pandemic. The decline in organic Base Business includes the lower Medicare and Medicaid pricing as a result of PAMA of 0.7%.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LCD revenues for the quarter were $2,704.2, an increase of 53.7% compared to revenues of $1,759.2 in the third quarter of 2019. The increase in revenues was primarily due to organic growth of 52.3% and acquisitions of 1.4%. The 52.3% increase in organic revenue was due to a 54.2% contribution from COVID-19 Testing, partially offset by a 1.9% decline in the organic Base Business, which includes the negative impact from PAMA of 1.1%.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total volume, measured by requisitions, increased by 21.8% as organic volume increased by 20.0% and acquisition volume contributed 1.8%. The organic volume growth includes increased demand for COVID-19 Testing of 28.8%, partially offset by an 8.9% reduction of organic Base Business due to the pandemic. Price/mix increased by 31.9% due to COVID-19 Testing of 25.4% and organic Base Business of 7.0%, which includes the negative impact from PAMA of 1.1%.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CDD revenues for the third quarter were $1,241.9, an increase of 5.7% over revenues of $1,175.4 in the third quarter of 2019.&#160;The increase in revenues was primarily due to organic growth of 3.8%, acquisitions of 0.5%, and favorable foreign currency translation of 1.4%. The increase in organic revenue was due to COVID-19 testing through its Central Laboratories business. Excluding COVID-19 Testing, organic revenue was flat compared to the third quarter of 2019. The pandemic continues to cause delays in clinical trial progression and associated testing, reductions in investigator site access, as well as interruptions to the supply chain particularly impacting the nonclinical business unit.</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Cost of Revenues</span></div><div style="margin-bottom:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,336.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,111.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues as a % of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenues decreased 10.7% during the three months ended September&#160;30, 2020, as compared with the corresponding period in 2019. Cost of revenues as a percentage of revenues during the three months ended September&#160;30, 2020, decreased to 60.0% as compared to 72.1% in the corresponding period in 2019. This decrease was primarily due to the impact of COVID-19 testing and LaunchPad savings, partially offset by the reduction in Base Business as a result of the pandemic and PAMA and higher personnel costs primarily driven by merit increases.</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Selling, General and Administrative Expenses</span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses as a % of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September&#160;30, 2020, the Company incurred $2.4 of acquisition and divestiture related costs, $1.9 in COVID-related costs and $1.8 in management transition costs. In addition, the Company recorded $0.2 of non-capitalized costs associated with the implementation of a major system as part of its LaunchPad business process improvement initiative and $0.7 related to miscellaneous other items. These items increased selling, general and administrative expenses by $7.0.&#160;</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September&#160;30, 2019, the Company incurred $9.6 in acquisition and divestiture costs, $5.3 in management transition costs and $11.3 in costs related to the AMCA data breach.  In addition, the Company recorded $2.4 of non-capitalized costs associated with the implementation of a major system as part of its LaunchPad business process improvement initiative and reversed $13.9 related to the settlement of a contingent purchase price related to a 2016 acquisition. These items increased selling, general and administrative expenses by $14.7.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding these charges, selling, general and administrative expenses as a percentage of revenues were 10.6% and 13.2% during the three months ended September&#160;30, 2020, and 2019, respectively, primarily due to leveraging the Company's infrastructure on higher revenue, partially offset by a $15.0 initial contribution to establish the LabCorp Charitable Foundation which supports the Company's strategic mission to improve health and improve lives with contributions focused on health and welfare, education and community.  </span></div><div style="margin-top:7pt;text-align:justify"><span><br/></span></div><div style="margin-top:7pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Goodwill and Other Asset Impairments</span></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:54.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.758%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.758%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.831%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other asset impairments</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2020, the Company recorded goodwill and other asset impairment charges of $10.1 and $17.7 for customer relationships and technology intangible assets, respectively, due to the loss of a contract from a CDD prior acquisition. The Company reversed the $5.0 charge for the estimated loss related to the CDD floating rate secured note receivable due 2022 from Envigo. The Company also recorded an impairment for a note receivable related to an LCD investment of $0.7 during the three months ended September 30, 2020. </span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Amortization of Intangibles and Other Assets</span></div><div style="margin-bottom:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 6.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LCD</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 6.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CDD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 6.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortization of intangibles and other assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in amortization of intangibles and other assets primarily reflects the impact of acquisitions occurring after September&#160;30, 2019, partially offset by the of impairment of intangible assets in fiscal 2020. </span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Restructuring and Other Special Charges</span></div><div style="margin-bottom:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other charges</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.8)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September&#160;30, 2020, the Company recorded net restructuring and other charges of $7.1: $1.6 within LCD and $5.5 within CDD. The charges were comprised of $2.3 related to severance and other personnel costs, $3.0 for a CDD lab facility and equipment impairment, and $4.0 in facility closures, impairment of operating lease right-of use assets and general integration activities. The charges were offset by the reversal of previously established liability of $0.1 and $2.1 in unused severance costs and facility-related costs, respectively.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September&#160;30, 2019, the Company recorded net restructuring and other special charges of $14.2: $6.7 within LCD and $7.5 within CDD. The charges were comprised of $5.9 related to severance and other personnel costs along with $8.5 in costs associated with facility closures, impairment of operating lease right-of-use assets and general integration initiatives. The charges were offset by the reversal of previously established reserves of $0.2 in unused facility reserves.</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Interest Expense</span></div><div style="margin-bottom:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.4)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.5)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.0)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in interest expense for the three months ended September&#160;30, 2020, as compared with the corresponding period in 2019, is primarily due to a lower outstanding balance on term loans, lower variable interest rates, the repayment of the 2.625% senior notes and the 4.625% senior notes, partially offset by the issuance of $1,050.0 in debt securities in November 2019.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Equity Method Income</span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method income, net</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Equity method income represents the Company's ownership share in joint venture partnerships along with equity investments in other companies in the health care industry. All of these partnerships and investments reside within LCD. The increase in income for the three months ended September&#160;30, 2020, as compared with the corresponding period in 2019, was primarily due to increased profitability of the Company's joint ventures.</span></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Other, net</span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54.2)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,096.1)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The change in other, net for the three months ended September&#160;30, 2020, as compared to the three months ended September 30, 2019, is primarily due to the derecognition of the income associated with the $55.9 from the CARES Act Provider Relief Funds received during the second quarter as the Company plans to return the funding. The Company recorded investment gains of $4.6, including a gain of $1.6 on the extinguishment of the interest rate swap arrangement. In addition, foreign currency transaction losses of $1.9 were recognized for the three months ended September&#160;30, 2020, and losses of $2.9 were recognized in the corresponding period of 2019.  </span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Income Tax Expense</span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense as a % of earnings before income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The 2020 tax rate was unfavorable to the 2019 tax rate due to the higher mix of earnings in the United States and the favorable impact of a reduction in tax rates in foreign jurisdictions in 2019. </span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Operating Income by Segment</span></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:55.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.605%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.605%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LCD operating income</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">964.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">LCD operating margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CDD operating income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">CDD operating margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:8pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LCD operating income was $964.6 for the three months ended September&#160;30, 2020, an increase of 267.8% over operating income of $262.2 in the corresponding period of 2019, and LCD operating margin increased 20.8% basis points year-over-year. The increase was primarily due to the increase in COVID-19 Testing and LaunchPad savings, partially offset by the negative impact of PAMA of $20.0. The Company remains on track to deliver approximately $200.0 of net savings from its three-year LCD LaunchPad initiative by the end of 2021.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CDD operating income was $142.0 for the three months ended September&#160;30, 2020, an increase over operating income of $123.8 in the corresponding period of 2019. The increase was primarily due to COVID Testing and LaunchPad savings, partially offset by higher personnel costs. The Company remains on track to deliver approximately $150.0 of net savings from its three-year CDD LaunchPad initiative by the end of 2020.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General corporate expenses are comprised primarily of administrative services such as executive management, human resources, legal, finance, corporate affairs, and information technology. Corporate expenses were 59.8 for the three months ended September&#160;30, 2020, an increase of 29.3% over corporate expenses of 46.2 in the corresponding period of 2019. The increase in corporate expenses in 2020 was primarily due to the funding of the LabCorp Charitable Foundation.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nine months ended September&#160;30, 2020, compared with nine months ended September&#160;30, 2019</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Revenues </span></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:53.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.565%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LCD</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,098.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,242.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CDD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,479.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,376.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intercompany eliminations and other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90.0)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,488.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,601.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues for the nine months ended September 30, 2020, were $9,488.7, an increase of 10.3% from $8,601.4 during the nine months ended September&#160;30, 2019. The increase in revenues was due to organic growth of 8.3%, acquisitions of 2.1%, and favorable foreign currency translation of 0.1%, partially offset by the disposition of a business of 0.2%. The 8.3% increase in organic revenue includes the 16.4% contribution from COVID-19 Testing, partially offset by the 8.3% reduction in the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company's organic Base Business due to the pandemic. The decline in the organic Base Business includes the negative impact from PAMA of 0.6%.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LCD revenues for the nine months ended September&#160;30, 2020, were $6,098.8, an increase of 16.3% compared to revenues of $5,242.1 for the nine months ended September&#160;30, 2019. The increase in revenue was due to organic growth of 14.9% and acquisitions of 1.4%. The 14.9% increase in organic revenue, was due to a 26.9% contribution from COVID-19 Testing, partially offset by a 12.0% decline of the organic Base Business due to the pandemic. The 12.0% decline of organic Base Business includes a 1.0% negative impact from PAMA and a 1.0% reduction due to the September 2019 nonrenewal of the BeaconLBS - UnitedHealthcare contract pertaining to the Florida market.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total volume, measured by requisition, decreased by 0.7% as organic volume decreased by 2.3% and acquisition volume contributed grwoth of 1.6%. The organic volume decline includes increased demand for COVID-19 Testing of 14.7%, more than offset by a 17.0% reduction of organic Base Business due to the pandemic. Price/mix increased by 17.2% due to COVID-19 Testing of 12.3% and Base Business of 4.8%. The Base Business price includes the negative impact from PAMA of 1.0% and the non-renewal of the BeaconLBS contract of 1.0%.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CDD revenues for nine months ended September&#160;30, 2020, were $3,479.4, an increase of 3.0% over revenues of $3,376.4 for the nine months ended September&#160;30, 2019.&#160;The increase in revenue was primarily due to the benefit of acquisitions of 3.2%, favorable foreign currency translation of 0.4% and organic growth of 0.1%, partially offset by the disposition of a business of  0.6%. The increase in organic revenue was primarily driven by COVID-19 PCR testing through its Central Laboratories, partially offset by the negative impact from the pandemic. The pandemic continues to cause delays in clinical trial progression and associated testing, reductions in investigator site access, as well as interruptions to the supply chain particularly impacting the nonclinical business unit.</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Cost of Revenues </span></div><div style="margin-bottom:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,440.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,169.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues as a % of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenues increased 4.4% during the nine months ended September&#160;30, 2020, as compared with the corresponding period in 2019. Cost of revenues as a percentage of revenues during the nine months ended September&#160;30, 2020, decreased to 67.9% as compared to 71.7% in the corresponding period in 2019. This decrease was primarily due to the impact of COVID-19, higher personnel costs (primarily driven by merit increases and one additional payroll day that predominantly impacted LCD), and PAMA, partially offset by LaunchPad savings.</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Selling, General and Administrative Expenses</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,211.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses as a % of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2020, the Company incurred $15.3 of acquisition and divestiture related costs, $5.8 in COVID-related costs and $12.4 in management transition costs. In addition, the Company recorded $1.3 of non-capitalized costs associated with the implementation of a major system as part of its LaunchPad business process improvement initiative and $1.7 related to miscellaneous other items. These charges were offset by insurance proceeds of $10.0 related to the 2018 ransomware attack. These items increased selling, general and administrative expenses by $26.5.&#160;</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2019, the Company incurred $53.9 in acquisition and divestiture costs, $8.2 in consulting expenses relating to fees incurred as part of its integration and management transition costs, $0.7 in costs related to the 2018 ransomware attack and $11.3 in costs related to the AMCA data breach. In addition, the Company recorded $7.4 of non-capitalized costs associated with the implementation of a major system as part of its LaunchPad business process improvement initiative and reversed $13.9 related to the settlement of a contingent purchase price related to a 2016 acquisition. These items increased selling, general and administrative expenses by $67.6.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding these charges, selling, general and administrative expenses as a percentage of revenues were 12.5% and 13.3% during the nine months ended September&#160;30, 2020, and 2019, respectively, primarily due to leveraging the Company's infrastructure on higher revenue, partially offset by a $15.0 initial contribution to establish the LabCorp Charitable Foundation which supports the Company's strategic mission to improve health and improve lives with contributions focused on health and welfare, education and community.</span></div><div style="margin-top:7pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Amortization of Intangibles and Other Assets</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 6.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LCD</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 6.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CDD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 6.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortization of intangibles and other assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in amortization of intangibles and other assets within both segments primarily reflects the impact of acquisitions occurring after September&#160;30, 2019, partially offset by impairment of intangible assets recorded in fiscal 2020.</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Goodwill and Other Asset Impairments</span></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:54.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.758%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.758%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.831%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other asset impairments</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2020, the Company recorded goodwill and other asset impairment charges of $460.9, $449.3 within CDD and $11.6 within LCD, representing 3.9% of the Company's total goodwill and intangible assets. The Company concluded that the fair value was less than carrying value for two of its reporting units and recorded goodwill impairment of $418.7 in the CDD segment and $3.7 in the LCD segment during the three months ended March 31, 2020. The Company recorded non-cash charges of $31.2 for the impairment of identifiable intangible assets during the nine months ended September 30, 2020, $30.5 within CDD and $0.7 within LCD. During the three months ended March 31, 2020, $2.7 and $7.3 impairment charges were recorded for tradename and software, respectively. During the three months ended September 30, 2020, additional impairment charges of $10.1 and $17.7 for customer relationships and technology intangible assets, respectively were recorded due to the loss of a contract from a prior acquisition. The Company also recorded an impairment for a note receivable related to an investment of $0.7 during the three months ended September 30, 2020.</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Restructuring and Other Special Charges</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other charges</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:7pt;margin-top:6pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2020, the Company recorded net restructuring and other charges of $38.9: $13.4 within LCD and $25.5 within CDD. The charges were comprised of $12.8 related to severance and other personnel costs, $11.0 for a CDD lab facility impairment, and $24.0 in facility closures, impairment of operating lease right-of use assets and general integration activities. The charges were offset by the reversal of previously established liability of $1.1 and $7.8 in unused severance costs and facility-related costs, respectively.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2019, the Company recorded net restructuring and other special charges of $48.4: $22.8 within LCD and $25.6 within CDD. The charges were comprised of $26.2 related to severance and other personnel costs along with $22.0 in costs associated with facility closures, impairment of operating lease right-of-use assets and general integration initiatives. The charges were increased by the adjustment of previously established reserves of $0.4 in facility reserves and decreased by a reversal of $0.2 in unused facility reserves.</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Interest Expense</span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159.1)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176.3)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.8)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in interest expense for the nine months ended September&#160;30, 2020, as compared with the corresponding period in 2019, is primarily due to a lower outstanding balance on term loans, lower variable interest rates, the repayment of the 2.625% senior notes and the 4.625% senior notes, partially offset by the issuance of $1,050.0 in debt securities in November 2019.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Equity Method Income</span></div><div style="margin-bottom:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method income, net</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123.0)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Equity method income represents the Company's ownership share in joint venture partnerships along with equity investments in other companies in the health care industry. All of these partnerships and investments reside within LCD. The decrease in income for the nine months ended September&#160;30, 2020, as compared with the corresponding period in 2019, was primarily due to the impairment of an equity method investment and decreased profitability of the Company's joint ventures.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Other, net</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.6)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.2)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in Other, net for the nine months ended September&#160;30, 2020, as compared to the nine months ended September&#160;30, 2019, was primarily due to an increase in the write-off or write down of certain of the Company's investments due to the negative impact of the COVID-19 global pandemic offset by lower foreign currency transaction losses. Foreign currency transaction losses of $6.4 were recognized for the nine months ended September&#160;30, 2020, and losses of $10.7 were recognized in the corresponding period of 2019.  </span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Income Tax Expense</span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense as a % of earnings before income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 tax rate was unfavorable to the 2019 tax rate due to impairment charges which were not deductible and or generated tax assets which require a valuation allowance. </span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Operating Income by Segment</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:55.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.605%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.605%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LCD operating income</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,451.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">LCD operating margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CDD operating income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">CDD operating margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,152.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:8pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LCD operating income was $1,451.5 for the nine months ended September&#160;30, 2020, an increase of 72.2% over operating income of $843.0 in the corresponding period of 2019, and LCD operating margin increased 7.7% basis points year-over-year. The increase in operating income and margin were primarily due to the increase in COVID-19 Testing and LaunchPad savings, partially offset by a reduction in Base Business (primarily due to the pandemic) and higher personnel costs. The Company remains on track to deliver approximately $200.0 of net savings from its three-year, phase II of LCD LaunchPad initiative by the end of 2021.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CDD operating loss was $131.2 for the nine months ended September&#160;30, 2020, a decrease over operating income of $277.6 in the corresponding period of 2019 and CDD operating margin decreased 12.0% basis points year-over-year. The decrease in operating income and margin was primarily due to the negative impact of COVID-19, specifically goodwill and other asset impairments of $449.3, and higher personnel costs, partially offset by organic demand, acquisitions, and LaunchPad savings. The Company is on track to deliver $150.0 of net savings from its three-year CDD LaunchPad initiative by the end of 2020.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">General corporate expenses are comprised primarily of administrative services such as executive management, human resources, legal, finance, corporate affairs, and information technology. Corporate expenses were $168.2 for the nine months ended September&#160;30, 2020, an increase of 32.6% over corporate expenses of $126.8 in the corresponding period of 2019. The increase in corporate expenses in 2020 was primarily due to higher personnel costs, including executive transition costs, COVID-19 related expenses and the funding of the LabCorp Charitable Foundation.</span></div><div id="i417074d9a2c24c34bcac25f32d2ec0c1_94"></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">LIQUIDITY AND CAPITAL RESOURCES (dollars and shares in millions)</span></div><div><span><br/></span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's strong cash-generating ability and financial condition typically have provided ready access to capital markets. The Company's principal source of liquidity is operating cash flow, supplemented by proceeds from debt offerings. The Company's senior unsecured revolving credit facility is further discussed in Note 7 Debt to the Company's Condensed Consolidated Financial Statements.</span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In summary, the Company's cash flows were as follows for the nine months ended September&#160;30, 2020, and 2019, respectively:</span></div><div style="margin-bottom:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:68.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.564%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,360.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">874.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(515.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,131.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used for) financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(516.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents at September&#160;30, 2020, and 2019, totaled $667.2 and $361.1, respectively. Cash and cash equivalents consist of highly liquid instruments, such as time deposits, commercial paper, and other money market investments, substantially all of which have original maturities of three months or less.  </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160; </span></div><div style="margin-bottom:7.1pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2020, the Company's operations provided $1,360.7 of cash as compared to $874.9 during the same period in 2019. The $485.8 increase in cash provided from operations in 2020 as compared with the corresponding 2019 period is primarily due to higher cash earnings partially offset by higher working capital. For the first nine months of 2020, operating cash flow benefited from income and payroll tax deferrals, but was negatively impacted by the increase in COVID-19 Testing related supplies and accounts receivable. In addition, operating cash flow included $132.1 in CARES Act Provider Relief Funds, which the Company plans to return in the fourth quarter of 2020. Based on current expectations of the impact of COVID-19, the Company expects to continue to generate positive cash flows from operating activities, however, should the COVID-19 impact worsen or last longer than anticipated, the Company may see a significant decline in cash flows from operating activities. For more information regarding the risks associated with the COVID-19 and its impact on the Company's business, see Risk Factors in Part II - Item IA.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%">Investing Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%"> </span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used for investing activities for the nine months ended September&#160;30, 2020, was $515.2 as compared to net cash used for investing activities of $1,131.0 for the nine months ended September&#160;30, 2019. The change in cash used for investing activities was primarily due to a decrease in business acquisitions during the nine months ended September&#160;30, 2020. Capital expenditures were $282.3 and $272.0 for the nine months ended September&#160;30, 2020, and 2019, respectively. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used for financing activities for the nine months ended September&#160;30, 2020, was $516.4 compared to net cash provided by financing activities of $196.7 for the nine months ended September&#160;30, 2019. The change in cash flows from financing activities for the nine months ended September&#160;30, 2020, as compared to the nine months ended September&#160;30, 2019, were primarily due to net financing proceeds from the term loan and revolving credit facilities in 2019 of $600.0, compared to the redemption of $412.2 in senior notes in 2020 offset by a $300.0 reduction in share repurchases. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revolving credit facility consists of a five-year revolving facility in the principal amount of up to $1,000.0, with the option of increasing the facility by up to an additional $350.0, subject to the agreement of one or more new or existing lenders to provide such additional amounts and certain other customary conditions.</span></div><div style="margin-top:7.1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Company's term loan credit facility and the revolving credit facility, the Company is subject to negative covenants limiting subsidiary indebtedness and certain other covenants typical for investment grade-rated borrowers and the Company is required to maintain certain leverage ratios. The Company was in compliance with all covenants under the term loan credit facility and the revolving credit facility at September&#160;30, 2020, and expects that it will remain in compliance with its existing debt covenants for the next twelve months.</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 17, 2020, the Company redeemed the remaining $412.2 of its 4.625% Senior Notes due November 15, 2020, using available cash on hand and borrowings under its revolving credit facility.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020, the Company had $667.2 of cash and $997.0 of available borrowings under its revolving credit facility, which does not mature until 2022. In May 2020, in order to obtain increased financial covenant flexibility, the Company and its lenders entered into amendments to the term loan facility and the revolving credit facility to increase the maximum leverage ratio to 5.0x debt to last twelve months EBITDA for the three month periods ending June 30, September 30 and December 31, 2020, and 4.5x for period ended March 31, 2021. From and including the period ending June 30, 2021 the maximum leverage ratio reverts back to 4.0x. The amendments also provide that during any period in which the Company's leverage ratio exceeds 4.5x debt to last twelve months EBITDA (i) the company will be prohibited from consummating share </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">repurchases, subject to limited exceptions, (ii) borrowings under the revolving credit facility will accrue interest at a per annum rate equal to, at the Company's election, either a LIBOR rate plus a margin of 1.25% or a base rate plus a margin of 0.25%, (iii) the facility fee that the Company is required to pay on the aggregate commitments under the revolving credit facility will be 0.25% per annum, and (iv) borrowings under the term loan facility will accrue interest at a per annum rate equal to, at the Company's election, either a LIBOR rate plus a margin of 1.175% or a base rate plus a margin of 0.175%.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the end of 2019, the Company had outstanding authorization from the board of directors to purchase up to&#160;$900.0 of Company common stock. As of September&#160;30, 2020, the Company had outstanding authorization from the board of directors to purchase up to $800.0 of the Company's common stock. The repurchase authorization has no expiration date. The Company reinstated its share repurchase program in October 2020 following the temporary suspension of stock repurchases beginning in March 2020 due to the impact of the COVID-19 pandemic.</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Ratings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investment grade debt ratings from Moody&#8217;s and from Standard and Poor&#8217;s (S&amp;P) contribute to its ability to access capital markets.</span></div><div id="i417074d9a2c24c34bcac25f32d2ec0c1_97"></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market risk is the potential loss arising from adverse changes in market rates and prices, such as foreign currency exchange rates, interest rates, and other relevant market rate or price changes. In the ordinary course of business, the Company is exposed to various market risks, including changes in foreign currency exchange and interest rates, and the Company regularly evaluates its exposure to such changes. The Company addresses its exposure to market risks, principally the market risks associated with changes in foreign currency exchange rates and interest rates, through a controlled program of risk management that includes, from time to time, the use of derivative financial instruments such as foreign currency forward contracts, and interest rate and cross currency swap agreements.</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Exchange Rates</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 11.0% of the Company's revenues for the nine months ended September&#160;30, 2020, and approximately 12.6% of the Company's revenue for the nine months ended September&#160;30, 2019, were denominated in currencies other than the U.S. dollar. The Company's financial statements are reported in U.S. dollars and, accordingly, fluctuations in exchange rates will affect the translation of revenues and expenses denominated in foreign currencies into U.S. dollars for purposes of reporting the Company's consolidated financial results. In the third quarter of 2020 and the year ended December&#160;31, 2019, the most significant currency exchange rate exposures were to the Canadian dollar, Swiss Franc, Euro and British Pound. Excluding the impacts from any outstanding or future hedging transactions, a hypothetical change of 10% in average exchange rates used to translate all foreign currencies to U.S. dollars would have impacted income before income taxes for the nine months ended September&#160;30, 2020, by approximately $2.2. Gross accumulated currency translation adjustments recorded as a separate component of shareholders&#8217; equity were $<ix:nonFraction unitRef="usd" contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV85Ny9mcmFnOjk5MDI4NzA5NWE4MjQxZGE4OWNiYThiNjBiZmYxZDBmL3RleHRyZWdpb246OTkwMjg3MDk1YTgyNDFkYTg5Y2JhOGI2MGJmZjFkMGZfMTkxOQ_661e336d-d70f-4f37-8123-43e5df1d3a19">52.4</ix:nonFraction> and $(<ix:nonFraction unitRef="usd" contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV85Ny9mcmFnOjk5MDI4NzA5NWE4MjQxZGE4OWNiYThiNjBiZmYxZDBmL3RleHRyZWdpb246OTkwMjg3MDk1YTgyNDFkYTg5Y2JhOGI2MGJmZjFkMGZfMTkyNg_b998e58a-7d0d-489a-9e43-e549934094b2">45.4</ix:nonFraction>) at September&#160;30, 2020, and 2019, respectively. The Company does not have significant operations in countries in which the economy is considered to be highly-inflationary.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company earns revenue from service contracts over a period of several months and, in some cases, over a period of several years. Accordingly, exchange rate fluctuations during this period may affect the Company's profitability with respect to such contracts. The Company is also subject to foreign currency transaction risk for fluctuations in exchange rates during the period of time between the consummation and cash settlement of transactions. The Company limits its foreign currency transaction risk through exchange rate fluctuation provisions stated in some of its contracts with customers, or it may hedge transaction risk with foreign currency forward contracts. At September&#160;30, 2020, the Company had 38 open foreign exchange forward contracts relating to service contracts with various amounts maturing monthly through October 2020 with a notional value totaling approximately $564.6. At December&#160;31, 2019, the Company had 34 open foreign exchange forward contracts relating to service contracts with various amounts maturing monthly through January 2020 with a notional value totaling approximately $369.2.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is party to U.S. Dollar to Swiss Franc cross-currency swap agreements with an aggregate notional amount of $<ix:nonFraction unitRef="usd" contextRef="i9f958adbe35f4caab3789a03b8cec98f_I20200930" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV85Ny9mcmFnOjk5MDI4NzA5NWE4MjQxZGE4OWNiYThiNjBiZmYxZDBmL3RleHRyZWdpb246OTkwMjg3MDk1YTgyNDFkYTg5Y2JhOGI2MGJmZjFkMGZfMzI2NA_9574127d-05fa-4fcc-8cd6-e1279c7718c2">600.0</ix:nonFraction>, maturing in 2022 and 2025, as a hedge against the impact of foreign exchange movements on its net investment in a Swiss Franc functional currency subsidiary.</span></div><div style="margin-bottom:3pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rates</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company's debt is subject to interest at variable rates. As a result, fluctuations in interest rates affect the business. The Company attempts to manage interest rate risk and overall borrowing costs through an appropriate mix of fixed and variable rate debt including by the utilization of derivative financial instruments, primarily interest rate swaps. </span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the Company's term loan credit facility and revolving credit facility are subject to variable interest rates, unless fixed through interest rate swaps or other agreements. As of September&#160;30, 2020, and December&#160;31, 2019, the Company </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">had $<ix:nonFraction unitRef="usd" contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930" decimals="-6" name="lh:A2019TermLoan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV85Ny9mcmFnOjk5MDI4NzA5NWE4MjQxZGE4OWNiYThiNjBiZmYxZDBmL3RleHRyZWdpb246OTkwMjg3MDk1YTgyNDFkYTg5Y2JhOGI2MGJmZjFkMGZfNDAyOQ_6fd128fa-a087-4432-ac9d-fc23e3af2fa2">375.0</ix:nonFraction> and $375.0, respectively, of unhedged variable debt from the 2019 term loan credit facility and $0.0 and $0.0, respectively, outstanding on its revolving credit facility. </span></div><div style="margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company exited the remaining fixed-to-variable interest rate swap arrangement in August 2020, in connection with the redemption of the <ix:nonFraction unitRef="number" contextRef="i391abd34dc914608a327d3e643899d6b_I20200930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV85Ny9mcmFnOjk5MDI4NzA5NWE4MjQxZGE4OWNiYThiNjBiZmYxZDBmL3RleHRyZWdpb246OTkwMjg3MDk1YTgyNDFkYTg5Y2JhOGI2MGJmZjFkMGZfMzI5ODUzNDg4ODQyMg_8c2e5805-ae45-4207-a91a-2b692be7c6a2">4.625</ix:nonFraction>% Senior Notes due 2020.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each quarter-point increase or decrease in the variable rate would result in the Company's interest expense changing by approximately $0.9 per year for the Company's unhedged variable rate debt.  </span></div><div id="i417074d9a2c24c34bcac25f32d2ec0c1_100"></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. Controls and Procedures</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:7.1pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the end of the period covered by this Quarterly Report on Form 10-Q, the Company carried out, under the supervision and with the participation of the Company&#8217;s management, including the Company&#8217;s principal executive officer and principal financial officer, an evaluation of the effectiveness of the design and operation of the Company&#8217;s disclosure controls and procedures (as defined in Rules13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended). Based upon this evaluation, the Company&#8217;s principal executive officer and principal financial officer concluded that the Company&#8217;s disclosure controls and procedures were effective as of September&#160;30, 2020.</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in the Company&#8217;s internal control over financial reporting (as defined in Rules13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended) that occurred during the quarter ended September&#160;30, 2020, that have materially affected, or are reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i417074d9a2c24c34bcac25f32d2ec0c1_103"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II - OTHER INFORMATION</span></div><div style="text-align:justify"><span><br/></span></div><div id="i417074d9a2c24c34bcac25f32d2ec0c1_106"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings</span></div><div style="margin-top:6pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 10 (Commitments and Contingencies) to the Company&#8217;s unaudited condensed consolidated financial statements, above, which is incorporated herein by reference.</span></div><div><span><br/></span></div><div id="i417074d9a2c24c34bcac25f32d2ec0c1_109"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risk factors set forth below update, and should be read in conjunction with, the risk factors set forth in Part I - Item 1A of the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2019, as amended. With the exception of the following, there have been no material changes in the risk factors that appear in Part I - Item&#160;1A of the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2019.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The effects of the outbreak of the COVID-19 pandemic have had and could continue to have material adverse impacts on the Company&#8217;s business, results of operations, cash flows, and financial position.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is closely monitoring the impact of the COVID-19 pandemic on all aspects of its business. In the second half of March, daily volume for routine tests started to decline as a result of decreased consumer demand driven by a significant reduction in physician office visits, the cancellation of elective medical procedures, and the negative impacts on discretionary spending resulting from the economic downturn, among other factors. In addition, the performance of the Company&#8217;s drug development business was challenged by COVID-19 due to actions that clients have taken and are taking that slowed clinical trial progress and the associated testing as well as restrictions in trial site access in certain countries and interruptions in the supply chain. Given the continued unpredictability pertaining to the COVID-19 pandemic and the corresponding government restrictions and customer behavior, the impact on the Company's business is not yet certain and depends on the number of evolving factors that the Company may not be able to predict or effectively respond to.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The further spread of COVID-19, and the Company&#8217;s initiatives to help limit the spread of the illness, will impact the Company&#8217;s ability to carry out its business as usual, which could materially adversely impact its business and financial condition. The Company has incurred additional costs for the safety of its employees and the continuity of its operations, including increased frequency of deep cleaning and sanitation at each of its physical locations, additional safety training and processes, enhanced hygiene practices and materials, flexible and remote working where possible, and allowing for greater social distancing for the Company&#8217;s employees who must work on-site. Additionally, the Company has made a number of changes at the Company&#8217;s patient service centers for the comfort and safety of the patients, many of which have also increased costs for the Company. For example, the Company has set aside the first business hour of every day for vulnerable patients, launched a mobile check-in process that allows patients to wait for their appointment from within their car or other nearby location, and increased sanitation and disinfection in check-in areas, waiting rooms, bathrooms, and hallways with Centers for Disease Control and Prevention (CDC)-approved disinfectants. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company faces increased cybersecurity risks due to the number of employees that are working remotely in regions impacted by stay-at-home orders. Increased levels of remote access create additional opportunities for cybercriminals to exploit vulnerabilities, and employees may be more susceptible to phishing and social engineering attempts. The Company may also be subject to increased cyber-attacks, such as phishing attacks by threat actors using the attention placed on the pandemic as a method for targeting the Company's personnel. In addition, technological resources may be strained due to the number of remote users. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Adverse changes in government and third-party payer regulations, reimbursement, or coverage policies (or in the interpretation of current regulations) relating to COVID-19 testing could materially impact the Company's results of operations, cash flows and financial position.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects to continue to incur additional costs, which may be significant, as it continues to implement operational changes in response to this pandemic. Further, the COVID-19 outbreak has disrupted and could continue to disrupt the Company&#8217;s supply chain, including by impacting its ability to secure test collection supplies, equipment and testing supplies for its facilities, personal protective equipment for its employees in its testing locations, patient service centers, and drug development clinics. For similar reasons, the COVID-19 pandemic has also adversely impacted, and may continue to adversely impact, third parties that are critical to the Company&#8217;s business, including vendors, suppliers, and business partners. These developments, and others that are difficult or impossible to predict, could impact materially the Company&#8217;s business, financial results, cash flows, and financial position. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has diverted resources to developing and enhancing the accessibility of COVID-19 testing, while at the same time taking certain steps with respect to its business strategy in order to increase cash flexibility. For example, the Company </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">temporarily suspended its share repurchase program, applied a heightened threshold to acquisition activity, and delayed some of its non-COVID-19 related capital expenditures. These measures, and any other measures the Company has taken and will continue to take to mitigate COVID-19, may be insufficient to ensure the financial stability of the Company, or may have other adverse impacts on the Company&#8217;s business, results of operations, cash flows, and financial position. Additionally, if the pandemic continues for an extended period of time, the Company may be forced to prioritize its application of resources to the continued mitigation of COVID-19, at the expense of other potentially profitable opportunities or initiatives, such as through the development of new products or selected business acquisitions.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the Company does not respond appropriately to the COVID-19 pandemic, or if the Company&#8217;s customers do not perceive its response to be adequate, the Company could suffer damage to its reputation, which could adversely affect its business.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11, 2020, the outbreak of COVID-19 was declared a global pandemic and containment and mitigation measures were recommended; six days prior to this characterization, the Company announced the availability of its LabCorp 2019 Novel Coronavirus (COVID-19) PCR test, which detects the presence of the underlying virus that causes COVID-19, for use with patients who meet current guidance for evaluation of infection with COVID-19. On April 9, 2020, the Company announced an agreement to collaborate on a comprehensive U.S.-based COVID-19 patient data registry. The Company also launched a self-collection kit for its COVID-19 PCR test under an emergency use authorization from the FDA, as well as expanded availability of antibody tests to detect antibodies to the virus that causes COVID-19. The Company has performed approximately 22 million COVID-19 tests, which represents about 19 million PCR tests and over 3 million antibody tests. The Company continues to increase capacity for COVID-19 PCR testing but the Company's testing capacity is dependent on access to multiple testing platforms and the availability of equipment and testing supplies and key personnel. The Company's central laboratory business has also seen a significant increase in demand for sample collection supplies and kits for clinical trials testing, which has caused some delays in delivery of kit orders. Despite the Company's efforts to expand capacity and access to COVID-19 testing and clincial trials collection kits, the Company may not be successful in meeting expectations, and the Company&#8217;s customers and other stakeholders may perceive the Company&#8217;s responses to the pandemic as insufficient, inadequate or not equivalent to or better than competitors, including with respect to the availability of testing, collection  kits, and the amount of time it takes for delivery of test results or fulfillment of kit orders. Factors that may be out of the Company&#8217;s control, such as the availability of equipment, supplies, and key personnel and geographical changes in demand, may impact the Company&#8217;s ability to meet customer demand and the Company's other responses to the COVID-19 pandemic, and may have an adverse effect on the Company&#8217;s operations. Any such disruptions could result in negative publicity, and the Company could suffer damage to its reputation, which could adversely affect its business, results of operations, cash flows, and financial position.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The success of the Company is dependent in part on the efforts of its management team and employees, and the COVID-19 pandemic could divert or hinder the Company&#8217;s human capital resources, which may adversely affect the Company&#8217;s operations. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management team and employees have been acutely focused on efforts to respond to and mitigate COVID-19, including developing COVID-19 Testing. The Company has been continuously working to increase the number of tests that can be performed and improve the time for delivering test results. The Company&#8217;s management team is also working closely with federal and state authorities, health officials, and other key constituencies to make testing available to patients who meet the CDC criteria for who should be tested, and Department of Health and Human Services (HHS) guidance for prioritization of testing. These response efforts have required, and will continue to require, a large investment of time and resources that would otherwise be focused on the development and growth of the Company. Further, the Company's ability to maintain and expand testing capacity depend upon maintaining and expanding its employee population. If the Company&#8217;s management team or employees become unavailable due to illness or from other related factors, its operations could be materially adversely affected. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The ongoing COVID-19 pandemic has created significant volatility, uncertainty, and economic disruption that could have an adverse impact on the Company&#8217;s financial position, including with respect to the Company&#8217;s ability to repay its senior notes when due and maintain its maximum leverage ratio covenant under its term loan facility and revolving credit facility. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company believes that it maintains a solid financial position, including a strong balance sheet, investment grade ratings, and significant access to credit, the sweeping nature of the rapidly-evolving COVID-19 pandemic has created cascading effects, all of which are difficult to predict. If the pandemic continues to create disruptions or turmoil in the credit and financial markets, the Company&#8217;s ability to access capital on favorable terms and continue to meet its liquidity needs in the future could be adversely impacted. The Company may also experience greater than normal impact due to fluctuations in foreign exchange rates and interest rates, decreased sales volumes, changes in employment rates and health insurance coverage, the speed of the anticipated recovery, the ability of its customers to pay for its services, and governmental and business reactions to the pandemic, all of which are highly uncertain and cannot be predicted. The Company implemented several measures in order to increase cash flexibility in light of these economic uncertainties, including temporarily suspending its share repurchase program, applying a heightened threshold to acquisition activity, and delaying some of its non-COVID-19 related capital </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expenditures. These measures, and any other measures the Company may take to mitigate COVID-19, may be insufficient to ensure the financial stability of the Company, and may have other adverse impacts on the Company&#8217;s business, results of operations, cash flows, and financial position.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, the Company and its lenders entered into amendments to the term loan facility and the revolving credit facility to increase the maximum leverage ratio covenant to 5.0x debt to last twelve months EBITDA for each of the three month periods ending June 30, September 30, and December 31, 2020, and 4.5x debt to last twelve months EBITDA for the three month period ending March 31, 2021. Violation of that covenant could preclude the Company from borrowing on the revolving credit facility and require repayment of its term loan of $375.0, if demanded by a majority of the Company's bank group. There can be no assurance that the Company will be able to maintain compliance with this modified covenant due to the uncertainties of the Company's financial performance as a result of the COVID-19 pandemic. If the Company were not able to do so, any future covenant amendment or waiver that the Company may need or seek in the future may lead to increased costs, increased interest rates, additional restrictive covenants and other available lender protections. There can be no assurance that the Company would be able to obtain additional amendments or waivers in a timely manner, on acceptable terms, or at all. </span></div><div style="margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A violation of its term loan and revolving credit facility leverage ratio covenants or other covenants, a failure to obtain any additional covenant amendments or waivers, or a failure to obtain alternative financing, if required, could result in a default, which would result in defaults under the Company&#8217;s other debt agreements and have material adverse consequences for the Company.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span><br/></span></div><div id="i417074d9a2c24c34bcac25f32d2ec0c1_112"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds (dollars in millions, except per share data)</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information with respect to purchases of shares of the Company&#8217;s common stock based on settled trades made during the three months ended&#160;September&#160;30, 2020, by or on behalf of the Company:</span></div><div style="margin-bottom:8pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.076%"><tr><td style="width:1.0%"></td><td style="width:30.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.318%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Number of Shares Repurchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average Price Paid Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Number of Shares Repurchased as Part of Publicly Announced Program</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum Dollar Value of Shares that May Yet Be Repurchased Under the Program</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1 - July 31</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1 - August 31</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1 - September 30</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800.0&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, the Company had outstanding authorization from the board of directors to purchase up to $800.0 of the Company's common stock. The repurchase authorization has no expiration date. The Company reinstated its share repurchase program in October 2020 following the temporary suspension of stock repurchases beginning in March 2020 due to the impact of the COVID-19 pandemic.</span></div><div id="i417074d9a2c24c34bcac25f32d2ec0c1_115"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Other Information</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None. </span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify"><span><br/></span></div><div id="i417074d9a2c24c34bcac25f32d2ec0c1_118"></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="ex311q32020.htm">Certification by the Chief Executive Certification by Certification by the Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) pursuant to Rule 13a-14(a) or Rule 15d-14(a)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex312q32020.htm">Certification by the Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex32q32020.htm">Written Statement of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.091%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">filed herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">furnished herewith</span></td></tr></table></div><div><span><br/></span></div><div id="i417074d9a2c24c34bcac25f32d2ec0c1_121"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i417074d9a2c24c34bcac25f32d2ec0c1_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">LABORATORY CORPORATION OF AMERICA HOLDINGS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.781%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.093%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/ ADAM H. SCHECHTER</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adam H. Schechter</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.781%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.093%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/ GLENN A. EISENBERG</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glenn A. Eisenberg</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October&#160;29, 2020 </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>ex311q32020.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="ib82f13e27fb04e628d69f74ea6e4e3c0_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit 31.1</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certification</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Adam H. Schechter, certify that&#58;</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this quarterly report on Form 10-Q of Laboratory Corporation of America Holdings&#59;</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59; </font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59;  and</font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:87.719%"><tr><td style="width:1.0%"></td><td style="width:5.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.734%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 29, 2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; ADAM H. SCHECHTER</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adam H. Schechter</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>ex312q32020.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="if1cc6977d6f64bf6a4450c41c29d037b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit 31.2</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certification</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Glenn A. Eisenberg, certify that&#58;</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this quarterly report on Form 10-Q of Laboratory Corporation of America Holdings&#59;</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59; </font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59;  and</font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:87.719%"><tr><td style="width:1.0%"></td><td style="width:5.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.734%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 29, 2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; GLENN A. EISENBERG</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glenn A. Eisenberg</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>ex32q32020.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i9d5a4adba7f64fa29000a6675eafece2_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-right:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit 32</font></div><div style="padding-right:45pt"><font><br></font></div><div style="padding-right:45pt"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written Statement of</font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer and Chief Financial Officer</font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     The undersigned, the Chief Executive Officer and the Chief Financial Officer of Laboratory Corporation of America Holdings (the &#8220;Company&#8221;), each hereby certifies that, to his knowledge on the date hereof&#58;</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     (a)  the Form 10-Q of the Company for the Period Ended September&#160;30, 2020, filed on the date hereof with the Securities and Exchange Commission (the &#8220;Report&#8221;) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     (b)  information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.935%"><tr><td style="width:1.0%"></td><td style="width:52.919%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.848%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.933%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; ADAM H. SCHECHTER</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adam H. Schechter</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 29, 2020</font></td></tr></table></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.935%"><tr><td style="width:1.0%"></td><td style="width:52.919%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.848%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.933%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; GLENN A. EISENBERG</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glenn A. Eisenberg</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 29, 2020</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Laboratory Corporation of America Holdings and will be retained by Laboratory Corporation of America Holdings and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>lh-20200930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:fc8a7d57-4cce-43ce-b480-996ae8b97c72,g:096b564a-e6b9-41cc-ab37-c90f57b146f8-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lh="http://www.labcorp.com/20200930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.labcorp.com/20200930">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lh-20200930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lh-20200930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lh-20200930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lh-20200930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.labcorp.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals" roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited" roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited" roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited">
        <link:definition>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFFINANCIALSTATEMENTPRESENTATION" roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATION">
        <link:definition>2101101 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFFINANCIALSTATEMENTPRESENTATIONUseofEstimatesPolicies" roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONUseofEstimatesPolicies">
        <link:definition>2202201 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION Use of Estimates (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFFINANCIALSTATEMENTPRESENTATIONNewAccountingPronouncementsPolicies" roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONNewAccountingPronouncementsPolicies">
        <link:definition>2203202 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION New Accounting Pronouncements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFFINANCIALSTATEMENTPRESENTATIONNovelCoronavirusCOVID19FinancialStatementImpactPolicies" roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONNovelCoronavirusCOVID19FinancialStatementImpactPolicies">
        <link:definition>2204203 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION Novel Coronavirus (COVID-19) Financial Statement Impact (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFFINANCIALSTATEMENTPRESENTATIONRecentlyAdoptedAccountingStandardsPolicies" roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONRecentlyAdoptedAccountingStandardsPolicies">
        <link:definition>2205204 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION Recently Adopted Accounting Standards (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFFINANCIALSTATEMENTPRESENTATIONRestatedFinancialStatements" roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONRestatedFinancialStatements">
        <link:definition>1307301 - Statement - BASIS OF FINANCIAL STATEMENT PRESENTATION Restated Financial Statements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFFINANCIALSTATEMENTPRESENTATIONDetails" roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails">
        <link:definition>2406401 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARE" roleURI="http://www.labcorp.com/role/EARNINGSPERSHARE">
        <link:definition>2107102 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARETables" roleURI="http://www.labcorp.com/role/EARNINGSPERSHARETables">
        <link:definition>2308302 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails" roleURI="http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails">
        <link:definition>2409402 - Disclosure - EARNINGS PER SHARE (Reconciliation of Basic Earnings Per Share to Diluted Earnings Per Share) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREPotentialcommonsharesnotincludedincomputationofdilutedearningspershareDetails" roleURI="http://www.labcorp.com/role/EARNINGSPERSHAREPotentialcommonsharesnotincludedincomputationofdilutedearningspershareDetails">
        <link:definition>2410403 - Disclosure - EARNINGS PER SHARE (Potential common shares not included in computation of diluted earnings per share) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NONCONTROLLINGINTERESTPUTS" roleURI="http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTS">
        <link:definition>2111103 - Disclosure - NONCONTROLLING INTEREST PUTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NONCONTROLLINGINTERESTPUTSDetails" roleURI="http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTSDetails">
        <link:definition>2412404 - Disclosure - NONCONTROLLING INTEREST PUTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGANDOTHERSPECIALCHARGES" roleURI="http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGES">
        <link:definition>2113104 - Disclosure - RESTRUCTURING AND OTHER SPECIAL CHARGES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables" roleURI="http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables">
        <link:definition>2314303 - Disclosure - RESTRUCTURING AND OTHER SPECIAL CHARGES Restructuring and Other Special Charges Detail (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGANDOTHERSPECIALCHARGESDetails" roleURI="http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails">
        <link:definition>2415405 - Disclosure - RESTRUCTURING AND OTHER SPECIAL CHARGES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGRESERVES" roleURI="http://www.labcorp.com/role/RESTRUCTURINGRESERVES">
        <link:definition>2116105 - Disclosure - RESTRUCTURING RESERVES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGRESERVESDetails" roleURI="http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails">
        <link:definition>2417406 - Disclosure - RESTRUCTURING RESERVES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETS" roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETS">
        <link:definition>2118106 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSTables" roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables">
        <link:definition>2319304 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails" roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails">
        <link:definition>2420407 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Changes in Carrying Amount of Goodwill) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails" roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails">
        <link:definition>2421408 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Components of identifiable intangible assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSDetails" roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails">
        <link:definition>2422409 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsGoodwillandOtherPolicies" roleURI="http://www.labcorp.com/role/IntangibleAssetsGoodwillandOtherPolicies">
        <link:definition>2223205 - Disclosure - Intangible Assets, Goodwill and Other (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT" roleURI="http://www.labcorp.com/role/DEBT">
        <link:definition>2124107 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails" roleURI="http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails">
        <link:definition>2425410 - Disclosure - DEBT (Short-term borrowings and current portion of long-term debt) (Table) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTLongtermdebtDetails" roleURI="http://www.labcorp.com/role/DEBTLongtermdebtDetails">
        <link:definition>2426411 - Disclosure - DEBT (Long-term debt) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTSeniorNotesDetails" roleURI="http://www.labcorp.com/role/DEBTSeniorNotesDetails">
        <link:definition>2427412 - Disclosure - DEBT (Senior Notes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTConvertibleSubordinatedNotesDetails" roleURI="http://www.labcorp.com/role/DEBTConvertibleSubordinatedNotesDetails">
        <link:definition>2428413 - Disclosure - DEBT (Convertible Subordinated Notes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTCreditFacilitiesDetails" roleURI="http://www.labcorp.com/role/DEBTCreditFacilitiesDetails">
        <link:definition>2429414 - Disclosure - DEBT (Credit Facilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY" roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY">
        <link:definition>2130108 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails" roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails">
        <link:definition>2431415 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails" roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails">
        <link:definition>2432416 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY - Accumulated Other Comprehensive Earnings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.labcorp.com/role/INCOMETAXES">
        <link:definition>2133109 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetails" roleURI="http://www.labcorp.com/role/INCOMETAXESDetails">
        <link:definition>2434417 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>2135110 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails">
        <link:definition>2436418 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PENSIONANDPOSTRETIREMENTPLANS" roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANS">
        <link:definition>2137111 - Disclosure - PENSION AND POSTRETIREMENT PLANS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PENSIONANDPOSTRETIREMENTPLANSDetails" roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails">
        <link:definition>2438419 - Disclosure - PENSION AND POSTRETIREMENT PLANS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails" roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails">
        <link:definition>2439420 - Disclosure - PENSION AND POSTRETIREMENT PLANS Defined Contribution Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTS" roleURI="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS">
        <link:definition>2140112 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSTables">
        <link:definition>2341305 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSDetails" roleURI="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails">
        <link:definition>2442421 - Disclosure - FAIR VALUE MEASUREMENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" roleURI="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES">
        <link:definition>2143113 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" roleURI="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables">
        <link:definition>2344306 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails" roleURI="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails">
        <link:definition>2445422 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWINFORMATION" roleURI="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATION">
        <link:definition>1108114 - Statement - SUPPLEMENTAL CASH FLOW INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWINFORMATIONTabularInformation" roleURI="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONTabularInformation">
        <link:definition>1309307 - Statement - SUPPLEMENTAL CASH FLOW INFORMATION Tabular Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation" roleURI="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation">
        <link:definition>1410423 - Statement - SUPPLEMENTAL CASH FLOW INFORMATION Description Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUISITIONS" roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONS">
        <link:definition>2146115 - Disclosure - BUSINESS ACQUISITIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUISITIONSBusinessAcquisitionsTablesTables" roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsTablesTables">
        <link:definition>2347308 - Disclosure - BUSINESS ACQUISITIONS Business Acquisitions Tables (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUISITIONSDetails" roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails">
        <link:definition>2448424 - Disclosure - BUSINESS ACQUISITIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails" roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails">
        <link:definition>2449425 - Disclosure - BUSINESS ACQUISITIONS Business Acquisitions in the Aggregate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUISITIONSDISPOSITIONSDetails" roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails">
        <link:definition>2450426 - Disclosure - BUSINESS ACQUISITIONS DISPOSITIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATIONNotes" roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONNotes">
        <link:definition>2151116 - Disclosure - BUSINESS SEGMENT INFORMATION (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATIONTables" roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONTables">
        <link:definition>2352309 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes" roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes">
        <link:definition>2153117 - Disclosure - BUSINESS SEGMENT INFORMATION Business Segment information (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails" roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails">
        <link:definition>2454427 - Disclosure - BUSINESS SEGMENT INFORMATION Business Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUENotes" roleURI="http://www.labcorp.com/role/REVENUENotes">
        <link:definition>2155118 - Disclosure - REVENUE (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUETables" roleURI="http://www.labcorp.com/role/REVENUETables">
        <link:definition>2356310 - Disclosure - REVENUE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEDetails" roleURI="http://www.labcorp.com/role/REVENUEDetails">
        <link:definition>2457428 - Disclosure - REVENUE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEDisaggregatedRevenueTableDetails" roleURI="http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails">
        <link:definition>2458429 - Disclosure - REVENUE Disaggregated Revenue Table (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuefromContractwithCustomerPolicies" roleURI="http://www.labcorp.com/role/RevenuefromContractwithCustomerPolicies">
        <link:definition>2259206 - Disclosure - Revenue from Contract with Customer (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNotes" roleURI="http://www.labcorp.com/role/LeasesNotes">
        <link:definition>2160119 - Disclosure - Leases (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.labcorp.com/role/LeasesTables">
        <link:definition>2361311 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesDetails" roleURI="http://www.labcorp.com/role/LeasesDetails">
        <link:definition>2462430 - Disclosure - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="lh_AllowanceforCreditLoss" abstract="false" name="AllowanceforCreditLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020" abstract="false" name="DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="lh_SeniorLongTermNotesDue2020Member" abstract="true" name="SeniorLongTermNotesDue2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_SeniorNotesDue2020Member" abstract="true" name="SeniorNotesDue2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_DeferredIncomeTaxesAndOtherTaxLiabilities" abstract="false" name="DeferredIncomeTaxesAndOtherTaxLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_ThirdpartyMember" abstract="true" name="ThirdpartyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_NoncontrollingInterestPutsAbstract" abstract="true" name="NoncontrollingInterestPutsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_AllowanceforCreditLossWriteOff" abstract="false" name="AllowanceforCreditLossWriteOff" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_RestructuringReserveSettledWithCashAndOtherAdjustment" abstract="false" name="RestructuringReserveSettledWithCashAndOtherAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock" abstract="false" name="NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="lh_CashPaymentReceivedAppropriatedbyU.S.CongressCovid19" abstract="false" name="CashPaymentReceivedAppropriatedbyU.S.CongressCovid19" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear" abstract="false" name="Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="lh_Crosscurrencyswapmaturing2022Member" abstract="true" name="Crosscurrencyswapmaturing2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_NoncontrollingInterestMezzanineEquity" abstract="false" name="NoncontrollingInterestMezzanineEquity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_CashFlowLocationAxis" abstract="true" name="CashFlowLocationAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="lh_UnbilledServicesCreditLossExpenseReversal" abstract="false" name="UnbilledServicesCreditLossExpenseReversal" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_Longtermdebtissuancecosts" abstract="false" name="Longtermdebtissuancecosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_CommonSharesIssuedRollforwardAbstract" abstract="true" name="CommonSharesIssuedRollforwardAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_AccruedLiabilityForCARESActFundsToBeReturnedToGovernmentDomain" abstract="true" name="AccruedLiabilityForCARESActFundsToBeReturnedToGovernmentDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_ScheduleofBusinessAcquisitionsbyAcquisitionAbstract" abstract="true" name="ScheduleofBusinessAcquisitionsbyAcquisitionAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_COVID19PandemicGoodwillAndIntangibleAssetImpairmentDomain" abstract="true" name="COVID19PandemicGoodwillAndIntangibleAssetImpairmentDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_PerShareAmountAbstract" abstract="true" name="PerShareAmountAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021" abstract="false" name="DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="lh_CreditFacilityMaximumLettersofCredit" abstract="false" name="CreditFacilityMaximumLettersofCredit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue" abstract="false" name="ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_LabCorpDiagnosticsMember" abstract="true" name="LabCorpDiagnosticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis" abstract="true" name="ScheduleOfOtherIntangibleAssetsByMajorClassAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="lh_NoteReceivableAllowanceforCreditLoss" abstract="false" name="NoteReceivableAllowanceforCreditLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_IncomeAbstract" abstract="true" name="IncomeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_ClientMember" abstract="true" name="ClientMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_CovanceMember" abstract="true" name="CovanceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_RestructuringImpairment" abstract="false" name="RestructuringImpairment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_DepreciationAndAmortizationOfLeasedAssets" abstract="false" name="DepreciationAndAmortizationOfLeasedAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_Seniornotesdue2045Member" abstract="true" name="Seniornotesdue2045Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_DefinedContributionPlanTotalExpense" abstract="false" name="DefinedContributionPlanTotalExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_CARESActFundsAxis" abstract="true" name="CARESActFundsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="lh_SalesCommissionAmortizationPeriodMinimum" abstract="false" name="SalesCommissionAmortizationPeriodMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lh_NetRestructuringCharges" abstract="false" name="NetRestructuringCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_COVID19PandemicGoodwillAndIntangibleAssetImpairment" abstract="false" name="COVID19PandemicGoodwillAndIntangibleAssetImpairment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_DiscretionaryContributionPercentageMinimum" abstract="false" name="DiscretionaryContributionPercentageMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="lh_Seniornotesdue2027Member" abstract="true" name="Seniornotesdue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_AccumulatedOtherComprehensiveEarningsRollForward" abstract="true" name="AccumulatedOtherComprehensiveEarningsRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_Seniornotesdue2025MemberMember" abstract="true" name="Seniornotesdue2025MemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_Contingentconsiderationadjustment" abstract="false" name="Contingentconsiderationadjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_ValueofReportingUnitsGoodwillFollowingImpairment" abstract="false" name="ValueofReportingUnitsGoodwillFollowingImpairment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_Seniornotesdue2023Member" abstract="true" name="Seniornotesdue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_A2.30seniornotesdue2024" abstract="false" name="A2.30seniornotesdue2024" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_OthercountriesMember" abstract="true" name="OthercountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_SalesCommissionAmortizationPeriodMaximum" abstract="false" name="SalesCommissionAmortizationPeriodMaximum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lh_UnbilledServicesAllowanceforCreditLoss" abstract="false" name="UnbilledServicesAllowanceforCreditLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_NoteReceivableCreditLossExpenseReversal" abstract="false" name="NoteReceivableCreditLossExpenseReversal" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_LongTermContractsDurationMinimum" abstract="false" name="LongTermContractsDurationMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lh_CashFlowLocationDomain" abstract="true" name="CashFlowLocationDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_GainInterestRateSwapArrangement" abstract="false" name="GainInterestRateSwapArrangement" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_SeniorNotesFairValue" abstract="false" name="SeniorNotesFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract" abstract="true" name="SegmentReconciliationofOperatingIncometoConsolidatedAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_Impairmentoffloatingratenotereceivable" abstract="false" name="Impairmentoffloatingratenotereceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_NetDefinedBenefitPlanAmortizationAndDeferral" abstract="false" name="NetDefinedBenefitPlanAmortizationAndDeferral" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments" abstract="false" name="RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings" abstract="false" name="CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" abstract="false" name="CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="lh_CommonStockRepurchaseAuthorizationOutstanding" abstract="false" name="CommonStockRepurchaseAuthorizationOutstanding" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_Unusedfacilityrestructuringreserves" abstract="false" name="Unusedfacilityrestructuringreserves" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_SeniorNotesDue2022Member" abstract="true" name="SeniorNotesDue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit" abstract="false" name="PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="lh_OutstandingStockRepurchaseAuthorizationAbstract" abstract="true" name="OutstandingStockRepurchaseAuthorizationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_A2019TermLoan" abstract="false" name="A2019TermLoan" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_Crosscurrencyswapmaturing2025Member" abstract="true" name="Crosscurrencyswapmaturing2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_CreditLossExpenseReversal" abstract="false" name="CreditLossExpenseReversal" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_A4.625Seniornotesdue2020" abstract="false" name="A4.625Seniornotesdue2020" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_A2019TermLoanMember" abstract="true" name="A2019TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_NonElectiveContribution" abstract="false" name="NonElectiveContribution" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="lh_PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill" abstract="false" name="PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="lh_ZeroCouponConvertibleSubordinatedNotesLineItems" abstract="true" name="ZeroCouponConvertibleSubordinatedNotesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_BiopharmaceuticalandmedicaldevicecompaniesMember" abstract="true" name="BiopharmaceuticalandmedicaldevicecompaniesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_Intercompanyrevenueelimination" abstract="false" name="Intercompanyrevenueelimination" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_BalanceOfSeniorNotesMatureDuringQ42020" abstract="false" name="BalanceOfSeniorNotesMatureDuringQ42020" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_MedicareandMedicaidMember" abstract="true" name="MedicareandMedicaidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_ZeroCouponConvertibleSubordinatedNotesTable" abstract="true" name="ZeroCouponConvertibleSubordinatedNotesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="lh_Lh_BusinessCombinationContingentConsiderationArrangementsPayments" abstract="false" name="Lh_BusinessCombinationContingentConsiderationArrangementsPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_LongTermContractsDurationMaximum" abstract="false" name="LongTermContractsDurationMaximum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lh_DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021" abstract="false" name="DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="lh_CostMethodInvestmentsMaximumOwnershipPercentage" abstract="false" name="CostMethodInvestmentsMaximumOwnershipPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="lh_SharesAbstract" abstract="true" name="SharesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_COVID19PandemicAxis" abstract="true" name="COVID19PandemicAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain" abstract="true" name="ScheduleOfOtherIntangibleAssetsByMajorClassDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_CreditFacilityMaximumSwingLineBorrowings" abstract="false" name="CreditFacilityMaximumSwingLineBorrowings" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_EnvigoMember" abstract="true" name="EnvigoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment" abstract="false" name="EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage" abstract="false" name="TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="lh_DecreaseinCapitalExpendituresIncurredbutnotyetPaid" abstract="false" name="DecreaseinCapitalExpendituresIncurredbutnotyetPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_TermLoanandRevolvingCreditFacilityMember" abstract="true" name="TermLoanandRevolvingCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit" abstract="false" name="ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_UnbilledContractsReceivableMember" abstract="true" name="UnbilledContractsReceivableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage" abstract="false" name="RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="lh_ConversionOfZeroCouponConvertibleDebt" abstract="false" name="ConversionOfZeroCouponConvertibleDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_CovanceDrugDevelopmentMember" abstract="true" name="CovanceDrugDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_A2.95seniornotesdue2029" abstract="false" name="A2.95seniornotesdue2029" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" abstract="false" name="FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit" abstract="false" name="PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="lh_CommonSharesHeldInTreasuryRollforwardAbstract" abstract="true" name="CommonSharesHeldInTreasuryRollforwardAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_Totalacquisitionconsiderationcashstocknotesetc." abstract="false" name="Totalacquisitionconsiderationcashstocknotesetc." nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_CommonSharesOutstandingRollforwardAbstract" abstract="true" name="CommonSharesOutstandingRollforwardAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_DiscretionaryContributionPercentageMaximum" abstract="false" name="DiscretionaryContributionPercentageMaximum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="lh_EquityMethodIncomeLossNetDomain" abstract="true" name="EquityMethodIncomeLossNetDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_PatentsLicensesAndTechnologyMember" abstract="true" name="PatentsLicensesAndTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest" abstract="false" name="IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock" abstract="false" name="ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="lh_OtherFinancingCashFlows" abstract="false" name="OtherFinancingCashFlows" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_NetProceedsFromIssuanceOfStockToEmployees" abstract="false" name="NetProceedsFromIssuanceOfStockToEmployees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" abstract="false" name="FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_PercentageFairValueofGoodwillExceededCarryingValue" abstract="false" name="PercentageFairValueofGoodwillExceededCarryingValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="lh_PercentofRevenueContributed" abstract="false" name="PercentofRevenueContributed" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="lh_CashPaidDuringPeriodForAbstract" abstract="true" name="CashPaidDuringPeriodForAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_Issuanceofcommonstockunderemployeeplans" abstract="false" name="Issuanceofcommonstockunderemployeeplans" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_CreditFacilityOptiontoIncrease" abstract="false" name="CreditFacilityOptiontoIncrease" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_IncreaseDecreaseinUnbilledContractReceivable" abstract="false" name="IncreaseDecreaseinUnbilledContractReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage" abstract="false" name="TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="lh_RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage" abstract="false" name="RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="lh_InterestPaidInCash" abstract="false" name="InterestPaidInCash" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_Seniornotesdue2024MemberMember" abstract="true" name="Seniornotesdue2024MemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_NumberofMeasurementFundsAvailableForParticipantElection" abstract="false" name="NumberofMeasurementFundsAvailableForParticipantElection" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="lh_CARESActFundsAccruedLiabilitiesAndOtherLiabilities" abstract="false" name="CARESActFundsAccruedLiabilitiesAndOtherLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_OtheracquireesMember" abstract="true" name="OtheracquireesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lh_NetRestructuringAndOtherSpecialCharges" abstract="false" name="NetRestructuringAndOtherSpecialCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_RecentlyAdoptedAccountingGuidancePolicyTextBlock" abstract="false" name="RecentlyAdoptedAccountingGuidancePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="lh_Shorttermdebtissuancecosts" abstract="false" name="Shorttermdebtissuancecosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>lh-20200930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:fc8a7d57-4cce-43ce-b480-996ae8b97c72,g:096b564a-e6b9-41cc-ab37-c90f57b146f8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.labcorp.com/role/CoverPage" xlink:type="simple" xlink:href="lh-20200930.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="simple" xlink:href="lh-20200930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3df4fadc-9aa9-4b2e-aad0-f6fa34ef4bff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_81b7897d-4116-4223-af29-0d6ca3a9f781" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3df4fadc-9aa9-4b2e-aad0-f6fa34ef4bff" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_81b7897d-4116-4223-af29-0d6ca3a9f781" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_da769ac8-f892-4bed-8310-dd5cf69b5ac4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3df4fadc-9aa9-4b2e-aad0-f6fa34ef4bff" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_da769ac8-f892-4bed-8310-dd5cf69b5ac4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_936f7d2d-17f4-43a7-a65b-e6d9abe28301" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3df4fadc-9aa9-4b2e-aad0-f6fa34ef4bff" xlink:to="loc_us-gaap_UnbilledContractsReceivable_936f7d2d-17f4-43a7-a65b-e6d9abe28301" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_875af638-40b2-4010-92a6-8e61240574a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3df4fadc-9aa9-4b2e-aad0-f6fa34ef4bff" xlink:to="loc_us-gaap_InventoryNet_875af638-40b2-4010-92a6-8e61240574a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_20fd327f-e37c-463b-a55c-5572e90968f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3df4fadc-9aa9-4b2e-aad0-f6fa34ef4bff" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_20fd327f-e37c-463b-a55c-5572e90968f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2f89ea60-60d7-4b6f-a6a6-643fb6b0bc00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3c8a931a-da48-4682-8db9-07a6519c627c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2f89ea60-60d7-4b6f-a6a6-643fb6b0bc00" xlink:to="loc_us-gaap_AssetsCurrent_3c8a931a-da48-4682-8db9-07a6519c627c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_496b5053-b92e-4e31-b8cd-8ce1e8f486f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2f89ea60-60d7-4b6f-a6a6-643fb6b0bc00" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_496b5053-b92e-4e31-b8cd-8ce1e8f486f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_07457870-9b01-4427-90f4-fd12b0623869" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2f89ea60-60d7-4b6f-a6a6-643fb6b0bc00" xlink:to="loc_us-gaap_Goodwill_07457870-9b01-4427-90f4-fd12b0623869" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e1ba1966-9987-4bee-980e-fd903328fd49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2f89ea60-60d7-4b6f-a6a6-643fb6b0bc00" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e1ba1966-9987-4bee-980e-fd903328fd49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_9813fed1-59d9-484c-be5f-9711e12fadae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2f89ea60-60d7-4b6f-a6a6-643fb6b0bc00" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_9813fed1-59d9-484c-be5f-9711e12fadae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent_96f08a68-49b0-4f63-8440-7e14311ec6a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2f89ea60-60d7-4b6f-a6a6-643fb6b0bc00" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent_96f08a68-49b0-4f63-8440-7e14311ec6a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_64ed2627-b02d-46d8-b9eb-054cac5af242" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2f89ea60-60d7-4b6f-a6a6-643fb6b0bc00" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_64ed2627-b02d-46d8-b9eb-054cac5af242" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8f66922d-0cd5-4f04-ad79-6ff5cc6ea50b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_6c76e80c-628c-41e2-8028-070ff2542cf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8f66922d-0cd5-4f04-ad79-6ff5cc6ea50b" xlink:to="loc_us-gaap_CommonStockValue_6c76e80c-628c-41e2-8028-070ff2542cf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_f0217efc-055e-453c-9934-dd7500203482" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8f66922d-0cd5-4f04-ad79-6ff5cc6ea50b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_f0217efc-055e-453c-9934-dd7500203482" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_dd407681-15be-4f9a-990f-25d205a369b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8f66922d-0cd5-4f04-ad79-6ff5cc6ea50b" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_dd407681-15be-4f9a-990f-25d205a369b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1e526be9-4049-43af-9b44-df27d63ba38c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8f66922d-0cd5-4f04-ad79-6ff5cc6ea50b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1e526be9-4049-43af-9b44-df27d63ba38c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_13921408-f6c1-4238-93de-c3d4f61b6621" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9caa2138-59d3-4ae1-8b18-05578ecd538b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_13921408-f6c1-4238-93de-c3d4f61b6621" xlink:to="loc_us-gaap_LiabilitiesCurrent_9caa2138-59d3-4ae1-8b18-05578ecd538b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_caddcc41-17bc-4d59-a051-ef50bbd3ca60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_13921408-f6c1-4238-93de-c3d4f61b6621" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_caddcc41-17bc-4d59-a051-ef50bbd3ca60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_876e2d97-82bd-4e31-b991-0895702177b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_13921408-f6c1-4238-93de-c3d4f61b6621" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_876e2d97-82bd-4e31-b991-0895702177b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_a51def50-4de6-4685-86ff-3a0d7c7934d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_13921408-f6c1-4238-93de-c3d4f61b6621" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_a51def50-4de6-4685-86ff-3a0d7c7934d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DeferredIncomeTaxesAndOtherTaxLiabilities_ab4e3eb0-6035-4955-b662-fd3916ac2649" xlink:href="lh-20200930.xsd#lh_DeferredIncomeTaxesAndOtherTaxLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_13921408-f6c1-4238-93de-c3d4f61b6621" xlink:to="loc_lh_DeferredIncomeTaxesAndOtherTaxLiabilities_ab4e3eb0-6035-4955-b662-fd3916ac2649" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ec2b088e-82fb-4704-b3ed-7e4297db5e29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_13921408-f6c1-4238-93de-c3d4f61b6621" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ec2b088e-82fb-4704-b3ed-7e4297db5e29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_bd00aee1-9fb4-4bb8-a8d9-1ed439d09648" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoncontrollingInterestMezzanineEquity_fbb729c2-350b-4fc7-a18b-76f21cfab55f" xlink:href="lh-20200930.xsd#lh_NoncontrollingInterestMezzanineEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bd00aee1-9fb4-4bb8-a8d9-1ed439d09648" xlink:to="loc_lh_NoncontrollingInterestMezzanineEquity_fbb729c2-350b-4fc7-a18b-76f21cfab55f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_6aa3371d-3816-47ff-83cf-1eb898fa21db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bd00aee1-9fb4-4bb8-a8d9-1ed439d09648" xlink:to="loc_us-gaap_Liabilities_6aa3371d-3816-47ff-83cf-1eb898fa21db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2580192f-3a46-4ca5-a3e0-0a8d4aa271f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bd00aee1-9fb4-4bb8-a8d9-1ed439d09648" xlink:to="loc_us-gaap_StockholdersEquity_2580192f-3a46-4ca5-a3e0-0a8d4aa271f9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals" xlink:type="simple" xlink:href="lh-20200930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="simple" xlink:href="lh-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_56e075a9-1adb-4c6a-abcc-9429541ee4ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_77acc7ad-b8c0-472c-a33e-3927222ad18f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_56e075a9-1adb-4c6a-abcc-9429541ee4ac" xlink:to="loc_us-gaap_ProfitLoss_77acc7ad-b8c0-472c-a33e-3927222ad18f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ecf4d429-6fa0-4241-9fff-b2085140719d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_56e075a9-1adb-4c6a-abcc-9429541ee4ac" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ecf4d429-6fa0-4241-9fff-b2085140719d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_abeb2e71-ea6e-4948-8039-0886f0084c64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_c9bf86f6-fc13-4c6a-90ac-e6f462cd7457" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_abeb2e71-ea6e-4948-8039-0886f0084c64" xlink:to="loc_us-gaap_Revenues_c9bf86f6-fc13-4c6a-90ac-e6f462cd7457" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_7215fd6d-ac11-4ef6-8282-d050c0d68512" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_abeb2e71-ea6e-4948-8039-0886f0084c64" xlink:to="loc_us-gaap_CostOfRevenue_7215fd6d-ac11-4ef6-8282-d050c0d68512" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_442991b9-6574-4be1-af90-3754c087b91e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_1c9c6319-47d7-41e0-b475-4af7ed150432" xlink:href="lh-20200930.xsd#lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_442991b9-6574-4be1-af90-3754c087b91e" xlink:to="loc_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_1c9c6319-47d7-41e0-b475-4af7ed150432" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_660eb73c-cc20-47e6-abe1-f806a2d57d0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_442991b9-6574-4be1-af90-3754c087b91e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_660eb73c-cc20-47e6-abe1-f806a2d57d0e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited" xlink:type="simple" xlink:href="lh-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1d4fc18f-a750-4a33-93ed-96e6c93e6767" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8ff54f61-8c48-499f-b571-9c494923ea0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1d4fc18f-a750-4a33-93ed-96e6c93e6767" xlink:to="loc_us-gaap_ProfitLoss_8ff54f61-8c48-499f-b571-9c494923ea0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3cea6594-5404-4f2a-aa66-ca269abd3b9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1d4fc18f-a750-4a33-93ed-96e6c93e6767" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3cea6594-5404-4f2a-aa66-ca269abd3b9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_5828315d-7bd8-48bc-9aa4-dadcdad04183" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_8b0bc4bd-cbd4-46a5-b9bc-a4fd2df63e76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_5828315d-7bd8-48bc-9aa4-dadcdad04183" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_8b0bc4bd-cbd4-46a5-b9bc-a4fd2df63e76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_dd399cb2-85b3-41c9-bb82-5da347e7fdeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_5828315d-7bd8-48bc-9aa4-dadcdad04183" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_dd399cb2-85b3-41c9-bb82-5da347e7fdeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2515886d-74a2-40df-8071-34acfa10cd7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_3e84693b-f723-41c7-b7b3-b49145bbc922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2515886d-74a2-40df-8071-34acfa10cd7c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_3e84693b-f723-41c7-b7b3-b49145bbc922" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_0571a587-4a83-48dd-b032-4c8f5e6f4308" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2515886d-74a2-40df-8071-34acfa10cd7c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_0571a587-4a83-48dd-b032-4c8f5e6f4308" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_269a4537-7859-472b-9ac4-e1266e3e51ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_01b7698e-a070-41dd-833b-0e5d6f621fc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_269a4537-7859-472b-9ac4-e1266e3e51ec" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_01b7698e-a070-41dd-833b-0e5d6f621fc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2c0c2f7e-979f-4197-a52d-af56b99e6c2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_269a4537-7859-472b-9ac4-e1266e3e51ec" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2c0c2f7e-979f-4197-a52d-af56b99e6c2d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited" xlink:type="simple" xlink:href="lh-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="lh-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfd1b53f-5e08-43ec-8cd8-e21f71b998ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7a8a0ee6-ce7a-4417-9328-a22666c533f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfd1b53f-5e08-43ec-8cd8-e21f71b998ac" xlink:to="loc_us-gaap_ProfitLoss_7a8a0ee6-ce7a-4417-9328-a22666c533f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_9292a525-3e59-4401-a7ef-ae6e28171aa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfd1b53f-5e08-43ec-8cd8-e21f71b998ac" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_9292a525-3e59-4401-a7ef-ae6e28171aa4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_64cc30b5-4b0d-4549-b9bc-00d880212127" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfd1b53f-5e08-43ec-8cd8-e21f71b998ac" xlink:to="loc_us-gaap_ShareBasedCompensation_64cc30b5-4b0d-4549-b9bc-00d880212127" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DepreciationAndAmortizationOfLeasedAssets_10872e9a-d6b7-45d1-b50b-6cba88278066" xlink:href="lh-20200930.xsd#lh_DepreciationAndAmortizationOfLeasedAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfd1b53f-5e08-43ec-8cd8-e21f71b998ac" xlink:to="loc_lh_DepreciationAndAmortizationOfLeasedAssets_10872e9a-d6b7-45d1-b50b-6cba88278066" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_92473e74-a0d7-47ed-a060-c837836f7a01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfd1b53f-5e08-43ec-8cd8-e21f71b998ac" xlink:to="loc_us-gaap_AssetImpairmentCharges_92473e74-a0d7-47ed-a060-c837836f7a01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_723caa5c-36f9-4f3d-82e5-93b29791eef9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfd1b53f-5e08-43ec-8cd8-e21f71b998ac" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_723caa5c-36f9-4f3d-82e5-93b29791eef9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_55314e51-a415-4abe-a055-1396fed21e14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfd1b53f-5e08-43ec-8cd8-e21f71b998ac" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_55314e51-a415-4abe-a055-1396fed21e14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_fb46c331-39d6-4f3d-be6b-72deb2637716" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfd1b53f-5e08-43ec-8cd8-e21f71b998ac" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_fb46c331-39d6-4f3d-be6b-72deb2637716" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncreaseDecreaseinUnbilledContractReceivable_3e2ecc39-2c7f-44f0-ad8c-43b95247cf98" xlink:href="lh-20200930.xsd#lh_IncreaseDecreaseinUnbilledContractReceivable"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfd1b53f-5e08-43ec-8cd8-e21f71b998ac" xlink:to="loc_lh_IncreaseDecreaseinUnbilledContractReceivable_3e2ecc39-2c7f-44f0-ad8c-43b95247cf98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_35379365-5ae8-4abb-9a37-fc5730750185" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfd1b53f-5e08-43ec-8cd8-e21f71b998ac" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_35379365-5ae8-4abb-9a37-fc5730750185" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_15b8c8b5-b4ea-4567-83e4-c23715628886" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfd1b53f-5e08-43ec-8cd8-e21f71b998ac" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_15b8c8b5-b4ea-4567-83e4-c23715628886" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c3fe2e8e-da1e-49b1-8b01-b424601b9107" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfd1b53f-5e08-43ec-8cd8-e21f71b998ac" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c3fe2e8e-da1e-49b1-8b01-b424601b9107" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_3ccc8ce4-af5b-4406-85f8-5c87a7302d44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfd1b53f-5e08-43ec-8cd8-e21f71b998ac" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_3ccc8ce4-af5b-4406-85f8-5c87a7302d44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_44e094c4-a31e-471e-9833-ebd24d6b1cb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfd1b53f-5e08-43ec-8cd8-e21f71b998ac" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_44e094c4-a31e-471e-9833-ebd24d6b1cb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Contingentconsiderationadjustment_1b382b8f-7262-480b-ae85-9bc80018432e" xlink:href="lh-20200930.xsd#lh_Contingentconsiderationadjustment"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfd1b53f-5e08-43ec-8cd8-e21f71b998ac" xlink:to="loc_lh_Contingentconsiderationadjustment_1b382b8f-7262-480b-ae85-9bc80018432e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bc5644ee-c66a-4ebb-ad0d-358a5aa5dcd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2be3f0ec-2ea5-45ad-b6e0-15bd482b3ca1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bc5644ee-c66a-4ebb-ad0d-358a5aa5dcd7" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2be3f0ec-2ea5-45ad-b6e0-15bd482b3ca1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_154cc121-04bc-4baf-a880-4ea5b8d99b2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bc5644ee-c66a-4ebb-ad0d-358a5aa5dcd7" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_154cc121-04bc-4baf-a880-4ea5b8d99b2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_21b890b7-ae1f-4905-9654-e66ac25d081b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bc5644ee-c66a-4ebb-ad0d-358a5aa5dcd7" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_21b890b7-ae1f-4905-9654-e66ac25d081b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_2eb3a392-2be0-4ebc-9ba2-c9a1f3204543" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bc5644ee-c66a-4ebb-ad0d-358a5aa5dcd7" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_2eb3a392-2be0-4ebc-9ba2-c9a1f3204543" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_517212ef-1452-4e31-8475-033ef4d9cf7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bc5644ee-c66a-4ebb-ad0d-358a5aa5dcd7" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_517212ef-1452-4e31-8475-033ef4d9cf7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_dbb235aa-b032-40a2-9ea2-bb5b0f071c2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bc5644ee-c66a-4ebb-ad0d-358a5aa5dcd7" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_dbb235aa-b032-40a2-9ea2-bb5b0f071c2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_35162b92-e87d-4c31-81ad-bd79c7418405" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2fca6bd5-6b83-42fa-8545-eb7facba67e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_35162b92-e87d-4c31-81ad-bd79c7418405" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2fca6bd5-6b83-42fa-8545-eb7facba67e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d6ffe9e6-d178-45c2-af82-c13ae40722be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_35162b92-e87d-4c31-81ad-bd79c7418405" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d6ffe9e6-d178-45c2-af82-c13ae40722be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ec4af5ec-fc14-4f47-aaac-5bde5972db72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_35162b92-e87d-4c31-81ad-bd79c7418405" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ec4af5ec-fc14-4f47-aaac-5bde5972db72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_6bf66032-b33c-49b4-9fae-a79d3eeab9c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_35162b92-e87d-4c31-81ad-bd79c7418405" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_6bf66032-b33c-49b4-9fae-a79d3eeab9c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7c791b6b-22ea-457c-9e4f-f4946c9a9f25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_faf98e3e-47fd-4ef0-9ac0-3f4a22a04ca6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7c791b6b-22ea-457c-9e4f-f4946c9a9f25" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_faf98e3e-47fd-4ef0-9ac0-3f4a22a04ca6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_4bec62df-a0bc-43d2-a453-668355786039" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7c791b6b-22ea-457c-9e4f-f4946c9a9f25" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_4bec62df-a0bc-43d2-a453-668355786039" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1dccfe24-f08b-49e7-b2db-9444c6358bf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7c791b6b-22ea-457c-9e4f-f4946c9a9f25" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1dccfe24-f08b-49e7-b2db-9444c6358bf8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetProceedsFromIssuanceOfStockToEmployees_315feb8c-f222-472a-8192-dab81db40dd6" xlink:href="lh-20200930.xsd#lh_NetProceedsFromIssuanceOfStockToEmployees"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7c791b6b-22ea-457c-9e4f-f4946c9a9f25" xlink:to="loc_lh_NetProceedsFromIssuanceOfStockToEmployees_315feb8c-f222-472a-8192-dab81db40dd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6f3853b6-da73-45ff-8cbe-c6edcb83d894" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7c791b6b-22ea-457c-9e4f-f4946c9a9f25" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6f3853b6-da73-45ff-8cbe-c6edcb83d894" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OtherFinancingCashFlows_43ec8f2e-966f-479f-bc24-c4050167204f" xlink:href="lh-20200930.xsd#lh_OtherFinancingCashFlows"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7c791b6b-22ea-457c-9e4f-f4946c9a9f25" xlink:to="loc_lh_OtherFinancingCashFlows_43ec8f2e-966f-479f-bc24-c4050167204f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt_a7cd5991-0d3b-4313-aa6c-6c7bef309d4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7c791b6b-22ea-457c-9e4f-f4946c9a9f25" xlink:to="loc_us-gaap_RepaymentsOfOtherLongTermDebt_a7cd5991-0d3b-4313-aa6c-6c7bef309d4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_6bf89650-9569-4b49-8bc7-4b4bf9236338" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7c791b6b-22ea-457c-9e4f-f4946c9a9f25" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_6bf89650-9569-4b49-8bc7-4b4bf9236338" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_82adc1bf-4a7a-4e12-8778-f494593d2e28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7c791b6b-22ea-457c-9e4f-f4946c9a9f25" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_82adc1bf-4a7a-4e12-8778-f494593d2e28" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATION" xlink:type="simple" xlink:href="lh-20200930.xsd#BASISOFFINANCIALSTATEMENTPRESENTATION"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATION" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONUseofEstimatesPolicies" xlink:type="simple" xlink:href="lh-20200930.xsd#BASISOFFINANCIALSTATEMENTPRESENTATIONUseofEstimatesPolicies"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONUseofEstimatesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONNewAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="lh-20200930.xsd#BASISOFFINANCIALSTATEMENTPRESENTATIONNewAccountingPronouncementsPolicies"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONNewAccountingPronouncementsPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONNovelCoronavirusCOVID19FinancialStatementImpactPolicies" xlink:type="simple" xlink:href="lh-20200930.xsd#BASISOFFINANCIALSTATEMENTPRESENTATIONNovelCoronavirusCOVID19FinancialStatementImpactPolicies"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONNovelCoronavirusCOVID19FinancialStatementImpactPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONRecentlyAdoptedAccountingStandardsPolicies" xlink:type="simple" xlink:href="lh-20200930.xsd#BASISOFFINANCIALSTATEMENTPRESENTATIONRecentlyAdoptedAccountingStandardsPolicies"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONRecentlyAdoptedAccountingStandardsPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONRestatedFinancialStatements" xlink:type="simple" xlink:href="lh-20200930.xsd#BASISOFFINANCIALSTATEMENTPRESENTATIONRestatedFinancialStatements"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONRestatedFinancialStatements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="lh-20200930.xsd#EARNINGSPERSHARE"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/EARNINGSPERSHARE" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="lh-20200930.xsd#EARNINGSPERSHARETables"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/EARNINGSPERSHARETables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/EARNINGSPERSHAREPotentialcommonsharesnotincludedincomputationofdilutedearningspershareDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#EARNINGSPERSHAREPotentialcommonsharesnotincludedincomputationofdilutedearningspershareDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/EARNINGSPERSHAREPotentialcommonsharesnotincludedincomputationofdilutedearningspershareDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTS" xlink:type="simple" xlink:href="lh-20200930.xsd#NONCONTROLLINGINTERESTPUTS"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTSDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#NONCONTROLLINGINTERESTPUTSDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTSDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGES" xlink:type="simple" xlink:href="lh-20200930.xsd#RESTRUCTURINGANDOTHERSPECIALCHARGES"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables" xlink:type="simple" xlink:href="lh-20200930.xsd#RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#RESTRUCTURINGANDOTHERSPECIALCHARGESDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/RESTRUCTURINGRESERVES" xlink:type="simple" xlink:href="lh-20200930.xsd#RESTRUCTURINGRESERVES"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/RESTRUCTURINGRESERVES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#RESTRUCTURINGRESERVESDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_2f238ecb-3229-4149-a674-bcbed2c68565" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_de951789-5f1e-4934-90d5-5166ba30e55b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringReserve_2f238ecb-3229-4149-a674-bcbed2c68565" xlink:to="loc_us-gaap_RestructuringReserveCurrent_de951789-5f1e-4934-90d5-5166ba30e55b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent_60dc007a-2c4f-4dc2-bc62-138c04646d6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringReserve_2f238ecb-3229-4149-a674-bcbed2c68565" xlink:to="loc_us-gaap_RestructuringReserveNoncurrent_60dc007a-2c4f-4dc2-bc62-138c04646d6c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="lh-20200930.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="lh-20200930.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#GOODWILLANDINTANGIBLEASSETSDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/IntangibleAssetsGoodwillandOtherPolicies" xlink:type="simple" xlink:href="lh-20200930.xsd#IntangibleAssetsGoodwillandOtherPolicies"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/IntangibleAssetsGoodwillandOtherPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBT" xlink:type="simple" xlink:href="lh-20200930.xsd#DEBT"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/DEBT" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTLongtermdebtDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#DEBTLongtermdebtDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/DEBTLongtermdebtDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTSeniorNotesDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#DEBTSeniorNotesDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/DEBTSeniorNotesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTConvertibleSubordinatedNotesDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#DEBTConvertibleSubordinatedNotesDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/DEBTConvertibleSubordinatedNotesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTCreditFacilitiesDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#DEBTCreditFacilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/DEBTCreditFacilitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="lh-20200930.xsd#PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/INCOMETAXES" xlink:type="simple" xlink:href="lh-20200930.xsd#INCOMETAXES"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/INCOMETAXES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#INCOMETAXESDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/INCOMETAXESDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="lh-20200930.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANS" xlink:type="simple" xlink:href="lh-20200930.xsd#PENSIONANDPOSTRETIREMENTPLANS"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#PENSIONANDPOSTRETIREMENTPLANSDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_04685307-feef-4e65-b738-12894fe31f47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_a9112cba-2b8f-4dcc-8201-d1d4bfa58cf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_04685307-feef-4e65-b738-12894fe31f47" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_a9112cba-2b8f-4dcc-8201-d1d4bfa58cf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_ef69d265-fea8-4f3e-9635-e50c202b3c86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_04685307-feef-4e65-b738-12894fe31f47" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_ef69d265-fea8-4f3e-9635-e50c202b3c86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_ad63ce1f-47c3-4f4a-9f0b-affdd8774711" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_04685307-feef-4e65-b738-12894fe31f47" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_ad63ce1f-47c3-4f4a-9f0b-affdd8774711" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetDefinedBenefitPlanAmortizationAndDeferral_bc587923-f322-4aaf-aff7-7c966c57c7b5" xlink:href="lh-20200930.xsd#lh_NetDefinedBenefitPlanAmortizationAndDeferral"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_04685307-feef-4e65-b738-12894fe31f47" xlink:to="loc_lh_NetDefinedBenefitPlanAmortizationAndDeferral_bc587923-f322-4aaf-aff7-7c966c57c7b5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="lh-20200930.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="lh-20200930.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#FAIRVALUEMEASUREMENTSDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" xlink:type="simple" xlink:href="lh-20200930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" xlink:type="simple" xlink:href="lh-20200930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATION" xlink:type="simple" xlink:href="lh-20200930.xsd#SUPPLEMENTALCASHFLOWINFORMATION"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATION" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONTabularInformation" xlink:type="simple" xlink:href="lh-20200930.xsd#SUPPLEMENTALCASHFLOWINFORMATIONTabularInformation"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONTabularInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation" xlink:type="simple" xlink:href="lh-20200930.xsd#SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONS" xlink:type="simple" xlink:href="lh-20200930.xsd#BUSINESSACQUISITIONS"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/BUSINESSACQUISITIONS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsTablesTables" xlink:type="simple" xlink:href="lh-20200930.xsd#BUSINESSACQUISITIONSBusinessAcquisitionsTablesTables"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsTablesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#BUSINESSACQUISITIONSDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#BUSINESSACQUISITIONSDISPOSITIONSDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONNotes" xlink:type="simple" xlink:href="lh-20200930.xsd#BUSINESSSEGMENTINFORMATIONNotes"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONNotes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="lh-20200930.xsd#BUSINESSSEGMENTINFORMATIONTables"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes" xlink:type="simple" xlink:href="lh-20200930.xsd#BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/REVENUENotes" xlink:type="simple" xlink:href="lh-20200930.xsd#REVENUENotes"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/REVENUENotes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/REVENUETables" xlink:type="simple" xlink:href="lh-20200930.xsd#REVENUETables"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/REVENUETables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/REVENUEDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#REVENUEDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/REVENUEDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#REVENUEDisaggregatedRevenueTableDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/RevenuefromContractwithCustomerPolicies" xlink:type="simple" xlink:href="lh-20200930.xsd#RevenuefromContractwithCustomerPolicies"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/RevenuefromContractwithCustomerPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/LeasesNotes" xlink:type="simple" xlink:href="lh-20200930.xsd#LeasesNotes"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/LeasesNotes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/LeasesTables" xlink:type="simple" xlink:href="lh-20200930.xsd#LeasesTables"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/LeasesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/LeasesDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#LeasesDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/LeasesDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>lh-20200930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:fc8a7d57-4cce-43ce-b480-996ae8b97c72,g:096b564a-e6b9-41cc-ab37-c90f57b146f8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/CoverPage" xlink:type="simple" xlink:href="lh-20200930.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/CoverPage" xlink:type="extended" id="i69e8e87eab63451f9bf24b39c92d6d7a_CoverPage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_44dd1266-c02a-43cd-ba92-834253416217" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_b106d781-ed57-4474-820f-c574cd46b9ff" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_44dd1266-c02a-43cd-ba92-834253416217" xlink:to="loc_dei_DocumentInformationTable_b106d781-ed57-4474-820f-c574cd46b9ff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationDocumentAxis_592c629c-7ee6-4662-b6cf-dbd4ab2bb3e2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationDocumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_b106d781-ed57-4474-820f-c574cd46b9ff" xlink:to="loc_dei_DocumentInformationDocumentAxis_592c629c-7ee6-4662-b6cf-dbd4ab2bb3e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain_592c629c-7ee6-4662-b6cf-dbd4ab2bb3e2_default" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_DocumentInformationDocumentAxis_592c629c-7ee6-4662-b6cf-dbd4ab2bb3e2" xlink:to="loc_dei_DocumentDomain_592c629c-7ee6-4662-b6cf-dbd4ab2bb3e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain_cd1e85b4-e650-40f7-8306-a921b61166d8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_DocumentInformationDocumentAxis_592c629c-7ee6-4662-b6cf-dbd4ab2bb3e2" xlink:to="loc_dei_DocumentDomain_cd1e85b4-e650-40f7-8306-a921b61166d8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="simple" xlink:href="lh-20200930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="extended" id="i65f05b85f6cc43398c082065d19cf9d2_CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals" xlink:type="simple" xlink:href="lh-20200930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals" xlink:type="extended" id="i7c35274c0fe44e34bc7d0ae22c14d4da_CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b76b4c21-bb29-46aa-a434-b0f8853fa138" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_19978e8a-06c8-4853-847a-afb96c5a4d3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b76b4c21-bb29-46aa-a434-b0f8853fa138" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_19978e8a-06c8-4853-847a-afb96c5a4d3e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ee65be36-dad8-4d46-ae73-813945a866cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b76b4c21-bb29-46aa-a434-b0f8853fa138" xlink:to="loc_us-gaap_StatementTable_ee65be36-dad8-4d46-ae73-813945a866cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_0838223b-d487-4a8c-88a0-911bcd34db1e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ee65be36-dad8-4d46-ae73-813945a866cc" xlink:to="loc_srt_RestatementAxis_0838223b-d487-4a8c-88a0-911bcd34db1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_0838223b-d487-4a8c-88a0-911bcd34db1e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_0838223b-d487-4a8c-88a0-911bcd34db1e" xlink:to="loc_srt_RestatementDomain_0838223b-d487-4a8c-88a0-911bcd34db1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_23fca1d9-69af-4b16-88a9-2fecae25614f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_0838223b-d487-4a8c-88a0-911bcd34db1e" xlink:to="loc_srt_RestatementDomain_23fca1d9-69af-4b16-88a9-2fecae25614f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_5b12c7ec-8aad-4a90-b0cb-f4ebd22c8deb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ee65be36-dad8-4d46-ae73-813945a866cc" xlink:to="loc_us-gaap_StatementClassOfStockAxis_5b12c7ec-8aad-4a90-b0cb-f4ebd22c8deb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_5b12c7ec-8aad-4a90-b0cb-f4ebd22c8deb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_5b12c7ec-8aad-4a90-b0cb-f4ebd22c8deb" xlink:to="loc_us-gaap_ClassOfStockDomain_5b12c7ec-8aad-4a90-b0cb-f4ebd22c8deb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_44d14f74-ec2a-4749-8e88-009e642329ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_5b12c7ec-8aad-4a90-b0cb-f4ebd22c8deb" xlink:to="loc_us-gaap_ClassOfStockDomain_44d14f74-ec2a-4749-8e88-009e642329ed" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="simple" xlink:href="lh-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="extended" id="i9319a500ffff40d7a78d43f5c6d44602_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8add8ff8-2cae-4647-b13e-cf83a38a37f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e6452c6d-dfaa-4401-9d23-beb143cd180a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_8add8ff8-2cae-4647-b13e-cf83a38a37f8" xlink:to="loc_us-gaap_StatementTable_e6452c6d-dfaa-4401-9d23-beb143cd180a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis_4098d983-3c7b-4048-a407-ad1018422c30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e6452c6d-dfaa-4401-9d23-beb143cd180a" xlink:to="loc_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis_4098d983-3c7b-4048-a407-ad1018422c30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingGuidanceMember_4098d983-3c7b-4048-a407-ad1018422c30_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingGuidanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis_4098d983-3c7b-4048-a407-ad1018422c30" xlink:to="loc_us-gaap_AccountingGuidanceMember_4098d983-3c7b-4048-a407-ad1018422c30_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingGuidanceMember_fa849e19-3020-46a3-ad91-da8c9375ac07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingGuidanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis_4098d983-3c7b-4048-a407-ad1018422c30" xlink:to="loc_us-gaap_AccountingGuidanceMember_fa849e19-3020-46a3-ad91-da8c9375ac07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e8b2f761-4b55-4aa7-9be9-99ced37b4e67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e6452c6d-dfaa-4401-9d23-beb143cd180a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e8b2f761-4b55-4aa7-9be9-99ced37b4e67" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8b2f761-4b55-4aa7-9be9-99ced37b4e67_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e8b2f761-4b55-4aa7-9be9-99ced37b4e67" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8b2f761-4b55-4aa7-9be9-99ced37b4e67_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c5ed534c-51db-48a2-b249-cd7b4617e440" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e8b2f761-4b55-4aa7-9be9-99ced37b4e67" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c5ed534c-51db-48a2-b249-cd7b4617e440" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceMember_78abfbf8-f6d5-4946-9cc5-3a70709f933f" xlink:href="lh-20200930.xsd#lh_CovanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c5ed534c-51db-48a2-b249-cd7b4617e440" xlink:to="loc_lh_CovanceMember_78abfbf8-f6d5-4946-9cc5-3a70709f933f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_8eb8d745-74fe-4e14-9e0e-5d5e1de7900b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e6452c6d-dfaa-4401-9d23-beb143cd180a" xlink:to="loc_srt_StatementScenarioAxis_8eb8d745-74fe-4e14-9e0e-5d5e1de7900b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_8eb8d745-74fe-4e14-9e0e-5d5e1de7900b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_8eb8d745-74fe-4e14-9e0e-5d5e1de7900b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_8eb8d745-74fe-4e14-9e0e-5d5e1de7900b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_3b2ece4d-00a1-449c-a20a-6afe9dbeb9bc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_8eb8d745-74fe-4e14-9e0e-5d5e1de7900b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_3b2ece4d-00a1-449c-a20a-6afe9dbeb9bc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited" xlink:type="simple" xlink:href="lh-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited" xlink:type="extended" id="ifc073072777141299ea36f6abe1f4da7_CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c9310371-9cd4-4efe-b5d3-e0abdd9eb364" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetRestructuringAndOtherSpecialCharges_85fcb5fb-92bc-4d4e-9268-af9d978526f0" xlink:href="lh-20200930.xsd#lh_NetRestructuringAndOtherSpecialCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c9310371-9cd4-4efe-b5d3-e0abdd9eb364" xlink:to="loc_lh_NetRestructuringAndOtherSpecialCharges_85fcb5fb-92bc-4d4e-9268-af9d978526f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_635ed6d2-2cfa-475b-a6c8-ad77b5992833" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c9310371-9cd4-4efe-b5d3-e0abdd9eb364" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_635ed6d2-2cfa-475b-a6c8-ad77b5992833" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_46eaf2db-3b29-4e92-bbaa-3c924723f286" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_c9310371-9cd4-4efe-b5d3-e0abdd9eb364" xlink:to="loc_us-gaap_StatementTable_46eaf2db-3b29-4e92-bbaa-3c924723f286" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_8f915a53-e950-4952-924e-17e9e16244f0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_46eaf2db-3b29-4e92-bbaa-3c924723f286" xlink:to="loc_srt_StatementScenarioAxis_8f915a53-e950-4952-924e-17e9e16244f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_8f915a53-e950-4952-924e-17e9e16244f0_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_8f915a53-e950-4952-924e-17e9e16244f0" xlink:to="loc_srt_ScenarioUnspecifiedDomain_8f915a53-e950-4952-924e-17e9e16244f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_92663898-cf29-4ddd-87fc-2573da642f3b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_8f915a53-e950-4952-924e-17e9e16244f0" xlink:to="loc_srt_ScenarioUnspecifiedDomain_92663898-cf29-4ddd-87fc-2573da642f3b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited" xlink:type="simple" xlink:href="lh-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited" xlink:type="extended" id="i5a2fe7273b444212ab8bdaefd8b32de8_CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e15fdeb6-e5cd-41db-a61a-ccd4fbd877ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e4fd63d5-f6e8-4dd0-b162-4875ad096caf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e15fdeb6-e5cd-41db-a61a-ccd4fbd877ee" xlink:to="loc_us-gaap_StockholdersEquity_e4fd63d5-f6e8-4dd0-b162-4875ad096caf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c3ef4f39-159d-4215-86bb-06a62b2fce03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e15fdeb6-e5cd-41db-a61a-ccd4fbd877ee" xlink:to="loc_us-gaap_NetIncomeLoss_c3ef4f39-159d-4215-86bb-06a62b2fce03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2737f23d-280b-445b-98f2-cf34e46f01aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e15fdeb6-e5cd-41db-a61a-ccd4fbd877ee" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2737f23d-280b-445b-98f2-cf34e46f01aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Issuanceofcommonstockunderemployeeplans_6cf6ae3b-01df-4d7d-9041-30a455c42334" xlink:href="lh-20200930.xsd#lh_Issuanceofcommonstockunderemployeeplans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e15fdeb6-e5cd-41db-a61a-ccd4fbd877ee" xlink:to="loc_lh_Issuanceofcommonstockunderemployeeplans_6cf6ae3b-01df-4d7d-9041-30a455c42334" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_1abd8b7d-3118-45dc-ac73-a0c7fef767df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e15fdeb6-e5cd-41db-a61a-ccd4fbd877ee" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_1abd8b7d-3118-45dc-ac73-a0c7fef767df" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ConversionOfZeroCouponConvertibleDebt_651eb808-dad2-4a4b-88d4-1d3316b555bf" xlink:href="lh-20200930.xsd#lh_ConversionOfZeroCouponConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e15fdeb6-e5cd-41db-a61a-ccd4fbd877ee" xlink:to="loc_lh_ConversionOfZeroCouponConvertibleDebt_651eb808-dad2-4a4b-88d4-1d3316b555bf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_6a01ebba-7446-4b48-9f51-a3af7b818a7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e15fdeb6-e5cd-41db-a61a-ccd4fbd877ee" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_6a01ebba-7446-4b48-9f51-a3af7b818a7a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_60031355-590f-4343-85e0-777f39242230" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e15fdeb6-e5cd-41db-a61a-ccd4fbd877ee" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_60031355-590f-4343-85e0-777f39242230" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_43b24799-1bb8-4b63-a176-a092ffd39087" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1b382f61-177f-48a2-9847-99db3b9c077a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e15fdeb6-e5cd-41db-a61a-ccd4fbd877ee" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1b382f61-177f-48a2-9847-99db3b9c077a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_91bd53dc-2dd8-4cbe-914b-27e3fceef908" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e15fdeb6-e5cd-41db-a61a-ccd4fbd877ee" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_91bd53dc-2dd8-4cbe-914b-27e3fceef908" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_efc02c8f-3959-4285-96aa-4e40c7b59810" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e15fdeb6-e5cd-41db-a61a-ccd4fbd877ee" xlink:to="loc_us-gaap_StatementTable_efc02c8f-3959-4285-96aa-4e40c7b59810" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_00a13334-8034-42ab-85dd-b180886a762b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_efc02c8f-3959-4285-96aa-4e40c7b59810" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_00a13334-8034-42ab-85dd-b180886a762b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_00a13334-8034-42ab-85dd-b180886a762b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_00a13334-8034-42ab-85dd-b180886a762b" xlink:to="loc_us-gaap_EquityComponentDomain_00a13334-8034-42ab-85dd-b180886a762b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_22dbaa9b-a84c-4597-8d70-ed2bf2cc6aa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_00a13334-8034-42ab-85dd-b180886a762b" xlink:to="loc_us-gaap_EquityComponentDomain_22dbaa9b-a84c-4597-8d70-ed2bf2cc6aa7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_75f89c53-dcfc-478d-b74b-4665fa9e30a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_22dbaa9b-a84c-4597-8d70-ed2bf2cc6aa7" xlink:to="loc_us-gaap_CommonStockMember_75f89c53-dcfc-478d-b74b-4665fa9e30a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_51643865-b0ee-4a35-bb7b-768462a2f61c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_22dbaa9b-a84c-4597-8d70-ed2bf2cc6aa7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_51643865-b0ee-4a35-bb7b-768462a2f61c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_2f360b9a-b271-4749-88db-60af0a0e5287" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_22dbaa9b-a84c-4597-8d70-ed2bf2cc6aa7" xlink:to="loc_us-gaap_RetainedEarningsMember_2f360b9a-b271-4749-88db-60af0a0e5287" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_cc75d62c-e91d-4633-a90c-e4129e1567ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_22dbaa9b-a84c-4597-8d70-ed2bf2cc6aa7" xlink:to="loc_us-gaap_TreasuryStockMember_cc75d62c-e91d-4633-a90c-e4129e1567ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_74db8996-b2e0-4e2e-b412-28d1fa98737b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_22dbaa9b-a84c-4597-8d70-ed2bf2cc6aa7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_74db8996-b2e0-4e2e-b412-28d1fa98737b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_6e6322ce-ff24-4738-b148-cdef16aff293" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_efc02c8f-3959-4285-96aa-4e40c7b59810" xlink:to="loc_srt_RestatementAxis_6e6322ce-ff24-4738-b148-cdef16aff293" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_6e6322ce-ff24-4738-b148-cdef16aff293_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_6e6322ce-ff24-4738-b148-cdef16aff293" xlink:to="loc_srt_RestatementDomain_6e6322ce-ff24-4738-b148-cdef16aff293_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_f046e313-c874-4cb4-99f1-e89744cc4b96" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_6e6322ce-ff24-4738-b148-cdef16aff293" xlink:to="loc_srt_RestatementDomain_f046e313-c874-4cb4-99f1-e89744cc4b96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_e96d1021-8f23-46ec-aa8e-6be481521fca" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_f046e313-c874-4cb4-99f1-e89744cc4b96" xlink:to="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_e96d1021-8f23-46ec-aa8e-6be481521fca" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="lh-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="extended" id="i61ccd49cdeba475fa79a6e9d610ce6d4_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_656745dc-1d37-4b7b-8452-7d270a0e113c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_24dc457f-40f0-4246-b5ee-19989cc398fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_656745dc-1d37-4b7b-8452-7d270a0e113c" xlink:to="loc_us-gaap_StatementTable_24dc457f-40f0-4246-b5ee-19989cc398fd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis_b13e951a-460a-4293-a2cf-e4de3fe3eabd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_24dc457f-40f0-4246-b5ee-19989cc398fd" xlink:to="loc_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis_b13e951a-460a-4293-a2cf-e4de3fe3eabd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingGuidanceMember_b13e951a-460a-4293-a2cf-e4de3fe3eabd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingGuidanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis_b13e951a-460a-4293-a2cf-e4de3fe3eabd" xlink:to="loc_us-gaap_AccountingGuidanceMember_b13e951a-460a-4293-a2cf-e4de3fe3eabd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingGuidanceMember_73049874-b059-4ad4-a920-6c8238fc8c5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingGuidanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis_b13e951a-460a-4293-a2cf-e4de3fe3eabd" xlink:to="loc_us-gaap_AccountingGuidanceMember_73049874-b059-4ad4-a920-6c8238fc8c5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_6cf38df9-a973-43f0-b863-a9784c9cf721" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_24dc457f-40f0-4246-b5ee-19989cc398fd" xlink:to="loc_srt_StatementScenarioAxis_6cf38df9-a973-43f0-b863-a9784c9cf721" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_6cf38df9-a973-43f0-b863-a9784c9cf721_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_6cf38df9-a973-43f0-b863-a9784c9cf721" xlink:to="loc_srt_ScenarioUnspecifiedDomain_6cf38df9-a973-43f0-b863-a9784c9cf721_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_24de143b-4f1c-4834-b42d-0eedcb481828" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_6cf38df9-a973-43f0-b863-a9784c9cf721" xlink:to="loc_srt_ScenarioUnspecifiedDomain_24de143b-4f1c-4834-b42d-0eedcb481828" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATION" xlink:type="simple" xlink:href="lh-20200930.xsd#BASISOFFINANCIALSTATEMENTPRESENTATION"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATION" xlink:type="extended" id="i6470ec60a3e34b168a58b81a4e691f9c_BASISOFFINANCIALSTATEMENTPRESENTATION"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONUseofEstimatesPolicies" xlink:type="simple" xlink:href="lh-20200930.xsd#BASISOFFINANCIALSTATEMENTPRESENTATIONUseofEstimatesPolicies"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONUseofEstimatesPolicies" xlink:type="extended" id="i25c9d8da56764af2aa33ec95587d4c7e_BASISOFFINANCIALSTATEMENTPRESENTATIONUseofEstimatesPolicies"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONNewAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="lh-20200930.xsd#BASISOFFINANCIALSTATEMENTPRESENTATIONNewAccountingPronouncementsPolicies"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONNewAccountingPronouncementsPolicies" xlink:type="extended" id="i08961ca7b21f437c9da45c2d3cd48116_BASISOFFINANCIALSTATEMENTPRESENTATIONNewAccountingPronouncementsPolicies"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONNovelCoronavirusCOVID19FinancialStatementImpactPolicies" xlink:type="simple" xlink:href="lh-20200930.xsd#BASISOFFINANCIALSTATEMENTPRESENTATIONNovelCoronavirusCOVID19FinancialStatementImpactPolicies"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONNovelCoronavirusCOVID19FinancialStatementImpactPolicies" xlink:type="extended" id="i460e12eaadf847239751b3b8a6f668ba_BASISOFFINANCIALSTATEMENTPRESENTATIONNovelCoronavirusCOVID19FinancialStatementImpactPolicies"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONRecentlyAdoptedAccountingStandardsPolicies" xlink:type="simple" xlink:href="lh-20200930.xsd#BASISOFFINANCIALSTATEMENTPRESENTATIONRecentlyAdoptedAccountingStandardsPolicies"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONRecentlyAdoptedAccountingStandardsPolicies" xlink:type="extended" id="icb074c3a902544119d06f388b10212d7_BASISOFFINANCIALSTATEMENTPRESENTATIONRecentlyAdoptedAccountingStandardsPolicies"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONRestatedFinancialStatements" xlink:type="simple" xlink:href="lh-20200930.xsd#BASISOFFINANCIALSTATEMENTPRESENTATIONRestatedFinancialStatements"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONRestatedFinancialStatements" xlink:type="extended" id="ie70ff4355944410ba7a09f8885da961f_BASISOFFINANCIALSTATEMENTPRESENTATIONRestatedFinancialStatements"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails" xlink:type="extended" id="iea1611e7f5ed48f4a232ea699eae38ac_BASISOFFINANCIALSTATEMENTPRESENTATIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_6d1187c5-fb2e-4328-a3a5-38f213e39f27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_AssetImpairmentCharges_6d1187c5-fb2e-4328-a3a5-38f213e39f27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_6cf2708b-59dd-4c9f-bf3a-9410bf2d0fb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_Revenues_6cf2708b-59dd-4c9f-bf3a-9410bf2d0fb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_b1a8a3f9-97e0-4f27-bb08-9a31e186e705" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_CostOfRevenue_b1a8a3f9-97e0-4f27-bb08-9a31e186e705" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_b98ed174-1d0c-4a09-b0e8-38d00e28e357" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_ContractWithCustomerLiability_b98ed174-1d0c-4a09-b0e8-38d00e28e357" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredSalesCommissions_e307652d-6be4-4f89-99de-52d457adae61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDeferredSalesCommissions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_AmortizationOfDeferredSalesCommissions_e307652d-6be4-4f89-99de-52d457adae61" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_dbcf85d1-3537-44db-9c0b-2677279957a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_AssetsCurrent_dbcf85d1-3537-44db-9c0b-2677279957a7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9eb25e95-1a8e-4fb9-8d45-549f8f86c058" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9eb25e95-1a8e-4fb9-8d45-549f8f86c058" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentofRevenueContributed_82739f04-50db-4f0c-99ab-45ed33530eae" xlink:href="lh-20200930.xsd#lh_PercentofRevenueContributed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_lh_PercentofRevenueContributed_82739f04-50db-4f0c-99ab-45ed33530eae" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b8ef8aba-b598-4d95-bf89-838618e6c10a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b8ef8aba-b598-4d95-bf89-838618e6c10a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_1da163f5-8d5e-463f-b88d-015a58cd5447" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_1da163f5-8d5e-463f-b88d-015a58cd5447" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b61fa9fb-a842-4ecb-bedc-791df25a483d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b61fa9fb-a842-4ecb-bedc-791df25a483d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0fdbc332-e19a-4a46-bf9c-097652515f0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_ProfitLoss_0fdbc332-e19a-4a46-bf9c-097652515f0c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d0b53f5f-680c-4461-a727-14b8b2d17d76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_NetIncomeLoss_d0b53f5f-680c-4461-a727-14b8b2d17d76" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_bd877f7f-27dd-4364-ad12-150a974f6fb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_EarningsPerShareBasic_bd877f7f-27dd-4364-ad12-150a974f6fb3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_0ca90b22-1e4a-40d0-abd6-8a86436a4de7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_EarningsPerShareDiluted_0ca90b22-1e4a-40d0-abd6-8a86436a4de7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fce88987-49b5-4a12-b5be-4671cdea697b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fce88987-49b5-4a12-b5be-4671cdea697b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_997bdf39-78f2-4043-9d18-1084c635f25f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_997bdf39-78f2-4043-9d18-1084c635f25f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_d86d5c03-00f3-4ef4-9f6c-8e2d0677e298" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_d86d5c03-00f3-4ef4-9f6c-8e2d0677e298" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_04cf5ab5-e3ad-44b5-9a43-88eef05cc9cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_Assets_04cf5ab5-e3ad-44b5-9a43-88eef05cc9cb" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1d499e49-ff15-46a8-ace2-b8344f85f5c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_LiabilitiesCurrent_1d499e49-ff15-46a8-ace2-b8344f85f5c5" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoncontrollingInterestMezzanineEquity_e4356315-4be2-4ddb-b7ae-1b6204511cbe" xlink:href="lh-20200930.xsd#lh_NoncontrollingInterestMezzanineEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_lh_NoncontrollingInterestMezzanineEquity_e4356315-4be2-4ddb-b7ae-1b6204511cbe" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9dbc024e-dbe4-49c3-8318-c8055fbd0a7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_StockholdersEquity_9dbc024e-dbe4-49c3-8318-c8055fbd0a7a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_debb6ca0-8147-46cb-ae04-876d3b35ad60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_debb6ca0-8147-46cb-ae04-876d3b35ad60" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_6e046185-d928-4bf8-86d9-78cc8b7f98df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_6e046185-d928-4bf8-86d9-78cc8b7f98df" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueRevenueRecognized1_92ebf5ca-2c12-45ab-96b2-db06774e37eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueRevenueRecognized1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_DeferredRevenueRevenueRecognized1_92ebf5ca-2c12-45ab-96b2-db06774e37eb" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_f8b4ee0b-c2ed-4a4d-8f8d-a678141fc6d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_f8b4ee0b-c2ed-4a4d-8f8d-a678141fc6d8" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_b4ae328b-7684-4523-b8ac-b21d0fc8607e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_b4ae328b-7684-4523-b8ac-b21d0fc8607e" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_df0530b8-ac36-4779-b29f-b15588e28667" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_df0530b8-ac36-4779-b29f-b15588e28667" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_453917fc-aa6d-44c3-9f4c-27aacb56eb5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_453917fc-aa6d-44c3-9f4c-27aacb56eb5e" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfInvestments_f8121b1b-46ab-4ae6-b165-d11a5037405c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_ImpairmentOfInvestments_f8121b1b-46ab-4ae6-b165-d11a5037405c" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashPaymentReceivedAppropriatedbyU.S.CongressCovid19_9d724221-33b6-4c45-98b7-207ec2d8f3d3" xlink:href="lh-20200930.xsd#lh_CashPaymentReceivedAppropriatedbyU.S.CongressCovid19"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_lh_CashPaymentReceivedAppropriatedbyU.S.CongressCovid19_9d724221-33b6-4c45-98b7-207ec2d8f3d3" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CARESActFundsAccruedLiabilitiesAndOtherLiabilities_707c32f0-f8ea-43e5-80ad-423bd76cbe02" xlink:href="lh-20200930.xsd#lh_CARESActFundsAccruedLiabilitiesAndOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_lh_CARESActFundsAccruedLiabilitiesAndOtherLiabilities_707c32f0-f8ea-43e5-80ad-423bd76cbe02" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairment_b577ffa2-e4f9-4b01-b260-09d93133d3ad" xlink:href="lh-20200930.xsd#lh_COVID19PandemicGoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairment_b577ffa2-e4f9-4b01-b260-09d93133d3ad" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fb877280-fff4-408f-9638-e0d494ba6b7d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:to="loc_srt_RangeAxis_fb877280-fff4-408f-9638-e0d494ba6b7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fb877280-fff4-408f-9638-e0d494ba6b7d_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fb877280-fff4-408f-9638-e0d494ba6b7d" xlink:to="loc_srt_RangeMember_fb877280-fff4-408f-9638-e0d494ba6b7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0281b7b4-1976-45e6-a7c2-4e41244db3c9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fb877280-fff4-408f-9638-e0d494ba6b7d" xlink:to="loc_srt_RangeMember_0281b7b4-1976-45e6-a7c2-4e41244db3c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f96cf080-59dc-4faa-8838-69977b519d21" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0281b7b4-1976-45e6-a7c2-4e41244db3c9" xlink:to="loc_srt_MinimumMember_f96cf080-59dc-4faa-8838-69977b519d21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f8803734-efee-4de4-a2d8-7816ec53d17a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0281b7b4-1976-45e6-a7c2-4e41244db3c9" xlink:to="loc_srt_MaximumMember_f8803734-efee-4de4-a2d8-7816ec53d17a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9f75e25e-7c48-4b10-96eb-c7d32aeb068f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9f75e25e-7c48-4b10-96eb-c7d32aeb068f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9f75e25e-7c48-4b10-96eb-c7d32aeb068f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9f75e25e-7c48-4b10-96eb-c7d32aeb068f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9f75e25e-7c48-4b10-96eb-c7d32aeb068f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fbf2ed18-bf07-4b4e-8e03-33dbc650cd14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9f75e25e-7c48-4b10-96eb-c7d32aeb068f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fbf2ed18-bf07-4b4e-8e03-33dbc650cd14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b4933984-9acc-4452-812b-ff9f74ddbcda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b4933984-9acc-4452-812b-ff9f74ddbcda" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b4933984-9acc-4452-812b-ff9f74ddbcda_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b4933984-9acc-4452-812b-ff9f74ddbcda" xlink:to="loc_us-gaap_EquityComponentDomain_b4933984-9acc-4452-812b-ff9f74ddbcda_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1edc297d-6771-486a-abbf-1dbfe496f5ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b4933984-9acc-4452-812b-ff9f74ddbcda" xlink:to="loc_us-gaap_EquityComponentDomain_1edc297d-6771-486a-abbf-1dbfe496f5ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_7d5a42dc-6d92-4314-bc14-2686b7269bb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1edc297d-6771-486a-abbf-1dbfe496f5ba" xlink:to="loc_us-gaap_RetainedEarningsMember_7d5a42dc-6d92-4314-bc14-2686b7269bb1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashFlowLocationAxis_3fcb2669-3ae9-4ba0-b2f0-9af68f8e4c81" xlink:href="lh-20200930.xsd#lh_CashFlowLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:to="loc_lh_CashFlowLocationAxis_3fcb2669-3ae9-4ba0-b2f0-9af68f8e4c81" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashFlowLocationDomain_3fcb2669-3ae9-4ba0-b2f0-9af68f8e4c81_default" xlink:href="lh-20200930.xsd#lh_CashFlowLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_lh_CashFlowLocationAxis_3fcb2669-3ae9-4ba0-b2f0-9af68f8e4c81" xlink:to="loc_lh_CashFlowLocationDomain_3fcb2669-3ae9-4ba0-b2f0-9af68f8e4c81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashFlowLocationDomain_c3472bf1-f9a3-490d-86b8-4f548c64896f" xlink:href="lh-20200930.xsd#lh_CashFlowLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_lh_CashFlowLocationAxis_3fcb2669-3ae9-4ba0-b2f0-9af68f8e4c81" xlink:to="loc_lh_CashFlowLocationDomain_c3472bf1-f9a3-490d-86b8-4f548c64896f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0b5bc051-b069-44e4-b810-b17754767df0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0b5bc051-b069-44e4-b810-b17754767df0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0b5bc051-b069-44e4-b810-b17754767df0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0b5bc051-b069-44e4-b810-b17754767df0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0b5bc051-b069-44e4-b810-b17754767df0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e69ad89d-0a00-43bb-b904-10e12d1868c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0b5bc051-b069-44e4-b810-b17754767df0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e69ad89d-0a00-43bb-b904-10e12d1868c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EquityMethodIncomeLossNetDomain_f196f2b8-1af5-49c1-93c6-aaa25ab819f0" xlink:href="lh-20200930.xsd#lh_EquityMethodIncomeLossNetDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e69ad89d-0a00-43bb-b904-10e12d1868c7" xlink:to="loc_lh_EquityMethodIncomeLossNetDomain_f196f2b8-1af5-49c1-93c6-aaa25ab819f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_5dbc6477-241b-4478-b793-322441d32b1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e69ad89d-0a00-43bb-b904-10e12d1868c7" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_5dbc6477-241b-4478-b793-322441d32b1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_3349c692-4020-48bb-905c-fdda198df4b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_3349c692-4020-48bb-905c-fdda198df4b4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3349c692-4020-48bb-905c-fdda198df4b4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3349c692-4020-48bb-905c-fdda198df4b4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3349c692-4020-48bb-905c-fdda198df4b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_55976be3-d1dd-47ee-91b6-5406b0e8bfac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3349c692-4020-48bb-905c-fdda198df4b4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_55976be3-d1dd-47ee-91b6-5406b0e8bfac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis_df84e5b6-da72-4c98-b6bf-a172d7776ddb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:to="loc_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis_df84e5b6-da72-4c98-b6bf-a172d7776ddb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingGuidanceMember_df84e5b6-da72-4c98-b6bf-a172d7776ddb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingGuidanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis_df84e5b6-da72-4c98-b6bf-a172d7776ddb" xlink:to="loc_us-gaap_AccountingGuidanceMember_df84e5b6-da72-4c98-b6bf-a172d7776ddb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingGuidanceMember_5b9ba2db-45a5-4a62-bfb4-8f98939713a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingGuidanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis_df84e5b6-da72-4c98-b6bf-a172d7776ddb" xlink:to="loc_us-gaap_AccountingGuidanceMember_5b9ba2db-45a5-4a62-bfb4-8f98939713a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9ba87d98-96c6-43f6-8614-b3d57929650b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9ba87d98-96c6-43f6-8614-b3d57929650b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9ba87d98-96c6-43f6-8614-b3d57929650b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9ba87d98-96c6-43f6-8614-b3d57929650b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9ba87d98-96c6-43f6-8614-b3d57929650b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f7b4fd79-e338-4472-8fd7-7977451bae64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9ba87d98-96c6-43f6-8614-b3d57929650b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f7b4fd79-e338-4472-8fd7-7977451bae64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_62b0b906-0c29-4f51-87f6-51decda2a468" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_62b0b906-0c29-4f51-87f6-51decda2a468" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_62b0b906-0c29-4f51-87f6-51decda2a468_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_62b0b906-0c29-4f51-87f6-51decda2a468" xlink:to="loc_us-gaap_SegmentDomain_62b0b906-0c29-4f51-87f6-51decda2a468_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_82776f12-64b9-4fc8-bd6b-afa66790d62c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_62b0b906-0c29-4f51-87f6-51decda2a468" xlink:to="loc_us-gaap_SegmentDomain_82776f12-64b9-4fc8-bd6b-afa66790d62c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_f9ad6dcd-7836-4c70-a7f1-31b877e5201f" xlink:href="lh-20200930.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_82776f12-64b9-4fc8-bd6b-afa66790d62c" xlink:to="loc_lh_LabCorpDiagnosticsMember_f9ad6dcd-7836-4c70-a7f1-31b877e5201f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_a11b2c5a-852c-4609-b2e1-8134c590876f" xlink:href="lh-20200930.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_82776f12-64b9-4fc8-bd6b-afa66790d62c" xlink:to="loc_lh_CovanceDrugDevelopmentMember_a11b2c5a-852c-4609-b2e1-8134c590876f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e3c5f723-6d3d-4b3e-aed0-053715c14749" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e3c5f723-6d3d-4b3e-aed0-053715c14749" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e3c5f723-6d3d-4b3e-aed0-053715c14749_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e3c5f723-6d3d-4b3e-aed0-053715c14749" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e3c5f723-6d3d-4b3e-aed0-053715c14749_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_70870c2f-10d2-401b-b379-679ab1514215" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e3c5f723-6d3d-4b3e-aed0-053715c14749" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_70870c2f-10d2-401b-b379-679ab1514215" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CARESActFundsAxis_32c5fd1d-201c-4199-b280-b2e876e10e62" xlink:href="lh-20200930.xsd#lh_CARESActFundsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:to="loc_lh_CARESActFundsAxis_32c5fd1d-201c-4199-b280-b2e876e10e62" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AccruedLiabilityForCARESActFundsToBeReturnedToGovernmentDomain_32c5fd1d-201c-4199-b280-b2e876e10e62_default" xlink:href="lh-20200930.xsd#lh_AccruedLiabilityForCARESActFundsToBeReturnedToGovernmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_lh_CARESActFundsAxis_32c5fd1d-201c-4199-b280-b2e876e10e62" xlink:to="loc_lh_AccruedLiabilityForCARESActFundsToBeReturnedToGovernmentDomain_32c5fd1d-201c-4199-b280-b2e876e10e62_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AccruedLiabilityForCARESActFundsToBeReturnedToGovernmentDomain_82f783f5-57ad-497a-b8e7-8c9e8bbd5f22" xlink:href="lh-20200930.xsd#lh_AccruedLiabilityForCARESActFundsToBeReturnedToGovernmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_lh_CARESActFundsAxis_32c5fd1d-201c-4199-b280-b2e876e10e62" xlink:to="loc_lh_AccruedLiabilityForCARESActFundsToBeReturnedToGovernmentDomain_82f783f5-57ad-497a-b8e7-8c9e8bbd5f22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_COVID19PandemicAxis_599a2115-b5a1-4f2e-85e2-e5fdd23c863e" xlink:href="lh-20200930.xsd#lh_COVID19PandemicAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:to="loc_lh_COVID19PandemicAxis_599a2115-b5a1-4f2e-85e2-e5fdd23c863e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairmentDomain_599a2115-b5a1-4f2e-85e2-e5fdd23c863e_default" xlink:href="lh-20200930.xsd#lh_COVID19PandemicGoodwillAndIntangibleAssetImpairmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_lh_COVID19PandemicAxis_599a2115-b5a1-4f2e-85e2-e5fdd23c863e" xlink:to="loc_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairmentDomain_599a2115-b5a1-4f2e-85e2-e5fdd23c863e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairmentDomain_9c3f5cf4-f1c9-4b94-9e97-bf231deefff6" xlink:href="lh-20200930.xsd#lh_COVID19PandemicGoodwillAndIntangibleAssetImpairmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_lh_COVID19PandemicAxis_599a2115-b5a1-4f2e-85e2-e5fdd23c863e" xlink:to="loc_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairmentDomain_9c3f5cf4-f1c9-4b94-9e97-bf231deefff6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="lh-20200930.xsd#EARNINGSPERSHARE"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/EARNINGSPERSHARE" xlink:type="extended" id="i70c7afdb24cf4180a0ce8904a363120e_EARNINGSPERSHARE"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="lh-20200930.xsd#EARNINGSPERSHARETables"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/EARNINGSPERSHARETables" xlink:type="extended" id="i28b5388e325b41e1a870d7da379b2358_EARNINGSPERSHARETables"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails" xlink:type="extended" id="ia58928f8a83443acb82ac9011403a3fa_EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/EARNINGSPERSHAREPotentialcommonsharesnotincludedincomputationofdilutedearningspershareDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#EARNINGSPERSHAREPotentialcommonsharesnotincludedincomputationofdilutedearningspershareDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/EARNINGSPERSHAREPotentialcommonsharesnotincludedincomputationofdilutedearningspershareDetails" xlink:type="extended" id="id059e35e73b94091a5dda9071cdb2a7e_EARNINGSPERSHAREPotentialcommonsharesnotincludedincomputationofdilutedearningspershareDetails"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTS" xlink:type="simple" xlink:href="lh-20200930.xsd#NONCONTROLLINGINTERESTPUTS"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTS" xlink:type="extended" id="iced7ee79e0fb4b749713285e083e80ae_NONCONTROLLINGINTERESTPUTS"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTSDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#NONCONTROLLINGINTERESTPUTSDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTSDetails" xlink:type="extended" id="iaa3bd62411f842e1b50d39c29506d6a2_NONCONTROLLINGINTERESTPUTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_64024f1a-825e-4e93-a21d-224a32356fc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_074b4f7c-3b74-404a-b6db-e8452a7f5dd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_64024f1a-825e-4e93-a21d-224a32356fc1" xlink:to="loc_us-gaap_MinorityInterestTable_074b4f7c-3b74-404a-b6db-e8452a7f5dd5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ad643429-7ec2-42d5-a5d1-d2a392e699ee" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_074b4f7c-3b74-404a-b6db-e8452a7f5dd5" xlink:to="loc_dei_LegalEntityAxis_ad643429-7ec2-42d5-a5d1-d2a392e699ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ad643429-7ec2-42d5-a5d1-d2a392e699ee_default" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_ad643429-7ec2-42d5-a5d1-d2a392e699ee" xlink:to="loc_dei_EntityDomain_ad643429-7ec2-42d5-a5d1-d2a392e699ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_05a8a847-f847-4be9-ab7b-767f528e4705" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_ad643429-7ec2-42d5-a5d1-d2a392e699ee" xlink:to="loc_dei_EntityDomain_05a8a847-f847-4be9-ab7b-767f528e4705" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGES" xlink:type="simple" xlink:href="lh-20200930.xsd#RESTRUCTURINGANDOTHERSPECIALCHARGES"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGES" xlink:type="extended" id="i6dfb47a7353e439d9ae6cab22fb41f53_RESTRUCTURINGANDOTHERSPECIALCHARGES"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables" xlink:type="simple" xlink:href="lh-20200930.xsd#RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables" xlink:type="extended" id="id9499e5509ba40cb88ada0598cba0a6e_RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_77e66412-555d-4616-a7b7-c12e9b7583b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_8defdd1c-9619-4e7a-87ed-3da4e3ded57d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_77e66412-555d-4616-a7b7-c12e9b7583b0" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_8defdd1c-9619-4e7a-87ed-3da4e3ded57d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4f27316e-d2ab-404f-91b2-c42d9d9bf8d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_77e66412-555d-4616-a7b7-c12e9b7583b0" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4f27316e-d2ab-404f-91b2-c42d9d9bf8d7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_532116cc-fb67-432b-a151-6de089740e2d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4f27316e-d2ab-404f-91b2-c42d9d9bf8d7" xlink:to="loc_srt_ConsolidationItemsAxis_532116cc-fb67-432b-a151-6de089740e2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_532116cc-fb67-432b-a151-6de089740e2d_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_532116cc-fb67-432b-a151-6de089740e2d" xlink:to="loc_srt_ConsolidationItemsDomain_532116cc-fb67-432b-a151-6de089740e2d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_51bd053e-ba96-4a62-808e-b58bc0ab08a8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_532116cc-fb67-432b-a151-6de089740e2d" xlink:to="loc_srt_ConsolidationItemsDomain_51bd053e-ba96-4a62-808e-b58bc0ab08a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1d32770e-c438-46f5-b613-f820de74b1a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4f27316e-d2ab-404f-91b2-c42d9d9bf8d7" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1d32770e-c438-46f5-b613-f820de74b1a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d32770e-c438-46f5-b613-f820de74b1a0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1d32770e-c438-46f5-b613-f820de74b1a0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d32770e-c438-46f5-b613-f820de74b1a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_442bb8f7-c611-47f9-a70f-8213aac91b5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1d32770e-c438-46f5-b613-f820de74b1a0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_442bb8f7-c611-47f9-a70f-8213aac91b5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_6f4cd2e0-306e-460c-acf4-a88d1e7b2ac4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4f27316e-d2ab-404f-91b2-c42d9d9bf8d7" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_6f4cd2e0-306e-460c-acf4-a88d1e7b2ac4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_6f4cd2e0-306e-460c-acf4-a88d1e7b2ac4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_6f4cd2e0-306e-460c-acf4-a88d1e7b2ac4" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_6f4cd2e0-306e-460c-acf4-a88d1e7b2ac4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_9e7488a0-b2b8-4dbb-aa13-d20e0ecea111" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_6f4cd2e0-306e-460c-acf4-a88d1e7b2ac4" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_9e7488a0-b2b8-4dbb-aa13-d20e0ecea111" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_e9b9be9f-37b7-4a0e-9cc9-6dcba8b3ed34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4f27316e-d2ab-404f-91b2-c42d9d9bf8d7" xlink:to="loc_us-gaap_RestructuringPlanAxis_e9b9be9f-37b7-4a0e-9cc9-6dcba8b3ed34" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_e9b9be9f-37b7-4a0e-9cc9-6dcba8b3ed34_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_e9b9be9f-37b7-4a0e-9cc9-6dcba8b3ed34" xlink:to="loc_us-gaap_RestructuringPlanDomain_e9b9be9f-37b7-4a0e-9cc9-6dcba8b3ed34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_8fb96a6f-620d-4f88-bcfa-9304742355e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_e9b9be9f-37b7-4a0e-9cc9-6dcba8b3ed34" xlink:to="loc_us-gaap_RestructuringPlanDomain_8fb96a6f-620d-4f88-bcfa-9304742355e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_30355b3c-0987-4380-a881-b65c829fb0d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4f27316e-d2ab-404f-91b2-c42d9d9bf8d7" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_30355b3c-0987-4380-a881-b65c829fb0d6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_30355b3c-0987-4380-a881-b65c829fb0d6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_30355b3c-0987-4380-a881-b65c829fb0d6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_30355b3c-0987-4380-a881-b65c829fb0d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d6f31fae-aa2d-4c10-bc2d-bc34c1b356c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_30355b3c-0987-4380-a881-b65c829fb0d6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d6f31fae-aa2d-4c10-bc2d-bc34c1b356c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_0d949fa6-5717-46cf-8646-84e59d3a39bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4f27316e-d2ab-404f-91b2-c42d9d9bf8d7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_0d949fa6-5717-46cf-8646-84e59d3a39bb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_0d949fa6-5717-46cf-8646-84e59d3a39bb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_0d949fa6-5717-46cf-8646-84e59d3a39bb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_0d949fa6-5717-46cf-8646-84e59d3a39bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_e16a4397-87f3-4641-b938-48a2af90bc46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_0d949fa6-5717-46cf-8646-84e59d3a39bb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_e16a4397-87f3-4641-b938-48a2af90bc46" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#RESTRUCTURINGANDOTHERSPECIALCHARGESDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails" xlink:type="extended" id="i97ac823232c34fb2999172f86c217925_RESTRUCTURINGANDOTHERSPECIALCHARGESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_db5f5561-4075-4365-8ba7-4ad61a959061" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:to="loc_us-gaap_RestructuringReserve_db5f5561-4075-4365-8ba7-4ad61a959061" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_b4e42b83-c661-4080-9c77-d8fb3a17514f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:to="loc_us-gaap_RestructuringCharges_b4e42b83-c661-4080-9c77-d8fb3a17514f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_RestructuringReserveSettledWithCashAndOtherAdjustment_41911c8a-7af7-4b47-81f9-88c06ca43c28" xlink:href="lh-20200930.xsd#lh_RestructuringReserveSettledWithCashAndOtherAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:to="loc_lh_RestructuringReserveSettledWithCashAndOtherAdjustment_41911c8a-7af7-4b47-81f9-88c06ca43c28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetRestructuringCharges_e1ba3d54-4936-4759-b343-69415cff6b92" xlink:href="lh-20200930.xsd#lh_NetRestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:to="loc_lh_NetRestructuringCharges_e1ba3d54-4936-4759-b343-69415cff6b92" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_45b1aabb-04d2-4530-911c-5b242390dfa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:to="loc_us-gaap_SeveranceCosts1_45b1aabb-04d2-4530-911c-5b242390dfa8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_4ccf2daf-6b48-4cee-96a3-334b9cbb6505" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_4ccf2daf-6b48-4cee-96a3-334b9cbb6505" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_64aaaa82-4dd0-481d-9083-961b9a51310e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:to="loc_us-gaap_BusinessExitCosts1_64aaaa82-4dd0-481d-9083-961b9a51310e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment_7dde11e7-6abd-41e9-b8f7-1c1b76d636f8" xlink:href="lh-20200930.xsd#lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:to="loc_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment_7dde11e7-6abd-41e9-b8f7-1c1b76d636f8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_RestructuringImpairment_fc51e1cd-8ffd-4e01-b14a-cec2776bce6e" xlink:href="lh-20200930.xsd#lh_RestructuringImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:to="loc_lh_RestructuringImpairment_fc51e1cd-8ffd-4e01-b14a-cec2776bce6e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Unusedfacilityrestructuringreserves_ca4e7092-2e6d-4513-9d6f-bf01a7bfbb63" xlink:href="lh-20200930.xsd#lh_Unusedfacilityrestructuringreserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:to="loc_lh_Unusedfacilityrestructuringreserves_ca4e7092-2e6d-4513-9d6f-bf01a7bfbb63" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_fbc146f3-79b1-4e84-9992-d90ed3559c15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:to="loc_us-gaap_RestructuringReserveCurrent_fbc146f3-79b1-4e84-9992-d90ed3559c15" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent_ec33e676-bb72-4a94-91eb-80f318231941" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:to="loc_us-gaap_RestructuringReserveNoncurrent_ec33e676-bb72-4a94-91eb-80f318231941" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f1c8073a-0f3c-488a-a768-de3d15c1bb3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f1c8073a-0f3c-488a-a768-de3d15c1bb3d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_be6dcf18-3e80-4b65-89f3-87be446cd577" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f1c8073a-0f3c-488a-a768-de3d15c1bb3d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_be6dcf18-3e80-4b65-89f3-87be446cd577" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_be6dcf18-3e80-4b65-89f3-87be446cd577_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_be6dcf18-3e80-4b65-89f3-87be446cd577" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_be6dcf18-3e80-4b65-89f3-87be446cd577_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3faa87fa-7dcb-46f0-9f01-48d3c1576bba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_be6dcf18-3e80-4b65-89f3-87be446cd577" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3faa87fa-7dcb-46f0-9f01-48d3c1576bba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceMember_37cd4300-c725-4bf8-9f73-6024213835f8" xlink:href="lh-20200930.xsd#lh_CovanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3faa87fa-7dcb-46f0-9f01-48d3c1576bba" xlink:to="loc_lh_CovanceMember_37cd4300-c725-4bf8-9f73-6024213835f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ab4aa1ed-7601-4964-bf21-02bbcafd889a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f1c8073a-0f3c-488a-a768-de3d15c1bb3d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ab4aa1ed-7601-4964-bf21-02bbcafd889a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ab4aa1ed-7601-4964-bf21-02bbcafd889a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ab4aa1ed-7601-4964-bf21-02bbcafd889a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ab4aa1ed-7601-4964-bf21-02bbcafd889a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_345fca65-3722-45b0-9947-cc1dfb975256" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ab4aa1ed-7601-4964-bf21-02bbcafd889a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_345fca65-3722-45b0-9947-cc1dfb975256" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_edb81221-704a-4a06-8296-383f7ee9afef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f1c8073a-0f3c-488a-a768-de3d15c1bb3d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_edb81221-704a-4a06-8296-383f7ee9afef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_edb81221-704a-4a06-8296-383f7ee9afef_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_edb81221-704a-4a06-8296-383f7ee9afef" xlink:to="loc_us-gaap_SegmentDomain_edb81221-704a-4a06-8296-383f7ee9afef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fc34d82d-c0d6-4f2f-8fc2-634b681856d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_edb81221-704a-4a06-8296-383f7ee9afef" xlink:to="loc_us-gaap_SegmentDomain_fc34d82d-c0d6-4f2f-8fc2-634b681856d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_e741e986-149e-4857-ae18-ff45b18ee695" xlink:href="lh-20200930.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_fc34d82d-c0d6-4f2f-8fc2-634b681856d8" xlink:to="loc_lh_CovanceDrugDevelopmentMember_e741e986-149e-4857-ae18-ff45b18ee695" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_6cdb4b49-3d7a-4e40-a910-640325ff5c77" xlink:href="lh-20200930.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_fc34d82d-c0d6-4f2f-8fc2-634b681856d8" xlink:to="loc_lh_LabCorpDiagnosticsMember_6cdb4b49-3d7a-4e40-a910-640325ff5c77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_125a483c-fcbb-4878-9000-7bd07378923e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f1c8073a-0f3c-488a-a768-de3d15c1bb3d" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_125a483c-fcbb-4878-9000-7bd07378923e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_125a483c-fcbb-4878-9000-7bd07378923e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_125a483c-fcbb-4878-9000-7bd07378923e" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_125a483c-fcbb-4878-9000-7bd07378923e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_ca3a4ccd-9c3f-46ca-8087-036d7e5b8092" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_125a483c-fcbb-4878-9000-7bd07378923e" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_ca3a4ccd-9c3f-46ca-8087-036d7e5b8092" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_28bdabc5-b6a2-4d38-a5fe-e73452031b4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_ca3a4ccd-9c3f-46ca-8087-036d7e5b8092" xlink:to="loc_us-gaap_EmployeeSeveranceMember_28bdabc5-b6a2-4d38-a5fe-e73452031b4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember_cfba6e5f-b1b6-4ce4-ad00-ff2971798ef7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FacilityClosingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_ca3a4ccd-9c3f-46ca-8087-036d7e5b8092" xlink:to="loc_us-gaap_FacilityClosingMember_cfba6e5f-b1b6-4ce4-ad00-ff2971798ef7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/RESTRUCTURINGRESERVES" xlink:type="simple" xlink:href="lh-20200930.xsd#RESTRUCTURINGRESERVES"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/RESTRUCTURINGRESERVES" xlink:type="extended" id="i8b0f34ef87b741f8b54a5744d9bf2f47_RESTRUCTURINGRESERVES"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#RESTRUCTURINGRESERVESDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails" xlink:type="extended" id="i89d07899efcc48858e6c8774168c41b1_RESTRUCTURINGRESERVESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_8472cb6e-320d-43a7-971f-fe795c28cd41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Unusedfacilityrestructuringreserves_958e8d7a-df2c-4c62-accb-714412a4e14e" xlink:href="lh-20200930.xsd#lh_Unusedfacilityrestructuringreserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8472cb6e-320d-43a7-971f-fe795c28cd41" xlink:to="loc_lh_Unusedfacilityrestructuringreserves_958e8d7a-df2c-4c62-accb-714412a4e14e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_1c95cc5e-708b-47f1-99f9-143f96d65aa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8472cb6e-320d-43a7-971f-fe795c28cd41" xlink:to="loc_us-gaap_RestructuringReserve_1c95cc5e-708b-47f1-99f9-143f96d65aa9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_bb3cdd17-d142-4ebc-8cbd-badd578afb1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8472cb6e-320d-43a7-971f-fe795c28cd41" xlink:to="loc_us-gaap_RestructuringCharges_bb3cdd17-d142-4ebc-8cbd-badd578afb1f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_RestructuringReserveSettledWithCashAndOtherAdjustment_12ffd800-7659-49f6-8f2b-cc7cf078a261" xlink:href="lh-20200930.xsd#lh_RestructuringReserveSettledWithCashAndOtherAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8472cb6e-320d-43a7-971f-fe795c28cd41" xlink:to="loc_lh_RestructuringReserveSettledWithCashAndOtherAdjustment_12ffd800-7659-49f6-8f2b-cc7cf078a261" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_c4b6370d-b21b-47d6-ad0e-b53c0cfdd1ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_5116ab27-e7ad-4f0e-9bde-b62fd54f4a75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8472cb6e-320d-43a7-971f-fe795c28cd41" xlink:to="loc_us-gaap_RestructuringReserveCurrent_5116ab27-e7ad-4f0e-9bde-b62fd54f4a75" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent_aacbf3da-16fa-479f-ba66-1e79666d78b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8472cb6e-320d-43a7-971f-fe795c28cd41" xlink:to="loc_us-gaap_RestructuringReserveNoncurrent_aacbf3da-16fa-479f-ba66-1e79666d78b4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_e903a230-147c-4a55-aa7f-b05b4e6c3ed3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment_b43121f6-bd5a-4bd0-92bb-63729dfb9952" xlink:href="lh-20200930.xsd#lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8472cb6e-320d-43a7-971f-fe795c28cd41" xlink:to="loc_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment_b43121f6-bd5a-4bd0-92bb-63729dfb9952" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0220d3dc-53bc-4383-8188-c00f68e405ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8472cb6e-320d-43a7-971f-fe795c28cd41" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0220d3dc-53bc-4383-8188-c00f68e405ab" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_cbd5ae5a-138a-443b-8f36-f4e99079a7c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0220d3dc-53bc-4383-8188-c00f68e405ab" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_cbd5ae5a-138a-443b-8f36-f4e99079a7c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cbd5ae5a-138a-443b-8f36-f4e99079a7c8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cbd5ae5a-138a-443b-8f36-f4e99079a7c8" xlink:to="loc_us-gaap_SegmentDomain_cbd5ae5a-138a-443b-8f36-f4e99079a7c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_259251a8-f23a-4ca5-a345-5467c3161109" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cbd5ae5a-138a-443b-8f36-f4e99079a7c8" xlink:to="loc_us-gaap_SegmentDomain_259251a8-f23a-4ca5-a345-5467c3161109" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_f8deb25a-017f-4956-9e8b-f55e81769d41" xlink:href="lh-20200930.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_259251a8-f23a-4ca5-a345-5467c3161109" xlink:to="loc_lh_LabCorpDiagnosticsMember_f8deb25a-017f-4956-9e8b-f55e81769d41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_7fecf751-43ae-437e-81b3-3569e151e4e8" xlink:href="lh-20200930.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_259251a8-f23a-4ca5-a345-5467c3161109" xlink:to="loc_lh_CovanceDrugDevelopmentMember_7fecf751-43ae-437e-81b3-3569e151e4e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6163512b-f037-40d1-a286-5560b6a10caf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0220d3dc-53bc-4383-8188-c00f68e405ab" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6163512b-f037-40d1-a286-5560b6a10caf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6163512b-f037-40d1-a286-5560b6a10caf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6163512b-f037-40d1-a286-5560b6a10caf" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6163512b-f037-40d1-a286-5560b6a10caf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8d154648-a2ac-4613-82ff-330a421b930d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6163512b-f037-40d1-a286-5560b6a10caf" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8d154648-a2ac-4613-82ff-330a421b930d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_6be9a0f0-2388-41ab-8fe0-74cb8e0d462a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0220d3dc-53bc-4383-8188-c00f68e405ab" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_6be9a0f0-2388-41ab-8fe0-74cb8e0d462a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_6be9a0f0-2388-41ab-8fe0-74cb8e0d462a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_6be9a0f0-2388-41ab-8fe0-74cb8e0d462a" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_6be9a0f0-2388-41ab-8fe0-74cb8e0d462a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_a2ee525d-53d0-4483-87b1-f82dca65f60d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_6be9a0f0-2388-41ab-8fe0-74cb8e0d462a" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_a2ee525d-53d0-4483-87b1-f82dca65f60d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_67854014-92c5-42d3-ae84-5509498ea04b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_a2ee525d-53d0-4483-87b1-f82dca65f60d" xlink:to="loc_us-gaap_EmployeeSeveranceMember_67854014-92c5-42d3-ae84-5509498ea04b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember_9bdf3bf4-6b06-4d56-a78a-8f6b261d7299" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FacilityClosingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_a2ee525d-53d0-4483-87b1-f82dca65f60d" xlink:to="loc_us-gaap_FacilityClosingMember_9bdf3bf4-6b06-4d56-a78a-8f6b261d7299" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="lh-20200930.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended" id="i047c6e4da89e42588284c5b6797e36a5_GOODWILLANDINTANGIBLEASSETS"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="lh-20200930.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended" id="ia25df1f43ede45d0a566aae87c47778f_GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails" xlink:type="extended" id="i3ca6fd7f9b6d455891d5bbd6c1cffadd_GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9ad64c24-1cdd-486f-a215-16711a10b84e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9ad64c24-1cdd-486f-a215-16711a10b84e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_97bc0d02-01da-4bd5-b0db-72a4207327c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_us-gaap_SeveranceCosts1_97bc0d02-01da-4bd5-b0db-72a4207327c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b32c4850-8ff9-4253-8cf5-dce961adc2e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b32c4850-8ff9-4253-8cf5-dce961adc2e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ee1cea86-4d78-4eb5-97b0-da142ef2ea3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_us-gaap_Goodwill_ee1cea86-4d78-4eb5-97b0-da142ef2ea3c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_b7d3fcfd-ad95-4274-ba37-708cbd015f97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_b7d3fcfd-ad95-4274-ba37-708cbd015f97" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_86b0c447-c067-41f3-b061-83687456f4ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_aedb6589-db17-4dd1-ad1d-c8bfd8a2f82b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_aedb6589-db17-4dd1-ad1d-c8bfd8a2f82b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a849435a-86aa-41de-9ddd-cd09dacb576a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a849435a-86aa-41de-9ddd-cd09dacb576a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_37bcc6dd-db2d-4b52-af76-9b6169e611a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_37bcc6dd-db2d-4b52-af76-9b6169e611a2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentageFairValueofGoodwillExceededCarryingValue_b4ceae23-b16e-4710-a7f2-38398c6f0bde" xlink:href="lh-20200930.xsd#lh_PercentageFairValueofGoodwillExceededCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_lh_PercentageFairValueofGoodwillExceededCarryingValue_b4ceae23-b16e-4710-a7f2-38398c6f0bde" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill_46198abc-2403-48ec-9126-2ef428683c08" xlink:href="lh-20200930.xsd#lh_PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_lh_PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill_46198abc-2403-48ec-9126-2ef428683c08" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit_ad3b2a6c-0aa6-46f5-bdd5-e6644c1a5d45" xlink:href="lh-20200930.xsd#lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit_ad3b2a6c-0aa6-46f5-bdd5-e6644c1a5d45" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit_d1e11561-f9a0-46fe-820d-7595f62193ab" xlink:href="lh-20200930.xsd#lh_PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_lh_PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit_d1e11561-f9a0-46fe-820d-7595f62193ab" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit_68a98d21-8e60-4fa6-94cc-b9db01316a79" xlink:href="lh-20200930.xsd#lh_PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_lh_PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit_68a98d21-8e60-4fa6-94cc-b9db01316a79" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ValueofReportingUnitsGoodwillFollowingImpairment_428055a6-cb55-4834-8e41-7833bec7b9b6" xlink:href="lh-20200930.xsd#lh_ValueofReportingUnitsGoodwillFollowingImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_lh_ValueofReportingUnitsGoodwillFollowingImpairment_428055a6-cb55-4834-8e41-7833bec7b9b6" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_30882638-f5eb-44af-810f-a09969618bd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_30882638-f5eb-44af-810f-a09969618bd5" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue_f0fa7e7b-2687-4cca-8e6c-e3fdfb475ca4" xlink:href="lh-20200930.xsd#lh_ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_lh_ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue_f0fa7e7b-2687-4cca-8e6c-e3fdfb475ca4" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_0e2fa157-2559-400d-a6e0-99357f574820" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_0e2fa157-2559-400d-a6e0-99357f574820" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_e2902365-d50f-43a1-a7d4-4e15e92c3ea8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_e2902365-d50f-43a1-a7d4-4e15e92c3ea8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f6b7790e-848c-4d63-89e8-7573c6db2a38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e2902365-d50f-43a1-a7d4-4e15e92c3ea8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f6b7790e-848c-4d63-89e8-7573c6db2a38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f6b7790e-848c-4d63-89e8-7573c6db2a38_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f6b7790e-848c-4d63-89e8-7573c6db2a38" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f6b7790e-848c-4d63-89e8-7573c6db2a38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5e69b2fd-3d5a-4afd-8959-aa8b476e9ee3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f6b7790e-848c-4d63-89e8-7573c6db2a38" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5e69b2fd-3d5a-4afd-8959-aa8b476e9ee3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_d0bc06c9-c7c0-4c25-a560-74f4841d4f97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5e69b2fd-3d5a-4afd-8959-aa8b476e9ee3" xlink:to="loc_us-gaap_TradeNamesMember_d0bc06c9-c7c0-4c25-a560-74f4841d4f97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_87a75848-b82b-4894-877e-6da8e6a9a8d2" xlink:href="lh-20200930.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e2902365-d50f-43a1-a7d4-4e15e92c3ea8" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_87a75848-b82b-4894-877e-6da8e6a9a8d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_87a75848-b82b-4894-877e-6da8e6a9a8d2_default" xlink:href="lh-20200930.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_87a75848-b82b-4894-877e-6da8e6a9a8d2" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_87a75848-b82b-4894-877e-6da8e6a9a8d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_f8e2a2dd-9159-4d03-ac20-231f455fe92d" xlink:href="lh-20200930.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_87a75848-b82b-4894-877e-6da8e6a9a8d2" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_f8e2a2dd-9159-4d03-ac20-231f455fe92d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_9326972f-2669-4ab1-be49-81c2f8779f7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_f8e2a2dd-9159-4d03-ac20-231f455fe92d" xlink:to="loc_us-gaap_CustomerRelationshipsMember_9326972f-2669-4ab1-be49-81c2f8779f7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PatentsLicensesAndTechnologyMember_e12b4d9b-966e-4a6a-8244-15421f5e3b96" xlink:href="lh-20200930.xsd#lh_PatentsLicensesAndTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_f8e2a2dd-9159-4d03-ac20-231f455fe92d" xlink:to="loc_lh_PatentsLicensesAndTechnologyMember_e12b4d9b-966e-4a6a-8244-15421f5e3b96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_eaf6e3b2-cbe4-4752-ae77-99b608fce93c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_f8e2a2dd-9159-4d03-ac20-231f455fe92d" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_eaf6e3b2-cbe4-4752-ae77-99b608fce93c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_c0767657-bcc9-4dde-b785-fe65b9569022" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_f8e2a2dd-9159-4d03-ac20-231f455fe92d" xlink:to="loc_us-gaap_TradeNamesMember_c0767657-bcc9-4dde-b785-fe65b9569022" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseRightsMember_b71c682b-ed0f-430b-bec1-5d9eb7877005" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_f8e2a2dd-9159-4d03-ac20-231f455fe92d" xlink:to="loc_us-gaap_UseRightsMember_b71c682b-ed0f-430b-bec1-5d9eb7877005" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_207b4d02-7479-4986-83d4-67665b9638aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_f8e2a2dd-9159-4d03-ac20-231f455fe92d" xlink:to="loc_us-gaap_LicensingAgreementsMember_207b4d02-7479-4986-83d4-67665b9638aa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_e47464fd-8c09-4e8d-9c53-94569542d042" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e2902365-d50f-43a1-a7d4-4e15e92c3ea8" xlink:to="loc_srt_ConsolidationItemsAxis_e47464fd-8c09-4e8d-9c53-94569542d042" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_e47464fd-8c09-4e8d-9c53-94569542d042_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_e47464fd-8c09-4e8d-9c53-94569542d042" xlink:to="loc_srt_ConsolidationItemsDomain_e47464fd-8c09-4e8d-9c53-94569542d042_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_99df8b03-af0b-4616-b72c-a9b5dca16aff" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_e47464fd-8c09-4e8d-9c53-94569542d042" xlink:to="loc_srt_ConsolidationItemsDomain_99df8b03-af0b-4616-b72c-a9b5dca16aff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c3f27bfc-cfbb-412c-a2c6-7d5981c3bb50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e2902365-d50f-43a1-a7d4-4e15e92c3ea8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c3f27bfc-cfbb-412c-a2c6-7d5981c3bb50" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c3f27bfc-cfbb-412c-a2c6-7d5981c3bb50_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c3f27bfc-cfbb-412c-a2c6-7d5981c3bb50" xlink:to="loc_us-gaap_SegmentDomain_c3f27bfc-cfbb-412c-a2c6-7d5981c3bb50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6f488cc2-5e38-4dfc-88ba-2a21251a7798" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c3f27bfc-cfbb-412c-a2c6-7d5981c3bb50" xlink:to="loc_us-gaap_SegmentDomain_6f488cc2-5e38-4dfc-88ba-2a21251a7798" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_e9a45eee-c29d-4dab-bd88-304ce8a20d22" xlink:href="lh-20200930.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6f488cc2-5e38-4dfc-88ba-2a21251a7798" xlink:to="loc_lh_LabCorpDiagnosticsMember_e9a45eee-c29d-4dab-bd88-304ce8a20d22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_bb11ee21-fd1b-40bb-8099-d8f6f1b1a61d" xlink:href="lh-20200930.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6f488cc2-5e38-4dfc-88ba-2a21251a7798" xlink:to="loc_lh_CovanceDrugDevelopmentMember_bb11ee21-fd1b-40bb-8099-d8f6f1b1a61d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_58f7bdae-2059-49ba-95eb-0f65ea4fa0eb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e2902365-d50f-43a1-a7d4-4e15e92c3ea8" xlink:to="loc_srt_RangeAxis_58f7bdae-2059-49ba-95eb-0f65ea4fa0eb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_58f7bdae-2059-49ba-95eb-0f65ea4fa0eb_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_58f7bdae-2059-49ba-95eb-0f65ea4fa0eb" xlink:to="loc_srt_RangeMember_58f7bdae-2059-49ba-95eb-0f65ea4fa0eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5bc987d7-8498-43ad-b032-d228500ed4e2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_58f7bdae-2059-49ba-95eb-0f65ea4fa0eb" xlink:to="loc_srt_RangeMember_5bc987d7-8498-43ad-b032-d228500ed4e2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails" xlink:type="extended" id="i8fcb1ea6169049c8b82d8299632bc9a8_GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5238a30e-beeb-4353-beef-dcdf5f25cc21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_86eaa45a-9ed4-4859-8b7e-8196f2e1f293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5238a30e-beeb-4353-beef-dcdf5f25cc21" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_86eaa45a-9ed4-4859-8b7e-8196f2e1f293" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8b44ec18-c46f-415d-9271-5e0cdfb8b549" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5238a30e-beeb-4353-beef-dcdf5f25cc21" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8b44ec18-c46f-415d-9271-5e0cdfb8b549" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_75dbd10f-7bff-4f97-a595-76bfe0a42d83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5238a30e-beeb-4353-beef-dcdf5f25cc21" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_75dbd10f-7bff-4f97-a595-76bfe0a42d83" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b69eed1d-03b8-425f-9ba6-fa7aef3b0ecc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5238a30e-beeb-4353-beef-dcdf5f25cc21" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b69eed1d-03b8-425f-9ba6-fa7aef3b0ecc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_877f0a39-28a8-4700-89c5-a972a0f4631d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b69eed1d-03b8-425f-9ba6-fa7aef3b0ecc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_877f0a39-28a8-4700-89c5-a972a0f4631d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_877f0a39-28a8-4700-89c5-a972a0f4631d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_877f0a39-28a8-4700-89c5-a972a0f4631d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_877f0a39-28a8-4700-89c5-a972a0f4631d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4290cade-a88b-4a8e-ab64-dcd956a49ab8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_877f0a39-28a8-4700-89c5-a972a0f4631d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4290cade-a88b-4a8e-ab64-dcd956a49ab8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_4c415e09-b708-4d4a-9ebd-635c6580c731" xlink:href="lh-20200930.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b69eed1d-03b8-425f-9ba6-fa7aef3b0ecc" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_4c415e09-b708-4d4a-9ebd-635c6580c731" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_4c415e09-b708-4d4a-9ebd-635c6580c731_default" xlink:href="lh-20200930.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_4c415e09-b708-4d4a-9ebd-635c6580c731" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_4c415e09-b708-4d4a-9ebd-635c6580c731_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_17f28da1-4078-4992-b1bf-00f6ffb5100d" xlink:href="lh-20200930.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_4c415e09-b708-4d4a-9ebd-635c6580c731" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_17f28da1-4078-4992-b1bf-00f6ffb5100d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_03302fa0-d1e2-4c24-9e83-af54f90380ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_17f28da1-4078-4992-b1bf-00f6ffb5100d" xlink:to="loc_us-gaap_CustomerRelationshipsMember_03302fa0-d1e2-4c24-9e83-af54f90380ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PatentsLicensesAndTechnologyMember_ee1aaad3-d223-43e5-a1a4-41284bde3404" xlink:href="lh-20200930.xsd#lh_PatentsLicensesAndTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_17f28da1-4078-4992-b1bf-00f6ffb5100d" xlink:to="loc_lh_PatentsLicensesAndTechnologyMember_ee1aaad3-d223-43e5-a1a4-41284bde3404" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_f88d5415-673e-418f-bd6b-908c4ba10134" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_17f28da1-4078-4992-b1bf-00f6ffb5100d" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_f88d5415-673e-418f-bd6b-908c4ba10134" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_bedf2412-561e-4731-8f29-38d41e3f1adb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_17f28da1-4078-4992-b1bf-00f6ffb5100d" xlink:to="loc_us-gaap_TradeNamesMember_bedf2412-561e-4731-8f29-38d41e3f1adb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseRightsMember_99ea48c1-c7f5-4398-a83d-a6b63ebffae0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_17f28da1-4078-4992-b1bf-00f6ffb5100d" xlink:to="loc_us-gaap_UseRightsMember_99ea48c1-c7f5-4398-a83d-a6b63ebffae0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_087d8c81-a7ba-4f64-b030-40cce729aff5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_17f28da1-4078-4992-b1bf-00f6ffb5100d" xlink:to="loc_us-gaap_LicensingAgreementsMember_087d8c81-a7ba-4f64-b030-40cce729aff5" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#GOODWILLANDINTANGIBLEASSETSDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="extended" id="i01722231ab8b4ef39cc50cedce1ecacb_GOODWILLANDINTANGIBLEASSETSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_98341372-16fc-41b9-a690-b8550c6dcac0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_de52c010-864b-4821-87b9-be5a0c94a064" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_98341372-16fc-41b9-a690-b8550c6dcac0" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_de52c010-864b-4821-87b9-be5a0c94a064" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongTermNotes_b35e7e3e-27ed-4c0f-ae44-5013578715bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorLongTermNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_98341372-16fc-41b9-a690-b8550c6dcac0" xlink:to="loc_us-gaap_SeniorLongTermNotes_b35e7e3e-27ed-4c0f-ae44-5013578715bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_25b1f045-c85f-42f5-ac38-34e5f745232e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_98341372-16fc-41b9-a690-b8550c6dcac0" xlink:to="loc_us-gaap_Goodwill_25b1f045-c85f-42f5-ac38-34e5f745232e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_71174ef7-299a-45ef-b643-631da9bc2d0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_98341372-16fc-41b9-a690-b8550c6dcac0" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_71174ef7-299a-45ef-b643-631da9bc2d0a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit_51136cc2-ca89-48c7-bb4b-8249787be95b" xlink:href="lh-20200930.xsd#lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_98341372-16fc-41b9-a690-b8550c6dcac0" xlink:to="loc_lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit_51136cc2-ca89-48c7-bb4b-8249787be95b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_2f15c8b9-4336-421a-951d-ee7fff96191c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_98341372-16fc-41b9-a690-b8550c6dcac0" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_2f15c8b9-4336-421a-951d-ee7fff96191c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_c4b9b3fd-c5af-49ef-92b5-6c28b44a8cbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_98341372-16fc-41b9-a690-b8550c6dcac0" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_c4b9b3fd-c5af-49ef-92b5-6c28b44a8cbf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Impairmentoffloatingratenotereceivable_5afdbc46-ea62-443b-9274-0ce6e8a490d8" xlink:href="lh-20200930.xsd#lh_Impairmentoffloatingratenotereceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_98341372-16fc-41b9-a690-b8550c6dcac0" xlink:to="loc_lh_Impairmentoffloatingratenotereceivable_5afdbc46-ea62-443b-9274-0ce6e8a490d8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e5e0f75a-8401-40ad-b5f4-26989f6bd631" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_98341372-16fc-41b9-a690-b8550c6dcac0" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e5e0f75a-8401-40ad-b5f4-26989f6bd631" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f04fa536-0dc8-44e3-adf6-51725a5f5cc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e5e0f75a-8401-40ad-b5f4-26989f6bd631" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f04fa536-0dc8-44e3-adf6-51725a5f5cc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f04fa536-0dc8-44e3-adf6-51725a5f5cc6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f04fa536-0dc8-44e3-adf6-51725a5f5cc6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f04fa536-0dc8-44e3-adf6-51725a5f5cc6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f2df526d-9c75-4313-a3be-bb273e3f4f3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f04fa536-0dc8-44e3-adf6-51725a5f5cc6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f2df526d-9c75-4313-a3be-bb273e3f4f3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2045Member_ef304e52-b69d-46a4-b9c7-ed66e4283557" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2045Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f2df526d-9c75-4313-a3be-bb273e3f4f3e" xlink:to="loc_lh_Seniornotesdue2045Member_ef304e52-b69d-46a4-b9c7-ed66e4283557" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_fda85863-343b-4e41-ae29-89307ea69f52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e5e0f75a-8401-40ad-b5f4-26989f6bd631" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_fda85863-343b-4e41-ae29-89307ea69f52" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fda85863-343b-4e41-ae29-89307ea69f52_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fda85863-343b-4e41-ae29-89307ea69f52" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fda85863-343b-4e41-ae29-89307ea69f52_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65d538a4-ad65-40fd-9b7a-80b311cdb96f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fda85863-343b-4e41-ae29-89307ea69f52" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65d538a4-ad65-40fd-9b7a-80b311cdb96f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceMember_4211eb06-6e06-4504-a390-66eb87e51817" xlink:href="lh-20200930.xsd#lh_CovanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65d538a4-ad65-40fd-9b7a-80b311cdb96f" xlink:to="loc_lh_CovanceMember_4211eb06-6e06-4504-a390-66eb87e51817" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a115c3b7-bd0f-4c3d-8dd6-8b463ea0e631" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e5e0f75a-8401-40ad-b5f4-26989f6bd631" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a115c3b7-bd0f-4c3d-8dd6-8b463ea0e631" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a115c3b7-bd0f-4c3d-8dd6-8b463ea0e631_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a115c3b7-bd0f-4c3d-8dd6-8b463ea0e631" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a115c3b7-bd0f-4c3d-8dd6-8b463ea0e631_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_60a66219-37aa-46ca-b8b0-415b70d15ec3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a115c3b7-bd0f-4c3d-8dd6-8b463ea0e631" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_60a66219-37aa-46ca-b8b0-415b70d15ec3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_f099b56d-cedf-4ed5-a398-10cec1672e0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_60a66219-37aa-46ca-b8b0-415b70d15ec3" xlink:to="loc_us-gaap_TradeNamesMember_f099b56d-cedf-4ed5-a398-10cec1672e0e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_9120386a-2f5b-4292-94af-ea66d8bacbed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_60a66219-37aa-46ca-b8b0-415b70d15ec3" xlink:to="loc_us-gaap_CustomerRelationshipsMember_9120386a-2f5b-4292-94af-ea66d8bacbed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_e90b3454-d1e0-46be-8144-330fbda4948a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_60a66219-37aa-46ca-b8b0-415b70d15ec3" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_e90b3454-d1e0-46be-8144-330fbda4948a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_bc68dd9e-9c07-4c45-819b-250ce165b8f9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e5e0f75a-8401-40ad-b5f4-26989f6bd631" xlink:to="loc_srt_ConsolidationItemsAxis_bc68dd9e-9c07-4c45-819b-250ce165b8f9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_bc68dd9e-9c07-4c45-819b-250ce165b8f9_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_bc68dd9e-9c07-4c45-819b-250ce165b8f9" xlink:to="loc_srt_ConsolidationItemsDomain_bc68dd9e-9c07-4c45-819b-250ce165b8f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_05cbf24b-085a-4dff-9164-a929d81198b2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_bc68dd9e-9c07-4c45-819b-250ce165b8f9" xlink:to="loc_srt_ConsolidationItemsDomain_05cbf24b-085a-4dff-9164-a929d81198b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6e1d730f-9b25-42ae-9491-d94dcfc26378" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e5e0f75a-8401-40ad-b5f4-26989f6bd631" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6e1d730f-9b25-42ae-9491-d94dcfc26378" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6e1d730f-9b25-42ae-9491-d94dcfc26378_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6e1d730f-9b25-42ae-9491-d94dcfc26378" xlink:to="loc_us-gaap_SegmentDomain_6e1d730f-9b25-42ae-9491-d94dcfc26378_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cfe252ab-4250-4b7a-ab4b-29180d87db6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6e1d730f-9b25-42ae-9491-d94dcfc26378" xlink:to="loc_us-gaap_SegmentDomain_cfe252ab-4250-4b7a-ab4b-29180d87db6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_12649da7-6eda-43db-b900-9125d7bc1117" xlink:href="lh-20200930.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cfe252ab-4250-4b7a-ab4b-29180d87db6f" xlink:to="loc_lh_LabCorpDiagnosticsMember_12649da7-6eda-43db-b900-9125d7bc1117" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_197e0bac-a639-4be0-9bb4-13d8f29c9dc8" xlink:href="lh-20200930.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cfe252ab-4250-4b7a-ab4b-29180d87db6f" xlink:to="loc_lh_CovanceDrugDevelopmentMember_197e0bac-a639-4be0-9bb4-13d8f29c9dc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_defb1ccb-45ac-47d9-b515-0db3b79a1411" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e5e0f75a-8401-40ad-b5f4-26989f6bd631" xlink:to="loc_srt_RangeAxis_defb1ccb-45ac-47d9-b515-0db3b79a1411" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_defb1ccb-45ac-47d9-b515-0db3b79a1411_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_defb1ccb-45ac-47d9-b515-0db3b79a1411" xlink:to="loc_srt_RangeMember_defb1ccb-45ac-47d9-b515-0db3b79a1411_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7845bafb-7dce-41a3-b38a-2a6ec7b4f871" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_defb1ccb-45ac-47d9-b515-0db3b79a1411" xlink:to="loc_srt_RangeMember_7845bafb-7dce-41a3-b38a-2a6ec7b4f871" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/IntangibleAssetsGoodwillandOtherPolicies" xlink:type="simple" xlink:href="lh-20200930.xsd#IntangibleAssetsGoodwillandOtherPolicies"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/IntangibleAssetsGoodwillandOtherPolicies" xlink:type="extended" id="ieccb1c4caac74415b1c81c3a0d30d323_IntangibleAssetsGoodwillandOtherPolicies"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBT" xlink:type="simple" xlink:href="lh-20200930.xsd#DEBT"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/DEBT" xlink:type="extended" id="i1469fbec465640979c9a25d5ab3acb16_DEBT"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails" xlink:type="extended" id="id433fe45c0bc4612b02056992bb95a0a_DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_2addd49b-ce11-40ef-8494-c17fd81aae68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_91743c00-560b-424f-b7d1-871ae9252510" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2addd49b-ce11-40ef-8494-c17fd81aae68" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_91743c00-560b-424f-b7d1-871ae9252510" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongTermNotes_a863d184-8f1c-411a-b06d-92f947639af9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorLongTermNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2addd49b-ce11-40ef-8494-c17fd81aae68" xlink:to="loc_us-gaap_SeniorLongTermNotes_a863d184-8f1c-411a-b06d-92f947639af9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d559d16d-5409-4841-8003-a1f5c4c5fe3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2addd49b-ce11-40ef-8494-c17fd81aae68" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d559d16d-5409-4841-8003-a1f5c4c5fe3f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_dd54cf1c-33e8-4714-b4a5-5cdc1b7e72d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2addd49b-ce11-40ef-8494-c17fd81aae68" xlink:to="loc_us-gaap_DebtCurrent_dd54cf1c-33e8-4714-b4a5-5cdc1b7e72d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2019TermLoan_63a11ed4-f73b-4673-996c-b7631fe8c082" xlink:href="lh-20200930.xsd#lh_A2019TermLoan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2addd49b-ce11-40ef-8494-c17fd81aae68" xlink:to="loc_lh_A2019TermLoan_63a11ed4-f73b-4673-996c-b7631fe8c082" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_78bf568f-6adf-4473-8806-5880722c1172" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2addd49b-ce11-40ef-8494-c17fd81aae68" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_78bf568f-6adf-4473-8806-5880722c1172" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_40882704-c3d2-4f19-baf7-b83f4917144b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_78bf568f-6adf-4473-8806-5880722c1172" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_40882704-c3d2-4f19-baf7-b83f4917144b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_40882704-c3d2-4f19-baf7-b83f4917144b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_40882704-c3d2-4f19-baf7-b83f4917144b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_40882704-c3d2-4f19-baf7-b83f4917144b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3b489ed6-7d0f-4705-8d27-3ece77e8a58e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_40882704-c3d2-4f19-baf7-b83f4917144b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3b489ed6-7d0f-4705-8d27-3ece77e8a58e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceMember_7eed4fc1-8b27-4967-bee5-2ea4371d7ae8" xlink:href="lh-20200930.xsd#lh_CovanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3b489ed6-7d0f-4705-8d27-3ece77e8a58e" xlink:to="loc_lh_CovanceMember_7eed4fc1-8b27-4967-bee5-2ea4371d7ae8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_32f86eb8-62de-4b7c-beec-bd47f106bb8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_78bf568f-6adf-4473-8806-5880722c1172" xlink:to="loc_us-gaap_CreditFacilityAxis_32f86eb8-62de-4b7c-beec-bd47f106bb8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_32f86eb8-62de-4b7c-beec-bd47f106bb8e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_32f86eb8-62de-4b7c-beec-bd47f106bb8e" xlink:to="loc_us-gaap_CreditFacilityDomain_32f86eb8-62de-4b7c-beec-bd47f106bb8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0d4faa13-6806-4d69-a0fe-29d65e3b27c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_32f86eb8-62de-4b7c-beec-bd47f106bb8e" xlink:to="loc_us-gaap_CreditFacilityDomain_0d4faa13-6806-4d69-a0fe-29d65e3b27c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c8629a52-051d-42ef-8722-6749a35cdcf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_78bf568f-6adf-4473-8806-5880722c1172" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c8629a52-051d-42ef-8722-6749a35cdcf0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c8629a52-051d-42ef-8722-6749a35cdcf0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c8629a52-051d-42ef-8722-6749a35cdcf0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c8629a52-051d-42ef-8722-6749a35cdcf0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5ce387fb-f32a-407d-a1c8-79ce807d06a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c8629a52-051d-42ef-8722-6749a35cdcf0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5ce387fb-f32a-407d-a1c8-79ce807d06a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2020Member_c9f3e59b-64e9-4c45-8ddb-3bafaea30b6d" xlink:href="lh-20200930.xsd#lh_SeniorNotesDue2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5ce387fb-f32a-407d-a1c8-79ce807d06a0" xlink:to="loc_lh_SeniorNotesDue2020Member_c9f3e59b-64e9-4c45-8ddb-3bafaea30b6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2022Member_760e6956-ae05-4ea9-a462-99f1e3d762e8" xlink:href="lh-20200930.xsd#lh_SeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5ce387fb-f32a-407d-a1c8-79ce807d06a0" xlink:to="loc_lh_SeniorNotesDue2022Member_760e6956-ae05-4ea9-a462-99f1e3d762e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2045Member_392176dc-4fa6-4a4d-921f-e0794e5d5aa6" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2045Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5ce387fb-f32a-407d-a1c8-79ce807d06a0" xlink:to="loc_lh_Seniornotesdue2045Member_392176dc-4fa6-4a4d-921f-e0794e5d5aa6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_5333032b-ead3-4da5-9b4c-fe5f3cf1cf83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_78bf568f-6adf-4473-8806-5880722c1172" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_5333032b-ead3-4da5-9b4c-fe5f3cf1cf83" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_5333032b-ead3-4da5-9b4c-fe5f3cf1cf83_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_5333032b-ead3-4da5-9b4c-fe5f3cf1cf83" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_5333032b-ead3-4da5-9b4c-fe5f3cf1cf83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_477f3529-1149-4091-8f0a-e676c6da2f06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_5333032b-ead3-4da5-9b4c-fe5f3cf1cf83" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_477f3529-1149-4091-8f0a-e676c6da2f06" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTLongtermdebtDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#DEBTLongtermdebtDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/DEBTLongtermdebtDetails" xlink:type="extended" id="i92ffc15b9e704e7eb2f24318e7cb4e65_DEBTLongtermdebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_9f2236b5-f43f-4811-8c0c-d4e210777f58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_9f2236b5-f43f-4811-8c0c-d4e210777f58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_47415381-3a9c-45f5-9457-49a8a15351fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_47415381-3a9c-45f5-9457-49a8a15351fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDescription_272d4d14-a2d1-424c-abd6-dcc4608ac7e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDescription"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDescription_272d4d14-a2d1-424c-abd6-dcc4608ac7e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_5729c87c-e62b-4499-928c-124b1bd35c6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_5729c87c-e62b-4499-928c-124b1bd35c6a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_6f8e4e87-4128-4b8f-874e-0b0b34fd79fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_6f8e4e87-4128-4b8f-874e-0b0b34fd79fb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongTermNotes_73a687d2-f313-4f92-8049-7590d3b232e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorLongTermNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_us-gaap_SeniorLongTermNotes_73a687d2-f313-4f92-8049-7590d3b232e1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_650de916-4351-4d14-a3fa-aab0e9ffa36f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_650de916-4351-4d14-a3fa-aab0e9ffa36f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c89b6fac-bb86-4b30-983d-340b63a7d89b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c89b6fac-bb86-4b30-983d-340b63a7d89b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityOptiontoIncrease_8188ac04-7668-449e-85a6-04138c6ee28f" xlink:href="lh-20200930.xsd#lh_CreditFacilityOptiontoIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_lh_CreditFacilityOptiontoIncrease_8188ac04-7668-449e-85a6-04138c6ee28f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumSwingLineBorrowings_32083c09-5a71-4d23-9aaf-f65dcf70e14d" xlink:href="lh-20200930.xsd#lh_CreditFacilityMaximumSwingLineBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_lh_CreditFacilityMaximumSwingLineBorrowings_32083c09-5a71-4d23-9aaf-f65dcf70e14d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumLettersofCredit_25ea9461-a442-4d9f-aaae-fbb5313dac28" xlink:href="lh-20200930.xsd#lh_CreditFacilityMaximumLettersofCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_lh_CreditFacilityMaximumLettersofCredit_25ea9461-a442-4d9f-aaae-fbb5313dac28" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020_6b948af4-9743-4874-b619-7dc336ab2db5" xlink:href="lh-20200930.xsd#lh_DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_lh_DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020_6b948af4-9743-4874-b619-7dc336ab2db5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021_af9ee791-5e62-41ac-94d7-e211488aded5" xlink:href="lh-20200930.xsd#lh_DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_lh_DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021_af9ee791-5e62-41ac-94d7-e211488aded5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable_857c0808-1e94-4e52-b09d-519da3ab776d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_us-gaap_NotesPayable_857c0808-1e94-4e52-b09d-519da3ab776d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_6b07a8e5-7c65-4045-bfba-32ffe4a0022e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_us-gaap_DebtInstrumentTable_6b07a8e5-7c65-4045-bfba-32ffe4a0022e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_0011ec35-1a58-499c-a674-1d1f86007448" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6b07a8e5-7c65-4045-bfba-32ffe4a0022e" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_0011ec35-1a58-499c-a674-1d1f86007448" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_0011ec35-1a58-499c-a674-1d1f86007448_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_0011ec35-1a58-499c-a674-1d1f86007448" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_0011ec35-1a58-499c-a674-1d1f86007448_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_2400f5ea-9a12-4dca-95d0-de7bb6bcea7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_0011ec35-1a58-499c-a674-1d1f86007448" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_2400f5ea-9a12-4dca-95d0-de7bb6bcea7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2019TermLoanMember_c7b0900a-8f1c-4965-91fd-98e3b1ba5001" xlink:href="lh-20200930.xsd#lh_A2019TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_2400f5ea-9a12-4dca-95d0-de7bb6bcea7f" xlink:to="loc_lh_A2019TermLoanMember_c7b0900a-8f1c-4965-91fd-98e3b1ba5001" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_ff005b42-dced-4c16-81fb-50eddbe8c4a1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6b07a8e5-7c65-4045-bfba-32ffe4a0022e" xlink:to="loc_srt_StatementScenarioAxis_ff005b42-dced-4c16-81fb-50eddbe8c4a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_ff005b42-dced-4c16-81fb-50eddbe8c4a1_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_ff005b42-dced-4c16-81fb-50eddbe8c4a1" xlink:to="loc_srt_ScenarioUnspecifiedDomain_ff005b42-dced-4c16-81fb-50eddbe8c4a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_09757535-1db0-489a-bc17-df39ae240ce6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_ff005b42-dced-4c16-81fb-50eddbe8c4a1" xlink:to="loc_srt_ScenarioUnspecifiedDomain_09757535-1db0-489a-bc17-df39ae240ce6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_62211146-6f51-4d4a-a6ea-d4e7535e392c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6b07a8e5-7c65-4045-bfba-32ffe4a0022e" xlink:to="loc_us-gaap_VariableRateAxis_62211146-6f51-4d4a-a6ea-d4e7535e392c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_62211146-6f51-4d4a-a6ea-d4e7535e392c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_62211146-6f51-4d4a-a6ea-d4e7535e392c" xlink:to="loc_us-gaap_VariableRateDomain_62211146-6f51-4d4a-a6ea-d4e7535e392c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_ff2bb5c3-f2c1-46c9-97df-54fa8d0491e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_62211146-6f51-4d4a-a6ea-d4e7535e392c" xlink:to="loc_us-gaap_VariableRateDomain_ff2bb5c3-f2c1-46c9-97df-54fa8d0491e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_644f4a37-036d-4468-b7f9-ef9992633c93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_ff2bb5c3-f2c1-46c9-97df-54fa8d0491e3" xlink:to="loc_us-gaap_PrimeRateMember_644f4a37-036d-4468-b7f9-ef9992633c93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_ce6f4711-368f-45bb-8fad-3d710c00254a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PrimeRateMember_644f4a37-036d-4468-b7f9-ef9992633c93" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_ce6f4711-368f-45bb-8fad-3d710c00254a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f3d25837-04cd-4c26-ac9b-059076d75d35" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6b07a8e5-7c65-4045-bfba-32ffe4a0022e" xlink:to="loc_srt_RangeAxis_f3d25837-04cd-4c26-ac9b-059076d75d35" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f3d25837-04cd-4c26-ac9b-059076d75d35_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f3d25837-04cd-4c26-ac9b-059076d75d35" xlink:to="loc_srt_RangeMember_f3d25837-04cd-4c26-ac9b-059076d75d35_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5b578a4c-c502-4256-bb4d-115dfc6d9197" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f3d25837-04cd-4c26-ac9b-059076d75d35" xlink:to="loc_srt_RangeMember_5b578a4c-c502-4256-bb4d-115dfc6d9197" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_49ccad1c-9bf0-4e2d-88d3-628264908aa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6b07a8e5-7c65-4045-bfba-32ffe4a0022e" xlink:to="loc_us-gaap_CreditFacilityAxis_49ccad1c-9bf0-4e2d-88d3-628264908aa4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_49ccad1c-9bf0-4e2d-88d3-628264908aa4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_49ccad1c-9bf0-4e2d-88d3-628264908aa4" xlink:to="loc_us-gaap_CreditFacilityDomain_49ccad1c-9bf0-4e2d-88d3-628264908aa4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_cb65a663-18e1-447f-8cd2-5b9f232308a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_49ccad1c-9bf0-4e2d-88d3-628264908aa4" xlink:to="loc_us-gaap_CreditFacilityDomain_cb65a663-18e1-447f-8cd2-5b9f232308a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_a70860e7-64b1-4d62-a7c1-dd97147e5fab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_cb65a663-18e1-447f-8cd2-5b9f232308a9" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_a70860e7-64b1-4d62-a7c1-dd97147e5fab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9cbbfe45-86b2-417c-9458-3c84dfe013a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6b07a8e5-7c65-4045-bfba-32ffe4a0022e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9cbbfe45-86b2-417c-9458-3c84dfe013a0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9cbbfe45-86b2-417c-9458-3c84dfe013a0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9cbbfe45-86b2-417c-9458-3c84dfe013a0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9cbbfe45-86b2-417c-9458-3c84dfe013a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64c73e27-fd0f-4836-89ac-0d27ff116686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9cbbfe45-86b2-417c-9458-3c84dfe013a0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64c73e27-fd0f-4836-89ac-0d27ff116686" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceMember_704e872f-7425-4128-ac1f-9d963400c748" xlink:href="lh-20200930.xsd#lh_CovanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64c73e27-fd0f-4836-89ac-0d27ff116686" xlink:to="loc_lh_CovanceMember_704e872f-7425-4128-ac1f-9d963400c748" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5c2a9c7c-d671-47ec-9106-d9c6872ef2d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6b07a8e5-7c65-4045-bfba-32ffe4a0022e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5c2a9c7c-d671-47ec-9106-d9c6872ef2d9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5c2a9c7c-d671-47ec-9106-d9c6872ef2d9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5c2a9c7c-d671-47ec-9106-d9c6872ef2d9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5c2a9c7c-d671-47ec-9106-d9c6872ef2d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e98ae111-2cb4-4be4-9ba5-2bd47f6493b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5c2a9c7c-d671-47ec-9106-d9c6872ef2d9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e98ae111-2cb4-4be4-9ba5-2bd47f6493b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2019TermLoanMember_ea899a7a-48d8-4119-b03b-2ef2f95d5679" xlink:href="lh-20200930.xsd#lh_A2019TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e98ae111-2cb4-4be4-9ba5-2bd47f6493b3" xlink:to="loc_lh_A2019TermLoanMember_ea899a7a-48d8-4119-b03b-2ef2f95d5679" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2020Member_b5648894-89be-4e14-818c-8fcb1bb7c399" xlink:href="lh-20200930.xsd#lh_SeniorNotesDue2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e98ae111-2cb4-4be4-9ba5-2bd47f6493b3" xlink:to="loc_lh_SeniorNotesDue2020Member_b5648894-89be-4e14-818c-8fcb1bb7c399" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2022Member_b8f86ca9-c2b5-448b-9b1e-7da6a37d37d8" xlink:href="lh-20200930.xsd#lh_SeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e98ae111-2cb4-4be4-9ba5-2bd47f6493b3" xlink:to="loc_lh_SeniorNotesDue2022Member_b8f86ca9-c2b5-448b-9b1e-7da6a37d37d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2023Member_fe254612-a7b4-469e-a67b-deeaa99b733f" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e98ae111-2cb4-4be4-9ba5-2bd47f6493b3" xlink:to="loc_lh_Seniornotesdue2023Member_fe254612-a7b4-469e-a67b-deeaa99b733f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2025MemberMember_d99f62db-1d41-4703-91dc-feee02617902" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2025MemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e98ae111-2cb4-4be4-9ba5-2bd47f6493b3" xlink:to="loc_lh_Seniornotesdue2025MemberMember_d99f62db-1d41-4703-91dc-feee02617902" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2045Member_edbc3d19-b437-4c3f-8106-9530aa29f430" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2045Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e98ae111-2cb4-4be4-9ba5-2bd47f6493b3" xlink:to="loc_lh_Seniornotesdue2045Member_edbc3d19-b437-4c3f-8106-9530aa29f430" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_a4032883-9380-4ccb-8aea-50720060d6fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e98ae111-2cb4-4be4-9ba5-2bd47f6493b3" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_a4032883-9380-4ccb-8aea-50720060d6fb" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTSeniorNotesDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#DEBTSeniorNotesDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/DEBTSeniorNotesDetails" xlink:type="extended" id="i537c0273c90f41598350f9ce9382ba46_DEBTSeniorNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Shorttermdebtissuancecosts_5f8871a0-b942-466c-9dcc-f465461b2346" xlink:href="lh-20200930.xsd#lh_Shorttermdebtissuancecosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_lh_Shorttermdebtissuancecosts_5f8871a0-b942-466c-9dcc-f465461b2346" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_eac2e0e9-c03f-4054-ae28-f30070157107" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_eac2e0e9-c03f-4054-ae28-f30070157107" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_a7f3f15c-b7c7-4868-b481-546d6eaaf9e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_a7f3f15c-b7c7-4868-b481-546d6eaaf9e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d930bb04-b014-4636-998d-36032ceff5bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d930bb04-b014-4636-998d-36032ceff5bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityOptiontoIncrease_0569f1e4-5f7f-4442-b72d-7c3ba6dca977" xlink:href="lh-20200930.xsd#lh_CreditFacilityOptiontoIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_lh_CreditFacilityOptiontoIncrease_0569f1e4-5f7f-4442-b72d-7c3ba6dca977" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumSwingLineBorrowings_4f107f07-06ef-42e0-b931-ecde25b4c52d" xlink:href="lh-20200930.xsd#lh_CreditFacilityMaximumSwingLineBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_lh_CreditFacilityMaximumSwingLineBorrowings_4f107f07-06ef-42e0-b931-ecde25b4c52d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumLettersofCredit_63a79dd1-a1c7-4952-a098-c868b5453ed5" xlink:href="lh-20200930.xsd#lh_CreditFacilityMaximumLettersofCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_lh_CreditFacilityMaximumLettersofCredit_63a79dd1-a1c7-4952-a098-c868b5453ed5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongTermNotes_6d8b807e-38ed-44b2-8097-3c329fb092ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorLongTermNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_us-gaap_SeniorLongTermNotes_6d8b807e-38ed-44b2-8097-3c329fb092ac" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgesAtFairValueNet_5545dcbc-c6b5-4fdb-829e-e9a8d91a7495" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgesAtFairValueNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_us-gaap_FairValueHedgesAtFairValueNet_5545dcbc-c6b5-4fdb-829e-e9a8d91a7495" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f2a844ae-28ab-4a92-9ded-bcdb4bc0ae40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f2a844ae-28ab-4a92-9ded-bcdb4bc0ae40" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDescription_75bdd347-89c1-4267-99e9-62ef943048c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDescription"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDescription_75bdd347-89c1-4267-99e9-62ef943048c4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_b83a9a77-f652-4754-87fb-b1acebd7ca77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_b83a9a77-f652-4754-87fb-b1acebd7ca77" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Longtermdebtissuancecosts_31af8a3d-9839-4016-9c32-050611709cb1" xlink:href="lh-20200930.xsd#lh_Longtermdebtissuancecosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_lh_Longtermdebtissuancecosts_31af8a3d-9839-4016-9c32-050611709cb1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_9594cfbc-a23f-4cfa-821a-3f736fec6fe5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_us-gaap_NotesPayableCurrent_9594cfbc-a23f-4cfa-821a-3f736fec6fe5" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_3858ef2d-2ed0-4b85-8d35-46d0801690e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_us-gaap_DebtCurrent_3858ef2d-2ed0-4b85-8d35-46d0801690e9" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_2d920042-4644-4a37-a903-7a09947579da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_2d920042-4644-4a37-a903-7a09947579da" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A4.625Seniornotesdue2020_16e99346-25a2-4d86-a073-d5ea01e3cad0" xlink:href="lh-20200930.xsd#lh_A4.625Seniornotesdue2020"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_lh_A4.625Seniornotesdue2020_16e99346-25a2-4d86-a073-d5ea01e3cad0" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2.30seniornotesdue2024_74109595-427d-43a5-9264-3b8a44ef3bdb" xlink:href="lh-20200930.xsd#lh_A2.30seniornotesdue2024"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_lh_A2.30seniornotesdue2024_74109595-427d-43a5-9264-3b8a44ef3bdb" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2.95seniornotesdue2029_ba55cae0-bcce-4c24-b77c-00cd9b5baeb1" xlink:href="lh-20200930.xsd#lh_A2.95seniornotesdue2029"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_lh_A2.95seniornotesdue2029_ba55cae0-bcce-4c24-b77c-00cd9b5baeb1" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_BalanceOfSeniorNotesMatureDuringQ42020_92fc2455-2a68-460a-b61a-5e15328410d6" xlink:href="lh-20200930.xsd#lh_BalanceOfSeniorNotesMatureDuringQ42020"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_lh_BalanceOfSeniorNotesMatureDuringQ42020_92fc2455-2a68-460a-b61a-5e15328410d6" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_8f0d372e-1b8f-4e59-9634-6c53f7da287a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_us-gaap_DebtInstrumentTable_8f0d372e-1b8f-4e59-9634-6c53f7da287a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b04bcf38-3366-494a-be40-35789c7e256f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8f0d372e-1b8f-4e59-9634-6c53f7da287a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b04bcf38-3366-494a-be40-35789c7e256f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b04bcf38-3366-494a-be40-35789c7e256f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b04bcf38-3366-494a-be40-35789c7e256f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b04bcf38-3366-494a-be40-35789c7e256f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b810fe2d-c5a9-4b16-b32e-b71c6bf0b94c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b04bcf38-3366-494a-be40-35789c7e256f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b810fe2d-c5a9-4b16-b32e-b71c6bf0b94c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceMember_017bc9fc-197a-42d4-94da-f9011a3554fe" xlink:href="lh-20200930.xsd#lh_CovanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b810fe2d-c5a9-4b16-b32e-b71c6bf0b94c" xlink:to="loc_lh_CovanceMember_017bc9fc-197a-42d4-94da-f9011a3554fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2b6c9540-8ed4-401d-b1e6-e5cebef629a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8f0d372e-1b8f-4e59-9634-6c53f7da287a" xlink:to="loc_us-gaap_DebtInstrumentAxis_2b6c9540-8ed4-401d-b1e6-e5cebef629a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2b6c9540-8ed4-401d-b1e6-e5cebef629a9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_2b6c9540-8ed4-401d-b1e6-e5cebef629a9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2b6c9540-8ed4-401d-b1e6-e5cebef629a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d5c2b020-0792-4069-9a59-569ac2d74ef3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_2b6c9540-8ed4-401d-b1e6-e5cebef629a9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d5c2b020-0792-4069-9a59-569ac2d74ef3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9706dd12-a4f2-42e6-b03a-d2f42be7a432" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8f0d372e-1b8f-4e59-9634-6c53f7da287a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9706dd12-a4f2-42e6-b03a-d2f42be7a432" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9706dd12-a4f2-42e6-b03a-d2f42be7a432_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9706dd12-a4f2-42e6-b03a-d2f42be7a432" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9706dd12-a4f2-42e6-b03a-d2f42be7a432_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_647d409c-1634-49de-8509-48d3372c1e6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9706dd12-a4f2-42e6-b03a-d2f42be7a432" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_647d409c-1634-49de-8509-48d3372c1e6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2023Member_6eb6449a-0960-42c6-9808-8b4b55135ff6" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_647d409c-1634-49de-8509-48d3372c1e6c" xlink:to="loc_lh_Seniornotesdue2023Member_6eb6449a-0960-42c6-9808-8b4b55135ff6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2024MemberMember_37632c95-40b3-40a2-be53-b84ce77940fc" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2024MemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_647d409c-1634-49de-8509-48d3372c1e6c" xlink:to="loc_lh_Seniornotesdue2024MemberMember_37632c95-40b3-40a2-be53-b84ce77940fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Crosscurrencyswapmaturing2025Member_e77809f1-c585-4b9f-8f2c-432ec8400161" xlink:href="lh-20200930.xsd#lh_Crosscurrencyswapmaturing2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_647d409c-1634-49de-8509-48d3372c1e6c" xlink:to="loc_lh_Crosscurrencyswapmaturing2025Member_e77809f1-c585-4b9f-8f2c-432ec8400161" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2027Member_05ade0c8-abe4-41f9-aed6-9bf67011dbdb" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_647d409c-1634-49de-8509-48d3372c1e6c" xlink:to="loc_lh_Seniornotesdue2027Member_05ade0c8-abe4-41f9-aed6-9bf67011dbdb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2045Member_6c251096-8f60-4e38-8eea-e5d6cd459201" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2045Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_647d409c-1634-49de-8509-48d3372c1e6c" xlink:to="loc_lh_Seniornotesdue2045Member_6c251096-8f60-4e38-8eea-e5d6cd459201" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2019TermLoanMember_c07b4964-4798-4089-b5b7-465730e935fe" xlink:href="lh-20200930.xsd#lh_A2019TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_647d409c-1634-49de-8509-48d3372c1e6c" xlink:to="loc_lh_A2019TermLoanMember_c07b4964-4798-4089-b5b7-465730e935fe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Crosscurrencyswapmaturing2022Member_95ca247a-4d5c-403e-96ff-3302cce94d9f" xlink:href="lh-20200930.xsd#lh_Crosscurrencyswapmaturing2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_647d409c-1634-49de-8509-48d3372c1e6c" xlink:to="loc_lh_Crosscurrencyswapmaturing2022Member_95ca247a-4d5c-403e-96ff-3302cce94d9f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2020Member_6257069f-0ef3-4bc2-b550-64b214860c00" xlink:href="lh-20200930.xsd#lh_SeniorNotesDue2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_647d409c-1634-49de-8509-48d3372c1e6c" xlink:to="loc_lh_SeniorNotesDue2020Member_6257069f-0ef3-4bc2-b550-64b214860c00" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTConvertibleSubordinatedNotesDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#DEBTConvertibleSubordinatedNotesDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/DEBTConvertibleSubordinatedNotesDetails" xlink:type="extended" id="i1d460f8c21ed46f791735177de9a90cb_DEBTConvertibleSubordinatedNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_lh_ZeroCouponConvertibleSubordinatedNotesLineItems_b8cea21c-72c6-40d9-b41d-0893e283c44c" xlink:href="lh-20200930.xsd#lh_ZeroCouponConvertibleSubordinatedNotesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ZeroCouponConvertibleSubordinatedNotesTable_389034e8-d5c7-4825-b111-0459ca2f4c5a" xlink:href="lh-20200930.xsd#lh_ZeroCouponConvertibleSubordinatedNotesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_lh_ZeroCouponConvertibleSubordinatedNotesLineItems_b8cea21c-72c6-40d9-b41d-0893e283c44c" xlink:to="loc_lh_ZeroCouponConvertibleSubordinatedNotesTable_389034e8-d5c7-4825-b111-0459ca2f4c5a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_6fd3bd60-f5c9-4145-92f2-26ee70cbf473" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lh_ZeroCouponConvertibleSubordinatedNotesTable_389034e8-d5c7-4825-b111-0459ca2f4c5a" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_6fd3bd60-f5c9-4145-92f2-26ee70cbf473" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_6fd3bd60-f5c9-4145-92f2-26ee70cbf473_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_6fd3bd60-f5c9-4145-92f2-26ee70cbf473" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_6fd3bd60-f5c9-4145-92f2-26ee70cbf473_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_80bdc58f-274c-439b-86cd-b98908155b7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_6fd3bd60-f5c9-4145-92f2-26ee70cbf473" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_80bdc58f-274c-439b-86cd-b98908155b7e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTCreditFacilitiesDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#DEBTCreditFacilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/DEBTCreditFacilitiesDetails" xlink:type="extended" id="i293c8ad14ca04c209fa85121a03f418f_DEBTCreditFacilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021_ca6a9999-eab6-4527-8c13-7170e312c1fa" xlink:href="lh-20200930.xsd#lh_DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_lh_DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021_ca6a9999-eab6-4527-8c13-7170e312c1fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage_5840e85f-9f46-496c-b697-764199a1bef5" xlink:href="lh-20200930.xsd#lh_TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_lh_TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage_5840e85f-9f46-496c-b697-764199a1bef5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2019TermLoan_741a8208-c9c7-425b-8208-e1aa1b2e2ef4" xlink:href="lh-20200930.xsd#lh_A2019TermLoan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_lh_A2019TermLoan_741a8208-c9c7-425b-8208-e1aa1b2e2ef4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_26dcfaae-4cde-4455-a1ae-8b3982fbef4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_26dcfaae-4cde-4455-a1ae-8b3982fbef4d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020_e267384c-7232-4115-9e0f-2ad2e5b93eec" xlink:href="lh-20200930.xsd#lh_DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_lh_DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020_e267384c-7232-4115-9e0f-2ad2e5b93eec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021_bd352701-4fc9-4898-9a4c-e34069f31c8a" xlink:href="lh-20200930.xsd#lh_DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_lh_DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021_bd352701-4fc9-4898-9a4c-e34069f31c8a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_BalanceOfSeniorNotesMatureDuringQ42020_e9e7c64c-ff9f-44ab-90e6-b0f4d5756a15" xlink:href="lh-20200930.xsd#lh_BalanceOfSeniorNotesMatureDuringQ42020"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_lh_BalanceOfSeniorNotesMatureDuringQ42020_e9e7c64c-ff9f-44ab-90e6-b0f4d5756a15" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_846fbd39-2923-481b-a912-d5f3c1cf3802" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_846fbd39-2923-481b-a912-d5f3c1cf3802" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongTermNotes_21ee40d0-d526-4831-a743-f27601300589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorLongTermNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_us-gaap_SeniorLongTermNotes_21ee40d0-d526-4831-a743-f27601300589" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_dcb9357b-262f-45bd-ba5f-4fb4ccd58af7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_dcb9357b-262f-45bd-ba5f-4fb4ccd58af7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d6c731d9-2700-46c0-a0de-2d0cdce49bf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d6c731d9-2700-46c0-a0de-2d0cdce49bf5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumLettersofCredit_f71c3023-e81e-4df0-9b3b-a058a352381a" xlink:href="lh-20200930.xsd#lh_CreditFacilityMaximumLettersofCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_lh_CreditFacilityMaximumLettersofCredit_f71c3023-e81e-4df0-9b3b-a058a352381a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_d165ef4e-c668-44a3-a0f1-6b15fd775330" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_d165ef4e-c668-44a3-a0f1-6b15fd775330" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c4e24e7f-3af8-41c1-8893-05a88de6011e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c4e24e7f-3af8-41c1-8893-05a88de6011e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_4212feb0-2a17-486c-8a73-afefb48eb9e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_4212feb0-2a17-486c-8a73-afefb48eb9e3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDescription_ae35462c-c039-4d1e-8630-5064c086fcc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDescription"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDescription_ae35462c-c039-4d1e-8630-5064c086fcc7" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_d8d64e29-f26a-4aac-ada7-c8987ec48bab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_d8d64e29-f26a-4aac-ada7-c8987ec48bab" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_faa8b301-5423-4171-a225-8d059c3d33b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_us-gaap_NotesPayableCurrent_faa8b301-5423-4171-a225-8d059c3d33b5" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_e8398e2e-d3e2-4743-ad5a-bc982cea9371" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_us-gaap_DebtCurrent_e8398e2e-d3e2-4743-ad5a-bc982cea9371" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityOptiontoIncrease_b3817152-61ed-4cce-9bab-5b2e1201d797" xlink:href="lh-20200930.xsd#lh_CreditFacilityOptiontoIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_lh_CreditFacilityOptiontoIncrease_b3817152-61ed-4cce-9bab-5b2e1201d797" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumSwingLineBorrowings_43d9a03b-63b0-4ed4-aead-6fdedb922e8f" xlink:href="lh-20200930.xsd#lh_CreditFacilityMaximumSwingLineBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_lh_CreditFacilityMaximumSwingLineBorrowings_43d9a03b-63b0-4ed4-aead-6fdedb922e8f" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable_1742ab7e-6613-44ac-a25c-bad20188b552" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_us-gaap_NotesPayable_1742ab7e-6613-44ac-a25c-bad20188b552" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage_bd0eaedb-75cc-4e87-ade2-12fd6451dfdf" xlink:href="lh-20200930.xsd#lh_RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_lh_RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage_bd0eaedb-75cc-4e87-ade2-12fd6451dfdf" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage_7daa724e-f2af-4b72-9457-623ed34efafd" xlink:href="lh-20200930.xsd#lh_RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_lh_RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage_7daa724e-f2af-4b72-9457-623ed34efafd" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments_65cf5405-7f94-480b-9adb-d4298c5d1bfe" xlink:href="lh-20200930.xsd#lh_RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_lh_RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments_65cf5405-7f94-480b-9adb-d4298c5d1bfe" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage_dcf1a687-8169-429d-9c6b-9e40350bd3e4" xlink:href="lh-20200930.xsd#lh_TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_lh_TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage_dcf1a687-8169-429d-9c6b-9e40350bd3e4" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021_683f506f-f4af-4e51-b341-812012cf17c6" xlink:href="lh-20200930.xsd#lh_DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_ca24bdb0-73d1-4821-b62f-3a341e6b658a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_ca24bdb0-73d1-4821-b62f-3a341e6b658a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_23b139ba-13b3-4908-be6a-92bcf5240b69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ca24bdb0-73d1-4821-b62f-3a341e6b658a" xlink:to="loc_us-gaap_DebtInstrumentAxis_23b139ba-13b3-4908-be6a-92bcf5240b69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_23b139ba-13b3-4908-be6a-92bcf5240b69_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_23b139ba-13b3-4908-be6a-92bcf5240b69" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_23b139ba-13b3-4908-be6a-92bcf5240b69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a4d97d9c-33b8-435c-bd67-e300792ced37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_23b139ba-13b3-4908-be6a-92bcf5240b69" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a4d97d9c-33b8-435c-bd67-e300792ced37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_31995873-0c77-4f14-8106-9e694d9d32af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ca24bdb0-73d1-4821-b62f-3a341e6b658a" xlink:to="loc_us-gaap_VariableRateAxis_31995873-0c77-4f14-8106-9e694d9d32af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_31995873-0c77-4f14-8106-9e694d9d32af_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_31995873-0c77-4f14-8106-9e694d9d32af" xlink:to="loc_us-gaap_VariableRateDomain_31995873-0c77-4f14-8106-9e694d9d32af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_8c0d91b1-d586-4a58-ae4c-e652d03d37b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_31995873-0c77-4f14-8106-9e694d9d32af" xlink:to="loc_us-gaap_VariableRateDomain_8c0d91b1-d586-4a58-ae4c-e652d03d37b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_ab92089c-50f0-4ff9-9a4d-92dfa430db65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_8c0d91b1-d586-4a58-ae4c-e652d03d37b5" xlink:to="loc_us-gaap_PrimeRateMember_ab92089c-50f0-4ff9-9a4d-92dfa430db65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_06e66be7-d18c-4340-96e8-b233d62fcec8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_8c0d91b1-d586-4a58-ae4c-e652d03d37b5" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_06e66be7-d18c-4340-96e8-b233d62fcec8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_757a8ea3-5115-4127-8130-44b481d404c5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ca24bdb0-73d1-4821-b62f-3a341e6b658a" xlink:to="loc_srt_RangeAxis_757a8ea3-5115-4127-8130-44b481d404c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_757a8ea3-5115-4127-8130-44b481d404c5_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_757a8ea3-5115-4127-8130-44b481d404c5" xlink:to="loc_srt_RangeMember_757a8ea3-5115-4127-8130-44b481d404c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_327df490-5a6a-4d8c-8ac6-78f4b9dafad6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_757a8ea3-5115-4127-8130-44b481d404c5" xlink:to="loc_srt_RangeMember_327df490-5a6a-4d8c-8ac6-78f4b9dafad6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_af1b06d4-488c-4a54-8c27-8c585f56ab99" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_327df490-5a6a-4d8c-8ac6-78f4b9dafad6" xlink:to="loc_srt_MinimumMember_af1b06d4-488c-4a54-8c27-8c585f56ab99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8e429904-94bf-4180-a36e-95ae9a688b67" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_327df490-5a6a-4d8c-8ac6-78f4b9dafad6" xlink:to="loc_srt_MaximumMember_8e429904-94bf-4180-a36e-95ae9a688b67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_8e94ee15-6308-4167-b0f6-3c617ebe1258" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ca24bdb0-73d1-4821-b62f-3a341e6b658a" xlink:to="loc_us-gaap_CreditFacilityAxis_8e94ee15-6308-4167-b0f6-3c617ebe1258" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8e94ee15-6308-4167-b0f6-3c617ebe1258_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_8e94ee15-6308-4167-b0f6-3c617ebe1258" xlink:to="loc_us-gaap_CreditFacilityDomain_8e94ee15-6308-4167-b0f6-3c617ebe1258_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_754ab21c-43c1-4e87-91bd-21bd9c06916f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_8e94ee15-6308-4167-b0f6-3c617ebe1258" xlink:to="loc_us-gaap_CreditFacilityDomain_754ab21c-43c1-4e87-91bd-21bd9c06916f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_TermLoanandRevolvingCreditFacilityMember_2de86e05-1556-4663-ac83-392f2ec4c01a" xlink:href="lh-20200930.xsd#lh_TermLoanandRevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_754ab21c-43c1-4e87-91bd-21bd9c06916f" xlink:to="loc_lh_TermLoanandRevolvingCreditFacilityMember_2de86e05-1556-4663-ac83-392f2ec4c01a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2019TermLoanMember_d245f661-6e31-4c68-82b3-b442c059e4e8" xlink:href="lh-20200930.xsd#lh_A2019TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_754ab21c-43c1-4e87-91bd-21bd9c06916f" xlink:to="loc_lh_A2019TermLoanMember_d245f661-6e31-4c68-82b3-b442c059e4e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_26658eb0-05e2-4dbb-b61a-e6e8c98f014a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_754ab21c-43c1-4e87-91bd-21bd9c06916f" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_26658eb0-05e2-4dbb-b61a-e6e8c98f014a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_f8fde358-fcfe-4078-a276-a04cc0ead1e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_754ab21c-43c1-4e87-91bd-21bd9c06916f" xlink:to="loc_us-gaap_PrimeRateMember_f8fde358-fcfe-4078-a276-a04cc0ead1e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_c8c69803-663e-4e83-9586-f532f7d576d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_754ab21c-43c1-4e87-91bd-21bd9c06916f" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_c8c69803-663e-4e83-9586-f532f7d576d1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_00554f52-7450-4304-be9a-c34930c1961e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ca24bdb0-73d1-4821-b62f-3a341e6b658a" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_00554f52-7450-4304-be9a-c34930c1961e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_00554f52-7450-4304-be9a-c34930c1961e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_00554f52-7450-4304-be9a-c34930c1961e" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_00554f52-7450-4304-be9a-c34930c1961e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_b95abffc-7b95-4aa6-a507-f6c3b4573bff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_00554f52-7450-4304-be9a-c34930c1961e" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_b95abffc-7b95-4aa6-a507-f6c3b4573bff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_1630d13b-3991-479c-b450-0d32160e5111" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_b95abffc-7b95-4aa6-a507-f6c3b4573bff" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_1630d13b-3991-479c-b450-0d32160e5111" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ab9d007a-8a64-4893-8ac2-b428d7a1ced6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ca24bdb0-73d1-4821-b62f-3a341e6b658a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ab9d007a-8a64-4893-8ac2-b428d7a1ced6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ab9d007a-8a64-4893-8ac2-b428d7a1ced6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ab9d007a-8a64-4893-8ac2-b428d7a1ced6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ab9d007a-8a64-4893-8ac2-b428d7a1ced6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_24e7b250-e818-4899-9e51-2bfd12aaebfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ab9d007a-8a64-4893-8ac2-b428d7a1ced6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_24e7b250-e818-4899-9e51-2bfd12aaebfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2027Member_cf8a8c11-5417-4829-b43f-79aadc204105" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_24e7b250-e818-4899-9e51-2bfd12aaebfb" xlink:to="loc_lh_Seniornotesdue2027Member_cf8a8c11-5417-4829-b43f-79aadc204105" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2024MemberMember_e7420e65-c4d3-4451-88ac-b1f638f70517" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2024MemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_24e7b250-e818-4899-9e51-2bfd12aaebfb" xlink:to="loc_lh_Seniornotesdue2024MemberMember_e7420e65-c4d3-4451-88ac-b1f638f70517" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2020Member_68637d8c-15c0-4a15-b5d6-48d266f1fda7" xlink:href="lh-20200930.xsd#lh_SeniorNotesDue2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_24e7b250-e818-4899-9e51-2bfd12aaebfb" xlink:to="loc_lh_SeniorNotesDue2020Member_68637d8c-15c0-4a15-b5d6-48d266f1fda7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2045Member_47a59d9e-cf38-4f34-8813-ff01bf2c6499" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2045Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_24e7b250-e818-4899-9e51-2bfd12aaebfb" xlink:to="loc_lh_Seniornotesdue2045Member_47a59d9e-cf38-4f34-8813-ff01bf2c6499" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2022Member_be5f88cc-8d41-40ae-b543-aa4c1c57cd65" xlink:href="lh-20200930.xsd#lh_SeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_24e7b250-e818-4899-9e51-2bfd12aaebfb" xlink:to="loc_lh_SeniorNotesDue2022Member_be5f88cc-8d41-40ae-b543-aa4c1c57cd65" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_28fab558-1f9f-4cc3-84ab-bceea5b4b72b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ca24bdb0-73d1-4821-b62f-3a341e6b658a" xlink:to="loc_srt_StatementScenarioAxis_28fab558-1f9f-4cc3-84ab-bceea5b4b72b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_28fab558-1f9f-4cc3-84ab-bceea5b4b72b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_28fab558-1f9f-4cc3-84ab-bceea5b4b72b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_28fab558-1f9f-4cc3-84ab-bceea5b4b72b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_afc5a2dc-61a7-4e1b-9b00-9c60ddecff20" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_28fab558-1f9f-4cc3-84ab-bceea5b4b72b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_afc5a2dc-61a7-4e1b-9b00-9c60ddecff20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_eb48c3e6-5d02-4bc2-89d9-627cf2915990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ca24bdb0-73d1-4821-b62f-3a341e6b658a" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_eb48c3e6-5d02-4bc2-89d9-627cf2915990" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_eb48c3e6-5d02-4bc2-89d9-627cf2915990_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_eb48c3e6-5d02-4bc2-89d9-627cf2915990" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_eb48c3e6-5d02-4bc2-89d9-627cf2915990_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_cf5bac88-a4a2-4826-b245-a00ebfe6fef9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_eb48c3e6-5d02-4bc2-89d9-627cf2915990" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_cf5bac88-a4a2-4826-b245-a00ebfe6fef9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_a3b8dc9b-db79-42d3-b191-20c93caa0008" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_cf5bac88-a4a2-4826-b245-a00ebfe6fef9" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_a3b8dc9b-db79-42d3-b191-20c93caa0008" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="lh-20200930.xsd#PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY" xlink:type="extended" id="iab700946922b4db59f386e1d9ef845f3_PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c5c92b69-7778-427a-ae74-7c599e514f6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b7729802-c657-441e-b075-247d29dbc9f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c5c92b69-7778-427a-ae74-7c599e514f6a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b7729802-c657-441e-b075-247d29dbc9f6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c09c85ab-88c6-4663-8e91-0b06be85343b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b7729802-c657-441e-b075-247d29dbc9f6" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c09c85ab-88c6-4663-8e91-0b06be85343b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c09c85ab-88c6-4663-8e91-0b06be85343b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c09c85ab-88c6-4663-8e91-0b06be85343b" xlink:to="loc_us-gaap_EquityComponentDomain_c09c85ab-88c6-4663-8e91-0b06be85343b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ab42f300-b6cd-435c-b7df-d1401f2bef4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c09c85ab-88c6-4663-8e91-0b06be85343b" xlink:to="loc_us-gaap_EquityComponentDomain_ab42f300-b6cd-435c-b7df-d1401f2bef4b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails" xlink:type="extended" id="i36085d693e2f4219900640e5b4fce8ff_PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_f770fc87-0fc2-4ee4-800f-a2ae20013285" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_f770fc87-0fc2-4ee4-800f-a2ae20013285" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonSharesIssuedRollforwardAbstract_8356397e-e440-4edd-a4fc-63b88c027581" xlink:href="lh-20200930.xsd#lh_CommonSharesIssuedRollforwardAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:to="loc_lh_CommonSharesIssuedRollforwardAbstract_8356397e-e440-4edd-a4fc-63b88c027581" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_92ef9c08-d986-4c31-9d62-bb0b5e4c2717" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_CommonSharesIssuedRollforwardAbstract_8356397e-e440-4edd-a4fc-63b88c027581" xlink:to="loc_us-gaap_CommonStockSharesIssued_92ef9c08-d986-4c31-9d62-bb0b5e4c2717" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_2c1c5eea-986d-4f91-a3f5-d7b2b0e9854e" xlink:href="lh-20200930.xsd#lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_CommonSharesIssuedRollforwardAbstract_8356397e-e440-4edd-a4fc-63b88c027581" xlink:to="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_2c1c5eea-986d-4f91-a3f5-d7b2b0e9854e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_09b9127c-62a5-49d5-b762-d468449e3dc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_CommonSharesIssuedRollforwardAbstract_8356397e-e440-4edd-a4fc-63b88c027581" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_09b9127c-62a5-49d5-b762-d468449e3dc0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_8d06e269-e2ce-4305-8fbe-31293a857a90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_2821d30f-b95e-43af-a032-b780763a0ac0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_5481c90e-637c-457b-958f-9cb55b6d343c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_5481c90e-637c-457b-958f-9cb55b6d343c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5ea0fb01-3816-49e6-a9bd-68c8749ea17b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5ea0fb01-3816-49e6-a9bd-68c8749ea17b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OutstandingStockRepurchaseAuthorizationAbstract_57f69921-6be8-4a6e-b0ea-b5ae7d6c697f" xlink:href="lh-20200930.xsd#lh_OutstandingStockRepurchaseAuthorizationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:to="loc_lh_OutstandingStockRepurchaseAuthorizationAbstract_57f69921-6be8-4a6e-b0ea-b5ae7d6c697f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonStockRepurchaseAuthorizationOutstanding_b8e3a36c-89dd-4cd7-9d75-7d6211933672" xlink:href="lh-20200930.xsd#lh_CommonStockRepurchaseAuthorizationOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_OutstandingStockRepurchaseAuthorizationAbstract_57f69921-6be8-4a6e-b0ea-b5ae7d6c697f" xlink:to="loc_lh_CommonStockRepurchaseAuthorizationOutstanding_b8e3a36c-89dd-4cd7-9d75-7d6211933672" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_61245b18-c1ec-4ee0-a692-2eb5cb0bf3ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_OutstandingStockRepurchaseAuthorizationAbstract_57f69921-6be8-4a6e-b0ea-b5ae7d6c697f" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_61245b18-c1ec-4ee0-a692-2eb5cb0bf3ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonStockRepurchaseAuthorizationOutstanding_24e35fce-071b-4972-a11d-5250ef6bc5a0" xlink:href="lh-20200930.xsd#lh_CommonStockRepurchaseAuthorizationOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonSharesOutstandingRollforwardAbstract_17b3ea60-f71d-4079-87b1-97f48fdf8023" xlink:href="lh-20200930.xsd#lh_CommonSharesOutstandingRollforwardAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:to="loc_lh_CommonSharesOutstandingRollforwardAbstract_17b3ea60-f71d-4079-87b1-97f48fdf8023" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d9f39e71-74ee-4bc0-9d5e-c1f9de958df2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_CommonSharesOutstandingRollforwardAbstract_17b3ea60-f71d-4079-87b1-97f48fdf8023" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d9f39e71-74ee-4bc0-9d5e-c1f9de958df2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_5d2ef727-87e0-41a6-abdf-4a0d3458e10b" xlink:href="lh-20200930.xsd#lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_01d4d189-d913-412e-9d00-237fc34a0b85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_68893b3a-ef2f-43eb-9add-20cb01bcd8cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_f3d4f3f6-ce62-4e70-9667-106a8a04b42b" xlink:href="lh-20200930.xsd#lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonSharesHeldInTreasuryRollforwardAbstract_45a4c01e-1cbd-4102-940d-a33160fa8511" xlink:href="lh-20200930.xsd#lh_CommonSharesHeldInTreasuryRollforwardAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:to="loc_lh_CommonSharesHeldInTreasuryRollforwardAbstract_45a4c01e-1cbd-4102-940d-a33160fa8511" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_996a94e2-30e5-48f3-a392-3a1c63c7816c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_996a94e2-30e5-48f3-a392-3a1c63c7816c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_7ce625a3-cfde-40b9-8fb6-9c76455e5fbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_7ce625a3-cfde-40b9-8fb6-9c76455e5fbe" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_e8900311-9a5c-44b3-8cd9-732963c7e0cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_e8900311-9a5c-44b3-8cd9-732963c7e0cf" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_84a89c7c-f80f-497c-8b23-e93f7c5b1fbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_84a89c7c-f80f-497c-8b23-e93f7c5b1fbf" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_7dabd125-7dec-43a3-8401-9cb0a6e94cd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_0a030573-02c0-4287-8c9f-d923e77a0acc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_0a030573-02c0-4287-8c9f-d923e77a0acc" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_28f65bad-a25b-4026-9eda-798c490f26f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_28f65bad-a25b-4026-9eda-798c490f26f1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_11ac26b3-5983-4d5e-a73c-a421e7d67529" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_28f65bad-a25b-4026-9eda-798c490f26f1" xlink:to="loc_us-gaap_CreditFacilityAxis_11ac26b3-5983-4d5e-a73c-a421e7d67529" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_11ac26b3-5983-4d5e-a73c-a421e7d67529_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_11ac26b3-5983-4d5e-a73c-a421e7d67529" xlink:to="loc_us-gaap_CreditFacilityDomain_11ac26b3-5983-4d5e-a73c-a421e7d67529_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_315ab111-1319-4845-85ca-72403c6299eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_11ac26b3-5983-4d5e-a73c-a421e7d67529" xlink:to="loc_us-gaap_CreditFacilityDomain_315ab111-1319-4845-85ca-72403c6299eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_16ff43a2-7318-46b1-b351-247802b07b64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_28f65bad-a25b-4026-9eda-798c490f26f1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_16ff43a2-7318-46b1-b351-247802b07b64" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_16ff43a2-7318-46b1-b351-247802b07b64_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_16ff43a2-7318-46b1-b351-247802b07b64" xlink:to="loc_us-gaap_ClassOfStockDomain_16ff43a2-7318-46b1-b351-247802b07b64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a76e3dda-2f2f-4efc-964d-a21959201445" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_16ff43a2-7318-46b1-b351-247802b07b64" xlink:to="loc_us-gaap_ClassOfStockDomain_a76e3dda-2f2f-4efc-964d-a21959201445" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_cbd747c2-62f0-4a5c-b89a-17d7fc7cea56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a76e3dda-2f2f-4efc-964d-a21959201445" xlink:to="loc_us-gaap_CommonStockMember_cbd747c2-62f0-4a5c-b89a-17d7fc7cea56" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails" xlink:type="extended" id="i15727e0273b54fb0829d3992d31963dc_PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4c495613-e789-4ce3-a915-7afa220af58a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_acf8b162-62fc-4305-b577-6ff64acb8f2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4c495613-e789-4ce3-a915-7afa220af58a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_acf8b162-62fc-4305-b577-6ff64acb8f2f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_63997f49-408a-423c-9723-b2fe640d4030" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_acf8b162-62fc-4305-b577-6ff64acb8f2f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_63997f49-408a-423c-9723-b2fe640d4030" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_63997f49-408a-423c-9723-b2fe640d4030_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_63997f49-408a-423c-9723-b2fe640d4030" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_63997f49-408a-423c-9723-b2fe640d4030_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_36897d43-0e6b-44b5-8541-cac6b1b41781" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_63997f49-408a-423c-9723-b2fe640d4030" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_36897d43-0e6b-44b5-8541-cac6b1b41781" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2e1c7304-0db8-4120-8f26-67721a280598" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_acf8b162-62fc-4305-b577-6ff64acb8f2f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2e1c7304-0db8-4120-8f26-67721a280598" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2e1c7304-0db8-4120-8f26-67721a280598_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2e1c7304-0db8-4120-8f26-67721a280598" xlink:to="loc_us-gaap_EquityComponentDomain_2e1c7304-0db8-4120-8f26-67721a280598_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_608d6b81-f7b9-43fe-8344-0726aab5fb1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2e1c7304-0db8-4120-8f26-67721a280598" xlink:to="loc_us-gaap_EquityComponentDomain_608d6b81-f7b9-43fe-8344-0726aab5fb1e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/INCOMETAXES" xlink:type="simple" xlink:href="lh-20200930.xsd#INCOMETAXES"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/INCOMETAXES" xlink:type="extended" id="ie4e740cb93fd494e91acf8abdaa7afae_INCOMETAXES"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#INCOMETAXESDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/INCOMETAXESDetails" xlink:type="extended" id="ibe76069bb7604b12a1d9a2a792b6faa3_INCOMETAXESDetails"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="lh-20200930.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended" id="i358471e815da4c00a325a0da4b45e268_COMMITMENTSANDCONTINGENCIES"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended" id="i88b8219e13be4c7497ae4aa2df039bab_COMMITMENTSANDCONTINGENCIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_d9f40849-9e94-4c97-9c6e-e2dfc7aa224b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_7ab0fae2-e0e5-44db-95a4-a9673988f43a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_d9f40849-9e94-4c97-9c6e-e2dfc7aa224b" xlink:to="loc_us-gaap_LossContingenciesTable_7ab0fae2-e0e5-44db-95a4-a9673988f43a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_876ac044-9c66-4b22-aefc-9394a1f9d79b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_7ab0fae2-e0e5-44db-95a4-a9673988f43a" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_876ac044-9c66-4b22-aefc-9394a1f9d79b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_876ac044-9c66-4b22-aefc-9394a1f9d79b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_876ac044-9c66-4b22-aefc-9394a1f9d79b" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_876ac044-9c66-4b22-aefc-9394a1f9d79b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_6b13b5a2-2bf0-4420-b694-33bc95783b0c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_876ac044-9c66-4b22-aefc-9394a1f9d79b" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_6b13b5a2-2bf0-4420-b694-33bc95783b0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e7a282ee-02ce-4fcf-b5b4-e22814448901" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_7ab0fae2-e0e5-44db-95a4-a9673988f43a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e7a282ee-02ce-4fcf-b5b4-e22814448901" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e7a282ee-02ce-4fcf-b5b4-e22814448901_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e7a282ee-02ce-4fcf-b5b4-e22814448901" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e7a282ee-02ce-4fcf-b5b4-e22814448901_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42e22a68-b0e6-426d-9731-9395c1b4d644" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e7a282ee-02ce-4fcf-b5b4-e22814448901" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42e22a68-b0e6-426d-9731-9395c1b4d644" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceMember_1c936c82-e1ed-4fa8-b170-e21e8a293b87" xlink:href="lh-20200930.xsd#lh_CovanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42e22a68-b0e6-426d-9731-9395c1b4d644" xlink:to="loc_lh_CovanceMember_1c936c82-e1ed-4fa8-b170-e21e8a293b87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b91900a4-c5f9-4215-9eed-ab6d72ea9bd4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_7ab0fae2-e0e5-44db-95a4-a9673988f43a" xlink:to="loc_srt_RangeAxis_b91900a4-c5f9-4215-9eed-ab6d72ea9bd4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b91900a4-c5f9-4215-9eed-ab6d72ea9bd4_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_b91900a4-c5f9-4215-9eed-ab6d72ea9bd4" xlink:to="loc_srt_RangeMember_b91900a4-c5f9-4215-9eed-ab6d72ea9bd4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_57870461-43b1-4a24-87e8-1322ae098e07" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_b91900a4-c5f9-4215-9eed-ab6d72ea9bd4" xlink:to="loc_srt_RangeMember_57870461-43b1-4a24-87e8-1322ae098e07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_7dfec7f0-f50c-479b-9991-c4a7be890f49" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_7ab0fae2-e0e5-44db-95a4-a9673988f43a" xlink:to="loc_dei_LegalEntityAxis_7dfec7f0-f50c-479b-9991-c4a7be890f49" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_7dfec7f0-f50c-479b-9991-c4a7be890f49_default" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_7dfec7f0-f50c-479b-9991-c4a7be890f49" xlink:to="loc_dei_EntityDomain_7dfec7f0-f50c-479b-9991-c4a7be890f49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_2fb0dcd1-adbc-49dc-9fef-d3666d66325e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_7dfec7f0-f50c-479b-9991-c4a7be890f49" xlink:to="loc_dei_EntityDomain_2fb0dcd1-adbc-49dc-9fef-d3666d66325e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANS" xlink:type="simple" xlink:href="lh-20200930.xsd#PENSIONANDPOSTRETIREMENTPLANS"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANS" xlink:type="extended" id="ifda342dee41748dea47aadcb3d96fd1c_PENSIONANDPOSTRETIREMENTPLANS"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#PENSIONANDPOSTRETIREMENTPLANSDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails" xlink:type="extended" id="i9f3a055b5b0f4bf8886694417ccc3c1a_PENSIONANDPOSTRETIREMENTPLANSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18d64835-3070-4187-9dc6-06f39cb16aae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NonElectiveContribution_1c1c0880-e97a-4639-82eb-0f152e7d3057" xlink:href="lh-20200930.xsd#lh_NonElectiveContribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18d64835-3070-4187-9dc6-06f39cb16aae" xlink:to="loc_lh_NonElectiveContribution_1c1c0880-e97a-4639-82eb-0f152e7d3057" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DiscretionaryContributionPercentageMaximum_20240e34-b69e-4121-b36c-d448e0b87f5b" xlink:href="lh-20200930.xsd#lh_DiscretionaryContributionPercentageMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18d64835-3070-4187-9dc6-06f39cb16aae" xlink:to="loc_lh_DiscretionaryContributionPercentageMaximum_20240e34-b69e-4121-b36c-d448e0b87f5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_b39c33b0-fd43-4aba-a94c-9b9c3b1433f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18d64835-3070-4187-9dc6-06f39cb16aae" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_b39c33b0-fd43-4aba-a94c-9b9c3b1433f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_49c04a0e-f44f-43fe-817f-53ef6ce874ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18d64835-3070-4187-9dc6-06f39cb16aae" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_49c04a0e-f44f-43fe-817f-53ef6ce874ef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_d0d91ec7-a4ad-40e3-9f52-57a25fb7e2f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_49c04a0e-f44f-43fe-817f-53ef6ce874ef" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_d0d91ec7-a4ad-40e3-9f52-57a25fb7e2f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_0605bbc3-b157-450a-9ef4-db68a669810f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_49c04a0e-f44f-43fe-817f-53ef6ce874ef" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_0605bbc3-b157-450a-9ef4-db68a669810f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_e888d6a9-040d-4c28-9ef3-e1cbc5952735" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_49c04a0e-f44f-43fe-817f-53ef6ce874ef" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_e888d6a9-040d-4c28-9ef3-e1cbc5952735" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_7873560d-782b-4b3e-ba84-850a41964333" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_49c04a0e-f44f-43fe-817f-53ef6ce874ef" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_7873560d-782b-4b3e-ba84-850a41964333" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_33f1e37e-9a0a-4a1e-aa2d-969eeb08f20b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_49c04a0e-f44f-43fe-817f-53ef6ce874ef" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_33f1e37e-9a0a-4a1e-aa2d-969eeb08f20b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetDefinedBenefitPlanAmortizationAndDeferral_21ec3c9f-c6df-4c10-a53e-14b5ad26046a" xlink:href="lh-20200930.xsd#lh_NetDefinedBenefitPlanAmortizationAndDeferral"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_49c04a0e-f44f-43fe-817f-53ef6ce874ef" xlink:to="loc_lh_NetDefinedBenefitPlanAmortizationAndDeferral_21ec3c9f-c6df-4c10-a53e-14b5ad26046a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6be87010-ceba-47eb-a015-db8be893b9f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_49c04a0e-f44f-43fe-817f-53ef6ce874ef" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6be87010-ceba-47eb-a015-db8be893b9f2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_d5d25f62-a072-409f-b957-ab25ce587c03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18d64835-3070-4187-9dc6-06f39cb16aae" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_d5d25f62-a072-409f-b957-ab25ce587c03" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_d0a8cd51-1dd6-487f-bee6-da3897880bed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18d64835-3070-4187-9dc6-06f39cb16aae" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_d0a8cd51-1dd6-487f-bee6-da3897880bed" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedContributionPlanTotalExpense_9d0f2b49-6d05-45a7-95f3-d3303ade96ed" xlink:href="lh-20200930.xsd#lh_DefinedContributionPlanTotalExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18d64835-3070-4187-9dc6-06f39cb16aae" xlink:to="loc_lh_DefinedContributionPlanTotalExpense_9d0f2b49-6d05-45a7-95f3-d3303ade96ed" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b8e672b-293b-4235-b04b-c4a5dfc7f049" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18d64835-3070-4187-9dc6-06f39cb16aae" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b8e672b-293b-4235-b04b-c4a5dfc7f049" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b1228fc8-c363-4bdc-bfd3-75d0509e2eca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b8e672b-293b-4235-b04b-c4a5dfc7f049" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b1228fc8-c363-4bdc-bfd3-75d0509e2eca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b1228fc8-c363-4bdc-bfd3-75d0509e2eca_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b1228fc8-c363-4bdc-bfd3-75d0509e2eca" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b1228fc8-c363-4bdc-bfd3-75d0509e2eca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_97184114-5ea2-4a85-a257-e2ab371b1046" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b1228fc8-c363-4bdc-bfd3-75d0509e2eca" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_97184114-5ea2-4a85-a257-e2ab371b1046" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceMember_ffd1a0d0-fc33-4b45-87c1-6a35656e114f" xlink:href="lh-20200930.xsd#lh_CovanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_97184114-5ea2-4a85-a257-e2ab371b1046" xlink:to="loc_lh_CovanceMember_ffd1a0d0-fc33-4b45-87c1-6a35656e114f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_8eb7c4c3-e774-4732-92aa-7ff8757c59d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b8e672b-293b-4235-b04b-c4a5dfc7f049" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_8eb7c4c3-e774-4732-92aa-7ff8757c59d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_8eb7c4c3-e774-4732-92aa-7ff8757c59d2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_8eb7c4c3-e774-4732-92aa-7ff8757c59d2" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_8eb7c4c3-e774-4732-92aa-7ff8757c59d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_04c262b0-fe60-4aa5-8540-16b5a8fb5350" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_8eb7c4c3-e774-4732-92aa-7ff8757c59d2" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_04c262b0-fe60-4aa5-8540-16b5a8fb5350" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansCostsMember_5fda00c7-48ce-4069-b0c1-fc4b8092b7ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_04c262b0-fe60-4aa5-8540-16b5a8fb5350" xlink:to="loc_us-gaap_PensionAndOtherPostretirementPlansCostsMember_5fda00c7-48ce-4069-b0c1-fc4b8092b7ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_cf0d4647-07aa-411d-a9f2-779307ccea69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_04c262b0-fe60-4aa5-8540-16b5a8fb5350" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_cf0d4647-07aa-411d-a9f2-779307ccea69" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails" xlink:type="extended" id="iacb52f0794ef42bca232d849fe20ccc8_PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_64e1c966-37eb-4bd0-a2f8-18f1675dc944" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_28456542-e59f-48ba-a909-462220fa5b88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_64e1c966-37eb-4bd0-a2f8-18f1675dc944" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_28456542-e59f-48ba-a909-462220fa5b88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NonElectiveContribution_0cc163c4-6bd8-4c74-9db2-1e6b8685782b" xlink:href="lh-20200930.xsd#lh_NonElectiveContribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_64e1c966-37eb-4bd0-a2f8-18f1675dc944" xlink:to="loc_lh_NonElectiveContribution_0cc163c4-6bd8-4c74-9db2-1e6b8685782b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DiscretionaryContributionPercentageMinimum_0326e6b7-10e8-4af8-9b39-342ea7965ac4" xlink:href="lh-20200930.xsd#lh_DiscretionaryContributionPercentageMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_64e1c966-37eb-4bd0-a2f8-18f1675dc944" xlink:to="loc_lh_DiscretionaryContributionPercentageMinimum_0326e6b7-10e8-4af8-9b39-342ea7965ac4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_f5cd0bf2-d8c2-4bc3-9299-40ac80d5bdb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_64e1c966-37eb-4bd0-a2f8-18f1675dc944" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_f5cd0bf2-d8c2-4bc3-9299-40ac80d5bdb2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedContributionPlanTotalExpense_28f331e8-28e3-42ee-8e35-57e91918d42b" xlink:href="lh-20200930.xsd#lh_DefinedContributionPlanTotalExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_64e1c966-37eb-4bd0-a2f8-18f1675dc944" xlink:to="loc_lh_DefinedContributionPlanTotalExpense_28f331e8-28e3-42ee-8e35-57e91918d42b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DiscretionaryContributionPercentageMaximum_5ce8747b-fbbb-45fb-b2f7-5349d6eaed1a" xlink:href="lh-20200930.xsd#lh_DiscretionaryContributionPercentageMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_64e1c966-37eb-4bd0-a2f8-18f1675dc944" xlink:to="loc_lh_DiscretionaryContributionPercentageMaximum_5ce8747b-fbbb-45fb-b2f7-5349d6eaed1a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_10119b2a-7739-40be-a415-cb89f0f1b8b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_64e1c966-37eb-4bd0-a2f8-18f1675dc944" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_10119b2a-7739-40be-a415-cb89f0f1b8b6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d4234705-cdf5-4efa-b47f-7116260213d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_64e1c966-37eb-4bd0-a2f8-18f1675dc944" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d4234705-cdf5-4efa-b47f-7116260213d7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_4bd992cd-fbe2-4cf3-baea-bb1d447fa344" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d4234705-cdf5-4efa-b47f-7116260213d7" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_4bd992cd-fbe2-4cf3-baea-bb1d447fa344" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_4bd992cd-fbe2-4cf3-baea-bb1d447fa344_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_4bd992cd-fbe2-4cf3-baea-bb1d447fa344" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_4bd992cd-fbe2-4cf3-baea-bb1d447fa344_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_bcc8dc2d-436c-4016-a50e-4af91a2233d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_4bd992cd-fbe2-4cf3-baea-bb1d447fa344" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_bcc8dc2d-436c-4016-a50e-4af91a2233d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2cb51d7d-5d40-4494-82e3-25649af70fc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d4234705-cdf5-4efa-b47f-7116260213d7" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2cb51d7d-5d40-4494-82e3-25649af70fc2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2cb51d7d-5d40-4494-82e3-25649af70fc2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2cb51d7d-5d40-4494-82e3-25649af70fc2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2cb51d7d-5d40-4494-82e3-25649af70fc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f6a0581c-0a8e-4019-a243-d79e040c968d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2cb51d7d-5d40-4494-82e3-25649af70fc2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f6a0581c-0a8e-4019-a243-d79e040c968d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceMember_a66459bc-a3c3-45aa-a2a8-835764687849" xlink:href="lh-20200930.xsd#lh_CovanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f6a0581c-0a8e-4019-a243-d79e040c968d" xlink:to="loc_lh_CovanceMember_a66459bc-a3c3-45aa-a2a8-835764687849" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_98bb31f3-6853-4255-9aae-f7dc20854f5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d4234705-cdf5-4efa-b47f-7116260213d7" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_98bb31f3-6853-4255-9aae-f7dc20854f5d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_98bb31f3-6853-4255-9aae-f7dc20854f5d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_98bb31f3-6853-4255-9aae-f7dc20854f5d" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_98bb31f3-6853-4255-9aae-f7dc20854f5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_25c803dc-d8d0-41f4-9824-40b7a31e792a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_98bb31f3-6853-4255-9aae-f7dc20854f5d" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_25c803dc-d8d0-41f4-9824-40b7a31e792a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="lh-20200930.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended" id="i3c6a4471736e45a084ca43704824360f_FAIRVALUEMEASUREMENTS"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="lh-20200930.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended" id="ifc20572f34d64ddb8ca6095a4a12dbba_FAIRVALUEMEASUREMENTSTables"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#FAIRVALUEMEASUREMENTSDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails" xlink:type="extended" id="i3515b1c50c3c4c0ab935be6ee91f0244_FAIRVALUEMEASUREMENTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NumberofMeasurementFundsAvailableForParticipantElection_b72a4af7-b88c-41b0-b73f-f6103579dcff" xlink:href="lh-20200930.xsd#lh_NumberofMeasurementFundsAvailableForParticipantElection"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_lh_NumberofMeasurementFundsAvailableForParticipantElection_b72a4af7-b88c-41b0-b73f-f6103579dcff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts_fcc489ea-78e9-42b4-b489-3ccd522e0c04" xlink:href="lh-20200930.xsd#lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts_fcc489ea-78e9-42b4-b489-3ccd522e0c04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesFairValue_61991f49-4d8e-4bc4-999b-91199d68b632" xlink:href="lh-20200930.xsd#lh_SeniorNotesFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_lh_SeniorNotesFairValue_61991f49-4d8e-4bc4-999b-91199d68b632" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure_79aca3ef-52e9-4448-8914-b7a67b445786" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_us-gaap_NotesReceivableFairValueDisclosure_79aca3ef-52e9-4448-8914-b7a67b445786" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_3c6395be-5e70-4fe0-933d-360347a69085" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_3c6395be-5e70-4fe0-933d-360347a69085" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability_c9cf890d-315c-4ce1-acbd-0b6e92afabd5" xlink:href="lh-20200930.xsd#lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability_c9cf890d-315c-4ce1-acbd-0b6e92afabd5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_2ef879f4-4e19-4ea3-aefc-bd8749ba0229" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_2ef879f4-4e19-4ea3-aefc-bd8749ba0229" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgesAtFairValueNet_3e722bcc-f2bb-4218-b94c-578c0a5cf23a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgesAtFairValueNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_us-gaap_FairValueHedgesAtFairValueNet_3e722bcc-f2bb-4218-b94c-578c0a5cf23a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_c209758c-05dd-4c92-b66a-0f8033074081" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_c209758c-05dd-4c92-b66a-0f8033074081" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_bbded7fd-1303-4023-ae55-713ff486ce0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_bbded7fd-1303-4023-ae55-713ff486ce0b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Contingentconsiderationadjustment_76c649ca-89f6-4fcf-85a5-73d9157b63c2" xlink:href="lh-20200930.xsd#lh_Contingentconsiderationadjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_lh_Contingentconsiderationadjustment_76c649ca-89f6-4fcf-85a5-73d9157b63c2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_7aa3ca6b-61a2-4db6-845f-65335499020d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_7aa3ca6b-61a2-4db6-845f-65335499020d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_4a40f32a-0ea6-43a9-90ad-16535738fdb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_4a40f32a-0ea6-43a9-90ad-16535738fdb8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Lh_BusinessCombinationContingentConsiderationArrangementsPayments_0499d196-0e3e-4dff-ba6c-0ff5b29bd0da" xlink:href="lh-20200930.xsd#lh_Lh_BusinessCombinationContingentConsiderationArrangementsPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_lh_Lh_BusinessCombinationContingentConsiderationArrangementsPayments_0499d196-0e3e-4dff-ba6c-0ff5b29bd0da" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e675573c-56d3-4cc5-838d-49ef1d0d9e29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e675573c-56d3-4cc5-838d-49ef1d0d9e29" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_7be51da3-e5e0-40b1-b1bf-65ddb3cd1789" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e675573c-56d3-4cc5-838d-49ef1d0d9e29" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_7be51da3-e5e0-40b1-b1bf-65ddb3cd1789" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_7be51da3-e5e0-40b1-b1bf-65ddb3cd1789_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_7be51da3-e5e0-40b1-b1bf-65ddb3cd1789" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_7be51da3-e5e0-40b1-b1bf-65ddb3cd1789_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_571029b7-5f76-4e75-b3eb-c18f18009132" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_7be51da3-e5e0-40b1-b1bf-65ddb3cd1789" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_571029b7-5f76-4e75-b3eb-c18f18009132" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6b0c66a0-f15d-4278-8748-e9721a862b2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e675573c-56d3-4cc5-838d-49ef1d0d9e29" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6b0c66a0-f15d-4278-8748-e9721a862b2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6b0c66a0-f15d-4278-8748-e9721a862b2a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6b0c66a0-f15d-4278-8748-e9721a862b2a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6b0c66a0-f15d-4278-8748-e9721a862b2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e2d92da8-e32a-460e-9eb7-20d266786e64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6b0c66a0-f15d-4278-8748-e9721a862b2a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e2d92da8-e32a-460e-9eb7-20d266786e64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_2bc3cab4-900d-4264-9e38-067c36ca485f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e2d92da8-e32a-460e-9eb7-20d266786e64" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_2bc3cab4-900d-4264-9e38-067c36ca485f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d1d06949-8af5-4dc7-8c65-7272ac45daec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e2d92da8-e32a-460e-9eb7-20d266786e64" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d1d06949-8af5-4dc7-8c65-7272ac45daec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_70dad4b0-acf8-4dfe-ac1d-e5a6daed2668" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e2d92da8-e32a-460e-9eb7-20d266786e64" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_70dad4b0-acf8-4dfe-ac1d-e5a6daed2668" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" xlink:type="simple" xlink:href="lh-20200930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" xlink:type="extended" id="i92a13c59604446da9e76c9cde8956a81_DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" xlink:type="simple" xlink:href="lh-20200930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" xlink:type="extended" id="id689f177164846758194b84e37e0428b_DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails" xlink:type="extended" id="i7a3c56fd99e44c559a3323d6d50d24cf_DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_6a98f60d-94d9-43de-a3e7-d2075bad8208" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_6a98f60d-94d9-43de-a3e7-d2075bad8208" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_f3498930-68b3-4fc5-9e2d-68c8bfba1775" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_f3498930-68b3-4fc5-9e2d-68c8bfba1775" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtFairValue_bd70cdeb-637d-498f-ab18-81935b49435e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShorttermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:to="loc_us-gaap_ShorttermDebtFairValue_bd70cdeb-637d-498f-ab18-81935b49435e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_e7ed539d-67e1-42e5-b2ce-61c5b83433be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_e7ed539d-67e1-42e5-b2ce-61c5b83433be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5f9c19ee-09c6-48d0-aa7d-b4933aab0a85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5f9c19ee-09c6-48d0-aa7d-b4933aab0a85" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_f521f3fe-55a6-460f-aca9-b4ef65fb4716" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_f521f3fe-55a6-460f-aca9-b4ef65fb4716" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeAssetsAtFairValue_014a9460-b7d3-41bf-b58e-292aedc5d379" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgeAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:to="loc_us-gaap_FairValueHedgeAssetsAtFairValue_014a9460-b7d3-41bf-b58e-292aedc5d379" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_82ed1c50-fc78-4646-a2f0-19d80c881e19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:to="loc_us-gaap_DerivativeNotionalAmount_82ed1c50-fc78-4646-a2f0-19d80c881e19" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_5d0aec7e-d814-4fa4-b5ba-bd308951e000" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_5d0aec7e-d814-4fa4-b5ba-bd308951e000" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_a885924d-82cc-4b69-a6af-ea95473bd82f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_a885924d-82cc-4b69-a6af-ea95473bd82f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_62c40fe8-f661-4e40-8a27-9ca973501450" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgeLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:to="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_62c40fe8-f661-4e40-8a27-9ca973501450" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_GainInterestRateSwapArrangement_44740fcc-de12-4473-8d3f-600b57cf3f22" xlink:href="lh-20200930.xsd#lh_GainInterestRateSwapArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:to="loc_lh_GainInterestRateSwapArrangement_44740fcc-de12-4473-8d3f-600b57cf3f22" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ea209976-7c4b-41d5-9f10-742a6eadb8ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ea209976-7c4b-41d5-9f10-742a6eadb8ea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2bfe78b1-7d80-47a1-b5fa-f90777459e2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ea209976-7c4b-41d5-9f10-742a6eadb8ea" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2bfe78b1-7d80-47a1-b5fa-f90777459e2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2bfe78b1-7d80-47a1-b5fa-f90777459e2d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2bfe78b1-7d80-47a1-b5fa-f90777459e2d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2bfe78b1-7d80-47a1-b5fa-f90777459e2d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_56aeb9e8-682e-43eb-b3af-b8ff10c671f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2bfe78b1-7d80-47a1-b5fa-f90777459e2d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_56aeb9e8-682e-43eb-b3af-b8ff10c671f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d0bfd804-df3b-465c-9d85-0af9eb5dd7c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_56aeb9e8-682e-43eb-b3af-b8ff10c671f1" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d0bfd804-df3b-465c-9d85-0af9eb5dd7c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0f7695b9-28f4-4a68-8aa8-f4314351757c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ea209976-7c4b-41d5-9f10-742a6eadb8ea" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0f7695b9-28f4-4a68-8aa8-f4314351757c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0f7695b9-28f4-4a68-8aa8-f4314351757c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0f7695b9-28f4-4a68-8aa8-f4314351757c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0f7695b9-28f4-4a68-8aa8-f4314351757c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e94c8a72-0803-43c9-84cf-23e32a9532e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0f7695b9-28f4-4a68-8aa8-f4314351757c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e94c8a72-0803-43c9-84cf-23e32a9532e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2022Member_845b0881-3b75-440e-8e36-bce04a91a192" xlink:href="lh-20200930.xsd#lh_SeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e94c8a72-0803-43c9-84cf-23e32a9532e3" xlink:to="loc_lh_SeniorNotesDue2022Member_845b0881-3b75-440e-8e36-bce04a91a192" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Crosscurrencyswapmaturing2022Member_5d0ab89c-99f3-4c01-82e5-2e567ca0d0ff" xlink:href="lh-20200930.xsd#lh_Crosscurrencyswapmaturing2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e94c8a72-0803-43c9-84cf-23e32a9532e3" xlink:to="loc_lh_Crosscurrencyswapmaturing2022Member_5d0ab89c-99f3-4c01-82e5-2e567ca0d0ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Crosscurrencyswapmaturing2025Member_09d1eb92-1512-4fa0-beb4-6930c9015045" xlink:href="lh-20200930.xsd#lh_Crosscurrencyswapmaturing2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e94c8a72-0803-43c9-84cf-23e32a9532e3" xlink:to="loc_lh_Crosscurrencyswapmaturing2025Member_09d1eb92-1512-4fa0-beb4-6930c9015045" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2020Member_1da34247-588a-491f-9767-72546da2efa3" xlink:href="lh-20200930.xsd#lh_SeniorNotesDue2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e94c8a72-0803-43c9-84cf-23e32a9532e3" xlink:to="loc_lh_SeniorNotesDue2020Member_1da34247-588a-491f-9767-72546da2efa3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorLongTermNotesDue2020Member_7d57d365-d467-466a-8935-2396c14876a2" xlink:href="lh-20200930.xsd#lh_SeniorLongTermNotesDue2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e94c8a72-0803-43c9-84cf-23e32a9532e3" xlink:to="loc_lh_SeniorLongTermNotesDue2020Member_7d57d365-d467-466a-8935-2396c14876a2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2025MemberMember_757a2c94-7893-4bdb-81b6-e93e6d5e899c" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2025MemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e94c8a72-0803-43c9-84cf-23e32a9532e3" xlink:to="loc_lh_Seniornotesdue2025MemberMember_757a2c94-7893-4bdb-81b6-e93e6d5e899c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2027Member_0f8441e4-088c-4687-9351-632cbdab494f" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e94c8a72-0803-43c9-84cf-23e32a9532e3" xlink:to="loc_lh_Seniornotesdue2027Member_0f8441e4-088c-4687-9351-632cbdab494f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f0c4be8a-0168-4ecf-962f-8d5aa45ea29b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ea209976-7c4b-41d5-9f10-742a6eadb8ea" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f0c4be8a-0168-4ecf-962f-8d5aa45ea29b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f0c4be8a-0168-4ecf-962f-8d5aa45ea29b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f0c4be8a-0168-4ecf-962f-8d5aa45ea29b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f0c4be8a-0168-4ecf-962f-8d5aa45ea29b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5e6028d6-0190-4d93-bb2c-407e4bcedb5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f0c4be8a-0168-4ecf-962f-8d5aa45ea29b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5e6028d6-0190-4d93-bb2c-407e4bcedb5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2020Member_f26e2bf1-34c4-4b18-bea3-ed727f51063f" xlink:href="lh-20200930.xsd#lh_SeniorNotesDue2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5e6028d6-0190-4d93-bb2c-407e4bcedb5d" xlink:to="loc_lh_SeniorNotesDue2020Member_f26e2bf1-34c4-4b18-bea3-ed727f51063f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_283a0531-0e6d-4654-a547-c89384c83b1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5e6028d6-0190-4d93-bb2c-407e4bcedb5d" xlink:to="loc_us-gaap_InterestRateSwapMember_283a0531-0e6d-4654-a547-c89384c83b1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_16094f49-5116-4af8-b525-befb001307e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5e6028d6-0190-4d93-bb2c-407e4bcedb5d" xlink:to="loc_us-gaap_CurrencySwapMember_16094f49-5116-4af8-b525-befb001307e6" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATION" xlink:type="simple" xlink:href="lh-20200930.xsd#SUPPLEMENTALCASHFLOWINFORMATION"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATION" xlink:type="extended" id="i5415e4aae0104164afa1a89472aa03c3_SUPPLEMENTALCASHFLOWINFORMATION"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONTabularInformation" xlink:type="simple" xlink:href="lh-20200930.xsd#SUPPLEMENTALCASHFLOWINFORMATIONTabularInformation"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONTabularInformation" xlink:type="extended" id="i20df3f204c014d83b9d8ff68bff16fef_SUPPLEMENTALCASHFLOWINFORMATIONTabularInformation"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation" xlink:type="simple" xlink:href="lh-20200930.xsd#SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation" xlink:type="extended" id="i2f5b08822d944ef1a6c95bb882710b44_SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionLineItems_473c4c02-9645-4ec4-ad39-15bb7b346e1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DecreaseinCapitalExpendituresIncurredbutnotyetPaid_d00dcc3f-4d3f-414d-93e7-10ec6b61bf64" xlink:href="lh-20200930.xsd#lh_DecreaseinCapitalExpendituresIncurredbutnotyetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtConversionLineItems_473c4c02-9645-4ec4-ad39-15bb7b346e1b" xlink:to="loc_lh_DecreaseinCapitalExpendituresIncurredbutnotyetPaid_d00dcc3f-4d3f-414d-93e7-10ec6b61bf64" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_31f4557a-de2e-45b4-adf5-7d84de779903" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtConversionLineItems_473c4c02-9645-4ec4-ad39-15bb7b346e1b" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_31f4557a-de2e-45b4-adf5-7d84de779903" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure_26d010c9-ced2-4b2e-bd7b-35944cae91b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtConversionLineItems_473c4c02-9645-4ec4-ad39-15bb7b346e1b" xlink:to="loc_us-gaap_NotesReceivableFairValueDisclosure_26d010c9-ced2-4b2e-bd7b-35944cae91b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionTable_d92a58bf-165b-4379-bf40-edbe89137ccc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtConversionLineItems_473c4c02-9645-4ec4-ad39-15bb7b346e1b" xlink:to="loc_us-gaap_DebtConversionTable_d92a58bf-165b-4379-bf40-edbe89137ccc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_da42af99-bd48-45ec-8bd7-a303a4e36edd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtConversionTable_d92a58bf-165b-4379-bf40-edbe89137ccc" xlink:to="loc_us-gaap_DebtInstrumentAxis_da42af99-bd48-45ec-8bd7-a303a4e36edd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_da42af99-bd48-45ec-8bd7-a303a4e36edd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_da42af99-bd48-45ec-8bd7-a303a4e36edd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_da42af99-bd48-45ec-8bd7-a303a4e36edd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_902be9b5-12da-4c3b-b7ec-61227ec547a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_da42af99-bd48-45ec-8bd7-a303a4e36edd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_902be9b5-12da-4c3b-b7ec-61227ec547a1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONS" xlink:type="simple" xlink:href="lh-20200930.xsd#BUSINESSACQUISITIONS"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/BUSINESSACQUISITIONS" xlink:type="extended" id="i36781ca375b34ec4b2e8e96583a1f996_BUSINESSACQUISITIONS"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsTablesTables" xlink:type="simple" xlink:href="lh-20200930.xsd#BUSINESSACQUISITIONSBusinessAcquisitionsTablesTables"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsTablesTables" xlink:type="extended" id="i04de8440e2734b468ea2b4eaba957055_BUSINESSACQUISITIONSBusinessAcquisitionsTablesTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_24099770-7d31-438c-9bb2-0c16b1df4c5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_e3c5a6d0-0040-4a9e-b5b2-44927c330039" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_24099770-7d31-438c-9bb2-0c16b1df4c5a" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_e3c5a6d0-0040-4a9e-b5b2-44927c330039" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_da1b4c43-6df9-4739-b9be-b7c31db39d21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_24099770-7d31-438c-9bb2-0c16b1df4c5a" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_da1b4c43-6df9-4739-b9be-b7c31db39d21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5c97c22f-9d54-4d49-a8e8-de394c9cb998" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_24099770-7d31-438c-9bb2-0c16b1df4c5a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5c97c22f-9d54-4d49-a8e8-de394c9cb998" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_33d5d7c0-e2dc-49a0-9b01-f5459025bab9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5c97c22f-9d54-4d49-a8e8-de394c9cb998" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_33d5d7c0-e2dc-49a0-9b01-f5459025bab9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_33d5d7c0-e2dc-49a0-9b01-f5459025bab9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_33d5d7c0-e2dc-49a0-9b01-f5459025bab9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_33d5d7c0-e2dc-49a0-9b01-f5459025bab9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_03a083f2-131c-4015-88cb-2a3d85364821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_33d5d7c0-e2dc-49a0-9b01-f5459025bab9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_03a083f2-131c-4015-88cb-2a3d85364821" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_79946840-837c-4586-b614-d4391e75f3c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5c97c22f-9d54-4d49-a8e8-de394c9cb998" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_79946840-837c-4586-b614-d4391e75f3c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_79946840-837c-4586-b614-d4391e75f3c3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_79946840-837c-4586-b614-d4391e75f3c3" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_79946840-837c-4586-b614-d4391e75f3c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5e627db8-0c32-4f47-8fd2-52f656241bca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_79946840-837c-4586-b614-d4391e75f3c3" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5e627db8-0c32-4f47-8fd2-52f656241bca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_46db8671-d001-44fc-adf6-8fd8cec7794b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5c97c22f-9d54-4d49-a8e8-de394c9cb998" xlink:to="loc_us-gaap_StatementClassOfStockAxis_46db8671-d001-44fc-adf6-8fd8cec7794b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_46db8671-d001-44fc-adf6-8fd8cec7794b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_46db8671-d001-44fc-adf6-8fd8cec7794b" xlink:to="loc_us-gaap_ClassOfStockDomain_46db8671-d001-44fc-adf6-8fd8cec7794b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_78bd055d-9c9f-4012-ad69-645078719a09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_46db8671-d001-44fc-adf6-8fd8cec7794b" xlink:to="loc_us-gaap_ClassOfStockDomain_78bd055d-9c9f-4012-ad69-645078719a09" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#BUSINESSACQUISITIONSDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails" xlink:type="extended" id="i8d980165f04049d0884c70bda0b3bf88_BUSINESSACQUISITIONSDetails"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails" xlink:type="extended" id="ic0e89335e7e54f83b722a0e150ede51c_BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_b42eef89-22d2-4c62-868e-a130f461d397" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_b42eef89-22d2-4c62-868e-a130f461d397" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_90b0dcb1-ea2e-4969-8355-5f4ca05fa01f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_90b0dcb1-ea2e-4969-8355-5f4ca05fa01f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_8a2aaeb3-9ddf-4ee2-a73f-e65a0669da4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_Revenues_8a2aaeb3-9ddf-4ee2-a73f-e65a0669da4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_cbe4b5cb-4706-4fab-a5a8-2d263325c0b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_cbe4b5cb-4706-4fab-a5a8-2d263325c0b1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_a9f5fdf3-6fe4-4a31-971f-cb1511a4c989" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_a9f5fdf3-6fe4-4a31-971f-cb1511a4c989" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7d0de990-93d3-4264-9e03-ec29e8d2f929" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_Goodwill_7d0de990-93d3-4264-9e03-ec29e8d2f929" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_5cefd49d-f0ef-4c3d-8f49-aeaf2e53bc02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_5cefd49d-f0ef-4c3d-8f49-aeaf2e53bc02" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ab89a008-bb10-4336-8b83-5c7896a558ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ab89a008-bb10-4336-8b83-5c7896a558ae" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_e8ae1b18-4e85-4397-9ad5-bf08c83b2ce6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_e8ae1b18-4e85-4397-9ad5-bf08c83b2ce6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_cb3a0e43-1328-435c-b686-e26fecab684d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_OperatingIncomeLoss_cb3a0e43-1328-435c-b686-e26fecab684d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure_c63ef308-a57e-48aa-a5ae-428c53fc5778" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_NotesReceivableFairValueDisclosure_c63ef308-a57e-48aa-a5ae-428c53fc5778" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Totalacquisitionconsiderationcashstocknotesetc._7d05ad1f-47fd-46e7-a011-be71493376d0" xlink:href="lh-20200930.xsd#lh_Totalacquisitionconsiderationcashstocknotesetc."/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_lh_Totalacquisitionconsiderationcashstocknotesetc._7d05ad1f-47fd-46e7-a011-be71493376d0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_608598f7-cea4-42a5-96ec-bc912f5b4821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_608598f7-cea4-42a5-96ec-bc912f5b4821" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_359a2a66-2ddb-43c0-ae8c-b2887463413a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_359a2a66-2ddb-43c0-ae8c-b2887463413a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_a26b7e26-8738-4707-8a11-404bb09ec53b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_a26b7e26-8738-4707-8a11-404bb09ec53b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_808addf5-c25a-4433-b87f-06b6a177ba82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_808addf5-c25a-4433-b87f-06b6a177ba82" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_aefe420c-1b20-40b4-bd95-f77eb10ac77c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_aefe420c-1b20-40b4-bd95-f77eb10ac77c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_1219dd82-13f0-46cc-8b14-fb440d8712e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_1219dd82-13f0-46cc-8b14-fb440d8712e4" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_dd1699cf-645c-46f1-80bd-a56938048f6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_dd1699cf-645c-46f1-80bd-a56938048f6b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_60558127-8a2a-49a8-9ad5-0330190d79aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_60558127-8a2a-49a8-9ad5-0330190d79aa" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_b710f7f4-39cd-406f-bc14-ccaec4b0d2fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_b710f7f4-39cd-406f-bc14-ccaec4b0d2fa" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_7d83f204-c262-43b3-9007-1f7455099832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_7d83f204-c262-43b3-9007-1f7455099832" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2bb7e7f6-cece-4139-a8a5-060a1bf94ef4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2bb7e7f6-cece-4139-a8a5-060a1bf94ef4" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_2fea63f1-98b0-4255-9857-5f438f6eca7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_2fea63f1-98b0-4255-9857-5f438f6eca7a" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_7d7a82b6-3a13-415c-9e67-ec4c095e80c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_7d7a82b6-3a13-415c-9e67-ec4c095e80c8" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_93dd3b10-cb28-4b56-86f0-7081e20ce9fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_93dd3b10-cb28-4b56-86f0-7081e20ce9fc" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_82966714-0848-4c80-9e6a-7d7d02fbf399" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_82966714-0848-4c80-9e6a-7d7d02fbf399" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_be0bb416-6c7b-445a-a9a3-5d14f36d7824" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_be0bb416-6c7b-445a-a9a3-5d14f36d7824" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_e7b4ebc0-63da-4ae6-9f6a-c2d534e20ebb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_e7b4ebc0-63da-4ae6-9f6a-c2d534e20ebb" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_890dcf8d-9328-49e5-a11a-9cefe6bad29d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_890dcf8d-9328-49e5-a11a-9cefe6bad29d" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_a283045b-18b0-4078-a6a5-364edff111e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_a283045b-18b0-4078-a6a5-364edff111e5" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f0eaa34-9017-43bd-ba40-cdf1fc43fb34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f0eaa34-9017-43bd-ba40-cdf1fc43fb34" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a5930890-5793-48fd-8c7d-c3880b7a4f6c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f0eaa34-9017-43bd-ba40-cdf1fc43fb34" xlink:to="loc_srt_StatementScenarioAxis_a5930890-5793-48fd-8c7d-c3880b7a4f6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a5930890-5793-48fd-8c7d-c3880b7a4f6c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_a5930890-5793-48fd-8c7d-c3880b7a4f6c" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a5930890-5793-48fd-8c7d-c3880b7a4f6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a0badf8a-87ad-4b33-9a6d-de9251a6c6ab" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_a5930890-5793-48fd-8c7d-c3880b7a4f6c" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a0badf8a-87ad-4b33-9a6d-de9251a6c6ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6f92f8d5-73f2-41e1-9d25-036f8fb08c4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f0eaa34-9017-43bd-ba40-cdf1fc43fb34" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6f92f8d5-73f2-41e1-9d25-036f8fb08c4d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f92f8d5-73f2-41e1-9d25-036f8fb08c4d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6f92f8d5-73f2-41e1-9d25-036f8fb08c4d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f92f8d5-73f2-41e1-9d25-036f8fb08c4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d5de8feb-416e-40b6-ade5-19f631506597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6f92f8d5-73f2-41e1-9d25-036f8fb08c4d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d5de8feb-416e-40b6-ade5-19f631506597" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_98bcc766-22c4-4725-95e2-74a7a029ea6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d5de8feb-416e-40b6-ade5-19f631506597" xlink:to="loc_us-gaap_CustomerRelationshipsMember_98bcc766-22c4-4725-95e2-74a7a029ea6a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_dcee31d1-8ebd-4963-a9ab-abd420719e78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d5de8feb-416e-40b6-ade5-19f631506597" xlink:to="loc_us-gaap_TradeNamesMember_dcee31d1-8ebd-4963-a9ab-abd420719e78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseRightsMember_295c2e19-c134-426b-86df-ca35fc92a73b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d5de8feb-416e-40b6-ade5-19f631506597" xlink:to="loc_us-gaap_UseRightsMember_295c2e19-c134-426b-86df-ca35fc92a73b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1d3bae3a-14ed-4113-847c-fc3419a89165" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f0eaa34-9017-43bd-ba40-cdf1fc43fb34" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1d3bae3a-14ed-4113-847c-fc3419a89165" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d3bae3a-14ed-4113-847c-fc3419a89165_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1d3bae3a-14ed-4113-847c-fc3419a89165" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d3bae3a-14ed-4113-847c-fc3419a89165_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_68ade0a2-9671-42ee-9820-c26262f57e9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1d3bae3a-14ed-4113-847c-fc3419a89165" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_68ade0a2-9671-42ee-9820-c26262f57e9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceMember_9983902e-6fec-49bd-ab10-75588cffe278" xlink:href="lh-20200930.xsd#lh_CovanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_68ade0a2-9671-42ee-9820-c26262f57e9e" xlink:to="loc_lh_CovanceMember_9983902e-6fec-49bd-ab10-75588cffe278" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OtheracquireesMember_8bc7db5f-bfcf-4771-8f50-e1cabba96525" xlink:href="lh-20200930.xsd#lh_OtheracquireesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_68ade0a2-9671-42ee-9820-c26262f57e9e" xlink:to="loc_lh_OtheracquireesMember_8bc7db5f-bfcf-4771-8f50-e1cabba96525" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EnvigoMember_0ff1b342-0f44-4391-af70-329e3fd396a4" xlink:href="lh-20200930.xsd#lh_EnvigoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_68ade0a2-9671-42ee-9820-c26262f57e9e" xlink:to="loc_lh_EnvigoMember_0ff1b342-0f44-4391-af70-329e3fd396a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a66f9feb-1666-4c86-b30b-0c70d2653f0c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f0eaa34-9017-43bd-ba40-cdf1fc43fb34" xlink:to="loc_srt_RangeAxis_a66f9feb-1666-4c86-b30b-0c70d2653f0c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a66f9feb-1666-4c86-b30b-0c70d2653f0c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a66f9feb-1666-4c86-b30b-0c70d2653f0c" xlink:to="loc_srt_RangeMember_a66f9feb-1666-4c86-b30b-0c70d2653f0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d07614dd-c14c-4b96-a02c-8f09122e1bc5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a66f9feb-1666-4c86-b30b-0c70d2653f0c" xlink:to="loc_srt_RangeMember_d07614dd-c14c-4b96-a02c-8f09122e1bc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_17807ca2-4c34-4e07-a354-2e56fd1146b3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d07614dd-c14c-4b96-a02c-8f09122e1bc5" xlink:to="loc_srt_MinimumMember_17807ca2-4c34-4e07-a354-2e56fd1146b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_78621920-77da-4d45-84f2-d083dbf4c487" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d07614dd-c14c-4b96-a02c-8f09122e1bc5" xlink:to="loc_srt_MaximumMember_78621920-77da-4d45-84f2-d083dbf4c487" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_048eaa9d-d424-44c0-b958-a6510daa4790" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f0eaa34-9017-43bd-ba40-cdf1fc43fb34" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_048eaa9d-d424-44c0-b958-a6510daa4790" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_048eaa9d-d424-44c0-b958-a6510daa4790_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_048eaa9d-d424-44c0-b958-a6510daa4790" xlink:to="loc_us-gaap_SegmentDomain_048eaa9d-d424-44c0-b958-a6510daa4790_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_da59b561-eb92-48d7-993a-e522223869d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_048eaa9d-d424-44c0-b958-a6510daa4790" xlink:to="loc_us-gaap_SegmentDomain_da59b561-eb92-48d7-993a-e522223869d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_96b80384-05e8-41f7-9e0e-7225ee60f039" xlink:href="lh-20200930.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_da59b561-eb92-48d7-993a-e522223869d5" xlink:to="loc_lh_CovanceDrugDevelopmentMember_96b80384-05e8-41f7-9e0e-7225ee60f039" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_d17127f6-95ec-4d58-b83c-f6a12a50a765" xlink:href="lh-20200930.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_da59b561-eb92-48d7-993a-e522223869d5" xlink:to="loc_lh_LabCorpDiagnosticsMember_d17127f6-95ec-4d58-b83c-f6a12a50a765" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#BUSINESSACQUISITIONSDISPOSITIONSDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails" xlink:type="extended" id="i6b1dfc59284344d892f5449b6b7a4a9f_BUSINESSACQUISITIONSDISPOSITIONSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_98be8a8b-f905-4f4f-93ae-895b75d8cffa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_98be8a8b-f905-4f4f-93ae-895b75d8cffa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_e5e94065-78fb-4352-a91f-29fcb34a2ce0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_e5e94065-78fb-4352-a91f-29fcb34a2ce0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_17d082ca-c404-4b72-9fd8-7d43053728d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_us-gaap_UnbilledContractsReceivable_17d082ca-c404-4b72-9fd8-7d43053728d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_1131b276-bf85-4fe5-abc7-065d81a7b26f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_us-gaap_InventoryNet_1131b276-bf85-4fe5-abc7-065d81a7b26f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_c6e139a9-9d00-40cd-8f43-13dc395a91f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_c6e139a9-9d00-40cd-8f43-13dc395a91f8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_34829c12-1355-4495-81c7-76c4d1a200b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_34829c12-1355-4495-81c7-76c4d1a200b0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_80aaa51c-7990-43e8-9207-8c3f15d20eca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_us-gaap_Goodwill_80aaa51c-7990-43e8-9207-8c3f15d20eca" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c07f084c-616b-4c49-a37b-0ce65f851548" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c07f084c-616b-4c49-a37b-0ce65f851548" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_52694a9f-6aa9-4d8a-972a-3a555541fa79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_52694a9f-6aa9-4d8a-972a-3a555541fa79" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_e31ce360-dd2b-416a-a4e1-e6400a9601f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_us-gaap_AccountsPayableCurrent_e31ce360-dd2b-416a-a4e1-e6400a9601f1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_7f601242-9038-4a08-b9e8-9153726fb106" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_7f601242-9038-4a08-b9e8-9153726fb106" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_9e4e65d7-dc63-40a4-b74e-016c4e37209b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_us-gaap_DeferredRevenueCurrent_9e4e65d7-dc63-40a4-b74e-016c4e37209b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DeferredIncomeTaxesAndOtherTaxLiabilities_d914b1bd-4688-40d2-9638-340071260537" xlink:href="lh-20200930.xsd#lh_DeferredIncomeTaxesAndOtherTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_lh_DeferredIncomeTaxesAndOtherTaxLiabilities_d914b1bd-4688-40d2-9638-340071260537" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_1868a462-1e75-47da-9ca8-c68cd28ff61b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_1868a462-1e75-47da-9ca8-c68cd28ff61b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e32f82e6-8971-4795-90c1-757512aa2d80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e32f82e6-8971-4795-90c1-757512aa2d80" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_20ad987d-c8b2-424f-bca3-7b5f9a62c31b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e32f82e6-8971-4795-90c1-757512aa2d80" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_20ad987d-c8b2-424f-bca3-7b5f9a62c31b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_20ad987d-c8b2-424f-bca3-7b5f9a62c31b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_20ad987d-c8b2-424f-bca3-7b5f9a62c31b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_20ad987d-c8b2-424f-bca3-7b5f9a62c31b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_14559567-5121-433d-9395-d731337f67c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_20ad987d-c8b2-424f-bca3-7b5f9a62c31b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_14559567-5121-433d-9395-d731337f67c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_a47d9750-b683-4dbf-93a2-66ee86f4e180" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e32f82e6-8971-4795-90c1-757512aa2d80" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_a47d9750-b683-4dbf-93a2-66ee86f4e180" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_a47d9750-b683-4dbf-93a2-66ee86f4e180_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_a47d9750-b683-4dbf-93a2-66ee86f4e180" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_a47d9750-b683-4dbf-93a2-66ee86f4e180_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e5ccaa12-ee0f-4908-a354-8eb90ead3cd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_a47d9750-b683-4dbf-93a2-66ee86f4e180" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e5ccaa12-ee0f-4908-a354-8eb90ead3cd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2f055a6d-6520-456f-a76e-84269a45bcbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e32f82e6-8971-4795-90c1-757512aa2d80" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2f055a6d-6520-456f-a76e-84269a45bcbc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2f055a6d-6520-456f-a76e-84269a45bcbc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2f055a6d-6520-456f-a76e-84269a45bcbc" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2f055a6d-6520-456f-a76e-84269a45bcbc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4d7899db-4c7d-417f-a55b-2239947b6ad2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2f055a6d-6520-456f-a76e-84269a45bcbc" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4d7899db-4c7d-417f-a55b-2239947b6ad2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONNotes" xlink:type="simple" xlink:href="lh-20200930.xsd#BUSINESSSEGMENTINFORMATIONNotes"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONNotes" xlink:type="extended" id="i6ec73eefb7b5458d8c590d657c6545c4_BUSINESSSEGMENTINFORMATIONNotes"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="lh-20200930.xsd#BUSINESSSEGMENTINFORMATIONTables"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="extended" id="id367f58e992c401883e021e2364e3cb7_BUSINESSSEGMENTINFORMATIONTables"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes" xlink:type="simple" xlink:href="lh-20200930.xsd#BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes" xlink:type="extended" id="icc5e5222637b4fb889711b4a95ef29c9_BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_713b55d7-1356-4550-89c0-69f69cd58f22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_270cac76-6cf0-4d6f-93ef-cac14024818b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_713b55d7-1356-4550-89c0-69f69cd58f22" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_270cac76-6cf0-4d6f-93ef-cac14024818b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a1344862-0ba6-4480-ad94-cb604714165e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_713b55d7-1356-4550-89c0-69f69cd58f22" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a1344862-0ba6-4480-ad94-cb604714165e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_80840898-3589-4ddc-a09b-4808382089a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a1344862-0ba6-4480-ad94-cb604714165e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_80840898-3589-4ddc-a09b-4808382089a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_80840898-3589-4ddc-a09b-4808382089a8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_80840898-3589-4ddc-a09b-4808382089a8" xlink:to="loc_us-gaap_SegmentDomain_80840898-3589-4ddc-a09b-4808382089a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bc0b7908-8414-4048-afe6-c56ef698cee7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_80840898-3589-4ddc-a09b-4808382089a8" xlink:to="loc_us-gaap_SegmentDomain_bc0b7908-8414-4048-afe6-c56ef698cee7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails" xlink:type="extended" id="ib962f8ea7f554d7fb9b119aeb1f15a63_BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_915666c6-31cd-49c1-944f-12a2133fc9c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentofRevenueContributed_544e921d-346a-441b-8653-10e7d0e1e193" xlink:href="lh-20200930.xsd#lh_PercentofRevenueContributed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_915666c6-31cd-49c1-944f-12a2133fc9c9" xlink:to="loc_lh_PercentofRevenueContributed_544e921d-346a-441b-8653-10e7d0e1e193" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Intercompanyrevenueelimination_21392ac1-0ce8-463d-98f2-c4a7ad158a16" xlink:href="lh-20200930.xsd#lh_Intercompanyrevenueelimination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_915666c6-31cd-49c1-944f-12a2133fc9c9" xlink:to="loc_lh_Intercompanyrevenueelimination_21392ac1-0ce8-463d-98f2-c4a7ad158a16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ab97d761-dbc4-43fd-9123-e4eef645dbac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_915666c6-31cd-49c1-944f-12a2133fc9c9" xlink:to="loc_us-gaap_Revenues_ab97d761-dbc4-43fd-9123-e4eef645dbac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e2b6c3d3-7ead-4b14-86d9-0a93c08016af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_915666c6-31cd-49c1-944f-12a2133fc9c9" xlink:to="loc_us-gaap_OperatingIncomeLoss_e2b6c3d3-7ead-4b14-86d9-0a93c08016af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_4c835a4d-4ccb-486e-b594-616b0e460065" xlink:href="lh-20200930.xsd#lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_915666c6-31cd-49c1-944f-12a2133fc9c9" xlink:to="loc_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_4c835a4d-4ccb-486e-b594-616b0e460065" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_94e37891-0bd7-474c-a31b-a108353a5a9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_915666c6-31cd-49c1-944f-12a2133fc9c9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_94e37891-0bd7-474c-a31b-a108353a5a9e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d656a561-c93c-4aa2-ac9c-2a0b35a2dbe4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_915666c6-31cd-49c1-944f-12a2133fc9c9" xlink:to="loc_us-gaap_ProfitLoss_d656a561-c93c-4aa2-ac9c-2a0b35a2dbe4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1f0a2d36-1480-4fc0-bcad-52b3866da032" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_915666c6-31cd-49c1-944f-12a2133fc9c9" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1f0a2d36-1480-4fc0-bcad-52b3866da032" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_2085b778-ca2f-4e80-8d4a-bbd0e737f0bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_915666c6-31cd-49c1-944f-12a2133fc9c9" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_2085b778-ca2f-4e80-8d4a-bbd0e737f0bf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c9103f36-d5c0-4acf-82d0-a6b740d9f597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_915666c6-31cd-49c1-944f-12a2133fc9c9" xlink:to="loc_us-gaap_NetIncomeLoss_c9103f36-d5c0-4acf-82d0-a6b740d9f597" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3bbbb400-8a78-4919-a4f2-7c06bf7035ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_915666c6-31cd-49c1-944f-12a2133fc9c9" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3bbbb400-8a78-4919-a4f2-7c06bf7035ff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c52d6a01-79f7-4136-9636-55984db2e88c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3bbbb400-8a78-4919-a4f2-7c06bf7035ff" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c52d6a01-79f7-4136-9636-55984db2e88c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c52d6a01-79f7-4136-9636-55984db2e88c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c52d6a01-79f7-4136-9636-55984db2e88c" xlink:to="loc_us-gaap_SegmentDomain_c52d6a01-79f7-4136-9636-55984db2e88c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f5597f6a-8f82-4b58-adc5-269538a33baa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c52d6a01-79f7-4136-9636-55984db2e88c" xlink:to="loc_us-gaap_SegmentDomain_f5597f6a-8f82-4b58-adc5-269538a33baa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_4c96f3c0-8f56-405f-abcf-664671dc53b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f5597f6a-8f82-4b58-adc5-269538a33baa" xlink:to="loc_us-gaap_CorporateMember_4c96f3c0-8f56-405f-abcf-664671dc53b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_30ef074d-8809-495f-ae3d-be989052cea9" xlink:href="lh-20200930.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f5597f6a-8f82-4b58-adc5-269538a33baa" xlink:to="loc_lh_LabCorpDiagnosticsMember_30ef074d-8809-495f-ae3d-be989052cea9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_b5c4cd32-9154-4869-9975-1170a40da9c3" xlink:href="lh-20200930.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f5597f6a-8f82-4b58-adc5-269538a33baa" xlink:to="loc_lh_CovanceDrugDevelopmentMember_b5c4cd32-9154-4869-9975-1170a40da9c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporationMember_92947a3f-4be4-48e6-af28-41261407e7d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f5597f6a-8f82-4b58-adc5-269538a33baa" xlink:to="loc_us-gaap_CorporationMember_92947a3f-4be4-48e6-af28-41261407e7d8" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/REVENUENotes" xlink:type="simple" xlink:href="lh-20200930.xsd#REVENUENotes"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/REVENUENotes" xlink:type="extended" id="i5e677f58c3bb4e42be5a9eb49bbd9ed2_REVENUENotes"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/REVENUETables" xlink:type="simple" xlink:href="lh-20200930.xsd#REVENUETables"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/REVENUETables" xlink:type="extended" id="i653066ed1c644b7088728ce6792181d0_REVENUETables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c4967e67-e751-4007-a87d-d5350000b54e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_bb30731c-6e2b-4985-9f28-3f5e7f3d7f5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c4967e67-e751-4007-a87d-d5350000b54e" xlink:to="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_bb30731c-6e2b-4985-9f28-3f5e7f3d7f5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_f5d2aebb-8c2c-4242-9678-4889807e3435" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c4967e67-e751-4007-a87d-d5350000b54e" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_f5d2aebb-8c2c-4242-9678-4889807e3435" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_9c129aaf-4774-4c9f-ab5f-6aaa34c15451" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c4967e67-e751-4007-a87d-d5350000b54e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_9c129aaf-4774-4c9f-ab5f-6aaa34c15451" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostTableTextBlock_bbae9325-01a1-43fd-abe4-502add8d8446" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c4967e67-e751-4007-a87d-d5350000b54e" xlink:to="loc_us-gaap_CapitalizedContractCostTableTextBlock_bbae9325-01a1-43fd-abe4-502add8d8446" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_e197a78d-fddd-418f-a8a5-0efec941e2a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c4967e67-e751-4007-a87d-d5350000b54e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_e197a78d-fddd-418f-a8a5-0efec941e2a4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_62ced467-92a1-4313-a1cb-a43952b85c0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e197a78d-fddd-418f-a8a5-0efec941e2a4" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_62ced467-92a1-4313-a1cb-a43952b85c0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_62ced467-92a1-4313-a1cb-a43952b85c0b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_62ced467-92a1-4313-a1cb-a43952b85c0b" xlink:to="loc_us-gaap_SegmentDomain_62ced467-92a1-4313-a1cb-a43952b85c0b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d64fb717-7e1a-4486-a42f-f02fff44cc3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_62ced467-92a1-4313-a1cb-a43952b85c0b" xlink:to="loc_us-gaap_SegmentDomain_d64fb717-7e1a-4486-a42f-f02fff44cc3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_a971c202-b85b-43b5-b551-7b67a351228e" xlink:href="lh-20200930.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d64fb717-7e1a-4486-a42f-f02fff44cc3c" xlink:to="loc_lh_CovanceDrugDevelopmentMember_a971c202-b85b-43b5-b551-7b67a351228e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_ea33af8b-8024-4365-b936-8758338969d0" xlink:href="lh-20200930.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d64fb717-7e1a-4486-a42f-f02fff44cc3c" xlink:to="loc_lh_LabCorpDiagnosticsMember_ea33af8b-8024-4365-b936-8758338969d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_2241e89c-6490-40cd-b5ad-0df1748b82f7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e197a78d-fddd-418f-a8a5-0efec941e2a4" xlink:to="loc_srt_StatementGeographicalAxis_2241e89c-6490-40cd-b5ad-0df1748b82f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2241e89c-6490-40cd-b5ad-0df1748b82f7_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_2241e89c-6490-40cd-b5ad-0df1748b82f7" xlink:to="loc_srt_SegmentGeographicalDomain_2241e89c-6490-40cd-b5ad-0df1748b82f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d6124491-8cf0-4fb8-9f98-ddd365f32e5d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_2241e89c-6490-40cd-b5ad-0df1748b82f7" xlink:to="loc_srt_SegmentGeographicalDomain_d6124491-8cf0-4fb8-9f98-ddd365f32e5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OthercountriesMember_6d49f316-a772-4538-b69a-2f891aa6f633" xlink:href="lh-20200930.xsd#lh_OthercountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d6124491-8cf0-4fb8-9f98-ddd365f32e5d" xlink:to="loc_lh_OthercountriesMember_6d49f316-a772-4538-b69a-2f891aa6f633" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_2c5feaf2-3828-4c35-91c3-37f0e95ee150" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d6124491-8cf0-4fb8-9f98-ddd365f32e5d" xlink:to="loc_country_GB_2c5feaf2-3828-4c35-91c3-37f0e95ee150" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_b61443b5-5b6a-449c-8504-43f966370725" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d6124491-8cf0-4fb8-9f98-ddd365f32e5d" xlink:to="loc_country_CA_b61443b5-5b6a-449c-8504-43f966370725" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_e9df7501-ad5a-43e7-afaa-b7637820df5f" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d6124491-8cf0-4fb8-9f98-ddd365f32e5d" xlink:to="loc_country_CH_e9df7501-ad5a-43e7-afaa-b7637820df5f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_e64cce4a-9244-464f-9cff-f758def4f024" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d6124491-8cf0-4fb8-9f98-ddd365f32e5d" xlink:to="loc_srt_EuropeMember_e64cce4a-9244-464f-9cff-f758def4f024" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_cfca5c99-1a9d-4c0a-a1d3-12655c4badfd" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d6124491-8cf0-4fb8-9f98-ddd365f32e5d" xlink:to="loc_country_US_cfca5c99-1a9d-4c0a-a1d3-12655c4badfd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_f1c97ad6-e2fd-4480-a7d3-22f14bcefcf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e197a78d-fddd-418f-a8a5-0efec941e2a4" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_f1c97ad6-e2fd-4480-a7d3-22f14bcefcf6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_f1c97ad6-e2fd-4480-a7d3-22f14bcefcf6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_f1c97ad6-e2fd-4480-a7d3-22f14bcefcf6" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_f1c97ad6-e2fd-4480-a7d3-22f14bcefcf6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_a396f9a8-7d96-4483-976d-e261e8838439" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_f1c97ad6-e2fd-4480-a7d3-22f14bcefcf6" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_a396f9a8-7d96-4483-976d-e261e8838439" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfPayMember_04dd6cf7-43c2-4849-99cc-1e6f52c830b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SelfPayMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_a396f9a8-7d96-4483-976d-e261e8838439" xlink:to="loc_us-gaap_SelfPayMember_04dd6cf7-43c2-4849-99cc-1e6f52c830b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ClientMember_e8621636-14ca-42e8-b4de-c4b2e7355e70" xlink:href="lh-20200930.xsd#lh_ClientMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_a396f9a8-7d96-4483-976d-e261e8838439" xlink:to="loc_lh_ClientMember_e8621636-14ca-42e8-b4de-c4b2e7355e70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_MedicareandMedicaidMember_0b14de5c-cb8a-4e2a-9742-9bf146ee70ae" xlink:href="lh-20200930.xsd#lh_MedicareandMedicaidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_a396f9a8-7d96-4483-976d-e261e8838439" xlink:to="loc_lh_MedicareandMedicaidMember_0b14de5c-cb8a-4e2a-9742-9bf146ee70ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ThirdpartyMember_988e1567-626b-4b34-9cb0-fbf7b465c823" xlink:href="lh-20200930.xsd#lh_ThirdpartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_a396f9a8-7d96-4483-976d-e261e8838439" xlink:to="loc_lh_ThirdpartyMember_988e1567-626b-4b34-9cb0-fbf7b465c823" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_ac44bed4-0de0-4bf6-aa2e-68960654ce65" xlink:href="lh-20200930.xsd#lh_BiopharmaceuticalandmedicaldevicecompaniesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_a396f9a8-7d96-4483-976d-e261e8838439" xlink:to="loc_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_ac44bed4-0de0-4bf6-aa2e-68960654ce65" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/REVENUEDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#REVENUEDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/REVENUEDetails" xlink:type="extended" id="i8890b574734744c4848fdd29669f6170_REVENUEDetails"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#REVENUEDisaggregatedRevenueTableDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails" xlink:type="extended" id="i21ffcd13535244ab9a07000be58a0214_REVENUEDisaggregatedRevenueTableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_95ac2bf1-70ec-483a-9cf5-359918aa2e31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_95ac2bf1-70ec-483a-9cf5-359918aa2e31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnbilledServicesAllowanceforCreditLoss_2199d1e6-65e7-45eb-b5a1-817381db5abf" xlink:href="lh-20200930.xsd#lh_UnbilledServicesAllowanceforCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_UnbilledServicesAllowanceforCreditLoss_2199d1e6-65e7-45eb-b5a1-817381db5abf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoteReceivableAllowanceforCreditLoss_141a2d37-452a-46f3-9450-04bb8a39c72e" xlink:href="lh-20200930.xsd#lh_NoteReceivableAllowanceforCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_NoteReceivableAllowanceforCreditLoss_141a2d37-452a-46f3-9450-04bb8a39c72e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AllowanceforCreditLoss_590eb519-1334-40af-b3f0-088535c9b4cb" xlink:href="lh-20200930.xsd#lh_AllowanceforCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_AllowanceforCreditLoss_590eb519-1334-40af-b3f0-088535c9b4cb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings_9f39654a-ffb0-49a1-9a86-da826514539c" xlink:href="lh-20200930.xsd#lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings_9f39654a-ffb0-49a1-9a86-da826514539c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_6c90a1b3-ace9-4264-9cc4-3e3842fe0e8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_6c90a1b3-ace9-4264-9cc4-3e3842fe0e8e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnbilledServicesCreditLossExpenseReversal_1ab0759a-76c7-4a66-ae0a-823316d9f219" xlink:href="lh-20200930.xsd#lh_UnbilledServicesCreditLossExpenseReversal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_UnbilledServicesCreditLossExpenseReversal_1ab0759a-76c7-4a66-ae0a-823316d9f219" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoteReceivableCreditLossExpenseReversal_320e656d-0146-4e71-836a-a63d30c79b79" xlink:href="lh-20200930.xsd#lh_NoteReceivableCreditLossExpenseReversal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_NoteReceivableCreditLossExpenseReversal_320e656d-0146-4e71-836a-a63d30c79b79" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditLossExpenseReversal_5555780c-731d-4f88-bdab-26630b5a6b74" xlink:href="lh-20200930.xsd#lh_CreditLossExpenseReversal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_CreditLossExpenseReversal_5555780c-731d-4f88-bdab-26630b5a6b74" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AllowanceforCreditLossWriteOff_904096df-562b-4740-84f8-c7b3dbf8dccc" xlink:href="lh-20200930.xsd#lh_AllowanceforCreditLossWriteOff"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_AllowanceforCreditLossWriteOff_904096df-562b-4740-84f8-c7b3dbf8dccc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SalesCommissionAmortizationPeriodMinimum_d3ec55ab-7cef-4a5e-8977-d95a1d16f837" xlink:href="lh-20200930.xsd#lh_SalesCommissionAmortizationPeriodMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_SalesCommissionAmortizationPeriodMinimum_d3ec55ab-7cef-4a5e-8977-d95a1d16f837" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueRevenueRecognized1_73e757af-abc1-4d07-8768-f8178c6ca095" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueRevenueRecognized1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_DeferredRevenueRevenueRecognized1_73e757af-abc1-4d07-8768-f8178c6ca095" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross_0decd257-473f-4284-ad1d-36fcbe9a4111" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_ContractWithCustomerAssetGross_0decd257-473f-4284-ad1d-36fcbe9a4111" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_7283b55b-2ed6-49ad-a728-94e83a21f860" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_7283b55b-2ed6-49ad-a728-94e83a21f860" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear_290ab545-e7da-4511-a8c7-1bffd6bdeeeb" xlink:href="lh-20200930.xsd#lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear_290ab545-e7da-4511-a8c7-1bffd6bdeeeb" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LongTermContractsDurationMinimum_4a6a5fd7-a703-4a60-8abb-d2cfbd953a2a" xlink:href="lh-20200930.xsd#lh_LongTermContractsDurationMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_LongTermContractsDurationMinimum_4a6a5fd7-a703-4a60-8abb-d2cfbd953a2a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LongTermContractsDurationMaximum_d3137c94-4ff3-42a8-b936-1f724ef98d51" xlink:href="lh-20200930.xsd#lh_LongTermContractsDurationMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_LongTermContractsDurationMaximum_d3137c94-4ff3-42a8-b936-1f724ef98d51" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_ef76d910-b666-41b0-8a87-cb0c89764c15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_ef76d910-b666-41b0-8a87-cb0c89764c15" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_0783725f-d358-40f5-b7dc-9b090437eb49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_ContractWithCustomerLiability_0783725f-d358-40f5-b7dc-9b090437eb49" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_90342745-6f48-4923-987d-a0f6ea5b30b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_90342745-6f48-4923-987d-a0f6ea5b30b9" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_f525deec-20b7-4aa0-bcc4-5b39dfd12867" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalesCommissionCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_f525deec-20b7-4aa0-bcc4-5b39dfd12867" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet_4dbf0d35-fb9e-4b05-8654-94bc6ea6f4a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_CapitalizedContractCostNet_4dbf0d35-fb9e-4b05-8654-94bc6ea6f4a7" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts_40e00723-f55b-40fe-8d4c-f79319aae130" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts_40e00723-f55b-40fe-8d4c-f79319aae130" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredSalesCommissions_882d2b46-a816-4b05-afb9-5a39df68bc10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDeferredSalesCommissions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_AmortizationOfDeferredSalesCommissions_882d2b46-a816-4b05-afb9-5a39df68bc10" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_9c4bd024-361a-4e11-a123-1717899f32d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_UnbilledContractsReceivable_9c4bd024-361a-4e11-a123-1717899f32d2" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentofRevenueContributed_5f468d5b-11fc-4eb4-b4fe-805ce0e7155c" xlink:href="lh-20200930.xsd#lh_PercentofRevenueContributed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_PercentofRevenueContributed_5f468d5b-11fc-4eb4-b4fe-805ce0e7155c" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SalesCommissionAmortizationPeriodMaximum_871dd010-34f0-4d6c-b943-e3c423891fdb" xlink:href="lh-20200930.xsd#lh_SalesCommissionAmortizationPeriodMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_SalesCommissionAmortizationPeriodMaximum_871dd010-34f0-4d6c-b943-e3c423891fdb" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_1571e56f-03de-4340-9a24-defba9a1421b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_1571e56f-03de-4340-9a24-defba9a1421b" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_e850d693-5c05-413c-82c8-72d59b258b9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_e850d693-5c05-413c-82c8-72d59b258b9a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_fd176c98-5687-4940-b92d-574f256fc1ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e850d693-5c05-413c-82c8-72d59b258b9a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_fd176c98-5687-4940-b92d-574f256fc1ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_fd176c98-5687-4940-b92d-574f256fc1ea_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fd176c98-5687-4940-b92d-574f256fc1ea" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_fd176c98-5687-4940-b92d-574f256fc1ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3acb62cd-20f1-4ddf-a87c-f39263af8cc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fd176c98-5687-4940-b92d-574f256fc1ea" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3acb62cd-20f1-4ddf-a87c-f39263af8cc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_58a27b19-9ea4-4452-b737-b86463ba011d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3acb62cd-20f1-4ddf-a87c-f39263af8cc0" xlink:to="loc_us-gaap_NotesReceivableMember_58a27b19-9ea4-4452-b737-b86463ba011d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnbilledContractsReceivableMember_ad10de60-19f8-4939-a4f3-77e4ca1061ad" xlink:href="lh-20200930.xsd#lh_UnbilledContractsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3acb62cd-20f1-4ddf-a87c-f39263af8cc0" xlink:to="loc_lh_UnbilledContractsReceivableMember_ad10de60-19f8-4939-a4f3-77e4ca1061ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_88a25850-f04b-4b29-bcee-b5f83b93abde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3acb62cd-20f1-4ddf-a87c-f39263af8cc0" xlink:to="loc_us-gaap_AccountsReceivableMember_88a25850-f04b-4b29-bcee-b5f83b93abde" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0f214eb8-4030-4ca2-827a-aeed11e14dba" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e850d693-5c05-413c-82c8-72d59b258b9a" xlink:to="loc_srt_RangeAxis_0f214eb8-4030-4ca2-827a-aeed11e14dba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0f214eb8-4030-4ca2-827a-aeed11e14dba_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_0f214eb8-4030-4ca2-827a-aeed11e14dba" xlink:to="loc_srt_RangeMember_0f214eb8-4030-4ca2-827a-aeed11e14dba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0cc5bf5c-c619-4cc4-9dd2-0719d758168b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_0f214eb8-4030-4ca2-827a-aeed11e14dba" xlink:to="loc_srt_RangeMember_0cc5bf5c-c619-4cc4-9dd2-0719d758168b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7e6959e6-3df0-4ae4-a4e0-ecd5ed63ae67" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0cc5bf5c-c619-4cc4-9dd2-0719d758168b" xlink:to="loc_srt_MinimumMember_7e6959e6-3df0-4ae4-a4e0-ecd5ed63ae67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5d7e9c99-d401-4db2-9f31-de7eac448926" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0cc5bf5c-c619-4cc4-9dd2-0719d758168b" xlink:to="loc_srt_MaximumMember_5d7e9c99-d401-4db2-9f31-de7eac448926" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0c5c3dd5-0c9d-4798-a637-772d8409f149" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e850d693-5c05-413c-82c8-72d59b258b9a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0c5c3dd5-0c9d-4798-a637-772d8409f149" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0c5c3dd5-0c9d-4798-a637-772d8409f149_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0c5c3dd5-0c9d-4798-a637-772d8409f149" xlink:to="loc_us-gaap_SegmentDomain_0c5c3dd5-0c9d-4798-a637-772d8409f149_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_512a2871-2cdb-45c7-a813-0ccfddcf3669" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0c5c3dd5-0c9d-4798-a637-772d8409f149" xlink:to="loc_us-gaap_SegmentDomain_512a2871-2cdb-45c7-a813-0ccfddcf3669" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_691792f8-6c48-4edd-b1ca-bd5f7a7c472c" xlink:href="lh-20200930.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_512a2871-2cdb-45c7-a813-0ccfddcf3669" xlink:to="loc_lh_LabCorpDiagnosticsMember_691792f8-6c48-4edd-b1ca-bd5f7a7c472c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_d314b656-02c3-4a7b-8065-6f0291b4f3ed" xlink:href="lh-20200930.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_512a2871-2cdb-45c7-a813-0ccfddcf3669" xlink:to="loc_lh_CovanceDrugDevelopmentMember_d314b656-02c3-4a7b-8065-6f0291b4f3ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_2b18f86d-829f-4a10-963a-e65e1428bab9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e850d693-5c05-413c-82c8-72d59b258b9a" xlink:to="loc_srt_ProductOrServiceAxis_2b18f86d-829f-4a10-963a-e65e1428bab9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2b18f86d-829f-4a10-963a-e65e1428bab9_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_2b18f86d-829f-4a10-963a-e65e1428bab9" xlink:to="loc_srt_ProductsAndServicesDomain_2b18f86d-829f-4a10-963a-e65e1428bab9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_dfb9dd75-78f4-4d85-b08c-991182de5dde" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_2b18f86d-829f-4a10-963a-e65e1428bab9" xlink:to="loc_srt_ProductsAndServicesDomain_dfb9dd75-78f4-4d85-b08c-991182de5dde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_3a76c627-cffb-4167-b79b-2391f694f34a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e850d693-5c05-413c-82c8-72d59b258b9a" xlink:to="loc_srt_StatementGeographicalAxis_3a76c627-cffb-4167-b79b-2391f694f34a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3a76c627-cffb-4167-b79b-2391f694f34a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_3a76c627-cffb-4167-b79b-2391f694f34a" xlink:to="loc_srt_SegmentGeographicalDomain_3a76c627-cffb-4167-b79b-2391f694f34a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_842ac0b9-1898-469b-b4b1-ee914bcc657f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_3a76c627-cffb-4167-b79b-2391f694f34a" xlink:to="loc_srt_SegmentGeographicalDomain_842ac0b9-1898-469b-b4b1-ee914bcc657f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8ad47270-491f-40a9-8ddd-5e7afba69a19" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_842ac0b9-1898-469b-b4b1-ee914bcc657f" xlink:to="loc_country_US_8ad47270-491f-40a9-8ddd-5e7afba69a19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_d8b203ab-7256-45b4-b267-966e3746cd0b" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_842ac0b9-1898-469b-b4b1-ee914bcc657f" xlink:to="loc_country_CA_d8b203ab-7256-45b4-b267-966e3746cd0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_0940e073-561f-48ca-b8ae-f18feb26f150" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_842ac0b9-1898-469b-b4b1-ee914bcc657f" xlink:to="loc_country_GB_0940e073-561f-48ca-b8ae-f18feb26f150" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_be561bf7-ebab-41d9-b41b-78579a18b8e9" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_842ac0b9-1898-469b-b4b1-ee914bcc657f" xlink:to="loc_country_CH_be561bf7-ebab-41d9-b41b-78579a18b8e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_cc0f9041-6fac-44db-93b6-fa3bd4d461c8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_842ac0b9-1898-469b-b4b1-ee914bcc657f" xlink:to="loc_srt_EuropeMember_cc0f9041-6fac-44db-93b6-fa3bd4d461c8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OthercountriesMember_032048e0-3aba-4fd6-969a-842f68c35701" xlink:href="lh-20200930.xsd#lh_OthercountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_842ac0b9-1898-469b-b4b1-ee914bcc657f" xlink:to="loc_lh_OthercountriesMember_032048e0-3aba-4fd6-969a-842f68c35701" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_e268a199-4a9e-4759-9443-209c1d99dcf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e850d693-5c05-413c-82c8-72d59b258b9a" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_e268a199-4a9e-4759-9443-209c1d99dcf3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_e268a199-4a9e-4759-9443-209c1d99dcf3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_e268a199-4a9e-4759-9443-209c1d99dcf3" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_e268a199-4a9e-4759-9443-209c1d99dcf3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_6833224d-0e8b-4744-9a89-ca624f32372c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_e268a199-4a9e-4759-9443-209c1d99dcf3" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_6833224d-0e8b-4744-9a89-ca624f32372c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationAxis_a4100202-0a47-4537-bd4a-832be1526de6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerDurationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e850d693-5c05-413c-82c8-72d59b258b9a" xlink:to="loc_us-gaap_ContractWithCustomerDurationAxis_a4100202-0a47-4537-bd4a-832be1526de6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationDomain_a4100202-0a47-4537-bd4a-832be1526de6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerDurationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerDurationAxis_a4100202-0a47-4537-bd4a-832be1526de6" xlink:to="loc_us-gaap_ContractWithCustomerDurationDomain_a4100202-0a47-4537-bd4a-832be1526de6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationDomain_45ca02a7-55fd-4b67-bd32-d43a73eb6f6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerDurationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerDurationAxis_a4100202-0a47-4537-bd4a-832be1526de6" xlink:to="loc_us-gaap_ContractWithCustomerDurationDomain_45ca02a7-55fd-4b67-bd32-d43a73eb6f6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_d591867d-5368-4297-aa92-362d28088b3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e850d693-5c05-413c-82c8-72d59b258b9a" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_d591867d-5368-4297-aa92-362d28088b3d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d591867d-5368-4297-aa92-362d28088b3d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_d591867d-5368-4297-aa92-362d28088b3d" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d591867d-5368-4297-aa92-362d28088b3d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_a80a5c22-48fe-4d30-871a-3e2a3247c7c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_d591867d-5368-4297-aa92-362d28088b3d" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_a80a5c22-48fe-4d30-871a-3e2a3247c7c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_5d6af7a7-9293-4fbf-8aa6-35c9405aeccb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e850d693-5c05-413c-82c8-72d59b258b9a" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_5d6af7a7-9293-4fbf-8aa6-35c9405aeccb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_5d6af7a7-9293-4fbf-8aa6-35c9405aeccb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_5d6af7a7-9293-4fbf-8aa6-35c9405aeccb" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_5d6af7a7-9293-4fbf-8aa6-35c9405aeccb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_86c9653a-21ef-4155-bd9b-dda6f3507886" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_5d6af7a7-9293-4fbf-8aa6-35c9405aeccb" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_86c9653a-21ef-4155-bd9b-dda6f3507886" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ClientMember_1be2926a-b28d-44c1-b18f-2ddb91152d8d" xlink:href="lh-20200930.xsd#lh_ClientMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_86c9653a-21ef-4155-bd9b-dda6f3507886" xlink:to="loc_lh_ClientMember_1be2926a-b28d-44c1-b18f-2ddb91152d8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfPayMember_de72c3e1-5e83-4bfc-a61b-850c6fa04033" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SelfPayMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_86c9653a-21ef-4155-bd9b-dda6f3507886" xlink:to="loc_us-gaap_SelfPayMember_de72c3e1-5e83-4bfc-a61b-850c6fa04033" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_MedicareandMedicaidMember_c676d9b2-97c0-4ad5-8e2a-2134f6d137cc" xlink:href="lh-20200930.xsd#lh_MedicareandMedicaidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_86c9653a-21ef-4155-bd9b-dda6f3507886" xlink:to="loc_lh_MedicareandMedicaidMember_c676d9b2-97c0-4ad5-8e2a-2134f6d137cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_b6d9f638-bd25-4a70-842d-f066c9645590" xlink:href="lh-20200930.xsd#lh_BiopharmaceuticalandmedicaldevicecompaniesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_86c9653a-21ef-4155-bd9b-dda6f3507886" xlink:to="loc_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_b6d9f638-bd25-4a70-842d-f066c9645590" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ThirdpartyMember_43a8a018-7d42-424b-9539-4549cb6b02a1" xlink:href="lh-20200930.xsd#lh_ThirdpartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_86c9653a-21ef-4155-bd9b-dda6f3507886" xlink:to="loc_lh_ThirdpartyMember_43a8a018-7d42-424b-9539-4549cb6b02a1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_32d6760e-3de0-49b9-b917-e24e13742801" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e850d693-5c05-413c-82c8-72d59b258b9a" xlink:to="loc_srt_MajorCustomersAxis_32d6760e-3de0-49b9-b917-e24e13742801" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_32d6760e-3de0-49b9-b917-e24e13742801_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_32d6760e-3de0-49b9-b917-e24e13742801" xlink:to="loc_srt_NameOfMajorCustomerDomain_32d6760e-3de0-49b9-b917-e24e13742801_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_222e8a66-980d-426b-a280-f17808ff2068" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_32d6760e-3de0-49b9-b917-e24e13742801" xlink:to="loc_srt_NameOfMajorCustomerDomain_222e8a66-980d-426b-a280-f17808ff2068" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/RevenuefromContractwithCustomerPolicies" xlink:type="simple" xlink:href="lh-20200930.xsd#RevenuefromContractwithCustomerPolicies"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/RevenuefromContractwithCustomerPolicies" xlink:type="extended" id="i56b0cfe1114e4dd281c62140a3d9bc88_RevenuefromContractwithCustomerPolicies"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/LeasesNotes" xlink:type="simple" xlink:href="lh-20200930.xsd#LeasesNotes"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/LeasesNotes" xlink:type="extended" id="ie63db91d201f4d2f863b3c6588ad96a6_LeasesNotes"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/LeasesTables" xlink:type="simple" xlink:href="lh-20200930.xsd#LeasesTables"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/LeasesTables" xlink:type="extended" id="i86552061548648bc81d6712772737406_LeasesTables"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/LeasesDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#LeasesDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/LeasesDetails" xlink:type="extended" id="ifb041759ff384d549f92aa6eb32314d5_LeasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_67e308b9-52b8-4e06-b256-aae7cbc9517b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2a5394ea-ff5f-4a68-951f-085554e448ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_67e308b9-52b8-4e06-b256-aae7cbc9517b" xlink:to="loc_us-gaap_StatementTable_2a5394ea-ff5f-4a68-951f-085554e448ec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_da35c26a-29e0-42b5-934c-2ef28f3e8062" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2a5394ea-ff5f-4a68-951f-085554e448ec" xlink:to="loc_srt_RangeAxis_da35c26a-29e0-42b5-934c-2ef28f3e8062" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_da35c26a-29e0-42b5-934c-2ef28f3e8062_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_da35c26a-29e0-42b5-934c-2ef28f3e8062" xlink:to="loc_srt_RangeMember_da35c26a-29e0-42b5-934c-2ef28f3e8062_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3a64fb3f-2cea-4f90-b4c7-985f0e1963e4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_da35c26a-29e0-42b5-934c-2ef28f3e8062" xlink:to="loc_srt_RangeMember_3a64fb3f-2cea-4f90-b4c7-985f0e1963e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_53f8192b-02b1-4bc1-baf9-5b478329dbc9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3a64fb3f-2cea-4f90-b4c7-985f0e1963e4" xlink:to="loc_srt_MinimumMember_53f8192b-02b1-4bc1-baf9-5b478329dbc9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_61f7c793-067a-4668-8143-2a6fca30d818" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3a64fb3f-2cea-4f90-b4c7-985f0e1963e4" xlink:to="loc_srt_MaximumMember_61f7c793-067a-4668-8143-2a6fca30d818" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>lh-20200930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:fc8a7d57-4cce-43ce-b480-996ae8b97c72,g:096b564a-e6b9-41cc-ab37-c90f57b146f8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_srt_RestatementAxis_6b5e18a5-505e-4adc-82c9-69c88a6e31b6_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_IncreaseDecreaseinUnbilledContractReceivable_e2ca12cb-ccd1-4756-a2e4-0ad02c190f7e_terseLabel_en-US" xlink:label="lab_lh_IncreaseDecreaseinUnbilledContractReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Unbilled Contract Receivable</link:label>
    <link:label id="lab_lh_IncreaseDecreaseinUnbilledContractReceivable_label_en-US" xlink:label="lab_lh_IncreaseDecreaseinUnbilledContractReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Unbilled Contract Receivable</link:label>
    <link:label id="lab_lh_IncreaseDecreaseinUnbilledContractReceivable_documentation_en-US" xlink:label="lab_lh_IncreaseDecreaseinUnbilledContractReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Unbilled Contract Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncreaseDecreaseinUnbilledContractReceivable" xlink:href="lh-20200930.xsd#lh_IncreaseDecreaseinUnbilledContractReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_IncreaseDecreaseinUnbilledContractReceivable" xlink:to="lab_lh_IncreaseDecreaseinUnbilledContractReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CovanceDrugDevelopmentMember_10a80d30-d636-4bbe-8ac5-cc1ccfb57f02_terseLabel_en-US" xlink:label="lab_lh_CovanceDrugDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covance Drug Development [Member]</link:label>
    <link:label id="lab_lh_CovanceDrugDevelopmentMember_label_en-US" xlink:label="lab_lh_CovanceDrugDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covance Drug Development [Member]</link:label>
    <link:label id="lab_lh_CovanceDrugDevelopmentMember_documentation_en-US" xlink:label="lab_lh_CovanceDrugDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covance Drug Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember" xlink:href="lh-20200930.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CovanceDrugDevelopmentMember" xlink:to="lab_lh_CovanceDrugDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_ecf4aac1-4415-4225-8291-6838f73aef0c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CashPaymentReceivedAppropriatedbyU.S.CongressCovid19_30d17fa0-fa86-4ecd-b335-49b4bfa61ca3_terseLabel_en-US" xlink:label="lab_lh_CashPaymentReceivedAppropriatedbyU.S.CongressCovid19" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Payment Received Appropriated by U.S. Congress Covid-19</link:label>
    <link:label id="lab_lh_CashPaymentReceivedAppropriatedbyU.S.CongressCovid19_label_en-US" xlink:label="lab_lh_CashPaymentReceivedAppropriatedbyU.S.CongressCovid19" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Payment Received Appropriated by U.S. Congress Covid-19</link:label>
    <link:label id="lab_lh_CashPaymentReceivedAppropriatedbyU.S.CongressCovid19_documentation_en-US" xlink:label="lab_lh_CashPaymentReceivedAppropriatedbyU.S.CongressCovid19" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Payment Received Appropriated by U.S. Congress Covid-19</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashPaymentReceivedAppropriatedbyU.S.CongressCovid19" xlink:href="lh-20200930.xsd#lh_CashPaymentReceivedAppropriatedbyU.S.CongressCovid19"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CashPaymentReceivedAppropriatedbyU.S.CongressCovid19" xlink:to="lab_lh_CashPaymentReceivedAppropriatedbyU.S.CongressCovid19" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_4735baa6-3840-4f50-82b0-ee23f82d8ead_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_a54b86c1-b971-4d96-af54-208ada9b04ef_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_2a62ecb6-052c-4740-a8f2-c168cfdda0a7_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestTable_8bfbe833-9012-4656-8ee8-eabd06a610c9_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestTable_label_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestTable" xlink:to="lab_us-gaap_MinorityInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_099e326d-f307-4e16-9d75-4e47216f565b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_9bf8dc7d-4e1c-44e6-b33e-b065365750e7_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_94167b58-8f19-4061-9691-b86b1009c781_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension And Postretirement Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_PerShareAmountAbstract_36c06233-3128-4a6e-a741-e39fe99a07b4_terseLabel_en-US" xlink:label="lab_lh_PerShareAmountAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Per Share Amount [Abstract]</link:label>
    <link:label id="lab_lh_PerShareAmountAbstract_label_en-US" xlink:label="lab_lh_PerShareAmountAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Per Share Amount [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PerShareAmountAbstract" xlink:href="lh-20200930.xsd#lh_PerShareAmountAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_PerShareAmountAbstract" xlink:to="lab_lh_PerShareAmountAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8e9aa56c-4448-4c4a-811a-811275d08d2d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8a7bd617-fa7f-472a-b649-f6d4f2a201ab_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_eee56df0-fe1e-4cd8-b73f-a5b51f9c9fc6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_ba17bd49-d1ec-4e52-866f-19bef00f38f5_terseLabel_en-US" xlink:label="lab_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commons Stock Issued During Period Shares Employee Stock Plans</link:label>
    <link:label id="lab_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_label_en-US" xlink:label="lab_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commons Stock Issued During Period Shares Employee Stock Plans</link:label>
    <link:label id="lab_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_documentation_en-US" xlink:label="lab_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of common shares issued during the period as a result of an employee stock purchase plan and/or stock option plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" xlink:href="lh-20200930.xsd#lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" xlink:to="lab_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d0f4687a-4f94-493d-b365-c0c21ca454ab_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7c3c6f92-5221-4ec0-aee0-5e63e0c0c1b6_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's Restructuring Activities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGross_40021697-b8c1-4d5e-9446-e28ecac40646_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, before Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGross_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetGross" xlink:to="lab_us-gaap_ContractWithCustomerAssetGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_d9d4ecf3-1094-4e2a-b7da-dd5ac777577d_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract_93e4e39b-cce4-4469-9b05-0dba449e3cd9_terseLabel_en-US" xlink:label="lab_lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciliation of Operating Income to Consolidated [Abstract]</link:label>
    <link:label id="lab_lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract_label_en-US" xlink:label="lab_lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciliation of Operating Income to Consolidated [Abstract]</link:label>
    <link:label id="lab_lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract_documentation_en-US" xlink:label="lab_lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciliation of Operating Income to Consolidated [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract" xlink:href="lh-20200930.xsd#lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract" xlink:to="lab_lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_c479fc31-8db8-4e8d-aae1-b784f870f591_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Future Amortization Expense</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ConversionOfZeroCouponConvertibleDebt_7350aa8c-0002-4a1f-a31f-5bbf7061ee54_terseLabel_en-US" xlink:label="lab_lh_ConversionOfZeroCouponConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of zero-coupon convertible debt</link:label>
    <link:label id="lab_lh_ConversionOfZeroCouponConvertibleDebt_label_en-US" xlink:label="lab_lh_ConversionOfZeroCouponConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of zero-coupon convertible debt</link:label>
    <link:label id="lab_lh_ConversionOfZeroCouponConvertibleDebt_documentation_en-US" xlink:label="lab_lh_ConversionOfZeroCouponConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of stock issued during the period upon the conversion of convertible securities (zero-coupon subordinated notes) and/or reversal of deferred tax liability to reflect the tax benefit realized upon issuance of the stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ConversionOfZeroCouponConvertibleDebt" xlink:href="lh-20200930.xsd#lh_ConversionOfZeroCouponConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ConversionOfZeroCouponConvertibleDebt" xlink:to="lab_lh_ConversionOfZeroCouponConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_c0221f34-0324-4668-8004-4c090c5b169e_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian licenses [Member]</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_d1757874-c15e-4643-a18b-e64f1721286c_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_05ea32b1-32fc-4abf-8bf8-f49dddc27ef9_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_56a90b6b-1bae-4d0e-9ad5-52a48b8911c6_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax_392418fc-509a-4241-bcba-60994e57d56b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effect of adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_6c26a79f-946b-49b2-b4e9-928299b0ccc8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments And Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_710c5699-ee4b-4e5c-9866-566a23e6c7c0_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_f07e61c8-72ea-4ab9-b5d4-cdc354c75c0b_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_ce2959df-d756-4012-908d-0deb9016fea9_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_6ed753b2-7bfd-4b36-89c7-57b4b28b532c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_68f26910-1794-44a7-a932-2bd94fb5186d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockRetiredCostMethodAmount_bdef7e7a-534a-4509-9e3e-a135a54a78fd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Retired, Cost Method, Amount</link:label>
    <link:label id="lab_us-gaap_TreasuryStockRetiredCostMethodAmount_label_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Retired, Cost Method, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:to="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PostemploymentBenefitsAbstract_b83f1a6f-0e8c-405a-ad55-25ccd5648dd0_terseLabel_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postemployment Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_PostemploymentBenefitsAbstract_label_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postemployment Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract" xlink:to="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_40391b48-4c96-4ebe-a1c6-12acaed2c214_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_7538965f-b0b6-49fc-871f-cb2d7a0ed398_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, less current portion</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_InterestPaidInCash_f2f246c9-4790-4c66-8537-875375cb4d5c_terseLabel_en-US" xlink:label="lab_lh_InterestPaidInCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest</link:label>
    <link:label id="lab_lh_InterestPaidInCash_label_en-US" xlink:label="lab_lh_InterestPaidInCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid In Cash</link:label>
    <link:label id="lab_lh_InterestPaidInCash_documentation_en-US" xlink:label="lab_lh_InterestPaidInCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of cash paid during the current period for interest owed on money borrowed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_InterestPaidInCash" xlink:href="lh-20200930.xsd#lh_InterestPaidInCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_InterestPaidInCash" xlink:to="lab_lh_InterestPaidInCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashSurrenderValueFairValueDisclosure_13a0f109-0a6c-479b-93fa-abfd37f97329_terseLabel_en-US" xlink:label="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Surrender Value, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_CashSurrenderValueFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Surrender Value, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:to="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_2d020dd1-e177-472b-b40f-80bf1dc97173_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges related to severance and other employee costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_98e8f68d-f5c9-49f7-95a2-7934d200e802_verboseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_c5fd751b-07a1-4339-af1c-9a1ca8ecc471_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset and Liability [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_75871858-e25d-4c88-9d25-a2d903537b34_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_c4d0933d-3e25-45ca-abd9-38bf0bd887db_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock_8846ecfa-c822-4553-b0bd-808ac91915cd_terseLabel_en-US" xlink:label="lab_lh_NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Novel Coranvirus (Covid-19) Financial Statement Impact [Policy Text Block]</link:label>
    <link:label id="lab_lh_NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock_label_en-US" xlink:label="lab_lh_NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Novel Coranvirus (Covid-19) Financial Statement Impact [Policy Text Block]</link:label>
    <link:label id="lab_lh_NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock_documentation_en-US" xlink:label="lab_lh_NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Novel Coranvirus (Covid-19) Financial Statement Impact [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock" xlink:href="lh-20200930.xsd#lh_NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock" xlink:to="lab_lh_NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_08e5d807-afc0-48ae-83ab-98f74ae6b25f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_957ef149-d6ff-4831-b07c-c70f6c0ca3e7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_5524a2a1-ce60-42e7-bebd-4d16b0ed2795_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_85996363-1b28-49c0-a009-0657adc53c71_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e26beb79-a5ed-4f5d-b95b-548565054c5c_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_7639fc5b-6228-45d2-b5f3-917651c619f3_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_5fa5dfac-91f6-4e54-acbb-cfcb64821222_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_a83554a7-c10a-4655-a73b-7dcf70750aa9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pensions and Postretirement Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_58d84986-4896-4fb0-b579-fc1985667552_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SalesCommissionAmortizationPeriodMinimum_7ab83fd2-7e4e-4bb5-811d-1d4407964a71_terseLabel_en-US" xlink:label="lab_lh_SalesCommissionAmortizationPeriodMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Commission Amortization Period Minimum</link:label>
    <link:label id="lab_lh_SalesCommissionAmortizationPeriodMinimum_label_en-US" xlink:label="lab_lh_SalesCommissionAmortizationPeriodMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Commission Amortization Period Minimum</link:label>
    <link:label id="lab_lh_SalesCommissionAmortizationPeriodMinimum_documentation_en-US" xlink:label="lab_lh_SalesCommissionAmortizationPeriodMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Commission Amortization Period Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SalesCommissionAmortizationPeriodMinimum" xlink:href="lh-20200930.xsd#lh_SalesCommissionAmortizationPeriodMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SalesCommissionAmortizationPeriodMinimum" xlink:to="lab_lh_SalesCommissionAmortizationPeriodMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_7ed06eb1-b339-4dfa-9f1b-e26ad68f1d47_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (loss) before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_26a51f7c-71bd-442c-aec1-6730bc433de5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ThirdpartyMember_eb594525-c4e8-43d1-8c8d-6162a35cf775_terseLabel_en-US" xlink:label="lab_lh_ThirdpartyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third party [Member]</link:label>
    <link:label id="lab_lh_ThirdpartyMember_label_en-US" xlink:label="lab_lh_ThirdpartyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third party [Member]</link:label>
    <link:label id="lab_lh_ThirdpartyMember_documentation_en-US" xlink:label="lab_lh_ThirdpartyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third party [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ThirdpartyMember" xlink:href="lh-20200930.xsd#lh_ThirdpartyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ThirdpartyMember" xlink:to="lab_lh_ThirdpartyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment_d3bfc4f0-8bed-4ba9-ac15-d31dcba73724_negatedTerseLabel_en-US" xlink:label="lab_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance Benefits Related Restructuring Reserve Accrual Adjustment</link:label>
    <link:label id="lab_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment_73bf293f-72a8-4e14-9c34-c4a121dfa399_terseLabel_en-US" xlink:label="lab_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance Benefits Related Restructuring Reserve Accrual Adjustment</link:label>
    <link:label id="lab_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment_label_en-US" xlink:label="lab_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance Benefits Related Restructuring Reserve Accrual Adjustment</link:label>
    <link:label id="lab_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment_documentation_en-US" xlink:label="lab_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of any reversal and other adjustment made during the period to the amount of a previously accrued liability for employee severance benefits related restructuring costs, excluding adjustments for costs incurred during the period, costs settled during the period, and foreign currency translation adjustments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment" xlink:href="lh-20200930.xsd#lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment" xlink:to="lab_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_0f23dbbe-629f-455f-b64a-e98e324de7a6_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelfPayMember_6040288a-0f62-407c-87e3-ba61ee2b6f3c_terseLabel_en-US" xlink:label="lab_us-gaap_SelfPayMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-Pay [Member]</link:label>
    <link:label id="lab_us-gaap_SelfPayMember_label_en-US" xlink:label="lab_us-gaap_SelfPayMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-Pay [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfPayMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SelfPayMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelfPayMember" xlink:to="lab_us-gaap_SelfPayMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_LabCorpDiagnosticsMember_99944074-eccc-4cd7-8d17-74d43ad33101_terseLabel_en-US" xlink:label="lab_lh_LabCorpDiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LabCorp Diagnostics [Member]</link:label>
    <link:label id="lab_lh_LabCorpDiagnosticsMember_label_en-US" xlink:label="lab_lh_LabCorpDiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LabCorp Diagnostics [Member]</link:label>
    <link:label id="lab_lh_LabCorpDiagnosticsMember_documentation_en-US" xlink:label="lab_lh_LabCorpDiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LabCorp Diagnostics [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember" xlink:href="lh-20200930.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_LabCorpDiagnosticsMember" xlink:to="lab_lh_LabCorpDiagnosticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationDocumentAxis_3ee6ed4a-498d-46f8-bab4-b835c108827e_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationDocumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information, Document [Axis]</link:label>
    <link:label id="lab_dei_DocumentInformationDocumentAxis_label_en-US" xlink:label="lab_dei_DocumentInformationDocumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information, Document [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationDocumentAxis" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationDocumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationDocumentAxis" xlink:to="lab_dei_DocumentInformationDocumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_061874b1-fc08-41ee-a464-8b855a554b32_negatedLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_5c3c9cac-e806-4569-83fc-3dac558c80a6_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_a4e24986-9670-4bc3-8e45-0fea63500a3d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_RecentlyAdoptedAccountingGuidancePolicyTextBlock_20099b18-a3b4-4e6c-af34-6f3fa6b208b8_terseLabel_en-US" xlink:label="lab_lh_RecentlyAdoptedAccountingGuidancePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Guidance [Policy Text Block]</link:label>
    <link:label id="lab_lh_RecentlyAdoptedAccountingGuidancePolicyTextBlock_label_en-US" xlink:label="lab_lh_RecentlyAdoptedAccountingGuidancePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Guidance [Policy Text Block]</link:label>
    <link:label id="lab_lh_RecentlyAdoptedAccountingGuidancePolicyTextBlock_documentation_en-US" xlink:label="lab_lh_RecentlyAdoptedAccountingGuidancePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Guidance [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_RecentlyAdoptedAccountingGuidancePolicyTextBlock" xlink:href="lh-20200930.xsd#lh_RecentlyAdoptedAccountingGuidancePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_RecentlyAdoptedAccountingGuidancePolicyTextBlock" xlink:to="lab_lh_RecentlyAdoptedAccountingGuidancePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_DefinedContributionPlanTotalExpense_b6a9996d-9585-40c3-a106-85a150f85dc9_terseLabel_en-US" xlink:label="lab_lh_DefinedContributionPlanTotalExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Total Expense</link:label>
    <link:label id="lab_lh_DefinedContributionPlanTotalExpense_label_en-US" xlink:label="lab_lh_DefinedContributionPlanTotalExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Total Expense</link:label>
    <link:label id="lab_lh_DefinedContributionPlanTotalExpense_documentation_en-US" xlink:label="lab_lh_DefinedContributionPlanTotalExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Total Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedContributionPlanTotalExpense" xlink:href="lh-20200930.xsd#lh_DefinedContributionPlanTotalExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_DefinedContributionPlanTotalExpense" xlink:to="lab_lh_DefinedContributionPlanTotalExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_8c74eba4-9892-4485-beb2-455a0511b5d4_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_AllowanceforCreditLoss_a510c931-826f-4ef0-8090-5184a91f7200_terseLabel_en-US" xlink:label="lab_lh_AllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss</link:label>
    <link:label id="lab_lh_AllowanceforCreditLoss_label_en-US" xlink:label="lab_lh_AllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss</link:label>
    <link:label id="lab_lh_AllowanceforCreditLoss_documentation_en-US" xlink:label="lab_lh_AllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AllowanceforCreditLoss" xlink:href="lh-20200930.xsd#lh_AllowanceforCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_AllowanceforCreditLoss" xlink:to="lab_lh_AllowanceforCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_b3e54f58-aec2-4058-9cf3-c26e361c9729_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c76e7b00-059d-4735-a5c2-79dbb1034780_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Longtermdebtissuancecosts_a564e4fd-1f20-49a7-b493-0622a832a68a_terseLabel_en-US" xlink:label="lab_lh_Longtermdebtissuancecosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt issuance costs</link:label>
    <link:label id="lab_lh_Longtermdebtissuancecosts_label_en-US" xlink:label="lab_lh_Longtermdebtissuancecosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt issuance costs</link:label>
    <link:label id="lab_lh_Longtermdebtissuancecosts_documentation_en-US" xlink:label="lab_lh_Longtermdebtissuancecosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt issuance costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Longtermdebtissuancecosts" xlink:href="lh-20200930.xsd#lh_Longtermdebtissuancecosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Longtermdebtissuancecosts" xlink:to="lab_lh_Longtermdebtissuancecosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionLineItems_e6c3e459-d7a9-442d-98ea-eab459d0340d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtConversionLineItems_label_en-US" xlink:label="lab_us-gaap_DebtConversionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionLineItems" xlink:to="lab_us-gaap_DebtConversionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_e75ab636-24fd-429e-822d-0f9f6e47bbdc_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CA_6c637f7b-1068-421b-aec7-2f869e06d209_terseLabel_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:label id="lab_country_CA_label_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA" xlink:to="lab_country_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax_9d5e423f-c748-48db-830c-fc9d313dac17_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CH_26ba1074-5181-4b53-a1a1-db7b53f2d11d_terseLabel_en-US" xlink:label="lab_country_CH" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SWITZERLAND</link:label>
    <link:label id="lab_country_CH_label_en-US" xlink:label="lab_country_CH" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SWITZERLAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CH"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CH" xlink:to="lab_country_CH" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_548ca1f6-162f-4ec9-9861-1fdc4258a6e9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity affiliates</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b9bcef39-3dfb-44e4-97d3-8229a1936aa3_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Earnings, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_d0cb54c2-9284-4013-bca7-970e79a6e81e_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_5f0bae07-e2e1-4dc5-b18b-b9659f00f21f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairment_81edc0e5-56f2-448d-9ac8-accbaa2ceaca_terseLabel_en-US" xlink:label="lab_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Pandemic Goodwill and Intangible Asset Impairment</link:label>
    <link:label id="lab_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairment_label_en-US" xlink:label="lab_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Pandemic Goodwill and Intangible Asset Impairment</link:label>
    <link:label id="lab_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairment_documentation_en-US" xlink:label="lab_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Pandemic Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairment" xlink:href="lh-20200930.xsd#lh_COVID19PandemicGoodwillAndIntangibleAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairment" xlink:to="lab_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_04fc5ff6-88bb-43f4-a951-ec6acf576c08_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingent liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_BalanceOfSeniorNotesMatureDuringQ42020_d6a9e816-107f-4017-8623-e5e8954445e1_terseLabel_en-US" xlink:label="lab_lh_BalanceOfSeniorNotesMatureDuringQ42020" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Became Due During Quarter</link:label>
    <link:label id="lab_lh_BalanceOfSeniorNotesMatureDuringQ42020_label_en-US" xlink:label="lab_lh_BalanceOfSeniorNotesMatureDuringQ42020" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance of Senior Notes Mature During Q4 2020</link:label>
    <link:label id="lab_lh_BalanceOfSeniorNotesMatureDuringQ42020_documentation_en-US" xlink:label="lab_lh_BalanceOfSeniorNotesMatureDuringQ42020" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance of Senior Notes Mature During Q4 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_BalanceOfSeniorNotesMatureDuringQ42020" xlink:href="lh-20200930.xsd#lh_BalanceOfSeniorNotesMatureDuringQ42020"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_BalanceOfSeniorNotesMatureDuringQ42020" xlink:to="lab_lh_BalanceOfSeniorNotesMatureDuringQ42020" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability_64ddf780-95f9-46c0-8012-828bd132bc1b_terseLabel_en-US" xlink:label="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability</link:label>
    <link:label id="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability_label_en-US" xlink:label="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability</link:label>
    <link:label id="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability_documentation_en-US" xlink:label="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" xlink:href="lh-20200930.xsd#lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" xlink:to="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_NoteReceivableCreditLossExpenseReversal_7dd10363-878c-4ca3-8fc5-9f97b6405d01_terseLabel_en-US" xlink:label="lab_lh_NoteReceivableCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:label id="lab_lh_NoteReceivableCreditLossExpenseReversal_label_en-US" xlink:label="lab_lh_NoteReceivableCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:label id="lab_lh_NoteReceivableCreditLossExpenseReversal_documentation_en-US" xlink:label="lab_lh_NoteReceivableCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoteReceivableCreditLossExpenseReversal" xlink:href="lh-20200930.xsd#lh_NoteReceivableCreditLossExpenseReversal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_NoteReceivableCreditLossExpenseReversal" xlink:to="lab_lh_NoteReceivableCreditLossExpenseReversal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveAbstract_bae907b0-48ee-47e8-88e6-aa1313fa9557_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveAbstract" xlink:to="lab_us-gaap_RestructuringReserveAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f5851921-7a3e-4bf7-a9e3-3a18ea73b544_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_TermLoanandRevolvingCreditFacilityMember_f7d19f23-1341-432e-8ff6-a76d9183d344_terseLabel_en-US" xlink:label="lab_lh_TermLoanandRevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan and Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_lh_TermLoanandRevolvingCreditFacilityMember_label_en-US" xlink:label="lab_lh_TermLoanandRevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan and Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_lh_TermLoanandRevolvingCreditFacilityMember_documentation_en-US" xlink:label="lab_lh_TermLoanandRevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan and Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_TermLoanandRevolvingCreditFacilityMember" xlink:href="lh-20200930.xsd#lh_TermLoanandRevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_TermLoanandRevolvingCreditFacilityMember" xlink:to="lab_lh_TermLoanandRevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_28aa2868-0513-4d1c-8751-6a50e242e89b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplies inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_7db2a223-0d1d-4713-a903-96c4b5412ab4_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_fedf5af0-bb55-477d-9a95-e78fa5b0b8c3_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_98e763f1-2fac-4531-9e7f-1125a097449a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_052d1100-70bd-4e53-93fb-8d2454c26fbf_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortization_fb7a0046-0f11-4a25-9ed7-e858afa3dfb8_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortization_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAmortization" xlink:to="lab_us-gaap_CapitalizedContractCostAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_0feef224-43f1-428a-aa58-1d8f847f1593_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_a0d6ad02-16c5-4812-bf52-f379d20734e9_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_00baa7d7-7b28-4b8e-aeea-7da104f25bab_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_26c6af98-8963-4a05-b6f9-b8f16d269bbb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Crosscurrencyswapmaturing2022Member_cc453ed2-6f7b-4ce2-a064-4e517092e01d_terseLabel_en-US" xlink:label="lab_lh_Crosscurrencyswapmaturing2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross currency swap maturing 2022 [Member]</link:label>
    <link:label id="lab_lh_Crosscurrencyswapmaturing2022Member_label_en-US" xlink:label="lab_lh_Crosscurrencyswapmaturing2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross currency swap maturing 2022 [Member]</link:label>
    <link:label id="lab_lh_Crosscurrencyswapmaturing2022Member_documentation_en-US" xlink:label="lab_lh_Crosscurrencyswapmaturing2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross currency swap maturing 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Crosscurrencyswapmaturing2022Member" xlink:href="lh-20200930.xsd#lh_Crosscurrencyswapmaturing2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Crosscurrencyswapmaturing2022Member" xlink:to="lab_lh_Crosscurrencyswapmaturing2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_83ff0ba8-9fac-4cf6-b657-2ab0b1f11d23_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential common shares not included in computation of diluted earnings per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Seniornotesdue2045Member_3df48850-8504-4566-8c1a-2c4adbc2343e_terseLabel_en-US" xlink:label="lab_lh_Seniornotesdue2045Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2045 [Member]</link:label>
    <link:label id="lab_lh_Seniornotesdue2045Member_label_en-US" xlink:label="lab_lh_Seniornotesdue2045Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2045 [Member]</link:label>
    <link:label id="lab_lh_Seniornotesdue2045Member_documentation_en-US" xlink:label="lab_lh_Seniornotesdue2045Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2045 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2045Member" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2045Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Seniornotesdue2045Member" xlink:to="lab_lh_Seniornotesdue2045Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_9b97b120-fc56-4c21-950b-a0474471b5a7_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_b45acc4c-087e-4a52-8f06-65beab92c56a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from revolving credit facilities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Issuanceofcommonstockunderemployeeplans_0ab4fd85-cc3f-4e5f-abda-a75b9b88b5a1_negatedTerseLabel_en-US" xlink:label="lab_lh_Issuanceofcommonstockunderemployeeplans" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock plans</link:label>
    <link:label id="lab_lh_Issuanceofcommonstockunderemployeeplans_label_en-US" xlink:label="lab_lh_Issuanceofcommonstockunderemployeeplans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee plans</link:label>
    <link:label id="lab_lh_Issuanceofcommonstockunderemployeeplans_documentation_en-US" xlink:label="lab_lh_Issuanceofcommonstockunderemployeeplans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate change in value for stock issued in period under ESPP combined with the value of stock issued as a result of option exercises.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Issuanceofcommonstockunderemployeeplans" xlink:href="lh-20200930.xsd#lh_Issuanceofcommonstockunderemployeeplans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Issuanceofcommonstockunderemployeeplans" xlink:to="lab_lh_Issuanceofcommonstockunderemployeeplans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_e25d3d42-bf02-4c81-aafa-f41850297fe6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_10e3fb83-37b9-4e88-bd99-ef4e0918bf67_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerDurationDomain_bcc44496-fa5a-4431-ae10-743b42cbd7d8_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerDurationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Duration [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerDurationDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerDurationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Duration [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerDurationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerDurationDomain" xlink:to="lab_us-gaap_ContractWithCustomerDurationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_56590b53-dde0-4300-a43f-719f60d9b030_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_PatentsLicensesAndTechnologyMember_afed54aa-fbde-464b-8f48-0ba9bf25ce4a_terseLabel_en-US" xlink:label="lab_lh_PatentsLicensesAndTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents, Licenses And Technology [Member]</link:label>
    <link:label id="lab_lh_PatentsLicensesAndTechnologyMember_label_en-US" xlink:label="lab_lh_PatentsLicensesAndTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents, Licenses And Technology [Member]</link:label>
    <link:label id="lab_lh_PatentsLicensesAndTechnologyMember_documentation_en-US" xlink:label="lab_lh_PatentsLicensesAndTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents are the exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law. Licenses are rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory). Technology-based intangible assets are innovations or scientific advances that have not been patented.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PatentsLicensesAndTechnologyMember" xlink:href="lh-20200930.xsd#lh_PatentsLicensesAndTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_PatentsLicensesAndTechnologyMember" xlink:to="lab_lh_PatentsLicensesAndTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_f53571b0-0edd-4e5d-9c58-4821ece3079e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CreditFacilityOptiontoIncrease_49210d19-ef6b-4ebc-a6b9-58cade482895_terseLabel_en-US" xlink:label="lab_lh_CreditFacilityOptiontoIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility Option to Increase</link:label>
    <link:label id="lab_lh_CreditFacilityOptiontoIncrease_label_en-US" xlink:label="lab_lh_CreditFacilityOptiontoIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility Option to Increase</link:label>
    <link:label id="lab_lh_CreditFacilityOptiontoIncrease_documentation_en-US" xlink:label="lab_lh_CreditFacilityOptiontoIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility Option to Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityOptiontoIncrease" xlink:href="lh-20200930.xsd#lh_CreditFacilityOptiontoIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CreditFacilityOptiontoIncrease" xlink:to="lab_lh_CreditFacilityOptiontoIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_64e6944f-c76d-4e82-9364-01d48befe844_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated amortization expense, Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SeniorNotesFairValue_b4cfb86f-d1d9-41b1-9e38-2c7977729e15_terseLabel_en-US" xlink:label="lab_lh_SeniorNotesFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair market value of senior notes</link:label>
    <link:label id="lab_lh_SeniorNotesFairValue_label_en-US" xlink:label="lab_lh_SeniorNotesFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Fair Value</link:label>
    <link:label id="lab_lh_SeniorNotesFairValue_documentation_en-US" xlink:label="lab_lh_SeniorNotesFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value of the debt instrument (senior notes) at the balance-sheet date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesFairValue" xlink:href="lh-20200930.xsd#lh_SeniorNotesFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SeniorNotesFairValue" xlink:to="lab_lh_SeniorNotesFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_a1d94731-67c3-476b-bec4-0f8feb978275_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost on benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_523482e0-85ff-440a-bab5-abb9f0fdce5f_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_f9e49cf0-0bce-4578-bc22-64015cf06e80_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_71492365-7459-4f58-9616-1f64597aa2d6_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CommonStockRepurchaseAuthorizationOutstanding_24c9fa11-ca4a-4125-9001-6acba359a83b_periodStartLabel_en-US" xlink:label="lab_lh_CommonStockRepurchaseAuthorizationOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding common stock repurchase authorization, beginning balance</link:label>
    <link:label id="lab_lh_CommonStockRepurchaseAuthorizationOutstanding_4161da0b-f0cd-43d5-a9f9-938dbc81587a_periodEndLabel_en-US" xlink:label="lab_lh_CommonStockRepurchaseAuthorizationOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding common stock repurchase authorization, ending balance</link:label>
    <link:label id="lab_lh_CommonStockRepurchaseAuthorizationOutstanding_label_en-US" xlink:label="lab_lh_CommonStockRepurchaseAuthorizationOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Repurchase Authorization Outstanding</link:label>
    <link:label id="lab_lh_CommonStockRepurchaseAuthorizationOutstanding_documentation_en-US" xlink:label="lab_lh_CommonStockRepurchaseAuthorizationOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The dollar amount of share (common shares) repurchase authorization approved by the Board of Directors which remains available to the Company.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonStockRepurchaseAuthorizationOutstanding" xlink:href="lh-20200930.xsd#lh_CommonStockRepurchaseAuthorizationOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CommonStockRepurchaseAuthorizationOutstanding" xlink:to="lab_lh_CommonStockRepurchaseAuthorizationOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_ada2ca04-7830-4495-a56d-4dde91a7355f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_NoteReceivableAllowanceforCreditLoss_ff016d62-d2c8-4178-b292-cc449eb4342c_terseLabel_en-US" xlink:label="lab_lh_NoteReceivableAllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Receivable, Allowance for Credit Loss</link:label>
    <link:label id="lab_lh_NoteReceivableAllowanceforCreditLoss_label_en-US" xlink:label="lab_lh_NoteReceivableAllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Receivable, Allowance for Credit Loss</link:label>
    <link:label id="lab_lh_NoteReceivableAllowanceforCreditLoss_documentation_en-US" xlink:label="lab_lh_NoteReceivableAllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoteReceivableAllowanceforCreditLoss" xlink:href="lh-20200930.xsd#lh_NoteReceivableAllowanceforCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_NoteReceivableAllowanceforCreditLoss" xlink:to="lab_lh_NoteReceivableAllowanceforCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings_fb91334c-4b7c-4a55-aee2-8d997123a268_terseLabel_en-US" xlink:label="lab_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings</link:label>
    <link:label id="lab_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings_label_en-US" xlink:label="lab_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings</link:label>
    <link:label id="lab_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings_documentation_en-US" xlink:label="lab_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings" xlink:href="lh-20200930.xsd#lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings" xlink:to="lab_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_8c2be8d8-ee02-4281-8d0b-8b7d2c8550fd_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Fair Value of Amount Outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Fair Value of Amount Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:to="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_35eb9a49-cd00-46ff-8d1c-aa590d907218_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_8f5c692c-aec9-46c0-bab9-8eea66b688ec_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ScheduleofBusinessAcquisitionsbyAcquisitionAbstract_7da081a3-c9a8-4379-88b8-ee20d9263cd0_terseLabel_en-US" xlink:label="lab_lh_ScheduleofBusinessAcquisitionsbyAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Abstract]</link:label>
    <link:label id="lab_lh_ScheduleofBusinessAcquisitionsbyAcquisitionAbstract_label_en-US" xlink:label="lab_lh_ScheduleofBusinessAcquisitionsbyAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Abstract]</link:label>
    <link:label id="lab_lh_ScheduleofBusinessAcquisitionsbyAcquisitionAbstract_documentation_en-US" xlink:label="lab_lh_ScheduleofBusinessAcquisitionsbyAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleofBusinessAcquisitionsbyAcquisitionAbstract" xlink:href="lh-20200930.xsd#lh_ScheduleofBusinessAcquisitionsbyAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ScheduleofBusinessAcquisitionsbyAcquisitionAbstract" xlink:to="lab_lh_ScheduleofBusinessAcquisitionsbyAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_NoncontrollingInterestPutsAbstract_539781b3-281c-4c4b-81ce-e4257edce3a5_terseLabel_en-US" xlink:label="lab_lh_NoncontrollingInterestPutsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Puts [Abstract]</link:label>
    <link:label id="lab_lh_NoncontrollingInterestPutsAbstract_label_en-US" xlink:label="lab_lh_NoncontrollingInterestPutsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Puts [Abstract]</link:label>
    <link:label id="lab_lh_NoncontrollingInterestPutsAbstract_documentation_en-US" xlink:label="lab_lh_NoncontrollingInterestPutsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Puts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoncontrollingInterestPutsAbstract" xlink:href="lh-20200930.xsd#lh_NoncontrollingInterestPutsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_NoncontrollingInterestPutsAbstract" xlink:to="lab_lh_NoncontrollingInterestPutsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_DepreciationAndAmortizationOfLeasedAssets_c1792191-1ec0-4205-86a7-a62c3ff3d636_terseLabel_en-US" xlink:label="lab_lh_DepreciationAndAmortizationOfLeasedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation And Amortization Of Leased Assets</link:label>
    <link:label id="lab_lh_DepreciationAndAmortizationOfLeasedAssets_label_en-US" xlink:label="lab_lh_DepreciationAndAmortizationOfLeasedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation And Amortization Of Leased Assets</link:label>
    <link:label id="lab_lh_DepreciationAndAmortizationOfLeasedAssets_documentation_en-US" xlink:label="lab_lh_DepreciationAndAmortizationOfLeasedAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of depreciation recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Also, may include amortization charged against earnings for the periodic recognition of capitalized leases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DepreciationAndAmortizationOfLeasedAssets" xlink:href="lh-20200930.xsd#lh_DepreciationAndAmortizationOfLeasedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_DepreciationAndAmortizationOfLeasedAssets" xlink:to="lab_lh_DepreciationAndAmortizationOfLeasedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1739466c-69f0-45b3-9c74-51c99f54912e_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Disclosure Items [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2c65f01f-e008-4463-972c-abd51bb5c1b9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_2830c290-c2d5-456a-bbf2-341b3e8b9088_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_9d5d6446-69d0-4c6a-8453-d36d828fb37e_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortizationPeriod_4364f863-5e31-4919-876d-fefbe2e944b0_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization Period</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortizationPeriod_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:to="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_30aa32a2-d2dc-4f64-b036-6bf39903e9d5_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansCostsMember_cb71abbf-dbe9-4f5f-92c4-95049e14eb73_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans Costs [Member]</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansCostsMember_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansCostsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementPlansCostsMember" xlink:to="lab_us-gaap_PensionAndOtherPostretirementPlansCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_9db21761-da45-4224-a050-10779f325c69_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_c0db1632-6600-4464-ac2c-25ada4159027_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Basic earnings per Share to Diluted Earnings per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1e4881dc-96db-447a-adaf-cbd03bf18f26_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_f4717f8e-a84a-4ba8-9c27-c8401e0712da_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest and penalties related to unrecognized income tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_295eb869-7905-4e87-97f6-fcb70612d95d_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_f7a25f83-c7bc-4579-97c0-f5f4736a2fe6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effect of adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_93cb1db2-3f2f-4a67-a4cc-caa868775725_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ClientMember_3fea8438-19e3-46ea-988e-4b353f495fe6_terseLabel_en-US" xlink:label="lab_lh_ClientMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client [Member]</link:label>
    <link:label id="lab_lh_ClientMember_label_en-US" xlink:label="lab_lh_ClientMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client [Member]</link:label>
    <link:label id="lab_lh_ClientMember_documentation_en-US" xlink:label="lab_lh_ClientMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ClientMember" xlink:href="lh-20200930.xsd#lh_ClientMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ClientMember" xlink:to="lab_lh_ClientMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SeniorLongTermNotesDue2020Member_326959e2-db91-4636-ba6e-fc19ba1788a2_terseLabel_en-US" xlink:label="lab_lh_SeniorLongTermNotesDue2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Long Term Notes Due2020 Member</link:label>
    <link:label id="lab_lh_SeniorLongTermNotesDue2020Member_label_en-US" xlink:label="lab_lh_SeniorLongTermNotesDue2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Long Term Notes Due2020 Member</link:label>
    <link:label id="lab_lh_SeniorLongTermNotesDue2020Member_documentation_en-US" xlink:label="lab_lh_SeniorLongTermNotesDue2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A senior note is a bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for [must receive] repayment [prior] relative to junior and unsecured (general) creditors.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorLongTermNotesDue2020Member" xlink:href="lh-20200930.xsd#lh_SeniorLongTermNotesDue2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SeniorLongTermNotesDue2020Member" xlink:to="lab_lh_SeniorLongTermNotesDue2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_6fa34c5c-be8f-4cb8-9e2d-44e34d46cd50_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_ca3ce969-927c-4f17-a915-2a225a68a319_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_7ee2ca9b-995a-4a0f-bb66-6ad55b6b6cad_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_OtherFinancingCashFlows_ad4eb604-263f-46be-a1d2-b572cf444f6f_negatedTerseLabel_en-US" xlink:label="lab_lh_OtherFinancingCashFlows" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Financing Cash Flows</link:label>
    <link:label id="lab_lh_OtherFinancingCashFlows_label_en-US" xlink:label="lab_lh_OtherFinancingCashFlows" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Financing Cash Flows</link:label>
    <link:label id="lab_lh_OtherFinancingCashFlows_documentation_en-US" xlink:label="lab_lh_OtherFinancingCashFlows" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Financing Cash Flows</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OtherFinancingCashFlows" xlink:href="lh-20200930.xsd#lh_OtherFinancingCashFlows"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_OtherFinancingCashFlows" xlink:to="lab_lh_OtherFinancingCashFlows" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_112ec869-797a-4d0d-828b-751c978b5629_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_country_GB_23f8d0c2-182c-46c4-a994-45dc9f9ca79c_terseLabel_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED KINGDOM</link:label>
    <link:label id="lab_country_GB_label_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED KINGDOM</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_GB"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_GB" xlink:to="lab_country_GB" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_58ba3bfb-8022-40c1-8493-11def940a1f5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) by Derivative Instrument Risk [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_caeba319-a3e0-4844-9cef-9f546abd202f_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Commission</link:label>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Commission</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalesCommissionCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_fc6064c2-487e-47ad-bdf0-c6d2f639fcee_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Impairmentoffloatingratenotereceivable_bac0bd04-e575-4f2f-a1c7-8214e32aba5d_terseLabel_en-US" xlink:label="lab_lh_Impairmentoffloatingratenotereceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">impairment of floating rate note receivable</link:label>
    <link:label id="lab_lh_Impairmentoffloatingratenotereceivable_label_en-US" xlink:label="lab_lh_Impairmentoffloatingratenotereceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">impairment of floating rate note receivable</link:label>
    <link:label id="lab_lh_Impairmentoffloatingratenotereceivable_documentation_en-US" xlink:label="lab_lh_Impairmentoffloatingratenotereceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">impairment of floating rate note receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Impairmentoffloatingratenotereceivable" xlink:href="lh-20200930.xsd#lh_Impairmentoffloatingratenotereceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Impairmentoffloatingratenotereceivable" xlink:to="lab_lh_Impairmentoffloatingratenotereceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1b8ffd94-6d22-487d-ba1f-e2a77f4b3510_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_67970649-944e-4c77-a227-3997d229e793_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_6dd64de1-270e-47a5-897b-a6c9cc8f3332_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Other Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Other Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A4.625Seniornotesdue2020_7bf2c73f-c7cd-4dd5-970c-47f14722458e_terseLabel_en-US" xlink:label="lab_lh_A4.625Seniornotesdue2020" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625% Senior notes due 2020</link:label>
    <link:label id="lab_lh_A4.625Seniornotesdue2020_label_en-US" xlink:label="lab_lh_A4.625Seniornotesdue2020" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625% Senior notes due 2020</link:label>
    <link:label id="lab_lh_A4.625Seniornotesdue2020_documentation_en-US" xlink:label="lab_lh_A4.625Seniornotesdue2020" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625% Senior notes due 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A4.625Seniornotesdue2020" xlink:href="lh-20200930.xsd#lh_A4.625Seniornotesdue2020"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A4.625Seniornotesdue2020" xlink:to="lab_lh_A4.625Seniornotesdue2020" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_cf255d65-1284-44d2-979e-2b16fbb30e4e_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_98907faa-b25d-459c-a684-7f8f62a6355f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_NetRestructuringAndOtherSpecialCharges_cde483c8-6035-4a1c-bd71-f953f435e86b_terseLabel_en-US" xlink:label="lab_lh_NetRestructuringAndOtherSpecialCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net restructuring and other special charges</link:label>
    <link:label id="lab_lh_NetRestructuringAndOtherSpecialCharges_label_en-US" xlink:label="lab_lh_NetRestructuringAndOtherSpecialCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net restructuring and other special charges</link:label>
    <link:label id="lab_lh_NetRestructuringAndOtherSpecialCharges_documentation_en-US" xlink:label="lab_lh_NetRestructuringAndOtherSpecialCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount charged against earnings in the period for incurred and estimated costs, excluding asset retirement obligations, associated with exit from or disposal of business activities or restructurings pursuant to a program planned and controlled by management, and materially changes either the scope or manner of conduct of a business undertaken. Also, may include reversals and other adjustments to accrued liabilities and special charges, if any, for asset abandonment, uncollectible balances, etc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetRestructuringAndOtherSpecialCharges" xlink:href="lh-20200930.xsd#lh_NetRestructuringAndOtherSpecialCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_NetRestructuringAndOtherSpecialCharges" xlink:to="lab_lh_NetRestructuringAndOtherSpecialCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_e64a11e2-7876-457e-a332-eb96b22f1b5a_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_UnbilledContractsReceivableMember_bee61c60-551a-4090-a2e9-fb6c05dc123e_terseLabel_en-US" xlink:label="lab_lh_UnbilledContractsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Contracts Receivable [Member]</link:label>
    <link:label id="lab_lh_UnbilledContractsReceivableMember_label_en-US" xlink:label="lab_lh_UnbilledContractsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Contracts Receivable [Member]</link:label>
    <link:label id="lab_lh_UnbilledContractsReceivableMember_documentation_en-US" xlink:label="lab_lh_UnbilledContractsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Contracts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnbilledContractsReceivableMember" xlink:href="lh-20200930.xsd#lh_UnbilledContractsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_UnbilledContractsReceivableMember" xlink:to="lab_lh_UnbilledContractsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_acea0018-a754-4192-bb25-0c868e1650b1_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_946a5869-1199-4bcd-92ff-0b45bfec9766_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerDurationAxis_6c2760cd-5d74-4e8b-8869-4bbe53dbcc9b_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerDurationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Duration [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerDurationAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerDurationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Duration [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerDurationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerDurationAxis" xlink:to="lab_us-gaap_ContractWithCustomerDurationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A2.30seniornotesdue2024_f9f24fe7-7657-48d3-a381-e11f4867d858_terseLabel_en-US" xlink:label="lab_lh_A2.30seniornotesdue2024" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.30% senior notes due 2024</link:label>
    <link:label id="lab_lh_A2.30seniornotesdue2024_label_en-US" xlink:label="lab_lh_A2.30seniornotesdue2024" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.30% senior notes due 2024</link:label>
    <link:label id="lab_lh_A2.30seniornotesdue2024_documentation_en-US" xlink:label="lab_lh_A2.30seniornotesdue2024" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.30% senior notes due 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2.30seniornotesdue2024" xlink:href="lh-20200930.xsd#lh_A2.30seniornotesdue2024"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A2.30seniornotesdue2024" xlink:to="lab_lh_A2.30seniornotesdue2024" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit_a6ed7e02-b5e0-415d-9df3-ccfe8be4332a_terseLabel_en-US" xlink:label="lab_lh_PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of Fair Value Exceeding Carrying Value Post Percent Change in Discount Rate Used to Calculate Fair Value of Goodwill for Reporting Unit</link:label>
    <link:label id="lab_lh_PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit_label_en-US" xlink:label="lab_lh_PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of Fair Value Exceeding Carrying Value Post Percent Change in Discount Rate Used to Calculate Fair Value of Goodwill for Reporting Unit</link:label>
    <link:label id="lab_lh_PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit_documentation_en-US" xlink:label="lab_lh_PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of Fair Value Exceeding Carrying Value Post Percent Change in Discount Rate Used to Calculate Fair Value of Goodwill for Reporting Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit" xlink:href="lh-20200930.xsd#lh_PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit" xlink:to="lab_lh_PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_df9410c3-066b-45c2-acac-56ddf1dd305b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_f2e2ee27-44a2-4d66-9937-716f0ba2f99b_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_9a086b86-65eb-4d57-bfb5-7226212d0c4c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_f07ac591-118d-493d-a620-eb8c888328fb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage_933a247d-98ff-49a9-add7-b774cd38cf13_terseLabel_en-US" xlink:label="lab_lh_TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Accrue Interest Per Annum Base Rate Plus Percentage</link:label>
    <link:label id="lab_lh_TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage_label_en-US" xlink:label="lab_lh_TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Accrue Interest Per Annum Base Rate Plus Percentage</link:label>
    <link:label id="lab_lh_TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage_documentation_en-US" xlink:label="lab_lh_TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Accrue Interest Per Annum Base Rate Plus Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage" xlink:href="lh-20200930.xsd#lh_TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage" xlink:to="lab_lh_TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Seniornotesdue2025MemberMember_fc0c874a-8c52-4335-a6ab-b1cbe6e2ef34_terseLabel_en-US" xlink:label="lab_lh_Seniornotesdue2025MemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2025 [Member] [Member]</link:label>
    <link:label id="lab_lh_Seniornotesdue2025MemberMember_label_en-US" xlink:label="lab_lh_Seniornotesdue2025MemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2025 [Member] [Member]</link:label>
    <link:label id="lab_lh_Seniornotesdue2025MemberMember_documentation_en-US" xlink:label="lab_lh_Seniornotesdue2025MemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2025 [Member] [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2025MemberMember" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2025MemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Seniornotesdue2025MemberMember" xlink:to="lab_lh_Seniornotesdue2025MemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_c30ba16c-3ad3-4ed1-8863-4e9329b40e08_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_0e011d85-8f00-4e2c-8b5a-9ce4f687523f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CommonSharesIssuedRollforwardAbstract_d7d4354c-1f32-47bb-b6b3-8e06be3fed85_terseLabel_en-US" xlink:label="lab_lh_CommonSharesIssuedRollforwardAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rollforward of common shares issued</link:label>
    <link:label id="lab_lh_CommonSharesIssuedRollforwardAbstract_label_en-US" xlink:label="lab_lh_CommonSharesIssuedRollforwardAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Shares Issued Rollforward [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonSharesIssuedRollforwardAbstract" xlink:href="lh-20200930.xsd#lh_CommonSharesIssuedRollforwardAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CommonSharesIssuedRollforwardAbstract" xlink:to="lab_lh_CommonSharesIssuedRollforwardAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments_9f81c2ca-e715-48bc-be86-2e92ba6e485d_terseLabel_en-US" xlink:label="lab_lh_RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility Fee Percentage Required to Pay on Outstanding Commitments</link:label>
    <link:label id="lab_lh_RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments_label_en-US" xlink:label="lab_lh_RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility Fee Percentage Required to Pay on Outstanding Commitments</link:label>
    <link:label id="lab_lh_RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments_documentation_en-US" xlink:label="lab_lh_RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility Fee Percentage Required to Pay on Outstanding Commitments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments" xlink:href="lh-20200930.xsd#lh_RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments" xlink:to="lab_lh_RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_03622c49-2e94-4f80-84e2-4aff51b5b0d4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0d6c0915-92f0-4928-a296-145737efb01f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_11f66741-edcb-4b10-b827-44701dc2f504_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_f9a1bbd2-46c2-443b-a5cc-8a298b2fc12c_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_UnbilledServicesCreditLossExpenseReversal_698f2835-b7d4-4866-896a-d2033f1602c3_terseLabel_en-US" xlink:label="lab_lh_UnbilledServicesCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Services, Credit Loss Expense (Reversal)</link:label>
    <link:label id="lab_lh_UnbilledServicesCreditLossExpenseReversal_label_en-US" xlink:label="lab_lh_UnbilledServicesCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Services, Credit Loss Expense (Reversal)</link:label>
    <link:label id="lab_lh_UnbilledServicesCreditLossExpenseReversal_documentation_en-US" xlink:label="lab_lh_UnbilledServicesCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Services, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnbilledServicesCreditLossExpenseReversal" xlink:href="lh-20200930.xsd#lh_UnbilledServicesCreditLossExpenseReversal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_UnbilledServicesCreditLossExpenseReversal" xlink:to="lab_lh_UnbilledServicesCreditLossExpenseReversal" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Seniornotesdue2024MemberMember_1310754b-49d4-4a92-bbb2-050f8ec1ef8d_terseLabel_en-US" xlink:label="lab_lh_Seniornotesdue2024MemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2024 [Member] [Member]</link:label>
    <link:label id="lab_lh_Seniornotesdue2024MemberMember_label_en-US" xlink:label="lab_lh_Seniornotesdue2024MemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2024 [Member] [Member]</link:label>
    <link:label id="lab_lh_Seniornotesdue2024MemberMember_documentation_en-US" xlink:label="lab_lh_Seniornotesdue2024MemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2024MemberMember" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2024MemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Seniornotesdue2024MemberMember" xlink:to="lab_lh_Seniornotesdue2024MemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_d840464b-820a-4669-80fc-7913dfecc006_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_3f0930db-d3bf-4971-9b2f-44bcfc119257_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_61740cdd-9174-4b2a-86cd-7d0fe6bc878c_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles and other assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_76144e2e-f27c-4873-8545-f710bff6ef0c_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_9e981c41-7660-4b82-8ceb-bcd629527cf3_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_7a0983c8-fea2-453a-ad58-a1246c2eb7ab_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock_29670871-4b35-4ea3-abe0-3fd55de15d0b_terseLabel_en-US" xlink:label="lab_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in common shares issued and held in treasury</link:label>
    <link:label id="lab_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock_label_en-US" xlink:label="lab_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes In Common Shares Issued And Held In Treasury [Table Text Block]</link:label>
    <link:label id="lab_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock_documentation_en-US" xlink:label="lab_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule is used to show the changes in common shares issued and held in treasury by the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock" xlink:href="lh-20200930.xsd#lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock" xlink:to="lab_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Unusedfacilityrestructuringreserves_50cd853c-35a1-44ed-a00f-4286a7e64126_negatedTerseLabel_en-US" xlink:label="lab_lh_Unusedfacilityrestructuringreserves" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused facility restructuring reserves</link:label>
    <link:label id="lab_lh_Unusedfacilityrestructuringreserves_23e7e3ec-a46a-4c7d-a72c-f3afbc5cedb1_terseLabel_en-US" xlink:label="lab_lh_Unusedfacilityrestructuringreserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused facility restructuring reserves</link:label>
    <link:label id="lab_lh_Unusedfacilityrestructuringreserves_label_en-US" xlink:label="lab_lh_Unusedfacilityrestructuringreserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused facility restructuring reserves</link:label>
    <link:label id="lab_lh_Unusedfacilityrestructuringreserves_documentation_en-US" xlink:label="lab_lh_Unusedfacilityrestructuringreserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused facility restructuring reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Unusedfacilityrestructuringreserves" xlink:href="lh-20200930.xsd#lh_Unusedfacilityrestructuringreserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Unusedfacilityrestructuringreserves" xlink:to="lab_lh_Unusedfacilityrestructuringreserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_dca6e5e8-4d53-44ac-b0b2-92ad8cc2e1c1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets, net</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_ce160f6f-e1d5-4337-b864-a6652dae3713_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_619bfcc9-9ccf-4eae-bacc-70bdeba7107a_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_06fc38cf-c982-404a-b326-df2a31130de1_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_5493958c-efc0-4bd1-9597-eae1d7f01d1c_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_b642fa35-cffd-4de1-8047-a4029af6b905_verboseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_2d78bca5-ed17-4153-84ba-6229e94cd407_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateMember_a30be66e-89f1-4538-a06f-3fad1149b247_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Segment [Member]</link:label>
    <link:label id="lab_us-gaap_CorporateMember_label_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateMember" xlink:to="lab_us-gaap_CorporateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_612f3e00-6d5e-4518-a070-b392a4c5e5e4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_314d5c4f-8a47-4b90-93c8-2c826c4f1601_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_NoncontrollingInterestMezzanineEquity_686cdfba-1640-4cd8-a39b-933c875d8744_terseLabel_en-US" xlink:label="lab_lh_NoncontrollingInterestMezzanineEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, 92.8 and 93.5 shares outstanding at March 31, 2013 and December 31, 2012, respectively</link:label>
    <link:label id="lab_lh_NoncontrollingInterestMezzanineEquity_label_en-US" xlink:label="lab_lh_NoncontrollingInterestMezzanineEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Mezzanine Equity</link:label>
    <link:label id="lab_lh_NoncontrollingInterestMezzanineEquity_documentation_en-US" xlink:label="lab_lh_NoncontrollingInterestMezzanineEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents contractual value of a noncontrolling interest put (includes underlying noncontrolling interest). In February 2010, the Company completed a transaction to sell the partnership units acquired from the previous noncontrolling interest holder to a new Canadian partner. As a result of this transaction, the Company recorded a component of noncontrolling interest in liabilities and a component in mezzanine equity. This item represents the mezzanine equity component.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoncontrollingInterestMezzanineEquity" xlink:href="lh-20200930.xsd#lh_NoncontrollingInterestMezzanineEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_NoncontrollingInterestMezzanineEquity" xlink:to="lab_lh_NoncontrollingInterestMezzanineEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerBasisOfPricingAxis_20c2b4c8-5267-47ed-966a-19745560ddd7_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerBasisOfPricingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Basis of Pricing [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerBasisOfPricingAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerBasisOfPricingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Basis of Pricing [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis" xlink:to="lab_us-gaap_ContractWithCustomerBasisOfPricingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessExitCosts1_275328e5-c74c-406d-8061-94a653bca6d4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges related to contractual obligations associated with leased facilities and other facility related costs</link:label>
    <link:label id="lab_us-gaap_BusinessExitCosts1_label_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Exit Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessExitCosts1" xlink:to="lab_us-gaap_BusinessExitCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CommonSharesOutstandingRollforwardAbstract_87e367f0-e341-47e7-89e1-6baebfe25b8d_terseLabel_en-US" xlink:label="lab_lh_CommonSharesOutstandingRollforwardAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Shares Outstanding Rollforward [Abstract]</link:label>
    <link:label id="lab_lh_CommonSharesOutstandingRollforwardAbstract_label_en-US" xlink:label="lab_lh_CommonSharesOutstandingRollforwardAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Shares Outstanding Rollforward [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonSharesOutstandingRollforwardAbstract" xlink:href="lh-20200930.xsd#lh_CommonSharesOutstandingRollforwardAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CommonSharesOutstandingRollforwardAbstract" xlink:to="lab_lh_CommonSharesOutstandingRollforwardAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_809883b0-6f58-4a3b-a5a4-2b0dee27c322_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_8cc8d308-6808-42d6-919e-b1a076e2183d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_a9e75d7b-fe90-480e-9e9a-7ac34b514e13_terseLabel_en-US" xlink:label="lab_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings before income taxes</link:label>
    <link:label id="lab_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_label_en-US" xlink:label="lab_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations Before Income Taxes and Noncontrolling Interest</link:label>
    <link:label id="lab_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_documentation_en-US" xlink:label="lab_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations Before Income Taxes and Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest" xlink:href="lh-20200930.xsd#lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest" xlink:to="lab_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_38980f6f-fb1b-4367-8680-c91b88bd7edf_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_680bf504-b792-4ac6-b903-4b4b5c5066a6_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_bd653171-40e3-49fa-a987-fc4898fb8ac2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_bf07f13a-61db-44d3-8954-a45f236ded25_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_a24002cd-cc7d-4fea-9f52-9e65d6d73516_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_8c0a9e84-e029-4d3f-8007-68562caece26_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CashPaidDuringPeriodForAbstract_900984a5-ac1b-4f5b-88f1-278db962a870_terseLabel_en-US" xlink:label="lab_lh_CashPaidDuringPeriodForAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during period for:</link:label>
    <link:label id="lab_lh_CashPaidDuringPeriodForAbstract_label_en-US" xlink:label="lab_lh_CashPaidDuringPeriodForAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid During Period For [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashPaidDuringPeriodForAbstract" xlink:href="lh-20200930.xsd#lh_CashPaidDuringPeriodForAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CashPaidDuringPeriodForAbstract" xlink:to="lab_lh_CashPaidDuringPeriodForAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_NetDefinedBenefitPlanAmortizationAndDeferral_f1415148-019b-4e64-a83b-658ef5d15924_terseLabel_en-US" xlink:label="lab_lh_NetDefinedBenefitPlanAmortizationAndDeferral" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net amortization and deferral</link:label>
    <link:label id="lab_lh_NetDefinedBenefitPlanAmortizationAndDeferral_label_en-US" xlink:label="lab_lh_NetDefinedBenefitPlanAmortizationAndDeferral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Defined Benefit Plan Amortization And Deferral</link:label>
    <link:label id="lab_lh_NetDefinedBenefitPlanAmortizationAndDeferral_documentation_en-US" xlink:label="lab_lh_NetDefinedBenefitPlanAmortizationAndDeferral" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Defined Benefit Plan Amortization And Deferral</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetDefinedBenefitPlanAmortizationAndDeferral" xlink:href="lh-20200930.xsd#lh_NetDefinedBenefitPlanAmortizationAndDeferral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_NetDefinedBenefitPlanAmortizationAndDeferral" xlink:to="lab_lh_NetDefinedBenefitPlanAmortizationAndDeferral" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_2189372e-9a5f-4826-a0b2-cc37fe1d676e_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_add1a3c5-2221-4c02-94b9-038816f133e0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b2ec26b5-9fc6-4c4d-8769-ea1fc44167ba_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_0e60f148-196c-463b-8f54-ea014ed158c2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_4aeaae34-bef2-4a8c-bbef-da8a8b77f109_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_498b43e1-f803-4ee7-89b1-977a39f770b0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_EnvigoMember_ebb2033f-fd13-4d2f-8b7f-696053104ba9_terseLabel_en-US" xlink:label="lab_lh_EnvigoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Envigo [Member]</link:label>
    <link:label id="lab_lh_EnvigoMember_label_en-US" xlink:label="lab_lh_EnvigoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Envigo [Member]</link:label>
    <link:label id="lab_lh_EnvigoMember_documentation_en-US" xlink:label="lab_lh_EnvigoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Envigo [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EnvigoMember" xlink:href="lh-20200930.xsd#lh_EnvigoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_EnvigoMember" xlink:to="lab_lh_EnvigoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f7966dc5-e5ba-4a68-ac31-0bd502702d96_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_4c524ae2-10b3-4482-96f4-c40fa7cd6ad3_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_578df366-127d-4525-a27b-39dd05d10596_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_76aeae5d-ea1a-467d-880d-6a4ab2b0424c_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_357a6995-3457-49fb-998b-99f11dd0c940_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_9040e45a-39ce-4705-9c3e-babdab8a3441_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_f6c8ecb2-3655-4d48-8e25-6a597c6de845_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage_6b2a0032-2a8d-406d-b16b-b9ca61ee3c68_terseLabel_en-US" xlink:label="lab_lh_RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility Accrue Interest per Annum at Libor Plus Margin Percentage</link:label>
    <link:label id="lab_lh_RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage_label_en-US" xlink:label="lab_lh_RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility Accrue Interest per Annum at Libor Plus Margin Percentage</link:label>
    <link:label id="lab_lh_RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage_documentation_en-US" xlink:label="lab_lh_RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility Accrue Interest per Annum at Libor Plus Margin Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage" xlink:href="lh-20200930.xsd#lh_RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage" xlink:to="lab_lh_RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_DiscretionaryContributionPercentageMinimum_3db2de43-651c-4e2d-b611-a846c477310c_terseLabel_en-US" xlink:label="lab_lh_DiscretionaryContributionPercentageMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discretionary Contribution Percentage Minimum</link:label>
    <link:label id="lab_lh_DiscretionaryContributionPercentageMinimum_label_en-US" xlink:label="lab_lh_DiscretionaryContributionPercentageMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discretionary Contribution Percentage Minimum</link:label>
    <link:label id="lab_lh_DiscretionaryContributionPercentageMinimum_documentation_en-US" xlink:label="lab_lh_DiscretionaryContributionPercentageMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discretionary contribution percentage by the company for eligible employees based on service, range minimum.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DiscretionaryContributionPercentageMinimum" xlink:href="lh-20200930.xsd#lh_DiscretionaryContributionPercentageMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_DiscretionaryContributionPercentageMinimum" xlink:to="lab_lh_DiscretionaryContributionPercentageMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_bc2cef04-7936-4eec-93d4-6c99bf918f9c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_047faa41-6332-4540-a9a2-d23faf42f1ce_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_d7f1a6a5-c410-43e8-8df2-c8dc049e5b51_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SeniorNotesDue2020Member_7be66366-b6a1-4109-bde8-9727ec2d0a89_terseLabel_en-US" xlink:label="lab_lh_SeniorNotesDue2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2020 [Member]</link:label>
    <link:label id="lab_lh_SeniorNotesDue2020Member_label_en-US" xlink:label="lab_lh_SeniorNotesDue2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2020 [Member]</link:label>
    <link:label id="lab_lh_SeniorNotesDue2020Member_documentation_en-US" xlink:label="lab_lh_SeniorNotesDue2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A senior note is a bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for [must receive] repayment [prior] relative to junior and unsecured (general) creditors.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2020Member" xlink:href="lh-20200930.xsd#lh_SeniorNotesDue2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SeniorNotesDue2020Member" xlink:to="lab_lh_SeniorNotesDue2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b5d419e6-c267-4e79-a57c-79b51563ea6e_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net earnings to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_de2692c0-81de-4934-a3d7-09becb0b0ca2_terseLabel_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Contracts Receivable</link:label>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_label_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnbilledContractsReceivable" xlink:to="lab_us-gaap_UnbilledContractsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_0cb75129-953d-4a0d-8709-ca35365b74f6_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_5bacaafc-a19f-4327-a041-b096eda94c5a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_cb3aca3f-5f85-446c-80c2-c3393efb8b57_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_c71335fc-4859-41fe-9efd-02ea3de879bc_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_6c478d0a-17bb-451a-bd7b-e8958dd1b39f_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_fe240efd-7a9b-48b5-8b3e-3956bbde48cd_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue_51fe94a5-7ff3-4b77-b5fa-361d7ecd34e0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedge Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue_label_en-US" xlink:label="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedge Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgeLiabilitiesAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:to="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_15a99090-55d0-4e70-9931-74b4ef2c5313_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_c5841814-87fb-42ea-a16f-978605afa0b2_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_39b36548-46db-447f-96b6-eb5451d5a139_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_5b000cdd-4777-4828-8f27-8950c08cff4f_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtLineItems" xlink:to="lab_us-gaap_ShortTermDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_938058d6-011d-46e1-9234-a5cc1a0cf795_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetImpairmentCharges_0bad231d-9700-4ee7-a3d0-d541ecc4ea90_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Asset Impairment Charges</link:label>
    <link:label id="lab_us-gaap_OtherAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetImpairmentCharges" xlink:to="lab_us-gaap_OtherAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_EquityMethodIncomeLossNetDomain_8956704d-df85-4e92-8eeb-f495bc314281_terseLabel_en-US" xlink:label="lab_lh_EquityMethodIncomeLossNetDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Income (Loss), Net [Domain]</link:label>
    <link:label id="lab_lh_EquityMethodIncomeLossNetDomain_label_en-US" xlink:label="lab_lh_EquityMethodIncomeLossNetDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Income (Loss), Net [Domain]</link:label>
    <link:label id="lab_lh_EquityMethodIncomeLossNetDomain_documentation_en-US" xlink:label="lab_lh_EquityMethodIncomeLossNetDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Income (Loss), Net [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EquityMethodIncomeLossNetDomain" xlink:href="lh-20200930.xsd#lh_EquityMethodIncomeLossNetDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_EquityMethodIncomeLossNetDomain" xlink:to="lab_lh_EquityMethodIncomeLossNetDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Crosscurrencyswapmaturing2025Member_85f47589-ed5e-464b-a42f-1a8c0f2e0107_terseLabel_en-US" xlink:label="lab_lh_Crosscurrencyswapmaturing2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2025 [Member] [Member]</link:label>
    <link:label id="lab_lh_Crosscurrencyswapmaturing2025Member_label_en-US" xlink:label="lab_lh_Crosscurrencyswapmaturing2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross currency swap maturing 2025 [Member]</link:label>
    <link:label id="lab_lh_Crosscurrencyswapmaturing2025Member_documentation_en-US" xlink:label="lab_lh_Crosscurrencyswapmaturing2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross currency swap maturing 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Crosscurrencyswapmaturing2025Member" xlink:href="lh-20200930.xsd#lh_Crosscurrencyswapmaturing2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Crosscurrencyswapmaturing2025Member" xlink:to="lab_lh_Crosscurrencyswapmaturing2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_2c353600-7e86-4218-9e5b-012b03a0fc57_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_a35cad78-3959-4536-8a53-c258283ce5b4_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of businesses, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_05727ab1-879b-462e-844c-4907bcebc80d_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_d40bc4fb-fa7c-4692-9861-0ce143c2f5f5_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of employee stock options and awards, (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_cc7d3461-efa0-45e7-a444-dac8e3d73460_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_NumberofMeasurementFundsAvailableForParticipantElection_07ecfd1e-9a01-49a0-8ca8-1af96fdd8932_terseLabel_en-US" xlink:label="lab_lh_NumberofMeasurementFundsAvailableForParticipantElection" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Measurement Funds Available For Participant Election</link:label>
    <link:label id="lab_lh_NumberofMeasurementFundsAvailableForParticipantElection_label_en-US" xlink:label="lab_lh_NumberofMeasurementFundsAvailableForParticipantElection" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Measurement Funds Available For Participant Election</link:label>
    <link:label id="lab_lh_NumberofMeasurementFundsAvailableForParticipantElection_documentation_en-US" xlink:label="lab_lh_NumberofMeasurementFundsAvailableForParticipantElection" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Measurement Funds Available For Participant Election</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NumberofMeasurementFundsAvailableForParticipantElection" xlink:href="lh-20200930.xsd#lh_NumberofMeasurementFundsAvailableForParticipantElection"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_NumberofMeasurementFundsAvailableForParticipantElection" xlink:to="lab_lh_NumberofMeasurementFundsAvailableForParticipantElection" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_1b4bf483-362c-40a1-b8fc-8ab703fdfcbd_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_01cbd9e5-2693-4496-b965-b11cfcfced3b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_16a7786b-c84f-48a4-9b2e-ffcc8e8b35a7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_27053a24-4b69-4d4a-8463-9528e6052565_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDeferredSalesCommissions_c0de4c1e-71e6-4466-a360-a99e3ebc9031_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredSalesCommissions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Deferred Sales Commissions</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDeferredSalesCommissions_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredSalesCommissions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Deferred Sales Commissions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredSalesCommissions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDeferredSalesCommissions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDeferredSalesCommissions" xlink:to="lab_us-gaap_AmortizationOfDeferredSalesCommissions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_0d2ea5e8-18fe-4acc-8075-c5d55b7c4c0d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_312352e2-0d38-4cc2-b78f-4408d0211c9b_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_4702e262-8472-426a-9a4b-6d8042a43050_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CreditFacilityMaximumSwingLineBorrowings_846b8139-efc7-4e2e-ac29-59e7de6b7133_terseLabel_en-US" xlink:label="lab_lh_CreditFacilityMaximumSwingLineBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility, Maximum Swing Line Borrowings</link:label>
    <link:label id="lab_lh_CreditFacilityMaximumSwingLineBorrowings_label_en-US" xlink:label="lab_lh_CreditFacilityMaximumSwingLineBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility, Maximum Swing Line Borrowings</link:label>
    <link:label id="lab_lh_CreditFacilityMaximumSwingLineBorrowings_documentation_en-US" xlink:label="lab_lh_CreditFacilityMaximumSwingLineBorrowings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility, Maximum Swing Line Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumSwingLineBorrowings" xlink:href="lh-20200930.xsd#lh_CreditFacilityMaximumSwingLineBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CreditFacilityMaximumSwingLineBorrowings" xlink:to="lab_lh_CreditFacilityMaximumSwingLineBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f7dfdb8b-1c97-41bf-a958-f8eaa292e835_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_4277c6ed-181e-435a-b38b-f7c06dfd58a4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CreditLossExpenseReversal_4f64ed7a-e7d0-4212-ad15-fefb9d4d984d_terseLabel_en-US" xlink:label="lab_lh_CreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Loss Expense (Reversal)</link:label>
    <link:label id="lab_lh_CreditLossExpenseReversal_label_en-US" xlink:label="lab_lh_CreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Loss Expense (Reversal)</link:label>
    <link:label id="lab_lh_CreditLossExpenseReversal_documentation_en-US" xlink:label="lab_lh_CreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditLossExpenseReversal" xlink:href="lh-20200930.xsd#lh_CreditLossExpenseReversal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CreditLossExpenseReversal" xlink:to="lab_lh_CreditLossExpenseReversal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_187dfe8b-ff56-440d-81cf-c9ce550f9b13_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:to="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_d807fec1-834a-4054-98b0-bea8b56f6bb9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_d0f3570f-a3ad-4313-bf00-c4239db2164f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated amortization expense, 2015</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_10116cdc-b385-43c3-ad80-587816c5b549_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_15cac0ef-0d3e-495c-809f-e36e7d8040f8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A2.95seniornotesdue2029_89b34500-838e-444b-b177-335680ae7e11_terseLabel_en-US" xlink:label="lab_lh_A2.95seniornotesdue2029" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.95% senior notes due 2029</link:label>
    <link:label id="lab_lh_A2.95seniornotesdue2029_label_en-US" xlink:label="lab_lh_A2.95seniornotesdue2029" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.95% senior notes due 2029</link:label>
    <link:label id="lab_lh_A2.95seniornotesdue2029_documentation_en-US" xlink:label="lab_lh_A2.95seniornotesdue2029" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.95% senior notes due 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2.95seniornotesdue2029" xlink:href="lh-20200930.xsd#lh_A2.95seniornotesdue2029"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A2.95seniornotesdue2029" xlink:to="lab_lh_A2.95seniornotesdue2029" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_56167bb5-cb4a-40cf-b176-8c785d4deef9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_eb83f7ab-f19c-4f12-90ed-0d24665b5cd5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_0af338b8-f68d-4f66-a1c6-717b3a82fe1e_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_6db4f6a6-1dc2-4895-979a-9c866fbcd3f8_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_928539e2-4dde-4b01-853b-22719132fbeb_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_83aa0703-50c4-4854-b6ff-bf4fb0cbdfa5_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit_5405ae77-6b99-4d6b-83c0-44acda97450e_terseLabel_en-US" xlink:label="lab_lh_PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent Change in Discount Rate Used to Calculate Fair Value of Goodwill for Reporting Unit</link:label>
    <link:label id="lab_lh_PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit_label_en-US" xlink:label="lab_lh_PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent Change in Discount Rate Used to Calculate Fair Value of Goodwill for Reporting Unit</link:label>
    <link:label id="lab_lh_PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit_documentation_en-US" xlink:label="lab_lh_PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent Change in Discount Rate Used to Calculate Fair Value of Goodwill for Reporting Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit" xlink:href="lh-20200930.xsd#lh_PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit" xlink:to="lab_lh_PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CommonSharesHeldInTreasuryRollforwardAbstract_bab84217-0087-4aa9-aa4a-7861000b1528_terseLabel_en-US" xlink:label="lab_lh_CommonSharesHeldInTreasuryRollforwardAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rollforward of common shares held in treasury</link:label>
    <link:label id="lab_lh_CommonSharesHeldInTreasuryRollforwardAbstract_label_en-US" xlink:label="lab_lh_CommonSharesHeldInTreasuryRollforwardAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Shares Held In Treasury Rollforward [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonSharesHeldInTreasuryRollforwardAbstract" xlink:href="lh-20200930.xsd#lh_CommonSharesHeldInTreasuryRollforwardAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CommonSharesHeldInTreasuryRollforwardAbstract" xlink:to="lab_lh_CommonSharesHeldInTreasuryRollforwardAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Seniornotesdue2027Member_788c0c2f-a471-497a-955b-99687a91e427_terseLabel_en-US" xlink:label="lab_lh_Seniornotesdue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2027 [Member]</link:label>
    <link:label id="lab_lh_Seniornotesdue2027Member_label_en-US" xlink:label="lab_lh_Seniornotesdue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2027 [Member]</link:label>
    <link:label id="lab_lh_Seniornotesdue2027Member_documentation_en-US" xlink:label="lab_lh_Seniornotesdue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2027Member" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Seniornotesdue2027Member" xlink:to="lab_lh_Seniornotesdue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_ad63ca16-1fe4-462a-a135-fa5c657c3456_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive earnings attributable to Laboratory Corporation of America Holdings</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_5a204bae-b0f2-486d-871f-51d1d4199400_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_5d059fd5-bc6d-410b-ad9b-7b000deba157_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_f4080876-8e0c-401a-8acb-b735bd5c7546_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostNet_98800079-19ac-4567-864c-d7881b3d44da_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Net</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostNet_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostNet" xlink:to="lab_us-gaap_CapitalizedContractCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_f178df76-8c0d-4898-b7cd-7be208c5c0d8_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_dac01664-3084-48d9-930a-8fe5f48cc179_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_886bf980-5091-459b-80bc-7a59ee120a8f_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_728fb883-bdce-4577-bbf0-dea8c27b155c_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_174138de-198f-4aa5-a955-fc16980cf38d_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CashFlowLocationDomain_6d935dbc-4000-409b-8d8e-9c0139c670d2_terseLabel_en-US" xlink:label="lab_lh_CashFlowLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Location [Domain]</link:label>
    <link:label id="lab_lh_CashFlowLocationDomain_label_en-US" xlink:label="lab_lh_CashFlowLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Location [Domain]</link:label>
    <link:label id="lab_lh_CashFlowLocationDomain_documentation_en-US" xlink:label="lab_lh_CashFlowLocationDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Cash Flow Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashFlowLocationDomain" xlink:href="lh-20200930.xsd#lh_CashFlowLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CashFlowLocationDomain" xlink:to="lab_lh_CashFlowLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_OthercountriesMember_541bf05e-2b5b-4f02-afce-ffd5df412ee5_terseLabel_en-US" xlink:label="lab_lh_OthercountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other countries [Member]</link:label>
    <link:label id="lab_lh_OthercountriesMember_label_en-US" xlink:label="lab_lh_OthercountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other countries [Member]</link:label>
    <link:label id="lab_lh_OthercountriesMember_documentation_en-US" xlink:label="lab_lh_OthercountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OthercountriesMember" xlink:href="lh-20200930.xsd#lh_OthercountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_OthercountriesMember" xlink:to="lab_lh_OthercountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_NetProceedsFromIssuanceOfStockToEmployees_2cf5dd28-416c-4340-9d3c-de9cc8a48b3b_terseLabel_en-US" xlink:label="lab_lh_NetProceedsFromIssuanceOfStockToEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of stock to employees</link:label>
    <link:label id="lab_lh_NetProceedsFromIssuanceOfStockToEmployees_label_en-US" xlink:label="lab_lh_NetProceedsFromIssuanceOfStockToEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of stock to employees</link:label>
    <link:label id="lab_lh_NetProceedsFromIssuanceOfStockToEmployees_documentation_en-US" xlink:label="lab_lh_NetProceedsFromIssuanceOfStockToEmployees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The cash inflow associated with the amount received from holders exercising their stock options and employees related to shares purchased under the employee stock purchase plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetProceedsFromIssuanceOfStockToEmployees" xlink:href="lh-20200930.xsd#lh_NetProceedsFromIssuanceOfStockToEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_NetProceedsFromIssuanceOfStockToEmployees" xlink:to="lab_lh_NetProceedsFromIssuanceOfStockToEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_056ebf6b-43a6-4154-afe2-bda15a639443_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method income, net</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_8935cedc-ba2b-47ca-83d6-d7bd2dba6286_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_26a09d99-05f6-4bf3-92c9-189f34f1384e_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_eb6afe21-052d-498e-9ec7-bf03104c401f_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_69094102-59fa-4e04-9150-289ba3fbfb67_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_87f737c0-628f-4762-b280-1c50667473a9_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_NonElectiveContribution_7a216ea7-7280-45fa-b8d7-a824427ec993_terseLabel_en-US" xlink:label="lab_lh_NonElectiveContribution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum non-elective contribution (NEC) % for the 401(K) plan (in hundredths)</link:label>
    <link:label id="lab_lh_NonElectiveContribution_5aff94fd-738b-4ab2-a49c-bdcac43de461_verboseLabel_en-US" xlink:label="lab_lh_NonElectiveContribution" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Elective Contribution</link:label>
    <link:label id="lab_lh_NonElectiveContribution_label_en-US" xlink:label="lab_lh_NonElectiveContribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Elective Contribution</link:label>
    <link:label id="lab_lh_NonElectiveContribution_documentation_en-US" xlink:label="lab_lh_NonElectiveContribution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The minimum non-elective contribution % by the company to all employees eligible for the defined contribution retirement plan. Contributions are concurrent with each payroll period and are non-forfeitable and vest immediately.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NonElectiveContribution" xlink:href="lh-20200930.xsd#lh_NonElectiveContribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_NonElectiveContribution" xlink:to="lab_lh_NonElectiveContribution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_2dca99f7-6c62-4893-9804-4f92cabf50dd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_b3b71c05-7f7d-449d-8f7b-70c8b55b46f7_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_8ea95c36-6cfd-450a-ae59-cd9a5bee496c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_02dba419-50c0-412f-9aa4-a6a04d25540e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_RestructuringReserveSettledWithCashAndOtherAdjustment_21ee0378-611e-4486-9f60-62bd9eaf6102_negatedTerseLabel_en-US" xlink:label="lab_lh_RestructuringReserveSettledWithCashAndOtherAdjustment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve Settled With Cash And Other Adjustment</link:label>
    <link:label id="lab_lh_RestructuringReserveSettledWithCashAndOtherAdjustment_90fba752-f652-41ce-9caa-31508b7ae71e_negatedLabel_en-US" xlink:label="lab_lh_RestructuringReserveSettledWithCashAndOtherAdjustment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments and other adjustments</link:label>
    <link:label id="lab_lh_RestructuringReserveSettledWithCashAndOtherAdjustment_label_en-US" xlink:label="lab_lh_RestructuringReserveSettledWithCashAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve Settled With Cash And Other Adjustment</link:label>
    <link:label id="lab_lh_RestructuringReserveSettledWithCashAndOtherAdjustment_documentation_en-US" xlink:label="lab_lh_RestructuringReserveSettledWithCashAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of cash paid and/or consideration other than cash paid in the period to fully or partially settle a specified, previously accrued type of restructuring cost.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_RestructuringReserveSettledWithCashAndOtherAdjustment" xlink:href="lh-20200930.xsd#lh_RestructuringReserveSettledWithCashAndOtherAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_RestructuringReserveSettledWithCashAndOtherAdjustment" xlink:to="lab_lh_RestructuringReserveSettledWithCashAndOtherAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_871af013-1629-447c-ae87-34864c8a7893_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_2982e027-7772-4f90-be32-0036827cf292_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_MedicareandMedicaidMember_88858363-b419-4963-aa3d-e8e089046e17_terseLabel_en-US" xlink:label="lab_lh_MedicareandMedicaidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare and Medicaid [Member]</link:label>
    <link:label id="lab_lh_MedicareandMedicaidMember_label_en-US" xlink:label="lab_lh_MedicareandMedicaidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare and Medicaid [Member]</link:label>
    <link:label id="lab_lh_MedicareandMedicaidMember_documentation_en-US" xlink:label="lab_lh_MedicareandMedicaidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare and Medicaid [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_MedicareandMedicaidMember" xlink:href="lh-20200930.xsd#lh_MedicareandMedicaidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_MedicareandMedicaidMember" xlink:to="lab_lh_MedicareandMedicaidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveNoncurrent_8d4ea8de-e410-438b-b513-9e317133455c_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Noncurrent</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveNoncurrent_f216ba08-d4a7-477c-b481-8d7035de5879_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveNoncurrent" xlink:to="lab_us-gaap_RestructuringReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueRevenueRecognized1_80f796cf-50f1-47ad-b3b5-64f8d463efb5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueRevenueRecognized1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Revenue Recognized</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueRevenueRecognized1_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueRevenueRecognized1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueRevenueRecognized1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueRevenueRecognized1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueRevenueRecognized1" xlink:to="lab_us-gaap_DeferredRevenueRevenueRecognized1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_4c2ccfaa-1de5-4734-b34c-b01c7a6c1af0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_af996075-029e-4f36-8ed3-191ee3b1a925_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_558bf0ca-8264-4e9b-b6c4-f57b2793a6bb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_9e07c423-4f2c-4a4b-9dcd-6900b664ce1f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_OtheracquireesMember_390faa7b-4d41-44e2-9c39-d5946c294651_terseLabel_en-US" xlink:label="lab_lh_OtheracquireesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other acquirees [Member]</link:label>
    <link:label id="lab_lh_OtheracquireesMember_label_en-US" xlink:label="lab_lh_OtheracquireesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other acquirees [Member]</link:label>
    <link:label id="lab_lh_OtheracquireesMember_documentation_en-US" xlink:label="lab_lh_OtheracquireesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other acquirees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OtheracquireesMember" xlink:href="lh-20200930.xsd#lh_OtheracquireesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_OtheracquireesMember" xlink:to="lab_lh_OtheracquireesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_48c3ae8d-148b-46d9-aa39-cdb90c3c2154_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e278963c-49d2-4049-8a83-a900402bae82_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) by Hedging Relationship [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_6442d2c6-13e0-461f-9684-89a07004d03a_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentDomain_8ddf8cea-d379-4f22-8a82-ce178d426c5e_terseLabel_en-US" xlink:label="lab_dei_DocumentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document [Domain]</link:label>
    <link:label id="lab_dei_DocumentDomain_label_en-US" xlink:label="lab_dei_DocumentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentDomain" xlink:to="lab_dei_DocumentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_3e93c3a9-3859-4baf-9a7c-548e5fe3e5e8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan and Postretirement Plan Disclosure</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_LongTermContractsDurationMaximum_43815b6e-9215-4e95-9ebe-b081c974582a_terseLabel_en-US" xlink:label="lab_lh_LongTermContractsDurationMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Contracts Duration Maximum</link:label>
    <link:label id="lab_lh_LongTermContractsDurationMaximum_label_en-US" xlink:label="lab_lh_LongTermContractsDurationMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Contracts Duration Maximum</link:label>
    <link:label id="lab_lh_LongTermContractsDurationMaximum_documentation_en-US" xlink:label="lab_lh_LongTermContractsDurationMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Contracts Duration Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LongTermContractsDurationMaximum" xlink:href="lh-20200930.xsd#lh_LongTermContractsDurationMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_LongTermContractsDurationMaximum" xlink:to="lab_lh_LongTermContractsDurationMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_e6a94ab9-277e-4b78-a1b1-1e520e50fa4b_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_dfe1d560-0f14-4839-8eeb-0d841e078379_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_93c2b569-2937-48fd-af0b-61dc4690de29_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_eabb6a07-1aa1-4cb6-a52e-791bff713207_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_863a27db-4e3b-428b-9f11-dd3684e07200_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost for benefits earned</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_367fa927-6094-4900-8a5f-5b74b422fdb2_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_4c7b8ae7-063b-4aee-a19b-b84332b32159_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_9ff22d0f-730d-489f-88c7-60a84c1e6e69_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_7bf6edc0-510c-4c90-90bb-466ae661a091_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_1bf20f3f-419a-4a16-9aec-775e77c007e1_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage_2319af55-40c8-4917-9d5f-9f8f41ec42db_terseLabel_en-US" xlink:label="lab_lh_TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Accrue Interest per Annum at Libor Plus Margin Percentage</link:label>
    <link:label id="lab_lh_TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage_label_en-US" xlink:label="lab_lh_TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Accrue Interest per Annum at Libor Plus Margin Percentage</link:label>
    <link:label id="lab_lh_TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage_documentation_en-US" xlink:label="lab_lh_TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Accrue Interest per Annum at Libor Plus Margin Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage" xlink:href="lh-20200930.xsd#lh_TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage" xlink:to="lab_lh_TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_03a17227-9d32-420f-9e05-a7b378144f06_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_59baeccc-6af2-4e2e-b2eb-0567a00118bb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_7b98c4d2-f643-44e0-96f6-1528fa61cc1a_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_c1296878-f33f-40d9-aa9e-d31f2ac50093_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_COVID19PandemicAxis_4855f118-6cc1-4f8f-ac89-d37cd9187c1b_terseLabel_en-US" xlink:label="lab_lh_COVID19PandemicAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Pandemic [Axis]</link:label>
    <link:label id="lab_lh_COVID19PandemicAxis_label_en-US" xlink:label="lab_lh_COVID19PandemicAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Pandemic [Axis]</link:label>
    <link:label id="lab_lh_COVID19PandemicAxis_documentation_en-US" xlink:label="lab_lh_COVID19PandemicAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Pandemic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_COVID19PandemicAxis" xlink:href="lh-20200930.xsd#lh_COVID19PandemicAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_COVID19PandemicAxis" xlink:to="lab_lh_COVID19PandemicAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_0a0b7bcb-f4c7-4c31-9572-e32b1de6d1b4_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_c9d06def-fd39-42ac-9ded-c1c4015c23a0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_7e679e7b-f19c-4b89-adb0-39dd36910917_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_6903d43e-1bd9-4193-a379-f9d44e36c991_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_53dbb703-63a3-4e3c-9575-2eb6b3562608_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_a1c5a448-df29-413e-baf4-8bdbd48bfe3e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_cc769eb2-7469-4539-b302-a6c6fd0e4694_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net earnings attributable to the noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0079ce33-3db9-4fa2-8b31-1f3687ff3bf2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Laboratory Corporation of America Holdings</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SeniorNotesDue2022Member_a6521f15-5ece-4484-a551-969570ab0641_terseLabel_en-US" xlink:label="lab_lh_SeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2022 [Member]</link:label>
    <link:label id="lab_lh_SeniorNotesDue2022Member_label_en-US" xlink:label="lab_lh_SeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2022 [Member]</link:label>
    <link:label id="lab_lh_SeniorNotesDue2022Member_documentation_en-US" xlink:label="lab_lh_SeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2022Member" xlink:href="lh-20200930.xsd#lh_SeniorNotesDue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SeniorNotesDue2022Member" xlink:to="lab_lh_SeniorNotesDue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_6b1b7413-8cfd-4fea-a14a-13d769795ba4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_c89d770b-1aa4-4589-8f44-3fb736cce1c6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's population of financial assets and liabilities subject to fair value measurements</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_ece6bc5f-31b1-4f62-a06b-0aeb24077c37_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_9e8f6f5c-f842-4b51-bf7a-b2a3c0b20767_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_9f10dbab-ecb9-4e86-842a-c82a53d0c2d7_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_923f1a96-7d7c-46ae-a2d9-2932489d37b4_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit/postretirement plan costs</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_9ff8af9f-ee57-49e4-913e-4ef07d9b903c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Shorttermdebtissuancecosts_b22cc616-2ee4-492f-bbab-2de7727d7466_terseLabel_en-US" xlink:label="lab_lh_Shorttermdebtissuancecosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term debt issuance costs</link:label>
    <link:label id="lab_lh_Shorttermdebtissuancecosts_label_en-US" xlink:label="lab_lh_Shorttermdebtissuancecosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term debt issuance costs</link:label>
    <link:label id="lab_lh_Shorttermdebtissuancecosts_documentation_en-US" xlink:label="lab_lh_Shorttermdebtissuancecosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term debt issuance costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Shorttermdebtissuancecosts" xlink:href="lh-20200930.xsd#lh_Shorttermdebtissuancecosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Shorttermdebtissuancecosts" xlink:to="lab_lh_Shorttermdebtissuancecosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_c1eb531a-f800-4ef8-ad31-6dcb2ebe5759_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_77364587-1ce2-490e-982b-a5573131d613_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_38b0406a-fd99-414c-a6a3-8c8e47259700_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock and Common Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_ff308a45-ef40-4687-b4ca-555a5d667805_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_86913c83-a134-4624-bf4f-4ed9b5d9354c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_78c9e411-4763-4d75-9fd3-7c1df3c51576_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_09357a09-35e0-45d3-8eac-a8cd5e807691_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_1c1e6814-7089-4517-92ef-495b40676a85_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_33f7c090-084a-4e2f-9512-1facbe1683da_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments, Beginning balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_5a32efe9-1b8d-4785-a675-e1f575a750b3_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments, Ending balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Contingentconsiderationadjustment_5d24c422-85c3-415b-a280-caa4b1c280ab_terseLabel_en-US" xlink:label="lab_lh_Contingentconsiderationadjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration adjustment</link:label>
    <link:label id="lab_lh_Contingentconsiderationadjustment_9a2e0c5b-5532-4c60-a4fd-1bf62304442b_negatedTerseLabel_en-US" xlink:label="lab_lh_Contingentconsiderationadjustment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration adjustment</link:label>
    <link:label id="lab_lh_Contingentconsiderationadjustment_label_en-US" xlink:label="lab_lh_Contingentconsiderationadjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration adjustment</link:label>
    <link:label id="lab_lh_Contingentconsiderationadjustment_documentation_en-US" xlink:label="lab_lh_Contingentconsiderationadjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Contingentconsiderationadjustment" xlink:href="lh-20200930.xsd#lh_Contingentconsiderationadjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Contingentconsiderationadjustment" xlink:to="lab_lh_Contingentconsiderationadjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_43f2e3b3-7311-4268-96ea-f618707399e6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_7954c066-596b-43c5-917b-157a396fc79f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_8a81bdc6-fe2f-448a-b4cf-0a2a2674ae95_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_6a638855-c8ce-4121-b41b-d313be781238_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_9d7c1b8c-5cf5-4b28-89be-f6d87f7b2895_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of assets</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_35d66fb0-780b-41c0-a9ce-7577cd695673_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b5b2d9f0-0920-443c-8f03-6cedd8c55a19_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_29723ac5-a2df-4bce-b3be-c6df894a34c2_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_2361bcc7-22a1-4d5f-9c4c-1ae01560719b_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_e4596286-aa0d-46e8-a24e-d18c94b03bc7_netLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_a81bd779-4934-4549-b0b3-7a03758ea7af_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_1cc6584d-73db-49d5-bead-b96fa86fdc39_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_562a73ba-1fac-4642-9803-95be5c331a4f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_9848bedf-f6da-4220-b115-8449d1a82e67_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_4583c108-1007-4875-840e-c3771f5185c9_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_dba179a1-df94-425c-bc30-106b815b7287_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Benefit Plan Adjustments, Beginning balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_f899862f-0f26-431f-8023-715a136f9acc_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Benefit Plan Adjustments, Ending balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_AccumulatedOtherComprehensiveEarningsRollForward_3a8fc24a-105f-48c0-bb87-8f4c9c6172b2_terseLabel_en-US" xlink:label="lab_lh_AccumulatedOtherComprehensiveEarningsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Earnings [Roll Forward]</link:label>
    <link:label id="lab_lh_AccumulatedOtherComprehensiveEarningsRollForward_label_en-US" xlink:label="lab_lh_AccumulatedOtherComprehensiveEarningsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Earnings [Roll Forward]</link:label>
    <link:label id="lab_lh_AccumulatedOtherComprehensiveEarningsRollForward_documentation_en-US" xlink:label="lab_lh_AccumulatedOtherComprehensiveEarningsRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Earnings [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward" xlink:href="lh-20200930.xsd#lh_AccumulatedOtherComprehensiveEarningsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward" xlink:to="lab_lh_AccumulatedOtherComprehensiveEarningsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021_0a1be8b9-60bc-45c5-88a9-36053961a39d_terseLabel_en-US" xlink:label="lab_lh_DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt to EBITDA (Leverage) Ratio Quarter Ending 1 Year From Present</link:label>
    <link:label id="lab_lh_DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021_label_en-US" xlink:label="lab_lh_DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt to EBITDA (Leverage) Ratio Quarter Ending Through March 31, 2021</link:label>
    <link:label id="lab_lh_DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021_documentation_en-US" xlink:label="lab_lh_DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt to EBITDA (Leverage) Ratio Quarter Ending Through March 31, 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021" xlink:href="lh-20200930.xsd#lh_DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021" xlink:to="lab_lh_DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_f7645084-7736-4b0a-a55e-4673805232f9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_1f8364b5-da0d-40e5-b185-524ac18103e2_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_760632c2-6d5f-44ca-8812-762458a94c49_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of period</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_b02fe415-41a3-47fe-84e9-1ca2c9ebaaa9_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of period</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_b7b86c84-7cce-4c2a-9b8d-76514b779f59_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Restructuring Reserve</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShorttermDebtFairValue_02803fc9-8517-4a98-b7d0-0c22ee49cdb5_terseLabel_en-US" xlink:label="lab_us-gaap_ShorttermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625% Senior notes due 2020</link:label>
    <link:label id="lab_us-gaap_ShorttermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_ShorttermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShorttermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShorttermDebtFairValue" xlink:to="lab_us-gaap_ShorttermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Seniornotesdue2023Member_4c49315e-5ccb-4066-a5bd-64d1d8d0aa29_terseLabel_en-US" xlink:label="lab_lh_Seniornotesdue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2023 [Member]</link:label>
    <link:label id="lab_lh_Seniornotesdue2023Member_label_en-US" xlink:label="lab_lh_Seniornotesdue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2023 [Member]</link:label>
    <link:label id="lab_lh_Seniornotesdue2023Member_documentation_en-US" xlink:label="lab_lh_Seniornotesdue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2023Member" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Seniornotesdue2023Member" xlink:to="lab_lh_Seniornotesdue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021_6dd86675-519b-4f21-8a6e-5285162ba3ed_terseLabel_en-US" xlink:label="lab_lh_DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt to EBITDA (Leverage) Ratio Quarter Ending Thereafter March 31, 2021</link:label>
    <link:label id="lab_lh_DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021_label_en-US" xlink:label="lab_lh_DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt to EBITDA (Leverage) Ratio Quarter Ending Thereafter March 31, 2021</link:label>
    <link:label id="lab_lh_DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021_documentation_en-US" xlink:label="lab_lh_DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt to EBITDA (Leverage) Ratio Quarter Ending Thereafter March 31, 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021" xlink:href="lh-20200930.xsd#lh_DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021" xlink:to="lab_lh_DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_531a3fe5-7b51-4b7e-b23f-6604253ed302_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_3810f13a-229b-4d6c-ad3b-f7e3ed700fab_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Totalacquisitionconsiderationcashstocknotesetc._2feabb53-24a9-463f-817a-16d70214eecf_terseLabel_en-US" xlink:label="lab_lh_Totalacquisitionconsiderationcashstocknotesetc." xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total acquisition consideration (cash, stock, notes, etc.)</link:label>
    <link:label id="lab_lh_Totalacquisitionconsiderationcashstocknotesetc._label_en-US" xlink:label="lab_lh_Totalacquisitionconsiderationcashstocknotesetc." xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total acquisition consideration (cash, stock, notes, etc.)</link:label>
    <link:label id="lab_lh_Totalacquisitionconsiderationcashstocknotesetc._documentation_en-US" xlink:label="lab_lh_Totalacquisitionconsiderationcashstocknotesetc." xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total acquisition consideration (cash, stock, notes, etc.)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Totalacquisitionconsiderationcashstocknotesetc." xlink:href="lh-20200930.xsd#lh_Totalacquisitionconsiderationcashstocknotesetc."/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Totalacquisitionconsiderationcashstocknotesetc." xlink:to="lab_lh_Totalacquisitionconsiderationcashstocknotesetc." xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_d100906d-bfba-4912-bc2c-393210fbf985_netLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, net</link:label>
    <link:label id="lab_us-gaap_Goodwill_05eb5db7-c30a-42bd-8adf-bbc4a4d4124c_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance as of January 1</link:label>
    <link:label id="lab_us-gaap_Goodwill_99a30e55-812c-4266-b303-a8288caf9bc9_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_2143132a-3c86-4e1a-88a2-4b10bd6c047a_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_f95b3e9b-4791-4dbf-9ba0-908833656815_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surrender of restricted stock and performance share awards</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_88ebac1e-66a3-4fc2-927b-7ddae88a46ad_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A2019TermLoan_c84b9202-ccf4-4e65-adb9-9d68dbb65852_terseLabel_en-US" xlink:label="lab_lh_A2019TermLoan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Term Loan</link:label>
    <link:label id="lab_lh_A2019TermLoan_label_en-US" xlink:label="lab_lh_A2019TermLoan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Term Loan</link:label>
    <link:label id="lab_lh_A2019TermLoan_documentation_en-US" xlink:label="lab_lh_A2019TermLoan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2019TermLoan" xlink:href="lh-20200930.xsd#lh_A2019TermLoan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A2019TermLoan" xlink:to="lab_lh_A2019TermLoan" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_UnbilledServicesAllowanceforCreditLoss_50671750-e502-46a5-8c07-b89abcb39566_terseLabel_en-US" xlink:label="lab_lh_UnbilledServicesAllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Services, Allowance for Credit Loss</link:label>
    <link:label id="lab_lh_UnbilledServicesAllowanceforCreditLoss_label_en-US" xlink:label="lab_lh_UnbilledServicesAllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Services, Allowance for Credit Loss</link:label>
    <link:label id="lab_lh_UnbilledServicesAllowanceforCreditLoss_documentation_en-US" xlink:label="lab_lh_UnbilledServicesAllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Services, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnbilledServicesAllowanceforCreditLoss" xlink:href="lh-20200930.xsd#lh_UnbilledServicesAllowanceforCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_UnbilledServicesAllowanceforCreditLoss" xlink:to="lab_lh_UnbilledServicesAllowanceforCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_921335e4-77be-4a97-a58f-516dbb0f374c_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_33fb74c7-1b16-44bf-a688-dcea4b69f7d8_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expenses):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_fc4748f6-8e28-4bcb-b6df-0b73c282e689_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_GainInterestRateSwapArrangement_59227c98-e7f6-4587-bd8e-9b13659ad890_terseLabel_en-US" xlink:label="lab_lh_GainInterestRateSwapArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Interest Rate Swap Arrangement</link:label>
    <link:label id="lab_lh_GainInterestRateSwapArrangement_label_en-US" xlink:label="lab_lh_GainInterestRateSwapArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Interest Rate Swap Arrangement</link:label>
    <link:label id="lab_lh_GainInterestRateSwapArrangement_documentation_en-US" xlink:label="lab_lh_GainInterestRateSwapArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Interest Rate Swap Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_GainInterestRateSwapArrangement" xlink:href="lh-20200930.xsd#lh_GainInterestRateSwapArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_GainInterestRateSwapArrangement" xlink:to="lab_lh_GainInterestRateSwapArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_a6dce315-530b-4b04-a652-762f66397042_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Carrying Amount of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_18cc4045-3bd5-4f7b-8ae1-abec36e41d63_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_cd34b3d3-c755-4e61-8377-8adddebd5f72_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of non-cash financing and investing activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_f3ed1f27-0d29-4225-a858-02c88387d7dc_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_56e464be-5f75-4e76-9073-cee16e2f3bba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_DecreaseinCapitalExpendituresIncurredbutnotyetPaid_30346ecd-606a-40dd-8b3a-903af642d66c_negatedTerseLabel_en-US" xlink:label="lab_lh_DecreaseinCapitalExpendituresIncurredbutnotyetPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Capital Expenditures Incurred but not yet Paid</link:label>
    <link:label id="lab_lh_DecreaseinCapitalExpendituresIncurredbutnotyetPaid_label_en-US" xlink:label="lab_lh_DecreaseinCapitalExpendituresIncurredbutnotyetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Capital Expenditures Incurred but not yet Paid</link:label>
    <link:label id="lab_lh_DecreaseinCapitalExpendituresIncurredbutnotyetPaid_documentation_en-US" xlink:label="lab_lh_DecreaseinCapitalExpendituresIncurredbutnotyetPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Capital Expenditures Incurred but not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DecreaseinCapitalExpendituresIncurredbutnotyetPaid" xlink:href="lh-20200930.xsd#lh_DecreaseinCapitalExpendituresIncurredbutnotyetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_DecreaseinCapitalExpendituresIncurredbutnotyetPaid" xlink:to="lab_lh_DecreaseinCapitalExpendituresIncurredbutnotyetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_3554b220-e1a6-4513-9f5b-767136226575_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_0aa3d058-b3be-4d82-bec8-5d57faf93983_terseLabel_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Accounting Standards Update, Adjustment</link:label>
    <link:label id="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_label_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Accounting Standards Update, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:to="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_47a169d7-f665-4fad-99db-cccd915dccf5_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_d0367958-8118-447f-a50c-9fcc8fc16184_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_6188e34f-fb7e-4eab-a620-127c45d878e9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract Type [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_40261336-feb3-4f11-925b-ec4b0a5e4866_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_de6c9628-60e7-4e2d-9811-0fc454137ca0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_87e1fc62-5f7b-4b31-a8e8-6634791f7a8a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_5b2d611d-eb7c-43bb-9371-17728ddc12e9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_DeferredIncomeTaxesAndOtherTaxLiabilities_7f50a4fd-3d70-400b-a3e5-8503574f2177_terseLabel_en-US" xlink:label="lab_lh_DeferredIncomeTaxesAndOtherTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes and other tax liabilities</link:label>
    <link:label id="lab_lh_DeferredIncomeTaxesAndOtherTaxLiabilities_label_en-US" xlink:label="lab_lh_DeferredIncomeTaxesAndOtherTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes and other tax liabilities</link:label>
    <link:label id="lab_lh_DeferredIncomeTaxesAndOtherTaxLiabilities_documentation_en-US" xlink:label="lab_lh_DeferredIncomeTaxesAndOtherTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the noncurrent portion of deferred tax liabilities, which result from applying the applicable tax rate to net taxable temporary differences pertaining to each jurisdiction to which the entity is obligated to pay income tax, combined with the noncurrent portion of the amount recognized for uncertain tax positions as of the balance sheet date. A noncurrent taxable temporary difference is a difference between the tax basis and the carrying amount of a noncurrent asset or liability in the financial statements prepared in accordance with generally accepted accounting principles. In a classified statement of financial position, an enterprise shall separate deferred tax liabilities and assets into a current amount and a noncurrent amount. Deferred tax liabilities and assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the expected reversal date of the temporary difference.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DeferredIncomeTaxesAndOtherTaxLiabilities" xlink:href="lh-20200930.xsd#lh_DeferredIncomeTaxesAndOtherTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_DeferredIncomeTaxesAndOtherTaxLiabilities" xlink:to="lab_lh_DeferredIncomeTaxesAndOtherTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_473ee100-fd57-4a93-8647-1c9fd00f4534_terseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Acquired</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_ef45aed0-3e95-41c1-a9e1-d420004f18e6_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts_d28b906a-801a-47ff-94cd-4ef875206871_terseLabel_en-US" xlink:label="lab_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Deferred Costs Related to Long-term Contracts</link:label>
    <link:label id="lab_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts_label_en-US" xlink:label="lab_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Deferred Costs Related to Long-term Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts" xlink:to="lab_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ZeroCouponConvertibleSubordinatedNotesLineItems_d65d27e3-15a0-4448-87b9-6f1dae2fd9f7_terseLabel_en-US" xlink:label="lab_lh_ZeroCouponConvertibleSubordinatedNotesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero Coupon Convertible Subordinated Notes [Line Items]</link:label>
    <link:label id="lab_lh_ZeroCouponConvertibleSubordinatedNotesLineItems_label_en-US" xlink:label="lab_lh_ZeroCouponConvertibleSubordinatedNotesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero Coupon Convertible Subordinated Notes [Line Items]</link:label>
    <link:label id="lab_lh_ZeroCouponConvertibleSubordinatedNotesLineItems_documentation_en-US" xlink:label="lab_lh_ZeroCouponConvertibleSubordinatedNotesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero Coupon Convertible Subordinated Notes [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ZeroCouponConvertibleSubordinatedNotesLineItems" xlink:href="lh-20200930.xsd#lh_ZeroCouponConvertibleSubordinatedNotesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ZeroCouponConvertibleSubordinatedNotesLineItems" xlink:to="lab_lh_ZeroCouponConvertibleSubordinatedNotesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_9049f50e-7af3-49d4-9e7e-29326c7ba252_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used for) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_2e72adf2-0147-4875-a463-1aee8f4f288b_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts_79f365c4-9f8d-423c-9373-e35957224b23_terseLabel_en-US" xlink:label="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest puts</link:label>
    <link:label id="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts_label_en-US" xlink:label="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Liabilities Measured On Recurring Basis Noncontrolling Interest Puts</link:label>
    <link:label id="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts_documentation_en-US" xlink:label="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents a certain statement of financial position liability caption which represents a class of liabilities, or which may include an individual liability, measured at fair value on a recurring basis.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" xlink:href="lh-20200930.xsd#lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" xlink:to="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_ddb492da-2a3b-45eb-8e45-45b5d39a0fbf_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CostMethodInvestmentsMaximumOwnershipPercentage_186f4059-1ba9-46db-be66-b758d26b6fda_terseLabel_en-US" xlink:label="lab_lh_CostMethodInvestmentsMaximumOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage below which investments are generally accounted for on the cost method (in thousandths)</link:label>
    <link:label id="lab_lh_CostMethodInvestmentsMaximumOwnershipPercentage_label_en-US" xlink:label="lab_lh_CostMethodInvestmentsMaximumOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Method Investments Maximum Ownership Percentage</link:label>
    <link:label id="lab_lh_CostMethodInvestmentsMaximumOwnershipPercentage_documentation_en-US" xlink:label="lab_lh_CostMethodInvestmentsMaximumOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the maximum ownership percentage of cost-method investments held by the Company. Generally, such investments do not have readily determinable fair values and are not required to be accounted for by the equity method. The carrying amount of such securities equates to cost, adjusted for other-than-temporary impairment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CostMethodInvestmentsMaximumOwnershipPercentage" xlink:href="lh-20200930.xsd#lh_CostMethodInvestmentsMaximumOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CostMethodInvestmentsMaximumOwnershipPercentage" xlink:to="lab_lh_CostMethodInvestmentsMaximumOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_d63bdaae-e61e-4592-a068-63bf961e9da3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_f29b0ff5-2254-4a51-b0e8-8c37d1513d61_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrecognized income tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_d1419ad9-5a0b-4063-9f13-5305302d94d0_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_f6ffccc3-9d8b-48a3-ac40-1f3c65b995f6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c4bd09dd-6c4e-40ac-93ce-38af27259ec2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_080184f5-e050-4646-a81d-9757296c3a24_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_AllowanceforCreditLossWriteOff_b9b9c0e6-f1c5-40d9-92e4-c03362909be5_terseLabel_en-US" xlink:label="lab_lh_AllowanceforCreditLossWriteOff" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss, Write Off</link:label>
    <link:label id="lab_lh_AllowanceforCreditLossWriteOff_label_en-US" xlink:label="lab_lh_AllowanceforCreditLossWriteOff" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss, Write Off</link:label>
    <link:label id="lab_lh_AllowanceforCreditLossWriteOff_documentation_en-US" xlink:label="lab_lh_AllowanceforCreditLossWriteOff" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss, Write Off</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AllowanceforCreditLossWriteOff" xlink:href="lh-20200930.xsd#lh_AllowanceforCreditLossWriteOff"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_AllowanceforCreditLossWriteOff" xlink:to="lab_lh_AllowanceforCreditLossWriteOff" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_b715f7e9-1444-4d58-ad78-aede3c41f6cc_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_8fb6b9a0-e76a-41de-b599-3414e9d35207_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill_f5df3883-b7f7-47ee-aa50-1750c4074902_terseLabel_en-US" xlink:label="lab_lh_PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Change in Discount Rate Used to Calculate Fair Value of Goodwill</link:label>
    <link:label id="lab_lh_PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill_label_en-US" xlink:label="lab_lh_PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Change in Discount Rate Used to Calculate Fair Value of Goodwill</link:label>
    <link:label id="lab_lh_PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill_documentation_en-US" xlink:label="lab_lh_PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Change in Discount Rate Used to Calculate Fair Value of Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill" xlink:href="lh-20200930.xsd#lh_PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill" xlink:to="lab_lh_PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_39537053-b478-4c8f-a615-f353fb515272_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated amortization expense, 2013</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_RestructuringImpairment_3f4e9c80-277f-4299-81a7-7e70d68e5ce5_terseLabel_en-US" xlink:label="lab_lh_RestructuringImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:label id="lab_lh_RestructuringImpairment_label_en-US" xlink:label="lab_lh_RestructuringImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Impairment</link:label>
    <link:label id="lab_lh_RestructuringImpairment_documentation_en-US" xlink:label="lab_lh_RestructuringImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_RestructuringImpairment" xlink:href="lh-20200930.xsd#lh_RestructuringImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_RestructuringImpairment" xlink:to="lab_lh_RestructuringImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporationMember_9ee69f8c-248d-4653-bfe2-2e042000daec_terseLabel_en-US" xlink:label="lab_us-gaap_CorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporation</link:label>
    <link:label id="lab_us-gaap_CorporationMember_label_en-US" xlink:label="lab_us-gaap_CorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporationMember" xlink:to="lab_us-gaap_CorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostTableTextBlock_85b8ca59-cc93-4309-99c3-92cc95a45b29_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostTableTextBlock" xlink:to="lab_us-gaap_CapitalizedContractCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_7cfc3b02-105e-478c-a393-0ecff6933a1a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_a6ded2a1-625a-472b-8456-7e735dbdc398_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total short-term borrowings and current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_90c44365-7e53-4d13-81fa-8adef3940c29_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_531dae70-45cc-49ec-94e8-fb2482a69e4e_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_AccruedLiabilityForCARESActFundsToBeReturnedToGovernmentDomain_f7b7ba61-7723-4043-91ea-250c406f6404_terseLabel_en-US" xlink:label="lab_lh_AccruedLiabilityForCARESActFundsToBeReturnedToGovernmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liability For CARES Act Funds To Be Returned to Government [Domain]</link:label>
    <link:label id="lab_lh_AccruedLiabilityForCARESActFundsToBeReturnedToGovernmentDomain_label_en-US" xlink:label="lab_lh_AccruedLiabilityForCARESActFundsToBeReturnedToGovernmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liability For CARES Act Funds To Be Returned to Government [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AccruedLiabilityForCARESActFundsToBeReturnedToGovernmentDomain" xlink:href="lh-20200930.xsd#lh_AccruedLiabilityForCARESActFundsToBeReturnedToGovernmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_AccruedLiabilityForCARESActFundsToBeReturnedToGovernmentDomain" xlink:to="lab_lh_AccruedLiabilityForCARESActFundsToBeReturnedToGovernmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_08c4f1a2-846e-4fb2-9f35-0eefe44dd77a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_LongTermContractsDurationMinimum_49a78aec-3146-4425-a804-f13ac83759bf_terseLabel_en-US" xlink:label="lab_lh_LongTermContractsDurationMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Contracts Duration Minimum</link:label>
    <link:label id="lab_lh_LongTermContractsDurationMinimum_label_en-US" xlink:label="lab_lh_LongTermContractsDurationMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Contracts Duration Minimum</link:label>
    <link:label id="lab_lh_LongTermContractsDurationMinimum_documentation_en-US" xlink:label="lab_lh_LongTermContractsDurationMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Contracts Duration Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LongTermContractsDurationMinimum" xlink:href="lh-20200930.xsd#lh_LongTermContractsDurationMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_LongTermContractsDurationMinimum" xlink:to="lab_lh_LongTermContractsDurationMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_IncomeAbstract_f9ce2264-c370-40aa-baf0-913ae06811c4_terseLabel_en-US" xlink:label="lab_lh_IncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income [Abstract]</link:label>
    <link:label id="lab_lh_IncomeAbstract_label_en-US" xlink:label="lab_lh_IncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeAbstract" xlink:href="lh-20200930.xsd#lh_IncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_IncomeAbstract" xlink:to="lab_lh_IncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7a10884b-c64b-4b54-8b75-c0b207432b06_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive earnings</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_4b7eab03-bfc2-453a-a630-0755a30330a6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_02de5083-59db-4c93-a37c-93f4e0a8a11a_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_37b4bccb-b843-4c8f-8ed4-5f243d8ab995_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SharesAbstract_a145c71e-1c53-49f8-b9d1-1c7f90a4c850_terseLabel_en-US" xlink:label="lab_lh_SharesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares [Abstract]</link:label>
    <link:label id="lab_lh_SharesAbstract_label_en-US" xlink:label="lab_lh_SharesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SharesAbstract" xlink:href="lh-20200930.xsd#lh_SharesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SharesAbstract" xlink:to="lab_lh_SharesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CreditFacilityMaximumLettersofCredit_2d43a3de-18eb-4cf0-b4fb-94d007b0d89e_terseLabel_en-US" xlink:label="lab_lh_CreditFacilityMaximumLettersofCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility, Maximum Letters of Credit</link:label>
    <link:label id="lab_lh_CreditFacilityMaximumLettersofCredit_label_en-US" xlink:label="lab_lh_CreditFacilityMaximumLettersofCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility, Maximum Letters of Credit</link:label>
    <link:label id="lab_lh_CreditFacilityMaximumLettersofCredit_documentation_en-US" xlink:label="lab_lh_CreditFacilityMaximumLettersofCredit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility, Maximum Letters of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumLettersofCredit" xlink:href="lh-20200930.xsd#lh_CreditFacilityMaximumLettersofCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CreditFacilityMaximumLettersofCredit" xlink:to="lab_lh_CreditFacilityMaximumLettersofCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_93e2f48b-67d6-4091-8109-95cd4d0006ac_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares issued, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_971cd976-a5da-4e70-8e17-6e7e14886f19_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares issued, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_944652a4-3f75-443e-817d-272ba875ed68_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4866e4b3-de75-4ac8-adbb-085014bfc287_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_ccf1941b-efef-4f16-90f9-ddae19d37455_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_c39e04f4-f94c-4216-bec8-ab395f3ac715_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0b94f717-3d41-4559-99ba-3c60e7ee463e_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_d941903e-9807-427e-a21a-4aebfa5ee055_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3d5cfa52-e30c-4a1c-b3a7-5c8c5d52f592_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9c3bf044-9a19-4405-ae28-81d23ac3e2b1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_fda72d28-8f14-48d1-b4a2-a8799074c718_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerBasisOfPricingDomain_d8669ecb-5c2e-4bcd-b0c7-cd03ad91b3ae_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerBasisOfPricingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Basis of Pricing [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerBasisOfPricingDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerBasisOfPricingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Basis of Pricing [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain" xlink:to="lab_us-gaap_ContractWithCustomerBasisOfPricingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Intercompanyrevenueelimination_a22c6eb6-a991-4690-ae3c-b3ebae8933d9_negatedTerseLabel_en-US" xlink:label="lab_lh_Intercompanyrevenueelimination" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany revenue elimination</link:label>
    <link:label id="lab_lh_Intercompanyrevenueelimination_label_en-US" xlink:label="lab_lh_Intercompanyrevenueelimination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany revenue elimination</link:label>
    <link:label id="lab_lh_Intercompanyrevenueelimination_documentation_en-US" xlink:label="lab_lh_Intercompanyrevenueelimination" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany revenue elimination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Intercompanyrevenueelimination" xlink:href="lh-20200930.xsd#lh_Intercompanyrevenueelimination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Intercompanyrevenueelimination" xlink:to="lab_lh_Intercompanyrevenueelimination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_262f8ca2-79f2-4081-9e72-7eeb509ba609_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_eb4683de-7ba4-45e7-90df-3cc80697ffa6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in accounts receivable (net)</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_d0e7767d-2877-4d6b-bcb7-6e54aa4cf0c8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_3a7d9e08-13b2-4397-adad-b41abb2eba1c_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_147ebc9c-9c20-4026-bcb9-7777ec30b46c_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BALANCE</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_e9bbf6a4-adeb-45c8-b604-5a5c742e1e56_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BALANCE</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_dcab8757-b0c9-4172-9794-1c1db9b01e52_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_194b577e-7cd1-48c7-9f1b-105737717e37_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_a2fc555c-1e41-4b72-9259-43e06d401852_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_ec1135aa-16be-4113-9023-5d9680d0c7e3_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfOtherLongTermDebt_9bb0d3c6-0287-4651-93e1-6febc313ded4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Other Long-term Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfOtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Other Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_cce32b1b-3c6d-4c1e-ba16-2f7862133a46_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders' equity</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_304cc6ac-9747-4640-a62d-03c4ae4c6924_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Earnings, Beginning balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fb4f2a21-a420-4d03-a092-1a6aae3d852f_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Earnings, Ending balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_b30f6a96-c8fc-438a-87e1-c565d1f66a6f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayable_bc9edff2-1c75-4067-98b9-c7e177557e97_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable</link:label>
    <link:label id="lab_us-gaap_NotesPayable_label_en-US" xlink:label="lab_us-gaap_NotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayable" xlink:to="lab_us-gaap_NotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_95f53313-9b68-49b1-8401-454845af965c_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Disclosure Items [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_fd15d550-6817-47ee-b6c7-60413f125722_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2c72107b-007e-42bc-ad15-dc030fb87367_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_bc0a8922-bfae-486e-ab4c-64d35171d25f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8bd3f93f-36f8-4bac-9620-b98ddc433d2c_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_c7838b40-1288-4da5-8e96-6047d17332f8_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ZeroCouponConvertibleSubordinatedNotesTable_e32fb9a0-b48a-414d-9a29-76e36407c494_terseLabel_en-US" xlink:label="lab_lh_ZeroCouponConvertibleSubordinatedNotesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero Coupon Convertible Subordinated Notes [Table]</link:label>
    <link:label id="lab_lh_ZeroCouponConvertibleSubordinatedNotesTable_label_en-US" xlink:label="lab_lh_ZeroCouponConvertibleSubordinatedNotesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero Coupon Convertible Subordinated Notes [Table]</link:label>
    <link:label id="lab_lh_ZeroCouponConvertibleSubordinatedNotesTable_documentation_en-US" xlink:label="lab_lh_ZeroCouponConvertibleSubordinatedNotesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero Coupon Convertible Subordinated Notes [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ZeroCouponConvertibleSubordinatedNotesTable" xlink:href="lh-20200930.xsd#lh_ZeroCouponConvertibleSubordinatedNotesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ZeroCouponConvertibleSubordinatedNotesTable" xlink:to="lab_lh_ZeroCouponConvertibleSubordinatedNotesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_fd575e1b-a78b-4b32-bb43-946e067e3c0a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_20509eb8-82f5-470e-b2a8-24cf77fcb46b_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate at Period End</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate at Period End</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_91bbd6a3-c4b1-483e-af8b-ce0f6d072db3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CovanceMember_93bd3cc5-2417-4f79-8666-6c6027547e35_terseLabel_en-US" xlink:label="lab_lh_CovanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covance [Member]</link:label>
    <link:label id="lab_lh_CovanceMember_label_en-US" xlink:label="lab_lh_CovanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covance [Member]</link:label>
    <link:label id="lab_lh_CovanceMember_documentation_en-US" xlink:label="lab_lh_CovanceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceMember" xlink:href="lh-20200930.xsd#lh_CovanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CovanceMember" xlink:to="lab_lh_CovanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_45e33c89-e74a-40bb-9de8-65b1b0938165_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_d38e8079-40b6-4a4e-89b9-8bb7b3fbdcc3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_97c99c84-136a-413a-a765-fe583564d766_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated amortization expense, 2014</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SalesCommissionAmortizationPeriodMaximum_b82bc1c9-876f-415d-a609-2afd5d09f148_terseLabel_en-US" xlink:label="lab_lh_SalesCommissionAmortizationPeriodMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Commission Amortization Period Maximum</link:label>
    <link:label id="lab_lh_SalesCommissionAmortizationPeriodMaximum_label_en-US" xlink:label="lab_lh_SalesCommissionAmortizationPeriodMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Commission Amortization Period Maximum</link:label>
    <link:label id="lab_lh_SalesCommissionAmortizationPeriodMaximum_documentation_en-US" xlink:label="lab_lh_SalesCommissionAmortizationPeriodMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Commission Amortization Period Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SalesCommissionAmortizationPeriodMaximum" xlink:href="lh-20200930.xsd#lh_SalesCommissionAmortizationPeriodMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SalesCommissionAmortizationPeriodMaximum" xlink:to="lab_lh_SalesCommissionAmortizationPeriodMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingGuidanceMember_4f4fd613-32e2-493d-8b83-7106aeb18c6d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingGuidanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Guidance [Domain]</link:label>
    <link:label id="lab_us-gaap_AccountingGuidanceMember_label_en-US" xlink:label="lab_us-gaap_AccountingGuidanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Guidance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingGuidanceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingGuidanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingGuidanceMember" xlink:to="lab_us-gaap_AccountingGuidanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_5691a165-932a-4aed-9f0c-57c1e97e7ddb_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to Laboratory Corporation of America Holdings</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_92b7f658-0488-4e87-84ea-f7472580a571_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to Laboratory Corporation of America Holdings</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_12f15598-0b77-40e2-8cfe-f3553d8abaa2_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_68f8e4e7-308f-4eda-8b4e-3ea10f38f99c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_4ce84313-9d20-4fde-a58d-3108ca008acd_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_582df4c1-2868-41a4-a035-d240f5469fba_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in assets and liabilities (net of effects of acquisitions):</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairmentDomain_bc84c602-453c-45c5-b46f-ad1a6e6d555a_terseLabel_en-US" xlink:label="lab_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Pandemic Goodwill and Intangible Asset Impairment [Domain]</link:label>
    <link:label id="lab_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairmentDomain_label_en-US" xlink:label="lab_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Pandemic Goodwill and Intangible Asset Impairment [Domain]</link:label>
    <link:label id="lab_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairmentDomain_documentation_en-US" xlink:label="lab_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairmentDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Pandemic Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairmentDomain" xlink:href="lh-20200930.xsd#lh_COVID19PandemicGoodwillAndIntangibleAssetImpairmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairmentDomain" xlink:to="lab_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_1d4a569c-d8cc-42e2-b22e-8990da6e9472_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_53143e88-d1a6-4b33-9689-2ab2e7c8bada_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2624a269-8002-4238-a13a-e4322a80ccc9_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ad7cfab2-c809-4ab7-8680-93b40faf7737_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_d5694091-b4ff-45cb-9c21-fadb6db6839c_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_736fb328-42b3-4eb6-9beb-c0361310aae5_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_37c14fe4-29df-42b8-b8f2-721a82b7aa16_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_b4255ced-e12e-406a-b9d5-8df2b6823fad_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_7689ec54-cd4e-44f5-b7dc-f3506aea5f43_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_53d4d093-1e69-4887-a529-f07f9f4a2bb4_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseRightsMember_fd0dac14-ce69-407c-91c7-1f431837211e_terseLabel_en-US" xlink:label="lab_us-gaap_UseRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use Rights [Member]</link:label>
    <link:label id="lab_us-gaap_UseRightsMember_label_en-US" xlink:label="lab_us-gaap_UseRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseRightsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseRightsMember" xlink:to="lab_us-gaap_UseRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_0da6eb72-f709-4342-90e4-e8956930e2eb_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_dd1ba0ce-0d09-450d-bf5a-feb0a6714d15_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_ef912eb6-e03c-4f99-b6ff-3e360bf9bcb4_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent_c15ca863-f8b0-4238-aada-bce67dff166c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Assets, Current</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_eeaec760-48f2-40f3-8e90-6c405a825ce8_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Classified as Equity, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Classified as Equity, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:to="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020_4efc5acb-b413-4732-bb3f-6b963d67bb3b_terseLabel_en-US" xlink:label="lab_lh_DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt to EBITDA (Leverage) Ratio Next Three Quarters</link:label>
    <link:label id="lab_lh_DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020_label_en-US" xlink:label="lab_lh_DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt to EBITDA (Leverage) Ratio Through Period Ending December 31, 2020</link:label>
    <link:label id="lab_lh_DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020_documentation_en-US" xlink:label="lab_lh_DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt to EBITDA (Leverage) Ratio Through Period Ending December 31, 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020" xlink:href="lh-20200930.xsd#lh_DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020" xlink:to="lab_lh_DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9d87fe01-251c-4bc7-a5bf-4de6927deba9_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_5e6da801-1f94-4fbf-a061-83227a5b6391_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_21478ce3-ee2d-41d4-b7ad-5cfd101a25de_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c2ac38fb-9311-4bdc-8fb8-2217b7ff66c4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_23485597-a03c-43de-bd53-d30ea5110864_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0da19fa4-42b5-4400-845f-dfd2ec4affbd_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated amortization expense, 2016</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_1172f344-6c70-4010-9c55-be213fa91a38_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableMember_6229c23f-15b8-4866-8dc2-90679ccc549a_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable [Member]</link:label>
    <link:label id="lab_us-gaap_NotesReceivableMember_label_en-US" xlink:label="lab_us-gaap_NotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableMember" xlink:to="lab_us-gaap_NotesReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_49a1f7e3-3603-4fac-a036-5d2849e0e723_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_68a4a7d3-9afc-4792-aa79-f0481177e6fd_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_9ebd167d-6b76-4444-a700-6d6bd113095b_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_c7deef5c-5567-479f-baf5-c4ac0141b18b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_2a8ce2e1-36f0-4c9e-b985-43e282146d11_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_cc97513e-5c72-48d6-8675-22756a0ab477_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_0c88a817-f6ed-4429-8315-f8681cca93b6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution retirement plan cost</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_f947ba75-94e4-4ed8-99ee-32c9410e7c93_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CARESActFundsAxis_d98f4cb3-b237-4b62-8a75-888d6d93563a_terseLabel_en-US" xlink:label="lab_lh_CARESActFundsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act Funds [Axis]</link:label>
    <link:label id="lab_lh_CARESActFundsAxis_label_en-US" xlink:label="lab_lh_CARESActFundsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act Funds [Axis]</link:label>
    <link:label id="lab_lh_CARESActFundsAxis_documentation_en-US" xlink:label="lab_lh_CARESActFundsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CARESActFundsAxis" xlink:href="lh-20200930.xsd#lh_CARESActFundsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CARESActFundsAxis" xlink:to="lab_lh_CARESActFundsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_efce4ad4-1320-4d1d-820b-10da7e2d1c2e_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableFairValueDisclosure_a3de1800-5cbf-4b6e-8bfa-88cc5e30b9c3_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_NotesReceivableFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_NotesReceivableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableFairValueDisclosure" xlink:to="lab_us-gaap_NotesReceivableFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A2019TermLoanMember_265da32f-276e-40c8-9ded-66de1b632a87_terseLabel_en-US" xlink:label="lab_lh_A2019TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Term Loan [Member]</link:label>
    <link:label id="lab_lh_A2019TermLoanMember_label_en-US" xlink:label="lab_lh_A2019TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Term Loan [Member]</link:label>
    <link:label id="lab_lh_A2019TermLoanMember_documentation_en-US" xlink:label="lab_lh_A2019TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2019TermLoanMember" xlink:href="lh-20200930.xsd#lh_A2019TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A2019TermLoanMember" xlink:to="lab_lh_A2019TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_c6df3c19-1474-4961-8a1c-c408598b9c49_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_ce510822-238e-4a4e-9695-bc70f04922ad_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effect of adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis_8591ea41-6f85-4580-84f9-0a5fe4c697f0_terseLabel_en-US" xlink:label="lab_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prospective Adoption of New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prospective Adoption of New Accounting Pronouncements [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_2b7f3232-0792-4727-9c40-55d6aa67bc0a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ValueofReportingUnitsGoodwillFollowingImpairment_9feefa7c-bc3d-4966-a5a4-10fa845178b2_terseLabel_en-US" xlink:label="lab_lh_ValueofReportingUnitsGoodwillFollowingImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of Reporting Unit's Goodwill Following Impairment</link:label>
    <link:label id="lab_lh_ValueofReportingUnitsGoodwillFollowingImpairment_label_en-US" xlink:label="lab_lh_ValueofReportingUnitsGoodwillFollowingImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of Reporting Unit's Goodwill Following Impairment</link:label>
    <link:label id="lab_lh_ValueofReportingUnitsGoodwillFollowingImpairment_documentation_en-US" xlink:label="lab_lh_ValueofReportingUnitsGoodwillFollowingImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of Reporting Unit's Goodwill Following Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ValueofReportingUnitsGoodwillFollowingImpairment" xlink:href="lh-20200930.xsd#lh_ValueofReportingUnitsGoodwillFollowingImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ValueofReportingUnitsGoodwillFollowingImpairment" xlink:to="lab_lh_ValueofReportingUnitsGoodwillFollowingImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_1aa3ee9f-c42e-4846-bc89-3129277851a1_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_5565cf57-b5a9-435f-a486-07178abcbaf6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_d814d8f6-6f44-4e70-a99c-e2c25ea9057a_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_a1ae0cee-af3b-41a3-9e36-53f20da9df0e_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_a572cb67-1caa-4a60-818e-ec5e26d51694_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Performance Obligation Satisfied in Previous Period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Performance Obligation Satisfied in Previous Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:to="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_DiscretionaryContributionPercentageMaximum_c7770624-ae93-4d21-a651-dd4986827060_terseLabel_en-US" xlink:label="lab_lh_DiscretionaryContributionPercentageMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discretionary Contribution Percentage Maximum</link:label>
    <link:label id="lab_lh_DiscretionaryContributionPercentageMaximum_label_en-US" xlink:label="lab_lh_DiscretionaryContributionPercentageMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discretionary Contribution Percentage Maximum</link:label>
    <link:label id="lab_lh_DiscretionaryContributionPercentageMaximum_documentation_en-US" xlink:label="lab_lh_DiscretionaryContributionPercentageMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The maximum discretionary contribution % by the company for eligible employees based on service.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DiscretionaryContributionPercentageMaximum" xlink:href="lh-20200930.xsd#lh_DiscretionaryContributionPercentageMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_DiscretionaryContributionPercentageMaximum" xlink:to="lab_lh_DiscretionaryContributionPercentageMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b19f6146-5fd9-4701-99b1-2af0b96e1f74_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_dae8d1b3-50c1-491f-a351-797ac1f2c2a8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_7e00ced2-213f-4b92-bf1d-1d85fa3f55b5_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue_818d2375-d623-4bea-bfb0-ff9a3748eaa6_terseLabel_en-US" xlink:label="lab_lh_ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of Reporting Units Goodwill Fair Value Exceeds Carrying Value</link:label>
    <link:label id="lab_lh_ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue_label_en-US" xlink:label="lab_lh_ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of Reporting Units Goodwill Fair Value Exceeds Carrying Value</link:label>
    <link:label id="lab_lh_ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue_documentation_en-US" xlink:label="lab_lh_ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of Reporting Units Goodwill Fair Value Exceeds Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue" xlink:href="lh-20200930.xsd#lh_ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue" xlink:to="lab_lh_ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorLongTermNotes_ad5b47c3-c96e-4421-a321-c5b989396903_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorLongTermNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Noncurrent</link:label>
    <link:label id="lab_us-gaap_SeniorLongTermNotes_label_en-US" xlink:label="lab_us-gaap_SeniorLongTermNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongTermNotes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorLongTermNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorLongTermNotes" xlink:to="lab_us-gaap_SeniorLongTermNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CARESActFundsAccruedLiabilitiesAndOtherLiabilities_6070e8f3-434b-4d89-92f8-dea4c7a60439_terseLabel_en-US" xlink:label="lab_lh_CARESActFundsAccruedLiabilitiesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act Funds Accrued Liabilities And Other Liabilities</link:label>
    <link:label id="lab_lh_CARESActFundsAccruedLiabilitiesAndOtherLiabilities_label_en-US" xlink:label="lab_lh_CARESActFundsAccruedLiabilitiesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act Funds Accrued Liabilities And Other Liabilities</link:label>
    <link:label id="lab_lh_CARESActFundsAccruedLiabilitiesAndOtherLiabilities_documentation_en-US" xlink:label="lab_lh_CARESActFundsAccruedLiabilitiesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act Funds Accrued Liabilities And Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CARESActFundsAccruedLiabilitiesAndOtherLiabilities" xlink:href="lh-20200930.xsd#lh_CARESActFundsAccruedLiabilitiesAndOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CARESActFundsAccruedLiabilitiesAndOtherLiabilities" xlink:to="lab_lh_CARESActFundsAccruedLiabilitiesAndOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_PercentageFairValueofGoodwillExceededCarryingValue_74ed9ce4-f216-4920-8f7a-0a336eb96d14_terseLabel_en-US" xlink:label="lab_lh_PercentageFairValueofGoodwillExceededCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Fair Value of Goodwill Exceeded Carrying Value</link:label>
    <link:label id="lab_lh_PercentageFairValueofGoodwillExceededCarryingValue_label_en-US" xlink:label="lab_lh_PercentageFairValueofGoodwillExceededCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Fair Value of Goodwill Exceeded Carrying Value</link:label>
    <link:label id="lab_lh_PercentageFairValueofGoodwillExceededCarryingValue_documentation_en-US" xlink:label="lab_lh_PercentageFairValueofGoodwillExceededCarryingValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Fair Value of Goodwill Exceeded Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentageFairValueofGoodwillExceededCarryingValue" xlink:href="lh-20200930.xsd#lh_PercentageFairValueofGoodwillExceededCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_PercentageFairValueofGoodwillExceededCarryingValue" xlink:to="lab_lh_PercentageFairValueofGoodwillExceededCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_3235ae9d-debe-4c0b-a8c7-65cb5213a125_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge</link:label>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_label_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:to="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromHedgeInvestingActivities_5e10f3f2-3ec1-4d50-aef3-de7b013df6e9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Hedge, Investing Activities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromHedgeInvestingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Hedge, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:to="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_OutstandingStockRepurchaseAuthorizationAbstract_70a69d8c-e821-4baf-b406-1db2ec37d30e_terseLabel_en-US" xlink:label="lab_lh_OutstandingStockRepurchaseAuthorizationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rollforward of Share Repurchase Program</link:label>
    <link:label id="lab_lh_OutstandingStockRepurchaseAuthorizationAbstract_label_en-US" xlink:label="lab_lh_OutstandingStockRepurchaseAuthorizationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Stock Repurchase Authorization [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OutstandingStockRepurchaseAuthorizationAbstract" xlink:href="lh-20200930.xsd#lh_OutstandingStockRepurchaseAuthorizationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_OutstandingStockRepurchaseAuthorizationAbstract" xlink:to="lab_lh_OutstandingStockRepurchaseAuthorizationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9f4f8349-f7c7-4c51-8363-05bb42f1c68c_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateDescription_cf4db4a5-cd53-49a5-b60a-fd689de8c406_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate Description</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateDescription_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate Description</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateDescription" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_f7152fcd-5873-4416-b9d1-8fdae99d57c9_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint venture partnerships and equity method investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_8772dd5a-43d4-4a29-8eb8-2c0947d008ee_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_8ee9f5e2-ba8d-46e4-85f6-89fa765128ef_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Current</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_799fae95-55c3-495d-aff2-7089a78b80f2_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveCurrent" xlink:to="lab_us-gaap_RestructuringReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfInvestments_891b31a9-02c9-4005-b371-81876754b167_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other than Temporary Impairment Losses, Investments</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfInvestments_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other than Temporary Impairment Losses, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfInvestments" xlink:to="lab_us-gaap_ImpairmentOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_60f26aca-51a8-4a78-ae38-09a766eb585f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_1f2be09b-047c-4319-8f88-00e204c6970b_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance and Other Employee Costs [Member]</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_d17dfaf3-4633-4f65-a78b-2401d812e9f3_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_2da21947-97bb-4d99-811c-3cc9b471797f_terseLabel_en-US" xlink:label="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Other Intangible Assets By Major Class [Domain]</link:label>
    <link:label id="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_label_en-US" xlink:label="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Other Intangible Assets By Major Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain" xlink:href="lh-20200930.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain" xlink:to="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_NetRestructuringCharges_705b520d-4088-4641-851b-e4be083bdce3_terseLabel_en-US" xlink:label="lab_lh_NetRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net restructuring charges</link:label>
    <link:label id="lab_lh_NetRestructuringCharges_label_en-US" xlink:label="lab_lh_NetRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Restructuring Charges</link:label>
    <link:label id="lab_lh_NetRestructuringCharges_documentation_en-US" xlink:label="lab_lh_NetRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount charged against earnings in the period for incurred and estimated costs, excluding asset retirement obligations, associated with exit from or disposal of business activities or restructurings pursuant to a program that is planned and controlled by management, and changes either scope of business by an entity, or manner business is conducted. May include amount of reversals and other adjustments during the period to amounts of previously accrued liabilities for specified types of restructuring costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetRestructuringCharges" xlink:href="lh-20200930.xsd#lh_NetRestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_NetRestructuringCharges" xlink:to="lab_lh_NetRestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgesAtFairValueNet_cc4fb7cd-914c-4706-81b7-383ef2538170_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgesAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedges, Net</link:label>
    <link:label id="lab_us-gaap_FairValueHedgesAtFairValueNet_label_en-US" xlink:label="lab_us-gaap_FairValueHedgesAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedges, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgesAtFairValueNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgesAtFairValueNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgesAtFairValueNet" xlink:to="lab_us-gaap_FairValueHedgesAtFairValueNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_5e548ecf-b850-4954-9eb3-b138d30d334b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated amortization expense, 2012</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_42002437-f99f-4603-b774-29d3e48e3b7f_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_93c9bedd-3c7a-4598-adcf-851d2b3fa782_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_0443fdcf-b439-4e98-b391-4b4cea4bf8cc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_355d3dab-c7fe-47d8-afc2-4fd9c04a7e0b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_d3606ab2-4573-49ce-8755-75b0865bfdde_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes, net of refunds</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_5f07f752-0743-4a14-a3c3-579a6953f2f0_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_2232400e-3e93-4fde-90b8-9003fd9da3ab_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_2e399efd-e02e-421a-b64a-20581ebd9ef9_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_027746d8-02f9-4f5f-a6a5-0e83c6134ec6_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_a3beda1f-20ec-4e21-9269-7ade17beb10c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_e4a99a88-756a-481c-9579-28c11abfcb42_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term borrowings and current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_1df7dcc1-5c12-4ed5-9509-078cd69b2626_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d7fc8682-56d2-460e-84cd-a254aef8df42_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_c1959058-fb55-442e-88e5-4bc052ceb9c6_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_f802ecdd-7b9d-45b4-b6c5-db6475e8973a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_95c206bf-cf6c-47aa-ba50-caf84feff377_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_label_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestLineItems" xlink:to="lab_us-gaap_MinorityInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_3089672d-5507-45d5-9fe9-d19503e9c39a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNet" xlink:to="lab_us-gaap_InvestmentIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_6bccea89-9468-448c-9fe6-ed0bc9d3c5d3_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_6e741e20-216b-4ddf-83d6-1ce813ab7669_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrimeRateMember_48139250-8bda-4b15-8758-f44e80639d87_terseLabel_en-US" xlink:label="lab_us-gaap_PrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prime Rate [Member]</link:label>
    <link:label id="lab_us-gaap_PrimeRateMember_label_en-US" xlink:label="lab_us-gaap_PrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prime Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrimeRateMember" xlink:to="lab_us-gaap_PrimeRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_dfec5a42-fb93-4f05-b72c-f212ed566b33_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_bc70ba1e-38b4-47d4-8e64-ad5c00152bc2_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_de37bc80-dcff-4149-9786-4281a0594c87_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_aebb3582-f524-4bee-aea6-b199e1d9d61f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_9c8a9ac8-337f-43a8-9f56-be9ab38d8324_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b0ca78ef-43bc-45d0-aee7-6d89c1d8f55e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_354ddc18-090e-42da-ab11-e2c9315e68ad_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage_aa669aaf-2da0-4a9d-846c-1f8ab431f15c_terseLabel_en-US" xlink:label="lab_lh_RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility Accrue Interest Per Annum Base Rate Plus Percentage</link:label>
    <link:label id="lab_lh_RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage_label_en-US" xlink:label="lab_lh_RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility Accrue Interest Per Annum Base Rate Plus Percentage</link:label>
    <link:label id="lab_lh_RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage_documentation_en-US" xlink:label="lab_lh_RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility Accrue Interest Per Annum Base Rate Plus Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage" xlink:href="lh-20200930.xsd#lh_RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage" xlink:to="lab_lh_RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_7c8bea6d-e891-4978-ac6e-82e1bd57c242_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_71b26deb-babe-4a29-a83a-7d43e7faa9e3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0169524e-0767-405c-9f8e-d7cae1812f49_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CashFlowLocationAxis_c3c4d32f-e222-4371-ab10-53f1ca7dcb05_terseLabel_en-US" xlink:label="lab_lh_CashFlowLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Location [Axis]</link:label>
    <link:label id="lab_lh_CashFlowLocationAxis_label_en-US" xlink:label="lab_lh_CashFlowLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Location [Axis]</link:label>
    <link:label id="lab_lh_CashFlowLocationAxis_documentation_en-US" xlink:label="lab_lh_CashFlowLocationAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashFlowLocationAxis" xlink:href="lh-20200930.xsd#lh_CashFlowLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CashFlowLocationAxis" xlink:to="lab_lh_CashFlowLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_0216c980-bdc1-4e66-908d-17fb24922bed_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_e5871ec4-1891-4526-8469-ce4bb80748d0_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_a06e09e6-2f69-4470-b597-6550ab9c25a8_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_fe78a16b-00fb-4e95-a889-fb5e5d4a7919_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit_45c8abba-482b-4fea-82d9-21f3985aa00e_terseLabel_en-US" xlink:label="lab_lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of Goodwill Impairment Following a Percentage Change in the Discount Rate Used to Calculate Goodwill for Reporting Unit</link:label>
    <link:label id="lab_lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit_label_en-US" xlink:label="lab_lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of Goodwill Impairment Following a Percentage Change in the Discount Rate Used to Calculate Goodwill for Reporting Unit</link:label>
    <link:label id="lab_lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit_documentation_en-US" xlink:label="lab_lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of Goodwill Impairment Following a Percentage Change in the Discount Rate Used to Calculate Goodwill for Reporting Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit" xlink:href="lh-20200930.xsd#lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit" xlink:to="lab_lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_5f6e1569-197e-4cea-975c-907b5d5010cd_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_4505be41-2770-404d-aaeb-3a16d5d06544_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_a420e338-e041-4e12-b1f5-78fde0b7b28b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_aa4063dc-2a88-4244-b716-a2272a49510d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_98b54aa3-3f08-4d7d-930c-da34bfdcf7db_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used for investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_6c104ee6-7813-40aa-89f0-55a4200384ad_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_f4682848-c682-42d4-9900-70fe05682212_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_8dab0ff6-889f-49d5-b90d-7857b0870a92_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_d391ec69-bf4a-413d-9c10-979a3f5ed4f2_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:to="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_6037ccc7-bbfb-4c75-9dd7-af3c436f00b5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_426cd1d1-d2e4-47f9-9313-ad3ad4d4fdcd_terseLabel_en-US" xlink:label="lab_lh_BiopharmaceuticalandmedicaldevicecompaniesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biopharmaceutical and medical device companies [Member]</link:label>
    <link:label id="lab_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_label_en-US" xlink:label="lab_lh_BiopharmaceuticalandmedicaldevicecompaniesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biopharmaceutical and medical device companies [Member]</link:label>
    <link:label id="lab_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_documentation_en-US" xlink:label="lab_lh_BiopharmaceuticalandmedicaldevicecompaniesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biopharmaceutical and medical device companies [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_BiopharmaceuticalandmedicaldevicecompaniesMember" xlink:href="lh-20200930.xsd#lh_BiopharmaceuticalandmedicaldevicecompaniesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_BiopharmaceuticalandmedicaldevicecompaniesMember" xlink:to="lab_lh_BiopharmaceuticalandmedicaldevicecompaniesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionTable_4ca267be-b459-4b7d-b42e-bc8f89d3cc15_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion [Table]</link:label>
    <link:label id="lab_us-gaap_DebtConversionTable_label_en-US" xlink:label="lab_us-gaap_DebtConversionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionTable" xlink:to="lab_us-gaap_DebtConversionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_e9128a67-c4f2-460b-9e6f-62bc27d75dc8_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_dec5a368-c4d0-4828-a589-bbf8b07f6fdf_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_816a5d6f-56e7-4a7c-a6c0-e2bfd65dacfb_terseLabel_en-US" xlink:label="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Other Intangible Assets By Major Class [Axis]</link:label>
    <link:label id="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Other Intangible Assets By Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis" xlink:href="lh-20200930.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis" xlink:to="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_289852d7-bcf9-4fc8-99fb-a0af24e6f967_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableCurrent_e9bd0c85-7efc-4bff-8d29-039e7c4da644_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableCurrent" xlink:to="lab_us-gaap_NotesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_PercentofRevenueContributed_b41a55e7-77ba-4248-8d48-00f60a97886a_terseLabel_en-US" xlink:label="lab_lh_PercentofRevenueContributed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of Revenue Contributed</link:label>
    <link:label id="lab_lh_PercentofRevenueContributed_label_en-US" xlink:label="lab_lh_PercentofRevenueContributed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of Revenue Contributed</link:label>
    <link:label id="lab_lh_PercentofRevenueContributed_documentation_en-US" xlink:label="lab_lh_PercentofRevenueContributed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of Revenue Contributed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentofRevenueContributed" xlink:href="lh-20200930.xsd#lh_PercentofRevenueContributed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_PercentofRevenueContributed" xlink:to="lab_lh_PercentofRevenueContributed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgeAssetsAtFairValue_89c4d2b8-25e0-4a34-9efd-45d2a0d9843a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgeAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedge Assets</link:label>
    <link:label id="lab_us-gaap_FairValueHedgeAssetsAtFairValue_label_en-US" xlink:label="lab_us-gaap_FairValueHedgeAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedge Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeAssetsAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgeAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgeAssetsAtFairValue" xlink:to="lab_us-gaap_FairValueHedgeAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FacilityClosingMember_36df7097-8ce9-46df-a14d-5ab32d8f4a80_verboseLabel_en-US" xlink:label="lab_us-gaap_FacilityClosingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Closing [Member]</link:label>
    <link:label id="lab_us-gaap_FacilityClosingMember_ae2fea22-b028-47fc-bf85-ba6d82b74776_terseLabel_en-US" xlink:label="lab_us-gaap_FacilityClosingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease and Other Facility Costs [Member]</link:label>
    <link:label id="lab_us-gaap_FacilityClosingMember_label_en-US" xlink:label="lab_us-gaap_FacilityClosingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Closing [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FacilityClosingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FacilityClosingMember" xlink:to="lab_us-gaap_FacilityClosingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Lh_BusinessCombinationContingentConsiderationArrangementsPayments_7542286c-eba1-48eb-bcab-dc9d15c9b362_negatedTerseLabel_en-US" xlink:label="lab_lh_Lh_BusinessCombinationContingentConsiderationArrangementsPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">lh_BusinessCombinationContingentConsiderationArrangementsPayments</link:label>
    <link:label id="lab_lh_Lh_BusinessCombinationContingentConsiderationArrangementsPayments_label_en-US" xlink:label="lab_lh_Lh_BusinessCombinationContingentConsiderationArrangementsPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">lh_BusinessCombinationContingentConsiderationArrangementsPayments</link:label>
    <link:label id="lab_lh_Lh_BusinessCombinationContingentConsiderationArrangementsPayments_documentation_en-US" xlink:label="lab_lh_Lh_BusinessCombinationContingentConsiderationArrangementsPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">lh_BusinessCombinationContingentConsiderationArrangementsPayments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Lh_BusinessCombinationContingentConsiderationArrangementsPayments" xlink:href="lh-20200930.xsd#lh_Lh_BusinessCombinationContingentConsiderationArrangementsPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Lh_BusinessCombinationContingentConsiderationArrangementsPayments" xlink:to="lab_lh_Lh_BusinessCombinationContingentConsiderationArrangementsPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_a0632b14-5ddc-4302-b8a3-68edd053e475_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_adc5e5b9-48c5-4f3a-bbbe-37e38c757733_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_ef51b3b8-e8f7-4358-863a-c2b43d082514_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_53ce8ca8-ccf5-41fe-9b81-4d63c4cf6a4f_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3a4073ca-9d53-4875-91b7-980a74d982d8_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_ddc30e6a-0ee1-4b9b-aee3-03e0e458b5dc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear_7c24515d-e7c8-48bb-9f9a-6b33c76c8301_terseLabel_en-US" xlink:label="lab_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of remaining performance obligations recognized as revenue in next year</link:label>
    <link:label id="lab_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear_label_en-US" xlink:label="lab_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of remaining performance obligations recognized as revenue in next year</link:label>
    <link:label id="lab_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear_documentation_en-US" xlink:label="lab_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of remaining performance obligations recognized as revenue in next year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear" xlink:href="lh-20200930.xsd#lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear" xlink:to="lab_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>lh-20200930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:fc8a7d57-4cce-43ce-b480-996ae8b97c72,g:096b564a-e6b9-41cc-ab37-c90f57b146f8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.labcorp.com/role/CoverPage" xlink:type="simple" xlink:href="lh-20200930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_b106d781-ed57-4474-820f-c574cd46b9ff" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_DocumentInformationTable_b106d781-ed57-4474-820f-c574cd46b9ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationDocumentAxis_592c629c-7ee6-4662-b6cf-dbd4ab2bb3e2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationDocumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_b106d781-ed57-4474-820f-c574cd46b9ff" xlink:to="loc_dei_DocumentInformationDocumentAxis_592c629c-7ee6-4662-b6cf-dbd4ab2bb3e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain_cd1e85b4-e650-40f7-8306-a921b61166d8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationDocumentAxis_592c629c-7ee6-4662-b6cf-dbd4ab2bb3e2" xlink:to="loc_dei_DocumentDomain_cd1e85b4-e650-40f7-8306-a921b61166d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_44dd1266-c02a-43cd-ba92-834253416217" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_b106d781-ed57-4474-820f-c574cd46b9ff" xlink:to="loc_dei_DocumentInformationLineItems_44dd1266-c02a-43cd-ba92-834253416217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_dd895800-0757-4ff6-a18a-ebd9a86fbc2f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_EntityInteractiveDataCurrent_dd895800-0757-4ff6-a18a-ebd9a86fbc2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_4bd53289-f27c-4d7a-80aa-1d97f5b6f2ed" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_EntityFilerCategory_4bd53289-f27c-4d7a-80aa-1d97f5b6f2ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_b3c8276a-0fe0-43e1-9aa4-093e57624104" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_EntitySmallBusiness_b3c8276a-0fe0-43e1-9aa4-093e57624104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_474fbd85-d90d-4c0c-a22d-67150d0e7107" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_EntityEmergingGrowthCompany_474fbd85-d90d-4c0c-a22d-67150d0e7107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_bf263779-36c1-4a06-b822-a300d26dae51" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_EntityShellCompany_bf263779-36c1-4a06-b822-a300d26dae51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_d10b7690-944c-4a6a-8f25-4b8c10779ce1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_d10b7690-944c-4a6a-8f25-4b8c10779ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_4d4632e9-0f06-4a61-aba3-f4d84cf3d1da" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_DocumentFiscalPeriodFocus_4d4632e9-0f06-4a61-aba3-f4d84cf3d1da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_aad55de0-a0c2-47a4-b176-6a37fe2bf6a1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_AmendmentFlag_aad55de0-a0c2-47a4-b176-6a37fe2bf6a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_e9e67ec8-c65c-4d21-9fa1-8dcafadb41d8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_DocumentType_e9e67ec8-c65c-4d21-9fa1-8dcafadb41d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_407a184a-74ac-4ba4-9b57-57daaa92fe7f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_DocumentQuarterlyReport_407a184a-74ac-4ba4-9b57-57daaa92fe7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_4eecc2e0-0ad1-4f39-8307-b377a5943d4e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_DocumentPeriodEndDate_4eecc2e0-0ad1-4f39-8307-b377a5943d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_a3fccb7f-a702-44ab-86a1-9d029f226b10" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_DocumentTransitionReport_a3fccb7f-a702-44ab-86a1-9d029f226b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_5177f174-1ff6-4682-9300-422043230d00" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_EntityFileNumber_5177f174-1ff6-4682-9300-422043230d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_6f8f695b-f140-4ca7-bcbf-a2cadec7d0b8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_EntityRegistrantName_6f8f695b-f140-4ca7-bcbf-a2cadec7d0b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_f709cbe2-eaad-4ea3-8468-ef9556f17d36" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_EntityIncorporationStateCountryCode_f709cbe2-eaad-4ea3-8468-ef9556f17d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_3b3fba46-e48e-4cc9-bc5d-7d71f272a8dc" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_EntityTaxIdentificationNumber_3b3fba46-e48e-4cc9-bc5d-7d71f272a8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_10b4f220-67f0-4650-a488-2dde5297df9b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_EntityAddressAddressLine1_10b4f220-67f0-4650-a488-2dde5297df9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_faa54407-c7e9-4dbc-bf24-6318e50ed8c7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_EntityAddressCityOrTown_faa54407-c7e9-4dbc-bf24-6318e50ed8c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_6d54dd79-409f-4e43-9c91-19649681a013" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_EntityAddressStateOrProvince_6d54dd79-409f-4e43-9c91-19649681a013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_3435406c-c64e-4261-9de6-1e2daee49509" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_EntityAddressPostalZipCode_3435406c-c64e-4261-9de6-1e2daee49509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_8d617b04-83d6-4b55-9320-09a17d12c013" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_CityAreaCode_8d617b04-83d6-4b55-9320-09a17d12c013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_2d0a4ed2-7656-487f-b382-cb73d3a0ac46" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_LocalPhoneNumber_2d0a4ed2-7656-487f-b382-cb73d3a0ac46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_1990bad7-f9ba-4c43-b6d8-1c4dd9173178" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_Security12bTitle_1990bad7-f9ba-4c43-b6d8-1c4dd9173178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_7c6664be-de9d-4f0f-91e3-1a9c6b880957" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_TradingSymbol_7c6664be-de9d-4f0f-91e3-1a9c6b880957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_91ea19f1-ac5a-4459-acd2-9d302bec698d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_SecurityExchangeName_91ea19f1-ac5a-4459-acd2-9d302bec698d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_ba70d6d5-5737-4227-aaad-6e059c0f4de6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_EntityCurrentReportingStatus_ba70d6d5-5737-4227-aaad-6e059c0f4de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_b08a05f4-7120-41b0-910d-270e2ef340a0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_DocumentFiscalYearFocus_b08a05f4-7120-41b0-910d-270e2ef340a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_f3653f8d-3ba5-4445-9bb4-879281f0b01b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_CurrentFiscalYearEndDate_f3653f8d-3ba5-4445-9bb4-879281f0b01b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_3f7fbda7-1b4a-4492-ac38-59a2bec7cd3b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6d072-d00f-416e-8d6d-e04d6799fc3f" xlink:to="loc_dei_EntityCentralIndexKey_3f7fbda7-1b4a-4492-ac38-59a2bec7cd3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="simple" xlink:href="lh-20200930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_291ba5e3-dbf9-4595-ba31-3767b402ce14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_8c192827-0de1-4481-99e9-b4722ea6b0dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_291ba5e3-dbf9-4595-ba31-3767b402ce14" xlink:to="loc_us-gaap_AccountsPayableCurrent_8c192827-0de1-4481-99e9-b4722ea6b0dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_e92ee7a0-f4f8-4d90-87c2-3a9b99f9675e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_291ba5e3-dbf9-4595-ba31-3767b402ce14" xlink:to="loc_us-gaap_AssetsAbstract_e92ee7a0-f4f8-4d90-87c2-3a9b99f9675e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_f0c55831-f4c7-4d93-baea-33da82080fe8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e92ee7a0-f4f8-4d90-87c2-3a9b99f9675e" xlink:to="loc_us-gaap_AssetsCurrentAbstract_f0c55831-f4c7-4d93-baea-33da82080fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f1d8c908-e429-41dd-a394-6d074a3aac3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f0c55831-f4c7-4d93-baea-33da82080fe8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f1d8c908-e429-41dd-a394-6d074a3aac3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_41deef9e-ec46-425e-ba48-4ed7352f92ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f0c55831-f4c7-4d93-baea-33da82080fe8" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_41deef9e-ec46-425e-ba48-4ed7352f92ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_eee55440-8c97-4d3c-9992-18171d9e92cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f0c55831-f4c7-4d93-baea-33da82080fe8" xlink:to="loc_us-gaap_UnbilledContractsReceivable_eee55440-8c97-4d3c-9992-18171d9e92cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_fe6352f1-605f-4d84-9584-2ed668ed5610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f0c55831-f4c7-4d93-baea-33da82080fe8" xlink:to="loc_us-gaap_InventoryNet_fe6352f1-605f-4d84-9584-2ed668ed5610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_bee2634a-9d49-414c-9cfd-98bbee3cce0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f0c55831-f4c7-4d93-baea-33da82080fe8" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_bee2634a-9d49-414c-9cfd-98bbee3cce0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c4d88835-7aaf-4ff0-ae92-0a8b42c39fec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f0c55831-f4c7-4d93-baea-33da82080fe8" xlink:to="loc_us-gaap_AssetsCurrent_c4d88835-7aaf-4ff0-ae92-0a8b42c39fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_15cda3af-5e0a-4fe8-bbbd-4f87944d959d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e92ee7a0-f4f8-4d90-87c2-3a9b99f9675e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_15cda3af-5e0a-4fe8-bbbd-4f87944d959d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d598718c-5c97-4070-bfd9-4af4c8f6dad6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e92ee7a0-f4f8-4d90-87c2-3a9b99f9675e" xlink:to="loc_us-gaap_Goodwill_d598718c-5c97-4070-bfd9-4af4c8f6dad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c4330a42-41c9-4edd-823d-849104d078f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e92ee7a0-f4f8-4d90-87c2-3a9b99f9675e" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c4330a42-41c9-4edd-823d-849104d078f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_2718f287-8282-4431-9d4a-6a0d9e101d25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e92ee7a0-f4f8-4d90-87c2-3a9b99f9675e" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_2718f287-8282-4431-9d4a-6a0d9e101d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent_02565661-7a6d-437a-8b76-4b9668923a7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e92ee7a0-f4f8-4d90-87c2-3a9b99f9675e" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent_02565661-7a6d-437a-8b76-4b9668923a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_066b4b07-2ba5-497f-a0aa-99d6d1086932" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e92ee7a0-f4f8-4d90-87c2-3a9b99f9675e" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_066b4b07-2ba5-497f-a0aa-99d6d1086932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_3c382493-4c5d-47ac-87f2-86fc6bce9a26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e92ee7a0-f4f8-4d90-87c2-3a9b99f9675e" xlink:to="loc_us-gaap_Assets_3c382493-4c5d-47ac-87f2-86fc6bce9a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_18d4c285-3e02-4997-b192-a62ea834815c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_291ba5e3-dbf9-4595-ba31-3767b402ce14" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_18d4c285-3e02-4997-b192-a62ea834815c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_fa198775-eb49-4a16-a4fc-59bdbacccf9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_18d4c285-3e02-4997-b192-a62ea834815c" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_fa198775-eb49-4a16-a4fc-59bdbacccf9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_83eb953d-79f6-4aa4-af51-e5eba3524648" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fa198775-eb49-4a16-a4fc-59bdbacccf9b" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_83eb953d-79f6-4aa4-af51-e5eba3524648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_6bce0d3f-6b93-45b5-8289-bcf943eafa4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fa198775-eb49-4a16-a4fc-59bdbacccf9b" xlink:to="loc_us-gaap_DeferredRevenueCurrent_6bce0d3f-6b93-45b5-8289-bcf943eafa4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_12a2697d-ce9a-49a5-8baa-525139bc7a70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fa198775-eb49-4a16-a4fc-59bdbacccf9b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_12a2697d-ce9a-49a5-8baa-525139bc7a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_0aa7d861-d8bb-4302-86f8-534ffc89c15a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fa198775-eb49-4a16-a4fc-59bdbacccf9b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_0aa7d861-d8bb-4302-86f8-534ffc89c15a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_6400716b-f9a3-42ea-9e89-17d19d8ec1d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fa198775-eb49-4a16-a4fc-59bdbacccf9b" xlink:to="loc_us-gaap_DebtCurrent_6400716b-f9a3-42ea-9e89-17d19d8ec1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a479ca4d-957b-43bb-8bf4-69ae3050d80d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_18d4c285-3e02-4997-b192-a62ea834815c" xlink:to="loc_us-gaap_LiabilitiesCurrent_a479ca4d-957b-43bb-8bf4-69ae3050d80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_2b17b802-e56a-4399-a8cd-dcd9b53d066e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_18d4c285-3e02-4997-b192-a62ea834815c" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_2b17b802-e56a-4399-a8cd-dcd9b53d066e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_6a71d858-b70b-43cb-85fc-e1e7651cbda7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_18d4c285-3e02-4997-b192-a62ea834815c" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_6a71d858-b70b-43cb-85fc-e1e7651cbda7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_326cd5d3-8de7-486d-84d5-0a27aba20cfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_18d4c285-3e02-4997-b192-a62ea834815c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_326cd5d3-8de7-486d-84d5-0a27aba20cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_01d44c4f-2aae-4ef6-84cc-1ee330a80c39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_18d4c285-3e02-4997-b192-a62ea834815c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_01d44c4f-2aae-4ef6-84cc-1ee330a80c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DeferredIncomeTaxesAndOtherTaxLiabilities_31f411b6-2923-4dfc-8767-5432692dc2f4" xlink:href="lh-20200930.xsd#lh_DeferredIncomeTaxesAndOtherTaxLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_18d4c285-3e02-4997-b192-a62ea834815c" xlink:to="loc_lh_DeferredIncomeTaxesAndOtherTaxLiabilities_31f411b6-2923-4dfc-8767-5432692dc2f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_6e676c4d-e2c8-482a-9708-4edf5925135e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_18d4c285-3e02-4997-b192-a62ea834815c" xlink:to="loc_us-gaap_Liabilities_6e676c4d-e2c8-482a-9708-4edf5925135e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_307a9c12-a173-475e-bfd9-2562712046af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_18d4c285-3e02-4997-b192-a62ea834815c" xlink:to="loc_us-gaap_StockholdersEquityAbstract_307a9c12-a173-475e-bfd9-2562712046af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoncontrollingInterestMezzanineEquity_4b48935a-b72f-4566-bfa1-cf0fc734f7a6" xlink:href="lh-20200930.xsd#lh_NoncontrollingInterestMezzanineEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_307a9c12-a173-475e-bfd9-2562712046af" xlink:to="loc_lh_NoncontrollingInterestMezzanineEquity_4b48935a-b72f-4566-bfa1-cf0fc734f7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_542609c9-41b2-472b-8bdb-69d12406ef29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_307a9c12-a173-475e-bfd9-2562712046af" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_542609c9-41b2-472b-8bdb-69d12406ef29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f0c2fd67-9c69-49e7-9720-ddf274f9ad38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_307a9c12-a173-475e-bfd9-2562712046af" xlink:to="loc_us-gaap_CommonStockValue_f0c2fd67-9c69-49e7-9720-ddf274f9ad38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d45caf4f-02b4-4447-897b-aac1e692124c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_307a9c12-a173-475e-bfd9-2562712046af" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d45caf4f-02b4-4447-897b-aac1e692124c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2fa16e85-4f0a-4724-9ec8-8af2c015acb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_18d4c285-3e02-4997-b192-a62ea834815c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2fa16e85-4f0a-4724-9ec8-8af2c015acb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e5e82b16-55ca-4947-846e-f938fa7e0eaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_291ba5e3-dbf9-4595-ba31-3767b402ce14" xlink:to="loc_us-gaap_StockholdersEquity_e5e82b16-55ca-4947-846e-f938fa7e0eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_12b4e100-eb57-4d48-8543-107a55b84246" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_291ba5e3-dbf9-4595-ba31-3767b402ce14" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_12b4e100-eb57-4d48-8543-107a55b84246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals" xlink:type="simple" xlink:href="lh-20200930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_dd6c65ab-49c7-4c91-a218-478cd122dfe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ee65be36-dad8-4d46-ae73-813945a866cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dd6c65ab-49c7-4c91-a218-478cd122dfe9" xlink:to="loc_us-gaap_StatementTable_ee65be36-dad8-4d46-ae73-813945a866cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_0838223b-d487-4a8c-88a0-911bcd34db1e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ee65be36-dad8-4d46-ae73-813945a866cc" xlink:to="loc_srt_RestatementAxis_0838223b-d487-4a8c-88a0-911bcd34db1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_23fca1d9-69af-4b16-88a9-2fecae25614f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_0838223b-d487-4a8c-88a0-911bcd34db1e" xlink:to="loc_srt_RestatementDomain_23fca1d9-69af-4b16-88a9-2fecae25614f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_5b12c7ec-8aad-4a90-b0cb-f4ebd22c8deb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ee65be36-dad8-4d46-ae73-813945a866cc" xlink:to="loc_us-gaap_StatementClassOfStockAxis_5b12c7ec-8aad-4a90-b0cb-f4ebd22c8deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_44d14f74-ec2a-4749-8e88-009e642329ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_5b12c7ec-8aad-4a90-b0cb-f4ebd22c8deb" xlink:to="loc_us-gaap_ClassOfStockDomain_44d14f74-ec2a-4749-8e88-009e642329ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b76b4c21-bb29-46aa-a434-b0f8853fa138" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ee65be36-dad8-4d46-ae73-813945a866cc" xlink:to="loc_us-gaap_StatementLineItems_b76b4c21-bb29-46aa-a434-b0f8853fa138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_19978e8a-06c8-4853-847a-afb96c5a4d3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b76b4c21-bb29-46aa-a434-b0f8853fa138" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_19978e8a-06c8-4853-847a-afb96c5a4d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_c8ddcb0a-82f6-4351-85a8-91b75845f85a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dd6c65ab-49c7-4c91-a218-478cd122dfe9" xlink:to="loc_us-gaap_AssetsAbstract_c8ddcb0a-82f6-4351-85a8-91b75845f85a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_72857e9c-89c5-4e8a-8c1a-fb6f6883f108" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c8ddcb0a-82f6-4351-85a8-91b75845f85a" xlink:to="loc_us-gaap_AssetsCurrentAbstract_72857e9c-89c5-4e8a-8c1a-fb6f6883f108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_541ce153-9f99-4bed-ab78-49d3f9cb83ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dd6c65ab-49c7-4c91-a218-478cd122dfe9" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_541ce153-9f99-4bed-ab78-49d3f9cb83ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_c94e1599-eefc-4035-99ad-c4eac96cc553" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_541ce153-9f99-4bed-ab78-49d3f9cb83ea" xlink:to="loc_us-gaap_StockholdersEquityAbstract_c94e1599-eefc-4035-99ad-c4eac96cc553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_2dd419f0-c0e3-463d-a60e-1f8178695d29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c94e1599-eefc-4035-99ad-c4eac96cc553" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_2dd419f0-c0e3-463d-a60e-1f8178695d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="simple" xlink:href="lh-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_3d6dc3cb-4089-4146-9a25-b254bb222b97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e6452c6d-dfaa-4401-9d23-beb143cd180a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3d6dc3cb-4089-4146-9a25-b254bb222b97" xlink:to="loc_us-gaap_StatementTable_e6452c6d-dfaa-4401-9d23-beb143cd180a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis_4098d983-3c7b-4048-a407-ad1018422c30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e6452c6d-dfaa-4401-9d23-beb143cd180a" xlink:to="loc_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis_4098d983-3c7b-4048-a407-ad1018422c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingGuidanceMember_fa849e19-3020-46a3-ad91-da8c9375ac07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingGuidanceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis_4098d983-3c7b-4048-a407-ad1018422c30" xlink:to="loc_us-gaap_AccountingGuidanceMember_fa849e19-3020-46a3-ad91-da8c9375ac07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e8b2f761-4b55-4aa7-9be9-99ced37b4e67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e6452c6d-dfaa-4401-9d23-beb143cd180a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e8b2f761-4b55-4aa7-9be9-99ced37b4e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c5ed534c-51db-48a2-b249-cd7b4617e440" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e8b2f761-4b55-4aa7-9be9-99ced37b4e67" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c5ed534c-51db-48a2-b249-cd7b4617e440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceMember_78abfbf8-f6d5-4946-9cc5-3a70709f933f" xlink:href="lh-20200930.xsd#lh_CovanceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c5ed534c-51db-48a2-b249-cd7b4617e440" xlink:to="loc_lh_CovanceMember_78abfbf8-f6d5-4946-9cc5-3a70709f933f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_8eb8d745-74fe-4e14-9e0e-5d5e1de7900b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e6452c6d-dfaa-4401-9d23-beb143cd180a" xlink:to="loc_srt_StatementScenarioAxis_8eb8d745-74fe-4e14-9e0e-5d5e1de7900b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_3b2ece4d-00a1-449c-a20a-6afe9dbeb9bc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_8eb8d745-74fe-4e14-9e0e-5d5e1de7900b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_3b2ece4d-00a1-449c-a20a-6afe9dbeb9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8add8ff8-2cae-4647-b13e-cf83a38a37f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e6452c6d-dfaa-4401-9d23-beb143cd180a" xlink:to="loc_us-gaap_StatementLineItems_8add8ff8-2cae-4647-b13e-cf83a38a37f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_56fde5ca-cb56-4a8b-a53d-5015f7ce1e67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3d6dc3cb-4089-4146-9a25-b254bb222b97" xlink:to="loc_us-gaap_Revenues_56fde5ca-cb56-4a8b-a53d-5015f7ce1e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_d20a5fba-a4c5-48f4-a737-9c668d78934f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3d6dc3cb-4089-4146-9a25-b254bb222b97" xlink:to="loc_us-gaap_CostOfRevenue_d20a5fba-a4c5-48f4-a737-9c668d78934f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_3a7f65cf-1409-4a72-933d-e48cc5671f9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3d6dc3cb-4089-4146-9a25-b254bb222b97" xlink:to="loc_us-gaap_GrossProfit_3a7f65cf-1409-4a72-933d-e48cc5671f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4fdb2e9a-b9b4-49de-a9a9-c09e51a39660" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3d6dc3cb-4089-4146-9a25-b254bb222b97" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4fdb2e9a-b9b4-49de-a9a9-c09e51a39660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_ef859ba2-3977-4597-a76b-c08a4baafdda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3d6dc3cb-4089-4146-9a25-b254bb222b97" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_ef859ba2-3977-4597-a76b-c08a4baafdda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_bb378b9a-7dcf-4f9b-9e36-f7a254c1076c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3d6dc3cb-4089-4146-9a25-b254bb222b97" xlink:to="loc_us-gaap_AssetImpairmentCharges_bb378b9a-7dcf-4f9b-9e36-f7a254c1076c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetRestructuringAndOtherSpecialCharges_0f0a735c-20a0-4773-8bba-07e1c6d84672" xlink:href="lh-20200930.xsd#lh_NetRestructuringAndOtherSpecialCharges"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3d6dc3cb-4089-4146-9a25-b254bb222b97" xlink:to="loc_lh_NetRestructuringAndOtherSpecialCharges_0f0a735c-20a0-4773-8bba-07e1c6d84672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_536703e4-64bf-47d1-b3fa-ee61252ab972" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3d6dc3cb-4089-4146-9a25-b254bb222b97" xlink:to="loc_us-gaap_OperatingIncomeLoss_536703e4-64bf-47d1-b3fa-ee61252ab972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_5fe67e90-3936-452c-a08b-bbdbeb03dd71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3d6dc3cb-4089-4146-9a25-b254bb222b97" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_5fe67e90-3936-452c-a08b-bbdbeb03dd71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_8272787e-8ebf-44e9-8b36-f1a777fcb0ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_5fe67e90-3936-452c-a08b-bbdbeb03dd71" xlink:to="loc_us-gaap_InterestExpense_8272787e-8ebf-44e9-8b36-f1a777fcb0ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_16864bf8-fe79-4d7a-8e0c-64e0ec7ecea4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_5fe67e90-3936-452c-a08b-bbdbeb03dd71" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_16864bf8-fe79-4d7a-8e0c-64e0ec7ecea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_af7028ac-05d4-4f21-a76e-d94183efc356" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_5fe67e90-3936-452c-a08b-bbdbeb03dd71" xlink:to="loc_us-gaap_InvestmentIncomeNet_af7028ac-05d4-4f21-a76e-d94183efc356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_34275be9-a706-491e-9451-4d0c50942fc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_5fe67e90-3936-452c-a08b-bbdbeb03dd71" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_34275be9-a706-491e-9451-4d0c50942fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_05d859a6-eced-4bd7-ad5f-e893ad2dab2f" xlink:href="lh-20200930.xsd#lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3d6dc3cb-4089-4146-9a25-b254bb222b97" xlink:to="loc_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_05d859a6-eced-4bd7-ad5f-e893ad2dab2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b017bb8c-9aa3-4de5-83f2-66baa66707e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3d6dc3cb-4089-4146-9a25-b254bb222b97" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b017bb8c-9aa3-4de5-83f2-66baa66707e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ae164418-baf1-4398-9f3b-09aceeb17ab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3d6dc3cb-4089-4146-9a25-b254bb222b97" xlink:to="loc_us-gaap_ProfitLoss_ae164418-baf1-4398-9f3b-09aceeb17ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c38944cf-f561-480d-912e-dbf051d0887f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3d6dc3cb-4089-4146-9a25-b254bb222b97" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c38944cf-f561-480d-912e-dbf051d0887f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_88e2b135-e79e-4bd0-93d7-a863c62ec4bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3d6dc3cb-4089-4146-9a25-b254bb222b97" xlink:to="loc_us-gaap_NetIncomeLoss_88e2b135-e79e-4bd0-93d7-a863c62ec4bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_31898c36-09ab-4ebc-9b40-1539708985c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3d6dc3cb-4089-4146-9a25-b254bb222b97" xlink:to="loc_us-gaap_EarningsPerShareBasic_31898c36-09ab-4ebc-9b40-1539708985c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_f302a3f8-a2b4-4cf8-8f65-ec8855264ee6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3d6dc3cb-4089-4146-9a25-b254bb222b97" xlink:to="loc_us-gaap_EarningsPerShareDiluted_f302a3f8-a2b4-4cf8-8f65-ec8855264ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited" xlink:type="simple" xlink:href="lh-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_5975f43f-eb66-4b62-8445-8c90e08d69d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_46eaf2db-3b29-4e92-bbaa-3c924723f286" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_5975f43f-eb66-4b62-8445-8c90e08d69d4" xlink:to="loc_us-gaap_StatementTable_46eaf2db-3b29-4e92-bbaa-3c924723f286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_8f915a53-e950-4952-924e-17e9e16244f0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_46eaf2db-3b29-4e92-bbaa-3c924723f286" xlink:to="loc_srt_StatementScenarioAxis_8f915a53-e950-4952-924e-17e9e16244f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_92663898-cf29-4ddd-87fc-2573da642f3b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_8f915a53-e950-4952-924e-17e9e16244f0" xlink:to="loc_srt_ScenarioUnspecifiedDomain_92663898-cf29-4ddd-87fc-2573da642f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c9310371-9cd4-4efe-b5d3-e0abdd9eb364" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_46eaf2db-3b29-4e92-bbaa-3c924723f286" xlink:to="loc_us-gaap_StatementLineItems_c9310371-9cd4-4efe-b5d3-e0abdd9eb364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetRestructuringAndOtherSpecialCharges_85fcb5fb-92bc-4d4e-9268-af9d978526f0" xlink:href="lh-20200930.xsd#lh_NetRestructuringAndOtherSpecialCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c9310371-9cd4-4efe-b5d3-e0abdd9eb364" xlink:to="loc_lh_NetRestructuringAndOtherSpecialCharges_85fcb5fb-92bc-4d4e-9268-af9d978526f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_635ed6d2-2cfa-475b-a6c8-ad77b5992833" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c9310371-9cd4-4efe-b5d3-e0abdd9eb364" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_635ed6d2-2cfa-475b-a6c8-ad77b5992833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_dabdf340-6a76-4d03-93d5-f6af0e5e3fbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_5975f43f-eb66-4b62-8445-8c90e08d69d4" xlink:to="loc_us-gaap_ProfitLoss_dabdf340-6a76-4d03-93d5-f6af0e5e3fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b1d707be-a8a6-4305-a7a9-683ec0dcd8f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_5975f43f-eb66-4b62-8445-8c90e08d69d4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b1d707be-a8a6-4305-a7a9-683ec0dcd8f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_8d1d4534-4950-4175-a12e-3371fefa36c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b1d707be-a8a6-4305-a7a9-683ec0dcd8f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_8d1d4534-4950-4175-a12e-3371fefa36c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_5ccccc73-1509-437d-9acf-40b2a250a6eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b1d707be-a8a6-4305-a7a9-683ec0dcd8f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_5ccccc73-1509-437d-9acf-40b2a250a6eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_70fff31a-9139-4efd-83da-12057e5791d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b1d707be-a8a6-4305-a7a9-683ec0dcd8f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_70fff31a-9139-4efd-83da-12057e5791d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_dc81447d-a33f-4fe4-bfd7-740282a37bfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b1d707be-a8a6-4305-a7a9-683ec0dcd8f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_dc81447d-a33f-4fe4-bfd7-740282a37bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_84409bce-9cc5-476a-9028-f1f64404ab39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b1d707be-a8a6-4305-a7a9-683ec0dcd8f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_84409bce-9cc5-476a-9028-f1f64404ab39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_8de30422-8865-4f9d-a23e-85edbe4feddc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_5975f43f-eb66-4b62-8445-8c90e08d69d4" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_8de30422-8865-4f9d-a23e-85edbe4feddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_5cb54565-998a-4fef-9442-7fa2b522005a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_5975f43f-eb66-4b62-8445-8c90e08d69d4" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_5cb54565-998a-4fef-9442-7fa2b522005a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_26f65061-ee30-4475-9a14-9af6c532e461" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_5975f43f-eb66-4b62-8445-8c90e08d69d4" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_26f65061-ee30-4475-9a14-9af6c532e461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited" xlink:type="simple" xlink:href="lh-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_d1533871-be2f-41bf-8160-1ab3e7b15cd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_efc02c8f-3959-4285-96aa-4e40c7b59810" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_d1533871-be2f-41bf-8160-1ab3e7b15cd3" xlink:to="loc_us-gaap_StatementTable_efc02c8f-3959-4285-96aa-4e40c7b59810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_00a13334-8034-42ab-85dd-b180886a762b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_efc02c8f-3959-4285-96aa-4e40c7b59810" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_00a13334-8034-42ab-85dd-b180886a762b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_22dbaa9b-a84c-4597-8d70-ed2bf2cc6aa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_00a13334-8034-42ab-85dd-b180886a762b" xlink:to="loc_us-gaap_EquityComponentDomain_22dbaa9b-a84c-4597-8d70-ed2bf2cc6aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_75f89c53-dcfc-478d-b74b-4665fa9e30a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_22dbaa9b-a84c-4597-8d70-ed2bf2cc6aa7" xlink:to="loc_us-gaap_CommonStockMember_75f89c53-dcfc-478d-b74b-4665fa9e30a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_51643865-b0ee-4a35-bb7b-768462a2f61c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_22dbaa9b-a84c-4597-8d70-ed2bf2cc6aa7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_51643865-b0ee-4a35-bb7b-768462a2f61c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_2f360b9a-b271-4749-88db-60af0a0e5287" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_22dbaa9b-a84c-4597-8d70-ed2bf2cc6aa7" xlink:to="loc_us-gaap_RetainedEarningsMember_2f360b9a-b271-4749-88db-60af0a0e5287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_cc75d62c-e91d-4633-a90c-e4129e1567ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_22dbaa9b-a84c-4597-8d70-ed2bf2cc6aa7" xlink:to="loc_us-gaap_TreasuryStockMember_cc75d62c-e91d-4633-a90c-e4129e1567ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_74db8996-b2e0-4e2e-b412-28d1fa98737b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_22dbaa9b-a84c-4597-8d70-ed2bf2cc6aa7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_74db8996-b2e0-4e2e-b412-28d1fa98737b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_6e6322ce-ff24-4738-b148-cdef16aff293" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_efc02c8f-3959-4285-96aa-4e40c7b59810" xlink:to="loc_srt_RestatementAxis_6e6322ce-ff24-4738-b148-cdef16aff293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_f046e313-c874-4cb4-99f1-e89744cc4b96" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_6e6322ce-ff24-4738-b148-cdef16aff293" xlink:to="loc_srt_RestatementDomain_f046e313-c874-4cb4-99f1-e89744cc4b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_e96d1021-8f23-46ec-aa8e-6be481521fca" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_f046e313-c874-4cb4-99f1-e89744cc4b96" xlink:to="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_e96d1021-8f23-46ec-aa8e-6be481521fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e15fdeb6-e5cd-41db-a61a-ccd4fbd877ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_efc02c8f-3959-4285-96aa-4e40c7b59810" xlink:to="loc_us-gaap_StatementLineItems_e15fdeb6-e5cd-41db-a61a-ccd4fbd877ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e4fd63d5-f6e8-4dd0-b162-4875ad096caf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e15fdeb6-e5cd-41db-a61a-ccd4fbd877ee" xlink:to="loc_us-gaap_StockholdersEquity_e4fd63d5-f6e8-4dd0-b162-4875ad096caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c3ef4f39-159d-4215-86bb-06a62b2fce03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e15fdeb6-e5cd-41db-a61a-ccd4fbd877ee" xlink:to="loc_us-gaap_NetIncomeLoss_c3ef4f39-159d-4215-86bb-06a62b2fce03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2737f23d-280b-445b-98f2-cf34e46f01aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e15fdeb6-e5cd-41db-a61a-ccd4fbd877ee" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2737f23d-280b-445b-98f2-cf34e46f01aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Issuanceofcommonstockunderemployeeplans_6cf6ae3b-01df-4d7d-9041-30a455c42334" xlink:href="lh-20200930.xsd#lh_Issuanceofcommonstockunderemployeeplans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e15fdeb6-e5cd-41db-a61a-ccd4fbd877ee" xlink:to="loc_lh_Issuanceofcommonstockunderemployeeplans_6cf6ae3b-01df-4d7d-9041-30a455c42334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_1abd8b7d-3118-45dc-ac73-a0c7fef767df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e15fdeb6-e5cd-41db-a61a-ccd4fbd877ee" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_1abd8b7d-3118-45dc-ac73-a0c7fef767df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ConversionOfZeroCouponConvertibleDebt_651eb808-dad2-4a4b-88d4-1d3316b555bf" xlink:href="lh-20200930.xsd#lh_ConversionOfZeroCouponConvertibleDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e15fdeb6-e5cd-41db-a61a-ccd4fbd877ee" xlink:to="loc_lh_ConversionOfZeroCouponConvertibleDebt_651eb808-dad2-4a4b-88d4-1d3316b555bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_6a01ebba-7446-4b48-9f51-a3af7b818a7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e15fdeb6-e5cd-41db-a61a-ccd4fbd877ee" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_6a01ebba-7446-4b48-9f51-a3af7b818a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_60031355-590f-4343-85e0-777f39242230" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e15fdeb6-e5cd-41db-a61a-ccd4fbd877ee" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_60031355-590f-4343-85e0-777f39242230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_43b24799-1bb8-4b63-a176-a092ffd39087" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e15fdeb6-e5cd-41db-a61a-ccd4fbd877ee" xlink:to="loc_us-gaap_StockholdersEquity_43b24799-1bb8-4b63-a176-a092ffd39087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1b382f61-177f-48a2-9847-99db3b9c077a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e15fdeb6-e5cd-41db-a61a-ccd4fbd877ee" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1b382f61-177f-48a2-9847-99db3b9c077a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_91bd53dc-2dd8-4cbe-914b-27e3fceef908" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e15fdeb6-e5cd-41db-a61a-ccd4fbd877ee" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_91bd53dc-2dd8-4cbe-914b-27e3fceef908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="lh-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_931a9d8b-3ad0-49ab-9d01-d7d43405491e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_24dc457f-40f0-4246-b5ee-19989cc398fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_931a9d8b-3ad0-49ab-9d01-d7d43405491e" xlink:to="loc_us-gaap_StatementTable_24dc457f-40f0-4246-b5ee-19989cc398fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis_b13e951a-460a-4293-a2cf-e4de3fe3eabd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_24dc457f-40f0-4246-b5ee-19989cc398fd" xlink:to="loc_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis_b13e951a-460a-4293-a2cf-e4de3fe3eabd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingGuidanceMember_73049874-b059-4ad4-a920-6c8238fc8c5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingGuidanceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis_b13e951a-460a-4293-a2cf-e4de3fe3eabd" xlink:to="loc_us-gaap_AccountingGuidanceMember_73049874-b059-4ad4-a920-6c8238fc8c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_6cf38df9-a973-43f0-b863-a9784c9cf721" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_24dc457f-40f0-4246-b5ee-19989cc398fd" xlink:to="loc_srt_StatementScenarioAxis_6cf38df9-a973-43f0-b863-a9784c9cf721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_24de143b-4f1c-4834-b42d-0eedcb481828" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_6cf38df9-a973-43f0-b863-a9784c9cf721" xlink:to="loc_srt_ScenarioUnspecifiedDomain_24de143b-4f1c-4834-b42d-0eedcb481828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_656745dc-1d37-4b7b-8452-7d270a0e113c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_24dc457f-40f0-4246-b5ee-19989cc398fd" xlink:to="loc_us-gaap_StatementLineItems_656745dc-1d37-4b7b-8452-7d270a0e113c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_15573457-0a22-4969-8f15-f094eb0e879d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_931a9d8b-3ad0-49ab-9d01-d7d43405491e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_15573457-0a22-4969-8f15-f094eb0e879d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f87eedf3-915a-4c3a-b6e1-58bdf4e5eede" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_15573457-0a22-4969-8f15-f094eb0e879d" xlink:to="loc_us-gaap_ProfitLoss_f87eedf3-915a-4c3a-b6e1-58bdf4e5eede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2f8eba88-5f13-47f0-b015-08b707334bb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_15573457-0a22-4969-8f15-f094eb0e879d" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2f8eba88-5f13-47f0-b015-08b707334bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Contingentconsiderationadjustment_951b738b-bd35-4214-8dd8-00cb7b3b6564" xlink:href="lh-20200930.xsd#lh_Contingentconsiderationadjustment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2f8eba88-5f13-47f0-b015-08b707334bb8" xlink:to="loc_lh_Contingentconsiderationadjustment_951b738b-bd35-4214-8dd8-00cb7b3b6564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DepreciationAndAmortizationOfLeasedAssets_ac5167f6-6156-453c-901f-db96da70b532" xlink:href="lh-20200930.xsd#lh_DepreciationAndAmortizationOfLeasedAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2f8eba88-5f13-47f0-b015-08b707334bb8" xlink:to="loc_lh_DepreciationAndAmortizationOfLeasedAssets_ac5167f6-6156-453c-901f-db96da70b532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_71d7c46b-6dbc-49aa-874d-b971acc49c47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2f8eba88-5f13-47f0-b015-08b707334bb8" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_71d7c46b-6dbc-49aa-874d-b971acc49c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e914f80b-0e93-41fc-83f3-93f43ad7805b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2f8eba88-5f13-47f0-b015-08b707334bb8" xlink:to="loc_us-gaap_ShareBasedCompensation_e914f80b-0e93-41fc-83f3-93f43ad7805b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_2c42ee16-d5f0-4bac-a14d-9ca3526cb502" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2f8eba88-5f13-47f0-b015-08b707334bb8" xlink:to="loc_us-gaap_AssetImpairmentCharges_2c42ee16-d5f0-4bac-a14d-9ca3526cb502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f3b551d2-2c25-4288-968d-bf074a6fcb8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2f8eba88-5f13-47f0-b015-08b707334bb8" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f3b551d2-2c25-4288-968d-bf074a6fcb8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_d614cc90-8efa-4539-bba5-ce1347a2d802" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2f8eba88-5f13-47f0-b015-08b707334bb8" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_d614cc90-8efa-4539-bba5-ce1347a2d802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cf6ef22b-a403-49c8-840f-ba4726a0274c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2f8eba88-5f13-47f0-b015-08b707334bb8" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cf6ef22b-a403-49c8-840f-ba4726a0274c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_43e06da6-3278-400b-96ac-caeaf0dddae5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cf6ef22b-a403-49c8-840f-ba4726a0274c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_43e06da6-3278-400b-96ac-caeaf0dddae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncreaseDecreaseinUnbilledContractReceivable_e1825ac4-8110-43d2-bc97-11382742126d" xlink:href="lh-20200930.xsd#lh_IncreaseDecreaseinUnbilledContractReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cf6ef22b-a403-49c8-840f-ba4726a0274c" xlink:to="loc_lh_IncreaseDecreaseinUnbilledContractReceivable_e1825ac4-8110-43d2-bc97-11382742126d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_8f73a668-ce5d-479f-8d00-7f11d444f04c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cf6ef22b-a403-49c8-840f-ba4726a0274c" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_8f73a668-ce5d-479f-8d00-7f11d444f04c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_8e2f539a-7eee-4f48-ae69-31e32c657841" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cf6ef22b-a403-49c8-840f-ba4726a0274c" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_8e2f539a-7eee-4f48-ae69-31e32c657841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d1d5b618-2d59-42b8-80cf-2ff0b2733dfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cf6ef22b-a403-49c8-840f-ba4726a0274c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d1d5b618-2d59-42b8-80cf-2ff0b2733dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_4e4c3335-2b2b-4c64-b205-28e62fa31a15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cf6ef22b-a403-49c8-840f-ba4726a0274c" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_4e4c3335-2b2b-4c64-b205-28e62fa31a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_4771de55-f585-4a32-8cfb-aacfe54e758a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_15573457-0a22-4969-8f15-f094eb0e879d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_4771de55-f585-4a32-8cfb-aacfe54e758a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1f5bb4c6-41fe-4732-8e2e-0472aacc01ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_15573457-0a22-4969-8f15-f094eb0e879d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1f5bb4c6-41fe-4732-8e2e-0472aacc01ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5b0dd8f8-b31e-42e9-8494-99cc1181cca0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_931a9d8b-3ad0-49ab-9d01-d7d43405491e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5b0dd8f8-b31e-42e9-8494-99cc1181cca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_015509ef-85dc-4c3a-9375-f766fe6f5091" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5b0dd8f8-b31e-42e9-8494-99cc1181cca0" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_015509ef-85dc-4c3a-9375-f766fe6f5091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_bfa063af-405c-4614-9d3f-e1f592582782" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5b0dd8f8-b31e-42e9-8494-99cc1181cca0" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_bfa063af-405c-4614-9d3f-e1f592582782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_7a072602-61a5-45fc-8f5d-6bbf889bfb26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5b0dd8f8-b31e-42e9-8494-99cc1181cca0" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_7a072602-61a5-45fc-8f5d-6bbf889bfb26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_43defe55-dbbe-4cb7-87c3-4aa6b2979892" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5b0dd8f8-b31e-42e9-8494-99cc1181cca0" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_43defe55-dbbe-4cb7-87c3-4aa6b2979892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_29bb2885-7b27-4f4e-abb6-5c9786298798" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5b0dd8f8-b31e-42e9-8494-99cc1181cca0" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_29bb2885-7b27-4f4e-abb6-5c9786298798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_733f6b26-1d13-4804-a766-ee583ba5fafb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5b0dd8f8-b31e-42e9-8494-99cc1181cca0" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_733f6b26-1d13-4804-a766-ee583ba5fafb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_62148fdf-b8cf-47ed-a6a7-e87566e94202" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5b0dd8f8-b31e-42e9-8494-99cc1181cca0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_62148fdf-b8cf-47ed-a6a7-e87566e94202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e2b95f8-5a17-43dc-8aec-4e4b7d5bafd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_931a9d8b-3ad0-49ab-9d01-d7d43405491e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e2b95f8-5a17-43dc-8aec-4e4b7d5bafd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_2aeacbe4-bd33-49d6-aa18-9fdfffae4d6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e2b95f8-5a17-43dc-8aec-4e4b7d5bafd8" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_2aeacbe4-bd33-49d6-aa18-9fdfffae4d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_8c096a88-bcb3-4890-9aa2-a347ef4a2331" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e2b95f8-5a17-43dc-8aec-4e4b7d5bafd8" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_8c096a88-bcb3-4890-9aa2-a347ef4a2331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetProceedsFromIssuanceOfStockToEmployees_bee59338-4638-4cbc-9860-f215a46b56d5" xlink:href="lh-20200930.xsd#lh_NetProceedsFromIssuanceOfStockToEmployees"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e2b95f8-5a17-43dc-8aec-4e4b7d5bafd8" xlink:to="loc_lh_NetProceedsFromIssuanceOfStockToEmployees_bee59338-4638-4cbc-9860-f215a46b56d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ae719c61-3d0f-461e-b5f8-a35bcf58857a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e2b95f8-5a17-43dc-8aec-4e4b7d5bafd8" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ae719c61-3d0f-461e-b5f8-a35bcf58857a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OtherFinancingCashFlows_f0fb943f-6bfc-469e-8012-f13aad434d7f" xlink:href="lh-20200930.xsd#lh_OtherFinancingCashFlows"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e2b95f8-5a17-43dc-8aec-4e4b7d5bafd8" xlink:to="loc_lh_OtherFinancingCashFlows_f0fb943f-6bfc-469e-8012-f13aad434d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_0c854f45-7f5d-4859-8313-80d3770e9851" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e2b95f8-5a17-43dc-8aec-4e4b7d5bafd8" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_0c854f45-7f5d-4859-8313-80d3770e9851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_fa9a25df-652b-42b3-91d6-af41a3f89707" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e2b95f8-5a17-43dc-8aec-4e4b7d5bafd8" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_fa9a25df-652b-42b3-91d6-af41a3f89707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6dc7f65a-527b-412c-9ada-cacd7f6e4016" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e2b95f8-5a17-43dc-8aec-4e4b7d5bafd8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6dc7f65a-527b-412c-9ada-cacd7f6e4016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_49215fd8-c9a2-4d96-8cd0-599b6dbbb735" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_931a9d8b-3ad0-49ab-9d01-d7d43405491e" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_49215fd8-c9a2-4d96-8cd0-599b6dbbb735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1f0423e3-68ab-40b3-bccb-64699ce55462" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_931a9d8b-3ad0-49ab-9d01-d7d43405491e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1f0423e3-68ab-40b3-bccb-64699ce55462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2e1dbe84-45cf-41fb-8c55-d459faddd4e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_931a9d8b-3ad0-49ab-9d01-d7d43405491e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2e1dbe84-45cf-41fb-8c55-d459faddd4e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7cef4139-4bdb-4764-bbf2-86a920e90a4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_931a9d8b-3ad0-49ab-9d01-d7d43405491e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7cef4139-4bdb-4764-bbf2-86a920e90a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_56a1f165-fe12-449b-8cbd-1249ab111f5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_931a9d8b-3ad0-49ab-9d01-d7d43405491e" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_56a1f165-fe12-449b-8cbd-1249ab111f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt_686d7423-d0e5-4ee1-aef8-e7e86a99dac6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_931a9d8b-3ad0-49ab-9d01-d7d43405491e" xlink:to="loc_us-gaap_RepaymentsOfOtherLongTermDebt_686d7423-d0e5-4ee1-aef8-e7e86a99dac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATION" xlink:type="simple" xlink:href="lh-20200930.xsd#BASISOFFINANCIALSTATEMENTPRESENTATION"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_58850ed3-0c69-4a10-9026-4c974d03d479" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_c17b4f7f-d9cc-4aea-9695-8a713a54233c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_58850ed3-0c69-4a10-9026-4c974d03d479" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_c17b4f7f-d9cc-4aea-9695-8a713a54233c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_e3c139c4-7322-4cd1-a54b-80b453b959c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_58850ed3-0c69-4a10-9026-4c974d03d479" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_e3c139c4-7322-4cd1-a54b-80b453b959c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONUseofEstimatesPolicies" xlink:type="simple" xlink:href="lh-20200930.xsd#BASISOFFINANCIALSTATEMENTPRESENTATIONUseofEstimatesPolicies"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONUseofEstimatesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d5c508ef-31cb-4f52-a3fa-d9b793bce2f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_875dae7a-e3ce-492a-91b6-bdde47f73e12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d5c508ef-31cb-4f52-a3fa-d9b793bce2f5" xlink:to="loc_us-gaap_UseOfEstimates_875dae7a-e3ce-492a-91b6-bdde47f73e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_RecentlyAdoptedAccountingGuidancePolicyTextBlock_d91be7bb-1189-40cb-82ce-7473b93f317f" xlink:href="lh-20200930.xsd#lh_RecentlyAdoptedAccountingGuidancePolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d5c508ef-31cb-4f52-a3fa-d9b793bce2f5" xlink:to="loc_lh_RecentlyAdoptedAccountingGuidancePolicyTextBlock_d91be7bb-1189-40cb-82ce-7473b93f317f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONNewAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="lh-20200930.xsd#BASISOFFINANCIALSTATEMENTPRESENTATIONNewAccountingPronouncementsPolicies"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONNewAccountingPronouncementsPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d05ddba0-f796-491f-9a6f-ab4b47379a8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_5bf24d1a-15fa-41bd-ad32-2efedba04bc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d05ddba0-f796-491f-9a6f-ab4b47379a8f" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_5bf24d1a-15fa-41bd-ad32-2efedba04bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONNovelCoronavirusCOVID19FinancialStatementImpactPolicies" xlink:type="simple" xlink:href="lh-20200930.xsd#BASISOFFINANCIALSTATEMENTPRESENTATIONNovelCoronavirusCOVID19FinancialStatementImpactPolicies"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONNovelCoronavirusCOVID19FinancialStatementImpactPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7e0339bc-20b2-41dc-b0cc-3f81fa4518f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock_f86ef9a8-d737-4862-a3da-c81311d88577" xlink:href="lh-20200930.xsd#lh_NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7e0339bc-20b2-41dc-b0cc-3f81fa4518f6" xlink:to="loc_lh_NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock_f86ef9a8-d737-4862-a3da-c81311d88577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONRecentlyAdoptedAccountingStandardsPolicies" xlink:type="simple" xlink:href="lh-20200930.xsd#BASISOFFINANCIALSTATEMENTPRESENTATIONRecentlyAdoptedAccountingStandardsPolicies"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONRecentlyAdoptedAccountingStandardsPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f7b84de0-c1b1-4a5e-80e6-f7c388bb3e46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_RecentlyAdoptedAccountingGuidancePolicyTextBlock_37a137ca-08f3-4e43-99d3-4ddf8697e7d9" xlink:href="lh-20200930.xsd#lh_RecentlyAdoptedAccountingGuidancePolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f7b84de0-c1b1-4a5e-80e6-f7c388bb3e46" xlink:to="loc_lh_RecentlyAdoptedAccountingGuidancePolicyTextBlock_37a137ca-08f3-4e43-99d3-4ddf8697e7d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONRestatedFinancialStatements" xlink:type="simple" xlink:href="lh-20200930.xsd#BASISOFFINANCIALSTATEMENTPRESENTATIONRestatedFinancialStatements"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONRestatedFinancialStatements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_71bf278c-1ab7-485a-b7ef-cb01f66b501b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_71bf278c-1ab7-485a-b7ef-cb01f66b501b" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fb877280-fff4-408f-9638-e0d494ba6b7d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:to="loc_srt_RangeAxis_fb877280-fff4-408f-9638-e0d494ba6b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0281b7b4-1976-45e6-a7c2-4e41244db3c9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fb877280-fff4-408f-9638-e0d494ba6b7d" xlink:to="loc_srt_RangeMember_0281b7b4-1976-45e6-a7c2-4e41244db3c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f96cf080-59dc-4faa-8838-69977b519d21" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0281b7b4-1976-45e6-a7c2-4e41244db3c9" xlink:to="loc_srt_MinimumMember_f96cf080-59dc-4faa-8838-69977b519d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f8803734-efee-4de4-a2d8-7816ec53d17a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0281b7b4-1976-45e6-a7c2-4e41244db3c9" xlink:to="loc_srt_MaximumMember_f8803734-efee-4de4-a2d8-7816ec53d17a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9f75e25e-7c48-4b10-96eb-c7d32aeb068f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9f75e25e-7c48-4b10-96eb-c7d32aeb068f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fbf2ed18-bf07-4b4e-8e03-33dbc650cd14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9f75e25e-7c48-4b10-96eb-c7d32aeb068f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fbf2ed18-bf07-4b4e-8e03-33dbc650cd14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b4933984-9acc-4452-812b-ff9f74ddbcda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b4933984-9acc-4452-812b-ff9f74ddbcda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1edc297d-6771-486a-abbf-1dbfe496f5ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b4933984-9acc-4452-812b-ff9f74ddbcda" xlink:to="loc_us-gaap_EquityComponentDomain_1edc297d-6771-486a-abbf-1dbfe496f5ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_7d5a42dc-6d92-4314-bc14-2686b7269bb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1edc297d-6771-486a-abbf-1dbfe496f5ba" xlink:to="loc_us-gaap_RetainedEarningsMember_7d5a42dc-6d92-4314-bc14-2686b7269bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashFlowLocationAxis_3fcb2669-3ae9-4ba0-b2f0-9af68f8e4c81" xlink:href="lh-20200930.xsd#lh_CashFlowLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:to="loc_lh_CashFlowLocationAxis_3fcb2669-3ae9-4ba0-b2f0-9af68f8e4c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashFlowLocationDomain_c3472bf1-f9a3-490d-86b8-4f548c64896f" xlink:href="lh-20200930.xsd#lh_CashFlowLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CashFlowLocationAxis_3fcb2669-3ae9-4ba0-b2f0-9af68f8e4c81" xlink:to="loc_lh_CashFlowLocationDomain_c3472bf1-f9a3-490d-86b8-4f548c64896f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0b5bc051-b069-44e4-b810-b17754767df0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0b5bc051-b069-44e4-b810-b17754767df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e69ad89d-0a00-43bb-b904-10e12d1868c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0b5bc051-b069-44e4-b810-b17754767df0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e69ad89d-0a00-43bb-b904-10e12d1868c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EquityMethodIncomeLossNetDomain_f196f2b8-1af5-49c1-93c6-aaa25ab819f0" xlink:href="lh-20200930.xsd#lh_EquityMethodIncomeLossNetDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e69ad89d-0a00-43bb-b904-10e12d1868c7" xlink:to="loc_lh_EquityMethodIncomeLossNetDomain_f196f2b8-1af5-49c1-93c6-aaa25ab819f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_5dbc6477-241b-4478-b793-322441d32b1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e69ad89d-0a00-43bb-b904-10e12d1868c7" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_5dbc6477-241b-4478-b793-322441d32b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_3349c692-4020-48bb-905c-fdda198df4b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_3349c692-4020-48bb-905c-fdda198df4b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_55976be3-d1dd-47ee-91b6-5406b0e8bfac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3349c692-4020-48bb-905c-fdda198df4b4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_55976be3-d1dd-47ee-91b6-5406b0e8bfac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis_df84e5b6-da72-4c98-b6bf-a172d7776ddb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:to="loc_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis_df84e5b6-da72-4c98-b6bf-a172d7776ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingGuidanceMember_5b9ba2db-45a5-4a62-bfb4-8f98939713a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingGuidanceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis_df84e5b6-da72-4c98-b6bf-a172d7776ddb" xlink:to="loc_us-gaap_AccountingGuidanceMember_5b9ba2db-45a5-4a62-bfb4-8f98939713a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9ba87d98-96c6-43f6-8614-b3d57929650b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9ba87d98-96c6-43f6-8614-b3d57929650b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f7b4fd79-e338-4472-8fd7-7977451bae64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9ba87d98-96c6-43f6-8614-b3d57929650b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f7b4fd79-e338-4472-8fd7-7977451bae64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_62b0b906-0c29-4f51-87f6-51decda2a468" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_62b0b906-0c29-4f51-87f6-51decda2a468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_82776f12-64b9-4fc8-bd6b-afa66790d62c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_62b0b906-0c29-4f51-87f6-51decda2a468" xlink:to="loc_us-gaap_SegmentDomain_82776f12-64b9-4fc8-bd6b-afa66790d62c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_f9ad6dcd-7836-4c70-a7f1-31b877e5201f" xlink:href="lh-20200930.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_82776f12-64b9-4fc8-bd6b-afa66790d62c" xlink:to="loc_lh_LabCorpDiagnosticsMember_f9ad6dcd-7836-4c70-a7f1-31b877e5201f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_a11b2c5a-852c-4609-b2e1-8134c590876f" xlink:href="lh-20200930.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_82776f12-64b9-4fc8-bd6b-afa66790d62c" xlink:to="loc_lh_CovanceDrugDevelopmentMember_a11b2c5a-852c-4609-b2e1-8134c590876f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e3c5f723-6d3d-4b3e-aed0-053715c14749" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e3c5f723-6d3d-4b3e-aed0-053715c14749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_70870c2f-10d2-401b-b379-679ab1514215" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e3c5f723-6d3d-4b3e-aed0-053715c14749" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_70870c2f-10d2-401b-b379-679ab1514215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CARESActFundsAxis_32c5fd1d-201c-4199-b280-b2e876e10e62" xlink:href="lh-20200930.xsd#lh_CARESActFundsAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:to="loc_lh_CARESActFundsAxis_32c5fd1d-201c-4199-b280-b2e876e10e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AccruedLiabilityForCARESActFundsToBeReturnedToGovernmentDomain_82f783f5-57ad-497a-b8e7-8c9e8bbd5f22" xlink:href="lh-20200930.xsd#lh_AccruedLiabilityForCARESActFundsToBeReturnedToGovernmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CARESActFundsAxis_32c5fd1d-201c-4199-b280-b2e876e10e62" xlink:to="loc_lh_AccruedLiabilityForCARESActFundsToBeReturnedToGovernmentDomain_82f783f5-57ad-497a-b8e7-8c9e8bbd5f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_COVID19PandemicAxis_599a2115-b5a1-4f2e-85e2-e5fdd23c863e" xlink:href="lh-20200930.xsd#lh_COVID19PandemicAxis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:to="loc_lh_COVID19PandemicAxis_599a2115-b5a1-4f2e-85e2-e5fdd23c863e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairmentDomain_9c3f5cf4-f1c9-4b94-9e97-bf231deefff6" xlink:href="lh-20200930.xsd#lh_COVID19PandemicGoodwillAndIntangibleAssetImpairmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_COVID19PandemicAxis_599a2115-b5a1-4f2e-85e2-e5fdd23c863e" xlink:to="loc_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairmentDomain_9c3f5cf4-f1c9-4b94-9e97-bf231deefff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b26a3a8e-7277-4816-99c4-6bfc9bf9f5a5" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_6d1187c5-fb2e-4328-a3a5-38f213e39f27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_AssetImpairmentCharges_6d1187c5-fb2e-4328-a3a5-38f213e39f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_6cf2708b-59dd-4c9f-bf3a-9410bf2d0fb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_Revenues_6cf2708b-59dd-4c9f-bf3a-9410bf2d0fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_b1a8a3f9-97e0-4f27-bb08-9a31e186e705" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_CostOfRevenue_b1a8a3f9-97e0-4f27-bb08-9a31e186e705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_b98ed174-1d0c-4a09-b0e8-38d00e28e357" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_ContractWithCustomerLiability_b98ed174-1d0c-4a09-b0e8-38d00e28e357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredSalesCommissions_e307652d-6be4-4f89-99de-52d457adae61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDeferredSalesCommissions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_AmortizationOfDeferredSalesCommissions_e307652d-6be4-4f89-99de-52d457adae61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_dbcf85d1-3537-44db-9c0b-2677279957a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_AssetsCurrent_dbcf85d1-3537-44db-9c0b-2677279957a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9eb25e95-1a8e-4fb9-8d45-549f8f86c058" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9eb25e95-1a8e-4fb9-8d45-549f8f86c058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentofRevenueContributed_82739f04-50db-4f0c-99ab-45ed33530eae" xlink:href="lh-20200930.xsd#lh_PercentofRevenueContributed"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_lh_PercentofRevenueContributed_82739f04-50db-4f0c-99ab-45ed33530eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b8ef8aba-b598-4d95-bf89-838618e6c10a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b8ef8aba-b598-4d95-bf89-838618e6c10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_1da163f5-8d5e-463f-b88d-015a58cd5447" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_1da163f5-8d5e-463f-b88d-015a58cd5447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b61fa9fb-a842-4ecb-bedc-791df25a483d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b61fa9fb-a842-4ecb-bedc-791df25a483d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0fdbc332-e19a-4a46-bf9c-097652515f0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_ProfitLoss_0fdbc332-e19a-4a46-bf9c-097652515f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d0b53f5f-680c-4461-a727-14b8b2d17d76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_NetIncomeLoss_d0b53f5f-680c-4461-a727-14b8b2d17d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_bd877f7f-27dd-4364-ad12-150a974f6fb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_EarningsPerShareBasic_bd877f7f-27dd-4364-ad12-150a974f6fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_0ca90b22-1e4a-40d0-abd6-8a86436a4de7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_EarningsPerShareDiluted_0ca90b22-1e4a-40d0-abd6-8a86436a4de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fce88987-49b5-4a12-b5be-4671cdea697b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fce88987-49b5-4a12-b5be-4671cdea697b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_997bdf39-78f2-4043-9d18-1084c635f25f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_997bdf39-78f2-4043-9d18-1084c635f25f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_d86d5c03-00f3-4ef4-9f6c-8e2d0677e298" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_d86d5c03-00f3-4ef4-9f6c-8e2d0677e298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_04cf5ab5-e3ad-44b5-9a43-88eef05cc9cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_Assets_04cf5ab5-e3ad-44b5-9a43-88eef05cc9cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1d499e49-ff15-46a8-ace2-b8344f85f5c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_LiabilitiesCurrent_1d499e49-ff15-46a8-ace2-b8344f85f5c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoncontrollingInterestMezzanineEquity_e4356315-4be2-4ddb-b7ae-1b6204511cbe" xlink:href="lh-20200930.xsd#lh_NoncontrollingInterestMezzanineEquity"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_lh_NoncontrollingInterestMezzanineEquity_e4356315-4be2-4ddb-b7ae-1b6204511cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9dbc024e-dbe4-49c3-8318-c8055fbd0a7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_StockholdersEquity_9dbc024e-dbe4-49c3-8318-c8055fbd0a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_debb6ca0-8147-46cb-ae04-876d3b35ad60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_debb6ca0-8147-46cb-ae04-876d3b35ad60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_6e046185-d928-4bf8-86d9-78cc8b7f98df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_6e046185-d928-4bf8-86d9-78cc8b7f98df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueRevenueRecognized1_92ebf5ca-2c12-45ab-96b2-db06774e37eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueRevenueRecognized1"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_DeferredRevenueRevenueRecognized1_92ebf5ca-2c12-45ab-96b2-db06774e37eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_f8b4ee0b-c2ed-4a4d-8f8d-a678141fc6d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_f8b4ee0b-c2ed-4a4d-8f8d-a678141fc6d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_b4ae328b-7684-4523-b8ac-b21d0fc8607e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_b4ae328b-7684-4523-b8ac-b21d0fc8607e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_df0530b8-ac36-4779-b29f-b15588e28667" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_df0530b8-ac36-4779-b29f-b15588e28667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_453917fc-aa6d-44c3-9f4c-27aacb56eb5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_453917fc-aa6d-44c3-9f4c-27aacb56eb5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfInvestments_f8121b1b-46ab-4ae6-b165-d11a5037405c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfInvestments"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_us-gaap_ImpairmentOfInvestments_f8121b1b-46ab-4ae6-b165-d11a5037405c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashPaymentReceivedAppropriatedbyU.S.CongressCovid19_9d724221-33b6-4c45-98b7-207ec2d8f3d3" xlink:href="lh-20200930.xsd#lh_CashPaymentReceivedAppropriatedbyU.S.CongressCovid19"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_lh_CashPaymentReceivedAppropriatedbyU.S.CongressCovid19_9d724221-33b6-4c45-98b7-207ec2d8f3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CARESActFundsAccruedLiabilitiesAndOtherLiabilities_707c32f0-f8ea-43e5-80ad-423bd76cbe02" xlink:href="lh-20200930.xsd#lh_CARESActFundsAccruedLiabilitiesAndOtherLiabilities"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_lh_CARESActFundsAccruedLiabilitiesAndOtherLiabilities_707c32f0-f8ea-43e5-80ad-423bd76cbe02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairment_b577ffa2-e4f9-4b01-b260-09d93133d3ad" xlink:href="lh-20200930.xsd#lh_COVID19PandemicGoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8761a28-e102-4d0c-b5cf-8f3ae8738835" xlink:to="loc_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairment_b577ffa2-e4f9-4b01-b260-09d93133d3ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CostMethodInvestmentsMaximumOwnershipPercentage_49930b40-0742-4886-8c21-e163ad5e4ac5" xlink:href="lh-20200930.xsd#lh_CostMethodInvestmentsMaximumOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_71bf278c-1ab7-485a-b7ef-cb01f66b501b" xlink:to="loc_lh_CostMethodInvestmentsMaximumOwnershipPercentage_49930b40-0742-4886-8c21-e163ad5e4ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="lh-20200930.xsd#EARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/EARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_275c7a97-24c0-4ae4-a950-7ef66933b349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_68fd1d67-022d-4b06-96f8-1c5f38a97687" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_275c7a97-24c0-4ae4-a950-7ef66933b349" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_68fd1d67-022d-4b06-96f8-1c5f38a97687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="lh-20200930.xsd#EARNINGSPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/EARNINGSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_01f724f4-732c-4a96-aa78-de2fb368f80b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e9a974be-202a-4b7d-bbde-c4b7684817d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_01f724f4-732c-4a96-aa78-de2fb368f80b" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e9a974be-202a-4b7d-bbde-c4b7684817d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_8f45ff17-a249-45a5-abcd-148770c04276" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_01f724f4-732c-4a96-aa78-de2fb368f80b" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_8f45ff17-a249-45a5-abcd-148770c04276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_be0c721e-69b8-4413-b9d7-ffffcd889758" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeAbstract_d90a4631-5100-4bff-9c79-dfada0d56a33" xlink:href="lh-20200930.xsd#lh_IncomeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_be0c721e-69b8-4413-b9d7-ffffcd889758" xlink:to="loc_lh_IncomeAbstract_d90a4631-5100-4bff-9c79-dfada0d56a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5f5c9643-01f6-47e9-9ae9-cf7db78be732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_IncomeAbstract_d90a4631-5100-4bff-9c79-dfada0d56a33" xlink:to="loc_us-gaap_NetIncomeLoss_5f5c9643-01f6-47e9-9ae9-cf7db78be732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SharesAbstract_b9751ef2-3a3f-40fa-ba5d-5f80a120a21d" xlink:href="lh-20200930.xsd#lh_SharesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_be0c721e-69b8-4413-b9d7-ffffcd889758" xlink:to="loc_lh_SharesAbstract_b9751ef2-3a3f-40fa-ba5d-5f80a120a21d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a6b7dd60-a554-4179-9703-346254ba3805" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_SharesAbstract_b9751ef2-3a3f-40fa-ba5d-5f80a120a21d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a6b7dd60-a554-4179-9703-346254ba3805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3ff59617-dbb3-45af-98f1-87a3a8b10c79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_SharesAbstract_b9751ef2-3a3f-40fa-ba5d-5f80a120a21d" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3ff59617-dbb3-45af-98f1-87a3a8b10c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PerShareAmountAbstract_cc968b6a-feec-43d3-ab77-f6af736cc173" xlink:href="lh-20200930.xsd#lh_PerShareAmountAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_be0c721e-69b8-4413-b9d7-ffffcd889758" xlink:to="loc_lh_PerShareAmountAbstract_cc968b6a-feec-43d3-ab77-f6af736cc173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_d5805a40-136b-4dc4-94c1-f5bba6649ffc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_PerShareAmountAbstract_cc968b6a-feec-43d3-ab77-f6af736cc173" xlink:to="loc_us-gaap_EarningsPerShareBasic_d5805a40-136b-4dc4-94c1-f5bba6649ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_6b2862d4-2fb4-4f53-b6ec-ac3d002e9261" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_PerShareAmountAbstract_cc968b6a-feec-43d3-ab77-f6af736cc173" xlink:to="loc_us-gaap_EarningsPerShareDiluted_6b2862d4-2fb4-4f53-b6ec-ac3d002e9261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_ca3e2a90-acdf-4bf1-aa62-e314d1c1859c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_be0c721e-69b8-4413-b9d7-ffffcd889758" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_ca3e2a90-acdf-4bf1-aa62-e314d1c1859c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4e3ecaed-0bc3-411a-9f54-1a255a7f5187" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_be0c721e-69b8-4413-b9d7-ffffcd889758" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4e3ecaed-0bc3-411a-9f54-1a255a7f5187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/EARNINGSPERSHAREPotentialcommonsharesnotincludedincomputationofdilutedearningspershareDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#EARNINGSPERSHAREPotentialcommonsharesnotincludedincomputationofdilutedearningspershareDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/EARNINGSPERSHAREPotentialcommonsharesnotincludedincomputationofdilutedearningspershareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_751a1417-9b49-4700-b390-0d34979aadae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2c23e9ef-9261-4199-b851-2f2040d4bd01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_751a1417-9b49-4700-b390-0d34979aadae" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2c23e9ef-9261-4199-b851-2f2040d4bd01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTS" xlink:type="simple" xlink:href="lh-20200930.xsd#NONCONTROLLINGINTERESTPUTS"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTSDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#NONCONTROLLINGINTERESTPUTSDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoncontrollingInterestPutsAbstract_92d87538-6f33-4702-abbd-74b4ab85cd44" xlink:href="lh-20200930.xsd#lh_NoncontrollingInterestPutsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_074b4f7c-3b74-404a-b6db-e8452a7f5dd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_NoncontrollingInterestPutsAbstract_92d87538-6f33-4702-abbd-74b4ab85cd44" xlink:to="loc_us-gaap_MinorityInterestTable_074b4f7c-3b74-404a-b6db-e8452a7f5dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ad643429-7ec2-42d5-a5d1-d2a392e699ee" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_074b4f7c-3b74-404a-b6db-e8452a7f5dd5" xlink:to="loc_dei_LegalEntityAxis_ad643429-7ec2-42d5-a5d1-d2a392e699ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_05a8a847-f847-4be9-ab7b-767f528e4705" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_ad643429-7ec2-42d5-a5d1-d2a392e699ee" xlink:to="loc_dei_EntityDomain_05a8a847-f847-4be9-ab7b-767f528e4705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_64024f1a-825e-4e93-a21d-224a32356fc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_074b4f7c-3b74-404a-b6db-e8452a7f5dd5" xlink:to="loc_us-gaap_MinorityInterestLineItems_64024f1a-825e-4e93-a21d-224a32356fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGES" xlink:type="simple" xlink:href="lh-20200930.xsd#RESTRUCTURINGANDOTHERSPECIALCHARGES"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0603d168-34fb-4f81-b966-bc50357f9416" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_89dd244c-66e3-4efe-867e-7613538e5a90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0603d168-34fb-4f81-b966-bc50357f9416" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_89dd244c-66e3-4efe-867e-7613538e5a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables" xlink:type="simple" xlink:href="lh-20200930.xsd#RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_3ff8b4ca-b51a-4ce9-aaf9-fd99c5720d95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4f27316e-d2ab-404f-91b2-c42d9d9bf8d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_3ff8b4ca-b51a-4ce9-aaf9-fd99c5720d95" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4f27316e-d2ab-404f-91b2-c42d9d9bf8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_532116cc-fb67-432b-a151-6de089740e2d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4f27316e-d2ab-404f-91b2-c42d9d9bf8d7" xlink:to="loc_srt_ConsolidationItemsAxis_532116cc-fb67-432b-a151-6de089740e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_51bd053e-ba96-4a62-808e-b58bc0ab08a8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_532116cc-fb67-432b-a151-6de089740e2d" xlink:to="loc_srt_ConsolidationItemsDomain_51bd053e-ba96-4a62-808e-b58bc0ab08a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1d32770e-c438-46f5-b613-f820de74b1a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4f27316e-d2ab-404f-91b2-c42d9d9bf8d7" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1d32770e-c438-46f5-b613-f820de74b1a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_442bb8f7-c611-47f9-a70f-8213aac91b5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1d32770e-c438-46f5-b613-f820de74b1a0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_442bb8f7-c611-47f9-a70f-8213aac91b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_6f4cd2e0-306e-460c-acf4-a88d1e7b2ac4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4f27316e-d2ab-404f-91b2-c42d9d9bf8d7" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_6f4cd2e0-306e-460c-acf4-a88d1e7b2ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_9e7488a0-b2b8-4dbb-aa13-d20e0ecea111" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_6f4cd2e0-306e-460c-acf4-a88d1e7b2ac4" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_9e7488a0-b2b8-4dbb-aa13-d20e0ecea111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_e9b9be9f-37b7-4a0e-9cc9-6dcba8b3ed34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4f27316e-d2ab-404f-91b2-c42d9d9bf8d7" xlink:to="loc_us-gaap_RestructuringPlanAxis_e9b9be9f-37b7-4a0e-9cc9-6dcba8b3ed34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_8fb96a6f-620d-4f88-bcfa-9304742355e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_e9b9be9f-37b7-4a0e-9cc9-6dcba8b3ed34" xlink:to="loc_us-gaap_RestructuringPlanDomain_8fb96a6f-620d-4f88-bcfa-9304742355e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_30355b3c-0987-4380-a881-b65c829fb0d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4f27316e-d2ab-404f-91b2-c42d9d9bf8d7" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_30355b3c-0987-4380-a881-b65c829fb0d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d6f31fae-aa2d-4c10-bc2d-bc34c1b356c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_30355b3c-0987-4380-a881-b65c829fb0d6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d6f31fae-aa2d-4c10-bc2d-bc34c1b356c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_0d949fa6-5717-46cf-8646-84e59d3a39bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4f27316e-d2ab-404f-91b2-c42d9d9bf8d7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_0d949fa6-5717-46cf-8646-84e59d3a39bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_e16a4397-87f3-4641-b938-48a2af90bc46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_0d949fa6-5717-46cf-8646-84e59d3a39bb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_e16a4397-87f3-4641-b938-48a2af90bc46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_77e66412-555d-4616-a7b7-c12e9b7583b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4f27316e-d2ab-404f-91b2-c42d9d9bf8d7" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_77e66412-555d-4616-a7b7-c12e9b7583b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_8defdd1c-9619-4e7a-87ed-3da4e3ded57d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_77e66412-555d-4616-a7b7-c12e9b7583b0" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_8defdd1c-9619-4e7a-87ed-3da4e3ded57d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#RESTRUCTURINGANDOTHERSPECIALCHARGESDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_171bf931-b258-4e85-83d1-05fe0af21fab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f1c8073a-0f3c-488a-a768-de3d15c1bb3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_171bf931-b258-4e85-83d1-05fe0af21fab" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f1c8073a-0f3c-488a-a768-de3d15c1bb3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_be6dcf18-3e80-4b65-89f3-87be446cd577" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f1c8073a-0f3c-488a-a768-de3d15c1bb3d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_be6dcf18-3e80-4b65-89f3-87be446cd577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3faa87fa-7dcb-46f0-9f01-48d3c1576bba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_be6dcf18-3e80-4b65-89f3-87be446cd577" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3faa87fa-7dcb-46f0-9f01-48d3c1576bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceMember_37cd4300-c725-4bf8-9f73-6024213835f8" xlink:href="lh-20200930.xsd#lh_CovanceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3faa87fa-7dcb-46f0-9f01-48d3c1576bba" xlink:to="loc_lh_CovanceMember_37cd4300-c725-4bf8-9f73-6024213835f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ab4aa1ed-7601-4964-bf21-02bbcafd889a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f1c8073a-0f3c-488a-a768-de3d15c1bb3d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ab4aa1ed-7601-4964-bf21-02bbcafd889a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_345fca65-3722-45b0-9947-cc1dfb975256" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ab4aa1ed-7601-4964-bf21-02bbcafd889a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_345fca65-3722-45b0-9947-cc1dfb975256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_edb81221-704a-4a06-8296-383f7ee9afef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f1c8073a-0f3c-488a-a768-de3d15c1bb3d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_edb81221-704a-4a06-8296-383f7ee9afef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fc34d82d-c0d6-4f2f-8fc2-634b681856d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_edb81221-704a-4a06-8296-383f7ee9afef" xlink:to="loc_us-gaap_SegmentDomain_fc34d82d-c0d6-4f2f-8fc2-634b681856d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_e741e986-149e-4857-ae18-ff45b18ee695" xlink:href="lh-20200930.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_fc34d82d-c0d6-4f2f-8fc2-634b681856d8" xlink:to="loc_lh_CovanceDrugDevelopmentMember_e741e986-149e-4857-ae18-ff45b18ee695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_6cdb4b49-3d7a-4e40-a910-640325ff5c77" xlink:href="lh-20200930.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_fc34d82d-c0d6-4f2f-8fc2-634b681856d8" xlink:to="loc_lh_LabCorpDiagnosticsMember_6cdb4b49-3d7a-4e40-a910-640325ff5c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_125a483c-fcbb-4878-9000-7bd07378923e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f1c8073a-0f3c-488a-a768-de3d15c1bb3d" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_125a483c-fcbb-4878-9000-7bd07378923e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_ca3a4ccd-9c3f-46ca-8087-036d7e5b8092" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_125a483c-fcbb-4878-9000-7bd07378923e" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_ca3a4ccd-9c3f-46ca-8087-036d7e5b8092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_28bdabc5-b6a2-4d38-a5fe-e73452031b4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_ca3a4ccd-9c3f-46ca-8087-036d7e5b8092" xlink:to="loc_us-gaap_EmployeeSeveranceMember_28bdabc5-b6a2-4d38-a5fe-e73452031b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember_cfba6e5f-b1b6-4ce4-ad00-ff2971798ef7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FacilityClosingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_ca3a4ccd-9c3f-46ca-8087-036d7e5b8092" xlink:to="loc_us-gaap_FacilityClosingMember_cfba6e5f-b1b6-4ce4-ad00-ff2971798ef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f1c8073a-0f3c-488a-a768-de3d15c1bb3d" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_db5f5561-4075-4365-8ba7-4ad61a959061" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:to="loc_us-gaap_RestructuringReserve_db5f5561-4075-4365-8ba7-4ad61a959061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_b4e42b83-c661-4080-9c77-d8fb3a17514f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:to="loc_us-gaap_RestructuringCharges_b4e42b83-c661-4080-9c77-d8fb3a17514f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_RestructuringReserveSettledWithCashAndOtherAdjustment_41911c8a-7af7-4b47-81f9-88c06ca43c28" xlink:href="lh-20200930.xsd#lh_RestructuringReserveSettledWithCashAndOtherAdjustment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:to="loc_lh_RestructuringReserveSettledWithCashAndOtherAdjustment_41911c8a-7af7-4b47-81f9-88c06ca43c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetRestructuringCharges_e1ba3d54-4936-4759-b343-69415cff6b92" xlink:href="lh-20200930.xsd#lh_NetRestructuringCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:to="loc_lh_NetRestructuringCharges_e1ba3d54-4936-4759-b343-69415cff6b92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_45b1aabb-04d2-4530-911c-5b242390dfa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:to="loc_us-gaap_SeveranceCosts1_45b1aabb-04d2-4530-911c-5b242390dfa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_4ccf2daf-6b48-4cee-96a3-334b9cbb6505" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_4ccf2daf-6b48-4cee-96a3-334b9cbb6505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_64aaaa82-4dd0-481d-9083-961b9a51310e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:to="loc_us-gaap_BusinessExitCosts1_64aaaa82-4dd0-481d-9083-961b9a51310e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment_7dde11e7-6abd-41e9-b8f7-1c1b76d636f8" xlink:href="lh-20200930.xsd#lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:to="loc_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment_7dde11e7-6abd-41e9-b8f7-1c1b76d636f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_RestructuringImpairment_fc51e1cd-8ffd-4e01-b14a-cec2776bce6e" xlink:href="lh-20200930.xsd#lh_RestructuringImpairment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:to="loc_lh_RestructuringImpairment_fc51e1cd-8ffd-4e01-b14a-cec2776bce6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Unusedfacilityrestructuringreserves_ca4e7092-2e6d-4513-9d6f-bf01a7bfbb63" xlink:href="lh-20200930.xsd#lh_Unusedfacilityrestructuringreserves"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:to="loc_lh_Unusedfacilityrestructuringreserves_ca4e7092-2e6d-4513-9d6f-bf01a7bfbb63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_fbc146f3-79b1-4e84-9992-d90ed3559c15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:to="loc_us-gaap_RestructuringReserveCurrent_fbc146f3-79b1-4e84-9992-d90ed3559c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent_ec33e676-bb72-4a94-91eb-80f318231941" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a9874331-d7d2-4d1f-ab3c-5c324dee8558" xlink:to="loc_us-gaap_RestructuringReserveNoncurrent_ec33e676-bb72-4a94-91eb-80f318231941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/RESTRUCTURINGRESERVES" xlink:type="simple" xlink:href="lh-20200930.xsd#RESTRUCTURINGRESERVES"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/RESTRUCTURINGRESERVES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#RESTRUCTURINGRESERVESDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAbstract_eeeaafc5-7371-4b21-ba0f-5a6e7c68e2ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0220d3dc-53bc-4383-8188-c00f68e405ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveAbstract_eeeaafc5-7371-4b21-ba0f-5a6e7c68e2ef" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0220d3dc-53bc-4383-8188-c00f68e405ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_cbd5ae5a-138a-443b-8f36-f4e99079a7c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0220d3dc-53bc-4383-8188-c00f68e405ab" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_cbd5ae5a-138a-443b-8f36-f4e99079a7c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_259251a8-f23a-4ca5-a345-5467c3161109" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cbd5ae5a-138a-443b-8f36-f4e99079a7c8" xlink:to="loc_us-gaap_SegmentDomain_259251a8-f23a-4ca5-a345-5467c3161109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_f8deb25a-017f-4956-9e8b-f55e81769d41" xlink:href="lh-20200930.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_259251a8-f23a-4ca5-a345-5467c3161109" xlink:to="loc_lh_LabCorpDiagnosticsMember_f8deb25a-017f-4956-9e8b-f55e81769d41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_7fecf751-43ae-437e-81b3-3569e151e4e8" xlink:href="lh-20200930.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_259251a8-f23a-4ca5-a345-5467c3161109" xlink:to="loc_lh_CovanceDrugDevelopmentMember_7fecf751-43ae-437e-81b3-3569e151e4e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6163512b-f037-40d1-a286-5560b6a10caf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0220d3dc-53bc-4383-8188-c00f68e405ab" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6163512b-f037-40d1-a286-5560b6a10caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8d154648-a2ac-4613-82ff-330a421b930d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6163512b-f037-40d1-a286-5560b6a10caf" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8d154648-a2ac-4613-82ff-330a421b930d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_6be9a0f0-2388-41ab-8fe0-74cb8e0d462a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0220d3dc-53bc-4383-8188-c00f68e405ab" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_6be9a0f0-2388-41ab-8fe0-74cb8e0d462a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_a2ee525d-53d0-4483-87b1-f82dca65f60d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_6be9a0f0-2388-41ab-8fe0-74cb8e0d462a" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_a2ee525d-53d0-4483-87b1-f82dca65f60d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_67854014-92c5-42d3-ae84-5509498ea04b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_a2ee525d-53d0-4483-87b1-f82dca65f60d" xlink:to="loc_us-gaap_EmployeeSeveranceMember_67854014-92c5-42d3-ae84-5509498ea04b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember_9bdf3bf4-6b06-4d56-a78a-8f6b261d7299" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FacilityClosingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_a2ee525d-53d0-4483-87b1-f82dca65f60d" xlink:to="loc_us-gaap_FacilityClosingMember_9bdf3bf4-6b06-4d56-a78a-8f6b261d7299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_8472cb6e-320d-43a7-971f-fe795c28cd41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0220d3dc-53bc-4383-8188-c00f68e405ab" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_8472cb6e-320d-43a7-971f-fe795c28cd41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Unusedfacilityrestructuringreserves_958e8d7a-df2c-4c62-accb-714412a4e14e" xlink:href="lh-20200930.xsd#lh_Unusedfacilityrestructuringreserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8472cb6e-320d-43a7-971f-fe795c28cd41" xlink:to="loc_lh_Unusedfacilityrestructuringreserves_958e8d7a-df2c-4c62-accb-714412a4e14e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_1c95cc5e-708b-47f1-99f9-143f96d65aa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8472cb6e-320d-43a7-971f-fe795c28cd41" xlink:to="loc_us-gaap_RestructuringReserve_1c95cc5e-708b-47f1-99f9-143f96d65aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_bb3cdd17-d142-4ebc-8cbd-badd578afb1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8472cb6e-320d-43a7-971f-fe795c28cd41" xlink:to="loc_us-gaap_RestructuringCharges_bb3cdd17-d142-4ebc-8cbd-badd578afb1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_RestructuringReserveSettledWithCashAndOtherAdjustment_12ffd800-7659-49f6-8f2b-cc7cf078a261" xlink:href="lh-20200930.xsd#lh_RestructuringReserveSettledWithCashAndOtherAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8472cb6e-320d-43a7-971f-fe795c28cd41" xlink:to="loc_lh_RestructuringReserveSettledWithCashAndOtherAdjustment_12ffd800-7659-49f6-8f2b-cc7cf078a261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_c4b6370d-b21b-47d6-ad0e-b53c0cfdd1ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8472cb6e-320d-43a7-971f-fe795c28cd41" xlink:to="loc_us-gaap_RestructuringReserve_c4b6370d-b21b-47d6-ad0e-b53c0cfdd1ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_5116ab27-e7ad-4f0e-9bde-b62fd54f4a75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8472cb6e-320d-43a7-971f-fe795c28cd41" xlink:to="loc_us-gaap_RestructuringReserveCurrent_5116ab27-e7ad-4f0e-9bde-b62fd54f4a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent_aacbf3da-16fa-479f-ba66-1e79666d78b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8472cb6e-320d-43a7-971f-fe795c28cd41" xlink:to="loc_us-gaap_RestructuringReserveNoncurrent_aacbf3da-16fa-479f-ba66-1e79666d78b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_e903a230-147c-4a55-aa7f-b05b4e6c3ed3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8472cb6e-320d-43a7-971f-fe795c28cd41" xlink:to="loc_us-gaap_RestructuringReserve_e903a230-147c-4a55-aa7f-b05b4e6c3ed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment_b43121f6-bd5a-4bd0-92bb-63729dfb9952" xlink:href="lh-20200930.xsd#lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8472cb6e-320d-43a7-971f-fe795c28cd41" xlink:to="loc_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment_b43121f6-bd5a-4bd0-92bb-63729dfb9952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="lh-20200930.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5cfbcd8d-e51d-42d6-990c-137f94111136" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f973bb9c-e35c-442e-b1df-05c15b0c4db3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5cfbcd8d-e51d-42d6-990c-137f94111136" xlink:to="loc_us-gaap_SegmentReportingAbstract_f973bb9c-e35c-442e-b1df-05c15b0c4db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="lh-20200930.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d9cf1957-fdec-45ab-b8d8-98426230ef88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_6e956b68-d81f-483f-b041-5825547140d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d9cf1957-fdec-45ab-b8d8-98426230ef88" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_6e956b68-d81f-483f-b041-5825547140d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_d76addd2-82e6-4db6-b68b-bcaa231e8a9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d9cf1957-fdec-45ab-b8d8-98426230ef88" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_d76addd2-82e6-4db6-b68b-bcaa231e8a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9f4d2148-2a1f-4e9b-9b64-2e4736587d25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_e2902365-d50f-43a1-a7d4-4e15e92c3ea8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9f4d2148-2a1f-4e9b-9b64-2e4736587d25" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_e2902365-d50f-43a1-a7d4-4e15e92c3ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f6b7790e-848c-4d63-89e8-7573c6db2a38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e2902365-d50f-43a1-a7d4-4e15e92c3ea8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f6b7790e-848c-4d63-89e8-7573c6db2a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5e69b2fd-3d5a-4afd-8959-aa8b476e9ee3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f6b7790e-848c-4d63-89e8-7573c6db2a38" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5e69b2fd-3d5a-4afd-8959-aa8b476e9ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_d0bc06c9-c7c0-4c25-a560-74f4841d4f97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5e69b2fd-3d5a-4afd-8959-aa8b476e9ee3" xlink:to="loc_us-gaap_TradeNamesMember_d0bc06c9-c7c0-4c25-a560-74f4841d4f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_87a75848-b82b-4894-877e-6da8e6a9a8d2" xlink:href="lh-20200930.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e2902365-d50f-43a1-a7d4-4e15e92c3ea8" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_87a75848-b82b-4894-877e-6da8e6a9a8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_f8e2a2dd-9159-4d03-ac20-231f455fe92d" xlink:href="lh-20200930.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_87a75848-b82b-4894-877e-6da8e6a9a8d2" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_f8e2a2dd-9159-4d03-ac20-231f455fe92d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_9326972f-2669-4ab1-be49-81c2f8779f7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_f8e2a2dd-9159-4d03-ac20-231f455fe92d" xlink:to="loc_us-gaap_CustomerRelationshipsMember_9326972f-2669-4ab1-be49-81c2f8779f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PatentsLicensesAndTechnologyMember_e12b4d9b-966e-4a6a-8244-15421f5e3b96" xlink:href="lh-20200930.xsd#lh_PatentsLicensesAndTechnologyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_f8e2a2dd-9159-4d03-ac20-231f455fe92d" xlink:to="loc_lh_PatentsLicensesAndTechnologyMember_e12b4d9b-966e-4a6a-8244-15421f5e3b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_eaf6e3b2-cbe4-4752-ae77-99b608fce93c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_f8e2a2dd-9159-4d03-ac20-231f455fe92d" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_eaf6e3b2-cbe4-4752-ae77-99b608fce93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_c0767657-bcc9-4dde-b785-fe65b9569022" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_f8e2a2dd-9159-4d03-ac20-231f455fe92d" xlink:to="loc_us-gaap_TradeNamesMember_c0767657-bcc9-4dde-b785-fe65b9569022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseRightsMember_b71c682b-ed0f-430b-bec1-5d9eb7877005" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseRightsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_f8e2a2dd-9159-4d03-ac20-231f455fe92d" xlink:to="loc_us-gaap_UseRightsMember_b71c682b-ed0f-430b-bec1-5d9eb7877005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_207b4d02-7479-4986-83d4-67665b9638aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_f8e2a2dd-9159-4d03-ac20-231f455fe92d" xlink:to="loc_us-gaap_LicensingAgreementsMember_207b4d02-7479-4986-83d4-67665b9638aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_e47464fd-8c09-4e8d-9c53-94569542d042" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e2902365-d50f-43a1-a7d4-4e15e92c3ea8" xlink:to="loc_srt_ConsolidationItemsAxis_e47464fd-8c09-4e8d-9c53-94569542d042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_99df8b03-af0b-4616-b72c-a9b5dca16aff" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_e47464fd-8c09-4e8d-9c53-94569542d042" xlink:to="loc_srt_ConsolidationItemsDomain_99df8b03-af0b-4616-b72c-a9b5dca16aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c3f27bfc-cfbb-412c-a2c6-7d5981c3bb50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e2902365-d50f-43a1-a7d4-4e15e92c3ea8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c3f27bfc-cfbb-412c-a2c6-7d5981c3bb50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6f488cc2-5e38-4dfc-88ba-2a21251a7798" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c3f27bfc-cfbb-412c-a2c6-7d5981c3bb50" xlink:to="loc_us-gaap_SegmentDomain_6f488cc2-5e38-4dfc-88ba-2a21251a7798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_e9a45eee-c29d-4dab-bd88-304ce8a20d22" xlink:href="lh-20200930.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6f488cc2-5e38-4dfc-88ba-2a21251a7798" xlink:to="loc_lh_LabCorpDiagnosticsMember_e9a45eee-c29d-4dab-bd88-304ce8a20d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_bb11ee21-fd1b-40bb-8099-d8f6f1b1a61d" xlink:href="lh-20200930.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6f488cc2-5e38-4dfc-88ba-2a21251a7798" xlink:to="loc_lh_CovanceDrugDevelopmentMember_bb11ee21-fd1b-40bb-8099-d8f6f1b1a61d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_58f7bdae-2059-49ba-95eb-0f65ea4fa0eb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e2902365-d50f-43a1-a7d4-4e15e92c3ea8" xlink:to="loc_srt_RangeAxis_58f7bdae-2059-49ba-95eb-0f65ea4fa0eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5bc987d7-8498-43ad-b032-d228500ed4e2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_58f7bdae-2059-49ba-95eb-0f65ea4fa0eb" xlink:to="loc_srt_RangeMember_5bc987d7-8498-43ad-b032-d228500ed4e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e2902365-d50f-43a1-a7d4-4e15e92c3ea8" xlink:to="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9ad64c24-1cdd-486f-a215-16711a10b84e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9ad64c24-1cdd-486f-a215-16711a10b84e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_97bc0d02-01da-4bd5-b0db-72a4207327c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_us-gaap_SeveranceCosts1_97bc0d02-01da-4bd5-b0db-72a4207327c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b32c4850-8ff9-4253-8cf5-dce961adc2e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b32c4850-8ff9-4253-8cf5-dce961adc2e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ee1cea86-4d78-4eb5-97b0-da142ef2ea3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_us-gaap_Goodwill_ee1cea86-4d78-4eb5-97b0-da142ef2ea3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_b7d3fcfd-ad95-4274-ba37-708cbd015f97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_b7d3fcfd-ad95-4274-ba37-708cbd015f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_86b0c447-c067-41f3-b061-83687456f4ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_us-gaap_Goodwill_86b0c447-c067-41f3-b061-83687456f4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_aedb6589-db17-4dd1-ad1d-c8bfd8a2f82b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_aedb6589-db17-4dd1-ad1d-c8bfd8a2f82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a849435a-86aa-41de-9ddd-cd09dacb576a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a849435a-86aa-41de-9ddd-cd09dacb576a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_37bcc6dd-db2d-4b52-af76-9b6169e611a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_37bcc6dd-db2d-4b52-af76-9b6169e611a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentageFairValueofGoodwillExceededCarryingValue_b4ceae23-b16e-4710-a7f2-38398c6f0bde" xlink:href="lh-20200930.xsd#lh_PercentageFairValueofGoodwillExceededCarryingValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_lh_PercentageFairValueofGoodwillExceededCarryingValue_b4ceae23-b16e-4710-a7f2-38398c6f0bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill_46198abc-2403-48ec-9126-2ef428683c08" xlink:href="lh-20200930.xsd#lh_PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_lh_PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill_46198abc-2403-48ec-9126-2ef428683c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit_ad3b2a6c-0aa6-46f5-bdd5-e6644c1a5d45" xlink:href="lh-20200930.xsd#lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit_ad3b2a6c-0aa6-46f5-bdd5-e6644c1a5d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit_d1e11561-f9a0-46fe-820d-7595f62193ab" xlink:href="lh-20200930.xsd#lh_PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_lh_PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit_d1e11561-f9a0-46fe-820d-7595f62193ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit_68a98d21-8e60-4fa6-94cc-b9db01316a79" xlink:href="lh-20200930.xsd#lh_PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_lh_PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit_68a98d21-8e60-4fa6-94cc-b9db01316a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ValueofReportingUnitsGoodwillFollowingImpairment_428055a6-cb55-4834-8e41-7833bec7b9b6" xlink:href="lh-20200930.xsd#lh_ValueofReportingUnitsGoodwillFollowingImpairment"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_lh_ValueofReportingUnitsGoodwillFollowingImpairment_428055a6-cb55-4834-8e41-7833bec7b9b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_30882638-f5eb-44af-810f-a09969618bd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_30882638-f5eb-44af-810f-a09969618bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue_f0fa7e7b-2687-4cca-8e6c-e3fdfb475ca4" xlink:href="lh-20200930.xsd#lh_ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_lh_ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue_f0fa7e7b-2687-4cca-8e6c-e3fdfb475ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_0e2fa157-2559-400d-a6e0-99357f574820" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_936fe0e6-9286-4d01-b55f-8664b709a6cb" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_0e2fa157-2559-400d-a6e0-99357f574820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_5fc13bae-dad6-468e-9593-94afb5e8db90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9f4d2148-2a1f-4e9b-9b64-2e4736587d25" xlink:to="loc_us-gaap_GoodwillRollForward_5fc13bae-dad6-468e-9593-94afb5e8db90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_424d95f7-f988-459b-8e32-1d5a07b0ea14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b69eed1d-03b8-425f-9ba6-fa7aef3b0ecc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_424d95f7-f988-459b-8e32-1d5a07b0ea14" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b69eed1d-03b8-425f-9ba6-fa7aef3b0ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_877f0a39-28a8-4700-89c5-a972a0f4631d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b69eed1d-03b8-425f-9ba6-fa7aef3b0ecc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_877f0a39-28a8-4700-89c5-a972a0f4631d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4290cade-a88b-4a8e-ab64-dcd956a49ab8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_877f0a39-28a8-4700-89c5-a972a0f4631d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4290cade-a88b-4a8e-ab64-dcd956a49ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_4c415e09-b708-4d4a-9ebd-635c6580c731" xlink:href="lh-20200930.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b69eed1d-03b8-425f-9ba6-fa7aef3b0ecc" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_4c415e09-b708-4d4a-9ebd-635c6580c731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_17f28da1-4078-4992-b1bf-00f6ffb5100d" xlink:href="lh-20200930.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_4c415e09-b708-4d4a-9ebd-635c6580c731" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_17f28da1-4078-4992-b1bf-00f6ffb5100d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_03302fa0-d1e2-4c24-9e83-af54f90380ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_17f28da1-4078-4992-b1bf-00f6ffb5100d" xlink:to="loc_us-gaap_CustomerRelationshipsMember_03302fa0-d1e2-4c24-9e83-af54f90380ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PatentsLicensesAndTechnologyMember_ee1aaad3-d223-43e5-a1a4-41284bde3404" xlink:href="lh-20200930.xsd#lh_PatentsLicensesAndTechnologyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_17f28da1-4078-4992-b1bf-00f6ffb5100d" xlink:to="loc_lh_PatentsLicensesAndTechnologyMember_ee1aaad3-d223-43e5-a1a4-41284bde3404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_f88d5415-673e-418f-bd6b-908c4ba10134" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_17f28da1-4078-4992-b1bf-00f6ffb5100d" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_f88d5415-673e-418f-bd6b-908c4ba10134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_bedf2412-561e-4731-8f29-38d41e3f1adb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_17f28da1-4078-4992-b1bf-00f6ffb5100d" xlink:to="loc_us-gaap_TradeNamesMember_bedf2412-561e-4731-8f29-38d41e3f1adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseRightsMember_99ea48c1-c7f5-4398-a83d-a6b63ebffae0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseRightsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_17f28da1-4078-4992-b1bf-00f6ffb5100d" xlink:to="loc_us-gaap_UseRightsMember_99ea48c1-c7f5-4398-a83d-a6b63ebffae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_087d8c81-a7ba-4f64-b030-40cce729aff5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_17f28da1-4078-4992-b1bf-00f6ffb5100d" xlink:to="loc_us-gaap_LicensingAgreementsMember_087d8c81-a7ba-4f64-b030-40cce729aff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5238a30e-beeb-4353-beef-dcdf5f25cc21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b69eed1d-03b8-425f-9ba6-fa7aef3b0ecc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5238a30e-beeb-4353-beef-dcdf5f25cc21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_86eaa45a-9ed4-4859-8b7e-8196f2e1f293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5238a30e-beeb-4353-beef-dcdf5f25cc21" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_86eaa45a-9ed4-4859-8b7e-8196f2e1f293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8b44ec18-c46f-415d-9271-5e0cdfb8b549" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5238a30e-beeb-4353-beef-dcdf5f25cc21" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8b44ec18-c46f-415d-9271-5e0cdfb8b549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_75dbd10f-7bff-4f97-a595-76bfe0a42d83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5238a30e-beeb-4353-beef-dcdf5f25cc21" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_75dbd10f-7bff-4f97-a595-76bfe0a42d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#GOODWILLANDINTANGIBLEASSETSDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5e9a9ccc-418b-4e24-9ac2-f95232b4845a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e5e0f75a-8401-40ad-b5f4-26989f6bd631" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5e9a9ccc-418b-4e24-9ac2-f95232b4845a" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e5e0f75a-8401-40ad-b5f4-26989f6bd631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f04fa536-0dc8-44e3-adf6-51725a5f5cc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e5e0f75a-8401-40ad-b5f4-26989f6bd631" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f04fa536-0dc8-44e3-adf6-51725a5f5cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f2df526d-9c75-4313-a3be-bb273e3f4f3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f04fa536-0dc8-44e3-adf6-51725a5f5cc6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f2df526d-9c75-4313-a3be-bb273e3f4f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2045Member_ef304e52-b69d-46a4-b9c7-ed66e4283557" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2045Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f2df526d-9c75-4313-a3be-bb273e3f4f3e" xlink:to="loc_lh_Seniornotesdue2045Member_ef304e52-b69d-46a4-b9c7-ed66e4283557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_fda85863-343b-4e41-ae29-89307ea69f52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e5e0f75a-8401-40ad-b5f4-26989f6bd631" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_fda85863-343b-4e41-ae29-89307ea69f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65d538a4-ad65-40fd-9b7a-80b311cdb96f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fda85863-343b-4e41-ae29-89307ea69f52" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65d538a4-ad65-40fd-9b7a-80b311cdb96f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceMember_4211eb06-6e06-4504-a390-66eb87e51817" xlink:href="lh-20200930.xsd#lh_CovanceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65d538a4-ad65-40fd-9b7a-80b311cdb96f" xlink:to="loc_lh_CovanceMember_4211eb06-6e06-4504-a390-66eb87e51817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a115c3b7-bd0f-4c3d-8dd6-8b463ea0e631" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e5e0f75a-8401-40ad-b5f4-26989f6bd631" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a115c3b7-bd0f-4c3d-8dd6-8b463ea0e631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_60a66219-37aa-46ca-b8b0-415b70d15ec3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a115c3b7-bd0f-4c3d-8dd6-8b463ea0e631" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_60a66219-37aa-46ca-b8b0-415b70d15ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_f099b56d-cedf-4ed5-a398-10cec1672e0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_60a66219-37aa-46ca-b8b0-415b70d15ec3" xlink:to="loc_us-gaap_TradeNamesMember_f099b56d-cedf-4ed5-a398-10cec1672e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_9120386a-2f5b-4292-94af-ea66d8bacbed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_60a66219-37aa-46ca-b8b0-415b70d15ec3" xlink:to="loc_us-gaap_CustomerRelationshipsMember_9120386a-2f5b-4292-94af-ea66d8bacbed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_e90b3454-d1e0-46be-8144-330fbda4948a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_60a66219-37aa-46ca-b8b0-415b70d15ec3" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_e90b3454-d1e0-46be-8144-330fbda4948a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_bc68dd9e-9c07-4c45-819b-250ce165b8f9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e5e0f75a-8401-40ad-b5f4-26989f6bd631" xlink:to="loc_srt_ConsolidationItemsAxis_bc68dd9e-9c07-4c45-819b-250ce165b8f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_05cbf24b-085a-4dff-9164-a929d81198b2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_bc68dd9e-9c07-4c45-819b-250ce165b8f9" xlink:to="loc_srt_ConsolidationItemsDomain_05cbf24b-085a-4dff-9164-a929d81198b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6e1d730f-9b25-42ae-9491-d94dcfc26378" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e5e0f75a-8401-40ad-b5f4-26989f6bd631" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6e1d730f-9b25-42ae-9491-d94dcfc26378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cfe252ab-4250-4b7a-ab4b-29180d87db6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6e1d730f-9b25-42ae-9491-d94dcfc26378" xlink:to="loc_us-gaap_SegmentDomain_cfe252ab-4250-4b7a-ab4b-29180d87db6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_12649da7-6eda-43db-b900-9125d7bc1117" xlink:href="lh-20200930.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cfe252ab-4250-4b7a-ab4b-29180d87db6f" xlink:to="loc_lh_LabCorpDiagnosticsMember_12649da7-6eda-43db-b900-9125d7bc1117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_197e0bac-a639-4be0-9bb4-13d8f29c9dc8" xlink:href="lh-20200930.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cfe252ab-4250-4b7a-ab4b-29180d87db6f" xlink:to="loc_lh_CovanceDrugDevelopmentMember_197e0bac-a639-4be0-9bb4-13d8f29c9dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_defb1ccb-45ac-47d9-b515-0db3b79a1411" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e5e0f75a-8401-40ad-b5f4-26989f6bd631" xlink:to="loc_srt_RangeAxis_defb1ccb-45ac-47d9-b515-0db3b79a1411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7845bafb-7dce-41a3-b38a-2a6ec7b4f871" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_defb1ccb-45ac-47d9-b515-0db3b79a1411" xlink:to="loc_srt_RangeMember_7845bafb-7dce-41a3-b38a-2a6ec7b4f871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_98341372-16fc-41b9-a690-b8550c6dcac0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e5e0f75a-8401-40ad-b5f4-26989f6bd631" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_98341372-16fc-41b9-a690-b8550c6dcac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_de52c010-864b-4821-87b9-be5a0c94a064" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_98341372-16fc-41b9-a690-b8550c6dcac0" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_de52c010-864b-4821-87b9-be5a0c94a064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongTermNotes_b35e7e3e-27ed-4c0f-ae44-5013578715bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorLongTermNotes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_98341372-16fc-41b9-a690-b8550c6dcac0" xlink:to="loc_us-gaap_SeniorLongTermNotes_b35e7e3e-27ed-4c0f-ae44-5013578715bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_25b1f045-c85f-42f5-ac38-34e5f745232e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_98341372-16fc-41b9-a690-b8550c6dcac0" xlink:to="loc_us-gaap_Goodwill_25b1f045-c85f-42f5-ac38-34e5f745232e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_71174ef7-299a-45ef-b643-631da9bc2d0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_98341372-16fc-41b9-a690-b8550c6dcac0" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_71174ef7-299a-45ef-b643-631da9bc2d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit_51136cc2-ca89-48c7-bb4b-8249787be95b" xlink:href="lh-20200930.xsd#lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_98341372-16fc-41b9-a690-b8550c6dcac0" xlink:to="loc_lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit_51136cc2-ca89-48c7-bb4b-8249787be95b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_2f15c8b9-4336-421a-951d-ee7fff96191c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_98341372-16fc-41b9-a690-b8550c6dcac0" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_2f15c8b9-4336-421a-951d-ee7fff96191c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_c4b9b3fd-c5af-49ef-92b5-6c28b44a8cbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_98341372-16fc-41b9-a690-b8550c6dcac0" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_c4b9b3fd-c5af-49ef-92b5-6c28b44a8cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Impairmentoffloatingratenotereceivable_5afdbc46-ea62-443b-9274-0ce6e8a490d8" xlink:href="lh-20200930.xsd#lh_Impairmentoffloatingratenotereceivable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_98341372-16fc-41b9-a690-b8550c6dcac0" xlink:to="loc_lh_Impairmentoffloatingratenotereceivable_5afdbc46-ea62-443b-9274-0ce6e8a490d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_cf85fe8a-832d-4a55-b72e-ab029e0ae3c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5e9a9ccc-418b-4e24-9ac2-f95232b4845a" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_cf85fe8a-832d-4a55-b72e-ab029e0ae3c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_ca9d3c18-9a21-421a-8a57-76dee6a0ab85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5e9a9ccc-418b-4e24-9ac2-f95232b4845a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_ca9d3c18-9a21-421a-8a57-76dee6a0ab85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7d3b0c93-064d-4bf1-aba9-a7723b78af59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_ca9d3c18-9a21-421a-8a57-76dee6a0ab85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7d3b0c93-064d-4bf1-aba9-a7723b78af59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_e40a1241-3009-458b-8d62-660638546385" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_ca9d3c18-9a21-421a-8a57-76dee6a0ab85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_e40a1241-3009-458b-8d62-660638546385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_9e71c04e-fa26-4ff2-aae7-194e7e36bb64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_ca9d3c18-9a21-421a-8a57-76dee6a0ab85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_9e71c04e-fa26-4ff2-aae7-194e7e36bb64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0ed83e6a-dbd5-4834-9417-7c4284029469" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_ca9d3c18-9a21-421a-8a57-76dee6a0ab85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0ed83e6a-dbd5-4834-9417-7c4284029469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_a42add61-56ca-4e27-97ac-d8e8c8466e21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_ca9d3c18-9a21-421a-8a57-76dee6a0ab85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_a42add61-56ca-4e27-97ac-d8e8c8466e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_fded37b5-8c4a-45e9-aee1-cadcfa3ac733" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_ca9d3c18-9a21-421a-8a57-76dee6a0ab85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_fded37b5-8c4a-45e9-aee1-cadcfa3ac733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/IntangibleAssetsGoodwillandOtherPolicies" xlink:type="simple" xlink:href="lh-20200930.xsd#IntangibleAssetsGoodwillandOtherPolicies"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/IntangibleAssetsGoodwillandOtherPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c0334287-4eaf-4a8d-b9d1-499f2094b956" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_59d72f74-d680-4f81-b0a8-fce77f3ea84e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c0334287-4eaf-4a8d-b9d1-499f2094b956" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_59d72f74-d680-4f81-b0a8-fce77f3ea84e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBT" xlink:type="simple" xlink:href="lh-20200930.xsd#DEBT"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/DEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e57c17f4-d9b8-4f06-a4e0-739eecc5bcc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_f8965ee6-444d-4698-bbd0-2fcd2a0ee4ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e57c17f4-d9b8-4f06-a4e0-739eecc5bcc4" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_f8965ee6-444d-4698-bbd0-2fcd2a0ee4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2ba38029-c9de-4903-90a2-096be95cd277" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_78bf568f-6adf-4473-8806-5880722c1172" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2ba38029-c9de-4903-90a2-096be95cd277" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_78bf568f-6adf-4473-8806-5880722c1172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_40882704-c3d2-4f19-baf7-b83f4917144b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_78bf568f-6adf-4473-8806-5880722c1172" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_40882704-c3d2-4f19-baf7-b83f4917144b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3b489ed6-7d0f-4705-8d27-3ece77e8a58e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_40882704-c3d2-4f19-baf7-b83f4917144b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3b489ed6-7d0f-4705-8d27-3ece77e8a58e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceMember_7eed4fc1-8b27-4967-bee5-2ea4371d7ae8" xlink:href="lh-20200930.xsd#lh_CovanceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3b489ed6-7d0f-4705-8d27-3ece77e8a58e" xlink:to="loc_lh_CovanceMember_7eed4fc1-8b27-4967-bee5-2ea4371d7ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_32f86eb8-62de-4b7c-beec-bd47f106bb8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_78bf568f-6adf-4473-8806-5880722c1172" xlink:to="loc_us-gaap_CreditFacilityAxis_32f86eb8-62de-4b7c-beec-bd47f106bb8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0d4faa13-6806-4d69-a0fe-29d65e3b27c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_32f86eb8-62de-4b7c-beec-bd47f106bb8e" xlink:to="loc_us-gaap_CreditFacilityDomain_0d4faa13-6806-4d69-a0fe-29d65e3b27c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c8629a52-051d-42ef-8722-6749a35cdcf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_78bf568f-6adf-4473-8806-5880722c1172" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c8629a52-051d-42ef-8722-6749a35cdcf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5ce387fb-f32a-407d-a1c8-79ce807d06a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c8629a52-051d-42ef-8722-6749a35cdcf0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5ce387fb-f32a-407d-a1c8-79ce807d06a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2020Member_c9f3e59b-64e9-4c45-8ddb-3bafaea30b6d" xlink:href="lh-20200930.xsd#lh_SeniorNotesDue2020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5ce387fb-f32a-407d-a1c8-79ce807d06a0" xlink:to="loc_lh_SeniorNotesDue2020Member_c9f3e59b-64e9-4c45-8ddb-3bafaea30b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2022Member_760e6956-ae05-4ea9-a462-99f1e3d762e8" xlink:href="lh-20200930.xsd#lh_SeniorNotesDue2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5ce387fb-f32a-407d-a1c8-79ce807d06a0" xlink:to="loc_lh_SeniorNotesDue2022Member_760e6956-ae05-4ea9-a462-99f1e3d762e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2045Member_392176dc-4fa6-4a4d-921f-e0794e5d5aa6" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2045Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5ce387fb-f32a-407d-a1c8-79ce807d06a0" xlink:to="loc_lh_Seniornotesdue2045Member_392176dc-4fa6-4a4d-921f-e0794e5d5aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_5333032b-ead3-4da5-9b4c-fe5f3cf1cf83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_78bf568f-6adf-4473-8806-5880722c1172" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_5333032b-ead3-4da5-9b4c-fe5f3cf1cf83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_477f3529-1149-4091-8f0a-e676c6da2f06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_5333032b-ead3-4da5-9b4c-fe5f3cf1cf83" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_477f3529-1149-4091-8f0a-e676c6da2f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_2addd49b-ce11-40ef-8494-c17fd81aae68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_78bf568f-6adf-4473-8806-5880722c1172" xlink:to="loc_us-gaap_ShortTermDebtLineItems_2addd49b-ce11-40ef-8494-c17fd81aae68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_91743c00-560b-424f-b7d1-871ae9252510" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2addd49b-ce11-40ef-8494-c17fd81aae68" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_91743c00-560b-424f-b7d1-871ae9252510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongTermNotes_a863d184-8f1c-411a-b06d-92f947639af9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorLongTermNotes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2addd49b-ce11-40ef-8494-c17fd81aae68" xlink:to="loc_us-gaap_SeniorLongTermNotes_a863d184-8f1c-411a-b06d-92f947639af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d559d16d-5409-4841-8003-a1f5c4c5fe3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2addd49b-ce11-40ef-8494-c17fd81aae68" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d559d16d-5409-4841-8003-a1f5c4c5fe3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_dd54cf1c-33e8-4714-b4a5-5cdc1b7e72d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2addd49b-ce11-40ef-8494-c17fd81aae68" xlink:to="loc_us-gaap_DebtCurrent_dd54cf1c-33e8-4714-b4a5-5cdc1b7e72d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2019TermLoan_63a11ed4-f73b-4673-996c-b7631fe8c082" xlink:href="lh-20200930.xsd#lh_A2019TermLoan"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_2addd49b-ce11-40ef-8494-c17fd81aae68" xlink:to="loc_lh_A2019TermLoan_63a11ed4-f73b-4673-996c-b7631fe8c082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_51afb73c-3dcf-4fb1-a495-6de731373451" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2ba38029-c9de-4903-90a2-096be95cd277" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_51afb73c-3dcf-4fb1-a495-6de731373451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTLongtermdebtDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#DEBTLongtermdebtDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/DEBTLongtermdebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f1ba5d9f-ba79-418d-9c87-315635ade1fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_6b07a8e5-7c65-4045-bfba-32ffe4a0022e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f1ba5d9f-ba79-418d-9c87-315635ade1fe" xlink:to="loc_us-gaap_DebtInstrumentTable_6b07a8e5-7c65-4045-bfba-32ffe4a0022e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_0011ec35-1a58-499c-a674-1d1f86007448" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6b07a8e5-7c65-4045-bfba-32ffe4a0022e" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_0011ec35-1a58-499c-a674-1d1f86007448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_2400f5ea-9a12-4dca-95d0-de7bb6bcea7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_0011ec35-1a58-499c-a674-1d1f86007448" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_2400f5ea-9a12-4dca-95d0-de7bb6bcea7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2019TermLoanMember_c7b0900a-8f1c-4965-91fd-98e3b1ba5001" xlink:href="lh-20200930.xsd#lh_A2019TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_2400f5ea-9a12-4dca-95d0-de7bb6bcea7f" xlink:to="loc_lh_A2019TermLoanMember_c7b0900a-8f1c-4965-91fd-98e3b1ba5001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_ff005b42-dced-4c16-81fb-50eddbe8c4a1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6b07a8e5-7c65-4045-bfba-32ffe4a0022e" xlink:to="loc_srt_StatementScenarioAxis_ff005b42-dced-4c16-81fb-50eddbe8c4a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_09757535-1db0-489a-bc17-df39ae240ce6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_ff005b42-dced-4c16-81fb-50eddbe8c4a1" xlink:to="loc_srt_ScenarioUnspecifiedDomain_09757535-1db0-489a-bc17-df39ae240ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_62211146-6f51-4d4a-a6ea-d4e7535e392c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6b07a8e5-7c65-4045-bfba-32ffe4a0022e" xlink:to="loc_us-gaap_VariableRateAxis_62211146-6f51-4d4a-a6ea-d4e7535e392c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_ff2bb5c3-f2c1-46c9-97df-54fa8d0491e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_62211146-6f51-4d4a-a6ea-d4e7535e392c" xlink:to="loc_us-gaap_VariableRateDomain_ff2bb5c3-f2c1-46c9-97df-54fa8d0491e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_644f4a37-036d-4468-b7f9-ef9992633c93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_ff2bb5c3-f2c1-46c9-97df-54fa8d0491e3" xlink:to="loc_us-gaap_PrimeRateMember_644f4a37-036d-4468-b7f9-ef9992633c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_ce6f4711-368f-45bb-8fad-3d710c00254a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrimeRateMember_644f4a37-036d-4468-b7f9-ef9992633c93" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_ce6f4711-368f-45bb-8fad-3d710c00254a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f3d25837-04cd-4c26-ac9b-059076d75d35" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6b07a8e5-7c65-4045-bfba-32ffe4a0022e" xlink:to="loc_srt_RangeAxis_f3d25837-04cd-4c26-ac9b-059076d75d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5b578a4c-c502-4256-bb4d-115dfc6d9197" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f3d25837-04cd-4c26-ac9b-059076d75d35" xlink:to="loc_srt_RangeMember_5b578a4c-c502-4256-bb4d-115dfc6d9197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_49ccad1c-9bf0-4e2d-88d3-628264908aa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6b07a8e5-7c65-4045-bfba-32ffe4a0022e" xlink:to="loc_us-gaap_CreditFacilityAxis_49ccad1c-9bf0-4e2d-88d3-628264908aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_cb65a663-18e1-447f-8cd2-5b9f232308a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_49ccad1c-9bf0-4e2d-88d3-628264908aa4" xlink:to="loc_us-gaap_CreditFacilityDomain_cb65a663-18e1-447f-8cd2-5b9f232308a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_a70860e7-64b1-4d62-a7c1-dd97147e5fab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_cb65a663-18e1-447f-8cd2-5b9f232308a9" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_a70860e7-64b1-4d62-a7c1-dd97147e5fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9cbbfe45-86b2-417c-9458-3c84dfe013a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6b07a8e5-7c65-4045-bfba-32ffe4a0022e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9cbbfe45-86b2-417c-9458-3c84dfe013a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64c73e27-fd0f-4836-89ac-0d27ff116686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9cbbfe45-86b2-417c-9458-3c84dfe013a0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64c73e27-fd0f-4836-89ac-0d27ff116686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceMember_704e872f-7425-4128-ac1f-9d963400c748" xlink:href="lh-20200930.xsd#lh_CovanceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64c73e27-fd0f-4836-89ac-0d27ff116686" xlink:to="loc_lh_CovanceMember_704e872f-7425-4128-ac1f-9d963400c748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5c2a9c7c-d671-47ec-9106-d9c6872ef2d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6b07a8e5-7c65-4045-bfba-32ffe4a0022e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5c2a9c7c-d671-47ec-9106-d9c6872ef2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e98ae111-2cb4-4be4-9ba5-2bd47f6493b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5c2a9c7c-d671-47ec-9106-d9c6872ef2d9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e98ae111-2cb4-4be4-9ba5-2bd47f6493b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2019TermLoanMember_ea899a7a-48d8-4119-b03b-2ef2f95d5679" xlink:href="lh-20200930.xsd#lh_A2019TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e98ae111-2cb4-4be4-9ba5-2bd47f6493b3" xlink:to="loc_lh_A2019TermLoanMember_ea899a7a-48d8-4119-b03b-2ef2f95d5679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2020Member_b5648894-89be-4e14-818c-8fcb1bb7c399" xlink:href="lh-20200930.xsd#lh_SeniorNotesDue2020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e98ae111-2cb4-4be4-9ba5-2bd47f6493b3" xlink:to="loc_lh_SeniorNotesDue2020Member_b5648894-89be-4e14-818c-8fcb1bb7c399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2022Member_b8f86ca9-c2b5-448b-9b1e-7da6a37d37d8" xlink:href="lh-20200930.xsd#lh_SeniorNotesDue2022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e98ae111-2cb4-4be4-9ba5-2bd47f6493b3" xlink:to="loc_lh_SeniorNotesDue2022Member_b8f86ca9-c2b5-448b-9b1e-7da6a37d37d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2023Member_fe254612-a7b4-469e-a67b-deeaa99b733f" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2023Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e98ae111-2cb4-4be4-9ba5-2bd47f6493b3" xlink:to="loc_lh_Seniornotesdue2023Member_fe254612-a7b4-469e-a67b-deeaa99b733f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2025MemberMember_d99f62db-1d41-4703-91dc-feee02617902" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2025MemberMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e98ae111-2cb4-4be4-9ba5-2bd47f6493b3" xlink:to="loc_lh_Seniornotesdue2025MemberMember_d99f62db-1d41-4703-91dc-feee02617902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2045Member_edbc3d19-b437-4c3f-8106-9530aa29f430" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2045Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e98ae111-2cb4-4be4-9ba5-2bd47f6493b3" xlink:to="loc_lh_Seniornotesdue2045Member_edbc3d19-b437-4c3f-8106-9530aa29f430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_a4032883-9380-4ccb-8aea-50720060d6fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e98ae111-2cb4-4be4-9ba5-2bd47f6493b3" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_a4032883-9380-4ccb-8aea-50720060d6fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6b07a8e5-7c65-4045-bfba-32ffe4a0022e" xlink:to="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_9f2236b5-f43f-4811-8c0c-d4e210777f58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_9f2236b5-f43f-4811-8c0c-d4e210777f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_47415381-3a9c-45f5-9457-49a8a15351fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_47415381-3a9c-45f5-9457-49a8a15351fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDescription_272d4d14-a2d1-424c-abd6-dcc4608ac7e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDescription"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDescription_272d4d14-a2d1-424c-abd6-dcc4608ac7e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_5729c87c-e62b-4499-928c-124b1bd35c6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_5729c87c-e62b-4499-928c-124b1bd35c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_6f8e4e87-4128-4b8f-874e-0b0b34fd79fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_6f8e4e87-4128-4b8f-874e-0b0b34fd79fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongTermNotes_73a687d2-f313-4f92-8049-7590d3b232e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorLongTermNotes"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_us-gaap_SeniorLongTermNotes_73a687d2-f313-4f92-8049-7590d3b232e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_650de916-4351-4d14-a3fa-aab0e9ffa36f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_650de916-4351-4d14-a3fa-aab0e9ffa36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c89b6fac-bb86-4b30-983d-340b63a7d89b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c89b6fac-bb86-4b30-983d-340b63a7d89b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityOptiontoIncrease_8188ac04-7668-449e-85a6-04138c6ee28f" xlink:href="lh-20200930.xsd#lh_CreditFacilityOptiontoIncrease"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_lh_CreditFacilityOptiontoIncrease_8188ac04-7668-449e-85a6-04138c6ee28f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumSwingLineBorrowings_32083c09-5a71-4d23-9aaf-f65dcf70e14d" xlink:href="lh-20200930.xsd#lh_CreditFacilityMaximumSwingLineBorrowings"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_lh_CreditFacilityMaximumSwingLineBorrowings_32083c09-5a71-4d23-9aaf-f65dcf70e14d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumLettersofCredit_25ea9461-a442-4d9f-aaae-fbb5313dac28" xlink:href="lh-20200930.xsd#lh_CreditFacilityMaximumLettersofCredit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_lh_CreditFacilityMaximumLettersofCredit_25ea9461-a442-4d9f-aaae-fbb5313dac28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020_6b948af4-9743-4874-b619-7dc336ab2db5" xlink:href="lh-20200930.xsd#lh_DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_lh_DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020_6b948af4-9743-4874-b619-7dc336ab2db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021_af9ee791-5e62-41ac-94d7-e211488aded5" xlink:href="lh-20200930.xsd#lh_DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_lh_DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021_af9ee791-5e62-41ac-94d7-e211488aded5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable_857c0808-1e94-4e52-b09d-519da3ab776d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayable"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b2a915c2-d062-4523-a5cd-e7dde58b527a" xlink:to="loc_us-gaap_NotesPayable_857c0808-1e94-4e52-b09d-519da3ab776d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTSeniorNotesDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#DEBTSeniorNotesDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/DEBTSeniorNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8d7b868b-ff40-4e83-b0dc-d060e55f27bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_8f0d372e-1b8f-4e59-9634-6c53f7da287a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8d7b868b-ff40-4e83-b0dc-d060e55f27bd" xlink:to="loc_us-gaap_DebtInstrumentTable_8f0d372e-1b8f-4e59-9634-6c53f7da287a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b04bcf38-3366-494a-be40-35789c7e256f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8f0d372e-1b8f-4e59-9634-6c53f7da287a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b04bcf38-3366-494a-be40-35789c7e256f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b810fe2d-c5a9-4b16-b32e-b71c6bf0b94c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b04bcf38-3366-494a-be40-35789c7e256f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b810fe2d-c5a9-4b16-b32e-b71c6bf0b94c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceMember_017bc9fc-197a-42d4-94da-f9011a3554fe" xlink:href="lh-20200930.xsd#lh_CovanceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b810fe2d-c5a9-4b16-b32e-b71c6bf0b94c" xlink:to="loc_lh_CovanceMember_017bc9fc-197a-42d4-94da-f9011a3554fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2b6c9540-8ed4-401d-b1e6-e5cebef629a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8f0d372e-1b8f-4e59-9634-6c53f7da287a" xlink:to="loc_us-gaap_DebtInstrumentAxis_2b6c9540-8ed4-401d-b1e6-e5cebef629a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d5c2b020-0792-4069-9a59-569ac2d74ef3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_2b6c9540-8ed4-401d-b1e6-e5cebef629a9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d5c2b020-0792-4069-9a59-569ac2d74ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9706dd12-a4f2-42e6-b03a-d2f42be7a432" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8f0d372e-1b8f-4e59-9634-6c53f7da287a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9706dd12-a4f2-42e6-b03a-d2f42be7a432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_647d409c-1634-49de-8509-48d3372c1e6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9706dd12-a4f2-42e6-b03a-d2f42be7a432" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_647d409c-1634-49de-8509-48d3372c1e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2023Member_6eb6449a-0960-42c6-9808-8b4b55135ff6" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_647d409c-1634-49de-8509-48d3372c1e6c" xlink:to="loc_lh_Seniornotesdue2023Member_6eb6449a-0960-42c6-9808-8b4b55135ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2024MemberMember_37632c95-40b3-40a2-be53-b84ce77940fc" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2024MemberMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_647d409c-1634-49de-8509-48d3372c1e6c" xlink:to="loc_lh_Seniornotesdue2024MemberMember_37632c95-40b3-40a2-be53-b84ce77940fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Crosscurrencyswapmaturing2025Member_e77809f1-c585-4b9f-8f2c-432ec8400161" xlink:href="lh-20200930.xsd#lh_Crosscurrencyswapmaturing2025Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_647d409c-1634-49de-8509-48d3372c1e6c" xlink:to="loc_lh_Crosscurrencyswapmaturing2025Member_e77809f1-c585-4b9f-8f2c-432ec8400161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2027Member_05ade0c8-abe4-41f9-aed6-9bf67011dbdb" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2027Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_647d409c-1634-49de-8509-48d3372c1e6c" xlink:to="loc_lh_Seniornotesdue2027Member_05ade0c8-abe4-41f9-aed6-9bf67011dbdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2045Member_6c251096-8f60-4e38-8eea-e5d6cd459201" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2045Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_647d409c-1634-49de-8509-48d3372c1e6c" xlink:to="loc_lh_Seniornotesdue2045Member_6c251096-8f60-4e38-8eea-e5d6cd459201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2019TermLoanMember_c07b4964-4798-4089-b5b7-465730e935fe" xlink:href="lh-20200930.xsd#lh_A2019TermLoanMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_647d409c-1634-49de-8509-48d3372c1e6c" xlink:to="loc_lh_A2019TermLoanMember_c07b4964-4798-4089-b5b7-465730e935fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Crosscurrencyswapmaturing2022Member_95ca247a-4d5c-403e-96ff-3302cce94d9f" xlink:href="lh-20200930.xsd#lh_Crosscurrencyswapmaturing2022Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_647d409c-1634-49de-8509-48d3372c1e6c" xlink:to="loc_lh_Crosscurrencyswapmaturing2022Member_95ca247a-4d5c-403e-96ff-3302cce94d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2020Member_6257069f-0ef3-4bc2-b550-64b214860c00" xlink:href="lh-20200930.xsd#lh_SeniorNotesDue2020Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_647d409c-1634-49de-8509-48d3372c1e6c" xlink:to="loc_lh_SeniorNotesDue2020Member_6257069f-0ef3-4bc2-b550-64b214860c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8f0d372e-1b8f-4e59-9634-6c53f7da287a" xlink:to="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Shorttermdebtissuancecosts_5f8871a0-b942-466c-9dcc-f465461b2346" xlink:href="lh-20200930.xsd#lh_Shorttermdebtissuancecosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_lh_Shorttermdebtissuancecosts_5f8871a0-b942-466c-9dcc-f465461b2346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_eac2e0e9-c03f-4054-ae28-f30070157107" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_eac2e0e9-c03f-4054-ae28-f30070157107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_a7f3f15c-b7c7-4868-b481-546d6eaaf9e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_a7f3f15c-b7c7-4868-b481-546d6eaaf9e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d930bb04-b014-4636-998d-36032ceff5bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d930bb04-b014-4636-998d-36032ceff5bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityOptiontoIncrease_0569f1e4-5f7f-4442-b72d-7c3ba6dca977" xlink:href="lh-20200930.xsd#lh_CreditFacilityOptiontoIncrease"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_lh_CreditFacilityOptiontoIncrease_0569f1e4-5f7f-4442-b72d-7c3ba6dca977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumSwingLineBorrowings_4f107f07-06ef-42e0-b931-ecde25b4c52d" xlink:href="lh-20200930.xsd#lh_CreditFacilityMaximumSwingLineBorrowings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_lh_CreditFacilityMaximumSwingLineBorrowings_4f107f07-06ef-42e0-b931-ecde25b4c52d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumLettersofCredit_63a79dd1-a1c7-4952-a098-c868b5453ed5" xlink:href="lh-20200930.xsd#lh_CreditFacilityMaximumLettersofCredit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_lh_CreditFacilityMaximumLettersofCredit_63a79dd1-a1c7-4952-a098-c868b5453ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongTermNotes_6d8b807e-38ed-44b2-8097-3c329fb092ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorLongTermNotes"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_us-gaap_SeniorLongTermNotes_6d8b807e-38ed-44b2-8097-3c329fb092ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgesAtFairValueNet_5545dcbc-c6b5-4fdb-829e-e9a8d91a7495" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgesAtFairValueNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_us-gaap_FairValueHedgesAtFairValueNet_5545dcbc-c6b5-4fdb-829e-e9a8d91a7495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f2a844ae-28ab-4a92-9ded-bcdb4bc0ae40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f2a844ae-28ab-4a92-9ded-bcdb4bc0ae40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDescription_75bdd347-89c1-4267-99e9-62ef943048c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDescription"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDescription_75bdd347-89c1-4267-99e9-62ef943048c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_b83a9a77-f652-4754-87fb-b1acebd7ca77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_b83a9a77-f652-4754-87fb-b1acebd7ca77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Longtermdebtissuancecosts_31af8a3d-9839-4016-9c32-050611709cb1" xlink:href="lh-20200930.xsd#lh_Longtermdebtissuancecosts"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_lh_Longtermdebtissuancecosts_31af8a3d-9839-4016-9c32-050611709cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_9594cfbc-a23f-4cfa-821a-3f736fec6fe5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_us-gaap_NotesPayableCurrent_9594cfbc-a23f-4cfa-821a-3f736fec6fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_3858ef2d-2ed0-4b85-8d35-46d0801690e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_us-gaap_DebtCurrent_3858ef2d-2ed0-4b85-8d35-46d0801690e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_2d920042-4644-4a37-a903-7a09947579da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_2d920042-4644-4a37-a903-7a09947579da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A4.625Seniornotesdue2020_16e99346-25a2-4d86-a073-d5ea01e3cad0" xlink:href="lh-20200930.xsd#lh_A4.625Seniornotesdue2020"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_lh_A4.625Seniornotesdue2020_16e99346-25a2-4d86-a073-d5ea01e3cad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2.30seniornotesdue2024_74109595-427d-43a5-9264-3b8a44ef3bdb" xlink:href="lh-20200930.xsd#lh_A2.30seniornotesdue2024"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_lh_A2.30seniornotesdue2024_74109595-427d-43a5-9264-3b8a44ef3bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2.95seniornotesdue2029_ba55cae0-bcce-4c24-b77c-00cd9b5baeb1" xlink:href="lh-20200930.xsd#lh_A2.95seniornotesdue2029"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_lh_A2.95seniornotesdue2029_ba55cae0-bcce-4c24-b77c-00cd9b5baeb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_BalanceOfSeniorNotesMatureDuringQ42020_92fc2455-2a68-460a-b61a-5e15328410d6" xlink:href="lh-20200930.xsd#lh_BalanceOfSeniorNotesMatureDuringQ42020"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6180460f-d3b9-4f69-b15a-5c0906f83d13" xlink:to="loc_lh_BalanceOfSeniorNotesMatureDuringQ42020_92fc2455-2a68-460a-b61a-5e15328410d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTConvertibleSubordinatedNotesDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#DEBTConvertibleSubordinatedNotesDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/DEBTConvertibleSubordinatedNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_457f38ac-1202-430f-8425-fc43556b56af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ZeroCouponConvertibleSubordinatedNotesTable_389034e8-d5c7-4825-b111-0459ca2f4c5a" xlink:href="lh-20200930.xsd#lh_ZeroCouponConvertibleSubordinatedNotesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_457f38ac-1202-430f-8425-fc43556b56af" xlink:to="loc_lh_ZeroCouponConvertibleSubordinatedNotesTable_389034e8-d5c7-4825-b111-0459ca2f4c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_6fd3bd60-f5c9-4145-92f2-26ee70cbf473" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ZeroCouponConvertibleSubordinatedNotesTable_389034e8-d5c7-4825-b111-0459ca2f4c5a" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_6fd3bd60-f5c9-4145-92f2-26ee70cbf473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_80bdc58f-274c-439b-86cd-b98908155b7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_6fd3bd60-f5c9-4145-92f2-26ee70cbf473" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_80bdc58f-274c-439b-86cd-b98908155b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ZeroCouponConvertibleSubordinatedNotesLineItems_b8cea21c-72c6-40d9-b41d-0893e283c44c" xlink:href="lh-20200930.xsd#lh_ZeroCouponConvertibleSubordinatedNotesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ZeroCouponConvertibleSubordinatedNotesTable_389034e8-d5c7-4825-b111-0459ca2f4c5a" xlink:to="loc_lh_ZeroCouponConvertibleSubordinatedNotesLineItems_b8cea21c-72c6-40d9-b41d-0893e283c44c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTCreditFacilitiesDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#DEBTCreditFacilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/DEBTCreditFacilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0c2759f4-8649-4150-a04e-1c5b15611a6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_ca24bdb0-73d1-4821-b62f-3a341e6b658a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0c2759f4-8649-4150-a04e-1c5b15611a6c" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_ca24bdb0-73d1-4821-b62f-3a341e6b658a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_23b139ba-13b3-4908-be6a-92bcf5240b69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ca24bdb0-73d1-4821-b62f-3a341e6b658a" xlink:to="loc_us-gaap_DebtInstrumentAxis_23b139ba-13b3-4908-be6a-92bcf5240b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a4d97d9c-33b8-435c-bd67-e300792ced37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_23b139ba-13b3-4908-be6a-92bcf5240b69" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a4d97d9c-33b8-435c-bd67-e300792ced37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_31995873-0c77-4f14-8106-9e694d9d32af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ca24bdb0-73d1-4821-b62f-3a341e6b658a" xlink:to="loc_us-gaap_VariableRateAxis_31995873-0c77-4f14-8106-9e694d9d32af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_8c0d91b1-d586-4a58-ae4c-e652d03d37b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_31995873-0c77-4f14-8106-9e694d9d32af" xlink:to="loc_us-gaap_VariableRateDomain_8c0d91b1-d586-4a58-ae4c-e652d03d37b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_ab92089c-50f0-4ff9-9a4d-92dfa430db65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_8c0d91b1-d586-4a58-ae4c-e652d03d37b5" xlink:to="loc_us-gaap_PrimeRateMember_ab92089c-50f0-4ff9-9a4d-92dfa430db65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_06e66be7-d18c-4340-96e8-b233d62fcec8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_8c0d91b1-d586-4a58-ae4c-e652d03d37b5" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_06e66be7-d18c-4340-96e8-b233d62fcec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_757a8ea3-5115-4127-8130-44b481d404c5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ca24bdb0-73d1-4821-b62f-3a341e6b658a" xlink:to="loc_srt_RangeAxis_757a8ea3-5115-4127-8130-44b481d404c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_327df490-5a6a-4d8c-8ac6-78f4b9dafad6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_757a8ea3-5115-4127-8130-44b481d404c5" xlink:to="loc_srt_RangeMember_327df490-5a6a-4d8c-8ac6-78f4b9dafad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_af1b06d4-488c-4a54-8c27-8c585f56ab99" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_327df490-5a6a-4d8c-8ac6-78f4b9dafad6" xlink:to="loc_srt_MinimumMember_af1b06d4-488c-4a54-8c27-8c585f56ab99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8e429904-94bf-4180-a36e-95ae9a688b67" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_327df490-5a6a-4d8c-8ac6-78f4b9dafad6" xlink:to="loc_srt_MaximumMember_8e429904-94bf-4180-a36e-95ae9a688b67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_8e94ee15-6308-4167-b0f6-3c617ebe1258" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ca24bdb0-73d1-4821-b62f-3a341e6b658a" xlink:to="loc_us-gaap_CreditFacilityAxis_8e94ee15-6308-4167-b0f6-3c617ebe1258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_754ab21c-43c1-4e87-91bd-21bd9c06916f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_8e94ee15-6308-4167-b0f6-3c617ebe1258" xlink:to="loc_us-gaap_CreditFacilityDomain_754ab21c-43c1-4e87-91bd-21bd9c06916f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_TermLoanandRevolvingCreditFacilityMember_2de86e05-1556-4663-ac83-392f2ec4c01a" xlink:href="lh-20200930.xsd#lh_TermLoanandRevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_754ab21c-43c1-4e87-91bd-21bd9c06916f" xlink:to="loc_lh_TermLoanandRevolvingCreditFacilityMember_2de86e05-1556-4663-ac83-392f2ec4c01a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2019TermLoanMember_d245f661-6e31-4c68-82b3-b442c059e4e8" xlink:href="lh-20200930.xsd#lh_A2019TermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_754ab21c-43c1-4e87-91bd-21bd9c06916f" xlink:to="loc_lh_A2019TermLoanMember_d245f661-6e31-4c68-82b3-b442c059e4e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_26658eb0-05e2-4dbb-b61a-e6e8c98f014a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_754ab21c-43c1-4e87-91bd-21bd9c06916f" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_26658eb0-05e2-4dbb-b61a-e6e8c98f014a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_f8fde358-fcfe-4078-a276-a04cc0ead1e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_754ab21c-43c1-4e87-91bd-21bd9c06916f" xlink:to="loc_us-gaap_PrimeRateMember_f8fde358-fcfe-4078-a276-a04cc0ead1e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_c8c69803-663e-4e83-9586-f532f7d576d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_754ab21c-43c1-4e87-91bd-21bd9c06916f" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_c8c69803-663e-4e83-9586-f532f7d576d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_00554f52-7450-4304-be9a-c34930c1961e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ca24bdb0-73d1-4821-b62f-3a341e6b658a" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_00554f52-7450-4304-be9a-c34930c1961e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_b95abffc-7b95-4aa6-a507-f6c3b4573bff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_00554f52-7450-4304-be9a-c34930c1961e" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_b95abffc-7b95-4aa6-a507-f6c3b4573bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_1630d13b-3991-479c-b450-0d32160e5111" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_b95abffc-7b95-4aa6-a507-f6c3b4573bff" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_1630d13b-3991-479c-b450-0d32160e5111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ab9d007a-8a64-4893-8ac2-b428d7a1ced6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ca24bdb0-73d1-4821-b62f-3a341e6b658a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ab9d007a-8a64-4893-8ac2-b428d7a1ced6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_24e7b250-e818-4899-9e51-2bfd12aaebfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ab9d007a-8a64-4893-8ac2-b428d7a1ced6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_24e7b250-e818-4899-9e51-2bfd12aaebfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2027Member_cf8a8c11-5417-4829-b43f-79aadc204105" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2027Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_24e7b250-e818-4899-9e51-2bfd12aaebfb" xlink:to="loc_lh_Seniornotesdue2027Member_cf8a8c11-5417-4829-b43f-79aadc204105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2024MemberMember_e7420e65-c4d3-4451-88ac-b1f638f70517" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2024MemberMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_24e7b250-e818-4899-9e51-2bfd12aaebfb" xlink:to="loc_lh_Seniornotesdue2024MemberMember_e7420e65-c4d3-4451-88ac-b1f638f70517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2020Member_68637d8c-15c0-4a15-b5d6-48d266f1fda7" xlink:href="lh-20200930.xsd#lh_SeniorNotesDue2020Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_24e7b250-e818-4899-9e51-2bfd12aaebfb" xlink:to="loc_lh_SeniorNotesDue2020Member_68637d8c-15c0-4a15-b5d6-48d266f1fda7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2045Member_47a59d9e-cf38-4f34-8813-ff01bf2c6499" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2045Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_24e7b250-e818-4899-9e51-2bfd12aaebfb" xlink:to="loc_lh_Seniornotesdue2045Member_47a59d9e-cf38-4f34-8813-ff01bf2c6499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2022Member_be5f88cc-8d41-40ae-b543-aa4c1c57cd65" xlink:href="lh-20200930.xsd#lh_SeniorNotesDue2022Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_24e7b250-e818-4899-9e51-2bfd12aaebfb" xlink:to="loc_lh_SeniorNotesDue2022Member_be5f88cc-8d41-40ae-b543-aa4c1c57cd65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_28fab558-1f9f-4cc3-84ab-bceea5b4b72b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ca24bdb0-73d1-4821-b62f-3a341e6b658a" xlink:to="loc_srt_StatementScenarioAxis_28fab558-1f9f-4cc3-84ab-bceea5b4b72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_afc5a2dc-61a7-4e1b-9b00-9c60ddecff20" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_28fab558-1f9f-4cc3-84ab-bceea5b4b72b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_afc5a2dc-61a7-4e1b-9b00-9c60ddecff20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_eb48c3e6-5d02-4bc2-89d9-627cf2915990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ca24bdb0-73d1-4821-b62f-3a341e6b658a" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_eb48c3e6-5d02-4bc2-89d9-627cf2915990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_cf5bac88-a4a2-4826-b245-a00ebfe6fef9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_eb48c3e6-5d02-4bc2-89d9-627cf2915990" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_cf5bac88-a4a2-4826-b245-a00ebfe6fef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_a3b8dc9b-db79-42d3-b191-20c93caa0008" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_cf5bac88-a4a2-4826-b245-a00ebfe6fef9" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_a3b8dc9b-db79-42d3-b191-20c93caa0008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ca24bdb0-73d1-4821-b62f-3a341e6b658a" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021_ca6a9999-eab6-4527-8c13-7170e312c1fa" xlink:href="lh-20200930.xsd#lh_DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_lh_DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021_ca6a9999-eab6-4527-8c13-7170e312c1fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage_5840e85f-9f46-496c-b697-764199a1bef5" xlink:href="lh-20200930.xsd#lh_TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_lh_TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage_5840e85f-9f46-496c-b697-764199a1bef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2019TermLoan_741a8208-c9c7-425b-8208-e1aa1b2e2ef4" xlink:href="lh-20200930.xsd#lh_A2019TermLoan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_lh_A2019TermLoan_741a8208-c9c7-425b-8208-e1aa1b2e2ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_26dcfaae-4cde-4455-a1ae-8b3982fbef4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_26dcfaae-4cde-4455-a1ae-8b3982fbef4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020_e267384c-7232-4115-9e0f-2ad2e5b93eec" xlink:href="lh-20200930.xsd#lh_DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_lh_DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020_e267384c-7232-4115-9e0f-2ad2e5b93eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021_bd352701-4fc9-4898-9a4c-e34069f31c8a" xlink:href="lh-20200930.xsd#lh_DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_lh_DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021_bd352701-4fc9-4898-9a4c-e34069f31c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_BalanceOfSeniorNotesMatureDuringQ42020_e9e7c64c-ff9f-44ab-90e6-b0f4d5756a15" xlink:href="lh-20200930.xsd#lh_BalanceOfSeniorNotesMatureDuringQ42020"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_lh_BalanceOfSeniorNotesMatureDuringQ42020_e9e7c64c-ff9f-44ab-90e6-b0f4d5756a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_846fbd39-2923-481b-a912-d5f3c1cf3802" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_846fbd39-2923-481b-a912-d5f3c1cf3802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongTermNotes_21ee40d0-d526-4831-a743-f27601300589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorLongTermNotes"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_us-gaap_SeniorLongTermNotes_21ee40d0-d526-4831-a743-f27601300589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_dcb9357b-262f-45bd-ba5f-4fb4ccd58af7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_dcb9357b-262f-45bd-ba5f-4fb4ccd58af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d6c731d9-2700-46c0-a0de-2d0cdce49bf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d6c731d9-2700-46c0-a0de-2d0cdce49bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumLettersofCredit_f71c3023-e81e-4df0-9b3b-a058a352381a" xlink:href="lh-20200930.xsd#lh_CreditFacilityMaximumLettersofCredit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_lh_CreditFacilityMaximumLettersofCredit_f71c3023-e81e-4df0-9b3b-a058a352381a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_d165ef4e-c668-44a3-a0f1-6b15fd775330" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_d165ef4e-c668-44a3-a0f1-6b15fd775330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c4e24e7f-3af8-41c1-8893-05a88de6011e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c4e24e7f-3af8-41c1-8893-05a88de6011e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_4212feb0-2a17-486c-8a73-afefb48eb9e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_4212feb0-2a17-486c-8a73-afefb48eb9e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDescription_ae35462c-c039-4d1e-8630-5064c086fcc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDescription"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDescription_ae35462c-c039-4d1e-8630-5064c086fcc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_d8d64e29-f26a-4aac-ada7-c8987ec48bab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_d8d64e29-f26a-4aac-ada7-c8987ec48bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_faa8b301-5423-4171-a225-8d059c3d33b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_us-gaap_NotesPayableCurrent_faa8b301-5423-4171-a225-8d059c3d33b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_e8398e2e-d3e2-4743-ad5a-bc982cea9371" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_us-gaap_DebtCurrent_e8398e2e-d3e2-4743-ad5a-bc982cea9371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityOptiontoIncrease_b3817152-61ed-4cce-9bab-5b2e1201d797" xlink:href="lh-20200930.xsd#lh_CreditFacilityOptiontoIncrease"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_lh_CreditFacilityOptiontoIncrease_b3817152-61ed-4cce-9bab-5b2e1201d797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumSwingLineBorrowings_43d9a03b-63b0-4ed4-aead-6fdedb922e8f" xlink:href="lh-20200930.xsd#lh_CreditFacilityMaximumSwingLineBorrowings"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_lh_CreditFacilityMaximumSwingLineBorrowings_43d9a03b-63b0-4ed4-aead-6fdedb922e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable_1742ab7e-6613-44ac-a25c-bad20188b552" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayable"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_us-gaap_NotesPayable_1742ab7e-6613-44ac-a25c-bad20188b552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage_bd0eaedb-75cc-4e87-ade2-12fd6451dfdf" xlink:href="lh-20200930.xsd#lh_RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_lh_RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage_bd0eaedb-75cc-4e87-ade2-12fd6451dfdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage_7daa724e-f2af-4b72-9457-623ed34efafd" xlink:href="lh-20200930.xsd#lh_RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_lh_RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage_7daa724e-f2af-4b72-9457-623ed34efafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments_65cf5405-7f94-480b-9adb-d4298c5d1bfe" xlink:href="lh-20200930.xsd#lh_RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_lh_RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments_65cf5405-7f94-480b-9adb-d4298c5d1bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage_dcf1a687-8169-429d-9c6b-9e40350bd3e4" xlink:href="lh-20200930.xsd#lh_TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a4972c01-9a61-4f89-86ba-ba9048cdb7ed" xlink:to="loc_lh_TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage_dcf1a687-8169-429d-9c6b-9e40350bd3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021_683f506f-f4af-4e51-b341-812012cf17c6" xlink:href="lh-20200930.xsd#lh_DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="lh-20200930.xsd#PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_35154f1d-e818-4e6f-8af0-5447d2b1e0ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock_a990858a-1f3f-4f01-b1eb-7e9ae50d2fb3" xlink:href="lh-20200930.xsd#lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_35154f1d-e818-4e6f-8af0-5447d2b1e0ac" xlink:to="loc_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock_a990858a-1f3f-4f01-b1eb-7e9ae50d2fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_e80a7d0e-1b1c-41b5-9bdc-0beb2b3c4a8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_35154f1d-e818-4e6f-8af0-5447d2b1e0ac" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_e80a7d0e-1b1c-41b5-9bdc-0beb2b3c4a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b7729802-c657-441e-b075-247d29dbc9f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_35154f1d-e818-4e6f-8af0-5447d2b1e0ac" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b7729802-c657-441e-b075-247d29dbc9f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c09c85ab-88c6-4663-8e91-0b06be85343b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b7729802-c657-441e-b075-247d29dbc9f6" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c09c85ab-88c6-4663-8e91-0b06be85343b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ab42f300-b6cd-435c-b7df-d1401f2bef4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c09c85ab-88c6-4663-8e91-0b06be85343b" xlink:to="loc_us-gaap_EquityComponentDomain_ab42f300-b6cd-435c-b7df-d1401f2bef4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c5c92b69-7778-427a-ae74-7c599e514f6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b7729802-c657-441e-b075-247d29dbc9f6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c5c92b69-7778-427a-ae74-7c599e514f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_055d7fd4-fc18-42e1-b183-8b7f165c3bb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_35154f1d-e818-4e6f-8af0-5447d2b1e0ac" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_055d7fd4-fc18-42e1-b183-8b7f165c3bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_20415158-9d86-47f8-8622-09700d84af48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_28f65bad-a25b-4026-9eda-798c490f26f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_20415158-9d86-47f8-8622-09700d84af48" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_28f65bad-a25b-4026-9eda-798c490f26f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_11ac26b3-5983-4d5e-a73c-a421e7d67529" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_28f65bad-a25b-4026-9eda-798c490f26f1" xlink:to="loc_us-gaap_CreditFacilityAxis_11ac26b3-5983-4d5e-a73c-a421e7d67529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_315ab111-1319-4845-85ca-72403c6299eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_11ac26b3-5983-4d5e-a73c-a421e7d67529" xlink:to="loc_us-gaap_CreditFacilityDomain_315ab111-1319-4845-85ca-72403c6299eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_16ff43a2-7318-46b1-b351-247802b07b64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_28f65bad-a25b-4026-9eda-798c490f26f1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_16ff43a2-7318-46b1-b351-247802b07b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a76e3dda-2f2f-4efc-964d-a21959201445" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_16ff43a2-7318-46b1-b351-247802b07b64" xlink:to="loc_us-gaap_ClassOfStockDomain_a76e3dda-2f2f-4efc-964d-a21959201445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_cbd747c2-62f0-4a5c-b89a-17d7fc7cea56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a76e3dda-2f2f-4efc-964d-a21959201445" xlink:to="loc_us-gaap_CommonStockMember_cbd747c2-62f0-4a5c-b89a-17d7fc7cea56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_28f65bad-a25b-4026-9eda-798c490f26f1" xlink:to="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_f770fc87-0fc2-4ee4-800f-a2ae20013285" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_f770fc87-0fc2-4ee4-800f-a2ae20013285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonSharesIssuedRollforwardAbstract_8356397e-e440-4edd-a4fc-63b88c027581" xlink:href="lh-20200930.xsd#lh_CommonSharesIssuedRollforwardAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:to="loc_lh_CommonSharesIssuedRollforwardAbstract_8356397e-e440-4edd-a4fc-63b88c027581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_92ef9c08-d986-4c31-9d62-bb0b5e4c2717" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CommonSharesIssuedRollforwardAbstract_8356397e-e440-4edd-a4fc-63b88c027581" xlink:to="loc_us-gaap_CommonStockSharesIssued_92ef9c08-d986-4c31-9d62-bb0b5e4c2717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_2c1c5eea-986d-4f91-a3f5-d7b2b0e9854e" xlink:href="lh-20200930.xsd#lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CommonSharesIssuedRollforwardAbstract_8356397e-e440-4edd-a4fc-63b88c027581" xlink:to="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_2c1c5eea-986d-4f91-a3f5-d7b2b0e9854e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_09b9127c-62a5-49d5-b762-d468449e3dc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CommonSharesIssuedRollforwardAbstract_8356397e-e440-4edd-a4fc-63b88c027581" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_09b9127c-62a5-49d5-b762-d468449e3dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_8d06e269-e2ce-4305-8fbe-31293a857a90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CommonSharesIssuedRollforwardAbstract_8356397e-e440-4edd-a4fc-63b88c027581" xlink:to="loc_us-gaap_CommonStockSharesIssued_8d06e269-e2ce-4305-8fbe-31293a857a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_2821d30f-b95e-43af-a032-b780763a0ac0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CommonSharesIssuedRollforwardAbstract_8356397e-e440-4edd-a4fc-63b88c027581" xlink:to="loc_us-gaap_CommonStockSharesIssued_2821d30f-b95e-43af-a032-b780763a0ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_5481c90e-637c-457b-958f-9cb55b6d343c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_5481c90e-637c-457b-958f-9cb55b6d343c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5ea0fb01-3816-49e6-a9bd-68c8749ea17b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5ea0fb01-3816-49e6-a9bd-68c8749ea17b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OutstandingStockRepurchaseAuthorizationAbstract_57f69921-6be8-4a6e-b0ea-b5ae7d6c697f" xlink:href="lh-20200930.xsd#lh_OutstandingStockRepurchaseAuthorizationAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:to="loc_lh_OutstandingStockRepurchaseAuthorizationAbstract_57f69921-6be8-4a6e-b0ea-b5ae7d6c697f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonStockRepurchaseAuthorizationOutstanding_b8e3a36c-89dd-4cd7-9d75-7d6211933672" xlink:href="lh-20200930.xsd#lh_CommonStockRepurchaseAuthorizationOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_OutstandingStockRepurchaseAuthorizationAbstract_57f69921-6be8-4a6e-b0ea-b5ae7d6c697f" xlink:to="loc_lh_CommonStockRepurchaseAuthorizationOutstanding_b8e3a36c-89dd-4cd7-9d75-7d6211933672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_61245b18-c1ec-4ee0-a692-2eb5cb0bf3ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_OutstandingStockRepurchaseAuthorizationAbstract_57f69921-6be8-4a6e-b0ea-b5ae7d6c697f" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_61245b18-c1ec-4ee0-a692-2eb5cb0bf3ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonStockRepurchaseAuthorizationOutstanding_24e35fce-071b-4972-a11d-5250ef6bc5a0" xlink:href="lh-20200930.xsd#lh_CommonStockRepurchaseAuthorizationOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_OutstandingStockRepurchaseAuthorizationAbstract_57f69921-6be8-4a6e-b0ea-b5ae7d6c697f" xlink:to="loc_lh_CommonStockRepurchaseAuthorizationOutstanding_24e35fce-071b-4972-a11d-5250ef6bc5a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonSharesOutstandingRollforwardAbstract_17b3ea60-f71d-4079-87b1-97f48fdf8023" xlink:href="lh-20200930.xsd#lh_CommonSharesOutstandingRollforwardAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:to="loc_lh_CommonSharesOutstandingRollforwardAbstract_17b3ea60-f71d-4079-87b1-97f48fdf8023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d9f39e71-74ee-4bc0-9d5e-c1f9de958df2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CommonSharesOutstandingRollforwardAbstract_17b3ea60-f71d-4079-87b1-97f48fdf8023" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d9f39e71-74ee-4bc0-9d5e-c1f9de958df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_5d2ef727-87e0-41a6-abdf-4a0d3458e10b" xlink:href="lh-20200930.xsd#lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CommonSharesOutstandingRollforwardAbstract_17b3ea60-f71d-4079-87b1-97f48fdf8023" xlink:to="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_5d2ef727-87e0-41a6-abdf-4a0d3458e10b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_01d4d189-d913-412e-9d00-237fc34a0b85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CommonSharesOutstandingRollforwardAbstract_17b3ea60-f71d-4079-87b1-97f48fdf8023" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_01d4d189-d913-412e-9d00-237fc34a0b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_68893b3a-ef2f-43eb-9add-20cb01bcd8cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CommonSharesOutstandingRollforwardAbstract_17b3ea60-f71d-4079-87b1-97f48fdf8023" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_68893b3a-ef2f-43eb-9add-20cb01bcd8cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_f3d4f3f6-ce62-4e70-9667-106a8a04b42b" xlink:href="lh-20200930.xsd#lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:to="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_f3d4f3f6-ce62-4e70-9667-106a8a04b42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonSharesHeldInTreasuryRollforwardAbstract_45a4c01e-1cbd-4102-940d-a33160fa8511" xlink:href="lh-20200930.xsd#lh_CommonSharesHeldInTreasuryRollforwardAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:to="loc_lh_CommonSharesHeldInTreasuryRollforwardAbstract_45a4c01e-1cbd-4102-940d-a33160fa8511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_996a94e2-30e5-48f3-a392-3a1c63c7816c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_996a94e2-30e5-48f3-a392-3a1c63c7816c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_7ce625a3-cfde-40b9-8fb6-9c76455e5fbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_7ce625a3-cfde-40b9-8fb6-9c76455e5fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_e8900311-9a5c-44b3-8cd9-732963c7e0cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_e8900311-9a5c-44b3-8cd9-732963c7e0cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_84a89c7c-f80f-497c-8b23-e93f7c5b1fbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_84a89c7c-f80f-497c-8b23-e93f7c5b1fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_7dabd125-7dec-43a3-8401-9cb0a6e94cd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_7dabd125-7dec-43a3-8401-9cb0a6e94cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_0a030573-02c0-4287-8c9f-d923e77a0acc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6f0b7af-e517-4e8e-acf6-c284bd2e0d14" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_0a030573-02c0-4287-8c9f-d923e77a0acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_3c2c5ffd-5300-4382-ab92-7ba02b03b34d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_acf8b162-62fc-4305-b577-6ff64acb8f2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3c2c5ffd-5300-4382-ab92-7ba02b03b34d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_acf8b162-62fc-4305-b577-6ff64acb8f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_63997f49-408a-423c-9723-b2fe640d4030" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_acf8b162-62fc-4305-b577-6ff64acb8f2f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_63997f49-408a-423c-9723-b2fe640d4030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_36897d43-0e6b-44b5-8541-cac6b1b41781" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_63997f49-408a-423c-9723-b2fe640d4030" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_36897d43-0e6b-44b5-8541-cac6b1b41781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2e1c7304-0db8-4120-8f26-67721a280598" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_acf8b162-62fc-4305-b577-6ff64acb8f2f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2e1c7304-0db8-4120-8f26-67721a280598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_608d6b81-f7b9-43fe-8344-0726aab5fb1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2e1c7304-0db8-4120-8f26-67721a280598" xlink:to="loc_us-gaap_EquityComponentDomain_608d6b81-f7b9-43fe-8344-0726aab5fb1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4c495613-e789-4ce3-a915-7afa220af58a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_acf8b162-62fc-4305-b577-6ff64acb8f2f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4c495613-e789-4ce3-a915-7afa220af58a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_55c01b2e-1e2c-4d30-9fd3-a2eb3a418e07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3c2c5ffd-5300-4382-ab92-7ba02b03b34d" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_55c01b2e-1e2c-4d30-9fd3-a2eb3a418e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax_fecd5555-f005-4e1f-a01a-e37787e1cc86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3c2c5ffd-5300-4382-ab92-7ba02b03b34d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax_fecd5555-f005-4e1f-a01a-e37787e1cc86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_647aac17-d3c4-4792-a54e-0c9e7954be40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3c2c5ffd-5300-4382-ab92-7ba02b03b34d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_647aac17-d3c4-4792-a54e-0c9e7954be40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_8088bb20-a666-4e19-9276-0e1b83be6f59" xlink:href="lh-20200930.xsd#lh_AccumulatedOtherComprehensiveEarningsRollForward"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3c2c5ffd-5300-4382-ab92-7ba02b03b34d" xlink:to="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_8088bb20-a666-4e19-9276-0e1b83be6f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_a1118fc7-961f-4e68-8c5f-1c48d9bd6b35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_8088bb20-a666-4e19-9276-0e1b83be6f59" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_a1118fc7-961f-4e68-8c5f-1c48d9bd6b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_a706401e-dd31-42a5-a25e-b11f1735a1b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_8088bb20-a666-4e19-9276-0e1b83be6f59" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_a706401e-dd31-42a5-a25e-b11f1735a1b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax_67dad0f7-e0e8-4ac0-8fd2-d39f7ff9a2ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_8088bb20-a666-4e19-9276-0e1b83be6f59" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax_67dad0f7-e0e8-4ac0-8fd2-d39f7ff9a2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_3355ab24-d068-454f-a699-70068747126a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_8088bb20-a666-4e19-9276-0e1b83be6f59" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_3355ab24-d068-454f-a699-70068747126a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_1620bd79-1d78-45cc-b716-57ec105ab155" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_8088bb20-a666-4e19-9276-0e1b83be6f59" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_1620bd79-1d78-45cc-b716-57ec105ab155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_910d7193-4781-43b5-93bb-2880a32e6a6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_8088bb20-a666-4e19-9276-0e1b83be6f59" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_910d7193-4781-43b5-93bb-2880a32e6a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_227c3e66-458e-492c-b1e1-4ac1f6e34ecb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_8088bb20-a666-4e19-9276-0e1b83be6f59" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_227c3e66-458e-492c-b1e1-4ac1f6e34ecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f80eee95-91a8-4dd2-84da-aa0b8edf9a2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_8088bb20-a666-4e19-9276-0e1b83be6f59" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f80eee95-91a8-4dd2-84da-aa0b8edf9a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_410c2cf1-6aa5-425d-b4e8-3852d3ecad4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_8088bb20-a666-4e19-9276-0e1b83be6f59" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_410c2cf1-6aa5-425d-b4e8-3852d3ecad4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_89aa6a2d-7f50-44e3-b2e4-d23064bf6a42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_8088bb20-a666-4e19-9276-0e1b83be6f59" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_89aa6a2d-7f50-44e3-b2e4-d23064bf6a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_acf2309a-fe70-4203-ba39-679f05dc49df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_8088bb20-a666-4e19-9276-0e1b83be6f59" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_acf2309a-fe70-4203-ba39-679f05dc49df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/INCOMETAXES" xlink:type="simple" xlink:href="lh-20200930.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1c0c2393-28ff-43ca-ae16-7e93719d5b8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_69cd8a75-333b-4c7d-8b96-a0063378c3d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1c0c2393-28ff-43ca-ae16-7e93719d5b8a" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_69cd8a75-333b-4c7d-8b96-a0063378c3d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#INCOMETAXESDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/INCOMETAXESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_25ebd818-b424-402d-8b56-ff31e6d8702d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_65c2d271-e526-4dd7-8765-965478722e6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_25ebd818-b424-402d-8b56-ff31e6d8702d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_65c2d271-e526-4dd7-8765-965478722e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_e32963ca-ede8-4735-8560-dfcee5b84fd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_25ebd818-b424-402d-8b56-ff31e6d8702d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_e32963ca-ede8-4735-8560-dfcee5b84fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_89dd9c7c-e057-4ceb-a9cc-a5d399677b02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_25ebd818-b424-402d-8b56-ff31e6d8702d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_89dd9c7c-e057-4ceb-a9cc-a5d399677b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="lh-20200930.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4a9fec48-6d33-43c3-9f4d-198b5c3991cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_d2a5a758-000f-4498-8620-f11ca51f54e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4a9fec48-6d33-43c3-9f4d-198b5c3991cb" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_d2a5a758-000f-4498-8620-f11ca51f54e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c5ead88b-5bf9-4cf4-af67-5685dbe98887" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_7ab0fae2-e0e5-44db-95a4-a9673988f43a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c5ead88b-5bf9-4cf4-af67-5685dbe98887" xlink:to="loc_us-gaap_LossContingenciesTable_7ab0fae2-e0e5-44db-95a4-a9673988f43a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_876ac044-9c66-4b22-aefc-9394a1f9d79b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_7ab0fae2-e0e5-44db-95a4-a9673988f43a" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_876ac044-9c66-4b22-aefc-9394a1f9d79b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_6b13b5a2-2bf0-4420-b694-33bc95783b0c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_876ac044-9c66-4b22-aefc-9394a1f9d79b" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_6b13b5a2-2bf0-4420-b694-33bc95783b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e7a282ee-02ce-4fcf-b5b4-e22814448901" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_7ab0fae2-e0e5-44db-95a4-a9673988f43a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e7a282ee-02ce-4fcf-b5b4-e22814448901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42e22a68-b0e6-426d-9731-9395c1b4d644" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e7a282ee-02ce-4fcf-b5b4-e22814448901" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42e22a68-b0e6-426d-9731-9395c1b4d644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceMember_1c936c82-e1ed-4fa8-b170-e21e8a293b87" xlink:href="lh-20200930.xsd#lh_CovanceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42e22a68-b0e6-426d-9731-9395c1b4d644" xlink:to="loc_lh_CovanceMember_1c936c82-e1ed-4fa8-b170-e21e8a293b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b91900a4-c5f9-4215-9eed-ab6d72ea9bd4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_7ab0fae2-e0e5-44db-95a4-a9673988f43a" xlink:to="loc_srt_RangeAxis_b91900a4-c5f9-4215-9eed-ab6d72ea9bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_57870461-43b1-4a24-87e8-1322ae098e07" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b91900a4-c5f9-4215-9eed-ab6d72ea9bd4" xlink:to="loc_srt_RangeMember_57870461-43b1-4a24-87e8-1322ae098e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_7dfec7f0-f50c-479b-9991-c4a7be890f49" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_7ab0fae2-e0e5-44db-95a4-a9673988f43a" xlink:to="loc_dei_LegalEntityAxis_7dfec7f0-f50c-479b-9991-c4a7be890f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_2fb0dcd1-adbc-49dc-9fef-d3666d66325e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_7dfec7f0-f50c-479b-9991-c4a7be890f49" xlink:to="loc_dei_EntityDomain_2fb0dcd1-adbc-49dc-9fef-d3666d66325e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_d9f40849-9e94-4c97-9c6e-e2dfc7aa224b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_7ab0fae2-e0e5-44db-95a4-a9673988f43a" xlink:to="loc_us-gaap_LossContingenciesLineItems_d9f40849-9e94-4c97-9c6e-e2dfc7aa224b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANS" xlink:type="simple" xlink:href="lh-20200930.xsd#PENSIONANDPOSTRETIREMENTPLANS"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_e7c4be7f-7cc2-43c8-b9b3-d668df6bb650" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_e3e309f6-8d5b-4912-bd61-ee87555aab6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_e7c4be7f-7cc2-43c8-b9b3-d668df6bb650" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_e3e309f6-8d5b-4912-bd61-ee87555aab6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#PENSIONANDPOSTRETIREMENTPLANSDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_3f7a66c8-bb64-4928-ac4e-25b5fa8d7d4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b8e672b-293b-4235-b04b-c4a5dfc7f049" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_3f7a66c8-bb64-4928-ac4e-25b5fa8d7d4d" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b8e672b-293b-4235-b04b-c4a5dfc7f049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b1228fc8-c363-4bdc-bfd3-75d0509e2eca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b8e672b-293b-4235-b04b-c4a5dfc7f049" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b1228fc8-c363-4bdc-bfd3-75d0509e2eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_97184114-5ea2-4a85-a257-e2ab371b1046" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b1228fc8-c363-4bdc-bfd3-75d0509e2eca" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_97184114-5ea2-4a85-a257-e2ab371b1046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceMember_ffd1a0d0-fc33-4b45-87c1-6a35656e114f" xlink:href="lh-20200930.xsd#lh_CovanceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_97184114-5ea2-4a85-a257-e2ab371b1046" xlink:to="loc_lh_CovanceMember_ffd1a0d0-fc33-4b45-87c1-6a35656e114f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_8eb7c4c3-e774-4732-92aa-7ff8757c59d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b8e672b-293b-4235-b04b-c4a5dfc7f049" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_8eb7c4c3-e774-4732-92aa-7ff8757c59d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_04c262b0-fe60-4aa5-8540-16b5a8fb5350" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_8eb7c4c3-e774-4732-92aa-7ff8757c59d2" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_04c262b0-fe60-4aa5-8540-16b5a8fb5350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansCostsMember_5fda00c7-48ce-4069-b0c1-fc4b8092b7ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_04c262b0-fe60-4aa5-8540-16b5a8fb5350" xlink:to="loc_us-gaap_PensionAndOtherPostretirementPlansCostsMember_5fda00c7-48ce-4069-b0c1-fc4b8092b7ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_cf0d4647-07aa-411d-a9f2-779307ccea69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_04c262b0-fe60-4aa5-8540-16b5a8fb5350" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_cf0d4647-07aa-411d-a9f2-779307ccea69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18d64835-3070-4187-9dc6-06f39cb16aae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b8e672b-293b-4235-b04b-c4a5dfc7f049" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18d64835-3070-4187-9dc6-06f39cb16aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NonElectiveContribution_1c1c0880-e97a-4639-82eb-0f152e7d3057" xlink:href="lh-20200930.xsd#lh_NonElectiveContribution"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18d64835-3070-4187-9dc6-06f39cb16aae" xlink:to="loc_lh_NonElectiveContribution_1c1c0880-e97a-4639-82eb-0f152e7d3057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DiscretionaryContributionPercentageMaximum_20240e34-b69e-4121-b36c-d448e0b87f5b" xlink:href="lh-20200930.xsd#lh_DiscretionaryContributionPercentageMaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18d64835-3070-4187-9dc6-06f39cb16aae" xlink:to="loc_lh_DiscretionaryContributionPercentageMaximum_20240e34-b69e-4121-b36c-d448e0b87f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_b39c33b0-fd43-4aba-a94c-9b9c3b1433f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18d64835-3070-4187-9dc6-06f39cb16aae" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_b39c33b0-fd43-4aba-a94c-9b9c3b1433f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_49c04a0e-f44f-43fe-817f-53ef6ce874ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18d64835-3070-4187-9dc6-06f39cb16aae" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_49c04a0e-f44f-43fe-817f-53ef6ce874ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_d0d91ec7-a4ad-40e3-9f52-57a25fb7e2f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_49c04a0e-f44f-43fe-817f-53ef6ce874ef" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_d0d91ec7-a4ad-40e3-9f52-57a25fb7e2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_0605bbc3-b157-450a-9ef4-db68a669810f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_49c04a0e-f44f-43fe-817f-53ef6ce874ef" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_0605bbc3-b157-450a-9ef4-db68a669810f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_e888d6a9-040d-4c28-9ef3-e1cbc5952735" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_49c04a0e-f44f-43fe-817f-53ef6ce874ef" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_e888d6a9-040d-4c28-9ef3-e1cbc5952735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_7873560d-782b-4b3e-ba84-850a41964333" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_49c04a0e-f44f-43fe-817f-53ef6ce874ef" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_7873560d-782b-4b3e-ba84-850a41964333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_33f1e37e-9a0a-4a1e-aa2d-969eeb08f20b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_49c04a0e-f44f-43fe-817f-53ef6ce874ef" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_33f1e37e-9a0a-4a1e-aa2d-969eeb08f20b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetDefinedBenefitPlanAmortizationAndDeferral_21ec3c9f-c6df-4c10-a53e-14b5ad26046a" xlink:href="lh-20200930.xsd#lh_NetDefinedBenefitPlanAmortizationAndDeferral"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_49c04a0e-f44f-43fe-817f-53ef6ce874ef" xlink:to="loc_lh_NetDefinedBenefitPlanAmortizationAndDeferral_21ec3c9f-c6df-4c10-a53e-14b5ad26046a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6be87010-ceba-47eb-a015-db8be893b9f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_49c04a0e-f44f-43fe-817f-53ef6ce874ef" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6be87010-ceba-47eb-a015-db8be893b9f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_d5d25f62-a072-409f-b957-ab25ce587c03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18d64835-3070-4187-9dc6-06f39cb16aae" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_d5d25f62-a072-409f-b957-ab25ce587c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_d0a8cd51-1dd6-487f-bee6-da3897880bed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18d64835-3070-4187-9dc6-06f39cb16aae" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_d0a8cd51-1dd6-487f-bee6-da3897880bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedContributionPlanTotalExpense_9d0f2b49-6d05-45a7-95f3-d3303ade96ed" xlink:href="lh-20200930.xsd#lh_DefinedContributionPlanTotalExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18d64835-3070-4187-9dc6-06f39cb16aae" xlink:to="loc_lh_DefinedContributionPlanTotalExpense_9d0f2b49-6d05-45a7-95f3-d3303ade96ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d61096c7-3abe-4f69-9f3e-44659cfb4801" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d4234705-cdf5-4efa-b47f-7116260213d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d61096c7-3abe-4f69-9f3e-44659cfb4801" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d4234705-cdf5-4efa-b47f-7116260213d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_4bd992cd-fbe2-4cf3-baea-bb1d447fa344" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d4234705-cdf5-4efa-b47f-7116260213d7" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_4bd992cd-fbe2-4cf3-baea-bb1d447fa344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_bcc8dc2d-436c-4016-a50e-4af91a2233d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_4bd992cd-fbe2-4cf3-baea-bb1d447fa344" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_bcc8dc2d-436c-4016-a50e-4af91a2233d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2cb51d7d-5d40-4494-82e3-25649af70fc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d4234705-cdf5-4efa-b47f-7116260213d7" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2cb51d7d-5d40-4494-82e3-25649af70fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f6a0581c-0a8e-4019-a243-d79e040c968d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2cb51d7d-5d40-4494-82e3-25649af70fc2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f6a0581c-0a8e-4019-a243-d79e040c968d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceMember_a66459bc-a3c3-45aa-a2a8-835764687849" xlink:href="lh-20200930.xsd#lh_CovanceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f6a0581c-0a8e-4019-a243-d79e040c968d" xlink:to="loc_lh_CovanceMember_a66459bc-a3c3-45aa-a2a8-835764687849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_98bb31f3-6853-4255-9aae-f7dc20854f5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d4234705-cdf5-4efa-b47f-7116260213d7" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_98bb31f3-6853-4255-9aae-f7dc20854f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_25c803dc-d8d0-41f4-9824-40b7a31e792a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_98bb31f3-6853-4255-9aae-f7dc20854f5d" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_25c803dc-d8d0-41f4-9824-40b7a31e792a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_64e1c966-37eb-4bd0-a2f8-18f1675dc944" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d4234705-cdf5-4efa-b47f-7116260213d7" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_64e1c966-37eb-4bd0-a2f8-18f1675dc944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_28456542-e59f-48ba-a909-462220fa5b88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_64e1c966-37eb-4bd0-a2f8-18f1675dc944" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_28456542-e59f-48ba-a909-462220fa5b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NonElectiveContribution_0cc163c4-6bd8-4c74-9db2-1e6b8685782b" xlink:href="lh-20200930.xsd#lh_NonElectiveContribution"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_64e1c966-37eb-4bd0-a2f8-18f1675dc944" xlink:to="loc_lh_NonElectiveContribution_0cc163c4-6bd8-4c74-9db2-1e6b8685782b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DiscretionaryContributionPercentageMinimum_0326e6b7-10e8-4af8-9b39-342ea7965ac4" xlink:href="lh-20200930.xsd#lh_DiscretionaryContributionPercentageMinimum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_64e1c966-37eb-4bd0-a2f8-18f1675dc944" xlink:to="loc_lh_DiscretionaryContributionPercentageMinimum_0326e6b7-10e8-4af8-9b39-342ea7965ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_f5cd0bf2-d8c2-4bc3-9299-40ac80d5bdb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_64e1c966-37eb-4bd0-a2f8-18f1675dc944" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_f5cd0bf2-d8c2-4bc3-9299-40ac80d5bdb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedContributionPlanTotalExpense_28f331e8-28e3-42ee-8e35-57e91918d42b" xlink:href="lh-20200930.xsd#lh_DefinedContributionPlanTotalExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_64e1c966-37eb-4bd0-a2f8-18f1675dc944" xlink:to="loc_lh_DefinedContributionPlanTotalExpense_28f331e8-28e3-42ee-8e35-57e91918d42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DiscretionaryContributionPercentageMaximum_5ce8747b-fbbb-45fb-b2f7-5349d6eaed1a" xlink:href="lh-20200930.xsd#lh_DiscretionaryContributionPercentageMaximum"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_64e1c966-37eb-4bd0-a2f8-18f1675dc944" xlink:to="loc_lh_DiscretionaryContributionPercentageMaximum_5ce8747b-fbbb-45fb-b2f7-5349d6eaed1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_10119b2a-7739-40be-a415-cb89f0f1b8b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_64e1c966-37eb-4bd0-a2f8-18f1675dc944" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_10119b2a-7739-40be-a415-cb89f0f1b8b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="lh-20200930.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_30756308-c63a-42c4-a41a-c50ac5301ac3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_8fb2afbf-8936-4e55-aa46-fcb23a3419ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_30756308-c63a-42c4-a41a-c50ac5301ac3" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_8fb2afbf-8936-4e55-aa46-fcb23a3419ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="lh-20200930.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c854e304-0195-42c4-8a4a-e5ca9a9693a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_c7b8c9c4-9a01-4617-bc95-e5685b17c0fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c854e304-0195-42c4-8a4a-e5ca9a9693a4" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_c7b8c9c4-9a01-4617-bc95-e5685b17c0fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_331afe28-bc4a-4861-ae6c-ec686d54f5e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c854e304-0195-42c4-8a4a-e5ca9a9693a4" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_331afe28-bc4a-4861-ae6c-ec686d54f5e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#FAIRVALUEMEASUREMENTSDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9c88cc20-6d5f-4f28-b612-11dfd349814a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e675573c-56d3-4cc5-838d-49ef1d0d9e29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9c88cc20-6d5f-4f28-b612-11dfd349814a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e675573c-56d3-4cc5-838d-49ef1d0d9e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_7be51da3-e5e0-40b1-b1bf-65ddb3cd1789" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e675573c-56d3-4cc5-838d-49ef1d0d9e29" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_7be51da3-e5e0-40b1-b1bf-65ddb3cd1789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_571029b7-5f76-4e75-b3eb-c18f18009132" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_7be51da3-e5e0-40b1-b1bf-65ddb3cd1789" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_571029b7-5f76-4e75-b3eb-c18f18009132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6b0c66a0-f15d-4278-8748-e9721a862b2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e675573c-56d3-4cc5-838d-49ef1d0d9e29" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6b0c66a0-f15d-4278-8748-e9721a862b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e2d92da8-e32a-460e-9eb7-20d266786e64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6b0c66a0-f15d-4278-8748-e9721a862b2a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e2d92da8-e32a-460e-9eb7-20d266786e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_2bc3cab4-900d-4264-9e38-067c36ca485f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e2d92da8-e32a-460e-9eb7-20d266786e64" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_2bc3cab4-900d-4264-9e38-067c36ca485f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d1d06949-8af5-4dc7-8c65-7272ac45daec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e2d92da8-e32a-460e-9eb7-20d266786e64" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d1d06949-8af5-4dc7-8c65-7272ac45daec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_70dad4b0-acf8-4dfe-ac1d-e5a6daed2668" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e2d92da8-e32a-460e-9eb7-20d266786e64" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_70dad4b0-acf8-4dfe-ac1d-e5a6daed2668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e675573c-56d3-4cc5-838d-49ef1d0d9e29" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NumberofMeasurementFundsAvailableForParticipantElection_b72a4af7-b88c-41b0-b73f-f6103579dcff" xlink:href="lh-20200930.xsd#lh_NumberofMeasurementFundsAvailableForParticipantElection"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_lh_NumberofMeasurementFundsAvailableForParticipantElection_b72a4af7-b88c-41b0-b73f-f6103579dcff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts_fcc489ea-78e9-42b4-b489-3ccd522e0c04" xlink:href="lh-20200930.xsd#lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts_fcc489ea-78e9-42b4-b489-3ccd522e0c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesFairValue_61991f49-4d8e-4bc4-999b-91199d68b632" xlink:href="lh-20200930.xsd#lh_SeniorNotesFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_lh_SeniorNotesFairValue_61991f49-4d8e-4bc4-999b-91199d68b632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure_79aca3ef-52e9-4448-8914-b7a67b445786" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_us-gaap_NotesReceivableFairValueDisclosure_79aca3ef-52e9-4448-8914-b7a67b445786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_3c6395be-5e70-4fe0-933d-360347a69085" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_3c6395be-5e70-4fe0-933d-360347a69085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability_c9cf890d-315c-4ce1-acbd-0b6e92afabd5" xlink:href="lh-20200930.xsd#lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability_c9cf890d-315c-4ce1-acbd-0b6e92afabd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_2ef879f4-4e19-4ea3-aefc-bd8749ba0229" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_2ef879f4-4e19-4ea3-aefc-bd8749ba0229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgesAtFairValueNet_3e722bcc-f2bb-4218-b94c-578c0a5cf23a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgesAtFairValueNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_us-gaap_FairValueHedgesAtFairValueNet_3e722bcc-f2bb-4218-b94c-578c0a5cf23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_c209758c-05dd-4c92-b66a-0f8033074081" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_c209758c-05dd-4c92-b66a-0f8033074081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_bbded7fd-1303-4023-ae55-713ff486ce0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_bbded7fd-1303-4023-ae55-713ff486ce0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Contingentconsiderationadjustment_76c649ca-89f6-4fcf-85a5-73d9157b63c2" xlink:href="lh-20200930.xsd#lh_Contingentconsiderationadjustment"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_lh_Contingentconsiderationadjustment_76c649ca-89f6-4fcf-85a5-73d9157b63c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_7aa3ca6b-61a2-4db6-845f-65335499020d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_7aa3ca6b-61a2-4db6-845f-65335499020d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_4a40f32a-0ea6-43a9-90ad-16535738fdb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_4a40f32a-0ea6-43a9-90ad-16535738fdb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Lh_BusinessCombinationContingentConsiderationArrangementsPayments_0499d196-0e3e-4dff-ba6c-0ff5b29bd0da" xlink:href="lh-20200930.xsd#lh_Lh_BusinessCombinationContingentConsiderationArrangementsPayments"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6c36c2a-c1e8-487a-8cf9-66627836e68a" xlink:to="loc_lh_Lh_BusinessCombinationContingentConsiderationArrangementsPayments_0499d196-0e3e-4dff-ba6c-0ff5b29bd0da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" xlink:type="simple" xlink:href="lh-20200930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2c511249-ac66-4ae7-9260-5af6d6f2aa34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_da8258ba-498c-432d-92a1-ef4c8b6f5429" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2c511249-ac66-4ae7-9260-5af6d6f2aa34" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_da8258ba-498c-432d-92a1-ef4c8b6f5429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_2650f36f-573d-4379-9e46-e99511132e46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2c511249-ac66-4ae7-9260-5af6d6f2aa34" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_2650f36f-573d-4379-9e46-e99511132e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_2fbc988d-b66d-451a-a22a-4f211bc36cb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2c511249-ac66-4ae7-9260-5af6d6f2aa34" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_2fbc988d-b66d-451a-a22a-4f211bc36cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" xlink:type="simple" xlink:href="lh-20200930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5f788227-f57d-4a01-abd4-5b9ae7bd4ed6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ea209976-7c4b-41d5-9f10-742a6eadb8ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5f788227-f57d-4a01-abd4-5b9ae7bd4ed6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ea209976-7c4b-41d5-9f10-742a6eadb8ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2bfe78b1-7d80-47a1-b5fa-f90777459e2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ea209976-7c4b-41d5-9f10-742a6eadb8ea" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2bfe78b1-7d80-47a1-b5fa-f90777459e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_56aeb9e8-682e-43eb-b3af-b8ff10c671f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2bfe78b1-7d80-47a1-b5fa-f90777459e2d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_56aeb9e8-682e-43eb-b3af-b8ff10c671f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d0bfd804-df3b-465c-9d85-0af9eb5dd7c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_56aeb9e8-682e-43eb-b3af-b8ff10c671f1" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d0bfd804-df3b-465c-9d85-0af9eb5dd7c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0f7695b9-28f4-4a68-8aa8-f4314351757c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ea209976-7c4b-41d5-9f10-742a6eadb8ea" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0f7695b9-28f4-4a68-8aa8-f4314351757c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e94c8a72-0803-43c9-84cf-23e32a9532e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0f7695b9-28f4-4a68-8aa8-f4314351757c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e94c8a72-0803-43c9-84cf-23e32a9532e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2022Member_845b0881-3b75-440e-8e36-bce04a91a192" xlink:href="lh-20200930.xsd#lh_SeniorNotesDue2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e94c8a72-0803-43c9-84cf-23e32a9532e3" xlink:to="loc_lh_SeniorNotesDue2022Member_845b0881-3b75-440e-8e36-bce04a91a192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Crosscurrencyswapmaturing2022Member_5d0ab89c-99f3-4c01-82e5-2e567ca0d0ff" xlink:href="lh-20200930.xsd#lh_Crosscurrencyswapmaturing2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e94c8a72-0803-43c9-84cf-23e32a9532e3" xlink:to="loc_lh_Crosscurrencyswapmaturing2022Member_5d0ab89c-99f3-4c01-82e5-2e567ca0d0ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Crosscurrencyswapmaturing2025Member_09d1eb92-1512-4fa0-beb4-6930c9015045" xlink:href="lh-20200930.xsd#lh_Crosscurrencyswapmaturing2025Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e94c8a72-0803-43c9-84cf-23e32a9532e3" xlink:to="loc_lh_Crosscurrencyswapmaturing2025Member_09d1eb92-1512-4fa0-beb4-6930c9015045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2020Member_1da34247-588a-491f-9767-72546da2efa3" xlink:href="lh-20200930.xsd#lh_SeniorNotesDue2020Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e94c8a72-0803-43c9-84cf-23e32a9532e3" xlink:to="loc_lh_SeniorNotesDue2020Member_1da34247-588a-491f-9767-72546da2efa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorLongTermNotesDue2020Member_7d57d365-d467-466a-8935-2396c14876a2" xlink:href="lh-20200930.xsd#lh_SeniorLongTermNotesDue2020Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e94c8a72-0803-43c9-84cf-23e32a9532e3" xlink:to="loc_lh_SeniorLongTermNotesDue2020Member_7d57d365-d467-466a-8935-2396c14876a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2025MemberMember_757a2c94-7893-4bdb-81b6-e93e6d5e899c" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2025MemberMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e94c8a72-0803-43c9-84cf-23e32a9532e3" xlink:to="loc_lh_Seniornotesdue2025MemberMember_757a2c94-7893-4bdb-81b6-e93e6d5e899c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2027Member_0f8441e4-088c-4687-9351-632cbdab494f" xlink:href="lh-20200930.xsd#lh_Seniornotesdue2027Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e94c8a72-0803-43c9-84cf-23e32a9532e3" xlink:to="loc_lh_Seniornotesdue2027Member_0f8441e4-088c-4687-9351-632cbdab494f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f0c4be8a-0168-4ecf-962f-8d5aa45ea29b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ea209976-7c4b-41d5-9f10-742a6eadb8ea" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f0c4be8a-0168-4ecf-962f-8d5aa45ea29b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5e6028d6-0190-4d93-bb2c-407e4bcedb5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f0c4be8a-0168-4ecf-962f-8d5aa45ea29b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5e6028d6-0190-4d93-bb2c-407e4bcedb5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2020Member_f26e2bf1-34c4-4b18-bea3-ed727f51063f" xlink:href="lh-20200930.xsd#lh_SeniorNotesDue2020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5e6028d6-0190-4d93-bb2c-407e4bcedb5d" xlink:to="loc_lh_SeniorNotesDue2020Member_f26e2bf1-34c4-4b18-bea3-ed727f51063f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_283a0531-0e6d-4654-a547-c89384c83b1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5e6028d6-0190-4d93-bb2c-407e4bcedb5d" xlink:to="loc_us-gaap_InterestRateSwapMember_283a0531-0e6d-4654-a547-c89384c83b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_16094f49-5116-4af8-b525-befb001307e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5e6028d6-0190-4d93-bb2c-407e4bcedb5d" xlink:to="loc_us-gaap_CurrencySwapMember_16094f49-5116-4af8-b525-befb001307e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ea209976-7c4b-41d5-9f10-742a6eadb8ea" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_6a98f60d-94d9-43de-a3e7-d2075bad8208" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_6a98f60d-94d9-43de-a3e7-d2075bad8208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_f3498930-68b3-4fc5-9e2d-68c8bfba1775" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_f3498930-68b3-4fc5-9e2d-68c8bfba1775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtFairValue_bd70cdeb-637d-498f-ab18-81935b49435e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShorttermDebtFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:to="loc_us-gaap_ShorttermDebtFairValue_bd70cdeb-637d-498f-ab18-81935b49435e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_e7ed539d-67e1-42e5-b2ce-61c5b83433be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_e7ed539d-67e1-42e5-b2ce-61c5b83433be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5f9c19ee-09c6-48d0-aa7d-b4933aab0a85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5f9c19ee-09c6-48d0-aa7d-b4933aab0a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_f521f3fe-55a6-460f-aca9-b4ef65fb4716" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_f521f3fe-55a6-460f-aca9-b4ef65fb4716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeAssetsAtFairValue_014a9460-b7d3-41bf-b58e-292aedc5d379" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgeAssetsAtFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:to="loc_us-gaap_FairValueHedgeAssetsAtFairValue_014a9460-b7d3-41bf-b58e-292aedc5d379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_82ed1c50-fc78-4646-a2f0-19d80c881e19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:to="loc_us-gaap_DerivativeNotionalAmount_82ed1c50-fc78-4646-a2f0-19d80c881e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_5d0aec7e-d814-4fa4-b5ba-bd308951e000" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_5d0aec7e-d814-4fa4-b5ba-bd308951e000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_a885924d-82cc-4b69-a6af-ea95473bd82f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_a885924d-82cc-4b69-a6af-ea95473bd82f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_62c40fe8-f661-4e40-8a27-9ca973501450" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgeLiabilitiesAtFairValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:to="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_62c40fe8-f661-4e40-8a27-9ca973501450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_GainInterestRateSwapArrangement_44740fcc-de12-4473-8d3f-600b57cf3f22" xlink:href="lh-20200930.xsd#lh_GainInterestRateSwapArrangement"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2c763105-73f7-4ef1-be71-a1eb0a13941b" xlink:to="loc_lh_GainInterestRateSwapArrangement_44740fcc-de12-4473-8d3f-600b57cf3f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATION" xlink:type="simple" xlink:href="lh-20200930.xsd#SUPPLEMENTALCASHFLOWINFORMATION"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_f502ba61-9407-4117-a876-d9a843b73885" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_00b06066-00ef-4447-a026-fc8c2487229d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_f502ba61-9407-4117-a876-d9a843b73885" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_00b06066-00ef-4447-a026-fc8c2487229d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_1d7d3feb-7a69-485c-8ac6-959a94ed27e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_f502ba61-9407-4117-a876-d9a843b73885" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_1d7d3feb-7a69-485c-8ac6-959a94ed27e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONTabularInformation" xlink:type="simple" xlink:href="lh-20200930.xsd#SUPPLEMENTALCASHFLOWINFORMATIONTabularInformation"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONTabularInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_19080f43-4ab3-447f-adc6-1af8f597b370" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_acd61eeb-d907-489d-94ce-d5ed00457194" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_19080f43-4ab3-447f-adc6-1af8f597b370" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_acd61eeb-d907-489d-94ce-d5ed00457194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_e8c27296-193c-483e-80e1-fb821db9a78a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_19080f43-4ab3-447f-adc6-1af8f597b370" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_e8c27296-193c-483e-80e1-fb821db9a78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation" xlink:type="simple" xlink:href="lh-20200930.xsd#SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_b88d1ce5-52f6-47b5-b5ee-0e888e3a3c1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionTable_d92a58bf-165b-4379-bf40-edbe89137ccc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_b88d1ce5-52f6-47b5-b5ee-0e888e3a3c1e" xlink:to="loc_us-gaap_DebtConversionTable_d92a58bf-165b-4379-bf40-edbe89137ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_da42af99-bd48-45ec-8bd7-a303a4e36edd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionTable_d92a58bf-165b-4379-bf40-edbe89137ccc" xlink:to="loc_us-gaap_DebtInstrumentAxis_da42af99-bd48-45ec-8bd7-a303a4e36edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_902be9b5-12da-4c3b-b7ec-61227ec547a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_da42af99-bd48-45ec-8bd7-a303a4e36edd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_902be9b5-12da-4c3b-b7ec-61227ec547a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionLineItems_473c4c02-9645-4ec4-ad39-15bb7b346e1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionTable_d92a58bf-165b-4379-bf40-edbe89137ccc" xlink:to="loc_us-gaap_DebtConversionLineItems_473c4c02-9645-4ec4-ad39-15bb7b346e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DecreaseinCapitalExpendituresIncurredbutnotyetPaid_d00dcc3f-4d3f-414d-93e7-10ec6b61bf64" xlink:href="lh-20200930.xsd#lh_DecreaseinCapitalExpendituresIncurredbutnotyetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionLineItems_473c4c02-9645-4ec4-ad39-15bb7b346e1b" xlink:to="loc_lh_DecreaseinCapitalExpendituresIncurredbutnotyetPaid_d00dcc3f-4d3f-414d-93e7-10ec6b61bf64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_31f4557a-de2e-45b4-adf5-7d84de779903" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionLineItems_473c4c02-9645-4ec4-ad39-15bb7b346e1b" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_31f4557a-de2e-45b4-adf5-7d84de779903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure_26d010c9-ced2-4b2e-bd7b-35944cae91b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionLineItems_473c4c02-9645-4ec4-ad39-15bb7b346e1b" xlink:to="loc_us-gaap_NotesReceivableFairValueDisclosure_26d010c9-ced2-4b2e-bd7b-35944cae91b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashPaidDuringPeriodForAbstract_3c199334-e228-4704-b0c0-7977e502315a" xlink:href="lh-20200930.xsd#lh_CashPaidDuringPeriodForAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_b88d1ce5-52f6-47b5-b5ee-0e888e3a3c1e" xlink:to="loc_lh_CashPaidDuringPeriodForAbstract_3c199334-e228-4704-b0c0-7977e502315a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_InterestPaidInCash_3be77f55-6b2d-4d3a-a71a-45942ebded8b" xlink:href="lh-20200930.xsd#lh_InterestPaidInCash"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CashPaidDuringPeriodForAbstract_3c199334-e228-4704-b0c0-7977e502315a" xlink:to="loc_lh_InterestPaidInCash_3be77f55-6b2d-4d3a-a71a-45942ebded8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_534fbe78-8666-47cc-917f-406e89c17538" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CashPaidDuringPeriodForAbstract_3c199334-e228-4704-b0c0-7977e502315a" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_534fbe78-8666-47cc-917f-406e89c17538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_d443616a-b7df-40a4-9fbb-237904d3038d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_b88d1ce5-52f6-47b5-b5ee-0e888e3a3c1e" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_d443616a-b7df-40a4-9fbb-237904d3038d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ConversionOfZeroCouponConvertibleDebt_a7765a66-a68f-45dd-b082-90ad1d6e465f" xlink:href="lh-20200930.xsd#lh_ConversionOfZeroCouponConvertibleDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_b88d1ce5-52f6-47b5-b5ee-0e888e3a3c1e" xlink:to="loc_lh_ConversionOfZeroCouponConvertibleDebt_a7765a66-a68f-45dd-b082-90ad1d6e465f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONS" xlink:type="simple" xlink:href="lh-20200930.xsd#BUSINESSACQUISITIONS"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BUSINESSACQUISITIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_bc489ad6-09a0-401e-890b-cb9857ad0e1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_1915ccad-806b-48bb-85b8-265f4906ed64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_bc489ad6-09a0-401e-890b-cb9857ad0e1d" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_1915ccad-806b-48bb-85b8-265f4906ed64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsTablesTables" xlink:type="simple" xlink:href="lh-20200930.xsd#BUSINESSACQUISITIONSBusinessAcquisitionsTablesTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsTablesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleofBusinessAcquisitionsbyAcquisitionAbstract_f9a9e245-b184-4fbb-ad6c-1b3bcd3bb0c7" xlink:href="lh-20200930.xsd#lh_ScheduleofBusinessAcquisitionsbyAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5c97c22f-9d54-4d49-a8e8-de394c9cb998" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleofBusinessAcquisitionsbyAcquisitionAbstract_f9a9e245-b184-4fbb-ad6c-1b3bcd3bb0c7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5c97c22f-9d54-4d49-a8e8-de394c9cb998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_33d5d7c0-e2dc-49a0-9b01-f5459025bab9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5c97c22f-9d54-4d49-a8e8-de394c9cb998" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_33d5d7c0-e2dc-49a0-9b01-f5459025bab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_03a083f2-131c-4015-88cb-2a3d85364821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_33d5d7c0-e2dc-49a0-9b01-f5459025bab9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_03a083f2-131c-4015-88cb-2a3d85364821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_79946840-837c-4586-b614-d4391e75f3c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5c97c22f-9d54-4d49-a8e8-de394c9cb998" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_79946840-837c-4586-b614-d4391e75f3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5e627db8-0c32-4f47-8fd2-52f656241bca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_79946840-837c-4586-b614-d4391e75f3c3" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5e627db8-0c32-4f47-8fd2-52f656241bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_46db8671-d001-44fc-adf6-8fd8cec7794b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5c97c22f-9d54-4d49-a8e8-de394c9cb998" xlink:to="loc_us-gaap_StatementClassOfStockAxis_46db8671-d001-44fc-adf6-8fd8cec7794b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_78bd055d-9c9f-4012-ad69-645078719a09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_46db8671-d001-44fc-adf6-8fd8cec7794b" xlink:to="loc_us-gaap_ClassOfStockDomain_78bd055d-9c9f-4012-ad69-645078719a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_24099770-7d31-438c-9bb2-0c16b1df4c5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5c97c22f-9d54-4d49-a8e8-de394c9cb998" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_24099770-7d31-438c-9bb2-0c16b1df4c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_e3c5a6d0-0040-4a9e-b5b2-44927c330039" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_24099770-7d31-438c-9bb2-0c16b1df4c5a" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_e3c5a6d0-0040-4a9e-b5b2-44927c330039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_da1b4c43-6df9-4739-b9be-b7c31db39d21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_24099770-7d31-438c-9bb2-0c16b1df4c5a" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_da1b4c43-6df9-4739-b9be-b7c31db39d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_60bac4d6-cb2b-4e2b-9178-dd21c6958d8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleofBusinessAcquisitionsbyAcquisitionAbstract_f9a9e245-b184-4fbb-ad6c-1b3bcd3bb0c7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_60bac4d6-cb2b-4e2b-9178-dd21c6958d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#BUSINESSACQUISITIONSDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_6f9021aa-1bce-4246-a46c-c769e49d1d1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_73a1de27-2019-41bf-b101-9e4ee0363793" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f0eaa34-9017-43bd-ba40-cdf1fc43fb34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_73a1de27-2019-41bf-b101-9e4ee0363793" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f0eaa34-9017-43bd-ba40-cdf1fc43fb34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a5930890-5793-48fd-8c7d-c3880b7a4f6c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f0eaa34-9017-43bd-ba40-cdf1fc43fb34" xlink:to="loc_srt_StatementScenarioAxis_a5930890-5793-48fd-8c7d-c3880b7a4f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a0badf8a-87ad-4b33-9a6d-de9251a6c6ab" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_a5930890-5793-48fd-8c7d-c3880b7a4f6c" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a0badf8a-87ad-4b33-9a6d-de9251a6c6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6f92f8d5-73f2-41e1-9d25-036f8fb08c4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f0eaa34-9017-43bd-ba40-cdf1fc43fb34" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6f92f8d5-73f2-41e1-9d25-036f8fb08c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d5de8feb-416e-40b6-ade5-19f631506597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6f92f8d5-73f2-41e1-9d25-036f8fb08c4d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d5de8feb-416e-40b6-ade5-19f631506597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_98bcc766-22c4-4725-95e2-74a7a029ea6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d5de8feb-416e-40b6-ade5-19f631506597" xlink:to="loc_us-gaap_CustomerRelationshipsMember_98bcc766-22c4-4725-95e2-74a7a029ea6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_dcee31d1-8ebd-4963-a9ab-abd420719e78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d5de8feb-416e-40b6-ade5-19f631506597" xlink:to="loc_us-gaap_TradeNamesMember_dcee31d1-8ebd-4963-a9ab-abd420719e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseRightsMember_295c2e19-c134-426b-86df-ca35fc92a73b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d5de8feb-416e-40b6-ade5-19f631506597" xlink:to="loc_us-gaap_UseRightsMember_295c2e19-c134-426b-86df-ca35fc92a73b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1d3bae3a-14ed-4113-847c-fc3419a89165" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f0eaa34-9017-43bd-ba40-cdf1fc43fb34" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1d3bae3a-14ed-4113-847c-fc3419a89165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_68ade0a2-9671-42ee-9820-c26262f57e9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1d3bae3a-14ed-4113-847c-fc3419a89165" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_68ade0a2-9671-42ee-9820-c26262f57e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceMember_9983902e-6fec-49bd-ab10-75588cffe278" xlink:href="lh-20200930.xsd#lh_CovanceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_68ade0a2-9671-42ee-9820-c26262f57e9e" xlink:to="loc_lh_CovanceMember_9983902e-6fec-49bd-ab10-75588cffe278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OtheracquireesMember_8bc7db5f-bfcf-4771-8f50-e1cabba96525" xlink:href="lh-20200930.xsd#lh_OtheracquireesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_68ade0a2-9671-42ee-9820-c26262f57e9e" xlink:to="loc_lh_OtheracquireesMember_8bc7db5f-bfcf-4771-8f50-e1cabba96525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EnvigoMember_0ff1b342-0f44-4391-af70-329e3fd396a4" xlink:href="lh-20200930.xsd#lh_EnvigoMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_68ade0a2-9671-42ee-9820-c26262f57e9e" xlink:to="loc_lh_EnvigoMember_0ff1b342-0f44-4391-af70-329e3fd396a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a66f9feb-1666-4c86-b30b-0c70d2653f0c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f0eaa34-9017-43bd-ba40-cdf1fc43fb34" xlink:to="loc_srt_RangeAxis_a66f9feb-1666-4c86-b30b-0c70d2653f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d07614dd-c14c-4b96-a02c-8f09122e1bc5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a66f9feb-1666-4c86-b30b-0c70d2653f0c" xlink:to="loc_srt_RangeMember_d07614dd-c14c-4b96-a02c-8f09122e1bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_17807ca2-4c34-4e07-a354-2e56fd1146b3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d07614dd-c14c-4b96-a02c-8f09122e1bc5" xlink:to="loc_srt_MinimumMember_17807ca2-4c34-4e07-a354-2e56fd1146b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_78621920-77da-4d45-84f2-d083dbf4c487" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d07614dd-c14c-4b96-a02c-8f09122e1bc5" xlink:to="loc_srt_MaximumMember_78621920-77da-4d45-84f2-d083dbf4c487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_048eaa9d-d424-44c0-b958-a6510daa4790" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f0eaa34-9017-43bd-ba40-cdf1fc43fb34" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_048eaa9d-d424-44c0-b958-a6510daa4790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_da59b561-eb92-48d7-993a-e522223869d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_048eaa9d-d424-44c0-b958-a6510daa4790" xlink:to="loc_us-gaap_SegmentDomain_da59b561-eb92-48d7-993a-e522223869d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_96b80384-05e8-41f7-9e0e-7225ee60f039" xlink:href="lh-20200930.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_da59b561-eb92-48d7-993a-e522223869d5" xlink:to="loc_lh_CovanceDrugDevelopmentMember_96b80384-05e8-41f7-9e0e-7225ee60f039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_d17127f6-95ec-4d58-b83c-f6a12a50a765" xlink:href="lh-20200930.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_da59b561-eb92-48d7-993a-e522223869d5" xlink:to="loc_lh_LabCorpDiagnosticsMember_d17127f6-95ec-4d58-b83c-f6a12a50a765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8f0eaa34-9017-43bd-ba40-cdf1fc43fb34" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_b42eef89-22d2-4c62-868e-a130f461d397" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_b42eef89-22d2-4c62-868e-a130f461d397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_90b0dcb1-ea2e-4969-8355-5f4ca05fa01f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_90b0dcb1-ea2e-4969-8355-5f4ca05fa01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_8a2aaeb3-9ddf-4ee2-a73f-e65a0669da4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_Revenues_8a2aaeb3-9ddf-4ee2-a73f-e65a0669da4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_cbe4b5cb-4706-4fab-a5a8-2d263325c0b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_cbe4b5cb-4706-4fab-a5a8-2d263325c0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_a9f5fdf3-6fe4-4a31-971f-cb1511a4c989" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_a9f5fdf3-6fe4-4a31-971f-cb1511a4c989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7d0de990-93d3-4264-9e03-ec29e8d2f929" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_Goodwill_7d0de990-93d3-4264-9e03-ec29e8d2f929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_5cefd49d-f0ef-4c3d-8f49-aeaf2e53bc02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_5cefd49d-f0ef-4c3d-8f49-aeaf2e53bc02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ab89a008-bb10-4336-8b83-5c7896a558ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ab89a008-bb10-4336-8b83-5c7896a558ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_e8ae1b18-4e85-4397-9ad5-bf08c83b2ce6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_e8ae1b18-4e85-4397-9ad5-bf08c83b2ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_cb3a0e43-1328-435c-b686-e26fecab684d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_OperatingIncomeLoss_cb3a0e43-1328-435c-b686-e26fecab684d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure_c63ef308-a57e-48aa-a5ae-428c53fc5778" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_NotesReceivableFairValueDisclosure_c63ef308-a57e-48aa-a5ae-428c53fc5778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Totalacquisitionconsiderationcashstocknotesetc._7d05ad1f-47fd-46e7-a011-be71493376d0" xlink:href="lh-20200930.xsd#lh_Totalacquisitionconsiderationcashstocknotesetc."/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_lh_Totalacquisitionconsiderationcashstocknotesetc._7d05ad1f-47fd-46e7-a011-be71493376d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_608598f7-cea4-42a5-96ec-bc912f5b4821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_608598f7-cea4-42a5-96ec-bc912f5b4821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_359a2a66-2ddb-43c0-ae8c-b2887463413a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_359a2a66-2ddb-43c0-ae8c-b2887463413a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_a26b7e26-8738-4707-8a11-404bb09ec53b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_a26b7e26-8738-4707-8a11-404bb09ec53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_808addf5-c25a-4433-b87f-06b6a177ba82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_808addf5-c25a-4433-b87f-06b6a177ba82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_aefe420c-1b20-40b4-bd95-f77eb10ac77c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_aefe420c-1b20-40b4-bd95-f77eb10ac77c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_1219dd82-13f0-46cc-8b14-fb440d8712e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_1219dd82-13f0-46cc-8b14-fb440d8712e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_dd1699cf-645c-46f1-80bd-a56938048f6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_dd1699cf-645c-46f1-80bd-a56938048f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_60558127-8a2a-49a8-9ad5-0330190d79aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_60558127-8a2a-49a8-9ad5-0330190d79aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_b710f7f4-39cd-406f-bc14-ccaec4b0d2fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_b710f7f4-39cd-406f-bc14-ccaec4b0d2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_7d83f204-c262-43b3-9007-1f7455099832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_7d83f204-c262-43b3-9007-1f7455099832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2bb7e7f6-cece-4139-a8a5-060a1bf94ef4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2bb7e7f6-cece-4139-a8a5-060a1bf94ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_2fea63f1-98b0-4255-9857-5f438f6eca7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_2fea63f1-98b0-4255-9857-5f438f6eca7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_7d7a82b6-3a13-415c-9e67-ec4c095e80c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_7d7a82b6-3a13-415c-9e67-ec4c095e80c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_93dd3b10-cb28-4b56-86f0-7081e20ce9fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_93dd3b10-cb28-4b56-86f0-7081e20ce9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_82966714-0848-4c80-9e6a-7d7d02fbf399" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_82966714-0848-4c80-9e6a-7d7d02fbf399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_be0bb416-6c7b-445a-a9a3-5d14f36d7824" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_be0bb416-6c7b-445a-a9a3-5d14f36d7824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_e7b4ebc0-63da-4ae6-9f6a-c2d534e20ebb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_e7b4ebc0-63da-4ae6-9f6a-c2d534e20ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_890dcf8d-9328-49e5-a11a-9cefe6bad29d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_890dcf8d-9328-49e5-a11a-9cefe6bad29d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_a283045b-18b0-4078-a6a5-364edff111e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_97a350ac-d0e2-4f24-8c52-55e0ea003e49" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_a283045b-18b0-4078-a6a5-364edff111e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#BUSINESSACQUISITIONSDISPOSITIONSDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_2f470238-0407-43a4-ab35-6150777b5ed7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e32f82e6-8971-4795-90c1-757512aa2d80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_2f470238-0407-43a4-ab35-6150777b5ed7" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e32f82e6-8971-4795-90c1-757512aa2d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_20ad987d-c8b2-424f-bca3-7b5f9a62c31b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e32f82e6-8971-4795-90c1-757512aa2d80" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_20ad987d-c8b2-424f-bca3-7b5f9a62c31b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_14559567-5121-433d-9395-d731337f67c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_20ad987d-c8b2-424f-bca3-7b5f9a62c31b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_14559567-5121-433d-9395-d731337f67c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_a47d9750-b683-4dbf-93a2-66ee86f4e180" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e32f82e6-8971-4795-90c1-757512aa2d80" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_a47d9750-b683-4dbf-93a2-66ee86f4e180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e5ccaa12-ee0f-4908-a354-8eb90ead3cd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_a47d9750-b683-4dbf-93a2-66ee86f4e180" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e5ccaa12-ee0f-4908-a354-8eb90ead3cd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2f055a6d-6520-456f-a76e-84269a45bcbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e32f82e6-8971-4795-90c1-757512aa2d80" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2f055a6d-6520-456f-a76e-84269a45bcbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4d7899db-4c7d-417f-a55b-2239947b6ad2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2f055a6d-6520-456f-a76e-84269a45bcbc" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4d7899db-4c7d-417f-a55b-2239947b6ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e32f82e6-8971-4795-90c1-757512aa2d80" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_98be8a8b-f905-4f4f-93ae-895b75d8cffa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_98be8a8b-f905-4f4f-93ae-895b75d8cffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_e5e94065-78fb-4352-a91f-29fcb34a2ce0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_e5e94065-78fb-4352-a91f-29fcb34a2ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_17d082ca-c404-4b72-9fd8-7d43053728d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_us-gaap_UnbilledContractsReceivable_17d082ca-c404-4b72-9fd8-7d43053728d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_1131b276-bf85-4fe5-abc7-065d81a7b26f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_us-gaap_InventoryNet_1131b276-bf85-4fe5-abc7-065d81a7b26f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_c6e139a9-9d00-40cd-8f43-13dc395a91f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_c6e139a9-9d00-40cd-8f43-13dc395a91f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_34829c12-1355-4495-81c7-76c4d1a200b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_34829c12-1355-4495-81c7-76c4d1a200b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_80aaa51c-7990-43e8-9207-8c3f15d20eca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_us-gaap_Goodwill_80aaa51c-7990-43e8-9207-8c3f15d20eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c07f084c-616b-4c49-a37b-0ce65f851548" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c07f084c-616b-4c49-a37b-0ce65f851548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_52694a9f-6aa9-4d8a-972a-3a555541fa79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_52694a9f-6aa9-4d8a-972a-3a555541fa79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_e31ce360-dd2b-416a-a4e1-e6400a9601f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_us-gaap_AccountsPayableCurrent_e31ce360-dd2b-416a-a4e1-e6400a9601f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_7f601242-9038-4a08-b9e8-9153726fb106" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_7f601242-9038-4a08-b9e8-9153726fb106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_9e4e65d7-dc63-40a4-b74e-016c4e37209b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_us-gaap_DeferredRevenueCurrent_9e4e65d7-dc63-40a4-b74e-016c4e37209b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DeferredIncomeTaxesAndOtherTaxLiabilities_d914b1bd-4688-40d2-9638-340071260537" xlink:href="lh-20200930.xsd#lh_DeferredIncomeTaxesAndOtherTaxLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_lh_DeferredIncomeTaxesAndOtherTaxLiabilities_d914b1bd-4688-40d2-9638-340071260537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_1868a462-1e75-47da-9ca8-c68cd28ff61b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_907fae13-4917-4fc1-854f-8724ab45c5e3" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_1868a462-1e75-47da-9ca8-c68cd28ff61b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONNotes" xlink:type="simple" xlink:href="lh-20200930.xsd#BUSINESSSEGMENTINFORMATIONNotes"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONNotes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="lh-20200930.xsd#BUSINESSSEGMENTINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract_ee985004-4cd8-4ab8-b577-4c1199df068b" xlink:href="lh-20200930.xsd#lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_5f9d2684-9dcc-4910-bf2b-5e3196c132dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract_ee985004-4cd8-4ab8-b577-4c1199df068b" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_5f9d2684-9dcc-4910-bf2b-5e3196c132dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes" xlink:type="simple" xlink:href="lh-20200930.xsd#BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ee92753c-ea54-4318-881e-3d2f310c3613" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a1344862-0ba6-4480-ad94-cb604714165e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ee92753c-ea54-4318-881e-3d2f310c3613" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a1344862-0ba6-4480-ad94-cb604714165e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_80840898-3589-4ddc-a09b-4808382089a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a1344862-0ba6-4480-ad94-cb604714165e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_80840898-3589-4ddc-a09b-4808382089a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bc0b7908-8414-4048-afe6-c56ef698cee7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_80840898-3589-4ddc-a09b-4808382089a8" xlink:to="loc_us-gaap_SegmentDomain_bc0b7908-8414-4048-afe6-c56ef698cee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_713b55d7-1356-4550-89c0-69f69cd58f22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a1344862-0ba6-4480-ad94-cb604714165e" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_713b55d7-1356-4550-89c0-69f69cd58f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_270cac76-6cf0-4d6f-93ef-cac14024818b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_713b55d7-1356-4550-89c0-69f69cd58f22" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_270cac76-6cf0-4d6f-93ef-cac14024818b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ffdc17fa-ddc8-41ae-9389-d315e1b11dd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3bbbb400-8a78-4919-a4f2-7c06bf7035ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ffdc17fa-ddc8-41ae-9389-d315e1b11dd6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3bbbb400-8a78-4919-a4f2-7c06bf7035ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c52d6a01-79f7-4136-9636-55984db2e88c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3bbbb400-8a78-4919-a4f2-7c06bf7035ff" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c52d6a01-79f7-4136-9636-55984db2e88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f5597f6a-8f82-4b58-adc5-269538a33baa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c52d6a01-79f7-4136-9636-55984db2e88c" xlink:to="loc_us-gaap_SegmentDomain_f5597f6a-8f82-4b58-adc5-269538a33baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_4c96f3c0-8f56-405f-abcf-664671dc53b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f5597f6a-8f82-4b58-adc5-269538a33baa" xlink:to="loc_us-gaap_CorporateMember_4c96f3c0-8f56-405f-abcf-664671dc53b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_30ef074d-8809-495f-ae3d-be989052cea9" xlink:href="lh-20200930.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f5597f6a-8f82-4b58-adc5-269538a33baa" xlink:to="loc_lh_LabCorpDiagnosticsMember_30ef074d-8809-495f-ae3d-be989052cea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_b5c4cd32-9154-4869-9975-1170a40da9c3" xlink:href="lh-20200930.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f5597f6a-8f82-4b58-adc5-269538a33baa" xlink:to="loc_lh_CovanceDrugDevelopmentMember_b5c4cd32-9154-4869-9975-1170a40da9c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporationMember_92947a3f-4be4-48e6-af28-41261407e7d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporationMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f5597f6a-8f82-4b58-adc5-269538a33baa" xlink:to="loc_us-gaap_CorporationMember_92947a3f-4be4-48e6-af28-41261407e7d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_915666c6-31cd-49c1-944f-12a2133fc9c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3bbbb400-8a78-4919-a4f2-7c06bf7035ff" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_915666c6-31cd-49c1-944f-12a2133fc9c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentofRevenueContributed_544e921d-346a-441b-8653-10e7d0e1e193" xlink:href="lh-20200930.xsd#lh_PercentofRevenueContributed"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_915666c6-31cd-49c1-944f-12a2133fc9c9" xlink:to="loc_lh_PercentofRevenueContributed_544e921d-346a-441b-8653-10e7d0e1e193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Intercompanyrevenueelimination_21392ac1-0ce8-463d-98f2-c4a7ad158a16" xlink:href="lh-20200930.xsd#lh_Intercompanyrevenueelimination"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_915666c6-31cd-49c1-944f-12a2133fc9c9" xlink:to="loc_lh_Intercompanyrevenueelimination_21392ac1-0ce8-463d-98f2-c4a7ad158a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ab97d761-dbc4-43fd-9123-e4eef645dbac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_915666c6-31cd-49c1-944f-12a2133fc9c9" xlink:to="loc_us-gaap_Revenues_ab97d761-dbc4-43fd-9123-e4eef645dbac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e2b6c3d3-7ead-4b14-86d9-0a93c08016af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_915666c6-31cd-49c1-944f-12a2133fc9c9" xlink:to="loc_us-gaap_OperatingIncomeLoss_e2b6c3d3-7ead-4b14-86d9-0a93c08016af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_4c835a4d-4ccb-486e-b594-616b0e460065" xlink:href="lh-20200930.xsd#lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_915666c6-31cd-49c1-944f-12a2133fc9c9" xlink:to="loc_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_4c835a4d-4ccb-486e-b594-616b0e460065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_94e37891-0bd7-474c-a31b-a108353a5a9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_915666c6-31cd-49c1-944f-12a2133fc9c9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_94e37891-0bd7-474c-a31b-a108353a5a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d656a561-c93c-4aa2-ac9c-2a0b35a2dbe4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_915666c6-31cd-49c1-944f-12a2133fc9c9" xlink:to="loc_us-gaap_ProfitLoss_d656a561-c93c-4aa2-ac9c-2a0b35a2dbe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1f0a2d36-1480-4fc0-bcad-52b3866da032" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_915666c6-31cd-49c1-944f-12a2133fc9c9" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1f0a2d36-1480-4fc0-bcad-52b3866da032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_2085b778-ca2f-4e80-8d4a-bbd0e737f0bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_915666c6-31cd-49c1-944f-12a2133fc9c9" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_2085b778-ca2f-4e80-8d4a-bbd0e737f0bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c9103f36-d5c0-4acf-82d0-a6b740d9f597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_915666c6-31cd-49c1-944f-12a2133fc9c9" xlink:to="loc_us-gaap_NetIncomeLoss_c9103f36-d5c0-4acf-82d0-a6b740d9f597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/REVENUENotes" xlink:type="simple" xlink:href="lh-20200930.xsd#REVENUENotes"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/REVENUENotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1d5c5287-b508-4993-80b4-8d82d659b1ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/REVENUETables" xlink:type="simple" xlink:href="lh-20200930.xsd#REVENUETables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/REVENUETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e3d920dd-4901-4fa4-b4c0-01e53f6a5de9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_e197a78d-fddd-418f-a8a5-0efec941e2a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e3d920dd-4901-4fa4-b4c0-01e53f6a5de9" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_e197a78d-fddd-418f-a8a5-0efec941e2a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_62ced467-92a1-4313-a1cb-a43952b85c0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e197a78d-fddd-418f-a8a5-0efec941e2a4" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_62ced467-92a1-4313-a1cb-a43952b85c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d64fb717-7e1a-4486-a42f-f02fff44cc3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_62ced467-92a1-4313-a1cb-a43952b85c0b" xlink:to="loc_us-gaap_SegmentDomain_d64fb717-7e1a-4486-a42f-f02fff44cc3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_a971c202-b85b-43b5-b551-7b67a351228e" xlink:href="lh-20200930.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d64fb717-7e1a-4486-a42f-f02fff44cc3c" xlink:to="loc_lh_CovanceDrugDevelopmentMember_a971c202-b85b-43b5-b551-7b67a351228e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_ea33af8b-8024-4365-b936-8758338969d0" xlink:href="lh-20200930.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d64fb717-7e1a-4486-a42f-f02fff44cc3c" xlink:to="loc_lh_LabCorpDiagnosticsMember_ea33af8b-8024-4365-b936-8758338969d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_2241e89c-6490-40cd-b5ad-0df1748b82f7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e197a78d-fddd-418f-a8a5-0efec941e2a4" xlink:to="loc_srt_StatementGeographicalAxis_2241e89c-6490-40cd-b5ad-0df1748b82f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d6124491-8cf0-4fb8-9f98-ddd365f32e5d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_2241e89c-6490-40cd-b5ad-0df1748b82f7" xlink:to="loc_srt_SegmentGeographicalDomain_d6124491-8cf0-4fb8-9f98-ddd365f32e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OthercountriesMember_6d49f316-a772-4538-b69a-2f891aa6f633" xlink:href="lh-20200930.xsd#lh_OthercountriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d6124491-8cf0-4fb8-9f98-ddd365f32e5d" xlink:to="loc_lh_OthercountriesMember_6d49f316-a772-4538-b69a-2f891aa6f633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_2c5feaf2-3828-4c35-91c3-37f0e95ee150" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_GB"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d6124491-8cf0-4fb8-9f98-ddd365f32e5d" xlink:to="loc_country_GB_2c5feaf2-3828-4c35-91c3-37f0e95ee150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_b61443b5-5b6a-449c-8504-43f966370725" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d6124491-8cf0-4fb8-9f98-ddd365f32e5d" xlink:to="loc_country_CA_b61443b5-5b6a-449c-8504-43f966370725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_e9df7501-ad5a-43e7-afaa-b7637820df5f" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CH"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d6124491-8cf0-4fb8-9f98-ddd365f32e5d" xlink:to="loc_country_CH_e9df7501-ad5a-43e7-afaa-b7637820df5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_e64cce4a-9244-464f-9cff-f758def4f024" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d6124491-8cf0-4fb8-9f98-ddd365f32e5d" xlink:to="loc_srt_EuropeMember_e64cce4a-9244-464f-9cff-f758def4f024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_cfca5c99-1a9d-4c0a-a1d3-12655c4badfd" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d6124491-8cf0-4fb8-9f98-ddd365f32e5d" xlink:to="loc_country_US_cfca5c99-1a9d-4c0a-a1d3-12655c4badfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_f1c97ad6-e2fd-4480-a7d3-22f14bcefcf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e197a78d-fddd-418f-a8a5-0efec941e2a4" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_f1c97ad6-e2fd-4480-a7d3-22f14bcefcf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_a396f9a8-7d96-4483-976d-e261e8838439" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_f1c97ad6-e2fd-4480-a7d3-22f14bcefcf6" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_a396f9a8-7d96-4483-976d-e261e8838439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfPayMember_04dd6cf7-43c2-4849-99cc-1e6f52c830b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SelfPayMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_a396f9a8-7d96-4483-976d-e261e8838439" xlink:to="loc_us-gaap_SelfPayMember_04dd6cf7-43c2-4849-99cc-1e6f52c830b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ClientMember_e8621636-14ca-42e8-b4de-c4b2e7355e70" xlink:href="lh-20200930.xsd#lh_ClientMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_a396f9a8-7d96-4483-976d-e261e8838439" xlink:to="loc_lh_ClientMember_e8621636-14ca-42e8-b4de-c4b2e7355e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_MedicareandMedicaidMember_0b14de5c-cb8a-4e2a-9742-9bf146ee70ae" xlink:href="lh-20200930.xsd#lh_MedicareandMedicaidMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_a396f9a8-7d96-4483-976d-e261e8838439" xlink:to="loc_lh_MedicareandMedicaidMember_0b14de5c-cb8a-4e2a-9742-9bf146ee70ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ThirdpartyMember_988e1567-626b-4b34-9cb0-fbf7b465c823" xlink:href="lh-20200930.xsd#lh_ThirdpartyMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_a396f9a8-7d96-4483-976d-e261e8838439" xlink:to="loc_lh_ThirdpartyMember_988e1567-626b-4b34-9cb0-fbf7b465c823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_ac44bed4-0de0-4bf6-aa2e-68960654ce65" xlink:href="lh-20200930.xsd#lh_BiopharmaceuticalandmedicaldevicecompaniesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_a396f9a8-7d96-4483-976d-e261e8838439" xlink:to="loc_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_ac44bed4-0de0-4bf6-aa2e-68960654ce65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c4967e67-e751-4007-a87d-d5350000b54e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e197a78d-fddd-418f-a8a5-0efec941e2a4" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_c4967e67-e751-4007-a87d-d5350000b54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_bb30731c-6e2b-4985-9f28-3f5e7f3d7f5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c4967e67-e751-4007-a87d-d5350000b54e" xlink:to="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_bb30731c-6e2b-4985-9f28-3f5e7f3d7f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_f5d2aebb-8c2c-4242-9678-4889807e3435" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c4967e67-e751-4007-a87d-d5350000b54e" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_f5d2aebb-8c2c-4242-9678-4889807e3435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_9c129aaf-4774-4c9f-ab5f-6aaa34c15451" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c4967e67-e751-4007-a87d-d5350000b54e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_9c129aaf-4774-4c9f-ab5f-6aaa34c15451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostTableTextBlock_bbae9325-01a1-43fd-abe4-502add8d8446" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c4967e67-e751-4007-a87d-d5350000b54e" xlink:to="loc_us-gaap_CapitalizedContractCostTableTextBlock_bbae9325-01a1-43fd-abe4-502add8d8446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/REVENUEDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#REVENUEDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/REVENUEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_589c0ee2-1a09-476b-b831-9ac1990d7c59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredSalesCommissions_2c9941a1-d91f-4c4d-8ffe-280f6bd22f48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDeferredSalesCommissions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_589c0ee2-1a09-476b-b831-9ac1990d7c59" xlink:to="loc_us-gaap_AmortizationOfDeferredSalesCommissions_2c9941a1-d91f-4c4d-8ffe-280f6bd22f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_3fc5f94e-619b-45af-998f-14d53e018bef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_589c0ee2-1a09-476b-b831-9ac1990d7c59" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_3fc5f94e-619b-45af-998f-14d53e018bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_4c6e1662-2faf-474f-aa7f-ba5e931052f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_589c0ee2-1a09-476b-b831-9ac1990d7c59" xlink:to="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_4c6e1662-2faf-474f-aa7f-ba5e931052f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueRevenueRecognized1_7740ccd6-18e7-4856-a55d-4669642be7e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueRevenueRecognized1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_589c0ee2-1a09-476b-b831-9ac1990d7c59" xlink:to="loc_us-gaap_DeferredRevenueRevenueRecognized1_7740ccd6-18e7-4856-a55d-4669642be7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#REVENUEDisaggregatedRevenueTableDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_265c7496-fc49-4977-bb25-e80937e79431" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_e850d693-5c05-413c-82c8-72d59b258b9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_265c7496-fc49-4977-bb25-e80937e79431" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_e850d693-5c05-413c-82c8-72d59b258b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_fd176c98-5687-4940-b92d-574f256fc1ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e850d693-5c05-413c-82c8-72d59b258b9a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_fd176c98-5687-4940-b92d-574f256fc1ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3acb62cd-20f1-4ddf-a87c-f39263af8cc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fd176c98-5687-4940-b92d-574f256fc1ea" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3acb62cd-20f1-4ddf-a87c-f39263af8cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_58a27b19-9ea4-4452-b737-b86463ba011d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3acb62cd-20f1-4ddf-a87c-f39263af8cc0" xlink:to="loc_us-gaap_NotesReceivableMember_58a27b19-9ea4-4452-b737-b86463ba011d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnbilledContractsReceivableMember_ad10de60-19f8-4939-a4f3-77e4ca1061ad" xlink:href="lh-20200930.xsd#lh_UnbilledContractsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3acb62cd-20f1-4ddf-a87c-f39263af8cc0" xlink:to="loc_lh_UnbilledContractsReceivableMember_ad10de60-19f8-4939-a4f3-77e4ca1061ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_88a25850-f04b-4b29-bcee-b5f83b93abde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3acb62cd-20f1-4ddf-a87c-f39263af8cc0" xlink:to="loc_us-gaap_AccountsReceivableMember_88a25850-f04b-4b29-bcee-b5f83b93abde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0f214eb8-4030-4ca2-827a-aeed11e14dba" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e850d693-5c05-413c-82c8-72d59b258b9a" xlink:to="loc_srt_RangeAxis_0f214eb8-4030-4ca2-827a-aeed11e14dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0cc5bf5c-c619-4cc4-9dd2-0719d758168b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_0f214eb8-4030-4ca2-827a-aeed11e14dba" xlink:to="loc_srt_RangeMember_0cc5bf5c-c619-4cc4-9dd2-0719d758168b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7e6959e6-3df0-4ae4-a4e0-ecd5ed63ae67" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0cc5bf5c-c619-4cc4-9dd2-0719d758168b" xlink:to="loc_srt_MinimumMember_7e6959e6-3df0-4ae4-a4e0-ecd5ed63ae67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5d7e9c99-d401-4db2-9f31-de7eac448926" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0cc5bf5c-c619-4cc4-9dd2-0719d758168b" xlink:to="loc_srt_MaximumMember_5d7e9c99-d401-4db2-9f31-de7eac448926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0c5c3dd5-0c9d-4798-a637-772d8409f149" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e850d693-5c05-413c-82c8-72d59b258b9a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0c5c3dd5-0c9d-4798-a637-772d8409f149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_512a2871-2cdb-45c7-a813-0ccfddcf3669" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0c5c3dd5-0c9d-4798-a637-772d8409f149" xlink:to="loc_us-gaap_SegmentDomain_512a2871-2cdb-45c7-a813-0ccfddcf3669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_691792f8-6c48-4edd-b1ca-bd5f7a7c472c" xlink:href="lh-20200930.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_512a2871-2cdb-45c7-a813-0ccfddcf3669" xlink:to="loc_lh_LabCorpDiagnosticsMember_691792f8-6c48-4edd-b1ca-bd5f7a7c472c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_d314b656-02c3-4a7b-8065-6f0291b4f3ed" xlink:href="lh-20200930.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_512a2871-2cdb-45c7-a813-0ccfddcf3669" xlink:to="loc_lh_CovanceDrugDevelopmentMember_d314b656-02c3-4a7b-8065-6f0291b4f3ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_2b18f86d-829f-4a10-963a-e65e1428bab9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e850d693-5c05-413c-82c8-72d59b258b9a" xlink:to="loc_srt_ProductOrServiceAxis_2b18f86d-829f-4a10-963a-e65e1428bab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_dfb9dd75-78f4-4d85-b08c-991182de5dde" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_2b18f86d-829f-4a10-963a-e65e1428bab9" xlink:to="loc_srt_ProductsAndServicesDomain_dfb9dd75-78f4-4d85-b08c-991182de5dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_3a76c627-cffb-4167-b79b-2391f694f34a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e850d693-5c05-413c-82c8-72d59b258b9a" xlink:to="loc_srt_StatementGeographicalAxis_3a76c627-cffb-4167-b79b-2391f694f34a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_842ac0b9-1898-469b-b4b1-ee914bcc657f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_3a76c627-cffb-4167-b79b-2391f694f34a" xlink:to="loc_srt_SegmentGeographicalDomain_842ac0b9-1898-469b-b4b1-ee914bcc657f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8ad47270-491f-40a9-8ddd-5e7afba69a19" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_842ac0b9-1898-469b-b4b1-ee914bcc657f" xlink:to="loc_country_US_8ad47270-491f-40a9-8ddd-5e7afba69a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_d8b203ab-7256-45b4-b267-966e3746cd0b" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_842ac0b9-1898-469b-b4b1-ee914bcc657f" xlink:to="loc_country_CA_d8b203ab-7256-45b4-b267-966e3746cd0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_0940e073-561f-48ca-b8ae-f18feb26f150" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_GB"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_842ac0b9-1898-469b-b4b1-ee914bcc657f" xlink:to="loc_country_GB_0940e073-561f-48ca-b8ae-f18feb26f150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_be561bf7-ebab-41d9-b41b-78579a18b8e9" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CH"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_842ac0b9-1898-469b-b4b1-ee914bcc657f" xlink:to="loc_country_CH_be561bf7-ebab-41d9-b41b-78579a18b8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_cc0f9041-6fac-44db-93b6-fa3bd4d461c8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_842ac0b9-1898-469b-b4b1-ee914bcc657f" xlink:to="loc_srt_EuropeMember_cc0f9041-6fac-44db-93b6-fa3bd4d461c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OthercountriesMember_032048e0-3aba-4fd6-969a-842f68c35701" xlink:href="lh-20200930.xsd#lh_OthercountriesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_842ac0b9-1898-469b-b4b1-ee914bcc657f" xlink:to="loc_lh_OthercountriesMember_032048e0-3aba-4fd6-969a-842f68c35701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_e268a199-4a9e-4759-9443-209c1d99dcf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e850d693-5c05-413c-82c8-72d59b258b9a" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_e268a199-4a9e-4759-9443-209c1d99dcf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_6833224d-0e8b-4744-9a89-ca624f32372c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_e268a199-4a9e-4759-9443-209c1d99dcf3" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_6833224d-0e8b-4744-9a89-ca624f32372c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationAxis_a4100202-0a47-4537-bd4a-832be1526de6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerDurationAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e850d693-5c05-413c-82c8-72d59b258b9a" xlink:to="loc_us-gaap_ContractWithCustomerDurationAxis_a4100202-0a47-4537-bd4a-832be1526de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationDomain_45ca02a7-55fd-4b67-bd32-d43a73eb6f6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerDurationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerDurationAxis_a4100202-0a47-4537-bd4a-832be1526de6" xlink:to="loc_us-gaap_ContractWithCustomerDurationDomain_45ca02a7-55fd-4b67-bd32-d43a73eb6f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_d591867d-5368-4297-aa92-362d28088b3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e850d693-5c05-413c-82c8-72d59b258b9a" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_d591867d-5368-4297-aa92-362d28088b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_a80a5c22-48fe-4d30-871a-3e2a3247c7c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_d591867d-5368-4297-aa92-362d28088b3d" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_a80a5c22-48fe-4d30-871a-3e2a3247c7c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_5d6af7a7-9293-4fbf-8aa6-35c9405aeccb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e850d693-5c05-413c-82c8-72d59b258b9a" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_5d6af7a7-9293-4fbf-8aa6-35c9405aeccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_86c9653a-21ef-4155-bd9b-dda6f3507886" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_5d6af7a7-9293-4fbf-8aa6-35c9405aeccb" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_86c9653a-21ef-4155-bd9b-dda6f3507886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ClientMember_1be2926a-b28d-44c1-b18f-2ddb91152d8d" xlink:href="lh-20200930.xsd#lh_ClientMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_86c9653a-21ef-4155-bd9b-dda6f3507886" xlink:to="loc_lh_ClientMember_1be2926a-b28d-44c1-b18f-2ddb91152d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfPayMember_de72c3e1-5e83-4bfc-a61b-850c6fa04033" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SelfPayMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_86c9653a-21ef-4155-bd9b-dda6f3507886" xlink:to="loc_us-gaap_SelfPayMember_de72c3e1-5e83-4bfc-a61b-850c6fa04033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_MedicareandMedicaidMember_c676d9b2-97c0-4ad5-8e2a-2134f6d137cc" xlink:href="lh-20200930.xsd#lh_MedicareandMedicaidMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_86c9653a-21ef-4155-bd9b-dda6f3507886" xlink:to="loc_lh_MedicareandMedicaidMember_c676d9b2-97c0-4ad5-8e2a-2134f6d137cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_b6d9f638-bd25-4a70-842d-f066c9645590" xlink:href="lh-20200930.xsd#lh_BiopharmaceuticalandmedicaldevicecompaniesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_86c9653a-21ef-4155-bd9b-dda6f3507886" xlink:to="loc_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_b6d9f638-bd25-4a70-842d-f066c9645590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ThirdpartyMember_43a8a018-7d42-424b-9539-4549cb6b02a1" xlink:href="lh-20200930.xsd#lh_ThirdpartyMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_86c9653a-21ef-4155-bd9b-dda6f3507886" xlink:to="loc_lh_ThirdpartyMember_43a8a018-7d42-424b-9539-4549cb6b02a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_32d6760e-3de0-49b9-b917-e24e13742801" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e850d693-5c05-413c-82c8-72d59b258b9a" xlink:to="loc_srt_MajorCustomersAxis_32d6760e-3de0-49b9-b917-e24e13742801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_222e8a66-980d-426b-a280-f17808ff2068" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_32d6760e-3de0-49b9-b917-e24e13742801" xlink:to="loc_srt_NameOfMajorCustomerDomain_222e8a66-980d-426b-a280-f17808ff2068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e850d693-5c05-413c-82c8-72d59b258b9a" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_95ac2bf1-70ec-483a-9cf5-359918aa2e31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_95ac2bf1-70ec-483a-9cf5-359918aa2e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnbilledServicesAllowanceforCreditLoss_2199d1e6-65e7-45eb-b5a1-817381db5abf" xlink:href="lh-20200930.xsd#lh_UnbilledServicesAllowanceforCreditLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_UnbilledServicesAllowanceforCreditLoss_2199d1e6-65e7-45eb-b5a1-817381db5abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoteReceivableAllowanceforCreditLoss_141a2d37-452a-46f3-9450-04bb8a39c72e" xlink:href="lh-20200930.xsd#lh_NoteReceivableAllowanceforCreditLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_NoteReceivableAllowanceforCreditLoss_141a2d37-452a-46f3-9450-04bb8a39c72e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AllowanceforCreditLoss_590eb519-1334-40af-b3f0-088535c9b4cb" xlink:href="lh-20200930.xsd#lh_AllowanceforCreditLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_AllowanceforCreditLoss_590eb519-1334-40af-b3f0-088535c9b4cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings_9f39654a-ffb0-49a1-9a86-da826514539c" xlink:href="lh-20200930.xsd#lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings_9f39654a-ffb0-49a1-9a86-da826514539c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_6c90a1b3-ace9-4264-9cc4-3e3842fe0e8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_6c90a1b3-ace9-4264-9cc4-3e3842fe0e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnbilledServicesCreditLossExpenseReversal_1ab0759a-76c7-4a66-ae0a-823316d9f219" xlink:href="lh-20200930.xsd#lh_UnbilledServicesCreditLossExpenseReversal"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_UnbilledServicesCreditLossExpenseReversal_1ab0759a-76c7-4a66-ae0a-823316d9f219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoteReceivableCreditLossExpenseReversal_320e656d-0146-4e71-836a-a63d30c79b79" xlink:href="lh-20200930.xsd#lh_NoteReceivableCreditLossExpenseReversal"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_NoteReceivableCreditLossExpenseReversal_320e656d-0146-4e71-836a-a63d30c79b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditLossExpenseReversal_5555780c-731d-4f88-bdab-26630b5a6b74" xlink:href="lh-20200930.xsd#lh_CreditLossExpenseReversal"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_CreditLossExpenseReversal_5555780c-731d-4f88-bdab-26630b5a6b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AllowanceforCreditLossWriteOff_904096df-562b-4740-84f8-c7b3dbf8dccc" xlink:href="lh-20200930.xsd#lh_AllowanceforCreditLossWriteOff"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_AllowanceforCreditLossWriteOff_904096df-562b-4740-84f8-c7b3dbf8dccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SalesCommissionAmortizationPeriodMinimum_d3ec55ab-7cef-4a5e-8977-d95a1d16f837" xlink:href="lh-20200930.xsd#lh_SalesCommissionAmortizationPeriodMinimum"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_SalesCommissionAmortizationPeriodMinimum_d3ec55ab-7cef-4a5e-8977-d95a1d16f837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueRevenueRecognized1_73e757af-abc1-4d07-8768-f8178c6ca095" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueRevenueRecognized1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_DeferredRevenueRevenueRecognized1_73e757af-abc1-4d07-8768-f8178c6ca095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross_0decd257-473f-4284-ad1d-36fcbe9a4111" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_ContractWithCustomerAssetGross_0decd257-473f-4284-ad1d-36fcbe9a4111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_7283b55b-2ed6-49ad-a728-94e83a21f860" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_7283b55b-2ed6-49ad-a728-94e83a21f860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear_290ab545-e7da-4511-a8c7-1bffd6bdeeeb" xlink:href="lh-20200930.xsd#lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear_290ab545-e7da-4511-a8c7-1bffd6bdeeeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LongTermContractsDurationMinimum_4a6a5fd7-a703-4a60-8abb-d2cfbd953a2a" xlink:href="lh-20200930.xsd#lh_LongTermContractsDurationMinimum"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_LongTermContractsDurationMinimum_4a6a5fd7-a703-4a60-8abb-d2cfbd953a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LongTermContractsDurationMaximum_d3137c94-4ff3-42a8-b936-1f724ef98d51" xlink:href="lh-20200930.xsd#lh_LongTermContractsDurationMaximum"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_LongTermContractsDurationMaximum_d3137c94-4ff3-42a8-b936-1f724ef98d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_ef76d910-b666-41b0-8a87-cb0c89764c15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_ef76d910-b666-41b0-8a87-cb0c89764c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_0783725f-d358-40f5-b7dc-9b090437eb49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_ContractWithCustomerLiability_0783725f-d358-40f5-b7dc-9b090437eb49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_90342745-6f48-4923-987d-a0f6ea5b30b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_90342745-6f48-4923-987d-a0f6ea5b30b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_f525deec-20b7-4aa0-bcc4-5b39dfd12867" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalesCommissionCurrentAndNoncurrent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_f525deec-20b7-4aa0-bcc4-5b39dfd12867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet_4dbf0d35-fb9e-4b05-8654-94bc6ea6f4a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_CapitalizedContractCostNet_4dbf0d35-fb9e-4b05-8654-94bc6ea6f4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts_40e00723-f55b-40fe-8d4c-f79319aae130" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts_40e00723-f55b-40fe-8d4c-f79319aae130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredSalesCommissions_882d2b46-a816-4b05-afb9-5a39df68bc10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDeferredSalesCommissions"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_AmortizationOfDeferredSalesCommissions_882d2b46-a816-4b05-afb9-5a39df68bc10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_9c4bd024-361a-4e11-a123-1717899f32d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_UnbilledContractsReceivable_9c4bd024-361a-4e11-a123-1717899f32d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentofRevenueContributed_5f468d5b-11fc-4eb4-b4fe-805ce0e7155c" xlink:href="lh-20200930.xsd#lh_PercentofRevenueContributed"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_PercentofRevenueContributed_5f468d5b-11fc-4eb4-b4fe-805ce0e7155c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SalesCommissionAmortizationPeriodMaximum_871dd010-34f0-4d6c-b943-e3c423891fdb" xlink:href="lh-20200930.xsd#lh_SalesCommissionAmortizationPeriodMaximum"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_lh_SalesCommissionAmortizationPeriodMaximum_871dd010-34f0-4d6c-b943-e3c423891fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_1571e56f-03de-4340-9a24-defba9a1421b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_38cb0e84-87d1-4636-8b97-37d4dca1eeb3" xlink:to="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_1571e56f-03de-4340-9a24-defba9a1421b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/RevenuefromContractwithCustomerPolicies" xlink:type="simple" xlink:href="lh-20200930.xsd#RevenuefromContractwithCustomerPolicies"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/RevenuefromContractwithCustomerPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_dd9f8fe4-b408-48bd-b73a-c0c20b7203e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_240a6159-c042-4c09-9570-823c77c1c68f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_dd9f8fe4-b408-48bd-b73a-c0c20b7203e7" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_240a6159-c042-4c09-9570-823c77c1c68f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/LeasesNotes" xlink:type="simple" xlink:href="lh-20200930.xsd#LeasesNotes"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/LeasesNotes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/LeasesTables" xlink:type="simple" xlink:href="lh-20200930.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f5280b5d-dde9-4433-afb3-e1b46fe52167" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_41557512-33a5-470d-aa64-dd7bd66f6b42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f5280b5d-dde9-4433-afb3-e1b46fe52167" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_41557512-33a5-470d-aa64-dd7bd66f6b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/LeasesDetails" xlink:type="simple" xlink:href="lh-20200930.xsd#LeasesDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/LeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_31bd1f8e-1eb8-4df7-adcf-96075c2ed7d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2a5394ea-ff5f-4a68-951f-085554e448ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_31bd1f8e-1eb8-4df7-adcf-96075c2ed7d9" xlink:to="loc_us-gaap_StatementTable_2a5394ea-ff5f-4a68-951f-085554e448ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_da35c26a-29e0-42b5-934c-2ef28f3e8062" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2a5394ea-ff5f-4a68-951f-085554e448ec" xlink:to="loc_srt_RangeAxis_da35c26a-29e0-42b5-934c-2ef28f3e8062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3a64fb3f-2cea-4f90-b4c7-985f0e1963e4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_da35c26a-29e0-42b5-934c-2ef28f3e8062" xlink:to="loc_srt_RangeMember_3a64fb3f-2cea-4f90-b4c7-985f0e1963e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_53f8192b-02b1-4bc1-baf9-5b478329dbc9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3a64fb3f-2cea-4f90-b4c7-985f0e1963e4" xlink:to="loc_srt_MinimumMember_53f8192b-02b1-4bc1-baf9-5b478329dbc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_61f7c793-067a-4668-8143-2a6fca30d818" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3a64fb3f-2cea-4f90-b4c7-985f0e1963e4" xlink:to="loc_srt_MaximumMember_61f7c793-067a-4668-8143-2a6fca30d818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_67e308b9-52b8-4e06-b256-aae7cbc9517b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2a5394ea-ff5f-4a68-951f-085554e448ec" xlink:to="loc_us-gaap_StatementLineItems_67e308b9-52b8-4e06-b256-aae7cbc9517b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_98ba5d0b-3d00-4373-8148-762afb536023" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_31bd1f8e-1eb8-4df7-adcf-96075c2ed7d9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_98ba5d0b-3d00-4373-8148-762afb536023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7a0f8868-019e-43fe-82b2-60e3387af77f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_31bd1f8e-1eb8-4df7-adcf-96075c2ed7d9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7a0f8868-019e-43fe-82b2-60e3387af77f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_3e200790-3782-48e3-9db5-3800970d59ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_31bd1f8e-1eb8-4df7-adcf-96075c2ed7d9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_3e200790-3782-48e3-9db5-3800970d59ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c2b7d668-a122-4e0b-9108-cb64f2c7096c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_31bd1f8e-1eb8-4df7-adcf-96075c2ed7d9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c2b7d668-a122-4e0b-9108-cb64f2c7096c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>lh-20200930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:lh="http://www.labcorp.com/20200930"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lh-20200930.xsd" xlink:type="simple"/>
    <context id="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3cbe3c928a064308830aa690527b4879_I20201028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <instant>2020-10-28</instant>
        </period>
    </context>
    <context id="i7da7c6b0d2814e079360edb6ac4a2611_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9dcbdb2a510240b49e6e31157090b5d1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibacb0200d2584d9189a696351c4be886_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3142bfab671e4d37943fa55426510724_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7ed61e2c58d04a4f96f4455f58dc8906_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ibaa1c40cdb9547b6aa52d2c4edcc8188_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i102884c59d1543caa2ca620678208c40_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i79d400b1fb3b429b8cf4d8afe9e3f8b2_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ibedc8534cf6f4afb870b205b0eee4330_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6ac49907696d40399215ce933a047245_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i9d1cc0f890c444fc8065f85eaf2c3eb2_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="if9805616bfc147a685777006a4f3a977_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i6fd2acd8725944849260da540e21b13e_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i6aecc811560c4997ad0a94f7656fb5f2_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ib3aa1360071d489f9642129871989937_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="iedd14e246c1d49da9ac324e7575d5643_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i2dd1e22b6a154e39814fd636f0fab4ce_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i749c4690686f45c3b2850fcbb9a0d1df_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ic9b90f619f8b4a7083d154d69233d90f_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="if4aa40f4beab4847b0614e40e1cd143c_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ib974ad7e470d46998daf31767f2af398_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i2bdc2fd7db454059a73ac63fbcf696e8_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ic342c0d96ffa4ec4ba03f2801ad1e983_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib09142dcedba4260954ddf2d9692acb6_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i83d083f1fa054115979e180a0197c0c3_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i9f0351d0ac5340749dcbd3417ca3b6cf_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i75641ae84a834af19a49dbc2f325caa0_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i1fed346eafa54192b0996a2c5e59af06_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia796b50fb78c4d8ea1305d6cb87f4c80_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ie5fd99aa026e4d049d9880148cd3673f_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i41dc70e79a434c8584c71c9871c4d297_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i3830d635761e46d59cb5beb48e8e5c06_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ic4332a0967964a7e951d06b4f757007e_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ifbf3e729d39d476fbac2a1d7b95feece_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i6cc52edd079c41dba66111baf03d7d8d_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5f2b2ef9fa394b91a5ebeb5644627072_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i92acbc0b60c64d71979b7d2ca0a3d393_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic8dc748344574f268131764ada7e2c98_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i330e9e0c1f764aa28705cf6255807ed9_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2e93e2032f774e388fbc09993a955665_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i219dadfad6ec4f15ab02c46b30294757_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i121e54f584574754a997b2e8da14cb33_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ibf92e2a580e040a495fdd34dbb61b1e3_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i52114c8d18b9499a9e0444fcbab899ab_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i3ebf6d35695d43bebd0e1036cfd88d00_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ib6295bf6566e4265bac5d6f0714100b1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i995498342f4d4bbeb12d006cd72d61b1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id047e5b85b904a12801017a2fd441c52_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie4d943c067664cd3bb4ef38017cfc703_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieb05081604c34e979bb4fd456055049e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie8a89f8ac83b437aa6f0f277429e7b04_I20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-01</instant>
        </period>
    </context>
    <context id="i3d1419fac15d45ba8998356ea892ab07_I20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-01</instant>
        </period>
    </context>
    <context id="ic71057ddd9b94ee9bbf0a3919bd94bd4_I20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-01</instant>
        </period>
    </context>
    <context id="ib0b1ac80eac24afe88d4fb1b2e16aefd_I20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-01</instant>
        </period>
    </context>
    <context id="ia31964c5cf72480688ceb520816d7665_I20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-01</instant>
        </period>
    </context>
    <context id="ib51bcbbe3b3b40dabc2fef3fab8b97b2_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i0abf8234cd2f4de5ad2609359991f8d3_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="id31a66599db3453db1095d8dd3713397_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic2584e4e56f14caaa4332a71ef56576f_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i25486ee4361d42f18c47644aa116250b_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ia962c16050fa4b28adc73e0d729703c5_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i5d6506b821ec4b6a89acd1558aaf0f20_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i1f1b50d6e33142a797ba59094a4d6109_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i9ecd2df0683345df840720ba03e366f6_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib4033d4ed5ac4e2a90cf122db9d649b7_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i906c32823da3454c88cf7e570cb8bde4_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i50a2dfaccda94b87acda43c31ec50e7a_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i6e645a01cc63416894fda41c9b202e41_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iceabf34577cf4df1ae006d401b431793_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if5513a927c4444339f73687e0a972d90_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5f4911a3cd4244faa921cef6beedbda0_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i70e36036ee974a9383e7b832ec83f7bf_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i612a5521f96f4a1db5dcc91dda46a2e8_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i0a0d6c3c99214086849193c76b863382_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6421b026529d4cb8a7d4ed4b2b200529_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i35550650089c49acaebcaf52a144d1f7_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iad6fff0892aa4905843f6f15944bd070_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ie055d220bf39404a910b28a899727919_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i8272c3d15f864e709f533b5532e0c9c8_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="idbbfb6e65e55467184de04732ad5dbca_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iafb98936914b4c85ad9a3c7728022c47_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i84ab37a796dd4ad595c43567718e60ab_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iba6759ae8a5847a883ff4cd2ca1523c4_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iec50023dc3d34301836e4d6d2ab126fe_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7b9f3b204a7e4d5bb84fdca35b0388af_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i02dd23ef8e2c4ff6ad5ce9aa02fd57a1_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i003fb35d67544342982c7134cef34000_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ifb420f938cb849e7b63729c500bdb2ef_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i42f654e418554a0aba5b6a17b3942bae_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1982102278bd444d897b0ac03dedfda5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4674d28875524974925c86ea26137e4b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i60bf6e0de9384f37926fac0c0db06385_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if366c14694954f6f84a2c0fe5708324e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6e46390b74524a39961dc3a71697bb7f_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">lh:EquityMethodIncomeLossNetDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="idf06093237eb40b7b4693f9bb03c1107_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i47c2cf5a89a849cd94e6efd1d321b938_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia74b9c93ead74b108c97cc4640c2fe07_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="id9626ef1cd2547cfa89fd9b389064cc6_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7c47ed00c06b4961a64f099959fe759f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic6ce3c437b1e4049899878b45e0fb6e0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib50b6d8435904455951c7565779b7341_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib2a6785d04ea48f7a2a1542a0d7d001d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3daf06395da4489ea42ddd3f54707d86_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i14aa48993fda4a6f8eaad4578904f2df_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic259290288f44d458eac49b83b8ad944_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i16c280dd720347169ee01886277f5b70_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5e98179fa8e44ec4aa8b9eb0699e9a4f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id6f7b06ec61042f192b8d0c0ecb380fa_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie27a2846b55f44e3bb10629c8b4a6d09_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i07d524d7631c4f689e36c4a9e9f86e2c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i14a4aff636b04769856789d12e03a871_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iea9e025d0f644fa485e22a580d3f4cd7_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4e22f6a7e0374793b9cefc9bcd3585b5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i90ac3c1fb02144f099e252661fe37fe8_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iad4735e1e849483bad4da486a568d55c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iea9b5f420b964fd5aace6048e7b0921e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic5ea73c3e164417cbd60d881836d1e1d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie17f2d3381d644e6bbd5e83aaa53ffe4_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0b07ec7181b24fe79db83b2887a77770_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i62b5c18a94ba4af9a2783e2211f603d6_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2ca0e774190547d58bf6ce7ab795efb9_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i085d47025332478a925481cbd318fc65_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5238791a93ca4316b581e997a3d384e3_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iee6febeb28ab42fbbe765be16edd24cb_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i43148fef08f94203b85d962c5ae8fb07_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i03c7187cc2214dcd9fbe27e11b92de30_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia185a66890a2414584681a11add7d192_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2a65613c19cd422597c0eebb88c2b3d0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9722f55060174cccbd82ef9b8610b196_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibaa23ac123cf4574b439cc76d55df4f2_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icd62d7344fa0462a991ba65da1c7ffb7_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic2c41f77470b457d9ed4965bab8f7ee3_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i38839c3f1f934895b768a54821da0a2c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifa2e5eb5177045ea88f2c41735e55445_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3f6b988e5cc14246b5d95a62c430643d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i61068721174646479a719d0d82691d66_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i599da8b7d2d14e4791521d86ea88a36f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5fc62abb869f43369975ea7f0bf80db0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6d47fd2ebbac412db1f27e585bf53e3f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id53db043a8034950b09968edb83a0607_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i204f3a1eb6b44643b050bf8f2540765d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id6f1cdadc4de42b38c3a6a8dddb06604_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6323cfeff41f4159acf7a53bb092c3c6_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9dfb8b56aede469ea13f92e3015dc958_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i01dfc480ee174b02ac0b09584e2317ce_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2cfe9d5cd85d46b3897e697a5fdd49c7_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7baa4f0065bd47a59ee4fe85f7b5755d_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i25a211144dd8470d8b356d8b001c8501_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2281dda8aa1a4d30af776c18df61d1c8_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i8052a0e56c404ff5a4113a6c4c023c88_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i49463c9f0be949a4b668835f86737567_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic45f90b4ea0f41e9a9f8d1a4f466f54f_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic549b3c324ba47f38e5480ce02fd0558_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie917065bc7e643ca9770aad73add4250_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9414919f80cf49ebb2777851ee4fed37_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie9474df2c9ec4f0588048ef29d346752_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3462aa035a72495e9fc1ecf11fbd2049_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i154bbdad5d524723b675883f9c7065a6_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5ccb82ced1094bd59e3d613df27e2c24_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie700d5333095493db55774137661401e_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i05e2445018784b01a0f279f4ffeb2d49_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9c1e1e6af87a4db689abaf6a994ffc67_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i450bf78169c642e09eeb275ebfaeea7c_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifecb6bbb2d3c42288aa163006edb1553_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i38357c17172f498586667865e1980e9b_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5fc1f599be994436af4c261f3c7f98c1_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i8cfaa96b273d45b1a241e9f02c7a7c7b_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia021b225de1b429189702e36fc573e16_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i333fbc87a53747a7b8553fad99660865_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i359c7aa0655644ea80c898242ddcf80d_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i43a981ae8185490d984dcb30bc0eee10_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i460eab215fae419a8cf81c41cdb90279_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3eef33bbb5e342da8dee7597bfe3f461_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i04baf8b50a6c40d5a4d98d6de87046e4_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="idd95aab1b5024137b07364cf3867cbf8_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2ee2ea6e83ea4fc29a6b36fe34613f52_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i42d9fc1bf025408c9fe447f1b3cafa5d_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id01bbc615be14b70965d98cee7de2b26_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id6502f4abf6b47edaf675df7d9727ce5_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2eab7066fb3e411da4d882666bb1218e_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie0ce21fe8c654b7c8a7360072ceba887_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9482ee714bc546369167c573a2564714_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifdb48a87cc234ca697c8b0c54bd62d31_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i389ae4c4c9f24473a15143884e9da492_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1df72b2b1d6d4c6fb88d7a315c3cc960_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i26560d40f7624e208364bac468677a3a_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i26e2079e9fa2414b8068d97842ea4ddb_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i631604fdcc4444ffaad24e9b13db902f_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i8d30dccc4d364639b665ffbe677c7647_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9b8a3952cfa54d32b76aeb203dd87494_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i05d10f6fbfbb494fb6fce435672dcf23_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ieff9b96c85334e939753b0c4e6ef2d63_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i77f9248d57974574bc9adc8bcfcdc8e1_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i280e8f364ec54f6bacf36535657ece2f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0e0eec8d36874fcb811be9de7dfc1394_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0174357050ce426eb9072c176613559e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id5b5a7fb19a640759ff41fd96d890a0a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i91c6a68811984e989e0f9bec6fbe7865_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7960720916204ded977638cc08e62b56_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i693603475db345f8b0944c13afcdbc10_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibc807183e1564343bd31c0159b51bcbb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i69a59eef10334badbbe7740a6961bf20_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5f8c193f87c34f2db43b82541239c4db_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i26a632e3297b4c43bc30ad60a11821cb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9f7285237d6143a88b08d4f6094f9950_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i37d8778b4638498d984b5ef4a80387ac_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iedc4cdb92e6d4a918e4cae457e5095e4_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6c4af8fb06a3468b842884b2d7f5e43f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id7ee075779ba482ba14540bf413c99c6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if2c8d81029dc4f4ea85b448efa38bad7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i10f238e753b94349a34e63521a517705_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i88f53878399541aab3dbf15a0f35c2ff_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1d952d8add4a423c841dcb828a6395d4_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6ec27280b43d41cfb61cf079469c0a60_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i067fa16ca9d545099aaef7dfae0ba189_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9ad7fc029ac844a49ffa1b856f5d56f6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5af8a070f9bc46658055f2e8175a8ce3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie14bb7a57ad64858b6c10be22525e07e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1ba4b7d86f204b6a9d7d562281386f61_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibeebbb5e419f4d849feadf2a965eda69_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iaa5d6637f88c446481fad357f1d45753_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iae17d5d53f964b1198bb9bec44994813_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia07d85355268435f99e328b11dc3a41b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if615f680db594c4abf7dda191e8cb043_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iaa1fd9f69a7b43eea8506545464daab0_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i652bd6addb2f48ccb11829f65d6bbfda_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id7fdd15f57ab4e47b5ba9a975330c61c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iee20f2c502354597935b92371dbe0d94_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie0e7e0d5ac1844e9950e43fe31ea5e07_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i339500f8642943c2b6c982af6cf9dfea_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id5a9b3edded440719a65fa42688ad89f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0729ff016c534ca29e10e62194985ae7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0f2f788044f24469ada3249aca7b98b1_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id0ca0a967b334598808b418e2700013f_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7bcbb30927c34620bf18c72d093bec3b_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib55a432be0f249e2afa7e0e1d560e1fe_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i56ef410ac516442db21e732867090a7d_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="icd34f489e3cf4bc68520fb4156dc30d5_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i860cb23b9d0b4f0f94851daff5988983_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iad868dce52b44ad790b6864d29035e06_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i86cabdaea3ff4402b13c640c489942dd_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6e295a8c616e4444bfb546859426b1d7_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6da967c8920c43edb991c0528d2ad964_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i765da38bd1524d5ea57eb2c302a51993_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i13839e115ef34c2e9cdbfd5996444ec4_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="idbaa79c605ea46b49097dafde16b4c63_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i03a302c67b6a4bb7a2a2e19bbbc2a9ab_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i38329f0d027145598d9b90d0a83b4b3d_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i24a86d409aee4a37b73db1b51534770c_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i23169375ab504448a8b52398bc5131ea_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9aeaac1d1f984a51bcb01399ecd48b56_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie8c943708ddb4c9a824d53b38aca3911_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if12ca51a38a34b098329f98278e9316d_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i65ba32b3197b47a89d8e18f5ce7bf26f_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib44011bd3f5846bebee1bd4b98050562_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1ba36fdfcf704ad6ba7b509e8b7da78f_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i27fed185eaf64f0c9df3d3de7b9cdfcf_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="idbafa9f2fce94b9b8a2c5abf17d6940a_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie3d222c52e0c4a28b8e6198bd6eb1ce8_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3d602e784d274adcb804041ffb3aa3d2_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6646c81346544c4d99e9fa1d0e57c80c_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia75364130e1648e78fa02c61892d115d_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i15b5a11fc3bb4619b499f9c929493fa1_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6959b7c2c57d4c76bebc490ae176fcfd_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if8eeb5ffe9464ea18f019180489ed088_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i54d000cbf2214f02a540a13d16a2e6fa_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iaf29f2ab93f848ea80feac95f899a8e9_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6b5a3389083844e18566cd906171e56b_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic3dc0765c3e2434885f5a3a11ecac3d6_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i272813f6653f43e188e55ba3267529a8_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ibc3a82b251f447e2bb647e6978c13daa_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i851a94e1b5a84e1aadc1d6c2a58c7df0_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia658bdb62dae4582bd04be509941c2b5_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i8425684776dc4bd99f6c93fbcbaeed28_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i8a6729fa89514d4e80eba6b05b6bdddc_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="idf7ad2e2b01e4065b8a00585446b245c_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia718fc35144f49d886e94436e951426b_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5ba397b83c7c4a58bcf44d9eead0473a_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i0269009dcd1e4b8e8b5484651bfc3b7f_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i78561ec2276d4506995dfccf9bff7d1c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i603496ec6a9840f2a7691f78b350638a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3d3f91adb0694c9f8cda5c55c146646b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib5f5b39b26164231afef597275eaa72d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib21823aba6f14b7abd5b9938f0373824_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i33a372065d96498db0755abec1a36919_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">lh:UnbilledContractsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibc7ed4faa9454198b02470d9bf8c948d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3e065a3d3a9a44bd9969178157790cfd_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:EnvigoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ifc042ac91d2148ea90e2852e684aa7d1_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2f8f9d7520ef4499b316c87363b01437_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifc1b3052e0d1420fae79ce70434a92f8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i29bbac08d4cd42b590e8d38341b247a4_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie8ba5b5579de49a1834d28dc2798cee3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i83cd8f691c1a4a83bc738d2b7ddb6e5f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id22f921dc2c74abe80fcd674d286c147_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9b54967480df4194966a376ec02d6eb4_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic7b895159e664819875373401fc83cfe_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if96ac9c12a5b46ffa647f1720c503604_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id93dacc653da4b5f9dccaf725dcbc769_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i32a9df56eb784dc7a4b220f78de9bd76_D20190603-20190603">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:EnvigoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-03</startDate>
            <endDate>2019-06-03</endDate>
        </period>
    </context>
    <context id="ieb6fe2a304194224befa49dcb5ed37d4_I20190603">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <instant>2019-06-03</instant>
        </period>
    </context>
    <context id="ie9cc69f41c9c44488b638ef3aaccdb61_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:EnvigoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iae23e3cdb39a44b8968341916d4a2dee_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:EnvigoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i05c3bfa9f9624b64841e19fc622f33fa_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:EnvigoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i08f70824033d48f0ad6009880d1268f6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i34ea8623f99d450ba0c680719bfe3105_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i43d39dfc46f64e9ca238eb8a039fa85f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if5bcb822134b4295bec55008826197e5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i616e955ba8fd4b48be31816f59836100_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1dfebc2c21b9448d96ac217371534543_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idb6c26b91b524c4abbfa955d1ddc4457_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8fb8d4ae4a074deead96aadd66375f97_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6cd3b488f83048afa58403e54590e370_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3b26803c2ed7463f9f6e7e437606b796_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia5fa039b6da0439ba94ea7516654e077_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id303bba4b3024ee9bc49c49292c283c3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i84f2eb55fbc34238bd4e45bb4e88d0d3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ied5787aeaaf147b3ac9ba7c20d2c10ca_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i074bfbf2d5a14f098b9866224c866c60_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0aec6588c61a425bbfbaa20d82e54da0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="icd1aeab8e4f84964b6228ddbf6f745c4_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i4e01eb55dbc7406c97793a4ef9f2d6fc_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="icb47c57b65f949f7a7c4c95751563b2f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9227de05b374430bb6014f0912ee355f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i07693b8e43fa40fd96c729928953fdf2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i667ca8a683be43908b933939e90db6ab_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">lh:PatentsLicensesAndTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i350c55aa64654b5eaec00a68eb64ffcc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">lh:PatentsLicensesAndTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic4b591e887b949ce852974492383726e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i565f137a551b40788c8efe1cd6a5249a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4bf99eb3ad5c4326ad848c0c5cbd06d0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i370b422d371e47b595a9edeb8e53d595_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iab6b50825a0346fda5c7a57c46854607_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:UseRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iabe5e13fb7d54f829c7b91d468ea08cd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:UseRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if63915653cb94496b21de8a1a2fa6d6c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2794dd6e7b2744c099a93cd25ba76ec6_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iab77a3a920bd45ec8c8a0ce85071ae92_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i16b4dd493f294c068810b89a1566d767_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4c8777e25b1f43d891ec105edf96653f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3dd7ebb2472d4c31906ef3769da45911_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3ccdf4f5309844119bbb0e0786d0933d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Seniornotesdue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i167711db2a824eb5abbd3592c79dac6a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Seniornotesdue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i657d0be39de346838d90040f8d8f348e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Seniornotesdue2024MemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1bd3af0136af40129f6e820d13a1ae7c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Seniornotesdue2024MemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7afb899941084ecea85f2f14bfb617e3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Seniornotesdue2025MemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id8a898daea154e4e8f10db94ed74cfa4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Seniornotesdue2025MemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9f958adbe35f4caab3789a03b8cec98f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Seniornotesdue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i717fbdf29e6443d699ab792d8711e563_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Seniornotesdue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i33c11262f4464ffea951db61842a0276_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Seniornotesdue2045Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1da5761b40b5492f8293785134f8ab79_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Seniornotesdue2045Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib861cf324bf4423f8474deaaa80a20a6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:A2019TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i391abd34dc914608a327d3e643899d6b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorNotesDue2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8826a53a9f514573b843bca48b3cf833_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">lh:A2019TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ieb68008a843e40baab3187013ce2c0a2_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">lh:A2019TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic0187e44c0d748c594cf9f1d3948e793_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">lh:A2019TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i68588eebfb8e4548bfe358f5a18f2c3f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if9247fa03b7041468d61fb949531d7c4_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i053c189109464dc2b30dcc1a0729589f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">lh:TermLoanandRevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic3ee871e124f4fbc9fc99ccaf3849f33_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">lh:TermLoanandRevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i772995039ebd4eb5b458fda1865f139f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">lh:A2019TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4dacd586a4f14b008d9dddcced9904a0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7ecb5a349ee9456dbdca2fe6adf8c4b3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1d95d9565fa048cabbe7fe142c315893_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1e01cc0ff9ce44ef99f7acd5a862967e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:CovanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib199336a2dd2420097e56516adfbc4d1_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:CovanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia13373a9d55d49f19ffcc37b5bd497f3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:CovanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3eb0e387c6aa4d82ac76ca334fbc0143_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:CovanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifc93dd882afa412083acfde2ba592eee_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia2cd501dd8ab4346aa80fd4754cc040c_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ibb40acae056445528eb8911537232df5_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icddc15843aad45e5aededcb204169bef_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if69fa5cada7744eeb0c7092963608d33_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionAndOtherPostretirementPlansCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9e0edd28826044888669adf1110662a2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionAndOtherPostretirementPlansCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5229937ecb2d46eaa667d49484539b53_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iab089143fc42417c81a2d2bfabbd8654_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iacfbc074fcc44dfb86499f5096b2b493_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7ded3a94ce0f45598710ac45a034a923_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib0f0ae542d5a48d89e69a0ec76905efe_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7abc6c3f0ace4f678cb9c9f7caec9b6b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i30fd4fe5553348999dc8935c8ef8e7ab_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">lh:SeniorNotesDue2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibe0d3f0eae0e4636b83723ad38c201f0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">lh:SeniorNotesDue2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i157730e7ca9e4995bdae523b7501fc18_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Crosscurrencyswapmaturing2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7e6ac05e86da4a5e81f44c16ffdf25ee_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Crosscurrencyswapmaturing2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5b2d1e688ceb488f882b2976928f2162_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9709977fa99a4330a25d6ae199b8dcef_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorLongTermNotesDue2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iedf8eaddfda44623be579df701c1a1fe_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i65cf17ee050f4482a7c6583428aea61b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorLongTermNotesDue2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9c7e9ea78df3464f91a5468557f3b4a3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibd87dafe403e465ea18e34466c3c7939_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8d5061e0be7847e68312a7cca228cf95_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iefe19a4e91fb49b3a68616c5ff46e9e5_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2ec6f971894c47229132bd1159446ec6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie7a8e6e061ca4fad8a9d6109d3fb30b9_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3ccde3dbf4f348e184653bd3cde3ece9_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id37ee09894034b178815f25b8d74e8e8_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3997aafec9e6480ba5de1fc7fc5ae356_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i57fefb8fd43c402695470e30d3a2fee3_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i060a850910964d4baaae2bbf8a6f8fa8_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib3059b6353b34be0bc21870bf9a54a49_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib5cb7f86911741a9b2e604fc4fb6237e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7613840514f4435bb5f3e61d09adf8b5_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3bc43a85b31c461e9c8951056efb762f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3b2b623128cd4e32a331207c59b1041a_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="rate">
        <measure>utr:Rate</measure>
    </unit>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMy9mcmFnOjEwN2ZkOTQ2ZjgwYjQyMjg4M2M5YTJjMTZhOWNmYTI4L3RhYmxlOmEwYmEwNmU3NzEzMTQwNTViOGZmOGY5OTA0OGU2YzhkL3RhYmxlcmFuZ2U6YTBiYTA2ZTc3MTMxNDA1NWI4ZmY4Zjk5MDQ4ZTZjOGRfMi0xLTEtMS0w_59c5087c-eff0-4120-afef-735f23faddd0"
      unitRef="usd">26600000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMy9mcmFnOjEwN2ZkOTQ2ZjgwYjQyMjg4M2M5YTJjMTZhOWNmYTI4L3RhYmxlOmEwYmEwNmU3NzEzMTQwNTViOGZmOGY5OTA0OGU2YzhkL3RhYmxlcmFuZ2U6YTBiYTA2ZTc3MTMxNDA1NWI4ZmY4Zjk5MDQ4ZTZjOGRfMi0zLTEtMS0w_c021f123-4ec4-41e5-92c2-6d39d9216f5d"
      unitRef="usd">19000000.0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMy9mcmFnOjEwN2ZkOTQ2ZjgwYjQyMjg4M2M5YTJjMTZhOWNmYTI4L3RhYmxlOmEwYmEwNmU3NzEzMTQwNTViOGZmOGY5OTA0OGU2YzhkL3RhYmxlcmFuZ2U6YTBiYTA2ZTc3MTMxNDA1NWI4ZmY4Zjk5MDQ4ZTZjOGRfNS0xLTEtMS0w_0c06064b-9f24-4c4d-8614-7577dbccc8e8"
      unitRef="shares">97400000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMy9mcmFnOjEwN2ZkOTQ2ZjgwYjQyMjg4M2M5YTJjMTZhOWNmYTI4L3RhYmxlOmEwYmEwNmU3NzEzMTQwNTViOGZmOGY5OTA0OGU2YzhkL3RhYmxlcmFuZ2U6YTBiYTA2ZTc3MTMxNDA1NWI4ZmY4Zjk5MDQ4ZTZjOGRfNS0zLTEtMS0w_854495a5-cd14-4bd4-a5c3-03e48bfaf61f"
      unitRef="shares">97200000</us-gaap:CommonStockSharesOutstanding>
    <dei:EntityCentralIndexKey
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMjQvZnJhZzo1ODVhMjgzNzI3MzU0ZGMzOTAxOTZkNDJjMjg0ZTA0MS90YWJsZTo1YzU4YTQ0ZWQ2YTU0ODkzYTQ2MjY5NDM4NGQwZGUwMS90YWJsZXJhbmdlOjVjNThhNDRlZDZhNTQ4OTNhNDYyNjk0Mzg0ZDBkZTAxXzQtMS0xLTEtMA_1799b277-aad9-49b1-9874-9ee8f0c1d96d">0000920148</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMjQvZnJhZzo1ODVhMjgzNzI3MzU0ZGMzOTAxOTZkNDJjMjg0ZTA0MS90YWJsZTo1YzU4YTQ0ZWQ2YTU0ODkzYTQ2MjY5NDM4NGQwZGUwMS90YWJsZXJhbmdlOjVjNThhNDRlZDZhNTQ4OTNhNDYyNjk0Mzg0ZDBkZTAxXzUtMS0xLTEtMA_43877e13-58eb-4423-9741-90cb59df6019">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMjQvZnJhZzo1ODVhMjgzNzI3MzU0ZGMzOTAxOTZkNDJjMjg0ZTA0MS90YWJsZTo1YzU4YTQ0ZWQ2YTU0ODkzYTQ2MjY5NDM4NGQwZGUwMS90YWJsZXJhbmdlOjVjNThhNDRlZDZhNTQ4OTNhNDYyNjk0Mzg0ZDBkZTAxXzktMS0xLTEtMA_b9a2ad55-849c-45e0-a164-c7d36f341ad5">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMjQvZnJhZzo1ODVhMjgzNzI3MzU0ZGMzOTAxOTZkNDJjMjg0ZTA0MS90YWJsZTo1YzU4YTQ0ZWQ2YTU0ODkzYTQ2MjY5NDM4NGQwZGUwMS90YWJsZXJhbmdlOjVjNThhNDRlZDZhNTQ4OTNhNDYyNjk0Mzg0ZDBkZTAxXzEwLTEtMS0xLTA_01b5fe14-28bb-4dee-9ed8-0698564348a9">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMjQvZnJhZzo1ODVhMjgzNzI3MzU0ZGMzOTAxOTZkNDJjMjg0ZTA0MS90YWJsZTo1YzU4YTQ0ZWQ2YTU0ODkzYTQ2MjY5NDM4NGQwZGUwMS90YWJsZXJhbmdlOjVjNThhNDRlZDZhNTQ4OTNhNDYyNjk0Mzg0ZDBkZTAxXzExLTEtMS0xLTA_e94037f3-8791-4e11-8a56-6add6577584b">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjg1_119280b8-d079-4c50-bc42-5afa831ad18a">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjg2_a2323689-df2f-45c2-863e-a2175afa1315">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8zODQ4MjkwNjk5ODAz_07e8d103-8ded-4d25-91e8-1d5d897a80f1">2020-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjg3_b64a2b03-e973-4959-9bab-c16f41cf0063">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjgw_5f4b8b3d-1e4f-4706-9173-7d8b32fec66d">1-11353</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjgx_9205ad08-ff96-4828-8d81-0f1aaeb93dc1">LABORATORY CORPORATION OF AMERICA HOLDINGS</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGFibGU6NzFmYzFmODFjMDEzNDY1MTgyNTkzZmU1MTdiNTFkYTMvdGFibGVyYW5nZTo3MWZjMWY4MWMwMTM0NjUxODI1OTNmZTUxN2I1MWRhM18wLTAtMS0xLTA_8fbdb34b-e8bd-4f0c-b76f-fbfe3d71484c">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGFibGU6NzFmYzFmODFjMDEzNDY1MTgyNTkzZmU1MTdiNTFkYTMvdGFibGVyYW5nZTo3MWZjMWY4MWMwMTM0NjUxODI1OTNmZTUxN2I1MWRhM18wLTItMS0xLTA_2dd04aa5-a4a0-4609-9f35-87e8cfc79799">13-3757370</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGFibGU6ODhkNWI2M2VjMGIyNDk0MDk2MzUzMTYxZDY5ZDYzYWYvdGFibGVyYW5nZTo4OGQ1YjYzZWMwYjI0OTQwOTYzNTMxNjFkNjlkNjNhZl8wLTAtMS0xLTA_d2dfe4f5-76ab-42cf-a305-c6ad4355562e">358 South Main Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGFibGU6ODhkNWI2M2VjMGIyNDk0MDk2MzUzMTYxZDY5ZDYzYWYvdGFibGVyYW5nZTo4OGQ1YjYzZWMwYjI0OTQwOTYzNTMxNjFkNjlkNjNhZl8xLTAtMS0xLTA_9448d893-9f81-41b2-9d1b-508a0c2ff2c9">Burlington,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGFibGU6ODhkNWI2M2VjMGIyNDk0MDk2MzUzMTYxZDY5ZDYzYWYvdGFibGVyYW5nZTo4OGQ1YjYzZWMwYjI0OTQwOTYzNTMxNjFkNjlkNjNhZl8xLTEtMS0xLTA_88e254de-0def-4d77-ad02-6892cfb09b9f">NC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGFibGU6ODhkNWI2M2VjMGIyNDk0MDk2MzUzMTYxZDY5ZDYzYWYvdGFibGVyYW5nZTo4OGQ1YjYzZWMwYjI0OTQwOTYzNTMxNjFkNjlkNjNhZl8xLTMtMS0xLTA_23c9ea1b-7ba6-4099-befa-b57fde61e192">27215</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjgy_c63bebcf-cb08-4fe7-88f5-4bc799ad1439">336</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjky_ca139a43-5d01-40f2-a3cc-c0151e52378b">229-1127</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjgz_f94942b1-b15c-4dce-95df-d5e28b3f16c1">Common Stock, $0.10 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjg0_2a6e0788-015c-4c94-9984-12ab85329ee7">LH</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjg5_3fffcfb4-626c-4728-bca2-96b1c7771d19">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjkw_c8b2aab9-da0b-418a-97e3-e9abf4621a44">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjkx_8d3cf5ea-0f8c-4a57-ab98-9d3e425d519a">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGFibGU6NzcxYThjYTgwOWUwNGY3MWE1ZDQ4ZjI1ZjVhZjM1YmYvdGFibGVyYW5nZTo3NzFhOGNhODA5ZTA0ZjcxYTVkNDhmMjVmNWFmMzViZl8wLTAtMS0xLTA_45f37070-7fcb-49fc-8252-6c134489e265">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGFibGU6NzcxYThjYTgwOWUwNGY3MWE1ZDQ4ZjI1ZjVhZjM1YmYvdGFibGVyYW5nZTo3NzFhOGNhODA5ZTA0ZjcxYTVkNDhmMjVmNWFmMzViZl8xLTMtMS0xLTA_d5e4de5a-f015-4ca8-8a6a-e15a3a8633c9">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGFibGU6NzcxYThjYTgwOWUwNGY3MWE1ZDQ4ZjI1ZjVhZjM1YmYvdGFibGVyYW5nZTo3NzFhOGNhODA5ZTA0ZjcxYTVkNDhmMjVmNWFmMzViZl8yLTMtMS0xLTA_baeb0e00-01c1-45f0-a029-272d8ac5e40a">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjg4_6f415ca7-b5b6-4d5d-b9c7-a2385aff822f">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i3cbe3c928a064308830aa690527b4879_I20201028"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xL2ZyYWc6ZjY3OTJkMDMwNDQxNGNlNmE1YTAyZTVjYTJjY2IzYzUvdGV4dHJlZ2lvbjpmNjc5MmQwMzA0NDE0Y2U2YTVhMDJlNWNhMmNjYjNjNV8yMjU0_c82d187a-bd87-41ae-a187-611f3e49f865"
      unitRef="shares">97400000</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMy0xLTEtMS0w_f01c3d48-8251-44a5-bec1-6b94d1e5c200"
      unitRef="usd">667200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMy0zLTEtMS0w_466cfca6-2b79-4385-9acd-335ae707aaa5"
      unitRef="usd">337500000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNC0xLTEtMS0w_f3a6c856-4d73-479a-9c03-56421925e6e3"
      unitRef="usd">2095200000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNC0zLTEtMS0w_f254bcc8-8ad2-4073-9453-2afbbf56053b"
      unitRef="usd">1543900000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:UnbilledContractsReceivable
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNS0xLTEtMS0w_7dbd2a43-a44d-4104-bff4-1b920fc9e26d"
      unitRef="usd">603500000</us-gaap:UnbilledContractsReceivable>
    <us-gaap:UnbilledContractsReceivable
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNS0zLTEtMS0w_e7c8a7e6-53ac-4343-b0df-a578bc3f34bd"
      unitRef="usd">481400000</us-gaap:UnbilledContractsReceivable>
    <us-gaap:InventoryNet
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNi0xLTEtMS0w_dfc16e75-57e3-491f-9a5c-9321b432eda0"
      unitRef="usd">392500000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNi0zLTEtMS0w_d8f381f1-9f2c-4757-8234-e26f38479d3d"
      unitRef="usd">244700000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNy0xLTEtMS0w_9f7f3717-afc6-4c7f-811d-e3fafe3f2798"
      unitRef="usd">327200000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNy0zLTEtMS0w_d5c5aa4d-26ec-434c-95d9-468e941006c6"
      unitRef="usd">373700000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfOS0xLTEtMS0w_828476be-da79-4842-929c-05be7b95924f"
      unitRef="usd">4085600000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfOS0zLTEtMS0w_416a2abb-12da-4e42-a114-c34d83ed3330"
      unitRef="usd">2981200000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTAtMS0xLTEtMA_de027f9a-6e54-4e27-bac6-e148af88a255"
      unitRef="usd">2608600000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTAtMy0xLTEtMA_1536a53e-26d6-4a99-a46e-7820f70dc9d8"
      unitRef="usd">2636600000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTEtMS0xLTEtMA_9631cead-1003-401e-8c3b-3e7cbaad01e3"
      unitRef="usd">7613800000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTEtMy0xLTEtMA_e4391530-dd76-46c6-892e-c80b7eddf028"
      unitRef="usd">7865000000.0</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTItMS0xLTEtMA_29a667fa-05c7-40a1-b274-c763cbd84284"
      unitRef="usd">3920500000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTItMy0xLTEtMA_d11649f9-72fd-45f8-a6c2-48034d65445c"
      unitRef="usd">4034500000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTMtMS0xLTEtMA_1ce9e408-b0ce-4faf-a817-47f42959727d"
      unitRef="usd">70700000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTMtMy0xLTEtMA_b34c2ac2-14ea-4e61-ae12-274dfcbe7270"
      unitRef="usd">84900000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:DeferredIncomeTaxesAndOtherAssetsCurrent
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTQtMS0xLTEtMA_0aac29e8-8158-4af6-b680-80b28775963d"
      unitRef="usd">3400000</us-gaap:DeferredIncomeTaxesAndOtherAssetsCurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherAssetsCurrent
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTQtMy0xLTEtMA_06aff0ac-86ed-42b8-9d89-5d32a5c51122"
      unitRef="usd">8800000</us-gaap:DeferredIncomeTaxesAndOtherAssetsCurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTUtMS0xLTEtMA_56e460af-1bae-4c40-a892-1885076a0be3"
      unitRef="usd">437000000.0</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTUtMy0xLTEtMA_6fbd1209-a748-4f9c-87ab-af2c5abe1c07"
      unitRef="usd">435400000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTctMS0xLTEtMA_503104ff-9c12-48f6-a457-63ba4a83bdc1"
      unitRef="usd">18739600000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMTctMy0xLTEtMA_8c3fa0ee-588d-4a76-9370-25e7c6cf6230"
      unitRef="usd">18046400000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjEtMS0xLTEtMA_fe79898d-81d9-4822-9b78-a394e30162c8"
      unitRef="usd">639500000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjEtMy0xLTEtMA_862074aa-4238-441a-bde4-ec0a450c53cb"
      unitRef="usd">632300000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjItMS0xLTEtMA_bdd9239d-4352-4998-9d14-470a609db88b"
      unitRef="usd">1297800000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjItMy0xLTEtMA_5d9e1271-ad1e-406a-bde2-2ae7021f004d"
      unitRef="usd">942400000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjMtMS0xLTEtMA_fb6d2424-5511-4c77-b22e-fc1b20013fb8"
      unitRef="usd">494800000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjMtMy0xLTEtMA_02a160f3-bdd9-404a-ac7c-f6da8e128d68"
      unitRef="usd">451000000.0</us-gaap:DeferredRevenueCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjQtMS0xLTEtMA_e6577228-2bd5-4b5c-b1ac-f8e644521168"
      unitRef="usd">193800000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjQtMy0xLTEtMA_28787d82-2f9b-4f6f-9ccb-895c882c2378"
      unitRef="usd">206500000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjUtMS0xLTEtMA_23695424-af28-4bfd-9b18-f6eaff36184b"
      unitRef="usd">7400000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjUtMy0xLTEtMA_935ab810-7fb2-4b2a-a8da-7e2b8d85cd9f"
      unitRef="usd">8400000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:DebtCurrent
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjYtMS0xLTEtMA_0ad26e3a-2246-456e-84f6-3430e8d9cf55"
      unitRef="usd">376600000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjYtMy0xLTEtMA_fb336c9f-f7b4-4ed3-a947-99b830a1ecbd"
      unitRef="usd">415200000</us-gaap:DebtCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjgtMS0xLTEtMA_e20b6646-8045-405c-a152-381343e41819"
      unitRef="usd">3009900000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjgtMy0xLTEtMA_d0fd9142-d4be-46d4-bdaa-8a16e9bd4009"
      unitRef="usd">2655800000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjktMS0xLTEtMA_f08dcd63-b5a4-4254-820b-a34257e7f3bd"
      unitRef="usd">5417300000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMjktMy0xLTEtMA_55b3078a-a5f1-4274-9b2b-5c12879350f1"
      unitRef="usd">5789800000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzAtMS0xLTEtMA_04afe47c-cd99-4a24-910c-6b6ac6a0f0a1"
      unitRef="usd">602400000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzAtMy0xLTEtMA_63d8d107-cde1-472c-b411-dd885115d783"
      unitRef="usd">596600000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzEtMS0xLTEtMA_49ed732c-8878-4e46-a742-0fa7fc3c9c34"
      unitRef="usd">86300000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzEtMy0xLTEtMA_86087fda-71b1-49f5-8b3f-82cc2ad5bbdd"
      unitRef="usd">91100000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <lh:DeferredIncomeTaxesAndOtherTaxLiabilities
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzItMS0xLTEtMA_ee501355-938b-48e1-abd5-d386f724a88d"
      unitRef="usd">891500000</lh:DeferredIncomeTaxesAndOtherTaxLiabilities>
    <lh:DeferredIncomeTaxesAndOtherTaxLiabilities
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzItMy0xLTEtMA_e2016c98-f8d5-4fc2-8186-e56b77a3b2c0"
      unitRef="usd">942800000</lh:DeferredIncomeTaxesAndOtherTaxLiabilities>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzMtMS0xLTEtMA_00126927-5792-452d-a114-28890ff3986a"
      unitRef="usd">473200000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzMtMy0xLTEtMA_25016e87-aca4-419e-a980-47f0246fdd64"
      unitRef="usd">383200000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzUtMS0xLTEtMA_ce1637fc-efc8-4666-ae6c-bda4436596ca"
      unitRef="usd">10480600000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzUtMy0xLTEtMA_06b7b1d4-f90e-472b-a2f8-cb1952b41ec3"
      unitRef="usd">10459300000</us-gaap:Liabilities>
    <lh:NoncontrollingInterestMezzanineEquity
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzctMS0xLTEtMA_83e6218b-5ec8-4c65-992d-c28bef1b54cf"
      unitRef="usd">19900000</lh:NoncontrollingInterestMezzanineEquity>
    <lh:NoncontrollingInterestMezzanineEquity
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzctMy0xLTEtMA_0bdf12bf-a282-478e-a63a-564116b0f503"
      unitRef="usd">20100000</lh:NoncontrollingInterestMezzanineEquity>
    <us-gaap:CommonStockValue
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzktMS0xLTEtMA_764b1a63-dca5-4689-8a19-af088dda5397"
      unitRef="usd">9000000.0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfMzktMy0xLTEtMA_b53481cd-1f44-4b61-adb4-25ab5a53629c"
      unitRef="usd">9000000.0</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNDAtMS0xLTEtMA_b2251445-4723-4c5e-89e4-776d089d161e"
      unitRef="usd">80700000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNDAtMy0xLTEtMA_1018bd17-d6e8-41f9-b126-7a17e25ddd41"
      unitRef="usd">26800000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNDEtMS0xLTEtMA_429d7838-80a3-4439-b0ee-5a5f3e0c5722"
      unitRef="usd">8464000000.0</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNDEtMy0xLTEtMA_2d0a25a2-a917-4587-b4e9-08fcae4966f2"
      unitRef="usd">7903600000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNDMtMS0xLTEtMA_b39256b6-3f1d-47f2-a271-eb8cf9335c06"
      unitRef="usd">-314600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNDMtMy0xLTEtMA_59c7b82c-c2c5-4732-b501-87da96ffe8bd"
      unitRef="usd">-372400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNDQtMS0xLTEtMA_94e472bc-880f-4af7-a243-401c27631598"
      unitRef="usd">8239100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNDQtMy0xLTEtMA_a734135d-8473-43c2-b999-97da2daf6740"
      unitRef="usd">7567000000.0</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNDUtMS0xLTEtMA_6045b635-bc0c-4aae-857a-6d9864b83584"
      unitRef="usd">18739600000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xMC9mcmFnOjhjYWZkNDdiMzgxODQxMmRhNWJiODZlYzJmYTZlYTUzL3RhYmxlOjBiYmY2OTVlMmVhYjQ0NzNiNDNmN2U1ZDgxNGQ1NTg1L3RhYmxlcmFuZ2U6MGJiZjY5NWUyZWFiNDQ3M2I0M2Y3ZTVkODE0ZDU1ODVfNDUtMy0xLTEtMA_67b42e9c-31d7-49c3-8ac6-f2d316e2a647"
      unitRef="usd">18046400000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMi0xLTEtMS0w_3d6b62ab-5fbd-4d7d-98ff-e2d6037623b3"
      unitRef="usd">3896100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMi0zLTEtMS0w_c3eba47f-e8d7-4f2e-851b-947c4024ef77"
      unitRef="usd">2928500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMi01LTEtMS0w_94240c3a-dac7-44ff-8391-3beecd4fa3e8"
      unitRef="usd">9488700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMi03LTEtMS0w_19e2dc00-1729-4197-9e49-124c7f6c1366"
      unitRef="usd">8601400000</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMy0xLTEtMS0w_703ec647-ac36-4491-9231-8b8f02ab2507"
      unitRef="usd">2336700000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMy0zLTEtMS0w_38b60cf5-4e09-4671-b7a6-910a344e090d"
      unitRef="usd">2111200000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMy01LTEtMS0w_8f9b3055-8345-4918-b1b9-6c71be0ac23c"
      unitRef="usd">6440800000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMy03LTEtMS0w_ccb3879f-7b1e-4c4d-b1d9-7e35041b76c3"
      unitRef="usd">6169600000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfNS0xLTEtMS0w_404b612a-8a32-47a0-a2b4-da08b05f2645"
      unitRef="usd">1559400000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfNS0zLTEtMS0w_0b4c7628-e7df-4c5d-beb9-a0a25ea75564"
      unitRef="usd">817300000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfNS01LTEtMS0w_fdb6e107-fad1-4ac4-99d2-a6ee900a3c20"
      unitRef="usd">3047900000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfNS03LTEtMS0w_d9b78f09-06f6-4589-b1eb-85ff3515a748"
      unitRef="usd">2431800000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfNi0xLTEtMS0w_cc44aeff-11e5-4f88-b448-2035dc305b19"
      unitRef="usd">419500000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfNi0zLTEtMS0w_19c872a5-4695-45c2-a216-184c4703873a"
      unitRef="usd">401500000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfNi01LTEtMS0w_29aec792-abd8-4471-bba5-279356b9add1"
      unitRef="usd">1211300000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfNi03LTEtMS0w_d7b0f676-9dd0-457c-87de-b9964d57d1ea"
      unitRef="usd">1210600000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfNy0xLTEtMS0w_76269eb2-c088-4970-8755-91de3feb2d1c"
      unitRef="usd">62200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfNy0zLTEtMS0w_f92fc852-8956-4494-a1c3-7f6bfd27a6a2"
      unitRef="usd">61700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfNy01LTEtMS0w_1f6b3d12-7cbd-4a85-8b0e-0c873a55b196"
      unitRef="usd">184600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfNy03LTEtMS0w_82833094-4b69-4412-bce6-1cb8b1d684b4"
      unitRef="usd">179000000.0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AssetImpairmentCharges
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfOC0xLTEtMS0w_a9af0adb-a7ca-4feb-a7f0-42661de9acaf"
      unitRef="usd">23500000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfOC0zLTEtMS0w_0d90958a-b10a-4bdf-a063-040fcf9a6fbc"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfOC01LTEtMS0w_6f8f9841-9be6-44ae-abc2-a4d365f5f6df"
      unitRef="usd">460900000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfOC03LTEtMS0w_8b2c098e-c5f6-4ede-870e-5fd2d9c2138f"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <lh:NetRestructuringAndOtherSpecialCharges
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfOS0xLTEtMS0w_5066a572-f483-49e3-97aa-7d54da3030d2"
      unitRef="usd">7100000</lh:NetRestructuringAndOtherSpecialCharges>
    <lh:NetRestructuringAndOtherSpecialCharges
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfOS0zLTEtMS0w_be50d2b8-79da-428f-92ec-e16c01a57d04"
      unitRef="usd">14200000</lh:NetRestructuringAndOtherSpecialCharges>
    <lh:NetRestructuringCharges
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfOS01LTEtMS0w_06232df5-c987-4874-b531-2ef3cb24bfdb"
      unitRef="usd">38900000</lh:NetRestructuringCharges>
    <lh:NetRestructuringCharges
      contextRef="i3142bfab671e4d37943fa55426510724_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfOS03LTEtMS0w_f89f8dc3-2bd9-4319-a632-7b77a4f985a3"
      unitRef="usd">48400000</lh:NetRestructuringCharges>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTAtMS0xLTEtMA_fa26ae48-4d7d-4cd0-a4a7-e509a46f7fe0"
      unitRef="usd">1047100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTAtMy0xLTEtMA_dfcd8c3b-c23a-47df-b1ba-e926042deaa8"
      unitRef="usd">339900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTAtNS0xLTEtMA_fce1ca46-47e2-4621-b297-2fbf51f84f25"
      unitRef="usd">1152200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTAtNy0xLTEtMA_6bb137d9-0949-4b0c-b739-2a29dbed6163"
      unitRef="usd">993800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTItMS0xLTEtMA_30277764-7921-4a14-869f-b8df639a0056"
      unitRef="usd">51400000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTItMy0xLTEtMA_4e80af1e-2489-4c86-b954-aa18b3681b68"
      unitRef="usd">60500000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTItNS0xLTEtMA_094f3a28-4fba-44cd-9262-22850df9ed2a"
      unitRef="usd">159100000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTItNy0xLTEtMA_04c52afc-2a51-4a86-8e21-42ef529952ce"
      unitRef="usd">176300000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTMtMS0xLTEtMA_a2e66619-abdf-492d-a8ec-aef9ccbae14b"
      unitRef="usd">3000000.0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTMtMy0xLTEtMA_84e545ab-70bd-4496-bbe2-0a9bb4865a68"
      unitRef="usd">2400000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTMtNS0xLTEtMA_939bfe9c-9aef-41c5-92cf-ed9dc1398c1c"
      unitRef="usd">-1800000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTMtNy0xLTEtMA_81357270-015e-4b61-b290-a92427098147"
      unitRef="usd">7900000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:InvestmentIncomeNet
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTQtMS0xLTEtMA_23a78b21-6296-4a9c-b5cb-430acaeecf73"
      unitRef="usd">2600000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTQtMy0xLTEtMA_18781e95-d20e-4f4f-be16-e36ea0544440"
      unitRef="usd">2900000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTQtNS0xLTEtMA_53a4d606-09ea-4d7f-9f00-4e30b2b690fe"
      unitRef="usd">7700000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTQtNy0xLTEtMA_a92f19be-d5c5-4154-9853-0797dd199f37"
      unitRef="usd">4800000</us-gaap:InvestmentIncomeNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTUtMS0xLTEtMA_cd4b7449-c2a4-4ba6-b5d9-d77b75e8acca"
      unitRef="usd">-54200000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTUtMy0xLTEtMA_f48b6f6c-9c96-4b3e-a358-bc930daf8dba"
      unitRef="usd">2700000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTUtNS0xLTEtMA_5a38575b-1771-47f4-ad5d-92e8ad95dbec"
      unitRef="usd">-22600000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTUtNy0xLTEtMA_588e8cd1-716a-4961-aa1e-ca328c32d4da"
      unitRef="usd">-18200000</us-gaap:OtherNonoperatingIncomeExpense>
    <lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTYtMS0xLTEtMA_cb227687-5dfe-48b7-88bf-b5b6de118d19"
      unitRef="usd">947100000</lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest>
    <lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTYtMy0xLTEtMA_feceb4cb-e229-4ec7-b26e-71678123ab20"
      unitRef="usd">287400000</lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest>
    <lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTYtNS0xLTEtMA_172c7167-f7a8-450d-b4a6-ae938e15e496"
      unitRef="usd">976400000</lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest>
    <lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTYtNy0xLTEtMA_34dbc3bd-90f4-433f-95f6-34d6b34dc1fb"
      unitRef="usd">812000000.0</lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTctMS0xLTEtMA_342c49d1-0c57-4f1f-8e7d-be7b1b446483"
      unitRef="usd">243400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTctMy0xLTEtMA_6a878fe1-105f-4f93-aea4-d43350dc320e"
      unitRef="usd">66400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTctNS0xLTEtMA_7fbf428d-cafc-4169-94a3-56c722db3177"
      unitRef="usd">358000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTctNy0xLTEtMA_8908efe3-f96f-4320-8e7d-e20388aa52e0"
      unitRef="usd">214400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTgtMS0xLTEtMA_3319bcda-da84-4270-b86f-d5f9a7add30c"
      unitRef="usd">703700000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTgtMy0xLTEtMA_685978d2-4c95-496c-86bb-4c6c283472a1"
      unitRef="usd">221000000.0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTgtNS0xLTEtMA_0dc5943b-bdb9-4ec8-bc29-8b696ab3616e"
      unitRef="usd">618400000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTgtNy0xLTEtMA_af1de74f-335b-474a-a234-c16ffa061bba"
      unitRef="usd">597600000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTktMS0xLTEtMA_d636050a-1827-41ef-ba43-10ea107f9343"
      unitRef="usd">300000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTktMy0xLTEtMA_6ce7191a-25fd-4e6e-9307-58983bf62b84"
      unitRef="usd">300000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTktNS0xLTEtMA_e822d39f-06c0-4e05-9604-d12cff3f6875"
      unitRef="usd">600000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMTktNy0xLTEtMA_9123a072-bb46-4f2f-9b80-b405c95d6689"
      unitRef="usd">900000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMjAtMS0xLTEtMA_600d58df-8667-43bf-9945-12bb2b314bcc"
      unitRef="usd">703400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMjAtMy0xLTEtMA_49117119-626c-4a46-a4fa-b583c9d237d5"
      unitRef="usd">220700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMjAtNS0xLTEtMA_571379b7-299d-4420-af54-acf26ca79392"
      unitRef="usd">617800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMjAtNy0xLTEtMA_73fe8b05-a6ff-4b85-840b-dd6b03d99de5"
      unitRef="usd">596700000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMjItMS0xLTEtMA_cb2f01e6-0af8-406a-b721-fec31af221d4"
      unitRef="usdPerShare">7.22</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMjItMy0xLTEtMA_f4249bcc-1505-4ca2-8a3a-3edb906b4481"
      unitRef="usdPerShare">2.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMjItNS0xLTEtMA_2588bbfa-8c68-4325-98e2-5bd62b67ee1f"
      unitRef="usdPerShare">6.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMjItNy0xLTEtMA_d295d5ff-3df9-4195-9a4a-6e29f879db97"
      unitRef="usdPerShare">6.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMjMtMS0xLTEtMA_a9c2f699-821d-4441-b55e-a8e78ff7f84c"
      unitRef="usdPerShare">7.17</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMjMtMy0xLTEtMA_aae399e8-8a5d-4c69-9b8f-c77b01c9a87b"
      unitRef="usdPerShare">2.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMjMtNS0xLTEtMA_56b87990-e333-456c-a126-acea499858f4"
      unitRef="usdPerShare">6.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xNi9mcmFnOjNkNTY4YjA3M2RlYTRmOWI4OGY1ZGFkNzUyM2VkZDk4L3RhYmxlOjY1ZWVjZTJiMDM2NTQ3ZDk4YzQ1MjRmNWQ0ZjFiNDdkL3RhYmxlcmFuZ2U6NjVlZWNlMmIwMzY1NDdkOThjNDUyNGY1ZDRmMWI0N2RfMjMtNy0xLTEtMA_77cb1670-b3f5-4df1-babd-ea94dee9f20e"
      unitRef="usdPerShare">6.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ProfitLoss
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMy0xLTEtMS0w_6afcda43-1c7c-4761-8547-2d02d4232525"
      unitRef="usd">703700000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMy0zLTEtMS0w_685978d2-4c95-496c-86bb-4c6c283472a1"
      unitRef="usd">221000000.0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMy01LTEtMS0w_1b0ca367-9db5-4032-a541-af5f8ee2ba4e"
      unitRef="usd">618400000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMy03LTEtMS0w_af1de74f-335b-474a-a234-c16ffa061bba"
      unitRef="usd">597600000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfNC0xLTEtMS0w_2c8c7508-78b6-4545-8586-812dc00c1ac3"
      unitRef="usd">132900000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfNC0zLTEtMS0w_85ea54ce-e02a-4a03-b272-365c0ce17487"
      unitRef="usd">-92600000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfNC01LTEtMS0w_661e336d-d70f-4f37-8123-43e5df1d3a19"
      unitRef="usd">52400000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfNC03LTEtMS0w_b998e58a-7d0d-489a-9e43-e549934094b2"
      unitRef="usd">-45400000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfNS0xLTEtMS0w_3ad2e75e-3483-464e-b96f-070cccf18c95"
      unitRef="usd">-2100000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfNS0zLTEtMS0w_7c978efc-d23c-42c4-8dce-c8990a2ac9d1"
      unitRef="usd">-3200000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfNS01LTEtMS0w_8ba87153-4067-4c95-819c-fe90e0782cb3"
      unitRef="usd">-7500000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfNS03LTEtMS0w_140b655e-dd47-49c4-9af0-d7246d9fdbc8"
      unitRef="usd">-8700000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfNy0xLTEtMS0w_f562ceef-4bbe-449e-a99e-785372e96f16"
      unitRef="usd">135000000.0</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfNy0zLTEtMS0w_0f763971-f546-4485-aca6-77314f001cab"
      unitRef="usd">-89400000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfNy01LTEtMS0w_48706be7-033b-44ae-a7c9-58a30fc20800"
      unitRef="usd">59900000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfNy03LTEtMS0w_b3e25680-8dfa-4cc7-9aa8-0d44b26e69e4"
      unitRef="usd">-36700000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfOC0xLTEtMS0w_b0b95bf6-e7c1-4c07-8cff-46bd4586b504"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfOC0zLTEtMS0w_f3aeb297-2753-46e8-8823-e65a1d136590"
      unitRef="usd">900000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfOC01LTEtMS0w_edb3af19-eb83-45bb-8fcf-7611c95ed8b4"
      unitRef="usd">2100000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfOC03LTEtMS0w_c0c7b733-c3f1-40b8-a1b2-d99aa4067f6f"
      unitRef="usd">2400000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfOS0xLTEtMS0w_f6d325a1-b2b5-407b-80ce-800a355c2290"
      unitRef="usd">134400000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfOS0zLTEtMS0w_77678110-3b8e-4c0c-8c76-b4f2a53d4103"
      unitRef="usd">-90300000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfOS01LTEtMS0w_c5e1cf2b-9dcc-4c71-8003-186766424147"
      unitRef="usd">57800000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfOS03LTEtMS0w_ce03bec2-dcac-4df7-977c-e5e82cb9ed94"
      unitRef="usd">-39100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMTAtMS0xLTEtMA_701d6cbd-236b-4bbe-930c-908e0d6a7b9e"
      unitRef="usd">838100000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMTAtMy0xLTEtMA_7589a320-725d-44ff-8071-7e6c078f3a83"
      unitRef="usd">130700000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMTAtNS0xLTEtMA_cf42d5e1-fc3f-4765-a642-994a1b04eae0"
      unitRef="usd">676200000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMTAtNy0xLTEtMA_f40ba535-5971-4f25-96a5-721c99e37229"
      unitRef="usd">558500000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMTEtMS0xLTEtMA_d636050a-1827-41ef-ba43-10ea107f9343"
      unitRef="usd">300000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMTEtMy0xLTEtMA_6ce7191a-25fd-4e6e-9307-58983bf62b84"
      unitRef="usd">300000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMTEtNS0xLTEtMA_e822d39f-06c0-4e05-9604-d12cff3f6875"
      unitRef="usd">600000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMTEtNy0xLTEtMA_9123a072-bb46-4f2f-9b80-b405c95d6689"
      unitRef="usd">900000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMTItMS0xLTEtMA_524622f6-73ae-4c22-9c69-a3f43232b30e"
      unitRef="usd">837800000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMTItMy0xLTEtMA_4abc2217-98dc-446c-a1fc-f1f05e09b0d8"
      unitRef="usd">130400000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMTItNS0xLTEtMA_8aafb777-7163-41f8-a741-4e27180c03ca"
      unitRef="usd">675600000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8xOS9mcmFnOmRlODI3MmZmOGI2MDQxNzNhNjNmMTM5N2YyYjY3OTBjL3RhYmxlOjliZDZiMTA0MmY2MTQ2MTliOTJjYzc1NDk0MmFjYzk4L3RhYmxlcmFuZ2U6OWJkNmIxMDQyZjYxNDYxOWI5MmNjNzU0OTQyYWNjOThfMTItNy0xLTEtMA_a6550c60-025c-46aa-8ce2-0e9786036d2a"
      unitRef="usd">557600000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i7ed61e2c58d04a4f96f4455f58dc8906_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMS0xLTEtMS0w_db11a56a-02d5-433f-9f73-727d83086c9a"
      unitRef="usd">11700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibaa1c40cdb9547b6aa52d2c4edcc8188_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMS0zLTEtMS0w_a19e6419-734f-4e0e-adff-afe1c52e6345"
      unitRef="usd">1451100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i102884c59d1543caa2ca620678208c40_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMS01LTEtMS0w_cc0f154b-3da3-42df-8116-f03ed2fe426a"
      unitRef="usd">7079800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i79d400b1fb3b429b8cf4d8afe9e3f8b2_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMS03LTEtMS0w_67aaf3b4-e961-4d6e-af22-a72d509cefc7"
      unitRef="usd">-1108100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibedc8534cf6f4afb870b205b0eee4330_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMS05LTEtMS0w_bc19dfda-acaa-42a1-b8e5-28f290d53a25"
      unitRef="usd">-463100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6ac49907696d40399215ce933a047245_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMS0xMS0xLTEtMA_f4b316b2-8696-416a-85f9-c8015595ccf4"
      unitRef="usd">6971400000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i9d1cc0f890c444fc8065f85eaf2c3eb2_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMi0xLTEtMS0w_4c5d3cf9-0a8a-4e79-9f1f-a9347d247da3"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if9805616bfc147a685777006a4f3a977_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMi0zLTEtMS0w_c5e73e5c-371a-453e-9f0c-c896f835d28d"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6fd2acd8725944849260da540e21b13e_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMi01LTEtMS0w_76bba64b-c792-4065-a976-0e7d19cf1993"
      unitRef="usd">185600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6aecc811560c4997ad0a94f7656fb5f2_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMi03LTEtMS0w_d7b4e85f-a31f-4669-b3ad-53244939916f"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib3aa1360071d489f9642129871989937_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMi05LTEtMS0w_c5d36dde-50a9-4c0b-b042-6f4db14e4a8d"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iedd14e246c1d49da9ac324e7575d5643_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMi0xMS0xLTEtMA_b672d8a1-b56c-49cb-b4c0-97d703d5895d"
      unitRef="usd">185600000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9d1cc0f890c444fc8065f85eaf2c3eb2_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMy0xLTEtMS0w_a76529f2-d09c-45ec-9b1e-ba9f4e4f18d2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if9805616bfc147a685777006a4f3a977_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMy0zLTEtMS0w_430b3c47-53ee-49c4-b1ac-5c5f3aa69b1b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6fd2acd8725944849260da540e21b13e_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMy01LTEtMS0w_37442adc-890e-4256-a0bb-877776504063"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6aecc811560c4997ad0a94f7656fb5f2_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMy03LTEtMS0w_f85d60e8-ce0b-4022-ba81-5c3cd34808e2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib3aa1360071d489f9642129871989937_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMy05LTEtMS0w_010b8f27-15e2-476e-8994-cf3269bef9c6"
      unitRef="usd">23600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iedd14e246c1d49da9ac324e7575d5643_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMy0xMS0xLTEtMA_c9941c5b-4134-48d8-850b-563c6f1f4ddc"
      unitRef="usd">23600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="i9d1cc0f890c444fc8065f85eaf2c3eb2_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNS0xLTEtMS0w_ad278cd8-002c-40eb-891e-a4f24fce5e29"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="if9805616bfc147a685777006a4f3a977_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNS0zLTEtMS0w_e6630a68-9d9f-4055-8462-b8205bb5dcc1"
      unitRef="usd">24700000</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="i6fd2acd8725944849260da540e21b13e_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNS01LTEtMS0w_fb19e5c6-2089-4565-a90d-22d5e4fa007a"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="i6aecc811560c4997ad0a94f7656fb5f2_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNS03LTEtMS0w_8ae4713f-c4cc-46b7-b7be-ac6776fa43dc"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="ib3aa1360071d489f9642129871989937_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNS05LTEtMS0w_e2e79771-2ffb-4acd-b384-69a40fa3f02d"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="iedd14e246c1d49da9ac324e7575d5643_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNS0xMS0xLTEtMA_a063a816-0ae8-4da7-84e7-3845c5d6f655"
      unitRef="usd">24700000</lh:Issuanceofcommonstockunderemployeeplans>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i9d1cc0f890c444fc8065f85eaf2c3eb2_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNi0xLTEtMS0w_1c9f20ba-8197-4d9b-89f9-6c18e3c5adb8"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="if9805616bfc147a685777006a4f3a977_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNi0zLTEtMS0w_6823a719-9d35-43f6-b421-b1faae57f45a"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i6fd2acd8725944849260da540e21b13e_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNi01LTEtMS0w_8b943f02-e403-43db-819f-49a8f1befe4a"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i6aecc811560c4997ad0a94f7656fb5f2_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNi03LTEtMS0w_ab8cab94-5c4e-45f7-a951-6c0743471185"
      unitRef="usd">19400000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="ib3aa1360071d489f9642129871989937_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNi05LTEtMS0w_e8ae97c5-480c-4d6c-a41f-375a2f7ec0cf"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="iedd14e246c1d49da9ac324e7575d5643_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNi0xMS0xLTEtMA_c3c65c46-9cd3-434a-8b2e-b5e6d8982058"
      unitRef="usd">19400000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9d1cc0f890c444fc8065f85eaf2c3eb2_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfOC0xLTEtMS0w_231e2ce3-df47-4795-a291-cd11991a9b87"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if9805616bfc147a685777006a4f3a977_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfOC0zLTEtMS0w_50e4c268-836c-464a-a8b4-96da685cd37a"
      unitRef="usd">25500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6fd2acd8725944849260da540e21b13e_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfOC01LTEtMS0w_9b647870-75fc-4900-92b7-3ecd919cf584"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6aecc811560c4997ad0a94f7656fb5f2_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfOC03LTEtMS0w_a2629559-ec96-4fe9-bd53-edc0c150936e"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib3aa1360071d489f9642129871989937_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfOC05LTEtMS0w_0be60dd0-1d2f-4255-837d-998b89892430"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iedd14e246c1d49da9ac324e7575d5643_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfOC0xMS0xLTEtMA_5fc282cf-f0eb-48c0-87e9-818811b4e9d9"
      unitRef="usd">25500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i9d1cc0f890c444fc8065f85eaf2c3eb2_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTAtMS0xLTEtMA_cd5db882-926e-41ce-ba57-cf395dbd9c7b"
      unitRef="usd">-100000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="if9805616bfc147a685777006a4f3a977_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTAtMy0xLTEtMA_fb5ae560-f4de-4062-9853-6abf8e9b5095"
      unitRef="usd">-100000000.0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i6fd2acd8725944849260da540e21b13e_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTAtNS0xLTEtMA_dfa94c08-ba86-457f-bc4d-909905796873"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i6aecc811560c4997ad0a94f7656fb5f2_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTAtNy0xLTEtMA_00ce493c-49f5-461f-99e5-ca1d72f5e525"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ib3aa1360071d489f9642129871989937_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTAtOS0xLTEtMA_f52dc22c-17f4-4f0b-921c-08cd811a6e24"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="iedd14e246c1d49da9ac324e7575d5643_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTAtMTEtMS0xLTA_a32f5008-9ed7-48ac-b3b1-edfae5952d50"
      unitRef="usd">100100000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockholdersEquity
      contextRef="i2dd1e22b6a154e39814fd636f0fab4ce_I20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTEtMS0xLTEtMA_8f170166-5248-441f-932a-2165ff96baa5"
      unitRef="usd">11600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i749c4690686f45c3b2850fcbb9a0d1df_I20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTEtMy0xLTEtMA_357577fe-647f-482d-80cf-9f36afc91a65"
      unitRef="usd">1401300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic9b90f619f8b4a7083d154d69233d90f_I20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTEtNS0xLTEtMA_3eb72f56-e827-4b34-bccb-ca3033757076"
      unitRef="usd">7265400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if4aa40f4beab4847b0614e40e1cd143c_I20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTEtNy0xLTEtMA_a59be3c3-0ce6-436f-840b-997b3f2f9059"
      unitRef="usd">-1127500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib974ad7e470d46998daf31767f2af398_I20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTEtOS0xLTEtMA_e11788b1-2e8f-4878-ac89-3974a44ad6da"
      unitRef="usd">-439500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2bdc2fd7db454059a73ac63fbcf696e8_I20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTEtMTEtMS0xLTA_ebea2820-2332-452a-8c2e-2937355f0b14"
      unitRef="usd">7111300000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ic342c0d96ffa4ec4ba03f2801ad1e983_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTItMS0xLTEtMA_8253688c-c8b7-469d-b216-b009ef34df6f"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib09142dcedba4260954ddf2d9692acb6_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTItMy0xLTEtMA_dd10f822-0939-4848-a548-b67035e58978"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i83d083f1fa054115979e180a0197c0c3_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTItNS0xLTEtMA_5dbe1905-a4a2-40ff-8be6-40c5eeffd28c"
      unitRef="usd">190400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9f0351d0ac5340749dcbd3417ca3b6cf_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTItNy0xLTEtMA_f494e579-8355-425b-a1f7-290f735a4d70"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i75641ae84a834af19a49dbc2f325caa0_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTItOS0xLTEtMA_6ea03b79-dce1-42d4-93a0-1665469c3b8f"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1fed346eafa54192b0996a2c5e59af06_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTItMTEtMS0xLTA_b92d84aa-2135-47cf-bd02-cbaa03ccd537"
      unitRef="usd">190400000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic342c0d96ffa4ec4ba03f2801ad1e983_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTMtMS0xLTEtMA_d65d7875-b1a0-49f4-9960-f5911842692d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib09142dcedba4260954ddf2d9692acb6_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTMtMy0xLTEtMA_707d377d-56cd-4ad2-8fd0-2c17249de7e9"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i83d083f1fa054115979e180a0197c0c3_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTMtNS0xLTEtMA_8fe7ec09-836b-4ab3-993a-4c3b2ebab378"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9f0351d0ac5340749dcbd3417ca3b6cf_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTMtNy0xLTEtMA_889de378-b1f1-422d-b115-d897ff7055d3"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i75641ae84a834af19a49dbc2f325caa0_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTMtOS0xLTEtMA_2f4d609a-3f7a-4de4-939b-1b40e635ce52"
      unitRef="usd">27600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1fed346eafa54192b0996a2c5e59af06_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTMtMTEtMS0xLTA_7933a56b-53c4-4b70-853d-79b1f7c30921"
      unitRef="usd">27600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="ic342c0d96ffa4ec4ba03f2801ad1e983_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTQtMS0xLTEtMA_8c48e178-e12d-48f1-a0d8-51320a3b2696"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="ib09142dcedba4260954ddf2d9692acb6_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTQtMy0xLTEtMA_31f0812e-5a1b-49fc-ae03-5134e5e92428"
      unitRef="usd">9200000</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="i83d083f1fa054115979e180a0197c0c3_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTQtNS0xLTEtMA_eb2918e6-1c2a-4f1f-ad63-eca3b0989c51"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="i9f0351d0ac5340749dcbd3417ca3b6cf_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTQtNy0xLTEtMA_2462e541-b465-46f8-9106-bf8b4293729c"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="i75641ae84a834af19a49dbc2f325caa0_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTQtOS0xLTEtMA_f1cc2c0c-5b53-4241-b1f4-4061600a6f51"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="i1fed346eafa54192b0996a2c5e59af06_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTQtMTEtMS0xLTA_982f52a0-21d9-420a-b05d-996e6648abf0"
      unitRef="usd">9200000</lh:Issuanceofcommonstockunderemployeeplans>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="ic342c0d96ffa4ec4ba03f2801ad1e983_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTUtMS0xLTEtMA_634f9b22-cf3e-4f3c-87d3-f412c9a0a33b"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="ib09142dcedba4260954ddf2d9692acb6_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTUtMy0xLTEtMA_f301ec13-9f8e-4b7a-9e4a-c14809d40a9a"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i83d083f1fa054115979e180a0197c0c3_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTUtNS0xLTEtMA_b8b0e205-f2f0-4361-befa-c8caaab7d942"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i9f0351d0ac5340749dcbd3417ca3b6cf_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTUtNy0xLTEtMA_c5d73689-3252-4606-8bdc-9940da0cbd2b"
      unitRef="usd">20700000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i75641ae84a834af19a49dbc2f325caa0_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTUtOS0xLTEtMA_6c6d7150-8fd5-40b8-be69-d0cd6fd553eb"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i1fed346eafa54192b0996a2c5e59af06_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTUtMTEtMS0xLTA_3ca4f99b-5930-45b5-bff1-85b3347f5f2f"
      unitRef="usd">20700000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic342c0d96ffa4ec4ba03f2801ad1e983_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTctMS0xLTEtMA_91855339-0e43-4d40-887b-f516c4951474"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib09142dcedba4260954ddf2d9692acb6_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTctMy0xLTEtMA_0ee028e5-7409-4092-b012-197f5b60a499"
      unitRef="usd">26500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i83d083f1fa054115979e180a0197c0c3_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTctNS0xLTEtMA_303ebfdd-d280-4ca0-8ceb-a146e1fb81c3"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9f0351d0ac5340749dcbd3417ca3b6cf_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTctNy0xLTEtMA_f0079269-28bc-4ee4-a90b-d9077ae7c061"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i75641ae84a834af19a49dbc2f325caa0_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTctOS0xLTEtMA_bc6aefbe-5439-4bbd-bedc-25d0ae4e75e3"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i1fed346eafa54192b0996a2c5e59af06_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTctMTEtMS0xLTA_aa7b0f84-a602-4d2f-9a46-b73863bce75e"
      unitRef="usd">26500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="ic342c0d96ffa4ec4ba03f2801ad1e983_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTgtMS0xLTEtMA_855c9cee-14fb-4d6e-a585-584497903885"
      unitRef="usd">2400000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="ib09142dcedba4260954ddf2d9692acb6_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTgtMy0xLTEtMA_dd1e5150-d79c-4314-840d-d42e8f5779b0"
      unitRef="usd">1145800000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i83d083f1fa054115979e180a0197c0c3_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTgtNS0xLTEtMA_944d89e3-f7c0-4f4f-af99-15a3ba6ecb5f"
      unitRef="usd">0</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i9f0351d0ac5340749dcbd3417ca3b6cf_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTgtNy0xLTEtMA_a3e7d646-d968-498e-907d-a5ba0fc4fd78"
      unitRef="usd">1148200000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i75641ae84a834af19a49dbc2f325caa0_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTgtOS0xLTEtMA_f2edd53b-100e-438f-b61b-8257ba4a57a9"
      unitRef="usd">0</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i1fed346eafa54192b0996a2c5e59af06_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTgtMTEtMS0xLTA_3b18aae7-f212-409b-a731-685272a2c7dd"
      unitRef="usd">0</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ic342c0d96ffa4ec4ba03f2801ad1e983_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTktMS0xLTEtMA_b2467373-e54f-4e5d-97a1-0f9a7516a3c1"
      unitRef="usd">-100000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ib09142dcedba4260954ddf2d9692acb6_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTktMy0xLTEtMA_e54e92c7-aa21-4e7c-9ea4-e41fa9be7cc6"
      unitRef="usd">-199800000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i83d083f1fa054115979e180a0197c0c3_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTktNS0xLTEtMA_78e6f382-b883-41fe-b637-21d4ab7327dc"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i9f0351d0ac5340749dcbd3417ca3b6cf_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTktNy0xLTEtMA_c5d73f02-40df-4bb5-a5f1-026cb33bf1e6"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i75641ae84a834af19a49dbc2f325caa0_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTktOS0xLTEtMA_9496b2af-70eb-45f5-9ee4-be4aa409acf6"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i1fed346eafa54192b0996a2c5e59af06_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMTktMTEtMS0xLTA_729cdc3c-57e8-4dd8-8a57-aeac04c5d9ae"
      unitRef="usd">199900000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockholdersEquity
      contextRef="ia796b50fb78c4d8ea1305d6cb87f4c80_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjAtMS0xLTEtMA_400199d4-6af5-4d5a-8149-7f9e83a2b135"
      unitRef="usd">9100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie5fd99aa026e4d049d9880148cd3673f_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjAtMy0xLTEtMA_cc9776af-a995-4266-95ad-a2751235463d"
      unitRef="usd">91400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i41dc70e79a434c8584c71c9871c4d297_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjAtNS0xLTEtMA_ba18cbf1-d18e-4c74-948c-583f0af48aab"
      unitRef="usd">7455800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3830d635761e46d59cb5beb48e8e5c06_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjAtNy0xLTEtMA_f81a4e80-96dd-4708-8144-a6ae5294322d"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic4332a0967964a7e951d06b4f757007e_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjAtOS0xLTEtMA_8eb6685c-69af-4089-bf81-a075209118ce"
      unitRef="usd">-411900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifbf3e729d39d476fbac2a1d7b95feece_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjAtMTEtMS0xLTA_2bdbdf63-babd-47ff-acab-65dcce590e1a"
      unitRef="usd">7144400000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i6cc52edd079c41dba66111baf03d7d8d_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjEtMS0xLTEtMA_5e8128a3-1f14-487b-8966-feba3714c704"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5f2b2ef9fa394b91a5ebeb5644627072_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjEtMy0xLTEtMA_83b0f68d-d418-4e1d-b74c-6e200934d656"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjEtNS0xLTEtMA_49117119-626c-4a46-a4fa-b583c9d237d5"
      unitRef="usd">220700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i92acbc0b60c64d71979b7d2ca0a3d393_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjEtNy0xLTEtMA_78a97c66-d10f-4d8f-af38-91d9f8af2061"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic8dc748344574f268131764ada7e2c98_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjEtOS0xLTEtMA_57c2670b-9837-4763-a7e6-b687c123b284"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjEtMTEtMS0xLTA_1543efcf-1023-4a20-b37e-045e4be0b565"
      unitRef="usd">220700000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6cc52edd079c41dba66111baf03d7d8d_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjItMS0xLTEtMA_75122e38-7e5e-45e8-89b7-08adce026c1f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5f2b2ef9fa394b91a5ebeb5644627072_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjItMy0xLTEtMA_d4991585-9f72-46be-9fc6-32e28273c4df"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i330e9e0c1f764aa28705cf6255807ed9_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjItNS0xLTEtMA_18854ba3-36ff-45a5-8b1c-66616b0db268"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i92acbc0b60c64d71979b7d2ca0a3d393_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjItNy0xLTEtMA_187f64e3-61db-41f0-9263-7ef764824a66"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjItOS0xLTEtMA_77678110-3b8e-4c0c-8c76-b4f2a53d4103"
      unitRef="usd">-90300000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjItMTEtMS0xLTA_44034b64-5003-43c1-b683-66e41b99b7dc"
      unitRef="usd">-90300000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="i6cc52edd079c41dba66111baf03d7d8d_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjMtMS0xLTEtMA_32720044-b76a-412c-8592-82e42cf6e064"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="i5f2b2ef9fa394b91a5ebeb5644627072_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjMtMy0xLTEtMA_66e6f43a-eb69-487e-bdda-1b143d2b036b"
      unitRef="usd">25100000</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="i330e9e0c1f764aa28705cf6255807ed9_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjMtNS0xLTEtMA_64d6c040-fdf1-4a81-9447-47b69f72fd4a"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="i92acbc0b60c64d71979b7d2ca0a3d393_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjMtNy0xLTEtMA_388f3664-263e-4412-b0c6-05e689c44c52"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="ic8dc748344574f268131764ada7e2c98_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjMtOS0xLTEtMA_ac2f6f2e-fc7c-4ae9-9274-c9f5cc67a0a1"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjMtMTEtMS0xLTA_01eda7ad-873f-4f8b-a3d4-c83a72094b6b"
      unitRef="usd">25100000</lh:Issuanceofcommonstockunderemployeeplans>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i6cc52edd079c41dba66111baf03d7d8d_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjQtMS0xLTEtMA_cc10649b-680a-4d56-93fc-f9ddb8394d9a"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i5f2b2ef9fa394b91a5ebeb5644627072_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjQtMy0xLTEtMA_552eb95a-6e8c-4b0d-bf53-8e677044dc65"
      unitRef="usd">300000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i330e9e0c1f764aa28705cf6255807ed9_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjQtNS0xLTEtMA_6981ac63-cadc-4ec3-84cb-47fe8e8018b1"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i92acbc0b60c64d71979b7d2ca0a3d393_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjQtNy0xLTEtMA_5c2911c1-b7ab-4073-bb24-24fbc770e944"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="ic8dc748344574f268131764ada7e2c98_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjQtOS0xLTEtMA_312a45c5-18a5-4a16-abbd-f3fd6e28b428"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjQtMTEtMS0xLTA_c23bbd4f-3e78-447f-bf79-9a5fb45fba18"
      unitRef="usd">300000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6cc52edd079c41dba66111baf03d7d8d_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjYtMS0xLTEtMA_f70ee729-a961-4029-9a9a-e14aaa347413"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5f2b2ef9fa394b91a5ebeb5644627072_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjYtMy0xLTEtMA_49329bc7-20b9-47eb-a489-13a0538788a4"
      unitRef="usd">31500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i330e9e0c1f764aa28705cf6255807ed9_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjYtNS0xLTEtMA_82ed2a21-b7ae-424e-902d-5bac00c1ea13"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i92acbc0b60c64d71979b7d2ca0a3d393_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjYtNy0xLTEtMA_164232ec-50ca-4b22-9899-6ff1560fbe45"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic8dc748344574f268131764ada7e2c98_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjYtOS0xLTEtMA_14252234-a3ce-450d-937a-c3389828b22c"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjYtMTEtMS0xLTA_3cee55cd-9720-4ae6-a0bc-d8cef5b81dab"
      unitRef="usd">31500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i6cc52edd079c41dba66111baf03d7d8d_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjctMS0xLTEtMA_520a7b80-5c11-4c88-8fc7-53cb3358b9b0"
      unitRef="usd">-100000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i5f2b2ef9fa394b91a5ebeb5644627072_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjctMy0xLTEtMA_8790cb7c-2678-4062-ae26-9f3b024159e9"
      unitRef="usd">99900000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i330e9e0c1f764aa28705cf6255807ed9_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjctNS0xLTEtMA_950248ed-94d6-45c5-9068-19563ffb77e2"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i92acbc0b60c64d71979b7d2ca0a3d393_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjctNy0xLTEtMA_f60a5c66-0dbb-48a6-a56b-47102788aba5"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ic8dc748344574f268131764ada7e2c98_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjctOS0xLTEtMA_789e62a8-8b57-445f-9265-461c89dd0f41"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjctMTEtMS0xLTA_ee905bc0-fca7-4c95-9586-dc7aaaa9af67"
      unitRef="usd">100000000.0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockholdersEquity
      contextRef="i2e93e2032f774e388fbc09993a955665_I20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjgtMS0xLTEtMA_2ac11d79-3155-446c-ab70-99e3bc1dd57b"
      unitRef="usd">9000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i219dadfad6ec4f15ab02c46b30294757_I20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjgtMy0xLTEtMA_d9fa696c-6ca6-4e96-9440-7621fcd24599"
      unitRef="usd">47800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i121e54f584574754a997b2e8da14cb33_I20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjgtNS0xLTEtMA_27c2d5df-6109-478f-b902-6a291ff38d9e"
      unitRef="usd">7676500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibf92e2a580e040a495fdd34dbb61b1e3_I20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjgtNy0xLTEtMA_e1598476-894f-4fe7-9967-10872227f317"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i52114c8d18b9499a9e0444fcbab899ab_I20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjgtOS0xLTEtMA_ed0411d5-470d-4e66-99c9-b2245c9a98b8"
      unitRef="usd">-502200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3ebf6d35695d43bebd0e1036cfd88d00_I20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMjgtMTEtMS0xLTA_c2410271-2f32-4543-90ac-46c8560cd666"
      unitRef="usd">7231100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib6295bf6566e4265bac5d6f0714100b1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzAtMS0xLTEtMA_0084f948-02a8-4e63-b8b1-aaaac30b499e"
      unitRef="usd">9000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i995498342f4d4bbeb12d006cd72d61b1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzAtMy0xLTEtMA_5973641b-548f-4dda-a839-fde306b94751"
      unitRef="usd">26800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id047e5b85b904a12801017a2fd441c52_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzAtNS0xLTEtMA_123d8f41-5b3f-4e07-b930-d0d34904dfda"
      unitRef="usd">7903600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie4d943c067664cd3bb4ef38017cfc703_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzAtNy0xLTEtMA_be5102e7-0bf7-4a25-afb4-058d7047fbbf"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ieb05081604c34e979bb4fd456055049e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzAtOS0xLTEtMA_7c00c236-2eff-4af5-b9be-acc981248f4b"
      unitRef="usd">-372400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzAtMTEtMS0xLTA_418d69e1-9078-4f9f-96ca-7f1f7de34257"
      unitRef="usd">7567000000.0</us-gaap:StockholdersEquity>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ie8a89f8ac83b437aa6f0f277429e7b04_I20200101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzEtMS0xLTEtMA_eb7c523d-d3ab-4f76-b3fa-2981aeaea689"
      unitRef="usd">0</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i3d1419fac15d45ba8998356ea892ab07_I20200101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzEtMy0xLTEtMA_d5a96bf6-66bc-4ba3-bf8a-d5dcafaa5f79"
      unitRef="usd">0</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ic71057ddd9b94ee9bbf0a3919bd94bd4_I20200101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzEtNS0xLTEtMA_849ac6b3-611c-4416-9251-6d1fc700ac63"
      unitRef="usd">-7000000.0</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ib0b1ac80eac24afe88d4fb1b2e16aefd_I20200101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzEtNy0xLTEtMA_8b873dac-8501-4b2c-af96-7f44aa5d0041"
      unitRef="usd">0</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ia31964c5cf72480688ceb520816d7665_I20200101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzEtOS0xLTEtMA_c14e47aa-e80e-4f97-af7d-7d5ebb1aa531"
      unitRef="usd">0</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ic71057ddd9b94ee9bbf0a3919bd94bd4_I20200101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzEtMTEtMS0xLTA_dcbef723-bd24-4f1c-864b-3946ab738014"
      unitRef="usd">-7000000.0</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:NetIncomeLoss
      contextRef="ib51bcbbe3b3b40dabc2fef3fab8b97b2_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzItMS0xLTEtMA_c2d0809c-a53b-4b79-a11c-4b6d97dd78c0"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0abf8234cd2f4de5ad2609359991f8d3_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzItMy0xLTEtMA_6283c357-1695-452c-88dc-28ac83a6832b"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id31a66599db3453db1095d8dd3713397_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzItNS0xLTEtMA_7d729707-4f67-494f-a7d1-d077a30cedbb"
      unitRef="usd">-317200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic2584e4e56f14caaa4332a71ef56576f_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzItNy0xLTEtMA_0a2c596f-2047-4d8a-ad84-ca13136c878b"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i25486ee4361d42f18c47644aa116250b_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzItOS0xLTEtMA_73acd66d-f5e6-4a6f-a97d-6c59c8a75579"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia962c16050fa4b28adc73e0d729703c5_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzItMTEtMS0xLTA_ff7ec535-34cd-4c78-a2e6-96c3a6aa0e57"
      unitRef="usd">-317200000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib51bcbbe3b3b40dabc2fef3fab8b97b2_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzMtMS0xLTEtMA_c114866f-086c-4737-9fed-cd991cf5fb08"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0abf8234cd2f4de5ad2609359991f8d3_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzMtMy0xLTEtMA_7ab2edfa-e205-41aa-be91-9048f97cf520"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id31a66599db3453db1095d8dd3713397_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzMtNS0xLTEtMA_c6481cf5-2b15-4ad8-96a1-bafc26fdc6f8"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic2584e4e56f14caaa4332a71ef56576f_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzMtNy0xLTEtMA_91be7005-b7b5-4200-b5c5-b23eb01fe6a9"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i25486ee4361d42f18c47644aa116250b_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzMtOS0xLTEtMA_442fcbd3-f696-48ec-8f2d-e7343b9bb9ea"
      unitRef="usd">-145500000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia962c16050fa4b28adc73e0d729703c5_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzMtMTEtMS0xLTA_234120ff-0c5f-4818-903c-6b760cd1a72a"
      unitRef="usd">-145500000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="ib51bcbbe3b3b40dabc2fef3fab8b97b2_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzQtMS0xLTEtMA_a82a74cd-b59a-4f73-9d96-dacc434f06de"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="i0abf8234cd2f4de5ad2609359991f8d3_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzQtMy0xLTEtMA_c4c7c388-48ba-4ea4-8cd3-033221ff35ad"
      unitRef="usd">26900000</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="id31a66599db3453db1095d8dd3713397_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzQtNS0xLTEtMA_0fd4b610-cef7-4370-b1df-75be113f724e"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="ic2584e4e56f14caaa4332a71ef56576f_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzQtNy0xLTEtMA_972a23dd-a135-4c9d-8f53-85f81445eaf7"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="i25486ee4361d42f18c47644aa116250b_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzQtOS0xLTEtMA_eee1d5ea-71bd-4445-a8fb-c9a8739d07fe"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="ia962c16050fa4b28adc73e0d729703c5_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzQtMTEtMS0xLTA_66c2fd44-e4b0-4b9f-968e-01a4496c8698"
      unitRef="usd">26900000</lh:Issuanceofcommonstockunderemployeeplans>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="ib51bcbbe3b3b40dabc2fef3fab8b97b2_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzUtMS0xLTEtMA_b2177d79-1030-4884-9498-1a2b8fe8cbdf"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i0abf8234cd2f4de5ad2609359991f8d3_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzUtMy0xLTEtMA_38f2bdac-9b61-4c5e-b7ec-186090ad723d"
      unitRef="usd">22000000.0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="id31a66599db3453db1095d8dd3713397_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzUtNS0xLTEtMA_de67b401-8f8b-44d6-b3c1-6a82987a99b0"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="ic2584e4e56f14caaa4332a71ef56576f_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzUtNy0xLTEtMA_71aee384-07e4-4367-9fbe-46c7d867a74f"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i25486ee4361d42f18c47644aa116250b_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzUtOS0xLTEtMA_ccb094e6-44c8-4dfd-89b7-6a54aa617068"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="ia962c16050fa4b28adc73e0d729703c5_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzUtMTEtMS0xLTA_8ca6b328-4e35-4b40-8a94-34f392b310fb"
      unitRef="usd">22000000.0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib51bcbbe3b3b40dabc2fef3fab8b97b2_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzctMS0xLTEtMA_036e7fc0-2920-4bee-a8ae-3f0ad5936d28"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0abf8234cd2f4de5ad2609359991f8d3_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzctMy0xLTEtMA_498a9cc6-b777-4dd2-a912-a4b7abfb5a71"
      unitRef="usd">17900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="id31a66599db3453db1095d8dd3713397_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzctNS0xLTEtMA_15f3a92e-38f0-4745-8d00-fb16185fca2c"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic2584e4e56f14caaa4332a71ef56576f_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzctNy0xLTEtMA_0b94d24e-c10b-4b5a-a8a3-b17af2eb22a6"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i25486ee4361d42f18c47644aa116250b_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzctOS0xLTEtMA_459a7e57-5c0c-4c29-aa47-a2008830389f"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia962c16050fa4b28adc73e0d729703c5_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzctMTEtMS0xLTA_d64ac46c-5b73-4c2e-8c61-4a6f5cc81a17"
      unitRef="usd">17900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ib51bcbbe3b3b40dabc2fef3fab8b97b2_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzktMS0xLTEtMA_447fd76a-ce93-4e3a-b6d4-4b19f1339d47"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i0abf8234cd2f4de5ad2609359991f8d3_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzktMy0xLTEtMA_a4d40d63-12f2-42ea-855f-e8d587815762"
      unitRef="usd">-49600000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="id31a66599db3453db1095d8dd3713397_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzktNS0xLTEtMA_09bd678c-abf7-4dba-a64e-985292063ef7"
      unitRef="usd">-50400000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ic2584e4e56f14caaa4332a71ef56576f_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzktNy0xLTEtMA_078c08eb-3cbb-4b3d-9474-92a9ec5ff4ec"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i25486ee4361d42f18c47644aa116250b_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzktOS0xLTEtMA_9636e789-1d57-4196-bbdc-b1e7799bff90"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ia962c16050fa4b28adc73e0d729703c5_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfMzktMTEtMS0xLTA_27b304d8-a773-404b-8bde-cbf867114135"
      unitRef="usd">100000000.0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockholdersEquity
      contextRef="i5d6506b821ec4b6a89acd1558aaf0f20_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDAtMS0xLTEtMA_26c3b8d4-7498-4ddf-8c53-3d9ef736e4bf"
      unitRef="usd">9000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1f1b50d6e33142a797ba59094a4d6109_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDAtMy0xLTEtMA_9f729795-2710-4940-b5b3-dd4a017aee90"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9ecd2df0683345df840720ba03e366f6_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDAtNS0xLTEtMA_771e8569-69c2-48be-a257-9813793c328a"
      unitRef="usd">7529000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib4033d4ed5ac4e2a90cf122db9d649b7_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDAtNy0xLTEtMA_3dd7511a-804f-4a07-bceb-47fdb7857420"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i906c32823da3454c88cf7e570cb8bde4_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDAtOS0xLTEtMA_117c7523-2996-4d9f-93d8-96b1c258e5d9"
      unitRef="usd">-517900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i50a2dfaccda94b87acda43c31ec50e7a_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDAtMTEtMS0xLTA_4901928a-0506-417b-be09-84bb477a5e87"
      unitRef="usd">7020100000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i6e645a01cc63416894fda41c9b202e41_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDEtMS0xLTEtMA_afd342d0-ffec-4990-b589-6c6e44baae87"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iceabf34577cf4df1ae006d401b431793_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDEtMy0xLTEtMA_b2c43694-59f4-4413-8f7b-846980509ac6"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if5513a927c4444339f73687e0a972d90_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDEtNS0xLTEtMA_c97c4eb5-3b36-421a-b578-cce733e25f09"
      unitRef="usd">231600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5f4911a3cd4244faa921cef6beedbda0_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDEtNy0xLTEtMA_e51c404c-4d7d-4247-ac18-c7b6f67e1f28"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i70e36036ee974a9383e7b832ec83f7bf_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDEtOS0xLTEtMA_08861c7d-1d0f-444e-9024-b0ef2f4c1b35"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i612a5521f96f4a1db5dcc91dda46a2e8_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDEtMTEtMS0xLTA_ebb75ad3-b119-43a5-b353-df732d0f48bd"
      unitRef="usd">231600000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6e645a01cc63416894fda41c9b202e41_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDItMS0xLTEtMA_8cf30ec1-bfbe-49ea-9c0c-4ee8469eb464"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iceabf34577cf4df1ae006d401b431793_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDItMy0xLTEtMA_c9d09daf-106f-4a07-9344-5fe28d8802bc"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if5513a927c4444339f73687e0a972d90_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDItNS0xLTEtMA_01ea1c4f-4a43-445e-b112-707a86e59309"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5f4911a3cd4244faa921cef6beedbda0_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDItNy0xLTEtMA_f359ba04-b9fb-48df-b94e-3501a8839668"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i70e36036ee974a9383e7b832ec83f7bf_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDItOS0xLTEtMA_3c228e40-4c6d-427e-aef8-02503d8bb683"
      unitRef="usd">68900000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i612a5521f96f4a1db5dcc91dda46a2e8_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDItMTEtMS0xLTA_582abfcc-da3f-41cf-b8bd-c3827b6c3813"
      unitRef="usd">68900000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="i6e645a01cc63416894fda41c9b202e41_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDMtMS0xLTEtMA_ad204abe-6813-4b99-89f3-35c0d1e24878"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="iceabf34577cf4df1ae006d401b431793_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDMtMy0xLTEtMA_57b7e0ea-de41-4cc5-bb45-c8492453bfe2"
      unitRef="usd">1800000</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="if5513a927c4444339f73687e0a972d90_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDMtNS0xLTEtMA_a52a216e-1695-4937-9a61-3c2b1db8bd5d"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="i5f4911a3cd4244faa921cef6beedbda0_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDMtNy0xLTEtMA_6d89683d-9dd2-47ba-8793-650faa2794e1"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="i70e36036ee974a9383e7b832ec83f7bf_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDMtOS0xLTEtMA_bf4880cf-0635-46c4-8baf-b73349eb9ccc"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="i612a5521f96f4a1db5dcc91dda46a2e8_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDMtMTEtMS0xLTA_18331624-a7d1-4e24-ab69-a4117dedb39c"
      unitRef="usd">1800000</lh:Issuanceofcommonstockunderemployeeplans>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i6e645a01cc63416894fda41c9b202e41_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDQtMS0xLTEtMA_14d40d09-38d4-48e3-9ff4-ef5f0615cb67"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="iceabf34577cf4df1ae006d401b431793_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDQtMy0xLTEtMA_88c770f3-e69e-4f98-999f-ebd6e6e59996"
      unitRef="usd">9500000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="if5513a927c4444339f73687e0a972d90_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDQtNS0xLTEtMA_fd08b2eb-de22-434a-b9d3-54fafc92fb5f"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i5f4911a3cd4244faa921cef6beedbda0_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDQtNy0xLTEtMA_90e83f5e-44f7-4eac-8d96-c4af5c73a2e5"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i70e36036ee974a9383e7b832ec83f7bf_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDQtOS0xLTEtMA_f98cbee3-3f71-4402-8c97-dc95570a051d"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i612a5521f96f4a1db5dcc91dda46a2e8_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDQtMTEtMS0xLTA_291c7fbb-f321-475b-ac48-9c8425fd47eb"
      unitRef="usd">9500000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6e645a01cc63416894fda41c9b202e41_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDYtMS0xLTEtMA_19a57c65-fe6d-41bb-b9cc-ee6c078a9161"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iceabf34577cf4df1ae006d401b431793_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDYtMy0xLTEtMA_2495e6f8-f0ff-4cc3-b650-f9dec29b0d0b"
      unitRef="usd">39800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if5513a927c4444339f73687e0a972d90_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDYtNS0xLTEtMA_f5eebbc9-74e3-4abd-a5c5-45bc735a1674"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5f4911a3cd4244faa921cef6beedbda0_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDYtNy0xLTEtMA_a94be5b6-ea26-4989-8dd4-7a3668e51bcc"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i70e36036ee974a9383e7b832ec83f7bf_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDYtOS0xLTEtMA_ef740e12-6a6c-41e1-b953-16c576e249bc"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i612a5521f96f4a1db5dcc91dda46a2e8_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDYtMTEtMS0xLTA_c1756827-1c4d-4a42-953f-7f9cf48c07b8"
      unitRef="usd">39800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockholdersEquity
      contextRef="i0a0d6c3c99214086849193c76b863382_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDktMS0xLTEtMA_756531b2-72cc-405d-a0d6-2cf6446d332a"
      unitRef="usd">9000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6421b026529d4cb8a7d4ed4b2b200529_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDktMy0xLTEtMA_9cf32bab-9a11-422e-b709-762e47d7d27c"
      unitRef="usd">32100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i35550650089c49acaebcaf52a144d1f7_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDktNS0xLTEtMA_2c60fb95-44ad-4e56-bee0-9d57a64b4c07"
      unitRef="usd">7760600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iad6fff0892aa4905843f6f15944bd070_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDktNy0xLTEtMA_8f99dcb9-5e74-441f-a4ca-796019c08044"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie055d220bf39404a910b28a899727919_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDktOS0xLTEtMA_61bd8e77-5c4b-4d37-bc6a-8f361b4d7c93"
      unitRef="usd">-449000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8272c3d15f864e709f533b5532e0c9c8_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNDktMTEtMS0xLTA_afa29eb5-e61e-4d7c-8221-5870565cc16e"
      unitRef="usd">7352700000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="idbbfb6e65e55467184de04732ad5dbca_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTAtMS0xLTEtMA_c7e9d035-49f4-478b-aab5-7d41a6e1e48f"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iafb98936914b4c85ad9a3c7728022c47_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTAtMy0xLTEtMA_c52d7b19-417d-4fc3-b73f-c4ef9d84ef51"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i84ab37a796dd4ad595c43567718e60ab_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTAtNS0xLTEtMA_7d67d65d-71b5-45ae-95db-c6f04e00d8d9"
      unitRef="usd">703400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iba6759ae8a5847a883ff4cd2ca1523c4_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTAtNy0xLTEtMA_461131ee-2512-416b-87f2-e2eb7d3edece"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iec50023dc3d34301836e4d6d2ab126fe_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTAtOS0xLTEtMA_6a50aa8c-a82b-4ef1-b85b-2331cf5c6bc8"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTAtMTEtMS0xLTA_8e28f457-f6c6-4019-9de5-686dfca31642"
      unitRef="usd">703400000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idbbfb6e65e55467184de04732ad5dbca_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTEtMS0xLTEtMA_2dc98809-f5a5-45fe-a8d0-d6be5f2f0aa9"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iafb98936914b4c85ad9a3c7728022c47_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTEtMy0xLTEtMA_51b5dda4-3df8-4131-94c1-0acee4aeacee"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i84ab37a796dd4ad595c43567718e60ab_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTEtNS0xLTEtMA_886ae8f7-5d8e-4ce4-9496-dc8b41055b1d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iba6759ae8a5847a883ff4cd2ca1523c4_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTEtNy0xLTEtMA_4857a68b-b15a-4af4-b5fb-3defc4f237a6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iec50023dc3d34301836e4d6d2ab126fe_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTEtOS0xLTEtMA_bf455847-aeda-4ee7-af9c-0ca8beaf33da"
      unitRef="usd">134400000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTEtMTEtMS0xLTA_9bdbd481-d4a2-4fca-9b6c-c21b456e77fe"
      unitRef="usd">134400000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="idbbfb6e65e55467184de04732ad5dbca_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTItMS0xLTEtMA_a9786519-8d80-42c9-9ef7-a5594b3680ea"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="iafb98936914b4c85ad9a3c7728022c47_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTItMy0xLTEtMA_55aa8095-24a6-4fef-8a41-7a8e84e1b0f8"
      unitRef="usd">21900000</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="i84ab37a796dd4ad595c43567718e60ab_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTItNS0xLTEtMA_f4f8b7b8-8ca9-4b28-8552-2ff2a73dc09e"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="iba6759ae8a5847a883ff4cd2ca1523c4_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTItNy0xLTEtMA_444ddd39-aa66-4926-8644-c200fffcc3a7"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="iec50023dc3d34301836e4d6d2ab126fe_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTItOS0xLTEtMA_c386c04a-09e1-4b26-8e81-de03f61b64d8"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTItMTEtMS0xLTA_2a663805-1f1f-4079-8362-67ffc09c91a8"
      unitRef="usd">21900000</lh:Issuanceofcommonstockunderemployeeplans>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="idbbfb6e65e55467184de04732ad5dbca_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTMtMS0xLTEtMA_dc71eabf-9f74-47ce-84b6-7a6bf78c33ed"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="iafb98936914b4c85ad9a3c7728022c47_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTMtMy0xLTEtMA_84659ed7-124a-4952-8837-3f2d8b5035b3"
      unitRef="usd">500000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i84ab37a796dd4ad595c43567718e60ab_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTMtNS0xLTEtMA_6fe4ac65-337f-43c1-950c-b97c179b4bdd"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="iba6759ae8a5847a883ff4cd2ca1523c4_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTMtNy0xLTEtMA_22e3cb03-cffa-4779-b892-3bd2a909f3de"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="iec50023dc3d34301836e4d6d2ab126fe_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTMtOS0xLTEtMA_cb027aa8-5db6-41aa-8f89-7e4564a61af1"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTMtMTEtMS0xLTA_c4bf3390-a56b-492c-8876-fd7f2f271725"
      unitRef="usd">500000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="idbbfb6e65e55467184de04732ad5dbca_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTUtMS0xLTEtMA_9524f1fc-f00f-46d3-88cc-0ec6844404f8"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iafb98936914b4c85ad9a3c7728022c47_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTUtMy0xLTEtMA_eb07f81f-64f4-4af2-9179-f9ac075ff8da"
      unitRef="usd">27200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i84ab37a796dd4ad595c43567718e60ab_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTUtNS0xLTEtMA_4da95aa7-161a-48ea-ac9a-543a0dc067ad"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iba6759ae8a5847a883ff4cd2ca1523c4_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTUtNy0xLTEtMA_dee6ff1b-6206-4481-b47c-798f6af2806a"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iec50023dc3d34301836e4d6d2ab126fe_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTUtOS0xLTEtMA_e0286977-4a00-44a7-83b0-7d73346165cd"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTUtMTEtMS0xLTA_6d6681f0-1fec-46fb-8b04-0d85f2dbea6a"
      unitRef="usd">27200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockholdersEquity
      contextRef="i7b9f3b204a7e4d5bb84fdca35b0388af_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTctMS0xLTEtMA_53090608-4506-4b2f-a51b-0c2c58fdad20"
      unitRef="usd">9000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i02dd23ef8e2c4ff6ad5ce9aa02fd57a1_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTctMy0xLTEtMA_01839383-0fe0-4d93-95bd-6ffe7f88cb88"
      unitRef="usd">80700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i003fb35d67544342982c7134cef34000_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTctNS0xLTEtMA_4921f4e4-0b2a-4039-bc71-5b8d8ec1235a"
      unitRef="usd">8464000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifb420f938cb849e7b63729c500bdb2ef_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTctNy0xLTEtMA_56f9d62e-08ed-42da-b597-4ca766f16bf6"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i42f654e418554a0aba5b6a17b3942bae_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTctOS0xLTEtMA_6c89eefa-70b0-4ca3-b887-46ede530c8ae"
      unitRef="usd">-314600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yMi9mcmFnOmEwNzFlZmUzNjc4NzQ2OWZiMjE2N2M2MTg3YmFjOTJlL3RhYmxlOjU0ZTdjODc0YjFjMzQ5NDNiM2NiYzllYTM4MzRiMjc2L3RhYmxlcmFuZ2U6NTRlN2M4NzRiMWMzNDk0M2IzY2JjOWVhMzgzNGIyNzZfNTctMTEtMS0xLTA_7950eafa-b060-495f-9171-ec3070575ca4"
      unitRef="usd">8239100000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMy0xLTEtMS0w_1b0ca367-9db5-4032-a541-af5f8ee2ba4e"
      unitRef="usd">618400000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMy0zLTEtMS0w_af1de74f-335b-474a-a234-c16ffa061bba"
      unitRef="usd">597600000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNS0xLTEtMS0w_90e3dc3d-91c1-49a2-8f56-5ca885fefefb"
      unitRef="usd">440800000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNS0zLTEtMS0w_3246a2e6-0862-49af-9dcf-d1a661e4051d"
      unitRef="usd">421400000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNi0xLTEtMS0w_66c0c5fd-7c7e-4b5e-be27-75ed811522f6"
      unitRef="usd">84900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNi0zLTEtMS0w_18349aa8-56b5-4edc-a71d-f947743d2cfb"
      unitRef="usd">83500000</us-gaap:ShareBasedCompensation>
    <lh:DepreciationAndAmortizationOfLeasedAssets
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTEtMS0xLTEtMA_446f4f4d-9203-4ea4-b86e-e2bd66dfe171"
      unitRef="usd">150700000</lh:DepreciationAndAmortizationOfLeasedAssets>
    <lh:DepreciationAndAmortizationOfLeasedAssets
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTEtMy0xLTEtMA_6e26bc4d-3c85-4414-9d50-d7e9a4991010"
      unitRef="usd">144100000</lh:DepreciationAndAmortizationOfLeasedAssets>
    <us-gaap:AssetImpairmentCharges
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTMtMS0xLTEtMA_d7c0a191-6bcf-49d0-82e1-30bece710993"
      unitRef="usd">460900000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTMtMy0xLTEtMA_fc6d7f74-1a02-42e4-bba7-59deff7e14d5"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTQtMS0xLTEtMA_abe04a66-a14c-490a-974a-840e5939e079"
      unitRef="usd">-48500000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTQtMy0xLTEtMA_8209b68f-8e06-4f3e-a67e-487b264b1acd"
      unitRef="usd">23300000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTUtMS0xLTEtMA_d4f38b0b-2c39-4e10-9dcd-9c14af5b2ba0"
      unitRef="usd">55200000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTUtMy0xLTEtMA_bb87f509-7a0c-4dcb-9062-e0b52ceb671e"
      unitRef="usd">12500000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTctMS0xLTEtMA_d5806e9f-a01e-4c62-bbcf-a44d709c73ef"
      unitRef="usd">546900000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTctMy0xLTEtMA_65c95e49-aee3-43fe-b2c1-cd0eef61b23b"
      unitRef="usd">144300000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <lh:IncreaseDecreaseinUnbilledContractReceivable
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTgtMS0xLTEtMA_d4f6c4b4-d01f-4b46-809d-6a826e180945"
      unitRef="usd">117800000</lh:IncreaseDecreaseinUnbilledContractReceivable>
    <lh:IncreaseDecreaseinUnbilledContractReceivable
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTgtMy0xLTEtMA_c1d57e1f-141e-4864-9d4d-49b1d0b1b491"
      unitRef="usd">59500000</lh:IncreaseDecreaseinUnbilledContractReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTktMS0xLTEtMA_09ba3c90-3e8c-4648-b909-e3b61a0368e8"
      unitRef="usd">147500000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMTktMy0xLTEtMA_5ff92097-d6b3-4a80-bdff-af010b321fe8"
      unitRef="usd">14500000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjAtMS0xLTEtMA_79bbfe4b-db80-44d6-a33b-5811f0e8d87a"
      unitRef="usd">-26100000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjAtMy0xLTEtMA_edd319e5-d905-4a23-97ae-38b1f77d7a26"
      unitRef="usd">-5800000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjEtMS0xLTEtMA_37a1568f-4d15-4919-b422-1497b16b441e"
      unitRef="usd">17300000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjEtMy0xLTEtMA_7070a55f-be08-41cf-a9f5-a80626205d07"
      unitRef="usd">-28200000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjItMS0xLTEtMA_ad7d37c6-aa85-49fe-a2ed-b2c2273deaed"
      unitRef="usd">44100000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjItMy0xLTEtMA_9bbba2b1-024e-4c25-9e14-2e0fefecb1c4"
      unitRef="usd">-1000000.0</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjQtMS0xLTEtMA_44c87b4d-51de-440b-b485-64056b89ddcc"
      unitRef="usd">323000000.0</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjQtMy0xLTEtMA_16db3f42-deb9-4099-98cc-c85dce29d0cb"
      unitRef="usd">-165800000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjUtMS0xLTEtMA_612a6203-0456-4c0d-8a2a-ab2c1b89c842"
      unitRef="usd">1360700000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjUtMy0xLTEtMA_1aa7e761-5b1f-4d4a-9e6e-df4cfa3dc285"
      unitRef="usd">874900000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjctMS0xLTEtMA_4fe6a417-f034-424b-a23e-f826f509dfab"
      unitRef="usd">282300000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjctMy0xLTEtMA_0ee79b88-1325-4150-ae65-2f648f57c2d0"
      unitRef="usd">272000000.0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjgtMS0xLTEtMA_addcb19b-d166-4dec-b82c-b9fadaec3eb7"
      unitRef="usd">1100000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjgtMy0xLTEtMA_18b601fe-71c8-409a-914c-5d2494a28c40"
      unitRef="usd">5800000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjktMS0xLTEtMA_c61561af-5645-44a9-83ee-eaa4727a6abd"
      unitRef="usd">1000000.0</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMjktMy0xLTEtMA_a31cd6c1-dc0a-4ebb-8df2-92ab6f746268"
      unitRef="usd">9400000</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:ProceedsFromHedgeInvestingActivities
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzItMS0xLTEtNTQ5Mg_68593234-4186-4bda-8a83-f8f9279028a8"
      unitRef="usd">3100000</us-gaap:ProceedsFromHedgeInvestingActivities>
    <us-gaap:ProceedsFromHedgeInvestingActivities
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzItMy0xLTEtNTQ5Ng_812494e9-0533-4eff-912c-d4cf411ab772"
      unitRef="usd">0</us-gaap:ProceedsFromHedgeInvestingActivities>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzItMS0xLTEtMA_e361182d-d0de-4afc-bf27-8d4721a416eb"
      unitRef="usd">29300000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzItMy0xLTEtMA_1f544b3c-94e4-4129-a402-70ff75774094"
      unitRef="usd">21300000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzMtMS0xLTEtMA_a26b98f8-19ea-4625-b5e5-3f539a1cb4e6"
      unitRef="usd">208800000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzMtMy0xLTEtMA_7582427a-27a8-45f5-91ca-544c86b777ff"
      unitRef="usd">852900000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzQtMS0xLTEtMA_721c4f72-8e78-4d92-82df-2cd480f67a14"
      unitRef="usd">-515200000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzQtMy0xLTEtMA_b554a4f1-6149-49c2-bf95-bd541d1bb245"
      unitRef="usd">-1131000000.0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzctMS0xLTEtMA_b737f81d-44ec-40e8-b588-7f3bf414c658"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzctMy0xLTEtMA_cdb47114-3a11-4654-8065-d99fc896008b"
      unitRef="usd">850000000.0</us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfOtherLongTermDebt
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzgtMS0xLTEtMA_8ffda8d6-dce8-446d-99f1-2c3677a221b7"
      unitRef="usd">0</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfOtherLongTermDebt
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzgtMy0xLTEtMA_550ba6b5-0a74-488a-821a-7e4b6c408fbf"
      unitRef="usd">250000000.0</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzktMS0xLTEtMA_90637fbe-3109-4229-beb4-4c3663e7c98f"
      unitRef="usd">151700000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfMzktMy0xLTEtMA_5d5be32e-499d-4036-ba68-67e67d325a4d"
      unitRef="usd">473000000.0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNDAtMS0xLTEtMA_eb90a932-3dbc-4f67-95b8-f4a6915e6c52"
      unitRef="usd">151700000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNDAtMy0xLTEtMA_b478565f-eebf-4845-aacb-33ef64930b9b"
      unitRef="usd">473000000.0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNDMtMS0xLTEtMA_9c3b05fb-c49f-4da4-a462-4153c9afef79"
      unitRef="usd">412200000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNDMtMy0xLTEtMA_5f5332a4-0629-42ce-8a82-dc2ffee0b3c8"
      unitRef="usd">0</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTEtMS0xLTEtMA_f6f311fd-89c2-4a23-be69-1400a06940cb"
      unitRef="usd">32000000.0</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTEtMy0xLTEtMA_c16bf478-67b6-443a-a6e3-043b6e90a179"
      unitRef="usd">40400000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <lh:NetProceedsFromIssuanceOfStockToEmployees
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTItMS0xLTEtMA_53bb76cd-595a-4753-9ca9-b316a6146b2e"
      unitRef="usd">50600000</lh:NetProceedsFromIssuanceOfStockToEmployees>
    <lh:NetProceedsFromIssuanceOfStockToEmployees
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTItMy0xLTEtMA_f4ce5af6-ddd2-4e5d-bf63-fa2fbd56627d"
      unitRef="usd">59000000.0</lh:NetProceedsFromIssuanceOfStockToEmployees>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTMtMS0xLTEtMA_01a54d39-e81c-48b1-8596-c193476c4fec"
      unitRef="usd">100000000.0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTMtMy0xLTEtMA_d5d7a2c9-618a-48ef-9068-ed9fa2c4fe01"
      unitRef="usd">400000000.0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <lh:OtherFinancingCashFlows
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTQtMS0xLTEtMA_fdd36af5-e4f9-4ed6-be2a-d67e906f1fa3"
      unitRef="usd">22800000</lh:OtherFinancingCashFlows>
    <lh:OtherFinancingCashFlows
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTQtMy0xLTEtMA_0dcf3283-a452-4cb5-afd3-4b5ee152f02a"
      unitRef="usd">21900000</lh:OtherFinancingCashFlows>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTUtMS0xLTEtMA_e0746aef-1752-4bdf-a3c3-d782e5463908"
      unitRef="usd">-516400000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTUtMy0xLTEtMA_1cef2205-e930-43a5-ad33-0648d661e9db"
      unitRef="usd">196700000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTYtMS0xLTEtMA_8773c214-d646-4de2-9373-a50577a687bc"
      unitRef="usd">600000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTYtMy0xLTEtMA_e9f82b28-d1de-4ed5-a152-d618cfed7326"
      unitRef="usd">-6300000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTctMS0xLTEtMA_6aa4edae-fb18-4957-8e71-22258824f788"
      unitRef="usd">329700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTctMy0xLTEtMA_83c3f756-4969-4db6-b3f5-d86797f9742f"
      unitRef="usd">-65700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTgtMS0xLTEtMA_74a5649e-4b8f-4ab6-bbf6-ec76ec318966"
      unitRef="usd">337500000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6ac49907696d40399215ce933a047245_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNTgtMy0xLTEtMA_a3320ee5-d19a-40a4-b292-fa6037296903"
      unitRef="usd">426800000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNjAtMS0xLTEtMA_eac8ae4f-d982-4e46-b79c-d3f623318469"
      unitRef="usd">667200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i3ebf6d35695d43bebd0e1036cfd88d00_I20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8yNS9mcmFnOjc1NzQ4NTQxNGMxMjRiYzdhZTU4NzEyMjNlYzIxMzk1L3RhYmxlOmZiMjAxNDgxYTg5MTQ2OThiY2I1MmFjOTE0MDI3OWFkL3RhYmxlcmFuZ2U6ZmIyMDE0ODFhODkxNDY5OGJjYjUyYWM5MTQwMjc5YWRfNjAtMy0xLTEtMA_8a26a42d-8638-4852-8203-00bb61934b9a"
      unitRef="usd">361100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMTE2NDc_4eb7c897-5327-4b4a-bdad-5da4fc27a4b7">BASIS OF FINANCIAL STATEMENT PRESENTATION&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Laboratory Corporation of America&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Holdings together with its subsidiaries (the Company) is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. The Company&#x2019;s mission is to improve health and improve lives by delivering world-class diagnostic solutions, bringing innovative medicines to patients faster and using technology to provide better care. The Company serves a broad range of customers, including managed care organizations (MCOs), biopharmaceutical and medical device companies, governmental agencies, physicians and other health care providers (e.g., physician assistants and nurse practitioners, generally referred to herein as physicians), hospitals and health systems, employers, patients and consumers, contract research organizations (CROs), and independent clinical laboratories. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reports its business in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). For further financial information about these segments, see Note 15 Business Segment Information to the Condensed Consolidated Financial Statements. During the three months ended September&#160;30, 2020, LCD and CDD contributed approximately 68% and 32% respectively, of revenues to the Company. During the nine months ended September&#160;30, 2020, LCD and CDD contributed approximately 63% and 37%, respectively, of revenues to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries for which it exercises control. Long-term investments in affiliated companies in which the Company exercises significant influence, but which it does not control, are accounted for using the equity method. Investments in which the Company does not exercise significant influence (generally, when the Company has an investment of less than 20.0% and no representation on the investee's board of directors) are accounted for at fair value or at cost minus impairment adjusted for observable price changes in orderly transactions for an identical or similar investment of the same issuer for those investments that do not have readily determinable fair values. All significant inter-company transactions and accounts have been eliminated. The Company does not have any significant variable interest entities or special purpose entities whose financial results are not included in the condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial statements of the Company's operating foreign subsidiaries are measured using the local currency as the functional currency.&#160;Assets and liabilities are translated at exchange rates as of the balance sheet date.&#160;Revenues and expenses are translated at average monthly exchange rates prevailing during the period.&#160;Resulting translation adjustments are included in &#x201c;Accumulated other comprehensive income.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements of the Company are unaudited. In the opinion of management, all adjustments necessary for a fair statement of results of operations, cash flows, and financial position have been made. Except as otherwise disclosed, all such adjustments are of a normal recurring nature. Interim results are not necessarily indicative of results for a full year. The year-end condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by generally accepted accounting principles.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements and notes are presented in accordance with the rules and regulations of the United States (U.S.) Securities and Exchange Commission (SEC) and do not contain certain information included in the Company&#x2019;s 2019 Annual Report on Form 10-K (Annual Report). Therefore, these interim statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company&#x2019;s Annual Report.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Adopted Guidance &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued a new accounting standard intended to provide financial statement users with more decision-useful information about expected credit losses and other commitments to extend credit held by the reporting entity. The standard replaces the incurred loss impairment methodology in current generally accepted accounting principles&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(GAAP) with one that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The Company recorded an opening retained earnings adjustment of $7.0 with the adoption of this standard on January 1, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued a new accounting standard to reduce, modify, and add to the disclosure requirements on fair value measurements. The Company adopted this standard effective January 1, 2020. The adoption of this standard did not have a material impact on the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued a new accounting standard to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to develop or obtain internal-use software. The Company adopted this standard effective January 1, 2020. The adoption of this standard did not have a material impact on the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued a new accounting standard to reduce, modify, and add to the disclosure requirements on defined benefit pension and other postretirement plans. The standard is effective on January 1, 2021, with early adoption permitted. The adoption of this standard is not expected to have a material impact on the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued a new accounting standard to simplify accounting for income taxes and remove, modify, and add to the disclosure requirements of income taxes. The standard is effective January 1, 2021, with early adoption permitted. The adoption of this standard is not expected to have a material impact on the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued a new accounting standard to clarify the interaction of the accounting for equity securities and investments accounted for under the equity method of accounting and the accounting for certain forward contracts and purchased options. The standard is effective January 1, 2021. The adoption of this standard is not expected to have a material impact on the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued a new accounting standard to provide optional expedients and exceptions if certain conditions are met for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform. The expedients and exceptions in the standard are effective between March 12, 2020, and December 31, 2022. The Company did not elect to apply any of the expedients or exceptions for the period ended September 30, 2020, and is currently evaluating the impact this new standard will have on the consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued a new accounting standard to address issues identified as a result of the complexity associated with applying generally accepted accounting principles for convertible instruments and contracts in an entity's own equity. The standard is effective January 1, 2022, with early adoption permitted. The Company is evaluating the impact this new standard will have on the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Novel Coronavirus (COVID-19) Financial Statement Impact&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, COVID-19 was declared a pandemic. COVID-19 has had and continues to have an extensive impact on the global health and economic environments. During the nine months ended September 30, 2020, the Company recorded goodwill and other asset impairment charges of $437.4, as a result of the negative financial impact of COVID-19 during the first quarter of 2020. See Note 6 Goodwill and Intangible Assets for a discussion of goodwill and intangible asset impairment and Note 2 Revenues for a discussion of credit losses and additional price concessions. The Company also impaired certain of the Company's investments by a total of $25.4 during the nine months ended September 30, 2020, due to the impact of COVID-19; $7.1 was included in Equity method earnings (loss), net during the three months ended March 31, 2020, and $13.1 and $5.2 were included in Other, net during the three months ended March 31, 2020, and June 30, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In April 2020, the Company received cash payments of approximately $55.9 from the Public Health and Social Services Emergency Fund for provider relief that was appropriated by Congress to the Department of Health and Human Services (HHS) in the Coronavirus Aid, Relief, and Economic Security Act (CARES Act Provider Relief Funds). Upon receiving and satisfying the terms and conditions associated with the distributed funds, the Company accounted for the transaction by applying the guidance in ASC 450-30 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Gain Contingencies, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;recorded these funds in Other, net non-operating income in the Consolidated Statement of Operations as of June 30, 2020. In August 2020, the Company received an additional $76.2 in CARES Act Provider Relief Funds. As the Company's Diagnostic business demonstrated recovery and demand for COVID-19 testing increased, the Company determined that the negative financial impact of COVID-19 which the CARES Act Provider Relief Funds were designed to address no longer applied to the Company. As a result, the Company derecognized the income associated with the $55.9 received during the second quarter as a change in estimate and did not recognize any income related to the cash payment of $76.2 received in the third quarter. The Company plans to return the CARES Act Provider Relief Funds to the government in the fourth quarter of 2020 and has recorded a liability of $132.1 in Accrued expenses and other as of September 30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The extent to which the COVID-19 pandemic has and will impact the Company&#x2019;s business and financial results depend on numerous evolving factors including, but not limited to: the magnitude and duration of the COVID-19 pandemic, the impact to worldwide macroeconomic conditions including interest rates, employment rates and health insurance coverage, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of September&#160;30, 2020, and through the date of this &lt;/span&gt;&lt;/div&gt;report. The accounting matters assessed included, but were not limited to, the Company&#x2019;s implicit price concessions and credit losses, equity investments, notes receivable and the carrying value of goodwill and other long-lived assets. The Company&#x2019;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in additional material impacts to the Company&#x2019;s consolidated financial statements in future reporting periods.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMTE2NTQ_de855777-e752-4a52-9dd9-d6ad69d09765">BASIS OF FINANCIAL STATEMENT PRESENTATION&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Laboratory Corporation of America&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Holdings together with its subsidiaries (the Company) is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. The Company&#x2019;s mission is to improve health and improve lives by delivering world-class diagnostic solutions, bringing innovative medicines to patients faster and using technology to provide better care. The Company serves a broad range of customers, including managed care organizations (MCOs), biopharmaceutical and medical device companies, governmental agencies, physicians and other health care providers (e.g., physician assistants and nurse practitioners, generally referred to herein as physicians), hospitals and health systems, employers, patients and consumers, contract research organizations (CROs), and independent clinical laboratories. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reports its business in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). For further financial information about these segments, see Note 15 Business Segment Information to the Condensed Consolidated Financial Statements. During the three months ended September&#160;30, 2020, LCD and CDD contributed approximately 68% and 32% respectively, of revenues to the Company. During the nine months ended September&#160;30, 2020, LCD and CDD contributed approximately 63% and 37%, respectively, of revenues to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries for which it exercises control. Long-term investments in affiliated companies in which the Company exercises significant influence, but which it does not control, are accounted for using the equity method. Investments in which the Company does not exercise significant influence (generally, when the Company has an investment of less than 20.0% and no representation on the investee's board of directors) are accounted for at fair value or at cost minus impairment adjusted for observable price changes in orderly transactions for an identical or similar investment of the same issuer for those investments that do not have readily determinable fair values. All significant inter-company transactions and accounts have been eliminated. The Company does not have any significant variable interest entities or special purpose entities whose financial results are not included in the condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial statements of the Company's operating foreign subsidiaries are measured using the local currency as the functional currency.&#160;Assets and liabilities are translated at exchange rates as of the balance sheet date.&#160;Revenues and expenses are translated at average monthly exchange rates prevailing during the period.&#160;Resulting translation adjustments are included in &#x201c;Accumulated other comprehensive income.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements of the Company are unaudited. In the opinion of management, all adjustments necessary for a fair statement of results of operations, cash flows, and financial position have been made. Except as otherwise disclosed, all such adjustments are of a normal recurring nature. Interim results are not necessarily indicative of results for a full year. The year-end condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by generally accepted accounting principles.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements and notes are presented in accordance with the rules and regulations of the United States (U.S.) Securities and Exchange Commission (SEC) and do not contain certain information included in the Company&#x2019;s 2019 Annual Report on Form 10-K (Annual Report). Therefore, these interim statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company&#x2019;s Annual Report.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <lh:PercentofRevenueContributed
      contextRef="i1982102278bd444d897b0ac03dedfda5_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMTI4NQ_793d0583-2bfe-43a6-a2a5-8f06a37d3703"
      unitRef="number">0.68</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i4674d28875524974925c86ea26137e4b_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMTI5Mg_d48ab2bb-678f-4ee4-b16d-b91460797a63"
      unitRef="number">0.32</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i60bf6e0de9384f37926fac0c0db06385_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMTQwNg_9b7c5d22-55f4-46de-a681-d719aca4ceb4"
      unitRef="number">0.63</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="if366c14694954f6f84a2c0fe5708324e_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMTQxMw_5ec8586b-c972-414a-a860-918aba28a618"
      unitRef="number">0.37</lh:PercentofRevenueContributed>
    <lh:CostMethodInvestmentsMaximumOwnershipPercentage
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMTkxOA_8785174e-de1a-466b-a950-cfe8a001bb4a"
      unitRef="number">0.200</lh:CostMethodInvestmentsMaximumOwnershipPercentage>
    <lh:RecentlyAdoptedAccountingGuidancePolicyTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMTE2NjI_65b0f3a8-36f6-4fb2-b8b6-5e751d8b3836">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Adopted Guidance &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued a new accounting standard intended to provide financial statement users with more decision-useful information about expected credit losses and other commitments to extend credit held by the reporting entity. The standard replaces the incurred loss impairment methodology in current generally accepted accounting principles&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(GAAP) with one that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The Company recorded an opening retained earnings adjustment of $7.0 with the adoption of this standard on January 1, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued a new accounting standard to reduce, modify, and add to the disclosure requirements on fair value measurements. The Company adopted this standard effective January 1, 2020. The adoption of this standard did not have a material impact on the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued a new accounting standard to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred &lt;/span&gt;&lt;/div&gt;to develop or obtain internal-use software. The Company adopted this standard effective January 1, 2020. The adoption of this standard did not have a material impact on the consolidated financial statements.</lh:RecentlyAdoptedAccountingGuidancePolicyTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ic71057ddd9b94ee9bbf0a3919bd94bd4_I20200101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfNDYwNQ_849ac6b3-611c-4416-9251-6d1fc700ac63"
      unitRef="usd">-7000000.0</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMTE2NDk_4ddebbd8-81cf-4b50-b155-231ef7a96bd7">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued a new accounting standard to reduce, modify, and add to the disclosure requirements on defined benefit pension and other postretirement plans. The standard is effective on January 1, 2021, with early adoption permitted. The adoption of this standard is not expected to have a material impact on the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued a new accounting standard to simplify accounting for income taxes and remove, modify, and add to the disclosure requirements of income taxes. The standard is effective January 1, 2021, with early adoption permitted. The adoption of this standard is not expected to have a material impact on the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued a new accounting standard to clarify the interaction of the accounting for equity securities and investments accounted for under the equity method of accounting and the accounting for certain forward contracts and purchased options. The standard is effective January 1, 2021. The adoption of this standard is not expected to have a material impact on the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued a new accounting standard to provide optional expedients and exceptions if certain conditions are met for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform. The expedients and exceptions in the standard are effective between March 12, 2020, and December 31, 2022. The Company did not elect to apply any of the expedients or exceptions for the period ended September 30, 2020, and is currently evaluating the impact this new standard will have on the consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued a new accounting standard to address issues identified as a result of the complexity associated with applying generally accepted accounting principles for convertible instruments and contracts in an entity's own equity. The standard is effective January 1, 2022, with early adoption permitted. The Company is evaluating the impact this new standard will have on the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <lh:NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMTE2NjM_4f21b5f2-a984-4435-a654-f30efc181f82">&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Novel Coronavirus (COVID-19) Financial Statement Impact&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, COVID-19 was declared a pandemic. COVID-19 has had and continues to have an extensive impact on the global health and economic environments. During the nine months ended September 30, 2020, the Company recorded goodwill and other asset impairment charges of $437.4, as a result of the negative financial impact of COVID-19 during the first quarter of 2020. See Note 6 Goodwill and Intangible Assets for a discussion of goodwill and intangible asset impairment and Note 2 Revenues for a discussion of credit losses and additional price concessions. The Company also impaired certain of the Company's investments by a total of $25.4 during the nine months ended September 30, 2020, due to the impact of COVID-19; $7.1 was included in Equity method earnings (loss), net during the three months ended March 31, 2020, and $13.1 and $5.2 were included in Other, net during the three months ended March 31, 2020, and June 30, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In April 2020, the Company received cash payments of approximately $55.9 from the Public Health and Social Services Emergency Fund for provider relief that was appropriated by Congress to the Department of Health and Human Services (HHS) in the Coronavirus Aid, Relief, and Economic Security Act (CARES Act Provider Relief Funds). Upon receiving and satisfying the terms and conditions associated with the distributed funds, the Company accounted for the transaction by applying the guidance in ASC 450-30 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Gain Contingencies, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;recorded these funds in Other, net non-operating income in the Consolidated Statement of Operations as of June 30, 2020. In August 2020, the Company received an additional $76.2 in CARES Act Provider Relief Funds. As the Company's Diagnostic business demonstrated recovery and demand for COVID-19 testing increased, the Company determined that the negative financial impact of COVID-19 which the CARES Act Provider Relief Funds were designed to address no longer applied to the Company. As a result, the Company derecognized the income associated with the $55.9 received during the second quarter as a change in estimate and did not recognize any income related to the cash payment of $76.2 received in the third quarter. The Company plans to return the CARES Act Provider Relief Funds to the government in the fourth quarter of 2020 and has recorded a liability of $132.1 in Accrued expenses and other as of September 30, 2020.&lt;/span&gt;&lt;/div&gt;</lh:NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock>
    <lh:COVID19PandemicGoodwillAndIntangibleAssetImpairment
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMzI5ODUzNDg5NjEyMQ_14c3b9a0-f9bb-41ca-8440-468cd2ac1a10"
      unitRef="usd">437400000</lh:COVID19PandemicGoodwillAndIntangibleAssetImpairment>
    <us-gaap:ImpairmentOfInvestments
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMjE5OTAyMzI2ODExNg_a04712c2-4e31-4fe8-9e05-e6f3ef9a831c"
      unitRef="usd">25400000</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="i6e46390b74524a39961dc3a71697bb7f_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMTY0OTI2NzQ1NDM5MA_b23ee77f-3db6-4b0f-98e9-7585cf7c8dea"
      unitRef="usd">7100000</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="idf06093237eb40b7b4693f9bb03c1107_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMTY0OTI2NzQ1NDQyMQ_d94b35d6-0889-4382-8ec6-a2149c834b53"
      unitRef="usd">13100000</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="i47c2cf5a89a849cd94e6efd1d321b938_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMzI5ODUzNDkwMDY4Mg_14a95e1a-f54e-4959-b900-b46d86a30490"
      unitRef="usd">5200000</us-gaap:ImpairmentOfInvestments>
    <lh:CashPaymentReceivedAppropriatedbyU.S.CongressCovid19
      contextRef="ia74b9c93ead74b108c97cc4640c2fe07_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfOTM2OA_f9efb503-2004-40a6-aed9-35b6c5de0bc4"
      unitRef="usd">55900000</lh:CashPaymentReceivedAppropriatedbyU.S.CongressCovid19>
    <lh:CashPaymentReceivedAppropriatedbyU.S.CongressCovid19
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMzI5ODUzNDkwMTkzOQ_97ac6864-9c92-4478-ad6d-20987d25a14b"
      unitRef="usd">76200000</lh:CashPaymentReceivedAppropriatedbyU.S.CongressCovid19>
    <lh:CashPaymentReceivedAppropriatedbyU.S.CongressCovid19
      contextRef="ia74b9c93ead74b108c97cc4640c2fe07_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMzI5ODUzNDg5OTU4NQ_f9efb503-2004-40a6-aed9-35b6c5de0bc4"
      unitRef="usd">55900000</lh:CashPaymentReceivedAppropriatedbyU.S.CongressCovid19>
    <lh:CashPaymentReceivedAppropriatedbyU.S.CongressCovid19
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMzI5ODUzNDg5OTY4NA_97ac6864-9c92-4478-ad6d-20987d25a14b"
      unitRef="usd">76200000</lh:CashPaymentReceivedAppropriatedbyU.S.CongressCovid19>
    <lh:CARESActFundsAccruedLiabilitiesAndOtherLiabilities
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMzI5ODUzNDg5OTAwNw_5dc9ce2f-f4c9-4cbb-8cba-62bd61a75e65"
      unitRef="usd">132100000</lh:CARESActFundsAccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:UseOfEstimates
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zMS9mcmFnOjBiMDg5OWU3NWIxNzQ3NmNiZmM5NTM1ZGI5NjNjZDg4L3RleHRyZWdpb246MGIwODk5ZTc1YjE3NDc2Y2JmYzk1MzVkYjk2M2NkODhfMTE2NTA_d0af313c-e007-4d5b-b4cd-d3762e2d8eae">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The extent to which the COVID-19 pandemic has and will impact the Company&#x2019;s business and financial results depend on numerous evolving factors including, but not limited to: the magnitude and duration of the COVID-19 pandemic, the impact to worldwide macroeconomic conditions including interest rates, employment rates and health insurance coverage, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of September&#160;30, 2020, and through the date of this &lt;/span&gt;&lt;/div&gt;report. The accounting matters assessed included, but were not limited to, the Company&#x2019;s implicit price concessions and credit losses, equity investments, notes receivable and the carrying value of goodwill and other long-lived assets. The Company&#x2019;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in additional material impacts to the Company&#x2019;s consolidated financial statements in future reporting periods.</us-gaap:UseOfEstimates>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfNDY5Ng_20e694b4-19f0-4105-a077-01fa155cfb3a">REVENUES&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's revenues by segment payers/customer groups for the three and nine months ended September&#160;30, 2020, and 2019, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.856%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.856%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.856%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payer/Customer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;LCD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Clients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Patients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Medicare and Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Third-party&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Total LCD revenues by payer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;CDD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Biopharmaceutical and medical device companies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.875%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payer/Customer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;LCD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Clients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Patients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Medicare and Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Third-party&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Total LCD revenues by payer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;CDD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Biopharmaceutical and medical device companies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.875%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payer/Customer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;LCD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Clients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Patients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Medicare and Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Third-party&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Total LCD revenues by payer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;CDD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Biopharmaceutical and medical device companies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.229%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.856%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.856%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.856%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payer/Customer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;LCD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Clients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Patients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Medicare and Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Third-party&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Total LCD revenues by payer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;CDD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Biopharmaceutical and medical device companies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CDD incurs sales commissions in the process of obtaining contracts with customers, which are recoverable through the service fees in the contract. Sales commissions that are payable upon contract award are recognized as assets and amortized over the expected contract term, along with related payroll tax expense. The amortization of commission expense is based on the weighted average contract duration for all commissionable awards in the respective business in which the commission expense is paid, which approximates the period over which goods and services are transferred to the customer. The amortization period of sales commissions ranges from approximately 1 to 5 years, depending on the business. For businesses that enter into primarily short-term contracts, the Company applies the practical expedient, which allows costs to obtain a contract to be expensed when incurred if the amortization period of the assets that would otherwise have been recognized is one year or less. Amortization of assets from sales commissions is included in selling, general, and administrative expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CDD incurs costs to fulfill contracts with customers, which are recoverable through the service fees in the contract. Contract fulfillment costs include software implementation costs and setup costs for certain market access solutions. These costs are recognized as assets and amortized over the expected term of the contract to which the implementation relates, which is the period over which services are expected to be provided to the customer. This period typically ranges from 2 to 5 years. Amortization of deferred contract fulfillment costs is included in cost of goods sold.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales commission assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred contract fulfillment costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization related to sales commission assets and associated payroll taxes for the three months ended September&#160;30, 2020, and 2019, was $6.0 and $5.8, respectively, and for the nine months ended September&#160;30, 2020, and 2019, was $16.8 and $15.3, respectively. Amortization related to deferred contract fulfillment costs for the three months ended September&#160;30, 2020, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and 2019, was $2.3 and $2.3, respectively, and was $7.6 and $6.1, respectively, for the nine months ended September&#160;30, 2020, and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Receivables, Unbilled Services and Unearned Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Unbilled services are comprised primarily of unbilled receivables, but also include contract assets. A contract asset is recorded when a right to payment has been earned for work performed, but billing and payment for that work is determined by certain contractual milestones, whereas unbilled receivables are billable upon the passage of time. While CDD attempts to negotiate terms that provide for billing and payment of services prior or in close proximity to the provision of services, this is not always possible and there are fluctuations in the level of unbilled services and unearned revenue from period to period. The following table provides information about receivables, unbilled services, and unearned revenue (contract liabilities) from contracts with customers for CDD.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, which are included in accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;834.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;771.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unbilled services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues recognized during the period, that were included in the unearned revenue balance at the beginning of the period for the nine months ended September&#160;30, 2020, and September&#160;30, 2019, were $237.2 and $232.8, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit Loss Rollforward&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;     &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With the adoption of the current expected credit loss standard in 2020, the Company estimates future expected losses on accounts receivable, unbilled services and notes receivable over the remaining collection period of the instrument. The rollforward for the allowance for credit losses for the nine months ended September 30, 2020, is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accounts Receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unbilled Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Note and Other Receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current expected credit losses opening balance impact on retained earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus, credit loss expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less, write offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Notes and other receivables includes the $110.0 due 2022 from the Envigo transaction which is recorded in Other assets, net. During the three months ended September 30, 2020, the Company recorded an impairment for a note receivable related to an LCD investment of $0.7.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance Obligations Under Long-Term Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term contracts at the Company consist primarily of fully managed clinical studies within CDD. The amount of existing performance obligations under such long-term contracts unsatisfied as of September&#160;30, 2020, was $4,795.0. The Company expects to recognize approximately 32% of the remaining performance obligations as of September&#160;30, 2020, as revenue over the next 12 months, and the balance thereafter. The Company's long-term contracts generally range from 1 to 8 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Within CDD, revenues of $44.8 and $67.7 were recognized during the nine months ended September&#160;30, 2020, and 2019, respectively, from performance obligations that were satisfied in previous periods. This revenue comes from adjustments related to changes in scope and estimates in full service clinical studies.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfNDcwNg_5acddf82-f761-4af0-b8e4-3944c3b9d26a">&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's revenues by segment payers/customer groups for the three and nine months ended September&#160;30, 2020, and 2019, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.856%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.856%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.856%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payer/Customer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;LCD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Clients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Patients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Medicare and Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Third-party&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Total LCD revenues by payer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;CDD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Biopharmaceutical and medical device companies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.875%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payer/Customer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;LCD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Clients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Patients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Medicare and Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Third-party&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Total LCD revenues by payer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;CDD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Biopharmaceutical and medical device companies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.875%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payer/Customer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;LCD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Clients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Patients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Medicare and Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Third-party&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Total LCD revenues by payer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;CDD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Biopharmaceutical and medical device companies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.229%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.856%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.856%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.856%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payer/Customer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;LCD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Clients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Patients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Medicare and Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Third-party&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Total LCD revenues by payer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;CDD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Biopharmaceutical and medical device companies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <lh:PercentofRevenueContributed
      contextRef="id9626ef1cd2547cfa89fd9b389064cc6_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNC0xLTEtMS0w_47f13909-693b-4639-acde-95e0c0d378dc"
      unitRef="number">0.21</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i7c47ed00c06b4961a64f099959fe759f_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNC0zLTEtMS0w_35762719-6db8-4fed-a39f-b17f81a91ad6"
      unitRef="number">0.01</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ic6ce3c437b1e4049899878b45e0fb6e0_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNC01LTEtMS0w_f60b6b95-7f61-4c76-b743-05c897dfedf8"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ib50b6d8435904455951c7565779b7341_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNC03LTEtMS0w_ac7797b0-85ec-49f4-b81a-149af4cc8ea1"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ib2a6785d04ea48f7a2a1542a0d7d001d_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNC05LTEtMS0w_a1235110-d431-4be5-b08d-14afde44ee04"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i3daf06395da4489ea42ddd3f54707d86_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNC0xMS0xLTEtMA_5a637180-464b-42aa-aa68-35c0e3991e64"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i14aa48993fda4a6f8eaad4578904f2df_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNC0xMy0xLTEtMA_2aae7d3b-9331-4cd2-9a4e-9ee175953d20"
      unitRef="number">0.22</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ic259290288f44d458eac49b83b8ad944_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNS0xLTEtMS0w_4fcaacc5-1154-4700-bf09-1743d07dc10a"
      unitRef="number">0.05</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i16c280dd720347169ee01886277f5b70_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNS0zLTEtMS0w_8e5ab853-da08-4730-ab1d-4a244a4c470d"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i5e98179fa8e44ec4aa8b9eb0699e9a4f_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNS01LTEtMS0w_03dab321-4f28-4b8d-8a7f-8e357063400a"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="id6f7b06ec61042f192b8d0c0ecb380fa_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNS03LTEtMS0w_909aff79-f47e-4f77-ab22-63f4b4966074"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ie27a2846b55f44e3bb10629c8b4a6d09_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNS05LTEtMS0w_cafcaed6-c5ff-499e-aa9a-bce28f59fa5e"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i3daf06395da4489ea42ddd3f54707d86_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNS0xMS0xLTEtMA_e57915f2-0908-440a-8ed4-5733852b9015"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i07d524d7631c4f689e36c4a9e9f86e2c_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNS0xMy0xLTEtMA_165cc204-767d-4aa7-9140-8191b5a3b390"
      unitRef="number">0.05</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i14a4aff636b04769856789d12e03a871_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNi0xLTEtMS0w_d45f0c78-ccfb-4b78-998f-4fff93c13088"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="iea9e025d0f644fa485e22a580d3f4cd7_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNi0zLTEtMS0w_9030912f-c164-4949-8b76-22dcc59ebd80"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i4e22f6a7e0374793b9cefc9bcd3585b5_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNi01LTEtMS0w_9fb7fd20-e32b-46d6-b36c-6c812281e029"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i90ac3c1fb02144f099e252661fe37fe8_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNi03LTEtMS0w_dbc033e4-5182-49fb-8ccc-6140689750c9"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="iad4735e1e849483bad4da486a568d55c_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNi05LTEtMS0w_b9b05dd9-94e1-4058-8b00-024f970182dc"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="iea9b5f420b964fd5aace6048e7b0921e_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNi0xMS0xLTEtMA_638b77a1-8717-4c6e-b5ba-49b29b33f8c2"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ic5ea73c3e164417cbd60d881836d1e1d_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNi0xMy0xLTEtMA_636963e2-fb1c-4b3a-8489-96e784d206c4"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ie17f2d3381d644e6bbd5e83aaa53ffe4_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNy0xLTEtMS0w_7f032044-5744-494b-8d2f-0f071c964e21"
      unitRef="number">0.33</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i0b07ec7181b24fe79db83b2887a77770_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNy0zLTEtMS0w_f959605a-a4e9-4489-8127-cd51070a0270"
      unitRef="number">0.01</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i62b5c18a94ba4af9a2783e2211f603d6_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNy01LTEtMS0w_90edf8cc-940c-4370-ae98-c695e900fc56"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i2ca0e774190547d58bf6ce7ab795efb9_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNy03LTEtMS0w_a126662a-efda-4bb1-a9c6-99d17196f077"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i085d47025332478a925481cbd318fc65_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNy05LTEtMS0w_b833d114-41d0-49cc-acad-e07d469bbd89"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i5238791a93ca4316b581e997a3d384e3_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNy0xMS0xLTEtMA_0e75a38e-4995-48d6-a948-3847c303d65e"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="iee6febeb28ab42fbbe765be16edd24cb_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfNy0xMy0xLTEtMA_a80db2c0-edce-4dd2-bc37-d1096bc0bdf6"
      unitRef="number">0.34</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i43148fef08f94203b85d962c5ae8fb07_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfOC0xLTEtMS0w_6bb29341-9ff6-4cc4-9f00-a23e9f664aac"
      unitRef="number">0.66</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i03c7187cc2214dcd9fbe27e11b92de30_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfOC0zLTEtMS0w_c942160c-0456-4aea-b63d-4827af13e2ae"
      unitRef="number">0.02</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ia185a66890a2414584681a11add7d192_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfOC01LTEtMS0w_b33da9be-2281-4f87-976e-ffed0a731e37"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i2a65613c19cd422597c0eebb88c2b3d0_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfOC03LTEtMS0w_0dbdadfd-974a-4e89-a20d-ba480b8a0d45"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i9722f55060174cccbd82ef9b8610b196_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfOC05LTEtMS0w_9722a486-7bee-40eb-a2b1-bf6e7cb47c2b"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i3daf06395da4489ea42ddd3f54707d86_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfOC0xMS0xLTEtMA_30154423-1dbc-454b-ac29-c59c51a93260"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i1982102278bd444d897b0ac03dedfda5_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfOC0xMy0xLTEtMA_96bf0859-0c4d-4504-b2af-082d514e213f"
      unitRef="number">0.68</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ibaa23ac123cf4574b439cc76d55df4f2_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTEtMS0xLTEtMA_e4594d47-17ed-490a-9a41-0b2d0532d037"
      unitRef="number">0.16</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="icd62d7344fa0462a991ba65da1c7ffb7_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTEtMy0xLTEtMA_09ccc768-f4c2-4245-88a0-c8805b0eb072"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ic2c41f77470b457d9ed4965bab8f7ee3_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTEtNS0xLTEtMA_34c8e357-1be2-4155-a22a-7a561d79f58a"
      unitRef="number">0.04</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i38839c3f1f934895b768a54821da0a2c_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTEtNy0xLTEtMA_e48d3103-c70a-45b9-956a-e90b0db614f6"
      unitRef="number">0.04</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ifa2e5eb5177045ea88f2c41735e55445_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTEtOS0xLTEtMA_0a3a1d97-1f1d-4f22-bee3-8a0e2c87ade8"
      unitRef="number">0.02</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i3f6b988e5cc14246b5d95a62c430643d_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTEtMTEtMS0xLTA_d35a5d52-fb23-450f-b196-65ed1d5b2242"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i61068721174646479a719d0d82691d66_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTEtMTMtMS0xLTA_009a8279-3ddc-45e8-8e72-3de8aa9aaf15"
      unitRef="number">0.32</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i599da8b7d2d14e4791521d86ea88a36f_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTMtMS0xLTEtMA_98190bc4-b2a3-4ab0-9cf3-1e831c8b0ff7"
      unitRef="number">0.82</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i5fc62abb869f43369975ea7f0bf80db0_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTMtMy0xLTEtMA_d52494d1-8417-41ee-9a7c-d3b8ac3ce963"
      unitRef="number">0.02</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i6d47fd2ebbac412db1f27e585bf53e3f_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTMtNS0xLTEtMA_d02f51a0-af34-497b-b1a5-7d84dbe4baf6"
      unitRef="number">0.04</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="id53db043a8034950b09968edb83a0607_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTMtNy0xLTEtMA_c6dc1e3d-5ba1-4b59-b2c5-8d00c3f09985"
      unitRef="number">0.04</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i204f3a1eb6b44643b050bf8f2540765d_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTMtOS0xLTEtMA_735a3237-66c7-4020-ad31-f92c0b926784"
      unitRef="number">0.02</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="id6f1cdadc4de42b38c3a6a8dddb06604_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTMtMTEtMS0xLTA_8d363820-0c6a-46a9-b85d-a31eaa24ab24"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmE0Zjc3NWYwZmZmMTQ0ZDY4M2VjNmI4ZDA5ZDAwZWE1L3RhYmxlcmFuZ2U6YTRmNzc1ZjBmZmYxNDRkNjgzZWM2YjhkMDlkMDBlYTVfMTMtMTMtMS0xLTA_6f81534a-2004-4dca-8461-b8b872cc5746"
      unitRef="number">1</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i6323cfeff41f4159acf7a53bb092c3c6_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNC0xLTEtMS0w_ab45877c-c524-4a2b-b5cc-62e67220137c"
      unitRef="number">0.16</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i9dfb8b56aede469ea13f92e3015dc958_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNC0zLTEtMS0w_218ce0eb-8b78-48a5-a1ef-9589cf67a520"
      unitRef="number">0.01</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i01dfc480ee174b02ac0b09584e2317ce_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNC01LTEtMS0w_7f3c7846-eed6-4da9-b052-0914ec573cbb"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i2cfe9d5cd85d46b3897e697a5fdd49c7_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNC03LTEtMS0w_bd6ed90b-79cb-4fec-961c-8d9d662eadd1"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i7baa4f0065bd47a59ee4fe85f7b5755d_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNC05LTEtMS0w_3183d684-c108-4eb8-bea0-3c67f4c8bace"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i25a211144dd8470d8b356d8b001c8501_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNC0xMS0xLTEtMA_c5642164-f6d0-4aee-8f39-67e50f14d17f"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i2281dda8aa1a4d30af776c18df61d1c8_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNC0xMy0xLTEtMA_cb6489ee-4545-49e2-aba6-7f5cc4dd2452"
      unitRef="number">0.17</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i8052a0e56c404ff5a4113a6c4c023c88_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNS0xLTEtMS0w_177fa725-ef4d-420c-8f06-34e2ac765ad5"
      unitRef="number">0.08</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i49463c9f0be949a4b668835f86737567_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNS0zLTEtMS0w_eb46d11c-97af-4e0d-b18a-ed3e748d4351"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ic45f90b4ea0f41e9a9f8d1a4f466f54f_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNS01LTEtMS0w_ee566951-760d-44ed-aa24-9cea97946e15"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ic549b3c324ba47f38e5480ce02fd0558_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNS03LTEtMS0w_c24d840d-e2a1-4088-bf5d-38d181dec59c"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ie917065bc7e643ca9770aad73add4250_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNS05LTEtMS0w_0d80f099-e935-423b-b023-c065b8287d32"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i25a211144dd8470d8b356d8b001c8501_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNS0xMS0xLTEtMA_569b857e-df0b-454e-a6e1-1850b7d621e6"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i9414919f80cf49ebb2777851ee4fed37_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNS0xMy0xLTEtMA_1ab0c003-8e6f-4bcd-a0d7-53657c0e6f0c"
      unitRef="number">0.08</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ie9474df2c9ec4f0588048ef29d346752_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNi0xLTEtMS0w_8c6814b5-55e7-4f87-aaab-7113abcb52f8"
      unitRef="number">0.08</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i3462aa035a72495e9fc1ecf11fbd2049_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNi0zLTEtMS0w_913b310c-1125-44c0-9e16-14dbc5878e5a"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i154bbdad5d524723b675883f9c7065a6_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNi01LTEtMS0w_ac964be5-904e-42dc-a3b5-ec0a2c53d4a5"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i5ccb82ced1094bd59e3d613df27e2c24_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNi03LTEtMS0w_0f0c4cf3-cef3-43be-b311-e835141b97db"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ie700d5333095493db55774137661401e_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNi05LTEtMS0w_a4a972b4-ce95-4a22-a6aa-943d3c3f17ef"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i05e2445018784b01a0f279f4ffeb2d49_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNi0xMS0xLTEtMA_ebcb1686-bdd9-4e4c-a461-36daf6341391"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i9c1e1e6af87a4db689abaf6a994ffc67_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNi0xMy0xLTEtMA_f01e7338-adaf-4311-9f42-d443ca074416"
      unitRef="number">0.08</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i450bf78169c642e09eeb275ebfaeea7c_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNy0xLTEtMS0w_36a369bd-a4ca-457c-b0b1-baea82aabd2d"
      unitRef="number">0.25</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ifecb6bbb2d3c42288aa163006edb1553_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNy0zLTEtMS0w_96e66783-59fc-41d6-a4b3-54a809d59e3e"
      unitRef="number">0.02</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i38357c17172f498586667865e1980e9b_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNy01LTEtMS0w_0f431658-bec0-4802-affd-639a53a4b69a"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i5fc1f599be994436af4c261f3c7f98c1_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNy03LTEtMS0w_8e75c39f-2727-4d1d-b092-7e971488c15d"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i8cfaa96b273d45b1a241e9f02c7a7c7b_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNy05LTEtMS0w_6de9f8ac-052d-4772-9899-274931c314e3"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ia021b225de1b429189702e36fc573e16_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNy0xMS0xLTEtMA_1a891cb9-cb05-4fb9-a496-5c33eb228e92"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i333fbc87a53747a7b8553fad99660865_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfNy0xMy0xLTEtMA_269bcafd-7dcc-4373-aa92-a93daabd0cfe"
      unitRef="number">0.27</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i359c7aa0655644ea80c898242ddcf80d_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfOC0xLTEtMS0w_77fa047c-3603-4852-80c5-0d5ab0e3ddb4"
      unitRef="number">0.57</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i43a981ae8185490d984dcb30bc0eee10_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfOC0zLTEtMS0w_365b365c-49b8-4d9e-8dd8-ba030d54db92"
      unitRef="number">0.03</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i460eab215fae419a8cf81c41cdb90279_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfOC01LTEtMS0w_888effc5-c2af-48da-bba8-3da45b759634"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i3eef33bbb5e342da8dee7597bfe3f461_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfOC03LTEtMS0w_294e5384-1227-4c48-8a1e-286d9fe36af9"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i04baf8b50a6c40d5a4d98d6de87046e4_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfOC05LTEtMS0w_4b65afe2-20f2-4335-8217-bde8fda11e7e"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i25a211144dd8470d8b356d8b001c8501_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfOC0xMS0xLTEtMA_9ac81d93-ddb5-44b4-b40c-91425896ffe7"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="idd95aab1b5024137b07364cf3867cbf8_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfOC0xMy0xLTEtMA_69695bcd-a474-41ae-8c25-a95fcab59ed2"
      unitRef="number">0.60</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i2ee2ea6e83ea4fc29a6b36fe34613f52_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTEtMS0xLTEtMA_d53869c2-f4c2-432e-9a75-d54a57c278d7"
      unitRef="number">0.21</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i42d9fc1bf025408c9fe447f1b3cafa5d_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTEtMy0xLTEtMA_2afcb233-7dfe-4759-8e3b-ba762763c3c9"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="id01bbc615be14b70965d98cee7de2b26_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTEtNS0xLTEtMA_fee7c913-5a52-4b90-9f2c-4822ce4d6677"
      unitRef="number">0.05</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="id6502f4abf6b47edaf675df7d9727ce5_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTEtNy0xLTEtMA_54a4183a-7cee-48a6-b34e-a03f58e43250"
      unitRef="number">0.04</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i2eab7066fb3e411da4d882666bb1218e_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTEtOS0xLTEtMA_476182ae-e61d-4dc8-9944-1952a3029105"
      unitRef="number">0.03</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ie0ce21fe8c654b7c8a7360072ceba887_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTEtMTEtMS0xLTA_6c6a9c72-ccc9-4af2-b93e-d950bda06f64"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i9482ee714bc546369167c573a2564714_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTEtMTMtMS0xLTA_4fc38445-1ec8-4585-910d-76a65e845174"
      unitRef="number">0.40</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ifdb48a87cc234ca697c8b0c54bd62d31_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTMtMS0xLTEtMA_6ea04552-f2d9-4c88-96c1-33a7f8c61a7b"
      unitRef="number">0.78</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i389ae4c4c9f24473a15143884e9da492_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTMtMy0xLTEtMA_644b8a20-3b1f-40f3-bc6b-e7619c59bed6"
      unitRef="number">0.03</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i1df72b2b1d6d4c6fb88d7a315c3cc960_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTMtNS0xLTEtMA_68939ea0-7e2e-4409-bc01-9377557d558c"
      unitRef="number">0.05</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i26560d40f7624e208364bac468677a3a_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTMtNy0xLTEtMA_202d5eae-f59c-4293-bfe7-928f0ce8ceff"
      unitRef="number">0.04</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i26e2079e9fa2414b8068d97842ea4ddb_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTMtOS0xLTEtMA_0701281d-7854-4824-8b3e-0077a08eb98a"
      unitRef="number">0.03</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i631604fdcc4444ffaad24e9b13db902f_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTMtMTEtMS0xLTA_b6a04f44-9dc0-4e9a-b3a9-4e942ac24ad4"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmM4MTJhMWFiNjU0MTQ0YzBhNDJmMjc1YzZiZmQwNzI5L3RhYmxlcmFuZ2U6YzgxMmExYWI2NTQxNDRjMGE0MmYyNzVjNmJmZDA3MjlfMTMtMTMtMS0xLTA_30a993a3-4356-4f4e-a603-f3aa75ea8044"
      unitRef="number">1</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i8d30dccc4d364639b665ffbe677c7647_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNC0xLTEtMS0w_682ce1fa-996d-4794-b04f-4e55fcf91771"
      unitRef="number">0.19</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i9b8a3952cfa54d32b76aeb203dd87494_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNC0zLTEtMS0w_fb55464e-1a43-4f8c-9acf-3588f62c514a"
      unitRef="number">0.01</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i05d10f6fbfbb494fb6fce435672dcf23_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNC01LTEtMS0w_27073a54-3fce-4cca-b055-9cf3b059420f"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ieff9b96c85334e939753b0c4e6ef2d63_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNC03LTEtMS0w_73000a05-fe64-4f3d-88d5-60cb54b82ed1"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i77f9248d57974574bc9adc8bcfcdc8e1_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNC05LTEtMS0w_3b20ea54-91e2-486b-8c15-31a922547dc5"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i280e8f364ec54f6bacf36535657ece2f_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNC0xMS0xLTEtMA_a76f1cca-7929-4e67-9fc4-520a80969e42"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i0e0eec8d36874fcb811be9de7dfc1394_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNC0xMy0xLTEtMA_1526ebbe-f114-49dc-86f5-4cacd8cff9a4"
      unitRef="number">0.20</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i0174357050ce426eb9072c176613559e_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNS0xLTEtMS0w_cd586fb6-06c3-4c50-a69c-fa3bb4fb0ab2"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="id5b5a7fb19a640759ff41fd96d890a0a_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNS0zLTEtMS0w_4491011b-785d-4c9c-a7af-a32c585b13ba"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i91c6a68811984e989e0f9bec6fbe7865_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNS01LTEtMS0w_40bc9ab9-d5bf-4d44-aeec-655fdb38f3fa"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i7960720916204ded977638cc08e62b56_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNS03LTEtMS0w_eb7da495-3eb0-4aa9-b959-c27a37dc478f"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i693603475db345f8b0944c13afcdbc10_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNS05LTEtMS0w_e22a70f3-0886-43ed-959d-dc3b1f59d9b7"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i280e8f364ec54f6bacf36535657ece2f_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNS0xMS0xLTEtMA_5555dd4a-ce87-422f-8cfb-a3045a654caf"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ibc807183e1564343bd31c0159b51bcbb_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNS0xMy0xLTEtMA_610f0292-80ee-4198-9737-a0fb91bec27b"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i69a59eef10334badbbe7740a6961bf20_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNi0xLTEtMS0w_b09e4aa9-d911-4670-b3cd-cf3e372f60e1"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i5f8c193f87c34f2db43b82541239c4db_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNi0zLTEtMS0w_0f736b48-1f9a-451e-845c-278c3c79856c"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i26a632e3297b4c43bc30ad60a11821cb_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNi01LTEtMS0w_888f16e1-e391-47cf-ac62-ff24bb401fab"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i9f7285237d6143a88b08d4f6094f9950_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNi03LTEtMS0w_66747bbe-d5e8-4847-90ea-c54e3658bf80"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i37d8778b4638498d984b5ef4a80387ac_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNi05LTEtMS0w_594f1ef0-e113-4c05-b20b-7d3b8ab0a508"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="iedc4cdb92e6d4a918e4cae457e5095e4_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNi0xMS0xLTEtMA_6ef9ddf0-c49c-4622-bfea-c7564304a407"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i6c4af8fb06a3468b842884b2d7f5e43f_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNi0xMy0xLTEtMA_91b6b18a-d745-4977-9845-4f56903f83f7"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="id7ee075779ba482ba14540bf413c99c6_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNy0xLTEtMS0w_59619fa1-27ab-4eb7-b797-63838b03d1c4"
      unitRef="number">0.29</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="if2c8d81029dc4f4ea85b448efa38bad7_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNy0zLTEtMS0w_036ab22a-e866-413d-8a8d-8187c3e960cd"
      unitRef="number">0.01</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i10f238e753b94349a34e63521a517705_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNy01LTEtMS0w_3be27469-39b0-49de-82e5-1a2f9ef67a35"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i88f53878399541aab3dbf15a0f35c2ff_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNy03LTEtMS0w_9e201b6f-c066-42f5-9cef-d3addc9442ea"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i1d952d8add4a423c841dcb828a6395d4_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNy05LTEtMS0w_86de6d9b-06ed-4d7a-a888-f07e2104e9c6"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i6ec27280b43d41cfb61cf079469c0a60_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNy0xMS0xLTEtMA_5140958a-9ef9-4827-bebb-7872d204d865"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i067fa16ca9d545099aaef7dfae0ba189_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfNy0xMy0xLTEtMA_410bc7c6-3f50-49de-af13-967702c444fd"
      unitRef="number">0.30</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i9ad7fc029ac844a49ffa1b856f5d56f6_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfOC0xLTEtMS0w_8f094869-026a-4f5d-970f-fcb6d1e824c2"
      unitRef="number">0.61</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i5af8a070f9bc46658055f2e8175a8ce3_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfOC0zLTEtMS0w_a9e5fa9d-e6c2-4a37-8852-66295b1518a5"
      unitRef="number">0.02</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ie14bb7a57ad64858b6c10be22525e07e_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfOC01LTEtMS0w_c7962d3f-47a6-4603-aebc-8c65f72fcda8"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i1ba4b7d86f204b6a9d7d562281386f61_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfOC03LTEtMS0w_da29b1e8-1491-461d-9db0-afb15aabd896"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ibeebbb5e419f4d849feadf2a965eda69_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfOC05LTEtMS0w_45b133a6-5807-4d08-a950-b49f87c41d7e"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i280e8f364ec54f6bacf36535657ece2f_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfOC0xMS0xLTEtMA_44fbf84c-6a8d-48fa-ae8b-eb1a4cda298c"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i60bf6e0de9384f37926fac0c0db06385_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfOC0xMy0xLTEtMA_98789c13-c315-4885-b109-a9e1d22062f6"
      unitRef="number">0.63</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="iaa5d6637f88c446481fad357f1d45753_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTEtMS0xLTEtMA_7b34c7bb-374b-4542-94a1-9c3436b3ee7e"
      unitRef="number">0.18</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="iae17d5d53f964b1198bb9bec44994813_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTEtMy0xLTEtMA_b661c224-33eb-451d-940d-e5b8d6c20370"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ia07d85355268435f99e328b11dc3a41b_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTEtNS0xLTEtMA_f5e47ed5-cd16-4717-aa4a-25c19bd5ce63"
      unitRef="number">0.05</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="if615f680db594c4abf7dda191e8cb043_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTEtNy0xLTEtMA_9e90e1d1-7a5a-433d-b588-2bd56f594304"
      unitRef="number">0.04</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="iaa1fd9f69a7b43eea8506545464daab0_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTEtOS0xLTEtMA_0271e808-8a89-48de-bfdc-0eadc714cdab"
      unitRef="number">0.03</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i652bd6addb2f48ccb11829f65d6bbfda_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTEtMTEtMS0xLTA_e36253eb-3cba-4995-9f0b-9377164ca2ae"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="id7fdd15f57ab4e47b5ba9a975330c61c_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTEtMTMtMS0xLTA_30da8f0d-66da-42bc-97af-8b3bace2ae31"
      unitRef="number">0.37</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="iee20f2c502354597935b92371dbe0d94_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTMtMS0xLTEtMA_0840b592-11b5-4482-a244-9b684e13bfd5"
      unitRef="number">0.79</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ie0e7e0d5ac1844e9950e43fe31ea5e07_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTMtMy0xLTEtMA_9bb2d42f-8e8d-4f3d-95f7-4417cda506e4"
      unitRef="number">0.02</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i339500f8642943c2b6c982af6cf9dfea_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTMtNS0xLTEtMA_00ba5dfc-214b-4be9-a178-92975a71841b"
      unitRef="number">0.05</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="id5a9b3edded440719a65fa42688ad89f_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTMtNy0xLTEtMA_b1145059-44ae-4fc6-ae47-da55bebb1344"
      unitRef="number">0.04</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i0729ff016c534ca29e10e62194985ae7_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTMtOS0xLTEtMA_24e9af31-fb54-4613-bd88-41836a42465f"
      unitRef="number">0.03</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i0f2f788044f24469ada3249aca7b98b1_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTMtMTEtMS0xLTA_5c35904d-ea97-46f3-b354-1508f697b1a3"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjRjMDM5NmUyZGRjOTQ2ZTNiYzJhMTUxOGMxZjY2YzYxL3RhYmxlcmFuZ2U6NGMwMzk2ZTJkZGM5NDZlM2JjMmExNTE4YzFmNjZjNjFfMTMtMTMtMS0xLTA_99dd70fc-367b-4544-ac5f-a08a03c9e5eb"
      unitRef="number">1</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="id0ca0a967b334598808b418e2700013f_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNC0xLTEtMS0w_cb047963-4d7a-4982-b2a4-49e796e79698"
      unitRef="number">0.16</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i7bcbb30927c34620bf18c72d093bec3b_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNC0zLTEtMS0w_afff637c-02a3-4246-b75d-cade9ca96bdb"
      unitRef="number">0.01</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ib55a432be0f249e2afa7e0e1d560e1fe_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNC01LTEtMS0w_4ca4a7a8-2ddf-4ae2-9b00-c22749bc8265"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i56ef410ac516442db21e732867090a7d_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNC03LTEtMS0w_ed8d2518-7a2d-41b5-b7c7-9d4a6337f77f"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="icd34f489e3cf4bc68520fb4156dc30d5_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNC05LTEtMS0w_28589c2a-5d3f-4e3c-84f8-64c3622b47b4"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i860cb23b9d0b4f0f94851daff5988983_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNC0xMS0xLTEtMA_fba57d1b-b0c5-4ead-abf5-aeb3f4c50bfe"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="iad868dce52b44ad790b6864d29035e06_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNC0xMy0xLTEtMA_14427614-7807-473b-8075-76fad3173621"
      unitRef="number">0.17</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i86cabdaea3ff4402b13c640c489942dd_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNS0xLTEtMS0w_92f07c82-485c-4154-8089-eac2d32e4535"
      unitRef="number">0.08</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i6e295a8c616e4444bfb546859426b1d7_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNS0zLTEtMS0w_c49c67ad-622e-4bc5-98d1-55568ff25036"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i6da967c8920c43edb991c0528d2ad964_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNS01LTEtMS0w_86709516-6d50-4a4d-b106-64c600e10964"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i765da38bd1524d5ea57eb2c302a51993_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNS03LTEtMS0w_4f57e3ae-1868-4f1c-83f3-00df63643a62"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i13839e115ef34c2e9cdbfd5996444ec4_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNS05LTEtMS0w_d5bdf69f-7ccb-45b1-849f-63005dbe15bf"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i860cb23b9d0b4f0f94851daff5988983_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNS0xMS0xLTEtMA_060c9e8d-5b79-4c71-9538-8a761268b850"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="idbaa79c605ea46b49097dafde16b4c63_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNS0xMy0xLTEtMA_48836f04-3f16-4c33-a910-acc0485734f9"
      unitRef="number">0.08</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i03a302c67b6a4bb7a2a2e19bbbc2a9ab_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNi0xLTEtMS0w_d9c9ca49-e44a-4ec2-a36d-78d4d1b840c7"
      unitRef="number">0.08</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i38329f0d027145598d9b90d0a83b4b3d_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNi0zLTEtMS0w_76355661-309e-4fda-a655-cf16b2634650"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i24a86d409aee4a37b73db1b51534770c_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNi01LTEtMS0w_624585df-2891-4f53-95d1-f23f53b06878"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i23169375ab504448a8b52398bc5131ea_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNi03LTEtMS0w_6dfff7fb-704a-4ab9-be11-bdb130181a43"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i9aeaac1d1f984a51bcb01399ecd48b56_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNi05LTEtMS0w_7de042a2-326e-4ef0-b182-bfea3c5f69f5"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ie8c943708ddb4c9a824d53b38aca3911_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNi0xMS0xLTEtMA_1e302391-78c4-47a0-8810-7158d58787bc"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="if12ca51a38a34b098329f98278e9316d_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNi0xMy0xLTEtMA_39205c47-4f63-45f0-b8df-1582437412fb"
      unitRef="number">0.08</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i65ba32b3197b47a89d8e18f5ce7bf26f_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNy0xLTEtMS0w_7c6d7bec-5450-4ad8-9a47-a1f3ed6fbd8d"
      unitRef="number">0.26</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ib44011bd3f5846bebee1bd4b98050562_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNy0zLTEtMS0w_e5a3df88-20a6-4c8a-90f1-b52b9f772e66"
      unitRef="number">0.02</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i1ba36fdfcf704ad6ba7b509e8b7da78f_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNy01LTEtMS0w_f3e337ba-8053-4105-95ed-a7852149c267"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i27fed185eaf64f0c9df3d3de7b9cdfcf_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNy03LTEtMS0w_bccdc0ab-e843-45f1-8004-a7dd6bd9c87c"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="idbafa9f2fce94b9b8a2c5abf17d6940a_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNy05LTEtMS0w_6729945d-9974-4bca-b1ad-674231168395"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ie3d222c52e0c4a28b8e6198bd6eb1ce8_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNy0xMS0xLTEtMA_5340ae6e-5ee2-485b-b913-192c8abac808"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i3d602e784d274adcb804041ffb3aa3d2_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfNy0xMy0xLTEtMA_b7bdff48-a2f2-4386-b563-3946fe94d0d8"
      unitRef="number">0.28</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i6646c81346544c4d99e9fa1d0e57c80c_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfOC0xLTEtMS0w_63a41009-8ab9-4a54-ae14-b45a092af9c8"
      unitRef="number">0.58</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ia75364130e1648e78fa02c61892d115d_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfOC0zLTEtMS0w_47f00588-4547-46cb-a0e1-86892e62136f"
      unitRef="number">0.03</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i15b5a11fc3bb4619b499f9c929493fa1_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfOC01LTEtMS0w_28236543-765f-4ac6-8751-bbac4acf61cb"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i6959b7c2c57d4c76bebc490ae176fcfd_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfOC03LTEtMS0w_9d037f70-8b6c-4e77-8695-2341fb55594d"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="if8eeb5ffe9464ea18f019180489ed088_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfOC05LTEtMS0w_6d5df48f-efb7-49a0-bd41-3ae1932aaf40"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i860cb23b9d0b4f0f94851daff5988983_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfOC0xMS0xLTEtMA_6d54b5f9-b402-4f77-8396-f1bc29574f65"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i54d000cbf2214f02a540a13d16a2e6fa_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfOC0xMy0xLTEtMA_a74fb2c8-ce8c-42b3-9674-39763761ae13"
      unitRef="number">0.61</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="iaf29f2ab93f848ea80feac95f899a8e9_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTEtMS0xLTEtMA_6d4c8ebb-56f9-4588-811f-de40583e3f3f"
      unitRef="number">0.20</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i6b5a3389083844e18566cd906171e56b_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTEtMy0xLTEtMA_fb905e13-587b-42ba-ba1c-3d738073c5ee"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ic3dc0765c3e2434885f5a3a11ecac3d6_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTEtNS0xLTEtMA_f5574f63-a37c-451b-bc34-843a99a963f4"
      unitRef="number">0.04</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i272813f6653f43e188e55ba3267529a8_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTEtNy0xLTEtMA_974fa715-f3a2-4246-8a9f-5fda5fce8bd4"
      unitRef="number">0.05</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ibc3a82b251f447e2bb647e6978c13daa_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTEtOS0xLTEtMA_fcc208db-c025-43ad-abb2-7ffa795948b5"
      unitRef="number">0.03</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i851a94e1b5a84e1aadc1d6c2a58c7df0_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTEtMTEtMS0xLTA_80ed816e-6a40-4e69-beec-8464f272c723"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ia658bdb62dae4582bd04be509941c2b5_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTEtMTMtMS0xLTA_ff0b0894-5098-484d-b21b-c3c510d5ff08"
      unitRef="number">0.39</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i8425684776dc4bd99f6c93fbcbaeed28_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTMtMS0xLTEtMA_1946a2c3-1d77-4966-b2eb-7bc2ff601b4b"
      unitRef="number">0.78</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i8a6729fa89514d4e80eba6b05b6bdddc_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTMtMy0xLTEtMA_565f735e-711d-4b4a-b80e-a87b36d0a703"
      unitRef="number">0.03</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="idf7ad2e2b01e4065b8a00585446b245c_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTMtNS0xLTEtMA_9d6685ee-2942-4613-8079-311ef7a5a206"
      unitRef="number">0.04</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ia718fc35144f49d886e94436e951426b_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTMtNy0xLTEtMA_99779516-26f7-4a28-9f30-6bafa0b7b70b"
      unitRef="number">0.05</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i5ba397b83c7c4a58bcf44d9eead0473a_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTMtOS0xLTEtMA_9118c6c0-fc8d-449a-a139-5f6cf7982104"
      unitRef="number">0.03</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i0269009dcd1e4b8e8b5484651bfc3b7f_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTMtMTEtMS0xLTA_decd5db4-2a7d-4569-adda-bb53b3745e21"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjdjODE3MGE2ZDY0OTQyOGQ4MmUyMzRiNzFhOWIyNmJjL3RhYmxlcmFuZ2U6N2M4MTcwYTZkNjQ5NDI4ZDgyZTIzNGI3MWE5YjI2YmNfMTMtMTMtMS0xLTA_3eb2f333-5146-42b7-ae76-a326e3f94a29"
      unitRef="number">1</lh:PercentofRevenueContributed>
    <lh:SalesCommissionAmortizationPeriodMinimum
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfODE0_d28b2658-2ff5-497a-a59d-76bfa14b2599">P1Y</lh:SalesCommissionAmortizationPeriodMinimum>
    <lh:SalesCommissionAmortizationPeriodMaximum
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfODIw_b01c3486-ca38-4d55-92b7-55a38beb85e8">P5Y</lh:SalesCommissionAmortizationPeriodMaximum>
    <us-gaap:CapitalizedContractCostAmortizationPeriod
      contextRef="i78561ec2276d4506995dfccf9bff7d1c_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMTcyNw_739652cc-8688-4791-9fce-e6ff34174743">P2Y</us-gaap:CapitalizedContractCostAmortizationPeriod>
    <us-gaap:CapitalizedContractCostAmortizationPeriod
      contextRef="i603496ec6a9840f2a7691f78b350638a_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMTczMw_bc6a91a4-669f-49a9-aa97-5faef006d6fd">P5Y</us-gaap:CapitalizedContractCostAmortizationPeriod>
    <us-gaap:CapitalizedContractCostTableTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfNDcwNw_0dd5ccd2-1b43-47e8-91e0-6b542d13d4d8">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales commission assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred contract fulfillment costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:CapitalizedContractCostTableTextBlock>
    <us-gaap:AccruedSalesCommissionCurrentAndNoncurrent
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjJkZTUxOTRhMjc5MDQwMjliOTRjNjE3ZGE3OTcyZmY2L3RhYmxlcmFuZ2U6MmRlNTE5NGEyNzkwNDAyOWI5NGM2MTdkYTc5NzJmZjZfMS0xLTEtMS0w_99d0e16f-3e0b-493f-84cf-6b9ebde226cd"
      unitRef="usd">32800000</us-gaap:AccruedSalesCommissionCurrentAndNoncurrent>
    <us-gaap:AccruedSalesCommissionCurrentAndNoncurrent
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjJkZTUxOTRhMjc5MDQwMjliOTRjNjE3ZGE3OTcyZmY2L3RhYmxlcmFuZ2U6MmRlNTE5NGEyNzkwNDAyOWI5NGM2MTdkYTc5NzJmZjZfMS0zLTEtMS0w_c9de9fdf-3d3a-46bb-8f8a-6b9994f2abea"
      unitRef="usd">28600000</us-gaap:AccruedSalesCommissionCurrentAndNoncurrent>
    <us-gaap:CapitalizedContractCostNet
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjJkZTUxOTRhMjc5MDQwMjliOTRjNjE3ZGE3OTcyZmY2L3RhYmxlcmFuZ2U6MmRlNTE5NGEyNzkwNDAyOWI5NGM2MTdkYTc5NzJmZjZfMi0xLTEtMS0w_059d47a2-de59-4411-8fb2-d0a8934667d0"
      unitRef="usd">12900000</us-gaap:CapitalizedContractCostNet>
    <us-gaap:CapitalizedContractCostNet
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjJkZTUxOTRhMjc5MDQwMjliOTRjNjE3ZGE3OTcyZmY2L3RhYmxlcmFuZ2U6MmRlNTE5NGEyNzkwNDAyOWI5NGM2MTdkYTc5NzJmZjZfMi0zLTEtMS0w_3e9e74f9-639a-4a67-aab7-fe56cb9a4788"
      unitRef="usd">14900000</us-gaap:CapitalizedContractCostNet>
    <us-gaap:AmountOfDeferredCostsRelatedToLongTermContracts
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjJkZTUxOTRhMjc5MDQwMjliOTRjNjE3ZGE3OTcyZmY2L3RhYmxlcmFuZ2U6MmRlNTE5NGEyNzkwNDAyOWI5NGM2MTdkYTc5NzJmZjZfMy0xLTEtMS0w_6cafff7b-6896-4248-8f77-0b7422ed045c"
      unitRef="usd">45700000</us-gaap:AmountOfDeferredCostsRelatedToLongTermContracts>
    <us-gaap:AmountOfDeferredCostsRelatedToLongTermContracts
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjJkZTUxOTRhMjc5MDQwMjliOTRjNjE3ZGE3OTcyZmY2L3RhYmxlcmFuZ2U6MmRlNTE5NGEyNzkwNDAyOWI5NGM2MTdkYTc5NzJmZjZfMy0zLTEtMS0w_11843984-4f68-4ab8-8e41-5cb7bc140657"
      unitRef="usd">43500000</us-gaap:AmountOfDeferredCostsRelatedToLongTermContracts>
    <us-gaap:AmortizationOfDeferredSalesCommissions
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMTk1Mg_309fbcb4-93ba-4163-beaf-fbd388d42c9e"
      unitRef="usd">6000000.0</us-gaap:AmortizationOfDeferredSalesCommissions>
    <us-gaap:AmortizationOfDeferredSalesCommissions
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMTk1OQ_167cce14-972d-4945-901f-0f127ad7e93b"
      unitRef="usd">5800000</us-gaap:AmortizationOfDeferredSalesCommissions>
    <us-gaap:AmortizationOfDeferredSalesCommissions
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMjAyOA_01bf8ab8-157d-4032-a104-3495b8e3d348"
      unitRef="usd">16800000</us-gaap:AmortizationOfDeferredSalesCommissions>
    <us-gaap:AmortizationOfDeferredSalesCommissions
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMjAzNQ_3c70e159-fa44-4777-be18-561c0d5f6404"
      unitRef="usd">15300000</us-gaap:AmortizationOfDeferredSalesCommissions>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMjE1Ng_60a28a8a-dcd7-4918-a8ce-739629e674cd"
      unitRef="usd">2300000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMjE2Mw_b43af797-c68b-406e-964e-5a60646a18af"
      unitRef="usd">2300000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMjE4OQ_53f3624f-55c7-406a-bb35-e20263307343"
      unitRef="usd">7600000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMjE5Ng_b51abb55-c683-488a-b2ec-8e829b72ab3f"
      unitRef="usd">6100000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfNDY5NA_3e45c5a9-17c1-4835-a47e-75614d18d430">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, which are included in accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;834.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;771.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unbilled services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:UnbilledContractsReceivable
      contextRef="i3d3f91adb0694c9f8cda5c55c146646b_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmQwZGUwZjQ4ZmM4MTQzZjQ5NmEzZjNmMGNjYThjOGViL3RhYmxlcmFuZ2U6ZDBkZTBmNDhmYzgxNDNmNDk2YTNmM2YwY2NhOGM4ZWJfMS0xLTEtMS0w_dc4835ba-e080-43b8-94a6-17e30d25bc5b"
      unitRef="usd">834000000.0</us-gaap:UnbilledContractsReceivable>
    <us-gaap:UnbilledContractsReceivable
      contextRef="ib5f5b39b26164231afef597275eaa72d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmQwZGUwZjQ4ZmM4MTQzZjQ5NmEzZjNmMGNjYThjOGViL3RhYmxlcmFuZ2U6ZDBkZTBmNDhmYzgxNDNmNDk2YTNmM2YwY2NhOGM4ZWJfMS0zLTEtMS0w_860f1f4d-2195-4d4d-8cef-15d56423d00e"
      unitRef="usd">771100000</us-gaap:UnbilledContractsReceivable>
    <us-gaap:ContractWithCustomerAssetGross
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmQwZGUwZjQ4ZmM4MTQzZjQ5NmEzZjNmMGNjYThjOGViL3RhYmxlcmFuZ2U6ZDBkZTBmNDhmYzgxNDNmNDk2YTNmM2YwY2NhOGM4ZWJfMi0xLTEtMS0w_73627dc0-a577-436e-8114-99962f248f86"
      unitRef="usd">609800000</us-gaap:ContractWithCustomerAssetGross>
    <us-gaap:ContractWithCustomerAssetGross
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmQwZGUwZjQ4ZmM4MTQzZjQ5NmEzZjNmMGNjYThjOGViL3RhYmxlcmFuZ2U6ZDBkZTBmNDhmYzgxNDNmNDk2YTNmM2YwY2NhOGM4ZWJfMi0zLTEtMS0w_5810eee8-b25d-4ff0-85d6-e25e27e7144d"
      unitRef="usd">483700000</us-gaap:ContractWithCustomerAssetGross>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmQwZGUwZjQ4ZmM4MTQzZjQ5NmEzZjNmMGNjYThjOGViL3RhYmxlcmFuZ2U6ZDBkZTBmNDhmYzgxNDNmNDk2YTNmM2YwY2NhOGM4ZWJfMy0xLTEtMS0w_9a99d4c8-ee58-4a3a-bc79-0bf166199d09"
      unitRef="usd">492900000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOmQwZGUwZjQ4ZmM4MTQzZjQ5NmEzZjNmMGNjYThjOGViL3RhYmxlcmFuZ2U6ZDBkZTBmNDhmYzgxNDNmNDk2YTNmM2YwY2NhOGM4ZWJfMy0zLTEtMS0w_a3924dab-7e8b-4787-9cf3-8e1c4a94bc43"
      unitRef="usd">449200000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:DeferredRevenueRevenueRecognized1
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMzI2MQ_ef472f9a-948d-4d59-b85c-c2102d8771cf"
      unitRef="usd">237200000</us-gaap:DeferredRevenueRevenueRecognized1>
    <us-gaap:DeferredRevenueRevenueRecognized1
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMzI2OA_ada9c589-e6a3-4b01-8b41-030ad96feb52"
      unitRef="usd">232800000</us-gaap:DeferredRevenueRevenueRecognized1>
    <us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfNDY5NQ_d27702d2-703d-4dde-8623-ece10ce249ac">The rollforward for the allowance for credit losses for the nine months ended September 30, 2020, is as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accounts Receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unbilled Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Note and Other Receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current expected credit losses opening balance impact on retained earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus, credit loss expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less, write offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfMi0xLTEtMS0w_c021f123-4ec4-41e5-92c2-6d39d9216f5d"
      unitRef="usd">19000000.0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <lh:UnbilledServicesAllowanceforCreditLoss
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfMi0zLTEtMS0w_81cbb13a-d0a6-4110-b50f-d85ccffd68a2"
      unitRef="usd">2300000</lh:UnbilledServicesAllowanceforCreditLoss>
    <lh:NoteReceivableAllowanceforCreditLoss
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfMi01LTEtMS0w_0f5590eb-edb3-4d35-b579-6c0b30ef41e7"
      unitRef="usd">0</lh:NoteReceivableAllowanceforCreditLoss>
    <lh:AllowanceforCreditLoss
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfMi03LTEtMS0w_15ef2fc3-7c91-4f73-bd5d-4d0287dd1e71"
      unitRef="usd">21300000</lh:AllowanceforCreditLoss>
    <lh:CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings
      contextRef="ib21823aba6f14b7abd5b9938f0373824_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfMy0xLTEtMS0w_f9e67e02-22c9-40be-8673-ca213ed55005"
      unitRef="usd">1800000</lh:CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings>
    <lh:CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings
      contextRef="i33a372065d96498db0755abec1a36919_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfMy0zLTEtMS0w_8bd66e55-febc-4999-9283-4d5dfe5055ef"
      unitRef="usd">200000</lh:CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings>
    <lh:CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings
      contextRef="ibc7ed4faa9454198b02470d9bf8c948d_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfMy01LTEtMS0w_9c3791ff-ab3a-44d5-b84c-6ddf20b18d0d"
      unitRef="usd">5000000.0</lh:CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings>
    <lh:CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfMy03LTEtMS0w_171c1ca7-a709-4893-ac43-a22401c36887"
      unitRef="usd">7000000.0</lh:CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfNC0xLTEtMS0w_3155d2ff-3a8a-4bb8-b1b9-fa46396bdecf"
      unitRef="usd">10000000.0</us-gaap:ProvisionForDoubtfulAccounts>
    <lh:UnbilledServicesCreditLossExpenseReversal
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfNC0zLTEtMS0w_b0481424-e6e2-49f7-ae65-4a18c0ba09a1"
      unitRef="usd">3900000</lh:UnbilledServicesCreditLossExpenseReversal>
    <lh:NoteReceivableCreditLossExpenseReversal
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfNC01LTEtMS0w_c57b16e5-de51-4cd9-b1bd-0fbc2d98f02d"
      unitRef="usd">700000</lh:NoteReceivableCreditLossExpenseReversal>
    <lh:CreditLossExpenseReversal
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfNC03LTEtMS0w_3a16dd94-35f4-4dae-b7c2-84cc5aa54e68"
      unitRef="usd">14600000</lh:CreditLossExpenseReversal>
    <lh:AllowanceforCreditLossWriteOff
      contextRef="ib21823aba6f14b7abd5b9938f0373824_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfNS0xLTEtMS0w_9e8e483d-1127-43e6-ba94-0f4411a746c0"
      unitRef="usd">4200000</lh:AllowanceforCreditLossWriteOff>
    <lh:AllowanceforCreditLossWriteOff
      contextRef="i33a372065d96498db0755abec1a36919_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfNS0zLTEtMS0w_b9779ced-203e-43e1-b345-5fbe83414dba"
      unitRef="usd">100000</lh:AllowanceforCreditLossWriteOff>
    <lh:AllowanceforCreditLossWriteOff
      contextRef="ibc7ed4faa9454198b02470d9bf8c948d_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfNS01LTEtMS0w_fd8760a9-5235-4622-920b-822bf37b416a"
      unitRef="usd">0</lh:AllowanceforCreditLossWriteOff>
    <lh:AllowanceforCreditLossWriteOff
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfNS03LTEtMS0w_fc3c353b-43cc-4707-937a-23fda88eb8fb"
      unitRef="usd">4300000</lh:AllowanceforCreditLossWriteOff>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfNi0xLTEtMS0w_59c5087c-eff0-4120-afef-735f23faddd0"
      unitRef="usd">26600000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <lh:UnbilledServicesAllowanceforCreditLoss
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfNi0zLTEtMS0w_0373b807-1d66-453d-8182-e65dd2945799"
      unitRef="usd">6300000</lh:UnbilledServicesAllowanceforCreditLoss>
    <lh:NoteReceivableAllowanceforCreditLoss
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfNi01LTEtMS0w_7678c777-5058-47b4-a248-da18c83213e6"
      unitRef="usd">5700000</lh:NoteReceivableAllowanceforCreditLoss>
    <lh:AllowanceforCreditLoss
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RhYmxlOjlkMzExM2Q4OTQwMjRmY2Q5NTE0ZDc0ZjExZDRiY2RkL3RhYmxlcmFuZ2U6OWQzMTEzZDg5NDAyNGZjZDk1MTRkNzRmMTFkNGJjZGRfNi03LTEtMS0w_0d666683-d85f-47e9-bfa9-d04d6d736659"
      unitRef="usd">38600000</lh:AllowanceforCreditLoss>
    <us-gaap:NotesReceivableFairValueDisclosure
      contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMzI5ODUzNDg4ODkxNg_4bfcfd76-d0c2-4bc2-9b6c-edcbd67ad95d"
      unitRef="usd">110000000.0</us-gaap:NotesReceivableFairValueDisclosure>
    <lh:Impairmentoffloatingratenotereceivable
      contextRef="i1982102278bd444d897b0ac03dedfda5_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfMzI5ODUzNDg4ODMxMQ_2369b258-26af-4b76-961c-4e596779695c"
      unitRef="usd">700000</lh:Impairmentoffloatingratenotereceivable>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfNDE4MQ_286df2d7-e393-40b7-9cca-a974a87db320"
      unitRef="usd">4795000000.0</us-gaap:RevenueRemainingPerformanceObligation>
    <lh:Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfNDIzMg_74940cfc-b67d-4c86-b4b6-7fd5cddc521f"
      unitRef="number">0.32</lh:Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear>
    <lh:LongTermContractsDurationMinimum
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfNDQwNQ_d8d079d2-59ce-4a46-ab7e-adac672a1c4d">P1Y</lh:LongTermContractsDurationMinimum>
    <lh:LongTermContractsDurationMaximum
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfNDQxMQ_688968d5-7619-465f-9b48-ce4ec734ad03">P8Y</lh:LongTermContractsDurationMaximum>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfNDQ0NQ_8b18f170-9cda-47b8-bb7e-e19b17e67e4a"
      unitRef="usd">44800000</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNC9mcmFnOjBiYWM2YWEyNzc2NzQ3YjZhYjg1YTEzNzIxNDI5NGE1L3RleHRyZWdpb246MGJhYzZhYTI3NzY3NDdiNmFiODVhMTM3MjE0Mjk0YTVfNDQ1Mg_afe61afc-6d90-417e-bbc4-fec272c82ae5"
      unitRef="usd">67700000</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMzE5Nw_7fb9be15-399b-42f1-8607-5d742029cb14">BUSINESS ACQUISITIONS AND DISPOSITIONS During the nine months ended September 30, 2020, the Company acquired various business and related assets for approximately $208.8 in cash (including contingent consideration of $6.0 and net of cash acquired), $113.4 within LCD and $95.4 within CDD. The purchase consideration for all acquisitions in the nine months ended September 30, 2020, has been allocated under the acquisition method of accounting to the estimated fair market value of the net assets acquired, including approximately $88.5 in identifiable intangible assets and a residual amount of non-tax deductible goodwill of approximately $128.9. The amortization periods for intangible assets acquired from these businesses range from 5 to 15 years for customer relationships and non-compete agreements. These acquisitions were made primarily to extend the Company's geographic reach in important market areas, enhance the Company's scientific differentiation and to expand the breadth and scope of the &lt;div style="margin-bottom:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company's CRO services. The excess of the fair value of the consideration conveyed over the fair value of the net assets acquired was recorded as goodwill. The goodwill reflects the Company's expectations to utilize the acquired businesses' workforce and established relationships and the benefits of being able to leverage operational efficiencies with favorable growth opportunities in these markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These acquisitions contributed $13.1 and $13.8 of revenue during the three and nine months ended September 30, 2020, respectively. The acquisitions contributed $3.5 and $3.6 of operating income, during the three and nine months ended September 30, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September&#160;30, 2019, the Company acquired various businesses and related assets for approximately $852.9 in cash (net of cash acquired), $647.4 within CDD and $205.5 within LCD. The purchase consideration for all acquisitions in the nine months ended September 30, 2019, has been allocated to the estimated fair market value of the net assets acquired, including approximately $324.1 in identifiable intangible assets and a residual amount of non-tax deductible goodwill for approximately $512.3. The amortization periods for intangible assets acquired from these businesses range from 11 to 15 years for customer relationships. These acquisitions were made primarily to extend the Company's geographic reach in important market areas, enhance the Company's scientific differentiation and to expand the breadth and scope of the Company's CRO services. The excess of the fair value of the consideration conveyed over the fair value of the net assets acquired was recorded as goodwill. The goodwill reflects the Company's expectations to utilize the acquired businesses' workforce and established relationships and the benefits of being able to leverage operational efficiencies with favorable growth opportunities in these markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June&#160;3, 2019, CDD acquired Envigo's nonclinical contract research services business, expanding CDD's global nonclinical drug development capabilities with additional locations and resources. Additionally, the Company divested the Covance Research Products business (CRP), which was a part of CDD, to Envigo. As part of this sale, CDD entered into a multi-year, renewable supply agreement with Envigo. The Company paid cash consideration of $601.0 (which is included in the nine month acquisition numbers above), received a floating rate secured note of $110.0, and recorded a loss on the sale of CRP of $12.2. The Company funded the transaction through a new term loan facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The final valuation of acquired assets and assumed liabilities in the transaction as of June 3, 2019, include the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.371%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consideration Transferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of CRP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Final &lt;br/&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Assets Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unbilled services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade name and trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Envigo assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Floating rate secured note receivable due 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:11pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The final purchase consideration for Envigo has been allocated to the estimated fair market value of the net assets acquired, including approximately $141.4 in identifiable intangible assets and a residual amount of non-tax-deductible goodwill of approximately $376.6. The amortization period for intangible assets acquired is 11 years for customer relationships. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Unaudited Pro Forma Information &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;     &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Had the Company's total 2019 and 2020 acquisitions been completed as of January 1, 2018, or January 1, 2019, respectively, the Company's pro forma results would have been as follows:&lt;/span&gt;&lt;span style="color:#0094ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,899.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,969.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,524.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,827.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to Laboratory Corporation of America Holdings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ifc042ac91d2148ea90e2852e684aa7d1_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMTA5OTUxMTYzMzA5NA_7c5c841c-ddd5-4a04-89d6-7f7fc482d28e"
      unitRef="usd">208800000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMTA5OTUxMTYzMzE0NQ_46aacc47-3856-4993-99cc-3b8cc75684fc"
      unitRef="usd">6000000.0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i2f8f9d7520ef4499b316c87363b01437_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfNDk0NzgwMjMzODA0MA_29d3ce24-c60c-4231-b59a-bc068cc00f21"
      unitRef="usd">113400000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ifc1b3052e0d1420fae79ce70434a92f8_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfNDk0NzgwMjMzODA2Mw_092e44c1-0896-4413-b16c-156c01dbbcd6"
      unitRef="usd">95400000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="ifc042ac91d2148ea90e2852e684aa7d1_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMTA5OTUxMTYzMzMzMA_0a77bcb2-6d56-4fa4-bf20-2c890d7996eb"
      unitRef="usd">88500000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ifc042ac91d2148ea90e2852e684aa7d1_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMTA5OTUxMTYzMzQzOA_1fc54fd5-64bd-4bb4-84f8-9abc11b369fc"
      unitRef="usd">128900000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i29bbac08d4cd42b590e8d38341b247a4_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMTA5OTUxMTYzNjc3MA_64166a6e-2960-4d0f-bfd5-0431d26f3c7e">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ie8ba5b5579de49a1834d28dc2798cee3_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMTA5OTUxMTYzNjc3Nw_08426bb4-ca2e-44ec-9902-7fd233e2992f">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:Revenues
      contextRef="i83cd8f691c1a4a83bc738d2b7ddb6e5f_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMTA5OTUxMTYzOTczNg_a5ac9fce-b654-4abc-9a22-f28d825c2747"
      unitRef="usd">13100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifc042ac91d2148ea90e2852e684aa7d1_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMzI5ODUzNDg5Nzc2Ng_44e548eb-7b51-4bc6-a844-1cc9113a3a69"
      unitRef="usd">13800000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="i83cd8f691c1a4a83bc738d2b7ddb6e5f_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMTA5OTUxMTYzOTc0NA_6faa1356-9a96-406c-9c8b-eb58fb898986"
      unitRef="usd">3500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifc042ac91d2148ea90e2852e684aa7d1_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMTA5OTUxMTYzOTc0OA_3096e43d-a033-4e73-9501-b82b7ea98a8b"
      unitRef="usd">3600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="id22f921dc2c74abe80fcd674d286c147_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMTkyOQ_2d3a4bd7-8c91-4cf5-9382-35b28d82edf5"
      unitRef="usd">852900000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i9b54967480df4194966a376ec02d6eb4_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfNDk0NzgwMjMzODA4Mg_1921ab86-ec6f-46a5-9c38-1bd37ee610ab"
      unitRef="usd">647400000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ic7b895159e664819875373401fc83cfe_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfNDk0NzgwMjMzODEwMQ_e7229d74-2478-4b38-a328-344fc8ba021d"
      unitRef="usd">205500000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="id22f921dc2c74abe80fcd674d286c147_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMjE1Nw_9324fabb-2359-4084-8dc1-f7e7566d99de"
      unitRef="usd">324100000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="id22f921dc2c74abe80fcd674d286c147_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMjI2NQ_4f89256e-40e9-4e9d-8efe-e565dd3ff62e"
      unitRef="usd">512300000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="if96ac9c12a5b46ffa647f1720c503604_D20190101-20190930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMjM1OA_f0150748-158f-481e-ad42-5802a89ed17b">P11Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="id93dacc653da4b5f9dccaf725dcbc769_D20190101-20190930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMjM2NA_d9210c3f-f42f-42ea-a96d-f1bad7877925">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i32a9df56eb784dc7a4b220f78de9bd76_D20190603-20190603"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMzI5ODUzNDg5Njk0Nw_89c54f18-82a1-4317-8dd8-a9f5f9de3617"
      unitRef="usd">601000000.0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:NotesReceivableFairValueDisclosure
      contextRef="ieb6fe2a304194224befa49dcb5ed37d4_I20190603"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMzI5ODUzNDg5Njk5Mw_bd4ba44f-d457-42c6-a61c-ec577e94317f"
      unitRef="usd">110000000.0</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="i3142bfab671e4d37943fa55426510724_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMzI5ODUzNDg5NzA0MA_f82cbc43-341c-4b6e-98b3-a7f9be94f5cb"
      unitRef="usd">-12200000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i612a5521f96f4a1db5dcc91dda46a2e8_D20200401-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMTA5OTUxMTY0MjE5Nw_ec718758-b11e-496a-8cea-3039b9efe08c">&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The final valuation of acquired assets and assumed liabilities in the transaction as of June 3, 2019, include the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.371%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consideration Transferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of CRP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Final &lt;br/&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Assets Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unbilled services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade name and trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Envigo assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Floating rate secured note receivable due 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i32a9df56eb784dc7a4b220f78de9bd76_D20190603-20190603"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMS01LTEtMS05MTY0_89c54f18-82a1-4317-8dd8-a9f5f9de3617"
      unitRef="usd">601000000.0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:NotesReceivableFairValueDisclosure
      contextRef="ieb6fe2a304194224befa49dcb5ed37d4_I20190603"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMi01LTEtMS05MTY0_bd4ba44f-d457-42c6-a61c-ec577e94317f"
      unitRef="usd">110000000.0</us-gaap:NotesReceivableFairValueDisclosure>
    <lh:Totalacquisitionconsiderationcashstocknotesetc.
      contextRef="ieb6fe2a304194224befa49dcb5ed37d4_I20190603"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMy0yLTEtMS05MzI2_c9e52ea7-e801-4902-ab73-606befd6857c"
      unitRef="usd">711000000.0</lh:Totalacquisitionconsiderationcashstocknotesetc.>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfNy02LTEtMS05MTU1_bb3970b4-3543-4d64-94e2-b7442f8a147f"
      unitRef="usd">11300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfOC02LTEtMS05MTU1_a36a1e11-752a-4ca0-845f-957dec7f2dc1"
      unitRef="usd">12100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfOS02LTEtMS05MTU1_31d80ad9-113c-49e7-8c43-3e47a1e2858c"
      unitRef="usd">25600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMTAtNi0xLTEtOTE1NQ_c86f5460-aa58-4ea5-885e-0ec8e0c2ec61"
      unitRef="usd">4500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMTEtNi0xLTEtOTE1NQ_a4ab6a59-03bb-4470-9113-76ed49d03326"
      unitRef="usd">10800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMTItNi0xLTEtOTE1NQ_e702f33d-9182-41b7-b396-881586f73742"
      unitRef="usd">128400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMTMtNi0xLTEtOTE1NQ_f2414e44-22b3-40cb-86f5-ce091798f28c"
      unitRef="usd">25200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMTQtNi0xLTEtOTE1NQ_49816b1e-e03c-48d1-87cd-e16382b77aaa"
      unitRef="usd">376600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="ie9cc69f41c9c44488b638ef3aaccdb61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMTUtNi0xLTEtOTE1NQ_e78f2a62-e6be-45e3-91a9-cf9b247d55f6"
      unitRef="usd">140800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="iae23e3cdb39a44b8968341916d4a2dee_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMTYtNi0xLTEtOTE1NQ_49dfe84b-6592-41bf-a963-c7897d3020ae"
      unitRef="usd">600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
      contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMTctNi0xLTEtOTE1NQ_0427e072-5468-491e-88f0-eeb162e2ad89"
      unitRef="usd">9900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMTgtNi0xLTEtOTE1NQ_bf64a532-92ac-458e-83bf-3721a2b8fb06"
      unitRef="usd">745800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMTktNi0xLTEtOTE1NQ_57533d1e-ac0a-49f6-8305-009e7f98679e"
      unitRef="usd">15200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMjAtNi0xLTEtOTE1NQ_32456fe5-028e-4bde-8977-b5b8bf6a450f"
      unitRef="usd">10400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMjEtNi0xLTEtOTE1NQ_a1ad8173-c3ce-46ef-b846-3a93f4e92484"
      unitRef="usd">49900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities
      contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMjQtNi0xLTEtOTE1NQ_088e784c-408f-4f45-9fc5-e4273a479dad"
      unitRef="usd">69300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMjUtNi0xLTEtOTE1NQ_53af557a-7c07-4342-91a7-6eb9e0abf8bf"
      unitRef="usd">144800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMjYtNi0xLTEtOTE1NQ_52e665c3-536e-4716-9888-f0d548a82d92"
      unitRef="usd">601000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:NotesReceivableFairValueDisclosure
      contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMjctMi0xLTEtOTE5Mw_4bfcfd76-d0c2-4bc2-9b6c-edcbd67ad95d"
      unitRef="usd">110000000.0</us-gaap:NotesReceivableFairValueDisclosure>
    <lh:Totalacquisitionconsiderationcashstocknotesetc.
      contextRef="i8272c3d15f864e709f533b5532e0c9c8_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmVjN2U1ZmNjMDM3ZTRiMDY4YjQ0ZWU3MTM1OWRjZjJjL3RhYmxlcmFuZ2U6ZWM3ZTVmY2MwMzdlNGIwNjhiNDRlZTcxMzU5ZGNmMmNfMjgtMi0xLTEtOTMyOA_75bf26e8-af29-43e8-a49e-ed801c3060e3"
      unitRef="usd">711000000.0</lh:Totalacquisitionconsiderationcashstocknotesetc.>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMzI5ODUzNDg5NzM5Mw_160a0d99-8e12-4465-a002-1d1630c138ce"
      unitRef="usd">141400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i3e065a3d3a9a44bd9969178157790cfd_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMzI5ODUzNDg5NzUwMQ_f0e49062-694b-47ae-bc40-e480277d8ef7"
      unitRef="usd">376600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i05c3bfa9f9624b64841e19fc622f33fa_D20200401-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMzI5ODUzNDg5NzU2NA_d27a2b78-49d7-48b5-8f17-bfbca3b53af5">P11Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RleHRyZWdpb246YzY0OWRkNDEyNDk1NGI0ZDk3MWIyZjJiZTk0YTk0ZjFfMzIwMg_ec0a4714-c452-4cdc-a256-212359f4b6be">&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Unaudited Pro Forma Information &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;     &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Had the Company's total 2019 and 2020 acquisitions been completed as of January 1, 2018, or January 1, 2019, respectively, the Company's pro forma results would have been as follows:&lt;/span&gt;&lt;span style="color:#0094ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,899.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,969.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,524.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,827.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to Laboratory Corporation of America Holdings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmQwZDFiZmY5ODBiNTRhYjFhOTZhNWVkNjEyOGY3ZDYzL3RhYmxlcmFuZ2U6ZDBkMWJmZjk4MGI1NGFiMWE5NmE1ZWQ2MTI4ZjdkNjNfMi0xLTEtMS0w_58f1990d-641f-447d-bd6b-afa96b6e05bf"
      unitRef="usd">3899700000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmQwZDFiZmY5ODBiNTRhYjFhOTZhNWVkNjEyOGY3ZDYzL3RhYmxlcmFuZ2U6ZDBkMWJmZjk4MGI1NGFiMWE5NmE1ZWQ2MTI4ZjdkNjNfMi0yLTEtMS0w_2fe60acf-8051-4f33-bac5-44e92af46bf3"
      unitRef="usd">2969000000.0</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmQwZDFiZmY5ODBiNTRhYjFhOTZhNWVkNjEyOGY3ZDYzL3RhYmxlcmFuZ2U6ZDBkMWJmZjk4MGI1NGFiMWE5NmE1ZWQ2MTI4ZjdkNjNfMi00LTEtMS0w_65d68f35-5e9b-4b06-8642-d828375086a5"
      unitRef="usd">9524200000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmQwZDFiZmY5ODBiNTRhYjFhOTZhNWVkNjEyOGY3ZDYzL3RhYmxlcmFuZ2U6ZDBkMWJmZjk4MGI1NGFiMWE5NmE1ZWQ2MTI4ZjdkNjNfMi01LTEtMS0w_2ab334a8-41e4-4f2e-baf2-e822465f3dda"
      unitRef="usd">8827700000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmQwZDFiZmY5ODBiNTRhYjFhOTZhNWVkNjEyOGY3ZDYzL3RhYmxlcmFuZ2U6ZDBkMWJmZjk4MGI1NGFiMWE5NmE1ZWQ2MTI4ZjdkNjNfMy0xLTEtMS0w_a78c6a84-ae77-448a-a6b0-353460abfa2a"
      unitRef="usd">744900000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmQwZDFiZmY5ODBiNTRhYjFhOTZhNWVkNjEyOGY3ZDYzL3RhYmxlcmFuZ2U6ZDBkMWJmZjk4MGI1NGFiMWE5NmE1ZWQ2MTI4ZjdkNjNfMy0yLTEtMS0w_7c6127b5-1b09-4153-a764-99930c2d9f1d"
      unitRef="usd">224300000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmQwZDFiZmY5ODBiNTRhYjFhOTZhNWVkNjEyOGY3ZDYzL3RhYmxlcmFuZ2U6ZDBkMWJmZjk4MGI1NGFiMWE5NmE1ZWQ2MTI4ZjdkNjNfMy00LTEtMS0w_5dba48da-952c-4a82-bbda-16454a770e9b"
      unitRef="usd">666300000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV8zNy9mcmFnOmM2NDlkZDQxMjQ5NTRiNGQ5NzFiMmYyYmU5NGE5NGYxL3RhYmxlOmQwZDFiZmY5ODBiNTRhYjFhOTZhNWVkNjEyOGY3ZDYzL3RhYmxlcmFuZ2U6ZDBkMWJmZjk4MGI1NGFiMWE5NmE1ZWQ2MTI4ZjdkNjNfMy01LTEtMS0w_260726a1-9e06-47a7-bb91-9111a52edacc"
      unitRef="usd">612900000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RleHRyZWdpb246OTU4OGQyMzhkODkyNDljZjlkNWVhNjIyNzQxN2ViYWRfMTQ1OA_9ffebff2-d816-4613-9540-2ad06cc025b9">EARNINGS PER SHARE&lt;div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is computed by dividing net earnings attributable to Laboratory Corporation of America Holdings by the weighted average number of common shares outstanding. Diluted earnings per share is computed by dividing net earnings including the impact of dilutive adjustments by the weighted average number of common shares outstanding plus potentially dilutive shares, as if they had been issued at the earlier of the date of issuance or the beginning of the period presented. Potentially dilutive common shares result primarily from the Company&#x2019;s outstanding stock options, restricted stock awards, restricted stock units, and performance share awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following represents a reconciliation of basic earnings per share to diluted earnings per share:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Per Share Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Per Share Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earning&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Per Share Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Per Share Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basic earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;703.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;97.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;220.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;97.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;617.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;97.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;596.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;98.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dilutive effect of employee&#160;stock options and awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings including impact of dilutive adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;703.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;98.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;220.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;98.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;617.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;97.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;596.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;98.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted earnings per share represent the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. These potential shares include dilutive stock options and unissued restricted stock awards. The following table summarizes the potential common shares not included in the computation of diluted earnings per share because their impact would have been antidilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock options and awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RleHRyZWdpb246OTU4OGQyMzhkODkyNDljZjlkNWVhNjIyNzQxN2ViYWRfMTQ1MA_52036e64-7efb-4bf2-80d0-1e36d0fcde4e">&lt;div style="margin-top:6pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following represents a reconciliation of basic earnings per share to diluted earnings per share:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Per Share Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Per Share Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earning&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Per Share Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Per Share Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basic earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;703.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;97.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;220.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;97.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;617.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;97.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;596.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;98.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dilutive effect of employee&#160;stock options and awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings including impact of dilutive adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;703.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;98.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;220.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;98.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;617.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;97.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;596.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;98.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNC0xLTEtMS0w_1cae89d9-0ad6-40ca-bcb0-f4ccc412e49d"
      unitRef="usd">703400000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNC0zLTEtMS0w_98b73f09-9203-44fa-8108-10ab9cb5c167"
      unitRef="shares">97400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNC01LTEtMS0w_cb2f01e6-0af8-406a-b721-fec31af221d4"
      unitRef="usdPerShare">7.22</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLoss
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNC03LTEtMS0w_49117119-626c-4a46-a4fa-b583c9d237d5"
      unitRef="usd">220700000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNC05LTEtMS0w_1d571c7b-4b70-4546-bf8e-3d56b7358d32"
      unitRef="shares">97600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNC0xMS0xLTEtMA_f4249bcc-1505-4ca2-8a3a-3edb906b4481"
      unitRef="usdPerShare">2.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLoss
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNC0xMy0xLTEtMA_5070a3f8-7f46-436f-a590-f64284d6c9b4"
      unitRef="usd">617800000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNC0xNS0xLTEtMA_1778eb66-9e01-470d-9240-903bd065ae6f"
      unitRef="shares">97300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNC0xNy0xLTEtMA_2588bbfa-8c68-4325-98e2-5bd62b67ee1f"
      unitRef="usdPerShare">6.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLoss
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNC0xOS0xLTEtMA_73fe8b05-a6ff-4b85-840b-dd6b03d99de5"
      unitRef="usd">596700000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNC0yMS0xLTEtMA_a6a309b9-75fd-4587-9abd-c31d8ba60250"
      unitRef="shares">98100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNC0yMy0xLTEtMA_d295d5ff-3df9-4195-9a4a-6e29f879db97"
      unitRef="usdPerShare">6.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNS0zLTEtMS0w_25a69057-75b6-44ca-9374-08eed84231e4"
      unitRef="shares">700000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNS05LTEtMS0w_ea01927e-74ea-448d-8be4-113165e7259b"
      unitRef="shares">700000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNS0xNS0xLTEtMA_f5193758-239b-480e-9341-1c8753340d23"
      unitRef="shares">600000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfNS0yMS0xLTEtMA_2266c5d7-a877-41db-a6ed-aaa08c9fc758"
      unitRef="shares">700000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfOC0xLTEtMS0w_dd9d3f0d-7ae7-40bf-b8c6-aa906a5e6c67"
      unitRef="usd">703400000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfOC0zLTEtMS0w_546d277f-9439-46a3-9f32-fc26752061fd"
      unitRef="shares">98100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfOC01LTEtMS0w_a9c2f699-821d-4441-b55e-a8e78ff7f84c"
      unitRef="usdPerShare">7.17</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfOC03LTEtMS0w_acdf1eb8-4519-4d22-9c21-be382bbbb3a6"
      unitRef="usd">220700000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfOC05LTEtMS0w_acba1609-6ac8-4859-b163-d09b5e3f1595"
      unitRef="shares">98300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfOC0xMS0xLTEtMA_aae399e8-8a5d-4c69-9b8f-c77b01c9a87b"
      unitRef="usdPerShare">2.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfOC0xMy0xLTEtMA_29648cb8-6681-47de-95ed-e290fd23396a"
      unitRef="usd">617800000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfOC0xNS0xLTEtMA_f2355de2-ac67-4f02-92f7-53becccdcd92"
      unitRef="shares">97900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfOC0xNy0xLTEtMA_56b87990-e333-456c-a126-acea499858f4"
      unitRef="usdPerShare">6.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfOC0xOS0xLTEtMA_54e47da4-1eac-492c-9000-81bfec2dd128"
      unitRef="usd">596700000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfOC0yMS0xLTEtMA_93582092-e77d-4b78-9026-0cecc5c45888"
      unitRef="shares">98800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjVlZTllM2ZiMGEzMDQ1OWNiY2ZlYWY3NDk5ZTliMTE5L3RhYmxlcmFuZ2U6NWVlOWUzZmIwYTMwNDU5Y2JjZmVhZjc0OTllOWIxMTlfOC0yMy0xLTEtMA_77cb1670-b3f5-4df1-babd-ea94dee9f20e"
      unitRef="usdPerShare">6.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RleHRyZWdpb246OTU4OGQyMzhkODkyNDljZjlkNWVhNjIyNzQxN2ViYWRfMTQyOA_c2dbd1ac-086e-4313-9da5-d97fea27b5c7">The following table summarizes the potential common shares not included in the computation of diluted earnings per share because their impact would have been antidilutive:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock options and awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjIxMzllM2M0NGRkNjRlOWI5NzJiYjc3Yzg5NzdhMzUwL3RhYmxlcmFuZ2U6MjEzOWUzYzQ0ZGQ2NGU5Yjk3MmJiNzdjODk3N2EzNTBfMi0xLTEtMS0w_c10562bf-e491-4afb-b4ca-3b6efe5090b3"
      unitRef="shares">200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjIxMzllM2M0NGRkNjRlOWI5NzJiYjc3Yzg5NzdhMzUwL3RhYmxlcmFuZ2U6MjEzOWUzYzQ0ZGQ2NGU5Yjk3MmJiNzdjODk3N2EzNTBfMi0zLTEtMS0w_50cdd7fe-0c2c-4033-b287-6424a41f1a7e"
      unitRef="shares">200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjIxMzllM2M0NGRkNjRlOWI5NzJiYjc3Yzg5NzdhMzUwL3RhYmxlcmFuZ2U6MjEzOWUzYzQ0ZGQ2NGU5Yjk3MmJiNzdjODk3N2EzNTBfMi01LTEtMS0w_ec4265f2-5cb2-4979-9944-5afeebdf8f52"
      unitRef="shares">400000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80MC9mcmFnOjk1ODhkMjM4ZDg5MjQ5Y2Y5ZDVlYTYyMjc0MTdlYmFkL3RhYmxlOjIxMzllM2M0NGRkNjRlOWI5NzJiYjc3Yzg5NzdhMzUwL3RhYmxlcmFuZ2U6MjEzOWUzYzQ0ZGQ2NGU5Yjk3MmJiNzdjODk3N2EzNTBfMi03LTEtMS0w_d9046031-6d1c-4d61-9fb0-2bc61d186077"
      unitRef="shares">200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfMTExNg_afe54f1e-6781-4b02-ad4b-b281550159c2">RESTRUCTURING AND OTHER CHARGES&lt;div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September&#160;30, 2020, the Company recorded net restructuring and other charges of $38.9: $13.4 within LCD and $25.5 within CDD. The charges were comprised of $12.8 related to severance and other personnel costs, $11.0 for a CDD leased lab facility and equipment impairments, and $24.0 in facility closures, impairment of operating lease right-of use assets and general integration activities. The charges were offset by the reversal of previously established liability of $1.1 and $7.8 in unused severance costs and facility-related costs, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September&#160;30, 2019, the Company recorded net restructuring and other charges of $48.4: $22.8 within LCD and $25.6 within CDD. The charges were comprised of $26.2 related to severance and other personnel costs and $22.0 in costs associated with facility closures, impairment of operating lease right-of-use assets and general integration initiatives. The charges were increased by the adjustment of previously established reserves of $0.4 in severance reserves and decreased by a reversal of $0.2 in unused facility reserves. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following represents the Company&#x2019;s restructuring reserve activities for the period indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LCD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CDD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and Other Employee Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Facility Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and Other Employee Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Facility Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment of lab facility and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <lh:NetRestructuringCharges
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfMTA5OTUxMTYyOTAwNA_06232df5-c987-4874-b531-2ef3cb24bfdb"
      unitRef="usd">38900000</lh:NetRestructuringCharges>
    <lh:NetRestructuringCharges
      contextRef="i60bf6e0de9384f37926fac0c0db06385_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfMTA5OTUxMTYyOTAxMQ_a404ccf5-ea15-4696-a6e8-a59c0581e555"
      unitRef="usd">13400000</lh:NetRestructuringCharges>
    <lh:NetRestructuringCharges
      contextRef="if366c14694954f6f84a2c0fe5708324e_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfMTA5OTUxMTYyOTAxOQ_a185c597-2e17-4470-9d73-e2e953a13f4a"
      unitRef="usd">25500000</lh:NetRestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfMTg3_ef0e0f78-79e8-4449-a623-00b7b409b853"
      unitRef="usd">12800000</us-gaap:SeveranceCosts1>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfMjM4_25ba2618-7295-423a-85f9-1a059ff771c2"
      unitRef="usd">11000000.0</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:BusinessExitCosts1
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfMjk1_bfba342c-1c5d-42aa-8f06-4854b2c673a8"
      unitRef="usd">24000000.0</us-gaap:BusinessExitCosts1>
    <lh:EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfNDg1_daba2453-2e38-42e6-8f43-189174478d9f"
      unitRef="usd">1100000</lh:EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment>
    <lh:Unusedfacilityrestructuringreserves
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfNDky_3cf76135-46b8-4a29-8e8e-bfbdbf13bb03"
      unitRef="usd">7800000</lh:Unusedfacilityrestructuringreserves>
    <lh:NetRestructuringCharges
      contextRef="i3142bfab671e4d37943fa55426510724_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfMTA5OTUxMTYyODk4Mw_f89f8dc3-2bd9-4319-a632-7b77a4f985a3"
      unitRef="usd">48400000</lh:NetRestructuringCharges>
    <lh:NetRestructuringCharges
      contextRef="i08f70824033d48f0ad6009880d1268f6_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfMTA5OTUxMTYyODk5MA_f748a733-d5e2-47ae-a826-d00751bc51fb"
      unitRef="usd">22800000</lh:NetRestructuringCharges>
    <lh:NetRestructuringCharges
      contextRef="i34ea8623f99d450ba0c680719bfe3105_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfMTA5OTUxMTYyODk5Nw_aa7a7a4c-f420-4966-a2fe-175d967e5435"
      unitRef="usd">25600000</lh:NetRestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="i3142bfab671e4d37943fa55426510724_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfNzA5_d7ab1ba8-2611-4ad7-87c5-04d734694fd7"
      unitRef="usd">26200000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i3142bfab671e4d37943fa55426510724_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfNzYz_ec0ccf34-4504-4a4f-8f11-0a60591c7fdc"
      unitRef="usd">22000000.0</us-gaap:BusinessExitCosts1>
    <lh:EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment
      contextRef="i3142bfab671e4d37943fa55426510724_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfOTgw_c80fe76f-20b7-43c1-a3ef-e953d459b406"
      unitRef="usd">400000</lh:EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment>
    <lh:Unusedfacilityrestructuringreserves
      contextRef="i3142bfab671e4d37943fa55426510724_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfMTY0OTI2NzQ0MjgzNA_57526324-1743-425a-9050-31c8697e4e36"
      unitRef="usd">200000</lh:Unusedfacilityrestructuringreserves>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RleHRyZWdpb246MmQxNDBmMTNjYjkzNDgwMmI0MGFmNDZiZTdlZjY4NDNfMTEyNw_aebfe503-db9e-4c28-963a-d8463a5aa351">&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following represents the Company&#x2019;s restructuring reserve activities for the period indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LCD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CDD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and Other Employee Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Facility Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and Other Employee Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Facility Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment of lab facility and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i43d39dfc46f64e9ca238eb8a039fa85f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfMi0xLTEtMS0w_5e0dc059-4a43-4665-9d93-b857c6722891"
      unitRef="usd">500000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="if5bcb822134b4295bec55008826197e5_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfMi0zLTEtMS0w_7795f3c0-291b-4166-a0ef-3bb5e5db5536"
      unitRef="usd">2700000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i616e955ba8fd4b48be31816f59836100_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfMi01LTEtMS0w_553aab91-e1c0-4dad-8b0f-c54cc8be48c4"
      unitRef="usd">5500000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i1dfebc2c21b9448d96ac217371534543_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfMi03LTEtMS0w_fea6a51e-bba1-41c4-b2bd-65240e75bd57"
      unitRef="usd">4700000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfMi05LTEtMS0w_e849feba-6b12-456c-a733-6f087cb5d2da"
      unitRef="usd">13400000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="idb6c26b91b524c4abbfa955d1ddc4457_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfNC0xLTEtMS0w_02ee4bcb-558b-4e9f-b0a6-2b93a647d50b"
      unitRef="usd">3900000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i8fb8d4ae4a074deead96aadd66375f97_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfNC0zLTEtMS0w_92395ca7-ce14-4fcf-aef2-388f7356f6af"
      unitRef="usd">5200000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i6cd3b488f83048afa58403e54590e370_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfNC01LTEtMS0w_ed80a376-b9d0-4a9f-b438-6503d1679f24"
      unitRef="usd">8900000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i3b26803c2ed7463f9f6e7e437606b796_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfNC03LTEtMS0w_f6d232a4-c5b8-45b4-aa72-088debfd4fde"
      unitRef="usd">6700000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfNC05LTEtMS0w_8e4569be-9020-4a9d-81dc-fd10a2ce6180"
      unitRef="usd">24700000</us-gaap:RestructuringCharges>
    <lh:RestructuringImpairment
      contextRef="idb6c26b91b524c4abbfa955d1ddc4457_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfNi0xLTEtMS0w_d5d5d16e-104d-4434-bec6-c8876ce3dc01"
      unitRef="usd">0</lh:RestructuringImpairment>
    <lh:RestructuringImpairment
      contextRef="i8fb8d4ae4a074deead96aadd66375f97_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfNi0zLTEtMS0w_4efcd719-c356-4e35-9d13-fdb5ef5967c3"
      unitRef="usd">5800000</lh:RestructuringImpairment>
    <lh:RestructuringImpairment
      contextRef="i6cd3b488f83048afa58403e54590e370_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfNi01LTEtMS0w_2bd0bc0d-03cc-4527-82f8-164057524042"
      unitRef="usd">0</lh:RestructuringImpairment>
    <lh:RestructuringImpairment
      contextRef="i3b26803c2ed7463f9f6e7e437606b796_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfNi03LTEtMS0w_009a4ada-4617-468a-b60c-fb9e48ccc4b5"
      unitRef="usd">17300000</lh:RestructuringImpairment>
    <lh:RestructuringImpairment
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfNi05LTEtMS0w_efa7c61f-5231-4387-b801-aa4dbdddaa28"
      unitRef="usd">23100000</lh:RestructuringImpairment>
    <lh:RestructuringReserveSettledWithCashAndOtherAdjustment
      contextRef="idb6c26b91b524c4abbfa955d1ddc4457_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfOC0xLTEtMS0w_b19b2a17-dc11-4fe2-844b-28839638b52b"
      unitRef="usd">4400000</lh:RestructuringReserveSettledWithCashAndOtherAdjustment>
    <lh:RestructuringReserveSettledWithCashAndOtherAdjustment
      contextRef="i8fb8d4ae4a074deead96aadd66375f97_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfOC0zLTEtMS0w_452d25f6-c7e6-4b81-9f31-b31a329c7a2b"
      unitRef="usd">12200000</lh:RestructuringReserveSettledWithCashAndOtherAdjustment>
    <lh:RestructuringReserveSettledWithCashAndOtherAdjustment
      contextRef="i6cd3b488f83048afa58403e54590e370_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfOC01LTEtMS0w_406b2512-eb75-4001-a719-cd76825a2867"
      unitRef="usd">10400000</lh:RestructuringReserveSettledWithCashAndOtherAdjustment>
    <lh:RestructuringReserveSettledWithCashAndOtherAdjustment
      contextRef="i3b26803c2ed7463f9f6e7e437606b796_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfOC03LTEtMS0w_2a1a5f47-17bb-4fa0-9d1a-ef75e7b3edf0"
      unitRef="usd">23800000</lh:RestructuringReserveSettledWithCashAndOtherAdjustment>
    <lh:RestructuringReserveSettledWithCashAndOtherAdjustment
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfOC05LTEtMS0w_80fbc23e-17d6-4e55-b67a-28507080b08b"
      unitRef="usd">50800000</lh:RestructuringReserveSettledWithCashAndOtherAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="ia5fa039b6da0439ba94ea7516654e077_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfOS0xLTEtMS0w_4da95a93-c9c1-4aa8-99b9-fb96e8e63dbd"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="id303bba4b3024ee9bc49c49292c283c3_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfOS0zLTEtMS0w_328fea7c-f3be-4c39-9e0e-508e863d0b0d"
      unitRef="usd">1500000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i84f2eb55fbc34238bd4e45bb4e88d0d3_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfOS01LTEtMS0w_eebd3c2b-4b1a-47ed-b1bb-4c2dfafb8994"
      unitRef="usd">4000000.0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ied5787aeaaf147b3ac9ba7c20d2c10ca_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfOS03LTEtMS0w_52699624-0b75-4bd5-af80-6b3d2df3bc58"
      unitRef="usd">4900000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfOS05LTEtMS0w_f4b5d3be-d6e5-4bd6-8d92-505f21181cd2"
      unitRef="usd">10400000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveCurrent
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfMTAtOS0xLTEtMA_76fe8f00-2bae-4856-8f34-56277e297823"
      unitRef="usd">8100000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:RestructuringReserveNoncurrent
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfMTEtOS0xLTEtMA_e56670fe-fcd4-41f7-838f-e8471fe095c5"
      unitRef="usd">2300000</us-gaap:RestructuringReserveNoncurrent>
    <us-gaap:RestructuringReserve
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80My9mcmFnOjJkMTQwZjEzY2I5MzQ4MDJiNDBhZjQ2YmU3ZWY2ODQzL3RhYmxlOjE5OTIwYmI1NjU3YjQ0NzJhYTY3NTVlZmUwODY3MDcyL3RhYmxlcmFuZ2U6MTk5MjBiYjU2NTdiNDQ3MmFhNjc1NWVmZTA4NjcwNzJfMTItOS0xLTEtMA_60d9540b-f3ca-4e8a-8734-636fe162dff1"
      unitRef="usd">10400000</us-gaap:RestructuringReserve>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfNTI5NA_f6fb66b2-fe2b-4a1a-97c5-5dc5c51f35cc">GOODWILL AND INTANGIBLE ASSETS&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amount of goodwill for the nine months ended September&#160;30, 2020, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LCD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CDD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,721.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,143.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,865.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(418.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(422.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency impact and other adjustments to goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,781.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,832.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,613.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:11pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses goodwill and indefinite-lived intangibles for impairment at least annually or whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Based upon the revised forecasted revenues and operating income following the declaration of the COVID-19 global pandemic, management concluded there was a triggering event and updated its annual 2019 goodwill impairment testing as of March 31, 2020, for its CDD reporting units and its LCD reporting units. Based on the quantitative impairment assessment, the Company concluded that the fair value was less than carrying value for two of its reporting units, including one where the 2019 fair value exceeded carrying value by approximately 10.0%, and recorded a goodwill impairment of $418.7 for the CDD segment and $3.7 for LCD segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company utilized a combination of income and market approaches to determine the fair value of the CDD reporting units. Based upon the results of the quantitative assessments, the Company concluded that the fair value was less than its carrying value for one of the CDD reporting units. A non-cash charge of $418.7 was recognized and included in goodwill and other asset impairments on the Consolidated Statement of Operations to reduce the carrying amount of goodwill for the CDD reporting unit to fair value. Following the impairment charge, the carrying value of goodwill for this reporting unit is $1,627.5 as of September 30, 2020. The other CDD reporting unit evaluated indicated a fair value that exceeded carrying value by less than 10.0%. Management notes that a +1.0% change in the discount rate in the March 31, 2020 analysis would reduce the headroom to approximately 2.0%. Goodwill for this reporting unit as of September 30, 2020 is $646.2. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company utilized the income approach to determine &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the fair value of the LCD reporting units. Based upon the results of the quantitative assessments, the Company concluded the fair value of one of the reporting units was less than its carrying value. A non-cash charge of $3.7 was recognized and included in goodwill and other asset impairments on the Consolidated Statement of Operations to reduce the carrying amount of goodwill for this LCD reporting unit to zero. The other LCD reporting unit evaluated indicated a fair value that exceeded carrying value by less than 10.0%. Management notes that a +1.0% change in the discount rate in the March 31, 2020 analysis would cause the fair value to be less than carrying value and would result in an impairment of approximately $40.0. Goodwill and indefinite-lived intangibles of Canadian licenses for this reporting unit as of September 30, 2020, were $86.0 and $468.4, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Company believes that the current assumptions and estimates used in its goodwill analysis are reasonable, supportable, and appropriate, continued efforts to maintain or improve the performance of these businesses could be impacted by unfavorable or unforeseen changes which could impact the existing assumptions used in the impairment analysis. Various factors could reasonably be expected to unfavorably impact existing assumptions: primarily delays in new customer bookings and the related delay in revenue from new customers, increases in customer termination activity or increases in operating costs. In addition, given the ongoing and rapidly changing nature of the COVID-19 pandemic, there is significant uncertainty &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;regarding the duration and severity of the pandemic as well as any future government restrictions, which may unfavorably impact existing assumptions. Accordingly, there can be no assurance that the estimates and assumptions made for the purposes of the goodwill impairment analysis will prove to be accurate predictions of future performance.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company will continue to monitor the financial performance of and assumptions for its reporting units. Management's impairment analysis utilizes significant judgments and assumptions related to the market comparable method analysis, such as selected market multiples, and those related to cash flow projections, such as revenue and terminal growth rates, projected operating margin, and the discount rate. A significant increase in the discount rate, decrease in the revenue and terminal growth rates, decreased operating margin, or substantial reductions in end markets and volume assumptions, could have a negative impact on the estimated fair value of the reporting units. A future impairment charge for goodwill or intangible assets could have a material effect on the Company's consolidated financial position and results of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of identifiable intangible assets are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.439%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.043%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.043%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.043%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.048%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,530.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,473.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,057.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,441.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,329.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,112.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents, licenses and technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(245.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(235.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(240.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(219.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land use right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canadian licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,953.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,032.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,920.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,885.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,851.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,034.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded non-cash charges of $30.5 for the impairment of identifiable intangible assets during the nine months ended September 30, 2020, within CDD. During the three months ended March 31, 2020, a $2.7 impairment charge was recorded for a tradename. During the three months ended September 30, 2020, additional impairment charges of $10.1 and $17.7 for customer relationships and technology intangible assets, respectively were recorded due to the loss of a contract from a prior acquisition. &lt;/span&gt;&lt;/div&gt;Amortization of intangible assets for the three months ended September&#160;30, 2020, and 2019, was $62.2 and $61.7, respectively and for the nine months ended September 30, 2020, and 2019 was $184.6 and $179.0, respectively. Amortization expense for the net carrying amount of intangible assets is estimated to be $60.0 for the remainder of fiscal 2020, $238.5 in fiscal 2021, $232.6 in fiscal 2022, $229.5 in fiscal 2023, $224.6 in fiscal 2024, and $2,380.2 thereafter.</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfNTI3OQ_84b7baf7-c0fd-483b-baf8-d58d1a880f31">&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amount of goodwill for the nine months ended September&#160;30, 2020, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LCD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CDD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,721.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,143.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,865.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(418.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(422.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency impact and other adjustments to goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,781.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,832.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,613.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i074bfbf2d5a14f098b9866224c866c60_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfMy0xLTEtMS0w_a08a6ea6-8309-43d9-ba6f-a5865c6621e5"
      unitRef="usd">3721500000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib5f5b39b26164231afef597275eaa72d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfMy01LTEtMS0w_99f53de5-b0db-48e1-be61-846829cab5cc"
      unitRef="usd">4143500000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfMy05LTEtMS0w_94c5ce94-3449-45ad-9a1c-fa7f016ef468"
      unitRef="usd">7865000000.0</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i60bf6e0de9384f37926fac0c0db06385_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfNC0xLTEtMS0w_54ed2684-1886-44d2-9b14-57afd457b5ca"
      unitRef="usd">66100000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="if366c14694954f6f84a2c0fe5708324e_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfNC01LTEtMS0w_ce57644f-9f1a-4e83-96a5-3bce38af1bb8"
      unitRef="usd">73000000.0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfNC05LTEtMS0w_ef50981a-dc8f-49bb-b27f-0d565ed9d01f"
      unitRef="usd">139100000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i60bf6e0de9384f37926fac0c0db06385_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfNy0xLTEtMS0w_52a04635-91cc-44ae-9f79-a3defbc3dd1b"
      unitRef="usd">3700000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if366c14694954f6f84a2c0fe5708324e_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfNy01LTEtMS0w_05e49bc6-be10-4f44-b6ba-c3d8c04c4576"
      unitRef="usd">418700000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfNy05LTEtMS0w_29c3ff84-143a-4f5a-8b0c-d0b2bbb8c5fc"
      unitRef="usd">422400000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i60bf6e0de9384f37926fac0c0db06385_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfOC0xLTEtMS0w_d8e98dae-89e4-4317-af21-34e07f9483a5"
      unitRef="usd">-2200000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="if366c14694954f6f84a2c0fe5708324e_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfOC01LTEtMS0w_1c258d45-d523-4438-be31-15c6a9f40a4b"
      unitRef="usd">34300000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfOC05LTEtMS0w_a5a5fd20-4a6b-4da5-b65b-c116a696e765"
      unitRef="usd">32100000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i0aec6588c61a425bbfbaa20d82e54da0_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfOS0xLTEtMS0w_944bfddf-6349-4e75-8b6e-7b40636e29a6"
      unitRef="usd">3781700000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i3d3f91adb0694c9f8cda5c55c146646b_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfOS01LTEtMS0w_33a65b9c-1da6-4b7b-861f-45fc1931353c"
      unitRef="usd">3832100000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOjYzZTc0MjQ0ODJjNzRkYjc5ZDJjNGY2MzVlYzFjNzQzL3RhYmxlcmFuZ2U6NjNlNzQyNDQ4MmM3NGRiNzlkMmM0ZjYzNWVjMWM3NDNfOS05LTEtMS0w_ba7ad626-034c-45d6-988c-659f37cfdb75"
      unitRef="usd">7613800000</us-gaap:Goodwill>
    <lh:PercentageFairValueofGoodwillExceededCarryingValue
      contextRef="icd1aeab8e4f84964b6228ddbf6f745c4_I20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMzI5ODUzNDg5MTYzMg_5ec85eed-85a9-4dbc-aee9-9f9df6ceb480"
      unitRef="number">0.100</lh:PercentageFairValueofGoodwillExceededCarryingValue>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if366c14694954f6f84a2c0fe5708324e_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMTA5OTUxMTYzMzEyNw_1c137812-e48e-4075-a395-bbc6fd321238"
      unitRef="usd">418700000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i60bf6e0de9384f37926fac0c0db06385_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMTA5OTUxMTYzMzEyMg_5870a483-d9dc-4de5-9fa3-3ed95fd3c1b6"
      unitRef="usd">3700000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if366c14694954f6f84a2c0fe5708324e_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMTI5NA_63de6383-8571-4069-841c-a5889099e41b"
      unitRef="usd">418700000</us-gaap:GoodwillImpairmentLoss>
    <lh:ValueofReportingUnitsGoodwillFollowingImpairment
      contextRef="icd1aeab8e4f84964b6228ddbf6f745c4_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMTU4NA_ddb62483-1d68-4a0a-a521-b0b16639f052"
      unitRef="usd">1627500000</lh:ValueofReportingUnitsGoodwillFollowingImpairment>
    <lh:PercentageFairValueofGoodwillExceededCarryingValue
      contextRef="icd1aeab8e4f84964b6228ddbf6f745c4_I20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMTY5Mg_5ec85eed-85a9-4dbc-aee9-9f9df6ceb480"
      unitRef="number">0.100</lh:PercentageFairValueofGoodwillExceededCarryingValue>
    <lh:PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit
      contextRef="icd1aeab8e4f84964b6228ddbf6f745c4_I20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMTcyMA_d501179a-5fb8-489c-aaef-1f744ad8eb3f"
      unitRef="number">0.010</lh:PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit>
    <lh:PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit
      contextRef="icd1aeab8e4f84964b6228ddbf6f745c4_I20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMTgyNg_e3219d3f-1401-41c3-9e7a-e2c6ac5ed0c7"
      unitRef="number">0.020</lh:PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit>
    <lh:ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue
      contextRef="i3d3f91adb0694c9f8cda5c55c146646b_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMTg3NQ_a915a8f0-34e3-4b96-8a47-097c2eea6e64"
      unitRef="usd">646200000</lh:ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i60bf6e0de9384f37926fac0c0db06385_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMjE1NQ_4fe380d4-3a62-4084-a764-73a867440e69"
      unitRef="usd">3700000</us-gaap:GoodwillImpairmentLoss>
    <lh:PercentageFairValueofGoodwillExceededCarryingValue
      contextRef="i4e01eb55dbc7406c97793a4ef9f2d6fc_I20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMjQ1Mw_3f039dee-3b8d-4313-a78f-7293c94de5d3"
      unitRef="number">0.100</lh:PercentageFairValueofGoodwillExceededCarryingValue>
    <lh:PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill
      contextRef="i4e01eb55dbc7406c97793a4ef9f2d6fc_I20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMjQ4MQ_7d52ebcd-4499-496c-a9df-2247310094e9"
      unitRef="number">0.010</lh:PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill>
    <lh:ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit
      contextRef="i4e01eb55dbc7406c97793a4ef9f2d6fc_I20200331"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMjY1Mw_4365c65a-611a-47c5-9738-527bda207852"
      unitRef="usd">40000000.0</lh:ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit>
    <lh:ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue
      contextRef="i0aec6588c61a425bbfbaa20d82e54da0_I20200930"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMjc1OA_744aa93e-8246-4860-a74b-a7f91c4a88f3"
      unitRef="usd">86.0</lh:ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="icb47c57b65f949f7a7c4c95751563b2f_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMjc2NQ_fe066692-1275-45f5-9ac3-b32eb109cf48"
      unitRef="usd">468400000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfNTI4Mw_8be4946a-9e09-4095-9e25-c2e7dc9d577b">&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of identifiable intangible assets are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.439%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.043%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.043%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.043%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.048%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,530.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,473.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,057.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,441.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,329.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,112.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents, licenses and technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(245.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(235.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(240.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(219.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land use right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canadian licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,953.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,032.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,920.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,885.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,851.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,034.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i9227de05b374430bb6014f0912ee355f_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfMi0xLTEtMS0w_4d52e21d-b413-4834-b79f-1eb5c4834ecc"
      unitRef="usd">4530700000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9227de05b374430bb6014f0912ee355f_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfMi0zLTEtMS0w_f3eb9017-a024-4382-a162-c56d98786503"
      unitRef="usd">1473100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i9227de05b374430bb6014f0912ee355f_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfMi01LTEtMS0w_1b40768c-a13d-479b-99b5-0a4e8faac757"
      unitRef="usd">3057600000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i07693b8e43fa40fd96c729928953fdf2_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfMi03LTEtMS0w_094768a5-f3ac-412c-b84e-95aac48e8aed"
      unitRef="usd">4441700000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i07693b8e43fa40fd96c729928953fdf2_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfMi05LTEtMS0w_3ec23f5b-0f1a-4c46-a8fe-545db1f57ada"
      unitRef="usd">1329500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i07693b8e43fa40fd96c729928953fdf2_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfMi0xMS0xLTEtMA_5c083513-fe23-429e-99a6-1c993428b4fb"
      unitRef="usd">3112200000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i667ca8a683be43908b933939e90db6ab_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfMy0xLTEtMS0w_769a7589-0b99-433a-a7c7-dd474d7c1fcd"
      unitRef="usd">427700000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i667ca8a683be43908b933939e90db6ab_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfMy0zLTEtMS0w_02e202e4-b5e8-400b-9b4f-edd511bb5075"
      unitRef="usd">245300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i667ca8a683be43908b933939e90db6ab_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfMy01LTEtMS0w_641d205d-9b35-4b5e-8537-ffb97f7690cb"
      unitRef="usd">182400000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i350c55aa64654b5eaec00a68eb64ffcc_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfMy03LTEtMS0w_aaa7c1d2-b05c-4c87-a8f5-4aecb88886c9"
      unitRef="usd">453600000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i350c55aa64654b5eaec00a68eb64ffcc_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfMy05LTEtMS0w_6d0949d2-5cc9-4cc8-82ef-644ddc774b0d"
      unitRef="usd">235700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i350c55aa64654b5eaec00a68eb64ffcc_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfMy0xMS0xLTEtMA_dde893ac-a310-43b5-adfe-f4e00d18eb79"
      unitRef="usd">217900000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ic4b591e887b949ce852974492383726e_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNC0xLTEtMS0w_fb49e429-1772-4715-b048-bfce7ad348f5"
      unitRef="usd">105300000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic4b591e887b949ce852974492383726e_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNC0zLTEtMS0w_d861adce-3bd5-452f-9d93-afec6eaded20"
      unitRef="usd">67600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic4b591e887b949ce852974492383726e_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNC01LTEtMS0w_2f7782ce-27fd-47f3-b443-5c6fdecece6d"
      unitRef="usd">37700000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i565f137a551b40788c8efe1cd6a5249a_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNC03LTEtMS0w_d6bf6dd5-1b1a-4b51-a288-70868abbc072"
      unitRef="usd">90900000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i565f137a551b40788c8efe1cd6a5249a_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNC05LTEtMS0w_ccc16b55-830e-4d62-96c2-85de96bbd1a9"
      unitRef="usd">60500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i565f137a551b40788c8efe1cd6a5249a_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNC0xMS0xLTEtMA_942bdeef-ac01-4377-af0c-bc8d4a84c6e9"
      unitRef="usd">30400000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i4bf99eb3ad5c4326ad848c0c5cbd06d0_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNS0xLTEtMS0w_e30d0c7e-0365-45e9-ab95-62e1defc559c"
      unitRef="usd">410200000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4bf99eb3ad5c4326ad848c0c5cbd06d0_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNS0zLTEtMS0w_e1918d0b-e8db-4e29-a856-2e755811cd0d"
      unitRef="usd">240100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i4bf99eb3ad5c4326ad848c0c5cbd06d0_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNS01LTEtMS0w_c8017bc7-7c87-464b-ac5d-3d06aa6cff7f"
      unitRef="usd">170100000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i370b422d371e47b595a9edeb8e53d595_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNS03LTEtMS0w_6ecd17b6-8ed0-48b9-a757-cbd3fdd0ff8f"
      unitRef="usd">408200000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i370b422d371e47b595a9edeb8e53d595_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNS05LTEtMS0w_4bdae146-ce8a-4fdb-867a-6cc9c5019334"
      unitRef="usd">219900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i370b422d371e47b595a9edeb8e53d595_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNS0xMS0xLTEtMA_0ea235a8-118c-4f06-a1b4-673c4fe2e410"
      unitRef="usd">188300000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="iab6b50825a0346fda5c7a57c46854607_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNi0xLTEtMS0w_60e289c1-a547-46ae-9c13-a24495fda47c"
      unitRef="usd">10800000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iab6b50825a0346fda5c7a57c46854607_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNi0zLTEtMS0w_34a4323f-2e7b-497b-97d0-5ac9b396f92a"
      unitRef="usd">6500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iab6b50825a0346fda5c7a57c46854607_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNi01LTEtMS0w_513dae14-9d23-4154-b355-de56d2560e29"
      unitRef="usd">4300000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="iabe5e13fb7d54f829c7b91d468ea08cd_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNi03LTEtMS0w_9c68f231-c430-486e-b774-829bffadba04"
      unitRef="usd">10900000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iabe5e13fb7d54f829c7b91d468ea08cd_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNi05LTEtMS0w_525d817a-8139-42bc-a37d-ea90e053aa4e"
      unitRef="usd">5500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iabe5e13fb7d54f829c7b91d468ea08cd_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNi0xMS0xLTEtMA_75012a15-2ff4-426b-87f7-5dffa2b6f70a"
      unitRef="usd">5400000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="icb47c57b65f949f7a7c4c95751563b2f_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNy0xLTEtMS0w_fe066692-1275-45f5-9ac3-b32eb109cf48"
      unitRef="usd">468400000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="icb47c57b65f949f7a7c4c95751563b2f_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNy0zLTEtMS0w_0aeab3d5-a33d-404c-b556-1e3a93ee6f63"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="icb47c57b65f949f7a7c4c95751563b2f_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNy01LTEtMS0w_ba5b3c6a-e7d8-46af-a877-afce22c17d9d"
      unitRef="usd">468400000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="if63915653cb94496b21de8a1a2fa6d6c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNy03LTEtMS0w_85f2e8b5-9357-4304-ad94-0b9849385b53"
      unitRef="usd">480300000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if63915653cb94496b21de8a1a2fa6d6c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNy05LTEtMS0w_9ffd2f12-0a6e-413a-8e19-455e5aefe4de"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="if63915653cb94496b21de8a1a2fa6d6c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfNy0xMS0xLTEtMA_a9a4fede-57d0-40d9-9407-e34fc1463e20"
      unitRef="usd">480300000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfOC0xLTEtMS0w_04787892-dcee-465d-a3ec-88a731d7d683"
      unitRef="usd">5953100000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfOC0zLTEtMS0w_51363a21-1322-4d0d-9b62-1cbbf93d5d48"
      unitRef="usd">2032600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfOC01LTEtMS0w_3208d361-f107-4893-97ad-c23886e460c3"
      unitRef="usd">3920500000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfOC03LTEtMS0w_1d781626-5e86-461a-b214-c15f008e7375"
      unitRef="usd">5885600000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfOC05LTEtMS0w_86ffa965-2495-4455-9d13-a03080180c4d"
      unitRef="usd">1851100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RhYmxlOmZmMWVlZjkzODkxMjQ5ZWQ5NGFhYjIzZmE0NThkMTZjL3RhYmxlcmFuZ2U6ZmYxZWVmOTM4OTEyNDllZDk0YWFiMjNmYTQ1OGQxNmNfOC0xMS0xLTEtMA_cc3df9f6-6148-47c5-b490-1bbc7961ef3b"
      unitRef="usd">4034500000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i60bf6e0de9384f37926fac0c0db06385_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMzI5ODUzNDg5MTQwMw_1ee03319-6955-4baa-925f-ac0b0b0b4a8b"
      unitRef="usd">30500000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i2794dd6e7b2744c099a93cd25ba76ec6_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMTA5OTUxMTYzMzQ4OA_c60fa013-4fc1-4580-8f28-2c13e0e2b2f7"
      unitRef="usd">2700000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="iab77a3a920bd45ec8c8a0ce85071ae92_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMTA5OTUxMTYzMzQ5NA_417dba07-ab35-4c51-8f57-f13c0a756d4f"
      unitRef="usd">10100000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i16b4dd493f294c068810b89a1566d767_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfMzI5ODUzNDg5MDY0OA_f7fb7541-a54a-4d44-8ad9-c4d9ff5b3d4b"
      unitRef="usd">17.7</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfNDk2NQ_de75e5a8-e408-4435-b8b3-56e2cdfa7f26"
      unitRef="usd">62200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfNDk3Mg_a14a10c7-4be6-4e34-a09e-d6ec14dec981"
      unitRef="usd">61700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfNTAzMg_2822b8fb-d933-4c30-8e04-0abeef33bbb1"
      unitRef="usd">184600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfNTAzOQ_1e143fa1-dd3d-4a4a-a8e6-d7731f42567c"
      unitRef="usd">179000000.0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfNTE0Ng_ba07713e-2840-4647-b1cf-5e9e1ad3d8f8"
      unitRef="usd">60000000.0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfNTE4Mg_c999cc65-21fd-4c57-83f5-f3cfa565ad10"
      unitRef="usd">238500000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfNTE5OQ_0fb31793-2cb4-43a0-8c23-e549051fc2c7"
      unitRef="usd">232600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfNTIxNg_85fd56e5-729a-427d-8f08-dff322c72ddb"
      unitRef="usd">229500000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfNTIzMw_44ea1f42-9acc-4b78-a5ab-0bfe31db928c"
      unitRef="usd">224600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80Ni9mcmFnOmJmNjMzMjJhZDJmNDRlMTY4N2E4YTFmYWU1ZjE1MzQ2L3RleHRyZWdpb246YmY2MzMyMmFkMmY0NGUxNjg3YThhMWZhZTVmMTUzNDZfNTI1NA_5a324a33-3c40-41b8-a4a0-43b4a9c0e22b"
      unitRef="usd">2380200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNDg1Mg_387fea9b-a103-42c8-9328-3b577c73ca4e">DEBT &lt;div style="margin-top:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term borrowings and the current portion of long-term debt at September&#160;30, 2020, and December&#160;31, 2019, consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625% senior notes due 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of note payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total short-term borrowings and current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt at September&#160;30, 2020, and December&#160;31, 2019, consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.20% senior notes due 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75% senior notes due 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00% senior notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25% senior notes due 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.30% senior notes due 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.60% senior notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.60% senior notes due 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.95% senior notes due 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.70% senior notes due 2045&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Note payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,417.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,789.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 17, 2020, the Company redeemed the remaining $412.2 of its 4.625% Senior Notes due November 15, 2020, using available cash on hand. The Company exited the remaining fixed-to-variable interest rate swap arrangement in August 2020, in connection with this redemption and recorded a gain of $1.6 on the extinguishment. The gain was included in Other, net on the Condensed Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 3, 2019, the Company entered into a new $850.0 2019 term loan facility that matures on June 3, 2021. The 2019 term loan facility accrues interest at a per annum rate equal to,&lt;/span&gt;&lt;span style="color:#1f497d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;at the Company's election, either a LIBOR rate plus a margin ranging from 0.55% to 1.175%, or a base rate determined according to a prime rate or federal funds rate plus a margin ranging from 0.0% to 0.175%. The 2019 term loan balance at September&#160;30, 2020, and December&#160;31, 2019, was $375.0 and $375.0, respectively. As of September&#160;30, 2020, the effective interest rate on the 2019 term loan was 0.95%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also maintains a senior revolving credit facility consisting of a five-year facility in the principal amount of up to $1,000.0, with the option of increasing the facility by up to an additional $350.0, subject to the agreement of one or more new or existing lenders to provide such additional amounts and certain other customary conditions. The revolving credit facility also provides for a subfacility of up to $100.0 for swing line borrowings and a subfacility of up to $150.0 for issuances of letters of credit. The Company is required to pay a facility fee on the aggregate commitments under the revolving credit facility, at a per annum rate ranging from 0.00% to 0.25%. The revolving credit facility is permitted to be used for general corporate purposes, including working capital, capital expenditures, funding of share repurchases and certain other payments, acquisitions and other investments. There were no balances outstanding on the Company's current revolving credit facility at September&#160;30, 2020, and December&#160;31, 2019. As of September&#160;30, 2020, the effective interest rate on the revolving credit facility was 1.12%. The credit facility expires on September 15, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the term loan facility and the revolving credit facility, the Company is subject to negative covenants limiting subsidiary indebtedness and certain other covenants typical for investment grade-rated borrowers, and the Company is required to maintain certain leverage ratios. In May 2020, the Company entered into amendments to its term loan facility and its revolving credit facility, in each case to, among other things, increase the maximum leverage ratio covenant to 5.0x debt to last twelve months EBITDA for each of the three periods ended June 30, September 30, and December 31, 2020, and 4.5x for period ended March 31, 2021. From and including the period ending June 30, 2021, the maximum leverage ratio reverts back to 4.0x. The Company was in compliance with all covenants in the term loan facility and the revolving credit facility at September&#160;30, 2020, and expects that it will remain in compliance with its existing debt covenants for the next twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's availability of $997.0 at September&#160;30, 2020, under its revolving credit facility reflects a reduction equivalent to the amount of the Company's outstanding letters of credit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liquidity&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;At September 30, 2020, the Company had $667.2 of cash and cash equivalents and $997.0 of available borrowings under its revolving credit facility, which does not mature until 2022, and the Company was in compliance with all of its debt covenants. In May 2020, in order to obtain increased financial covenant flexibility, the Company and its lenders entered into amendments &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;to the term loan facility and the revolving credit facility to increase the maximum leverage ratio to 5.0x debt to last twelve months EBITDA for the three month periods ending June 30, September 30 and December 31, 2020, and 4.5x for the period ended March 31, 2021. From and including the period ending June 30, 2021, the maximum leverage ratio reverts back to 4.0x. The amendments also provide that during any period in which the Company's leverage ratio exceeds 4.5x debt to last twelve months EBITDA (i) the Company will be prohibited from consummating share repurchases, subject to limited exceptions, (ii) borrowings under the revolving credit facility will accrue interest at a per annum rate equal to, at the Company's election, either a LIBOR rate plus a margin of 1.25% or a base rate plus a margin of 0.25%, (iii) the facility fee that the Company is required to pay on the aggregate commitments under the revolving credit facility will be 0.25% per annum, and (iv) borrowings under the term loan facility will accrue interest at a per annum rate equal to, at the Company's election, either a LIBOR rate plus a margin of 1.175% or a base rate plus a margin of 0.175%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is closely monitoring the impact of the COVID-19 pandemic on all aspects of its business and the effects such impacts are having and will have on the Company's liquidity. The significance of the impact on the Company&#x2019;s business is not yet certain and depends on numerous evolving factors that the Company may not be able to accurately predict.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfShortTermDebtTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNDg2Mw_a1a69783-b4bd-4fed-be8c-7df6ed90ca3b">&lt;div style="margin-top:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term borrowings and the current portion of long-term debt at September&#160;30, 2020, and December&#160;31, 2019, consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625% senior notes due 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of note payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total short-term borrowings and current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShortTermDebtTextBlock>
    <lh:A4.625Seniornotesdue2020
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjA3MmM0NDFiYjk4YzRmNzRiZTg1Y2VmNzcyZTRiN2ZiL3RhYmxlcmFuZ2U6MDcyYzQ0MWJiOThjNGY3NGJlODVjZWY3NzJlNGI3ZmJfMi0xLTEtMS0w_f6bbc7f3-8392-4a43-88f3-305327713c25"
      unitRef="usd">0</lh:A4.625Seniornotesdue2020>
    <lh:A4.625Seniornotesdue2020
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjA3MmM0NDFiYjk4YzRmNzRiZTg1Y2VmNzcyZTRiN2ZiL3RhYmxlcmFuZ2U6MDcyYzQ0MWJiOThjNGY3NGJlODVjZWY3NzJlNGI3ZmJfMi0zLTEtMS0w_59e4d68e-1207-4263-9bb9-a1a6804e7de7"
      unitRef="usd">413700000</lh:A4.625Seniornotesdue2020>
    <lh:A2019TermLoan
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjA3MmM0NDFiYjk4YzRmNzRiZTg1Y2VmNzcyZTRiN2ZiL3RhYmxlcmFuZ2U6MDcyYzQ0MWJiOThjNGY3NGJlODVjZWY3NzJlNGI3ZmJfMy0xLTEtMS0w_6fd128fa-a087-4432-ac9d-fc23e3af2fa2"
      unitRef="usd">375000000.0</lh:A2019TermLoan>
    <lh:A2019TermLoan
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjA3MmM0NDFiYjk4YzRmNzRiZTg1Y2VmNzcyZTRiN2ZiL3RhYmxlcmFuZ2U6MDcyYzQ0MWJiOThjNGY3NGJlODVjZWY3NzJlNGI3ZmJfMy0zLTEtMS0w_32c665cc-d74d-4c52-9773-04a2c7451382"
      unitRef="usd">0</lh:A2019TermLoan>
    <lh:Shorttermdebtissuancecosts
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjA3MmM0NDFiYjk4YzRmNzRiZTg1Y2VmNzcyZTRiN2ZiL3RhYmxlcmFuZ2U6MDcyYzQ0MWJiOThjNGY3NGJlODVjZWY3NzJlNGI3ZmJfNC0xLTEtMS0w_a2b81453-5576-4e60-88e1-378e35175847"
      unitRef="usd">600000</lh:Shorttermdebtissuancecosts>
    <lh:Shorttermdebtissuancecosts
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjA3MmM0NDFiYjk4YzRmNzRiZTg1Y2VmNzcyZTRiN2ZiL3RhYmxlcmFuZ2U6MDcyYzQ0MWJiOThjNGY3NGJlODVjZWY3NzJlNGI3ZmJfNC0zLTEtMS0w_cfb7136d-51cc-40df-ac83-07588e5c1dbd"
      unitRef="usd">700000</lh:Shorttermdebtissuancecosts>
    <us-gaap:NotesPayableCurrent
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjA3MmM0NDFiYjk4YzRmNzRiZTg1Y2VmNzcyZTRiN2ZiL3RhYmxlcmFuZ2U6MDcyYzQ0MWJiOThjNGY3NGJlODVjZWY3NzJlNGI3ZmJfNS0xLTEtMS0w_5e0a0f41-37a9-48ac-99f7-520d9a22622b"
      unitRef="usd">2200000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjA3MmM0NDFiYjk4YzRmNzRiZTg1Y2VmNzcyZTRiN2ZiL3RhYmxlcmFuZ2U6MDcyYzQ0MWJiOThjNGY3NGJlODVjZWY3NzJlNGI3ZmJfNS0zLTEtMS0w_d4293a68-66d9-4324-9af1-0a1d0154ccfe"
      unitRef="usd">2200000</us-gaap:NotesPayableCurrent>
    <us-gaap:DebtCurrent
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjA3MmM0NDFiYjk4YzRmNzRiZTg1Y2VmNzcyZTRiN2ZiL3RhYmxlcmFuZ2U6MDcyYzQ0MWJiOThjNGY3NGJlODVjZWY3NzJlNGI3ZmJfNi0xLTEtMS0w_c43c9418-2a02-477d-8f70-682e38e45ede"
      unitRef="usd">376600000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjA3MmM0NDFiYjk4YzRmNzRiZTg1Y2VmNzcyZTRiN2ZiL3RhYmxlcmFuZ2U6MDcyYzQ0MWJiOThjNGY3NGJlODVjZWY3NzJlNGI3ZmJfNi0zLTEtMS0w_c9cb44c9-5e2b-4b6c-b2db-3db53b9882de"
      unitRef="usd">415200000</us-gaap:DebtCurrent>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNDg4OA_1efd2ee8-b7f9-4f2d-a8cb-9b2aafc15fa6">&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt at September&#160;30, 2020, and December&#160;31, 2019, consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.20% senior notes due 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75% senior notes due 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00% senior notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25% senior notes due 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.30% senior notes due 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.60% senior notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.60% senior notes due 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.95% senior notes due 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.70% senior notes due 2045&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Note payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,417.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,789.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:SeniorLongTermNotes
      contextRef="i4c8777e25b1f43d891ec105edf96653f_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfNC0xLTEtMS0w_5e14614e-a3ba-4173-a937-419761409a4a"
      unitRef="usd">500000000.0</us-gaap:SeniorLongTermNotes>
    <us-gaap:SeniorLongTermNotes
      contextRef="i3dd7ebb2472d4c31906ef3769da45911_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfNC0zLTEtMS0w_899a5266-33cc-4409-8534-52310788cb61"
      unitRef="usd">500000000.0</us-gaap:SeniorLongTermNotes>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i4c8777e25b1f43d891ec105edf96653f_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfNS0xLTEtMS0w_e8d7b55f-ccb8-4ba4-b142-d89c836c572d"
      unitRef="usd">500000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i3dd7ebb2472d4c31906ef3769da45911_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfNS0zLTEtMS0w_afdf91a0-0141-4003-8651-a38b5faf686b"
      unitRef="usd">500000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i3ccdf4f5309844119bbb0e0786d0933d_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfNi0xLTEtMS0w_d7a33730-33b0-49aa-85cc-2cb47ab4d9b8"
      unitRef="usd">300000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i167711db2a824eb5abbd3592c79dac6a_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfNi0zLTEtMS0w_f790a995-ce62-45db-8525-552bd49dcd5c"
      unitRef="usd">300000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i657d0be39de346838d90040f8d8f348e_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfNy0xLTEtMS0w_05378721-df19-4fe5-8ab5-db7fcde3350d"
      unitRef="usd">600000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1bd3af0136af40129f6e820d13a1ae7c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfNy0zLTEtMS0w_8ad884fd-4172-4a21-8110-bcc18c4cf684"
      unitRef="usd">600000000.0</us-gaap:LongTermDebtNoncurrent>
    <lh:A2.30seniornotesdue2024
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfOC0xLTEtMS04MzQy_55104a20-ba92-4130-bb86-35d44f2c9059"
      unitRef="usd">400000000.0</lh:A2.30seniornotesdue2024>
    <lh:A2.30seniornotesdue2024
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfOC0zLTEtMS04MzQy_d5bd5d7d-0b75-419e-90a3-6cd0dae87c0d"
      unitRef="usd">400000000.0</lh:A2.30seniornotesdue2024>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i7afb899941084ecea85f2f14bfb617e3_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfOC0xLTEtMS0w_891c6d4d-dfa7-42c9-85e9-cdfdb3836aac"
      unitRef="usd">1000000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id8a898daea154e4e8f10db94ed74cfa4_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfOC0zLTEtMS0w_997d8ce9-f8a3-424d-ac0a-1983b333d52f"
      unitRef="usd">1000000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9f958adbe35f4caab3789a03b8cec98f_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfOS0xLTEtMS0w_b04167d0-4410-4993-a35f-4feda3470c6c"
      unitRef="usd">600000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i717fbdf29e6443d699ab792d8711e563_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfOS0zLTEtMS0w_b8e14ed5-1c1b-4c7d-8268-4a1e2a130415"
      unitRef="usd">600000000.0</us-gaap:LongTermDebtNoncurrent>
    <lh:A2.95seniornotesdue2029
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfMTItMS0xLTEtMA_dbd46711-8a4c-4af6-a553-ecf6a09c239e"
      unitRef="usd">650000000.0</lh:A2.95seniornotesdue2029>
    <lh:A2.95seniornotesdue2029
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfMTItMy0xLTEtMA_e9c977d0-8cd9-4446-88d5-9dead4c9895b"
      unitRef="usd">650000000.0</lh:A2.95seniornotesdue2029>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i33c11262f4464ffea951db61842a0276_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfMTQtMS0xLTEtODMzNw_4e3baf0c-d350-41f5-818a-bf70db4b0554"
      unitRef="usd">900000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1da5761b40b5492f8293785134f8ab79_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfMTQtMy0xLTEtODMzNw_bbd52885-b282-414b-ab7e-26f90ca2c46f"
      unitRef="usd">900000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="ib861cf324bf4423f8474deaaa80a20a6_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfMTQtMS0xLTEtMA_1e793651-8446-4afa-a8ee-cda98106dca6"
      unitRef="usd">0</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfMTQtMy0xLTEtMA_30dbb0d5-7ff3-4ba8-9c9e-95c2d75f7cb3"
      unitRef="usd">375000000.0</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <lh:Longtermdebtissuancecosts
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfMTYtMS0xLTEtMA_73263d2e-bc08-48fb-82e2-f709c0494b65"
      unitRef="usd">38800000</lh:Longtermdebtissuancecosts>
    <lh:Longtermdebtissuancecosts
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfMTYtMy0xLTEtMA_c2030e0d-6a1d-4951-86b3-6f5a121a2129"
      unitRef="usd">42200000</lh:Longtermdebtissuancecosts>
    <us-gaap:NotesPayable
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfMTgtMS0xLTEtMA_eb4b5ce4-9ff8-4505-a10d-a570c812257d"
      unitRef="usd">6100000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfMTgtMy0xLTEtMA_421cebaf-0ee9-4977-bdef-c5a1a7467810"
      unitRef="usd">7000000.0</us-gaap:NotesPayable>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfMTktMS0xLTEtMA_5d24a008-5803-47f3-a5e2-014a20551ecb"
      unitRef="usd">5417300000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RhYmxlOjE5MjI0ZDUxNmNkYzQwNTE5YmZlNmYxN2I3NDI0ODU2L3RhYmxlcmFuZ2U6MTkyMjRkNTE2Y2RjNDA1MTliZmU2ZjE3Yjc0MjQ4NTZfMTktMy0xLTEtMA_6d101c50-1a99-4373-9bbb-16b009a320e3"
      unitRef="usd">5789800000</us-gaap:LongTermDebtNoncurrent>
    <lh:BalanceOfSeniorNotesMatureDuringQ42020
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMTA5OTUxMTYzMjgxMQ_f691c758-e732-44ae-a4a5-876eecbbeae8"
      unitRef="usd">412200000</lh:BalanceOfSeniorNotesMatureDuringQ42020>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i391abd34dc914608a327d3e643899d6b_I20200930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMTA5OTUxMTYzMjgyMQ_8c2e5805-ae45-4207-a91a-2b692be7c6a2"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <lh:GainInterestRateSwapArrangement
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMzI5ODUzNDg4OTc0NQ_e2792842-7455-4bc0-952c-2f3f391de1c9"
      unitRef="usd">1600000</lh:GainInterestRateSwapArrangement>
    <lh:A2019TermLoan
      contextRef="ieb6fe2a304194224befa49dcb5ed37d4_I20190603"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMjYy_c49c5dd5-58b3-4176-ba14-fa7524db8e0c"
      unitRef="usd">850000000.0</lh:A2019TermLoan>
    <us-gaap:LineOfCreditFacilityInterestRateDescription
      contextRef="i8826a53a9f514573b843bca48b3cf833_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNDY4_08fd4892-0d88-4c9c-9fe5-68a8dc03c03e">0.55% to 1.175%</us-gaap:LineOfCreditFacilityInterestRateDescription>
    <us-gaap:LineOfCreditFacilityInterestRateDescription
      contextRef="ieb68008a843e40baab3187013ce2c0a2_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNTcz_69bbcbe5-99d1-448f-912c-fdae68d18edd">0.0% to 0.175%</us-gaap:LineOfCreditFacilityInterestRateDescription>
    <lh:A2019TermLoan
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNjIy_6fd128fa-a087-4432-ac9d-fc23e3af2fa2"
      unitRef="usd">375000000.0</lh:A2019TermLoan>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNjI5_30dbb0d5-7ff3-4ba8-9c9e-95c2d75f7cb3"
      unitRef="usd">375000000.0</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="ic0187e44c0d748c594cf9f1d3948e793_I20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNzEx_0f7d92df-12be-43c0-8e47-d23e4b979b52"
      unitRef="number">0.0095</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfODQ1_4b8db779-9d3c-4c59-9751-8b52e4e7afdc"
      unitRef="usd">1000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <lh:CreditFacilityOptiontoIncrease
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfOTE1_c8cb0dd1-f076-486d-91c8-50d5a1abd297"
      unitRef="usd">350000000.0</lh:CreditFacilityOptiontoIncrease>
    <lh:CreditFacilityMaximumSwingLineBorrowings
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMTEyOQ_44a4846d-aa49-494e-9c40-5c719355ae93"
      unitRef="usd">100000000.0</lh:CreditFacilityMaximumSwingLineBorrowings>
    <lh:CreditFacilityMaximumLettersofCredit
      contextRef="i68588eebfb8e4548bfe358f5a18f2c3f_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMTE4NQ_a2f1dfcf-1e09-42f3-979d-290634c741e5"
      unitRef="usd">150000000.0</lh:CreditFacilityMaximumLettersofCredit>
    <us-gaap:LineOfCreditFacilityInterestRateDescription
      contextRef="if9247fa03b7041468d61fb949531d7c4_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMTM2OQ_0b2c61df-3853-4090-8ffa-2d47b85f5ee4">0.00% to 0.25%</us-gaap:LineOfCreditFacilityInterestRateDescription>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="i68588eebfb8e4548bfe358f5a18f2c3f_I20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMTc3Nw_7434d7ae-1b00-4a77-9ff9-d23e6819f6dc"
      unitRef="rate">0.0112</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <lh:DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020
      contextRef="i053c189109464dc2b30dcc1a0729589f_I20200930"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMjMwOQ_9475774f-131a-4c56-b7b8-93fefde6f793"
      unitRef="number">5.0</lh:DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020>
    <lh:DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021
      contextRef="ic3ee871e124f4fbc9fc99ccaf3849f33_I20200930"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMjQyOQ_03bcde31-1935-4e88-ab7b-9c435afa0afa"
      unitRef="number">4.5</lh:DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021>
    <lh:DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021
      contextRef="ic3ee871e124f4fbc9fc99ccaf3849f33_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMjQ5MA_7ef3047c-cdaf-4751-b410-a7a44d598d90"
      unitRef="number">4.0</lh:DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i68588eebfb8e4548bfe358f5a18f2c3f_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMjc0Nw_b014dc2e-7b0c-4da3-946b-b8fea3ef7642"
      unitRef="usd">997000000.0</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMzE1MQ_f01c3d48-8251-44a5-bec1-6b94d1e5c200"
      unitRef="usd">667200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i68588eebfb8e4548bfe358f5a18f2c3f_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMzE2Ng_b014dc2e-7b0c-4da3-946b-b8fea3ef7642"
      unitRef="usd">997000000.0</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <lh:DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020
      contextRef="i053c189109464dc2b30dcc1a0729589f_I20200930"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMzU1OA_9475774f-131a-4c56-b7b8-93fefde6f793"
      unitRef="number">5.0</lh:DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020>
    <lh:DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021
      contextRef="ic3ee871e124f4fbc9fc99ccaf3849f33_I20200930"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMzY3OQ_03bcde31-1935-4e88-ab7b-9c435afa0afa"
      unitRef="number">4.5</lh:DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021>
    <lh:DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021
      contextRef="ic3ee871e124f4fbc9fc99ccaf3849f33_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNDk0NzgwMjMzMjE2Ng_7ef3047c-cdaf-4751-b410-a7a44d598d90"
      unitRef="number">4.0</lh:DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021>
    <lh:DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021
      contextRef="ic3ee871e124f4fbc9fc99ccaf3849f33_I20200930"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfMzgxNw_03bcde31-1935-4e88-ab7b-9c435afa0afa"
      unitRef="number">4.5</lh:DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021>
    <lh:RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage
      contextRef="i68588eebfb8e4548bfe358f5a18f2c3f_I20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNDEyNQ_de869942-8a48-461e-a4d4-450e8759a3b7"
      unitRef="rate">0.0125</lh:RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage>
    <lh:RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage
      contextRef="i68588eebfb8e4548bfe358f5a18f2c3f_I20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNDE2MA_73a56cd3-a5d8-453a-acf3-f9b1afa32a31"
      unitRef="rate">0.0025</lh:RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage>
    <lh:RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments
      contextRef="i68588eebfb8e4548bfe358f5a18f2c3f_I20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNDI5Ng_abb45510-bb6f-4847-b16e-d18adce93ed2"
      unitRef="rate">0.0025</lh:RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments>
    <lh:TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage
      contextRef="i772995039ebd4eb5b458fda1865f139f_I20200930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNDQ3NA_feb251a4-c79f-40c7-8ceb-1e7c3ff50e04"
      unitRef="rate">0.01175</lh:TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage>
    <lh:TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage
      contextRef="i772995039ebd4eb5b458fda1865f139f_I20200930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV80OS9mcmFnOmYzYWQ3MmEzNmQxOTQzNDI5OWU3MTVjMWRiNjVkZWI3L3RleHRyZWdpb246ZjNhZDcyYTM2ZDE5NDM0Mjk5ZTcxNWMxZGI2NWRlYjdfNDUwOQ_787f108f-9206-429f-abfe-c255ad8e1c43"
      unitRef="rate">0.00175</lh:TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RleHRyZWdpb246YjU4MzY2NTBiZjM2NGQ4ZTk3NDRlMDkyZTI1N2Q2NGRfMTM3Ng_2e0c6fb4-bbbb-465b-a7ce-07860c751986">PREFERRED STOCK AND COMMON SHAREHOLDERS&#x2019; EQUITY&lt;div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is authorized to issue up to 265.0 shares of common stock, par value $0.10 per share. The Company is authorized to issue up to 30.0 shares of preferred stock, par value $0.10 per share. There were no preferred shares outstanding as of September&#160;30, 2020, and December&#160;31, 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in common shares issued are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issued and Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common shares at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued under employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retirement of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common shares at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7.1pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At the end of 2019, the Company had outstanding authorization from the board of directors to purchase $900.0 of Company common stock. During three months ended March 31, 2020, the Company purchased&#160;0.6&#160;shares of its common stock. When the Company repurchases shares, the amount paid to repurchase the shares in excess of the par or stated value is allocated to additional paid-in-capital unless subject to limitation or the balance in additional paid-in-capital is exhausted. Remaining amounts are recognized as a reduction in retained earnings. As of September&#160;30, 2020, the Company had outstanding authorization from the board of directors to purchase up to $800.0 of the Company's common stock. The repurchase authorization has no expiration date. The Company reinstated its share repurchase program in October 2020 following the temporary suspension of stock repurchases beginning in March 2020 as a result of the anticipated impact of the COVID-19 pandemic.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accumulated Other Comprehensive Earnings &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of accumulated other comprehensive earnings (loss) are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.813%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net Benefit Plan Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Earnings (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(285.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(372.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Tax effect of adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(233.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(314.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RleHRyZWdpb246YjU4MzY2NTBiZjM2NGQ4ZTk3NDRlMDkyZTI1N2Q2NGRfMTAy_4081969c-b47b-4737-a75c-1b6761826904"
      unitRef="shares">265000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RleHRyZWdpb246YjU4MzY2NTBiZjM2NGQ4ZTk3NDRlMDkyZTI1N2Q2NGRfMTM5_c2e83488-22ac-4115-ba8c-d59bb7e0b11e"
      unitRef="usdPerShare">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RleHRyZWdpb246YjU4MzY2NTBiZjM2NGQ4ZTk3NDRlMDkyZTI1N2Q2NGRfMTk0_0afdb8bb-6e49-4ceb-b5dc-e1beecc393be"
      unitRef="shares">30000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RleHRyZWdpb246YjU4MzY2NTBiZjM2NGQ4ZTk3NDRlMDkyZTI1N2Q2NGRfMjM0_80bf0689-0e1a-49f9-b426-1470ffd43dee"
      unitRef="usdPerShare">0.10</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RleHRyZWdpb246YjU4MzY2NTBiZjM2NGQ4ZTk3NDRlMDkyZTI1N2Q2NGRfMjU5_c0247d63-9b55-4774-a51d-cc4a03ec1c8b"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <lh:ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RleHRyZWdpb246YjU4MzY2NTBiZjM2NGQ4ZTk3NDRlMDkyZTI1N2Q2NGRfMTM3OQ_ea1436f1-146f-4c20-9dfb-4cac9b936253">&lt;div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in common shares issued are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issued and Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common shares at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued under employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retirement of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common shares at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</lh:ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock>
    <us-gaap:CommonStockSharesIssued
      contextRef="i4dacd586a4f14b008d9dddcced9904a0_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOjhmNjM3ZjkzNjdkNDQ3YzNiNGY5YjdlNjIwNmI1MjYwL3RhYmxlcmFuZ2U6OGY2MzdmOTM2N2Q0NDdjM2I0ZjliN2U2MjA2YjUyNjBfMS0xLTEtMS0w_5bde1f26-e21e-48ee-a6e4-4523ed301f0f"
      unitRef="shares">97200000</us-gaap:CommonStockSharesIssued>
    <lh:CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans
      contextRef="i7ecb5a349ee9456dbdca2fe6adf8c4b3_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOjhmNjM3ZjkzNjdkNDQ3YzNiNGY5YjdlNjIwNmI1MjYwL3RhYmxlcmFuZ2U6OGY2MzdmOTM2N2Q0NDdjM2I0ZjliN2U2MjA2YjUyNjBfMi0xLTEtMS0w_4fb64227-625d-46e6-af58-918f8de8853a"
      unitRef="shares">800000</lh:CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i7ecb5a349ee9456dbdca2fe6adf8c4b3_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOjhmNjM3ZjkzNjdkNDQ3YzNiNGY5YjdlNjIwNmI1MjYwL3RhYmxlcmFuZ2U6OGY2MzdmOTM2N2Q0NDdjM2I0ZjliN2U2MjA2YjUyNjBfNS0xLTEtMS0w_83ce5611-5d18-455b-a9a8-3e22bf04e68d"
      unitRef="shares">600000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:CommonStockSharesIssued
      contextRef="i1d95d9565fa048cabbe7fe142c315893_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOjhmNjM3ZjkzNjdkNDQ3YzNiNGY5YjdlNjIwNmI1MjYwL3RhYmxlcmFuZ2U6OGY2MzdmOTM2N2Q0NDdjM2I0ZjliN2U2MjA2YjUyNjBfNy0xLTEtMS0w_971b4221-ef2c-4bb4-995b-e56804758ddb"
      unitRef="shares">97400000</us-gaap:CommonStockSharesIssued>
    <lh:CommonStockRepurchaseAuthorizationOutstanding
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RleHRyZWdpb246YjU4MzY2NTBiZjM2NGQ4ZTk3NDRlMDkyZTI1N2Q2NGRfNDk2_6ff8272b-0217-4bf0-9e8d-0cd10cf359e7"
      unitRef="usd">900000000.0</lh:CommonStockRepurchaseAuthorizationOutstanding>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ia962c16050fa4b28adc73e0d729703c5_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RleHRyZWdpb246YjU4MzY2NTBiZjM2NGQ4ZTk3NDRlMDkyZTI1N2Q2NGRfNTcy_1f5564aa-92dd-46bb-88a7-ef1bc3e7471a"
      unitRef="shares">600000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RleHRyZWdpb246YjU4MzY2NTBiZjM2NGQ4ZTk3NDRlMDkyZTI1N2Q2NGRfMTAxNw_cdb8048f-b37b-4e79-ba4e-8539cbeed4e8"
      unitRef="shares">800000000.0</us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RleHRyZWdpb246YjU4MzY2NTBiZjM2NGQ4ZTk3NDRlMDkyZTI1N2Q2NGRfMTM4OQ_5a58e983-a116-4ec2-abc0-9ef0f5711a7a">The components of accumulated other comprehensive earnings (loss) are as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.813%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net Benefit Plan Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Earnings (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(285.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(372.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Tax effect of adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(233.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(314.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOmFkYjg5ODBiOTE5ZTRkMTM4YWViMTU5MzNlMmM5NzIwL3RhYmxlcmFuZ2U6YWRiODk4MGI5MTllNGQxMzhhZWIxNTkzM2UyYzk3MjBfMS0xLTEtMS0w_df745509-a408-4521-94cb-aba46d004899"
      unitRef="usd">-285400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOmFkYjg5ODBiOTE5ZTRkMTM4YWViMTU5MzNlMmM5NzIwL3RhYmxlcmFuZ2U6YWRiODk4MGI5MTllNGQxMzhhZWIxNTkzM2UyYzk3MjBfMS0zLTEtMS0w_0f122fa3-1ed3-44f4-988b-e004b1a66ca7"
      unitRef="usd">-87000000.0</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOmFkYjg5ODBiOTE5ZTRkMTM4YWViMTU5MzNlMmM5NzIwL3RhYmxlcmFuZ2U6YWRiODk4MGI5MTllNGQxMzhhZWIxNTkzM2UyYzk3MjBfMS03LTEtMS0w_bd1ff757-d805-4560-abdf-65fff5411719"
      unitRef="usd">-372400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOmFkYjg5ODBiOTE5ZTRkMTM4YWViMTU5MzNlMmM5NzIwL3RhYmxlcmFuZ2U6YWRiODk4MGI5MTllNGQxMzhhZWIxNTkzM2UyYzk3MjBfMi0xLTEtMS0w_6da58af7-088e-4242-9fb9-63895223452b"
      unitRef="usd">52400000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOmFkYjg5ODBiOTE5ZTRkMTM4YWViMTU5MzNlMmM5NzIwL3RhYmxlcmFuZ2U6YWRiODk4MGI5MTllNGQxMzhhZWIxNTkzM2UyYzk3MjBfMi0zLTEtMS0w_c7ea36c1-a0a3-4d44-bd06-327bce27b1ff"
      unitRef="usd">7500000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOmFkYjg5ODBiOTE5ZTRkMTM4YWViMTU5MzNlMmM5NzIwL3RhYmxlcmFuZ2U6YWRiODk4MGI5MTllNGQxMzhhZWIxNTkzM2UyYzk3MjBfMi03LTEtMS0w_12dd1cb8-5d14-49a1-aa78-3cdfb6f3813d"
      unitRef="usd">59900000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOmFkYjg5ODBiOTE5ZTRkMTM4YWViMTU5MzNlMmM5NzIwL3RhYmxlcmFuZ2U6YWRiODk4MGI5MTllNGQxMzhhZWIxNTkzM2UyYzk3MjBfNC0xLTEtMS0w_4b563add-5960-40ca-a005-12ecbe8c8e71"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOmFkYjg5ODBiOTE5ZTRkMTM4YWViMTU5MzNlMmM5NzIwL3RhYmxlcmFuZ2U6YWRiODk4MGI5MTllNGQxMzhhZWIxNTkzM2UyYzk3MjBfNC0zLTEtMS0w_998e5fe3-26a2-4c6b-ad48-bd1911ad042b"
      unitRef="usd">2100000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOmFkYjg5ODBiOTE5ZTRkMTM4YWViMTU5MzNlMmM5NzIwL3RhYmxlcmFuZ2U6YWRiODk4MGI5MTllNGQxMzhhZWIxNTkzM2UyYzk3MjBfNC03LTEtMS0w_d9f08af4-28e9-49c6-ba1d-2267aea06748"
      unitRef="usd">2100000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOmFkYjg5ODBiOTE5ZTRkMTM4YWViMTU5MzNlMmM5NzIwL3RhYmxlcmFuZ2U6YWRiODk4MGI5MTllNGQxMzhhZWIxNTkzM2UyYzk3MjBfNS0xLTEtMS0w_f231448f-88dc-4802-9fe9-650bfe3434f2"
      unitRef="usd">-233000000.0</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOmFkYjg5ODBiOTE5ZTRkMTM4YWViMTU5MzNlMmM5NzIwL3RhYmxlcmFuZ2U6YWRiODk4MGI5MTllNGQxMzhhZWIxNTkzM2UyYzk3MjBfNS0zLTEtMS0w_e9ce9324-2923-479b-8375-0fdef97173d4"
      unitRef="usd">-81600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81NS9mcmFnOmI1ODM2NjUwYmYzNjRkOGU5NzQ0ZTA5MmUyNTdkNjRkL3RhYmxlOmFkYjg5ODBiOTE5ZTRkMTM4YWViMTU5MzNlMmM5NzIwL3RhYmxlcmFuZ2U6YWRiODk4MGI5MTllNGQxMzhhZWIxNTkzM2UyYzk3MjBfNS03LTEtMS0w_e0a065d0-7c78-4bf2-8c30-f95c316e2b96"
      unitRef="usd">-314600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81OC9mcmFnOjUxMDVlYjhlODc0NDRmMTFiOTZkMGNhNzE1ZTYzMjE0L3RleHRyZWdpb246NTEwNWViOGU4NzQ0NGYxMWI5NmQwY2E3MTVlNjMyMTRfMTY0Nw_7171d93a-c81e-4eb1-b31a-bf8486783aab">INCOME TAXES&lt;div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not recognize a tax benefit unless it concludes that it is more likely than not that the benefit will be sustained on audit by the taxing authority based solely on the technical merits of the associated tax position. If the recognition threshold is met, the Company recognizes a tax benefit measured at the largest amount of the tax benefit that it believes is greater than 50% likely to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gross unrecognized income tax benefits were $41.3 and $31.7 at September&#160;30, 2020, and December&#160;31, 2019, respectively. It is anticipated that the amount of the unrecognized income tax benefits will change within the next 12 months; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;however, these changes are not expected to have a significant impact on the results of operations, cash flows or the financial position of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2020, and December&#160;31, 2019, $41.3 and $31.7, respectively, are the approximate amounts of gross unrecognized income tax benefits that, if recognized, would favorably affect the effective income tax rate in future periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7.1pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes interest and penalties related to unrecognized income tax benefits in income tax expense. Accrued interest and penalties related to uncertain tax positions totaled $9.0 and $5.5 as of September&#160;30, 2020, and December&#160;31, 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7.1pt;text-align:justify;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company has substantially concluded all U.S. federal income tax matters for years through 2016. Substantially all material state and local and foreign income tax matters have been concluded through 2015 and 2011, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has various state and foreign income tax examinations ongoing throughout the year. The Company believes adequate provisions have been recorded related to all open tax years.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81OC9mcmFnOjUxMDVlYjhlODc0NDRmMTFiOTZkMGNhNzE1ZTYzMjE0L3RleHRyZWdpb246NTEwNWViOGU4NzQ0NGYxMWI5NmQwY2E3MTVlNjMyMTRfNDEz_a69f7ed7-79c4-42f9-821e-e4c16bc19bae"
      unitRef="number">0.50</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81OC9mcmFnOjUxMDVlYjhlODc0NDRmMTFiOTZkMGNhNzE1ZTYzMjE0L3RleHRyZWdpb246NTEwNWViOGU4NzQ0NGYxMWI5NmQwY2E3MTVlNjMyMTRfNDg3_117a93d0-f70c-4c37-98d9-be6eb8374b70"
      unitRef="usd">41300000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81OC9mcmFnOjUxMDVlYjhlODc0NDRmMTFiOTZkMGNhNzE1ZTYzMjE0L3RleHRyZWdpb246NTEwNWViOGU4NzQ0NGYxMWI5NmQwY2E3MTVlNjMyMTRfNDk0_9e7a4afc-0886-4822-a07c-931c72032b68"
      unitRef="usd">31700000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81OC9mcmFnOjUxMDVlYjhlODc0NDRmMTFiOTZkMGNhNzE1ZTYzMjE0L3RleHRyZWdpb246NTEwNWViOGU4NzQ0NGYxMWI5NmQwY2E3MTVlNjMyMTRfODA3_47dec33e-7db0-4e1a-af17-52ca48e3cd65"
      unitRef="usd">41300000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81OC9mcmFnOjUxMDVlYjhlODc0NDRmMTFiOTZkMGNhNzE1ZTYzMjE0L3RleHRyZWdpb246NTEwNWViOGU4NzQ0NGYxMWI5NmQwY2E3MTVlNjMyMTRfODE0_122d4c86-4ea5-4a56-905b-af8aec1f7b1e"
      unitRef="usd">31700000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81OC9mcmFnOjUxMDVlYjhlODc0NDRmMTFiOTZkMGNhNzE1ZTYzMjE0L3RleHRyZWdpb246NTEwNWViOGU4NzQ0NGYxMWI5NmQwY2E3MTVlNjMyMTRfMTE4Mw_2a8cc678-1576-4552-9b29-120f3b8e761d"
      unitRef="usd">9000000.0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV81OC9mcmFnOjUxMDVlYjhlODc0NDRmMTFiOTZkMGNhNzE1ZTYzMjE0L3RleHRyZWdpb246NTEwNWViOGU4NzQ0NGYxMWI5NmQwY2E3MTVlNjMyMTRfMTE5MA_8374e54a-2d12-44ae-b4ad-3d1eb10b4027"
      unitRef="usd">5500000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82MS9mcmFnOmQwYzNiZGUwZTIyMTQ4ZGQ4MzZkNTQ2NWYzMDFjZDViL3RleHRyZWdpb246ZDBjM2JkZTBlMjIxNDhkZDgzNmQ1NDY1ZjMwMWNkNWJfMjQyMjM_236b218a-e99d-4a2b-9f69-edc8eab1bcc1">COMMITMENTS AND CONTINGENCIES &lt;div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is involved from time to time in various claims and legal actions, including arbitrations, class actions, and other litigation (including those described in more detail below), arising in the ordinary course of business. Some of these actions involve claims that are substantial in amount. These matters include, but are not limited to, intellectual property disputes; commercial and contract disputes; professional liability claims; employee-related matters; and inquiries, including subpoenas and other civil investigative demands, from governmental agencies, Medicare or Medicaid payers and MCOs reviewing billing practices or requesting comment on allegations of billing irregularities that are brought to their attention through billing audits or third parties. The Company receives civil investigative demands or other inquiries from various governmental bodies in the ordinary course of its business. Such inquiries can relate to the Company or other parties, including physicians and other health care providers. The Company works cooperatively to respond to appropriate requests for information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also is named from time to time in suits brought under the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; provisions of the False Claims Act and comparable state laws. These suits typically allege that the Company has made false statements and/or certifications in connection with claims for payment from U.S. federal or state healthcare programs. The suits may remain under seal (hence, unknown to the Company) for some time while the government decides whether to intervene on behalf of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; plaintiff. Such claims are an inevitable part of doing business in the healthcare field today.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company believes that it is in compliance in all material respects with all statutes, regulations, and other requirements applicable to its commercial laboratory operations and drug development support services. The healthcare diagnostics and drug development industries are, however, subject to extensive regulation, and the courts have not interpreted many of the applicable statutes and regulations. Therefore, the applicable statutes and regulations could be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that would adversely affect the Company. Potential sanctions for violation of these statutes and regulations include significant civil and criminal penalties, fines, the loss of various licenses, certificates and authorizations, additional liabilities from third-party claims, and/or exclusion from participation in government programs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Many of the current claims and legal actions against the Company are in preliminary stages, and many of these cases seek an indeterminate amount of damages. The Company records an aggregate legal reserve, which is determined using calculations based on historical loss rates and assessment of trends experienced in settlements and defense costs. In accordance with FASB Accounting Standards Codification Topic 450 &#x201c;Contingencies,&#x201d; the Company establishes reserves for judicial, regulatory, and arbitration matters outside the aggregate legal reserve if and when those matters present loss contingencies that are both probable and estimable and would exceed the aggregate legal reserve. When loss contingencies are not both probable and estimable, the Company does not establish separate reserves.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is unable to estimate a range of reasonably probable loss for the proceedings described in more detail below in which damages either have not been specified or, in the Company's judgment, are unsupported and/or exaggerated and (i) the proceedings are in early stages; (ii) there is uncertainty as to the outcome of pending appeals or motions; (iii) there are significant factual issues to be resolved; and/or (iv) there are novel legal issues to be presented. For these proceedings, however, the Company does not believe, based on currently available information, that the outcomes will have a material adverse effect on the Company's financial condition, though the outcomes could be material to the Company's operating results for any particular period, depending, in part, upon the operating results for such period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As previously reported, the Company responded to an October 2007 subpoena from the U.S. Department of Health &amp;amp; Human Services Office of Inspector General's regional office in New York. On August 17, 2011, the U.S. District Court for the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Southern District of New York unsealed a False Claims Act lawsuit, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States of America ex rel. NPT Associates v. Laboratory Corporation of America Holdings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which alleges that the Company offered UnitedHealthcare kickbacks in the form of discounts in return for Medicare business. The Plaintiff's Third Amended Complaint further alleges that the Company's billing practices violated the False Claims Acts of 14 states and the District of Columbia. The lawsuit seeks actual and treble damages and civil penalties for each alleged false claim, as well as recovery of costs, attorney's fees, and legal expenses. Neither the U.S. government nor any state government has intervened in the lawsuit. The Company's Motion to Dismiss was granted in October 2014 and Plaintiff was granted the right to replead. On January 11, 2016, Plaintiff filed a motion requesting leave to file an amended complaint under seal and to vacate the briefing schedule for the Company's Motion to Dismiss, while the government reviews the amended complaint. The Court granted the motion and vacated the briefing dates. Plaintiff then filed the Amended Complaint under seal. The Company will vigorously defend the lawsuit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company has received various other subpoenas since 2007 related to Medicaid billing. In October 2009, the Company received a subpoena from the State of Michigan Department of Attorney General seeking documents related to its billing to Michigan Medicaid. The Company cooperated with this request. In October 2013, the Company received a Civil Investigative Demand from the State of Texas Office of the Attorney General requesting documents related to its billing to Texas Medicaid. The Company cooperated with this request. On October 5, 2018, the Company received a second Civil Investigative Demand from the State of Texas Office of the Attorney General requesting documents related to its billing to Texas Medicaid. The Company is cooperating with this request.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 31, 2015, the Company was served with a putative class action lawsuit, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Patty Davis v. Laboratory Corporation of America, et al.,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; filed in the Circuit Court of the Thirteenth Judicial Circuit for Hillsborough County, Florida. The complaint alleges that the Company violated the Florida Consumer Collection Practices Act by billing patients who were collecting benefits under the Workers' Compensation Statutes. The lawsuit seeks injunctive relief and actual and statutory damages, as well as recovery of attorney's fees and legal expenses. In April 2017, the Circuit Court granted the Company&#x2019;s Motion for Judgment on the Pleadings. The Plaintiff appealed the Circuit Court&#x2019;s ruling to the Florida Second District Court of Appeal. On October 16, 2019, the Court of Appeal reversed the Circuit Court&#x2019;s dismissal, but certified a controlling issue of Florida law to the Florida Supreme Court. On February 17, 2020, the Florida Supreme Court accepted jurisdiction of the lawsuit. The Court has scheduled oral arguments for December 9, 2020. The Company will vigorously defend the lawsuit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2014, the Company received a Civil Investigative Demand issued pursuant to the U.S. False Claims Act from the U.S. Attorney's Office for South Carolina, which requested information regarding alleged remuneration and services provided by the Company to physicians who also received draw and processing/handling fees from competitor laboratories Health Diagnostic Laboratory, Inc. (HDL) and Singulex, Inc. (Singulex). The Company cooperated with the request. On April 4, 2018, the U.S. District Court for the District of South Carolina, Beaufort Division, unsealed a False Claims Act lawsuit, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States of America ex rel. Scarlett Lutz, et al. v. Laboratory Corporation of America Holdings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which alleges that the Company's financial relationships with referring physicians violate federal and state anti-kickback statutes. The Plaintiffs' Fourth Amended Complaint further alleges that the Company conspired with HDL and Singulex in violation of the Federal False Claims Act and the California and Illinois insurance fraud prevention acts by facilitating HDL's and Singulex's offers of illegal inducements to physicians and the referral of patients to HDL and Singulex for laboratory testing. The lawsuit seeks actual and treble damages and civil penalties for each alleged false claim, as well as recovery of costs, attorney's fees, and legal expenses. Neither the U.S. government nor any state government has intervened in the lawsuit. The Company filed a Motion to Dismiss seeking the dismissal of the claims asserted under the California and Illinois insurance fraud prevention statutes, the conspiracy claim, the reverse False Claims Act claim, and all claims based on the theory that the Company performed medically unnecessary testing. On January 16, 2019, the Court entered an order granting in part and denying in part the Motion to Dismiss. The Court dismissed the Plaintiffs' claims based on the theory that the Company performed medically unnecessary testing, the claims asserted under the California and Illinois insurance fraud prevention statutes, and the reverse False Claims Act claim. The Court denied the Motion to Dismiss as to the conspiracy claim. The Company will vigorously defend the lawsuit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the Company's acquisition of Sequenom, Inc. (Sequenom) between August 15, 2016 and August 24, 2016, six putative class-action lawsuits were filed on behalf of purported Sequenom stockholders (captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Malkoff v. Sequenom, Inc., et al., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No. 16-cv-02054- JAH-BLM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Gupta v. Sequenom, Inc., et al&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;., No. 16-cv-02084-JAH-KSC,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Fruchter v. Sequenom, Inc., et al&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;., No. 16-cv-02101- WQH-KSC, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Asiatrade Development Ltd. v. Sequenom, Inc., et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 16-cv-02113-AJB-JMA, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Nunes v. Sequenom, Inc., et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 16-cv-02128-AJB-MDD, and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cusumano v. Sequenom, Inc., et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 16-cv-02134-LAB-JMA) in the U.S. District Court for the Southern District of California challenging the acquisition transaction. The complaints asserted claims against Sequenom and members of its board of directors (the Individual Defendants). The &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Nunes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;action also named the Company and Savoy Acquisition Corp. (Savoy), a wholly owned subsidiary of the Company, as defendants. The complaints alleged that the defendants violated Sections 14(e), 14(d)(4) and 20 of the Securities Exchange Act of 1934 by failing to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;disclose certain allegedly material information. In addition, the complaints in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Malkoff &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;action, the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Asiatrade &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;action, and the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cusumano &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;action alleged that the Individual Defendants breached their fiduciary duties to Sequenom shareholders. The actions sought, among other things, injunctive relief enjoining the merger. On August 30, 2016, the parties entered into a Memorandum of Understanding (MOU) in each of the above-referenced actions. On September 6, 2016, the Court entered an order consolidating for all pre-trial purposes the six individual actions described above under the caption &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re Sequenom, Inc. Shareholder Litig.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Lead Case No. 16-cv-02054-JAH-BLM, and designating the complaint from the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Malkoff &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;action as the operative complaint for the consolidated action. On November 11, 2016, two competing motions were filed by two separate stockholders (James Reilly and Shikha Gupta) seeking appointment as lead plaintiff under the terms of the Private Securities Litigation Reform Act of 1995. On June 7, 2017, the Court entered an order declaring Mr. Reilly as the lead plaintiff and approving Mr. Reilly's selection of lead counsel. The parties agree that the MOU has been terminated. The Plaintiffs filed a Consolidated Amended Class Action Complaint on July 24, 2017, and the Defendants filed a Motion to Dismiss, which remains pending. On March 13, 2019, the Court stayed the action in its entirety pending the U.S. Supreme Court's anticipated decision in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Emulex Corp. v. Varjabedian&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. On April 23, 2019, however, the U.S. Supreme Court dismissed the writ of certiorari in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Emulex &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;as improvidently granted. The Company will vigorously defend the lawsuit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 10, 2017, the Company was served with a putative class action lawsuit, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Victoria Bouffard, et al. v. Laboratory Corporation of America Holdings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, filed in the U.S. District Court for the Middle District of North Carolina. The complaint alleges that the Company's patient list prices unlawfully exceed the rates negotiated for the same services with private and public health insurers in violation of various state consumer protection laws. The lawsuit also alleges breach of implied contract or quasi-contract, unjust enrichment, and fraud. The lawsuit seeks statutory, exemplary, and punitive damages, injunctive relief, and recovery of attorney's fees and costs. In May 2017, the Company filed a Motion to Dismiss Plaintiffs' Complaint and Strike Class Allegations; the Motion to Dismiss was granted in March 2018 without prejudice. On October 10, 2017, a second putative class action lawsuit, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sheryl Anderson, et al. v. Laboratory Corporation of America Holdings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, was filed in the U.S. District Court for the Middle District of North Carolina. The complaint contained similar allegations and sought similar relief to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Bouffard&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaint, and added additional counts regarding state consumer protection laws. On August 10, 2018, the Plaintiffs filed an Amended Complaint, which consolidated the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Bouffard&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Anderson&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; actions. On September 10, 2018, the Company filed a Motion to Dismiss Plaintiffs' Amended Complaint and Strike Class Allegations. On August 16, 2019, the Court entered an order granting in part and denying in part the Motion to Dismiss the Amended Complaint, and denying the Motion to Strike the Class Allegations. The Company will vigorously defend the lawsuit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2019, Covance Research Products was served with a Grand Jury Subpoena issued by the Department of Justice (DOJ) in Miami, Florida requiring the production of documents related to the importation into the United States of live non-human primate shipments originating from or transiting through China, Cambodia, and/or Vietnam from April 1, 2014 through March 28, 2019. The Company is cooperating with the DOJ.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 14, 2019, Retrieval-Masters Creditors Bureau, Inc. d/b/a American Medical Collection Agency (AMCA), an external collection agency, notified the Company about a security incident AMCA experienced that may have involved certain personal information about some of the Company&#x2019;s patients (the AMCA Incident). The Company referred patient balances to AMCA only when direct collection efforts were unsuccessful. The Company&#x2019;s systems were not impacted by the AMCA Incident. Upon learning of the AMCA Incident, the Company promptly stopped sending new collection requests to AMCA and stopped AMCA from continuing to work on any pending collection requests from the Company. AMCA informed the Company that it appeared that an unauthorized user had access to AMCA&#x2019;s system between August 1, 2018, and March 30, 2019, and that AMCA could not rule out the possibility that personal information on AMCA&#x2019;s system was at risk during that time period. Information on AMCA&#x2019;s affected system from the Company may have included name, address, and balance information for the patient and person responsible for payment, along with the patient&#x2019;s phone number, date of birth, referring physician, and date of service. The Company was later informed by AMCA that health insurance information may have been included for some individuals, and because some insurance carriers utilize the Social Security Number as a subscriber identification number, the Social Security Number for &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;some &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;individuals may also have been affected. No ordered tests, laboratory test results, or diagnostic information from the Company were in the AMCA affected system. The Company notified individuals for whom it had a valid mailing address. For the individuals whose Social Security Number was affected, the notice included an offer to enroll in credit monitoring and identity protection services that will be provided free of charge for 24 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Twenty-three putative class action lawsuits were filed against the Company related to the AMCA Incident in various U.S. District Courts. Numerous similar lawsuits have been filed against other health care providers who used AMCA. These lawsuits have been consolidated into a multidistrict litigation in the District of New Jersey. On November 15, 2019, the Plaintiffs filed a Consolidated Class Action Complaint in the U.S. District Court of New Jersey. On January 22, 2020, the Company filed Motions to Dismiss all claims. The consolidated Complaint generally alleges that the Company did not adequately protect its &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;patients&#x2019; data and failed to timely notify those patients of the AMCA Incident. The Complaint asserts various causes of action, including but not limited to negligence, breach of implied contract, unjust enrichment, and the violation of state data protection statutes. The Complaint seeks damages on behalf of a class of all affected Company customers. The Company will vigorously defend the multi-district litigation. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company was served with a shareholder derivative lawsuit, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Raymond Eugenio, Derivatively on Behalf of Nominal Defendant, Laboratory Corporation of America Holdings v. Lance Berberian, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, filed in the Court of Chancery of the State of Delaware on April 23, 2020.&#160;The complaint asserts derivative claims on the Company&#x2019;s behalf against the Company&#x2019;s board of directors and certain executive officers.&#160;The complaint generally alleges that the defendants failed to ensure that the Company utilized proper cybersecurity safeguards and failed to implement a sufficient response to data security incidents, including the AMCA Incident.&#160;The complaint asserts derivative claims for breach of fiduciary duty and seeks relief including damages, certain disclosures, and certain changes to the Company&#x2019;s internal governance practices. On June 2, 2020, the Company filed a Motion to Stay the lawsuit due to its overlap with the multi-district litigation referenced above. On July 2, 2020, the Company filed a Motion to Dismiss. On July 14, 2020, the Court entered an order staying the lawsuit pending the resolution of the multi-district litigation. The lawsuit will be vigorously defended.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain governmental entities have requested information from the Company related to the AMCA Incident. The Company received a request for information from the Office for Civil Rights (OCR) of the Department of Health and Human Services.&#160;On April 28, 2020, OCR notified the Company of the closure of its inquiry. The Company has also received requests from a multi-state group of state Attorneys General and is cooperating with these requests for information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Three putative class action lawsuits related to California wage and hour laws have been served on the Company. On September 21, 2018, the Company was served with a putative class action lawsuit, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Alma Haro v. Laboratory Corporation of America, et al&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;., filed in the Superior Court of California, County of Los Angeles. On June 10, 2019, the Company was served with a putative class action lawsuit, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Ignacio v. Laboratory Corporation of America&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, filed in Superior Court of California, County of Los Angeles. On July 1, 2019, the Company was served with a putative class action lawsuit, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Jan v. Laboratory Corporation of America&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, filed in the Superior Court of California, County of Sacramento. All three lawsuits were subsequently removed to the U.S. District Court for the Central District of California, and then consolidated for all pre-trial proceedings. In the lawsuits, the Plaintiffs allege that employees were not properly paid overtime compensation, minimum wages, meal and rest break premiums, did not receive compliant wage statements, and were not properly paid wages upon termination of employment. The Plaintiffs assert these actions violate various California Labor Code provisions and constitute an unfair competition practice under California law. The lawsuits seek monetary damages, civil penalties, and recovery of attorney's fees and costs. On July 22, 2020, the Court issued an order granting preliminary approval of a settlement resolving all three lawsuits. If the settlement does not receive final approval, the Company will vigorously defend the lawsuits. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 30, 2019, the Company was served with a class action lawsuit, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mitchell v. Covance, Inc. et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, filed in the U.S. District Court for the Eastern District of Pennsylvania. Plaintiff alleges that certain individuals employed by Covance Inc. and Chiltern International Inc. were misclassified as exempt employees under the Fair Labor Standards Act and the Pennsylvania Minimum Wage Act and were thereby not properly paid overtime compensation. The lawsuit seeks monetary damages, liquidated damages, and recovery of attorneys&#x2019; fees and costs. On February 3, 2020, the Court denied without prejudice the Plaintiff's motion to conditionally certify a putative class action. On July 20, 2020, Plaintiff executed a settlement agreement resolving the lawsuit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 31, 2020, the Company was served with a putative class action lawsuit, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Luke Davis and Julian Vargas, et al. v. Laboratory Corporation of America Holdings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, filed in the U.S. District Court for the Central District of California. The lawsuit alleges that visually impaired patients are unable to use the Company's touchscreen kiosks at Company patient service centers in violation of the Americans with Disabilities Act and similar California statutes. The lawsuit seeks statutory damages, injunctive relief, and attorney's fees and costs. On March 20, 2020, the Company filed a Motion to Dismiss Plaintiffs' Complaint and to Strike Class Allegations. In August 2020, the Plaintiffs filed an Amended Complaint. The Company will vigorously defend the lawsuit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 14, 2020, the Company was served with a putative class action lawsuit, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Jose Bermejo v. Laboratory Corporation of America&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; filed in the Superior Court of California, County of Los Angeles Central District, alleging that certain non-exempt California-based employees were not properly compensated for driving time or properly paid wages upon termination of employment. The Plaintiff asserts these actions violate various California Labor Code provisions and Section 17200 of the Business and Professional Code. The lawsuit seeks monetary damages, civil penalties, and recovery of attorney&#x2019;s fees and costs. On June 15, 2020, the lawsuit was removed to the U.S. District Court for the Central District of California. On June 16, 2020, the Company was served with a Private Attorney General Act lawsuit by the same plaintiff in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Jose Bermejo v. Laboratory &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Corporation of America, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;filed in the Superior Court of California, County of Los Angeles Central District, alleging that certain Company practices violated California Labor Code penalty provisions related to unpaid and minimum wages, unpaid overtime, unpaid mean and rest break premiums, untimely payment of wages following separation of employment, failure to maintain accurate pay records, and non-reimbursement of business expenses. The second lawsuit seeks to recover civil penalties and recovery of attorney's fees and costs. The Company will vigorously defend both lawsuits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 14, 2020, the Company was served with a Subpoena Duces Tecum issued by the State of Colorado Office of the Attorney General requiring the production of documents related to urine drug testing in all states. The Company is cooperating with this request.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 2, 2020, the Company was served with a putative class action lawsuit, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Peterson v. Laboratory Corporation of America Holdings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, filed in the U.S. District Court for the Northern District of New York, alleging claims for a failure to properly pay service representatives compensation for all hours worked and overtime under the Fair Labor Standards Act, as well as notice and recordkeeping claims under the New York Labor Code. The lawsuit seeks monetary damages, liquidated damages, equitable and injunctive relief, and recovery of attorney's fees and costs. The Company will vigorously defend the lawsuit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 5, 2020, the Company was served with a putative class action lawsuit, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Williams v. LabCorp Employer Services, Inc. et al, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;filed in the Superior Court of California, County of Los Angeles, alleging that certain non-exempt California-based employees were not properly compensated for work and overtime hours, not properly paid meal and rest break premiums, not reimbursed for certain business-related expenses, not properly paid for driving or wait times, and received inaccurate wage statements. The Plaintiff also asserts claims for unfair competition under Section 17200 of the Business and Professional Code. The lawsuit seeks monetary damages, liquidated damages, civil penalties, and recovery of attorney's fees and costs. The Company will vigorously defend the lawsuit. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Company's present insurance programs, coverage is obtained for catastrophic exposure as well as those risks required to be insured by law or contract. The Company is responsible for the uninsured portion of losses related primarily to general, professional and vehicle liability, certain medical costs and workers' compensation. The self-insured retentions are on a per-occurrence basis without any aggregate annual limit. Provisions for losses expected under these programs are recorded based upon the Company's estimates of the aggregated liability of claims incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfNDQ4Nw_ac953705-b230-4e42-9a96-39a9af874fb1">PENSION AND POSTRETIREMENT PLANS&lt;div style="margin-bottom:3pt;margin-top:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Retirement Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7.1pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All employees eligible for the LCD defined-contribution retirement plan (LCD 401(k) Plan) receive a minimum 3% non-elective contribution (NEC) concurrent with each payroll period. Employees are not required to make a contribution to the LCD 401(k) Plan to receive the NEC. The NEC is non-forfeitable and vests immediately. The LCD 401(k) Plan also permits discretionary contributions by the Company of 1% to 3% of pay for eligible employees based on service. The Company incurred expense of $14.0 and $16.7 for the LCD 401(k) Plan during the three months ended September&#160;30, 2020, and 2019, respectively, and $41.4 and $48.9 during the nine months ended September&#160;30, 2020, and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the CDD U.S. employees are eligible to participate in the CDD 401(k) Plan, which is available on a voluntary basis and features a maximum 4.5% Company match, based upon a percentage of the employee&#x2019;s contributions. The Company incurred expense of $21.0 and $18.2 for the Covance 401(k) plan during the three months ended September&#160;30, 2020, and 2019, respectively, and $64.8 and $56.0 during the nine months ended September&#160;30, 2020, and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also maintains several other small 401(k) plans associated with companies acquired over the last several years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Pension Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a defined-benefit retirement plan (Company Plan) and a nonqualified supplemental retirement plan (PEP). Both plans have been closed to new participants since December 31, 2009. Employees participating in the Company Plan and PEP no longer earn service-based credits, but continue to earn investment credits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company Plan covers substantially all LCD employees employed prior to December 31, 2009. The benefits to be paid under the Company Plan are based on years of credited service through December 31, 2009, interest credits and average compensation. The Company's policy is to fund the Company Plan with at least the minimum amount required by applicable regulations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The PEP covers a portion of the Company's senior management group. Prior to 2010, the PEP provided for the payment of the difference, if any, between the amount of any maximum limitation on annual benefit payments under the Employee Retirement Income Security Act of 1974 and the annual benefit that would be payable under the Company Plan but for such limitation. Effective January 1, 2010, employees participating in the PEP no longer earn service-based credits. The PEP is an unfunded plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effect on operations for the Company Plan and the PEP is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.086%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost for administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net amortization and deferral&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Defined benefit plan costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The service cost component of net periodic pension cost and net periodic post-retirement benefit cost is included in operating expenses with other employee compensation costs. The other components of net benefit cost, including amortization or prior service cost/credit and settlement and curtailment effects are included in other, net non-operating expenses. During the nine months ended September&#160;30, 2020, the Company made no contributions to the Company Plan. The related net pension obligation for the Company Plan and PEP was $92.6 and $93.4 as of September&#160;30, 2020, and December&#160;31, 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the Covance acquisition, the Company sponsors two defined benefit pension plans for the benefit of its employees at two U.K. subsidiaries (U.K. Plans) and one defined benefit pension plan for the benefit of its employees at a German subsidiary (German Plan), all of which are legacy plans of previously acquired companies. The U.K. Plans were closed to future accrual as of December 31, 2019. Benefit amounts for all three plans are based upon years of service and compensation; however, the U.K. Plans were based on service and compensation through December 31, 2019. The German Plan is unfunded while the U.K. Plans are funded. The Company&#x2019;s funding policy has been to contribute annually a fixed percentage of the eligible employee's salary, and additional amounts, at least equal to the local statutory funding requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the Envigo acquisition, the Company assumed a defined benefit pension plan for the benefit of Envigo's U.K. employees (the Envigo Plan), which is a legacy plan of a company previously acquired by Envigo. The Envigo Plan is a funded plan that is closed to future accrual. The Company&#x2019;s funding policy has been to contribute amounts at least equal to the local statutory funding requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The related net pension obligation for these plans inclusive of the U.K. Plans, German Plan, and the Envigo Plan, was&#160;$85.4 and $99.1&#160;as of September&#160;30, 2020, and December&#160;31, 2019, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <lh:NonElectiveContribution
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfMTY4_832a7ac2-55dc-4b1b-b71e-32dde53157d3"
      unitRef="number">0.03</lh:NonElectiveContribution>
    <lh:DiscretionaryContributionPercentageMinimum
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfNDYy_c80af34a-afe8-412d-9f0a-414d432155d3"
      unitRef="number">0.01</lh:DiscretionaryContributionPercentageMinimum>
    <lh:DiscretionaryContributionPercentageMaximum
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfNDY4_b873c01a-038e-4ef7-99f8-e686ac5d2d9e"
      unitRef="number">0.03</lh:DiscretionaryContributionPercentageMaximum>
    <lh:DefinedContributionPlanTotalExpense
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfNTUx_b8de94bc-6c9a-444c-a24e-00f938fd4aef"
      unitRef="usd">14000000.0</lh:DefinedContributionPlanTotalExpense>
    <lh:DefinedContributionPlanTotalExpense
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfNTU4_506a23e6-4185-48d5-a67e-3efa8e7bcb72"
      unitRef="usd">16700000</lh:DefinedContributionPlanTotalExpense>
    <lh:DefinedContributionPlanTotalExpense
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfNjQz_f03ad28e-4bc4-4975-ae02-9941a9c3c2ed"
      unitRef="usd">41400000</lh:DefinedContributionPlanTotalExpense>
    <lh:DefinedContributionPlanTotalExpense
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfNjUw_8aa6725e-d1d4-465a-aa09-cbc837bdc6f7"
      unitRef="usd">48900000</lh:DefinedContributionPlanTotalExpense>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfODUy_70346423-9593-4389-a140-7a114006397d"
      unitRef="number">0.045</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i1e01cc0ff9ce44ef99f7acd5a862967e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfOTU5_32e61a85-30ff-45b3-8747-d3698206f54e"
      unitRef="usd">21000000.0</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="ib199336a2dd2420097e56516adfbc4d1_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfOTY2_95483a97-13f5-424e-9430-1886c088cbcb"
      unitRef="usd">18200000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="ia13373a9d55d49f19ffcc37b5bd497f3_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfMTA1OA_2ea2ee7d-cbac-4075-a5e9-3dd657e50d0e"
      unitRef="usd">64800000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i3eb0e387c6aa4d82ac76ca334fbc0143_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfMTA2NQ_2234f820-4319-4cd2-8697-5abab51a9bbd"
      unitRef="usd">56000000.0</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfNDUwOQ_3d2123bf-6ed6-4f5f-b86a-29747e25ed96">&lt;div style="text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effect on operations for the Company Plan and the PEP is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.086%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost for administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net amortization and deferral&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Defined benefit plan costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ifc93dd882afa412083acfde2ba592eee_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfMi0xLTEtMS0w_99c9b3c5-f1b7-4f78-b48c-01dd3c1e8ce9"
      unitRef="usd">1300000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ia2cd501dd8ab4346aa80fd4754cc040c_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfMi0zLTEtMS0w_acf28e08-211d-4e7d-9102-3e1f960b4b15"
      unitRef="usd">1100000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ibb40acae056445528eb8911537232df5_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfMi01LTEtMS0w_7c1e96de-1c8d-46b8-bd4f-90977e8dfd58"
      unitRef="usd">3900000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="icddc15843aad45e5aededcb204169bef_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfMi03LTEtMS0w_dd71aa25-d7e1-4f7b-9c24-6a612240512c"
      unitRef="usd">3100000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ifc93dd882afa412083acfde2ba592eee_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfMy0xLTEtMS0w_a027629c-f1e0-4e39-a0a9-7af913b2f732"
      unitRef="usd">2800000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ia2cd501dd8ab4346aa80fd4754cc040c_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfMy0zLTEtMS0w_a0064227-9023-4353-a5ec-3e265f9b6d0b"
      unitRef="usd">3400000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ibb40acae056445528eb8911537232df5_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfMy01LTEtMS0w_bf82a3da-c3f6-41dd-8d74-f8a4e05754a0"
      unitRef="usd">8400000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="icddc15843aad45e5aededcb204169bef_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfMy03LTEtMS0w_72995dbf-2435-444a-8a62-6565b0da5097"
      unitRef="usd">10400000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ifc93dd882afa412083acfde2ba592eee_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfNC0xLTEtMS0w_e39e9287-0e13-4830-8b80-4ee97d097a42"
      unitRef="usd">3700000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ia2cd501dd8ab4346aa80fd4754cc040c_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfNC0zLTEtMS0w_f492976c-14cc-4c03-94eb-29a906b40111"
      unitRef="usd">3700000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ibb40acae056445528eb8911537232df5_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfNC01LTEtMS0w_34dd4aa1-e1cf-4c94-b859-dd4684fbe98f"
      unitRef="usd">11200000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="icddc15843aad45e5aededcb204169bef_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfNC03LTEtMS0w_d0242721-dc69-485b-abb1-d76af575cd48"
      unitRef="usd">11300000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <lh:NetDefinedBenefitPlanAmortizationAndDeferral
      contextRef="ifc93dd882afa412083acfde2ba592eee_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfNS0xLTEtMS0w_869970bd-4f9e-451e-bd8c-b99a1f41fff5"
      unitRef="usd">2400000</lh:NetDefinedBenefitPlanAmortizationAndDeferral>
    <lh:NetDefinedBenefitPlanAmortizationAndDeferral
      contextRef="ia2cd501dd8ab4346aa80fd4754cc040c_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfNS0zLTEtMS0w_17100af8-f4b5-419b-9f80-81e21719736d"
      unitRef="usd">3000000.0</lh:NetDefinedBenefitPlanAmortizationAndDeferral>
    <lh:NetDefinedBenefitPlanAmortizationAndDeferral
      contextRef="ibb40acae056445528eb8911537232df5_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfNS01LTEtMS0w_5353bc3f-b14c-4c3f-8c16-0675fac9ae60"
      unitRef="usd">7200000</lh:NetDefinedBenefitPlanAmortizationAndDeferral>
    <lh:NetDefinedBenefitPlanAmortizationAndDeferral
      contextRef="icddc15843aad45e5aededcb204169bef_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfNS03LTEtMS0w_a1c5722f-7138-4a23-8a65-118acc23e3c2"
      unitRef="usd">8200000</lh:NetDefinedBenefitPlanAmortizationAndDeferral>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ifc93dd882afa412083acfde2ba592eee_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfNi0xLTEtMS0w_a6682e09-cf80-4ff2-b92e-f7e341d196bd"
      unitRef="usd">2800000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ia2cd501dd8ab4346aa80fd4754cc040c_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfNi0zLTEtMS0w_65ee376a-8449-4133-a1ad-774ebfb4b737"
      unitRef="usd">3800000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ibb40acae056445528eb8911537232df5_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfNi01LTEtMS0w_cda67b34-d7cb-4e89-bf18-6e66a97527fd"
      unitRef="usd">8300000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="icddc15843aad45e5aededcb204169bef_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RhYmxlOmYwYTUyM2VkM2IzZTRkMzY4MTc0YzY2ZmMyYzIyNjQ5L3RhYmxlcmFuZ2U6ZjBhNTIzZWQzYjNlNGQzNjgxNzRjNjZmYzJjMjI2NDlfNi03LTEtMS0w_fd99092f-bdd2-440f-a9aa-ef7e1d66f707"
      unitRef="usd">10400000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfMzAzMA_2672d6b8-202c-4a83-8ae4-956fb467b2ed"
      unitRef="usd">-92600000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfMzAzNw_6cc704fa-8d1e-41ad-bd2f-4919b0f0e640"
      unitRef="usd">-93400000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
      contextRef="if69fa5cada7744eeb0c7092963608d33_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfNDQzOQ_772e63fa-1847-4ac2-bf89-294b19c5e65c"
      unitRef="usd">85400000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
      contextRef="i9e0edd28826044888669adf1110662a2_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82NC9mcmFnOjk3MjU1N2FjZmYxMTRmZmNhN2JiNTI0NTM5YmZhMjE1L3RleHRyZWdpb246OTcyNTU3YWNmZjExNGZmY2E3YmI1MjQ1MzliZmEyMTVfNDQ0Ng_068ab0f3-387e-4968-bcc1-9e5dd57591ef"
      unitRef="usd">99100000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RleHRyZWdpb246ZjNhZDBiYWZkZjViNDI2MmI4ZTY1NDU2MmMxMDUwZThfMjY3NQ_8b53c4f8-5c5a-48c6-b81f-4c46d3385a28">FAIR VALUE MEASUREMENTS&lt;div style="margin-bottom:6pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s population of financial assets and liabilities subject to fair value measurements as of September&#160;30, 2020, and December&#160;31, 2019, is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.665%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.101%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value Measurements as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value&lt;br/&gt;as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Using Fair Value Hierarchy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest put&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.138%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value Measurements as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value&lt;br/&gt;as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Using Fair Value Hierarchy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest put&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value Measurement of Level 3 Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7.1pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a noncontrolling interest put related to its Ontario subsidiary that has been classified as mezzanine equity in the Company&#x2019;s condensed consolidated balance sheets. The noncontrolling interest put is valued at its contractually determined value, which approximates fair value.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7.1pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company offers certain employees the opportunity to participate in an employee-funded deferred compensation plan (DCP). A participant's deferrals are allocated by the participant to one or more of 16 measurement funds, which are indexed to externally managed funds. From time to time, to offset the cost of the growth in the participant's investment accounts, the Company purchases life insurance policies, with the Company named as beneficiary of the policies. Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments, which are typically invested in a similar manner to the participants' allocations. Changes in the fair value of the DCP obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units. The cash surrender value and the DCP obligations are classified within Level 2 because their inputs are derived principally from observable market data by correlation to the hypothetical investments.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent acquisition consideration liabilities are measured at fair value using Level 3 valuations. These contingent consideration liabilities were recorded at fair value on the acquisition date and are remeasured quarterly based on the then assessed fair value and adjusted if necessary. The increases or decreases in the fair value of contingent consideration payable can result from changes in anticipated revenue levels and changes in assumed discount periods and rates. As the fair value measure is based on significant inputs that are not observable in the market, they are categorized as Level 3.&lt;/span&gt;&lt;/div&gt;The carrying amounts of cash and cash equivalents, accounts receivable, income taxes receivable, and accounts payable are considered to be representative of their respective fair values due to their short-term nature. The fair market value of the Senior Notes, based on market pricing, was approximately $6,107.9 and $6,140.6 as of September&#160;30, 2020, and December&#160;31, 2019, respectively. The Company's note and debt instruments are classified as Level 2 instruments, as the fair market values of these instruments are determined using other observable inputs.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RleHRyZWdpb246ZjNhZDBiYWZkZjViNDI2MmI4ZTY1NDU2MmMxMDUwZThfMjY2Mw_7db3e3dd-6868-4cf8-897e-c400ac34252a">&lt;div style="margin-bottom:6pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s population of financial assets and liabilities subject to fair value measurements as of September&#160;30, 2020, and December&#160;31, 2019, is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.665%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.101%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value Measurements as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value&lt;br/&gt;as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Using Fair Value Hierarchy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest put&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.138%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value Measurements as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value&lt;br/&gt;as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Using Fair Value Hierarchy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest put&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfNC0zLTEtMS0w_303afa02-2005-47e4-b6f9-db67eac3a448"
      unitRef="usd">15400000</lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts
      contextRef="i5229937ecb2d46eaa667d49484539b53_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfNC01LTEtMS0w_83219034-ef07-4c89-8335-af4276d9c0be"
      unitRef="usd">0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts
      contextRef="iab089143fc42417c81a2d2bfabbd8654_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfNC03LTEtMS0w_b383cda8-9dac-4e59-9db5-f484f2f5cd1f"
      unitRef="usd">15400000</lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts
      contextRef="iacfbc074fcc44dfb86499f5096b2b493_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfNC05LTEtMS0w_35b94413-6bcd-436e-a9e2-b753d88c768f"
      unitRef="usd">0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfNS0zLTEtMS0w_90a581ff-5b37-43e0-b51a-6e2f70632d26"
      unitRef="usd">8800000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i5229937ecb2d46eaa667d49484539b53_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfNS01LTEtMS0w_7b672e2c-1716-4ec5-a00c-37da049eb7d9"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="iab089143fc42417c81a2d2bfabbd8654_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfNS03LTEtMS0w_fc8b5a55-a3d5-4211-b618-00ab6b488d10"
      unitRef="usd">8800000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="iacfbc074fcc44dfb86499f5096b2b493_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfNS05LTEtMS0w_93986c89-63c8-4cc8-9e3c-c9942fa2ba90"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfOS0zLTEtMS0w_5fee85f8-e0d7-4fcc-be4e-5307cb466391"
      unitRef="usd">82900000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i5229937ecb2d46eaa667d49484539b53_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfOS01LTEtMS0w_ebf1a97b-028e-49eb-8e62-2bbaa531bccc"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="iab089143fc42417c81a2d2bfabbd8654_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfOS03LTEtMS0w_3e43966a-28f3-4b18-a7a0-33a7630652bf"
      unitRef="usd">82900000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="iacfbc074fcc44dfb86499f5096b2b493_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfOS05LTEtMS0w_e55e8bdf-61bd-4b78-80cc-edaa2f2a3440"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfMTAtMy0xLTEtMA_73b18bba-357a-443a-a2d1-837955a02982"
      unitRef="usd">81000000.0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability
      contextRef="i5229937ecb2d46eaa667d49484539b53_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfMTAtNS0xLTEtMA_95de986d-d0ae-4865-aa7b-57fd69e5cf30"
      unitRef="usd">0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability
      contextRef="iab089143fc42417c81a2d2bfabbd8654_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfMTAtNy0xLTEtMA_be006461-9c86-4dac-aa37-8f7c07587f7f"
      unitRef="usd">81000000.0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability
      contextRef="iacfbc074fcc44dfb86499f5096b2b493_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfMTAtOS0xLTEtMA_ff11ff45-bfcb-4b0e-9649-53514b9f7f9b"
      unitRef="usd">0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfMTEtMy0xLTEtMA_e13de405-8fcf-4917-a599-1d95be146d46"
      unitRef="usd">9000000.0</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i5229937ecb2d46eaa667d49484539b53_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfMTEtNS0xLTEtMA_0bb0ce9a-bf9a-41ed-b5f1-9d88e16fdab5"
      unitRef="usd">0</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="iab089143fc42417c81a2d2bfabbd8654_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfMTEtNy0xLTEtMA_51167198-d878-4071-9732-a5748ebbc74d"
      unitRef="usd">0</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="iacfbc074fcc44dfb86499f5096b2b493_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOmZhMDcwYmYwOTIyZjQ2M2U4YWI3ZjlmMjAwZDlhYmY5L3RhYmxlcmFuZ2U6ZmEwNzBiZjA5MjJmNDYzZThhYjdmOWYyMDBkOWFiZjlfMTEtOS0xLTEtMA_10ac9ecd-a44f-4d3d-8e1b-fa0982c4d566"
      unitRef="usd">9000000.0</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNC0zLTEtMS0w_05bb5ecc-f571-4bb9-8210-ee65e7bf56a8"
      unitRef="usd">15800000</lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts
      contextRef="i7ded3a94ce0f45598710ac45a034a923_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNC01LTEtMS0w_a09c7cec-c413-494c-936a-14baedb1ab07"
      unitRef="usd">0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts
      contextRef="ib0f0ae542d5a48d89e69a0ec76905efe_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNC03LTEtMS0w_2363c244-bb5f-4bdd-9d24-8fe1ae20e562"
      unitRef="usd">15800000</lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts
      contextRef="i7abc6c3f0ace4f678cb9c9f7caec9b6b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNC05LTEtMS0w_7d71cf51-c0df-4a97-941a-e46806702abe"
      unitRef="usd">0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNS0zLTEtMS0w_51b0907e-5eb0-449c-9bbe-d0bc577bf5de"
      unitRef="usd">3200000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i7ded3a94ce0f45598710ac45a034a923_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNS01LTEtMS0w_1e70b3d1-5a2e-489e-804b-dce09c1becdd"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ib0f0ae542d5a48d89e69a0ec76905efe_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNS03LTEtMS0w_f04b68df-e2c4-4395-be43-ca56b2d071b1"
      unitRef="usd">3200000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i7abc6c3f0ace4f678cb9c9f7caec9b6b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNS05LTEtMS0w_d62d9ff5-e44d-458c-acfe-20b77851dec1"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:FairValueHedgesAtFairValueNet
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNi0zLTEtMS0w_16fe9b34-ef41-4c5b-9ecd-fcf3606ab891"
      unitRef="usd">1500000</us-gaap:FairValueHedgesAtFairValueNet>
    <us-gaap:FairValueHedgesAtFairValueNet
      contextRef="i7ded3a94ce0f45598710ac45a034a923_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNi01LTEtMS0w_bd44f0c8-f449-48d2-8110-347858101df2"
      unitRef="usd">0</us-gaap:FairValueHedgesAtFairValueNet>
    <us-gaap:FairValueHedgesAtFairValueNet
      contextRef="ib0f0ae542d5a48d89e69a0ec76905efe_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNi03LTEtMS0w_4fa4c269-da84-4862-97cb-2e0bdcb247b9"
      unitRef="usd">1500000</us-gaap:FairValueHedgesAtFairValueNet>
    <us-gaap:FairValueHedgesAtFairValueNet
      contextRef="i7abc6c3f0ace4f678cb9c9f7caec9b6b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNi05LTEtMS0w_6730d6cb-5ffb-46d8-a87a-eab6ee9bfcc0"
      unitRef="usd">0</us-gaap:FairValueHedgesAtFairValueNet>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNy0zLTEtMS0w_7a9b9438-108d-4237-a9df-baaeda9a0423"
      unitRef="usd">80200000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i7ded3a94ce0f45598710ac45a034a923_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNy01LTEtMS0w_981f2fe9-76a6-4c3f-b2f2-cf1795234f34"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="ib0f0ae542d5a48d89e69a0ec76905efe_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNy03LTEtMS0w_64606877-85f7-4eb9-9491-448ff7d568d1"
      unitRef="usd">80200000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i7abc6c3f0ace4f678cb9c9f7caec9b6b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfNy05LTEtMS0w_0a019c2a-0e0b-4471-ae71-6573dbb1c965"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfOC0zLTEtMS0w_d3897df8-dbb0-4534-bce1-ceefd6ce1e97"
      unitRef="usd">76700000</lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability
      contextRef="i7ded3a94ce0f45598710ac45a034a923_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfOC01LTEtMS0w_6a711298-0b92-4920-85d3-77dd061bcdfc"
      unitRef="usd">0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability
      contextRef="ib0f0ae542d5a48d89e69a0ec76905efe_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfOC03LTEtMS0w_ff05c068-c301-442b-9cd8-26d40bda30a7"
      unitRef="usd">76700000</lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability
      contextRef="i7abc6c3f0ace4f678cb9c9f7caec9b6b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfOC05LTEtMS0w_8d09cf74-ce24-4e01-843b-391852eab9d5"
      unitRef="usd">0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfOS0zLTEtMS0w_e27ed8fc-326c-4568-ad0f-6f129a2e0314"
      unitRef="usd">9100000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i7ded3a94ce0f45598710ac45a034a923_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfOS01LTEtMS0w_4cfefb91-e6d5-4e48-a142-c6ef5cfe602f"
      unitRef="usd">9100000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ib0f0ae542d5a48d89e69a0ec76905efe_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfOS03LTEtMS0w_31078709-48c9-493f-9956-ca741ccede6f"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i7abc6c3f0ace4f678cb9c9f7caec9b6b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfOS05LTEtMS0w_e93b22f6-7790-41e2-9456-931d1eae0aa8"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfMTAtMy0xLTEtMA_3fdd225b-32b3-47d1-b631-b3996ede44f1"
      unitRef="usd">9900000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i7ded3a94ce0f45598710ac45a034a923_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfMTAtNS0xLTEtMA_1da959ad-1962-4b85-b8bc-9ab51ab624aa"
      unitRef="usd">0</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="ib0f0ae542d5a48d89e69a0ec76905efe_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfMTAtNy0xLTEtMA_72322132-4c44-41e6-84b4-d05954d69c01"
      unitRef="usd">0</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i7abc6c3f0ace4f678cb9c9f7caec9b6b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjIyNzkwOTM4MTEyNzRhOGU4ZjE4NzliNTE4YzMzZWNjL3RhYmxlcmFuZ2U6MjI3OTA5MzgxMTI3NGE4ZThmMTg3OWI1MThjMzNlY2NfMTAtOS0xLTEtMA_77cd1deb-7957-4207-b38d-28688b865a65"
      unitRef="usd">9900000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RleHRyZWdpb246ZjNhZDBiYWZkZjViNDI2MmI4ZTY1NDU2MmMxMDUwZThfMjY2MQ_447b1478-509f-49ff-906f-7416533c24f7">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value Measurement of Level 3 Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i7abc6c3f0ace4f678cb9c9f7caec9b6b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjA5N2RmOTE2MmE0YzQyNzZhMDJkMTM2NzAyNWNmMjMzL3RhYmxlcmFuZ2U6MDk3ZGY5MTYyYTRjNDI3NmEwMmQxMzY3MDI1Y2YyMzNfMy0yLTEtMS0w_4ca09870-8642-4de5-9d55-8ce2e9d80c85"
      unitRef="usd">9900000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <lh:Lh_BusinessCombinationContingentConsiderationArrangementsPayments
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjA5N2RmOTE2MmE0YzQyNzZhMDJkMTM2NzAyNWNmMjMzL3RhYmxlcmFuZ2U6MDk3ZGY5MTYyYTRjNDI3NmEwMmQxMzY3MDI1Y2YyMzNfNC0yLTEtMS0w_ea8548d4-9927-468b-a1ab-3b18d2527210"
      unitRef="usd">4800000</lh:Lh_BusinessCombinationContingentConsiderationArrangementsPayments>
    <lh:Contingentconsiderationadjustment
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjA5N2RmOTE2MmE0YzQyNzZhMDJkMTM2NzAyNWNmMjMzL3RhYmxlcmFuZ2U6MDk3ZGY5MTYyYTRjNDI3NmEwMmQxMzY3MDI1Y2YyMzNfNS0yLTEtMS0w_c0cc2405-4994-41ca-b533-22beda699824"
      unitRef="usd">2100000</lh:Contingentconsiderationadjustment>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjA5N2RmOTE2MmE0YzQyNzZhMDJkMTM2NzAyNWNmMjMzL3RhYmxlcmFuZ2U6MDk3ZGY5MTYyYTRjNDI3NmEwMmQxMzY3MDI1Y2YyMzNfNi0yLTEtMS0w_730beb06-5e26-4df6-93ed-6806ae477ffa"
      unitRef="usd">6000000.0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="iacfbc074fcc44dfb86499f5096b2b493_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RhYmxlOjA5N2RmOTE2MmE0YzQyNzZhMDJkMTM2NzAyNWNmMjMzL3RhYmxlcmFuZ2U6MDk3ZGY5MTYyYTRjNDI3NmEwMmQxMzY3MDI1Y2YyMzNfNy0yLTEtMS0w_0a78593a-d886-4f8d-86d4-4f42fba8eb30"
      unitRef="usd">9000000.0</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <lh:NumberofMeasurementFundsAvailableForParticipantElection
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RleHRyZWdpb246ZjNhZDBiYWZkZjViNDI2MmI4ZTY1NDU2MmMxMDUwZThfNjY3_5be9b8fd-537a-4567-9d18-608835882ae2"
      unitRef="number">16</lh:NumberofMeasurementFundsAvailableForParticipantElection>
    <lh:SeniorNotesFairValue
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RleHRyZWdpb246ZjNhZDBiYWZkZjViNDI2MmI4ZTY1NDU2MmMxMDUwZThfMjQ0Mg_713cee0b-c3db-4395-a85f-9141f2ac6c84"
      unitRef="usd">6107900000</lh:SeniorNotesFairValue>
    <lh:SeniorNotesFairValue
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV82Ny9mcmFnOmYzYWQwYmFmZGY1YjQyNjJiOGU2NTQ1NjJjMTA1MGU4L3RleHRyZWdpb246ZjNhZDBiYWZkZjViNDI2MmI4ZTY1NDU2MmMxMDUwZThfMjQ0OQ_ba2ebf1e-3427-4430-9df1-01c80129b0f9"
      unitRef="usd">6140600000</lh:SeniorNotesFairValue>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RleHRyZWdpb246ZTFmM2MyZTk4OTVlNDM1MWFiZWQzNDRkNWFkNzhmNjFfMzM2Mg_5cd73284-d1bc-41db-b155-b493fe304a1d">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES&lt;div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company addresses its exposure to market risks, principally the market risk associated with changes in interest rates and foreign currency exchange rates, through a controlled program of risk management that includes, from time to time, the use of derivative financial instruments.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company does not hold or issue derivative financial instruments for trading purposes. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not believe that its exposure to market risk is material to the Company&#x2019;s financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Interest Rate Swap&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; On August 17, 2020, the Company redeemed its remaining $412.2 4.625% Senior Notes due November 15, 2020, using available cash on hand. The Company exited the remaining fixed-to-variable interest rate swap arrangement in August 2020, in connection with the redemption of the 4.625% Senior Notes due 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.465%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.646%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying amount of hedged liabilities as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Liabilities as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance Sheet Line Item in which Hedged Items are Included&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion, long term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cross Currency Swap&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7.1pt;text-align:justify;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2018, the Company entered into six U.S. Dollar to Swiss Franc cross-currency swap agreements with an aggregate notional value of $600.0 and which are accounted for as a hedge against the impact of foreign exchange movements on its net investment in a Swiss subsidiary. Of the notional value, $300.0 matures in 2022 and $300.0 matures in 2025. These cross currency swaps maturing in 2022 and 2025 are included in other long-term assets as of September&#160;30, 2020. Changes in the fair value of the cross-currency swaps are recorded as a component of the foreign currency translation adjustment in accumulated other comprehensive income in the Condensed Consolidated Balance Sheet until the hedged item is recognized in earnings. The cumulative amount of the fair value hedging adjustment included in the current value of the cross currency swaps was $(23.1) and $(12.0) for the three and nine months ended September&#160;30, 2020, respectively, and was recognized as currency translation within the Condensed Consolidated Statement of Comprehensive Earnings. There were no amounts reclassified from the Condensed Consolidated Statement of Comprehensive Earnings to the Condensed Consolidated Statement of Operations during the three months or nine months ended September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the fair value of derivatives on a gross basis and the balance sheet classification of those instruments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12.1pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.228%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value of Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value of Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance Sheet Caption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="30" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;Derivatives Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other/Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net or Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below provides information regarding the location and amount of pretax (gains) losses of derivatives designated in fair value hedging:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12.1pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.371%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of pre-tax gain/(loss) included in other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to the &lt;br/&gt;Statement of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of pre-tax gain/(loss) included in other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to the &lt;br/&gt;Statement of Operations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded a gain of $1.6 on the extinguishment of the interest rate swap arrangement, which was included in Other, net on the Condensed Consolidated Statement of Operations. No additional gains or losses from derivative instruments have been recognized into income for the three and nine months ended September&#160;30, 2020, and 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <lh:BalanceOfSeniorNotesMatureDuringQ42020
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RleHRyZWdpb246ZTFmM2MyZTk4OTVlNDM1MWFiZWQzNDRkNWFkNzhmNjFfMzI5ODUzNDg4OTc5Mg_f691c758-e732-44ae-a4a5-876eecbbeae8"
      unitRef="usd">412200000</lh:BalanceOfSeniorNotesMatureDuringQ42020>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i391abd34dc914608a327d3e643899d6b_I20200930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RleHRyZWdpb246ZTFmM2MyZTk4OTVlNDM1MWFiZWQzNDRkNWFkNzhmNjFfMzI5ODUzNDg4OTc5Ng_8c2e5805-ae45-4207-a91a-2b692be7c6a2"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i391abd34dc914608a327d3e643899d6b_I20200930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RleHRyZWdpb246ZTFmM2MyZTk4OTVlNDM1MWFiZWQzNDRkNWFkNzhmNjFfMzI5ODUzNDg5MDE0NA_8c2e5805-ae45-4207-a91a-2b692be7c6a2"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RleHRyZWdpb246ZTFmM2MyZTk4OTVlNDM1MWFiZWQzNDRkNWFkNzhmNjFfMzM1Mg_83b0551b-7eaf-405d-a014-bc69cf836673">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.465%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.646%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying amount of hedged liabilities as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Liabilities as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance Sheet Line Item in which Hedged Items are Included&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion, long term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:ShorttermDebtFairValue
      contextRef="i30fd4fe5553348999dc8935c8ef8e7ab_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjkzZThlZTRiNDkyZTQ5MmQ4NTNmYzdkN2M2MDU2NjRiL3RhYmxlcmFuZ2U6OTNlOGVlNGI0OTJlNDkyZDg1M2ZjN2Q3YzYwNTY2NGJfMy0yLTEtMS0w_e7391242-7b98-4468-a050-169f26082661"
      unitRef="usd">0</us-gaap:ShorttermDebtFairValue>
    <us-gaap:ShorttermDebtFairValue
      contextRef="ibe0d3f0eae0e4636b83723ad38c201f0_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjkzZThlZTRiNDkyZTQ5MmQ4NTNmYzdkN2M2MDU2NjRiL3RhYmxlcmFuZ2U6OTNlOGVlNGI0OTJlNDkyZDg1M2ZjN2Q3YzYwNTY2NGJfMy00LTEtMS0w_fbd8392b-eee7-4b80-91d4-330a097dd09e"
      unitRef="usd">301500000</us-gaap:ShorttermDebtFairValue>
    <us-gaap:FairValueHedgeLiabilitiesAtFairValue
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjkzZThlZTRiNDkyZTQ5MmQ4NTNmYzdkN2M2MDU2NjRiL3RhYmxlcmFuZ2U6OTNlOGVlNGI0OTJlNDkyZDg1M2ZjN2Q3YzYwNTY2NGJfMy02LTEtMS0w_cc391a21-e15a-48dd-acd6-41a0dfe1861d"
      unitRef="usd">0</us-gaap:FairValueHedgeLiabilitiesAtFairValue>
    <us-gaap:FairValueHedgeLiabilitiesAtFairValue
      contextRef="i9dcbdb2a510240b49e6e31157090b5d1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjkzZThlZTRiNDkyZTQ5MmQ4NTNmYzdkN2M2MDU2NjRiL3RhYmxlcmFuZ2U6OTNlOGVlNGI0OTJlNDkyZDg1M2ZjN2Q3YzYwNTY2NGJfMy04LTEtMS0w_8936972d-a924-4f9a-91ff-d24c5f3dc1c3"
      unitRef="usd">1500000</us-gaap:FairValueHedgeLiabilitiesAtFairValue>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9f958adbe35f4caab3789a03b8cec98f_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RleHRyZWdpb246ZTFmM2MyZTk4OTVlNDM1MWFiZWQzNDRkNWFkNzhmNjFfMTg2MA_9574127d-05fa-4fcc-8cd6-e1279c7718c2"
      unitRef="usd">600000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i157730e7ca9e4995bdae523b7501fc18_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RleHRyZWdpb246ZTFmM2MyZTk4OTVlNDM1MWFiZWQzNDRkNWFkNzhmNjFfMjAxOQ_4ed2ae79-b784-418b-9320-a5272992ca44"
      unitRef="usd">300000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7e6ac05e86da4a5e81f44c16ffdf25ee_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RleHRyZWdpb246ZTFmM2MyZTk4OTVlNDM1MWFiZWQzNDRkNWFkNzhmNjFfMjA0Mg_26f9eda6-6ab2-4f4b-a901-ab8b8f1b2246"
      unitRef="usd">300000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RleHRyZWdpb246ZTFmM2MyZTk4OTVlNDM1MWFiZWQzNDRkNWFkNzhmNjFfMjU0OA_485572b7-6a2a-43d7-9285-a796f6126c30"
      unitRef="usd">-23100000</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RleHRyZWdpb246ZTFmM2MyZTk4OTVlNDM1MWFiZWQzNDRkNWFkNzhmNjFfMjU1NQ_6fcaf344-8068-4c64-a053-487eff95dd44"
      unitRef="usd">-12000000.0</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RleHRyZWdpb246ZTFmM2MyZTk4OTVlNDM1MWFiZWQzNDRkNWFkNzhmNjFfMzM1OA_6a1a173d-6aec-4e40-8913-be5d2718e156">&lt;div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the fair value of derivatives on a gross basis and the balance sheet classification of those instruments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12.1pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.228%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value of Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value of Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance Sheet Caption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="30" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;Derivatives Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other/Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net or Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:FairValueHedgeAssetsAtFairValue
      contextRef="i5b2d1e688ceb488f882b2976928f2162_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOmUwYTU5ZTJhYzQyNTRkYzRhOGRlNjIyMjA0OGU5ZjI1L3RhYmxlcmFuZ2U6ZTBhNTllMmFjNDI1NGRjNGE4ZGU2MjIyMDQ4ZTlmMjVfNS0zLTEtMS0w_9f7c6d62-74fe-486e-b292-79519d1f2034"
      unitRef="usd">0</us-gaap:FairValueHedgeAssetsAtFairValue>
    <us-gaap:FairValueHedgeLiabilitiesAtFairValue
      contextRef="i5b2d1e688ceb488f882b2976928f2162_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOmUwYTU5ZTJhYzQyNTRkYzRhOGRlNjIyMjA0OGU5ZjI1L3RhYmxlcmFuZ2U6ZTBhNTllMmFjNDI1NGRjNGE4ZGU2MjIyMDQ4ZTlmMjVfNS01LTEtMS0w_d18a6d39-a05a-48f4-a1e5-37b0d2ee2cdb"
      unitRef="usd">0</us-gaap:FairValueHedgeLiabilitiesAtFairValue>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9709977fa99a4330a25d6ae199b8dcef_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOmUwYTU5ZTJhYzQyNTRkYzRhOGRlNjIyMjA0OGU5ZjI1L3RhYmxlcmFuZ2U6ZTBhNTllMmFjNDI1NGRjNGE4ZGU2MjIyMDQ4ZTlmMjVfNS03LTEtMS0w_2a65bc8d-67b7-48ce-9ff1-fbfc1e090666"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:FairValueHedgeAssetsAtFairValue
      contextRef="iedf8eaddfda44623be579df701c1a1fe_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOmUwYTU5ZTJhYzQyNTRkYzRhOGRlNjIyMjA0OGU5ZjI1L3RhYmxlcmFuZ2U6ZTBhNTllMmFjNDI1NGRjNGE4ZGU2MjIyMDQ4ZTlmMjVfNS05LTEtMS0w_5d577a91-42e0-4c36-9d89-01dcd1fafeb5"
      unitRef="usd">1500000</us-gaap:FairValueHedgeAssetsAtFairValue>
    <us-gaap:FairValueHedgeLiabilitiesAtFairValue
      contextRef="iedf8eaddfda44623be579df701c1a1fe_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOmUwYTU5ZTJhYzQyNTRkYzRhOGRlNjIyMjA0OGU5ZjI1L3RhYmxlcmFuZ2U6ZTBhNTllMmFjNDI1NGRjNGE4ZGU2MjIyMDQ4ZTlmMjVfNS0xMS0xLTEtMA_3d1e5c3b-c893-4bac-8106-38b440107277"
      unitRef="usd">0</us-gaap:FairValueHedgeLiabilitiesAtFairValue>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i65cf17ee050f4482a7c6583428aea61b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOmUwYTU5ZTJhYzQyNTRkYzRhOGRlNjIyMjA0OGU5ZjI1L3RhYmxlcmFuZ2U6ZTBhNTllMmFjNDI1NGRjNGE4ZGU2MjIyMDQ4ZTlmMjVfNS0xMy0xLTEtMA_7a4973ac-2cf8-4309-b82e-0e23fcd757fa"
      unitRef="usd">300000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:FairValueHedgeAssetsAtFairValue
      contextRef="i9c7e9ea78df3464f91a5468557f3b4a3_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOmUwYTU5ZTJhYzQyNTRkYzRhOGRlNjIyMjA0OGU5ZjI1L3RhYmxlcmFuZ2U6ZTBhNTllMmFjNDI1NGRjNGE4ZGU2MjIyMDQ4ZTlmMjVfNi0zLTEtMS0w_1095bb59-6d45-4760-ba58-879186123a49"
      unitRef="usd">0</us-gaap:FairValueHedgeAssetsAtFairValue>
    <us-gaap:FairValueHedgeLiabilitiesAtFairValue
      contextRef="i9c7e9ea78df3464f91a5468557f3b4a3_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOmUwYTU5ZTJhYzQyNTRkYzRhOGRlNjIyMjA0OGU5ZjI1L3RhYmxlcmFuZ2U6ZTBhNTllMmFjNDI1NGRjNGE4ZGU2MjIyMDQ4ZTlmMjVfNi01LTEtMS0w_10429038-e54d-4fd6-bfca-3afc9da10ab4"
      unitRef="usd">8800000</us-gaap:FairValueHedgeLiabilitiesAtFairValue>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9f958adbe35f4caab3789a03b8cec98f_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOmUwYTU5ZTJhYzQyNTRkYzRhOGRlNjIyMjA0OGU5ZjI1L3RhYmxlcmFuZ2U6ZTBhNTllMmFjNDI1NGRjNGE4ZGU2MjIyMDQ4ZTlmMjVfNi03LTEtMS0w_9c3e1ba2-b2b9-46b7-bc2b-dcc27ba0df6d"
      unitRef="usd">600000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:FairValueHedgeAssetsAtFairValue
      contextRef="ibd87dafe403e465ea18e34466c3c7939_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOmUwYTU5ZTJhYzQyNTRkYzRhOGRlNjIyMjA0OGU5ZjI1L3RhYmxlcmFuZ2U6ZTBhNTllMmFjNDI1NGRjNGE4ZGU2MjIyMDQ4ZTlmMjVfNi05LTEtMS0w_017c10e4-132b-4a34-82cf-67992f54e435"
      unitRef="usd">3200000</us-gaap:FairValueHedgeAssetsAtFairValue>
    <us-gaap:FairValueHedgeLiabilitiesAtFairValue
      contextRef="ibd87dafe403e465ea18e34466c3c7939_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOmUwYTU5ZTJhYzQyNTRkYzRhOGRlNjIyMjA0OGU5ZjI1L3RhYmxlcmFuZ2U6ZTBhNTllMmFjNDI1NGRjNGE4ZGU2MjIyMDQ4ZTlmMjVfNi0xMS0xLTEtMA_3dd382ee-66ee-4dbe-91be-9f6793cfa25d"
      unitRef="usd">0</us-gaap:FairValueHedgeLiabilitiesAtFairValue>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i717fbdf29e6443d699ab792d8711e563_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOmUwYTU5ZTJhYzQyNTRkYzRhOGRlNjIyMjA0OGU5ZjI1L3RhYmxlcmFuZ2U6ZTBhNTllMmFjNDI1NGRjNGE4ZGU2MjIyMDQ4ZTlmMjVfNi0xMy0xLTEtMA_659287c4-db39-4fb8-b41b-e41cecc15796"
      unitRef="usd">600000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RleHRyZWdpb246ZTFmM2MyZTk4OTVlNDM1MWFiZWQzNDRkNWFkNzhmNjFfMzM1OQ_c2a81a95-97e4-4caa-899b-ce5080a62dbf">&lt;div style="text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below provides information regarding the location and amount of pretax (gains) losses of derivatives designated in fair value hedging:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12.1pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.371%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of pre-tax gain/(loss) included in other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to the &lt;br/&gt;Statement of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of pre-tax gain/(loss) included in other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to the &lt;br/&gt;Statement of Operations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i8d5061e0be7847e68312a7cca228cf95_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfMy0yLTEtMS0w_7024274b-c10e-402d-b0ec-fff8fc3a61ba"
      unitRef="usd">0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="iefe19a4e91fb49b3a68616c5ff46e9e5_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfMy00LTEtMS0w_6a8ec044-418d-44f2-ac5f-e3caef479e74"
      unitRef="usd">400000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i8d5061e0be7847e68312a7cca228cf95_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfMy02LTEtMS0w_d6a3327b-86bb-4290-9be1-2584d7e308ae"
      unitRef="usd">1600000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="iefe19a4e91fb49b3a68616c5ff46e9e5_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfMy04LTEtMS0w_d2770087-0fd3-4e65-ac86-a26653740c50"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i2ec6f971894c47229132bd1159446ec6_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfMy0xMC0xLTEtMA_eaf431f0-5479-487a-a03e-8e94993ff8ed"
      unitRef="usd">800000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="ie7a8e6e061ca4fad8a9d6109d3fb30b9_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfMy0xMi0xLTEtMA_f0a576a7-bd76-4208-bcf5-6f9af053df18"
      unitRef="usd">7200000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i2ec6f971894c47229132bd1159446ec6_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfMy0xNC0xLTEtMA_87e50f2b-7455-441e-8be8-15931d5a9abe"
      unitRef="usd">1600000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ie7a8e6e061ca4fad8a9d6109d3fb30b9_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfMy0xNi0xLTEtMA_be5f0203-b28d-4726-b801-99dc41cfaf31"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i3ccde3dbf4f348e184653bd3cde3ece9_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfNC0yLTEtMS0w_94a53c85-2599-4cb6-beae-6e2747992f7e"
      unitRef="usd">-23100000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="id37ee09894034b178815f25b8d74e8e8_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfNC00LTEtMS0w_d25864ff-67c3-41ea-ad47-0e5919a2315d"
      unitRef="usd">18800000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i3ccde3dbf4f348e184653bd3cde3ece9_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfNC02LTEtMS0w_2309dcb2-b259-4590-8767-2f7099e8e06c"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="id37ee09894034b178815f25b8d74e8e8_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfNC04LTEtMS0w_86c60135-4b37-4694-b9d4-579f513afd7f"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i3997aafec9e6480ba5de1fc7fc5ae356_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfNC0xMC0xLTEtMA_39039bd4-8c5c-4267-9ac9-ee2d4e242dd5"
      unitRef="usd">-12000000.0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i57fefb8fd43c402695470e30d3a2fee3_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfNC0xMi0xLTEtMA_1b667a06-7493-4acf-b604-fd17ee19adb8"
      unitRef="usd">22800000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i3997aafec9e6480ba5de1fc7fc5ae356_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfNC0xNC0xLTEtMA_cb620fa1-f3ff-428d-ba07-842312d09d47"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i57fefb8fd43c402695470e30d3a2fee3_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RhYmxlOjU4OWZlMGQxNTkxMjQ0ODZhYmYyZWY3MmMxOWYwYTAzL3RhYmxlcmFuZ2U6NTg5ZmUwZDE1OTEyNDQ4NmFiZjJlZjcyYzE5ZjBhMDNfNC0xNi0xLTEtMA_bca31a2e-f561-4781-be5d-a691f9e94d4c"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <lh:GainInterestRateSwapArrangement
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83MC9mcmFnOmUxZjNjMmU5ODk1ZTQzNTFhYmVkMzQ0ZDVhZDc4ZjYxL3RleHRyZWdpb246ZTFmM2MyZTk4OTVlNDM1MWFiZWQzNDRkNWFkNzhmNjFfMTY0OTI2NzQ0OTQ0Ng_e2792842-7455-4bc0-952c-2f3f391de1c9"
      unitRef="usd">1600000</lh:GainInterestRateSwapArrangement>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83Ni9mcmFnOmFkNzBmOWRhNjkwZTQ3NjM4MTFmMTllYjhlMzdmNDRlL3RleHRyZWdpb246YWQ3MGY5ZGE2OTBlNDc2MzgxMWYxOWViOGUzN2Y0NGVfNjE_d88651c0-cde6-4c9c-8b0c-591794c5bd14">SUPPLEMENTAL CASH FLOW INFORMATION&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplemental schedule of cash flow information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid during period for:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 24.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 24.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes, net of refunds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disclosure of non-cash financing and investing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Conversion of zero-coupon convertible debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in accrued property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Floating rate secured note receivable due 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83Ni9mcmFnOmFkNzBmOWRhNjkwZTQ3NjM4MTFmMTllYjhlMzdmNDRlL3RleHRyZWdpb246YWQ3MGY5ZGE2OTBlNDc2MzgxMWYxOWViOGUzN2Y0NGVfNTE_e30ee9e1-4a74-49ed-b89c-54d2100f8b01">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplemental schedule of cash flow information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid during period for:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 24.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 24.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes, net of refunds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disclosure of non-cash financing and investing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Conversion of zero-coupon convertible debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in accrued property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Floating rate secured note receivable due 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <lh:InterestPaidInCash
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83Ni9mcmFnOmFkNzBmOWRhNjkwZTQ3NjM4MTFmMTllYjhlMzdmNDRlL3RhYmxlOjg4MDE1NWVjZDViOTQwMGQ5ODhmNDc0YWJjYzYzMzI1L3RhYmxlcmFuZ2U6ODgwMTU1ZWNkNWI5NDAwZDk4OGY0NzRhYmNjNjMzMjVfNC0xLTEtMS0w_2ba91862-49bc-4a81-bc3c-26ae550049d1"
      unitRef="usd">195800000</lh:InterestPaidInCash>
    <lh:InterestPaidInCash
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83Ni9mcmFnOmFkNzBmOWRhNjkwZTQ3NjM4MTFmMTllYjhlMzdmNDRlL3RhYmxlOjg4MDE1NWVjZDViOTQwMGQ5ODhmNDc0YWJjYzYzMzI1L3RhYmxlcmFuZ2U6ODgwMTU1ZWNkNWI5NDAwZDk4OGY0NzRhYmNjNjMzMjVfNC0zLTEtMS0w_269cdb23-ea92-4666-bb7f-78aaeac7a5b9"
      unitRef="usd">216500000</lh:InterestPaidInCash>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83Ni9mcmFnOmFkNzBmOWRhNjkwZTQ3NjM4MTFmMTllYjhlMzdmNDRlL3RhYmxlOjg4MDE1NWVjZDViOTQwMGQ5ODhmNDc0YWJjYzYzMzI1L3RhYmxlcmFuZ2U6ODgwMTU1ZWNkNWI5NDAwZDk4OGY0NzRhYmNjNjMzMjVfNS0xLTEtMS0w_c85a7b5a-3561-4b33-b3a3-3bcbe6fd42e0"
      unitRef="usd">217500000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83Ni9mcmFnOmFkNzBmOWRhNjkwZTQ3NjM4MTFmMTllYjhlMzdmNDRlL3RhYmxlOjg4MDE1NWVjZDViOTQwMGQ5ODhmNDc0YWJjYzYzMzI1L3RhYmxlcmFuZ2U6ODgwMTU1ZWNkNWI5NDAwZDk4OGY0NzRhYmNjNjMzMjVfNS0zLTEtMS0w_9e2055af-18d5-470a-9f4b-c8e25a14a958"
      unitRef="usd">181600000</us-gaap:IncomeTaxesPaidNet>
    <lh:ConversionOfZeroCouponConvertibleDebt
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83Ni9mcmFnOmFkNzBmOWRhNjkwZTQ3NjM4MTFmMTllYjhlMzdmNDRlL3RhYmxlOjg4MDE1NWVjZDViOTQwMGQ5ODhmNDc0YWJjYzYzMzI1L3RhYmxlcmFuZ2U6ODgwMTU1ZWNkNWI5NDAwZDk4OGY0NzRhYmNjNjMzMjVfOC0xLTEtMS0w_a90a2cff-718e-410b-92d9-ca24a4cad6e8"
      unitRef="usd">0</lh:ConversionOfZeroCouponConvertibleDebt>
    <lh:ConversionOfZeroCouponConvertibleDebt
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83Ni9mcmFnOmFkNzBmOWRhNjkwZTQ3NjM4MTFmMTllYjhlMzdmNDRlL3RhYmxlOjg4MDE1NWVjZDViOTQwMGQ5ODhmNDc0YWJjYzYzMzI1L3RhYmxlcmFuZ2U6ODgwMTU1ZWNkNWI5NDAwZDk4OGY0NzRhYmNjNjMzMjVfOC0zLTEtMS0w_4522dde5-0a7b-47c9-a60b-bd6bc4376256"
      unitRef="usd">1700000</lh:ConversionOfZeroCouponConvertibleDebt>
    <lh:DecreaseinCapitalExpendituresIncurredbutnotyetPaid
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83Ni9mcmFnOmFkNzBmOWRhNjkwZTQ3NjM4MTFmMTllYjhlMzdmNDRlL3RhYmxlOjg4MDE1NWVjZDViOTQwMGQ5ODhmNDc0YWJjYzYzMzI1L3RhYmxlcmFuZ2U6ODgwMTU1ZWNkNWI5NDAwZDk4OGY0NzRhYmNjNjMzMjVfMTAtMS0xLTEtMA_6ab1e9d8-6c16-4f7b-bfae-a161ebbcf7ae"
      unitRef="usd">24500000</lh:DecreaseinCapitalExpendituresIncurredbutnotyetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83Ni9mcmFnOmFkNzBmOWRhNjkwZTQ3NjM4MTFmMTllYjhlMzdmNDRlL3RhYmxlOjg4MDE1NWVjZDViOTQwMGQ5ODhmNDc0YWJjYzYzMzI1L3RhYmxlcmFuZ2U6ODgwMTU1ZWNkNWI5NDAwZDk4OGY0NzRhYmNjNjMzMjVfMTAtMy0xLTEtMA_d2bd6ff6-f93e-4504-b7c3-08beb9fd2e2f"
      unitRef="usd">15900000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:NotesReceivableFairValueDisclosure
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83Ni9mcmFnOmFkNzBmOWRhNjkwZTQ3NjM4MTFmMTllYjhlMzdmNDRlL3RhYmxlOjg4MDE1NWVjZDViOTQwMGQ5ODhmNDc0YWJjYzYzMzI1L3RhYmxlcmFuZ2U6ODgwMTU1ZWNkNWI5NDAwZDk4OGY0NzRhYmNjNjMzMjVfMTEtMS0xLTEtMA_a9581278-c90a-4fb1-a475-977395b51809"
      unitRef="usd">0</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:NotesReceivableFairValueDisclosure
      contextRef="i3ebf6d35695d43bebd0e1036cfd88d00_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83Ni9mcmFnOmFkNzBmOWRhNjkwZTQ3NjM4MTFmMTllYjhlMzdmNDRlL3RhYmxlOjg4MDE1NWVjZDViOTQwMGQ5ODhmNDc0YWJjYzYzMzI1L3RhYmxlcmFuZ2U6ODgwMTU1ZWNkNWI5NDAwZDk4OGY0NzRhYmNjNjMzMjVfMTEtMy0xLTEtMA_56bbe2b7-3f22-49b9-9ef6-ad04b2138d7e"
      unitRef="usd">110000000.0</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RleHRyZWdpb246N2U5YmM0NWM1YzkwNDFlOTk1MTM2MDVjZTljZjdlYjhfMTAxMA_3363d55e-e939-4d91-9aa6-235838c20529">BUSINESS SEGMENT INFORMATION&lt;div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of segment information for the three and nine months ended September&#160;30, 2020, and 2019. The management approach has been used to present the following segment information. This approach is based upon the way the management of the Company organizes segments within an enterprise for making operating decisions and assessing performance. Financial information is reported on the basis that it is used internally by the chief operating decision maker (CODM) for evaluating segment performance and deciding how to allocate resources to segments. The Company&#x2019;s chief executive officer has been identified as the CODM. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment asset information is not presented because it is not used by the CODM at the segment level. Operating earnings of each segment represents revenues less directly identifiable expenses to arrive at operating income for the segment. General management and administrative corporate expenses are included in general corporate expenses below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LCD&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,704.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,759.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,098.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,242.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CDD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,241.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,175.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,479.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,376.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intercompany eliminations and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90.0)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,896.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,928.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,488.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,601.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating earnings (loss):&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LCD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;964.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,451.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CDD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(131.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(126.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,152.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;993.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-operating expenses, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;947.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;703.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Net earnings attributable to the noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to Laboratory Corporation of America Holdings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;703.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RleHRyZWdpb246N2U5YmM0NWM1YzkwNDFlOTk1MTM2MDVjZTljZjdlYjhfMTAwNg_953caf9f-6222-4ed1-bd43-f6eef3be6207">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LCD&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,704.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,759.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,098.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,242.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CDD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,241.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,175.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,479.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,376.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intercompany eliminations and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90.0)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,896.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,928.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,488.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,601.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating earnings (loss):&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LCD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;964.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,451.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CDD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(131.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(126.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,152.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;993.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-operating expenses, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;947.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;703.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Net earnings attributable to the noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to Laboratory Corporation of America Holdings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;703.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:Revenues
      contextRef="i1982102278bd444d897b0ac03dedfda5_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNC0xLTEtMS0w_a16cdbd3-4298-4219-a45e-a79e55dd8c21"
      unitRef="usd">2704200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idd95aab1b5024137b07364cf3867cbf8_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNC0zLTEtMS0w_c44f38c0-9045-402a-a3e8-4671dd2c232c"
      unitRef="usd">1759200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i60bf6e0de9384f37926fac0c0db06385_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNC01LTEtMS0w_b88f466b-3c6c-406e-a0c0-f28c0529442b"
      unitRef="usd">6098800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i54d000cbf2214f02a540a13d16a2e6fa_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNC03LTEtMS0w_f0b35468-21b2-4a6f-92de-4dd3a2f30f98"
      unitRef="usd">5242100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4674d28875524974925c86ea26137e4b_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNS0xLTEtMS0w_be158454-afcf-4d08-985b-57a6b5ec84ba"
      unitRef="usd">1241900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i060a850910964d4baaae2bbf8a6f8fa8_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNS0zLTEtMS0w_923a9a55-1c98-4777-afbd-fb07318867b3"
      unitRef="usd">1175400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if366c14694954f6f84a2c0fe5708324e_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNS01LTEtMS0w_02620113-37ed-452a-a51d-703bae2af216"
      unitRef="usd">3479400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib3059b6353b34be0bc21870bf9a54a49_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNS03LTEtMS0w_706a0978-b09d-4c34-8707-53f6a92a74a6"
      unitRef="usd">3376400000</us-gaap:Revenues>
    <lh:Intercompanyrevenueelimination
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNi0xLTEtMS0w_8a282604-a3e2-4705-b08f-2d1d3d3588f6"
      unitRef="usd">50000000.0</lh:Intercompanyrevenueelimination>
    <lh:Intercompanyrevenueelimination
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNi0zLTEtMS0w_5371455d-da0d-451d-962d-daf458f5674b"
      unitRef="usd">6200000</lh:Intercompanyrevenueelimination>
    <lh:Intercompanyrevenueelimination
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNi01LTEtMS0w_cfdd7f57-7fff-45a7-a5ff-9513cb129105"
      unitRef="usd">90000000.0</lh:Intercompanyrevenueelimination>
    <lh:Intercompanyrevenueelimination
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNi03LTEtMS0w_619b62b8-9318-4be9-8eaf-446f9c360735"
      unitRef="usd">17100000</lh:Intercompanyrevenueelimination>
    <us-gaap:Revenues
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNy0xLTEtMS0w_3d6b62ab-5fbd-4d7d-98ff-e2d6037623b3"
      unitRef="usd">3896100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNy0zLTEtMS0w_c3eba47f-e8d7-4f2e-851b-947c4024ef77"
      unitRef="usd">2928500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNy01LTEtMS0w_e2929ded-8376-47f2-a77e-bcd4ec4efbf9"
      unitRef="usd">9488700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfNy03LTEtMS0w_19e2dc00-1729-4197-9e49-124c7f6c1366"
      unitRef="usd">8601400000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1982102278bd444d897b0ac03dedfda5_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTAtMS0xLTEtMA_463f87a0-82b0-404a-9fe7-959a542ce6b3"
      unitRef="usd">964900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="idd95aab1b5024137b07364cf3867cbf8_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTAtMy0xLTEtMA_2c3d240e-c167-487d-9e7f-77b5d0a9fdb1"
      unitRef="usd">262200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i60bf6e0de9384f37926fac0c0db06385_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTAtNS0xLTEtMA_c121c245-381c-4ba7-9588-034c54a0a39e"
      unitRef="usd">1451500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i54d000cbf2214f02a540a13d16a2e6fa_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTAtNy0xLTEtMA_f67ca67e-dd73-4694-8a13-31cbfbccac6c"
      unitRef="usd">843000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4674d28875524974925c86ea26137e4b_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTEtMS0xLTEtMA_c2663f32-5a65-4955-9d04-b14b85de7e2b"
      unitRef="usd">142000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i060a850910964d4baaae2bbf8a6f8fa8_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTEtMy0xLTEtMA_80928e3c-5140-4270-a288-ae66fadbe6f0"
      unitRef="usd">123800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if366c14694954f6f84a2c0fe5708324e_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTEtNS0xLTEtMA_daf7a216-022a-47ee-960b-8ac8f346a9c6"
      unitRef="usd">-131200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib3059b6353b34be0bc21870bf9a54a49_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTEtNy0xLTEtMA_d2a5caa8-83ce-4c3c-b1b5-afbb0b12736e"
      unitRef="usd">277600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib5cb7f86911741a9b2e604fc4fb6237e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTItMS0xLTEtMA_2bd6aa5c-e014-4965-9163-64f72be493bd"
      unitRef="usd">-59800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7613840514f4435bb5f3e61d09adf8b5_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTItMy0xLTEtMA_f7117842-8c42-416f-a577-dcc4ec1e1302"
      unitRef="usd">-46100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3bc43a85b31c461e9c8951056efb762f_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTItNS0xLTEtMA_3237c4c9-a7a8-4442-80ef-e9d78093e75f"
      unitRef="usd">-168200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3b2b623128cd4e32a331207c59b1041a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTItNy0xLTEtMA_4765c152-7c63-49dd-830a-41c9ed172a6a"
      unitRef="usd">-126800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTMtMS0xLTEtMA_ded7f873-6cdc-4fca-a885-e3c0be484f35"
      unitRef="usd">1047100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTMtMy0xLTEtMA_dfcd8c3b-c23a-47df-b1ba-e926042deaa8"
      unitRef="usd">339900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTMtNS0xLTEtMA_7a4c81ca-fa1f-4128-ab9b-506b61a24c03"
      unitRef="usd">1152200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTMtNy0xLTEtMA_6bb137d9-0949-4b0c-b739-2a29dbed6163"
      unitRef="usd">993800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTQtMS0xLTEtMA_fa440425-86b4-4b67-b96c-13e48eb2ad0f"
      unitRef="usd">-100000000.0</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTQtMy0xLTEtMA_db083abd-a41b-4ced-bf1c-fcaff89db1e5"
      unitRef="usd">-52500000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTQtNS0xLTEtMA_6a009c98-d226-4db4-b340-90074916fa0c"
      unitRef="usd">-175700000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTQtNy0xLTEtMA_61e5965c-e562-4c15-afa5-e6bef4b48aa2"
      unitRef="usd">-181800000</us-gaap:NonoperatingIncomeExpense>
    <lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTUtMS0xLTEtMA_71bb94ab-e54d-4eae-b271-11d3a1290d11"
      unitRef="usd">947100000</lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest>
    <lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTUtMy0xLTEtMA_feceb4cb-e229-4ec7-b26e-71678123ab20"
      unitRef="usd">287400000</lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest>
    <lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTUtNS0xLTEtMA_1d3cc2e6-083e-4f3e-a5d3-5f1b154ce917"
      unitRef="usd">976400000</lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest>
    <lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTUtNy0xLTEtMA_34dbc3bd-90f4-433f-95f6-34d6b34dc1fb"
      unitRef="usd">812000000.0</lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTYtMS0xLTEtMA_342c49d1-0c57-4f1f-8e7d-be7b1b446483"
      unitRef="usd">243400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTYtMy0xLTEtMA_6a878fe1-105f-4f93-aea4-d43350dc320e"
      unitRef="usd">66400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTYtNS0xLTEtMA_7fbf428d-cafc-4169-94a3-56c722db3177"
      unitRef="usd">358000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTYtNy0xLTEtMA_8908efe3-f96f-4320-8e7d-e20388aa52e0"
      unitRef="usd">214400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTctMS0xLTEtMA_81f1f1b6-f1b6-4b66-b2bf-bc1967cb81ff"
      unitRef="usd">703700000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTctMy0xLTEtMA_685978d2-4c95-496c-86bb-4c6c283472a1"
      unitRef="usd">221000000.0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTctNS0xLTEtMA_1b0ca367-9db5-4032-a541-af5f8ee2ba4e"
      unitRef="usd">618400000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTctNy0xLTEtMA_af1de74f-335b-474a-a234-c16ffa061bba"
      unitRef="usd">597600000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTgtMS0xLTEtMA_d636050a-1827-41ef-ba43-10ea107f9343"
      unitRef="usd">300000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTgtMy0xLTEtMA_6ce7191a-25fd-4e6e-9307-58983bf62b84"
      unitRef="usd">300000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTgtNS0xLTEtMA_e822d39f-06c0-4e05-9604-d12cff3f6875"
      unitRef="usd">600000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTgtNy0xLTEtMA_9123a072-bb46-4f2f-9b80-b405c95d6689"
      unitRef="usd">900000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTktMS0xLTEtMA_3630dd92-4512-4cf7-b7fb-b2510e933b7c"
      unitRef="usd">703400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibacb0200d2584d9189a696351c4be886_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTktMy0xLTEtMA_49117119-626c-4a46-a4fa-b583c9d237d5"
      unitRef="usd">220700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTktNS0xLTEtMA_5070a3f8-7f46-436f-a590-f64284d6c9b4"
      unitRef="usd">617800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV83OS9mcmFnOjdlOWJjNDVjNWM5MDQxZTk5NTEzNjA1Y2U5Y2Y3ZWI4L3RhYmxlOjYxODYzODAxZWU3MzRlM2NhOThmODQ2MDAwMTY4N2JiL3RhYmxlcmFuZ2U6NjE4NjM4MDFlZTczNGUzY2E5OGY4NDYwMDAxNjg3YmJfMTktNy0xLTEtMA_73fe8b05-a6ff-4b85-840b-dd6b03d99de5"
      unitRef="usd">596700000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV85Ny9mcmFnOjk5MDI4NzA5NWE4MjQxZGE4OWNiYThiNjBiZmYxZDBmL3RleHRyZWdpb246OTkwMjg3MDk1YTgyNDFkYTg5Y2JhOGI2MGJmZjFkMGZfMTkxOQ_661e336d-d70f-4f37-8123-43e5df1d3a19"
      unitRef="usd">52400000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i774554fa2e2a4ea8958da8a32fb2880a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV85Ny9mcmFnOjk5MDI4NzA5NWE4MjQxZGE4OWNiYThiNjBiZmYxZDBmL3RleHRyZWdpb246OTkwMjg3MDk1YTgyNDFkYTg5Y2JhOGI2MGJmZjFkMGZfMTkyNg_b998e58a-7d0d-489a-9e43-e549934094b2"
      unitRef="usd">-45400000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9f958adbe35f4caab3789a03b8cec98f_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV85Ny9mcmFnOjk5MDI4NzA5NWE4MjQxZGE4OWNiYThiNjBiZmYxZDBmL3RleHRyZWdpb246OTkwMjg3MDk1YTgyNDFkYTg5Y2JhOGI2MGJmZjFkMGZfMzI2NA_9574127d-05fa-4fcc-8cd6-e1279c7718c2"
      unitRef="usd">600000000.0</us-gaap:LongTermDebtNoncurrent>
    <lh:A2019TermLoan
      contextRef="i7da7c6b0d2814e079360edb6ac4a2611_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV85Ny9mcmFnOjk5MDI4NzA5NWE4MjQxZGE4OWNiYThiNjBiZmYxZDBmL3RleHRyZWdpb246OTkwMjg3MDk1YTgyNDFkYTg5Y2JhOGI2MGJmZjFkMGZfNDAyOQ_6fd128fa-a087-4432-ac9d-fc23e3af2fa2"
      unitRef="usd">375000000.0</lh:A2019TermLoan>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i391abd34dc914608a327d3e643899d6b_I20200930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxNzA3NGQ5YTJjMjRjMzRiY2FjMjVmMzJkMmVjMGMxL3NlYzo0MTcwNzRkOWEyYzI0YzM0YmNhYzI1ZjMyZDJlYzBjMV85Ny9mcmFnOjk5MDI4NzA5NWE4MjQxZGE4OWNiYThiNjBiZmYxZDBmL3RleHRyZWdpb246OTkwMjg3MDk1YTgyNDFkYTg5Y2JhOGI2MGJmZjFkMGZfMzI5ODUzNDg4ODQyMg_8c2e5805-ae45-4207-a91a-2b692be7c6a2"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074959605448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Oct. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-11353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">LABORATORY CORPORATION OF AMERICA HOLDINGS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">13-3757370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">358 South Main Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Burlington,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">NC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">27215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">229-1127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Common Stock, $0.10 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">LH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000920148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 13<br> -Subsection a-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1-<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074959996568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts Payable, Current</a></td>
<td class="nump">$ 639.5<span></span>
</td>
<td class="nump">$ 632.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">667.2<span></span>
</td>
<td class="nump">337.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts Receivable, after Allowance for Credit Loss, Current</a></td>
<td class="nump">2,095.2<span></span>
</td>
<td class="nump">1,543.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnbilledContractsReceivable', window );">Unbilled Contracts Receivable</a></td>
<td class="nump">603.5<span></span>
</td>
<td class="nump">481.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Supplies inventories</a></td>
<td class="nump">392.5<span></span>
</td>
<td class="nump">244.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">327.2<span></span>
</td>
<td class="nump">373.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">4,085.6<span></span>
</td>
<td class="nump">2,981.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">2,608.6<span></span>
</td>
<td class="nump">2,636.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net</a></td>
<td class="nump">7,613.8<span></span>
</td>
<td class="nump">7,865.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">3,920.5<span></span>
</td>
<td class="nump">4,034.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Joint venture partnerships and equity method investments</a></td>
<td class="nump">70.7<span></span>
</td>
<td class="nump">84.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent', window );">Deferred Income Taxes and Other Assets, Current</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">8.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets, net</a></td>
<td class="nump">437.0<span></span>
</td>
<td class="nump">435.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">18,739.6<span></span>
</td>
<td class="nump">18,046.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued Liabilities, Current</a></td>
<td class="nump">1,297.8<span></span>
</td>
<td class="nump">942.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred Revenue, Current</a></td>
<td class="nump">494.8<span></span>
</td>
<td class="nump">451.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease, Liability, Current</a></td>
<td class="nump">193.8<span></span>
</td>
<td class="nump">206.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance Lease, Liability, Current</a></td>
<td class="nump">7.4<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Debt, Current</a></td>
<td class="nump">376.6<span></span>
</td>
<td class="nump">415.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">3,009.9<span></span>
</td>
<td class="nump">2,655.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">5,417.3<span></span>
</td>
<td class="nump">5,789.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Commitments and contingent liabilities</a></td>
<td class="nump">473.2<span></span>
</td>
<td class="nump">383.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">602.4<span></span>
</td>
<td class="nump">596.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance Lease, Liability, Noncurrent</a></td>
<td class="nump">86.3<span></span>
</td>
<td class="nump">91.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_DeferredIncomeTaxesAndOtherTaxLiabilities', window );">Deferred income taxes and other tax liabilities</a></td>
<td class="nump">891.5<span></span>
</td>
<td class="nump">942.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Noncontrolling interest</a></td>
<td class="nump">10,480.6<span></span>
</td>
<td class="nump">10,459.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_NoncontrollingInterestMezzanineEquity', window );">Common stock, 92.8 and 93.5 shares outstanding at March 31, 2013 and December 31, 2012, respectively</a></td>
<td class="nump">19.9<span></span>
</td>
<td class="nump">20.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">80.7<span></span>
</td>
<td class="nump">26.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Retained earnings</a></td>
<td class="nump">9.0<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated other comprehensive income</a></td>
<td class="num">(8,464.0)<span></span>
</td>
<td class="num">(7,903.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Total liabilities and shareholders' equity</a></td>
<td class="num">(314.6)<span></span>
</td>
<td class="num">(372.4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="nump">8,239.1<span></span>
</td>
<td class="nump">7,567.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Liabilities and Equity</a></td>
<td class="nump">$ 18,739.6<span></span>
</td>
<td class="nump">$ 18,046.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DeferredIncomeTaxesAndOtherTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the noncurrent portion of deferred tax liabilities, which result from applying the applicable tax rate to net taxable temporary differences pertaining to each jurisdiction to which the entity is obligated to pay income tax, combined with the noncurrent portion of the amount recognized for uncertain tax positions as of the balance sheet date. A noncurrent taxable temporary difference is a difference between the tax basis and the carrying amount of a noncurrent asset or liability in the financial statements prepared in accordance with generally accepted accounting principles. In a classified statement of financial position, an enterprise shall separate deferred tax liabilities and assets into a current amount and a noncurrent amount. Deferred tax liabilities and assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the expected reversal date of the temporary difference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DeferredIncomeTaxesAndOtherTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_NoncontrollingInterestMezzanineEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents contractual value of a noncontrolling interest put (includes underlying noncontrolling interest). In February 2010, the Company completed a transaction to sell the partnership units acquired from the previous noncontrolling interest holder to a new Canadian partner. As a result of this transaction, the Company recorded a component of noncontrolling interest in liabilities and a component in mezzanine equity. This item represents the mezzanine equity component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_NoncontrollingInterestMezzanineEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and other assets expected to be realized or consumed within one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118261985&amp;loc=d3e55302-109406<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140075048798344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parentheticals) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts Receivable, Allowance for Credit Loss</a></td>
<td class="nump">$ 26.6<span></span>
</td>
<td class="nump">$ 19.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">97.4<span></span>
</td>
<td class="nump">97.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140075040358104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 3,896,100,000<span></span>
</td>
<td class="nump">$ 2,928,500,000<span></span>
</td>
<td class="nump">$ 9,488,700,000<span></span>
</td>
<td class="nump">$ 8,601,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of Revenue</a></td>
<td class="nump">2,336,700,000<span></span>
</td>
<td class="nump">2,111,200,000<span></span>
</td>
<td class="nump">6,440,800,000<span></span>
</td>
<td class="nump">6,169,600,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="nump">1,559,400,000<span></span>
</td>
<td class="nump">817,300,000<span></span>
</td>
<td class="nump">3,047,900,000<span></span>
</td>
<td class="nump">2,431,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">419,500,000<span></span>
</td>
<td class="nump">401,500,000<span></span>
</td>
<td class="nump">1,211,300,000<span></span>
</td>
<td class="nump">1,210,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles and other assets</a></td>
<td class="nump">62,200,000<span></span>
</td>
<td class="nump">61,700,000<span></span>
</td>
<td class="nump">184,600,000<span></span>
</td>
<td class="nump">179,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset Impairment Charges</a></td>
<td class="nump">23,500,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">460,900,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_NetRestructuringAndOtherSpecialCharges', window );">Net restructuring and other special charges</a></td>
<td class="nump">7,100,000<span></span>
</td>
<td class="nump">14,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">1,047,100,000<span></span>
</td>
<td class="nump">339,900,000<span></span>
</td>
<td class="nump">1,152,200,000<span></span>
</td>
<td class="nump">993,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expenses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(51,400,000)<span></span>
</td>
<td class="num">(60,500,000)<span></span>
</td>
<td class="num">(159,100,000)<span></span>
</td>
<td class="num">(176,300,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity method income, net</a></td>
<td class="nump">3,000,000.0<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="num">(1,800,000)<span></span>
</td>
<td class="nump">7,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment income</a></td>
<td class="nump">2,600,000<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="nump">7,700,000<span></span>
</td>
<td class="nump">4,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="num">(54,200,000)<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="num">(22,600,000)<span></span>
</td>
<td class="num">(18,200,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">947,100,000<span></span>
</td>
<td class="nump">287,400,000<span></span>
</td>
<td class="nump">976,400,000<span></span>
</td>
<td class="nump">812,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">243,400,000<span></span>
</td>
<td class="nump">66,400,000<span></span>
</td>
<td class="nump">358,000,000.0<span></span>
</td>
<td class="nump">214,400,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">703,700,000<span></span>
</td>
<td class="nump">221,000,000.0<span></span>
</td>
<td class="nump">618,400,000<span></span>
</td>
<td class="nump">597,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net earnings attributable to the noncontrolling interest</a></td>
<td class="num">(300,000)<span></span>
</td>
<td class="num">(300,000)<span></span>
</td>
<td class="num">(600,000)<span></span>
</td>
<td class="num">(900,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Laboratory Corporation of America Holdings</a></td>
<td class="nump">$ 703,400,000<span></span>
</td>
<td class="nump">$ 220,700,000<span></span>
</td>
<td class="nump">$ 617,800,000<span></span>
</td>
<td class="nump">$ 596,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per common share (in dollars per share)</a></td>
<td class="nump">$ 7.22<span></span>
</td>
<td class="nump">$ 2.26<span></span>
</td>
<td class="nump">$ 6.35<span></span>
</td>
<td class="nump">$ 6.08<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per common share (in dollars per share)</a></td>
<td class="nump">$ 7.17<span></span>
</td>
<td class="nump">$ 2.25<span></span>
</td>
<td class="nump">$ 6.31<span></span>
</td>
<td class="nump">$ 6.04<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Continuing Operations Before Income Taxes and Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_NetRestructuringAndOtherSpecialCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against earnings in the period for incurred and estimated costs, excluding asset retirement obligations, associated with exit from or disposal of business activities or restructurings pursuant to a program planned and controlled by management, and materially changes either the scope or manner of conduct of a business undertaken. Also, may include reversals and other adjustments to accrued liabilities and special charges, if any, for asset abandonment, uncollectible balances, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_NetRestructuringAndOtherSpecialCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140075040491336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_NetRestructuringAndOtherSpecialCharges', window );">Net restructuring and other special charges</a></td>
<td class="nump">$ 7,100,000<span></span>
</td>
<td class="nump">$ 14,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">243,400,000<span></span>
</td>
<td class="nump">66,400,000<span></span>
</td>
<td class="nump">$ 358,000,000.0<span></span>
</td>
<td class="nump">$ 214,400,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">703,700,000<span></span>
</td>
<td class="nump">221,000,000.0<span></span>
</td>
<td class="nump">618,400,000<span></span>
</td>
<td class="nump">597,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other Comprehensive Earnings, Net of Tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">132,900,000<span></span>
</td>
<td class="num">(92,600,000)<span></span>
</td>
<td class="nump">52,400,000<span></span>
</td>
<td class="num">(45,400,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</a></td>
<td class="nump">2,100,000<span></span>
</td>
<td class="nump">3,200,000<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
<td class="nump">8,700,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other comprehensive earnings (loss) before tax</a></td>
<td class="nump">135,000,000.0<span></span>
</td>
<td class="num">(89,400,000)<span></span>
</td>
<td class="nump">59,900,000<span></span>
</td>
<td class="num">(36,700,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Tax effect of adjustments</a></td>
<td class="num">(600,000)<span></span>
</td>
<td class="num">(900,000)<span></span>
</td>
<td class="num">(2,100,000)<span></span>
</td>
<td class="num">(2,400,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (loss), net of tax</a></td>
<td class="nump">134,400,000<span></span>
</td>
<td class="num">(90,300,000)<span></span>
</td>
<td class="nump">57,800,000<span></span>
</td>
<td class="num">(39,100,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive earnings</a></td>
<td class="nump">838,100,000<span></span>
</td>
<td class="nump">130,700,000<span></span>
</td>
<td class="nump">676,200,000<span></span>
</td>
<td class="nump">558,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net earnings attributable to the noncontrolling interest</a></td>
<td class="num">(300,000)<span></span>
</td>
<td class="num">(300,000)<span></span>
</td>
<td class="num">(600,000)<span></span>
</td>
<td class="num">(900,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive earnings attributable to Laboratory Corporation of America Holdings</a></td>
<td class="nump">$ 837,800,000<span></span>
</td>
<td class="nump">$ 130,400,000<span></span>
</td>
<td class="nump">$ 675,600,000<span></span>
</td>
<td class="nump">$ 557,600,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_NetRestructuringAndOtherSpecialCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against earnings in the period for incurred and estimated costs, excluding asset retirement obligations, associated with exit from or disposal of business activities or restructurings pursuant to a program planned and controlled by management, and materially changes either the scope or manner of conduct of a business undertaken. Also, may include reversals and other adjustments to accrued liabilities and special charges, if any, for asset abandonment, uncollectible balances, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_NetRestructuringAndOtherSpecialCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33775-111570<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074956245800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">BALANCE at Dec. 31, 2018</a></td>
<td class="nump">$ 6,971,400,000<span></span>
</td>
<td class="nump">$ 11,700,000<span></span>
</td>
<td class="nump">$ 1,451,100,000<span></span>
</td>
<td class="nump">$ 7,079,800,000<span></span>
</td>
<td class="num">$ (1,108,100,000)<span></span>
</td>
<td class="num">$ (463,100,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Laboratory Corporation of America Holdings</a></td>
<td class="nump">185,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">185,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings, net of tax</a></td>
<td class="nump">23,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">23,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_Issuanceofcommonstockunderemployeeplans', window );">Issuance of common stock under employee stock plans</a></td>
<td class="num">(24,700,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(24,700,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Surrender of restricted stock and performance share awards</a></td>
<td class="num">(19,400,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(19,400,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock compensation</a></td>
<td class="nump">25,500,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">25,500,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Purchase of common stock</a></td>
<td class="num">(100,100,000)<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000,000.0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">BALANCE at Mar. 31, 2019</a></td>
<td class="nump">7,111,300,000<span></span>
</td>
<td class="nump">11,600,000<span></span>
</td>
<td class="nump">1,401,300,000<span></span>
</td>
<td class="nump">7,265,400,000<span></span>
</td>
<td class="num">(1,127,500,000)<span></span>
</td>
<td class="num">(439,500,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">BALANCE at Dec. 31, 2018</a></td>
<td class="nump">6,971,400,000<span></span>
</td>
<td class="nump">11,700,000<span></span>
</td>
<td class="nump">1,451,100,000<span></span>
</td>
<td class="nump">7,079,800,000<span></span>
</td>
<td class="num">(1,108,100,000)<span></span>
</td>
<td class="num">(463,100,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Laboratory Corporation of America Holdings</a></td>
<td class="nump">596,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings, net of tax</a></td>
<td class="num">(39,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_ConversionOfZeroCouponConvertibleDebt', window );">Conversion of zero-coupon convertible debt</a></td>
<td class="nump">1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">BALANCE at Sep. 30, 2019</a></td>
<td class="nump">7,231,100,000<span></span>
</td>
<td class="nump">9,000,000.0<span></span>
</td>
<td class="nump">47,800,000<span></span>
</td>
<td class="nump">7,676,500,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(502,200,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">BALANCE at Mar. 31, 2019</a></td>
<td class="nump">7,111,300,000<span></span>
</td>
<td class="nump">11,600,000<span></span>
</td>
<td class="nump">1,401,300,000<span></span>
</td>
<td class="nump">7,265,400,000<span></span>
</td>
<td class="num">(1,127,500,000)<span></span>
</td>
<td class="num">(439,500,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Laboratory Corporation of America Holdings</a></td>
<td class="nump">190,400,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">190,400,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings, net of tax</a></td>
<td class="nump">27,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">27,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_Issuanceofcommonstockunderemployeeplans', window );">Issuance of common stock under employee stock plans</a></td>
<td class="num">(9,200,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(9,200,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Surrender of restricted stock and performance share awards</a></td>
<td class="num">(20,700,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(20,700,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock compensation</a></td>
<td class="nump">26,500,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">26,500,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Purchase of common stock</a></td>
<td class="num">(199,900,000)<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">199,800,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">BALANCE at Jun. 30, 2019</a></td>
<td class="nump">7,144,400,000<span></span>
</td>
<td class="nump">9,100,000<span></span>
</td>
<td class="nump">91,400,000<span></span>
</td>
<td class="nump">7,455,800,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(411,900,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Treasury Stock, Retired, Cost Method, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,400,000)<span></span>
</td>
<td class="num">(1,145,800,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,148,200,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Laboratory Corporation of America Holdings</a></td>
<td class="nump">220,700,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings, net of tax</a></td>
<td class="num">(90,300,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_Issuanceofcommonstockunderemployeeplans', window );">Issuance of common stock under employee stock plans</a></td>
<td class="num">(25,100,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(25,100,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Surrender of restricted stock and performance share awards</a></td>
<td class="num">(300,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(300,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock compensation</a></td>
<td class="nump">31,500,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">31,500,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Purchase of common stock</a></td>
<td class="num">(100,000,000.0)<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">BALANCE at Sep. 30, 2019</a></td>
<td class="nump">7,231,100,000<span></span>
</td>
<td class="nump">9,000,000.0<span></span>
</td>
<td class="nump">47,800,000<span></span>
</td>
<td class="nump">7,676,500,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(502,200,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Treasury Stock, Retired, Cost Method, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(99,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
<td class="nump">7,903,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">BALANCE at Dec. 31, 2019</a></td>
<td class="nump">7,567,000,000.0<span></span>
</td>
<td class="nump">9,000,000.0<span></span>
</td>
<td class="nump">26,800,000<span></span>
</td>
<td class="nump">7,903,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(372,400,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Laboratory Corporation of America Holdings</a></td>
<td class="num">(317,200,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(317,200,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings, net of tax</a></td>
<td class="num">(145,500,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(145,500,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_Issuanceofcommonstockunderemployeeplans', window );">Issuance of common stock under employee stock plans</a></td>
<td class="num">(26,900,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(26,900,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Surrender of restricted stock and performance share awards</a></td>
<td class="num">(22,000,000.0)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(22,000,000.0)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock compensation</a></td>
<td class="nump">17,900,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">17,900,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Purchase of common stock</a></td>
<td class="num">(100,000,000.0)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">49,600,000<span></span>
</td>
<td class="nump">50,400,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">BALANCE at Mar. 31, 2020</a></td>
<td class="nump">7,020,100,000<span></span>
</td>
<td class="nump">9,000,000.0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,529,000,000.0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(517,900,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">BALANCE at Dec. 31, 2019</a></td>
<td class="nump">7,567,000,000.0<span></span>
</td>
<td class="nump">9,000,000.0<span></span>
</td>
<td class="nump">26,800,000<span></span>
</td>
<td class="nump">7,903,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(372,400,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Laboratory Corporation of America Holdings</a></td>
<td class="nump">617,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings, net of tax</a></td>
<td class="nump">57,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_ConversionOfZeroCouponConvertibleDebt', window );">Conversion of zero-coupon convertible debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">BALANCE at Sep. 30, 2020</a></td>
<td class="nump">8,239,100,000<span></span>
</td>
<td class="nump">9,000,000.0<span></span>
</td>
<td class="nump">80,700,000<span></span>
</td>
<td class="nump">8,464,000,000.0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(314,600,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">BALANCE at Mar. 31, 2020</a></td>
<td class="nump">7,020,100,000<span></span>
</td>
<td class="nump">9,000,000.0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,529,000,000.0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(517,900,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Laboratory Corporation of America Holdings</a></td>
<td class="nump">231,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">231,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings, net of tax</a></td>
<td class="nump">68,900,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">68,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_Issuanceofcommonstockunderemployeeplans', window );">Issuance of common stock under employee stock plans</a></td>
<td class="num">(1,800,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,800,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Surrender of restricted stock and performance share awards</a></td>
<td class="num">(9,500,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(9,500,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock compensation</a></td>
<td class="nump">39,800,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">39,800,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">BALANCE at Jun. 30, 2020</a></td>
<td class="nump">7,352,700,000<span></span>
</td>
<td class="nump">9,000,000.0<span></span>
</td>
<td class="nump">32,100,000<span></span>
</td>
<td class="nump">7,760,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(449,000,000.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Laboratory Corporation of America Holdings</a></td>
<td class="nump">703,400,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">703,400,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings, net of tax</a></td>
<td class="nump">134,400,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">134,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_Issuanceofcommonstockunderemployeeplans', window );">Issuance of common stock under employee stock plans</a></td>
<td class="num">(21,900,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(21,900,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Surrender of restricted stock and performance share awards</a></td>
<td class="num">(500,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(500,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock compensation</a></td>
<td class="nump">27,200,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">27,200,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">BALANCE at Sep. 30, 2020</a></td>
<td class="nump">8,239,100,000<span></span>
</td>
<td class="nump">$ 9,000,000.0<span></span>
</td>
<td class="nump">$ 80,700,000<span></span>
</td>
<td class="nump">$ 8,464,000,000.0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (314,600,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
<td class="nump">$ 8,464,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ConversionOfZeroCouponConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period upon the conversion of convertible securities (zero-coupon subordinated notes) and/or reversal of deferred tax liability to reflect the tax benefit realized upon issuance of the stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ConversionOfZeroCouponConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Issuanceofcommonstockunderemployeeplans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued in period under ESPP combined with the value of stock issued as a result of option exercises.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Issuanceofcommonstockunderemployeeplans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockRetiredCostMethodAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockRetiredCostMethodAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074956447832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">$ 618,400,000<span></span>
</td>
<td class="nump">$ 597,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_Contingentconsiderationadjustment', window );">Contingent consideration adjustment</a></td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_DepreciationAndAmortizationOfLeasedAssets', window );">Depreciation And Amortization Of Leased Assets</a></td>
<td class="nump">150,700,000<span></span>
</td>
<td class="nump">144,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">440,800,000<span></span>
</td>
<td class="nump">421,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation</a></td>
<td class="nump">84,900,000<span></span>
</td>
<td class="nump">83,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset Impairment Charges</a></td>
<td class="nump">460,900,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(48,500,000)<span></span>
</td>
<td class="nump">23,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other Operating Activities, Cash Flow Statement</a></td>
<td class="nump">55,200,000<span></span>
</td>
<td class="nump">12,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in assets and liabilities (net of effects of acquisitions):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Increase in accounts receivable (net)</a></td>
<td class="num">(546,900,000)<span></span>
</td>
<td class="num">(144,300,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_IncreaseDecreaseinUnbilledContractReceivable', window );">Increase (Decrease) in Unbilled Contract Receivable</a></td>
<td class="nump">117,800,000<span></span>
</td>
<td class="nump">59,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Increase in inventories</a></td>
<td class="num">(147,500,000)<span></span>
</td>
<td class="num">(14,500,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Decrease in prepaid expenses and other</a></td>
<td class="nump">26,100,000<span></span>
</td>
<td class="nump">5,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Decrease in accounts payable</a></td>
<td class="nump">17,300,000<span></span>
</td>
<td class="num">(28,200,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Increase (Decrease) in Deferred Revenue</a></td>
<td class="nump">44,100,000<span></span>
</td>
<td class="num">(1,000,000.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</a></td>
<td class="nump">323,000,000.0<span></span>
</td>
<td class="num">(165,800,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">1,360,700,000<span></span>
</td>
<td class="nump">874,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(282,300,000)<span></span>
</td>
<td class="num">(272,000,000.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of assets</a></td>
<td class="nump">1,100,000<span></span>
</td>
<td class="nump">5,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments', window );">Proceeds from Sale of Equity Method Investments</a></td>
<td class="nump">1,000,000.0<span></span>
</td>
<td class="nump">9,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromHedgeInvestingActivities', window );">Proceeds from Hedge, Investing Activities</a></td>
<td class="nump">3,100,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Investments in equity affiliates</a></td>
<td class="num">(29,300,000)<span></span>
</td>
<td class="num">(21,300,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of businesses, net of cash acquired</a></td>
<td class="num">(208,800,000)<span></span>
</td>
<td class="num">(852,900,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used for investing activities</a></td>
<td class="num">(515,200,000)<span></span>
</td>
<td class="num">(1,131,000,000.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from revolving credit facilities</a></td>
<td class="nump">151,700,000<span></span>
</td>
<td class="nump">473,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payment, Tax Withholding, Share-based Payment Arrangement</a></td>
<td class="num">(32,000,000.0)<span></span>
</td>
<td class="num">(40,400,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_NetProceedsFromIssuanceOfStockToEmployees', window );">Net proceeds from issuance of stock to employees</a></td>
<td class="nump">50,600,000<span></span>
</td>
<td class="nump">59,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for Repurchase of Common Stock</a></td>
<td class="num">(100,000,000.0)<span></span>
</td>
<td class="num">(400,000,000.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_OtherFinancingCashFlows', window );">Other Financing Cash Flows</a></td>
<td class="num">(22,800,000)<span></span>
</td>
<td class="num">(21,900,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayments of Lines of Credit</a></td>
<td class="num">(151,700,000)<span></span>
</td>
<td class="num">(473,000,000.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Repayments of Senior Debt</a></td>
<td class="num">(412,200,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used for) financing activities</a></td>
<td class="num">(516,400,000)<span></span>
</td>
<td class="nump">196,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="num">(6,300,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</a></td>
<td class="nump">329,700,000<span></span>
</td>
<td class="num">(65,700,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">337,500,000<span></span>
</td>
<td class="nump">426,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">667,200,000<span></span>
</td>
<td class="nump">361,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt', window );">Proceeds from Issuance of Other Long-term Debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">850,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfOtherLongTermDebt', window );">Repayments of Other Long-term Debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (250,000,000.0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Contingentconsiderationadjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent consideration adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Contingentconsiderationadjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DepreciationAndAmortizationOfLeasedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Also, may include amortization charged against earnings for the periodic recognition of capitalized leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DepreciationAndAmortizationOfLeasedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_IncreaseDecreaseinUnbilledContractReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Unbilled Contract Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_IncreaseDecreaseinUnbilledContractReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_NetProceedsFromIssuanceOfStockToEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock options and employees related to shares purchased under the employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_NetProceedsFromIssuanceOfStockToEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_OtherFinancingCashFlows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Financing Cash Flows</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_OtherFinancingCashFlows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromHedgeInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3581-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromHedgeInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074954323928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW INFORMATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Cash Flow Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Supplemental Cash Flow Information</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.960%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental schedule of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during period for:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 24.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 24.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes, net of refunds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosure of non-cash financing and investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion of zero-coupon convertible debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in accrued property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating rate secured note receivable due 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">Supplemental Cash Flow Information</a></td>
<td class="text">SUPPLEMENTAL CASH FLOW INFORMATION<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.960%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental schedule of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during period for:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 24.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 24.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes, net of refunds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosure of non-cash financing and investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion of zero-coupon convertible debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in accrued property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating rate secured note receivable due 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI http://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074955615560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW INFORMATION Tabular Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Cash Flow Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Supplemental Cash Flow Information</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.960%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental schedule of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during period for:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 24.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 24.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes, net of refunds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosure of non-cash financing and investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion of zero-coupon convertible debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in accrued property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating rate secured note receivable due 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">Supplemental Cash Flow Information</a></td>
<td class="text">SUPPLEMENTAL CASH FLOW INFORMATION<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.960%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental schedule of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during period for:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 24.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 24.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes, net of refunds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosure of non-cash financing and investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion of zero-coupon convertible debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in accrued property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating rate secured note receivable due 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI http://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140075043675704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW INFORMATION Description Information - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionLineItems', window );"><strong>Debt Conversion [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_DecreaseinCapitalExpendituresIncurredbutnotyetPaid', window );">Decrease in Capital Expenditures Incurred but not yet Paid</a></td>
<td class="num">$ (24.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital Expenditures Incurred but Not yet Paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (15.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">Notes Receivable, Fair Value Disclosure</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">110.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_CashPaidDuringPeriodForAbstract', window );"><strong>Cash paid during period for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_InterestPaidInCash', window );">Interest</a></td>
<td class="nump">195.8<span></span>
</td>
<td class="nump">216.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes, net of refunds</a></td>
<td class="nump">217.5<span></span>
</td>
<td class="nump">181.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Disclosure of non-cash financing and investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_ConversionOfZeroCouponConvertibleDebt', window );">Conversion of zero-coupon convertible debt</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 1.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CashPaidDuringPeriodForAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CashPaidDuringPeriodForAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ConversionOfZeroCouponConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period upon the conversion of convertible securities (zero-coupon subordinated notes) and/or reversal of deferred tax liability to reflect the tax benefit realized upon issuance of the stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ConversionOfZeroCouponConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DecreaseinCapitalExpendituresIncurredbutnotyetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in Capital Expenditures Incurred but not yet Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DecreaseinCapitalExpendituresIncurredbutnotyetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_InterestPaidInCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period for interest owed on money borrowed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_InterestPaidInCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of an agreement for an unconditional promise by the maker to pay the holder a definite sum of money at a future date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074954263368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF FINANCIAL STATEMENT PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</a></td>
<td class="text">BASIS OF FINANCIAL STATEMENT PRESENTATION<div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory Corporation of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Holdings together with its subsidiaries (the Company) is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. The Company&#8217;s mission is to improve health and improve lives by delivering world-class diagnostic solutions, bringing innovative medicines to patients faster and using technology to provide better care. The Company serves a broad range of customers, including managed care organizations (MCOs), biopharmaceutical and medical device companies, governmental agencies, physicians and other health care providers (e.g., physician assistants and nurse practitioners, generally referred to herein as physicians), hospitals and health systems, employers, patients and consumers, contract research organizations (CROs), and independent clinical laboratories. </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports its business in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). For further financial information about these segments, see Note 15 Business Segment Information to the Condensed Consolidated Financial Statements. During the three months ended September&#160;30, 2020, LCD and CDD contributed approximately 68% and 32% respectively, of revenues to the Company. During the nine months ended September&#160;30, 2020, LCD and CDD contributed approximately 63% and 37%, respectively, of revenues to the Company.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries for which it exercises control. Long-term investments in affiliated companies in which the Company exercises significant influence, but which it does not control, are accounted for using the equity method. Investments in which the Company does not exercise significant influence (generally, when the Company has an investment of less than 20.0% and no representation on the investee's board of directors) are accounted for at fair value or at cost minus impairment adjusted for observable price changes in orderly transactions for an identical or similar investment of the same issuer for those investments that do not have readily determinable fair values. All significant inter-company transactions and accounts have been eliminated. The Company does not have any significant variable interest entities or special purpose entities whose financial results are not included in the condensed consolidated financial statements.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of the Company's operating foreign subsidiaries are measured using the local currency as the functional currency.&#160;Assets and liabilities are translated at exchange rates as of the balance sheet date.&#160;Revenues and expenses are translated at average monthly exchange rates prevailing during the period.&#160;Resulting translation adjustments are included in &#8220;Accumulated other comprehensive income.&#8221;</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements of the Company are unaudited. In the opinion of management, all adjustments necessary for a fair statement of results of operations, cash flows, and financial position have been made. Except as otherwise disclosed, all such adjustments are of a normal recurring nature. Interim results are not necessarily indicative of results for a full year. The year-end condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by generally accepted accounting principles.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements and notes are presented in accordance with the rules and regulations of the United States (U.S.) Securities and Exchange Commission (SEC) and do not contain certain information included in the Company&#8217;s 2019 Annual Report on Form 10-K (Annual Report). Therefore, these interim statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company&#8217;s Annual Report.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Guidance </span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued a new accounting standard intended to provide financial statement users with more decision-useful information about expected credit losses and other commitments to extend credit held by the reporting entity. The standard replaces the incurred loss impairment methodology in current generally accepted accounting principles</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(GAAP) with one that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The Company recorded an opening retained earnings adjustment of $7.0 with the adoption of this standard on January 1, 2020. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued a new accounting standard to reduce, modify, and add to the disclosure requirements on fair value measurements. The Company adopted this standard effective January 1, 2020. The adoption of this standard did not have a material impact on the consolidated financial statements.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued a new accounting standard to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to develop or obtain internal-use software. The Company adopted this standard effective January 1, 2020. The adoption of this standard did not have a material impact on the consolidated financial statements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Pronouncements</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued a new accounting standard to reduce, modify, and add to the disclosure requirements on defined benefit pension and other postretirement plans. The standard is effective on January 1, 2021, with early adoption permitted. The adoption of this standard is not expected to have a material impact on the consolidated financial statements.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued a new accounting standard to simplify accounting for income taxes and remove, modify, and add to the disclosure requirements of income taxes. The standard is effective January 1, 2021, with early adoption permitted. The adoption of this standard is not expected to have a material impact on the consolidated financial statements.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued a new accounting standard to clarify the interaction of the accounting for equity securities and investments accounted for under the equity method of accounting and the accounting for certain forward contracts and purchased options. The standard is effective January 1, 2021. The adoption of this standard is not expected to have a material impact on the consolidated financial statements.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued a new accounting standard to provide optional expedients and exceptions if certain conditions are met for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform. The expedients and exceptions in the standard are effective between March 12, 2020, and December 31, 2022. The Company did not elect to apply any of the expedients or exceptions for the period ended September 30, 2020, and is currently evaluating the impact this new standard will have on the consolidated financial statements. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued a new accounting standard to address issues identified as a result of the complexity associated with applying generally accepted accounting principles for convertible instruments and contracts in an entity's own equity. The standard is effective January 1, 2022, with early adoption permitted. The Company is evaluating the impact this new standard will have on the consolidated financial statements.</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Novel Coronavirus (COVID-19) Financial Statement Impact</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, COVID-19 was declared a pandemic. COVID-19 has had and continues to have an extensive impact on the global health and economic environments. During the nine months ended September 30, 2020, the Company recorded goodwill and other asset impairment charges of $437.4, as a result of the negative financial impact of COVID-19 during the first quarter of 2020. See Note 6 Goodwill and Intangible Assets for a discussion of goodwill and intangible asset impairment and Note 2 Revenues for a discussion of credit losses and additional price concessions. The Company also impaired certain of the Company's investments by a total of $25.4 during the nine months ended September 30, 2020, due to the impact of COVID-19; $7.1 was included in Equity method earnings (loss), net during the three months ended March 31, 2020, and $13.1 and $5.2 were included in Other, net during the three months ended March 31, 2020, and June 30, 2020, respectively.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In April 2020, the Company received cash payments of approximately $55.9 from the Public Health and Social Services Emergency Fund for provider relief that was appropriated by Congress to the Department of Health and Human Services (HHS) in the Coronavirus Aid, Relief, and Economic Security Act (CARES Act Provider Relief Funds). Upon receiving and satisfying the terms and conditions associated with the distributed funds, the Company accounted for the transaction by applying the guidance in ASC 450-30 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Gain Contingencies, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">recorded these funds in Other, net non-operating income in the Consolidated Statement of Operations as of June 30, 2020. In August 2020, the Company received an additional $76.2 in CARES Act Provider Relief Funds. As the Company's Diagnostic business demonstrated recovery and demand for COVID-19 testing increased, the Company determined that the negative financial impact of COVID-19 which the CARES Act Provider Relief Funds were designed to address no longer applied to the Company. As a result, the Company derecognized the income associated with the $55.9 received during the second quarter as a change in estimate and did not recognize any income related to the cash payment of $76.2 received in the third quarter. The Company plans to return the CARES Act Provider Relief Funds to the government in the fourth quarter of 2020 and has recorded a liability of $132.1 in Accrued expenses and other as of September 30, 2020.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which the COVID-19 pandemic has and will impact the Company&#8217;s business and financial results depend on numerous evolving factors including, but not limited to: the magnitude and duration of the COVID-19 pandemic, the impact to worldwide macroeconomic conditions including interest rates, employment rates and health insurance coverage, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of September&#160;30, 2020, and through the date of this </span></div>report. The accounting matters assessed included, but were not limited to, the Company&#8217;s implicit price concessions and credit losses, equity investments, notes receivable and the carrying value of goodwill and other long-lived assets. The Company&#8217;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in additional material impacts to the Company&#8217;s consolidated financial statements in future reporting periods.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Basis of Presentation and Significant Accounting Policies [Text Block]</a></td>
<td class="text">BASIS OF FINANCIAL STATEMENT PRESENTATION<div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory Corporation of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Holdings together with its subsidiaries (the Company) is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. The Company&#8217;s mission is to improve health and improve lives by delivering world-class diagnostic solutions, bringing innovative medicines to patients faster and using technology to provide better care. The Company serves a broad range of customers, including managed care organizations (MCOs), biopharmaceutical and medical device companies, governmental agencies, physicians and other health care providers (e.g., physician assistants and nurse practitioners, generally referred to herein as physicians), hospitals and health systems, employers, patients and consumers, contract research organizations (CROs), and independent clinical laboratories. </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports its business in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). For further financial information about these segments, see Note 15 Business Segment Information to the Condensed Consolidated Financial Statements. During the three months ended September&#160;30, 2020, LCD and CDD contributed approximately 68% and 32% respectively, of revenues to the Company. During the nine months ended September&#160;30, 2020, LCD and CDD contributed approximately 63% and 37%, respectively, of revenues to the Company.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries for which it exercises control. Long-term investments in affiliated companies in which the Company exercises significant influence, but which it does not control, are accounted for using the equity method. Investments in which the Company does not exercise significant influence (generally, when the Company has an investment of less than 20.0% and no representation on the investee's board of directors) are accounted for at fair value or at cost minus impairment adjusted for observable price changes in orderly transactions for an identical or similar investment of the same issuer for those investments that do not have readily determinable fair values. All significant inter-company transactions and accounts have been eliminated. The Company does not have any significant variable interest entities or special purpose entities whose financial results are not included in the condensed consolidated financial statements.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of the Company's operating foreign subsidiaries are measured using the local currency as the functional currency.&#160;Assets and liabilities are translated at exchange rates as of the balance sheet date.&#160;Revenues and expenses are translated at average monthly exchange rates prevailing during the period.&#160;Resulting translation adjustments are included in &#8220;Accumulated other comprehensive income.&#8221;</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements of the Company are unaudited. In the opinion of management, all adjustments necessary for a fair statement of results of operations, cash flows, and financial position have been made. Except as otherwise disclosed, all such adjustments are of a normal recurring nature. Interim results are not necessarily indicative of results for a full year. The year-end condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by generally accepted accounting principles.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements and notes are presented in accordance with the rules and regulations of the United States (U.S.) Securities and Exchange Commission (SEC) and do not contain certain information included in the Company&#8217;s 2019 Annual Report on Form 10-K (Annual Report). Therefore, these interim statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company&#8217;s Annual Report.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074955602712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">EARNINGS PER SHARE<div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing net earnings attributable to Laboratory Corporation of America Holdings by the weighted average number of common shares outstanding. Diluted earnings per share is computed by dividing net earnings including the impact of dilutive adjustments by the weighted average number of common shares outstanding plus potentially dilutive shares, as if they had been issued at the earlier of the date of issuance or the beginning of the period presented. Potentially dilutive common shares result primarily from the Company&#8217;s outstanding stock options, restricted stock awards, restricted stock units, and performance share awards.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents a reconciliation of basic earnings per share to diluted earnings per share:</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.309%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.309%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.309%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.309%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.349%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Per Share Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Per Share Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earning</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Per Share Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Per Share Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">703.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">220.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">617.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">596.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.08&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dilutive effect of employee&#160;stock options and awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings including impact of dilutive adjustments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">703.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98.1&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">220.7&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98.3&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">617.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">596.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.04&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per share represent the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. These potential shares include dilutive stock options and unissued restricted stock awards. The following table summarizes the potential common shares not included in the computation of diluted earnings per share because their impact would have been antidilutive:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.087%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock options and awards</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074954277000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING AND OTHER SPECIAL CHARGES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring and Related Activities Disclosure [Text Block]</a></td>
<td class="text">RESTRUCTURING AND OTHER CHARGES<div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2020, the Company recorded net restructuring and other charges of $38.9: $13.4 within LCD and $25.5 within CDD. The charges were comprised of $12.8 related to severance and other personnel costs, $11.0 for a CDD leased lab facility and equipment impairments, and $24.0 in facility closures, impairment of operating lease right-of use assets and general integration activities. The charges were offset by the reversal of previously established liability of $1.1 and $7.8 in unused severance costs and facility-related costs, respectively. </span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2019, the Company recorded net restructuring and other charges of $48.4: $22.8 within LCD and $25.6 within CDD. The charges were comprised of $26.2 related to severance and other personnel costs and $22.0 in costs associated with facility closures, impairment of operating lease right-of-use assets and general integration initiatives. The charges were increased by the adjustment of previously established reserves of $0.4 in severance reserves and decreased by a reversal of $0.2 in unused facility reserves. </span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents the Company&#8217;s restructuring reserve activities for the period indicated:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"/><td style="width:40.763%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.692%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.775%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.692%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.775%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.747%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LCD</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CDD</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and Other Employee Costs</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and Other Employee Costs</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of lab facility and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074956154056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">DEBT <div style="margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term borrowings and the current portion of long-term debt at September&#160;30, 2020, and December&#160;31, 2019, consisted of the following:</span></div><div style="margin-bottom:11pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625% senior notes due 2020</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Term Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of note payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term borrowings and current portion of long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt at September&#160;30, 2020, and December&#160;31, 2019, consisted of the following:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.20% senior notes due 2022</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75% senior notes due 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00% senior notes due 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25% senior notes due 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30% senior notes due 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.60% senior notes due 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.60% senior notes due 2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.95% senior notes due 2029</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.70% senior notes due 2045</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Term Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,417.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,789.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Senior Notes</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 17, 2020, the Company redeemed the remaining $412.2 of its 4.625% Senior Notes due November 15, 2020, using available cash on hand. The Company exited the remaining fixed-to-variable interest rate swap arrangement in August 2020, in connection with this redemption and recorded a gain of $1.6 on the extinguishment. The gain was included in Other, net on the Condensed Consolidated Statement of Operations.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Facilities</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 3, 2019, the Company entered into a new $850.0 2019 term loan facility that matures on June 3, 2021. The 2019 term loan facility accrues interest at a per annum rate equal to,</span><span style="color:#1f497d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">at the Company's election, either a LIBOR rate plus a margin ranging from 0.55% to 1.175%, or a base rate determined according to a prime rate or federal funds rate plus a margin ranging from 0.0% to 0.175%. The 2019 term loan balance at September&#160;30, 2020, and December&#160;31, 2019, was $375.0 and $375.0, respectively. As of September&#160;30, 2020, the effective interest rate on the 2019 term loan was 0.95%.</span></div><div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains a senior revolving credit facility consisting of a five-year facility in the principal amount of up to $1,000.0, with the option of increasing the facility by up to an additional $350.0, subject to the agreement of one or more new or existing lenders to provide such additional amounts and certain other customary conditions. The revolving credit facility also provides for a subfacility of up to $100.0 for swing line borrowings and a subfacility of up to $150.0 for issuances of letters of credit. The Company is required to pay a facility fee on the aggregate commitments under the revolving credit facility, at a per annum rate ranging from 0.00% to 0.25%. The revolving credit facility is permitted to be used for general corporate purposes, including working capital, capital expenditures, funding of share repurchases and certain other payments, acquisitions and other investments. There were no balances outstanding on the Company's current revolving credit facility at September&#160;30, 2020, and December&#160;31, 2019. As of September&#160;30, 2020, the effective interest rate on the revolving credit facility was 1.12%. The credit facility expires on September 15, 2022. </span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the term loan facility and the revolving credit facility, the Company is subject to negative covenants limiting subsidiary indebtedness and certain other covenants typical for investment grade-rated borrowers, and the Company is required to maintain certain leverage ratios. In May 2020, the Company entered into amendments to its term loan facility and its revolving credit facility, in each case to, among other things, increase the maximum leverage ratio covenant to 5.0x debt to last twelve months EBITDA for each of the three periods ended June 30, September 30, and December 31, 2020, and 4.5x for period ended March 31, 2021. From and including the period ending June 30, 2021, the maximum leverage ratio reverts back to 4.0x. The Company was in compliance with all covenants in the term loan facility and the revolving credit facility at September&#160;30, 2020, and expects that it will remain in compliance with its existing debt covenants for the next twelve months.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's availability of $997.0 at September&#160;30, 2020, under its revolving credit facility reflects a reduction equivalent to the amount of the Company's outstanding letters of credit.</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At September 30, 2020, the Company had $667.2 of cash and cash equivalents and $997.0 of available borrowings under its revolving credit facility, which does not mature until 2022, and the Company was in compliance with all of its debt covenants. In May 2020, in order to obtain increased financial covenant flexibility, the Company and its lenders entered into amendments </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">to the term loan facility and the revolving credit facility to increase the maximum leverage ratio to 5.0x debt to last twelve months EBITDA for the three month periods ending June 30, September 30 and December 31, 2020, and 4.5x for the period ended March 31, 2021. From and including the period ending June 30, 2021, the maximum leverage ratio reverts back to 4.0x. The amendments also provide that during any period in which the Company's leverage ratio exceeds 4.5x debt to last twelve months EBITDA (i) the Company will be prohibited from consummating share repurchases, subject to limited exceptions, (ii) borrowings under the revolving credit facility will accrue interest at a per annum rate equal to, at the Company's election, either a LIBOR rate plus a margin of 1.25% or a base rate plus a margin of 0.25%, (iii) the facility fee that the Company is required to pay on the aggregate commitments under the revolving credit facility will be 0.25% per annum, and (iv) borrowings under the term loan facility will accrue interest at a per annum rate equal to, at the Company's election, either a LIBOR rate plus a margin of 1.175% or a base rate plus a margin of 0.175%.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is closely monitoring the impact of the COVID-19 pandemic on all aspects of its business and the effects such impacts are having and will have on the Company's liquidity. The significance of the impact on the Company&#8217;s business is not yet certain and depends on numerous evolving factors that the Company may not be able to accurately predict.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074958263592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock', window );">Changes in common shares issued and held in treasury</a></td>
<td class="text"><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in common shares issued are summarized below:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.166%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.634%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued and Outstanding</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares at September 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</a></td>
<td class="text">The components of accumulated other comprehensive earnings (loss) are as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.885%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.813%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.334%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.120%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Benefit Plan Adjustments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Earnings (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285.4)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87.0)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(372.4)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year adjustments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Tax effect of adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(314.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Preferred Stock and Common Shareholders' Equity</a></td>
<td class="text">PREFERRED STOCK AND COMMON SHAREHOLDERS&#8217; EQUITY<div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to issue up to 265.0 shares of common stock, par value $0.10 per share. The Company is authorized to issue up to 30.0 shares of preferred stock, par value $0.10 per share. There were no preferred shares outstanding as of September&#160;30, 2020, and December&#160;31, 2019. </span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in common shares issued are summarized below:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.166%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.634%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued and Outstanding</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares at September 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:15pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div style="margin-bottom:7.1pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the end of 2019, the Company had outstanding authorization from the board of directors to purchase $900.0 of Company common stock. During three months ended March 31, 2020, the Company purchased&#160;0.6&#160;shares of its common stock. When the Company repurchases shares, the amount paid to repurchase the shares in excess of the par or stated value is allocated to additional paid-in-capital unless subject to limitation or the balance in additional paid-in-capital is exhausted. Remaining amounts are recognized as a reduction in retained earnings. As of September&#160;30, 2020, the Company had outstanding authorization from the board of directors to purchase up to $800.0 of the Company's common stock. The repurchase authorization has no expiration date. The Company reinstated its share repurchase program in October 2020 following the temporary suspension of stock repurchases beginning in March 2020 as a result of the anticipated impact of the COVID-19 pandemic.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Earnings </span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive earnings (loss) are as follows:</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.885%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.813%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.334%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.120%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Benefit Plan Adjustments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Earnings (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285.4)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87.0)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(372.4)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year adjustments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Tax effect of adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(314.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule is used to show the changes in common shares issued and held in treasury by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074954219848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">INCOME TAXES<div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not recognize a tax benefit unless it concludes that it is more likely than not that the benefit will be sustained on audit by the taxing authority based solely on the technical merits of the associated tax position. If the recognition threshold is met, the Company recognizes a tax benefit measured at the largest amount of the tax benefit that it believes is greater than 50% likely to be realized.</span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross unrecognized income tax benefits were $41.3 and $31.7 at September&#160;30, 2020, and December&#160;31, 2019, respectively. It is anticipated that the amount of the unrecognized income tax benefits will change within the next 12 months; </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">however, these changes are not expected to have a significant impact on the results of operations, cash flows or the financial position of the Company.</span></div><div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, and December&#160;31, 2019, $41.3 and $31.7, respectively, are the approximate amounts of gross unrecognized income tax benefits that, if recognized, would favorably affect the effective income tax rate in future periods. </span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes interest and penalties related to unrecognized income tax benefits in income tax expense. Accrued interest and penalties related to uncertain tax positions totaled $9.0 and $5.5 as of September&#160;30, 2020, and December&#160;31, 2019, respectively. </span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company has substantially concluded all U.S. federal income tax matters for years through 2016. Substantially all material state and local and foreign income tax matters have been concluded through 2015 and 2011, respectively.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has various state and foreign income tax examinations ongoing throughout the year. The Company believes adequate provisions have been recorded related to all open tax years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074954290504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES <div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved from time to time in various claims and legal actions, including arbitrations, class actions, and other litigation (including those described in more detail below), arising in the ordinary course of business. Some of these actions involve claims that are substantial in amount. These matters include, but are not limited to, intellectual property disputes; commercial and contract disputes; professional liability claims; employee-related matters; and inquiries, including subpoenas and other civil investigative demands, from governmental agencies, Medicare or Medicaid payers and MCOs reviewing billing practices or requesting comment on allegations of billing irregularities that are brought to their attention through billing audits or third parties. The Company receives civil investigative demands or other inquiries from various governmental bodies in the ordinary course of its business. Such inquiries can relate to the Company or other parties, including physicians and other health care providers. The Company works cooperatively to respond to appropriate requests for information.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also is named from time to time in suits brought under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provisions of the False Claims Act and comparable state laws. These suits typically allege that the Company has made false statements and/or certifications in connection with claims for payment from U.S. federal or state healthcare programs. The suits may remain under seal (hence, unknown to the Company) for some time while the government decides whether to intervene on behalf of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> plaintiff. Such claims are an inevitable part of doing business in the healthcare field today.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that it is in compliance in all material respects with all statutes, regulations, and other requirements applicable to its commercial laboratory operations and drug development support services. The healthcare diagnostics and drug development industries are, however, subject to extensive regulation, and the courts have not interpreted many of the applicable statutes and regulations. Therefore, the applicable statutes and regulations could be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that would adversely affect the Company. Potential sanctions for violation of these statutes and regulations include significant civil and criminal penalties, fines, the loss of various licenses, certificates and authorizations, additional liabilities from third-party claims, and/or exclusion from participation in government programs.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the current claims and legal actions against the Company are in preliminary stages, and many of these cases seek an indeterminate amount of damages. The Company records an aggregate legal reserve, which is determined using calculations based on historical loss rates and assessment of trends experienced in settlements and defense costs. In accordance with FASB Accounting Standards Codification Topic 450 &#8220;Contingencies,&#8221; the Company establishes reserves for judicial, regulatory, and arbitration matters outside the aggregate legal reserve if and when those matters present loss contingencies that are both probable and estimable and would exceed the aggregate legal reserve. When loss contingencies are not both probable and estimable, the Company does not establish separate reserves.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is unable to estimate a range of reasonably probable loss for the proceedings described in more detail below in which damages either have not been specified or, in the Company's judgment, are unsupported and/or exaggerated and (i) the proceedings are in early stages; (ii) there is uncertainty as to the outcome of pending appeals or motions; (iii) there are significant factual issues to be resolved; and/or (iv) there are novel legal issues to be presented. For these proceedings, however, the Company does not believe, based on currently available information, that the outcomes will have a material adverse effect on the Company's financial condition, though the outcomes could be material to the Company's operating results for any particular period, depending, in part, upon the operating results for such period. </span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously reported, the Company responded to an October 2007 subpoena from the U.S. Department of Health &amp; Human Services Office of Inspector General's regional office in New York. On August 17, 2011, the U.S. District Court for the </span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Southern District of New York unsealed a False Claims Act lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States of America ex rel. NPT Associates v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which alleges that the Company offered UnitedHealthcare kickbacks in the form of discounts in return for Medicare business. The Plaintiff's Third Amended Complaint further alleges that the Company's billing practices violated the False Claims Acts of 14 states and the District of Columbia. The lawsuit seeks actual and treble damages and civil penalties for each alleged false claim, as well as recovery of costs, attorney's fees, and legal expenses. Neither the U.S. government nor any state government has intervened in the lawsuit. The Company's Motion to Dismiss was granted in October 2014 and Plaintiff was granted the right to replead. On January 11, 2016, Plaintiff filed a motion requesting leave to file an amended complaint under seal and to vacate the briefing schedule for the Company's Motion to Dismiss, while the government reviews the amended complaint. The Court granted the motion and vacated the briefing dates. Plaintiff then filed the Amended Complaint under seal. The Company will vigorously defend the lawsuit.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company has received various other subpoenas since 2007 related to Medicaid billing. In October 2009, the Company received a subpoena from the State of Michigan Department of Attorney General seeking documents related to its billing to Michigan Medicaid. The Company cooperated with this request. In October 2013, the Company received a Civil Investigative Demand from the State of Texas Office of the Attorney General requesting documents related to its billing to Texas Medicaid. The Company cooperated with this request. On October 5, 2018, the Company received a second Civil Investigative Demand from the State of Texas Office of the Attorney General requesting documents related to its billing to Texas Medicaid. The Company is cooperating with this request.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 31, 2015, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patty Davis v. Laboratory Corporation of America, et al.,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> filed in the Circuit Court of the Thirteenth Judicial Circuit for Hillsborough County, Florida. The complaint alleges that the Company violated the Florida Consumer Collection Practices Act by billing patients who were collecting benefits under the Workers' Compensation Statutes. The lawsuit seeks injunctive relief and actual and statutory damages, as well as recovery of attorney's fees and legal expenses. In April 2017, the Circuit Court granted the Company&#8217;s Motion for Judgment on the Pleadings. The Plaintiff appealed the Circuit Court&#8217;s ruling to the Florida Second District Court of Appeal. On October 16, 2019, the Court of Appeal reversed the Circuit Court&#8217;s dismissal, but certified a controlling issue of Florida law to the Florida Supreme Court. On February 17, 2020, the Florida Supreme Court accepted jurisdiction of the lawsuit. The Court has scheduled oral arguments for December 9, 2020. The Company will vigorously defend the lawsuit.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2014, the Company received a Civil Investigative Demand issued pursuant to the U.S. False Claims Act from the U.S. Attorney's Office for South Carolina, which requested information regarding alleged remuneration and services provided by the Company to physicians who also received draw and processing/handling fees from competitor laboratories Health Diagnostic Laboratory, Inc. (HDL) and Singulex, Inc. (Singulex). The Company cooperated with the request. On April 4, 2018, the U.S. District Court for the District of South Carolina, Beaufort Division, unsealed a False Claims Act lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States of America ex rel. Scarlett Lutz, et al. v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which alleges that the Company's financial relationships with referring physicians violate federal and state anti-kickback statutes. The Plaintiffs' Fourth Amended Complaint further alleges that the Company conspired with HDL and Singulex in violation of the Federal False Claims Act and the California and Illinois insurance fraud prevention acts by facilitating HDL's and Singulex's offers of illegal inducements to physicians and the referral of patients to HDL and Singulex for laboratory testing. The lawsuit seeks actual and treble damages and civil penalties for each alleged false claim, as well as recovery of costs, attorney's fees, and legal expenses. Neither the U.S. government nor any state government has intervened in the lawsuit. The Company filed a Motion to Dismiss seeking the dismissal of the claims asserted under the California and Illinois insurance fraud prevention statutes, the conspiracy claim, the reverse False Claims Act claim, and all claims based on the theory that the Company performed medically unnecessary testing. On January 16, 2019, the Court entered an order granting in part and denying in part the Motion to Dismiss. The Court dismissed the Plaintiffs' claims based on the theory that the Company performed medically unnecessary testing, the claims asserted under the California and Illinois insurance fraud prevention statutes, and the reverse False Claims Act claim. The Court denied the Motion to Dismiss as to the conspiracy claim. The Company will vigorously defend the lawsuit.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Company's acquisition of Sequenom, Inc. (Sequenom) between August 15, 2016 and August 24, 2016, six putative class-action lawsuits were filed on behalf of purported Sequenom stockholders (captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Malkoff v. Sequenom, Inc., et al., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No. 16-cv-02054- JAH-BLM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Gupta v. Sequenom, Inc., et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., No. 16-cv-02084-JAH-KSC,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Fruchter v. Sequenom, Inc., et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., No. 16-cv-02101- WQH-KSC, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asiatrade Development Ltd. v. Sequenom, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 16-cv-02113-AJB-JMA, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nunes v. Sequenom, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 16-cv-02128-AJB-MDD, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cusumano v. Sequenom, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 16-cv-02134-LAB-JMA) in the U.S. District Court for the Southern District of California challenging the acquisition transaction. The complaints asserted claims against Sequenom and members of its board of directors (the Individual Defendants). The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nunes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">action also named the Company and Savoy Acquisition Corp. (Savoy), a wholly owned subsidiary of the Company, as defendants. The complaints alleged that the defendants violated Sections 14(e), 14(d)(4) and 20 of the Securities Exchange Act of 1934 by failing to </span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">disclose certain allegedly material information. In addition, the complaints in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Malkoff </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">action, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asiatrade </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">action, and the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cusumano </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">action alleged that the Individual Defendants breached their fiduciary duties to Sequenom shareholders. The actions sought, among other things, injunctive relief enjoining the merger. On August 30, 2016, the parties entered into a Memorandum of Understanding (MOU) in each of the above-referenced actions. On September 6, 2016, the Court entered an order consolidating for all pre-trial purposes the six individual actions described above under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re Sequenom, Inc. Shareholder Litig.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Lead Case No. 16-cv-02054-JAH-BLM, and designating the complaint from the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Malkoff </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">action as the operative complaint for the consolidated action. On November 11, 2016, two competing motions were filed by two separate stockholders (James Reilly and Shikha Gupta) seeking appointment as lead plaintiff under the terms of the Private Securities Litigation Reform Act of 1995. On June 7, 2017, the Court entered an order declaring Mr. Reilly as the lead plaintiff and approving Mr. Reilly's selection of lead counsel. The parties agree that the MOU has been terminated. The Plaintiffs filed a Consolidated Amended Class Action Complaint on July 24, 2017, and the Defendants filed a Motion to Dismiss, which remains pending. On March 13, 2019, the Court stayed the action in its entirety pending the U.S. Supreme Court's anticipated decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Emulex Corp. v. Varjabedian</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On April 23, 2019, however, the U.S. Supreme Court dismissed the writ of certiorari in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Emulex </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as improvidently granted. The Company will vigorously defend the lawsuit.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2017, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Victoria Bouffard, et al. v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the U.S. District Court for the Middle District of North Carolina. The complaint alleges that the Company's patient list prices unlawfully exceed the rates negotiated for the same services with private and public health insurers in violation of various state consumer protection laws. The lawsuit also alleges breach of implied contract or quasi-contract, unjust enrichment, and fraud. The lawsuit seeks statutory, exemplary, and punitive damages, injunctive relief, and recovery of attorney's fees and costs. In May 2017, the Company filed a Motion to Dismiss Plaintiffs' Complaint and Strike Class Allegations; the Motion to Dismiss was granted in March 2018 without prejudice. On October 10, 2017, a second putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sheryl Anderson, et al. v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was filed in the U.S. District Court for the Middle District of North Carolina. The complaint contained similar allegations and sought similar relief to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bouffard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint, and added additional counts regarding state consumer protection laws. On August 10, 2018, the Plaintiffs filed an Amended Complaint, which consolidated the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bouffard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anderson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> actions. On September 10, 2018, the Company filed a Motion to Dismiss Plaintiffs' Amended Complaint and Strike Class Allegations. On August 16, 2019, the Court entered an order granting in part and denying in part the Motion to Dismiss the Amended Complaint, and denying the Motion to Strike the Class Allegations. The Company will vigorously defend the lawsuit.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2019, Covance Research Products was served with a Grand Jury Subpoena issued by the Department of Justice (DOJ) in Miami, Florida requiring the production of documents related to the importation into the United States of live non-human primate shipments originating from or transiting through China, Cambodia, and/or Vietnam from April 1, 2014 through March 28, 2019. The Company is cooperating with the DOJ.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 14, 2019, Retrieval-Masters Creditors Bureau, Inc. d/b/a American Medical Collection Agency (AMCA), an external collection agency, notified the Company about a security incident AMCA experienced that may have involved certain personal information about some of the Company&#8217;s patients (the AMCA Incident). The Company referred patient balances to AMCA only when direct collection efforts were unsuccessful. The Company&#8217;s systems were not impacted by the AMCA Incident. Upon learning of the AMCA Incident, the Company promptly stopped sending new collection requests to AMCA and stopped AMCA from continuing to work on any pending collection requests from the Company. AMCA informed the Company that it appeared that an unauthorized user had access to AMCA&#8217;s system between August 1, 2018, and March 30, 2019, and that AMCA could not rule out the possibility that personal information on AMCA&#8217;s system was at risk during that time period. Information on AMCA&#8217;s affected system from the Company may have included name, address, and balance information for the patient and person responsible for payment, along with the patient&#8217;s phone number, date of birth, referring physician, and date of service. The Company was later informed by AMCA that health insurance information may have been included for some individuals, and because some insurance carriers utilize the Social Security Number as a subscriber identification number, the Social Security Number for </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">some </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">individuals may also have been affected. No ordered tests, laboratory test results, or diagnostic information from the Company were in the AMCA affected system. The Company notified individuals for whom it had a valid mailing address. For the individuals whose Social Security Number was affected, the notice included an offer to enroll in credit monitoring and identity protection services that will be provided free of charge for 24 months.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Twenty-three putative class action lawsuits were filed against the Company related to the AMCA Incident in various U.S. District Courts. Numerous similar lawsuits have been filed against other health care providers who used AMCA. These lawsuits have been consolidated into a multidistrict litigation in the District of New Jersey. On November 15, 2019, the Plaintiffs filed a Consolidated Class Action Complaint in the U.S. District Court of New Jersey. On January 22, 2020, the Company filed Motions to Dismiss all claims. The consolidated Complaint generally alleges that the Company did not adequately protect its </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">patients&#8217; data and failed to timely notify those patients of the AMCA Incident. The Complaint asserts various causes of action, including but not limited to negligence, breach of implied contract, unjust enrichment, and the violation of state data protection statutes. The Complaint seeks damages on behalf of a class of all affected Company customers. The Company will vigorously defend the multi-district litigation. </span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was served with a shareholder derivative lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Raymond Eugenio, Derivatively on Behalf of Nominal Defendant, Laboratory Corporation of America Holdings v. Lance Berberian, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the Court of Chancery of the State of Delaware on April 23, 2020.&#160;The complaint asserts derivative claims on the Company&#8217;s behalf against the Company&#8217;s board of directors and certain executive officers.&#160;The complaint generally alleges that the defendants failed to ensure that the Company utilized proper cybersecurity safeguards and failed to implement a sufficient response to data security incidents, including the AMCA Incident.&#160;The complaint asserts derivative claims for breach of fiduciary duty and seeks relief including damages, certain disclosures, and certain changes to the Company&#8217;s internal governance practices. On June 2, 2020, the Company filed a Motion to Stay the lawsuit due to its overlap with the multi-district litigation referenced above. On July 2, 2020, the Company filed a Motion to Dismiss. On July 14, 2020, the Court entered an order staying the lawsuit pending the resolution of the multi-district litigation. The lawsuit will be vigorously defended.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain governmental entities have requested information from the Company related to the AMCA Incident. The Company received a request for information from the Office for Civil Rights (OCR) of the Department of Health and Human Services.&#160;On April 28, 2020, OCR notified the Company of the closure of its inquiry. The Company has also received requests from a multi-state group of state Attorneys General and is cooperating with these requests for information.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three putative class action lawsuits related to California wage and hour laws have been served on the Company. On September 21, 2018, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Alma Haro v. Laboratory Corporation of America, et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., filed in the Superior Court of California, County of Los Angeles. On June 10, 2019, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ignacio v. Laboratory Corporation of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in Superior Court of California, County of Los Angeles. On July 1, 2019, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jan v. Laboratory Corporation of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the Superior Court of California, County of Sacramento. All three lawsuits were subsequently removed to the U.S. District Court for the Central District of California, and then consolidated for all pre-trial proceedings. In the lawsuits, the Plaintiffs allege that employees were not properly paid overtime compensation, minimum wages, meal and rest break premiums, did not receive compliant wage statements, and were not properly paid wages upon termination of employment. The Plaintiffs assert these actions violate various California Labor Code provisions and constitute an unfair competition practice under California law. The lawsuits seek monetary damages, civil penalties, and recovery of attorney's fees and costs. On July 22, 2020, the Court issued an order granting preliminary approval of a settlement resolving all three lawsuits. If the settlement does not receive final approval, the Company will vigorously defend the lawsuits. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 30, 2019, the Company was served with a class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mitchell v. Covance, Inc. et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the U.S. District Court for the Eastern District of Pennsylvania. Plaintiff alleges that certain individuals employed by Covance Inc. and Chiltern International Inc. were misclassified as exempt employees under the Fair Labor Standards Act and the Pennsylvania Minimum Wage Act and were thereby not properly paid overtime compensation. The lawsuit seeks monetary damages, liquidated damages, and recovery of attorneys&#8217; fees and costs. On February 3, 2020, the Court denied without prejudice the Plaintiff's motion to conditionally certify a putative class action. On July 20, 2020, Plaintiff executed a settlement agreement resolving the lawsuit.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2020, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Luke Davis and Julian Vargas, et al. v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the U.S. District Court for the Central District of California. The lawsuit alleges that visually impaired patients are unable to use the Company's touchscreen kiosks at Company patient service centers in violation of the Americans with Disabilities Act and similar California statutes. The lawsuit seeks statutory damages, injunctive relief, and attorney's fees and costs. On March 20, 2020, the Company filed a Motion to Dismiss Plaintiffs' Complaint and to Strike Class Allegations. In August 2020, the Plaintiffs filed an Amended Complaint. The Company will vigorously defend the lawsuit.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 14, 2020, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jose Bermejo v. Laboratory Corporation of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> filed in the Superior Court of California, County of Los Angeles Central District, alleging that certain non-exempt California-based employees were not properly compensated for driving time or properly paid wages upon termination of employment. The Plaintiff asserts these actions violate various California Labor Code provisions and Section 17200 of the Business and Professional Code. The lawsuit seeks monetary damages, civil penalties, and recovery of attorney&#8217;s fees and costs. On June 15, 2020, the lawsuit was removed to the U.S. District Court for the Central District of California. On June 16, 2020, the Company was served with a Private Attorney General Act lawsuit by the same plaintiff in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jose Bermejo v. Laboratory </span></div><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporation of America, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">filed in the Superior Court of California, County of Los Angeles Central District, alleging that certain Company practices violated California Labor Code penalty provisions related to unpaid and minimum wages, unpaid overtime, unpaid mean and rest break premiums, untimely payment of wages following separation of employment, failure to maintain accurate pay records, and non-reimbursement of business expenses. The second lawsuit seeks to recover civil penalties and recovery of attorney's fees and costs. The Company will vigorously defend both lawsuits.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 14, 2020, the Company was served with a Subpoena Duces Tecum issued by the State of Colorado Office of the Attorney General requiring the production of documents related to urine drug testing in all states. The Company is cooperating with this request.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 2, 2020, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Peterson v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the U.S. District Court for the Northern District of New York, alleging claims for a failure to properly pay service representatives compensation for all hours worked and overtime under the Fair Labor Standards Act, as well as notice and recordkeeping claims under the New York Labor Code. The lawsuit seeks monetary damages, liquidated damages, equitable and injunctive relief, and recovery of attorney's fees and costs. The Company will vigorously defend the lawsuit.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 5, 2020, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Williams v. LabCorp Employer Services, Inc. et al, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">filed in the Superior Court of California, County of Los Angeles, alleging that certain non-exempt California-based employees were not properly compensated for work and overtime hours, not properly paid meal and rest break premiums, not reimbursed for certain business-related expenses, not properly paid for driving or wait times, and received inaccurate wage statements. The Plaintiff also asserts claims for unfair competition under Section 17200 of the Business and Professional Code. The lawsuit seeks monetary damages, liquidated damages, civil penalties, and recovery of attorney's fees and costs. The Company will vigorously defend the lawsuit. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Company's present insurance programs, coverage is obtained for catastrophic exposure as well as those risks required to be insured by law or contract. The Company is responsible for the uninsured portion of losses related primarily to general, professional and vehicle liability, certain medical costs and workers' compensation. The self-insured retentions are on a per-occurrence basis without any aggregate annual limit. Provisions for losses expected under these programs are recorded based upon the Company's estimates of the aggregated liability of claims incurred.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074956071256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PENSION AND POSTRETIREMENT PLANS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsAbstract', window );"><strong>Postemployment Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Pension And Postretirement Plans</a></td>
<td class="text">PENSION AND POSTRETIREMENT PLANS<div style="margin-bottom:3pt;margin-top:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retirement Plans</span></div><div style="margin-bottom:7.1pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All employees eligible for the LCD defined-contribution retirement plan (LCD 401(k) Plan) receive a minimum 3% non-elective contribution (NEC) concurrent with each payroll period. Employees are not required to make a contribution to the LCD 401(k) Plan to receive the NEC. The NEC is non-forfeitable and vests immediately. The LCD 401(k) Plan also permits discretionary contributions by the Company of 1% to 3% of pay for eligible employees based on service. The Company incurred expense of $14.0 and $16.7 for the LCD 401(k) Plan during the three months ended September&#160;30, 2020, and 2019, respectively, and $41.4 and $48.9 during the nine months ended September&#160;30, 2020, and 2019, respectively.</span></div><div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the CDD U.S. employees are eligible to participate in the CDD 401(k) Plan, which is available on a voluntary basis and features a maximum 4.5% Company match, based upon a percentage of the employee&#8217;s contributions. The Company incurred expense of $21.0 and $18.2 for the Covance 401(k) plan during the three months ended September&#160;30, 2020, and 2019, respectively, and $64.8 and $56.0 during the nine months ended September&#160;30, 2020, and 2019, respectively.</span></div><div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains several other small 401(k) plans associated with companies acquired over the last several years. </span></div><div style="margin-bottom:3pt;margin-top:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pension Plans</span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a defined-benefit retirement plan (Company Plan) and a nonqualified supplemental retirement plan (PEP). Both plans have been closed to new participants since December 31, 2009. Employees participating in the Company Plan and PEP no longer earn service-based credits, but continue to earn investment credits.</span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company Plan covers substantially all LCD employees employed prior to December 31, 2009. The benefits to be paid under the Company Plan are based on years of credited service through December 31, 2009, interest credits and average compensation. The Company's policy is to fund the Company Plan with at least the minimum amount required by applicable regulations.</span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PEP covers a portion of the Company's senior management group. Prior to 2010, the PEP provided for the payment of the difference, if any, between the amount of any maximum limitation on annual benefit payments under the Employee Retirement Income Security Act of 1974 and the annual benefit that would be payable under the Company Plan but for such limitation. Effective January 1, 2010, employees participating in the PEP no longer earn service-based credits. The PEP is an unfunded plan.</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect on operations for the Company Plan and the PEP is summarized as follows:</span></div><div style="margin-bottom:11pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.086%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost for administrative expenses</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on benefit obligation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amortization and deferral</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit plan costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The service cost component of net periodic pension cost and net periodic post-retirement benefit cost is included in operating expenses with other employee compensation costs. The other components of net benefit cost, including amortization or prior service cost/credit and settlement and curtailment effects are included in other, net non-operating expenses. During the nine months ended September&#160;30, 2020, the Company made no contributions to the Company Plan. The related net pension obligation for the Company Plan and PEP was $92.6 and $93.4 as of September&#160;30, 2020, and December&#160;31, 2019, respectively.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Covance acquisition, the Company sponsors two defined benefit pension plans for the benefit of its employees at two U.K. subsidiaries (U.K. Plans) and one defined benefit pension plan for the benefit of its employees at a German subsidiary (German Plan), all of which are legacy plans of previously acquired companies. The U.K. Plans were closed to future accrual as of December 31, 2019. Benefit amounts for all three plans are based upon years of service and compensation; however, the U.K. Plans were based on service and compensation through December 31, 2019. The German Plan is unfunded while the U.K. Plans are funded. The Company&#8217;s funding policy has been to contribute annually a fixed percentage of the eligible employee's salary, and additional amounts, at least equal to the local statutory funding requirements.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Envigo acquisition, the Company assumed a defined benefit pension plan for the benefit of Envigo's U.K. employees (the Envigo Plan), which is a legacy plan of a company previously acquired by Envigo. The Envigo Plan is a funded plan that is closed to future accrual. The Company&#8217;s funding policy has been to contribute amounts at least equal to the local statutory funding requirements.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The related net pension obligation for these plans inclusive of the U.K. Plans, German Plan, and the Envigo Plan, was&#160;$85.4 and $99.1&#160;as of September&#160;30, 2020, and December&#160;31, 2019, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140075048027992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div style="margin-bottom:6pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s population of financial assets and liabilities subject to fair value measurements as of September&#160;30, 2020, and December&#160;31, 2019, is as follows:</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:37.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.665%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.101%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Measurements as of</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value<br/>as of</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Using Fair Value Hierarchy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest put</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:36.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.458%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.194%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.138%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Measurements as of</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value<br/>as of</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Using Fair Value Hierarchy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest put</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Measurement of Level 3 Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a noncontrolling interest put related to its Ontario subsidiary that has been classified as mezzanine equity in the Company&#8217;s condensed consolidated balance sheets. The noncontrolling interest put is valued at its contractually determined value, which approximates fair value.  </span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers certain employees the opportunity to participate in an employee-funded deferred compensation plan (DCP). A participant's deferrals are allocated by the participant to one or more of 16 measurement funds, which are indexed to externally managed funds. From time to time, to offset the cost of the growth in the participant's investment accounts, the Company purchases life insurance policies, with the Company named as beneficiary of the policies. Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments, which are typically invested in a similar manner to the participants' allocations. Changes in the fair value of the DCP obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units. The cash surrender value and the DCP obligations are classified within Level 2 because their inputs are derived principally from observable market data by correlation to the hypothetical investments.  </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent acquisition consideration liabilities are measured at fair value using Level 3 valuations. These contingent consideration liabilities were recorded at fair value on the acquisition date and are remeasured quarterly based on the then assessed fair value and adjusted if necessary. The increases or decreases in the fair value of contingent consideration payable can result from changes in anticipated revenue levels and changes in assumed discount periods and rates. As the fair value measure is based on significant inputs that are not observable in the market, they are categorized as Level 3.</span></div>The carrying amounts of cash and cash equivalents, accounts receivable, income taxes receivable, and accounts payable are considered to be representative of their respective fair values due to their short-term nature. The fair market value of the Senior Notes, based on market pricing, was approximately $6,107.9 and $6,140.6 as of September&#160;30, 2020, and December&#160;31, 2019, respectively. The Company's note and debt instruments are classified as Level 2 instruments, as the fair market values of these instruments are determined using other observable inputs.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074958206712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Derivative Instruments, Gain (Loss) [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides information regarding the location and amount of pretax (gains) losses of derivatives designated in fair value hedging:</span></div><div style="margin-bottom:12.1pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:19.371%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.178%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.589%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of pre-tax gain/(loss) included in other comprehensive income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified to the <br/>Statement of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of pre-tax gain/(loss) included in other comprehensive income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified to the <br/>Statement of Operations</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Instruments And Hedging Activities</a></td>
<td class="text">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES<div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company addresses its exposure to market risks, principally the market risk associated with changes in interest rates and foreign currency exchange rates, through a controlled program of risk management that includes, from time to time, the use of derivative financial instruments.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company does not hold or issue derivative financial instruments for trading purposes. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not believe that its exposure to market risk is material to the Company&#8217;s financial position or results of operations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Swap</span></div><div style="margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On August 17, 2020, the Company redeemed its remaining $412.2 4.625% Senior Notes due November 15, 2020, using available cash on hand. The Company exited the remaining fixed-to-variable interest rate swap arrangement in August 2020, in connection with the redemption of the 4.625% Senior Notes due 2020. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:26.465%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.641%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.646%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount of hedged liabilities as of</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Liabilities as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance Sheet Line Item in which Hedged Items are Included</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion, long term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cross Currency Swap</span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2018, the Company entered into six U.S. Dollar to Swiss Franc cross-currency swap agreements with an aggregate notional value of $600.0 and which are accounted for as a hedge against the impact of foreign exchange movements on its net investment in a Swiss subsidiary. Of the notional value, $300.0 matures in 2022 and $300.0 matures in 2025. These cross currency swaps maturing in 2022 and 2025 are included in other long-term assets as of September&#160;30, 2020. Changes in the fair value of the cross-currency swaps are recorded as a component of the foreign currency translation adjustment in accumulated other comprehensive income in the Condensed Consolidated Balance Sheet until the hedged item is recognized in earnings. The cumulative amount of the fair value hedging adjustment included in the current value of the cross currency swaps was $(23.1) and $(12.0) for the three and nine months ended September&#160;30, 2020, respectively, and was recognized as currency translation within the Condensed Consolidated Statement of Comprehensive Earnings. There were no amounts reclassified from the Condensed Consolidated Statement of Comprehensive Earnings to the Condensed Consolidated Statement of Operations during the three months or nine months ended September&#160;30, 2020.</span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of derivatives on a gross basis and the balance sheet classification of those instruments:</span></div><div style="margin-bottom:12.1pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:17.228%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.530%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.084%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.084%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.383%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value of Derivative</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value of Derivative</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance Sheet Caption</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liability</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liability</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Dollar Notional</span></td></tr><tr><td colspan="30" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Derivatives Designated as Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net or Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides information regarding the location and amount of pretax (gains) losses of derivatives designated in fair value hedging:</span></div><div style="margin-bottom:12.1pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:19.371%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.178%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.589%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of pre-tax gain/(loss) included in other comprehensive income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified to the <br/>Statement of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of pre-tax gain/(loss) included in other comprehensive income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified to the <br/>Statement of Operations</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a gain of $1.6 on the extinguishment of the interest rate swap arrangement, which was included in Other, net on the Condensed Consolidated Statement of Operations. No additional gains or losses from derivative instruments have been recognized into income for the three and nine months ended September&#160;30, 2020, and 2019.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Derivative Instruments [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of derivatives on a gross basis and the balance sheet classification of those instruments:</span></div><div style="margin-bottom:12.1pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:17.228%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.530%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.084%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.084%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.383%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value of Derivative</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value of Derivative</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance Sheet Caption</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liability</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liability</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Dollar Notional</span></td></tr><tr><td colspan="30" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Derivatives Designated as Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net or Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41620-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41678-113959<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41641-113959<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074955579496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS ACQUISITIONS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combination Disclosure [Text Block]</a></td>
<td class="text">BUSINESS ACQUISITIONS AND DISPOSITIONS During the nine months ended September 30, 2020, the Company acquired various business and related assets for approximately $208.8 in cash (including contingent consideration of $6.0 and net of cash acquired), $113.4 within LCD and $95.4 within CDD. The purchase consideration for all acquisitions in the nine months ended September 30, 2020, has been allocated under the acquisition method of accounting to the estimated fair market value of the net assets acquired, including approximately $88.5 in identifiable intangible assets and a residual amount of non-tax deductible goodwill of approximately $128.9. The amortization periods for intangible assets acquired from these businesses range from 5 to 15 years for customer relationships and non-compete agreements. These acquisitions were made primarily to extend the Company's geographic reach in important market areas, enhance the Company's scientific differentiation and to expand the breadth and scope of the <div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company's CRO services. The excess of the fair value of the consideration conveyed over the fair value of the net assets acquired was recorded as goodwill. The goodwill reflects the Company's expectations to utilize the acquired businesses' workforce and established relationships and the benefits of being able to leverage operational efficiencies with favorable growth opportunities in these markets.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These acquisitions contributed $13.1 and $13.8 of revenue during the three and nine months ended September 30, 2020, respectively. The acquisitions contributed $3.5 and $3.6 of operating income, during the three and nine months ended September 30, 2020, respectively.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2019, the Company acquired various businesses and related assets for approximately $852.9 in cash (net of cash acquired), $647.4 within CDD and $205.5 within LCD. The purchase consideration for all acquisitions in the nine months ended September 30, 2019, has been allocated to the estimated fair market value of the net assets acquired, including approximately $324.1 in identifiable intangible assets and a residual amount of non-tax deductible goodwill for approximately $512.3. The amortization periods for intangible assets acquired from these businesses range from 11 to 15 years for customer relationships. These acquisitions were made primarily to extend the Company's geographic reach in important market areas, enhance the Company's scientific differentiation and to expand the breadth and scope of the Company's CRO services. The excess of the fair value of the consideration conveyed over the fair value of the net assets acquired was recorded as goodwill. The goodwill reflects the Company's expectations to utilize the acquired businesses' workforce and established relationships and the benefits of being able to leverage operational efficiencies with favorable growth opportunities in these markets.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;3, 2019, CDD acquired Envigo's nonclinical contract research services business, expanding CDD's global nonclinical drug development capabilities with additional locations and resources. Additionally, the Company divested the Covance Research Products business (CRP), which was a part of CDD, to Envigo. As part of this sale, CDD entered into a multi-year, renewable supply agreement with Envigo. The Company paid cash consideration of $601.0 (which is included in the nine month acquisition numbers above), received a floating rate secured note of $110.0, and recorded a loss on the sale of CRP of $12.2. The Company funded the transaction through a new term loan facility.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final valuation of acquired assets and assumed liabilities in the transaction as of June 3, 2019, include the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:81.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.371%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consideration Transferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration</span></td><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of CRP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Final <br/>June 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Assets Acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name and trademarks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Envigo assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating rate secured note receivable due 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:7pt;margin-top:11pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final purchase consideration for Envigo has been allocated to the estimated fair market value of the net assets acquired, including approximately $141.4 in identifiable intangible assets and a residual amount of non-tax-deductible goodwill of approximately $376.6. The amortization period for intangible assets acquired is 11 years for customer relationships. </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Information </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Had the Company's total 2019 and 2020 acquisitions been completed as of January 1, 2018, or January 1, 2019, respectively, the Company's pro forma results would have been as follows:</span><span style="color:#0094ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.991%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,899.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,969.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,524.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,827.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Laboratory Corporation of America Holdings</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074954356808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION Business Segment information (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting Disclosure [Text Block]</a></td>
<td class="text">BUSINESS SEGMENT INFORMATION<div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of segment information for the three and nine months ended September&#160;30, 2020, and 2019. The management approach has been used to present the following segment information. This approach is based upon the way the management of the Company organizes segments within an enterprise for making operating decisions and assessing performance. Financial information is reported on the basis that it is used internally by the chief operating decision maker (CODM) for evaluating segment performance and deciding how to allocate resources to segments. The Company&#8217;s chief executive officer has been identified as the CODM. </span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment asset information is not presented because it is not used by the CODM at the segment level. Operating earnings of each segment represents revenues less directly identifiable expenses to arrive at operating income for the segment. General management and administrative corporate expenses are included in general corporate expenses below. </span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.407%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues:</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LCD</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,704.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,759.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,098.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,242.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CDD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,175.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,479.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,376.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intercompany eliminations and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90.0)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,896.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,928.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,488.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,601.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating earnings (loss):</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LCD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">964.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,451.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CDD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,152.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating expenses, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net earnings attributable to the noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings attributable to Laboratory Corporation of America Holdings</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074953145128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF FINANCIAL STATEMENT PRESENTATION Use of Estimates (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates, Policy [Policy Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which the COVID-19 pandemic has and will impact the Company&#8217;s business and financial results depend on numerous evolving factors including, but not limited to: the magnitude and duration of the COVID-19 pandemic, the impact to worldwide macroeconomic conditions including interest rates, employment rates and health insurance coverage, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of September&#160;30, 2020, and through the date of this </span></div>report. The accounting matters assessed included, but were not limited to, the Company&#8217;s implicit price concessions and credit losses, equity investments, notes receivable and the carrying value of goodwill and other long-lived assets. The Company&#8217;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in additional material impacts to the Company&#8217;s consolidated financial statements in future reporting periods.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_RecentlyAdoptedAccountingGuidancePolicyTextBlock', window );">Recently Adopted Accounting Guidance [Policy Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Guidance </span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued a new accounting standard intended to provide financial statement users with more decision-useful information about expected credit losses and other commitments to extend credit held by the reporting entity. The standard replaces the incurred loss impairment methodology in current generally accepted accounting principles</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(GAAP) with one that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The Company recorded an opening retained earnings adjustment of $7.0 with the adoption of this standard on January 1, 2020. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued a new accounting standard to reduce, modify, and add to the disclosure requirements on fair value measurements. The Company adopted this standard effective January 1, 2020. The adoption of this standard did not have a material impact on the consolidated financial statements.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued a new accounting standard to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred </span></div>to develop or obtain internal-use software. The Company adopted this standard effective January 1, 2020. The adoption of this standard did not have a material impact on the consolidated financial statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_RecentlyAdoptedAccountingGuidancePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recently Adopted Accounting Guidance [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_RecentlyAdoptedAccountingGuidancePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074956066472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF FINANCIAL STATEMENT PRESENTATION New Accounting Pronouncements (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements, Policy [Policy Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Pronouncements</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued a new accounting standard to reduce, modify, and add to the disclosure requirements on defined benefit pension and other postretirement plans. The standard is effective on January 1, 2021, with early adoption permitted. The adoption of this standard is not expected to have a material impact on the consolidated financial statements.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued a new accounting standard to simplify accounting for income taxes and remove, modify, and add to the disclosure requirements of income taxes. The standard is effective January 1, 2021, with early adoption permitted. The adoption of this standard is not expected to have a material impact on the consolidated financial statements.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued a new accounting standard to clarify the interaction of the accounting for equity securities and investments accounted for under the equity method of accounting and the accounting for certain forward contracts and purchased options. The standard is effective January 1, 2021. The adoption of this standard is not expected to have a material impact on the consolidated financial statements.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued a new accounting standard to provide optional expedients and exceptions if certain conditions are met for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform. The expedients and exceptions in the standard are effective between March 12, 2020, and December 31, 2022. The Company did not elect to apply any of the expedients or exceptions for the period ended September 30, 2020, and is currently evaluating the impact this new standard will have on the consolidated financial statements. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued a new accounting standard to address issues identified as a result of the complexity associated with applying generally accepted accounting principles for convertible instruments and contracts in an entity's own equity. The standard is effective January 1, 2022, with early adoption permitted. The Company is evaluating the impact this new standard will have on the consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074954304776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF FINANCIAL STATEMENT PRESENTATION Novel Coronavirus (COVID-19) Financial Statement Impact (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock', window );">Novel Coranvirus (Covid-19) Financial Statement Impact [Policy Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Novel Coronavirus (COVID-19) Financial Statement Impact</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, COVID-19 was declared a pandemic. COVID-19 has had and continues to have an extensive impact on the global health and economic environments. During the nine months ended September 30, 2020, the Company recorded goodwill and other asset impairment charges of $437.4, as a result of the negative financial impact of COVID-19 during the first quarter of 2020. See Note 6 Goodwill and Intangible Assets for a discussion of goodwill and intangible asset impairment and Note 2 Revenues for a discussion of credit losses and additional price concessions. The Company also impaired certain of the Company's investments by a total of $25.4 during the nine months ended September 30, 2020, due to the impact of COVID-19; $7.1 was included in Equity method earnings (loss), net during the three months ended March 31, 2020, and $13.1 and $5.2 were included in Other, net during the three months ended March 31, 2020, and June 30, 2020, respectively.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In April 2020, the Company received cash payments of approximately $55.9 from the Public Health and Social Services Emergency Fund for provider relief that was appropriated by Congress to the Department of Health and Human Services (HHS) in the Coronavirus Aid, Relief, and Economic Security Act (CARES Act Provider Relief Funds). Upon receiving and satisfying the terms and conditions associated with the distributed funds, the Company accounted for the transaction by applying the guidance in ASC 450-30 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Gain Contingencies, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">recorded these funds in Other, net non-operating income in the Consolidated Statement of Operations as of June 30, 2020. In August 2020, the Company received an additional $76.2 in CARES Act Provider Relief Funds. As the Company's Diagnostic business demonstrated recovery and demand for COVID-19 testing increased, the Company determined that the negative financial impact of COVID-19 which the CARES Act Provider Relief Funds were designed to address no longer applied to the Company. As a result, the Company derecognized the income associated with the $55.9 received during the second quarter as a change in estimate and did not recognize any income related to the cash payment of $76.2 received in the third quarter. The Company plans to return the CARES Act Provider Relief Funds to the government in the fourth quarter of 2020 and has recorded a liability of $132.1 in Accrued expenses and other as of September 30, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Novel Coranvirus (Covid-19) Financial Statement Impact [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074956066472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF FINANCIAL STATEMENT PRESENTATION Recently Adopted Accounting Standards (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_RecentlyAdoptedAccountingGuidancePolicyTextBlock', window );">Recently Adopted Accounting Guidance [Policy Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Guidance </span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued a new accounting standard intended to provide financial statement users with more decision-useful information about expected credit losses and other commitments to extend credit held by the reporting entity. The standard replaces the incurred loss impairment methodology in current generally accepted accounting principles</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(GAAP) with one that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The Company recorded an opening retained earnings adjustment of $7.0 with the adoption of this standard on January 1, 2020. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued a new accounting standard to reduce, modify, and add to the disclosure requirements on fair value measurements. The Company adopted this standard effective January 1, 2020. The adoption of this standard did not have a material impact on the consolidated financial statements.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued a new accounting standard to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred </span></div>to develop or obtain internal-use software. The Company adopted this standard effective January 1, 2020. The adoption of this standard did not have a material impact on the consolidated financial statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_RecentlyAdoptedAccountingGuidancePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recently Adopted Accounting Guidance [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_RecentlyAdoptedAccountingGuidancePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074955528312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Goodwill and Other (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill and Intangible Assets, Goodwill, Policy</a></td>
<td class="text">GOODWILL AND INTANGIBLE ASSETS<div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the nine months ended September&#160;30, 2020, are as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LCD</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CDD</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,721.5&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,143.5&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,865.0&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(418.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(422.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency impact and other adjustments to goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,781.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,832.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,613.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:7pt;margin-top:11pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses goodwill and indefinite-lived intangibles for impairment at least annually or whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Based upon the revised forecasted revenues and operating income following the declaration of the COVID-19 global pandemic, management concluded there was a triggering event and updated its annual 2019 goodwill impairment testing as of March 31, 2020, for its CDD reporting units and its LCD reporting units. Based on the quantitative impairment assessment, the Company concluded that the fair value was less than carrying value for two of its reporting units, including one where the 2019 fair value exceeded carrying value by approximately 10.0%, and recorded a goodwill impairment of $418.7 for the CDD segment and $3.7 for LCD segment. </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilized a combination of income and market approaches to determine the fair value of the CDD reporting units. Based upon the results of the quantitative assessments, the Company concluded that the fair value was less than its carrying value for one of the CDD reporting units. A non-cash charge of $418.7 was recognized and included in goodwill and other asset impairments on the Consolidated Statement of Operations to reduce the carrying amount of goodwill for the CDD reporting unit to fair value. Following the impairment charge, the carrying value of goodwill for this reporting unit is $1,627.5 as of September 30, 2020. The other CDD reporting unit evaluated indicated a fair value that exceeded carrying value by less than 10.0%. Management notes that a +1.0% change in the discount rate in the March 31, 2020 analysis would reduce the headroom to approximately 2.0%. Goodwill for this reporting unit as of September 30, 2020 is $646.2. </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilized the income approach to determine </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the fair value of the LCD reporting units. Based upon the results of the quantitative assessments, the Company concluded the fair value of one of the reporting units was less than its carrying value. A non-cash charge of $3.7 was recognized and included in goodwill and other asset impairments on the Consolidated Statement of Operations to reduce the carrying amount of goodwill for this LCD reporting unit to zero. The other LCD reporting unit evaluated indicated a fair value that exceeded carrying value by less than 10.0%. Management notes that a +1.0% change in the discount rate in the March 31, 2020 analysis would cause the fair value to be less than carrying value and would result in an impairment of approximately $40.0. Goodwill and indefinite-lived intangibles of Canadian licenses for this reporting unit as of September 30, 2020, were $86.0 and $468.4, respectively.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company believes that the current assumptions and estimates used in its goodwill analysis are reasonable, supportable, and appropriate, continued efforts to maintain or improve the performance of these businesses could be impacted by unfavorable or unforeseen changes which could impact the existing assumptions used in the impairment analysis. Various factors could reasonably be expected to unfavorably impact existing assumptions: primarily delays in new customer bookings and the related delay in revenue from new customers, increases in customer termination activity or increases in operating costs. In addition, given the ongoing and rapidly changing nature of the COVID-19 pandemic, there is significant uncertainty </span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">regarding the duration and severity of the pandemic as well as any future government restrictions, which may unfavorably impact existing assumptions. Accordingly, there can be no assurance that the estimates and assumptions made for the purposes of the goodwill impairment analysis will prove to be accurate predictions of future performance.&#160;</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will continue to monitor the financial performance of and assumptions for its reporting units. Management's impairment analysis utilizes significant judgments and assumptions related to the market comparable method analysis, such as selected market multiples, and those related to cash flow projections, such as revenue and terminal growth rates, projected operating margin, and the discount rate. A significant increase in the discount rate, decrease in the revenue and terminal growth rates, decreased operating margin, or substantial reductions in end markets and volume assumptions, could have a negative impact on the estimated fair value of the reporting units. A future impairment charge for goodwill or intangible assets could have a material effect on the Company's consolidated financial position and results of operations. </span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of identifiable intangible assets are as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:25.439%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.043%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.043%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.043%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.048%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,530.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,473.1)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,057.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,441.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,329.5)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,112.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents, licenses and technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(245.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(235.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(219.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land use right</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canadian licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,953.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,032.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,920.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,885.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,851.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,034.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded non-cash charges of $30.5 for the impairment of identifiable intangible assets during the nine months ended September 30, 2020, within CDD. During the three months ended March 31, 2020, a $2.7 impairment charge was recorded for a tradename. During the three months ended September 30, 2020, additional impairment charges of $10.1 and $17.7 for customer relationships and technology intangible assets, respectively were recorded due to the loss of a contract from a prior acquisition. </span></div>Amortization of intangible assets for the three months ended September&#160;30, 2020, and 2019, was $62.2 and $61.7, respectively and for the nine months ended September 30, 2020, and 2019 was $184.6 and $179.0, respectively. Amortization expense for the net carrying amount of intangible assets is estimated to be $60.0 for the remainder of fiscal 2020, $238.5 in fiscal 2021, $232.6 in fiscal 2022, $229.5 in fiscal 2023, $224.6 in fiscal 2024, and $2,380.2 thereafter.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074954172968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue from Contract with Customer (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue</a></td>
<td class="text">REVENUES<div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues by segment payers/customer groups for the three and nine months ended September&#160;30, 2020, and 2019, were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:23.936%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.856%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.856%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.856%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.712%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Canada</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United Kingdom</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Switzerland</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payer/Customer</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">LCD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Clients</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Patients</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Medicare and Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Third-party</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Total LCD revenues by payer</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">CDD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Biopharmaceutical and medical device companies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:24.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.875%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Canada</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United Kingdom</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Switzerland</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payer/Customer</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">LCD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Clients</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Patients</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Medicare and Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Third-party</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Total LCD revenues by payer</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">CDD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Biopharmaceutical and medical device companies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:24.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.875%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Canada</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United Kingdom</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Switzerland</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payer/Customer</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">LCD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Clients</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Patients</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Medicare and Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Third-party</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Total LCD revenues by payer</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">CDD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Biopharmaceutical and medical device companies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:24.229%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.856%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.856%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.856%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.859%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Canada</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United Kingdom</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Switzerland</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payer/Customer</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">LCD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Clients</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Patients</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Medicare and Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Third-party</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Total LCD revenues by payer</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">CDD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Biopharmaceutical and medical device companies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract costs</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CDD incurs sales commissions in the process of obtaining contracts with customers, which are recoverable through the service fees in the contract. Sales commissions that are payable upon contract award are recognized as assets and amortized over the expected contract term, along with related payroll tax expense. The amortization of commission expense is based on the weighted average contract duration for all commissionable awards in the respective business in which the commission expense is paid, which approximates the period over which goods and services are transferred to the customer. The amortization period of sales commissions ranges from approximately 1 to 5 years, depending on the business. For businesses that enter into primarily short-term contracts, the Company applies the practical expedient, which allows costs to obtain a contract to be expensed when incurred if the amortization period of the assets that would otherwise have been recognized is one year or less. Amortization of assets from sales commissions is included in selling, general, and administrative expense.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CDD incurs costs to fulfill contracts with customers, which are recoverable through the service fees in the contract. Contract fulfillment costs include software implementation costs and setup costs for certain market access solutions. These costs are recognized as assets and amortized over the expected term of the contract to which the implementation relates, which is the period over which services are expected to be provided to the customer. This period typically ranges from 2 to 5 years. Amortization of deferred contract fulfillment costs is included in cost of goods sold.</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:60.720%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.136%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.110%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales commission assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract fulfillment costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization related to sales commission assets and associated payroll taxes for the three months ended September&#160;30, 2020, and 2019, was $6.0 and $5.8, respectively, and for the nine months ended September&#160;30, 2020, and 2019, was $16.8 and $15.3, respectively. Amortization related to deferred contract fulfillment costs for the three months ended September&#160;30, 2020, </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and 2019, was $2.3 and $2.3, respectively, and was $7.6 and $6.1, respectively, for the nine months ended September&#160;30, 2020, and 2019.</span></div><div style="margin-bottom:3pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receivables, Unbilled Services and Unearned Revenue</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Unbilled services are comprised primarily of unbilled receivables, but also include contract assets. A contract asset is recorded when a right to payment has been earned for work performed, but billing and payment for that work is determined by certain contractual milestones, whereas unbilled receivables are billable upon the passage of time. While CDD attempts to negotiate terms that provide for billing and payment of services prior or in close proximity to the provision of services, this is not always possible and there are fluctuations in the level of unbilled services and unearned revenue from period to period. The following table provides information about receivables, unbilled services, and unearned revenue (contract liabilities) from contracts with customers for CDD.</span></div><div style="margin-bottom:8pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, which are included in accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">771.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized during the period, that were included in the unearned revenue balance at the beginning of the period for the nine months ended September&#160;30, 2020, and September&#160;30, 2019, were $237.2 and $232.8, respectively. </span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Loss Rollforward</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the adoption of the current expected credit loss standard in 2020, the Company estimates future expected losses on accounts receivable, unbilled services and notes receivable over the remaining collection period of the instrument. The rollforward for the allowance for credit losses for the nine months ended September 30, 2020, is as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:52.938%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.153%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accounts Receivable</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unbilled Services</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Note and Other Receivables</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current expected credit losses opening balance impact on retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus, credit loss expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less, write offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending allowance for credit losses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes and other receivables includes the $110.0 due 2022 from the Envigo transaction which is recorded in Other assets, net. During the three months ended September 30, 2020, the Company recorded an impairment for a note receivable related to an LCD investment of $0.7.</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Obligations Under Long-Term Contracts</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term contracts at the Company consist primarily of fully managed clinical studies within CDD. The amount of existing performance obligations under such long-term contracts unsatisfied as of September&#160;30, 2020, was $4,795.0. The Company expects to recognize approximately 32% of the remaining performance obligations as of September&#160;30, 2020, as revenue over the next 12 months, and the balance thereafter. The Company's long-term contracts generally range from 1 to 8 years.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within CDD, revenues of $44.8 and $67.7 were recognized during the nine months ended September&#160;30, 2020, and 2019, respectively, from performance obligations that were satisfied in previous periods. This revenue comes from adjustments related to changes in scope and estimates in full service clinical studies.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074954223752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliation of Basic earnings per Share to Diluted Earnings per Share</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents a reconciliation of basic earnings per share to diluted earnings per share:</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.309%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.309%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.309%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.309%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.349%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Per Share Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Per Share Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earning</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Per Share Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Per Share Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">703.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">220.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">617.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">596.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.08&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dilutive effect of employee&#160;stock options and awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings including impact of dilutive adjustments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">703.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98.1&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">220.7&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98.3&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">617.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">596.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.04&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Potential common shares not included in computation of diluted earnings per share</a></td>
<td class="text">The following table summarizes the potential common shares not included in the computation of diluted earnings per share because their impact would have been antidilutive:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.087%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock options and awards</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074955604616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING AND OTHER SPECIAL CHARGES Restructuring and Other Special Charges Detail (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</a></td>
<td class="text"><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents the Company&#8217;s restructuring reserve activities for the period indicated:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"/><td style="width:40.763%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.692%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.775%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.692%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.775%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.747%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LCD</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CDD</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and Other Employee Costs</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and Other Employee Costs</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of lab facility and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074955594344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in Carrying Amount of Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the nine months ended September&#160;30, 2020, are as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LCD</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CDD</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,721.5&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,143.5&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,865.0&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(418.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(422.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency impact and other adjustments to goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,781.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,832.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,613.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Intangible Assets and Goodwill [Table Text Block]</a></td>
<td class="text"><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of identifiable intangible assets are as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:25.439%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.043%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.043%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.043%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.048%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,530.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,473.1)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,057.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,441.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,329.5)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,112.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents, licenses and technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(245.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(235.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(219.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land use right</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canadian licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,953.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,032.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,920.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,885.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,851.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,034.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074956705624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock', window );">Company's population of financial assets and liabilities subject to fair value measurements</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s population of financial assets and liabilities subject to fair value measurements as of September&#160;30, 2020, and December&#160;31, 2019, is as follows:</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:37.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.665%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.101%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Measurements as of</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value<br/>as of</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Using Fair Value Hierarchy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest put</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:36.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.458%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.194%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.138%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Measurements as of</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value<br/>as of</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Using Fair Value Hierarchy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest put</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Measurement of Level 3 Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).  Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074957268280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS ACQUISITIONS Business Acquisitions Tables (Tables)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Business Acquisition, Pro Forma Information [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Information </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Had the Company's total 2019 and 2020 acquisitions been completed as of January 1, 2018, or January 1, 2019, respectively, the Company's pro forma results would have been as follows:</span><span style="color:#0094ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.991%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,899.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,969.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,524.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,827.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Laboratory Corporation of America Holdings</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:26.465%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.641%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.646%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount of hedged liabilities as of</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Liabilities as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance Sheet Line Item in which Hedged Items are Included</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion, long term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final valuation of acquired assets and assumed liabilities in the transaction as of June 3, 2019, include the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:81.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.371%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consideration Transferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration</span></td><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of CRP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Final <br/>June 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Assets Acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name and trademarks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Envigo assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating rate secured note receivable due 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074954263368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract', window );"><strong>Segment Reconciliation of Operating Income to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.407%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues:</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LCD</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,704.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,759.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,098.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,242.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CDD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,175.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,479.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,376.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intercompany eliminations and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90.0)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,896.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,928.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,488.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,601.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating earnings (loss):</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LCD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">964.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,451.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CDD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,152.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating expenses, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net earnings attributable to the noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings attributable to Laboratory Corporation of America Holdings</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment Reconciliation of Operating Income to Consolidated [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074956335224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock', window );">Financing Receivable, Allowance for Credit Loss [Table Text Block]</a></td>
<td class="text">The rollforward for the allowance for credit losses for the nine months ended September 30, 2020, is as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:52.938%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.153%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accounts Receivable</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unbilled Services</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Note and Other Receivables</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current expected credit losses opening balance impact on retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus, credit loss expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less, write offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending allowance for credit losses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Contract with Customer, Asset and Liability [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, which are included in accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">771.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues by segment payers/customer groups for the three and nine months ended September&#160;30, 2020, and 2019, were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:23.936%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.856%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.856%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.856%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.712%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Canada</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United Kingdom</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Switzerland</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payer/Customer</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">LCD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Clients</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Patients</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Medicare and Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Third-party</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Total LCD revenues by payer</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">CDD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Biopharmaceutical and medical device companies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:24.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.875%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Canada</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United Kingdom</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Switzerland</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payer/Customer</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">LCD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Clients</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Patients</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Medicare and Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Third-party</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Total LCD revenues by payer</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">CDD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Biopharmaceutical and medical device companies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:24.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.875%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Canada</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United Kingdom</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Switzerland</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payer/Customer</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">LCD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Clients</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Patients</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Medicare and Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Third-party</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Total LCD revenues by payer</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">CDD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Biopharmaceutical and medical device companies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:24.229%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.856%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.856%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.856%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.859%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Canada</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United Kingdom</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Switzerland</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payer/Customer</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">LCD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Clients</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Patients</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Medicare and Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Third-party</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Total LCD revenues by payer</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">CDD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Biopharmaceutical and medical device companies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostTableTextBlock', window );">Capitalized Contract Cost [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:60.720%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.136%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.110%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales commission assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract fulfillment costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=SL6953423-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost capitalized in obtaining or fulfilling contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68051541&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074955395208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">Supplemental Cash Flow Information</a></td>
<td class="text">SUPPLEMENTAL CASH FLOW INFORMATION<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.960%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental schedule of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during period for:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 24.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 24.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes, net of refunds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosure of non-cash financing and investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion of zero-coupon convertible debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in accrued property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 11.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating rate secured note receivable due 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI http://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074963606552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF FINANCIAL STATEMENT PRESENTATION (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset Impairment Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 460,900,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,896,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,928,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,488,700,000<span></span>
</td>
<td class="nump">8,601,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,336,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,111,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,440,800,000<span></span>
</td>
<td class="nump">6,169,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">492,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">492,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 449,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredSalesCommissions', window );">Amortization of Deferred Sales Commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,800,000<span></span>
</td>
<td class="nump">15,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Assets, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,085,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,085,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,981,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Provided by (Used in) Operating Activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,360,700,000<span></span>
</td>
<td class="nump">$ 874,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 419,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 401,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,211,300,000<span></span>
</td>
<td class="nump">$ 1,210,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Nonoperating Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(52,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(175,700,000)<span></span>
</td>
<td class="num">(181,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">243,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">358,000,000.0<span></span>
</td>
<td class="nump">214,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">703,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">221,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">618,400,000<span></span>
</td>
<td class="nump">597,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 703,400,000<span></span>
</td>
<td class="nump">$ 231,600,000<span></span>
</td>
<td class="num">$ (317,200,000)<span></span>
</td>
<td class="nump">$ 220,700,000<span></span>
</td>
<td class="nump">$ 190,400,000<span></span>
</td>
<td class="nump">$ 185,600,000<span></span>
</td>
<td class="nump">$ 617,800,000<span></span>
</td>
<td class="nump">$ 596,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per common share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.35<span></span>
</td>
<td class="nump">$ 6.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per common share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.31<span></span>
</td>
<td class="nump">$ 6.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash Provided by (Used in) Investing Activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (515,200,000)<span></span>
</td>
<td class="num">$ (1,131,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net Cash Provided by (Used in) Financing Activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(516,400,000)<span></span>
</td>
<td class="nump">196,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="num">(6,300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,739,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,739,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,046,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Long-term debt, less current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,009,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,009,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,655,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_NoncontrollingInterestMezzanineEquity', window );">Common stock, 92.8 and 93.5 shares outstanding at March 31, 2013 and December 31, 2012, respectively</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,239,100,000<span></span>
</td>
<td class="nump">7,352,700,000<span></span>
</td>
<td class="nump">7,020,100,000<span></span>
</td>
<td class="nump">$ 7,231,100,000<span></span>
</td>
<td class="nump">7,144,400,000<span></span>
</td>
<td class="nump">7,111,300,000<span></span>
</td>
<td class="nump">8,239,100,000<span></span>
</td>
<td class="nump">7,231,100,000<span></span>
</td>
<td class="nump">7,567,000,000.0<span></span>
</td>
<td class="nump">$ 6,971,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Liabilities and Equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,739,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,739,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,046,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Capitalized Contract Cost, Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,600,000<span></span>
</td>
<td class="nump">6,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueRevenueRecognized1', window );">Deferred Revenue, Revenue Recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">237,200,000<span></span>
</td>
<td class="nump">232,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,795,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,795,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod', window );">Contract with Customer, Performance Obligation Satisfied in Previous Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,800,000<span></span>
</td>
<td class="nump">67,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">422,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Other than Temporary Impairment Losses, Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_CashPaymentReceivedAppropriatedbyU.S.CongressCovid19', window );">Cash Payment Received Appropriated by U.S. Congress Covid-19</a></td>
<td class="nump">$ 55,900,000<span></span>
</td>
<td class="nump">76,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_CARESActFundsAccruedLiabilitiesAndOtherLiabilities', window );">CARES Act Funds Accrued Liabilities And Other Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairment', window );">COVID-19 Pandemic Goodwill and Intangible Asset Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 437,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_CostMethodInvestmentsMaximumOwnershipPercentage', window );">Ownership percentage below which investments are generally accounted for on the cost method (in thousandths)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,704,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,759,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,098,800,000<span></span>
</td>
<td class="nump">$ 5,242,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63.00%<span></span>
</td>
<td class="nump">61.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of Intangible Assets (Excluding Goodwill)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember', window );">Covance Drug Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,241,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,175,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,479,400,000<span></span>
</td>
<td class="nump">$ 3,376,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 418,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=lh_EquityMethodIncomeLossNetDomain', window );">Equity Method Income (Loss), Net [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Other than Temporary Impairment Losses, Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other Nonoperating Income (Expense) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Other than Temporary Impairment Losses, Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,200,000<span></span>
</td>
<td class="nump">13,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 703,400,000<span></span>
</td>
<td class="nump">231,600,000<span></span>
</td>
<td class="num">(317,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">190,400,000<span></span>
</td>
<td class="nump">185,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,464,000,000.0<span></span>
</td>
<td class="nump">$ 7,760,600,000<span></span>
</td>
<td class="nump">$ 7,529,000,000.0<span></span>
</td>
<td class="nump">$ 7,676,500,000<span></span>
</td>
<td class="nump">$ 7,455,800,000<span></span>
</td>
<td class="nump">$ 7,265,400,000<span></span>
</td>
<td class="nump">$ 8,464,000,000.0<span></span>
</td>
<td class="nump">$ 7,676,500,000<span></span>
</td>
<td class="nump">$ 7,903,600,000<span></span>
</td>
<td class="nump">$ 7,079,800,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CARESActFundsAccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>CARES Act Funds Accrued Liabilities And Other Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CARESActFundsAccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_COVID19PandemicGoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>COVID-19 Pandemic Goodwill and Intangible Asset Impairment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_COVID19PandemicGoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CashPaymentReceivedAppropriatedbyU.S.CongressCovid19">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Payment Received Appropriated by U.S. Congress Covid-19</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CashPaymentReceivedAppropriatedbyU.S.CongressCovid19</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CostMethodInvestmentsMaximumOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the maximum ownership percentage of cost-method investments held by the Company. Generally, such investments do not have readily determinable fair values and are not required to be accounted for by the equity method. The carrying amount of such securities equates to cost, adjusted for other-than-temporary impairment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CostMethodInvestmentsMaximumOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_NoncontrollingInterestMezzanineEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents contractual value of a noncontrolling interest put (includes underlying noncontrolling interest). In February 2010, the Company completed a transaction to sell the partnership units acquired from the previous noncontrolling interest holder to a new Canadian partner. As a result of this transaction, the Company recorded a component of noncontrolling interest in liabilities and a component in mezzanine equity. This item represents the mezzanine equity component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_NoncontrollingInterestMezzanineEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_PercentofRevenueContributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percent of Revenue Contributed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_PercentofRevenueContributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredSalesCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period for the periodic realization of capitalized fees that were paid to salespeople, distributors, brokers, and agents at the time of the conclusion of the sale. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredSalesCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68051541&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12A<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL108322424-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueRevenueRecognized1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously reported as deferred or unearned revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueRevenueRecognized1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=lh_EquityMethodIncomeLossNetDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=lh_EquityMethodIncomeLossNetDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074959008408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Reconciliation of Basic Earnings Per Share to Diluted Earnings Per Share) (Details) - USD ($)<br> $ / shares in Units, shares in Millions</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_IncomeAbstract', window );"><strong>Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Laboratory Corporation of America Holdings</a></td>
<td class="nump">$ 703,400,000<span></span>
</td>
<td class="nump">$ 231,600,000<span></span>
</td>
<td class="num">$ (317,200,000)<span></span>
</td>
<td class="nump">$ 220,700,000<span></span>
</td>
<td class="nump">$ 190,400,000<span></span>
</td>
<td class="nump">$ 185,600,000<span></span>
</td>
<td class="nump">$ 617,800,000<span></span>
</td>
<td class="nump">$ 596,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_SharesAbstract', window );"><strong>Shares [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Net earnings, basic (in shares)</a></td>
<td class="nump">97.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.3<span></span>
</td>
<td class="nump">98.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of employee stock options and awards, (in shares)</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PerShareAmountAbstract', window );"><strong>Per Share Amount [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per common share (in dollars per share)</a></td>
<td class="nump">$ 7.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.35<span></span>
</td>
<td class="nump">$ 6.08<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per common share (in dollars per share)</a></td>
<td class="nump">$ 7.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.31<span></span>
</td>
<td class="nump">$ 6.04<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net Income (Loss) Available to Common Stockholders, Diluted</a></td>
<td class="nump">$ 703,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 220,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 617,800,000<span></span>
</td>
<td class="nump">$ 596,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Number of Shares Outstanding, Diluted</a></td>
<td class="nump">98.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.9<span></span>
</td>
<td class="nump">98.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_IncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_IncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_PerShareAmountAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_PerShareAmountAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_SharesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_SharesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074958328392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Potential common shares not included in computation of diluted earnings per share) (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Stock options (in shares)</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074957387096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING AND OTHER SPECIAL CHARGES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">$ 10,400,000<span></span>
</td>
<td class="nump">$ 13,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="nump">24,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_RestructuringReserveSettledWithCashAndOtherAdjustment', window );">Restructuring Reserve Settled With Cash And Other Adjustment</a></td>
<td class="num">(50,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_NetRestructuringCharges', window );">Net restructuring charges</a></td>
<td class="nump">38,900,000<span></span>
</td>
<td class="nump">48,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Restructuring charges related to severance and other employee costs</a></td>
<td class="nump">12,800,000<span></span>
</td>
<td class="nump">26,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetImpairmentCharges', window );">Other Asset Impairment Charges</a></td>
<td class="nump">11,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Restructuring charges related to contractual obligations associated with leased facilities and other facility related costs</a></td>
<td class="nump">24,000,000.0<span></span>
</td>
<td class="nump">22,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment', window );">Employee Severance Benefits Related Restructuring Reserve Accrual Adjustment</a></td>
<td class="num">(1,100,000)<span></span>
</td>
<td class="num">(400,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_RestructuringImpairment', window );">Asset Impairment Charges</a></td>
<td class="nump">23,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_Unusedfacilityrestructuringreserves', window );">Unused facility restructuring reserves</a></td>
<td class="num">(7,800,000)<span></span>
</td>
<td class="num">(200,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveCurrent', window );">Restructuring Reserve, Current</a></td>
<td class="nump">8,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveNoncurrent', window );">Restructuring Reserve, Noncurrent</a></td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember', window );">Covance Drug Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_NetRestructuringCharges', window );">Net restructuring charges</a></td>
<td class="nump">25,500,000<span></span>
</td>
<td class="nump">25,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember', window );">Covance Drug Development [Member] | Employee Severance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">4,000,000.0<span></span>
</td>
<td class="nump">5,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="nump">8,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_RestructuringReserveSettledWithCashAndOtherAdjustment', window );">Restructuring Reserve Settled With Cash And Other Adjustment</a></td>
<td class="num">(10,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_RestructuringImpairment', window );">Asset Impairment Charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember', window );">Covance Drug Development [Member] | Facility Closing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">4,900,000<span></span>
</td>
<td class="nump">4,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="nump">6,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_RestructuringReserveSettledWithCashAndOtherAdjustment', window );">Restructuring Reserve Settled With Cash And Other Adjustment</a></td>
<td class="num">(23,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_RestructuringImpairment', window );">Asset Impairment Charges</a></td>
<td class="nump">17,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_NetRestructuringCharges', window );">Net restructuring charges</a></td>
<td class="nump">13,400,000<span></span>
</td>
<td class="nump">22,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Employee Severance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="nump">3,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_RestructuringReserveSettledWithCashAndOtherAdjustment', window );">Restructuring Reserve Settled With Cash And Other Adjustment</a></td>
<td class="num">(4,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_RestructuringImpairment', window );">Asset Impairment Charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Facility Closing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">$ 2,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="nump">5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_RestructuringReserveSettledWithCashAndOtherAdjustment', window );">Restructuring Reserve Settled With Cash And Other Adjustment</a></td>
<td class="num">(12,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_RestructuringImpairment', window );">Asset Impairment Charges</a></td>
<td class="nump">$ 5,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of any reversal and other adjustment made during the period to the amount of a previously accrued liability for employee severance benefits related restructuring costs, excluding adjustments for costs incurred during the period, costs settled during the period, and foreign currency translation adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_NetRestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against earnings in the period for incurred and estimated costs, excluding asset retirement obligations, associated with exit from or disposal of business activities or restructurings pursuant to a program that is planned and controlled by management, and changes either scope of business by an entity, or manner business is conducted. May include amount of reversals and other adjustments during the period to amounts of previously accrued liabilities for specified types of restructuring costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_NetRestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_RestructuringImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring Impairment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_RestructuringImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_RestructuringReserveSettledWithCashAndOtherAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid and/or consideration other than cash paid in the period to fully or partially settle a specified, previously accrued type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_RestructuringReserveSettledWithCashAndOtherAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Unusedfacilityrestructuringreserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unused facility restructuring reserves</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Unusedfacilityrestructuringreserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessExitCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessExitCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074959728040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING RESERVES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_Unusedfacilityrestructuringreserves', window );">Unused facility restructuring reserves</a></td>
<td class="nump">$ 7,800,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, beginning of period</a></td>
<td class="nump">13,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">24,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_RestructuringReserveSettledWithCashAndOtherAdjustment', window );">Cash payments and other adjustments</a></td>
<td class="num">(50,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, end of period</a></td>
<td class="nump">10,400,000<span></span>
</td>
<td class="nump">13,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveCurrent', window );">Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveNoncurrent', window );">Non-current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Total Restructuring Reserve</a></td>
<td class="nump">10,400,000<span></span>
</td>
<td class="nump">13,400,000<span></span>
</td>
<td class="nump">10,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment', window );">Employee Severance Benefits Related Restructuring Reserve Accrual Adjustment</a></td>
<td class="nump">1,100,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Severance and Other Employee Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, beginning of period</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">3,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_RestructuringReserveSettledWithCashAndOtherAdjustment', window );">Cash payments and other adjustments</a></td>
<td class="num">(4,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, end of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Total Restructuring Reserve</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Lease and Other Facility Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, beginning of period</a></td>
<td class="nump">2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_RestructuringReserveSettledWithCashAndOtherAdjustment', window );">Cash payments and other adjustments</a></td>
<td class="num">(12,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, end of period</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Total Restructuring Reserve</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember', window );">Covance Drug Development [Member] | Severance and Other Employee Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, beginning of period</a></td>
<td class="nump">5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">8,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_RestructuringReserveSettledWithCashAndOtherAdjustment', window );">Cash payments and other adjustments</a></td>
<td class="num">(10,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, end of period</a></td>
<td class="nump">4,000,000.0<span></span>
</td>
<td class="nump">5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Total Restructuring Reserve</a></td>
<td class="nump">4,000,000.0<span></span>
</td>
<td class="nump">5,500,000<span></span>
</td>
<td class="nump">4,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember', window );">Covance Drug Development [Member] | Lease and Other Facility Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, beginning of period</a></td>
<td class="nump">4,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">6,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_RestructuringReserveSettledWithCashAndOtherAdjustment', window );">Cash payments and other adjustments</a></td>
<td class="num">(23,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, end of period</a></td>
<td class="nump">4,900,000<span></span>
</td>
<td class="nump">4,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Total Restructuring Reserve</a></td>
<td class="nump">$ 4,900,000<span></span>
</td>
<td class="nump">$ 4,700,000<span></span>
</td>
<td class="nump">$ 4,900,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of any reversal and other adjustment made during the period to the amount of a previously accrued liability for employee severance benefits related restructuring costs, excluding adjustments for costs incurred during the period, costs settled during the period, and foreign currency translation adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_RestructuringReserveSettledWithCashAndOtherAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid and/or consideration other than cash paid in the period to fully or partially settle a specified, previously accrued type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_RestructuringReserveSettledWithCashAndOtherAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Unusedfacilityrestructuringreserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unused facility restructuring reserves</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Unusedfacilityrestructuringreserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140075040043176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Changes in Carrying Amount of Goodwill) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles and other assets</a></td>
<td class="nump">$ 62,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61,700,000<span></span>
</td>
<td class="nump">$ 184,600,000<span></span>
</td>
<td class="nump">$ 179,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">5,953,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,953,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,885,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance as of January 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,865,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,865,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Adjustments to goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at end of period</a></td>
<td class="nump">7,613,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,613,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,865,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">2,032,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,032,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,851,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">3,920,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,920,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,034,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">422,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">139,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance as of January 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,721,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,721,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Adjustments to goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at end of period</a></td>
<td class="nump">3,781,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,781,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,721,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentageFairValueofGoodwillExceededCarryingValue', window );">Percentage Fair Value of Goodwill Exceeded Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill', window );">Percentage Change in Discount Rate Used to Calculate Fair Value of Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit', window );">Value of Goodwill Impairment Following a Percentage Change in the Discount Rate Used to Calculate Goodwill for Reporting Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of Intangible Assets (Excluding Goodwill)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue', window );">Value of Reporting Units Goodwill Fair Value Exceeds Carrying Value</a></td>
<td class="nump">86.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember', window );">Covance Drug Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance as of January 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,143,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,143,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Adjustments to goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at end of period</a></td>
<td class="nump">3,832,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,832,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,143,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">418,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentageFairValueofGoodwillExceededCarryingValue', window );">Percentage Fair Value of Goodwill Exceeded Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit', window );">Percent Change in Discount Rate Used to Calculate Fair Value of Goodwill for Reporting Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit', window );">Percent of Fair Value Exceeding Carrying Value Post Percent Change in Discount Rate Used to Calculate Fair Value of Goodwill for Reporting Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_ValueofReportingUnitsGoodwillFollowingImpairment', window );">Value of Reporting Unit's Goodwill Following Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,627,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue', window );">Value of Reporting Units Goodwill Fair Value Exceeds Carrying Value</a></td>
<td class="nump">646,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">646,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">4,530,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,530,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,441,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">1,473,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,473,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,329,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">3,057,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,057,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,112,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=lh_PatentsLicensesAndTechnologyMember', window );">Patents, Licenses And Technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">427,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">427,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">453,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">245,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">245,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">182,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">217,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">105,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">67,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">37,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">410,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">410,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">408,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">240,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">219,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">170,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_UseRightsMember', window );">Use Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">10,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">6,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Canadian licenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">468,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">468,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">480,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">$ 468,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 468,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 480,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member] | Covance Drug Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of Intangible Assets (Excluding Goodwill)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percent Change in Discount Rate Used to Calculate Fair Value of Goodwill for Reporting Unit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage Change in Discount Rate Used to Calculate Fair Value of Goodwill</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_PercentageFairValueofGoodwillExceededCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage Fair Value of Goodwill Exceeded Carrying Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_PercentageFairValueofGoodwillExceededCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percent of Fair Value Exceeding Carrying Value Post Percent Change in Discount Rate Used to Calculate Fair Value of Goodwill for Reporting Unit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of Goodwill Impairment Following a Percentage Change in the Discount Rate Used to Calculate Goodwill for Reporting Unit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of Reporting Units Goodwill Fair Value Exceeds Carrying Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ValueofReportingUnitsGoodwillFollowingImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of Reporting Unit's Goodwill Following Impairment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ValueofReportingUnitsGoodwillFollowingImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=lh_PatentsLicensesAndTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=lh_PatentsLicensesAndTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_UseRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_UseRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074956248264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Components of identifiable intangible assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">$ 5,953.1<span></span>
</td>
<td class="nump">$ 5,885.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(2,032.6)<span></span>
</td>
<td class="num">(1,851.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">3,920.5<span></span>
</td>
<td class="nump">4,034.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">4,530.7<span></span>
</td>
<td class="nump">4,441.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(1,473.1)<span></span>
</td>
<td class="num">(1,329.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">3,057.6<span></span>
</td>
<td class="nump">3,112.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=lh_PatentsLicensesAndTechnologyMember', window );">Patents, Licenses And Technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">427.7<span></span>
</td>
<td class="nump">453.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(245.3)<span></span>
</td>
<td class="num">(235.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">182.4<span></span>
</td>
<td class="nump">217.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">105.3<span></span>
</td>
<td class="nump">90.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(67.6)<span></span>
</td>
<td class="num">(60.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">37.7<span></span>
</td>
<td class="nump">30.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">410.2<span></span>
</td>
<td class="nump">408.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(240.1)<span></span>
</td>
<td class="num">(219.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">170.1<span></span>
</td>
<td class="nump">188.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_UseRightsMember', window );">Use Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">10.8<span></span>
</td>
<td class="nump">10.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(6.5)<span></span>
</td>
<td class="num">(5.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">4.3<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Canadian licenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">468.4<span></span>
</td>
<td class="nump">480.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">$ 468.4<span></span>
</td>
<td class="nump">$ 480.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=lh_PatentsLicensesAndTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=lh_PatentsLicensesAndTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_UseRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_UseRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074959173320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">$ 5,953,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,953,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,885,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">7,613,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,613,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,865,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles and other assets</a></td>
<td class="nump">62,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61,700,000<span></span>
</td>
<td class="nump">184,600,000<span></span>
</td>
<td class="nump">$ 179,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">422,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">62,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61,700,000<span></span>
</td>
<td class="nump">184,600,000<span></span>
</td>
<td class="nump">$ 179,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Finite-Lived Intangible Assets, Future Amortization Expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Estimated amortization expense, 2012</a></td>
<td class="nump">60,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Estimated amortization expense, 2013</a></td>
<td class="nump">238,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">238,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Estimated amortization expense, 2014</a></td>
<td class="nump">232,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Estimated amortization expense, 2015</a></td>
<td class="nump">229,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">229,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Estimated amortization expense, 2016</a></td>
<td class="nump">224,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Estimated amortization expense, Thereafter</a></td>
<td class="nump">2,380,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,380,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,781,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,781,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,721,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit', window );">Value of Goodwill Impairment Following a Percentage Change in the Discount Rate Used to Calculate Goodwill for Reporting Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of Intangible Assets (Excluding Goodwill)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_Impairmentoffloatingratenotereceivable', window );">impairment of floating rate note receivable</a></td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember', window );">Covance Drug Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,832,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,832,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,143,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 418,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member] | Covance Drug Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of Intangible Assets (Excluding Goodwill)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member] | Covance Drug Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">10,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology-Based Intangible Assets [Member] | Covance Drug Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">$ 17.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Impairmentoffloatingratenotereceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>impairment of floating rate note receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Impairmentoffloatingratenotereceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of Goodwill Impairment Following a Percentage Change in the Discount Rate Used to Calculate Goodwill for Reporting Unit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074958379224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Short-term borrowings and current portion of long-term debt) (Table) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jun. 03, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Line of Credit Facility, Fair Value of Amount Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 375.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Total short-term borrowings and current portion of long-term debt</a></td>
<td class="nump">$ 376.6<span></span>
</td>
<td class="nump">415.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_A2019TermLoan', window );">2019 Term Loan</a></td>
<td class="nump">$ 375.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">$ 850.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShortTermDebtTextBlock', window );">Short-term borrowings and current portion of long-term debt</a></td>
<td class="text"><div style="margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term borrowings and the current portion of long-term debt at September&#160;30, 2020, and December&#160;31, 2019, consisted of the following:</span></div><div style="margin-bottom:11pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625% senior notes due 2020</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Term Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of note payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term borrowings and current portion of long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2020Member', window );">Senior notes due 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2022Member', window );">Senior notes due 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior Notes, Noncurrent</a></td>
<td class="nump">$ 500.0<span></span>
</td>
<td class="nump">$ 500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A2019TermLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>2019 Term Loan</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A2019TermLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the amount outstanding under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorLongTermNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorLongTermNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074963534824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Long-term debt) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Long-term Debt [Text Block]</a></td>
<td class="text"><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt at September&#160;30, 2020, and December&#160;31, 2019, consisted of the following:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.20% senior notes due 2022</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75% senior notes due 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00% senior notes due 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25% senior notes due 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30% senior notes due 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.60% senior notes due 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.60% senior notes due 2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.95% senior notes due 2029</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.70% senior notes due 2045</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Term Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,417.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,789.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">$ 5,417.3<span></span>
</td>
<td class="nump">$ 5,789.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Line of Credit Facility, Fair Value of Amount Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="nump">1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_CreditFacilityOptiontoIncrease', window );">Credit Facility Option to Increase</a></td>
<td class="nump">350.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_CreditFacilityMaximumSwingLineBorrowings', window );">Credit Facility, Maximum Swing Line Borrowings</a></td>
<td class="nump">100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">6.1<span></span>
</td>
<td class="nump">7.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_A2019TermLoanMember', window );">2019 Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Line of Credit Facility, Fair Value of Amount Outstanding</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2020Member', window );">Senior notes due 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate percentage</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2022Member', window );">Senior notes due 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">$ 500.0<span></span>
</td>
<td class="nump">500.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior Notes, Noncurrent</a></td>
<td class="nump">500.0<span></span>
</td>
<td class="nump">500.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2023Member', window );">Senior notes due 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">300.0<span></span>
</td>
<td class="nump">300.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2025MemberMember', window );">Senior notes due 2025 [Member] [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">1,000.0<span></span>
</td>
<td class="nump">1,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2045Member', window );">Senior notes due 2045 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">900.0<span></span>
</td>
<td class="nump">$ 900.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_CreditFacilityMaximumLettersofCredit', window );">Credit Facility, Maximum Letters of Credit</a></td>
<td class="nump">$ 150.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember', window );">Prime Rate [Member] | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDescription', window );">Line of Credit Facility, Interest Rate Description</a></td>
<td class="text">0.00% to 0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=lh_A2019TermLoanMember', window );">2019 Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt Instrument, Interest Rate, Effective Percentage</a></td>
<td class="nump">0.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CreditFacilityMaximumLettersofCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Credit Facility, Maximum Letters of Credit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CreditFacilityMaximumLettersofCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CreditFacilityMaximumSwingLineBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Credit Facility, Maximum Swing Line Borrowings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CreditFacilityMaximumSwingLineBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CreditFacilityOptiontoIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Credit Facility Option to Increase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CreditFacilityOptiontoIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the amount outstanding under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the interest rate for the amounts borrowed under the credit facility, including the terms and the method for determining the interest rate (for example, fixed or variable, LIBOR plus a percentage, increasing rate, timing of interest rate resets, remarketing provisions).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorLongTermNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorLongTermNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_A2019TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_A2019TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2025MemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2025MemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2045Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2045Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_PrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=lh_A2019TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=lh_A2019TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074956369848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT (Senior Notes) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_Shorttermdebtissuancecosts', window );">Short term debt issuance costs</a></td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">5,417.3<span></span>
</td>
<td class="nump">5,789.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="nump">1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_CreditFacilityOptiontoIncrease', window );">Credit Facility Option to Increase</a></td>
<td class="nump">350.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_CreditFacilityMaximumSwingLineBorrowings', window );">Credit Facility, Maximum Swing Line Borrowings</a></td>
<td class="nump">100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueHedgesAtFairValueNet', window );">Fair Value Hedges, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Line of Credit Facility, Fair Value of Amount Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_Longtermdebtissuancecosts', window );">Long term debt issuance costs</a></td>
<td class="nump">38.8<span></span>
</td>
<td class="nump">42.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes Payable</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Debt, Current</a></td>
<td class="nump">376.6<span></span>
</td>
<td class="nump">415.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_A4.625Seniornotesdue2020', window );">4.625% Senior notes due 2020</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">413.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_A2.30seniornotesdue2024', window );">2.30% senior notes due 2024</a></td>
<td class="nump">400.0<span></span>
</td>
<td class="nump">400.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_A2.95seniornotesdue2029', window );">2.95% senior notes due 2029</a></td>
<td class="nump">650.0<span></span>
</td>
<td class="nump">650.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_BalanceOfSeniorNotesMatureDuringQ42020', window );">Senior Notes Became Due During Quarter</a></td>
<td class="nump">412.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2023Member', window );">Senior notes due 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">300.0<span></span>
</td>
<td class="nump">300.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2024MemberMember', window );">Senior notes due 2024 [Member] [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">600.0<span></span>
</td>
<td class="nump">600.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2027Member', window );">Senior notes due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">600.0<span></span>
</td>
<td class="nump">600.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2045Member', window );">Senior notes due 2045 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">900.0<span></span>
</td>
<td class="nump">$ 900.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_A2019TermLoanMember', window );">2019 Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Line of Credit Facility, Fair Value of Amount Outstanding</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2020Member', window );">Senior notes due 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate percentage</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A2.30seniornotesdue2024">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>2.30% senior notes due 2024</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A2.30seniornotesdue2024</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A2.95seniornotesdue2029">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>2.95% senior notes due 2029</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A2.95seniornotesdue2029</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A4.625Seniornotesdue2020">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>4.625% Senior notes due 2020</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A4.625Seniornotesdue2020</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_BalanceOfSeniorNotesMatureDuringQ42020">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Balance of Senior Notes Mature During Q4 2020</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_BalanceOfSeniorNotesMatureDuringQ42020</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CreditFacilityMaximumSwingLineBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Credit Facility, Maximum Swing Line Borrowings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CreditFacilityMaximumSwingLineBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CreditFacilityOptiontoIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Credit Facility Option to Increase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CreditFacilityOptiontoIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Longtermdebtissuancecosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long term debt issuance costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Longtermdebtissuancecosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Shorttermdebtissuancecosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Short term debt issuance costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Shorttermdebtissuancecosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueHedgesAtFairValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net fair value of all derivative instruments designated as fair value hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=117331979&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueHedgesAtFairValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the amount outstanding under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2024MemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2024MemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2045Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2045Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_A2019TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_A2019TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140075040051704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Credit Facilities) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>Rate</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 03, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_A2019TermLoan', window );">2019 Term Loan</a></td>
<td class="nump">$ 375.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_BalanceOfSeniorNotesMatureDuringQ42020', window );">Senior Notes Became Due During Quarter</a></td>
<td class="nump">412.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">667.2<span></span>
</td>
<td class="nump">337.5<span></span>
</td>
<td class="nump">$ 361.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 426.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">5,417.3<span></span>
</td>
<td class="nump">5,789.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Line of Credit Facility, Fair Value of Amount Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving Credit Facility, maximum borrowing capacity</a></td>
<td class="nump">1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes Payable</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Debt, Current</a></td>
<td class="nump">376.6<span></span>
</td>
<td class="nump">415.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_CreditFacilityOptiontoIncrease', window );">Credit Facility Option to Increase</a></td>
<td class="nump">350.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_CreditFacilityMaximumSwingLineBorrowings', window );">Credit Facility, Maximum Swing Line Borrowings</a></td>
<td class="nump">100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">6.1<span></span>
</td>
<td class="nump">7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2027Member', window );">Senior notes due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">600.0<span></span>
</td>
<td class="nump">600.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2024MemberMember', window );">Senior notes due 2024 [Member] [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">$ 600.0<span></span>
</td>
<td class="nump">600.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2020Member', window );">Senior notes due 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2045Member', window );">Senior notes due 2045 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">$ 900.0<span></span>
</td>
<td class="nump">900.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2022Member', window );">Senior notes due 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorLongTermNotes', window );">Senior Notes, Noncurrent</a></td>
<td class="nump">500.0<span></span>
</td>
<td class="nump">500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">$ 500.0<span></span>
</td>
<td class="nump">$ 500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=lh_TermLoanandRevolvingCreditFacilityMember', window );">Term Loan and Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021', window );">Debt to EBITDA (Leverage) Ratio Quarter Ending Thereafter March 31, 2021</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021', window );">Debt to EBITDA (Leverage) Ratio Quarter Ending 1 Year From Present</a></td>
<td class="nump">4.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=lh_A2019TermLoanMember', window );">2019 Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage', window );">Term Loan Accrue Interest per Annum at Libor Plus Margin Percentage | Rate</a></td>
<td class="nump">1.175%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage', window );">Term Loan Accrue Interest Per Annum Base Rate Plus Percentage | Rate</a></td>
<td class="nump">0.175%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Line of Credit Facility, Remaining Borrowing Capacity</a></td>
<td class="nump">$ 997.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_CreditFacilityMaximumLettersofCredit', window );">Credit Facility, Maximum Letters of Credit</a></td>
<td class="nump">$ 150.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Line of Credit Facility, Interest Rate at Period End | Rate</a></td>
<td class="nump">1.12%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage', window );">Revolving Credit Facility Accrue Interest per Annum at Libor Plus Margin Percentage | Rate</a></td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage', window );">Revolving Credit Facility Accrue Interest Per Annum Base Rate Plus Percentage | Rate</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments', window );">Revolving Credit Facility Fee Percentage Required to Pay on Outstanding Commitments | Rate</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Term Loan and Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020', window );">Debt to EBITDA (Leverage) Ratio Next Three Quarters</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember', window );">Prime Rate [Member] | 2019 Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDescription', window );">Line of Credit Facility, Interest Rate Description</a></td>
<td class="text">0.0% to 0.175%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember', window );">Prime Rate [Member] | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDescription', window );">Line of Credit Facility, Interest Rate Description</a></td>
<td class="text">0.00% to 0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">London Interbank Offered Rate (LIBOR) [Member] | 2019 Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDescription', window );">Line of Credit Facility, Interest Rate Description</a></td>
<td class="text">0.55% to 1.175%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A2019TermLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>2019 Term Loan</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A2019TermLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_BalanceOfSeniorNotesMatureDuringQ42020">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Balance of Senior Notes Mature During Q4 2020</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_BalanceOfSeniorNotesMatureDuringQ42020</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CreditFacilityMaximumLettersofCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Credit Facility, Maximum Letters of Credit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CreditFacilityMaximumLettersofCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CreditFacilityMaximumSwingLineBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Credit Facility, Maximum Swing Line Borrowings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CreditFacilityMaximumSwingLineBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CreditFacilityOptiontoIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Credit Facility Option to Increase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CreditFacilityOptiontoIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt to EBITDA (Leverage) Ratio Quarter Ending Thereafter March 31, 2021</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt to EBITDA (Leverage) Ratio Quarter Ending Through March 31, 2021</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt to EBITDA (Leverage) Ratio Through Period Ending December 31, 2020</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revolving Credit Facility Accrue Interest Per Annum Base Rate Plus Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revolving Credit Facility Accrue Interest per Annum at Libor Plus Margin Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revolving Credit Facility Fee Percentage Required to Pay on Outstanding Commitments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term Loan Accrue Interest Per Annum Base Rate Plus Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term Loan Accrue Interest per Annum at Libor Plus Margin Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the amount outstanding under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the interest rate for the amounts borrowed under the credit facility, including the terms and the method for determining the interest rate (for example, fixed or variable, LIBOR plus a percentage, increasing rate, timing of interest rate resets, remarketing provisions).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorLongTermNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorLongTermNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2024MemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2024MemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2045Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2045Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=lh_TermLoanandRevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=lh_TermLoanandRevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=lh_A2019TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=lh_A2019TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_PrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074959233208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased', window );">Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_CommonSharesIssuedRollforwardAbstract', window );"><strong>Rollforward of common shares issued</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock Repurchased During Period, Shares</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for Repurchase of Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100.0<span></span>
</td>
<td class="nump">$ 400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_OutstandingStockRepurchaseAuthorizationAbstract', window );"><strong>Rollforward of Share Repurchase Program</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_CommonStockRepurchaseAuthorizationOutstanding', window );">Outstanding common stock repurchase authorization, beginning balance</a></td>
<td class="nump">$ 900.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Purchase of common stock</a></td>
<td class="num">$ (100.0)<span></span>
</td>
<td class="num">$ (100.0)<span></span>
</td>
<td class="num">$ (199.9)<span></span>
</td>
<td class="num">$ (100.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_CommonSharesOutstandingRollforwardAbstract', window );"><strong>Common Shares Outstanding Rollforward [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares outstanding, beginning balance (in shares)</a></td>
<td class="nump">97.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_CommonSharesHeldInTreasuryRollforwardAbstract', window );"><strong>Rollforward of common shares held in treasury</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">265.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_CommonSharesIssuedRollforwardAbstract', window );"><strong>Rollforward of common shares issued</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares issued, beginning balance (in shares)</a></td>
<td class="nump">97.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans', window );">Commons Stock Issued During Period Shares Employee Stock Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Stock Repurchased and Retired During Period, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares issued, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">97.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_CommonSharesOutstandingRollforwardAbstract', window );"><strong>Common Shares Outstanding Rollforward [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans', window );">Commons Stock Issued During Period Shares Employee Stock Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Stock Repurchased and Retired During Period, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans', window );">Commons Stock Issued During Period Shares Employee Stock Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_CommonSharesHeldInTreasuryRollforwardAbstract', window );"><strong>Rollforward of common shares held in treasury</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Stock Repurchased and Retired During Period, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CommonSharesHeldInTreasuryRollforwardAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CommonSharesHeldInTreasuryRollforwardAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CommonSharesIssuedRollforwardAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CommonSharesIssuedRollforwardAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CommonSharesOutstandingRollforwardAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CommonSharesOutstandingRollforwardAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CommonStockRepurchaseAuthorizationOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The dollar amount of share (common shares) repurchase authorization approved by the Board of Directors which remains available to the Company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CommonStockRepurchaseAuthorizationOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issued during the period as a result of an employee stock purchase plan and/or stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_OutstandingStockRepurchaseAuthorizationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_OutstandingStockRepurchaseAuthorizationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074956370872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY - Accumulated Other Comprehensive Earnings (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</a></td>
<td class="text">The components of accumulated other comprehensive earnings (loss) are as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.885%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.813%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.334%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.120%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Benefit Plan Adjustments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Earnings (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285.4)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87.0)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(372.4)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year adjustments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Tax effect of adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(314.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment and Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other Comprehensive Income (Loss), before Reclassifications, before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_AccumulatedOtherComprehensiveEarningsRollForward', window );"><strong>Accumulated Other Comprehensive Earnings [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign Currency Translation Adjustments, Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(285.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax', window );">Other comprehensive income before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax', window );">Tax effect of adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign Currency Translation Adjustments, Ending balance</a></td>
<td class="num">$ (233.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(233.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Net Benefit Plan Adjustments, Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(87.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax', window );">Tax effect of adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Net Benefit Plan Adjustments, Ending balance</a></td>
<td class="num">(81.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(81.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Earnings, Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(372.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax', window );">Other comprehensive income before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Tax effect of adjustments</a></td>
<td class="num">(0.6)<span></span>
</td>
<td class="num">$ (0.9)<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
<td class="num">$ (2.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Earnings, Ending balance</a></td>
<td class="num">$ (314.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (314.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_AccumulatedOtherComprehensiveEarningsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Earnings [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_AccumulatedOtherComprehensiveEarningsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=116690757&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121605123&amp;loc=d3e30304-110892<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), before reclassification adjustments, related to increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074955694344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies', window );">Effective Income Tax Rate Reconciliation, Tax Contingency, Percent</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Gross unrecognized income tax benefits</a></td>
<td class="nump">$ 41.3<span></span>
</td>
<td class="nump">$ 31.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest and penalties related to unrecognized income tax benefits</a></td>
<td class="nump">$ 9.0<span></span>
</td>
<td class="nump">$ 5.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax contingencies. Includes, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074959899976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PENSION AND POSTRETIREMENT PLANS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_NonElectiveContribution', window );">Minimum non-elective contribution (NEC) % for the 401(K) plan (in hundredths)</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_DiscretionaryContributionPercentageMaximum', window );">Discretionary Contribution Percentage Maximum</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract', window );"><strong>Defined Benefit Plan and Postretirement Plan Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock', window );">Schedule of Pensions and Postretirement Plans</a></td>
<td class="text"><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect on operations for the Company Plan and the PEP is summarized as follows:</span></div><div style="margin-bottom:11pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.086%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost for administrative expenses</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on benefit obligation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amortization and deferral</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit plan costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Pension And Postretirement Plans</a></td>
<td class="text">PENSION AND POSTRETIREMENT PLANS<div style="margin-bottom:3pt;margin-top:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retirement Plans</span></div><div style="margin-bottom:7.1pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All employees eligible for the LCD defined-contribution retirement plan (LCD 401(k) Plan) receive a minimum 3% non-elective contribution (NEC) concurrent with each payroll period. Employees are not required to make a contribution to the LCD 401(k) Plan to receive the NEC. The NEC is non-forfeitable and vests immediately. The LCD 401(k) Plan also permits discretionary contributions by the Company of 1% to 3% of pay for eligible employees based on service. The Company incurred expense of $14.0 and $16.7 for the LCD 401(k) Plan during the three months ended September&#160;30, 2020, and 2019, respectively, and $41.4 and $48.9 during the nine months ended September&#160;30, 2020, and 2019, respectively.</span></div><div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the CDD U.S. employees are eligible to participate in the CDD 401(k) Plan, which is available on a voluntary basis and features a maximum 4.5% Company match, based upon a percentage of the employee&#8217;s contributions. The Company incurred expense of $21.0 and $18.2 for the Covance 401(k) plan during the three months ended September&#160;30, 2020, and 2019, respectively, and $64.8 and $56.0 during the nine months ended September&#160;30, 2020, and 2019, respectively.</span></div><div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains several other small 401(k) plans associated with companies acquired over the last several years. </span></div><div style="margin-bottom:3pt;margin-top:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pension Plans</span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a defined-benefit retirement plan (Company Plan) and a nonqualified supplemental retirement plan (PEP). Both plans have been closed to new participants since December 31, 2009. Employees participating in the Company Plan and PEP no longer earn service-based credits, but continue to earn investment credits.</span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company Plan covers substantially all LCD employees employed prior to December 31, 2009. The benefits to be paid under the Company Plan are based on years of credited service through December 31, 2009, interest credits and average compensation. The Company's policy is to fund the Company Plan with at least the minimum amount required by applicable regulations.</span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PEP covers a portion of the Company's senior management group. Prior to 2010, the PEP provided for the payment of the difference, if any, between the amount of any maximum limitation on annual benefit payments under the Employee Retirement Income Security Act of 1974 and the annual benefit that would be payable under the Company Plan but for such limitation. Effective January 1, 2010, employees participating in the PEP no longer earn service-based credits. The PEP is an unfunded plan.</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect on operations for the Company Plan and the PEP is summarized as follows:</span></div><div style="margin-bottom:11pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.086%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost for administrative expenses</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on benefit obligation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amortization and deferral</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit plan costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The service cost component of net periodic pension cost and net periodic post-retirement benefit cost is included in operating expenses with other employee compensation costs. The other components of net benefit cost, including amortization or prior service cost/credit and settlement and curtailment effects are included in other, net non-operating expenses. During the nine months ended September&#160;30, 2020, the Company made no contributions to the Company Plan. The related net pension obligation for the Company Plan and PEP was $92.6 and $93.4 as of September&#160;30, 2020, and December&#160;31, 2019, respectively.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Covance acquisition, the Company sponsors two defined benefit pension plans for the benefit of its employees at two U.K. subsidiaries (U.K. Plans) and one defined benefit pension plan for the benefit of its employees at a German subsidiary (German Plan), all of which are legacy plans of previously acquired companies. The U.K. Plans were closed to future accrual as of December 31, 2019. Benefit amounts for all three plans are based upon years of service and compensation; however, the U.K. Plans were based on service and compensation through December 31, 2019. The German Plan is unfunded while the U.K. Plans are funded. The Company&#8217;s funding policy has been to contribute annually a fixed percentage of the eligible employee's salary, and additional amounts, at least equal to the local statutory funding requirements.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Envigo acquisition, the Company assumed a defined benefit pension plan for the benefit of Envigo's U.K. employees (the Envigo Plan), which is a legacy plan of a company previously acquired by Envigo. The Envigo Plan is a funded plan that is closed to future accrual. The Company&#8217;s funding policy has been to contribute amounts at least equal to the local statutory funding requirements.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The related net pension obligation for these plans inclusive of the U.K. Plans, German Plan, and the Envigo Plan, was&#160;$85.4 and $99.1&#160;as of September&#160;30, 2020, and December&#160;31, 2019, respectively.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Defined Benefit Plan, Funded (Unfunded) Status of Plan</a></td>
<td class="num">$ (92.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (92.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (93.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_DefinedContributionPlanTotalExpense', window );">Defined Contribution Plan Total Expense</a></td>
<td class="nump">14.0<span></span>
</td>
<td class="nump">$ 16.7<span></span>
</td>
<td class="nump">41.4<span></span>
</td>
<td class="nump">$ 48.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionAndOtherPostretirementPlansCostsMember', window );">Pension and Other Postretirement Plans Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract', window );"><strong>Defined Benefit Plan and Postretirement Plan Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation', window );">Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation</a></td>
<td class="nump">85.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract', window );"><strong>Defined Benefit Plan and Postretirement Plan Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost for benefits earned</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">3.9<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost on benefit obligation</a></td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
<td class="nump">10.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(3.7)<span></span>
</td>
<td class="num">(3.7)<span></span>
</td>
<td class="num">(11.2)<span></span>
</td>
<td class="num">(11.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_NetDefinedBenefitPlanAmortizationAndDeferral', window );">Net amortization and deferral</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">7.2<span></span>
</td>
<td class="nump">8.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Defined benefit/postretirement plan costs</a></td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">8.3<span></span>
</td>
<td class="nump">10.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lh_CovanceMember', window );">Covance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Defined contribution retirement plan cost</a></td>
<td class="num">$ (21.0)<span></span>
</td>
<td class="num">$ (18.2)<span></span>
</td>
<td class="num">$ (64.8)<span></span>
</td>
<td class="num">$ (56.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DefinedContributionPlanTotalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Plan Total Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DefinedContributionPlanTotalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DiscretionaryContributionPercentageMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum discretionary contribution % by the company for eligible employees based on service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DiscretionaryContributionPercentageMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_NetDefinedBenefitPlanAmortizationAndDeferral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Defined Benefit Plan Amortization And Deferral</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_NetDefinedBenefitPlanAmortizationAndDeferral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_NonElectiveContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum non-elective contribution % by the company to all employees eligible for the defined contribution retirement plan. Contributions are concurrent with each payroll period and are non-forfeitable and vest immediately.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_NonElectiveContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of projected benefit obligation for defined benefit pension plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2439-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2410-114920<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionAndOtherPostretirementPlansCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionAndOtherPostretirementPlansCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lh_CovanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lh_CovanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074958253128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PENSION AND POSTRETIREMENT PLANS Defined Contribution Plans (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_NonElectiveContribution', window );">Non Elective Contribution</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_DiscretionaryContributionPercentageMinimum', window );">Discretionary Contribution Percentage Minimum</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_DefinedContributionPlanTotalExpense', window );">Defined Contribution Plan Total Expense</a></td>
<td class="nump">$ 14.0<span></span>
</td>
<td class="nump">$ 16.7<span></span>
</td>
<td class="nump">$ 41.4<span></span>
</td>
<td class="nump">$ 48.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_DiscretionaryContributionPercentageMaximum', window );">Discretionary Contribution Percentage Maximum</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lh_CovanceMember', window );">Covance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Defined Contribution Plan, Cost</a></td>
<td class="nump">$ 21.0<span></span>
</td>
<td class="nump">$ 18.2<span></span>
</td>
<td class="nump">$ 64.8<span></span>
</td>
<td class="nump">$ 56.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DefinedContributionPlanTotalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Plan Total Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DefinedContributionPlanTotalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DiscretionaryContributionPercentageMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum discretionary contribution % by the company for eligible employees based on service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DiscretionaryContributionPercentageMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DiscretionaryContributionPercentageMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discretionary contribution percentage by the company for eligible employees based on service, range minimum.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DiscretionaryContributionPercentageMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_NonElectiveContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum non-elective contribution % by the company to all employees eligible for the defined contribution retirement plan. Contributions are concurrent with each payroll period and are non-forfeitable and vest immediately.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_NonElectiveContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lh_CovanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lh_CovanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074956965768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 03, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_NumberofMeasurementFundsAvailableForParticipantElection', window );">Number of Measurement Funds Available For Participant Election</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts', window );">Noncontrolling interest puts</a></td>
<td class="nump">$ 15.4<span></span>
</td>
<td class="nump">$ 15.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_SeniorNotesFairValue', window );">Fair market value of senior notes</a></td>
<td class="nump">6,107.9<span></span>
</td>
<td class="nump">6,140.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">Notes Receivable, Fair Value Disclosure</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110.0<span></span>
</td>
<td class="nump">$ 110.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash Surrender Value, Fair Value Disclosure</a></td>
<td class="nump">82.9<span></span>
</td>
<td class="nump">80.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability', window );">Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability</a></td>
<td class="nump">81.0<span></span>
</td>
<td class="nump">76.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent Consideration Classified as Equity, Fair Value Disclosure</a></td>
<td class="nump">9.0<span></span>
</td>
<td class="nump">9.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueHedgesAtFairValueNet', window );">Fair Value Hedges, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</a></td>
<td class="nump">6.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_Contingentconsiderationadjustment', window );">Contingent consideration adjustment</a></td>
<td class="num">(2.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_Lh_BusinessCombinationContingentConsiderationArrangementsPayments', window );">lh_BusinessCombinationContingentConsiderationArrangementsPayments</a></td>
<td class="num">(4.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts', window );">Noncontrolling interest puts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash Surrender Value, Fair Value Disclosure</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability', window );">Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent Consideration Classified as Equity, Fair Value Disclosure</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueHedgesAtFairValueNet', window );">Fair Value Hedges, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts', window );">Noncontrolling interest puts</a></td>
<td class="nump">15.4<span></span>
</td>
<td class="nump">15.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash Surrender Value, Fair Value Disclosure</a></td>
<td class="nump">82.9<span></span>
</td>
<td class="nump">80.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability', window );">Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability</a></td>
<td class="nump">81.0<span></span>
</td>
<td class="nump">76.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent Consideration Classified as Equity, Fair Value Disclosure</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueHedgesAtFairValueNet', window );">Fair Value Hedges, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts', window );">Noncontrolling interest puts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash Surrender Value, Fair Value Disclosure</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability', window );">Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent Consideration Classified as Equity, Fair Value Disclosure</a></td>
<td class="nump">9.0<span></span>
</td>
<td class="nump">9.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueHedgesAtFairValueNet', window );">Fair Value Hedges, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Contingentconsiderationadjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent consideration adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Contingentconsiderationadjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents a certain statement of financial position liability caption which represents a class of liabilities, or which may include an individual liability, measured at fair value on a recurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Lh_BusinessCombinationContingentConsiderationArrangementsPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>lh_BusinessCombinationContingentConsiderationArrangementsPayments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Lh_BusinessCombinationContingentConsiderationArrangementsPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_NumberofMeasurementFundsAvailableForParticipantElection">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Measurement Funds Available For Participant Election</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_NumberofMeasurementFundsAvailableForParticipantElection</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_SeniorNotesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated fair value of the debt instrument (senior notes) at the balance-sheet date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_SeniorNotesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashSurrenderValueFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashSurrenderValueFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of contingent consideration in a business combination that is classified in shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueHedgesAtFairValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net fair value of all derivative instruments designated as fair value hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=117331979&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueHedgesAtFairValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of an agreement for an unconditional promise by the maker to pay the holder a definite sum of money at a future date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074958345592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1', window );">Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge</a></td>
<td class="num">$ (23,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (12,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">5,417,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,417,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,789,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">8,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueHedgeLiabilitiesAtFairValue', window );">Fair Value Hedge Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_GainInterestRateSwapArrangement', window );">Gain Interest Rate Swap Arrangement</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=lh_SeniorNotesDue2020Member', window );">Senior notes due 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShorttermDebtFairValue', window );">4.625% Senior notes due 2020</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">301,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">$ 7,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueHedgeAssetsAtFairValue', window );">Fair Value Hedge Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueHedgeLiabilitiesAtFairValue', window );">Fair Value Hedge Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss)</a></td>
<td class="num">(23,100,000)<span></span>
</td>
<td class="nump">18,800,000<span></span>
</td>
<td class="num">(12,000,000.0)<span></span>
</td>
<td class="nump">22,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueHedgeAssetsAtFairValue', window );">Fair Value Hedge Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueHedgeLiabilitiesAtFairValue', window );">Fair Value Hedge Liabilities</a></td>
<td class="nump">8,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2022Member', window );">Senior notes due 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">500,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_Crosscurrencyswapmaturing2022Member', window );">Cross currency swap maturing 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">300,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_Crosscurrencyswapmaturing2025Member', window );">Senior notes due 2025 [Member] [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">$ 300,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2020Member', window );">Senior notes due 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorLongTermNotesDue2020Member', window );">Senior Long Term Notes Due2020 Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2025MemberMember', window );">Senior notes due 2025 [Member] [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2027Member', window );">Senior notes due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">600,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">$ 8,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_GainInterestRateSwapArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain Interest Rate Swap Arrangement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_GainInterestRateSwapArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121577467&amp;loc=d3e76258-113986<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueHedgeAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of all derivative assets designated as fair value hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueHedgeAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueHedgeLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of all derivative liabilities designated as fair value hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueHedgeLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in other comprehensive income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShorttermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount of short-term debt existing as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShorttermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=lh_SeniorNotesDue2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=lh_SeniorNotesDue2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_Crosscurrencyswapmaturing2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_Crosscurrencyswapmaturing2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_Crosscurrencyswapmaturing2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_Crosscurrencyswapmaturing2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorLongTermNotesDue2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_SeniorLongTermNotesDue2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2025MemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2025MemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074964030936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS ACQUISITIONS Business Acquisitions in the Aggregate (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 03, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 139,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Business Acquisition, Pro Forma Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,899,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,969,000,000.0<span></span>
</td>
<td class="nump">9,524,200,000<span></span>
</td>
<td class="nump">$ 8,827,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,896,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,928,500,000<span></span>
</td>
<td class="nump">9,488,700,000<span></span>
</td>
<td class="nump">8,601,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">208,800,000<span></span>
</td>
<td class="nump">852,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,613,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,613,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,865,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Business Acquisition, Pro Forma Net Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">744,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224,300,000<span></span>
</td>
<td class="nump">666,300,000<span></span>
</td>
<td class="nump">612,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,047,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">339,900,000<span></span>
</td>
<td class="nump">1,152,200,000<span></span>
</td>
<td class="nump">993,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">Notes Receivable, Fair Value Disclosure</a></td>
<td class="nump">$ 110,000,000.0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,000,000.0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">110,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_Totalacquisitionconsiderationcashstocknotesetc.', window );">Total acquisition consideration (cash, stock, notes, etc.)</a></td>
<td class="nump">711,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 711,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Gain (Loss) on Disposition of Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember', window );">Covance Drug Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,241,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,175,400,000<span></span>
</td>
<td class="nump">3,479,400,000<span></span>
</td>
<td class="nump">3,376,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,832,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,832,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,143,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123,800,000<span></span>
</td>
<td class="num">(131,200,000)<span></span>
</td>
<td class="nump">277,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,704,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,759,200,000<span></span>
</td>
<td class="nump">6,098,800,000<span></span>
</td>
<td class="nump">5,242,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,781,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,781,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,721,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">964,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 262,200,000<span></span>
</td>
<td class="nump">1,451,500,000<span></span>
</td>
<td class="nump">843,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lh_OtheracquireesMember', window );">Other acquirees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,900,000<span></span>
</td>
<td class="nump">512,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">208,800,000<span></span>
</td>
<td class="nump">852,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,500,000<span></span>
</td>
<td class="nump">324,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lh_OtheracquireesMember', window );">Other acquirees [Member] | Covance Drug Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,400,000<span></span>
</td>
<td class="nump">205,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lh_OtheracquireesMember', window );">Other acquirees [Member] | LabCorp Diagnostics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,400,000<span></span>
</td>
<td class="nump">$ 647,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lh_OtheracquireesMember', window );">Other acquirees [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lh_OtheracquireesMember', window );">Other acquirees [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lh_EnvigoMember', window );">Envigo [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="nump">$ 601,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">Notes Receivable, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">745,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">601,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">376,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member] | Envigo [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member] | Envigo [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Totalacquisitionconsiderationcashstocknotesetc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total acquisition consideration (cash, stock, notes, etc.)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Totalacquisitionconsiderationcashstocknotesetc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of an agreement for an unconditional promise by the maker to pay the holder a definite sum of money at a future date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lh_OtheracquireesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lh_OtheracquireesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lh_EnvigoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lh_EnvigoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074959547608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS ACQUISITIONS DISPOSITIONS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="num">$ (667.2)<span></span>
</td>
<td class="num">$ (337.5)<span></span>
</td>
<td class="num">$ (361.1)<span></span>
</td>
<td class="num">$ (426.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts Receivable, after Allowance for Credit Loss, Current</a></td>
<td class="nump">2,095.2<span></span>
</td>
<td class="nump">1,543.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnbilledContractsReceivable', window );">Unbilled Contracts Receivable</a></td>
<td class="nump">603.5<span></span>
</td>
<td class="nump">481.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Supplies inventories</a></td>
<td class="nump">392.5<span></span>
</td>
<td class="nump">244.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">327.2<span></span>
</td>
<td class="nump">373.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">2,608.6<span></span>
</td>
<td class="nump">2,636.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">7,613.8<span></span>
</td>
<td class="nump">7,865.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">3,920.5<span></span>
</td>
<td class="nump">4,034.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets, net</a></td>
<td class="nump">437.0<span></span>
</td>
<td class="nump">435.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts Payable, Current</a></td>
<td class="nump">639.5<span></span>
</td>
<td class="nump">632.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued Liabilities, Current</a></td>
<td class="nump">1,297.8<span></span>
</td>
<td class="nump">942.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred Revenue, Current</a></td>
<td class="nump">494.8<span></span>
</td>
<td class="nump">451.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_DeferredIncomeTaxesAndOtherTaxLiabilities', window );">Deferred income taxes and other tax liabilities</a></td>
<td class="nump">891.5<span></span>
</td>
<td class="nump">942.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Commitments and contingent liabilities</a></td>
<td class="nump">$ 473.2<span></span>
</td>
<td class="nump">$ 383.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DeferredIncomeTaxesAndOtherTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the noncurrent portion of deferred tax liabilities, which result from applying the applicable tax rate to net taxable temporary differences pertaining to each jurisdiction to which the entity is obligated to pay income tax, combined with the noncurrent portion of the amount recognized for uncertain tax positions as of the balance sheet date. A noncurrent taxable temporary difference is a difference between the tax basis and the carrying amount of a noncurrent asset or liability in the financial statements prepared in accordance with generally accepted accounting principles. In a classified statement of financial position, an enterprise shall separate deferred tax liabilities and assets into a current amount and a noncurrent amount. Deferred tax liabilities and assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the expected reversal date of the temporary difference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DeferredIncomeTaxesAndOtherTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118261985&amp;loc=d3e55302-109406<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074956958792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION Business Segment Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_Intercompanyrevenueelimination', window );">Intercompany revenue elimination</a></td>
<td class="num">$ (50,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (6,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (90,000,000.0)<span></span>
</td>
<td class="num">$ (17,100,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">3,896,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,928,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,488,700,000<span></span>
</td>
<td class="nump">8,601,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">1,047,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">339,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,152,200,000<span></span>
</td>
<td class="nump">993,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">947,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">976,400,000<span></span>
</td>
<td class="nump">812,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">243,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">358,000,000.0<span></span>
</td>
<td class="nump">214,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">703,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">221,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">618,400,000<span></span>
</td>
<td class="nump">597,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to Laboratory Corporation of America Holdings</a></td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(600,000)<span></span>
</td>
<td class="num">(900,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Nonoperating Income (Expense)</a></td>
<td class="num">(100,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(52,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(175,700,000)<span></span>
</td>
<td class="num">(181,800,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">703,400,000<span></span>
</td>
<td class="nump">$ 231,600,000<span></span>
</td>
<td class="num">$ (317,200,000)<span></span>
</td>
<td class="nump">$ 220,700,000<span></span>
</td>
<td class="nump">$ 190,400,000<span></span>
</td>
<td class="nump">$ 185,600,000<span></span>
</td>
<td class="nump">$ 617,800,000<span></span>
</td>
<td class="nump">$ 596,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember', window );">Corporate Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="num">$ (59,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">68.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63.00%<span></span>
</td>
<td class="nump">61.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 2,704,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,759,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,098,800,000<span></span>
</td>
<td class="nump">$ 5,242,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">$ 964,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">262,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,451,500,000<span></span>
</td>
<td class="nump">843,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember', window );">Covance Drug Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">32.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,241,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,175,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,479,400,000<span></span>
</td>
<td class="nump">3,376,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">$ 142,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(131,200,000)<span></span>
</td>
<td class="nump">277,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporationMember', window );">Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (46,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (168,200,000)<span></span>
</td>
<td class="num">$ (126,800,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Continuing Operations Before Income Taxes and Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Intercompanyrevenueelimination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intercompany revenue elimination</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Intercompanyrevenueelimination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_PercentofRevenueContributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percent of Revenue Contributed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_PercentofRevenueContributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140075049224824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredSalesCommissions', window );">Amortization of Deferred Sales Commissions</a></td>
<td class="nump">$ 6.0<span></span>
</td>
<td class="nump">$ 5.8<span></span>
</td>
<td class="nump">$ 16.8<span></span>
</td>
<td class="nump">$ 15.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Capitalized Contract Cost, Amortization</a></td>
<td class="nump">$ 2.3<span></span>
</td>
<td class="nump">$ 2.3<span></span>
</td>
<td class="nump">7.6<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod', window );">Contract with Customer, Performance Obligation Satisfied in Previous Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.8<span></span>
</td>
<td class="nump">67.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueRevenueRecognized1', window );">Deferred Revenue, Revenue Recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 237.2<span></span>
</td>
<td class="nump">$ 232.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredSalesCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period for the periodic realization of capitalized fees that were paid to salespeople, distributors, brokers, and agents at the time of the conclusion of the sale. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredSalesCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68051541&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12A<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL108322424-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueRevenueRecognized1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously reported as deferred or unearned revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueRevenueRecognized1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074947973320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE Disaggregated Revenue Table (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts Receivable, Allowance for Credit Loss</a></td>
<td class="nump">$ 26.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_UnbilledServicesAllowanceforCreditLoss', window );">Unbilled Services, Allowance for Credit Loss</a></td>
<td class="nump">6.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_NoteReceivableAllowanceforCreditLoss', window );">Note Receivable, Allowance for Credit Loss</a></td>
<td class="nump">5.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_AllowanceforCreditLoss', window );">Allowance for Credit Loss</a></td>
<td class="nump">$ 38.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings', window );">Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Accounts Receivable, Credit Loss Expense (Reversal)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_UnbilledServicesCreditLossExpenseReversal', window );">Unbilled Services, Credit Loss Expense (Reversal)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_NoteReceivableCreditLossExpenseReversal', window );">Note Receivable, Credit Loss Expense (Reversal)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_CreditLossExpenseReversal', window );">Credit Loss Expense (Reversal)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_AllowanceforCreditLossWriteOff', window );">Allowance for Credit Loss, Write Off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_SalesCommissionAmortizationPeriodMinimum', window );">Sales Commission Amortization Period Minimum</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueRevenueRecognized1', window );">Deferred Revenue, Revenue Recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">237.2<span></span>
</td>
<td class="nump">$ 232.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGross', window );">Contract with Customer, Asset, before Allowance for Credit Loss</a></td>
<td class="nump">$ 609.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">609.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">483.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="nump">$ 4,795.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,795.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear', window );">Percent of remaining performance obligations recognized as revenue in next year</a></td>
<td class="nump">32.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_LongTermContractsDurationMinimum', window );">Long Term Contracts Duration Minimum</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_LongTermContractsDurationMaximum', window );">Long Term Contracts Duration Maximum</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod', window );">Contract with Customer, Performance Obligation Satisfied in Previous Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.8<span></span>
</td>
<td class="nump">67.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="nump">$ 492.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">492.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">449.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Capitalized Contract Cost, Amortization</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">$ 2.3<span></span>
</td>
<td class="nump">7.6<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent', window );">Accrued Sales Commission</a></td>
<td class="nump">32.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNet', window );">Capitalized Contract Cost, Net</a></td>
<td class="nump">12.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts', window );">Amount of Deferred Costs Related to Long-term Contracts</a></td>
<td class="nump">45.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredSalesCommissions', window );">Amortization of Deferred Sales Commissions</a></td>
<td class="nump">6.0<span></span>
</td>
<td class="nump">$ 5.8<span></span>
</td>
<td class="nump">16.8<span></span>
</td>
<td class="nump">$ 15.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnbilledContractsReceivable', window );">Unbilled Contracts Receivable</a></td>
<td class="nump">$ 603.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 603.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">481.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_SalesCommissionAmortizationPeriodMaximum', window );">Sales Commission Amortization Period Maximum</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=lh_MedicareandMedicaidMember', window );">Medicare and Medicaid [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">82.00%<span></span>
</td>
<td class="nump">78.00%<span></span>
</td>
<td class="nump">79.00%<span></span>
</td>
<td class="nump">78.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">CANADA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_GB', window );">UNITED KINGDOM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CH', window );">SWITZERLAND</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=lh_OthercountriesMember', window );">Other countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">68.00%<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="nump">63.00%<span></span>
</td>
<td class="nump">61.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Client [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">22.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Self-Pay [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Third party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">66.00%<span></span>
</td>
<td class="nump">57.00%<span></span>
</td>
<td class="nump">61.00%<span></span>
</td>
<td class="nump">58.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | UNITED STATES | Client [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | UNITED STATES | Self-Pay [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | UNITED STATES | Medicare and Medicaid [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | UNITED STATES | Third party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">33.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">29.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | CANADA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | CANADA | Client [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | CANADA | Self-Pay [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | CANADA | Medicare and Medicaid [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | CANADA | Third party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | UNITED KINGDOM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | UNITED KINGDOM | Client [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | UNITED KINGDOM | Self-Pay [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | UNITED KINGDOM | Medicare and Medicaid [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | UNITED KINGDOM | Third party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | SWITZERLAND</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | SWITZERLAND | Client [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | SWITZERLAND | Self-Pay [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | SWITZERLAND | Medicare and Medicaid [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | SWITZERLAND | Third party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Europe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Europe [Member] | Client [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Europe [Member] | Self-Pay [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Europe [Member] | Medicare and Medicaid [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Europe [Member] | Third party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Other countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Other countries [Member] | Medicare and Medicaid [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Other countries [Member] | Third party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember', window );">Covance Drug Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnbilledContractsReceivable', window );">Unbilled Contracts Receivable</a></td>
<td class="nump">$ 834.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 834.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 771.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">32.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember', window );">Covance Drug Development [Member] | Biopharmaceutical and medical device companies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">32.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
<td class="nump">39.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember', window );">Covance Drug Development [Member] | UNITED STATES | Biopharmaceutical and medical device companies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember', window );">Covance Drug Development [Member] | CANADA | Biopharmaceutical and medical device companies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember', window );">Covance Drug Development [Member] | UNITED KINGDOM | Biopharmaceutical and medical device companies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember', window );">Covance Drug Development [Member] | SWITZERLAND | Biopharmaceutical and medical device companies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember', window );">Covance Drug Development [Member] | Europe [Member] | Biopharmaceutical and medical device companies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember', window );">Covance Drug Development [Member] | Other countries [Member] | Biopharmaceutical and medical device companies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortizationPeriod', window );">Capitalized Contract Cost, Amortization Period</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortizationPeriod', window );">Capitalized Contract Cost, Amortization Period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_NotesReceivableMember', window );">Notes Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings', window );">Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_AllowanceforCreditLossWriteOff', window );">Allowance for Credit Loss, Write Off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=lh_UnbilledContractsReceivableMember', window );">Unbilled Contracts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings', window );">Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_AllowanceforCreditLossWriteOff', window );">Allowance for Credit Loss, Write Off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings', window );">Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lh_AllowanceforCreditLossWriteOff', window );">Allowance for Credit Loss, Write Off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_AllowanceforCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Allowance for Credit Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_AllowanceforCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_AllowanceforCreditLossWriteOff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Allowance for Credit Loss, Write Off</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_AllowanceforCreditLossWriteOff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CreditLossExpenseReversal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Credit Loss Expense (Reversal)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CreditLossExpenseReversal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_LongTermContractsDurationMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long Term Contracts Duration Maximum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_LongTermContractsDurationMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_LongTermContractsDurationMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long Term Contracts Duration Minimum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_LongTermContractsDurationMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_NoteReceivableAllowanceforCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Note Receivable, Allowance for Credit Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_NoteReceivableAllowanceforCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_NoteReceivableCreditLossExpenseReversal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Note Receivable, Credit Loss Expense (Reversal)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_NoteReceivableCreditLossExpenseReversal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_PercentofRevenueContributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percent of Revenue Contributed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_PercentofRevenueContributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percent of remaining performance obligations recognized as revenue in next year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_SalesCommissionAmortizationPeriodMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sales Commission Amortization Period Maximum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_SalesCommissionAmortizationPeriodMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_SalesCommissionAmortizationPeriodMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sales Commission Amortization Period Minimum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_SalesCommissionAmortizationPeriodMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_UnbilledServicesAllowanceforCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unbilled Services, Allowance for Credit Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_UnbilledServicesAllowanceforCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_UnbilledServicesCreditLossExpenseReversal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unbilled Services, Credit Loss Expense (Reversal)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_UnbilledServicesCreditLossExpenseReversal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredSalesCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period for the periodic realization of capitalized fees that were paid to salespeople, distributors, brokers, and agents at the time of the conclusion of the sale. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredSalesCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred costs for long-term contracts and programs. Includes, but is not limited to, initial tooling costs and deferred production costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(d)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68051541&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68051541&amp;loc=SL49131251-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=68051541&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12A<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL108322424-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueRevenueRecognized1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously reported as deferred or unearned revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueRevenueRecognized1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118261985&amp;loc=d3e55302-109406<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=lh_MedicareandMedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=lh_MedicareandMedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=lh_OthercountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=lh_OthercountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=lh_ClientMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=lh_ClientMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SelfPayMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SelfPayMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=lh_ThirdpartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=lh_ThirdpartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=lh_BiopharmaceuticalandmedicaldevicecompaniesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=lh_BiopharmaceuticalandmedicaldevicecompaniesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_NotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_NotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=lh_UnbilledContractsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=lh_UnbilledContractsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140074956302360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease, Liability, Current</a></td>
<td class="nump">$ 193.8<span></span>
</td>
<td class="nump">$ 206.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">602.4<span></span>
</td>
<td class="nump">596.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance Lease, Liability, Current</a></td>
<td class="nump">7.4<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance Lease, Liability, Noncurrent</a></td>
<td class="nump">$ 86.3<span></span>
</td>
<td class="nump">$ 91.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140075040568216">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">AOCI Attributable to Parent [Member] | Revision of Prior Period, Accounting Standards Update, Adjustment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Revision of Prior Period, Accounting Standards Update, Adjustment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital [Member] | Revision of Prior Period, Accounting Standards Update, Adjustment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock [Member] | Revision of Prior Period, Accounting Standards Update, Adjustment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings [Member] | Revision of Prior Period, Accounting Standards Update, Adjustment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
<td class="num">$ (7,000,000.0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>73
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MR\4:?]K06 ]H)?Z5\V<YN49:E;T0/_3-E^QRX6E$O."ITE,P^'GB&UX4>B;
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M&!!-*>+[R\@.,1D@)DZ(=PVO69XA_@)T*@&J=FBA#KRQ 4U,H,3T8HM41.>
M8F_,[YX3ZC>A((NE)W%LS=6>N9=>'"S#=S M<B2!32<S0"=$A']B4ZA-&O5Z
MANJ"::A@4IT>:IV3SU#%K5'53WH")_1B$[9-CH83N5/8(VM@XH3]3R&R9XBM
M>83$6#D*,5W&[Q%V<M%4+@YGLA@>B0:[F>9+I5CUF$.8HW6[^6?H%JK##]<O
M:0&47CVB-PT^6M%36Y1Y1IA9Y'R/^G-9&(\$A'TG_C]%#LZ@$\&QX:AFC:IX
M(P]Y+0</4:^HY.H@LC9C2%7.T4F_U,E6>),0ZU4QI6)_F7B3#Y[1:B1![&;!
M+7_@$)$9^E*EHN3H&WOIL\A7G46&K7+P";;0WB3U]KJ80O$R]GY%EY$HL9LI
M.\2L1SP7!:'AW3XU+&^2GT^#.3[!(_EA-_MU.="1^TP>PW$$-9:116R"GA_.
M0APY#\?.0NLF9\#04&GR<==_K>3$(VEA-VM!2=,<P>=L:UG-8E(2)DED9BY3
M+O')G$W(2%W$35U#D-QSB/^CNT@F%OY*? -K+W;BA\%,")"1NXB;N[X"<S&E
MD^D-AY[R;##QJQNS24HX,9G!(D:\<"ZUDDG#XZ:NKLGA_R=F"YT9:<<B%,_Z
MPTAEQ$UE6[Y7;FP6LHI"(XHM8CX.YBH8,E(5<5/5C:@>SZ%!*%'6(BVXE$/E
M58M&MY%6V";A4,]+)C5_C]N4(V$03/SE%/C(1L3-1B/PSL1C;?"6B?YB0+]M
MQK J8+),X.-HTGSV"ECDHCB956"D(.*FH(THR[SC_:ZWA"X'X&ODQ9CLK- M
ME -E]_OBW")&8SKK,B,S$3<SN1+'K:A2AZ_;.C1B1J(I%B2S92\9^8JXF[3Y
MW/$3V&8_%H>FHYA2"5YZR?0SH\'(AL3-A@.[Y%T)IH82K&WD]/U/G<<DOAAP
MOJ^-+6*:'V>\GH[\2-W\J"VMVWE1%-J#H$[F#92_UB,DDQVQY\>>D1OM@D$R
M=Y!$1XZDV'V^=F -/X@B@_+]'WW=[CI0HB./43>/Z>@7%9)*I#_.4 *6;;<1
MF#1 4J\JD3@J"7U0F].83F=->G@[/*2M]):GO-S#OO=/R1F"@35OCYF+5ZM1
M39;#9M:V2$'_-%-RT,D!XD].$+.L/9>$PE8?19SG%4I9G4.A:X5J4EYL=CX6
M*1+.^NG(B]3-B_=<,7@$S1IK*M@!:RSU<TP+,\.2+I%3;"/U43?U04U\+(\%
M4_PM[B$9U."H^DW%$^^3@Q5P8* YC_WP?0*F)N>=1XE'YU(P'4F/NDFOZVHF
M*:KU8VD),RM\D]'.*?;-A&"3BV:K>SI2'W53WTZ'ZP#TNNOCUTHU^?ZH]+$D
M4@+=L=E#<9/88@(M&WZ//S*/58)PYEB-COQ'W?QW\\[LU_.&CHV#>7MS:16T
M-9>KR>L>_:X-LMEC7DFH-Q]@)(0U&*7I7E]U-TK4[1N@O5!*E.WE@3,PO!:
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MLC1R19C1I8C:%=#^2BE[2-S<U=?LY"]02P,$%     @ O$Y=47;NT7K]!0
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M_<7P5WQ'H+9E28_U6!O*DA@O?B1K'&'0'($FO34_)L;6,U&W:0('_5QV[U%
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M&GY]8N2R>\_\)(V1=7>X$+P0J@7 ]S,IS?M).\#FQY#+OP%02P,$%     @
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MG1'J(_M(HUVD>B#]>CX<!XYGU__.!E^/^X6..DX P"D /=]Q !KJ:& 'XQ%
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M"+X2RAC [VLI]=N-&:#Y8.3\?U!+ P04    " "\3EU1<>&YYB #  "B"
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M:_-$L'7N3:9X7ZRHW#.N2 ([E/0Z0XRD+$IVT=$BLU5O*S364-L\X#,'I)F
MWW<"#W_9,0M4#Z?9_U!+ P04    " "\3EU1S95I7K40   U0   &0   'AL
M+W=O<FMS:&5E=',O<VAE970Q,2YX;6SM7%ES&S<2_BLHY5BK2J(DRK*=^*BB
M#L?*^E"93O9A*P_@#(9$,@-,@!E1S*_?KQN8BZ2U4I*M[&[IQ2+G0-_=7S=
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M&GP3EPOY,]RP6NW;I<%Z@U0/BXKE0B=4!82Z42[1GC,ZY+/Y2+RU9KZ//%2
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M[CP7\#YX,8Q8POYP((VZJ=)VQD '&70Y2!4A@0[/L>%"JTVDB=B$1I?J /$
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MQE.#&(8E=>1H68#V5X8N;#MA!VV//_T;4$L#!!0    ( +Q.75'OG'R0EP0
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M3= P..\UBDM9+:S*_*-JI2P]T?QT2V]BU$Z SM=*V6KA#-2O[-$_4$L#!!0
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MWENQL#)1YY8[?JA=U%^W<?U(Y=64W%A+U0I07G CTP:(>9V+MRC/I^/;[C@
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M.AOA/5!&,E" 21K+'6(QE\9,:/"]+LS0<(54]0;DJJ3J%KWTO8O3'[%)#Z8
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M&F9&A8P/$R3DU6N5N%Q)B,D0:T0F\D;#"BC/^ :JSV")$<2(TAK6-9K57D=
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M->W'"B\V[F0Q=H1>PJ89!\,#Q,6<K[K0G&@S>S-33HN]";R/#12>N]U&U.L
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M?L@L"TL1-JG2^8U;<D&=AY_IN'J+V # R*4C%T1(1 +2*Y(-BIT8^#BY\@4
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M!^$*R/A+:Q?\%XB K5H[YQ]G6H$/] "^GUC;QE]H@O0GJ7[]7U!+ P04
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M25G/1#19\X0;.IG6=&Q"0LSU([6\YX>GIX=B&FND ?(Q1626,<<)C1CL_F;
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MSNG*WQ:"(Q^T >]SC5;1/I"!_F>C\[\ 4$L#!!0    ( +Q.75$OV."=(@@
M '(;   9    >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;.U976_;N!+]*X1O
M]B(+./[*1[/9)(#CI*V!-BGBM/=AL0^T1-N\E40O2<7._OI[9BC+4F,[V2[V
MX0(% D<2R9GAS#DS0^E\8>Q7-U/*BV6:9.ZB,?-^?M9NNVBF4NE:9JXRC$R,
M3:7'K9VVW=PJ&?.B-&GW.IV3=BIUUK@\YV>?[.6YR7VB,_7)"I>GJ;1/5RHQ
MBXM&M[%Z<*^G,T\/VI?G<SE5(^4_SS]9W+5+*;%.5>:TR815DXM&OWMV=4+S
M><(7K1:N<BUH)V-COM+-,+YH=,@@E:C(DP2)?X]JH)*$!,&,/PJ9C5(E+:Q>
MKZ2_Y;UC+V/IU, D_]&QGUTT3ALB5A.9)_[>+-ZK8C_')"\RB>-?L0AS3S Y
MRITW:;$8%J0Z"__ELO!#9<%I9\N"7K&@QW8'16SEM?3R\MR:A; T&]+H@K?*
MJV&<SB@H(V\QJK'.7U[?W ^_]!^&7V[$\';T</_YX\WMPTCT;Z_%^YOK=\/;
M=Z(_P/#P87@S.F][J*2%[:@0?Q7$][:(/Q0?3>9G3MQDL8KKZ]LPM;2WM[+W
MJK=3X$C-6^*PTQ2]3J^S0]YAN?]#EG>X;?_*ZD=)R!##S'F; W#>"9G%XKV*
MISJ;BCX!1WNMG+C6+DJ,RZT2O_7'F Y0_;[#BJ/2BB.VXN@O6=$4[\ JL?_!
M./>S^.U!CA,E'M32BZO$1%]_WQ2.G7J(X6=N+B-UT0"%G;*/JG'Y,%/"L^PQ
M<53,K7G4,7:KLT#ZP+^IM#&YPV,ZU(?'Y">9FCSSPDRP4GFY%/M3F V+X2D'
M,1B(R_TY7#L]S:17,12(B=16/,HD5V(6_'TF^E6!!R21!+;W$_:#SJ(DC\-J
M V.LB$R*B3/*%' @QDVJ"B$.AD>)=$Y/-)9XP^;_XPH>9E:I&O0%@.M5.H8T
M0N^+$VX1N;\S3O3 3_>7%ZZ&F5= @A<6$1%N(>?8;<; =F)/_/M?I[UN[U=<
M=5I'^.VV3KYY>HK?-ZW>L[&!A3.1P:Q56?3$DDG@?N^PU?V99I_RTK6H]=5^
MM]?JT)Q>;\N<'90[+BEW_!V4$_V-Q-_$M!?$_Y6\*HB" X!,9D]"QC$"0L31
ML$<MYR'? %FHFE]1IJUV7Y$;YA9 U'.9)$^,N<JH !Y-I)EC"^UG(IK);,J,
MQE\EX"'1@>4H7MDZ6&H9%H0Y38BW)I_.A S8,$D"P4@34RM38A'K3&6&*DY>
MQ'SI5S3"\HDUJ? HY4P/_&^RP;E3]=P@)CJ3V)-,L+@,2:OFG=C Z,QX,3-)
M+(P5VCGDCI>$T!X%4,T9;)Y;.%5MDXPLJ!4$A5ULCP%4XQ;>)%T%\0MAC-,W
MO[J*,1"A.67"$/@?30-G1G17EE,IK"FY>$]<'!$7[S+1SZ=H T3W32!ULZH'
MDF(%G\=LIU74A=$.]XY H9XX:IWTCG]"9L@TM-X:"G@,;]V:QY INL<KH;FC
M=?)1ZH1+023=3,!:X""N^TDM->&*K%@KG.BEB@^\.7B4< <)T,\3B[264,40
MT>7&@G[< UM9T:LQ:(.&6*7SX+<)/]FV)Q+3$@/H>.*=E"F>R@KL36"63D(9
ME^SZ09[F2<#,NB"\I7KTA>M1F0;B_\).MGI8*0T<AI6ZM0!Z_#ZH_/!,Y88<
M?:VBXDFW&5+RJR9=R03  DJX<_] U6"(56388J:CV<H&>@CM5JUM'S#-/1!I
MR;%-U&DJZ\JFH-'8UQ+N8:?;.JX]H?N0VP>K=,%(O<[MJCN8F-PB?G_DTD(J
M[1LFG]:!JQ@>Y$@PQ^FE^-P:M<0U4HNT1*;1 L06;P&82$2D[J!62H2<6J4"
MM1DL$KW(=$I="M &%F-C(%UH+&# WDFGT^IPM@ON(8_(***H*<Z %"$9P ))
MU,!X-EC#WH@CNTJ3979,B49L N!)!,P4 1M-CE]A7!8;<?G8Z5CCV-,2=P$D
M=2.;8N^0341&0:KA5(W0]]CDC4/'3$ODT&A3I>6Y%)"J'%K%.W_>XA &#A@#
MJ!W*;P<L.+8N)ASM=0=7P']#O ($T2H92VK9U]15F4RM:?.L#B%A9RXI.LTU
M"\FO4138"V$[>K0530TZI,P1]I%H3:)C7ECG$)"@$YY>9 S-?.(&STPS_6=P
MEY*6,EY1/*)U#I&U%/"\KZWOH)Y'HH*2S]WX;5P7<-U>T40Q-(IFB>L;-?+<
M6-)(1CDA#1VBVM(A-JD4S16?C).G9N"'K&U9NLWQ(-;M=N_(XU]:Q'=0"\]-
MU8D QH)^,E/X\)N>.K0/?TO/NCR_+.&NK,BH*V5."WXMW E?O\:[ 2+UHQ4(
M2QM\3ISJ$8G@+J8<_K%T.G1IM&1<(#:\KUGYJ#B+,6S0UU3[GK/759-*U8.4
M2FN\=:#.G8$,-;I/N:.L>T^UI'Z[RG>OFG1=<<?U^L0(-*[*<K5KWW"*^635
M7.J8FC>*>/ AIXKV7<AXE>J\^1Q2+WKULDCY>.,1)P@/2;3)%0%HV:TQG(1"
MA8)L/DRM1\/S'X?T'X?T_[-#^D/MG+*J_!Q%;LG(%!,JB%IZ@"K7;I96^H'=
M1XAFT<E1O:JB@;E6,._U]>FN<@Z[-70(UT4F8IX0B0NF<#FJG#>KI\R9?"2"
MJJS>- !P!1Z_MTR'[JW[2VO'FX^3\LW'R<Y7$Z,(),Z3;S-Z-9^^[EWC3C6O
M?=?XHR#^*(C?4Q W$:%=^0Z2*COEKSTPB&I ^"12/BT_*/7#=Y3U]/ UZJ.T
M4^)]HB98VFF].6X(&[[PA!MOYOQ596R\-RE?SI0$:&D"QB?&^-4-*2@_LUW^
M#U!+ P04    " "\3EU1S!Q'L7<(  #;&   &0   'AL+W=O<FMS:&5E=',O
M<VAE970R,2YX;6SM65UOXS86_2N$$:!3P&-;LIW801(@<:8[*=HDFX_N0]$'
M6J(M8B12)2D[Z:_?<TE)MC-.FJ([^]2'&4L4>3_.O?=<DCE9:_/%9D(X]E3D
MRIYV,N?*XW[?)IDHN.WI4BA\66A3<(=7L^S;T@B>^D5%WH\'@\-^P:7JG)WX
ML5MS=J(KETLE;@VS55%P\WPA<KT^[42=9N!.+C-' _VSDY(OQ;UPC^6MP5N_
ME9+*0B@KM6)&+$X[Y]'QQ8CF^PF_2+&V6\^,/)EK_85>KM+3SH ,$KE('$G@
M^%F)F<AS$@0S?J]E=EJ5M'#[N9'^@_<=OLRY%3.=_T>F+COM3#HL%0M>Y>Y.
MKS^+VI\QR4MT;OW_;!WFCL8=EE36Z:)># L*J<(O?ZIQV%HP&;RR(*X7Q-[N
MH,A;><D=/SLQ>LT,S88T>O"N^M4P3BH*RKTS^"JQSIU=/-Y?77^ZOV?GLW\_
M7MU?/5S=7-^?]!U$TX1^4HNY"&+B5\1,V<]:N<RR3RH5Z>[Z/DQJ[8H;NR[B
M-P7>B[+'AH,NBP?QX UYP];/H9<W?,W/RF+$6C;3Q5PJ3BEAV:_G<^L,,N.W
M-U2,6A4CKV+T%U2P2VF37-O*"/;K@WAR["+7R9??]B'\IG0JSF-;\D2<=E!]
M5IB5Z.R/'CN_OF275_>W-\W 966D6C*7":8@EA4A5H)BQ8"T$\5<F!;NKI\)
M+TJNGE$WOU?28.**&ZDKR^:-GUREJ,N<.WSDU@IG&5B"\;(T^DFB8D3^S [B
MP:0W85*QA-N,?9 JR:N4S$E@!7Z%<O1H92I,P$POV,%A;^#E*_ 2WOW:QI+O
MN^P@BH:]$6K%99#\T^S23SZ8CC>#L\O+'GN (V5ED@R%^T*+-S7/@U0K0T)@
MW?M1@E V%T*1&)UX&"I,-E[$EEA6")?IE/S@2:(K[S9SVL\3UGFH4K;@TJ"T
MS1>XO.)Y)6B!MP8#-;X-!%VVP?$%WI-);TQ^P%,H6D@^SP7>'5=+28^-).#%
M$3X@4G&@4)!=I%%I]='Q)U!;6H$R:<E2ZW0M@15YL*LMBB>]:< 9(HR3?P1T
M2X%D24-"[%'>Y-3"Z()\1'2:M!*6&4P7X=N8<(K&[%EP$Z0%4@3*/O4H:IDL
M@S]D>H*T%0Z:ED8(= ^T+++.BMU KP4JLN ITL/ &2/A##2A0A'O[?S_SK*E
MT$O#RTRB3@5/,H]N4<);#LCJB'%\LEUD2\95(EY(L(D,P4A8*A<+Z,9; (KL
M]HI+7BN>4W-UF?]B$[3?)@\V\F9W-XPH0"8BN(?U"95D/=.GTDX.[>8^WE;B
M&?CK59VN7Z_8DW5LC8PW(M$F]27?)D:PH4T3-%;JNO:%U? 1HS7UPN?*R5S^
M(3;E0BHV:?"=;^@(.> D+% IR&6)7I?NB;U'3BBQD,[#,!>^-BCIH"H7<!2;
M# 8X P;(>;% 0! 8_+.>-8#"2AN_9@GRQX N*<R50M:(AAVLJ&.^/[.(UHR<
M5U32!V"I*% 3GB9DEX$E"BBG&TYV&5(U)/"[> =%2T!B-Y,_UZ7WJ@%#D('7
M/^P=DOK:?V@&@:",NO\[0_Y2EXFF[^PRXKU]9C*.>]--GWFM<1R.CG9Z1$ G
M'HP!U*:=?,/.09[OZ1S?JAT,XQ%2\!OU@SUA&$=Q;_@-&T(4O;,C_$/[_]#^
MMZ+]&\5^K%#HPZ:@/9$TOGQ2*[G4\!REDV ?+Q-H]:R,DP:5&#(7Z=1$LO6]
M6Z<#>0"!E(*YGF/MMIS45$O4(BA7EX7?._.2SX&H:]WA:2IK7SV[>. #B5H-
M2J/D.6_GY,^[3)R"SJUG)#^X\GE]UQA]:S31P-8IX,/L[A;$ND:=9#Y3."NY
M\=0!)[H4A@ (E-KV$X@6]<%S$;"#(X*@ S-H""APII8?J<*IR2BQ]L&Q55FB
M7MN=7?"V$?ZPY4/)91JH?\_)8A#A;/$AV"MMS9Q>]PL&W]G#JXHX'-[-43S?
MDUF) %)$FHM<AY8*+;!2)!6YHK3S186CRJ 'Y@\!:(H(D:&Z#2H)!X_7W6U8
M$??B78<6E>\EODF##"T/=QIHV+I:PE"4[9H!P@)R.3H43R@CZMW!0E(J4)6W
M*+2YNLW^UE8%AG*YR:<:DVV=W-?9;OK7& 9*T>AI:\!Q#.NWP7\@(2!!4CO[
M.C8'+$3FAQU*(D@\@.Q!.WAQP(XB/\O[= VR.@\>G#<>>='DCX^_P"B$T3D
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M: XT*><D4&!1(_GH2&7< J(SJM$9$H.G/3=M%CON?OTE"8/%[Z8#!*^0-32
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M N_KH$D WV\4WMRZ!W(P_ ,X^Q=02P,$%     @ O$Y=45'6V6B8!0  , T
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MN840?GK0MJOMWX%!>@5OQ--_B??2S7$9"TTS'.WM'X-W77J?ITFP57P33VW
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M$&8Q$+6IE0\U+1XD#4!>D4% /&H2IP%/9W,XDEMB(ZM,E:(-I<[-N<@*3@M
M#@+0T,W[3W>W/R-ZEH6:(\A@P5R4,@L@4H53Q]DC4U56-!2UY%/!UO 29U;+
MY5*X&'(F<1(T=<Y)+&E-:ST?G+TO!F:VPCA9O<_?<@U[^&@F,#B?@ H!0(M:
M:;>VJ3QESX$ LC?7V:RUV.>&5U9:3F?;CHM=D-!CX.W0!L]0U=9U"^QA#[QH
MO.*(%T.3U=:G?M)A?:U(%Y)M3ZZ 7 +*-*"0#-;.DD3?V6? 1'S)A" )]NC/
M$=IUK=47B<-6("BC<3C^:^",04&C:0\_:FF(=.*@VR<DLJH1R[+SVTG23I))
MVXEP!U:-E87\ZE@@M.:RZN.HC34B@\+E#U1*3DZ. LF!/A=6Z)(RX)XYNQ@\
M]/"1R#>H(TRW9<>M6U^:'W<FN>R(0\E53XEY#=A6/P.+*\H&>BD&MB8&Y)AE
MY>WFLE K$%+&3GIJLR5E@X'C3!?&-ZHR..4\MNZAM^C\^MY#'O-D:N3U)A/?
M?2P=JD1$MC8*D>&'"6004E[;8)=5[]8]3G(?#@PC)U$PC2]P2#V6\WW\><L<
MD500-Y]LVG1+L3EPL'/Z$VC:.M\A*40*ZE,>DK$PG@)G?X\PW6;[[M3/4?8X
MNVK*\^W@;@Z#8WFQ,5!UK9HB'SIGA?Y *U62N7=!'3M)7G_+?H^>DV38:3H-
MXT?0Z]S8 K9%Z?=@](E,^__#Z#[C ?CV3X!O@?<Q9"9_ ES*8P<;4?DJM!J"
MXLBJ/QTH,MZ8@Z"#KJB$'CUIR3$=I"CDB!-%P<Z!MPNKDQ3:A+N]VY,E(2C<
M0-1<@C#:"[39;9WXOZ Q8&LZY4]FTW#LC]ET.@O3@.2NA6NXBPU"M; KU2Q7
M.\"8BT*BKC*#&M)5V:YV:<K:QQ81I3**U#2L,3Z$"0^#,&X-3NV%1EVK*BHN
M Q2@-6GA7XB0,UFM)6@%!$PHV("@6$!O7[_3-8;%?^8+9HU*M6L@W 4(E? >
ML7#JO#%(**X4SYRWYJ)M$$ 4H=94"_Z@7*5+]/"JJ T355]8KU<2H>,WMZT%
M<1-?9%<Y;BW1Z;YW3G7:A^P31Y/3P(D@HW0G4V\0LC@HDULH&:F!>'U?<XSQ
M,P:+H>Z16):+@F]</U")=7L]@7"@2Q?L\M[RV:QPR'3K:7E;Q;.%QIDPW.OK
M1A*R[3,ZFCY=\^W5C;2N3=E9O>T',F4H8]]A<9Y+VA6P)<+/VTM52^74HE*2
MUS*'+LX'- @FU-SO-PS;3L$W!0@P@UY0+I!U8/<&H: I5""6%DNN\[X+:=H6
MA+@9:JF<Z)Y\1Y4@M184O62U#5LT3H@EM4:5<RQ"!1V(N[N"D7RD4!OUG6X#
MZC*JF3%<;#H=(#E%0:7<2NW"N8??%F8.*X/0*WDN^IJJ;G2MC.B/P6/U^#8'
MTD0+(Y?S>)8U+GG6.#):[8A2J_\ 9[OGNR/40=8A52$QM2(AR6&'I/9N%Z?[
MBG0]U\%)OST$?C)'%6GKB]T8^+W)E_ZXW&?4 0""DH!MVY"1,CX?E (I,>_I
M!UVWS/R%I>A;C1+Y7];(V$&++MA^2-X5  O4L&3FWT47+QVY#GANKX=4P99:
MK>W*'6)8VNX3P_8:S(&-H ?TSL%'M<?0#!TDCYZ2 77E.]/?(5*WY9A(BJZ4
MYW038<GCKO+P1@=]T?=HWB</JFA*,71-T.;%%:>J#;EHN>V= :6V[NFPD!\I
M%8_T2&WT'K0/+N!Z@+CLU=_SM3<C.](02TU:X4@26VE:$/Q$JP?UV"#LE9%]
MRAF4J:HOTCR:* !1=%9^5N9X@A-=0!Y*MG];=Z08/[RD>ZT5BIJ;KIZY]C4@
M4E&#0'928PC6^^I3Y#M$^ ]LN>E."0<$TF\E:^/N!2?)V-VAG49!>I&$T9F[
M3QM/+L*IFT_3J)M/XLMPXN>C* YC]@'<7 '?%T0^1K-5I0JUW+ 4_=P%.XW3
M29B<L6@6ARE+)PE(G\;)A&X.X^@BO&3OJ#*'K=%T,+[40O@L$8VQCYU.(<L9
M2XC4Y1BK3Z=CD@."I^RCIEQ;<01MB@(U)F9CTB*ZP ]+QS,W%EV&ER3 #/3>
MN'LIR@KT!8+*VAE($D6Z?8P<APF]3D#_L.9S%1O[VU]F<13_HWU+9V-L[<?<
MVPF;!)?0E:XE3^-@G,2D!1GO$JWLQ,W/9A-G9AAW-HF\\5,L33$_S.;]=<Y>
M"V-\#T/DNN-FM^C]1L@.KGR_[T9Z+5'N5M1]A^QVN]FNX+/=W?O7=YR=Q'#@
M(>2[[LOI1UK032*<2C[]%I.CE^9M/<.+0V;>7A%%AJN^HXOVEBL[#I"]<#XP
MX&[A[HO[7I?<'[PD>D&(I?/5'<GT1<17=IQJ15*9[N!]2@K9L6\EYX,O5A!S
MZ;[+N6186?_QJA_M/_U=^R]>V^7^N^%;=RY0M[S 5H!_,O)(Z%ZLJMWWK[FR
ML(E[I.L)H6D!YA<*;5_[0@SZ#Z)7_P502P,$%     @ O$Y=43*']QWE"@
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M1,.L=R&&8WR$&GHJQN>]*?T;]<YW=4RE $;8#YT=ESMG%GJ_:*C],Y=CCEJ
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M=U[30,^TXI=1:* $L,,;&\W=YGV7M^$UCW9Y>%GF1VG17<"G:HFMB-SSDS
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M 3-AJ%AS3#6,M&9&PY3KO)1ZIQA\&2VU4:CWKQ=HXX8V=K3Q&[23#1(Q#5S
MA"KUS,4:1I7<"0-R!4>GSJ7GHEU;;*[UEN9LX&$UT4Q]9]YPL6&0GPB-[1Y)
M:4.Z/F8":Y);(] V5/7N,[O[@,DWK%HRU>Q &RBFAFH$E5B)]#7<3:8PF4YA
M(0TM84Q+*G*W BFF+#_ B863'KR#J-T-B9]@*VZ3.'*M;CM+$S^ T^;DWW9<
MH0?%3EFOK7M;IK@L($U] MT(5Y.HA\U9M:5<88$ST(K\[A6T8I+5_S#TXRO
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M01CF;=!BRRC/K>6I%'^\*QSM]$!0*^BPH T+R<<N.K&?VC%CUMK=T><%4E_
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M7UIT4CJ',^>PQ)T551G$#I8"-?J#+3%1=9%J^A(&M:&UD:.@(GA(['L>WG>
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M$P%^GRL<PJL%*:B/"H__ U!+ P04    " "\3EU1$0<LS X#   A!@  &0
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M-8'"TJ=1C_+"?0)D?+0^0#QDJK:NH%J_9:H:5VS][P[^K<,/_BWL2BE^\(]
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MR'H]#N!3I.LY P-R>HK\ZCF^:X#.#$9=VS<@OYTBG< V.7IO0 [[)D?#4^3
M\8<&Y/P4V0\&-3\_O-I^]6K[C>&R+(IAJW 95#8'K</E2FT/H)Y?0+DM"N^E
M*0P*@_VC]05^MU"W_#BU-V=D](/C3TUM(\.K"6T #;NVV>P'<?Q*'+]1'-W"
M8,^%R'H-FS"5)R3-$_9&"((.'+T@EJL$@D3+8H3WF,<@XB?R^2=>VUV_)E@+
M3&C"#&H*-=OYH,FPTF38&(3O/7Z2LETFVX5C4%D/&A4O-A15_<IA,BB1*2L5
MU=K&+$DP+Q[J4:/,Q3S!<;'JNFY-YU.0VW5K(H:GH$'7Z]>4-H'LH5EJQW[?
MA-F?!R#LH?X/0<JI/BKBU"//@ )):JL-#2C0I);V<R/*[IT1Y6AGZGQ:LLK.
M>?&#"=A$3EYA,WGH<7>%/$N5GUOH9H1#3I9"&G5QVK:UF0%ZI@6%!NBY?F&
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ML<]0OUNY_4O?BO^<JBW#CG'88*A@\!$S5:V@MALC:Z<8:VE0?]RRQ'\0*.N
MYQN)"M%M;(#^KY;^ 5!+ P04    " "\3EU1+&,X>;$%   >'0  &0   'AL
M+W=O<FMS:&5E=',O<VAE970T,"YX;6R]6=]SVC@0_E<TS#VT,TUL2>9'.H09
M8M(V,TF:@>;ZT+D'Q0CPU;8X281FIG_\R<:Q (LM3CO)0\!F=_6M5OOM2NJO
MA?RN%IQK]"--,G7>6FB]?.]Y*EKPE*E3L>29^64F9,JT>91S3RTE9]-"*4T\
MXOL=+V5QUAKTBW=W<M 7*YW$&;^32*W2E,FG"YZ(]7D+MYY?C./Y0N<OO$%_
MR>9\PO7]\DZ:)Z^R,HU3GJE89$CRV7EKB-^'03M7*"3^COE:;7U'N2L/0GS/
M'ZZFYRT_1\03'NG<!#,?CSSD29);,CC^*XVVJC%SQ>WOS]8_%,X;9QZ8XJ%(
MOL93O3AO]5IHRF=LE>BQ6'_BI4,%P$@DJOB/UJ6LWT+12FF1ELH&01IGFT_V
MHYR(+05CQZU 2@6RK] YH$!+!5HXND%6N#5BF@WZ4JR1S*6-M?Q+,3>%MO$F
MSO(P3K0TO\9&3P_&EY,OX_OPR_WXZO8C&MZ.T.<OGR[':')W&5X-KU'X:3C^
M>#E!;T9<LSA1;]$)NI^,T)N_WO8];0#D9KRH'.QB,Q@Y,-@9NA&97BATF4WY
MU*$?POJ8  8\XWGE/GEV_X* %B=\>8JH_PX1G_@N0+#ZB$=&'>?J^ R 0ZMH
MT,(>/10-KK1<17HEXVR.0J$T8MD4F==</G+T[=K(HRO-4_4/,%I0C184HP5'
MC58.XHKJQDRO,)/SPN, ^X&?__6]Q^W9<@C2/<$=I.T*:;L!TG#!Y)PK%]*-
MF>X6 !)T 0"="D"G^50A0W(ZX5/T-=8+%#*U0$,3K<]ZP24:3O\UV6L(3[MP
M=FHX3]I^#P#:K8!V0:"WAOGE#MCH\&QU:RAH[\P5U[I@T(/BVJO0]AI,:XG4
MX$^8-M.J!5+\D4N61;S( U',+$^7B7CB'$4F/YQ^]6IP,>FY_*H+D@X!_#JK
M_#H#_2J7@%(F&E?IDL4R7PC0PCVK0\8^@ 3[EN#]WYOCR%"J-.5TQ1(D'I)X
MSO("JQ!32D1Q(;7.%WC"3;F<HAF+XB36L3%B8U*^?*KL'HQ-B78W17U7<%R2
M!)R3K:*'P3FY?%Y"DVI]7?",SV*M3')O/'"G_#"*9#Y1<'J7P^_D=QG/?2<=
MDE!F86)])*"/359?:6IGJBF&8-B*ABD(XSY;;:V:ISURDIMI=8.B]:GI.M/8
M)0FE,;85$K^@1+Y#X4K*0Z$/:EAZX$S:&HB;%,$*RZW((@".HR)2"(ZMB!@N
MB:%X+!)G)%=S-#)YE(AEL<Z^W?#T@4NH0\&VG.'N*W1$V!8D#%>D1O43.^I'
MN^U<H2[)#A0'6VHP7&M^&0?T$SGX[H@H$5MCB/\*42*6OPG,WT=WKJ1.K^YB
MXQ#<C^0N5LO#!.;AHWM74B?A_6YL%X+E8 )S\)_N7HF#;VL[@EVLEG$)S+A-
MRA:I<^VA\2W+$IAECTFG#\_%+$R$RJ?TF&2RQ$HZKY%,EF()O&4X/ID<VP#G
M=L$E".W"B*5GTF3# "V-.N%V0 B6;PG,MW\\F>JM_PFAT%Z06EZF<._?))EH
MO=W&7:A5H):N*4S7U^PA%'*)1C&;9V8]QY$Z)F6HY5A*7B%EZ-8Q#4RHC;H$
M6F?+VJG()F\<DF1_X[J+V-(JA6D5"L&+&P1J696V7R- ED/I"\YKG,&IG\34
MHE(7@3H#:HF7-B%>*#4=!S509T MG](F?/K[9$;KM'L20(T!M;Q+8=YMQ&5U
M3CTP?F"Y-("Y]!<9])*>(+ ,&N#7.!BVA!HT:5JAH^%ZTXJ=.Z!2</MLF$ %
M.;!D'#3I;H%5$=3IM0T=$P1;!^DO.";XC30*ZHWM"28@5DO% =S@-LFCTM1V
MT-K.>N1MW4"EW)C++^84BL0JTYO+J.IM=?DW+*Z\/"N^N3F\,6CB3*&$SXRJ
M?]HU&.3F,F[SH,6RN,]Z$%J+M/BZX&S*92Y@?I\)H9\?\@&J*]'!_U!+ P04
M    " "\3EU1+[4P$T$%   R&P  &0   'AL+W=O<FMS:&5E=',O<VAE970T
M,2YX;6R]F5MSVC@4@/^*AMF'=J:)+<G<.H29!-+=S"3=##3=ATX?A!'@K6VQ
MLH!FIC]^)>-8$(N#R6:3AV";<]7E.\>HMQ'R1[;@7*&?29QF%XV%4LN/GI>%
M"YZP[%PL>:J_F0F9,*5OY=S+EI*S::Z4Q![Q_9:7L"AM]'OYLWO9[XF5BJ.4
MWTN4K9*$R<<K'HO-10,WGAZ,HOE"F0=>O[=D<S[FZF%Y+_6=5UJ91@E/LTBD
M2/+91>,2?QP&OE'();Y&?)/M7".3RD2('^;F9GK1\$U$/.:A,B:8_ECS 8]C
M8TG'\4]AM%'Z-(J[UT_6/^7)ZV0F+.,#$?\53=7BHM%IH"F?L56L1F+S!R\2
M:AI[H8BS_#_:%+)^ X6K3(FD4-81)%&Z_60_BX'84=!VW JD4"#/%5H'%&BA
M0)\K! <4@D(AR$=FFTH^#D.F6+\GQ09)(ZVMF8M\,'-MG7Z4FGD?*ZF_C;2>
MZH^NQU]&#X,O#Z.;S[\C?7<]^GH]1N^&7+$HSMZC,_0P'J)WO[WO>4K[,UI>
M6-B^VMHF!VQWT9U(U2)#U^F43QWZ U@?$\" IQ,MLR5/V5X1T.*8+\\1]3\@
MXA/?%1"L/N2A5L=&'7<=ZL,7>]_+AI9S1W-[]-#<\4S)5:A6,DKG:" RA5@Z
M1?HQEVN.OMUJ>72C>))]![P%I;<@]Q8<\/:0KC(^13,61G&D'O6FW_4NMTXS
MURK9VNWD=@V'UOUVQS=_/6^]._A5.;(OMA=WLXR["<9]Q6*6AOP#FO!YE*8F
M6#%#2RXCX5J35UMK[9TH, V .%IE'"TPCOW9"A=,SMW#U:H$0((V$$"[#* -
M!C!@V0(MV:.FMLKRE2+4@DO$IG]KSN1/7>&T*^&<-?T.$$^GC*=3;V*X"06:
MDDYU2OS M8(<@N#<=<M0N_#0K:34X^/:\MW*HNU@P"/V+9A]T.=GD9Z%A_T6
MVGO+A$*.=RH"!AU_$8K%:'^Y%DQQU@!<=W9<DL^GITBNALW][(C-CH#972?+
M6#QRCL9\S:59@.B*IWP6Z3TQXC%3?.K.'5V&H5SID;DL]XMS.$@U=.P<C:H@
MF*&M"IB"&=ZRR4#()1I&;)[JHA"%&?IVQY,)E]_1KYV\#0+^S!%0#HHI(E8:
MJ!K8E@T<O$&5PA;W^'5YCZO ;T+S8'F/7PGXN$I\VH5"L,3'_PORL8/Y ;@X
M+?/Q:T$?5V%>V4)5$7#J+.XQS/M3$=@]'FI5I.DD'V1JO^>UE83 E>0($&ZY
M?F_:@<&GIPZO-@R(K2T$OP$,B*4]@6E_*@Q(%<H$ZKV(I3*!J5R;!H6=O94"
M]<'$DIC '?P+:5!8W:,!)F!(%M:D)JR/XH X^G+7#AHX!.$IM$ G,-!/I *I
M8OU Q(Z.O^V"0PV+^ZG90D&.% JQSEN"H5S-T5!W"+%8F@7Q^HT#L:6"=-Z"
M%1;Z!(;^R:QP(!V:#6J!36%@UV8%K;X$=*#.@5I04_@EX(6LH-7&_0SNW*EE
M.:W)\J.LH(=:Z^<[SR$(3^'.3S,P[D]D!:U"_T#$CNK@;"1J6-Q/S981>J2,
MU&#%?^\IJ*TAM/D&G*"V#%"X#)S*"5JE-OA[#K74IC"UZW.BVM"WP! LI"G<
MS[^4$]7._8Q0Z%<E:CE.:W+\.">J! ^ZSEWG$(3&+["H#V#4G\B)PEKG:,0N
M06=/4</B-C5OYY AX7JEF<.:#(5BE:KM>4/YM#P0NLR/03PKOCU-NM,+-4HS
M%/.95O7/VWJ#R^T!S?9&B65^9#$12HDDOUQP-N72".CO9T*HIQOCH#PFZ_\+
M4$L#!!0    ( +Q.75%V'ME=U @  (0U   9    >&PO=V]R:W-H965T<R]S
M:&5E=#0R+GAM;+V;;W/:N!:'OXJ&V3NWG6F+)5FRZ229(4!\<R?-9IIF]\7.
M?>&  MXU%FN;I-W9#W]EXR"##P>S(>F+!LSO2.?HSWDDV3YYTND?V4RIG'R?
MQTEVVIGE^>)SMYN-9VH>9I_T0B7FEP>=SL/<?$VGW6R1JG!2&LWC+G,<V9V'
M4=(Y.RFOW:1G)WJ9QU&B;E*2+>?S,/UQKF+]=-JAG><+7Z/I+"\N=,].%N%4
MW:K\;G&3FF_==2F3:*Z2+-()2=7#::=//P>>4QB4BE\B]935/I,BE'NM_RB^
M7$Y..T[AD8K5."^*",V?1S50<5R49/SXLRJTLZZS,*Q_?B[]H@S>!',?9FJ@
MXU^C23X[[?@=,E$/X3+.O^JG_Z@J(%&4-]9Q5OY/GBJMTR'C99;K>65L/)A'
MR>IO^+UJB)J!*0<V8)4!VS;P=ACPRH!O&[@[#-S*P&WKDJ@,Q+:!W&$@*P/9
MUL"K#+RRLU:M6W;-,,S#LY-4/Y&T4)O2B@]E_Y;6ID>BI!B*MWEJ?HV,77X6
M_/SS\-?+JRO2OQZ2R^MO_>O@\OQJ1/JWMZ-OM^3=8!8F4Y61*"&#,$U_1,F4
M].=ZF>1$/Y! Z\E3%,?OR;NARL,HSMZ3C^3N=DC>_?3^I)L;!XMJNN/*F?.5
M,VR',YQ\T4D^R\@HF:@)8#_"[7O[[ /<GC*D@*YIV77SLN?F/6=HB;=J\8EP
MYP-A#G, AP:X^9<P->9TI_FP=>VT!S7GRYR_>%GM 6X^5./GV+?--[J"KT<Z
M+\OCNT9Z-5;);U?F%W*9JWGV/Z1<=UVN6Y;K[BC7S(8TC_X*R\QJYD24Y&;*
M1/>QF35A,B$ZGZF4A%FF\@R:$JO2_;+T AR/9Y(9D)A_)]W'>E\#0NH!PE%3
M2'U7 LH+0.GUG$WE1J.(=:,(M%%NU:-*PV2LR$!G8-RC50%>O6[F TX&HN$D
MDPSQ4:Y]E*B/E^N.(OVR=SZ0(-591MZ-OH_CY:1(=>L$!_6<;$0@>H)3J$O:
M2P- ZOM"(@%[ZX ]-.#S,"Z[),R*<?K?,%F:Q0>A4%KR&FWN^5(X4&A>PU]
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ME _ZMIN3EI#BN(24EI#RE0DI(>R!S\.T5@:@$AN2TO)1OAT?)< R\$R^K3
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M3+>GA<#\_J!U_OREJ&#]XM79_P%02P,$%     @ O$Y=4?]21P#-!   $A@
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MPSGH8F"3/^#2'W"K_H UNE^7'QT*5E;./O?2&_!Q;WB.J<_ C(;LI(6 *[\
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M@-_G M>,XB%+4/Z9,?H/4$L#!!0    ( +Q.75%%X]/C_@0  -X5   9
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M?DBBV*<18&1YUKLP/UW90ZF02GSUR7-<N@;2E#FEW^67Z\59SY"(2$ \+H?
MXN.)3$@0R)$$CA_YH+UB3JE8OMZ.?I4:+XR9XYA,:/"/O^#KL]ZP!Q9DB9.
MW]/G/TEND"W'\V@0I__!<RYK]("7Q)R&N;) $/I1]HE?<D>4%*#=H !S!;BO
M8#8H6+F"U54!Y0JHJX*=*]A=%9Q<P4E]GSDK]?04<WQ^RN@S8%):C"8OTG"E
MVL+!?B0SZX$S<=<7>OQ\>CE^!$<31A8^!U?8\P.?^R0^!D=3PK$?B*L/P(_
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M@<Q2,L,I^5LYT?E"QN5:[U8H+,$R?W^%PC(9VXW)7E0H7":B+(""V@=,I:$
M;/4M9S&<L]"B C /!RD8M,0:(VZYA.-<\E[;-MQMWK;MVP"FSVS<<,M<'._S
M>G$:E_IS$M^;)+E(2].CQZ;=:Y0]CL#MI0)POZT/6'(C'3$ EA0Y3HHOJ%O<
M[9,VE5:#S"5-CBD1OK(;C7/FMN)"_DO>TM9PRUM<[&_/W9()Q\GDW6X2@&G
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M;?&FS&;U#Z7NLM+<>?7+B3;QRRL#\_THR\JG-]5OKY8_,#SY'U!+ P04
M" "\3EU1?&(+D)0$  #]#@  &0   'AL+W=O<FMS:&5E=',O<VAE970U-RYX
M;6R-EU]OXC@0P+^*A?:AE;KY3T)6%(E";P^IVW+E>O=PN@>3&+ VB;.V4]IO
MO^,DA-"8E!>(DYGQ;\;C&7N\9_RGV!$BT5N:9.)VL),R_V::(MJ1% N#Y22#
M+QO&4RQAR+>FR#G!<:F4)J9C6;Z98IH-)N/RW9)/QJR0"<W(DB-1I"GF[W<D
M8?O;@3TXO'BFVYU4+\S).,=;LB+R)5]R&)F-E9BF)!.498B3S>U@:G^[MWVE
M4$K\0\E>M)Z1<F7-V$\U6,2W TL1D81$4IG \/=*9B1)E"7@^%4;'31S*L7V
M\\'Z'Z7SX,P:"S)CR;\TEKO;P6B 8K+!12*?V?Y/4CLT5/8BEHCR%^UK66N
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M*J*$B8(3@=;O:I@S >^_<U;DX@:!N:2(:;8M)5DF:5:0&#WEA&-E0J#_'H
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M>MB5 /32;@$.U\#F#N =%3G\#0M1<JF[6>IN>I[V#I[!I^$U&5BK^32W="J
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M"AFIF5[US@@/\E=(:<W?]U$/MA%=U"!_L=L+EFW!X:4:_P102P,$%     @
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MX!.41E!$Y2BD<A13.0JJ'$55CL(J1W&5H\#*4605*+(*%%D%BJP"15:!(JM
MD56@R"I09!4HL@H4626*K!)%5HDBJT215:+(*E%DE2BR2A19)8JL$D56A2*K
M0I%5H<BJ4&15*+(J%%D5BJP*15:%(JM"D56CR*I19-4HLFH4636*K!I%5HTB
MJT:15:/(JE%D+5!D+5!D+?Y3UF=KEW\</SSSUM3=(9\-?S*:O0%02P$"% ,4
M    " "\3EU1!T%-8H$   "Q    $               @ $     9&]C4')O
M<',O87!P+GAM;%!+ 0(4 Q0    ( +Q.75&W$[_0[P   "L"   1
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M965T,BYX;6Q02P$"% ,4    " "\3EU1\13"]W8"  !R!0  &
M    @($F%0  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @
MO$Y=47;NT7K]!0  &!D  !@              ("!TA<  'AL+W=O<FMS:&5E
M=',O<VAE970T+GAM;%!+ 0(4 Q0    ( +Q.75&\(,%EP00  (81   8
M          " @04>  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4
M    " "\3EU1O*%ZT\P*  #.2P  &               @('\(@  >&PO=V]R
M:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ O$Y=4=]^$,8P"   /"(
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M:&5E=#$Q+GAM;%!+ 0(4 Q0    ( +Q.75%*!&_MAP0  .\+   9
M      " @:E1  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%
M  @ O$Y=4>^<?)"7!   <0L  !D              ("!9U8  'AL+W=O<FMS
M:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " "\3EU1Q:$/1[()  #L'
M&0              @($U6P  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+
M 0(4 Q0    ( +Q.75&)#>;%O04  /L0   9              " @1YE  !X
M;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ O$Y=42>7)%2>
M!   " L  !D              ("!$FL  'AL+W=O<FMS:&5E=',O<VAE970Q
M-BYX;6Q02P$"% ,4    " "\3EU180P=^E@@  ">:@  &0
M@('G;P  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( +Q.
M75&NH2)WZ@@  " 8   9              " @7:0  !X;"]W;W)K<VAE971S
M+W-H965T,3@N>&UL4$L! A0#%     @ O$Y=4<)JUP_'!@  0A(  !D
M         ("!EYD  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4
M    " "\3EU1+]C@G2((  !R&P  &0              @(&5H   >&PO=V]R
M:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( +Q.75','$>Q=P@  -L8
M   9              " @>ZH  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL
M4$L! A0#%     @ O$Y=41ELJR&8!0  #0P  !D              ("!G+$
M 'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " "\3EU14=;9
M:)@%   P#0  &0              @(%KMP  >&PO=V]R:W-H965T<R]S:&5E
M=#(S+GAM;%!+ 0(4 Q0    ( +Q.75%Q>DP[NP0  #<-   9
M  " @3J]  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @
MO$Y=4:VB9K,B!@  >0X  !D              ("!+,(  'AL+W=O<FMS:&5E
M=',O<VAE970R-2YX;6Q02P$"% ,4    " "\3EU1-4?0TC@$  ";"0  &0
M            @(&%R   >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4
M Q0    ( +Q.75$$2*SQFPH  !P=   9              " @?3,  !X;"]W
M;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ O$Y=43*']QWE"@
M$20  !D              ("!QM<  'AL+W=O<FMS:&5E=',O<VAE970R."YX
M;6Q02P$"% ,4    " "\3EU18)^.;7,#  !#"0  &0              @('B
MX@  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( +Q.75%.
MG$L&8 ,  !X'   9              " @8SF  !X;"]W;W)K<VAE971S+W-H
M965T,S N>&UL4$L! A0#%     @ O$Y=47F+Y(^ !   )0H  !D
M     ("!(^H  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( +Q.75$1!RS,#@,  "$&   9              "
M@?T" 0!X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ O$Y=
M4:CQ?R=Q"P  ?C@  !D              ("!0@8! 'AL+W=O<FMS:&5E=',O
M<VAE970S-RYX;6Q02P$"% ,4    " "\3EU17.;/29($  #P$   &0
M        @('J$0$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0
M   ( +Q.75'BC:JQD (  .$&   9              " @;,6 0!X;"]W;W)K
M<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ O$Y=42QC.'FQ!0  'AT
M !D              ("!>AD! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q0
M2P$"% ,4    " "\3EU1+[4P$T$%   R&P  &0              @(%B'P$
M>&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( +Q.75%V'ME=
MU @  (0U   9              " @=HD 0!X;"]W;W)K<VAE971S+W-H965T
M-#(N>&UL4$L! A0#%     @ O$Y=4?]21P#-!   $A@  !D
M ("!Y2T! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    " "\
M3EU18;2'$[ %   W&P  &0              @('I,@$ >&PO=V]R:W-H965T
M<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( +Q.75&VS3-T[0,  $\,   9
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M970T.2YX;6Q02P$"% ,4    " "\3EU1+-IDV],$   '$@  &0
M    @(%?50$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    (
M +Q.75$>#5T4LP(  (T&   9              " @6E: 0!X;"]W;W)K<VAE
M971S+W-H965T-3$N>&UL4$L! A0#%     @ O$Y=4=Z.E.@+#   Y2H  !D
M             ("!4UT! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"
M% ,4    " "\3EU10R3:'UD#   T"P  &0              @(&5:0$ >&PO
M=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( +Q.75'L??HA.@8
M -X?   9              " @25M 0!X;"]W;W)K<VAE971S+W-H965T-30N
M>&UL4$L! A0#%     @ O$Y=4>[Q#<'A!@  ?R4  !D              ("!
MEG,! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4    " "\3EU1
M1XB54& )  !L.   &0              @(&N>@$ >&PO=V]R:W-H965T<R]S
M:&5E=#4V+GAM;%!+ 0(4 Q0    ( +Q.75%\8@N0E 0  /T.   9
M      " @46$ 0!X;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%
M  @ O$Y=481V)\(9!@  FQT  !D              ("!$(D! 'AL+W=O<FMS
M:&5E=',O<VAE970U."YX;6Q02P$"% ,4    " "\3EU1J:$-W!0#   E"0
M&0              @(%@CP$ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+
M 0(4 Q0    ( +Q.75&)77.EV0\  '.-   9              " @:N2 0!X
M;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ O$Y=4>L&M@1%
M @  )@8  !D              ("!NZ(! 'AL+W=O<FMS:&5E=',O<VAE970V
M,2YX;6Q02P$"% ,4    " "\3EU1H:U?<;\"   7"P  &0
M@($WI0$ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    ( +Q.
M75$8L)R(/0(  +8*   -              "  2VH 0!X;"]S='EL97,N>&UL
M4$L! A0#%     @ O$Y=49>*NQS     $P(   L              ( !E:H!
M %]R96QS+RYR96QS4$L! A0#%     @ O$Y=4:Z_W()4!0  2"D   \
M         ( !?JL! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( +Q.75%W
M2W&%!@(  /$D   :              "  ?^P 0!X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<U!+ 0(4 Q0    ( +Q.75'_)Z=UXP$  &PD   3
M      "  3VS 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !& $8 (1,
' %&U 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>405</ContextCount>
  <ElementCount>419</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>68</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1108114 - Statement - SUPPLEMENTAL CASH FLOW INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATION</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW INFORMATION</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>1309307 - Statement - SUPPLEMENTAL CASH FLOW INFORMATION Tabular Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONTabularInformation</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW INFORMATION Tabular Information</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>1410423 - Statement - SUPPLEMENTAL CASH FLOW INFORMATION Description Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW INFORMATION Description Information</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATION</Role>
      <ShortName>BASIS OF FINANCIAL STATEMENT PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2107102 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/EARNINGSPERSHARE</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2113104 - Disclosure - RESTRUCTURING AND OTHER SPECIAL CHARGES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGES</Role>
      <ShortName>RESTRUCTURING AND OTHER SPECIAL CHARGES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2124107 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/DEBT</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2130108 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY</Role>
      <ShortName>PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2133109 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2135110 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2137111 - Disclosure - PENSION AND POSTRETIREMENT PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANS</Role>
      <ShortName>PENSION AND POSTRETIREMENT PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2140112 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2143113 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2146115 - Disclosure - BUSINESS ACQUISITIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/BUSINESSACQUISITIONS</Role>
      <ShortName>BUSINESS ACQUISITIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2153117 - Disclosure - BUSINESS SEGMENT INFORMATION Business Segment information (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION Business Segment information (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION Use of Estimates (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONUseofEstimatesPolicies</Role>
      <ShortName>BASIS OF FINANCIAL STATEMENT PRESENTATION Use of Estimates (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2203202 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION New Accounting Pronouncements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONNewAccountingPronouncementsPolicies</Role>
      <ShortName>BASIS OF FINANCIAL STATEMENT PRESENTATION New Accounting Pronouncements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2204203 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION Novel Coronavirus (COVID-19) Financial Statement Impact (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONNovelCoronavirusCOVID19FinancialStatementImpactPolicies</Role>
      <ShortName>BASIS OF FINANCIAL STATEMENT PRESENTATION Novel Coronavirus (COVID-19) Financial Statement Impact (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2205204 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION Recently Adopted Accounting Standards (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONRecentlyAdoptedAccountingStandardsPolicies</Role>
      <ShortName>BASIS OF FINANCIAL STATEMENT PRESENTATION Recently Adopted Accounting Standards (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2223205 - Disclosure - Intangible Assets, Goodwill and Other (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/IntangibleAssetsGoodwillandOtherPolicies</Role>
      <ShortName>Intangible Assets, Goodwill and Other (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2259206 - Disclosure - Revenue from Contract with Customer (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/RevenuefromContractwithCustomerPolicies</Role>
      <ShortName>Revenue from Contract with Customer (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2308302 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/EARNINGSPERSHARETables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/EARNINGSPERSHARE</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2314303 - Disclosure - RESTRUCTURING AND OTHER SPECIAL CHARGES Restructuring and Other Special Charges Detail (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables</Role>
      <ShortName>RESTRUCTURING AND OTHER SPECIAL CHARGES Restructuring and Other Special Charges Detail (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2319304 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2341305 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2347308 - Disclosure - BUSINESS ACQUISITIONS Business Acquisitions Tables (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsTablesTables</Role>
      <ShortName>BUSINESS ACQUISITIONS Business Acquisitions Tables (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2352309 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONTables</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2356310 - Disclosure - REVENUE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/REVENUETables</Role>
      <ShortName>REVENUE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2361311 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2406401 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails</Role>
      <ShortName>BASIS OF FINANCIAL STATEMENT PRESENTATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONUseofEstimatesPolicies</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2409402 - Disclosure - EARNINGS PER SHARE (Reconciliation of Basic Earnings Per Share to Diluted Earnings Per Share) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails</Role>
      <ShortName>EARNINGS PER SHARE (Reconciliation of Basic Earnings Per Share to Diluted Earnings Per Share) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/EARNINGSPERSHARETables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2410403 - Disclosure - EARNINGS PER SHARE (Potential common shares not included in computation of diluted earnings per share) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/EARNINGSPERSHAREPotentialcommonsharesnotincludedincomputationofdilutedearningspershareDetails</Role>
      <ShortName>EARNINGS PER SHARE (Potential common shares not included in computation of diluted earnings per share) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/EARNINGSPERSHARETables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2415405 - Disclosure - RESTRUCTURING AND OTHER SPECIAL CHARGES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails</Role>
      <ShortName>RESTRUCTURING AND OTHER SPECIAL CHARGES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2417406 - Disclosure - RESTRUCTURING RESERVES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails</Role>
      <ShortName>RESTRUCTURING RESERVES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2420407 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Changes in Carrying Amount of Goodwill) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Changes in Carrying Amount of Goodwill) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2421408 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Components of identifiable intangible assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Components of identifiable intangible assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2422409 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2425410 - Disclosure - DEBT (Short-term borrowings and current portion of long-term debt) (Table) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails</Role>
      <ShortName>DEBT (Short-term borrowings and current portion of long-term debt) (Table) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/DEBT</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2426411 - Disclosure - DEBT (Long-term debt) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/DEBTLongtermdebtDetails</Role>
      <ShortName>DEBT (Long-term debt) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/DEBT</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2427412 - Disclosure - DEBT (Senior Notes) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.labcorp.com/role/DEBTSeniorNotesDetails</Role>
      <ShortName>DEBT (Senior Notes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/DEBT</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2429414 - Disclosure - DEBT (Credit Facilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/DEBTCreditFacilitiesDetails</Role>
      <ShortName>DEBT (Credit Facilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/DEBT</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2431415 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails</Role>
      <ShortName>PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2432416 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY - Accumulated Other Comprehensive Earnings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails</Role>
      <ShortName>PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY - Accumulated Other Comprehensive Earnings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2434417 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/INCOMETAXESDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/INCOMETAXES</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2438419 - Disclosure - PENSION AND POSTRETIREMENT PLANS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails</Role>
      <ShortName>PENSION AND POSTRETIREMENT PLANS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANS</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2439420 - Disclosure - PENSION AND POSTRETIREMENT PLANS Defined Contribution Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails</Role>
      <ShortName>PENSION AND POSTRETIREMENT PLANS Defined Contribution Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2442421 - Disclosure - FAIR VALUE MEASUREMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2445422 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2449425 - Disclosure - BUSINESS ACQUISITIONS Business Acquisitions in the Aggregate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails</Role>
      <ShortName>BUSINESS ACQUISITIONS Business Acquisitions in the Aggregate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2450426 - Disclosure - BUSINESS ACQUISITIONS DISPOSITIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails</Role>
      <ShortName>BUSINESS ACQUISITIONS DISPOSITIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2454427 - Disclosure - BUSINESS SEGMENT INFORMATION Business Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION Business Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2457428 - Disclosure - REVENUE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/REVENUEDetails</Role>
      <ShortName>REVENUE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/REVENUETables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2458429 - Disclosure - REVENUE Disaggregated Revenue Table (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails</Role>
      <ShortName>REVENUE Disaggregated Revenue Table (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2462430 - Disclosure - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/LeasesDetails</Role>
      <ShortName>Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/LeasesTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="lh-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - lh-20200930.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - lh-20200930.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="lh-20200930.htm">lh-20200930.htm</File>
    <File>ex311q32020.htm</File>
    <File>ex312q32020.htm</File>
    <File>ex32q32020.htm</File>
    <File>lh-20200930.xsd</File>
    <File>lh-20200930_cal.xml</File>
    <File>lh-20200930_def.xml</File>
    <File>lh-20200930_lab.xml</File>
    <File>lh-20200930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>79
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "lh-20200930.htm": {
   "axisCustom": 1,
   "axisStandard": 19,
   "contextCount": 405,
   "dts": {
    "calculationLink": {
     "local": [
      "lh-20200930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "lh-20200930_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "lh-20200930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lh-20200930_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lh-20200930_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "lh-20200930.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 597,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 4,
    "http://xbrl.sec.gov/dei/2019-01-31": 5,
    "total": 9
   },
   "keyCustom": 80,
   "keyStandard": 339,
   "memberCustom": 25,
   "memberStandard": 37,
   "nsprefix": "lh",
   "nsuri": "http://www.labcorp.com/20200930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityInteractiveDataCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.labcorp.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityInteractiveDataCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "lh:DecreaseinCapitalExpendituresIncurredbutnotyetPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1410423 - Statement - SUPPLEMENTAL CASH FLOW INFORMATION Description Information",
     "role": "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation",
     "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION Description Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "lh:DecreaseinCapitalExpendituresIncurredbutnotyetPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION",
     "role": "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATION",
     "shortName": "BASIS OF FINANCIAL STATEMENT PRESENTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2107102 - Disclosure - EARNINGS PER SHARE",
     "role": "http://www.labcorp.com/role/EARNINGSPERSHARE",
     "shortName": "EARNINGS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113104 - Disclosure - RESTRUCTURING AND OTHER SPECIAL CHARGES",
     "role": "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGES",
     "shortName": "RESTRUCTURING AND OTHER SPECIAL CHARGES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124107 - Disclosure - DEBT",
     "role": "http://www.labcorp.com/role/DEBT",
     "shortName": "DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "lh:ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130108 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY",
     "role": "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY",
     "shortName": "PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "lh:ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133109 - Disclosure - INCOME TAXES",
     "role": "http://www.labcorp.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135110 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2137111 - Disclosure - PENSION AND POSTRETIREMENT PLANS",
     "role": "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANS",
     "shortName": "PENSION AND POSTRETIREMENT PLANS",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2140112 - Disclosure - FAIR VALUE MEASUREMENTS",
     "role": "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7da7c6b0d2814e079360edb6ac4a2611_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "role": "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7da7c6b0d2814e079360edb6ac4a2611_I20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2143113 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES",
     "role": "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2146115 - Disclosure - BUSINESS ACQUISITIONS",
     "role": "http://www.labcorp.com/role/BUSINESSACQUISITIONS",
     "shortName": "BUSINESS ACQUISITIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2153117 - Disclosure - BUSINESS SEGMENT INFORMATION Business Segment information (Notes)",
     "role": "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes",
     "shortName": "BUSINESS SEGMENT INFORMATION Business Segment information (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION Use of Estimates (Policies)",
     "role": "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONUseofEstimatesPolicies",
     "shortName": "BASIS OF FINANCIAL STATEMENT PRESENTATION Use of Estimates (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2203202 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION New Accounting Pronouncements (Policies)",
     "role": "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONNewAccountingPronouncementsPolicies",
     "shortName": "BASIS OF FINANCIAL STATEMENT PRESENTATION New Accounting Pronouncements (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "lh:NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204203 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION Novel Coronavirus (COVID-19) Financial Statement Impact (Policies)",
     "role": "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONNovelCoronavirusCOVID19FinancialStatementImpactPolicies",
     "shortName": "BASIS OF FINANCIAL STATEMENT PRESENTATION Novel Coronavirus (COVID-19) Financial Statement Impact (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "lh:NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "lh:RecentlyAdoptedAccountingGuidancePolicyTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2205204 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION Recently Adopted Accounting Standards (Policies)",
     "role": "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONRecentlyAdoptedAccountingStandardsPolicies",
     "shortName": "BASIS OF FINANCIAL STATEMENT PRESENTATION Recently Adopted Accounting Standards (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": null
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2223205 - Disclosure - Intangible Assets, Goodwill and Other (Policies)",
     "role": "http://www.labcorp.com/role/IntangibleAssetsGoodwillandOtherPolicies",
     "shortName": "Intangible Assets, Goodwill and Other (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRecognitionPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2259206 - Disclosure - Revenue from Contract with Customer (Policies)",
     "role": "http://www.labcorp.com/role/RevenuefromContractwithCustomerPolicies",
     "shortName": "Revenue from Contract with Customer (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRecognitionPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2308302 - Disclosure - EARNINGS PER SHARE (Tables)",
     "role": "http://www.labcorp.com/role/EARNINGSPERSHARETables",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": null,
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parentheticals)",
     "role": "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2314303 - Disclosure - RESTRUCTURING AND OTHER SPECIAL CHARGES Restructuring and Other Special Charges Detail (Tables)",
     "role": "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables",
     "shortName": "RESTRUCTURING AND OTHER SPECIAL CHARGES Restructuring and Other Special Charges Detail (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2319304 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "role": "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2341305 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "role": "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2347308 - Disclosure - BUSINESS ACQUISITIONS Business Acquisitions Tables (Tables)",
     "role": "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsTablesTables",
     "shortName": "BUSINESS ACQUISITIONS Business Acquisitions Tables (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2352309 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)",
     "role": "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONTables",
     "shortName": "BUSINESS SEGMENT INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2356310 - Disclosure - REVENUE (Tables)",
     "role": "http://www.labcorp.com/role/REVENUETables",
     "shortName": "REVENUE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2361311 - Disclosure - Leases (Tables)",
     "role": "http://www.labcorp.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406401 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION (Details)",
     "role": "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
     "shortName": "BASIS OF FINANCIAL STATEMENT PRESENTATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "lh:NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409402 - Disclosure - EARNINGS PER SHARE (Reconciliation of Basic Earnings Per Share to Diluted Earnings Per Share) (Details)",
     "role": "http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails",
     "shortName": "EARNINGS PER SHARE (Reconciliation of Basic Earnings Per Share to Diluted Earnings Per Share) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410403 - Disclosure - EARNINGS PER SHARE (Potential common shares not included in computation of diluted earnings per share) (Details)",
     "role": "http://www.labcorp.com/role/EARNINGSPERSHAREPotentialcommonsharesnotincludedincomputationofdilutedearningspershareDetails",
     "shortName": "EARNINGS PER SHARE (Potential common shares not included in computation of diluted earnings per share) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)",
     "role": "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7da7c6b0d2814e079360edb6ac4a2611_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415405 - Disclosure - RESTRUCTURING AND OTHER SPECIAL CHARGES (Details)",
     "role": "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails",
     "shortName": "RESTRUCTURING AND OTHER SPECIAL CHARGES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "lh:NetRestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "lh:Unusedfacilityrestructuringreserves",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417406 - Disclosure - RESTRUCTURING RESERVES (Details)",
     "role": "http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails",
     "shortName": "RESTRUCTURING RESERVES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420407 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Changes in Carrying Amount of Goodwill) (Details)",
     "role": "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Changes in Carrying Amount of Goodwill) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7da7c6b0d2814e079360edb6ac4a2611_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421408 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Components of identifiable intangible assets) (Details)",
     "role": "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Components of identifiable intangible assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7da7c6b0d2814e079360edb6ac4a2611_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422409 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details)",
     "role": "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i1982102278bd444d897b0ac03dedfda5_D20200701-20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "lh:Impairmentoffloatingratenotereceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i9dcbdb2a510240b49e6e31157090b5d1_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425410 - Disclosure - DEBT (Short-term borrowings and current portion of long-term debt) (Table) (Details)",
     "role": "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails",
     "shortName": "DEBT (Short-term borrowings and current portion of long-term debt) (Table) (Details)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShortTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426411 - Disclosure - DEBT (Long-term debt) (Details)",
     "role": "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
     "shortName": "DEBT (Long-term debt) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShortTermDebtTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7da7c6b0d2814e079360edb6ac4a2611_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "lh:Shorttermdebtissuancecosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427412 - Disclosure - DEBT (Senior Notes) (Details)",
     "role": "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
     "shortName": "DEBT (Senior Notes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShortTermDebtTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7da7c6b0d2814e079360edb6ac4a2611_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "lh:Shorttermdebtissuancecosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7da7c6b0d2814e079360edb6ac4a2611_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "lh:A2019TermLoan",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429414 - Disclosure - DEBT (Credit Facilities) (Details)",
     "role": "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
     "shortName": "DEBT (Credit Facilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "ic3ee871e124f4fbc9fc99ccaf3849f33_I20200930",
      "decimals": "2",
      "lang": "en-US",
      "name": "lh:DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7da7c6b0d2814e079360edb6ac4a2611_I20200930",
      "decimals": "-7",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431415 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY (Details)",
     "role": "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails",
     "shortName": "PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7da7c6b0d2814e079360edb6ac4a2611_I20200930",
      "decimals": "-7",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lh:NetRestructuringAndOtherSpecialCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (Unaudited)",
     "role": "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432416 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY - Accumulated Other Comprehensive Earnings (Details)",
     "role": "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails",
     "shortName": "PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY - Accumulated Other Comprehensive Earnings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434417 - Disclosure - INCOME TAXES (Details)",
     "role": "http://www.labcorp.com/role/INCOMETAXESDetails",
     "shortName": "INCOME TAXES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "lh:NonElectiveContribution",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438419 - Disclosure - PENSION AND POSTRETIREMENT PLANS (Details)",
     "role": "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
     "shortName": "PENSION AND POSTRETIREMENT PLANS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "lh:NonElectiveContribution",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439420 - Disclosure - PENSION AND POSTRETIREMENT PLANS Defined Contribution Plans (Details)",
     "role": "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails",
     "shortName": "PENSION AND POSTRETIREMENT PLANS Defined Contribution Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": "2",
      "lang": "en-US",
      "name": "lh:DiscretionaryContributionPercentageMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7da7c6b0d2814e079360edb6ac4a2611_I20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "lh:NumberofMeasurementFundsAvailableForParticipantElection",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442421 - Disclosure - FAIR VALUE MEASUREMENTS (Details)",
     "role": "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7da7c6b0d2814e079360edb6ac4a2611_I20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "lh:NumberofMeasurementFundsAvailableForParticipantElection",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445422 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Details)",
     "role": "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449425 - Disclosure - BUSINESS ACQUISITIONS Business Acquisitions in the Aggregate (Details)",
     "role": "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails",
     "shortName": "BUSINESS ACQUISITIONS Business Acquisitions in the Aggregate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7da7c6b0d2814e079360edb6ac4a2611_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450426 - Disclosure - BUSINESS ACQUISITIONS DISPOSITIONS (Details)",
     "role": "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails",
     "shortName": "BUSINESS ACQUISITIONS DISPOSITIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "lh:PercentofRevenueContributed",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454427 - Disclosure - BUSINESS SEGMENT INFORMATION Business Segment Information (Details)",
     "role": "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
     "shortName": "BUSINESS SEGMENT INFORMATION Business Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "lh:Intercompanyrevenueelimination",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfDeferredSalesCommissions",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457428 - Disclosure - REVENUE (Details)",
     "role": "http://www.labcorp.com/role/REVENUEDetails",
     "shortName": "REVENUE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6ac49907696d40399215ce933a047245_I20181231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited)",
     "role": "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i9d1cc0f890c444fc8065f85eaf2c3eb2_D20190101-20190331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7da7c6b0d2814e079360edb6ac4a2611_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "lh:UnbilledServicesAllowanceforCreditLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458429 - Disclosure - REVENUE Disaggregated Revenue Table (Details)",
     "role": "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
     "shortName": "REVENUE Disaggregated Revenue Table (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i9dcbdb2a510240b49e6e31157090b5d1_I20191231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "lh:UnbilledServicesAllowanceforCreditLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7da7c6b0d2814e079360edb6ac4a2611_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLiabilityCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462430 - Disclosure - Leases (Details)",
     "role": "http://www.labcorp.com/role/LeasesDetails",
     "shortName": "Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "role": "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i7009e5ba49e7481bb5691c90f6c5789c_D20200101-20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "lh:DepreciationAndAmortizationOfLeasedAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1108114 - Statement - SUPPLEMENTAL CASH FLOW INFORMATION",
     "role": "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATION",
     "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "i6d89708734bd4e0fbd8f475e6bb5602e_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1309307 - Statement - SUPPLEMENTAL CASH FLOW INFORMATION Tabular Information",
     "role": "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONTabularInformation",
     "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION Tabular Information",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R9999": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20200930.htm",
      "contextRef": "ia31964c5cf72480688ceb520816d7665_I20200101",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - lh-20200930.htm",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - lh-20200930.htm",
     "subGroupType": "",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 68,
   "tag": {
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "CANADA",
        "terseLabel": "CANADA"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "country_CH": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "SWITZERLAND",
        "terseLabel": "SWITZERLAND"
       }
      }
     },
     "localname": "CH",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "country_GB": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "UNITED KINGDOM",
        "terseLabel": "UNITED KINGDOM"
       }
      }
     },
     "localname": "GB",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards.",
        "label": "Document [Domain]",
        "terseLabel": "Document [Domain]"
       }
      }
     },
     "localname": "DocumentDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationDocumentAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Document Information, Document [Axis]",
        "terseLabel": "Document Information, Document [Axis]"
       }
      }
     },
     "localname": "DocumentInformationDocumentAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r598"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r599"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r601"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r597"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "lh_A2.30seniornotesdue2024": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.30% senior notes due 2024",
        "label": "2.30% senior notes due 2024",
        "terseLabel": "2.30% senior notes due 2024"
       }
      }
     },
     "localname": "A2.30seniornotesdue2024",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_A2.95seniornotesdue2029": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.95% senior notes due 2029",
        "label": "2.95% senior notes due 2029",
        "terseLabel": "2.95% senior notes due 2029"
       }
      }
     },
     "localname": "A2.95seniornotesdue2029",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_A2019TermLoan": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2019 Term Loan",
        "label": "2019 Term Loan",
        "terseLabel": "2019 Term Loan"
       }
      }
     },
     "localname": "A2019TermLoan",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_A2019TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2019 Term Loan [Member]",
        "label": "2019 Term Loan [Member]",
        "terseLabel": "2019 Term Loan [Member]"
       }
      }
     },
     "localname": "A2019TermLoanMember",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_A4.625Seniornotesdue2020": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.625% Senior notes due 2020",
        "label": "4.625% Senior notes due 2020",
        "terseLabel": "4.625% Senior notes due 2020"
       }
      }
     },
     "localname": "A4.625Seniornotesdue2020",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_AccruedLiabilityForCARESActFundsToBeReturnedToGovernmentDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accrued Liability For CARES Act Funds To Be Returned to Government [Domain]",
        "terseLabel": "Accrued Liability For CARES Act Funds To Be Returned to Government [Domain]"
       }
      }
     },
     "localname": "AccruedLiabilityForCARESActFundsToBeReturnedToGovernmentDomain",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_AccumulatedOtherComprehensiveEarningsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Earnings [Roll Forward]",
        "label": "Accumulated Other Comprehensive Earnings [Roll Forward]",
        "terseLabel": "Accumulated Other Comprehensive Earnings [Roll Forward]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveEarningsRollForward",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_AllowanceforCreditLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Allowance for Credit Loss",
        "label": "Allowance for Credit Loss",
        "terseLabel": "Allowance for Credit Loss"
       }
      }
     },
     "localname": "AllowanceforCreditLoss",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_AllowanceforCreditLossWriteOff": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Allowance for Credit Loss, Write Off",
        "label": "Allowance for Credit Loss, Write Off",
        "terseLabel": "Allowance for Credit Loss, Write Off"
       }
      }
     },
     "localname": "AllowanceforCreditLossWriteOff",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_BalanceOfSeniorNotesMatureDuringQ42020": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Balance of Senior Notes Mature During Q4 2020",
        "label": "Balance of Senior Notes Mature During Q4 2020",
        "terseLabel": "Senior Notes Became Due During Quarter"
       }
      }
     },
     "localname": "BalanceOfSeniorNotesMatureDuringQ42020",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_BiopharmaceuticalandmedicaldevicecompaniesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Biopharmaceutical and medical device companies [Member]",
        "label": "Biopharmaceutical and medical device companies [Member]",
        "terseLabel": "Biopharmaceutical and medical device companies [Member]"
       }
      }
     },
     "localname": "BiopharmaceuticalandmedicaldevicecompaniesMember",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_CARESActFundsAccruedLiabilitiesAndOtherLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "CARES Act Funds Accrued Liabilities And Other Liabilities",
        "label": "CARES Act Funds Accrued Liabilities And Other Liabilities",
        "terseLabel": "CARES Act Funds Accrued Liabilities And Other Liabilities"
       }
      }
     },
     "localname": "CARESActFundsAccruedLiabilitiesAndOtherLiabilities",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_CARESActFundsAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "CARES Act Funds",
        "label": "CARES Act Funds [Axis]",
        "terseLabel": "CARES Act Funds [Axis]"
       }
      }
     },
     "localname": "CARESActFundsAxis",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_COVID19PandemicAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "COVID-19 Pandemic",
        "label": "COVID-19 Pandemic [Axis]",
        "terseLabel": "COVID-19 Pandemic [Axis]"
       }
      }
     },
     "localname": "COVID19PandemicAxis",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_COVID19PandemicGoodwillAndIntangibleAssetImpairment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "COVID-19 Pandemic Goodwill and Intangible Asset Impairment",
        "label": "COVID-19 Pandemic Goodwill and Intangible Asset Impairment",
        "terseLabel": "COVID-19 Pandemic Goodwill and Intangible Asset Impairment"
       }
      }
     },
     "localname": "COVID19PandemicGoodwillAndIntangibleAssetImpairment",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_COVID19PandemicGoodwillAndIntangibleAssetImpairmentDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "COVID-19 Pandemic Goodwill and Intangible Asset Impairment",
        "label": "COVID-19 Pandemic Goodwill and Intangible Asset Impairment [Domain]",
        "terseLabel": "COVID-19 Pandemic Goodwill and Intangible Asset Impairment [Domain]"
       }
      }
     },
     "localname": "COVID19PandemicGoodwillAndIntangibleAssetImpairmentDomain",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_CashFlowLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash Flow Location [Axis]",
        "label": "Cash Flow Location [Axis]",
        "terseLabel": "Cash Flow Location [Axis]"
       }
      }
     },
     "localname": "CashFlowLocationAxis",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_CashFlowLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Cash Flow Location [Axis]",
        "label": "Cash Flow Location [Domain]",
        "terseLabel": "Cash Flow Location [Domain]"
       }
      }
     },
     "localname": "CashFlowLocationDomain",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_CashPaidDuringPeriodForAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cash Paid During Period For [Abstract]",
        "terseLabel": "Cash paid during period for:"
       }
      }
     },
     "localname": "CashPaidDuringPeriodForAbstract",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_CashPaymentReceivedAppropriatedbyU.S.CongressCovid19": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash Payment Received Appropriated by U.S. Congress Covid-19",
        "label": "Cash Payment Received Appropriated by U.S. Congress Covid-19",
        "terseLabel": "Cash Payment Received Appropriated by U.S. Congress Covid-19"
       }
      }
     },
     "localname": "CashPaymentReceivedAppropriatedbyU.S.CongressCovid19",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule is used to show the changes in common shares issued and held in treasury by the entity.",
        "label": "Changes In Common Shares Issued And Held In Treasury [Table Text Block]",
        "terseLabel": "Changes in common shares issued and held in treasury"
       }
      }
     },
     "localname": "ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lh_ClientMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Client [Member]",
        "label": "Client [Member]",
        "terseLabel": "Client [Member]"
       }
      }
     },
     "localname": "ClientMember",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_CommonSharesHeldInTreasuryRollforwardAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Common Shares Held In Treasury Rollforward [Abstract]",
        "terseLabel": "Rollforward of common shares held in treasury"
       }
      }
     },
     "localname": "CommonSharesHeldInTreasuryRollforwardAbstract",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_CommonSharesIssuedRollforwardAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Common Shares Issued Rollforward [Abstract]",
        "terseLabel": "Rollforward of common shares issued"
       }
      }
     },
     "localname": "CommonSharesIssuedRollforwardAbstract",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_CommonSharesOutstandingRollforwardAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Common Shares Outstanding Rollforward [Abstract]",
        "terseLabel": "Common Shares Outstanding Rollforward [Abstract]"
       }
      }
     },
     "localname": "CommonSharesOutstandingRollforwardAbstract",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_CommonStockRepurchaseAuthorizationOutstanding": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The dollar amount of share (common shares) repurchase authorization approved by the Board of Directors which remains available to the Company.",
        "label": "Common Stock Repurchase Authorization Outstanding",
        "periodEndLabel": "Outstanding common stock repurchase authorization, ending balance",
        "periodStartLabel": "Outstanding common stock repurchase authorization, beginning balance"
       }
      }
     },
     "localname": "CommonStockRepurchaseAuthorizationOutstanding",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of common shares issued during the period as a result of an employee stock purchase plan and/or stock option plan.",
        "label": "Commons Stock Issued During Period Shares Employee Stock Plans",
        "terseLabel": "Commons Stock Issued During Period Shares Employee Stock Plans"
       }
      }
     },
     "localname": "CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "lh_Contingentconsiderationadjustment": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contingent consideration adjustment",
        "label": "Contingent consideration adjustment",
        "negatedTerseLabel": "Contingent consideration adjustment",
        "terseLabel": "Contingent consideration adjustment"
       }
      }
     },
     "localname": "Contingentconsiderationadjustment",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_ConversionOfZeroCouponConvertibleDebt": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of stock issued during the period upon the conversion of convertible securities (zero-coupon subordinated notes) and/or reversal of deferred tax liability to reflect the tax benefit realized upon issuance of the stock.",
        "label": "Conversion of zero-coupon convertible debt",
        "terseLabel": "Conversion of zero-coupon convertible debt"
       }
      }
     },
     "localname": "ConversionOfZeroCouponConvertibleDebt",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited",
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_CostMethodInvestmentsMaximumOwnershipPercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents the maximum ownership percentage of cost-method investments held by the Company. Generally, such investments do not have readily determinable fair values and are not required to be accounted for by the equity method. The carrying amount of such securities equates to cost, adjusted for other-than-temporary impairment.",
        "label": "Cost Method Investments Maximum Ownership Percentage",
        "terseLabel": "Ownership percentage below which investments are generally accounted for on the cost method (in thousandths)"
       }
      }
     },
     "localname": "CostMethodInvestmentsMaximumOwnershipPercentage",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_CovanceDrugDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Covance Drug Development [Member]",
        "label": "Covance Drug Development [Member]",
        "terseLabel": "Covance Drug Development [Member]"
       }
      }
     },
     "localname": "CovanceDrugDevelopmentMember",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails",
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_CovanceMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Covance [Member]",
        "label": "Covance [Member]",
        "terseLabel": "Covance [Member]"
       }
      }
     },
     "localname": "CovanceMember",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails",
      "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_CreditFacilityMaximumLettersofCredit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Credit Facility, Maximum Letters of Credit",
        "label": "Credit Facility, Maximum Letters of Credit",
        "terseLabel": "Credit Facility, Maximum Letters of Credit"
       }
      }
     },
     "localname": "CreditFacilityMaximumLettersofCredit",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_CreditFacilityMaximumSwingLineBorrowings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Credit Facility, Maximum Swing Line Borrowings",
        "label": "Credit Facility, Maximum Swing Line Borrowings",
        "terseLabel": "Credit Facility, Maximum Swing Line Borrowings"
       }
      }
     },
     "localname": "CreditFacilityMaximumSwingLineBorrowings",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_CreditFacilityOptiontoIncrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Credit Facility Option to Increase",
        "label": "Credit Facility Option to Increase",
        "terseLabel": "Credit Facility Option to Increase"
       }
      }
     },
     "localname": "CreditFacilityOptiontoIncrease",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_CreditLossExpenseReversal": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Credit Loss Expense (Reversal)",
        "label": "Credit Loss Expense (Reversal)",
        "terseLabel": "Credit Loss Expense (Reversal)"
       }
      }
     },
     "localname": "CreditLossExpenseReversal",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_Crosscurrencyswapmaturing2022Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cross currency swap maturing 2022 [Member]",
        "label": "Cross currency swap maturing 2022 [Member]",
        "terseLabel": "Cross currency swap maturing 2022 [Member]"
       }
      }
     },
     "localname": "Crosscurrencyswapmaturing2022Member",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_Crosscurrencyswapmaturing2025Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cross currency swap maturing 2025 [Member]",
        "label": "Cross currency swap maturing 2025 [Member]",
        "terseLabel": "Senior notes due 2025 [Member] [Member]"
       }
      }
     },
     "localname": "Crosscurrencyswapmaturing2025Member",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings",
        "label": "Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings",
        "terseLabel": "Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings"
       }
      }
     },
     "localname": "CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt to EBITDA (Leverage) Ratio Quarter Ending Thereafter March 31, 2021",
        "label": "Debt to EBITDA (Leverage) Ratio Quarter Ending Thereafter March 31, 2021",
        "terseLabel": "Debt to EBITDA (Leverage) Ratio Quarter Ending Thereafter March 31, 2021"
       }
      }
     },
     "localname": "DebtToEBITDALeverageRatioQuarterEndingThereafterMarch312021",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "lh_DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt to EBITDA (Leverage) Ratio Quarter Ending Through March 31, 2021",
        "label": "Debt to EBITDA (Leverage) Ratio Quarter Ending Through March 31, 2021",
        "terseLabel": "Debt to EBITDA (Leverage) Ratio Quarter Ending 1 Year From Present"
       }
      }
     },
     "localname": "DebtToEBITDALeverageRatioQuarterEndingThroughMarch312021",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "lh_DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt to EBITDA (Leverage) Ratio Through Period Ending December 31, 2020",
        "label": "Debt to EBITDA (Leverage) Ratio Through Period Ending December 31, 2020",
        "terseLabel": "Debt to EBITDA (Leverage) Ratio Next Three Quarters"
       }
      }
     },
     "localname": "DebtToEBITDALeverageRatioThroughPeriodEndingDecember312020",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "lh_DecreaseinCapitalExpendituresIncurredbutnotyetPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Decrease in Capital Expenditures Incurred but not yet Paid",
        "label": "Decrease in Capital Expenditures Incurred but not yet Paid",
        "negatedTerseLabel": "Decrease in Capital Expenditures Incurred but not yet Paid"
       }
      }
     },
     "localname": "DecreaseinCapitalExpendituresIncurredbutnotyetPaid",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_DeferredIncomeTaxesAndOtherTaxLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the noncurrent portion of deferred tax liabilities, which result from applying the applicable tax rate to net taxable temporary differences pertaining to each jurisdiction to which the entity is obligated to pay income tax, combined with the noncurrent portion of the amount recognized for uncertain tax positions as of the balance sheet date. A noncurrent taxable temporary difference is a difference between the tax basis and the carrying amount of a noncurrent asset or liability in the financial statements prepared in accordance with generally accepted accounting principles. In a classified statement of financial position, an enterprise shall separate deferred tax liabilities and assets into a current amount and a noncurrent amount. Deferred tax liabilities and assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the expected reversal date of the temporary difference.",
        "label": "Deferred income taxes and other tax liabilities",
        "terseLabel": "Deferred income taxes and other tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndOtherTaxLiabilities",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_DefinedContributionPlanTotalExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Defined Contribution Plan Total Expense",
        "label": "Defined Contribution Plan Total Expense",
        "terseLabel": "Defined Contribution Plan Total Expense"
       }
      }
     },
     "localname": "DefinedContributionPlanTotalExpense",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_DepreciationAndAmortizationOfLeasedAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of depreciation recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Also, may include amortization charged against earnings for the periodic recognition of capitalized leases.",
        "label": "Depreciation And Amortization Of Leased Assets",
        "terseLabel": "Depreciation And Amortization Of Leased Assets"
       }
      }
     },
     "localname": "DepreciationAndAmortizationOfLeasedAssets",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_DiscretionaryContributionPercentageMaximum": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum discretionary contribution % by the company for eligible employees based on service.",
        "label": "Discretionary Contribution Percentage Maximum",
        "terseLabel": "Discretionary Contribution Percentage Maximum"
       }
      }
     },
     "localname": "DiscretionaryContributionPercentageMaximum",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_DiscretionaryContributionPercentageMinimum": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discretionary contribution percentage by the company for eligible employees based on service, range minimum.",
        "label": "Discretionary Contribution Percentage Minimum",
        "terseLabel": "Discretionary Contribution Percentage Minimum"
       }
      }
     },
     "localname": "DiscretionaryContributionPercentageMinimum",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of any reversal and other adjustment made during the period to the amount of a previously accrued liability for employee severance benefits related restructuring costs, excluding adjustments for costs incurred during the period, costs settled during the period, and foreign currency translation adjustments.",
        "label": "Employee Severance Benefits Related Restructuring Reserve Accrual Adjustment",
        "negatedTerseLabel": "Employee Severance Benefits Related Restructuring Reserve Accrual Adjustment",
        "terseLabel": "Employee Severance Benefits Related Restructuring Reserve Accrual Adjustment"
       }
      }
     },
     "localname": "EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_EnvigoMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Envigo [Member]",
        "label": "Envigo [Member]",
        "terseLabel": "Envigo [Member]"
       }
      }
     },
     "localname": "EnvigoMember",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_EquityMethodIncomeLossNetDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Method Income (Loss), Net [Domain]",
        "label": "Equity Method Income (Loss), Net [Domain]",
        "terseLabel": "Equity Method Income (Loss), Net [Domain]"
       }
      }
     },
     "localname": "EquityMethodIncomeLossNetDomain",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability",
        "label": "Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability",
        "terseLabel": "Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents a certain statement of financial position liability caption which represents a class of liabilities, or which may include an individual liability, measured at fair value on a recurring basis.",
        "label": "Fair Value Liabilities Measured On Recurring Basis Noncontrolling Interest Puts",
        "terseLabel": "Noncontrolling interest puts"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_GainInterestRateSwapArrangement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gain Interest Rate Swap Arrangement",
        "label": "Gain Interest Rate Swap Arrangement",
        "terseLabel": "Gain Interest Rate Swap Arrangement"
       }
      }
     },
     "localname": "GainInterestRateSwapArrangement",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_Impairmentoffloatingratenotereceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "impairment of floating rate note receivable",
        "label": "impairment of floating rate note receivable",
        "terseLabel": "impairment of floating rate note receivable"
       }
      }
     },
     "localname": "Impairmentoffloatingratenotereceivable",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_IncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income [Abstract]",
        "terseLabel": "Income [Abstract]"
       }
      }
     },
     "localname": "IncomeAbstract",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Income (Loss) from Continuing Operations Before Income Taxes and Noncontrolling Interest",
        "label": "Income (Loss) from Continuing Operations Before Income Taxes and Noncontrolling Interest",
        "terseLabel": "Earnings before income taxes"
       }
      }
     },
     "localname": "IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_IncreaseDecreaseinUnbilledContractReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Increase (Decrease) in Unbilled Contract Receivable",
        "label": "Increase (Decrease) in Unbilled Contract Receivable",
        "terseLabel": "Increase (Decrease) in Unbilled Contract Receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseinUnbilledContractReceivable",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_Intercompanyrevenueelimination": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Intercompany revenue elimination",
        "label": "Intercompany revenue elimination",
        "negatedTerseLabel": "Intercompany revenue elimination"
       }
      }
     },
     "localname": "Intercompanyrevenueelimination",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_InterestPaidInCash": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of cash paid during the current period for interest owed on money borrowed",
        "label": "Interest Paid In Cash",
        "terseLabel": "Interest"
       }
      }
     },
     "localname": "InterestPaidInCash",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_Issuanceofcommonstockunderemployeeplans": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate change in value for stock issued in period under ESPP combined with the value of stock issued as a result of option exercises.",
        "label": "Issuance of common stock under employee plans",
        "negatedTerseLabel": "Issuance of common stock under employee stock plans"
       }
      }
     },
     "localname": "Issuanceofcommonstockunderemployeeplans",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_LabCorpDiagnosticsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "LabCorp Diagnostics [Member]",
        "label": "LabCorp Diagnostics [Member]",
        "terseLabel": "LabCorp Diagnostics [Member]"
       }
      }
     },
     "localname": "LabCorpDiagnosticsMember",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails",
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_Lh_BusinessCombinationContingentConsiderationArrangementsPayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "lh_BusinessCombinationContingentConsiderationArrangementsPayments",
        "label": "lh_BusinessCombinationContingentConsiderationArrangementsPayments",
        "negatedTerseLabel": "lh_BusinessCombinationContingentConsiderationArrangementsPayments"
       }
      }
     },
     "localname": "Lh_BusinessCombinationContingentConsiderationArrangementsPayments",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_LongTermContractsDurationMaximum": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Long Term Contracts Duration Maximum",
        "label": "Long Term Contracts Duration Maximum",
        "terseLabel": "Long Term Contracts Duration Maximum"
       }
      }
     },
     "localname": "LongTermContractsDurationMaximum",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lh_LongTermContractsDurationMinimum": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Long Term Contracts Duration Minimum",
        "label": "Long Term Contracts Duration Minimum",
        "terseLabel": "Long Term Contracts Duration Minimum"
       }
      }
     },
     "localname": "LongTermContractsDurationMinimum",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lh_Longtermdebtissuancecosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Long term debt issuance costs",
        "label": "Long term debt issuance costs",
        "terseLabel": "Long term debt issuance costs"
       }
      }
     },
     "localname": "Longtermdebtissuancecosts",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_MedicareandMedicaidMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Medicare and Medicaid [Member]",
        "label": "Medicare and Medicaid [Member]",
        "terseLabel": "Medicare and Medicaid [Member]"
       }
      }
     },
     "localname": "MedicareandMedicaidMember",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_NetDefinedBenefitPlanAmortizationAndDeferral": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net Defined Benefit Plan Amortization And Deferral",
        "label": "Net Defined Benefit Plan Amortization And Deferral",
        "terseLabel": "Net amortization and deferral"
       }
      }
     },
     "localname": "NetDefinedBenefitPlanAmortizationAndDeferral",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_NetProceedsFromIssuanceOfStockToEmployees": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock options and employees related to shares purchased under the employee stock purchase plan.",
        "label": "Net proceeds from issuance of stock to employees",
        "terseLabel": "Net proceeds from issuance of stock to employees"
       }
      }
     },
     "localname": "NetProceedsFromIssuanceOfStockToEmployees",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_NetRestructuringAndOtherSpecialCharges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount charged against earnings in the period for incurred and estimated costs, excluding asset retirement obligations, associated with exit from or disposal of business activities or restructurings pursuant to a program planned and controlled by management, and materially changes either the scope or manner of conduct of a business undertaken. Also, may include reversals and other adjustments to accrued liabilities and special charges, if any, for asset abandonment, uncollectible balances, etc.",
        "label": "Net restructuring and other special charges",
        "terseLabel": "Net restructuring and other special charges"
       }
      }
     },
     "localname": "NetRestructuringAndOtherSpecialCharges",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_NetRestructuringCharges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount charged against earnings in the period for incurred and estimated costs, excluding asset retirement obligations, associated with exit from or disposal of business activities or restructurings pursuant to a program that is planned and controlled by management, and changes either scope of business by an entity, or manner business is conducted. May include amount of reversals and other adjustments during the period to amounts of previously accrued liabilities for specified types of restructuring costs.",
        "label": "Net Restructuring Charges",
        "terseLabel": "Net restructuring charges"
       }
      }
     },
     "localname": "NetRestructuringCharges",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_NonElectiveContribution": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The minimum non-elective contribution % by the company to all employees eligible for the defined contribution retirement plan. Contributions are concurrent with each payroll period and are non-forfeitable and vest immediately.",
        "label": "Non Elective Contribution",
        "terseLabel": "Minimum non-elective contribution (NEC) % for the 401(K) plan (in hundredths)",
        "verboseLabel": "Non Elective Contribution"
       }
      }
     },
     "localname": "NonElectiveContribution",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_NoncontrollingInterestMezzanineEquity": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents contractual value of a noncontrolling interest put (includes underlying noncontrolling interest). In February 2010, the Company completed a transaction to sell the partnership units acquired from the previous noncontrolling interest holder to a new Canadian partner. As a result of this transaction, the Company recorded a component of noncontrolling interest in liabilities and a component in mezzanine equity. This item represents the mezzanine equity component.",
        "label": "Noncontrolling Interest Mezzanine Equity",
        "terseLabel": "Common stock, 92.8 and 93.5 shares outstanding at March 31, 2013 and December 31, 2012, respectively"
       }
      }
     },
     "localname": "NoncontrollingInterestMezzanineEquity",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_NoncontrollingInterestPutsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Noncontrolling Interest Puts [Abstract]",
        "label": "Noncontrolling Interest Puts [Abstract]",
        "terseLabel": "Noncontrolling Interest Puts [Abstract]"
       }
      }
     },
     "localname": "NoncontrollingInterestPutsAbstract",
     "nsuri": "http://www.labcorp.com/20200930",
     "xbrltype": "stringItemType"
    },
    "lh_NoteReceivableAllowanceforCreditLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Note Receivable, Allowance for Credit Loss",
        "label": "Note Receivable, Allowance for Credit Loss",
        "terseLabel": "Note Receivable, Allowance for Credit Loss"
       }
      }
     },
     "localname": "NoteReceivableAllowanceforCreditLoss",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_NoteReceivableCreditLossExpenseReversal": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Note Receivable, Credit Loss Expense (Reversal)",
        "label": "Note Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Note Receivable, Credit Loss Expense (Reversal)"
       }
      }
     },
     "localname": "NoteReceivableCreditLossExpenseReversal",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Novel Coranvirus (Covid-19) Financial Statement Impact [Policy Text Block]",
        "label": "Novel Coranvirus (Covid-19) Financial Statement Impact [Policy Text Block]",
        "terseLabel": "Novel Coranvirus (Covid-19) Financial Statement Impact [Policy Text Block]"
       }
      }
     },
     "localname": "NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONNovelCoronavirusCOVID19FinancialStatementImpactPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lh_NumberofMeasurementFundsAvailableForParticipantElection": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of Measurement Funds Available For Participant Election",
        "label": "Number of Measurement Funds Available For Participant Election",
        "terseLabel": "Number of Measurement Funds Available For Participant Election"
       }
      }
     },
     "localname": "NumberofMeasurementFundsAvailableForParticipantElection",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "lh_OtherFinancingCashFlows": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Financing Cash Flows",
        "label": "Other Financing Cash Flows",
        "negatedTerseLabel": "Other Financing Cash Flows"
       }
      }
     },
     "localname": "OtherFinancingCashFlows",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_OtheracquireesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other acquirees [Member]",
        "label": "Other acquirees [Member]",
        "terseLabel": "Other acquirees [Member]"
       }
      }
     },
     "localname": "OtheracquireesMember",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_OthercountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other countries [Member]",
        "label": "Other countries [Member]",
        "terseLabel": "Other countries [Member]"
       }
      }
     },
     "localname": "OthercountriesMember",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_OutstandingStockRepurchaseAuthorizationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Outstanding Stock Repurchase Authorization [Abstract]",
        "terseLabel": "Rollforward of Share Repurchase Program"
       }
      }
     },
     "localname": "OutstandingStockRepurchaseAuthorizationAbstract",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_PatentsLicensesAndTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Patents are the exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law. Licenses are rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory). Technology-based intangible assets are innovations or scientific advances that have not been patented.",
        "label": "Patents, Licenses And Technology [Member]",
        "terseLabel": "Patents, Licenses And Technology [Member]"
       }
      }
     },
     "localname": "PatentsLicensesAndTechnologyMember",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_PerShareAmountAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Per Share Amount [Abstract]",
        "terseLabel": "Per Share Amount [Abstract]"
       }
      }
     },
     "localname": "PerShareAmountAbstract",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percent Change in Discount Rate Used to Calculate Fair Value of Goodwill for Reporting Unit",
        "label": "Percent Change in Discount Rate Used to Calculate Fair Value of Goodwill for Reporting Unit",
        "terseLabel": "Percent Change in Discount Rate Used to Calculate Fair Value of Goodwill for Reporting Unit"
       }
      }
     },
     "localname": "PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage Change in Discount Rate Used to Calculate Fair Value of Goodwill",
        "label": "Percentage Change in Discount Rate Used to Calculate Fair Value of Goodwill",
        "terseLabel": "Percentage Change in Discount Rate Used to Calculate Fair Value of Goodwill"
       }
      }
     },
     "localname": "PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_PercentageFairValueofGoodwillExceededCarryingValue": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage Fair Value of Goodwill Exceeded Carrying Value",
        "label": "Percentage Fair Value of Goodwill Exceeded Carrying Value",
        "terseLabel": "Percentage Fair Value of Goodwill Exceeded Carrying Value"
       }
      }
     },
     "localname": "PercentageFairValueofGoodwillExceededCarryingValue",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percent of Fair Value Exceeding Carrying Value Post Percent Change in Discount Rate Used to Calculate Fair Value of Goodwill for Reporting Unit",
        "label": "Percent of Fair Value Exceeding Carrying Value Post Percent Change in Discount Rate Used to Calculate Fair Value of Goodwill for Reporting Unit",
        "terseLabel": "Percent of Fair Value Exceeding Carrying Value Post Percent Change in Discount Rate Used to Calculate Fair Value of Goodwill for Reporting Unit"
       }
      }
     },
     "localname": "PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_PercentofRevenueContributed": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percent of Revenue Contributed",
        "label": "Percent of Revenue Contributed",
        "terseLabel": "Percent of Revenue Contributed"
       }
      }
     },
     "localname": "PercentofRevenueContributed",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percent of remaining performance obligations recognized as revenue in next year",
        "label": "Percent of remaining performance obligations recognized as revenue in next year",
        "terseLabel": "Percent of remaining performance obligations recognized as revenue in next year"
       }
      }
     },
     "localname": "Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_RecentlyAdoptedAccountingGuidancePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Recently Adopted Accounting Guidance [Policy Text Block]",
        "label": "Recently Adopted Accounting Guidance [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Guidance [Policy Text Block]"
       }
      }
     },
     "localname": "RecentlyAdoptedAccountingGuidancePolicyTextBlock",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONRecentlyAdoptedAccountingStandardsPolicies",
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONUseofEstimatesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lh_RestructuringImpairment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Restructuring Impairment",
        "label": "Restructuring Impairment",
        "terseLabel": "Asset Impairment Charges"
       }
      }
     },
     "localname": "RestructuringImpairment",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_RestructuringReserveSettledWithCashAndOtherAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash paid and/or consideration other than cash paid in the period to fully or partially settle a specified, previously accrued type of restructuring cost.",
        "label": "Restructuring Reserve Settled With Cash And Other Adjustment",
        "negatedLabel": "Cash payments and other adjustments",
        "negatedTerseLabel": "Restructuring Reserve Settled With Cash And Other Adjustment"
       }
      }
     },
     "localname": "RestructuringReserveSettledWithCashAndOtherAdjustment",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revolving Credit Facility Accrue Interest Per Annum Base Rate Plus Percentage",
        "label": "Revolving Credit Facility Accrue Interest Per Annum Base Rate Plus Percentage",
        "terseLabel": "Revolving Credit Facility Accrue Interest Per Annum Base Rate Plus Percentage"
       }
      }
     },
     "localname": "RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revolving Credit Facility Accrue Interest per Annum at Libor Plus Margin Percentage",
        "label": "Revolving Credit Facility Accrue Interest per Annum at Libor Plus Margin Percentage",
        "terseLabel": "Revolving Credit Facility Accrue Interest per Annum at Libor Plus Margin Percentage"
       }
      }
     },
     "localname": "RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revolving Credit Facility Fee Percentage Required to Pay on Outstanding Commitments",
        "label": "Revolving Credit Facility Fee Percentage Required to Pay on Outstanding Commitments",
        "terseLabel": "Revolving Credit Facility Fee Percentage Required to Pay on Outstanding Commitments"
       }
      }
     },
     "localname": "RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_SalesCommissionAmortizationPeriodMaximum": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sales Commission Amortization Period Maximum",
        "label": "Sales Commission Amortization Period Maximum",
        "terseLabel": "Sales Commission Amortization Period Maximum"
       }
      }
     },
     "localname": "SalesCommissionAmortizationPeriodMaximum",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lh_SalesCommissionAmortizationPeriodMinimum": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sales Commission Amortization Period Minimum",
        "label": "Sales Commission Amortization Period Minimum",
        "terseLabel": "Sales Commission Amortization Period Minimum"
       }
      }
     },
     "localname": "SalesCommissionAmortizationPeriodMinimum",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Schedule Of Other Intangible Assets By Major Class [Axis]",
        "terseLabel": "Schedule Of Other Intangible Assets By Major Class [Axis]"
       }
      }
     },
     "localname": "ScheduleOfOtherIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Schedule Of Other Intangible Assets By Major Class [Domain]",
        "terseLabel": "Schedule Of Other Intangible Assets By Major Class [Domain]"
       }
      }
     },
     "localname": "ScheduleOfOtherIntangibleAssetsByMajorClassDomain",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_ScheduleofBusinessAcquisitionsbyAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of Business Acquisitions, by Acquisition [Abstract]",
        "label": "Schedule of Business Acquisitions, by Acquisition [Abstract]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Abstract]"
       }
      }
     },
     "localname": "ScheduleofBusinessAcquisitionsbyAcquisitionAbstract",
     "nsuri": "http://www.labcorp.com/20200930",
     "xbrltype": "stringItemType"
    },
    "lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Segment Reconciliation of Operating Income to Consolidated [Abstract]",
        "label": "Segment Reconciliation of Operating Income to Consolidated [Abstract]",
        "terseLabel": "Segment Reconciliation of Operating Income to Consolidated [Abstract]"
       }
      }
     },
     "localname": "SegmentReconciliationofOperatingIncometoConsolidatedAbstract",
     "nsuri": "http://www.labcorp.com/20200930",
     "xbrltype": "stringItemType"
    },
    "lh_SeniorLongTermNotesDue2020Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A senior note is a bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for [must receive] repayment [prior] relative to junior and unsecured (general) creditors.",
        "label": "Senior Long Term Notes Due2020 Member",
        "terseLabel": "Senior Long Term Notes Due2020 Member"
       }
      }
     },
     "localname": "SeniorLongTermNotesDue2020Member",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_SeniorNotesDue2020Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A senior note is a bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for [must receive] repayment [prior] relative to junior and unsecured (general) creditors.",
        "label": "Senior notes due 2020 [Member]",
        "terseLabel": "Senior notes due 2020 [Member]"
       }
      }
     },
     "localname": "SeniorNotesDue2020Member",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_SeniorNotesDue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior notes due 2022 [Member]",
        "label": "Senior notes due 2022 [Member]",
        "terseLabel": "Senior notes due 2022 [Member]"
       }
      }
     },
     "localname": "SeniorNotesDue2022Member",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_SeniorNotesFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Estimated fair value of the debt instrument (senior notes) at the balance-sheet date",
        "label": "Senior Notes Fair Value",
        "terseLabel": "Fair market value of senior notes"
       }
      }
     },
     "localname": "SeniorNotesFairValue",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_Seniornotesdue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior notes due 2023 [Member]",
        "label": "Senior notes due 2023 [Member]",
        "terseLabel": "Senior notes due 2023 [Member]"
       }
      }
     },
     "localname": "Seniornotesdue2023Member",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_Seniornotesdue2024MemberMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior notes due 2024 [Member]",
        "label": "Senior notes due 2024 [Member] [Member]",
        "terseLabel": "Senior notes due 2024 [Member] [Member]"
       }
      }
     },
     "localname": "Seniornotesdue2024MemberMember",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_Seniornotesdue2025MemberMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior notes due 2025 [Member] [Member]",
        "label": "Senior notes due 2025 [Member] [Member]",
        "terseLabel": "Senior notes due 2025 [Member] [Member]"
       }
      }
     },
     "localname": "Seniornotesdue2025MemberMember",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_Seniornotesdue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior notes due 2027 [Member]",
        "label": "Senior notes due 2027 [Member]",
        "terseLabel": "Senior notes due 2027 [Member]"
       }
      }
     },
     "localname": "Seniornotesdue2027Member",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_Seniornotesdue2045Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior notes due 2045 [Member]",
        "label": "Senior notes due 2045 [Member]",
        "terseLabel": "Senior notes due 2045 [Member]"
       }
      }
     },
     "localname": "Seniornotesdue2045Member",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_SharesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Shares [Abstract]",
        "terseLabel": "Shares [Abstract]"
       }
      }
     },
     "localname": "SharesAbstract",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_Shorttermdebtissuancecosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Short term debt issuance costs",
        "label": "Short term debt issuance costs",
        "terseLabel": "Short term debt issuance costs"
       }
      }
     },
     "localname": "Shorttermdebtissuancecosts",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term Loan Accrue Interest Per Annum Base Rate Plus Percentage",
        "label": "Term Loan Accrue Interest Per Annum Base Rate Plus Percentage",
        "terseLabel": "Term Loan Accrue Interest Per Annum Base Rate Plus Percentage"
       }
      }
     },
     "localname": "TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term Loan Accrue Interest per Annum at Libor Plus Margin Percentage",
        "label": "Term Loan Accrue Interest per Annum at Libor Plus Margin Percentage",
        "terseLabel": "Term Loan Accrue Interest per Annum at Libor Plus Margin Percentage"
       }
      }
     },
     "localname": "TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_TermLoanandRevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term Loan and Revolving Credit Facility [Member]",
        "label": "Term Loan and Revolving Credit Facility [Member]",
        "terseLabel": "Term Loan and Revolving Credit Facility [Member]"
       }
      }
     },
     "localname": "TermLoanandRevolvingCreditFacilityMember",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_ThirdpartyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Third party [Member]",
        "label": "Third party [Member]",
        "terseLabel": "Third party [Member]"
       }
      }
     },
     "localname": "ThirdpartyMember",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_Totalacquisitionconsiderationcashstocknotesetc.": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total acquisition consideration (cash, stock, notes, etc.)",
        "label": "Total acquisition consideration (cash, stock, notes, etc.)",
        "terseLabel": "Total acquisition consideration (cash, stock, notes, etc.)"
       }
      }
     },
     "localname": "Totalacquisitionconsiderationcashstocknotesetc.",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_UnbilledContractsReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unbilled Contracts Receivable [Member]",
        "label": "Unbilled Contracts Receivable [Member]",
        "terseLabel": "Unbilled Contracts Receivable [Member]"
       }
      }
     },
     "localname": "UnbilledContractsReceivableMember",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_UnbilledServicesAllowanceforCreditLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unbilled Services, Allowance for Credit Loss",
        "label": "Unbilled Services, Allowance for Credit Loss",
        "terseLabel": "Unbilled Services, Allowance for Credit Loss"
       }
      }
     },
     "localname": "UnbilledServicesAllowanceforCreditLoss",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_UnbilledServicesCreditLossExpenseReversal": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unbilled Services, Credit Loss Expense (Reversal)",
        "label": "Unbilled Services, Credit Loss Expense (Reversal)",
        "terseLabel": "Unbilled Services, Credit Loss Expense (Reversal)"
       }
      }
     },
     "localname": "UnbilledServicesCreditLossExpenseReversal",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_Unusedfacilityrestructuringreserves": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unused facility restructuring reserves",
        "label": "Unused facility restructuring reserves",
        "negatedTerseLabel": "Unused facility restructuring reserves",
        "terseLabel": "Unused facility restructuring reserves"
       }
      }
     },
     "localname": "Unusedfacilityrestructuringreserves",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of Goodwill Impairment Following a Percentage Change in the Discount Rate Used to Calculate Goodwill for Reporting Unit",
        "label": "Value of Goodwill Impairment Following a Percentage Change in the Discount Rate Used to Calculate Goodwill for Reporting Unit",
        "terseLabel": "Value of Goodwill Impairment Following a Percentage Change in the Discount Rate Used to Calculate Goodwill for Reporting Unit"
       }
      }
     },
     "localname": "ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of Reporting Units Goodwill Fair Value Exceeds Carrying Value",
        "label": "Value of Reporting Units Goodwill Fair Value Exceeds Carrying Value",
        "terseLabel": "Value of Reporting Units Goodwill Fair Value Exceeds Carrying Value"
       }
      }
     },
     "localname": "ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_ValueofReportingUnitsGoodwillFollowingImpairment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of Reporting Unit's Goodwill Following Impairment",
        "label": "Value of Reporting Unit's Goodwill Following Impairment",
        "terseLabel": "Value of Reporting Unit's Goodwill Following Impairment"
       }
      }
     },
     "localname": "ValueofReportingUnitsGoodwillFollowingImpairment",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_ZeroCouponConvertibleSubordinatedNotesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Zero Coupon Convertible Subordinated Notes [Line Items]",
        "label": "Zero Coupon Convertible Subordinated Notes [Line Items]",
        "terseLabel": "Zero Coupon Convertible Subordinated Notes [Line Items]"
       }
      }
     },
     "localname": "ZeroCouponConvertibleSubordinatedNotesLineItems",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTConvertibleSubordinatedNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_ZeroCouponConvertibleSubordinatedNotesTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Zero Coupon Convertible Subordinated Notes [Table]",
        "label": "Zero Coupon Convertible Subordinated Notes [Table]",
        "terseLabel": "Zero Coupon Convertible Subordinated Notes [Table]"
       }
      }
     },
     "localname": "ZeroCouponConvertibleSubordinatedNotesTable",
     "nsuri": "http://www.labcorp.com/20200930",
     "presentation": [
      "http://www.labcorp.com/role/DEBTConvertibleSubordinatedNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r178",
      "r191",
      "r192",
      "r193",
      "r194",
      "r196",
      "r198",
      "r202"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r178",
      "r191",
      "r192",
      "r193",
      "r194",
      "r196",
      "r198",
      "r202"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r130",
      "r135",
      "r220",
      "r413",
      "r414",
      "r415",
      "r428",
      "r429"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r130",
      "r135",
      "r220",
      "r413",
      "r414",
      "r415",
      "r428",
      "r429"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe [Member]"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r208",
      "r312",
      "r316",
      "r574"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r403",
      "r409",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r571",
      "r575"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails",
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/LeasesDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r403",
      "r409",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r571",
      "r575"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails",
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/LeasesDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r208",
      "r312",
      "r316",
      "r574"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r204",
      "r312",
      "r314",
      "r537",
      "r570",
      "r572"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r204",
      "r312",
      "r314",
      "r537",
      "r570",
      "r572"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r346",
      "r403",
      "r409",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r571",
      "r575"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails",
      "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/LeasesDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r346",
      "r403",
      "r409",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r571",
      "r575"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails",
      "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/LeasesDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r126",
      "r127",
      "r128",
      "r129",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r159",
      "r221",
      "r222",
      "r416",
      "r429",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Restatement [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r126",
      "r127",
      "r128",
      "r129",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r159",
      "r221",
      "r222",
      "r416",
      "r429",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Restatement [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember": {
     "auth_ref": [
      "r131",
      "r132",
      "r135",
      "r221",
      "r222",
      "r416",
      "r429",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Revision of Prior Period, Accounting Standards Update, Adjustment [Member]",
        "terseLabel": "Revision of Prior Period, Accounting Standards Update, Adjustment"
       }
      }
     },
     "localname": "RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r404"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r205",
      "r206",
      "r312",
      "r315",
      "r573",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r205",
      "r206",
      "r312",
      "r315",
      "r573",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r280",
      "r404",
      "r525"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]",
        "verboseLabel": "Statement, Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingGuidanceMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Previous accounting guidance and the new accounting guidance.",
        "label": "Accounting Guidance [Domain]",
        "terseLabel": "Accounting Guidance [Domain]"
       }
      }
     },
     "localname": "AccountingGuidanceMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r42"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts Payable, Current"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable [Member]"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r16",
      "r30",
      "r210",
      "r211"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts Receivable, after Allowance for Credit Loss, Current"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r47"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued Liabilities, Current"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalesCommissionCurrentAndNoncurrent": {
     "auth_ref": [
      "r24",
      "r26",
      "r543",
      "r557"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions.",
        "label": "Accrued Sales Commission",
        "terseLabel": "Accrued Sales Commission"
       }
      }
     },
     "localname": "AccruedSalesCommissionCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r63",
      "r68",
      "r367"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "periodEndLabel": "Net Benefit Plan Adjustments, Ending balance",
        "periodStartLabel": "Net Benefit Plan Adjustments, Beginning balance"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r61",
      "r65",
      "r67",
      "r68",
      "r505"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "periodEndLabel": "Foreign Currency Translation Adjustments, Ending balance",
        "periodStartLabel": "Foreign Currency Translation Adjustments, Beginning balance"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r33",
      "r65",
      "r67",
      "r68",
      "r559",
      "r581",
      "r585"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Accumulated Other Comprehensive Earnings, Ending balance",
        "periodStartLabel": "Accumulated Other Comprehensive Earnings, Beginning balance",
        "terseLabel": "Total liabilities and shareholders' equity"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r518"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r64",
      "r68",
      "r69",
      "r126",
      "r127",
      "r129",
      "r465",
      "r576",
      "r577"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r126",
      "r127",
      "r129",
      "r413",
      "r414",
      "r415"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r411",
      "r412",
      "r417",
      "r418"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net earnings to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock": {
     "auth_ref": [
      "r212",
      "r227"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on financing receivable.",
        "label": "Financing Receivable, Allowance for Credit Loss [Table Text Block]",
        "terseLabel": "Financing Receivable, Allowance for Credit Loss [Table Text Block]"
       }
      }
     },
     "localname": "AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r213",
      "r223",
      "r224",
      "r226"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDeferredSalesCommissions": {
     "auth_ref": [
      "r89",
      "r108"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of expense recognized in the current period for the periodic realization of capitalized fees that were paid to salespeople, distributors, brokers, and agents at the time of the conclusion of the sale. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Deferred Sales Commissions",
        "terseLabel": "Amortization of Deferred Sales Commissions"
       }
      }
     },
     "localname": "AmortizationOfDeferredSalesCommissions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/REVENUEDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r108",
      "r245",
      "r253"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangibles and other assets",
        "verboseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts": {
     "auth_ref": [
      "r38"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred costs for long-term contracts and programs. Includes, but is not limited to, initial tooling costs and deferred production costs.",
        "label": "Amount of Deferred Costs Related to Long-term Contracts",
        "terseLabel": "Amount of Deferred Costs Related to Long-term Contracts"
       }
      }
     },
     "localname": "AmountOfDeferredCostsRelatedToLongTermContracts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Stock options (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/EARNINGSPERSHAREPotentialcommonsharesnotincludedincomputationofdilutedearningspershareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r108",
      "r257"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Asset Impairment Charges"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r121",
      "r186",
      "r193",
      "r200",
      "r219",
      "r460",
      "r467",
      "r507",
      "r541",
      "r556"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r18",
      "r20",
      "r60",
      "r121",
      "r219",
      "r460",
      "r467",
      "r507"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "terseLabel": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:",
        "verboseLabel": "Current Assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r479",
      "r482"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r399",
      "r405"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsTablesTables",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails",
      "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r399",
      "r405",
      "r446",
      "r447"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsTablesTables",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails",
      "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsTablesTables",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r444",
      "r445"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Business Acquisition, Pro Forma Information [Table Text Block]"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsTablesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r444",
      "r445"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Business Acquisition, Pro Forma Net Income (Loss)"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r444",
      "r445"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Business Acquisition, Pro Forma Revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r107",
      "r456"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combination Disclosure [Text Block]"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r449"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r449"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": {
     "auth_ref": [
      "r449"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r449"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r449"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r449"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "auth_ref": [
      "r449"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
     "auth_ref": [
      "r449"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "auth_ref": [
      "r449"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "terseLabel": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": {
     "auth_ref": [
      "r449"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r448",
      "r449"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r448",
      "r449"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r449"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r448",
      "r449"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets": {
     "auth_ref": [
      "r449"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities": {
     "auth_ref": [
      "r449"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r448",
      "r449"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r449"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessExitCosts1": {
     "auth_ref": [
      "r108",
      "r264",
      "r269",
      "r273"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Business Exit Costs",
        "terseLabel": "Restructuring charges related to contractual obligations associated with leased facilities and other facility related costs"
       }
      }
     },
     "localname": "BusinessExitCosts1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r112",
      "r113",
      "r114"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "negatedTerseLabel": "Capital Expenditures Incurred but Not yet Paid"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostAmortization": {
     "auth_ref": [
      "r232"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost, Amortization",
        "terseLabel": "Capitalized Contract Cost, Amortization"
       }
      }
     },
     "localname": "CapitalizedContractCostAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/REVENUEDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostAmortizationPeriod": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Capitalized Contract Cost, Amortization Period",
        "terseLabel": "Capitalized Contract Cost, Amortization Period"
       }
      }
     },
     "localname": "CapitalizedContractCostAmortizationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_CapitalizedContractCostNet": {
     "auth_ref": [
      "r231"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost, Net",
        "terseLabel": "Capitalized Contract Cost, Net"
       }
      }
     },
     "localname": "CapitalizedContractCostNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostTableTextBlock": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of cost capitalized in obtaining or fulfilling contract with customer.",
        "label": "Capitalized Contract Cost [Table Text Block]",
        "terseLabel": "Capitalized Contract Cost [Table Text Block]"
       }
      }
     },
     "localname": "CapitalizedContractCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r14",
      "r39",
      "r110"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "negatedTerseLabel": "Cash and cash equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r104",
      "r510"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Disclosure of non-cash financing and investing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "terseLabel": "Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/LeasesTables",
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATION",
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONTabularInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashSurrenderValueFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).",
        "label": "Cash Surrender Value, Fair Value Disclosure",
        "terseLabel": "Cash Surrender Value, Fair Value Disclosure"
       }
      }
     },
     "localname": "CashSurrenderValueFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1": {
     "auth_ref": [
      "r493"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.",
        "label": "Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge",
        "terseLabel": "Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge"
       }
      }
     },
     "localname": "ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r119",
      "r121",
      "r145",
      "r149",
      "r150",
      "r153",
      "r155",
      "r163",
      "r164",
      "r165",
      "r219",
      "r507"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsTablesTables",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r276",
      "r277",
      "r278",
      "r286"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r126",
      "r127"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common Stock, Shares Authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Common shares issued, ending balance (in shares)",
        "periodStartLabel": "Common shares issued, beginning balance (in shares)",
        "terseLabel": "Common Stock, Shares, Issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r29",
      "r295"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Common shares outstanding, ending balance (in shares)",
        "periodStartLabel": "Common shares outstanding, beginning balance (in shares)",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r72",
      "r74",
      "r75",
      "r83",
      "r550",
      "r567"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive earnings attributable to Laboratory Corporation of America Holdings"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]",
        "terseLabel": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r72",
      "r74",
      "r82",
      "r459",
      "r470",
      "r549",
      "r566"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive earnings"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure": {
     "auth_ref": [
      "r496"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of contingent consideration in a business combination that is classified in shareholders' equity.",
        "label": "Contingent Consideration Classified as Equity, Fair Value Disclosure",
        "terseLabel": "Contingent Consideration Classified as Equity, Fair Value Disclosure"
       }
      }
     },
     "localname": "ContingentConsiderationClassifiedAsEquityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Contract with Customer, Asset and Liability [Table Text Block]"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetGross": {
     "auth_ref": [
      "r306",
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, before Allowance for Credit Loss",
        "terseLabel": "Contract with Customer, Asset, before Allowance for Credit Loss"
       }
      }
     },
     "localname": "ContractWithCustomerAssetGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerBasisOfPricingAxis": {
     "auth_ref": [
      "r312",
      "r317"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by basis of pricing for contract representing right to consideration in exchange for good or service transferred to customer.",
        "label": "Contract with Customer, Basis of Pricing [Axis]",
        "terseLabel": "Contract with Customer, Basis of Pricing [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerBasisOfPricingAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerBasisOfPricingDomain": {
     "auth_ref": [
      "r312",
      "r317"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Basis of pricing for contract with customer. Includes, but is not limited to, fixed-price and time-and-materials contracts.",
        "label": "Contract with Customer, Basis of Pricing [Domain]",
        "terseLabel": "Contract with Customer, Basis of Pricing [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerBasisOfPricingDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerDurationAxis": {
     "auth_ref": [
      "r312",
      "r318"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by duration of contract with customer. Includes, but is not limited to, short-term and long-term contracts.",
        "label": "Contract with Customer, Duration [Axis]",
        "terseLabel": "Contract with Customer, Duration [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerDurationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerDurationDomain": {
     "auth_ref": [
      "r312",
      "r318"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Duration of contract with customer. Includes, but is not limited to, short-term and long-term contracts.",
        "label": "Contract with Customer, Duration [Domain]",
        "terseLabel": "Contract with Customer, Duration [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerDurationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r306",
      "r307",
      "r313"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Contract with Customer, Liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod": {
     "auth_ref": [
      "r310"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.",
        "label": "Contract with Customer, Performance Obligation Satisfied in Previous Period",
        "terseLabel": "Contract with Customer, Performance Obligation Satisfied in Previous Period"
       }
      }
     },
     "localname": "ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/REVENUEDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelAxis": {
     "auth_ref": [
      "r312",
      "r320"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by sales channel for delivery of good or service in contract with customer.",
        "label": "Contract with Customer, Sales Channel [Axis]",
        "terseLabel": "Contract with Customer, Sales Channel [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelDomain": {
     "auth_ref": [
      "r312",
      "r320"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary.",
        "label": "Contract with Customer, Sales Channel [Domain]",
        "terseLabel": "Contract with Customer, Sales Channel [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateMember": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate Segment [Member]",
        "terseLabel": "Corporate Segment [Member]"
       }
      }
     },
     "localname": "CorporateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Legal entity in the form of a corporation created to conduct business.",
        "label": "Corporation [Member]",
        "terseLabel": "Corporation"
       }
      }
     },
     "localname": "CorporationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r88",
      "r121",
      "r219",
      "r507"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of Revenue"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Currency Swap [Member]"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r453"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships [Member]"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtConversionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Conversion [Line Items]",
        "terseLabel": "Debt Conversion [Line Items]"
       }
      }
     },
     "localname": "DebtConversionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtConversionTable": {
     "auth_ref": [
      "r112",
      "r114"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table that contains information on an original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion [Table]",
        "terseLabel": "Debt Conversion [Table]"
       }
      }
     },
     "localname": "DebtConversionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.",
        "label": "Debt, Current",
        "terseLabel": "Debt, Current",
        "verboseLabel": "Total short-term borrowings and current portion of long-term debt"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r23",
      "r24",
      "r25",
      "r542",
      "r544",
      "r555"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r49",
      "r290",
      "r521"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "netLabel": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Debt Instrument, Interest Rate, Effective Percentage",
        "verboseLabel": "Debt Instrument, Interest Rate, Effective Percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage",
        "verboseLabel": "Stated interest rate percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r50",
      "r123",
      "r296",
      "r299",
      "r300",
      "r301",
      "r520",
      "r521",
      "r523",
      "r554"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r108",
      "r122",
      "r427",
      "r432",
      "r433",
      "r434"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and other assets expected to be realized or consumed within one year or normal operating cycle, if longer.",
        "label": "Deferred Income Taxes and Other Assets, Current",
        "terseLabel": "Deferred Income Taxes and Other Assets, Current"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r37"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred Revenue, Current"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueRevenueRecognized1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously reported as deferred or unearned revenue.",
        "label": "Deferred Revenue, Revenue Recognized",
        "terseLabel": "Deferred Revenue, Revenue Recognized"
       }
      }
     },
     "localname": "DeferredRevenueRevenueRecognized1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/REVENUEDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r346",
      "r347",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r372",
      "r393"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "verboseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosures [Line Items]",
        "verboseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r324",
      "r361",
      "r386",
      "r393",
      "r394"
     ],
     "calculation": {
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r323",
      "r345",
      "r393"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "terseLabel": "Defined Benefit Plan, Funded (Unfunded) Status of Plan"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r324",
      "r328",
      "r360",
      "r385",
      "r393",
      "r394"
     ],
     "calculation": {
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost on benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r358",
      "r383",
      "r393",
      "r394"
     ],
     "calculation": {
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Defined benefit/postretirement plan costs"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation": {
     "auth_ref": [
      "r380"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of projected benefit obligation for defined benefit pension plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation",
        "terseLabel": "Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r326",
      "r359",
      "r384",
      "r393",
      "r394"
     ],
     "calculation": {
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost for benefits earned"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]",
        "terseLabel": "Defined Benefit Plan and Postretirement Plan Disclosure"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r397"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "negatedTerseLabel": "Defined contribution retirement plan cost",
        "verboseLabel": "Defined Contribution Plan, Cost"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage employer matches of the employee's percentage contribution matched.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "terseLabel": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r108",
      "r181"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract Type [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r480",
      "r481",
      "r485",
      "r488"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instruments, Gain (Loss) by Derivative Instrument Risk [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Instruments And Hedging Activities"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r477",
      "r480",
      "r485",
      "r488",
      "r489",
      "r492",
      "r494"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) by Hedging Relationship [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": {
     "auth_ref": [
      "r484",
      "r487"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net",
        "terseLabel": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r474",
      "r476"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, Notional Amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r312",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue [Table Text Block]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r399",
      "r405"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r84",
      "r133",
      "r134",
      "r135",
      "r136",
      "r137",
      "r143",
      "r145",
      "r153",
      "r154",
      "r155",
      "r159",
      "r160",
      "r551",
      "r568"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic earnings per common share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r84",
      "r133",
      "r134",
      "r135",
      "r136",
      "r137",
      "r145",
      "r153",
      "r154",
      "r155",
      "r159",
      "r160",
      "r551",
      "r568"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted earnings per common share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r156",
      "r157",
      "r158",
      "r161"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/EARNINGSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
     "auth_ref": [
      "r510"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
        "label": "Effect of Exchange Rate on Cash and Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies": {
     "auth_ref": [
      "r421",
      "r435"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax contingencies. Includes, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Tax Contingency, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee Severance [Member]",
        "verboseLabel": "Severance and Other Employee Costs [Member]"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r126",
      "r127",
      "r129",
      "r132",
      "r138",
      "r141",
      "r162",
      "r220",
      "r295",
      "r302",
      "r413",
      "r414",
      "r415",
      "r428",
      "r429",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r518",
      "r576",
      "r577",
      "r578"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r504"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "terseLabel": "Equity Securities, FV-NI"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FacilityClosingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Closing of a facility associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Facility Closing [Member]",
        "terseLabel": "Lease and Other Facility Costs [Member]",
        "verboseLabel": "Facility Closing [Member]"
       }
      }
     },
     "localname": "FacilityClosingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r496",
      "r497",
      "r498",
      "r503"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r499",
      "r503"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r347",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r393",
      "r497",
      "r526",
      "r527",
      "r528"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "verboseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Disclosure Items [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgeAssetsAtFairValue": {
     "auth_ref": [
      "r481"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of all derivative assets designated as fair value hedging instruments.",
        "label": "Fair Value Hedge Assets",
        "terseLabel": "Fair Value Hedge Assets"
       }
      }
     },
     "localname": "FairValueHedgeAssetsAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueHedgeLiabilitiesAtFairValue": {
     "auth_ref": [
      "r481"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of all derivative liabilities designated as fair value hedging instruments.",
        "label": "Fair Value Hedge Liabilities",
        "terseLabel": "Fair Value Hedge Liabilities"
       }
      }
     },
     "localname": "FairValueHedgeLiabilitiesAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueHedgesAtFairValueNet": {
     "auth_ref": [
      "r472"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net fair value of all derivative instruments designated as fair value hedging instruments.",
        "label": "Fair Value Hedges, Net",
        "terseLabel": "Fair Value Hedges, Net"
       }
      }
     },
     "localname": "FairValueHedgesAtFairValueNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r347",
      "r349",
      "r354",
      "r393",
      "r497",
      "r526"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r347",
      "r349",
      "r354",
      "r393",
      "r497",
      "r527"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r347",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r393",
      "r497",
      "r528"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r496",
      "r497"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).  Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Company's population of financial assets and liabilities subject to fair value measurements"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r347",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r393",
      "r526",
      "r527",
      "r528"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "verboseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Disclosure Items [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss": {
     "auth_ref": [
      "r500",
      "r502"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in other comprehensive income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss)",
        "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r524"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance Lease, Liability, Current"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r524"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r252"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated Amortization",
        "terseLabel": "Finite-Lived Intangible Assets, Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Estimated amortization expense, Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Estimated amortization expense, 2012"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Estimated amortization expense, 2016"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Estimated amortization expense, 2015"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Estimated amortization expense, 2014"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Estimated amortization expense, 2013"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r246",
      "r249",
      "r252",
      "r255",
      "r538",
      "r539"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Future Amortization Expense"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r246",
      "r251"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "auth_ref": [
      "r247"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.",
        "label": "Finite-lived Intangible Assets Acquired",
        "terseLabel": "Finite-lived Intangible Assets Acquired"
       }
      }
     },
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.",
        "label": "Foreign Currency Contract, Asset, Fair Value Disclosure",
        "terseLabel": "Foreign Currency Contract, Asset, Fair Value Disclosure"
       }
      }
     },
     "localname": "ForeignCurrencyContractAssetFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.",
        "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure",
        "terseLabel": "Foreign Currency Contracts, Liability, Fair Value Disclosure"
       }
      }
     },
     "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "auth_ref": [
      "r108"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.",
        "label": "Gain (Loss) on Disposition of Assets",
        "negatedTerseLabel": "Gain (Loss) on Disposition of Assets"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r234",
      "r236",
      "r540"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "netLabel": "Goodwill, net",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance as of January 1",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r237"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill, Acquired During Period"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r116",
      "r241"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, Goodwill, Policy"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/IntangibleAssetsGoodwillandOtherPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r108",
      "r235",
      "r238",
      "r242"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill, Impairment Loss"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r239",
      "r240",
      "r443"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Translation and Purchase Accounting Adjustments",
        "terseLabel": "Adjustments to goodwill"
       }
      }
     },
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r86",
      "r121",
      "r186",
      "r192",
      "r196",
      "r199",
      "r202",
      "r219",
      "r507"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross Profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r108",
      "r256"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Impairment of Intangible Assets (Excluding Goodwill)"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfInvestments": {
     "auth_ref": [
      "r215"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.",
        "label": "Other than Temporary Impairment Losses, Investments",
        "terseLabel": "Other than Temporary Impairment Losses, Investments"
       }
      }
     },
     "localname": "ImpairmentOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r79",
      "r108",
      "r183",
      "r216",
      "r546",
      "r563"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "terseLabel": "Equity method income, net"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r399",
      "r405"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r0",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r10",
      "r11",
      "r12",
      "r262",
      "r263"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsTablesTables",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables",
      "http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsTablesTables",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables",
      "http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r422",
      "r425",
      "r426",
      "r430",
      "r436",
      "r440",
      "r441",
      "r442"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r122",
      "r140",
      "r141",
      "r184",
      "r420",
      "r431",
      "r438",
      "r569"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r111"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes, net of refunds"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Decrease in accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Increase in accounts receivable (net)"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "terseLabel": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Increase (Decrease) in Deferred Revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Increase in inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Change in assets and liabilities (net of effects of acquisitions):"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Decrease in prepaid expenses and other"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r146",
      "r147",
      "r148",
      "r155"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Dilutive effect of employee stock options and awards, (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Intangible Assets, Gross (Excluding Goodwill)"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r244",
      "r250"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible Assets, Net (Excluding Goodwill)",
        "verboseLabel": "Intangible Assets, Net (Excluding Goodwill)"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r77",
      "r180",
      "r519",
      "r522",
      "r552"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap [Member]"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r15",
      "r59"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Supplies inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r91",
      "r93"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Net",
        "terseLabel": "Investment income"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "terseLabel": "Joint venture partnerships and equity method investments"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r46",
      "r121",
      "r194",
      "r219",
      "r461",
      "r467",
      "r468",
      "r507"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Noncontrolling interest"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r36",
      "r121",
      "r219",
      "r507",
      "r545",
      "r561"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "terseLabel": "Liabilities and Equity",
        "totalLabel": "Liabilities and Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND SHAREHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r48",
      "r121",
      "r219",
      "r461",
      "r467",
      "r468",
      "r507"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "terseLabel": "Long-term debt, less current portion"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Liabilities, Current [Abstract]"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Canadian licenses [Member]"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r43",
      "r123"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": {
     "auth_ref": [
      "r506"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of the amount outstanding under the credit facility.",
        "label": "Line of Credit Facility, Fair Value of Amount Outstanding",
        "terseLabel": "Line of Credit Facility, Fair Value of Amount Outstanding"
       }
      }
     },
     "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The effective interest rate at the end of the reporting period.",
        "label": "Line of Credit Facility, Interest Rate at Period End",
        "terseLabel": "Line of Credit Facility, Interest Rate at Period End"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateDescription": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of the interest rate for the amounts borrowed under the credit facility, including the terms and the method for determining the interest rate (for example, fixed or variable, LIBOR plus a percentage, increasing rate, timing of interest rate resets, remarketing provisions).",
        "label": "Line of Credit Facility, Interest Rate Description",
        "terseLabel": "Line of Credit Facility, Interest Rate Description"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r43"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity",
        "verboseLabel": "Revolving Credit Facility, maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r43"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Remaining Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r43",
      "r123"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR) [Member]"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term Debt, Excluding Current Maturities"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r50",
      "r289"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r287",
      "r288"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Noncontrolling Interest [Line Items]",
        "terseLabel": "Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "MinorityInterestLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestTable": {
     "auth_ref": [
      "r58",
      "r87",
      "r458",
      "r466"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest [Table]",
        "terseLabel": "Noncontrolling Interest [Table]"
       }
      }
     },
     "localname": "MinorityInterestTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "terseLabel": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used for) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "terseLabel": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used for investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r104",
      "r105",
      "r109"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "terseLabel": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r12",
      "r70",
      "r73",
      "r80",
      "r109",
      "r121",
      "r131",
      "r133",
      "r134",
      "r135",
      "r136",
      "r140",
      "r141",
      "r151",
      "r186",
      "r192",
      "r196",
      "r199",
      "r202",
      "r219",
      "r507",
      "r547",
      "r564"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net earnings attributable to Laboratory Corporation of America Holdings",
        "verboseLabel": "Net earnings attributable to Laboratory Corporation of America Holdings"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r70",
      "r73",
      "r140",
      "r141",
      "r463",
      "r469"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      },
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Less: Net earnings attributable to the noncontrolling interest",
        "negatedTerseLabel": "Net income attributable to Laboratory Corporation of America Holdings"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r144",
      "r152",
      "r155"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "terseLabel": "Net Income (Loss) Available to Common Stockholders, Diluted"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONNewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r452"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Noncompete Agreements [Member]"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r92"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Nonoperating Income (Expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expenses):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesPayable": {
     "auth_ref": [
      "r25",
      "r544",
      "r558"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.",
        "label": "Notes Payable",
        "terseLabel": "Notes Payable"
       }
      }
     },
     "localname": "NotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayableCurrent": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.",
        "label": "Notes Payable, Current",
        "terseLabel": "Notes Payable"
       }
      }
     },
     "localname": "NotesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesReceivableFairValueDisclosure": {
     "auth_ref": [
      "r55"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of an agreement for an unconditional promise by the maker to pay the holder a definite sum of money at a future date.",
        "label": "Notes Receivable, Fair Value Disclosure",
        "terseLabel": "Notes Receivable, Fair Value Disclosure"
       }
      }
     },
     "localname": "NotesReceivableFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails",
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s) within one year of the balance sheet date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.",
        "label": "Notes Receivable [Member]",
        "terseLabel": "Notes Receivable [Member]"
       }
      }
     },
     "localname": "NotesReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r186",
      "r192",
      "r196",
      "r199",
      "r202"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating Income (Loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails",
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r524"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating Lease, Liability, Current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r524"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r13",
      "r125",
      "r173",
      "r471"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r125",
      "r142",
      "r173",
      "r471"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation and Significant Accounting Policies [Text Block]"
       }
      }
     },
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetImpairmentCharges": {
     "auth_ref": [
      "r108",
      "r259"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.",
        "label": "Other Asset Impairment Charges",
        "terseLabel": "Other Asset Impairment Charges"
       }
      }
     },
     "localname": "OtherAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets, net"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r61",
      "r65",
      "r508",
      "r509",
      "r511"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other comprehensive income before reclassifications",
        "verboseLabel": "Other comprehensive income before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in other comprehensive income.",
        "label": "Other Comprehensive Income Location [Axis]",
        "terseLabel": "Other Comprehensive Income Location [Axis]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in other comprehensive income.",
        "label": "Other Comprehensive Income Location [Domain]",
        "terseLabel": "Other Comprehensive Income Location [Domain]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r68",
      "r512",
      "r514",
      "r518"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), before Reclassifications, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTax": {
     "auth_ref": [
      "r81",
      "r217",
      "r512",
      "r517",
      "r518",
      "r548",
      "r565"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Tax",
        "totalLabel": "Other comprehensive earnings (loss) before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": {
     "auth_ref": [
      "r61",
      "r65"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r71",
      "r74",
      "r76",
      "r81",
      "r295",
      "r512",
      "r517",
      "r518",
      "r548",
      "r565"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive earnings, net of tax",
        "totalLabel": "Other comprehensive earnings (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "verboseLabel": "Other Comprehensive Earnings, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax": {
     "auth_ref": [
      "r63",
      "r65"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment and Tax",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": {
     "auth_ref": [
      "r63",
      "r65",
      "r366",
      "r393"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax",
        "negatedTerseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": {
     "auth_ref": [
      "r63",
      "r66",
      "r459"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax",
        "negatedTerseLabel": "Tax effect of adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "auth_ref": [
      "r66",
      "r81",
      "r420",
      "r437",
      "r439",
      "r512",
      "r515",
      "r518",
      "r548",
      "r565"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Tax",
        "negatedTerseLabel": "Tax effect of adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax": {
     "auth_ref": [
      "r62",
      "r66"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax expense (benefit), before reclassification adjustments, related to increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax",
        "negatedTerseLabel": "Tax effect of adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Commitments and contingent liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r94"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other Nonoperating Income (Expense) [Member]"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other Operating Activities, Cash Flow Statement"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Payments for Repurchase of Common Stock",
        "terseLabel": "Payments for Repurchase of Common Stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Payment, Tax Withholding, Share-based Payment Arrangement"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisition of businesses, net of cash acquired",
        "terseLabel": "Payments to Acquire Businesses, Net of Cash Acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedTerseLabel": "Investments in equity affiliates"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r346",
      "r348",
      "r354",
      "r371",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r393",
      "r395",
      "r396",
      "r397",
      "r410"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Pension And Postretirement Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANS",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementPlansCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rate action of a regulator resulting in capitalization or accrual of pension and other postretirement costs.",
        "label": "Pension and Other Postretirement Plans Costs [Member]",
        "terseLabel": "Pension and Other Postretirement Plans Costs [Member]"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementPlansCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r321",
      "r323",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r372",
      "r375",
      "r379",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r397",
      "r398",
      "r405",
      "r406",
      "r407",
      "r408"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plan [Member]"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r346",
      "r347",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r372",
      "r393"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PostemploymentBenefitsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Postemployment Benefits [Abstract]",
        "terseLabel": "Postemployment Benefits [Abstract]"
       }
      }
     },
     "localname": "PostemploymentBenefitsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred Stock, Shares Authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred Stock, Shares Outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r17",
      "r19",
      "r228",
      "r229"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrimeRateMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.",
        "label": "Prime Rate [Member]",
        "terseLabel": "Prime Rate [Member]"
       }
      }
     },
     "localname": "PrimeRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromHedgeInvestingActivities": {
     "auth_ref": [
      "r97",
      "r106"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.",
        "label": "Proceeds from Hedge, Investing Activities",
        "terseLabel": "Proceeds from Hedge, Investing Activities"
       }
      }
     },
     "localname": "ProceedsFromHedgeInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of long-term debt classified as other.",
        "label": "Proceeds from Issuance of Other Long-term Debt",
        "terseLabel": "Proceeds from Issuance of Other Long-term Debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfOtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Proceeds from Long-term Lines of Credit",
        "terseLabel": "Proceeds from revolving credit facilities"
       }
      }
     },
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfEquityMethodInvestments": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Proceeds from Sale of Equity Method Investments",
        "terseLabel": "Proceeds from Sale of Equity Method Investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from sale of assets"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r12",
      "r70",
      "r73",
      "r103",
      "r121",
      "r131",
      "r140",
      "r141",
      "r186",
      "r192",
      "r196",
      "r199",
      "r202",
      "r219",
      "r459",
      "r462",
      "r464",
      "r469",
      "r470",
      "r507",
      "r553"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net earnings",
        "totalLabel": "Net earnings"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r21",
      "r22",
      "r258",
      "r562"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information related to prospectively adopted accounting guidance.",
        "label": "Prospective Adoption of New Accounting Pronouncements [Axis]",
        "terseLabel": "Prospective Adoption of New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "ProspectiveAdoptionOfNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r85",
      "r225"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Accounts Receivable, Credit Loss Expense (Reversal)"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r192",
      "r196"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r102",
      "r124"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedTerseLabel": "Repayments of Lines of Credit"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfOtherLongTermDebt": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer.",
        "label": "Repayments of Other Long-term Debt",
        "negatedTerseLabel": "Repayments of Other Long-term Debt"
       }
      }
     },
     "localname": "RepaymentsOfOtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSeniorDebt": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.",
        "label": "Repayments of Senior Debt",
        "negatedTerseLabel": "Repayments of Senior Debt"
       }
      }
     },
     "localname": "RepaymentsOfSeniorDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring and Related Activities Disclosure [Text Block]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r108",
      "r264",
      "r269",
      "r273"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring charges",
        "verboseLabel": "Restructuring Charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]",
        "verboseLabel": "Restructuring Cost and Reserve [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables",
      "http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables",
      "http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r265",
      "r270"
     ],
     "calculation": {
      "http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Balance, end of period",
        "periodStartLabel": "Balance, beginning of period",
        "terseLabel": "Restructuring Reserve",
        "totalLabel": "Total Restructuring Reserve"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Restructuring Reserve [Abstract]",
        "terseLabel": "Restructuring Reserve [Abstract]"
       }
      }
     },
     "localname": "RestructuringReserveAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveCurrent": {
     "auth_ref": [
      "r264",
      "r272"
     ],
     "calculation": {
      "http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringReserve",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
        "label": "Restructuring Reserve, Current",
        "terseLabel": "Current",
        "verboseLabel": "Restructuring Reserve, Current"
       }
      }
     },
     "localname": "RestructuringReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveNoncurrent": {
     "auth_ref": [
      "r264"
     ],
     "calculation": {
      "http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringReserve",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
        "label": "Restructuring Reserve, Noncurrent",
        "terseLabel": "Non-current",
        "verboseLabel": "Restructuring Reserve, Noncurrent"
       }
      }
     },
     "localname": "RestructuringReserveNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r32",
      "r302",
      "r416",
      "r560",
      "r580",
      "r585"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "negatedLabel": "Accumulated other comprehensive income",
        "terseLabel": "Retained Earnings (Accumulated Deficit)"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r126",
      "r127",
      "r129",
      "r132",
      "r138",
      "r141",
      "r220",
      "r413",
      "r414",
      "r415",
      "r428",
      "r429",
      "r576",
      "r578"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r321",
      "r322",
      "r323",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r372",
      "r375",
      "r379",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r405",
      "r406",
      "r407",
      "r408"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r321",
      "r322",
      "r323",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r372",
      "r375",
      "r379",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r405",
      "r406",
      "r407",
      "r408"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r117",
      "r118"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/RevenuefromContractwithCustomerPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r311"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Revenue, Remaining Performance Obligation, Amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r78",
      "r121",
      "r177",
      "r178",
      "r191",
      "r197",
      "r198",
      "r204",
      "r205",
      "r208",
      "r219",
      "r507",
      "r553"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails",
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r68",
      "r517",
      "r518"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]",
        "verboseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Potential common shares not included in computation of diluted earnings per share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r446",
      "r447"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsTablesTables",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r446",
      "r447"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsTablesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsTablesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATION",
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONTabularInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r50",
      "r123",
      "r296",
      "r299",
      "r300",
      "r301",
      "r520",
      "r521",
      "r523",
      "r554"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "verboseLabel": "Long-term Debt [Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r378",
      "r379",
      "r381",
      "r382",
      "r393"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDefinedContributionPlansDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock": {
     "auth_ref": [
      "r378",
      "r379",
      "r381",
      "r382",
      "r393"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]",
        "terseLabel": "Schedule of Pensions and Postretirement Plans"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r480",
      "r485",
      "r489"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r473",
      "r475",
      "r476",
      "r477",
      "r478",
      "r483",
      "r485",
      "r490",
      "r491"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Reconciliation of Basic earnings per Share to Diluted Earnings per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r246",
      "r251",
      "r538"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]",
        "verboseLabel": "Schedule of Finite-Lived Intangible Assets by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r241",
      "r243"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r241",
      "r243"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Changes in Carrying Amount of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets and Goodwill [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r267",
      "r268",
      "r271"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]",
        "verboseLabel": "Company's Restructuring Activities [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables",
      "http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r265",
      "r272"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r186",
      "r189",
      "r195",
      "r241"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-term Debt [Table]",
        "terseLabel": "Schedule of Short-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTextBlock": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-term Debt [Table Text Block]",
        "terseLabel": "Short-term borrowings and current portion of long-term debt"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r52",
      "r119",
      "r163",
      "r164",
      "r292",
      "r293",
      "r294",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r174",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r191",
      "r192",
      "r193",
      "r194",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r202",
      "r208",
      "r570"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]",
        "verboseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails",
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r174",
      "r175",
      "r176",
      "r186",
      "r190",
      "r196",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r207",
      "r208",
      "r209"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Reporting Disclosure [Text Block]"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SelfPayMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Patients who pay out of pocket for a health-related service in absence of insurance to cover the medical or surgical procedure performed.",
        "label": "Self-Pay [Member]",
        "terseLabel": "Self-Pay [Member]"
       }
      }
     },
     "localname": "SelfPayMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r90"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorLongTermNotes": {
     "auth_ref": [
      "r50"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. Senior note holders are paid off in full before any payments are made to junior note holders.",
        "label": "Senior Notes, Noncurrent",
        "terseLabel": "Senior Notes, Noncurrent"
       }
      }
     },
     "localname": "SeniorLongTermNotes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r108",
      "r264",
      "r269",
      "r273"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Restructuring charges related to severance and other employee costs",
        "verboseLabel": "Severance Costs"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-term Debt [Line Items]",
        "terseLabel": "Short-term Debt [Line Items]"
       }
      }
     },
     "localname": "ShortTermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTConvertibleSubordinatedNotesDetails",
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTConvertibleSubordinatedNotesDetails",
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShorttermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount of short-term debt existing as of the balance sheet date.",
        "label": "Short-term Debt, Fair Value",
        "terseLabel": "4.625% Senior notes due 2020"
       }
      }
     },
     "localname": "ShorttermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r1",
      "r174",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r191",
      "r192",
      "r193",
      "r194",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r202",
      "r208",
      "r241",
      "r261",
      "r266",
      "r274",
      "r570"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails",
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r119",
      "r121",
      "r145",
      "r149",
      "r150",
      "r153",
      "r155",
      "r163",
      "r164",
      "r165",
      "r219",
      "r295",
      "r507"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsTablesTables",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r54",
      "r126",
      "r127",
      "r129",
      "r132",
      "r138",
      "r141",
      "r162",
      "r220",
      "r295",
      "r302",
      "r413",
      "r414",
      "r415",
      "r428",
      "r429",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r518",
      "r576",
      "r577",
      "r578"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Statement, Equity Components [Axis]",
        "verboseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.labcorp.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r126",
      "r127",
      "r129",
      "r162",
      "r537"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.labcorp.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures": {
     "auth_ref": [
      "r28",
      "r29",
      "r295",
      "r302"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards forfeited during the period.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Forfeitures",
        "negatedTerseLabel": "Surrender of restricted stock and performance share awards"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased",
        "terseLabel": "Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r28",
      "r29",
      "r295",
      "r302"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "negatedTerseLabel": "Stock Repurchased and Retired During Period, Shares"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r28",
      "r29",
      "r295",
      "r302"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Stock Repurchased During Period, Shares"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r28",
      "r29",
      "r295",
      "r302"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedTerseLabel": "Purchase of common stock"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r29",
      "r34",
      "r35",
      "r121",
      "r214",
      "r219",
      "r507"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "BALANCE",
        "periodStartLabel": "BALANCE",
        "terseLabel": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Stockholders' Equity Attributable to Parent"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders' equity:",
        "verboseLabel": "Shareholders' Equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r120",
      "r302",
      "r305"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Preferred Stock and Common Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology-Based Intangible Assets [Member]"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r312",
      "r319"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing of Transfer of Good or Service [Axis]",
        "terseLabel": "Timing of Transfer of Good or Service [Axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r312",
      "r319"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.",
        "label": "Timing of Transfer of Good or Service [Domain]",
        "terseLabel": "Timing of Transfer of Good or Service [Domain]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade Names [Member]"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r53",
      "r304"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockRetiredCostMethodAmount": {
     "auth_ref": [
      "r29",
      "r295",
      "r303"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.",
        "label": "Treasury Stock, Retired, Cost Method, Amount",
        "negatedTerseLabel": "Treasury Stock, Retired, Cost Method, Amount"
       }
      }
     },
     "localname": "TreasuryStockRetiredCostMethodAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESDetails",
      "http://www.labcorp.com/role/RESTRUCTURINGANDOTHERSPECIALCHARGESRestructuringandOtherSpecialChargesDetailTables",
      "http://www.labcorp.com/role/RESTRUCTURINGRESERVESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnbilledContractsReceivable": {
     "auth_ref": [
      "r56",
      "r536"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.",
        "label": "Unbilled Contracts Receivable",
        "terseLabel": "Unbilled Contracts Receivable"
       }
      }
     },
     "localname": "UnbilledContractsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r419",
      "r424"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Gross unrecognized income tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r423"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Accrued interest and penalties related to unrecognized income tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONUseofEstimatesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_UseRightsMember": {
     "auth_ref": [
      "r455"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Legal right to use or benefit from the use of natural resources or access. Examples include, but are not limited to, drilling rights, water rights, air rights, timber cutting rights and route authorities.",
        "label": "Use Rights [Member]",
        "terseLabel": "Use Rights [Member]"
       }
      }
     },
     "localname": "UseRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSBusinessAcquisitionsintheAggregateDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r144",
      "r155"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted Average Number of Shares Outstanding, Diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r143",
      "r155"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Net earnings, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3581-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "http://asc.fasb.org/topic&trid=2134446"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e22044-107793"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=SL6284422-111562"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131251-203054"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131252-203054"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131252-203054"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131252-203054"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130533-203044"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL108322424-203045"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(d)(i))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2919-114920"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4587-114921"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e39076-109324"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e961-128460"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5227-128473"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5419-128473"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5419-128473"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=117331979&loc=d3e41228-113958"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=SL116692626-108610"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30304-110892"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=118261985&loc=d3e55302-109406"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(c)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r596": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r597": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r598": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-13"
  },
  "r599": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r601": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>80
<FILENAME>0000920148-20-000058-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000920148-20-000058-xbrl.zip
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M#-5*> &YLAF*'-?+J7)C+-"6%'L'66\)UW2"94XP+1'1;#D,'B_BD0-F\ G
MD$A5@91P=A<I: (M$,>P61I718I=&_:F*N*L2J 3:5Z*=Q,04;S32V2) <;
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M\5<B21#TAOE2;-8<?19TOB%4)LNHW)@Z5L"Y.>ELC%'@>JP$08\[4W!B5^X
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MUTDI_HD3"H22&VV-C&,H<KQCK63:W.U,_S3',RC_ON'^2-+_&U!+ P04
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M 7NE->%::PY_6?!"<W4?65VDGSJGZB)5J#2U/RGUS6R:)5'06/$KX&U"/SY
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MM7.F'>[.F2L^L77^\=,B]HKHFW[:A>\/BB63Q^!JHZ"$=25%DN*,9\X)$ 9
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M2:FN.EM0XW[N"7%GDT\V> C@5Y\BRQY!&;D-X1*KBP5M"0XJ4.EQ7PALF2M
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MR\W9Z%8?GG]MV:[/NEB@)J=G?8+V(X5J(/!@,H@I-4(D\-Z0"QQ)+&+)7&4
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M<C"]@$D$AD)$XDIIF6++C89D<C_3+CR#-+PJ:@.6Z%4/J2<54ZKKI>=*0PI
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MP>/JKZR%B[^"$[F;:[XW7O)]__6K[L:A[?[WHCV\S+)J)EEEIS5323S'2!K
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M-"<8"".$ID%)IDECB\K*:E+E _('@^S@W*<\C6AWM[NV=^:?<AC^M)8E2TU
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M1,2C[OK]]Q@A<Q@K)8];@3S6'XV5/NBN/S@__F&2AOKFTCNL^!$ G\G6_8:
MX$AK[WM?[,?K3@?%;E1+7'$4B=2?F<BD!&[<6[9W#=:F%5]YZ-+\X/FYXM)H
M4_KO^Y86=>4ZE+&ZVVJ?9;:SY [6_&E.GN^Y+\6CDMA6<:V1>LI:Y^7,CVY=
M'MTUB:S[7A/$&=)OUZO"Q,SS7]Z#GWG7+:QAFYF#H_$1S]EAYV!GC^R?O3T[
M^'T/[^^D[VV=MCZTSO:/]UD+GUR>?#@A!\>_?9@<\73:;W?>MO>/FW#_[ 3O
M'_\5_^^T#^(X3[Y:U-KY&%]_&7^?' M='?$<_//GQ];9WI?X/9=O/YQ\:>V<
M?#GX9X_MG\5O_/H&'AS_=7GR3^O#P?%IN YQ.8*?WW$=K"M;+UAA 14< <FH
M -A!["@FF&%64;O'69_\FA] 9P9;.P9;B]:62T)A7R<4MKC&EIG",H4M-X55
M'_>7*>RQ%(:N*0P9:#7A BAG(H5!@H%F%*5RA4%ZC^-^5=7#,U-8IK EI[!U
MZ%>Z)!1&KBEL@=U*%T5A:U+O[66O'__L%O:BW_==>UD,^_%NG5&+$NW2D,L8
MPD>U(WUH$8*E9J3*/5L'PU/?W^Z=G??]J>\.VI_\I)+J>+NVQ[MUG#9K-,1F
MUQU/MJYYO7._^1 _<ZR_9':;@=U:VU-N,FRE%0Q*(*3A@#+*@&22 XFPLQ!:
MI"UI;"&"[VBYM/051E8<Z OL6YJ0/H@3CK]ER-<2\A.WDF0^VF#6 P^Q!E1#
M @P6&!#.++0>1?-9-+84?E*3Q SV^DKURAL[9(C7 N(3MPOGR!/"'7 "!D #
M$4F@$T")9R[:,T2G) ^&*VO7E7%>1Z'^1(="%NIU1_S$2V&4DIY)#82##M"H
MO@'E*0&>4:4(A8H:W-BB[ [$/XM0GT,D4>U\GBF,R/BN#^UA<=[13_<Y+&\+
MY\7Z'!Y!6J_3"R5#E5>][@V&?3]L]_V(G\I-?!WW<)!9ZXFL=33E?2#:81_W
M%A JHW;"J0=&\0#B[EIK Y)6I7Y\FRM8!B(#_GE=#QGPBP/\Q/<@K!+2!PL<
M)A90;"F0SGI@I5)08VV50XTMLOGD=@X9\/4%? 7^APSX6@-^XHF01DN!&$F]
M6\0HD$TB94'P"GHH)+:&I&J7*UAJ+@/^>?T0&?"+ _S$$8$H-#S5LW6.1L"K
M*.&5#A X@2EW*CAC96-+5A9UOP!G1/T2=I?ERHH"34:$B#8QJ[G'IR2:5(-]
MPD>3\NP_=2(I_5R8DF.*H?[RE+B3IX4'+K4T66A02I8(CY((TYE8@7&<N!I0
M8SR@4>L'6L4?0C(BL%<\()Y"3-C3TQ@>D8*[+$=5JP;X^@>G9.@_$OH3=P\,
M@A,E$ B,\@A]R8"VF@,A"*(AFOA6FZ@,JBI.I3+HZP_ZN@:I9*@_$NH31P^5
M G+C!8"$F AU':6\L JP:.?#8#&4$*8P^<KB2#/>ZX_W^@>K9.0_$OE3H2?$
M8\8E!-(%#:BU BBM)8".4H.YY\K3QA;A=[A\ZB?DUZ3"S=C]6<2'OVB78$@.
MB:*LC>U=,>P5[:$_&Z3BW'=[,]8L?F46(ENH?R(SUVS,=3"=_&*@4<P$#KRP
M*#(7%$#:$ #E<>>8Y(;!R%SP28'P^5RJQE"MP+&0H3I'J$X\"8%H;[ 2 (MT
MF,Q3]S*)"?"<:>00X4S!!-5OK8L,U96 ZD+] 1FJ,T-UX@GPSA =D +>I*!.
M9@R0P08@.(H;QKR3AMX=U)FANAI0?;HEGZ$Z1ZA.3'<+K3""$&!)B HP-!)H
M9#!P*EKP*6(K\)"@^A3W_.+B-%:E;L4#H@@VBJX?M<[*803+$$;0\L.#D*EJ
M1JJ:3A4)W!$<=7U@<%E)3$2M EH??T!-&+,8)P, $5I93FL^8*@_WNL?19"1
M_SCD3^6,""XD0A 0(WWRTED@K># T( U(XXB2!I;"FZ2)3A?R)A?V2""C/3'
M(7WB.;#,(QNP <I9&Y$N4!+O!"#)!><44T1%8XN)39E%_-K O?XQ!!GXCP/^
ME!_"0V*\Q<!9;5,W;@&4$!9XYE.&F/).I1 "]22?80XAJ!27VY7'!:P:<SVG
M,^(.JKJBJ?A7YR*MY>M>OZS#,QSVV^:B[.EZW&OUNFED_5XG3NC]7NI)Y0?#
M3&VSE \^;B9:&_DNFN_BICENC0.8<#-*@HC;9X&"TD/'M8C\UMB21%96YJ(V
M:DV%9R9K3 Z51RED<GAF<KB<D .+NTDP! (S!R@-(9H\T>X1GELH9"!:EO5W
MX=JUJ<KD\#PNCDP.STL.K8GF8 /%CGD$@B4A];!C0'.*@5)4(P.CA>MA8XL+
M7EF]G$P.JT4.54=B9')X9G*8: Z!0J,988"E!$L:, .*:Q85B4C_RA.!<:KQ
MRV1EM77JYSE9\G(1K_Q@\**8[C9<Z"G4I#2,X:DONC>P4[3'X%FSMB4+3,&X
MHY-2W*2)PS=36^74MCOM,7&<<,B@!DAB 2CR 9BRE2_T&D$1%*$D!7M7<."[
MI(<\*X[?ZOO19OS.';\3U81;+Y!"&F 6'*">EQY/ 9A4DIC L9$TXW>%\5M]
M,]:,WWGC=\KOX"7&CJ@ (+<PXA<FTP)2X!"V(9# I6!/S8O,^*TS?BOO1)KQ
M.W?\3N2O0IAH*# P)I5="C@ 920$AD)F%7.<2_749,D*\;L.O4#NCI;XQMQ_
MI4VOKX>]_F6QW>N?I]\35'NA:)[%+[:Z^*/7<7<%6CS0>3-:A!<D;I7K7:1O
MO9I[;CA=V0+56Q#4-"PE$_Y,A+\W[3!AF'*, P>"Z!0BCS%0EBN@2: $$VP(
M+$-,*HB<K1PMSWR2E'DS\^921^QDWIR5-R>*,M4F<B420$EG :7< HV"!0$%
MR#Q4!CHYBKYY<E)AYLW,FYDW:Q3,E'ES1MZ<<A!*K8,10@"!. $4!0FTH A0
MCP62T$)B=0I,8G>X"#-O9M[,O+F\<5Z9-V?ES8F^J3ECT'(((&91W^1: VD]
M!M K(3DDW&&=8K;$"O%FZ=W]I?1PQG]=^]/6?\H?HWF8_B];UW.Z^>8"\883
MWHY/?:%M*KNCNY<IT*K;&\:[ZWY\N5M&7;WOZTYQKONCRCNG?N C*/6%:Z>:
MN1&0+N)E]%NYC&4IW=#NZJYMQP\.AO&%LOGSYCTSOF<YKA9B/%J*-T6*;#OO
M#=KIR7A15NV-./WU<]L-3Z_88^J#X]V'DX]H$T=X,;S_(U-[;'TZDED\"9:;
M0F^NQO3/--J2@"@24$0S6V.+J2746&TQ"P0[["VTZ!W&C:L/G?:O9G"NWWM@
M^EY_!#K$";[0G<_Z<M#XY<8ZG+6[X-:ZWUZR>Q<FA+DMS B#D<'')P0O(O)]
M/UT5QZ1K,Y;BM)_DT[]^O$6TL;77VMG]O__\HN_C@[O0\0U&%O_<BCN?VU?-
MWPX.F\<'AR?%]L'AZ_3[WD&K.'A9-/=W#_>VF\4?!Z]V]EJ_'Q7-UDYQ].:W
MH[V=O>;AWN[1O?BOR]RV#^).M8YV=^+46D<'K_9VFL?QCZ/C^,_^;NOX*$US
M^X]FZ_?=HV*O5?OY'/W1/-Q-V[%[>/0__Y(8B5^+W;_>[!V?U'[H/[6[1;QM
M)\)N\/.]HSW3_?>1Q\9B@-^T")YW_-?RLXK1_T!^WKQ1HO+Q*TGY8??<=W0T
M>RU(2V4IKDY'GP_\BZM??KUJ?MCNEG,L/W1;+8K?,I8=2FTRCI+X&)]ZCV\_
MEBR;I62YI>&-WJ-\DY#[WX:;Z-[WOG=;MLF@>-1=O_\>([3RL?)X5[8T8R52
M+LU8H5J6=56;5. E&:O<)) \Z*X_B(/Y8=S:MY?>X0 :$=MB'!UBDSTT..:L
MURW)^VC8LQ_OS6Q9A\5HQM$F-5IWR@5YK=L.M$>+LZW/V\/X^CHOSZ$?ZOBB
M*Q=D]T=59]9A18ZC#3NXZ%]F_(SP8^W%V479QZA<D;)RUP@^TT[-&\]/\5,*
M2_TF^'&MUNVX-QQ3SM&ICLO4ZT15=S"VAT:K]=^+]O#RQB(M=>BF_)&),FJ5
MU7S5;&WO%LWC8F=W>W?_M]W#@J"- D,DYY9!^\QG-[=7IMJCF_J>S#QLWK,<
MS'C'D<>620>IID'Q0"EC(?YMI8+\W5YZC! FZ/OG,26MCR$Y@F%=CF$N]]M7
MQS"[\3,O.V_/WGQM?;"T]?4O?/#/V_;^AUW<POMX__@].3E[^>'@^,_.Y!CF
M#7Q[[#X<[%AX\B&.Y^M?K+73:N_C5OOD:Z=S<KQ/TUCW/UA\^QBF=7S8B?>-
MWQ/?_V?_:WED@_>^GN _/QS\\_?I_M?W7UN_[UVVOKX-^].5Q)U!2#.N <2.
M 4I( "H( @063A(HN56ZL870VE7<R>R5V>M6&*-&ED+KC&)4&*XUPPY;ZIVU
M$DEY/WN%7O],#^,MO@Q?="_.7&\X?C\36]7$-BF4KI'RG"(%!*$AI>UYH%T(
M0 >/+,.>$\HBL6U0AM:NU&#FMLQM-[@-02PEM4PYQ"BQ6F.K.89<2 QE)+W,
M;37@MJG2\!:&N%$&$*<)H-@%(!'B($#B'0Z>8AZ5-K$!A:HZQR5S6ZTPOJ[<
M-E/^MG+Q)@8%0PS%RD@;J)-1#U">!&GP_>1V7?X^L]S"6&Y2!Y\+K4/<,N 5
M1X Z'C6X@#'0(IJJ4%D?K$@:'()W%8N>N2=?)KA,</69]TP%HJ()*AFA-O!
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M7BXO([:VB)VS?SWC>%XXGGC7@T'*,\OC!DD%*"M#U*$#&#OF:= 0"IV%[QI
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MTZ9GP_P71Y>,TAFR;L.8B[,0=2%0;10[U_]:'WKWE<?/L,X292B4I*F.2ZQ
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MX-!]950WTKJH[:>H1:R"E9&SH82L*(A4I%(YAFPQ1->-M/O6LT&'S9R=D9+
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M@?D0<UTJ+Z$Z0:K5KA*$:!,D)2,:R\X5'A^W>W!TJLV=H[/$+<I>G_C36?L
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MU*>3(:;)\</@-772Z*CV>/WH:YH"W9]/]L_'U%J:G]WWC[OY->G>[NF3AI%
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M).^0/GXT[JO=+_<Z=2OQ.GV;?A\/B6<XNC2?:S/&-+.ZVWNJ&DF?I*DUSA=
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M>&6(]MX[J&F8%HQU@\J)41>E0D^+IU-+ZE*-:-_*1.C:--FA%P:Z:N<D,=8
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M*5:?C1MSAS(O5ID CHGBD8$6F3G0D4GKHHK6.VUBB\UM]%BU6<:@43(KZ6V
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M*6$R+:VP@BT%6Q8-6XAPPA*2/'..2V(<-P9DH:&&&P8,IMB$%@AQR%A-1,J
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MF6$ *)=G+E"A>3!$&RN-9()X[J+6P^J+ZI:XX3+##YCAK8][1"H0! 1F6-&
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M"[2*3TAW6HFQ>TV_XD+P9&FDED>KC=#!:LMH<E1K;//T$S.8?GA1IG^NTT^
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M:<X-F^S>6K5\."9HM([@D;!2X=<@07K1OPYGW8MHN]>7U'"-O+T]T]&72A
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M&&M-)3$JB@K G@[ )N7/E#(B,8\1-<0A3G(,((X),>=$%,$)D??,Z<-[OU4
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M2L0CX\AB$Q%H\YYPF%>C"2PMF8'B5Y X+_08!6YGGHSY_\[LKX"C(Q@7W$1
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MPDC@J\_B.12V.(!'9UI^?+#:JK^?0JL/\-Q+A NOMC%YL^6%J7.X9^T+W/N
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M L$03YV3.%I:O3S[ND4OX,YX^MM2Y+WMK_8)B4,>!T%D1MQE(+5[\"O K 7
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MYC@G&(WU009:Q&8!XB4H Y@RP(-",5KYH'H@'5T"G,AGY!IAQ"O\8Y255CE
MKMH,4GM-2ZN_CF^\CFW?RZKW$(:"Y7.ZUF: 0SP(<YBS&-R$JYWQ%P"WC.^,
M^.]K+X"YN;VKDX"XA =4F'9L62:A08 9BI&T&/BA'26^U' V[?G8I?]2Z#I[
MZ(!)J?8&5E!5QK8XF\:=K RK;%8XJMC6(N_FB-_$T<9M#MK0#T;((Q'=6'8I
M1A1YY" %JH?#P&-%RE,4Z7$38J"$(U$LE/VKE\?3"XQ_57R]HD3&:4ZY,',9
MB*$$/>#Q&]74EW#WTGA2?6T@+H'PGDIG4YH!?=L=&5T0 >8#'-OA # 'K@0
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M<". 6.(.R"5IU>6\:<_05H="(17>0H1!80<M$LC:YT1$Y"\Z;[) Q@/0)(\
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M9ZA+QNOTS=Q$-;42-!^4=.H=/*B>Q'M%[6X')D&+4NP'S&#:9@4L2]G4+BY
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M96/#BZPH4MU32CZ\$!H191;,!BD^O)*GQ;G!)YHPHSD#NY.4%6QWKQE'-0+
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MPPRD:=.VA#5I-=G94H(5_$ Q$"<+X)R(AOGC4F9=ID,4U&2M*_7&[,A2H[G
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MH-;:843]R'<]FY%8A*&/!VM'^F#AQ_I@[WVPY,2S?.JXP@=:'GHF";EG4C\
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M+_AD(/82;0_18>Q25ZI#V8O?-Y;]Z&KOZXG+'=MQX\3T!?=-DGB)&8<^-1T
MQD XGN"1/QN;_IP:=PD)\HBK.K.]S(99J(F-:^ M)D/, OJAJLRJB@[%VULJ
M5O:,L4;M@8H_K41A+#Z-?;0']*(0;\L?[WA: +),WZ8CN2+YTCN9-,CH0&\U
MC%D+C9N6$AS'.?R?E^/KVYORUA]C/G_/#3<C+UQZV]JTE]Z[;E@X<BM<_NIU
MPUY_SW.7?_3>DR6;MD6>RV2?U<[B9/U;#?N'A%P%O8 &B&'2E5[I5-(D]]8R
M;(E&Y7C5H]'<H\[%=V-&\E$RXBPB*7S]]?3)JMOA=)7U>*=M/<8RZ!6QF5WP
M;[ W/32LWW)K;@D_"Q:.5MZ56K;.]KOYX#7[0.;B@'(AVV$8Y?R>UU&C!/=0
M*UZ*!R]TY^SH(8C$"]V<-5@]$%C=0&!CRLY1%Q]ACJ"<(F,"!._KEETJ"ZNT
M[H.R8'JF>QE2CC;T8IRKLBUE.8U9J+II&VX-&I;Q''C4?S[>^IOKSO&3*[7P
M.P1U)"QR.0]#AR:4@#8:NI0E7#@Q]2)'B'M'^#6,&!I:,:SCN0=S](^'WP=[
MP^.KX\.C:=?Y^[SK[/[X=KA_WOUQ3.#[\,UCY]NPB]^?]LZ^>N4[\*W)-^?(
M_W;VH0_C_OCVS]<?QV>] :SO1^_L%-:Z?];#&?S M>XZO>U!TDVM[Y\/=\;=
M ^OJ)(I8%+O,,Q,[#DR2!*$9DY"9ELVYRVP1,A&]>F]OSN>)+9;4'@P5@ @8
M=T2)ZYC3311ZEL&M2=J:I,U&(CJ,>X@7(8V)2WQ*0ROA)/ (8Q:QV'V#6M<D
M[2%(VH^*I &C<4)AA:9CV]PD&,48V99CNL).(M^*26Q[2-+F,YO7)&U-TGXK
MDA;'Q**,"LOS"?$\0)LXC&S;<P/'=7CBW3>X>DW2'H*DV15)"T 2BWPN3)N%
M0-+\&*0T3A(3F$P0B) GW M?O7<79.VM2=J:I/U6)(UQSFPO)"ZEG'C"HX(+
MSF+'(K8?Q2*Y;S;!FJ0]!$ES*Y+&>6!3ZG@F#X2-BF=L1LPAID]]VW&(Y=D.
M0Y+V;*2T^SMA5M$4N%M%ZJ(M$%"N#,3)8IB<#"-8:EMV%BYZ(8E]UJ3F%]BX
MRF-8TYJ[TIIIP\A%+2?PG8B9B2VP7J4;F=2BD1G0)++=V$D"UWGUWEF0S'8M
MK7D\0>A&M\OO@F*_P.:R1K'[HUC#Z&)9/G&< %02!^L4>"XFC#+3%8[O)5'L
M<RM&=CY?,&:-8B_>!K!&L?NC6&T$B!.0-%Q.3>8F6-F+<S/D 3&3D!(X/:")
MU'KU/ERCV,JAV"_02=<H=G\4JY72P(DBC\>)Z0 'PX*(U RI[YB^YWNQQ:EG
M1<&K][;U%#CVF\2@[)3=&7(QGN0RR43F*&-?E?%<Y,D"4G*KC7@F-.;U:FFC
MY=GLRZ/9DU4U.O)<UB3G#B2GM]7034$9%9$3!J8E;!"<0]<RPSA$+55$ 0=Z
M0XF#@O-\I<XW=S6!K9#A?HVWOU+%7>/M0^%MK? F)'*BP&>F#>=D$F:Y9D1$
M;#H1C2P?="K;MM=X^X+Q]A?HS6N\?2B\K;5HEW!.*+5-8;,$\#8B9AQZD0E7
M_9 DL8C"1+:BFB^3MT;<%X&XOT ;7R/N0R%NPV%L.<0)'-ODS(] 4/9BD\8Q
M_#/P:>(%'N,DE(@['ZK\)(C[LOS!/6QQ.\32%#]4\0?,%L?6GWE.!VM/\$/I
MWMBK2XSG"4JGL?6=$=_6&[^F)G>A)@<-M3OTHRBP8FZ2)!(F\6QAQCQD9AQ%
MU$Z(G22)AR[AM3%]U7#MP?3E-:X]*J[5JK(=P"'3)#03$GLFL:/8C)+0,D-;
M.' O"ER?HZH\7VEVC6LOQ#>\QK5'Q;5:O?5<SXV9FYBQ3= L!;]"9ONFY0=>
M0EE$A6^]>A\LT&[7N/9"G,1K7'M47*LU4FHS+W"<Q QL-S0)=5ST%GNF;8>4
M,<<5+G,P(.,)<.TW<19K(*_K#ZH*R<6\H_B6X>%U772#9Q.L5E8N8IU*\F ;
M]&)(]B]PN0,E_R+[1:=,7UU'^-R59C?K'5#?#QV!'>]0 R%)XH#*[P@S"81+
M;&Y'/K:]N',H^"] F^>1:K<FH&L"NE*Q#VL"^A $M#;F^)X0;N!3,R0D,HGM
MNB:U*3>#@(@XB4D<N $:<]8$=$U UP3TV1CHU@3T<0EH;:%CG/I![!*3!RPV
MB0@C,T[LT/2%[],H\)P@X6@U>."*6VL"NB:@:P+Z%,% :P+Z$ 2T-KLF/()S
M<!(SYMPQ";$2DT:4F@)T>)O[?A)8]TK266$**LVY?\A.",WF9'7WD&M:,?AS
MG1A6OVUFT2Q$BWWALI%N7#,2LI&0Q";C0K=_E(]A0%+[+EPU&ZT.2R.Q?#K%
M'D5L,,'"ZFG5&V-T6M6X5?WD5(/.LC=,JT6=LC.K?B_JL6JB13G3YB<W] ?Q
M(ZU(JBS73?J:J_Y#]9-1/97$>*QZ-\I_LDD^INE _EMU]RAD:[[6>G!"&W(.
M "3F_/(VC>U[-7%M=@T94BZP*4ZK43SV(9IM+:(V23;'$^4AJ9.KJXDL[TF"
M_4BN:'&GGL(!IP'S8XL[H4V$%42N;PD>^Y01ZOBV?;*[3!PN "O@U\UD_:/L
MZW,PIN-)L9?@E>=.TN_?4OA'YT>W<^+X@<.Q-AGL+3,)#=$?)H@9>7X2$Q!Z
M'0&2;>1L^C_?-#H")LUCAWJVY1 K)I'PA0N*3V!%5NQQ><!V9#NNO3[@ASG@
MWM6)SUA@D82:(;>%2=#L$W-@Q"2RH]A*+.$3"PYX494'["$$1/':YM!EPU!]
M3[7FNFN[Z-NVAG[*ODP=[/,&JYH,QG6;MTN*W71E>V?5&K1-; M@+466 WV]
MRLI^P+7?4Y-3U;RWI*15R:;$P%ZK=8<S.I:C'&W^[Z9L))ORE.;87/JUO"0[
MA*DNPL#.KOW8K;Y%C4\B'^(VE]^:&J_U)=FP>$,VL(57K_HIZTMF-A"GE$WU
M@N#.12XNTVQ28+/;L@-VU11;\9=Z[L:5@"'JSL7)9#S)<6]9CCWE%"C.M*>U
MHTU#([_N?*<V$F<VEGUJ=&?NJ@GNY*+9!K=DWI)#-\2$=T8_N\+FW.HX9R=9
M]=-=]OZR=KJV[M_;V$<4:JI^<["5 S'[29R\NM]JL/O?_Q$Z=O"ND/=0*-#M
M=K'YM&P"/6XP^;(U'YZ$D:3?L;>=R+&+ S;QU> L /%2%)%+0,#^A70 )Z]0
M'65B7!V>AMKLC;IWK\"VU:4<,<B Y *" A4>9P XY11U-U_9;O#6[9[OWD%^
MQ<C$SN@R/<V64PE:%* 0\+IE^*VQ5HT,QR3!I<;?UXW/:F156(K]#9MH*AM%
M:IR<+L37>*H'4L#7&%0-UNB4J/H]PM5E2/Q3\*O1^Q$![CF U^UE\J(D?E+%
M*+ 5B(;'FK9L-"G11M5,L''(&RC%*]Y^%TDO\:.$>HR"1!\0(D1L@1 2.9$/
M(GW(77>Y*'^3@/=%+5A._Q_0]CJ,3883N2'ZJ;UJ*XK=T<YW)@HM":IDKL[I
M:0X(,!9?\NQ,)GS-O??;BHR][:\_]KZ>!($C?!=$1CLD >@$S#'C)(Q,)R*Q
M'3%/^!Y[]3[T%HJ,=]4)!.AXH/&%CF\1$H:A[T>4)[9M6[[O4&>Y3K"&E*>%
M%*MW>F+Y(04EPC7=, #E(O)#,V;,-B/A<>X%7F2+!)2+:&E%V,?1,/Z8Z4FM
MJ+T\H!L[L/O!JYM9A+8/FNA?>&N'-S,-$Q]Z=)ZQN->W[6P::O/F_WSD?L8?
M:9K_30<3L8J]BZ<:98;'/X[_^7IU//PX_/;IV#X^^SKMG?V5[GTZ<GJ'7VWX
M?=8][-C=3T=D%F6^G?7ZW[8_I,?_?#O_=O9WVMO>=;K#7?+M\-CN;1_![^[W
M[O;1U;?#?M(].W9[7T_"V',924(3.Z2;)&2^&8<V9K43'SACZ%$G5#02H%?P
MSABV2$2)8!'QXCB.2,3\R'-DGV.?.#8/;&>VU_''SNZ^\7?G\]&.T=WI'!SM
MEUWI9^S/LYVMY_NXW_SE]DP=9@.K]WD<Q#8:D\(X 6CQHBCV8AY;SJO'[J!=
M0=SGE,;I ,1M471!8 3(XWNC?>Q>CB;4#[1(?V=(=+I7)P&/7>%R;OHAT&W"
M "9A^X7)0/2D0!H=SZ&SYYLP(;AM.<P%;@TB7>Q2VXXL-XR(%=EL#A)O[>*X
MC>#]Y"Z.6=7E(KM @4(*X GHU2,Z8JDT5J#\(+G7H 9#-*6@'"$5(P!3XQ+A
MU!@JZ)0ZRL]8W-+B'CV_PU_5\AMD@-!S[]7Q.]B,(N?A6SV'F[[O/4I?ZD>8
MK+/IV;?K2_WTDPTVK2A:S_41YFI;MYO/S_8F?TZ/VMXS;1:.DHHA116C.\<"
M%G6R+2=8L25%K%?I,.#1'+C/-3F@S^E<_B?._W@_?QR_&Z"V>M@;<QVJ?PUT
M/H^M^D 'TB-XT!=B_+!-SE\N?!T5:*IOD,,_4Y'3G/6G=^GG?<V:5RX*='%(
MV[.'_JT!*#YI M.YMM70;T ';B"9/[T;=PE>7/&M^BPNQ<"P;[$_MUKT[[AY
MSGKS[K]Y[EV8S'UJ,"SB/K!]3U43,!M)KWHV&"#73<N6<1>3V\@K#]*I[]EM
MSL]LS.IT07VZ;7W*%JA/M^I?$OE<50^ZB]^C#>9E%YHODU6J='L_EXA.</G6
M[VXS>.?X:N]P=_KM[*O3=8[(\3^[[K>SP;![UKGZMCV 9X_G$UR&.S#'#^FW
MLX[7/?MKV-L^_O'ML-\_/N/#O7^.I]WM#S#_CW!_IK2\:[DTH99CPCEY)@D$
M,6,_B4PXQ4!0YE(B*]TNBIE8F=ZH"E?65&Y-Y1Z%RGF.$T5N(%CL<.(+2GT_
MX"0B(?'<*/:N"0I+LGQ(T?WX??SVA\@S3HO^FO8],>VKLZ-#UT$?,#%%8@4F
M86%DAJ[KF30A3N#SB%FQ0*-'Z-C.NS7Y6Y._WY+\T=@*(YNX"2,.L0,6VM3A
M3IS0..:A[Y&UD+>BA*[.8H[=T&6<AF;$*3.)\"+X%7MF CPL<1*/<3M9"WEK
M*O<[4SF6Q,P*2,(8(3R)0Y]$4>)9D1\[,8G60M[SHGU>K>!Z<42([9I^S+A)
M7%^8-!*.&0>>R\.0!3[V8'I.0MZ=;;V)_.^NYLRG=<GE65%@]8%<C-C4**[H
MQ?)^K"]L[7NRP$,C /,A%GZO'ET+-N_EU4+_62-F%<&=Y3"#T9:&V2TDY/#U
MHJ3[TP5)!6NR?A>RWNSS$5G4"^TD,;W8!=W=%989>S8U?>$D@>5C7HR/E<U^
MNC3D8@+RJ+7)UJC[I):Y&Q!:)MFM<?FG<;FVPP6Q'SC"8:8=V#ZHI\PSJ64Q
MTP72;)%(Q &/'DQ$6^/SZN+SSYJ:UJSXUZ%OHT8>"V./>H"T+O=,XMBV&?MV
M:%H6C?V8A"&WK34K?NFH^RCVDS4K_B6X7%M+(C<*?72$^2[#W$KX(Q(N,UD4
M$2>A3DPC:Q59\0TVD3+G#R8KKB<!ZR<?_\GU83VC)]>']8R>_$5AP$]K&@;Y
MP"BD),!%F8R>)<8@3; N+=R1J4RR+-=]C:?/LT.=,ARK)'Y9C_<Q H!O)?(N
MV+^7)_(^E.$8 ?J@A&<IR:Y%VI\3:?>:EF(O$2+TDM 4%@],5%#,6!!A>JX5
ML)CXOAO9H)XZF]$#>?]6J(W%&EE_C:EXC<*/@,*U@5C$B4VC(#8M)\1R;2(V
M0^$[IA/'E'JN'3/&'MJ'O\;B%<3BAS(0K_'U$?"UM@B[@KB1[U/3"1/7)+$=
MFC2@ENFZ-/!=R_?@R-8L]\4CZZ.:A-<H_ @H7!N"A>>),.:)Z=LQ!Q0.0C.T
M0'06G%(G<:A+R,,9@A\0BW^'X+AMD8B\;$I0U>XO \:FCQ0GM[H6CW6HW#.Q
M>-PQ'+J$\ZT&F%<N_#5IOP-IA^^.NU/=FKYS$K@@DH'N9+I>0$U"7&J"'&V;
MH1M$GD<M)PH=D,_L36N%7'QK;'X6)I$UCC\ACO<.*AR//"ZBT.<FMZ@P"6C'
M)J5!;'I!POU(>"QQ5]*3OT;S%;.9K!'Z*1&Z9MJQL"R?^+89L= W"69R4NH&
M9I@$H&5[89 $R9IIOWAL7H4\Q36./R2.[]5,.TEL.TF(9\8)BTT26\*,X(!-
MS_5L$D> X5&\BDS[MX@[R;"AQ"EV0@:,+%(NVQS?JE[HRPHP^5ESR]J _JL#
M3"K(W6H";EGV5O!.L?/OR3HMX@&H^4[3S")LEPMB>2"B,=FX.#"I%T6FS2,O
M%C;Q0>U^]3[Z>8%M[05;721^Y,"3-6K_.M1N6%>L.+:8B"@(:O 'L04W8R\!
MW8R'H;#]A-/86T7WV!J]5\:ZLD;O54/OFG-[MNT'=A2:/ Q"DU@!8';@.L"^
M Q**.&8!X6OT_AW0^][FEC4B/QDB-PPJMD59)!@W*2$@@G.7F\"?8X K*PH=
M1KCGKYP(OLZX>D9/RL/Z0S:1?-_HXMSJ5KNPJ[,>4Q,FXF%WYJQ(\8&WN<#N
MG)="]Z#45*OQENZ":=6OT+C(!I/Q\E?F>EK\>N(K^Y$Z=>,*M5N-/_M5-ZX+
M>BK,.!?TW*0)3/8M'5S1:?'JCW9/T'14#AXX\/79M2]=89(\V@H5L@,OR!2)
M?SO! $5\"N9$5V8N1C]'!O<?-S<6)Z_>[_:V=_[O?_Z@[Y=V9_WUT+6X9_CG
MSH>]_<[AWOZQL;6W_P5_[^[UC+V/1J>[L[^[U3'^W/N\O=O[=&!T>MO&P=&'
M@]WMW<[^[L[!RJ^MMW>X<V <[AE'O<[1]N[ASC:L$4ZF=Z!^'>Q]WMWNX.6/
MN[U.;VNW\]DX.(0+NHGVBB_O-<<.O;EJ/UST:0Y#IR,#OC0 T"TV#/&="6"I
M%R)7MPU.Q_3-(FJRL"7XC2V^C7;+Z#BP ]>BB6-Q ?J=%R5^9"6,@QX0^;[G
MO[IK>^*%L[JQ,?7[QVIK3&SO7FV-_4UB+;_]$VV-_S][;]X4-Y*M#W\5!7?N
M;[HC2%J92BWIGI<(VF /<TWA-KA][7\Z<@7918E;BS'^].\Y*:FD@@(#+J H
M-!%#EZNTY'+.<Y8\"X^S>^EH>[=FR=<.EF]0P9_(8-,->L>G=F/]T5AO1K!=
M6^,GT%6M:VN\[/O2M36NLC]TU:*38HM.*KJNQEU7XZZK<=?5^/EU-18+ ,R?
M7HN5ZRS;]33N>AH_SN(]2D_C1YWW$VAKO(SKLQJ=C1]U91^S(]13.?T71BNC
MF(QIR'BHN+")C2B-TU"$*C8^ )<*RB+:M;Z[00C Y]WSWO<O9_N'>WSO< <^
MOSN&Z_FGSSN\][V?]PYW.+S[^Z</O<\70P#V/N]&^X=;\=[WHV][A[LPOQW^
MZ?#X9._P*-K_L$OW#H]AGC ?UIOM;QS&2L56:^+BE!*NE" 9HR&Q-HEMJER<
MR+*_\4]7)[^_WD_W$N/3P5T'=Y?R#:R)I.#:AH['L<A2#)_AL0PC+@6+KH:[
MK@?>$H)@4S]/AD*GVFJBL1$>AQTF(DHDH5Q):Q25*DR?0 ^\#@<[''P('%2A
M"Z6-.3.QY)G)0.T3,K0Z34086V<[M6])$:^I0,BB)-*,<P+:GP.USQ@B#.,D
M<Y9*RT(;)ZQ3^SJXZ^ .U#ZI=*(CP#QMN4O23"NAA4NUM%JH1'5JWY,"P::&
M8VI2JEU,B0X-@* 4*1&<2F)YDH5)&C*I[)-3^YY#@<>N^_'/-K'HZLD\D(OS
M67=H>RA0GVEG015L36I);%5(.!=@RRMEB0F5CE/T:!H ]6B#+5%YF(YKGX2G
MKN/E!^'EQB]';1JJR% 22X8U&H4E6<@5,;"O0E-EM5E<FG''S\O+SS_K<>HX
M]T$XM]7S&-@TR<"JLDQSPB,18U.IB&@9)XJ9,*6*=E)XQ;GV?APG'2\_""\W
M;A*3,".<BXGEW! >9YI([2QAH4K3+*:P=709I?!SB(^K'8'!4([M3SA"GN#4
MNVZ>3],14D/SOZTYLJ.M!JM[=MR!]&U .F^Y/6CBK% 1)]9Q2KB.%?%U79QV
M41(F4F78Q9-NQ$M4R*7CT:?E]N@X=W&<VS@YE.'<A3HCCG-!P+IE)*,T)!$'
MY2JC(36.=;74G@'W+LS)T?'IXOBT<6EP)[EFB2!&9AP;QC B4JT(LZ$"W8CQ
M5(E.PJXXC]ZS2Z/CW,5Q;N/ 2-(H- FP:NR<(CPQ&9%9*HF5*K&@-3NMNUZ=
MCQ7* 6P0C.H^M<%7GU)?N*"?.QOD _C%ER@X+?JY7E#_RJ>P+%V4QY-T;CRC
MILL/!>3G+2='*H42/,H(#3-#.(M2(H5Q1$EIC01E&;Y:V\S"[EAIE9GU?KT<
M'0O? PLWW@Z14<><%21-9$(XJ-)$,<>(=C05,8NXB_@R'B9U7+RDWHZ.7^^!
M7QNO1\*3,,G2E&2Q2PFW2A#!!26<9\ZE)DXR0SN1N^K,>K]NCXZ%[X&%&_='
M*&%O-),DM*$"QDTID1;^)'$:&:6H%LGB>C%U\1NW+%99=HJ%"3:M8J<=),^?
M5RQ'USCSB;@[NG;(CX3K^^W2/2;*1&I<1@#$0\+CB!.E+25(P2:!3U:D:YMI
MLI$ND4^[X^4GX0WI./SQ.+QQEB0RI92)C(1*,,(%"\$,,Q%)4V/"A"IMG%[&
M@ZN.R9?,6=*Q\^.Q<RLIQH6Q#I.,Z"A$#PI31&B3$988T,*,C$+9">R5Y^6E
M*"?2<?@".;QQM60F%-JE''1PQ@FWP.89CQ2)!,UB9J429BG;7C^'2)/=P5<[
M&F/3&FR;9GTWV6"$7'%WC\,37(;2U5+63AE7$29=<,DR>UMJ-WG9 /E@2K&O
MOO;R#JIO ]7M.B&6I=9D3I.()9KP&-0R:4)'$@<6EV0VC"C'SL=TB3SB'6LN
MC?.D8\U%LV;C]N#:6:<$)38Q,6A1'%B3<D9T8ET,OR4A<QUKKCAKWMWE<9,C
MYXYA?YYA&\=&1,,T W6&\$S#'Q$Y(D2<$"U33L%,,39QRWC"W#'MD_!M=$R[
M.*9M?!561(HQEY T%2'AU#(B0 TF(J*&6FE#B9T_EH]I[R$LY/-D-,[=^5)Q
M'=:S@>&BD0XL-LJ-'=ZT46$7$M)YI1\M V9*MB_;5%LWV[1F:U3">!?B]W-8
M#N\=[YV'WSR>;_T=.6,8BQ6)F(H(3PTE*HG@3R1$ @H8YXZBS226R.O<,?'2
MN#-N%*;;L?;#L7;O8,K:U$@1"VD(%0DC7&4Q49G21$@54ZD2QJ5<QD.ECKV?
ME$ND8^^'9.]&<J<L8HQ&P-F:<[3#$I)QQ8D)8Q%SDP@=+JZ\8L?>R\O>=W>>
M=(S\:(R\W\CI--6&&JM(*N*4<!:FH'UGAK LR3*5);'$/)OE4L&],^6WL51]
MN^F'I3WQ3#S%P#<F_[KY+_A3#^9$#H_R 2D?\B(#%JB^P88VL6?L<FZ]R0DP
MC)ZE\ 1D5AIF:<25X:"C*I,YGL8V42I.0F;_WF8A"\,TI,1_$%%X98D<7^?W
MROBF]X-" <=^Q8GM#DXG,  8B<[[N9_9(0SICWZAOSQ-*N_;?[\[__3!G"K&
MDT^?>\>?MO_(/W[X].73Y[_RWO8NVSO9!:K]2'O;[^'SWK>][?=G0,5N[_-'
MMO?GWYRGBO(T(W$H'.'".2+"Q)&4TR2.L#&<2]<""U!P"DL_'DXL[*LGDBE1
MEFV,@"#[\G1D7]0??C?YZ+0OSU_D X^%_J:+) BT\OM9;L;'B)$;88F3E4>O
M>G[U\X;_Z0)#E+^ER0:+Q)4_AQOTCK]E++K3G=<-EH4;<93=Z+$_<&\^)1<>
M\FK@F36H^-1'7Q4N>&._VGX0!6]NY=[[H0IQHV72%FLF+]5"M7R]+Z_T]3Z'
M=,@_9-^7>Y+C8-MJ>Z+L,(CH>H"*SWWX?W]T7]?ML>OVV&GA=]7"M^(>>W>R
M?[@#.L@.O ?N^?[I>&\;QG2XQV#<Y[T/O9,]&/$E+7S[2P3OB?<./YY_/'SW
M&72:J'>R<[9W\N>WO>^P MN[]"/[> Z:N-L[#\];H4,R%%D:DBSA8%$;&Q-A
MXIADVC(K3!;J;*$Z>-?.<0'<^5:>HV+0A2'??NE^N0VR@4%E8R6YL"G/*-I<
M@FH1ND3':29T97W1&>OKBFRR-\=__S$9P7!&HY?%B<H');C-Q[RMX5#"MWZ/
MZ[WN(.X6$-=[V8(X*[.89X83(5A*>)(I(JE4)%(T,RQF*:/AVB:?T[G[UQ4)
MUU@Z -LR&$%R=PQ[WB[2Q\*P!JUF FSD=#,[C+H-1AVT,$J'6C,>QH0+@6<:
M6A(51Q%A3%DC$R$RQM<VV9P([IMC5)?^=DN,,CFN<*=EW:_YN"B JNW(NZE9
M+X_QX^Y@ZP1V8+SOKKAEFO)+.ZR[#=;E+:Q+HU!9%28DMBP!D]-A"*TU),G"
M1%J>IL[)M<UD(USM&-JE [R6+_' GHXK9V*(SD06/J(SL3H[BV#K3#'!,Y5Z
M+5K.!/J,O8V+6*"5D2=2.Z7#E#NM.6"+RA)0J5P<BD0QQ84/Z;N)&.G<D0\E
M&]KNR%"F62PB24R6@6QPF2%9 J8[=YPY)3.K8-\VQ<_+AH5ST,(""II8@!^&
M$Z0;5^1E^*_R@0'J?4'CC;0,-'A@SF7(N8?'-L":*7)P'AS+42 #F!\R[+#H
MP]5'05XW9#V=C(.A[<NQ-<&X"/+Q*-@?C.4P+X+11 $'YG)X'HR/03SA@Y2U
M@T!/N3& KT[L]^]R $.HBU7D [A^^GX?$9;^/D*\@)49^2*B [^C_J6JDG^C
M8VO'HXT AW[=8/-1V7W%H,3$X?HK@1PGLM\_!W"!:T]@-*:\;#TX.\[U<2!/
M3X?%-\"=,:RRPQ-?__-&$$R)=Z5VO7#.#F%Q@ DDUA$Y.>T7YQ;>A5M3G)X6
MPS'"^3EN^JE$3LE/L3<O7"N;RXD#YH6E-'/KOY["S@6_;+]\^^M&L-4\93#^
MYZBZ U ^D$-0;OK]0I?;?>Y'T+H81U  ]13#X*08^JXZ5PJ>P035HTOAY#+5
MB0H-RRBW82JB)+1&)5)SR1)*Y\N>L.5BZ?G'%JYU_/\*)C[:^BKS/F+$JV+X
MMAGQ3M_Z<4T%3O@T!<Z=XW-ZGS]&?\?*"I4Y0^(HE5B9(B7"T(PD899%<98Q
M:=G:)DTNR0Q C";* @EL-&72(1*@L=]*,((=ML.!9VO@#7D$W_K+-X)7P^(D
M& /OX&7XWW5/1<Z-[-C3ERY&/H(#/X,(.AL?U[ T2Z9Y4VU':HU&* RFA5X
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MR]]8G H^7:I?7!6T?S\86E#M8'U>@_QZ X/>'Y2'R7B6O#N8M9.6IJS](^#
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M=RZ)F32"&<Y5F&8\83)-N7!2.):E%[NT'[Q_^_:-9U)@V)=;!_\.7KW9_Q"
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M$1V?+IQ/&Q4@"P7#)HPDICPDG*4AD8"K1-H$-#2C0$\+@4]9]/-%[#H^7>*
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MIKCV"G3X"<78*5WSLE?)"[68I_DH,8]J;-"+[H:\V[ECB4BR(&S]P#_.ZE1
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MJYB9QOH&=^4V:74?TO8WJ-H,TVKT!]VU!<36=^F%38::7VI^636V,##[>N?
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M'?X^34)[C&%TQ,K(M9^U\+2ZZGELC0N,MM[;T[KSK/J9MY.&S0WO&/4P7==
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M>7;^?W]]9\T3\V)*WYAMJA,](9R:O 5;QTQV,@RQ4Y.M8R9US*2.F>S=Z@[
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MY"ZE&1XF%[S6AE:$B+?8^2[29LP*C_']Q_A3H9E?:6^]N-#N[_3JGQ=GQ\9
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M@P,;%\YT[<3SA.<S*KZ'D%&RD6'NKL-RX!OS7F):Z,_Q#2/PRIQS>!Z6!$B
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M% S2$*PD'@>A^R</A$EOU3"P0AK! ?+B@2LD,<&7W#O!C;&C08IMFKX":2[
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M\L:A#3>ARRCWOZ&8R%$R11=YE 9>Y"U(4'0$$J9<A,54Y2R13TV/+/MF!M[
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MBO44<LT,6WX*7.A%#XS19>U;U#A)2$@P45S'FQW+DUO.%J!&VQ;-4]1O-:C
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M3L:$M4@]20D\89*6,9%3I5S+)[5Q83N!HC_G,:,"OM_1FS\XF'2, 4_LD/+
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M05<ZGD8WN/*TTWOL#Y^S7+N9A**0G*:5[S1M]Q;M,.#FAE04PCS+*!@),$C
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M&$\N,47O:=]REQTH__S*:,ZXD^W%1RJ2O+<*Y N1;6..%_JO/_T_4$L#!!0
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M$Z!680A^<0Q)9H9DQ/@X,=5X[-U!/6D;;6]#.U>$!^&P0Z4(% (?+9#FS$"
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M\1"8M=QK5I@<EG\(9>L%J?KJJIYT[<Z7.+@5W,O"(HZE1;3TD!P66$)R6(2
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M[BK@"@\)4\$+9"41,EX.I?/<PK4<SCX5Y=B1#TE@EWREQ^_MJ1286*V910
M!K] ')+8,XBG#(:LN_0^SRGE9W#M4[V.G<4JZ2R5=G%EB:11(>_&]>=1J]MN
MF?6<,5)2SR!VHF7<FFWBY"!CJ"2*!^]PZ<LLD>_*"/>I5OF.*)7'>BFWV#=Q
M$#WT\W\'DX?779X'0[DE!.RN')_3WGAND,#.&\R)$&66K4FK@%N%4G*'ARUW
MP:GD1DL1+M\'54WNWY!Y"QSQV$,TKQ"V(D"^%PJD72R!3HQB,$;;H.2S$?,Z
M/:Y"$_63T"2G,3(ZGIN+-:/8A!&A"&>(:2^C+XQK'$2@8)D@A6!%*=EN/,XM
M5"M-^!4_"8G2VRDC=187<]Z$;XNH[>X],N<E,])*PY"A7D-^R 62Q%-D,1$E
MXUA*N:-1;!6X*Y&M_.G)EMRR.XB<3O37SJ]:$L"S2H^<+N.991/+2P,_#,64
M%Z"*LL@RD?@LLI6X]9--0Z<U5T86W5#]YKPZL=9*"VS6@9DX-<Z19$$B9J70
MX&2QHUF2NF>1K<2BGVQJ.JVY\OJB9N;=W5)O=W/1VP7[*/6%HA90D\A]4<9[
M( E!WCA,'3>ES7.!R[; 5^+@3S(9_D.,G2(SG)<>N("@T=:3*:AF7GY ?SL)
M<%X:(K&1 9)3CA&5A4$03S*DC)4%Q)"4X&=VB:S2S4ID^4GFP9.K/>46PF6"
MSZ\4O2NXL8P#63VRG$-<YR&[T*YPB#"IF=;,V3SU[5>'N/6&%OVUNT7UK.[9
M_YU5C7_TMNYS;#P)!=@>>\T@R(WUVK@OXM5.CH(9B=5Y-KRL#''-#3$_)&/9
MEF8/=L3D,6#*PD/6>S=]!PH:Z;$?AL<!EHQ:6^(2%33>A&)T0%K* C2B(<%R
M2IG[7CC9EJI5,;Z _3/)&9;)@ADI-J_[^[MO+VMWZZKH<UP:J0HC8)0I V18
M!0PUG%'D>;P@@;E"EEG.?ZZ,\ 5LMLE/KQ362T>N^_[U473>$$T41N!F(^'C
MP5:C,;)*EX'@@C*:I>; J@#7W+7S<PZ.*8R7CUIO9]-JXJ=3/S]O%S6T>,>=
MLU+@$ON 2LKP_/XG&>N?%83X0)VR0>09&]< N>8VGY^38JF,F&5X_.#=A5^F
M F<,)B#KXL1E =Q7'GX8PTP1"E%:G&7K_BK@7L ^H)R#8A*;I3LO"]+'_Z,G
M_03#=;?F/VV;RK;>=62?N+LOW/KDB6^JZ'COSQ\M3A_VO]A+/;GPI[KU_1"\
M;<\)*SDVX)B]% Y1&Y^8,B8N3B@K:"EID64==K=B9IK26#:7@X/5W#B&N(F'
MK''02#+*D#<B:&LT%SY+%K_I&9T??!9W?]F^Y&1E#@[\B&DWQT$=RG/D2B$1
M918C'21$8R71GA8"0Y2V3]-N/[APW(OGZ+8<R,W1^=V;=_%Y2W5@WL:"[;'Z
M'86T5&N+F'&>*8&=$5G*TJP.<9_F$EX^1[?E0#*.SD4<AMMB#R<+'=[3W#DW
M@?,8'1I";-Q20)$*VB,ME"/>:Z-LEM%^'9#[=)SH!?$T&P]^A#>--Q27AAN$
M<;>!2EA(96A @2K*K=(JX"QA_J;>=+LL_.8B^*,X43 ,!XUW57L>=%#2D[@@
M'N(-WZ&(934*1 +5&.N"0M"6.P5?BFR? O),G'HJ_][>6LF>J%-_O9AN&H:[
M<*CQEF,7D"[BP@MQ$"Y11A#GDC F)#S\68YP/8IHKZK9[(@U:<R3?'[YU(/F
MO3NKS_27/ZOV,EZ."4*_JYM'#CJ7SMK@,46AD 9&"R^0@6 &*4JIY81)$[(4
M]=H4\)J1[D_!M9T8-\7F*]#';6\ZF$YGH @_#-U%K6=U_^IZ7'_U<2]_R8(W
M$L)IC'&L*Z4A&H+@R&DC2V=HX=SSI]A7[FZ?PL[,G,EFA>2N"F@+3G360$@[
M!7! W*MZTD$\YX%(1@P'((* X/%*9VOB[+IWUDCBI,JR#?EY:"]AV2N7^TED
ML!2.IMMO^DW.F^.MT_.X7U$&[)'B/ "AX]48%OR?A>2J*+G !0W/NI5'&E]S
M:>I%FSZ1BK,$PQVPFT#]T)OV7 OKF%(E*AR!88Z4)-Y.81&WPOA "N7N6SU]
M0/P U9K'SU\T7=*;*<N*^/>1\"$X#J&0X@PR.\85HH8J)(T5\3<3%":<D#QQ
M\&KXUCQY_C.0*8?ELCBDD9]4==-AD5@[6QKPBSH6JO,E1E((V<G+%*2"'F=A
MT7(X+^$<>DX7M*%A<E:6?=L;#4;#=^\&Q[WC@T'OZ%N1SY/3_@C^Z9T-AL=W
M@:Q2MW2U9A-4*MT _]:57U?J$]A4A_ZTK8",?GI2CRL;9W+S:/*1SG:EWU5D
MW8W6C_WGQ<G66%"\J2?PJ^TJS.0VP2H][\H>:VMA1\:I/_GQ00UX]*>JF4T/
MAG\,#DNU\+AZ_*T:4"Q=9MO<!ML0S<Z,F$);NS%L+*<R:<=?>ZZ^;KW[SCW
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M/OO0+Y;UXP\#7_C;7_XO4$L#!!0    ( +Q.75&H3;<A=+,  /[-!P 3
M;&@M,C R,# Y,S!?9&5F+GAM;.R]:W<;1Y(F_'U^A5_OUS?:>;_TF9X]LB2[
M=8XL:26Y>W>_\.0E4L(T16@ 4+;GUV\D2$@B"!!5J$H0A-PSAZ8H"O5D/%$9
M$9EQ^??_^?N'\^\^X6P^F5[\[7O^%_;]=WB1IGER\>YOW__Z]B=PW__/__BW
M?_OW_P_@?__X^OEW3Z;I\@->++Y[/,.PP/S=;Y/%^^_^F7'^K^_*;/KANW].
M9_^:? H _['\1X^G'_^83=Z]7WPGF&#K?SO[:TDNV*PMJ)00E*0O43D&WIN
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M_:_I?#I'TOW%[!*__'!ZL:!7X^DYUF?3VXKOZC<C:\;J1X]^G\S/M!?)")_
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M3&9U?Y\O?L'%^VE^]*&6()UY'K.6Y'F*7'N(I(C@.3DGPJ(L";'0^]!"0[J
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MY3IQ9=5H;2>Z /H6G+8FY(PY9[H+P%7R0@>(8S>AZ0;M\/UIQN>TA\(,X./
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M,E!G _@L@_2Q26?\+N!.W0R-3E"#(6.[,*X2@SN@;&F8NL&\'PLU/LT]]6@
M1_>P+:W"-VZ"DM[6SKZ2T"K:D7V]O7!!A.)93*J)6WR?FK3#BAV+(O6AYEBJ
M /8N"^WQV0?)'N]2*.IM(-=%TO^1IU&B\-YS*XHS27#KA>Z2%3Y.Q6BGA,I
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M-8J13&DJW$%M&@PJUOL93[NHLQ&5,BEKVZ0+S0.N$^]%?\<Z\3XTW$O%;Q>
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M(Q^D+$%<JU07&&,'TE\]__"Q\YX,K',X0'PMWLP5G)B\L]F"4]Y5M<Q 49P
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M&5UM]UZ W%X#)=B 14:&J4FZ7'>(AZJ7;JXYC5AYB%75SMK"@O0@7*#U6<;
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M[B.J%E4U-TZOEBHJ17&U$AJ,R%A3!5)%1%^RLH4S$V.;%_DVE)-S"09*NT&
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MM\ /=''ZO*;(S%8E8AWP-2W#V0'PG@IR1J&S@XX,YN(^=$8HQ@H%410D\QI
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M*%)K/%]D-6 ANN),"AZ2B.1Y*!=IB1S!YF""M)G^_P3&4HQ%Y#Y2&S%O?<.
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MGN+PTS&0CAQ\B5@K:I#ID@J+)FHZY:476FL?^-ZB[Z=Q&/4I\0:AT_67 5T
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M)A@OAW.2C.I!\@UN869Y]W]<CA$NZN"NV:K?74Y+I')=^?GEP[HI,4"'V:A
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M?8W#R^F=86W!1#Y[#337B!0]Y^:*\GZ Z^3EE_KE^>7-]'HRRI;_D[MIT6*
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MD,A]L!&R#$TJ])JO[!?3&[%@"<]WOI'\&\FWEC&^NWPUG'P;W0CO7;E9CQB
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M]3[?3^=7YVYQZ4*ZN2X!+EK7Y<JZ+F+Z?1K2NAKQ7?[=!2%\B@)(3!CY^JS
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M=<WY^GZ]- $'%6L<.+,SY[#5EG:[?F))*(UBLT5">H9S1"'V_>H_01()#XO
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M]N?&.KO78OD=+6YE"8JF'- J!V4K?W4Q(*_N@FVJU7&CDV/E@&=X$RRQBK&
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MA#2(K7)9#2;1W-B]-?8VP=>=^:*-PD8ST*@&*MU K9P)A&K5VQ2AL_?M##/
MY[UJDP_;V.ZV/_F(V;OI)A^YJ6YF336"3AZX0=$^[IH;IIO)?':#HM)UY@W;
M<#\OWSO=5EM8I#UIW 04?U#7E7.YZV+'/& 2"PRE-(G9 ^SKE=1C$+/$;(ZB
MR%-69=?["C"WU=/(OZVALSD<O^K<%:C*NM9>>N<CD-[C9.<H&Q/]D1?!X8%W
M]F/U16](SY2S#)/ZFOHB]-Q[U+N=P<X^RFM65ADQ%V$D&:&(0"X\#Z)8*<V
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M!<'$2Q2ED 61-N$BPO4.4_-7HK"* QJ'4>1R?=6U_QX^M"DNM3;B@Z[\H%4
ML/7*Y,L"3W(%C!*N?&8Y-+9\-B#24_'9(.CV8#,WJ(9E,\N^)V8S-T3VV<SQ
M?>>]YWNY>GYKJ]K9?GZ0/*7+5W>TN#4Y781$..08QEX8041]#IE(?*B(R;@:
M1A+'S'(G:M?CW*PND]>BV+O:6*>:*VO) :]%M]Z$66)_=M,Z/*(C$]0+@FF]
MOQT>U*GR)=Z;"V$-?@+06YIFY6I;QC>MDQX^R"+-196V,&V7!C,*<A.(R4U-
M]BL@O_'E6E2#9/SS8%MI .1LF=Y6ZNCG]%]SC8QY\VNZNM/OI:O:\VER)Z;E
M0U[J8<V57H":[.;;_$?FD9T/H@0/Z\*XVE8F52(U"91N"WI?';=EC:2:@U<:
MV&6=8^:>9O16UJ4SS%^-#H4>J.63@2+38P5D6GUA1ON2YP_2]'IOVBN,6+HY
ML6XJJFQE7&>:1DV6R>P'<+TL\RO]QI-!3&-B@GX>-??09=GY@#OE6"K9F\L&
MRTY&=O/PL^_\"J2ZW^SIJAJ1&FG*](-Y5NNTSKC154-F3OP971HWI!F>%1\F
M0Z3;!W_4I6'9S%0.#C>M.NX.QQ=[;B/,)ZRGP=_TE_E*?S7YO>Z@NMQP9[[+
M95.K5<9ZQ?5E !.<Q*9*DH0T# ,H&8E9$"B?14YU(^VZG=L2W$I=TTLK]U5[
MC:<6O6?U7,N!L-PR# [OV!N&89!UWS X 37H=L&NYVDW"TYH[&T5W-YVWBC\
MENGE2Z^U;3_EITW899.$FDD9^SSV8!3Y%"*/>) &DD#%8NY%@OM!:'M:=;:S
MN7%3*S#82 RV(KM7,3@/]ME-P: 0CLP_DZ-GO0L8%,6)-@ 7HNEB,UK#<]1<
M/-_"5):BM2X=(]'^'3>^+8O5XK/^3JK]S,_2['T>[E).EU6(LQYVZGD^AC2)
M$$0^"2!C000]CF,L_3CRF&]#M"=[F1O#=N5S"B(_C>5I'AT,H9$)U 4<Z_EM
MI?P)HTR_WS'(]$_/C;'3'4PR[ZUT;">\W</NQ:S?Z2%8?KS+,_E^72U/!,4T
M,KG]?#WR$#$N( F4@AY#$5.2DR2V*G!UJ/&YS>M*/E )"&H)[<M:[P%W>C9?
M"L?(D]@!":<"U\=4OJ#&]5Z3DY6Y/J9,M]+UT6>&<]*\7A>5%5?7].!!$GMZ
MDD8B0:;\/(/8S%[$F(Q"P3@G5H<CMAW.;0H?<Q^T,O>Z\W46]?Z^F+Y8OI 7
MQA;&0=POA[ 9V_&RT^>+NUP.(6#C;#GXGGLL</!#Z)7/@^S00A$5("43F,11
M A$6(:0A]J'T?85PG @<8=M0X,-=S(U5C)3_JUO[:Q.TB>S#7(^@>=9[,@!&
M([/%F/#8!P%?#M-$3I$^<#F% )]&XG@$\)'W)@L /BUW-_[WS)/.5/=1ZK$U
M%_HW"5G>?#,7+:K,ZIWD+::\??/LJ^HD-\U,1)\YY?ZD-V.F%L4J?T67?&VR
M#6\:R]7/>2Z^ILNERHM/\B$O3-* W[)TM:"Q%(GT3!$)DU;0C_3^2J@0<JZT
M\291& 96YVDOJ<3<Z+I1SAR?;S,X@0T8SY(^ 8,':-^I$3&1"2TFP( "JK(Q
MJQQL<.DVK3MJL:G.S#?H  ./-0>^W%=X=A'Z4WQ;(R]S__]GY?I962_>?XK/
M:R+SX,_RF;F8)"\^OD>-GI>3;"JSZL6Q[QAN+R]+SQRL\M;,_";T1BB"?(^'
MT(MC!E'$ T@YY3"*A5"^$*$7.3G9=EJ?FS'5"%?VC&;:14X%,I R2"!"-(!(
MQ#$D)$Q@XL?*8S10A#"WDL.]L9NFJ/"@Z-FY&7LC,K+Y9 ^%>Z[40RH/FNMT
MIX-I<Y4>TFTOU^C!AWIR77NL:!*7-E7%KEE9.1D7A'HX9CB&<20U]8DH@4RQ
M""9!$ =^(#R.K K<V'0V.R9L9:T3![?UZL#OK<"ND_L4T)9S?2#XQI[Z_9%S
MYP(+2 :EAE/]3<L4%IKO$8?-._UXY*?FWL(U_^]U6J;5U8R/1?[67 U_+U<W
M&<_OI<FDM5!>0GE$?.C[6$!$0@%IK,&6#'.,<1A@Y61/6?<\-X9I!0<=R:],
M^6)0R0[,9:5:^B8'F1OAV(^('?N,@O/(5#0<Q,[,Y S7D#1EW_FDG.6,R7,"
M<V_ ^7# 9%5ZE].LKOAQDYDTO]7V]#K+UO<_T5*:/>G'Y;ILMJST5BY(&-(
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M^>!X3M9I\[%V#JY!I3^7FR<[&_SDRZ>JP@ 'JY?(YPWRCT\;\$N^DLLG93^
M)[L,*I?/[HH3-_SZF\OD^ZA%^<3+9_<)1%=5.ICKX,!7SRZ/['&I-V[_ *PB
MJ[75Q4U"+NU,+Y?5M8^\W*SL)W^?/UJ1N=6:-YL.Q[;U-:7^F1=/ZY.:UZ6:
MW'.M=?I/<,-77.5\U3S]-[L7L7^RUSXM-PZ$S7V^;JOT4N_2+AU+5:GM3"A6
MSIME[SHE/E^!96MS5#4\:-UI__RP>ZEU]=[\!FZ=!G:-^6"E[0;,*?'ZTOV#
MALFO"WJO3Z8 ^#UEJB2 ()M::0!A]_5UE]<?X7_FF_N;)SOE/.ARY\7/JVY;
M;AD:1S(6V"[T29S:=7^F%61I:F=HEF%"TD@I%>A%]Q$[OXFYUAK\:=4&C=XO
MCN8JW7OM!#Q'PM<1/S2^H_OGAX&VA],^!*EA??E>DB=V\8>@<>CY#[K[L@.!
M#W_EFYMBO5FC19R1)*::0)EA"7&4*DBC%$&&>4H2(7D:U@CY4,3<F.C[BQ0\
M:3<%+CF^U$N7&.Q6&NW%52&6^5VUKEN[$.1"YM55U9>VU+R5VY>_J&/82OBK
MGRL=%OT<[*W1"O.#]QN#J=S53CMPTPE+;T?RH>5C^'M;4M[$+7MHY2GOZ9$K
MPTO:M$H-M#JV?[=++%.4?_)2[<KZTDPG:68BJ!.,W)(G@Y1I!%/!M3 Z)L*[
M886_U+GQS,M**2W=04OYX,+*80-QUK<P#KRC+W@&0C:H>DDP4J>KE?@_:K+J
M),'6M:N1A-_<M\K>CP>^7#:LMJ 1HS01$4P-H1#SJB\CQS 6D=(ZSF02QV'%
M]5X\?VZ,LBT25^FX"UX,K:3W$L%N@A@ EY&I( R2'M7RCAI^<9&\ET^=N#;>
M49,.2^(=OZS?QJ-QP#2=/*F45"41A2FU_\&Q2B%#3$.!>)2E.D8T43V:>[\2
MX_6>3E\8:.<0UV>:>GI!Z;<EZ(/,-%_P#HW!6YR>L'G(G<!K$9-N T[8]WH/
M<.JRX W OF.ST\4Y+/+5DYWGOS[JLMXBUVV9Z^MN^5]Z;1<"QSVQ"\YT1E0F
MH-$L@IA&&C+-.,RX3+ @"&N_8@D#ZS6[*9^7*ZO>NFF[GE<V@(TSPGO#,.C
MG=U2O-5PC,Y3%?*_.,-^K4^P]K:!O7&@M@YLKZ_LJQQ#)XY%WV84O0]+WVHT
M)SI3G7Q40[:<8V!_<E,ZJ+"IMJUC(-3:V([R^+X=#1]+[;S/5JK]>:F;;*!6
M_XM%0AFM*A 9@03$29I!:E?84#(D*!4JT\J$=3<\+W1N,V9;Y_K OJ5L:*]#
M#\S]UM]#(SGR9-=6]PKL%*Z3(WWP[-$0T1^@89LC>LB=N%&B/Q*'31,#[NWK
M@_N8+W5Y8W?+=T7I(@XC84B$H<A8##&7*10L2B 6=ADO292FW*NCZHGGSXU>
MM@ZG2D?0*!GJ@WN)H*\/KC<NT_C@/"'IX8,[:OC%/KB73YW8!W?4I$,?W/'+
MWCX;\(:O[^T?7!C53[YT$6X+H5*2(->V(M+VZV>&0\YH!HW$=E5B!.72RQ<_
MC;ISHY61DKB<X=5?6Z:_79;?D;?&;_4TGW=A9"J=PVOPIME[IT=GK@E[1S3^
M'YNC=QK],=/R.J2&UZ7[5A;J26Z^EC]T^3.7NBZK9J+,H(3#%"F[+\8J@901
M##DF)DY2I55,?,O2'1,PM]EDJV-=WJA6,[BBVE$@N^EZ"'A&)M@>R 255NLR
M_]+*:D>?/5EAM2[+VG75.J_KVX9U1QD+'N,HBJ6"TG4WP49SR R)(=,I4:G*
M$H+2D)JWK6<'?<43%+[]<CPI);3%ZAX[O\563T1&_G!;6@W9,O7 U&&;I.X?
M/W%;U .[#ANA'E[2UR%TK53IU@+VQZ_E;?'G:D%EQ)FF&.HH9M#.MP;2*,I@
M2DD:2ZZEC@.=0@<RYC;G;KT@6SWMFMO]JRB!TS74/W0(J*^/Z"*8IO$3A2'4
MPUUT$H.+74:'3Y[8;732M$/7T>E+PR._[0+]&\_5^RIEXILN\T)]+,I=E#&+
M(D8Q)Y!+=^QDB("4&@3CC"K!TIC3+/(-]^X6-;>/OMI8/UI]@:K321XKC8$I
MRG_SC^<^ V_WMS\L:"-30(674Q74NH):66"U'3Q>VP^4TT':9^Z?+#+;SXYV
M.+;G'>$E*/3FO2N@H]4[O;(_;+[9P6T?+=E=O+U ER5?+@S"B"!,+9$R2PK:
M-<*AB8 IH=H0A0B+O2M1!,B=&T-8W5^<0%<[3[55UK\"0@CR9_EB+#Q')@\'
MY59OL%4<.,U?G$A7O8C?CXJO?Z&)D7">*#9J0+R#RACT0.UT-8.0ATU6U*"'
MA>W:!GUN[^=Y^:XW>5E5R7<R;NU#ZI(&B+(DBS5DG!B(:9Q"[IH=2IED1B.5
M9JD..>L[+F9N5+[7LOX,G)Z]RA6<0-7//7,Y5B/3=!^8@CTWW2@,Z<0Y(6E2
M?TZWM:]=.V>NOJ#KJ2NC4^I[O5KG/W43'%D7-WM?//!\M>!*(9Y( N,X1A#+
M*(8,"[N;3BA%J4%)HKVV@F%BY\84=?//%VHWD<.-XN"/6O70EA)^P^!')<.#
M.S*U#()KOT:KWC -WGGUO.3I6[%ZHW&T-ZO_W7T+,ST\Y!M'@&N[%*K#MN_T
MRK5*V/=BW+E71*QEG H"F9&II2RL(,U2!C5'1F*,TDSPL/I, =+GQEPMY:N=
MZ@OU7W0?#:Q;T&]L_'AL-,3']H8-"':/XDT]0!NVAE.( A.7<NJ!S6%%ISX/
MZ<=X'WE>_H>K _EI]?BT67_6/_42;=N/1#J-C'/$(99*B--$0&H(MOP6(:P5
M(C0L,+-#UMS8K-(-H)Y]7+I ]2.F@: :F8:<EJ!2TU7]=XI> 6_D@GG' Y,A
M6:9+W*2<XF'W:P;QN:5G.WMYK]734G\UVVY2ZR_%1J\_%WSER.ICON(K5W/N
MNY8Z_^GB^&[=?Q:8:\YU@J'0QB5[4 F%_1$J3CD56690Q():W/?38VX\TYCA
MBBTVAER!RA3[*3ECJOE]9P[8VP/^J"P*I*:^X^='6Q.,RLB4-N: !#/>A7 .
MR89]59F4*2_$ZS6+7OJXOA5O9.GJ0[[7]?]_6GU:_;1KP:)TD7B848$3C:"A
M+E5.5P7R!((LRWC"3)9%(NI5_Z9#J-?G^1;5<&I=73'M?*]M:%&<+K3]6.]R
M\"8K1%$#]DNCZ:\.NT\>V/4HH>.!R; %=;H$3EQ>Q\/VPV([/C<%1UY\6/W,
M[XKMWD,+$4=)8J!1R)*'B@VT:R\#4Y9&)$$1%MQK$?;JN7-;5-6Z!>[=7F/5
M_>E?@,#('_D@QGL'*O0%8:) !%\P0J(,CIE\,HK@Q<5310D<T[ 5!7#TSQ=Z
MC[;)6B^2M'ZW-/94:O75)7@]E2ZD[+JJ<5(V_ZS*E-?["Y.Q-%620$T$M_O#
ME$(N$P0CH4@49U&LF%?<]^":S8W<VCZ7=LIF8Q,H5F!GU;:2?Z^=XG!C&^CR
MFG+$)G20[0=E6_UII_KP&\?!L1S%L7:Q<F_CAAL*TY-.N\$$A*?EO-_.RQ_S
MM>3+_]*\_&A_8[>=DL28ZQBB2-B5(Z8Q9*G!4.+(\$RJE"NOHHL=,N9&M(V:
MH-83.$5!I:E_4LXI.+L9<2"01N:V'O@$I>2<0>""E)Q33YXL)>>,:>V4G'.7
M#N5C:CQ<W_AS-6>3C"J3I"E$L<N6)3&!/,X$3)A2$5$H(F'KL;,29_?YZ[UW
MB6]5!8^UKI>ZF%Z#W=?-= &$;^-J:A0&W\X .8"_Z00XX_J<7@M]8[_3"0S.
M^YY.W=B/;F[S!U?[TMRZ[HI&EU_-WXI"[1+]MZ&'6<HUUT2Y^"F[!4PM[U :
M*9ARS$4L(AQC&4(Y7E+G1CNUTN[TJ5';_>P4=PFON\(3O4) _8;!CXP&!W=D
M0AH(UV!>"L)I2&[R$SPI/P5A\9JCPF[N6RI7;#ZM7),WM^2J4BL2DO&4,0(3
M3#)7G$Y ^ZJY_QB$[%)(,AP4EGXH8FX,Y#0$>Q5[Y:D< =*/5BZ#9^P=3Q@R
M/2K9GC)^V+JU!U(FKE)[RLK#FK0GK^SW?5\KE;L#![YT6<Z?5C?\,=_PY?;0
M@T4XTIAPN\>1&N(L(I#)1$/!A>*"\@1C%/*I=TJ;VU>_5[;*LH=VL;[5MV<,
M9#?6?FPP&((C$\,EX 6SA!<H0Q)&M\!)N</+]M<TXG?3I>&035W#JF#A.J]K
M_#^W_G6K_]J\L\;\<V%22;44,4Q20B!6F$*J8V(W.H1E,E6:8J^B@I<H,3?^
M:<?=[6J9MLVX N*Y_8N^88\!X^1'4F.C/S)W!0._/:T"SAA063-*Q&,XF..$
M.P;H\4:QCN%(G0YT[/&LX)"D[_IGL?QI-W,WI;;,_'';\/I:RM(%K->U"A]U
M>;U:/3WPS>=<%.6WY=/Z=U[>Y:MOVK[XJPV_TXM4Q-PB%\.84U5W(!<H%5 P
MR5.D=2)3ZAG.-)1.<Z/5G5V@-@PTEH':M%W;(5=_"E36 ;X!E7W &0AJ"\'>
M1.^(HL'&N9N'WVCT1J;E_RL&SCN,["T&<*(0M"D',B2,;6C(3X; #29HJO"Y
MH9%IA=X-_NC@R=<ED)95<Q]>/KO4TC(73^Z?^X?_GJ_RAZ>'1:)$K#1.8$J0
MA%C'=GI-$8*<XE3B+$M0Y'4>$R1U;A/H"\U!6_76!PFVRGLS;, HG)W\QL%V
M;%?J6\/J/36- ^]$D\]+F&4;YL<]S'9_M[G7]L\/CWSU[$J0 KW,[W*WR],/
MC\OB6>LU$'Q=1Y>NZQ.7*U!:41H\U-;_-LBL%([VR7DGX%%3S2SAUK7FCAXW
M7U"P:=NH<G5W+3?YSRH$T54'_;@L_OQAW]JJ2-1"R%AJ$V&8L21UR6@2LD1A
MF$K&A&&(&A9T8N\M>6ZS1%U>:*<YV*N^;:'CM <[]7M4;O(:#S^'U2@HCSQ?
M# 5POQ).(6 -7L7)2_CTA9Q",#E:RRGH 3W/\_,UO[LK74JJY<FOQBZ_]>I)
M?\Y7^I,5L%Y$.#.<8P33)(DA)CB"G/$8JC@QW.#8(!E4CO*<P+GQUDM]G0MX
MJS'XP^D,*J5#S_[/@>X9"3 @E.,O9B]!,3Q.P!.:0:,&SLF<-H; $X&#B +?
M^WJ6CUOR]?JK^;$IY#_W[[O*#.(I)U!B%$&<: JI,C&45,D(,TT$"8HK."IE
M;LQ2*>D^A4K-"^CD.*9^''(Q4B,31Q^0PLNU=8$P:%FVHX*F+;_69>M!F;7.
MBX,]:S_T*B_*JD+(^R?M,-K&NF1"IZE+I1 I1]!R (-"61)@69QI&:N(4]^L
M^U,RYO;UUWJ"E5,4*#L1.E7#<])/0GK6*38$4&,?O(^,D;>':PBL)O)G78/U
M'C60KP$'HE@IL+GG&[#A_[1(/I;V[U5_J)\NQKO:-RH7N+EVB9)UKO2Z6*K&
MZY6OUT^Z_ U\6E7_= N"3>L/X*ZH?%^K?Y9/CYNK1G[UQ'O[&/LQ@;*J_Z/W
MHIT'[8^'I_6F^=/_;W]XY,]UU&AUF?O-TJ)E;]L4X!]/U5-=8O#3JE)4*_#+
MG5[9+=+R5R"KTX*B7 _C9#LWX"==:B=OG,J!=D[SEKOL[*5]0TC_8<>UJLUY
M6[C&M2N9+_47O6FJ$:_M[ZL^.F7Q,U=:O7O^^UJK3ZLCV]U](6&B,&(ZA3).
M,XAUQB GF809LTM#DB::AW5%&$/)N4TQ+1O=%U0V5H*5W@#-RY6UHOJ+^[>L
MNFUMC75??K'S)/&=I9Y]MT9]$_S6M6\]OB//C*^&=F<@<'UEME7;?W%&_NK^
M7'<&:XWM+\Y6D*]^/>HO'*4D\I@#,FPH[PAZ3AP!/![2AX'#(\KJ-_W\?27R
MY5)71:'=X];[VH,+I>.4Q3*"%"D-,4LPY(G*8,2$EB(2D>1!Y9H[9,UM,FA4
M!3M=6W4YPVB]"V$_=AX(MY%)MA]DP<SH <:0!-<E;E*>\K#[-=WXW-*S3%=1
MZOQN=?-4EGHEGQL!59V97=69?6GY121%1E#,(".)@IA'KK%%Q*#D"4E2(C)L
MPHIQA<F?&[MLU0>-_KM/Y@I4)ER!?9VG5O.%P');@6/DQT4C(C\R/PT->G@-
MK7[0#5HI*U"%:>MA]</GH.I5S\?T;4M8'?A\M-8TDOXSW]S?V'6>7='M.R<3
MP27G1D*.F($XB3/((XR@B%BJ%6=8DJ#6/IYRY\9\S3FF&_W=!PC^M)J#1O7>
M_7Q\A\*/Z$8 >&2"&PC;'@T0@Y :MB.BG^B)6R0&X7'8,S'L]GZ\U>1EW10/
M(E]57G:W(;U;Y?]M-YS*;E%SD[N5XK9VH$O8*K5Z64/0_NWI0;NB@;)BVYID
MUPLI$LMVB8'$4 (Q3B6DD8RA3!*6:".H(%D(V8VI[-P8<I<RV3*VJO6Y-1>T
M[:U7+MOT2N?B=P[_=A'7K=&NX41C]O:>,&X=]77Q(^2YO 0CL_B;CW\P_T\Q
M,$-.&J/J.^E,,P7RKZ>G263V;[99K*KPBQ_WW'Z47Y\VZXW])/+5W4)F*$F(
M78!C2AC$R&C(M%$PBC5/E*89$T&AY5W"YC:GU+J"M5/V"JPK=4&QUQ?\DJ^V
MO_XUO(?F2<A=4A=5$8<H$P)B@C@4*A-04T:H4D@DS"P>=9D7ZL>&EYMI@7\M
M>'SX#W"_ D+?Y2MWL@@$M_=(/=)0&!WCR+WN&6=V*.P"#%*1:)@PD@JA-*92
M;8?B@_U2WV @&K%O,@RZ_@S&'0._9<Y0J(Z\3-F"^:.FE%K3*]#2==CVL.<0
M&;H;[$EYDS=_/6?YL5ZO9^^YL#G'OVMUI]O3^=ZQMB!V9F68$Y@9DT LL@P*
M8CA,4J0R+56"=5!]0Q^A<YMO6X[D2NOVDKQGSXPNR#T]]P,#.;:[O@^&_?M:
M>( R2LN*+KEOTXW" XF3C29\[NU=8+YXT+?\KR.MV1'AC$4L@H2HR$6[19"Q
M!,$,"ZQ-+$F"O'I)>,B:&]-L@Y>LKH%-VH-!]B.9@: ;F5MZH]:GBOPY/ :N
M'W]2W-25X\_9?:1F_-E;>I_1'2N2L@UKEX1B1!&&-#-V:Q1K#CE*#60932/"
M#8]$4)13I[2Y\<?I8D+]BK1V0^U]\C8,@..?M_7%KL\9VWE,!CY9ZQ X]7G:
M>=N/G*)YW'1IC597,?[/?+FLV](E3"0IP13B5%DFP9DED52D4 N""5*$HZ1G
M2_H7<N;&(>V"GXVBE_:2?PFL'V\, -?(C-$+J0M*GA[%89RJIB]%O5'ATJ/V
MGJY->OSRGIQP7Y2;6UT^N!KSGW=IQ41$4225@CC+,HAI3"$UL6NQ3B(946D,
M-D&4<%3,[!C!:0FMI =0M3CHGZQ] E9/0K@8K+'YH ].X7S0"<.@='!<TK1L
MT&GM 1ET7]VWZXNQ3U+O],K^L/EFA_R;7JU=82W[X]H%\UQ+^?3PM.2;W55?
MQ3*OBTBL/ZT^_"6URR1WUV^/4;=%)O2WLOB'EL?N6["$1H2JU X,LH23:@19
M['(VB)2(1])D+*@*_-N8,3<NVZ( MHH"9\P5V")1_:L.L6MAL;MV;Y7K55?#
MX>;^ZJX:D2NP@^+(;:%-<M[DO?,CX_F_32.3_3Q?I!X]A=YR'(?M6_0FEDS<
M&^DM1^NP_]*;:G-!]<I*V*>'1YZ7+GWSYIZ7=WJ]B 17<6)G6Y9%[N1!9RY#
M,H**8*2EQ)JSH,/.#EESFQ?K HJ5KF"O+-AJVZ,@Y0F(_6:7@8 ;>0KHB5F_
M&I/=: Q>5?*$N.GK2';;?;1RY)E;@BLW??C?3Y6O<7-?J'UJ]Q>]V79$M;O_
M-(NP@JJ*C]<LAE1K 0UF1,@$X9AZ%7 [+VINK%&K"VI]7Y9>N*JJ,80UHO7
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MR))C&D.*LQCB..60<2Q@JFB$8XZ3B 1%?IZ0,S<&W-:WV.EY88N(0US].&P
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M@/*,^L5Y= F9FS]DFUZV5_(*?/P/^.53V*[F*)Q^&YE+01IY-@G&)WBWT@7
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M)!)40B(-@5C$%%(F-#2IHIG)[+_#%H@!LN?&Z(WJ]:>^YG4?YKI?2!@GAPR
M'_&.!.O([/H2T1];1!O-KZK:?)NK*MEFI_YPO-D#LR'),43\I S8 Y?7--?G
M$;T3;.P;E=O)M5HRK_]66@K]\)=</KGHFK\5A?HS7RX7B<LE-B*"&8V$7;/*
M"')F5Z\9R3*I4D;2+*A>C)_8N3'87FM0JWT%*L7!+SO50:-[8&%1SW'P8[/A
MT1V9R(8!MD\23P!. R?U^$B>.LDG (TC23\A=U]VWGA3/(A\5:T!]T><-^TC
MSNNRM.K4->/L[M_^^&EU_>!2%K^:$[<T39*>T4(0$2MF[,@Q.WP8)Q)2$R4P
ME5HI*@GA**CRWD1ZSXTO=X=Y+;NO0.OP_X4=H&W[%:BM=^'YM?UN:7/JUGV?
ML\":-%.]4&%GM#-Z3:8Z[IW#&]+[!'FB\1KC,'ILU=_D7'NB\3AU1#Z5^+Y>
M[*8Y@=M+W-J';#- 8Y;%"9?$]7$P$ N[O!>)T%"FRE"&>8)E'.:7/BYH;K/4
M7L]JPPR<IH&IM6>Q]77_7H[8Z [=/F#U\,EV(S&LE_6$K(G]IMT6'WI"SUS?
MM_^+V.P[[;4S^3\8HUV)1KUMW,3O]").4B2DS& <<P2Q(@8RB25$7$>(I%&&
MF%C\U*4H_-N/!,@/^2[:6HSW>3CU6^TFK\"+8A178&<$V%L1VH$D9( T)BR-
M:0HYCQ3$J::6W;&&"E')L(@2(;/%2GMF'PX_.+L ^+'S"><V,%7<2)8QB)FK
MQ44P@R)RL;(\2C)"-<]X4#3;:-_--+U[YC4X?K/U:)"//(4/BG:/[CT]4!NV
MA4^( A/W\>F!S6$SGSX/"2_*LS]9M;N3*@SX^J]\O4!2IH1B!;-$"<MNBD"A
MN8*"I8;3U"B9>+G.3HN8&WN]T+*.4@=_.$4#ZO*< +.;B(:!:&2VZ8%.4&F>
M;@ NK<MSXNF3%>7IMJY=D>?,E?UV Z%9M%Q6WHV5.II3^TX;>T]5("&->98(
M7E7#L,M2'$-&HP0R(C2128(X#EK]C*3GW)BFR9>73;[\II4OOT_J"HRF&&N0
M_591,QBZD1FP=R&$VM0J?.-48011V3ML88211V3(M=Q8JDZZZAL9[]?KP['%
M]9MIF@/B?<RVTV?!**9"*^/BY3C$L7T+!$($4FQ7EHC36*=>3;V[Q<R-YQLM
MK]KY T[1,&(_@:D?+U^.U,BT&@Y2,!-V8S DD9V0-"D/=5O[FD;.7#U4FPO7
M-:ABH\T"$YI(%%&(HBB#F&:.!B(-99)ER!!$B0P*RN@2-C=&.-+"X0IP8T6#
MZ^6R^+/J[6F9&-3=EJOOX&J[G/"L2N$U!G[<,12R(S/(.* .T#CC$*UQFV>T
MY+UQ XU#R\\WT3ARSZAE(%]URW9_KM9'U3W?BO6F?'$TM]Y5B%."HXQQ!)5A
MV"YFB(1")I'ELU101$06TVRTDI!]M0[Y7J<K#^D*PK4[T+]%2<C>[X&AUKPT
M-C R<0IQ@@RD49S #!&.DM0P+N5(Y2&G>PO&+Q79_0Y,4!ZR]PO@/8O.94C'
MGX@[RT;^4EO[ZW8&WEK\8O";B?LM2D1>.@)O4"ZRM\IS+!UY*?X]RTA>+#:X
MI&2G8A]XZ::\]?=BN?Q8E'_R4BT23HV,,;=+#&+LEDE&4 B:06JP9#)%62R\
M0OIZR)[A#JJ38QH3P!_."+"UPO,(K\_8=$\"(R/^QH0^.=C>U13'!'VBXHI#
M@Q]2<+$O?"?K+P8_<*IRC'TM;55G[/V(X(G#Q83<%A_>?;I]?_U9_]0EO]/?
MW6OX_SW9O9HNZ\7R[7U9/-W=_VZ??)\@.Q)H$7$D-!4,II&0$!-)(*6<P22-
M2,)2Q!.F/">0OCK,;2*IPJ<V!:@M ;\TMOP**FO UIQF X+ ?VE> I?)"[Y9
M/;S]<9<,V]FY98K!&'F."1R'K2V@,@8DZ HX>\8?"N^99XHAF6@&&G=H0N:C
M2T$].2_U?O!4\].EEK?FJ8L?-73PD:P/H5V$G,E23"**898E*<0BXI 3HB%.
MLX1&)$YB$W0HY"-T;C-21X!)HW900&+0 %P:Y=,/UK<+V?%%=,"PFT.(IHFA
M:<F=24#,(1+^T2U'[NV;0.F"J^7FJ;2L9_^ARY]Z@0Q-4BP(5%6B3:0)%(@2
M2&+,):(H2G1@\N2AD+GQS@L=P5;)T(3)(UAF:90FL8QAZA+*,);<;CI0#+,T
MQL3N/K#$+/R<[%)$ISO<>E>?6;CHON8<JS"@EC\ O"**C<:(0&RW;Q!G1D.*
M7;,RR6/)M."<L]#CIV' '?_,: >M7JEA0<T$3:5;ATA7U%/&'#+7_"U+"<(B
MRY@A=AU2;/ARHN]_)VH\,&^=## 6"_@M+"[%:>2%1!@X/=*D3UL_;(KT$3D3
MIT>?MO0P-;KCVIXM"NZ+<F/GU >W%_K(\_(_^/))+Z*81HF1#%+7AAAS1J'(
ME$50QK'6F$DE@JH['A<SMWD?_Y;&Y%_ #[W*BQ*LBHU> _6DW:X]"FPZ<!Q6
MOT__<K!&_O@K!:'3$#@5KX!3$E1:#MA%H!.%0=L&')<T;9^ 3FL/&@-T7QWL
M1J_?^.J%M^^[A2GY73\(72[<BC1!1$,BI;"K_S2%G @%4ZR0HBKB//;R0G3(
MF!L)'/OZ$_!'K:S_2=Y)2,^ZL(< :FP"&!DC;]_R$%A-Y#ONB5F(4_@<&B>=
MOB=OG,JI>T[SEM/V[*6C'2+J4E>Q6.U3D%0IFKH6V 0Q2Y F1I#RU/)E;%=.
M:2QXHH<^1SRBQMPX-/B<I+%I[%.L8T,XV)GBA0,SMV/%MQR3P0\7+QR;N9XO
MAH[1&$>,'=!>?,IX[-ES.VCLL+_'66/7TP9PZ]\4:U=E?>L\J ZZ2()X8C2!
MF2 (8I%I*.+$P#2-<$SL_)5$_3W\A_+F-E>]]&359?]ZG"F>0SFA*#(HX3".
MW4)!I1)RE0AH,FTASJ+(\,"*<@/B/$T-N9=(.XVK$@!;G4=!O8>O]3(D)W6[
M^KRLE[E>3X,QFA?VB,BW<\B>MK_3-]MQ6_#NI#J,X/OFM"\:7DN^OE^[UI#5
M?DAOY&^+V&@N!$E@C#F#.+5,3E'&(4HMR\0(:RV]2M"$BYX;L]?'."W]7_5D
M_\69< 4J(Z[JC?D5<(9XMKCH,3AG]QHC0CXR-<T0;>]=Q(BH3[1S& ']D+U"
M3P!/[@]"GS?5GJ"GG:U]0-\G7%9]9J&0Q3=*%11&<(@9BJ&0L80)2V*[,!6&
M4>)?+S>HT\YDI7#WA5.LK'X59181T8(HD4&91*XNCU"0<F6@$!)SK#"*L0P/
MT>G3F6CRL!S URYRY/_A*[LC?0:>CIX#!!GC2:0)L:L.^W[A.$VA2*($<AI3
M*KEA0@9'X?3';[+(&\ WE\3>[."S*[0$)3&'B:0IQ!JY&#$>VWTYBH3=-48X
MXWT*0\UM<=;HU1,FOXW=##N"G;6[=S&G,79F;].PZUQ+KH&:;OUP,^VG]?I)
MJ_?5MNU;]>%69^G5=BZ7&ZVJJZY=FMK'HC0ZMSL\O5X81D2BG2<G8ZY!@#"0
M"1Y!%E&:)"E)*7+SZ5W=GM4_3J:_2F%S\2O%1CSVK"K8V$%QS%CN3*A7HI7_
MQ]*E*<J'BD37][RT5.I,"ZP)=\E@^I')V&,ST=%]A7MM!JCM +4A5W4$SQ78
M&P/JJRMSJF*>C4$#AOE<CNJ@L4 7J#-MP-#EN!U$%0WPR+[-6<K\)]]420U-
M@??UWWB^<N4HOFNYY.MU;G*M7+9I.[OXYM.GU::H,R'V5>"+TFVFONC-@E(M
MN$0:IJD+"3<RABS.!,R4XMJNJW#*O8[GQU9T;JNSO9VMA@JN>:DUM6ELWS:W
M;M3\(D'_YA/(K<G;]*(7W1=JLZ_ E]!MVFCOB=\,,(?1'SU*X*T'OD?CC7%'
M9=@>'2/I.G$[CW$1/^S\,;*\\()%<82873X_?"[X:B$I%LR..)328+MG3PGD
M2C#(5$J5$.G_X>Y=NQO'D33AOX(O[YFJ<XP>7D "F&].9V9-[F:5\\W,[CZS
M]4$'5YO3LN01I;STKU^ %"5:$B6  FGV[IFM=MHD(N(!\2  !"(RDCEG(VHW
M/+59P>H&K'+ :N>>U.8%6!>/0'I#,# U!K'>/5]/7Q1&.G!P1,,KQ\XID[L3
MZ+QX>K3L.*=T;*>^.?EW;W[YZX(7\[EQMM7J6R%4N4O;:U;*==+>*N-Y%N4X
MQED$56;8QSBS&20BPI 3RKC@*<WRW)%XW"1.C9$:K4&C]DUWAF/G$>L(_D4B
M"P_IP SWFF@Z$V-X5$=BS"#H^O"I'U*=1.O8S%@,[&=5BYH]7^RWD_&U>"H6
M#_>ZJBFBU>I>V\WJ^]56:!641I,X33-E4[MP92]78L@RHF$6Y\9;C'2*D?#9
ME'"0.37>KE6V6\*-TO9GJ[9!NQD@O2("73K ;;4?&-:!N3L(HMYK;P^,0BZC
M7<2.NB+VP.%P<>OS:C].^F.Y6#Y7$2:+A^U:^,>S6I3JEIO5-!/K69IJ;D@'
MPYC'.42(:\AR0J 4BB&>4XTE\6&DBQ*GQD=U7J1B6[Q,U<J6O_Z''_=<!MJ-
M>8+"-S#OM'7=57_;JONKX9NMQ@$YQQF=D(QS6>BH?..,P2';N+_8CVMVE]$_
M+)XWZ]+>=)DGVUN]6B",B,XA40F!R"Q0(<^EAA''J4ALR3/BE=+NC*RI\<L^
M08*M2FVUO0&5OB#QO#;M K0;RP2";V!^N0HY;VYQP"0DJYP3-RJ?.-A]R"0N
MKWCO>]E-_79E[R_?V?/MRGA&#U6Y@5E&DP0+2J#"AD=01C#DDBA(>9SF&662
MT,AQP^N"J*DQ2'4 ]Z*@/; :@Y;*SELREU"^N+,5$+N!Z6-,V)RWL +"-]+>
MU34P^FQ9.2+3N5=UZ?VQ-JD<[6CM3KF^T3/443PJN9FK>G%I8R>_JA_K-T;;
M?\Q8;I9Y:9S!+(VXS32,S.(OJ[)2ZCQ/*8Z0U_W?,[*F1JIWCQ;?TBS\P!U;
MK7[:-<SMDRW#UVR>^(<HGX/:S3$+!.# S-IHV48*_/G5%BX$5E]0*1S0-W.
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M%UX?*T##S8I6/(;C"]>DN_MX*G_5Q]U-<H[C3&-%88P0@DAF!#*)S7^45*E
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MC ^L($MBLY)FBFN6*1491EJH!UN*X.MK$!.M>^-(A?]'^,EQQ1?ZXQYZ_==
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MZSQGN?9/X7):V-0\A^V ,LKZWL@\"ZD;3X4":F!2VF/4NA<._K2J@DK7X)E
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M%TQCVX$SI+3(F."0HSB%"*<)Y#S5,.<T3V6.S3^<MO&NTF)J[&LML;E5:UO
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M^%#(*^^HG_BIT9[5'BPUJ/4'C0$W8&<"V-D &B,\BWK[]8^;JS4<Z@.3:EC
M_4N$]\(M:/%P/PW&+2O>"YVC@N/]6NG'?N=R0WUE/V9"97%$D@0F*3%>'$,*
MTIQFD L<Z0C1)&&RQTGL!;$3/8,UF@&EM1)K.P29_.]-N;9>@F=MNDN8NU%8
M" C'X:R+R>9N;+&I<"3EB$Q(5KHD<E0:<K3_D'=<7^M'-)]6R])FS#'-WLKE
ML_6K[_4?ZONM$/8"HF$T\\3"_"BJ>(;ZW,9X5+%B*(:YMC&>&;&9H#2%$<NT
M0B*G6$<^SE8?):;F<K5L (T1EHZ,&6!O!WAIB-<1VE5=YD9>0W?$P(PV2!]X
M\]PU((8DOUYZC,J(UR!U2)-7M76%D_:':;1.-;]XJ(EYFW6JV6_C6*=)FL#(
M7J-&.,'0K$4CF&4R9RS'7$1>J5Q<A$Z-&VM/HZWTSM'8ZOUKS\-'IR[P<-P"
M CN*]W8EIOU\.$>0@CMRE^2.[\TY(G'2I7-]UWO7OSH^6.K/ZMEFPEL\_'51
MK,O?EDOYO9C/WR_G\VJA^N'IF14K2X4SJI72# NS>DREW3O+(<L8@G&D&4%9
MC E/'(\$?&5/C:GJ<S+C,NPL -:$?RM!8P3860'V9CAOGGOWS<7#AB$1'YC"
M)@>V\S'&D*"/=,81&GR?,Y"^\'4>D'@W.-;I25]+6T<KO9OPOP7V694V]9!M
M97M1*68L58IJ*%"B("(H-Y,$H69Z3FB",<EBYG2O\V3K4R/_EH(];GL=@W>>
MNZ^&9&!V_JR^%>5V ?UI52Q73>W(L%>\.B&X]FK7<<.C7>GJM*E]E:O[H;Y7
MN/CZPZ)<KZK9HTH<;R1\-B*J?&+2])ZPT\J#FF59G@F=8<@S1B%*,PT9(KE9
MHAI?CW'!F<Z]BC0ZBY[:D*_*INY5OP&-\K9LJMJFR)-@;X#O52+G/I$D1I+H
M'.8:V;M<.(*,4@%5(I),,1IEF/G>Y1JB5T:J?%;C7C2]L;*9"I^'[P6WK8)A
MD!V8S\-]ZCTN>_GB%?;&E[/TD:]]^:)R?/?+NX7>IT2U,_!^N7J[W/"UWLRW
M&ZOEC,5,14(IR'3*(8I9"JFR26I3G4224:DCK^L5YX1-;?YH]'H1<;L- K$'
M=&"[IP-^^6RK-Y=L_JOW84\W\LZ'.D'P')B?0D+9Y\SF(D:!SV:ZY8U]!G/1
M\A-G+9??Z9M::%'E1OM[L7Z\VY3KY9-:&1JK<J<9>^[YO'BHD^2:_Y:ZL-<V
M/JW,4F6Y*>OUR8QE.!$\QS 6C$'$\@B2F"BH1*:27&9Q3KU*.UZOTM18J[$(
M?#<F@<:F&]"R"NS- CN[C#\&&LNVJT'?E$=7]ZX;YXW;9P,SXQC=U2,54RB$
MP^9NNEJKD9,]A4+Q.#M4L):]3Z#LW16; V6Y8#:#>2LSP<XA_9W]*)XV3S.!
M,8[R!$&F: J13&+(\BR&4B)*<I*8/SJ%$GE)G1H?O]#\(/?&3G>P5=[Y^,.C
M%RZ>,@V#[= KWM>&U?D\:1AX1SI)^OJHP%.M'9 O('^1%.G_ _PG6)MGQ?+I
MF2U^ D-%0!D6JFY+JZ?G^?*G4B7@U45J\T)9)[CZ2Y C)W^$.P^;/)H:ZYC)
MW[K6 5./EWOZ]JQ\M/_?5G[_QN8V"LMN@J\*6[#1_N%V(5_^HO5D/2=]6!A5
MS0?R5M7_:_X]W]@R7.]^B$?S42J[^?&NB@6?\9CJ/$8YS+2D$&'C+5#*8Y@P
M'7&:JUACLPY8KMG<<1TPJOI><]3.B &=4&//39V2O&66O>#26%S_T28#//S=
MBQ>VIT@-%."7!HQ?[9;D%@_0 %)M3H(:$L^UQKA?F^.Z9++?T-!KF E_/OYK
MGU?IQ:#KI'$M&'=-]2J]<[3^>ATMKBLE<+=\XL6B\A?W^0>^JA_K-P;@?\PD
M4T3&/(59)&*(:*PA2\UB#5/,1*P3D3"G$K=^8J>V6MOEPF^IW4JM ?ZTFH-*
M]9Z5!2YT@]M4$Q[<@:>((+CV+C3@!M,0U08N2'Z5D@-N:'35'7!\NV]&I8ZX
MZ1E642243* MN T1IPGD.I8PEB33+-59QC._1$H=DJ;&2&=O ?AF3>I"UXUU
M@F V,-'T@ZM'9J0+4(1-B-0E;.0\2!=L/DY_=.F%P/<?FOQ*QH=22I9W;+7Z
M:1ZJ?C<C,9%)BC,H\R0U#**881 >0:TI2S$BBC&GP+BKM)@:NW1$BK<#Q?<I
MQK8&@<:B^M>!0O;/]MW%/>QQ>F1@[OH7Z8Q -RE"=<KKWJD(TCGA[E>X@-KS
MIL79IJ=QY\+%>N?;%TZ-]:Q)JA;%<O5QN7BP:;6J+($S)C..L$BAH#9W'[*'
MI:GYC\@X)32E.8V\,H6>D#&UR:=6$52ZW=CKKF*S6CE? CL'IIL_>R5$ \\&
MWNCX5P;MMC]H%= 38L:M^-EMYU%USS./7EE?08C51LF/!>,VO52A;)V?ZK)P
MZU>S/,*1(MKXIRGB$$E"(4TT@5(Q)##+(Y0ZI;KK)7UJ_'!8DV!K!&BI#(P9
MH+XNW_IMS[(%3CUTT14=%O>ACW*F"'G/4A*AH7^=6A,!NJ!_50H?"!W+5C@U
M^3IU+7RL[2Q\X=6(]Y2R#]O8^:=+W;BLM:=J#YS:RS6,E*1"(:B3.(>(FCF:
M:,Q@Q-(T5YSF,G8*F>XE?6I32BLVK+5<,ZNZW2JN,:/OPKI'#UV<4H;%?> I
M99*0.T\IPT(_TI02O@M\II3^$'9.*3V:'&M*Z6]M:TJYHI&>X7M5S,&'Q5\7
M*\7FMJS<;ZQ8V*M9]XO_5/)!R0]K]?1AL5.G^F4\2Y,T8XI*LT#A"B(1<<B(
MP##/!,^2.&5QXG4LUU./J4TSM1GVCL;>$& MV69?M2&PM3G VF,?; W,ZB^>
M 7$]^\]MHV2$7AEZ73-@A_B'F%T'9]!8L9ZJC!OT=1U>1]%;5S;7^YIUM8_\
MWIA7-?AA\4V5=MOYUB:VK%>ZF8HCG>H$ILH&8<DL@DSIU+ KYE&<2ITKKTH'
M+D*GQIV-SL!^"/70L]&?6[W!7G'OR]:7\7>CP]"H#NV 7PUHGRO7S@@%OGI]
M6>[85["=D3AQ%=O]7>^MA/O-NERSA8TY_;)>BG]\5L_FBWMDI;K=K!^7J^*?
MU:KDEI?57<,9CEA.)1%0D<1P$V<:<A3E,)8\42+%,G5+!>$O>FH,]7DYG^OE
MZCM;2;N(^O+(5@KL;; YJ!]6S/W6F6]/7-PO&!#?@;FJI3FH5&_C^D)Y\&>C
M?IC:33TQZURB^K8WUOJTIYVMQ6G?%OKY37]7Q</C6LG;;VIEUL-_;&P"W7M=
M#;JRI<H;5A9B1C72)$44:FQ6H4AD,21IGL(HXQPE.A8Y$3X.E)?TJ?'4'VH-
M%%O9&C;EC;U[60CPBUG9E)7VGL&C?OW@YD@-AN[ +-7H#;:*@UKSW610@I;R
M-Z!2/YQSU0NUD%Z6GP*CNEN]L#GTN_HU$JX47CO9UUM5BE51E3R8"8TD1RR#
M0F8I1-3\Q/.(02US0J4BPKACU];!ZY ]-6K[V%63[47B.]"RX/H*>%W=XL9U
M X$],-,%Q#E(X;L+B U=]:Y+_*N7O+N BTN]NTM-]..W>LE:567YL+C5VH@R
M[9=?-KPL9,%6]H"\+)>B^NWM0OZO9;%8_\T\OC&ZS#2.LT0+"3."#>.A.(><
M2N/3:<D4I3+#PFL_["IMIL:!E7+@6ZT=>&:K]<)(?2R>R^JFM?J?C>E5\*2,
M3V[31>TL]V/"ZSK0C1M'ZY:!V;)EASU!L+UP*[]5.;S62[ W[ :T3;L!>^-N
MJI?JGFT,#,>H07 .R;'7*30JZP;![I"'PS3:EYD/;Z!WQR[=-]>XVF%Y!.-$
MRHQ!E$H$$4LH)(H3F(B((BRCB"BOW+#7*C0U?CZ1QL*RPJEX/K:+Y]L9YA]<
M&:QC74E[O.X:G+<'[ZD>7!T&WK!T?:5.(S-V& 2/23M0N_UXNTHLLA%F"C#-
MFG^HU3=U5U\-F1%;SR53">2,2(ARA2#)= X)U0SG69P0I?T*#9R1YC. QZDL
M\$)9L-7V!MSUN59T#F9,#9Z*9C#+A-V(R21D6B<01X0R3#B)M%-1M< @CQ+9
M%!I+M\DF$$(#SR,]OS_ON<$!C9"T?T[<J(SN8/<A6;N\TM-_WE7ENM<M/WY&
M:,S3F%$8)8)"%$49Y"F.;9YRG.,,\3C'7F[Q:3E3(X;:*5H_L@7XJIZ>ERN;
M)'2O>Y7FWZYO/_3>B.C V]%;O1[%H8^^ P+H[VV>AR>H$]DA:ES?\+R]1R[?
MA<?[,<B[;5[<+[;FA=TEVM8TSHW[D#/!8!8S8A;6F$"F4@(CXUSDN>*9\>E\
M&*1#SM08I%$3[/3L63BZ"]=8)UQ%E,,(80%1&E-(-#&X1BJ)D,@ICKB?=QP
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MY]&PEO+&/ZFTOP%)%">>/'1==SD2U6B=,#2358; RI*CI?\-L 94I=7:5MV
M_S(.*[A?!,Q@$P;0H)1XG4;C<F80](Y(-4RK?8,2OZG%QJP"D0$D02F&FE(-
M41X9ZL08P83*5!EF3;G;!NEAPU-CPD8OWT"X+4QNO-7'^($9Z*+=/8+97AH9
M-G)MV_;(86HO+3J.23OX>\\J FLS$]LU<;5_>*^K9 RW/XIR1E-!N9(2I@(S
MB#)*()/&IR%9+!.>:H:)5WQJIZ2IC<IZR]M>PZ]RA_QI=?0\P>Q&U6W,!L%J
MX$'L!Y-_78%+$ 2M+M I;-P: Y=L/JHT</&%GJRP.W)XJU;%-S/G?U,?%G9[
MIMH^VU>:C!!*M64%CE(*D3(DP5-J,SLAH1CBF@BO5"FN@J?&&;LS-3,>]IJ#
MENK;0W[0N_:G<Y\X4LP 2(]U<!D$9']&\D0L*$&YRAZ7KSP1.:(OW_=[7U)=
M/JFO[,=VV?)&+90NUK,TRV0J&8<":P41EL;#T2*!2$LJ(L2PBKRV:3KD3(VK
M/JV6WXK2;KEL#YML><LU^]'CBNA)6-WX)P!8 ]/-MO"G41%L=02_;+4,6 3T
M @Z!;UZ>%#7VA<IS]IZX)WGV\2L9096?6"'M:85,\RAGW(S^S&8)H4)!@K,,
MXHQ'),^XEM+W(OJ!B*GQP(?6R+\!"[4].-6V DE/)MC#Z4D"O4 :;?RK$ECU
M I_X=!L_R*#?2WF=\7YD9>=0/WXRQ.6ZE[N9[YHHBJ8@PBS3$=8X2V"$D2$
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MYNN)SR$1]FVF'R^>#$F\74A[W?1%]=RW12GFRW*S4KOBJA)K07*2P"R7B;W
MI"!!0D*69(@I3:3V\]^NT&5J?-D1N&M]NZTUK6+28&^/2ZG6X/WH1J C]<[
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MEO:0]ZKNCBEURF8#;9W7,E/ 7ERW1((K\;,_ U+.AQ$B(3;3N8- Y'R6< Z
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M:/>'__3E<\WX7]=M8SZ*/BS3/J[$Z^[?HZM>,@1Q*1B@LBK-$L@67<LY!I1
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MZ*<S445K9F\6[X^/R=R/.M(KDRN8SG]\&GEDQS@5*_^JQ#2*CF0J)C3?,U%
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MIF'2?:KL\[>$2K((#%6FRP[U<X!$?#"XJUP2V<5@!511/_]$+98.44Q5Y-2
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M,;+FTW0XF2ZS0&ZGV>-V&2<_3;/?KQ*N\3;A<J4"P>G$*&?$9B[PV(5(O+=
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MKR_>PC<83:X*6U;+\(P%'I4G5O$R#)0Z$CC@CF!"1N6H-=MD&3SSAIX3R;O
M0&<,[+E(Y?3Z\GKDBS^ZG&RT'(6$Q^[*.UUH1Q!19<,%T4DD(H, XB&APE?"
M,!69-+*SBK5M".I[?,&1*QX[EU'CF%OM3(/[!(_C3!A-)2C, CH/:/+CKO2!
M*28YVZ9XNQ/4]6G!U(' #OC:0QX]GVXGG\_.3^+\E^MQ6MIW M5Q3BRA[!EJ
M9.:*1K8EJ0Q0&0.C\'"VWZ8C[>%CM\/#/T7E]<%<[1<1R*#I-;YPZ,-P-)S_
M^&4RO;><+Y,W\!GFU],QI"^37R??8#J^9R1D-.FR(LIXW%G.>!(L&&*C QM"
M4IF_#)_#:.@O/_,PL4_ZD$'/ZF?9</&3'R>X',8%SY1SGC.F2%">H9G) 8U#
MX 20DXF+:+5XH<7-Y@=O!XM_BJ+,#CC;%"Y^G4S2'\/1"/GTH(BO="4<3N]@
MWT4$?LR29!9+.K23Q($S)&0N6 +(^6&OS)?1L_WK^U,]AXK[2>14XGT#@;][
M^Q"7M]B*M]OO_7 ,[^9P.1M$U-7,<TM089=AT#0B2V,F-@N/>EQ86V=H][8$
M;H>Z?ZJ2RBJR:P&3]S?6Z5<_O8#90"?&K(F*9+0<B!2X'F2=(L)FS@0(EWF5
M[/+-Y#31?*MCT3_$U^%R: !-G^$;C*\+W1$)HS:47C"IY$5D5,K"$R<91>V<
M: Z51FLN"6AB9D==Q.S%ZP8P<CJ9S3_F%?6#P+SU(COB#-!B,^#I':@ES@L&
MS&HPM,Y@\[M4]-LAX"AHV9_K34!FO&AV^+?A_.OI]6P^N83IC:\Z",Y"8D82
M5C@B?0GI4["H(Q.EP"T(5>6L>I:J?BMZCP2IKJ32 ,1.+B?3^6IPX,?\=D7$
MN1_!['1R>3F<S? 7)8Y+C58\H<T($C>.=:7G,A#\D2S!#P^Z2M> [<CKM]SS
M.'92]W)J 7V+_D"GU]/"YT$*,5N5$ 2JS#B0*1 7:2!<&_1<G,,%U#.^UU3T
M6_!R/)M[+ZXW )D/,"\E]9^F97X&I#<_?I^5CE,?U\5A)R63>3@?HH'H(' %
M3A%6G%^9@R,6MP%1TF6;K8Y454EBVY[$?@L/C@*V2O+J-VSZ":9E:,%D;5@N
M3()AN)Y#*MD;Z)Y2210MJ>P9F>6<+TGMD 3N,0K^Y;#Z,R_H-Y^[*F8ZY&P#
MFNH<1J-2Y !CA'H)ZYZDR^%X6/J7+RZVE_6K@V A6Q\\LL=99!3B/Y1SVPJK
MF04=&:W3.VXK\OK-N3V*AJH@IP;0]V3!]( ESW2YM;1)H9K%+TFP-B%$E%<V
M)B5E%3/K28IZSITZSC'8B3@:P-62^"_^^XK^-[AM\G ^")IE[W(@WLK20SD&
M$B!%8AQ+F2LOK=AFS,">?5D>T=-S'LQ1,-6%*!I %)J&2'7I'3*@&;T1(3AR
MPWDBO=2H8UTDU!6O5C&%9WX-$-V2T'/RPE%PLR?#]X?*9.Y'73E_MYUF!HD&
MA8HS$VU+J$UJ1CRZK(3)8 -/S"13Y;+E'A4]WPD?RX?;D^T-J)=U*T[T+,Z_
M(D_?^-DP#D*RQF23"3?E\DAH27QBG#!%O3,RZQQ$#>QLI&8[#+WNJ/GA8F@0
M2V^'HX5G2J-W-'"D&R2J49HH\2%I8KW5N"@O$U0QJ9^@9SL\O>Z >!>B: !1
M3X3'WHV_P>Q!>"Q'L-990Z0+I3T";I.@0G$9#(L)O':F2E^![4G<#G>O.WA>
M26#M0O$FK>QNI!8I3UDX8FPN=1=E!&N9Y<"HE5$+A5Y&E<DPVY.X'13_*4/K
MAPJL 2@NBWX^YK/O\6N9V/39S^'CN"P6>5G^*;TGO_E1*98>)*N3BE002A?S
M@+,D+NM(+/!$M3' 795KGEV(W Z.KS-J7UUH#0!R>64ZH#)FY5&9@R@%'Q*_
M<A[WDK4 F:H87:PSQG;Q^NU ]+J#\7LPN@%XK--_4-6NK]59DLZ!="1GAH>_
M]I;X"&@!6"%EMBJK6"7![S$IV^6$ON[P^H$"Z/<V^<-D',LUYV1Q#_5NC ]%
M6_(W^,<_/+HXL.RS/  IE!9E*0$*>U(@P7@@+&A.I6(LAI?OE;=ZU7: >9VQ
M\RKL;D #G<\G\>]?)R.4S6RU I="I%P"28M<,!=1?0JT^:*E2N60J-]JO.?N
M%\N/2-D.4*\[J'Z@ !J T!T=BDS:L)X$(>CH*;%,HE.K8R >J"3(M22"4#[I
M*H,^7B)L.WB][A!\I\)I &RG_FHX]Z/A/R"M\ZE+JO[=-->!1OHULXHDQ\LX
MRFP)>@W%AXW1!I-+ ^8J">XOT[8=Y%YWQ+YK$36 NG7>]"JY[.:?.+D8EW6R
M@>,0T#+TA$?&2R/:0)P.'%5X\4HE" -5/+P7*=L.<:\[IM^M>!K V\T*2MEV
MZ:0,TSR97I8V71_#:'BQW$39!@E  XD<4KF$3\@MFXC7!I4YRU&G*@&LK:C;
M#G>O.Z;?O9@:P-ZF,J6-"SO'OV=Y6$+'GZ;P;3BYGBW;+0V"]""X#<1HBP:L
MX@*]9X^,Y2S1'*VF!JH<P >3OAUJ7W?X_\@";@#2ZQ89M_7BRX243)6@H<1W
M2H]+8TKSGU(-S)2R%KC5NLKM^V9RMH/>ZP[U=R"(!N!T2_W'_'!F_=GW.+I.
M)2U\M=2!5,(QDR/Q7I>0-'KS+LM(N/$^!J4AJ"K*<"<JMP/?Z[XBJ">VYC!9
M<@H6':'1^&"<A3+:3)>*%P\:=Y5&OXLQKZ@PDJHJF;%/T+-=YX#7?:?0A2CZ
M']G\R?\H9"^9 ^GDZFHZN9H._1Q2^/'[G\__C&;$!<IO=EJR")@;N&2XY!R1
M($+I&"T5<>C*(T ,1)Z0<^E!9N03 YUW??-VF'JUUP[5A=%2@]/[?1670<O%
M',<[/QH8:J(H([2S!4^D $4L+=>]7(1D= Q =^V NLU[M\/9Z[R-J"^(5]>O
M<!"4,3E[3D#FTBT/#[G -1YV+CG!!.X@GUZ&V>XOW@YGK_-:X@BBZ'L:0;D2
M7HXVOCGZ?_/?AY?7EQ__&.,KO@ZO5L7*_@(&TB%8@L2EF%)S9:TF-J+>!J9Q
M30JD?YCNL7% P4XO;:+95PF734;#6%1+F"T"$@/#0N;&1L)\* T'E2?!0"81
M!9ZU#HJR1X.6*O.\,S3]V\^/N(U;Z>^+7RU^4_[79\@_E7]___SNWO,18W$R
MO?ISG%PNGWYV\OG#NP^_GG\Z^WS^%U3<]\F=#2^O1B\D=3QZPL^WI#PD<O6@
M1S#8D2SX/@?<].E/W193W,"'&Q6-=V66<Z3%P);$.T4)0DAKAY:0V&JVP\'5
M%&N"NJX:^8(,?(,?^/M V]*T6AM".2_M\:DF3F=+6%196&2!MD>I&[FAJ-^.
MDYT@XJ5"D?VX_TKTQZ+AZ^QP+;)Z3@U=LHG$VAH%CQWTH[(D1I3I-]YIXKVQ
M) '/02 .;)V1G+4TRFTGX(UE=6B#K<JA%LR^13RX4E47H-"+AGXPB820@$3\
M4EMIF4E5-.N>]#:JC79!TZ,TL2-(KH$PYIU6U6@BIK*DX3<XAW@]7;B<RS@M
MI%^0ZZ>3RZOK^:JSW=/:VF:I<F:&>"[=<D0PJII$F+3&T$@EKU/MW?U2^K7;
M*\.Z%WF_DM.Y9+*,XW T7#QXDA=;_B$'YI.5!GA4X0IS/QQU<+AW0T8-VZ "
M@VJ;%@%H-)P!T2Z4L;],D."2(1G_Q&2M,W6:#'9M6J#_O>SQ<+.RY*B76C"B
M&*4EMR\3%XTC*?OD:5+:BY<O NX_L]$#?1<9WHE7',"O!H[H^TT]2CF,TU*0
M$J$ATH CSN-?,9L4C U@!*\!XSUZJ70-CP,E^6ROE%W8NC<FOL$T3 X/>2[V
MQ&T0+R#J&61.A!>92)H]"5XEHM .\(Q3S]G+8?/[SVS4\-ES^Q_ KP:V_]]@
M>/$5#]$31(^_@ _794SLQ[Q<U,?K^6SNQR618MFGQ6OT.)*FQ"LEB62FM-"G
M@@BIN9+!"UMG7,%.5/:F/@Y!PN188FD <Z@8IXN!YWY4FI9/QBO&S9<M7A<>
M[V3M#$-:W9:?3*>EG'R9?"%R5DZC5Y!"$,4K0-5L<QF-7D8<!88[N4H$XW#2
M^U%^W:+SR +LO<GS\IRX+/=<-_R+>*#;H#W) .@FBR30+S5X6FB?C= Q,O.R
M6;SYV?W.8^GZ?.R ?PWHK,U]RY)"S>HE)4SH0&2*DC@9&<DJ!*^U=,B98WA]
M_9Y[74AXJS9QN["[0<RL>Y/IP*WF21*>0YG.H7 C:621CR)1RL'Q.E-4#FD3
M5^-$.@)N]F%Y \BYYSV>?//#T?),79VV=\I^UPN,7@#W#DW F'+Q55G)=.8$
M!).)16:5JZ*)=J:TW\E0G1YNQY%6 W!\PAM9K>:14S*0("!Z2(2&B,8=8YZX
MC)X)\UPI;[)B=?(9=J2SWWE15:!84U*OY';ETV2.3QWZ45QLO]EBS>/)?#A>
MWCT-RU9=WSQ-<EJR!E;2N"KI95W>LG1+3HW;EHH,JWWK@BZL9Q*]2!?*Y:"A
ME 2!:I4F(9UQODPZ>PVW+C?)E(?=FBX-J0&/7( #]*C1JL%-[1P)5C&T?3B5
M-,F0:)TI?5U0W^C=T"Y(>]3,[NA2;515?_CXX?3CAR^?/[Y_CPKHW8<O9Y_/
MSK]\^OW+^>YZ]IEG=:$DMR7U1L/]W#E/]CZ"7GYD70[5. J>;-CV":V9FUWJ
M>+)&"4MT%J+L4HZN8TC$R" ][I:8I'R>=UN]YU U_]MP/$$E\&/][$62UX 6
M*K.)1 0C2W->CSYJ"@2L5+S88BE5N5S92$UOP:2.I?Q0%Q_.^A[]L03#P7NX
M\*,S/%'F/TZ^#V<#G[04DCM2*@&)Y$D17\9X)NZ%XZ"=@PTFT&P-FQG$/U],
MOOV,CT92F2M?D/+%':!L>&V_IW0'0IQTP]&>P;"D^NVD-*P94.6MMQ(=Q?*7
M#.!*W*PT]<"U<PMRXRSYG9%P]YW]P.!@H4TZX& #89F'V^#]32V?EI3+C,Z\
MY668'#A!RGT>X5QZP872.5;Q )ZDJ-^4C^[T1;>L;]1,+W;<Y]]/O^ '/_QZ
M\N'MQR]_.?M\_NGL]-W)^]._G'S^]6P/>WV;AW9AENY,?$<QBL^(@NEUG*-W
M-[XX&:?/,"KU_+?#%VX3K#45B6E+A,QE?JUE)#BM28B*"F6RDZQ*!OO6%![>
M[NZ%%[T=SN)H,KN^E^?M4N)21J(U+"8! +': .I>)M#6 ^5=E:ZR^Q#;K_53
M!VF/F^%5%N+K57[W6.-7C13.KR ._>CTJY]>(',6+O"^97@5:#B2:CV(-4?7
MQ"*79HZQS'+& UO&8N_Y[$A.SD5E.$VNBL=]-$U\6X_SQ"M+K?UL:0[)S(U@
M&HK)'(HYE(EC@9.(QK1++F2;JES:[4#C:]&[N^#JZ1*J;D76H[\RF\Y+E\K9
M9#1,"VDM+.6%VZ8$9TS'2'+0Z'$)'HAGBA&=@%IG) 6^S;AH?,,=P.%W#\'V
M- G]8JJ:M">=LKXY\*P<=L5"HDH ":5,4984"DLM?JMLB-0'BNY\/?CT&0/I
M2K#/XF0/+C<0%GES/4-O?#8[B?]U/9P-%Y(H?&%)<&-H*986EDB=%?K[3)!L
M42&#D8'Y*A[&$_3T&Q*IK7BZ%$:CF"I?3@%6FT1*'H+-AD3-&)'H7!%O:":6
M,^%]1(:I;4ZR3M!UC[)^#[A.Y+\%IO871@/HNK<%%\,URC:<P?0;+)BELXR)
M R6"ZC(WEI;$U2R)MS8Q,('[**O[*8_IZK=.X5@:K$OA-("U+_BY!RQ;;1J'
MV\Y:3TG@)>\P!;0;/&[)Q"E0B. 9JW)I\"1%#;E[A\I]4D,(#:#IWA(^C?Q2
MN8,++H#+1)C2^,^CFG<Q.K1 8_ V"$BBOKY:4]-OPGDO6FHO0;2(IM6FL#DX
M[74F&HV#$L>V),3LB1-4&LF%4E#_;N"6GH;TTGZ2?@D[>["] ?0L:S#.41*P
M'$41_8VY*2A2&T0DU-GB$UM:]#1#FU-%RUT.-%6Y<WN&IGZK#XZEE[H22KOX
M6FV6I+-@V0,>UZ6+9&1XA$?\*D2!WP2A=!1'1%@+FJHSV6^'J3T$T0"J%C=D
M)?]["E]A/!M^@W4MV1UNT>2DRUX39=ABJB>ZLEIJ8B4HEX07+E1I7+D-<5MA
MK-I@N&/IL<[%] J@M]I0P+27PAEB31:X*EFR"$K0QGKNLZ,ARBIGYW;D]:OB
MNH?%CKC;0T8-(.\9W_K]32:=,:!Q(9PHI5"1:Z:)+\9M9!RM7:.L"/6M_B>(
MVPIUU>8*-A#ZVD],#4#O"=ZMEO7FQS(T4Q9[)ZTI04Z)1>(T<T2"\;C/(!&1
MO 21("E3);:_!ZT-^::= &:[[(C.I/=ZD]+VKA;;X=E'2B*K64J\?1(/*^-+
MG"BC:10>I& 5L2(Q0E4&ZC-''Z.*S=UD<EAFT5(C/*$9?;82H<8]JTM3:&2)
M0K<JB&-JP-><'+8+K@Y)#MM%9 V<RT]=% ?0*69FB0!;FK!J9)=#&]>: !)M
M:=3>5=(2#\G::")=;"?Y;YFUL8LP&L74_40!D;U'E\D3DV*9Y)DI<1G!(&T2
MD2FC0_#_?];&?O+?.6MC%V'T/1;N6YFM_AN4]CH#86*2@E(2#5>EFY-%NHT@
MFG+)F;!"9?N\#?;PD>U)_P!)33I@6P/*Y+EHM@_2>X8^A=&%"TY+$O D)Y2'
M$'TN39NJJ)%#KY>:2"\\Y*#J2BCMXFN]XZ3*T:.^%89S(E7 '><D.LV1I5QZ
M^7)US O,%@ZISF2_T_72+H)H %4WRU@K]7.X6'1@7F8-I&!9F2MM2O6S]%03
MRYTFJ'RS 7 ^0Z[BUCU'U>M)*SQ$<W4GF!90MJ1]M45R%#)9GDBD21.9>1DB
M'#G1 BU&RZS2J<HLG'M4].RH=2?=A[C9F]5-F,QOI]<7;^$;C"9791DK4Q",
M9."L)DPZ*)."#?& ;D;.J&"9!= /"S&?MJ WOJ%G-.POLT?&\^$,[!<'^/]/
M)].KMT-_,49-.HRSU1+0>PRR--<3R>"F $F)=XP2+:G@*F<5'P9Z-F#@J:?W
M; UW(?].&-? 6?%27C7CRDN+YVF. 7U+:] MI.@EFI#PK#76<5&EIV<7Q0Y-
MI!$?8I5T*9Q>!UF]G&D?O? RQD1<+ -0=/2EJM$0*G0RH(*EKLJHLU=:[K"3
MY+<N=]A%" WHKK/+J]'D!\ YE/[:MZ$L;D/R(98:-H].81*6>)6!@$%WD5/!
M@JQR/?8$/?TBJ2-I/YSLT 'K&T#0+[[,-9W_.!U-T#&X6"TBYN UJ$P""[HT
MC)#$)]Q<.7-GF'$6<I5+KHW4]&LKU4'/X6QOXC3;*K_&.VND$(PDD\J.8)GX
MDFFMHN R 5A59Q1M9WES310]5+*B]A-3 XIK4[[5( 65E2KMR*E11(IR'QA\
MJ3]*FGFG'*TSR6@3,<V:3WN*_#E,[</_UC"T:@<V".BQ\F %B7JQ$$O+E%U#
MDLU!>&84DU5BT)N(Z??H.RZ&]N%_W[.)-VV"<YC/1Y#^-IQ_/?6SKR>KIG,G
MZ3^O9_,2=AE(YAAJ<T^,SZ6MKS3$LNR(M9&B%2%%Y"_?S^_UZGZO,JKAZ2B2
MV!UK;HFU,5R4L_Q+%]'*#S#?N&F !2]2&;;K1!GHK1P)0@JBG43C(&<='@8/
M-@T:V/SP?B---4'3!3<;.,9N7-"%N<@&)<3N?0B$RL(-)5"#(LR)"EQRX6C*
M6W4AV^.^ZQX=_=K6U0^O0[C> &B6JG V@_F[RRL_G!9]N,8_>K69)Y^)#M(6
M/Q2(TUX0(61P,02MZHQ5?X:F?JLZJX.I*VDT *SU#?/9]^%\M36T]/C'%J8D
MBKXK2\11M/"<9L%YQ02C5:Y0'I/2;YU<=1@=R/M^;V(?153?P!CR<#Y;!4,V
MF7@G,4ZO_>B.26=2 L; $.U#(N46FBPZK['(@M%)"[U%\FLGI&R%-?OJL-:+
MI)HPON\MZU9/#W)4#%A,Q.:,"P%41(%)3R)$;HP.$?0+-6]//WPK$+G7"*(N
MN-FOPOI]?#T#-.N6H?SIW?5,ETR:#=")!$,=)QPTK@;U+7%)9Q(R9=Z$C,>W
M>!$;6[QHNV@C?8U Z9K-_>N2YV*HI]?3Z6(;A,BDSH(8%U@IRY/$.5Q@<A22
M4,I%5G\6P'V:ML/8/U=(>Q]QM'<UMUI,F66X6@]$(4 ;34(PR"?O<#T, K$T
M"V:Y8$X>[:;DEJSM$/9/$O ^3"@=@JQB;P#\YNSS7P^>SW7SF,XK_C<3>/ 4
MW8WOZ*8EPL.G56/)T=H>K#V$=44Z 'B/9B QPJ"N#1PM0$\S45Z#B=H"KU,%
M\AQ1QVQN0#FG2214*2+$THM.$,NL)9'2C*N75-7I]/ ZFQL<@IY#^AGL(J4F
M+(+G:T!B2,J#\H0)ZXF4 H^=+#3)$IRCQGD3ZUP:'%QZU41W@YW0L%/IU2Z"
M:2#\>[^V@"O'%?.69"[*Y"FOB!=2$26UB8)IQJBK@JK74GJUDW2?+;W:A=6-
MEMQDFR!P9 9E)A/IE"8.;"!9*;#,:)<>.B5=E]P<J>1J)UEM47*S"^,:+KLS
M&6(V"D]MX0'_,H!*- @BE'; % /TNU^4_\%E=T<JN]H3 YTQL(&SXKF*><VT
M4(PCAJDP1-+$B/]_V7NW)CER'%WPKZSM.V9XOYB=%Y6DZI&M2M*HU'/V[$L:
M+Z 4TZD,G8C,ZJ[Y]0M&7I27R SW"&<XH^>TS525I*IT$/@( B3P03@#6AL6
M3> LA29)P#\%A<4AT<A41ND77[?C!#*GO:8<+2&DROM(2A*E@)0L*,$C^90F
M33(G2F$QRO:C*"S&&*(#5.WJ3#,1/26<#(2D+:=XJ"$=,K J18<L*R.:D.],
MT3#:!8W%(=YK2N-T@+7GNX^"0-1"9U)2K>M0;L-ZQNO NESY8(IIX[U.M%UT
ME-T'MXN.,4(':'JN9]%8IQ7C"KQ(&I3($D)]X=*:>>4=!J::7#B>6+OH*&L/
M;!<=H_HN;A&W=R[ZF(N,18&)S(#*NG)HNT![S$1A>+;"-[GG.:F&T4/P<[C:
M._ _@]Y7G;(B18,@-U.^9+#@+2]0T'J=A$M/+H$Z:Q?M@G2C40RUGYGZ+]/R
MVJ&K=#6Y"%)7,@)"2A$L5XJ+H)"KW25\DY5IS5K?,,JPXZJTQFBY-W=UHZ<S
MGD@+22-8YF(=Y<S!^^*!*UF\R4:'T.2DVR;,";2'[H.FR?2_-X9^X&JQS+]?
MAM5EPT;C*%/.W$+F2H!"\M,NQ0PQY*SI%"^1]]5H/&]CZ&1(VD?_\YY@VS;"
M[N96+DK)KE(B&>U!^6(H+A014K*I,%J@>$R&<-0VXWD[1O<\Y=I;XM#JY'8G
M7U+12$O:BH)7SYM-9:=!B%HFENI((VQ_KSGFY)NWMW3RDV^,_@\\^=Y>M,/1
M;46UYMR$*"R@#76:<YT0'3,MQXB2M2HJV"X+W.=M,IT:5?M8H]/0_%XA=0@I
M%ID#<%,";15?Z%0W!CAIR1B3K8OJ6-@:6=T^;_/IU/#:TR:=(NP,/9-!2$;9
MAJ4$-F@-(5A:"--1H4EUK'U71^"\[:63'X%C]+\_AI:7X;R/9N:H)!><PL5:
M)0@J9@9>Q @4!PA?QSMXO9O6Y7C-S//VH>X9TA_?4IT.]?S+QX]O_N>[]^]?
M?7CS[L.75Q_^\NZ7]V]?_?[[VR][M.^\],.FZ%@9+.Q$#2M_62[SWQ?GYP2\
M=R3OQ==%/,<-8<?ZS6*=SI?KJ]7/'@2=2DS994#-<WW5,^ ]2\"E+5YQ^I]L
M,AUGE)0357I_QA_+U65]A[A=??%6QN@3H-3DI96@,)+G DPGKB-+*L<FI^1S
M LU[Z=X..<_4@Q]FD--S3IL'KSVZZG;_R,:.:IO@L[BK[%/A7ELH&0D?.D2(
M+COP3@E#X186UZ3WY[CNZN[U]/:S/T=R&_3:Q,JFZRA@4$[6D%)QT$YHK2Q7
M++=I4WE>IE-R6F/P\WS+W6%FZ2!E_+F4QSHC-=ZMKF[ZGTO,UH2<LP GL%9P
M1(H@C2/]I4")#D<7?!-JK#UDG?>U<0Y$MC'CZ9VPK[^1&G"]N'@=5JL_:V3Q
M?7EU<;F\V[)[=[9/\='&I_1^BY_E'/=%9<&5 Q&JOT0?P4>C0*"RTFAGLVAR
MI3[W.;ZI>$+AF:B,XUFS4M-_#L%F16K@&KU($ANQGFZ7YY3.[S&X&7!^CS9'
M!V?WKXN+Q26^7_R!3Q3VRY^_A?]<KEZ?A_5USVXQT5K/$)QR=+AD(\%Y=&"U
ME<GD*()L@K01,O;2.'\ )AX7P#8R4-_8^[FP#^'[[;1SC<9'43+(S5UCH']R
M7GL(P45E*6A&;'*_,E+.>3'8#"_#<7FP\3K YI=5R%C%OVTUSRQ6;GP/R28&
M*@D-09O:2%.44SRKXIN,AGHL2+?H.MSJC]N/#C'!O(5K/P^"34G4SHWH;+":
M-B$E:Z(.]?,*G+4()@>')OC@\N[WKI$?[:6K^_"CLK'"3P9*MW-M'8H@<@;/
M:]5=9A)"$K4#D!>E=2$UYBG!-.>IU]KT>R%L#SMT<.*]OEI?+K_C:O/\2V9;
M?UO\N/6\7@KCK2@@C*&EA,@AHO+@>!*%M.>+;5*R_8),IX"W?8"P;&.5>9W8
MIW!9F9_>+Q)>K+'>)W[!].UB>;[\^N?MY'0NHLHU S<&:3$F@!-* ==*\*)1
M1F]V>JW=WYGGU#L:;*;7=0>>J1;3+;__P$M\]76%&R:-VRV H1@25T BY->)
M10("6@O>1\-<2>AE:N&8GA=IGHZ2H_NEB6S2 ;J>I!F)66.-MA!3JFJIU<#6
M:2AH=/3:4(#:9B#Y/IG>Y-TD1T?20?KO #]_7>/GQ==O=_"/EB=30TO,FPR&
M13J5$P>=/=(ZK&5MAD@]DF.>3I&CH^<0[7< GNM3NCZN/?:B@EDZHYD JVSM
MG7(&G*1$F+9&W09&NM"DZ^A9B>9I$CDZH*:QR(S06J\NSUY3HK \7^2->395
MPIO4%Y551M4[N,1\'>909[AK"5Z15Z78+S,UY&2C+]S#$_WJ,9:>%Z$7,J[#
M+YTF4G-W0+G90M[GXF+=.(5<J#+<T"$L$@0?=4Z!FU"&9/Q[0F7.*Z6I#/LB
M3O;0<@>GU0Y*9UF$C25!*I$6P^LZ1#)@L_:.)QFC9BU.K,.9U(_ 7#/=@_!T
M1NB"5^LA.; IRKF4!&B4CDYN6HAS,0 =Y[RR!EOK&XWP/17>]#'V?9$W?8RJ
MYYXW_RP!./J@-")"$C[3(FJ]8W8.)%,)71 L/\[53Y0Y?92U!C"GCU%<Q\SI
M,7*.*#B47+D!6*Q#H[R'[(HI//)@^.ZWKE-A3M\3 Y,I<.98]7.M1]TX0>V*
MC3D@67+#*T(Z\!HCL&(T!E4"PR&\G8."T[NOSDN],77JLI\R>T# #7!U3-[9
M;,%1)EX7GH$":0'DMYQF#+/"R7+9>]^=+R?9TV*/;;Z'^CK(/&Y!__ZNZ]E+
M4Y"A 5_)V%6NXW*U+N",4=$R'TQJPMW[1))YR5-:9!B'*;L#M+SZ7AM!_VMC
MA*?=+&<^9*.24,!3IMC'F4(Q--? C>4\<!;=8]++::#SLEA]%,[O:?-E,P-T
M *<[AH0-SRP_\S8F5B^"&<\;S@--OC-'L"(HP:P4-K6YZ'@H1Q]]:=, YA 5
M=W&-\1CC?UDMU^NW_TCG5WEQ\?5666=1BJ3H@*U#WNGH%EJ"2X6\=$)O>,A)
M8!."A&'BS7L[/RVB&ABD U=T)S<B3W2$5ZU85TD\-=">89 #5P*+P-"F\&44
M5)K=JTX+E;V4V@W'[EW<1_YS?5TD^.HB?[I:I6]A71E[:M=F?<^\(^U9GT6;
M94DE0\B^3E^P"F*0MG(+ITBZTXV:&?:0==ZTNPW06IFJ)P?E3"584182,Q84
M+Y).<,/!2>.LTJ:HT"3('N6@FJ5EC1S4&*5V0H7Z0L<0 ?[J^]6&;.Q^PG 6
M,$>CG8<<N:T%8)2[9IXAN5BR"Z(XT22U'R_JO,R6TX*LL:$Z\$V/E_4!+Y\&
MA,$IKZ0.I+- F0?/"#Y3EIHR\SFDJ*UI4G<U1+AYJ2_;QN<'&Z,#@-W*_>[[
MC[!874]\7*_/)"6SR9#8.8I,R6PMB"[65*X!;CP:SD.3@N+MXLS+:-GF8#Q
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M9UXT'6[F';C90^<SE^O@Q6*YNEA>XCI?H6!*W[ZY%LD4:@'1U $\)BB(M!K
M; PJX:36]N7(ZH6?WA<*]C':<EH-=N ^;L=Y;9JVUHN-,3;;(P>GG9$@E:S'
MMN(04'AP9&>+P7A26@O_\8P\)U,9>,AQ-(4M.H74=4O@[9XS.FO*?!5Y7$-[
MCA7:?=&2SEB4G*<<O1DRQG,2<#V0;%X/-8G]!V!J?V-T,7/MQM$JP3E&9L @
M_45I1BN0G@&YV>@L:N[X[J/JP8_LS_H'6.K)I+4]U-:!,QE3^!\XUTE&"W$S
M93W)#"YG RXJ(S$P;)2X3]W<T\-KX2'G6"N;]0W'K?TAA@53B;= VDH5;%*
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M&0>\KZIG1<KYMS/Z[U\O5S_>+,+7B^7Z<I%N(S<NC/(Y6#!8)QK+'"%ZQNI
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M[== 1Y"U0D;K0M%')^?;+7:W#Q@3PVL$@=_$MCXY9/\O#*LO?U^>H6*!"T6
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M(&SM=%,I,0R98Y/'WWTNW)L%NY-#YQ M=P"2EP_3Y)+QCDF@8Q2K8B3E=\Y
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M2I$<37:6?N?$_,K;4C!=WAV+](W/=&Q2ZK"\2(OSQ<9,])NOEQ>7=$)3]K'
M]9G1261A.: 6IN;@E3G<4$INM++.BGJQVJ29;0]A^_5#8]#TI-.MM=DZJ)>I
MY1%I^?6B%DC06FZN,M=G>$W_%@!S+8"PLK8=&P:Y)$1RWJKD)M5AS\@S;V-0
M*X!-H?Q^,72GM4]X$<XO:7.\NLCO+NB[N+ZD[&&U&5/L<]Y0PB'3MO;E10@^
M)0@Z2^^-M9$UN5<X0.9YNW".C,7)C=AI3%;IE-Y]^>WMAR^_;\B5/GQY]^$O
M;S^\?K=/FO?2#YLB2ALL[$3A&J7VWQ=WG50/SKLM*%3!T[FI')@L90W])?BB
M,G!/8$P$"-[FY7.4E%/0)^_\V,^L)8N@*6EQP%AEOE3>@3.TBL)Y"IH7K;!)
MM= X,><-X]JA;!O7<B/CG9Y[VSL%'? S&SN[EBGJ.#0FC2$[%T''4ND%BH)0
MC 5MG,X1O7.N2;_]47U>O<Y]\(EK'@<;(BL!1:V5UK0]<IW>'D@!=/)+6GE1
MLDFBNEV<4_)A8U#SV(=-8(P94X?UZO(>1\)UC^1O>/EM2;'E'WA=??ST=Q$_
MA.^X8;"AG#HDIA3X5%\NHA 0L"3PTJM0I_A9/R3((#GN 8Y^]1ALAPHZ+QRG
M ,ER!HO-C,SGUG'+=12YC#H($+'4UU8"3#1>@90Q>6V=C&P(Y?(@[+TLRCSH
M.BX4EDWLTL&UR7-\@FB#< *Q,DDCJ)(*1!T5H!".*Z6<9T>C7YR='F]"#S:E
MWCN%ST/J2"5(]&!<G>U-VTR8#-Y*7K>93CRJ;)0Z%I!.@,=SE/U'\WB.,<;<
ML^K^"!<)?\/O$5=G/'EIDJ.=QC&35@*M@%M&6N'H@O R/LYLMLZBN_<C^[/^
M 99:3J"VF:.=SX%\ZV8'1,\]8^1&DZ[YB. :/)+X(9IL!08?\Q"',2BPN?OJ
MO-?I$T?(^^FR!P#<X);"),N4V?3QU'X$H>J\:@=<TIY Y@<2!PZ'P)P^X0"+
M/;;Y'NJ;T>H9%V?O\6LX?TO(O_QSLWR;"R9+@7/1+%7:*8*\]QR2"C;6*6%%
M^:>67]^:?HWI7[XN__A7^M$D*O?U'Z#^PSVC;_GLO)1?$^[^0U4Z,QJNI;XY
M 46)+*?,(>1(<OM,J5G! ED:8[(Q4N@M/,JCH7#_F_,X@(.-MIQ @QWD$D_V
MP?L[XMSLBV).>?*%E$JKY&W-VI$"F5R2#4&(-@TOSXLT+Y];@X1T(NUW^O3T
MZ>V'W]]]_/#JPYM/'W__\OGMEW>?W];7G$_O7WW8XVW]Y1\WR4RFX0)/]-94
M6T5Q,][\7G_U^NZ9 &U2$6T!FY*H3YV42_@H@?R(R\7$:'03*L^7Q3IXL-V
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MN&MGHGXH+K>$ [M)]>\%##_;W7UB*C"$HE3E4RL(CML"6F(Q"9U5;2913;6
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M4XPQ$.<L^9BB\5O1\?MSAW&0^E;6M"_)-1"3W53'?W5_I7EAHI3%2RXR,F'
MJ#+#%H,+L%2C/T<41AN!:LFKI#C\3LHP]J,27'J2> .861O34GN''\]P%YXO
MRC#(25R-B-\R&#(*P155KI10%2Z= )N]!X:1+<$E0[BI<L!X*.'#NCS'.- ^
MJFH'=I!NO<=/^?]+L^F;Z?75='+SU<48_;_B8HZ<UDHZ7)5.&>1'QH@KW:![
M25RD426A9(>1)EU>-6RO@MK.4N_";O02^/6W\[./[\[/7[WY7]_.SL_*O>CY
M[G>\&Y_2QQ7N=O)ZNJ%]?3W'F&P^?S/]X=%P+!O9W8$H"&-=Z:!H'4$C01,8
M2SP$;PT&\9$D6L7^/T?4H9OBAF??F<=[28F6RA!<!$.4!V'0-!KI#3"$MK"X
MW\?')Y/56-] WK 'F+UAYO&N5D$W)V1^UMR_"O_[>CP?+\6ZO%=8_=F/>=KZ
MEEKF:S?V#C1OI8'T*LENFC>]V?^Z]Z^[?&?K;&("]TIJ2BDM(@NA'(!Z[D/D
M'H,'O=6+V./%_66&;GKEZ_NOO+FIDL'JP%@&&R4R&H4%9Y*!F+@5P>)BM55B
MQUT)'>P@HC9ZGDX)K:#!!F+1#5PM[]LYCS)J#,D3BP%$V3.L1]QD*:0E3'KG
MJW2W>(*>@5.AJH+@B<WV$(TT"JSR<9;6V1>$.V)X9D Y+=V_J01C H:ZCD<C
MN1*&5<EYV4I9&U[<0?KO@*G]E=$ NIYHY[T4E+96*%/JR;E&5J11X!45$ 6W
M-&F9>:ARY?<,30-?Y!S3?/6EF79!=C?&@.F(X0T)O(P+%1I,CFQYL",5$]2'
M*L41SU(UK.GJ3??=,+6'(AI U2T;;TKCY4_Y?(&Q\U)$0B$72E.(!-4N1 XE
M"4,5;DQ(06LKJN3Q/4G1P.?UQS1;_6BE 7C=IW^U0+3QD4@9P09;[A0H*_&/
M!24DT493="6J^/*_DS*P&]^/CA]?^1PF\ 8@LV%Y?;CKZ2+* !1-0$>.HN$F
MH-OI&1I;JCR-683'>2[5O/1;H@:^ZADX&MQ/-VWB[/-L^K[<D=V[*KM7T\B1
M?A41'03]!N%L*@WT2@<@RW3@'$D\UAG$<W0V%R[N"9#MR.M-6PV \7ZM]VSV
M:SRY6.8JSE]-XKOY8ORC9*K>9C"B?7]81/*X CPZZD40'%3,%H3F%KSU* 'D
MG$;/;:QSEM$K%\-&J=6 /)RFFX+Y]LWJED=%O LB*@B>>1 )_[!4XX:%O 5E
MI8EU\HOV(7:P'+>6;R+VTN0)7<F^30LWONSIYG7]L%H7K!N)/4::B,J6,.H<
MPBLD$*STQ1:(MJ"53<)&&H=*$QGFTGX\67Q/KRXN9LLZE%XQU/UUQ[S&[\#P
M,7"HN:,Q,8UBI';5\9\B;!"$*1&NN+95#N1KIBOM' 2:3))S7( E5*,'XR-X
MAXYRB)EF]">RYY6;/;5\L]\[C@Z^Q]]%7P/Z>?/9XNY<ZSRDB9N-I\LS+2=M
MZ3-/0*)80)@<P00=(7!CB-=.9-6ED0F^X![8\%^/@?8D!2=V9[^3PJ=]2G]H
M^*SH_C:97Z6PG 2Y.L=TZ#W&;!P8[2((SSE8#/$A)LLD=2HHU^5"HAN$GJ)B
M&!CUI-EIWV)N(*1\/YZ,%^G#^&<9F;MPDXN2?WXSY^?UKS_=?TUGRR/QI;#0
M!679Q&5'<(8F.Z&UCDP"6NMLLB<&@Y,:N]X.-)[8W?P^9JJVYMH&Y1UC]UJ_
M1!F3*<UM!548&Q&/L5%,$JC-BE-)E+3ZR,#<1.>P>V@UO'3'Y<'*:P";;Z[G
MB^F/-/N2+F\\VN_CJ_F?Z8=/LY$U/F \KH"Q($!HE)B5B8$63CO";'*J3HO-
MIVEJ%G.'8^'QU6U/BFD 8U]GR'41RYK^&%+B-%(PR9>!RHJ#L\Z#\U$PHJE-
MNDHF^6-"AMU>CXFF@U30 (2^S=.7\<7WQ9I\9F5@"2/M0-'=$$QY,"IF"([+
M'"QSFE=)1WI$Q[!)2,<$T"$*:  _3R4NT\B]2]P!%2F6804<C- !<N""6F<L
M555&M1Q22M!.4MLA_GX?&FD46 ^SUY7!149<Z5JDE^/8$UB#H A,X?^RU,E6
MZ5-\HJ4$.^E_YU*"790Q= N#GVX2TMKCLX9;PA*HG$J!!:XTYRD!+:4Q(>?$
M'GM,&UL5W'MD>]H_0%/3'L0VK+H_+;ZGF5N)8+W)HINOHY<9? X9_7P4A,F2
M0*+!>>^LDDQNU?JF)S>73=./\@\6XK 8>#?Y.;Z8KL@F.5/</AF0+-#!XI:"
MRYH Q_".Y\BM<MO;G-Y_XK"^136=[RVT@6\VOI01DC>']DIE6]QRNNP0%4KU
M"2<>2- D,B5Y)KU=AMV^]<32E/>] -M/RBU 8QVG$ZVHB!'C+%$F(%M59NT%
M-&'$4H81F ]= I3NX!C2.SA 8X]UOH?X!M;ZGQC-_[C^L2*<:D-T0&LH0HFO
M$RGMY*4 EJ3*D5*A.O6&[:3W!V\>6//[Z&W:AQ"'UK[[ZQ[AVBA&+2I*Z]+\
M/PJ)05!F$(GAT6<1A.ER ]1-^_??/(QCV)OV]Q9B R<)MS?ZZRWQ/%TLD[R7
MQI (@QN@C1 %0RB+0,!;:< I24ET3FA;9TSA<U1U0HL\:2>B?^VT +4;VM?'
MPDY:+Q6%Y"V:2A,U6,L=),GP/VZ4C77&5=^GHI'JR\.U^Q@W>XNZB>.GM[/K
MB[?I9[J<7A4VUL<JRAO"C0 BDP%!,[*12 +-F$Q)D?Q;\=O3IU$;WS P&O;7
MV6\'48<+<%@<X.^_F<ZNWH[=Q60Z7XS#[04BU93I7$8NEZ.UB.O!&QX@*T>9
MD\3IQS<G&S#PU-,'SGOJ0_^]"*Z!O>+9TC>KT9\F+J!/E4I["S2/)D@&4B*:
M'5*3Q+&J8&^)ZH0=]2*<DMYTTP#._IA.X[_&EY>K4\$'[=E'OAP'9F.!L3*:
M(R@&1ID$CG*2A:*1U\F(>XZHYBY0]E3]M)(>&L#4IB6XKA/_@IORY#J-+/$D
M!H_FW97I0E99,%Q*D!@@.B*S(S0?R80]IJVY6YI^$-:W5AH VHKL^<@XYESR
M'&PL+?(3"L=IGB$IZ8A"5\&)*FA:$]#<)4\_D-E+O@W@XK/[=5.G/UV9T[6$
MTOQC6I2B__GWM:$=!9^$E\&7F2,*!52R\:0S@*96<<YD(+Y*GX9=B!SVVJ@:
MOJKIJ0$,WF0)7F[*$ERS1$?.9IECYB510H!PG(+5- .:8$FI$\&:*HY\%^*&
M/66LAKG>]=( UM;.XTA'$I.U!"R/O*2'BG+ P2$%9I.)+%M6!4]K H8- JL[
MYSO)MP%</.?RH8&]Z:'Y83J?CV1(.0H; </B7.[M(IA<FI(EEUF2W ?"CNV.
M/Z"P$[+TR2&KCH8:@-[:ECZ3+/^?J62VI_CJ9YJYB_1MGO+UY8=Q3B/GC47!
M&? E:U!PKL!XPT$&;:QR4AI7)7?W$*([ =2<'$"/IL<&,+NAT\2;Z:3,:BL-
M0DOS%%3B2J6S<F^^=%[??"\?SR:O?DRO)\5IW?PK'\;.CR_'BU]TE)!MZJG!
M0,K(DBZGP;HHP6=B@N&>A:1J&MO*_'5:"?;D5D*+Z&A@T7RZ6K(PN;BW5P7/
M'4F" ^5EEB>7 ;PR"A(K">$./]<I\=] 2[?C8G)R:#Q4[ T@I\-L\*!XRAPW
M$"=U F&<*S%_:5R&@N(Y2%VG8K6G4>WT].XA>E;*L+?H7Z<+=^GN1!3NF]PR
MC'5>.G1/"LMI$?ZCA'?215K*%7($H9(&1R@%GS05EG.MXJ-LKPV7ZSN^M!N0
M3N>ZH;+8&[!;&QP!7##3B\GXO]$YCBCT<1Z[WTZ57DWB>I<?ISE^[_I'BLL3
MSDE\AS_RTUT6AV&DB)'69 TAN5+BZR18E="4!TM9EK[V#*0Z;'6#^>E=D30$
MAI>V-*YG1;,W/WFW(\U'7%K'RDAC%J-'-R<0<,F@3)@Q6B@N**\Z?J F<]V6
MR>G=]#0'C)>\6);UF"/'E-?H^H/1W)1+,PW&X:XJB/">V(2^6I5>'779ZK9
M3N]:JB$PO+"E<3;YB3\_G?T:&6)<C%E"8-*!$)R#-SH#45XYJK5WINHE1Z_<
M=%L(IW?7-KSJ7QC^'UB#S[-TY<;QW5]7:3)/^/-+\W#SO9%#9@4C9?8 *_/@
MO0 ?K82L=?(4]:EUEXKH=G:,Y[CMMGY.]T:Q7>B\L/7U>3:]2K/%K\^7#D5U
M$[XMBTY&E%$;HRD#=#,*184 QE,!V0M!HM&4I2K]W8_"7;?U<WH7GNU!XX6M
ME[<K%KZZOU;&(T:JK VY#$,,*(Q,P9#2,T@JRPT1)JOF(Y7?N.JV/E[$->A
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M3^+*$AA\&HHK2ZL@(G5(CZ_B0SY'U+ S+D\'FSVIM0&(WH[_-,0Y)VD 76:
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M[M"'4'"HY7_XTD]W+_T\F^;QHK2/>(\F<$7B_.L#(KZB]%_CT_XYDME&IHP
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M0A&B9(>MJS^*AFWZ57>C&TAO#=B[6YY6;<I>ITG*X\7(ELI38W%W]U&#T"*
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MH]9R%R3]%B;TKZ9V-\#[S(YX#C);D4#1,E)1XNYN+4;_5* 13X0:GZJT'NE
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M .HZC1624;F2! :6X7(5V6<PSBG@,EA!I$LA=*GHZ&4KW6L*F#TY ]>[7DX
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M5!%V ]M5AP.6U8$QE9HFJ3(0'C$@X8* =6A 8\K>64<%HW7:IW:EL!OR3O3
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MVE/^]0_05]\H?W@D^/_YO_Y_4$L! A0#%     @ O$Y=48'_O(W.!P  AB@
M  \              ( !     &5X,S$Q<3,R,#(P+FAT;5!+ 0(4 Q0    (
M +Q.75$PQQ6DR@<  "XH   /              "  ?L'  !E>#,Q,G$S,C R
M,"YH=&U02P$"% ,4    " "\3EU1+NJ(<J8%  "C(@  #@
M@ 'R#P  97@S,G$S,C R,"YH=&U02P$"% ,4    " "\3EU1?*%)4@G- @"4
M;2( #P              @ '$%0  ;&@M,C R,# Y,S N:'1M4$L! A0#%
M  @ O$Y=4=RU'-U,&0  $P<!  \              ( !^N(" &QH+3(P,C P
M.3,P+GAS9%!+ 0(4 Q0    ( +Q.75%Y.;M4BQP  #H@ 0 3
M  "  7/\ @!L:"TR,#(P,#DS,%]C86PN>&UL4$L! A0#%     @ O$Y=4:A-
MMR%TLP  _LT' !,              ( !+QD# &QH+3(P,C P.3,P7V1E9BYX
M;6Q02P$"% ,4    " "\3EU1H1U@X(HA 0"OX0L $P              @ '4
MS , ;&@M,C R,# Y,S!?;&%B+GAM;%!+ 0(4 Q0    ( +Q.75$?$.W( ^(
M ,<?"@ 3              "  8_N! !L:"TR,#(P,#DS,%]P<F4N>&UL4$L%
3!@     )  D - (  ,/0!0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
